"company_uuid","company_permalink","funding_type","series","announced_on","money_raised_usd"
"35f04970a5c31f5e3f0db8693c5ce0fe","redlink-2",NA,NA,NA,NA
"01fb5dd2a8075db996ca51125586256c","art-data-institute",NA,NA,NA,NA
"5fd09f047c76c0ec89d5e0442549496a","algo-rhythm",NA,NA,NA,NA
"2dbc6e0635e4050e18531cd7ad2f01e4","once",NA,NA,NA,NA
"cc2a3b0b2e9b9c72a036dc8ad08b8eb2","bratpackstyle-llc","seed",NA,"2015-06-01",NA
"12310c337e9bd0b6fb49a28dbfef842f","077football-news-media-limited",NA,NA,NA,NA
"e4c742590b8ca9874798fea1fd18c3e2","1000-likes-com",NA,NA,NA,NA
"b78ede2d76c1d86e26e488709affd838","100plus","venture",NA,"2011-11-02",5e+05
"b78ede2d76c1d86e26e488709affd838","100plus","seed",NA,"2011-11-30",750000
"a5809eccb6a08793b1a25edc092ee2e1","101-holidays",NA,NA,NA,NA
"52dc204d8f66e9ff9e1890a450cce899","10fold-solutions",NA,NA,NA,NA
"863994caa47542f73f005c669df4ec02","10k-wizard",NA,NA,NA,NA
"cf3b00cfffbf0e4f6427a60e5060de39","10x-genomics","venture","B","2015-01-12",5.5e+07
"ae200f1a0753ccb9fbd2b7ca95cd294e","10x-technologies","debt_financing",NA,"2012-11-07",3e+06
"ae200f1a0753ccb9fbd2b7ca95cd294e","10x-technologies","venture","1","2015-01-12",550000
"304dce05c26c1f80c95a7ae7fae3ad68","11ants-analytics",NA,NA,NA,NA
"3c0db51a46faf88fab6c815519189ca7","1234enter","venture",NA,"2013-11-22",150267
"3c0db51a46faf88fab6c815519189ca7","1234enter","seed",NA,"2012-09-01",5e+05
"c83491aaadeec5a059328385497ca38b","140-proof","venture","b","2011-04-28",2500000
"c83491aaadeec5a059328385497ca38b","140-proof","venture","a","2009-07-01",3e+06
"8c72dc147ba9c54cef9abd3f1dbfe7e8","17e-technologies",NA,NA,NA,NA
"5ac72a7fb3cab45882b4420ee441826d","1datapoint-diagnostics",NA,NA,NA,NA
"28af18e33818bff47aa87cbd0faa82fb","1degreebio",NA,NA,NA,NA
"da183f46e064945db727b2bbafcfbfd7","1world-online","venture","a","2013-12-01",5e+05
"da183f46e064945db727b2bbafcfbfd7","1world-online","venture","a","2013-07-02",1e+06
"da183f46e064945db727b2bbafcfbfd7","1world-online","venture","A","2015-08-13",2500000
"a42a8311c5f3f083ac3e1c85f805d9a1","2-minute-medicine",NA,NA,NA,NA
"0dc705d6b6bb87ed836e72a5777c0a93","2-pro-media-group","undisclosed",NA,"2014-01-01",41250
"f335a63669f52752be8e20dee701a665","20-20-insights",NA,NA,NA,NA
"7e456d6244d8a0ddd5cf6ef315af80a8","20-20-gene-systems-inc","venture","A","2016-01-14",4500000
"7e456d6244d8a0ddd5cf6ef315af80a8","20-20-gene-systems-inc","venture",NA,"2015-08-28",2158413
"7e456d6244d8a0ddd5cf6ef315af80a8","20-20-gene-systems-inc","venture",NA,"2012-09-25",150000
"e3522e90b72e5c6b35ea5b7f24feeb35","22-barcelona",NA,NA,NA,NA
"879f5bee5780e20f77e4f8cfc7567832","22nd-century-group","venture","a","2012-11-16",2428500
"879f5bee5780e20f77e4f8cfc7567832","22nd-century-group","venture",NA,"2010-12-28",1e+05
"879f5bee5780e20f77e4f8cfc7567832","22nd-century-group","debt_financing",NA,"2012-08-23",530000
"879f5bee5780e20f77e4f8cfc7567832","22nd-century-group","debt_financing",NA,"2011-12-28",1926250
"879f5bee5780e20f77e4f8cfc7567832","22nd-century-group","venture",NA,"2014-09-18",1e+07
"879f5bee5780e20f77e4f8cfc7567832","22nd-century-group","debt_financing",NA,"2014-09-18",50000
"65cbde85c8f2c2f274f81582a2f0d477","2338-technologies",NA,NA,NA,NA
"f93d65c711daf0850bddd54510f77a41","23andme","post_ipo_equity",NA,"2005-11-02",1e+05
"f93d65c711daf0850bddd54510f77a41","23andme","venture","1","2011-01-07",9e+06
"f93d65c711daf0850bddd54510f77a41","23andme","venture","1","2007-10-03",9e+06
"f93d65c711daf0850bddd54510f77a41","23andme","venture","1","2010-11-09",2.2e+07
"f93d65c711daf0850bddd54510f77a41","23andme","venture","1","2009-06-18",12600000
"f93d65c711daf0850bddd54510f77a41","23andme","venture","1","2012-12-21",57949900
"f93d65c711daf0850bddd54510f77a41","23andme","grant",NA,"2014-07-29",1400000
"f93d65c711daf0850bddd54510f77a41","23andme","venture","1","2015-07-03",1.15e+08
"22ad4add01e42ca6e8054f9474afa155","24h00","seed",NA,"2006-08-01",NA
"51d02eec75524d761aa56f3266e28744","25trends",NA,NA,NA,NA
"b62060b953111034a7286d0f24ca6353","2adpro-media-solutions","venture","a","2008-03-31",NA
"960b160588e647e62893b45d142e4203","2findlocal-com-database",NA,NA,NA,NA
"4fc5edc256c7605319f5b7dd6da7ea52","2mares",NA,NA,NA,NA
"62af89d6e7ea892d2514203a10c8f61e","2thinknow",NA,NA,NA,NA
"58e612732716eee5f6726e0370c829b7","3-kinds-of-ice","seed",NA,"2015-01-10",NA
"a19f1ddc9ea771dd275b6f71f62f6eaf","3-v-biosciences","venture","A","2007-05-22",7610000
"a19f1ddc9ea771dd275b6f71f62f6eaf","3-v-biosciences","venture","b","2009-07-10",3e+07
"a19f1ddc9ea771dd275b6f71f62f6eaf","3-v-biosciences","venture",NA,"2012-10-01",8089000
"a19f1ddc9ea771dd275b6f71f62f6eaf","3-v-biosciences","venture","c","2013-06-21",2e+07
"a19f1ddc9ea771dd275b6f71f62f6eaf","3-v-biosciences","venture",NA,"2012-01-05",2e+07
"a19f1ddc9ea771dd275b6f71f62f6eaf","3-v-biosciences","venture","D","2014-12-30",28500000
"a19f1ddc9ea771dd275b6f71f62f6eaf","3-v-biosciences","venture",NA,"2015-03-17",14278567
"e5f2fcdc029f85b92a3b8ce712bbd715","30-digits-gmbh",NA,NA,NA,NA
"9e7645e60a5b089171235dac9c53d1fe","31hex",NA,NA,NA,NA
"95f91af2780f39d5c2c2fc78b8f54d63","32-digital",NA,NA,NA,NA
"0224b436e323571ecb0ce1a7c4573f55","33across","seed",NA,"2009-03-13",750000
"0224b436e323571ecb0ce1a7c4573f55","33across","venture","1","2012-07-19",13100000
"0224b436e323571ecb0ce1a7c4573f55","33across","venture","1","2011-01-05",9e+06
"0224b436e323571ecb0ce1a7c4573f55","33across","venture",NA,"2009-02-06",1520000
"0224b436e323571ecb0ce1a7c4573f55","33across","venture","1","2010-04-22",1284560
"0e81bc57194db638e0c8b58e0f1d290c","36-labs-llc",NA,NA,NA,NA
"fb77c177e885e8c3cc9795aefc31a0e7","360-thinking",NA,NA,NA,NA
"6900f282e87e5b8ef2300130b3dd5f25","360guanxi","venture",NA,"2009-06-01",5e+06
"8ededb53bd71ce12bc9385e0c7c61b71","360imaging","venture","A","2013-01-01",5e+05
"8ededb53bd71ce12bc9385e0c7c61b71","360imaging","venture","A","2011-11-01",5e+05
"760029366523c4cb4f0252b4c93be72a","365-media",NA,NA,NA,NA
"02f44c49453024b3879694551b5ed9a8","3ality-digital",NA,NA,NA,NA
"3cd81f93bfedda6704328c67eeb0e52b","3blades",NA,NA,NA,NA
"4d4c92262e65590f05719dba00a9d702","3ci","grant",NA,"2011-01-01",133620
"aa2a4fb986d22b2c920383ae6fbc9d18","3c-interactive","debt_financing",NA,"2011-03-01",6e+06
"52bd7a269c0f604058498006c0b9e8c3","3claps-the-fastest-baby-fashion","seed",NA,"2015-10-01",NA
"52bd7a269c0f604058498006c0b9e8c3","3claps-the-fastest-baby-fashion","seed",NA,"2015-07-01",NA
"52bd7a269c0f604058498006c0b9e8c3","3claps-the-fastest-baby-fashion","seed",NA,"2015-12-01",NA
"1fe65457b4782fb20d09b2b27e0e20e0","3d-biomatrix","seed",NA,"2013-02-05",1465000
"1fe65457b4782fb20d09b2b27e0e20e0","3d-biomatrix","venture",NA,"2009-10-05",NA
"01fe586930459665bf460fd1af531c09","3d-rilbits",NA,NA,NA,NA
"8650b719cb123b713fd5fd5075b3fe93","3dr-laboratories","venture",NA,"2012-08-23",7200000
"8650b719cb123b713fd5fd5075b3fe93","3dr-laboratories","debt_financing",NA,"2009-05-29",236500
"69a9f2f2cd84695378a745ef1af4aea8","3factorindexing",NA,NA,NA,NA
"d2853fe2ab36f9b7f8a950216d74e10b","3i-infotech",NA,NA,NA,NA
"6a5d16cf5096c90e12884b141854962d","3i-mind",NA,NA,NA,NA
"69f3e121a130bfad3dc2f4f8958080db","3loq-labs",NA,NA,NA,NA
"1844d47ef9a46d7a96a1d552cac271dc","3p-biopharmaceuticals","venture",NA,"2008-02-05",732000
"1844d47ef9a46d7a96a1d552cac271dc","3p-biopharmaceuticals","venture",NA,"2007-06-29",4051500
"93c4b05cf8b69a57e21acc8a3faee068","3q-digital",NA,NA,NA,NA
"b38252921a0e0efcbbcfae8236e69ec1","3radical",NA,NA,NA,NA
"8cd792f9cdf59f44344764dc0d2535d8","3sbio",NA,NA,NA,NA
"846c9f08dcaf730e78b42e998f01a0b3","3scan","grant",NA,"2012-04-23",350000
"846c9f08dcaf730e78b42e998f01a0b3","3scan","seed",NA,"2013-07-16",NA
"846c9f08dcaf730e78b42e998f01a0b3","3scan","seed",NA,"2011-08-31",40000
"846c9f08dcaf730e78b42e998f01a0b3","3scan","venture","1","2014-12-05",6673012
"42d816fe05d6f2511b60c462e9e08d45","405labs","venture",NA,"2014-10-22",81000
"7f376b865d24ec495815015ff08e347b","40nuggets",NA,NA,NA,NA
"f485fd7f5a1b82137fc0de9a33da76d4","42reports",NA,NA,NA,NA
"db06662d20e262b1d886687610293f76","451-degrees",NA,NA,NA,NA
"6c3c21f969cd38dd2962c0262346b014","480-biomedical","venture","a","2012-02-14",1.5e+07
"6c3c21f969cd38dd2962c0262346b014","480-biomedical","debt_financing",NA,"2012-10-30",5e+06
"6c3c21f969cd38dd2962c0262346b014","480-biomedical","venture",NA,"2013-04-12",17956999
"6c3c21f969cd38dd2962c0262346b014","480-biomedical","venture","C","2015-06-01",10500000
"6c3c21f969cd38dd2962c0262346b014","480-biomedical","venture","C","2015-06-19",1200000
"ec98b9555d9facf37d3eb077fb443b6a","484-group",NA,NA,NA,NA
"2ffdea0fc4a1178afe654de1dfd95a29","4c-insights","venture",NA,"2014-01-21",NA
"310235fd88ee87ddd394b71762ba2431","4d-molecular-therapeutics","venture",NA,"2015-08-13",6999995
"5ee3dbe79c739f89974e06a358f77afa","4deep","seed",NA,"2015-11-20",5e+05
"6692945ac4714d5e529af4409826aebc","4diq",NA,NA,NA,NA
"a126e1d46a80dfbe73c34dfd8e1c903d","4info","venture","d","2011-10-27",1.4e+07
"a126e1d46a80dfbe73c34dfd8e1c903d","4info","venture","d","2007-06-01",1e+07
"a126e1d46a80dfbe73c34dfd8e1c903d","4info","venture","c","2005-03-01",8e+06
"a126e1d46a80dfbe73c34dfd8e1c903d","4info","venture","E","2007-10-31",2.5e+08
"a126e1d46a80dfbe73c34dfd8e1c903d","4info","venture",NA,"2009-01-22",2e+07
"a126e1d46a80dfbe73c34dfd8e1c903d","4info","venture",NA,"2013-04-01",4288000
"a126e1d46a80dfbe73c34dfd8e1c903d","4info","venture","e","2013-08-04",8e+06
"a126e1d46a80dfbe73c34dfd8e1c903d","4info","debt_financing",NA,"2014-08-01",6e+06
"085b6df74f48a779c3a7097c8208201b","4pia-inc",NA,NA,NA,NA
"fd602df98bf2c48cedca38e0e9c2fa0b","4quant",NA,NA,NA,NA
"fbc5e49ae38382c3743a595da3105887","4tech","venture",NA,"2015-12-22",26414543
"fbc5e49ae38382c3743a595da3105887","4tech","private_equity",NA,"2011-12-21",7e+06
"0ab1237c963da36d70f2d550d4c97755","4tiitoo","venture",NA,"2015-10-01",NA
"0ab1237c963da36d70f2d550d4c97755","4tiitoo","seed",NA,"2014-08-18",NA
"0ab1237c963da36d70f2d550d4c97755","4tiitoo","angel",NA,"2013-12-10",NA
"0ab1237c963da36d70f2d550d4c97755","4tiitoo","venture","1","2011-11-15",NA
"1e5928f282146dd19ef810d0348f61bf","5-prime-ventures",NA,NA,NA,NA
"3a90bb23d02a1969f61449c6802a2fb1","500-miles","angel",NA,"2015-05-18",NA
"9c314f5f68a0eba81ef2eee8159c61ee","5000fish",NA,NA,NA,NA
"19c7fd1d0eb262839e65156cfc632e01","60east-technologies",NA,NA,NA,NA
"5a123ee08effb9b466222e65ac577dab","6th-man-apps",NA,NA,NA,NA
"fae3964cf719143928f3574c2fce957d","7-billion-people","venture",NA,"2012-07-13",2368902
"fae3964cf719143928f3574c2fce957d","7-billion-people","seed",NA,"2009-02-09",3800000
"fae3964cf719143928f3574c2fce957d","7-billion-people","debt_financing",NA,"2012-06-19",360000
"42bb4dd9e5e9f8a0f54b50ad67f8856e","7-oaks-pharmaceutical","venture",NA,"2011-06-06",1613014
"c046329f9de61659bd9830f55c348662","7-second-strategies",NA,NA,NA,NA
"ff0b305b1df8c8956e8c72b77d4ec077","71lbs","venture",NA,"2013-03-31",1e+05
"ff0b305b1df8c8956e8c72b77d4ec077","71lbs","venture",NA,"2013-01-04",150000
"ff0b305b1df8c8956e8c72b77d4ec077","71lbs","seed",NA,"2012-06-01",75000
"ff0b305b1df8c8956e8c72b77d4ec077","71lbs","angel",NA,"2012-03-20",NA
"ff0b305b1df8c8956e8c72b77d4ec077","71lbs","seed",NA,"2013-01-08",75000
"ff0b305b1df8c8956e8c72b77d4ec077","71lbs","angel",NA,"2014-06-08",2e+06
"4a99b63beb0981f39cd201483a420148","you-us-capital",NA,NA,NA,NA
"0738d50cf89f320eb79858ea1f89ae63","720","seed",NA,"2014-10-23",190035
"9019e4374d09adf10e60a15e136521ab","7park-data","venture","A","2015-08-26",3e+06
"e169629e653ceb9f1e7e6556b0905df9","7puentes",NA,NA,NA,NA
"89000d277cc2de683881e60c6741e606","7segments",NA,NA,NA,NA
"09b2f5e41191beed610dd6f4b3d0d096","7sheep",NA,NA,NA,NA
"56d0c3e2dba48c914fdaf27795048690","7tm-pharma","venture","D","2007-06-12",2.2e+07
"5b9ebe489ad200aafd7730a5662ca0b1","89-degrees",NA,NA,NA,NA
"e765a76951e709228726206ed72d41f4","8bit-2","seed",NA,"2014-02-01",30000
"e765a76951e709228726206ed72d41f4","8bit-2","seed",NA,"2014-07-01",110000
"2f378cad9cab1af893a27d668cf3e43d","8digits","seed",NA,"2012-06-01",NA
"2f378cad9cab1af893a27d668cf3e43d","8digits","venture","1","2013-11-28",NA
"00ec61bbd2984811c1b4068f28d177db","8villages","convertible_note",NA,"2013-12-01",150000
"4d73ea531f6989bb52ad83d6f0a232a1","90-degree-software",NA,NA,NA,NA
"35a0d5956e8919271c92d0aede6a25ff","904labs",NA,NA,NA,NA
"281b5a1ba00779d7faf3382360f0d05c","945signals",NA,NA,NA,NA
"fff3af3232446747c95f5954c594785e","97th-floor",NA,NA,NA,NA
"25ac973a5cdabf4e5860b31837f8909d","99jobs","seed",NA,"2013-06-01",NA
"6bc561378db5ada63dab019f9f52788e","apollotech",NA,NA,NA,NA
"1807d7a0d92e012be080d9c13fafaaf0","a-plus-id",NA,NA,NA,NA
"f8d482a7e15e9150405d8a4e7192799f","a-life-medical","venture",NA,"2009-06-03",3e+06
"315d6990c9e1a6cba5acc8d56944a9a5","a-p-pharma","venture",NA,"2011-07-11",24000001
"315d6990c9e1a6cba5acc8d56944a9a5","a-p-pharma","venture",NA,"2009-11-05",8142817
"2fad9eba683c56401597b828020197e9","a-r-i-flow-control-accessories",NA,NA,NA,NA
"580e78cb4ddb2ea94be0dceba1390a22","a-b-test-master",NA,NA,NA,NA
"0726b210bce34b79a4fc23133e4ef4f0","a-g-pharmaceutical","venture","a","2005-09-08",2e+06
"0726b210bce34b79a4fc23133e4ef4f0","a-g-pharmaceutical","venture",NA,"2010-04-27",100002
"54dc3ed4832439dedbba34c642fa3456","a3logics-india-limited",NA,NA,NA,NA
"45cf2fdf16d5a19892c95ba237890754","a4-data-technology-inc","angel",NA,"2013-05-01",NA
"45cf2fdf16d5a19892c95ba237890754","a4-data-technology-inc","debt_financing",NA,"2014-01-01",NA
"cc1d410533535777ad3497b091205897","a6-corporation",NA,NA,NA,NA
"3b100f2bec2d58eff1d64387dbdc783a","aaipharma-services","private_equity",NA,"2012-01-11",2e+07
"224a2bd586e4df87c2ecb0ceae15c109","aalto-helsinki",NA,NA,NA,NA
"97b90643e4bdffb04a07f047682e8f81","aarden-pharmaceuticals","seed",NA,"2011-01-03",5e+05
"d6bde457d6708a42b2564ae479078e1f","aarkstore",NA,NA,NA,NA
"a254ff609de91a9b237814066ca17ae5","aastrom-biosciences","venture",NA,"2012-03-09",4e+07
"29f67a20390432091061172abf05757d","ab-tasty","seed",NA,"2014-09-23",1412834
"44df7b0ec8626af3e776ab8df6a7718f","ab2-bio","venture","B","2016-01-14",20918418.1691
"af921816106a0d34dc62ec2c0117ab69","abacast-inc","venture",NA,"2010-11-11",5e+05
"565f1a0d5f3a4587e6f3a464801f52ae","abate-solutions",NA,NA,NA,NA
"4a9bae150ebb050fd50d95b101998cd9","abattis-bioceuticals","venture",NA,"2014-04-07",83709
"4a9bae150ebb050fd50d95b101998cd9","abattis-bioceuticals","venture",NA,"2010-11-03",297265
"4a9bae150ebb050fd50d95b101998cd9","abattis-bioceuticals","seed",NA,"2012-03-21",20014
"806757759ef1d3c7c1c91cf8a0f74388","abbott-labboratories",NA,NA,NA,NA
"2e1af00d10be49582cde8c7d2566b52f","abbott","debt_financing",NA,"2009-03-16",6690000
"2e1af00d10be49582cde8c7d2566b52f","abbott","debt_financing",NA,"2011-03-15",1e+05
"ee82b5db06eb97f97d6d988606a471de","abbvie",NA,NA,NA,NA
"91b0b3d99b63065ddb8b8b58cb74b7ae","abcam","venture",NA,"2011-06-08",1800000
"91b0b3d99b63065ddb8b8b58cb74b7ae","abcam","private_equity",NA,"2012-04-27",76999653
"4ca1fc7127e520ed789a378279669da2","abcelex-technologies","venture","A","2014-04-28",2e+06
"fbf4912f1ddd10b550c58e8db67915d6","abcellute","undisclosed",NA,"2007-09-21",805908
"506c80c43e50776644e9332854d2b29e","abcodia","undisclosed",NA,"2011-05-25",1622347
"506c80c43e50776644e9332854d2b29e","abcodia","venture",NA,"2014-02-26",166681
"506c80c43e50776644e9332854d2b29e","abcodia","venture",NA,"2014-11-05",159810
"506c80c43e50776644e9332854d2b29e","abcodia","venture","1","2015-05-18",8259067
"9403e67301501655f771a4021b8c5b71","abcro",NA,NA,NA,NA
"0be9c27e18c925aa639e9951ba2a71c1","abd-serotec",NA,NA,NA,NA
"5c20b9de28f864bce09cb463d7988076","abeja-inc-","angel",NA,"2013-09-25",NA
"5c20b9de28f864bce09cb463d7988076","abeja-inc-","seed",NA,"2014-07-11",NA
"5c20b9de28f864bce09cb463d7988076","abeja-inc-","venture","1","2014-12-04",NA
"aa4e648063f8760913f2dfee6c44ba71","abeona-therapeutics","seed",NA,"2013-12-16",750000
"aa4e648063f8760913f2dfee6c44ba71","abeona-therapeutics","venture",NA,"2014-12-01",3600000
"aa4e648063f8760913f2dfee6c44ba71","abeona-therapeutics","venture",NA,"2015-07-28",8500000
"8123cf641bf6e134aede7592d94b298f","abfrontier",NA,NA,NA,NA
"6a6a591f84deb2eca0a52042ef464a62","abgenomics","venture","a","2012-06-19",16850000
"6a6a591f84deb2eca0a52042ef464a62","abgenomics","venture","B","2013-07-18",9600000
"6a6a591f84deb2eca0a52042ef464a62","abgenomics","venture","C","2014-08-27",13160000
"6bf0ac6de7951d9dc0749b39a1fc2072","abi-research",NA,NA,NA,NA
"5ebcd036ba80f04a897d1e827c7b9e9a","abiba-systems",NA,NA,NA,NA
"7f51bbbd1719ca6306a9725496d95795","abide-therapeutics","seed",NA,"2011-11-18",2250180
"140ad45fb1d935479317c61e0f82f16f","abilis-solutions",NA,NA,NA,NA
"a28c7a01e63e27b5c13007d74ca86118","abiobot","seed",NA,"2015-02-03",50000
"f105d51bb97602284a01b22f1f2d4060","abionic","venture","B","2014-10-14",3986362
"75e3454ba314d158b79d037787d9c282","abiotic-technologies",NA,NA,NA,NA
"7e823b17d780c376c448ed70a15d1eed","abivax",NA,NA,NA,NA
"f2fe88848821711d6b2edb5bc670624b","abivin",NA,NA,NA,NA
"a31d4b4e74d2aeda957f2f9c38a597ed","abizinabox","seed",NA,"2008-10-08",5e+05
"6028514066f84539b42f2ed4a502beeb","ablative-solutions","venture",NA,"2015-11-12",2460000
"6028514066f84539b42f2ed4a502beeb","ablative-solutions","debt_financing",NA,"2013-03-26",8e+06
"6028514066f84539b42f2ed4a502beeb","ablative-solutions","venture","1","2014-02-04",9575077
"6028514066f84539b42f2ed4a502beeb","ablative-solutions","seed",NA,"2012-01-04",5000
"6028514066f84539b42f2ed4a502beeb","ablative-solutions","venture","1","2012-06-19",5300000
"6028514066f84539b42f2ed4a502beeb","ablative-solutions","debt_financing",NA,"2012-03-29",3050500
"6028514066f84539b42f2ed4a502beeb","ablative-solutions","venture",NA,"2015-01-12",14590000
"e85b80abd867aa0f5f6394f81c10c0bf","ablexis","venture","a","2010-06-04",1.2e+07
"5b640e48766d05331018e76c93ef418a","ablynx","post_ipo_equity",NA,"2013-02-28",41356350
"5b640e48766d05331018e76c93ef418a","ablynx","post_ipo_equity",NA,"2014-06-30",56972661
"5b640e48766d05331018e76c93ef418a","ablynx","grant",NA,"2014-08-13",2808275
"5b640e48766d05331018e76c93ef418a","ablynx","venture","1","2004-04-06",3e+07
"5b640e48766d05331018e76c93ef418a","ablynx","venture",NA,"2002-09-25",4898950
"5b640e48766d05331018e76c93ef418a","ablynx","venture","1","2006-08-23",5e+07
"db8eae08d06d23fc0a252f542dcd66f2","aboutmystar","seed",NA,"2011-09-15",275166
"55c761f90242e50d2de96586a16231d7","aboutourwork-com","seed",NA,"2014-04-20",NA
"9ed5048a19c0da35fbd58c07481d314c","aboutplace",NA,NA,NA,NA
"e4154dbf293932e39c860ab00c22644e","above-labs",NA,NA,NA,NA
"2ed313239717b28c756d8f6771710838","abpro",NA,NA,NA,NA
"f74f6beb6dce7888124b2d199ea6565b","abr-affinity-bioreagents",NA,NA,NA,NA
"1a36a6e1120a61bcefd8cb729e08b16b","abraresto","seed",NA,"2014-01-29",1500000
"a3a547b6437cf7ea1aa6201e9d652e9f","abraxis-bioscience",NA,NA,NA,NA
"6816180229a749d9895e5b5c469eb4e6","abreos-biosciences","debt_financing",NA,"2015-03-18",175000
"de3491c5a891f3d338f42548096d0970","absolutdata","venture",NA,"2012-08-23",2e+07
"098697998b2deb844e12d80ee7f316b4","absolute-software-gmbh",NA,NA,NA,NA
"98fe7634ec905913299b3ab50951774e","absorption-pharmaceuticals","venture",NA,"2014-02-14",1200000
"0b579f434b03f7daaa1a462ff54506d3","absynth-biologics","seed",NA,"2015-11-30",375838.119
"0b579f434b03f7daaa1a462ff54506d3","absynth-biologics","seed",NA,"2013-07-18",1287963
"03cfad3caee51e9433d503ddc3379cc5","abzena","post_ipo_equity",NA,"2015-11-24",30339345.5803
"03cfad3caee51e9433d503ddc3379cc5","abzena","post_ipo_equity",NA,"2014-07-07",34300806
"c24078c7d8d4820f9ca6a727abada7cd","ac-immune-sa","venture","B","2005-05-12",17270000
"c24078c7d8d4820f9ca6a727abada7cd","ac-immune-sa","venture","d","2014-01-09",22009460
"b8a37f17d93d18ba0c228bf24b7a1630","acacia-pharma","venture","b","2013-09-03",23500000
"b8a37f17d93d18ba0c228bf24b7a1630","acacia-pharma","venture","a","2011-03-31",1e+07
"f4f8e05c58153fbb6e84067546ccd442","acadia-pharmaceuticals","venture",NA,"2011-01-11",1.5e+07
"f4f8e05c58153fbb6e84067546ccd442","acadia-pharmaceuticals","private_equity",NA,"2013-01-02",86385000
"a5cd7776ffffba86d43696894e20c6c7","acambis",NA,NA,NA,NA
"3fa403060689a9a561022b0ac3958220","acambis-plc",NA,NA,NA,NA
"7cf324bba40e99f8b646292d2e8dbe1f","beijing-accb-biotech-ltd","venture","D","2011-05-01",770416
"7cf324bba40e99f8b646292d2e8dbe1f","beijing-accb-biotech-ltd","venture","B","2006-11-01",NA
"7cf324bba40e99f8b646292d2e8dbe1f","beijing-accb-biotech-ltd","venture","A","2005-12-01",NA
"2081557b965a77f0aa97023b3f6ef7c9","accelalox","debt_financing",NA,"2009-10-10",430000
"eab7cf78bb55525d02d64a338f4eb9a6","accelerated-vision-group","venture",NA,"2013-10-25",2500000
"eab7cf78bb55525d02d64a338f4eb9a6","accelerated-vision-group","venture","1","2012-05-21",6e+06
"62dfc3f3f5d078044e93ee0ee735a5f6","accelerator-capital",NA,NA,NA,NA
"f82ce7e4494dafc6a32fee0a8e84366c","accelero-bioanalytics",NA,NA,NA,NA
"0fe5e7d398d0a322328623500fa52590","acceleron-pharma","grant",NA,"2011-01-06",1500000
"0fe5e7d398d0a322328623500fa52590","acceleron-pharma","venture","1","2006-08-02",3e+07
"0fe5e7d398d0a322328623500fa52590","acceleron-pharma","venture",NA,"2009-12-15",10951121
"0fe5e7d398d0a322328623500fa52590","acceleron-pharma","venture","1","2011-12-23",3e+07
"0fe5e7d398d0a322328623500fa52590","acceleron-pharma","venture","1","2007-10-01",3.1e+07
"0fe5e7d398d0a322328623500fa52590","acceleron-pharma","venture",NA,"2010-06-10",10250006
"3450e0b8777d1333a19bf277a908e3b8","accelio-corporation",NA,NA,NA,NA
"ac77fed7056829edd27526a3e8944944","accelops","venture","a","2007-10-01",7e+06
"ac77fed7056829edd27526a3e8944944","accelops","venture","b","2012-05-01",1.8e+07
"143f1d6961581389a68360488c16b0e3","accentia-biopharmaceuticals-inc","venture",NA,"2012-02-08",4e+05
"143f1d6961581389a68360488c16b0e3","accentia-biopharmaceuticals-inc","venture",NA,"2013-06-25",375000
"3210cdf21434d83dfdaa8dd287496a96","accentix",NA,NA,NA,NA
"6bbf40107469ab6cd3ed66db9940e358","acceptys",NA,NA,NA,NA
"65e01dc62d0e0d99ac1e2b11fa4852a1","accera","venture","a","2004-09-16",6e+06
"65e01dc62d0e0d99ac1e2b11fa4852a1","accera","venture","b","2006-08-16",7500000
"65e01dc62d0e0d99ac1e2b11fa4852a1","accera","venture","d","2011-01-03",1.1e+07
"65e01dc62d0e0d99ac1e2b11fa4852a1","accera","private_equity",NA,"2013-10-25",79081610
"65e01dc62d0e0d99ac1e2b11fa4852a1","accera","venture","c","2008-11-12",3.5e+07
"ae331822c3b710e8d89b3afcb3540b4a","accern","angel",NA,"2016-01-01",NA
"9cd7cbfc731990f990287696cdc431c0","accertify","venture","a","2008-06-03",4e+06
"9cd7cbfc731990f990287696cdc431c0","accertify","venture",NA,"2010-05-04",7e+05
"9cd7cbfc731990f990287696cdc431c0","accertify","venture","b","2009-06-06",2431124
"9f5a6d7d318f1458a7147238d485ce88","prelytis",NA,NA,NA,NA
"fa89e3db08410cc02706c880575c91dd","access-marketing-company",NA,NA,NA,NA
"8dddb73ea3237af97b24c72980a2ff0b","access-pharmaceuticals","venture",NA,"2011-11-14",5581502
"8dddb73ea3237af97b24c72980a2ff0b","access-pharmaceuticals","venture","1","2012-11-06",1e+07
"d6ef188331de893f9022e60728cafb87","access-psychiatry-solutions","venture",NA,"2011-05-20",250000
"c456384255e268053c6de37c27e8844d","accessbio","venture",NA,"2011-05-25",1.2e+07
"1c6346390e5389ca1fc86f427cc2a97a","accessfuel",NA,NA,NA,NA
"d8b2f6ff71d7fbaf32be774a3c543615","accesto-internet-software-house",NA,NA,NA,NA
"afae084cdfaa472a9ff9d653372c4c4f","accion-labs",NA,NA,NA,NA
"037ea3d6b0dc64ea6a889ade5174f9d2","accipiter-systems","venture",NA,"2014-01-02",250920
"037ea3d6b0dc64ea6a889ade5174f9d2","accipiter-systems","debt_financing",NA,"2014-01-02",250920
"037ea3d6b0dc64ea6a889ade5174f9d2","accipiter-systems","venture",NA,"2013-06-05",3827799
"037ea3d6b0dc64ea6a889ade5174f9d2","accipiter-systems","debt_financing",NA,"2012-02-29",650000
"5c6dee700594be5dd4762397052af706","acclaimd","seed",NA,"2012-08-07",70000
"5c6dee700594be5dd4762397052af706","acclaimd","seed",NA,"2012-06-01",20000
"ba05fe94cd8132d84874fb4542e63e4f","acclarent","venture","C","2007-04-23",3.5e+07
"dff2e040e10a518a2042a37497ff2ec9","accompliceio","venture","A","2015-03-03",5e+06
"5467ce8b11fbd08f917882e978c15baa","accord-biomaterials","venture",NA,"2010-10-21",1200000
"dad5fb42208622ca30fc7db8349a3a1c","accordion-health","seed",NA,"2014-07-02",150000
"03c7e600c74287f5b446e7dd42fe00d2","accountagility",NA,NA,NA,NA
"20a18570511b979cbab6aacbea523e74","accu-break-pharmaceuticals","venture",NA,"2007-06-01",5650000
"20a18570511b979cbab6aacbea523e74","accu-break-pharmaceuticals","seed",NA,"2013-05-21",1e+06
"43bc9e5a694742f182e382372f150dbf","accu-time-systems",NA,NA,NA,NA
"49ba94c64d7ca516496393c08209a239","accudial-pharmaceutical","venture",NA,"2013-05-30",2476019
"49ba94c64d7ca516496393c08209a239","accudial-pharmaceutical","venture",NA,"2012-10-16",4931250
"49ba94c64d7ca516496393c08209a239","accudial-pharmaceutical","venture",NA,"2010-05-27",4617500
"32b59cfd115367795c4b77a64506ed97","accugenix",NA,NA,NA,NA
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","venture","d","2008-02-21",28800000
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","undisclosed",NA,"2003-05-16",11566
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","venture","b","2004-07-01",13500000
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","venture","c","2006-02-06",8250000
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","seed",NA,"2009-12-01",NA
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","private_equity",NA,"2013-08-30",6000001
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","venture","e","2010-01-21",16600000
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","venture",NA,"2010-09-01",7e+06
"2dc0c52d2b29cce5ad4080947f6e66f2","accumetrics","debt_financing",NA,"2013-04-11",30478899
"daf7ccd258ea1f729ce89e00b98ccc36","accuray",NA,NA,NA,NA
"35dbb1da225bf9817adc76a0f20e5480","accuri-cytometers","venture","b","2007-04-30",5e+06
"35dbb1da225bf9817adc76a0f20e5480","accuri-cytometers","venture","b","2007-09-01",1e+05
"35dbb1da225bf9817adc76a0f20e5480","accuri-cytometers","venture",NA,"2008-04-29",2e+06
"35dbb1da225bf9817adc76a0f20e5480","accuri-cytometers","venture","c","2008-07-08",1.3e+07
"35dbb1da225bf9817adc76a0f20e5480","accuri-cytometers","venture","a","2005-03-01",805000
"35dbb1da225bf9817adc76a0f20e5480","accuri-cytometers","venture",NA,"2005-09-01",1750000
"35dbb1da225bf9817adc76a0f20e5480","accuri-cytometers","venture","e","2010-10-19",6e+06
"35dbb1da225bf9817adc76a0f20e5480","accuri-cytometers","venture","d","2009-08-10",4e+06
"185f8af0d42374c857c0329f5318a02f","accutest-laboratories",NA,NA,NA,NA
"6c67291b3ee4a83790b5c7ff2217b66a","ace","seed",NA,"2011-09-26",500184
"6c67291b3ee4a83790b5c7ff2217b66a","ace","venture",NA,"2010-05-17",250000
"6c67291b3ee4a83790b5c7ff2217b66a","ace","venture",NA,"2014-06-20",494908
"3332bb86669fad682feb0890b6748a42","acea-bio","venture",NA,"2015-11-09",3e+07
"d24e5ecab2afadfb57b9fb83ae244168","acelrx-pharmaceuticals","debt_financing",NA,"2010-09-21",8000800
"d24e5ecab2afadfb57b9fb83ae244168","acelrx-pharmaceuticals","debt_financing",NA,"2011-07-13",20839994
"d24e5ecab2afadfb57b9fb83ae244168","acelrx-pharmaceuticals","private_equity",NA,"2012-06-07",10000002
"d24e5ecab2afadfb57b9fb83ae244168","acelrx-pharmaceuticals","debt_financing",NA,"2013-12-19",4e+07
"d24e5ecab2afadfb57b9fb83ae244168","acelrx-pharmaceuticals","venture",NA,"2009-11-23",14814106
"ec6935fd2a3e6e6c8dcc612ec8b1bb49","acerta-pharma","seed",NA,"2013-03-14",NA
"1f979a93c83e9184591357db29d2ca1d","acesion-pharma","undisclosed",NA,"2013-06-16",NA
"1f979a93c83e9184591357db29d2ca1d","acesion-pharma","undisclosed",NA,"2012-12-28",NA
"405cf338a2602b4d77c936ea6ddb5210","acetylon-pharmaceuticals","venture","a","2009-08-01",7250000
"405cf338a2602b4d77c936ea6ddb5210","acetylon-pharmaceuticals","private_equity",NA,"2012-02-09",1.5e+07
"405cf338a2602b4d77c936ea6ddb5210","acetylon-pharmaceuticals","private_equity",NA,"2013-07-29",1e+08
"405cf338a2602b4d77c936ea6ddb5210","acetylon-pharmaceuticals","venture","a","2010-01-08",2e+06
"405cf338a2602b4d77c936ea6ddb5210","acetylon-pharmaceuticals","venture","b","2011-02-22",12400000
"405cf338a2602b4d77c936ea6ddb5210","acetylon-pharmaceuticals","venture","b","2011-06-29",14600000
"bf21d239238600f484b627b13af0f88b","achaogen","venture","c","2010-04-07",5.6e+07
"bf21d239238600f484b627b13af0f88b","achaogen","venture","b","2006-10-10",2.6e+07
"bf21d239238600f484b627b13af0f88b","achaogen","venture","D","2013-03-22",18905707
"bf21d239238600f484b627b13af0f88b","achaogen","venture","A","2004-08-01",15700000
"253380c6e9564d98ab5121f25935cbdc","acheev-it","venture",NA,"2012-08-02",NA
"f277f3a6e0b2488fda3c0e35f0386f45","achelios-therapeutics","venture",NA,"2014-03-14",3170442
"e08a3bbf31e8ad52af9ebb42ceb8709c","achieving-health",NA,NA,NA,NA
"cd8a58a314e904b93a45ba8536c8489f","achillion-pharmaceuticals","venture",NA,"2010-08-18",50100000
"40734a10534af57d6dcdb5197d380bc2","acidophil",NA,NA,NA,NA
"75b64feca8168362a8bdd9c0496e94b3","acier-century-inc-",NA,NA,NA,NA
"2490e25da5215e825336fb949dcbd6c8","aciex-therapeutics","venture",NA,"2011-08-12",8e+06
"2490e25da5215e825336fb949dcbd6c8","aciex-therapeutics","debt_financing",NA,"2014-04-24",1599860
"2490e25da5215e825336fb949dcbd6c8","aciex-therapeutics","venture","1","2007-09-01",NA
"33f92de9f60563515adfc442758e097c","aclaris-therapeutics","venture","a","2012-10-24",2.1e+07
"33f92de9f60563515adfc442758e097c","aclaris-therapeutics","venture","B","2014-10-02",2.1e+07
"33f92de9f60563515adfc442758e097c","aclaris-therapeutics","venture","C","2015-09-09",4e+07
"4439544812314e8ecfb24ad00e421610","acmeware",NA,NA,NA,NA
"f41cb6ac2dcbbe6e009d3ea27b3867f7","acn-newswire",NA,NA,NA,NA
"41ec65851744e213c80f6c69d63535a5","acopio","seed",NA,"2012-04-01",20000
"de4843d8f411758530c1325edb00bf76","acorda-therapeutics","venture",NA,"2006-11-29",1e+07
"48ad501e670729a30d90bd52311276ff","acquis-consulting-group",NA,NA,NA,NA
"b7502f1fb4493c207f3ba3b89b4447f7","acquisio","seed",NA,"2008-09-15",1974921.63009404
"b7502f1fb4493c207f3ba3b89b4447f7","acquisio","undisclosed",NA,"2009-04-15",1813186.81318681
"b7502f1fb4493c207f3ba3b89b4447f7","acquisio","venture","1","2011-08-16",12100000
"b7502f1fb4493c207f3ba3b89b4447f7","acquisio","undisclosed",NA,"2012-08-07",5e+06
"b7502f1fb4493c207f3ba3b89b4447f7","acquisio","undisclosed",NA,"2014-01-30",2238805.97014925
"8dffb9b472ccd96ad1a0d2666fc12733","acquisition",NA,NA,NA,NA
"66a4a0f2929bce08cd733150d211373d","acrelic-interactive",NA,NA,NA,NA
"cf25e162c1af1b32ff405282463a65e6","acris-antibodies",NA,NA,NA,NA
"cabea2315f1de3ebb9d80f17b13f7912","acrobotic-industries",NA,NA,NA,NA
"666f9a571415de69e79f239957470e7b","acronym-media-inc","angel",NA,"2001-09-05",NA
"2903cc4d35c89e4b0450d803a86c1210","across-systems",NA,NA,NA,NA
"51581adad0392cbc2dbed13bee19f7c4","acs-biomarker","undisclosed",NA,"2011-05-20",NA
"d02d41807e14762b6e66fe92d9449c08","entrepreneurial-resources-showcase",NA,NA,NA,NA
"d28a0d709271403ee9cb71d9b53a60c8","acs-global","venture",NA,"2011-04-28",930000
"d28a0d709271403ee9cb71d9b53a60c8","acs-global","venture",NA,"2011-07-01",2232000
"36c0f4a1d59cce8f06b6ddd692dcc9bb","act-biotech","venture",NA,"2009-10-14",5e+05
"36c0f4a1d59cce8f06b6ddd692dcc9bb","act-biotech","venture","1","2008-09-08",6242000
"36c0f4a1d59cce8f06b6ddd692dcc9bb","act-biotech","venture","1","2009-03-01",11671000
"36c0f4a1d59cce8f06b6ddd692dcc9bb","act-biotech","venture","1","2008-05-06",6567000
"36c0f4a1d59cce8f06b6ddd692dcc9bb","act-biotech","debt_financing",NA,"2010-05-03",1e+06
"36c0f4a1d59cce8f06b6ddd692dcc9bb","act-biotech","debt_financing",NA,"2010-06-11",1e+06
"9f9f4b5a36341bbc9f04b941a7916edf","act-on-software","venture","c","2011-06-01",1e+07
"9f9f4b5a36341bbc9f04b941a7916edf","act-on-software","venture",NA,"2010-08-27",5e+05
"9f9f4b5a36341bbc9f04b941a7916edf","act-on-software","venture","d","2012-09-05",1.6e+07
"9f9f4b5a36341bbc9f04b941a7916edf","act-on-software","venture","b","2010-11-15",4e+06
"9f9f4b5a36341bbc9f04b941a7916edf","act-on-software","venture",NA,"2014-04-15",4.2e+07
"2cdbd54e9ba87866c3d08c44af901547","actagene-oncology",NA,NA,NA,NA
"7b8a066b02cfbda8853705fd54f3607b","actavis",NA,NA,NA,NA
"dfa16ef10afcb8854b7317c8dd76f427","actea-ventures",NA,NA,NA,NA
"3d66acca81aec3c029400cb65833bf62","actelion-pharmaceuticals",NA,NA,NA,NA
"587e35f86b3c38f0aff5ba14f5b51e34","actian",NA,NA,NA,NA
"ca79651f3a8972dca4c7f633e80cab97","actimis-pharmaceuticals","venture","a","2005-04-28",6e+06
"ca79651f3a8972dca4c7f633e80cab97","actimis-pharmaceuticals","venture",NA,"2008-06-06",9600000
"e3999b10eb3a2db5f85dcbde22ada243","actinium-pharmaceuticals","debt_financing",NA,"2011-11-03",364000
"e3999b10eb3a2db5f85dcbde22ada243","actinium-pharmaceuticals","venture",NA,"2014-01-21",6636720
"eaca5b8fad2774fefbbf7110e4762e4e","actinobac-biomed","venture","b","2013-02-21",1e+05
"eaca5b8fad2774fefbbf7110e4762e4e","actinobac-biomed","venture",NA,"2009-03-20",5e+05
"69ef83f83422aef8a6fcd136fce6f15e","action-pharma","venture","A","2006-10-27",6e+06
"69ef83f83422aef8a6fcd136fce6f15e","action-pharma","venture","c","2010-07-16",6300000
"e1cccf3cf96918ddd75f3dc1d8c73864","actionfinish",NA,NA,NA,NA
"078a1b51dbde3d01c3e00d19cbc2c058","actioniq","seed",NA,"2014-08-21",NA
"8c71617af8c1fb7bb4ba320bc84a1206","actito","angel",NA,"2000-12-01",9e+05
"437d5194a09c824e4c1ad83125c2ffb5","activaero","venture","a","2009-11-20",15830000
"437d5194a09c824e4c1ad83125c2ffb5","activaero","venture","a","2011-02-16",6755000
"41fec8d92bf9c9706a1042aceef197b8","mednetworks","venture","a","2012-04-27",1e+06
"41fec8d92bf9c9706a1042aceef197b8","mednetworks","venture","a","2010-08-09",5e+06
"41fec8d92bf9c9706a1042aceef197b8","mednetworks","venture","b","2012-11-13",1e+07
"553e7634965f08cfe0e2acf77670ba0a","activation-life","venture",NA,"2013-05-15",40000
"67b9f54908e33d297c74a55ab9c8cc90","activatr",NA,NA,NA,NA
"d9ce85985baf168c723b55c73630f62b","active-biotech",NA,NA,NA,NA
"b855667d0b0263ac7de1fa0025486d78","active-implants","venture",NA,"2004-12-23",55000
"b855667d0b0263ac7de1fa0025486d78","active-implants","venture","1","2006-05-11",1e+05
"b855667d0b0263ac7de1fa0025486d78","active-implants","venture","1","2007-05-01",6600000
"b855667d0b0263ac7de1fa0025486d78","active-implants","venture","1","2007-12-01",3110000
"b855667d0b0263ac7de1fa0025486d78","active-implants","venture","1","2008-08-01",2e+06
"b855667d0b0263ac7de1fa0025486d78","active-implants","debt_financing",NA,"2013-06-18",6e+05
"b855667d0b0263ac7de1fa0025486d78","active-implants","venture",NA,"2013-08-28",48666666
"b855667d0b0263ac7de1fa0025486d78","active-implants","venture","1","2009-12-02",1.5e+07
"b855667d0b0263ac7de1fa0025486d78","active-implants","debt_financing",NA,"2012-01-10",1e+07
"b855667d0b0263ac7de1fa0025486d78","active-implants","venture",NA,"2009-04-06",8585841
"c9d8563e7a2dcebf95f83dee14e7d9bb","activelifescientific","venture",NA,"2012-03-31",NA
"c9d8563e7a2dcebf95f83dee14e7d9bb","activelifescientific","venture",NA,"2010-07-19",275000
"c9d8563e7a2dcebf95f83dee14e7d9bb","activelifescientific","debt_financing",NA,"2010-04-20",150000
"c9d8563e7a2dcebf95f83dee14e7d9bb","activelifescientific","venture","1","2013-05-16",5e+05
"700ab6aa8c7e83537fdf435288b04b63","activecampaign",NA,NA,NA,NA
"8c910d1bc9bfd11646b2b843f2d92a0a","activeconversion",NA,NA,NA,NA
"8ca63b8f8544ecaa62ad717490bac0fa","activecyte-inc",NA,NA,NA,NA
"c9c3c86cfa51080ef679e4a240d97ebf","activeinsight",NA,NA,NA,NA
"7d85d0fa6df260e23fc3035378827511","activelifetech",NA,NA,NA,NA
"b23e79d3635aa6aaccb0e04e26d0e826","activeprospect",NA,NA,NA,NA
"a2ef9fddbee518f32d5220782cce3fb0","activeviews",NA,NA,NA,NA
"1ee89855c3d4278d1bc3edfebd095804","activeweb",NA,NA,NA,NA
"7f0f95b0bc31f9ff8fbea895ec27255e","activiomics","venture",NA,"2011-03-15",805000
"a2ec88bcb414d52a737d4a4ad9c1922c","activity-stream","seed","A","2015-12-10",2100000
"7095e0ba0afd40836bdf8046400a5075","activx-biosciences",NA,NA,NA,NA
"1f69ec25a8bf864fb2621fe342aaa3b2","actogenix","venture",NA,"2007-02-08",26004758.8709
"1f69ec25a8bf864fb2621fe342aaa3b2","actogenix","grant",NA,"2007-07-14",4200000
"d048b73bf52379a2e8193fdc6dd9b224","acton-pharmaceuticals","venture",NA,"2009-12-16",5e+05
"d048b73bf52379a2e8193fdc6dd9b224","acton-pharmaceuticals","venture","1","2013-05-21",7000005
"d048b73bf52379a2e8193fdc6dd9b224","acton-pharmaceuticals","venture","1","2010-01-06",1.5e+07
"d048b73bf52379a2e8193fdc6dd9b224","acton-pharmaceuticals","venture","1","2010-09-30",14200000
"73a9cb3a802baf6490e7c2405e411569","actual-experience","undisclosed",NA,"2013-11-20",6061005
"38b072957ce105112fe9f55437ca2a49","actuate",NA,NA,NA,NA
"1aa80aa6abc7af421ea3dd7838696c73","actucast",NA,NA,NA,NA
"424320ed75c343a0c04dc359b5d29e24","actus-data",NA,NA,NA,NA
"e5017b5d222ebb29b1a7a96d39d24449","actus-digital","venture","A","2008-10-01",1250000
"e5017b5d222ebb29b1a7a96d39d24449","actus-digital","venture","B","2009-10-01",2e+06
"e5017b5d222ebb29b1a7a96d39d24449","actus-digital","grant",NA,"2011-01-01",5e+05
"474ddabb4927fbed9ac5e75963174db3","actx","seed",NA,"2014-01-12",1920391
"474ddabb4927fbed9ac5e75963174db3","actx","seed",NA,"2014-07-18",750003
"58f2c8b46f15a837eab2a3e851a1eacf","actywatch",NA,NA,NA,NA
"019f9f584a6b686f965891a93038ff26","acucela","venture",NA,"2009-09-04",439603
"1c2c364ba24747f1752f9e1c6ed7d6c4","acuity-trading-ltd",NA,NA,NA,NA
"b4098f01ae0e52c8c27c8e6cd8430a86","acumen-pharmaceuticals","seed",NA,"2013-05-15",7e+05
"b4098f01ae0e52c8c27c8e6cd8430a86","acumen-pharmaceuticals","venture",NA,"2006-08-17",1500000
"ab34672541c4b4ec43b9a5a07662ef7d","acunote","seed",NA,"2011-03-01",NA
"4ca5b9d573d4975979a08eb66cae833f","acunu","seed",NA,"2009-07-01",1317075
"4ca5b9d573d4975979a08eb66cae833f","acunu","venture","1","2011-01-01",3415207
"4ca5b9d573d4975979a08eb66cae833f","acunu","undisclosed",NA,"2012-09-19",5831219
"bcd8aa174e71c7c534c53ab9662cc125","acura-pharmaceuticals","debt_financing",NA,"2013-12-31",1e+07
"bcd8aa174e71c7c534c53ab9662cc125","acura-pharmaceuticals","grant",NA,"2014-08-27",3e+05
"1efa1879504faf15152adbfa24659e59","acusphere","debt_financing",NA,"2012-02-23",2500000
"1efa1879504faf15152adbfa24659e59","acusphere","venture",NA,"2011-07-07",7500000
"3dd63a763d828f27bfa939e0c9b4b429","acutus-medical","venture",NA,"2011-08-08",1e+06
"3dd63a763d828f27bfa939e0c9b4b429","acutus-medical","debt_financing",NA,"2012-08-28",2500000
"3dd63a763d828f27bfa939e0c9b4b429","acutus-medical","venture","1","2013-08-20",2.8e+07
"3dd63a763d828f27bfa939e0c9b4b429","acutus-medical","venture",NA,"2011-09-30",5476464
"3dd63a763d828f27bfa939e0c9b4b429","acutus-medical","venture","1","2014-09-30",26200000
"f29ce33d4f826f246f8e3d8e72ba51cc","acxiom",NA,NA,NA,NA
"e18dd7232062cb059cb4a6e85e91193a","acylin-therapeutics","venture","a","2011-01-11",4400000
"e18dd7232062cb059cb4a6e85e91193a","acylin-therapeutics","venture","a","2012-06-04",2e+06
"8604fcaee780ebfdcabf8b160e0efe1d","ad-pure",NA,NA,NA,NA
"6b4941dd9ebb54e50f6ffafe9da95f1d","ad-iq","venture",NA,"2006-03-06",2629540
"6b4941dd9ebb54e50f6ffafe9da95f1d","ad-iq","venture",NA,"2006-12-01",1180918
"6b4941dd9ebb54e50f6ffafe9da95f1d","ad-iq","venture",NA,"2007-08-20",1529765
"6b4941dd9ebb54e50f6ffafe9da95f1d","ad-iq","undisclosed",NA,"2008-03-28",1364895
"6b4941dd9ebb54e50f6ffafe9da95f1d","ad-iq","venture",NA,"2009-02-18",514798
"6b4941dd9ebb54e50f6ffafe9da95f1d","ad-iq","venture",NA,"2010-07-27",486677
"e2c8d792c4af37ee9a9adafa9a78bfdb","adadyn",NA,NA,NA,NA
"33d2cd384af4af7cd43899464c8fb537","adagility","seed",NA,"2015-07-24",1600000
"3dd33084a96d8e6015f5885dd22cdc56","adalta","venture","A","2010-12-24",3007428.348
"f730b91e160d61ec91cefed83effabc6","adamas-consulting",NA,NA,NA,NA
"b4c671b38d25b80930fe428aa70d1c34","adamis-pharmaceuticals","debt_financing",NA,"2013-04-24",575000
"b4c671b38d25b80930fe428aa70d1c34","adamis-pharmaceuticals","convertible_note",NA,"2012-07-09",1e+06
"b4c671b38d25b80930fe428aa70d1c34","adamis-pharmaceuticals","debt_financing",NA,"2013-07-11",6502158
"b4c671b38d25b80930fe428aa70d1c34","adamis-pharmaceuticals","venture",NA,"2012-04-06",3299920
"b4c671b38d25b80930fe428aa70d1c34","adamis-pharmaceuticals","venture","1","2014-08-20",5e+06
"0b6772b7e3250fa96a315db8690f19bb","adaptimmune","grant",NA,"2014-03-26",3500000
"0b6772b7e3250fa96a315db8690f19bb","adaptimmune","venture","1","2014-09-25",1.04e+08
"6536a15ef86bbf7ab39dba4e26aac014","adaptive-biotechnologies","venture","d","2014-04-15",104999480
"6536a15ef86bbf7ab39dba4e26aac014","adaptive-biotechnologies","venture","c","2014-04-07",5e+06
"6536a15ef86bbf7ab39dba4e26aac014","adaptive-biotechnologies","grant",NA,"2013-09-13",2500000
"6536a15ef86bbf7ab39dba4e26aac014","adaptive-biotechnologies","venture","E","2015-01-07",9.4e+07
"6536a15ef86bbf7ab39dba4e26aac014","adaptive-biotechnologies","venture","F","2015-05-07",1.95e+08
"087a6ce56fc30e58bca2583059e564c2","adaptive-insights","venture","F","2013-05-21",45900000
"087a6ce56fc30e58bca2583059e564c2","adaptive-insights","venture","c","2007-03-01",7500000
"087a6ce56fc30e58bca2583059e564c2","adaptive-insights","venture","E","2012-03-14",22100000
"087a6ce56fc30e58bca2583059e564c2","adaptive-insights","venture","D","2008-01-22",1.4e+07
"087a6ce56fc30e58bca2583059e564c2","adaptive-insights","venture","A","2003-09-01",4600000
"087a6ce56fc30e58bca2583059e564c2","adaptive-insights","venture","B","2005-08-01",7175000
"087a6ce56fc30e58bca2583059e564c2","adaptive-insights","venture","G","2015-06-30",7.5e+07
"5ef7ca6f8e45f7afc028e18586bddc19","adaptive-planning-2","venture","C","2007-03-09",7500000
"5ef7ca6f8e45f7afc028e18586bddc19","adaptive-planning-2","venture","D","2008-01-22",1e+07
"5ef7ca6f8e45f7afc028e18586bddc19","adaptive-planning-2","venture","B","2005-09-16",5e+06
"7850b4f195c060af668ccc0de701287b","adaptive-semantics",NA,NA,NA,NA
"932a38f99de524d80f15d0446f79b57d","adaptive-symbiotic-technologies","venture","A","2016-01-21",3400000
"932a38f99de524d80f15d0446f79b57d","adaptive-symbiotic-technologies","venture",NA,"2014-08-28",1099000
"3199301228c2f70d8cd7f98cfd23e5fa","adaptive-tcr","venture","a","2010-03-26",4550000
"3199301228c2f70d8cd7f98cfd23e5fa","adaptive-tcr","venture","b","2011-06-10",5800000
"b181bb7df8417bda3748191572213d2d","adaptive-technologies-ati",NA,NA,NA,NA
"ae31d729d86a8328eefc98da4570edaf","adaptivewell-technologies","seed",NA,"2015-07-01",125000
"ae31d729d86a8328eefc98da4570edaf","adaptivewell-technologies","seed",NA,"2014-06-01",675000
"3ee112ccadf289d94712781b993125cf","adartis","equity_crowdfunding",NA,"2014-01-16",NA
"9435661ca30c00fec508ea560001a696","adarza-biosystems","undisclosed",NA,"2013-04-17",NA
"9435661ca30c00fec508ea560001a696","adarza-biosystems","seed",NA,"2013-07-18",250000
"9435661ca30c00fec508ea560001a696","adarza-biosystems","venture","1","2014-10-02",6800000
"9435661ca30c00fec508ea560001a696","adarza-biosystems","venture","1","2014-06-04",NA
"0f2759f75a64de0043d4b2805637779a","adbeat",NA,NA,NA,NA
"d99e5a4fc7599b62243626c7ecfa3f1d","adbrain","venture","B","2016-02-17",7500000
"d99e5a4fc7599b62243626c7ecfa3f1d","adbrain","venture",NA,"2012-12-01",NA
"d99e5a4fc7599b62243626c7ecfa3f1d","adbrain","seed",NA,"2013-05-01",1500000
"d99e5a4fc7599b62243626c7ecfa3f1d","adbrain","venture","a","2014-03-11",7500000
"ca7f19e512a3e1a4eb934ffd02485143","adbuka",NA,NA,NA,NA
"fb3f015aded2204598348b76f028841c","adc-therapeutics","venture",NA,"2013-10-16",4e+07
"fb3f015aded2204598348b76f028841c","adc-therapeutics","private_equity",NA,"2015-09-02",8e+07
"f3e350208a80ecc62e20e3aea977902c","adcare-health-systems","debt_financing",NA,"2011-05-11",4508700
"f3e350208a80ecc62e20e3aea977902c","adcare-health-systems","venture",NA,"2014-04-07",6500000
"f3e350208a80ecc62e20e3aea977902c","adcare-health-systems","debt_financing",NA,"2010-11-02",11800000
"f3e350208a80ecc62e20e3aea977902c","adcare-health-systems","venture",NA,"2012-07-11",7500000
"f3e350208a80ecc62e20e3aea977902c","adcare-health-systems","venture",NA,"2012-04-11",1250000
"f3e350208a80ecc62e20e3aea977902c","adcare-health-systems","venture",NA,"2009-12-14",2800000
"f3e350208a80ecc62e20e3aea977902c","adcare-health-systems","venture",NA,"2015-04-13",1685000
"4296e386271155ffa5cf9208be7f0882","adchemix",NA,NA,NA,NA
"46f10b3f70d8bdc2b959b7da1f096a37","adconnection",NA,NA,NA,NA
"95e03b79f644474efebeff3dc96da86a","addex-therapeutics","post_ipo_equity",NA,"2015-03-09",2842048
"70520ea41d37c5bde153d6cbd35127f0","addgene",NA,NA,NA,NA
"1c055f8d03aceedc912e7b2d4f7dfa2d","additive-analytics",NA,NA,NA,NA
"5061187a6dbbc49932530e227e7144f2","addresses-com-database",NA,NA,NA,NA
"8adc0255fdd0ca3782fb2a9817a646d5","add-shoppers","seed",NA,"2012-10-13",725000
"8adc0255fdd0ca3782fb2a9817a646d5","add-shoppers","undisclosed",NA,"2015-06-09",2910000
"fc89cfdea28ee12c443cedccb6c93fd4","addthis","venture","a","2006-05-01",2500000
"fc89cfdea28ee12c443cedccb6c93fd4","addthis","venture","b","2007-02-01",5500000
"fc89cfdea28ee12c443cedccb6c93fd4","addthis","venture","c","2008-05-20",1.8e+07
"fc89cfdea28ee12c443cedccb6c93fd4","addthis","venture","b","2007-07-27",1e+07
"fc89cfdea28ee12c443cedccb6c93fd4","addthis","venture","d","2011-05-10",2e+07
"fc89cfdea28ee12c443cedccb6c93fd4","addthis","private_equity",NA,"2011-10-31",1.7e+07
"fc89cfdea28ee12c443cedccb6c93fd4","addthis","secondary_market",NA,"2014-09-01",NA
"2ee7fafbca9d125293f9f3881796b512","add-to-any",NA,NA,NA,NA
"4476dd50d681329b82faedbb3cfb9ad9","addwalk",NA,NA,NA,NA
"a8e9e30447e4a965e9be8b3a4ed089fb","ade-parques-bioincubadora-ptb",NA,NA,NA,NA
"38a22cdc21658a99591af71b893adff5","adel-solutions",NA,NA,NA,NA
"4aa9b6d2790665b6197b032f4b353964","adello-group","venture","A","2014-08-12",2e+06
"3a3de53d370186a099e607cd1ff76b26","adenios","venture",NA,"2010-02-16",810000
"b7a391afb39e5403da011d88667dfa22","adenovir-pharma","venture",NA,"2010-06-15",787000
"c0cb12bedf9a96e58c415a58861c5404","adeptbio",NA,NA,NA,NA
"7f06727bf1bb6519ec329d2864acbff8","adeptia",NA,NA,NA,NA
"77f5ab1d5d3fa30301e436d78196d148","adestra","venture","A","2016-01-19",7200000
"a06a161b3ecb04649c9d73e7769f5deb","adeva-it",NA,NA,NA,NA
"f95877abc9778312855a0190a1a6ab37","adfin-solutions",NA,NA,NA,NA
"c4af3a10c81a990574e4a230144db5e9","adgibbon","angel",NA,"2011-10-01",501958
"882d99fda6683a75fde3b7b79cac58d0","adgistics",NA,NA,NA,NA
"8c6abcdc5bc1b0d77b0cf918e14d758f","stargreetz","angel",NA,"2011-12-31",6400000
"b7ecbe37ec72497b833df9399d5a5a31","adhack","seed",NA,"2009-01-01",81874
"7f712744acad23405e56369ab035bccc","adhawk","seed",NA,"2015-11-18",1400000
"6b641bc4498cc533ee5d1c69012951cf","adherex-technologies","venture",NA,"2013-11-27",1600000
"35f6bbf87a2da43e129b3dd623cfe774","adheron-therapeutics","convertible_note",NA,"2015-07-31",1500000
"d5eae8004c1cb824b52dcc48d67d7d66","adhezion-biomedical","debt_financing",NA,"2011-01-20",1285000
"d5eae8004c1cb824b52dcc48d67d7d66","adhezion-biomedical","debt_financing",NA,"2012-07-25",250000
"d5eae8004c1cb824b52dcc48d67d7d66","adhezion-biomedical","venture",NA,"2010-02-25",2500000
"f572346b4ea601d38dc9d4a40826ad30","adial-pharmaceuticals","venture",NA,"2011-03-16",4100000
"f572346b4ea601d38dc9d4a40826ad30","adial-pharmaceuticals","venture",NA,"2013-10-02",2631042
"d3475596e68bcb0bc64e4967a0ceaaf7","adiam",NA,NA,NA,NA
"68afb85bbb13c1ad7416642588894be9","adiana","venture","d","2005-08-25",2.3e+07
"ff4fe4a0f190a8fe64755a385427a9bf","adicet-bio","venture","A","2016-01-27",5.1e+07
"ff4fe4a0f190a8fe64755a385427a9bf","adicet-bio","venture",NA,"2015-08-26",14625000
"69b0b006863d000c355bffd20efb6e8a","adicyte","seed",NA,"2012-01-23",1110000
"69b0b006863d000c355bffd20efb6e8a","adicyte","seed",NA,"2013-03-12",1539402
"a5975405150d1d0c9d613974182a0931","adigami",NA,NA,NA,NA
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture",NA,"2007-07-16",2384
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture","1","2007-07-20",6e+06
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture","1","2007-09-21",5900000
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture","1","2008-04-01",3180000
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture","1","2010-01-22",8200000
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture","1","2008-11-20",4e+06
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture","1","2012-04-02",NA
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture",NA,"2012-04-03",1.4e+07
"e912ac45f8ead5d0c12e7a80a4bd47f9","adimab","venture",NA,"2010-12-01",4e+06
"cc3a7baca9d6b2b10779ed6dd8f4cc19","adispell",NA,NA,NA,NA
"544a3730e73b1b41f043c2c24c8ad22e","aditi",NA,NA,NA,NA
"3e727f576f7ddb0fee9c4dbf7357c366","aditu-sas","venture",NA,"2006-07-24",253000
"d4d2716cd4f68af527f811555c6f6d63","aditya-birla-chemicals",NA,NA,NA,NA
"0b028643b35967d8c58b22d7a149d39e","adivy",NA,NA,NA,NA
"a9c99b38cdb6097a01c18797ec7050a2","adjust-2","venture","D","2015-10-21",17017736.2629
"a9c99b38cdb6097a01c18797ec7050a2","adjust-2","venture","a","2012-04-01",NA
"a9c99b38cdb6097a01c18797ec7050a2","adjust-2","venture","b","2013-06-20",4300000
"a9c99b38cdb6097a01c18797ec7050a2","adjust-2","venture","D","2014-09-08",7600000
"681922e2e2d2563ebdf2271becff6207","adknowledge","venture","B","2011-01-12",2e+08
"681922e2e2d2563ebdf2271becff6207","adknowledge","venture","a","2006-03-01",4.8e+07
"57d06c5033ef3b409a4cf05af5018c52","adl",NA,NA,NA,NA
"6536ffebd3bcb4ab62d5eada41e76c90","adlab",NA,NA,NA,NA
"3559365df54be597781e4592c3fc177e","adlicious-gmbh",NA,NA,NA,NA
"b87edffcdc8f5deaabce99789f1194bb","adlyfe","convertible_note",NA,"2013-02-20",5e+06
"b87edffcdc8f5deaabce99789f1194bb","adlyfe","venture","1","2006-01-17",3300000
"ae9dfa4007cec8f629480ddf84d0a16e","adma-biologics","post_ipo_debt",NA,"2014-02-27",1.5e+07
"ae9dfa4007cec8f629480ddf84d0a16e","adma-biologics","post_ipo_equity",NA,"2013-10-23",26500000
"ae9dfa4007cec8f629480ddf84d0a16e","adma-biologics","post_ipo_debt",NA,"2014-12-15",5e+06
"96e1e8f1410dddc7d2fdf5fb322dde8d","adman-media","seed",NA,"2011-02-04",1368157
"c1515d3bcda80deff46329ee1e38b229","admatic","seed",NA,"2013-07-01",NA
"642833b208c7dca157ffcc8fbd6e1a07","admetry",NA,NA,NA,NA
"ef6dfbe4fb288e100c84d2051b7ca239","admill",NA,NA,NA,NA
"217c63dcda31a8a87ae1d89b23831153","admiral-records-management","private_equity",NA,"2006-01-11",2300000
"78f7d5cd9d717349080a25a55c87849b","admobilize","seed","A","2015-01-02",4500000
"d91469d32f9e5c4f34dc156130bad0c6","adnagen",NA,NA,NA,NA
"9b1c641a6bbc8a15504a7fe51278160e","adnavance-technologies","venture","b","2008-02-26",3738201
"9b1c641a6bbc8a15504a7fe51278160e","adnavance-technologies","venture","a","2005-11-29",3850000
"a24bc4d026eda36c39e4d938a188affa","adnexus","venture","c","2007-08-07",15500000
"a24bc4d026eda36c39e4d938a188affa","adnexus","venture","b","2006-06-26",2.7e+07
"172a34b49eddb0aec768cbfa8e1ab52c","adobe-systems",NA,NA,NA,NA
"606dbf8546b2f06d7fab634acf86e4c7","adocia","venture",NA,"2008-01-21",17378400
"606dbf8546b2f06d7fab634acf86e4c7","adocia","venture","1","2010-01-27",19700800
"fc641155d6b0a32102281c2074cc404e","adolade","seed",NA,"2014-06-01",20000
"3044dfc21515718ed1cc2acee5327b99","adolor",NA,NA,NA,NA
"bfe08d459a84ccd622b7fa0f11b396ec","adometry","venture","D","2012-12-28",8100000
"bfe08d459a84ccd622b7fa0f11b396ec","adometry","venture","A","2007-02-07",5e+06
"bfe08d459a84ccd622b7fa0f11b396ec","adometry","venture","B","2008-03-07",10025000
"bfe08d459a84ccd622b7fa0f11b396ec","adometry","venture","c","2010-06-30",6e+06
"bfe08d459a84ccd622b7fa0f11b396ec","adometry","angel",NA,"2010-01-12",450000
"812fc2898a83331a60951ec3f39964da","adonomics",NA,NA,NA,NA
"12de30b2d0ea8ef9e15ffd70d7f65db6","adoreboard",NA,NA,NA,NA
"81cd7b2818e6d8e4a65e4b83b3521403","adori-labs-inc",NA,NA,NA,NA
"90c44993231cafed6ff1a218f251cffc","adps-automated-dynamic-pricing-system",NA,NA,NA,NA
"6fa66cc259256286d168430ef2239baa","adremixer",NA,NA,NA,NA
"f6d5d0ef5469801f4f19ca13fea66ab6","adriacell",NA,NA,NA,NA
"a0c43afa79df0bdd6f706c3ce9e89b35","adroit",NA,NA,NA,NA
"93afad59b9a7b0539d995a8b7bb7ed98","adroitlogic",NA,NA,NA,NA
"9101267dd976fdb7c0794744aa1d76ff","adshark-marketing",NA,NA,NA,NA
"360b3ff456ea726878f6c01978e94f60","adshift",NA,NA,NA,NA
"127ec953bb108d3deec752d18ac949e2","adsoftware",NA,NA,NA,NA
"ec2262dcbd9d707280964da1fb650438","adsovo",NA,NA,NA,NA
"207e0fe386497e9e49e0add608de1c5e","adspired-technologies","seed",NA,"2014-09-15",NA
"37ae9f7fdd8228d555a4329495b3e4ef","adsquare","seed",NA,"2013-05-01",1400000
"37ae9f7fdd8228d555a4329495b3e4ef","adsquare","venture","1","2014-10-28",4300000
"dd371610ca33b9df67eb37689b0fd223","adstage","seed",NA,"2013-06-21",1e+05
"dd371610ca33b9df67eb37689b0fd223","adstage","seed",NA,"2013-03-01",1400000
"dd371610ca33b9df67eb37689b0fd223","adstage","seed",NA,"2014-02-24",1e+06
"dd371610ca33b9df67eb37689b0fd223","adstage","venture","1","2014-08-13",6250000
"dd371610ca33b9df67eb37689b0fd223","adstage","debt_financing",NA,"2015-06-01",1500000
"5d6a10e0faaddbb0fb91cfbda7ad820e","adsuit",NA,NA,NA,NA
"01b2eea469a9076d7a29fbccff5fd129","adtelligence","seed",NA,"2009-01-01",NA
"01b2eea469a9076d7a29fbccff5fd129","adtelligence","angel",NA,"2011-01-01",NA
"01b2eea469a9076d7a29fbccff5fd129","adtelligence","venture","1","2013-01-01",NA
"3313c15247965b38db113ed56c1cf592","traffic-smart-adthena","seed",NA,"2015-04-13",1500000
"38da8b0576315851fbbcff437df67717","adtoapp","venture",NA,"2015-08-04",6e+06
"af55861860bd817bd9ede16e936111b9","adtonik","angel",NA,"2011-10-01",5e+05
"247aeb3044f23776e052c5859026b557","adtruth",NA,NA,NA,NA
"3068f22ad1fb3fbc012590e1becea31f","aduro-biotech","venture","b","2013-01-31",6500000
"3068f22ad1fb3fbc012590e1becea31f","aduro-biotech","venture","b","2011-04-20",19250000
"3068f22ad1fb3fbc012590e1becea31f","aduro-biotech","venture",NA,"2013-09-10",7e+06
"3068f22ad1fb3fbc012590e1becea31f","aduro-biotech","venture",NA,"2010-04-09",768847
"3068f22ad1fb3fbc012590e1becea31f","aduro-biotech","venture","C","2014-06-11",5.5e+07
"3068f22ad1fb3fbc012590e1becea31f","aduro-biotech","venture",NA,"2009-11-17",2950000
"3068f22ad1fb3fbc012590e1becea31f","aduro-biotech","debt_financing",NA,"2011-12-05",512100
"3068f22ad1fb3fbc012590e1becea31f","aduro-biotech","venture","D","2015-01-05",51400000
"5512da104931cc386f5a688b6df0bd18","advanced-accelerator-applications","private_equity",NA,"2014-02-17",52750600
"ba3f82731a0521718aa1f4c964c1e2c7","advanced-animal-diagnostics","venture","b","2013-04-10",6e+06
"ba3f82731a0521718aa1f4c964c1e2c7","advanced-animal-diagnostics","venture","b","2011-03-15",1.1e+07
"ba3f82731a0521718aa1f4c964c1e2c7","advanced-animal-diagnostics","venture","C","2014-12-08",1.5e+07
"69c1394e5b47271cb540e5dd0af83bb6","advanced-bioenergy","venture",NA,"2009-12-30",7746327
"00771e9e79d39afedf5a1d5f26dd30c8","advanced-biohealing","venture","c","2007-02-27",25500000
"00771e9e79d39afedf5a1d5f26dd30c8","advanced-biohealing","venture","b","2005-11-21",8e+06
"d44c546c63fedde35c099432d6e01481","advanced-biomedical-technologies","venture",NA,"2011-01-08",205250
"7860181987a7b97f27d9753474c2301a","advanced-bionutrition","venture","C","2007-06-26",7750000
"7860181987a7b97f27d9753474c2301a","advanced-bionutrition","venture","B","2005-01-14",7500000
"7860181987a7b97f27d9753474c2301a","advanced-bionutrition","venture",NA,"2010-03-11",910275
"7860181987a7b97f27d9753474c2301a","advanced-bionutrition","venture",NA,"2011-05-25",9e+05
"d2898308b1dca8253ca7cd850448bb96","advanced-biotechnology-incubator",NA,NA,NA,NA
"637fdc29c8cdcbdaec8265f268b99a94","advanced-cancer-therapeutics",NA,NA,NA,NA
"3e67c3ae5538414924481a7a198bff53","advanced-cardiac-therapeutics","venture","b","2010-01-11",5e+06
"3e67c3ae5538414924481a7a198bff53","advanced-cardiac-therapeutics","venture",NA,"2014-04-21",7300000
"319a34ca603ec7d4151821d698ce0cb2","advanced-catheter-therapies","venture","b","2013-06-05",3e+06
"319a34ca603ec7d4151821d698ce0cb2","advanced-catheter-therapies","venture","B","2014-08-20",3400000
"319a34ca603ec7d4151821d698ce0cb2","advanced-catheter-therapies","venture","A","2011-09-29",3e+06
"319a34ca603ec7d4151821d698ce0cb2","advanced-catheter-therapies","seed",NA,"2013-06-01",450000
"319a34ca603ec7d4151821d698ce0cb2","advanced-catheter-therapies","venture","B","2015-03-17",4500000
"de753d6c8e4259ec91074ca88d30e5ec","advanced-catheter-therapies-inc",NA,NA,NA,NA
"f93d07481e3073e3879803470e5ebcd3","advanced-cell-diagnostics","venture","a","2009-09-03",5400000
"f93d07481e3073e3879803470e5ebcd3","advanced-cell-diagnostics","venture","b","2012-11-01",1.2e+07
"f93d07481e3073e3879803470e5ebcd3","advanced-cell-diagnostics","grant",NA,"2014-10-08",1400000
"f93d07481e3073e3879803470e5ebcd3","advanced-cell-diagnostics","venture","C","2015-06-18",2.2e+07
"4d714e5372113196cb687f751c559609","advanced-cell-technology","venture",NA,"2011-01-02",2.5e+07
"4d714e5372113196cb687f751c559609","advanced-cell-technology","debt_financing",NA,"2009-11-12",2777000
"4d714e5372113196cb687f751c559609","advanced-cell-technology","post_ipo_equity",NA,"2014-07-03",3e+07
"de11b760e7050e60e0a2028c4e658ac8","advanced-imaging-technologies","venture",NA,"2009-05-20",440000
"03be62c193c5c40fef18776121c325cd","advanced-inhalation-research",NA,NA,NA,NA
"8040847da02f5fcdc44fbc9e78ecf32a","advanced-life-sciences-holdings",NA,NA,NA,NA
"a3416ae90dfed56976a7ce617aa6b618","advanced-marketing-media-group","seed",NA,"2007-02-15",5e+05
"eaa4eedaf33a352135ccbdfff31c7473","advanced-medical-isotope","venture",NA,"2013-05-03",525000
"1b04c9dff8600fc0ec01ba24e4394f04","advanced-ophthalmic-pharma","venture",NA,"2010-05-02",2e+06
"c9ec918b11198d59111c1f53c10b6b5e","advanced-pain-remedies",NA,NA,NA,NA
"db2d91bb4a3c4fe88dfd0b58e46a5d16","advanced-photonix","venture",NA,"2010-06-30",562336
"6a8bd96d279dc1c3b59a2676c5506325","advanced-plasma-therapies","venture",NA,"2013-04-08",5e+05
"d32299a931be09a1010f9a75a9513f3b","advanced-proteome-therapeutics","seed",NA,"2013-02-28",160050
"d32299a931be09a1010f9a75a9513f3b","advanced-proteome-therapeutics","seed",NA,"2013-02-04",690000
"d32299a931be09a1010f9a75a9513f3b","advanced-proteome-therapeutics","venture",NA,"2010-11-08",9e+05
"d32299a931be09a1010f9a75a9513f3b","advanced-proteome-therapeutics","debt_financing",NA,"2012-03-05",35000
"d32299a931be09a1010f9a75a9513f3b","advanced-proteome-therapeutics","seed",NA,"2012-09-11",292900
"d7bcbef8c1ebdd6df27a3fa1d2e19f3d","advanced-scientifics-asi-",NA,NA,NA,NA
"093bd5a260fc53929ca1858768295be3","advanced-technology-services",NA,NA,NA,NA
"720731efdf5abb361b985b43940d8467","advanced-vector-analytics","seed",NA,"2012-05-25",131839
"50e212dfaf68ac5e3250ccaa1bb612d9","advanced-visual-systems",NA,NA,NA,NA
"8594328d229928e9d5d1bf1724362bca","advancemed",NA,NA,NA,NA
"35886e04bebf191001d5de1b60697a33","advandx","venture","C","2007-09-18",1.5e+07
"35886e04bebf191001d5de1b60697a33","advandx","venture","c","2009-10-12",8e+06
"35886e04bebf191001d5de1b60697a33","advandx","venture",NA,"2012-10-29",2200000
"35886e04bebf191001d5de1b60697a33","advandx","venture","b","2014-04-08",1.2e+07
"35886e04bebf191001d5de1b60697a33","advandx","debt_financing",NA,"2015-03-17",2500000
"d8fa55576777d92659e0769624d69f76","advantage-home-telehealth",NA,NA,NA,NA
"8824026e25df601f44cda1c237b2bf70","advantagene","debt_financing",NA,"2015-12-21",2200000
"8824026e25df601f44cda1c237b2bf70","advantagene","grant",NA,"2011-05-25",5e+05
"41c9ee9641822a2e0a47d003efded0d5","advantech-solutions","venture",NA,"2004-03-02",26200000
"9fd533a92a90ace53672f494cdc5a74d","advanti",NA,NA,NA,NA
"89d1efa16ae50e4e32038424c3b50e27","advanzis",NA,NA,NA,NA
"7daf673ac6d70fa860ba0ca19697fae7","advaxis-inc","debt_financing",NA,"2011-05-27",6016250
"7daf673ac6d70fa860ba0ca19697fae7","advaxis-inc","venture",NA,"2012-05-29",4473673
"7daf673ac6d70fa860ba0ca19697fae7","advaxis-inc","debt_financing",NA,"2009-10-01",5e+06
"7daf673ac6d70fa860ba0ca19697fae7","advaxis-inc","venture",NA,"2010-07-30",7500000
"7daf673ac6d70fa860ba0ca19697fae7","advaxis-inc","post_ipo_equity",NA,"2013-10-23",26500000
"7daf673ac6d70fa860ba0ca19697fae7","advaxis-inc","debt_financing",NA,"2012-01-09",1047500
"7daf673ac6d70fa860ba0ca19697fae7","advaxis-inc","post_ipo_equity",NA,"2015-02-19",2.3e+07
"7daf673ac6d70fa860ba0ca19697fae7","advaxis-inc","post_ipo_equity",NA,"2015-08-26",2.5e+07
"6958772476d059022f1df26513c90d42","advenchen-laboratories","venture",NA,"2010-05-20",4475000
"08468a6526ecbfee76ac8cade4192377","advent-health-partners","venture",NA,"2011-01-19",1500000
"6ea77d12a6711dd1a33958ea1c82c2ad","adventrx-pharmaceuticals","venture",NA,"2011-01-07",22500000
"63bb450a51e8114142ef6d520930f4ce","adverseevents","venture","a","2014-04-16",2e+06
"ae91ac07b9e20be1d0338a52054c94ab","adverlytics",NA,NA,NA,NA
"3d6b4bce6fc6c4625ba764bfb7e23310","adverplans",NA,NA,NA,NA
"c47b223a748d84436865956004b1b2f0","adverteyes",NA,NA,NA,NA
"6cd9a69c3e3b7e2fd47cc504bf947550","adverti-se",NA,NA,NA,NA
"0b9c980bea9b86725ebca534be3e8dcd","advertology",NA,NA,NA,NA
"f0cad8221f420a3666d8101c0112828d","advicegames","undisclosed",NA,"2015-02-09",570000
"f0cad8221f420a3666d8101c0112828d","advicegames","seed",NA,"2013-12-24",1100000
"394f62d60520835feb74d75f5b1191c3","advion-inc","debt_financing",NA,"2014-06-30",1500000
"e7e50978091861e9c2d119ab55e8fa6f","advisorfi",NA,NA,NA,NA
"80390026423789bde10c07182a0642b9","advitech","venture",NA,"2010-07-21",1440000
"782e9dbe674d11adb0ff3f5b32f48183","advolume","venture",NA,"2013-09-10",1200000
"ac11a1f10cf2e7017f552cd73065d22f","adxpose","venture","a","2007-02-01",9800000
"ac11a1f10cf2e7017f552cd73065d22f","adxpose","venture","b","2008-06-11",1e+07
"ac11a1f10cf2e7017f552cd73065d22f","adxpose","venture","c","2011-04-04",3e+06
"f8080037b1a9b17d9084a567f8dcd5de","adyapper-com","seed",NA,"2013-09-05",1200000
"f8080037b1a9b17d9084a567f8dcd5de","adyapper-com","seed",NA,"2014-05-08",1e+06
"f8080037b1a9b17d9084a567f8dcd5de","adyapper-com","venture","1","2015-07-13",4500000
"c1a42c97a44ad6f00b7b628ece94b85c","adynxx","venture","a","2011-01-11",4800000
"c1a42c97a44ad6f00b7b628ece94b85c","adynxx","venture",NA,"2010-08-03",740560
"c1a42c97a44ad6f00b7b628ece94b85c","adynxx","private_equity",NA,"2012-07-01",2e+06
"2281c00a67bd0c60fc183abde84e4383","adzone-research",NA,NA,NA,NA
"ec853f49157722a46e419617ae767c7e","aeci",NA,NA,NA,NA
"e300c97940c68b4608ba6b4dad88736a","aegea-medical","debt_financing",NA,"2013-05-20",6000600
"e300c97940c68b4608ba6b4dad88736a","aegea-medical","private_equity",NA,"2011-05-25",13366498
"e300c97940c68b4608ba6b4dad88736a","aegea-medical","venture","1","2015-05-04",3.6e+07
"e5e4ddf1f3b65e5f176848876c36d634","aegera-therapeutics-inc","venture","C","2006-11-20",12173913.0435
"38836c8c47ae60f52cb0a36f56551bc2","aegerion-pharmaceuticals","venture",NA,"2010-10-11",1500000
"38836c8c47ae60f52cb0a36f56551bc2","aegerion-pharmaceuticals","venture",NA,"2010-06-28",18314760
"fbef6e2d1ce4ad5b4e8fa95f70ed1c86","aegis-sciences",NA,NA,NA,NA
"e651c67b4f5b0e9269e0d513308bcfa2","ethan-millar",NA,NA,NA,NA
"8d6ad0c3f625560f8190f2162573a945","aegle-2",NA,NA,NA,NA
"55c20f7153b8b8607e3980c366709d88","aeglea-biotherapeutics","venture",NA,"2014-01-09",1.2e+07
"55c20f7153b8b8607e3980c366709d88","aeglea-biotherapeutics","venture","1","2014-02-06",1.2e+07
"55c20f7153b8b8607e3980c366709d88","aeglea-biotherapeutics","venture","1","2015-03-23",4.4e+07
"41cf8e16101eb185e82fddebc6ab34e4","aentropico","seed",NA,"2013-03-13",25000
"41cf8e16101eb185e82fddebc6ab34e4","aentropico","seed",NA,"2012-08-08",40000
"41cf8e16101eb185e82fddebc6ab34e4","aentropico","seed",NA,"2013-03-01",350000
"41cf8e16101eb185e82fddebc6ab34e4","aentropico","grant",NA,"2013-07-29",88757
"c3c9cadaf13a6f2df57a04f5631569ff","aeolus-pharmaceuticals","post_ipo_equity",NA,"2015-12-14",6750000
"c3c9cadaf13a6f2df57a04f5631569ff","aeolus-pharmaceuticals","venture",NA,"2013-03-05",3615500
"c3c9cadaf13a6f2df57a04f5631569ff","aeolus-pharmaceuticals","venture",NA,"2012-04-18",690050
"c3c9cadaf13a6f2df57a04f5631569ff","aeolus-pharmaceuticals","venture",NA,"2010-08-11",1e+06
"c3c9cadaf13a6f2df57a04f5631569ff","aeolus-pharmaceuticals","venture",NA,"2010-08-09",3300000
"c3c9cadaf13a6f2df57a04f5631569ff","aeolus-pharmaceuticals","venture",NA,"2009-04-06",1500000
"c3c9cadaf13a6f2df57a04f5631569ff","aeolus-pharmaceuticals","venture",NA,"2009-10-06",1650000
"7ad8d03a82fc0b34501b1067493ece27","aer-sustainable-energy",NA,NA,NA,NA
"a43775a0e7aa9bf14cd988eb83a861c8","aereus-technologies",NA,NA,NA,NA
"d0959a386537369e2694320ec9b65f9c","aerial-biopharma","venture",NA,"2012-07-12",5e+05
"d0959a386537369e2694320ec9b65f9c","aerial-biopharma","venture","1","2013-02-20",9500000
"d0959a386537369e2694320ec9b65f9c","aerial-biopharma","venture",NA,"2012-10-11",9500000
"b859005a206899680e9b5e02f80ebd81","aerie-pharmaceuticals","post_ipo_equity",NA,"2013-10-25",6.7e+07
"b859005a206899680e9b5e02f80ebd81","aerie-pharmaceuticals","debt_financing",NA,"2013-08-29",1.5e+07
"b859005a206899680e9b5e02f80ebd81","aerie-pharmaceuticals","debt_financing",NA,"2010-09-01",5250000
"b859005a206899680e9b5e02f80ebd81","aerie-pharmaceuticals","venture","1","2011-03-07",41364965
"b859005a206899680e9b5e02f80ebd81","aerie-pharmaceuticals","post_ipo_equity",NA,"2014-09-09",1.25e+08
"c37e637abcdd8c95b0f108c92a6ef024","aerin-medical","venture",NA,"2014-02-14",524998
"c37e637abcdd8c95b0f108c92a6ef024","aerin-medical","venture",NA,"2012-10-12",125000
"c37e637abcdd8c95b0f108c92a6ef024","aerin-medical","venture",NA,"2011-12-12",125000
"c37e637abcdd8c95b0f108c92a6ef024","aerin-medical","venture",NA,"2015-09-02",6698125
"9658041d576f42459e864f02c9a39659","aeris-therapeutics",NA,NA,NA,NA
"2159f307358410fbb7fb2c8cc22f1d8d","aerolase",NA,NA,NA,NA
"00291af44b07e1d4e7500279010ed42f","aeroleads",NA,NA,NA,NA
"b051c73bf5fc2ff0ccaf2d9240aeec0b","aeromics","venture",NA,"2014-03-20",1349360
"8a5881353d5bced3bcb673107c87dfa8","aerospike","venture","b","2012-08-27",NA
"8a5881353d5bced3bcb673107c87dfa8","aerospike","venture","C","2014-06-24",2e+07
"8a5881353d5bced3bcb673107c87dfa8","aerospike","venture","A","2011-03-30",2e+06
"1c60bc6ab81b2594984bd448b314d365","aerovance","venture",NA,"2009-04-07",3.8e+07
"1c60bc6ab81b2594984bd448b314d365","aerovance","debt_financing",NA,"2010-09-16",2e+06
"1c60bc6ab81b2594984bd448b314d365","aerovance","venture",NA,"2011-03-21",5e+05
"1c60bc6ab81b2594984bd448b314d365","aerovance","debt_financing",NA,"2008-03-28",2e+07
"1c60bc6ab81b2594984bd448b314d365","aerovance","venture","1","2007-03-28",6e+07
"b95b61b255e5561d86e5ada6f2242018","aerpio-therapeutics","venture","a","2012-08-30",2.7e+07
"b95b61b255e5561d86e5ada6f2242018","aerpio-therapeutics","venture",NA,"2012-01-05",5e+06
"b95b61b255e5561d86e5ada6f2242018","aerpio-therapeutics","venture","a","2013-11-06",9e+06
"b95b61b255e5561d86e5ada6f2242018","aerpio-therapeutics","venture","A","2014-04-23",2.2e+07
"09ac510080e92e9b462d35a6ae565c83","aerse",NA,NA,NA,NA
"aca4d2ed99e7c33431ee3125e97e09f5","aesica-pharmaceuticals","undisclosed",NA,"2011-09-30",NA
"c2ba98232f89b263d240db0dc2ebc25a","aesrx","debt_financing",NA,"2013-05-09",1355150
"c2ba98232f89b263d240db0dc2ebc25a","aesrx","debt_financing",NA,"2011-06-30",1500000
"c2ba98232f89b263d240db0dc2ebc25a","aesrx","debt_financing",NA,"2013-12-10",6e+05
"0b02061195196efef3e27085bd902b7c","aeterna-zentaris",NA,NA,NA,NA
"81c02bc66f0772d5276ac09ca94f9d0e","aetilius",NA,NA,NA,NA
"5f5d91c4b9d88ba4a70ded0b4b330f5c","aexpense",NA,NA,NA,NA
"62a015862894a1e6d67d1334f7cf583a","affclicks",NA,NA,NA,NA
"f722053f6dd212648b83995a8a86b149","affect-labs",NA,NA,NA,NA
"5a28722c4892939f552eda2bef5ab366","affectiva","venture","B","2011-07-19",5725000
"5a28722c4892939f552eda2bef5ab366","affectiva","grant",NA,"2012-06-01",5e+05
"5a28722c4892939f552eda2bef5ab366","affectiva","venture","c","2012-08-07",1.2e+07
"5a28722c4892939f552eda2bef5ab366","affectiva","venture","A","2010-02-01",1999999
"7027bd55f0d5d87525299e1a858702fa","affective-interfaces",NA,NA,NA,NA
"e67dd2fc5420c3637626993aed00dd89","affective-systems-plc","equity_crowdfunding",NA,"2015-09-07",589007.640554257
"542da8b195ae115a237d33502820cecf","afferent-pharmaceuticals","venture","a","2009-12-16",2.3e+07
"542da8b195ae115a237d33502820cecf","afferent-pharmaceuticals","convertible_note",NA,"2009-10-23",150000
"542da8b195ae115a237d33502820cecf","afferent-pharmaceuticals","venture",NA,"2012-01-01",5e+06
"542da8b195ae115a237d33502820cecf","afferent-pharmaceuticals","venture",NA,"2013-04-01",5e+06
"542da8b195ae115a237d33502820cecf","afferent-pharmaceuticals","venture","C","2015-07-08",5.5e+07
"785ba67d9501971c165948b9a9554060","affibody","venture",NA,"2007-03-30",28499283
"1cb0dc9282facb02eff7812addb26975","affilae",NA,NA,NA,NA
"07806e6a7436ea7c20184ad59cade1f7","affilogic",NA,NA,NA,NA
"f322f1831110c35f81897eb210115603","affimed-therapeutics","venture","B","2007-04-04",3.2e+07
"f322f1831110c35f81897eb210115603","affimed-therapeutics","venture","c","2010-04-29",26512000
"f322f1831110c35f81897eb210115603","affimed-therapeutics","venture","D","2012-10-08",20165224
"f322f1831110c35f81897eb210115603","affimed-therapeutics","venture","E","2014-09-02",15700000
"f322f1831110c35f81897eb210115603","affimed-therapeutics","debt_financing",NA,"2014-09-02",1.4e+07
"f9f50331c65d9cde2a30926d106b2d2d","affine-analytics","angel",NA,"2012-01-01",1e+05
"79d221633e5d2197ced3281636e5d756","affinergy","venture","b","2006-03-08",3e+06
"9e7e0cf3e945630da767061b489c6dc3","affinimark-technologies","venture",NA,"2010-10-13",1359394
"8281d538a5bce26f5f25cce964a16920","affinio","venture","A","2015-11-03",3052899.1093
"8281d538a5bce26f5f25cce964a16920","affinio","seed",NA,"2013-10-31",1500000
"8281d538a5bce26f5f25cce964a16920","affinio","seed",NA,"2014-12-01",50000
"d8f1b9ea15f4cfcdf052db0a2edcb84c","affinity-informatics",NA,NA,NA,NA
"623297b5a02a54358740a8f5e16fe5f2","affinity-therapeutics","grant",NA,"2014-01-09",4e+05
"4d784c1e8fe0779d22580238a859edde","affinium-pharmaceuticals","venture","A","2007-03-26",1.8e+07
"4d784c1e8fe0779d22580238a859edde","affinium-pharmaceuticals","venture","B","2011-08-29",1.5e+07
"4d784c1e8fe0779d22580238a859edde","affinium-pharmaceuticals","debt_financing",NA,"2013-09-11",11900000
"4d784c1e8fe0779d22580238a859edde","affinium-pharmaceuticals","debt_financing",NA,"2011-08-19",18900000
"4d784c1e8fe0779d22580238a859edde","affinium-pharmaceuticals","venture",NA,"2010-05-21",1.8e+07
"1e9d4748ecaabe7886867e39fb3485a3","affinivax",NA,NA,NA,NA
"7f361e110256c71d336fabf5a6455268","affiris","venture",NA,"2011-11-09",34082500
"dc2ef7f784e7985c59ca275f28f432e0","affixx",NA,NA,NA,NA
"d94ee869c145b5d8b84dfea8d4dd034f","affmeter-com",NA,NA,NA,NA
"71e727175f448d80e2200bb2678d998d","affomix-corporation","venture","a","2008-02-22",7e+06
"bf0e73e0b22b06a40db9bf4d68998f18","affygility-solutions",NA,NA,NA,NA
"df715e9a57a168afcf1afe943765b0c4","affymax","venture",NA,"2009-03-03",41999999
"54c2492fd6bfab398edb2d58337418bc","affymetrix",NA,NA,NA,NA
"9a3baa0352ef99517174244e1a4c7d0f","afi",NA,NA,NA,NA
"303f5f180f21288658bbbccc45d64f4c","afinity-life-sciences","seed",NA,"2013-09-10",1500000
"51d739ff03fb220b1a7c9871151402c4","afj-brand-strategy",NA,NA,NA,NA
"21fc13b3f83df4b5e23757a28c95dc3a","aframe-digital","angel",NA,"2005-01-01",NA
"ee8da1a3db72efe4d584bc5919cd4cf1","african-foodie",NA,NA,NA,NA
"0cfcfbc82f8c636b51d1e77f590f8725","afs-technologies-inc",NA,NA,NA,NA
"4f308f38f15893529ceeeec8cb474c06","aftercollege-com","undisclosed",NA,"2011-11-01",NA
"4f308f38f15893529ceeeec8cb474c06","aftercollege-com","debt_financing",NA,"2014-09-01",NA
"8c920c1273777c05ad168c4caaf0d727","agalimmune",NA,NA,NA,NA
"20839b54e6b4bd09014379a050f9b525","agarigen-inc",NA,NA,NA,NA
"84c6e48c6df65d6823d7d4754799079b","agbio-sphere",NA,NA,NA,NA
"2513bc1e9b7365b2a522c5aa401c864b","agbiome","venture","a","2013-04-11",17500000
"2513bc1e9b7365b2a522c5aa401c864b","agbiome","venture","B","2015-08-20",34500000
"7fd3bc56ed04e4884378e8a08616c68a","agdata",NA,NA,NA,NA
"3fa0ffe7aea67c9e3145d06404c8d737","agdirect-crossmedia-brazil",NA,NA,NA,NA
"c78389ee8545f14e6c035cf009dc6a11","agenciaclick",NA,NA,NA,NA
"b130e2bb56e96eeb9b27e61a022d3dab","agencio-digital",NA,NA,NA,NA
"15b53e7f7f56882f3fed96e4fdbc2170","agencourt-bioscience","seed",NA,"1998-01-01",NA
"9c9295714f6083de46bc4620f614db44","agency-for-student-health-research","seed",NA,"2014-05-01",350000
"9c9295714f6083de46bc4620f614db44","agency-for-student-health-research","venture",NA,"2015-01-07",75000
"78762f3b9d4c57e0d55d735a37686c4b","agency-spotter","seed",NA,"2012-11-01",35000
"78762f3b9d4c57e0d55d735a37686c4b","agency-spotter","seed",NA,"2014-12-31",NA
"a924e1ffe75fc348aabff258118f1027","agendia","venture","e","2009-09-23",2.3e+07
"a924e1ffe75fc348aabff258118f1027","agendia","private_equity",NA,"2012-05-31",6.5e+07
"a924e1ffe75fc348aabff258118f1027","agendia","venture","d","2007-08-28",3.4e+07
"97bb551cd328f1a93cef7bfd79a57fa9","agenebio","debt_financing",NA,"2009-06-30",50000
"97bb551cd328f1a93cef7bfd79a57fa9","agenebio","debt_financing",NA,"2010-04-12",3e+05
"97bb551cd328f1a93cef7bfd79a57fa9","agenebio","venture",NA,"2013-11-18",1000113
"97bb551cd328f1a93cef7bfd79a57fa9","agenebio","venture",NA,"2013-06-04",1e+06
"97bb551cd328f1a93cef7bfd79a57fa9","agenebio","debt_financing",NA,"2011-12-22",3688610
"97bb551cd328f1a93cef7bfd79a57fa9","agenebio","debt_financing",NA,"2012-09-25",450000
"97bb551cd328f1a93cef7bfd79a57fa9","agenebio","venture",NA,"2014-10-17",4113127
"97bb551cd328f1a93cef7bfd79a57fa9","agenebio","debt_financing",NA,"2015-02-06",4e+05
"0249643f15eb02a53b6c3822b16d36e3","agennix","venture",NA,"2005-03-31",2.2e+07
"0249643f15eb02a53b6c3822b16d36e3","agennix","venture",NA,"2010-03-22",1.3e+07
"483bba626ddbe4bedc08410d7530cd72","agensys","venture","d","2007-07-12",41300000
"bdf3848960b45cb7df5e905d3453ad24","agent-analytics",NA,NA,NA,NA
"dc25ce60e4e7dd4efb7f937d81e3333d","agent-marketing",NA,NA,NA,NA
"9cfa8374704d6d0545db90448afe1990","agent-z-project",NA,NA,NA,NA
"2d509e04b4697ed5d184d2cf50ec7db5","agenus","post_ipo_debt",NA,"2015-09-23",1e+08
"2d509e04b4697ed5d184d2cf50ec7db5","agenus","debt_financing",NA,"2013-04-25",5e+06
"2d509e04b4697ed5d184d2cf50ec7db5","agenus","venture",NA,"2009-08-04",1e+07
"2d509e04b4697ed5d184d2cf50ec7db5","agenus","venture",NA,"2015-03-11",3.5e+07
"2d509e04b4697ed5d184d2cf50ec7db5","agenus","debt_financing",NA,"2015-03-11",21140000
"d85c260df45570a6fa86c0dc05543289","ageria","venture",NA,"2015-04-30",NA
"8aa40af4d0ed6379b2a744bd001d7dee","aggamin-pharmaceuticals","private_equity",NA,"2013-04-18",3722355
"a75d210591f7e2b5199cb29b96ab3cba","aggredyne","venture","a","2012-04-23",3e+06
"178c24ccc5c0c2b1e65aeeda7d458339","aggregame",NA,NA,NA,NA
"d5a59a9d0c86005386bedd1e873c8bbd","agi-biopharmaceuticals","venture",NA,"2011-11-28",4710000
"3f7a4738ef8225b3adcd3db017602db0","agile-algorithms",NA,NA,NA,NA
"eac589857f0d64efb527a354b0f7a772","agile-crm",NA,NA,NA,NA
"6eaaa6391f1720b8098f6b2c19d330ef","agile-customer-insight","seed",NA,"2011-11-01",640000
"0b5f14b26c49620e150c70afd42fd27c","agile-sciences","venture",NA,"2007-11-12",1308642
"0b5f14b26c49620e150c70afd42fd27c","agile-sciences","grant",NA,"2014-07-17",1500000
"f9e2bec06e6bdc27c5bce952506b9262","agile-search-marketing",NA,NA,NA,NA
"f174d4f3fc0610a174afc676a2aa5449","agile-therapeutics","venture","c","2012-07-19",4e+07
"f174d4f3fc0610a174afc676a2aa5449","agile-therapeutics","venture","b","2010-06-14",4.5e+07
"f174d4f3fc0610a174afc676a2aa5449","agile-therapeutics","debt_financing",NA,"2009-10-28",989178
"f174d4f3fc0610a174afc676a2aa5449","agile-therapeutics","venture","a","2010-05-05",1005000
"f174d4f3fc0610a174afc676a2aa5449","agile-therapeutics","venture","a","2010-01-12",1010822
"f174d4f3fc0610a174afc676a2aa5449","agile-therapeutics","debt_financing",NA,"2014-05-09",3e+06
"f174d4f3fc0610a174afc676a2aa5449","agile-therapeutics","post_ipo_equity",NA,"2015-02-06",2e+07
"813de97d696aef8c5142e59377ad5ecf","agilenano","venture",NA,"2008-09-01",NA
"813de97d696aef8c5142e59377ad5ecf","agilenano","venture",NA,"2011-02-01",272500
"743ccb6078a845cd35bbf6f1797f38f5","agilent",NA,NA,NA,NA
"d4d6d319d90bdefdcf9e1be46bb037bf","agilesense",NA,NA,NA,NA
"f883aa54ea76495bb82ce8c2977ef8ab","agilex-technologies",NA,NA,NA,NA
"385eedda41c58593d68225be1240903f","agilis-biotherapeutics","venture","A","2014-01-01",8e+06
"0f86fc4a5540590bc2ed57c3437be1ea","agilis-international",NA,NA,NA,NA
"f56fcd75a739657bc297fa6189d1916a","agilone","venture","a","2011-01-01",6e+06
"f56fcd75a739657bc297fa6189d1916a","agilone","venture","b","2012-11-28",1e+07
"f56fcd75a739657bc297fa6189d1916a","agilone","venture","c","2014-04-15",25000016
"9e24a5bf66ffdd8c88f8eab6d9712e60","agilvax","venture",NA,"2014-06-12",1150000
"9e24a5bf66ffdd8c88f8eab6d9712e60","agilvax","venture","1","2014-07-31",2e+06
"8619cca8f0d5034be4cb6163f448d490","aginity","venture",NA,"2015-12-28",1.2e+07
"8619cca8f0d5034be4cb6163f448d490","aginity","venture","1","2015-01-07",1500000
"8619cca8f0d5034be4cb6163f448d490","aginity","venture",NA,"2015-06-02",275000
"28defb239173db55f1e362501a8c952c","agios-pharmaceuticals","venture","A","2008-07-07",3.3e+07
"28defb239173db55f1e362501a8c952c","agios-pharmaceuticals","undisclosed",NA,"2009-12-23",NA
"28defb239173db55f1e362501a8c952c","agios-pharmaceuticals","venture","c","2011-11-17",7.8e+07
"28defb239173db55f1e362501a8c952c","agios-pharmaceuticals","venture",NA,"2010-04-26",8823937
"a10149cef76f540fdae9dedcaced712b","agolo","seed",NA,"2013-06-03",40000
"a10149cef76f540fdae9dedcaced712b","agolo","seed",NA,"2014-02-28",50000
"ded63e4b4ecc5bf62f40f216cb40f95f","agradis","venture",NA,"2011-08-05",2e+07
"ded63e4b4ecc5bf62f40f216cb40f95f","agradis","venture",NA,"2012-01-18",4e+06
"b60f4476ac14c8af36f872183976b838","agraquest","venture",NA,"2007-03-13",1e+07
"b60f4476ac14c8af36f872183976b838","agraquest","venture",NA,"2007-12-04",2e+07
"b60f4476ac14c8af36f872183976b838","agraquest","venture",NA,"2011-03-21",17700000
"b6ef68544e3c2d3306b512cce44353a2","agreen-biotech",NA,NA,NA,NA
"4213f11f0945212308f2e8185b654eec","agri-neo","venture",NA,"2015-09-10",118508
"87501c544f5c8519a1a08c7a9a7cdd6c","agribotix","grant",NA,"2015-05-18",250000
"68c103ca8c28b40a98d6d7d465a3f10c","agrisoma-biosciences","venture",NA,"2009-01-02",2320000
"68c103ca8c28b40a98d6d7d465a3f10c","agrisoma-biosciences","venture","1","2014-09-26",NA
"ede0cf21ba79108b6852f7b8c4e2f140","agritope",NA,NA,NA,NA
"e89c522f582b4475029a28e2ee6b63de","agrivida","seed",NA,"2006-11-22",6e+05
"e89c522f582b4475029a28e2ee6b63de","agrivida","grant",NA,"2009-11-20",2e+06
"e89c522f582b4475029a28e2ee6b63de","agrivida","venture","1","2012-09-12",1.5e+07
"e89c522f582b4475029a28e2ee6b63de","agrivida","venture",NA,"2011-06-13",2e+06
"e89c522f582b4475029a28e2ee6b63de","agrivida","debt_financing",NA,"2014-10-14",1249500
"e89c522f582b4475029a28e2ee6b63de","agrivida","venture","1","2015-01-05",12348733
"e89c522f582b4475029a28e2ee6b63de","agrivida","venture","1","2015-08-18",10700000
"9aa4155d45420a6b3e1e96aaf4aadd96","agronometrics","grant",NA,"2014-02-02",65000
"fc1c987a7186632a4420c6e1399f33d7","agrosavfe","venture",NA,"2013-01-11",6637000
"7ab868efa8bf164691e6ad6c351b4d40","agrowatcher",NA,NA,NA,NA
"e363e06ab818e738fbee13e3e610a36f","agselo",NA,NA,NA,NA
"9f8b231d8d9ee1fabc17cca1edda1646","agt-international",NA,NA,NA,NA
"ec9096d83d8efc939b7656a862a9f9fe","agtech-products",NA,NA,NA,NA
"37bb97aa05c3bf87ae3d78529aaadcce","agua",NA,NA,NA,NA
"506a5c83bbd78f1a5071ce237cab84e1","ah-design",NA,NA,NA,NA
"14dfd82f10c53b4943412518984f54ae","ahsantech",NA,NA,NA,NA
"e345264d4a2e30292db2ec3d46ac7070","ahura-scientific","venture","b","2005-01-19",1e+07
"e345264d4a2e30292db2ec3d46ac7070","ahura-scientific","venture","b","2007-03-09",7e+06
"4829128d06ee506aa8a89d78ae2fbf7e","a-i-type",NA,NA,NA,NA
"dd102a9847fa672cf7bcf6fbe200e158","ai2-uk","venture",NA,"2010-01-29",403000
"dd102a9847fa672cf7bcf6fbe200e158","ai2-uk","undisclosed",NA,"2012-01-06",2705469
"f01e44207b8fc93064d2012518849faf","aiaioo",NA,NA,NA,NA
"60aa07718ea56ceda898272907e727ab","aibiotech",NA,NA,NA,NA
"8beeec55961ce01280b20168e7d2d908","aicon-me",NA,NA,NA,NA
"cf55dc43e41598ccca71f56a245ba5c6","aicuris","venture","b","2010-04-23",74800000
"fb30743e3aa2dd98409c24068384ad09","aida-pharmaceuticals",NA,NA,NA,NA
"b6be007af900e277fd1d869f2a1b1a10","aidbits","venture",NA,"2014-02-03",NA
"28d7979f677c314d9cdc166b09434995","aidmics",NA,NA,NA,NA
"e08f104e469237e71d604ac12100f695","aihit","venture","A","2011-10-07",5500000
"e08f104e469237e71d604ac12100f695","aihit","seed",NA,"2007-12-12",2e+06
"87a5f141830d2586558a421899e74ff4","aiko-biotechnology","venture",NA,"2009-11-05",850000
"36b2885bd6a0596bb950e509cc715e4d","aileron-therapeutics","venture","B","2007-06-07",7e+06
"36b2885bd6a0596bb950e509cc715e4d","aileron-therapeutics","venture","d","2013-01-14",1.2e+07
"36b2885bd6a0596bb950e509cc715e4d","aileron-therapeutics","venture","e","2013-11-18",3e+07
"36b2885bd6a0596bb950e509cc715e4d","aileron-therapeutics","venture","d","2009-06-11",4e+07
"36b2885bd6a0596bb950e509cc715e4d","aileron-therapeutics","venture","b","2008-04-15",10500000
"36b2885bd6a0596bb950e509cc715e4d","aileron-therapeutics","venture","a","2006-12-01",7e+06
"36b2885bd6a0596bb950e509cc715e4d","aileron-therapeutics","venture","E","2014-10-29",3.3e+07
"64b49c65359c64949325fbe4c7e74757","aimatchmaker","seed",NA,"2015-09-01",138000
"4d6e8bc9259b4d9ed92d7493a6524f3f","aimbrain","seed",NA,"2015-12-17",526036.2915
"4d6e8bc9259b4d9ed92d7493a6524f3f","aimbrain","venture",NA,"2014-12-01",NA
"b33a5d703bdd0924163599eb5b3c89ce","aimeesoft",NA,NA,NA,NA
"fe3355271ca75849f11dd88703f45ef2","aimm-therapeutics","undisclosed",NA,"2009-06-03",NA
"38b630a37351a9e038a6b30b2d506d3b","aimru-technologies",NA,NA,NA,NA
"022bc34b5a48daa7c66887c4cbafe00a","aims-innovation",NA,NA,NA,NA
"8332b089c2a08ca80edbb3d30b1c7f92","air-and-gas-systems",NA,NA,NA,NA
"990830059388f60c67a82949c0cc0995","aira","venture","A","2016-01-19",3002231
"990830059388f60c67a82949c0cc0995","aira","seed",NA,"2015-10-29",790000
"fde393cea06a5ab9e6faf291e1e3cf05","aircharts",NA,NA,NA,NA
"adac9b403abab169a4b48bf986336f41","airdna",NA,NA,NA,NA
"3ce1b4f2b41999c04fae755e414da042","aire","seed",NA,"2014-06-16",3e+05
"3ce1b4f2b41999c04fae755e414da042","aire","seed",NA,"2015-01-30",1100000
"b2fed33c732c35f571b4760b7bce29d6","aires-pharmaceuticals","venture","b","2010-11-11",2e+07
"62b05362c9947b76e6b727e4cc6dd14d","aireum","venture",NA,"2013-06-28",1017026
"62b05362c9947b76e6b727e4cc6dd14d","aireum","venture",NA,"2014-08-01",2471007
"3694c934c4dc3a6accdc5d7892d5c459","airinspace","venture","b","2007-10-08",8500000
"d42959a7c15ca636fef4dbbf17a38e21","airnet-group",NA,NA,NA,NA
"45254e2682aa064ab164fd7d900d2d0c","airseed","seed",NA,"2013-05-01",5e+05
"7e0996784cb375d471993452ea8ece04","airstone-labs","private_equity",NA,"2013-01-01",2511000
"082892ff6a086fc18b1f9767a0ad7228","airware-lab","venture",NA,"2013-07-25",65000
"082892ff6a086fc18b1f9767a0ad7228","airware-lab","venture",NA,"2015-09-25",185000
"8567787af41081b3eed8d70fb65bf37b","airway-therapeutics","seed",NA,"2011-06-06",5e+05
"8567787af41081b3eed8d70fb65bf37b","airway-therapeutics","venture","1","2014-09-10",4600000
"53182e21517d40c3f1fc2288936bc111","airwoot","angel",NA,"2013-08-26",NA
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","debt_financing",NA,"2014-04-03",7e+06
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","venture","1","2012-01-23",1080000
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","venture","1","2012-04-20",1.1e+07
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","venture","1","2014-09-03",1e+06
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","venture",NA,"2009-03-25",752428
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","private_equity",NA,"2012-01-01",10308000
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","venture",NA,"2006-12-29",4e+06
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","venture",NA,"2011-03-02",5e+06
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","venture",NA,"2011-03-02",3e+06
"2779eddbf86101bbf873c1382d61d6c2","airxpanders","venture",NA,"2010-04-29",5449144
"671d1ba06d8c9dd9b5cb89fdfb426316","aisle50","venture",NA,"2012-01-05",2600000
"671d1ba06d8c9dd9b5cb89fdfb426316","aisle50","venture","1","2013-08-08",2600000
"671d1ba06d8c9dd9b5cb89fdfb426316","aisle50","seed",NA,"2011-10-18",NA
"9bd0efee367c55b4de0a29a912f57b2c","aislelabs","seed",NA,"2014-03-19",1347305
"9388754091a484ce2a2bbbc369a7321e","ait","venture",NA,"2012-12-05",1250000
"804da49d842bd77a95a19add9a912f31","ait-bioscience","venture",NA,"2014-01-07",1e+06
"a45f868ab1d2fbd13a297f2dfa562505","ajour",NA,NA,NA,NA
"7754b10e8100a9fe712f89d033f859af","akadeum-life-sciences","seed",NA,"2015-08-13",905063
"e8cc55250735997bb1920aaf1d04013e","akado-oy",NA,NA,NA,NA
"2fca45127283f87c317b4911e74e8d60","akanoo","angel",NA,"2013-01-01",5e+05
"50d6be78208ad636968b4b7146744ba1","celsus-therapeutics","private_equity",NA,"2013-10-01",12500000
"50d6be78208ad636968b4b7146744ba1","celsus-therapeutics","post_ipo_equity",NA,"2015-09-21",7.5e+07
"8f597bb5c6b31286144f9185567bd91d","akarx","venture","A","2005-08-22",6050000
"8f597bb5c6b31286144f9185567bd91d","akarx","venture","A","2006-05-10",8050000
"8f597bb5c6b31286144f9185567bd91d","akarx","venture","A","2006-10-23",2e+06
"8f597bb5c6b31286144f9185567bd91d","akarx","venture",NA,"2007-02-26",5e+06
"8f597bb5c6b31286144f9185567bd91d","akarx","venture",NA,"2007-07-13",5e+06
"67aee65069957dfc2e1db460d4d8ca55","dart-therapeutics","venture",NA,"2014-07-03",1500000
"cbfe8196af6a9727269cb18e560e1fd2","akebia-therapeutics","venture","b","2011-04-26",2.2e+07
"cbfe8196af6a9727269cb18e560e1fd2","akebia-therapeutics","venture","c","2013-06-04",4.1e+07
"cbfe8196af6a9727269cb18e560e1fd2","akebia-therapeutics","venture","A","2009-07-28",2.5e+07
"77c5e3e9a3794fb2c6d2064fad3a20bb","akelex","venture","a","2013-06-26",1e+06
"77c5e3e9a3794fb2c6d2064fad3a20bb","akelex","venture","A","2014-08-08",1500000
"77c5e3e9a3794fb2c6d2064fad3a20bb","akelex","angel",NA,"2013-07-01",1500000
"567755e3cc6aac6654435e82e789d256","akermin","venture","a","2007-11-12",5e+06
"567755e3cc6aac6654435e82e789d256","akermin","venture",NA,"2011-01-05",4077500
"567755e3cc6aac6654435e82e789d256","akermin","debt_financing",NA,"2009-08-17",6e+05
"567755e3cc6aac6654435e82e789d256","akermin","venture",NA,"2010-01-13",6073670
"567755e3cc6aac6654435e82e789d256","akermin","venture","a","2013-02-19",1500000
"567755e3cc6aac6654435e82e789d256","akermin","debt_financing",NA,"2013-08-08",1302194
"567755e3cc6aac6654435e82e789d256","akermin","grant",NA,"2013-10-21",3e+06
"4e5d2f124472d0828302b43aebc78a95","akers-biosciences",NA,NA,NA,NA
"6235d411b1fbe39925ddb5cbccc36771","akeso-biomedical","seed",NA,"2014-12-19",225000
"6235d411b1fbe39925ddb5cbccc36771","akeso-biomedical","venture",NA,"2015-07-13",535000
"c41172379c838adbad855fa24b60c592","akili-2",NA,NA,NA,NA
"4c9b00b523b52772f5821d26aa4beb30","akita","seed",NA,"2014-02-23",27478
"6db9a7ec5d476c9962c108c8f67edc95","aklero-risk-analytics",NA,NA,NA,NA
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","venture",NA,"2012-05-14",2127919
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","grant",NA,"2010-07-27",435000
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","grant",NA,"2010-09-28",3e+06
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","grant",NA,"2011-04-11",3e+05
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","grant",NA,"2012-10-02",280000
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","debt_financing",NA,"2010-03-16",5e+06
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","grant",NA,"2009-12-01",3200000
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","venture","1","2012-08-17",2.5e+07
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","venture",NA,"2010-12-13",912598
"8275c559e492641955b2b85a0fd4679a","akonni-biosystems","venture",NA,"2015-12-07",618998
"b7b5035289ea2ea314747db6e8f7b240","akorn",NA,NA,NA,NA
"31fed70a345dcf5ce4b3d9da566ff668","akoubacredit","seed",NA,"2015-07-06",118000
"afc701996fa81228dec2333da1a0a266","akshay-wellness","venture","a","2011-10-07",1797641
"afc701996fa81228dec2333da1a0a266","akshay-wellness","venture",NA,"2015-12-13",6290565
"3cc9b886c79869102ce254564bbf6616","aktana","venture","A","2013-06-24",5500000
"3cc9b886c79869102ce254564bbf6616","aktana","venture",NA,"2012-06-01",1050000
"3cc9b886c79869102ce254564bbf6616","aktana","venture","A","2011-08-23",2930000
"3cc9b886c79869102ce254564bbf6616","aktana","venture","A","2012-05-29",2049999
"3cc9b886c79869102ce254564bbf6616","aktana","venture",NA,"2013-01-08",1010000
"257ef6006f27bd4a8d0441830fc72be1","aktivax","debt_financing",NA,"2011-07-22",415252
"257ef6006f27bd4a8d0441830fc72be1","aktivax","debt_financing",NA,"2012-03-21",1e+05
"6c5aa7df2f278e277c66fbe459883950","akzo-nobel-electronic-products-inc",NA,NA,NA,NA
"bbc8c505b62afebc80751d25cf5253fe","ala-septic","equity_crowdfunding",NA,"2013-04-03",NA
"b98191b924450d051efbc456e9e5d96e","alacurity-services",NA,NA,NA,NA
"0d228dc230019fa3ad9ba3cce1d7d900","alafair-biosciences","venture",NA,"2012-01-09",702000
"0d228dc230019fa3ad9ba3cce1d7d900","alafair-biosciences","venture",NA,"2013-09-11",525000
"0d228dc230019fa3ad9ba3cce1d7d900","alafair-biosciences","debt_financing",NA,"2014-05-15",1e+06
"0d228dc230019fa3ad9ba3cce1d7d900","alafair-biosciences","non_equity_assistance",NA,"2010-12-20",NA
"2d48d4a3e41314e4215d9717cc0ec61c","alavita-pharmaceuticals-inc","venture",NA,"2009-09-21",6e+05
"f748761694ee8a62b1308229eefd9c9d","albany-molecular-research",NA,NA,NA,NA
"ec45bac6f6a375a033ca4fa023d24440","albatross-golf-network","equity_crowdfunding",NA,"2014-07-14",NA
"8f954c1bb0df59bea38b3af7bfe7349b","albert-inc",NA,NA,NA,NA
"7cf1dd1a4e3e85658cffb4cbe635c564","alberta-innovates-bio-solutions",NA,NA,NA,NA
"5097a38ade72a449aa89390756a19973","albireo","venture","a","2008-02-01",4e+07
"3386d3003f9387f77ddf3b2d698266ea","albridge",NA,NA,NA,NA
"5c0ba7dadf8e442e8c87df1453fccdb7","alchemia-oncology","venture",NA,"2011-12-23",708825
"5c0ba7dadf8e442e8c87df1453fccdb7","alchemia-oncology","venture",NA,"2011-11-11",604935
"440db59c5a37b4ee5c1d8da0f05e711b","alchemy-intellectual-property-technology-counsel",NA,NA,NA,NA
"ce71e68ddf2b3bfcb6441fc557b96b86","alchemyapi","venture","A","2013-02-15",2e+06
"789238f5c38e1b0a7af44ef61946b95c","alchimedics","venture","A","2007-03-01",3286360
"9245a864009c326a4f3208871cd24f59","alcobra-pharmaceuticals",NA,NA,NA,NA
"09ca0f0e8e232527b3db2d8151d538a3","alcon",NA,NA,NA,NA
"bb2c2d73aa27ca6cc35f9907543e92f3","alcresta","venture","a","2012-04-17",1e+07
"bb2c2d73aa27ca6cc35f9907543e92f3","alcresta","venture","b","2013-07-22",1e+07
"97a3647e9af548e01de21d01fc51f91c","alcyone-lifesciences","venture",NA,"2015-12-24",3640319
"97a3647e9af548e01de21d01fc51f91c","alcyone-lifesciences","private_equity",NA,"2013-05-09",1000004
"97a3647e9af548e01de21d01fc51f91c","alcyone-lifesciences","venture","1","2012-03-28",1800000
"97a3647e9af548e01de21d01fc51f91c","alcyone-lifesciences","venture","1","2014-01-15",4e+06
"604815139a8582ada0b00229a4a8aacd","alcyone-resources","venture",NA,"2013-10-07",4900000
"40c640807975be470cf881e04fd7d85a","alda-analytical-life-science-and-diagnostic-association",NA,NA,NA,NA
"db7000496d5f3fa7ce734eca21cfaf3f","aldagen","venture","C","2006-12-20",14300000
"db7000496d5f3fa7ce734eca21cfaf3f","aldagen","debt_financing",NA,"2012-01-13",585004
"db7000496d5f3fa7ce734eca21cfaf3f","aldagen","venture","d","2008-04-23",18400000
"db7000496d5f3fa7ce734eca21cfaf3f","aldagen","venture","c","2007-09-01",9e+06
"db7000496d5f3fa7ce734eca21cfaf3f","aldagen","debt_financing",NA,"2011-06-23",1080377
"db7000496d5f3fa7ce734eca21cfaf3f","aldagen","debt_financing",NA,"2009-10-22",7287902
"b168da22a3c416f185478dd4b0f2d4cd","aldea-pharmaceuticals","venture","a","2013-11-18",11483692
"b168da22a3c416f185478dd4b0f2d4cd","aldea-pharmaceuticals","debt_financing",NA,"2012-05-08",4513491
"b168da22a3c416f185478dd4b0f2d4cd","aldea-pharmaceuticals","venture",NA,"2013-04-01",2e+06
"b168da22a3c416f185478dd4b0f2d4cd","aldea-pharmaceuticals","venture","B","2014-08-25",2.4e+07
"2c822961bfdbf88585d32a1fcbe21915","alder-biopharmaceuticals","venture","d","2012-04-19",3.8e+07
"2c822961bfdbf88585d32a1fcbe21915","alder-biopharmaceuticals","venture","B","2006-07-01",1.6e+07
"2c822961bfdbf88585d32a1fcbe21915","alder-biopharmaceuticals","venture","A","2005-07-01",1.1e+07
"2c822961bfdbf88585d32a1fcbe21915","alder-biopharmaceuticals","venture","C","2007-12-01",4e+07
"cb0945f6a23533e243d2c558d93bc7fd","aldexa-therapeutics","venture",NA,"2013-01-03",4793666
"9dd3b221ff3bbdb834da7774e6510b63","alector","venture","D","2016-01-07",29500000
"9dd3b221ff3bbdb834da7774e6510b63","alector","venture","a","2013-10-31",NA
"9dd3b221ff3bbdb834da7774e6510b63","alector","venture","C","2015-09-16",3.2e+07
"3bb22f0fab3a211780d7fff7ac6a9cba","alenty","angel",NA,"2007-10-20",571520
"bc4d2a858d1645a23b836e081b652785","aleph-archives-srl",NA,NA,NA,NA
"2148ca5bbc57319429c91deba180e67a","alere-analytics","venture","b","2010-10-25",5e+06
"5b1e38804b28a2da1d58c8048f688175","aleth","seed",NA,"2013-10-12",15000
"93722850b0ccdbba0ebe50879c9a115c","alethia-biotherapeutics","venture","b","2012-11-02",4700000
"93722850b0ccdbba0ebe50879c9a115c","alethia-biotherapeutics","venture","a","2010-09-07",9200000
"13d54f6cb1a87e6b16321854aac78e92","alexar-therapeutics","venture","A","2015-04-30",NA
"1c89f16934bf7038d6124fe01c65c481","alexion-pharmaceuticals","seed",NA,"2015-04-02",31322.8138
"ee38d4b3e35ddbd0060df66d0d679029","alexo-therapeutics","venture",NA,"2015-05-21",18022500
"e399c3e6dce53909ab6c3bfd2d516620","alexza-pharmaceuticals","venture",NA,"2010-05-12",1010000
"e399c3e6dce53909ab6c3bfd2d516620","alexza-pharmaceuticals","post_ipo_equity",NA,"2014-03-19",4.5e+07
"e399c3e6dce53909ab6c3bfd2d516620","alexza-pharmaceuticals","venture",NA,"2009-10-06",19720309
"e399c3e6dce53909ab6c3bfd2d516620","alexza-pharmaceuticals","seed",NA,"2012-03-15",3e+06
"21023e4369dcc766af5fa7e6ae473508","alfalight","undisclosed",NA,"2011-03-03",NA
"1b827056fc1217d77d45758f6d99e56d","algae-healthcare",NA,NA,NA,NA
"a490e3fb4b6de1ca9cc08e6961487d7a","algaentis","equity_crowdfunding",NA,"2014-06-04",29000
"ea0fb3f73014d5ee66f240974ddee402","algaeon","venture",NA,"2013-05-30",770864
"ea0fb3f73014d5ee66f240974ddee402","algaeon","venture",NA,"2012-12-19",524999
"ea0fb3f73014d5ee66f240974ddee402","algaeon","venture",NA,"2014-09-17",50000
"e335bbf6720a7ebe6ad3004c873f4c84","algaeventure-systems","venture",NA,"2014-09-10",2921625
"e335bbf6720a7ebe6ad3004c873f4c84","algaeventure-systems","venture",NA,"2015-05-26",1565000
"8994cc6404a05ee8d59de8ec5d8290db","algatechnologies",NA,NA,NA,NA
"b638def69b4807f05d0f98063ac0dc63","algenetix","venture","a","2013-04-02",2e+06
"152a735a73b8704d9f6de45d50d7c118","algeta",NA,NA,NA,NA
"d9ecd725ffe76519a6b9bf06967801ce","algiax-pharmaceuticals","venture","a","2012-05-16",5477340
"03909bb78bb9845e97a91c487ae2d91e","algisys","venture",NA,"2013-08-14",6153863
"3a56b2d59879490a6f499bc04b4fe2fc","algolytics","venture","A","2013-01-01",NA
"541f1d45f49efdf45f41f1f0d6c57c77","algonell",NA,NA,NA,NA
"6666148692692b9115e52ea38fe8b08c","algonomics","venture",NA,"2007-06-20",2012351.3655
"499228d819c3d7e67ec68bb1476058ec","algonquin",NA,NA,NA,NA
"35d3397672a50dc14a7c93c1a8fb816b","algoreit",NA,NA,NA,NA
"172e09a91f9a4e73d31b07530d375d81","algorithms-io",NA,NA,NA,NA
"69b74430ab41a64b1ee6f29174875735","algoritmica",NA,NA,NA,NA
"5737a5389aab6410104487162b78a73c","algowire-technologies",NA,NA,NA,NA
"65747e969d500e8865b783a8502174a8","alignalytics","venture","a","2008-06-20",NA
"bb4f8b742f91d12de8d196203c400849","aligned-project",NA,NA,NA,NA
"35a658994b976dac6ef5eb151120e93c","alimera-sciences","post_ipo_equity",NA,"2012-10-03",4e+07
"35a658994b976dac6ef5eb151120e93c","alimera-sciences","venture","1","2009-10-01",5e+06
"35a658994b976dac6ef5eb151120e93c","alimera-sciences","venture","1","2005-11-30",31800000
"35a658994b976dac6ef5eb151120e93c","alimera-sciences","venture","1","2008-03-01",3e+07
"35a658994b976dac6ef5eb151120e93c","alimera-sciences","post_ipo_equity",NA,"2014-01-28",37500000
"35a658994b976dac6ef5eb151120e93c","alimera-sciences","post_ipo_debt",NA,"2014-04-24",3.5e+07
"b83b6b760b562fbb24aceb3444e4b650","alios-biopharma","venture","a","2009-02-12",2.4e+07
"b83b6b760b562fbb24aceb3444e4b650","alios-biopharma","venture","b","2014-04-07",4.1e+07
"b83b6b760b562fbb24aceb3444e4b650","alios-biopharma","venture","a","2009-06-11",8e+06
"163d404c8c1acaaecff6af8ff2199cec","aliva-biopharmaceuticals","venture","a","2010-01-13",12870407
"b0437c05899de9d0fd4f4c0fd7ad78e3","alive-cn","venture",NA,"2013-01-11",550000
"b0437c05899de9d0fd4f4c0fd7ad78e3","alive-cn","venture","1","2011-09-01",5e+05
"5262bbc325b4277542287f91bc3e19c2","alivestats",NA,NA,NA,NA
"c0c0532939600b7f5d9a1a883f0496ab","alix",NA,NA,NA,NA
"fc16bfe805307a6d883b4ce9562e05cb","alixarx","private_equity",NA,"2013-07-02",1e+08
"84256b4e2712c2c74c31cf4b96aa0e0b","aliz-pharma","venture",NA,"2012-06-04",4104210
"84256b4e2712c2c74c31cf4b96aa0e0b","aliz-pharma","venture","1","2014-09-10",6458571
"d8995bc87c60ca8ccd7dc2ba0fa77888","alkermes","private_equity",NA,"2014-01-13",2.5e+08
"8e10dc7c99317ff9f531f4ceaf060308","alkeus-pharmaceuticals","seed",NA,"2010-10-21",1e+05
"10c040ea145166c31028dc72ca0faead","alkyme",NA,NA,NA,NA
"4425caa92fa4e63f0e1ce8b3a88b5d0f","all-com",NA,NA,NA,NA
"59c90381c386d74a8c9eba13c7c75b3a","allakos","venture",NA,"2015-03-25",27949545
"59c90381c386d74a8c9eba13c7c75b3a","allakos","venture","1","2014-08-27",24500000
"59c90381c386d74a8c9eba13c7c75b3a","allakos","venture","1","2014-09-30",1e+07
"77682ea6792287a25a3d74aaeccfdfec","allant",NA,NA,NA,NA
"c661253501aea1ec2e971e95671dc567","allayo",NA,NA,NA,NA
"5e58e5f8b36dd6ef24be8c50cc0197e6","alldigital","venture",NA,"2011-11-08",762704
"5e58e5f8b36dd6ef24be8c50cc0197e6","alldigital","debt_financing",NA,"2013-08-30",1325000
"5e58e5f8b36dd6ef24be8c50cc0197e6","alldigital","venture",NA,"2014-02-12",637500
"5e58e5f8b36dd6ef24be8c50cc0197e6","alldigital","convertible_note",NA,"2014-12-12",750000
"b3b3893875d3c1e8e879875243912a65","allecra-therapeutics","venture","a","2013-04-18",19567500
"4d9cc2bcc56e5ed8cd6c9f676de57a16","allegiance","venture",NA,"2014-02-04",19807905
"4d9cc2bcc56e5ed8cd6c9f676de57a16","allegiance","venture",NA,"2013-01-17",14154370
"4d9cc2bcc56e5ed8cd6c9f676de57a16","allegiance","venture",NA,"2007-04-25",5700000
"4d9cc2bcc56e5ed8cd6c9f676de57a16","allegiance","venture","1","2011-06-23",1.2e+07
"4d9cc2bcc56e5ed8cd6c9f676de57a16","allegiance","venture","1","2007-01-01",5600000
"99e07ae808d6e6ea7211d976c7448702","allegro-diagnostics","venture","a","2011-07-07",5400000
"3b920e3a57cdf8c409a922751f9feea5","allegro-ophthalmics","venture",NA,"2015-01-13",2e+07
"3b920e3a57cdf8c409a922751f9feea5","allegro-ophthalmics","grant",NA,"2015-02-03",2e+06
"df2eb71b4b26828bba7c3e0c45b8012c","allegro",NA,NA,NA,NA
"1df7fd3defc50ef25f1977e11a0d0e04","allele-biotech","venture","A","2014-09-24",7e+06
"dfd587308b842a3f7314d1d8d0b2fea1","allena-pharmaceuticals","venture","C","2015-12-09",5.3e+07
"dfd587308b842a3f7314d1d8d0b2fea1","allena-pharmaceuticals","venture","a","2011-11-16",1.5e+07
"dfd587308b842a3f7314d1d8d0b2fea1","allena-pharmaceuticals","venture","B","2014-12-04",2.5e+07
"b3bf0097d53fb316091eb4559f9e7003","allenex",NA,NA,NA,NA
"3fd92a776fd06c4186dfdb8dc9fe09df","allergan",NA,NA,NA,NA
"b32f89250a9dfeb848a60d090c86382c","allergease","debt_financing",NA,"2014-04-07",1080959
"563808efb26b8ae69f08fda099654286","allfollowers-info",NA,NA,NA,NA
"af7fd36d542dc58af0fdb3c50c3211f2","allgoo",NA,NA,NA,NA
"9484e21e8a7ff6fb8359665f673a4745","alliance-pharmaceuticals",NA,NA,NA,NA
"d5e8fa869faf731ee116dd4af28305aa","alliedpath","debt_financing",NA,"2010-05-21",490000
"1f598d063d7eaaff5e81b713e39d1f15","alligacom",NA,NA,NA,NA
"3a674c8f4cb435773b6903e91b2eb689","alligator-bioscience","venture",NA,"2007-05-29",7443779
"2ad58418797327c086ff8b6138799275","alliqua","venture",NA,"2013-07-07",3e+06
"2ad58418797327c086ff8b6138799275","alliqua","venture",NA,"2012-11-16",815000
"2ad58418797327c086ff8b6138799275","alliqua","venture",NA,"2011-03-17",1e+06
"2ad58418797327c086ff8b6138799275","alliqua","venture",NA,"2013-11-06",1e+06
"2ad58418797327c086ff8b6138799275","alliqua","post_ipo_equity",NA,"2014-04-15",20300000
"2ad58418797327c086ff8b6138799275","alliqua","venture",NA,"2013-11-26",13651578
"2ad58418797327c086ff8b6138799275","alliqua","venture",NA,"2012-03-01",1050000
"c008cfdd539fe0312ad0a210504316a1","allisonhouse",NA,NA,NA,NA
"577ed9db921f57e5c41eb1afd7bbf90f","allmedic",NA,NA,NA,NA
"86828caaaa60451cbabd4dbb34077da5","allmydata",NA,NA,NA,NA
"825982b181e4e0b94477bd433135e7c6","allocade","venture","c","2010-04-07",5e+06
"825982b181e4e0b94477bd433135e7c6","allocade","venture",NA,"2009-08-07",3428218
"825982b181e4e0b94477bd433135e7c6","allocade","private_equity",NA,"2011-08-15",3159045
"6fa56d0eb44f84a98d362291bc7fbed2","allocure","venture","A","2008-07-02",14500000
"6fa56d0eb44f84a98d362291bc7fbed2","allocure","debt_financing",NA,"2011-10-13",1500000
"6fa56d0eb44f84a98d362291bc7fbed2","allocure","venture",NA,"2009-11-18",5588179
"6fa56d0eb44f84a98d362291bc7fbed2","allocure","venture","b","2012-04-02",2.5e+07
"6fa56d0eb44f84a98d362291bc7fbed2","allocure","debt_financing",NA,"2009-07-08",400080
"0e390c76e4aa38c809c387fd0954370e","allon-therapeutics","venture",NA,"2012-05-17",1626182
"0e390c76e4aa38c809c387fd0954370e","allon-therapeutics","venture",NA,"2010-03-03",1e+07
"f1855be8d2b6a59a5a6d4ff084237308","allostera-pharma","venture","c","2009-07-27",15400000
"acd59e97e7a94d70a77c998626501709","alloy-media-marketing",NA,NA,NA,NA
"e460ed8438896cf2b11c11de4bdb4756","allozyne","debt_financing",NA,"2012-02-11",2502500
"e460ed8438896cf2b11c11de4bdb4756","allozyne","venture","1","2007-10-26",3e+07
"e460ed8438896cf2b11c11de4bdb4756","allozyne","venture","1","2005-12-06",3500000
"e460ed8438896cf2b11c11de4bdb4756","allozyne","debt_financing",NA,"2013-04-05",9e+05
"1331d265edb2f2cb9ee8ef9efd4c0de5","alltech",NA,NA,NA,NA
"b69bb56af671d9f65b7a855afe7efae0","allure-security-technology-inc",NA,NA,NA,NA
"5c9da028fae7521da8dfa03019ac04f7","alluviate",NA,NA,NA,NA
"5721c86ea1da04f746a8fdf00a97f1d9","ally","venture","A","2015-04-01",2500000
"5721c86ea1da04f746a8fdf00a97f1d9","ally","angel",NA,"2014-01-01",4e+05
"8b49587b519646c2383e3a534cab4b29","allyde","seed",NA,"2014-02-01",150000
"05b65d817ba3b5b4dbc66f6e0dcb882e","allylix","venture",NA,"2007-11-29",3350000
"05b65d817ba3b5b4dbc66f6e0dcb882e","allylix","venture",NA,"2012-03-12",18200000
"05b65d817ba3b5b4dbc66f6e0dcb882e","allylix","venture","1","2010-01-28",9e+06
"bd5fa1f5b92e50222518981d9f07d8eb","allyoucanupload",NA,NA,NA,NA
"98ca0dacc7ac0cbda2e4b291c84fa49e","almirall",NA,NA,NA,NA
"1b5668bf477234bf5c1daf4253c8a737","alnara-pharmaceuticals","venture","b","2010-01-28",3.5e+07
"1b5668bf477234bf5c1daf4253c8a737","alnara-pharmaceuticals","venture","a","2008-10-30",2e+07
"ffdd1f966ff520b34930d8c0f74be3b9","alpacadb","angel",NA,"2014-02-19",48938.0444
"ffdd1f966ff520b34930d8c0f74be3b9","alpacadb","debt_financing",NA,"2014-08-12",195723.0597
"ffdd1f966ff520b34930d8c0f74be3b9","alpacadb","seed",NA,"2015-10-19",1e+06
"253352343a81e4de78b5bb0f7bcd9a86","alpha-cloud-labs",NA,NA,NA,NA
"f2d64b02496f99802014b222bcfc09b3","alpha-innotech",NA,NA,NA,NA
"dbf78c88fb10397ac9afd9d53a66ef40","alpha-lujo-inc",NA,NA,NA,NA
"2294ec944d103bb4a3cf7f54dd02d445","alpha-outlook",NA,NA,NA,NA
"acb02f507b0bc539eac6c3d85b64d79d","alpha-software-technologies-india",NA,NA,NA,NA
"096694c6bcd2a975b95cfab77c81d915","alphabet",NA,NA,NA,NA
"7c8b054acb0f90fb0629ad27b4c8bcc2","alphabeta-labs","seed",NA,"2012-07-17",40000
"d5f9759b7601bc968b626ea6022a2579","alphablox-corporation",NA,NA,NA,NA
"7c8c700b3b275e2215629b318925e734","alphabricks-technologies",NA,NA,NA,NA
"a27b818de6f51d40a07b344bd38cfb4f","alphacare-holdings","venture",NA,"2014-01-14",17415364
"a27b818de6f51d40a07b344bd38cfb4f","alphacare-holdings","undisclosed",NA,"2013-08-14",NA
"6d7a729d9db93f5d83d0f0c0387cda5c","alphacet",NA,NA,NA,NA
"243782d9243cf9b0ebbd6f16c5a3d087","alphagenius",NA,NA,NA,NA
"66b399280ef8d74afa0e2278f2f9955a","alpharma",NA,NA,NA,NA
"199ace3d592ea35d900308ba0544e534","alphateam",NA,NA,NA,NA
"b8810c1c7e5b887220b41fdc13df4ea3","alphavax","venture","E","2007-02-05",12620000
"d7d7e52c0e3f4fb0c47bc83317842585","alpine-biomed",NA,NA,NA,NA
"e371fe5081bc1ff0e717570a90e1c22c","alpine-biosciences",NA,NA,NA,NA
"ffcb23d4af1880dac8adb56e7ed1f9b4","alpine-data-labs","venture","a","2011-05-11",7500000
"ffcb23d4af1880dac8adb56e7ed1f9b4","alpine-data-labs","venture","b","2013-11-22",1.6e+07
"3a8f3b66225fe2d327237349205da46b","alpine-immune-sciences","seed",NA,"2015-01-23",1300000
"ad740d0750a98bd5dfef69f72eaf91a9","alpine-metrics",NA,NA,NA,NA
"1d0834556c6f20fad268c248f7d6b48d","alrise-biosystems",NA,NA,NA,NA
"3906bb907c52cd238c1ad757c6f6a27c","als-therapy-development-institute",NA,NA,NA,NA
"58ccfd5a0f71d8ddec6e843bfe819aea","alsamarketing",NA,NA,NA,NA
"b4a743f6aadde101d27c71b3ef0e3bd0","alseres-pharmaceuticals","venture",NA,"2009-11-04",1e+06
"b4a743f6aadde101d27c71b3ef0e3bd0","alseres-pharmaceuticals","venture",NA,"2009-03-19",3900000
"b4a743f6aadde101d27c71b3ef0e3bd0","alseres-pharmaceuticals","venture",NA,"2009-03-31",1e+06
"d1bac71829edeb05e79d24423d88f306","alshain",NA,NA,NA,NA
"744f34af181da9bf62294e1eeef31203","alt-bioscience","venture",NA,"2010-09-16",920190
"744f34af181da9bf62294e1eeef31203","alt-bioscience","venture",NA,"2015-06-26",6377770
"744f34af181da9bf62294e1eeef31203","alt-bioscience","venture",NA,"2009-11-13",853501
"a17d03370c08597718ff25c833ba066c","altacor","undisclosed",NA,"2011-02-09",3050505
"54219580ea2f9724aa12dd3bfd872181","altair-therapeutics","venture","b","2010-02-02",1.7e+07
"54219580ea2f9724aa12dd3bfd872181","altair-therapeutics","venture",NA,"2009-11-17",6466666
"529a7e7cf2b3edd1a562768dcbd28672","altammune","debt_financing",NA,"2011-01-15",46000
"4f7252d0e1f5973b40d72ad9e700d14b","altana-pharna-ag-nycomed",NA,NA,NA,NA
"8f56afdc5abbcd5abba9f7fb5862a03c","altea-therapeutics","venture",NA,"2009-05-13",3e+06
"8f56afdc5abbcd5abba9f7fb5862a03c","altea-therapeutics","debt_financing",NA,"2010-10-24",685000
"458e0b6a31e9c117e494663c225cd5bf","altegrity",NA,NA,NA,NA
"f30e2b2a52ef63cd3108780a25418003","altermune-technologies","angel",NA,"2011-09-22",7e+06
"27524b111d6f5e73cfa62944653bbffd","alternate-energy-company",NA,NA,NA,NA
"eb9673d8b6e1a68ac84591e8ab6d99b4","alterola-biotech",NA,NA,NA,NA
"60cbbd191b5d1e85ab85fdc84fa68319","alteryx","venture","C","2015-10-28",8.5e+07
"60cbbd191b5d1e85ab85fdc84fa68319","alteryx","venture","a","2011-04-05",6e+06
"60cbbd191b5d1e85ab85fdc84fa68319","alteryx","venture","a","2013-05-20",1.2e+07
"60cbbd191b5d1e85ab85fdc84fa68319","alteryx","venture","B","2014-10-06",6e+07
"e59d9594e0722352e8ee59d8706e46fc","altheadx","venture","C","2015-12-14",3e+07
"e59d9594e0722352e8ee59d8706e46fc","altheadx","venture",NA,"2009-08-13",3574514
"e59d9594e0722352e8ee59d8706e46fc","altheadx","venture",NA,"2014-04-10",150000
"e59d9594e0722352e8ee59d8706e46fc","altheadx","venture","a","2013-06-27",7249849
"cedb849f7d11a2d0d795f07864d97739","altheos","venture","a","2012-02-09",12500000
"cedb849f7d11a2d0d795f07864d97739","altheos","venture","a","2010-04-05",2e+07
"19da9366192a94f58024e82393c93a08","altherx-pharmaceuticals","venture",NA,"2013-05-02",1.5e+07
"18fdf62a34b384a65868c24eac4f3165","altheus-therapeutics","private_equity",NA,"2013-01-04",8085705
"18fdf62a34b384a65868c24eac4f3165","altheus-therapeutics","debt_financing",NA,"2011-12-08",1970243
"750d5ac6bd5e7b9ac86923f8d5228479","althia","venture",NA,"2012-11-04",3855000
"9632dcc593095d203a24240408c129ca","altilia","venture","A","2012-07-01",3284998
"79102ccac15569d36a21caa15d539b3f","altitude-organic-corporation",NA,NA,NA,NA
"ccf02155c25dcb8e99d6d453f5bc5334","altocloud","seed",NA,"2015-03-16",2e+06
"7296cd79969f9520bbb3e6807c66b9dc","altogen-labs","non_equity_assistance",NA,"2012-12-20",NA
"3746ac6a1bdf75429af6625439ec36d2","altor-bioscience","venture","C","2007-04-25",1.5e+07
"3746ac6a1bdf75429af6625439ec36d2","altor-bioscience","venture","d","2011-01-19",10300000
"3746ac6a1bdf75429af6625439ec36d2","altor-bioscience","venture",NA,"2011-01-18",11300000
"3746ac6a1bdf75429af6625439ec36d2","altor-bioscience","venture",NA,"2009-10-21",1189045
"3746ac6a1bdf75429af6625439ec36d2","altor-bioscience","venture",NA,"2010-07-26",1625000
"3746ac6a1bdf75429af6625439ec36d2","altor-bioscience","debt_financing",NA,"2010-03-29",647000
"3746ac6a1bdf75429af6625439ec36d2","altor-bioscience","private_equity",NA,"2013-03-21",5500000
"3746ac6a1bdf75429af6625439ec36d2","altor-bioscience","private_equity",NA,"2015-06-01",10715447
"bf1b2365137bb6e8151ece01ee81abd6","altoros-systems",NA,NA,NA,NA
"43d35b769357040c9aebbe25d228d25d","altra-inc",NA,NA,NA,NA
"06a6a0b047ba2cf32c0ee3c2803da7f1","altra-industrial-motion-inc",NA,NA,NA,NA
"1e7c4dbffabed8c1846b15f39dc37fec","altravax","venture","a","2009-11-30",2e+06
"5265c027267ee4fc688392155583eac1","alugue-seu-site",NA,NA,NA,NA
"6fa7eb38efc21da5703ea8539edd8bc3","alung-technologies","venture","b","2012-02-06",1e+07
"6fa7eb38efc21da5703ea8539edd8bc3","alung-technologies","venture",NA,"2010-10-22",13500000
"6fa7eb38efc21da5703ea8539edd8bc3","alung-technologies","venture","a","2010-10-11",1.4e+07
"6fa7eb38efc21da5703ea8539edd8bc3","alung-technologies","venture",NA,"2009-10-01",2581340
"6fa7eb38efc21da5703ea8539edd8bc3","alung-technologies","venture","B","2013-09-11",15800000
"6fa7eb38efc21da5703ea8539edd8bc3","alung-technologies","venture","B","2014-05-19",1e+07
"6fa7eb38efc21da5703ea8539edd8bc3","alung-technologies","venture",NA,"2011-11-11",6610403
"6fa7eb38efc21da5703ea8539edd8bc3","alung-technologies","debt_financing",NA,"2015-12-04",10531797
"f1e284e4c5d4fd9d13d1d9a7db345098","alvine-pharmaceuticals","venture","a","2009-09-15",21500000
"f1e284e4c5d4fd9d13d1d9a7db345098","alvine-pharmaceuticals","debt_financing",NA,"2011-10-21",6006000
"f1e284e4c5d4fd9d13d1d9a7db345098","alvine-pharmaceuticals","venture","a","2006-09-06",8e+06
"f1e284e4c5d4fd9d13d1d9a7db345098","alvine-pharmaceuticals","venture",NA,"2011-03-10",26500000
"f1e284e4c5d4fd9d13d1d9a7db345098","alvine-pharmaceuticals","debt_financing",NA,"2013-01-03",6006000
"f1e284e4c5d4fd9d13d1d9a7db345098","alvine-pharmaceuticals","private_equity",NA,"2013-05-14",7e+07
"9bd48ee6f48e7774466feede03e9a415","alvos-therapeutic","venture",NA,"2010-08-12",2e+06
"10115ff7bee276fe6f45cdf65ac3bab4","aly-participacoes",NA,NA,NA,NA
"d8a1413f19a4f65fd6fe142b17077602","alynome",NA,NA,NA,NA
"ba0b6b9fe23fb21af9135d9c0c8fd24d","alzheimers-drug-discovery-foundation",NA,NA,NA,NA
"e1c519f378aa678e65563f2b63dc5e9f","alzheon","venture",NA,"2015-01-09",3050000
"e1c519f378aa678e65563f2b63dc5e9f","alzheon","venture","1","2015-04-08",1e+07
"e1c519f378aa678e65563f2b63dc5e9f","alzheon","debt_financing",NA,"2015-07-27",6905000
"7fe1366a3a673f6e3922af43c6d092a1","am-pharma","venture","C","2007-08-07",3442356.5914
"7fe1366a3a673f6e3922af43c6d092a1","am-pharma","venture","d","2011-09-13",39843400
"7fe1366a3a673f6e3922af43c6d092a1","am-pharma","venture","E","2014-09-11",15773584
"f18b12cc57ec0cfc187adab0b76ddc2b","am-technology","undisclosed",NA,"2013-04-20",61399
"1fec6b61c40a08140bbc2cab5dc27d1a","amadesa","venture","a","2007-12-03",5400000
"1fec6b61c40a08140bbc2cab5dc27d1a","amadesa","venture","b","2011-10-05",7400000
"059ad7551998ec705dd077d9e858f979","amadix","venture",NA,"2013-02-10",2674800
"ab441aa1db2a059e92788a2f1f71543a","amag-pharmaceuticals",NA,NA,NA,NA
"5dbaaa4e277223a124502ef4e33dba12","amakem-nv","venture","a","2011-09-06",25378200
"f3228a1f8a06b06cbbbfb19e4ead478f","amal-therapeutics","seed",NA,"2014-02-21",NA
"3f74b00779285c7849096537a932e629","amaranth-medical","venture","b","2013-10-08",2e+07
"359b130eefd76c15164dd218ab9e168b","amarantus-biosciences","seed",NA,"2013-08-28",1299327
"359b130eefd76c15164dd218ab9e168b","amarantus-biosciences","venture",NA,"2014-11-17",3e+06
"8bf63d3914a31847ebab8c8518bf801c","amarillo-biosciences",NA,NA,NA,NA
"a2bfe6affc299e7ec773ed55e6b03c6b","amarin","private_equity",NA,"2009-10-13",7e+07
"c5e84669606760c2a69eb543c8a75ba0","amarin-neuroscience",NA,NA,NA,NA
"3c1bdd23fa740f95567f3aacd3c27e4f","amassare",NA,NA,NA,NA
"4554d7d6eca7faf475edb9f8418e62c7","amauta-marketing-internet",NA,NA,NA,NA
"3ee19a2a0d36de96676ac9b8ce4c75aa","amaxa-biosystems","undisclosed",NA,"1998-10-01",NA
"55b9172fd58f6f31f21848bbdb11afce","amber-2",NA,NA,NA,NA
"7338079f429af2c670ae77f5b3383096","amber-diagnostics",NA,NA,NA,NA
"19653ecfe076018c9c4a94fc5e197b27","ambiata",NA,NA,NA,NA
"0add5030cf300ff002795084905a85f5","ambion",NA,NA,NA,NA
"480e31e30b0ac8652deaf7247f8441cb","ambit-biosciences","venture","D","2007-11-14",49300000
"480e31e30b0ac8652deaf7247f8441cb","ambit-biosciences","venture","C","2005-05-12",3.1e+07
"480e31e30b0ac8652deaf7247f8441cb","ambit-biosciences","debt_financing",NA,"2009-06-05",6428542
"480e31e30b0ac8652deaf7247f8441cb","ambit-biosciences","venture","d","2010-04-15",1.2e+07
"480e31e30b0ac8652deaf7247f8441cb","ambit-biosciences","venture",NA,"2012-11-06",5e+07
"480e31e30b0ac8652deaf7247f8441cb","ambit-biosciences","venture","d","2011-06-10",3e+07
"480e31e30b0ac8652deaf7247f8441cb","ambit-biosciences","debt_financing",NA,"2010-10-15",14999327
"71c9d737fc48f25605136ab4526e60b4","ambria-dermatology","venture",NA,"2006-11-20",706924
"2858bf3eeb19d18934f2c216e26720f2","ambrx","venture","d","2009-04-01",1e+07
"75a3785616ffea8e8e3235654da5c8c0","amc-health",NA,NA,NA,NA
"a1d391d586373ffa3ed74bf51a2fc0c3","amcure","venture","A","2014-07-23",6747501
"e4764dfa64d62757938d9f5cfabfa0c9","amdl","debt_financing",NA,"2009-05-04",1327250
"e32cb2fd6a38bfe7937a66fc0e64da82","amedica","venture","D","2007-05-17",13200000
"e32cb2fd6a38bfe7937a66fc0e64da82","amedica","venture",NA,"2012-02-16",3e+07
"e32cb2fd6a38bfe7937a66fc0e64da82","amedica","debt_financing",NA,"2013-01-09",21500000
"e32cb2fd6a38bfe7937a66fc0e64da82","amedica","debt_financing",NA,"2011-07-15",22125000
"e32cb2fd6a38bfe7937a66fc0e64da82","amedica","venture",NA,"2010-09-07",3e+07
"e32cb2fd6a38bfe7937a66fc0e64da82","amedica","debt_financing",NA,"2014-07-02",2.6e+07
"93c18bad7efcf16afc7c1d0e6355b313","amedrix","venture",NA,"2010-01-20",989240
"61da535261d409aaa5bcfdf50bf08114","amendia","venture",NA,"2011-02-01",3450000
"61da535261d409aaa5bcfdf50bf08114","amendia","venture",NA,"2009-05-14",280000
"cbd7cbf48d9e360373d8f89e3a6b01f2","ameregen-immunocure",NA,NA,NA,NA
"1f46d2ef992a3eec75b32a7a6f0a3358","american-addiction-centers","venture",NA,"2014-02-27",1929015
"1f46d2ef992a3eec75b32a7a6f0a3358","american-addiction-centers","venture",NA,"2010-02-24",110000
"1f46d2ef992a3eec75b32a7a6f0a3358","american-addiction-centers","venture",NA,"2013-03-29",6488000
"1f46d2ef992a3eec75b32a7a6f0a3358","american-addiction-centers","debt_financing",NA,"2012-03-30",350000
"271d3b2615e86141b4b05cfc3aaad875","american-association-of-pharmaceutical-scientists",NA,NA,NA,NA
"3c758c8e7872b32dc72ae61bc2997424","american-biocare","venture",NA,"2012-01-20",553731
"3c758c8e7872b32dc72ae61bc2997424","american-biocare","venture",NA,"2012-07-25",1001500
"3c758c8e7872b32dc72ae61bc2997424","american-biocare","venture",NA,"2010-12-22",249999
"7d4595dd06254272ed086a1d4f1931c8","american-caresource-holdings-inc","post_ipo_equity",NA,"2014-05-09",2e+06
"7d4595dd06254272ed086a1d4f1931c8","american-caresource-holdings-inc","post_ipo_debt",NA,"2014-07-31",5e+06
"7d4595dd06254272ed086a1d4f1931c8","american-caresource-holdings-inc","venture",NA,"2014-09-04",2520000
"7d4595dd06254272ed086a1d4f1931c8","american-caresource-holdings-inc","post_ipo_debt",NA,"2014-12-09",6e+06
"7d4595dd06254272ed086a1d4f1931c8","american-caresource-holdings-inc","post_ipo_debt",NA,"2014-12-10",2601600
"f1be9cfef31ee1bb50faad7cfbd477a2","american-code-development",NA,NA,NA,NA
"c5f839a609902b64d7ac65e57e7e1a15","american-dental-partners","undisclosed",NA,"1996-01-12",NA
"ca7c5e40dcec448d23da74f9644999b5","american-gene-technologies-international","seed",NA,"2013-09-16",1324999
"ca7c5e40dcec448d23da74f9644999b5","american-gene-technologies-international","venture",NA,"2014-10-02",340000
"4aaa92bb850b5b65cd0cbeca765e019d","american-healthtech",NA,NA,NA,NA
"132ef2042cf4cb48d37f3a6c357b7080","american-kidney-stone-management","venture",NA,"2009-10-26",90328
"132ef2042cf4cb48d37f3a6c357b7080","american-kidney-stone-management","venture",NA,"2011-02-10",127380
"8f867f9ebd03faefe3c6a4bf89b11c64","american-pathology-partners","private_equity",NA,"2012-09-01",5999999
"fef93d7cd9c0ef55393bc7f7aecac6f5","american-renal-associates-holdings","venture",NA,"2013-01-14",9422891
"fef93d7cd9c0ef55393bc7f7aecac6f5","american-renal-associates-holdings","venture",NA,"2014-06-01",5e+06
"fef93d7cd9c0ef55393bc7f7aecac6f5","american-renal-associates-holdings","venture",NA,"2015-05-04",155838
"1259810a9432ba3ff1449ff22477e2fc","american-retail-group","debt_financing",NA,"2010-07-13",1081000
"37029fb5a469a9165b6c7baae06d7d39","american-telecare","debt_financing",NA,"2009-02-25",1350000
"362cd46785b13686d769d3ced15d9e07","american-well","venture",NA,"2015-08-06",5e+06
"362cd46785b13686d769d3ced15d9e07","american-well","debt_financing",NA,"2009-10-23",1e+07
"362cd46785b13686d769d3ced15d9e07","american-well","venture","1","2012-06-28",37149345
"362cd46785b13686d769d3ced15d9e07","american-well","venture","1","2014-12-16",8.1e+07
"29b0bea2f13dfb9e8592a39d08ca487c","americantowns-com-database",NA,NA,NA,NA
"b8ebc7183e384b88317e0a480a75f8e6","amerisourcebergen-specialty-group",NA,NA,NA,NA
"a9846f7ea124006fc918baa3817445de","amersham-biosciences",NA,NA,NA,NA
"11f1f9cadb8bd91b652ebc3865ea83b1","ames-technology","debt_financing",NA,"2013-06-14",315000
"e84eede535e9d8e904e9493c78969f75","amfar","grant",NA,"2015-11-30",2e+07
"d0a09d24bab6541611c8c8fae8e3dbb1","amgen","venture",NA,"2012-03-12",175463420
"b508cd39a57df3d7f3502080e88ec792","amgen-biotech-experience","grant",NA,"2013-11-11",2500000
"e63b69b4e699ed7a6130c91648474475","ami-software",NA,NA,NA,NA
"bc653683f7933e0471b6b63517dbb6e2","amiato","seed",NA,"2013-03-15",2e+06
"75c1a0ded866fbffd9fed0cddc636eb3","amicrobe","venture","b","2011-02-22",999987
"cc4bef6f71d8447231d214323b002a6d","amicus-therapeutics","debt_financing",NA,"2013-12-31",1e+07
"cc4bef6f71d8447231d214323b002a6d","amicus-therapeutics","debt_financing",NA,"2013-12-03",1.5e+07
"cc4bef6f71d8447231d214323b002a6d","amicus-therapeutics","venture",NA,"2010-11-05",31284583
"cc4bef6f71d8447231d214323b002a6d","amicus-therapeutics","venture",NA,"2012-07-30",18582360
"e8562bf0460972749a1ff080355754f2","amidebio","venture",NA,"2011-05-09",575000
"e8562bf0460972749a1ff080355754f2","amidebio","venture",NA,"2010-02-04",274997
"e8562bf0460972749a1ff080355754f2","amidebio","debt_financing",NA,"2012-05-25",3e+05
"e8562bf0460972749a1ff080355754f2","amidebio","debt_financing",NA,"2014-05-07",4e+05
"e8562bf0460972749a1ff080355754f2","amidebio","venture",NA,"2015-01-12",279287
"383f1be76ac7f18f31d2a52eaa74618b","amigo-da-cultura","seed",NA,"2012-04-03",30000
"383f1be76ac7f18f31d2a52eaa74618b","amigo-da-cultura","seed",NA,"2011-04-06",30000
"468f92d6fff9859e678c3cdd26754bae","aminex-therapeutics","venture","A","2015-11-09",4e+06
"468f92d6fff9859e678c3cdd26754bae","aminex-therapeutics","venture",NA,"2014-07-11",1592697
"468f92d6fff9859e678c3cdd26754bae","aminex-therapeutics","venture",NA,"2014-10-12",410000
"17f667eecb91e8b037be06fa653eb15c","aminus3",NA,NA,NA,NA
"ef44a540055ae94c30e476ca0f187cac","amira-pharmaceuticals","venture","B","2007-03-23",2.5e+07
"6e2b382a93ae881b3994bd82c2c5e339","amiro-consulting-llc",NA,NA,NA,NA
"a8127fc4c7fcd0ac95f026445e50353b","amnestix",NA,NA,NA,NA
"f191ba322da9c53aadf97ccc92220991","amniochor","seed",NA,"2015-08-02",NA
"9da23ece1f8b9e7445dc5bd55a44eeaa","amniolife","venture","A","2016-01-06",689000
"9da23ece1f8b9e7445dc5bd55a44eeaa","amniolife","venture","A","2015-06-03",833000
"374e34790690bdbc60fd8cabf190abc5","amo-pharma","private_equity",NA,"2015-09-30",2.5e+07
"0e50eb84d43485cf1a3760e6b68092a8","amodo","seed",NA,"2015-11-01",36000
"9c1fbb445a941aca33fc5ea23e2b4ad0","amoobi","seed",NA,"2011-08-01",180187
"5ed39a41f17d47a8aa0e74d33f812946","amorcyte","venture",NA,"2010-11-30",525000
"5ed39a41f17d47a8aa0e74d33f812946","amorcyte","debt_financing",NA,"2011-07-21",5e+05
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2014-03-14",379233
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2013-05-02",113991
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2012-05-28",20000
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2012-01-26",100474
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2013-04-11",128218
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2014-02-11",251821
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2014-01-22",256082
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2011-03-09",350000
"ffffb228025abbf05afe89322e8df6fe","amorfix-life-sciences","venture",NA,"2013-03-16",25220
"421c61a78ed45515667433eb18873651","amepllo-labs",NA,NA,NA,NA
"448c387d2217f552a20f2db42cd912f1","ampere-analysis",NA,NA,NA,NA
"e0f72291fe8075682935849cf0925448","ampere-life-sciences","venture",NA,"2009-11-13",1367143
"6e32eb5236f296b3463138b4661c0f1d","amphastar-pharmaceuticals",NA,NA,NA,NA
"44cd86f2675ec96de83acbaf716db260","amphivena-therapeutics","venture","a","2013-07-15",1.4e+07
"9ac9ba554a7216dc04e1e4abdd6ad731","amphora-medical","venture",NA,"2015-07-15",12782106
"9ac9ba554a7216dc04e1e4abdd6ad731","amphora-medical","venture",NA,"2013-06-05",6e+05
"8859aa4cadd03cc565a12123a5081b17","ampio-pharmaceuticals","post_ipo_equity",NA,"2014-03-05",63300000
"8859aa4cadd03cc565a12123a5081b17","ampio-pharmaceuticals","venture",NA,"2011-03-25",585000
"c9440f28a2c830d5345e3d345c99cf63","ampla-pharmaceuticals","venture",NA,"2011-05-02",1500000
"c9440f28a2c830d5345e3d345c99cf63","ampla-pharmaceuticals","venture",NA,"2010-02-10",295271
"c9440f28a2c830d5345e3d345c99cf63","ampla-pharmaceuticals","venture","1","2006-12-06",5470000
"a63457a32b2c6fb91724a07ec3f5d77a","amplab",NA,NA,NA,NA
"c131e7dd692dc95d70cc407305eefb1d","amplidata","venture","a","2010-05-26",3074955
"c131e7dd692dc95d70cc407305eefb1d","amplidata","venture","C","2012-10-15",8e+06
"c131e7dd692dc95d70cc407305eefb1d","amplidata","venture","B","2012-09-12",6e+06
"c131e7dd692dc95d70cc407305eefb1d","amplidata","venture","B","2010-09-17",6e+06
"c131e7dd692dc95d70cc407305eefb1d","amplidata","venture","D","2014-03-24",1.1e+07
"c131e7dd692dc95d70cc407305eefb1d","amplidata","venture","E","2014-09-08",1e+07
"90ff0384216fa0354de3a58e45e56709","amplifinity","venture","B","2014-03-18",7e+06
"90ff0384216fa0354de3a58e45e56709","amplifinity","venture","A","2011-12-09",3600000
"90ff0384216fa0354de3a58e45e56709","amplifinity","seed",NA,"2010-01-10",2500000
"90ff0384216fa0354de3a58e45e56709","amplifinity","venture","B","2015-05-20",2489114
"062050b961b4a4b813f6f9078ce74c98","amplifr",NA,NA,NA,NA
"fd9695a4e39b648f5d3ca8cf237ff3c8","amplify-interactive",NA,NA,NA,NA
"86514dc4704e317ea0e12b381b85e02a","amplii",NA,NA,NA,NA
"a3eb315dba0fe2cc019151a9c6bd7461","amplimed-corporation","venture","C","2008-01-14",5e+06
"a3eb315dba0fe2cc019151a9c6bd7461","amplimed-corporation","venture",NA,"2010-03-03",7142093
"a3eb315dba0fe2cc019151a9c6bd7461","amplimed-corporation","debt_financing",NA,"2009-04-30",1998340
"1d6c329183cd14abfd174ebb2038df57","amplimmune","venture","A","2006-01-01",2e+07
"205cfff0eb8cd00b62931366c964ca2d","amplion-research","seed",NA,"2015-01-07",1e+06
"b2f692f326ed9d1c25ab461fdb2befc0","ampliphi-biosciences","post_ipo_equity",NA,"2013-12-16",1.8e+07
"b2f692f326ed9d1c25ab461fdb2befc0","ampliphi-biosciences","debt_financing",NA,"2013-02-25",5e+05
"b2f692f326ed9d1c25ab461fdb2befc0","ampliphi-biosciences","private_equity",NA,"2013-07-10",12490999
"b2f692f326ed9d1c25ab461fdb2befc0","ampliphi-biosciences","post_ipo_equity",NA,"2015-03-11",1.3e+07
"0fef70cbaf81c9b6b9e0aa5fc3b50829","amplitude","seed",NA,"2012-01-01",NA
"0fef70cbaf81c9b6b9e0aa5fc3b50829","amplitude","seed",NA,"2014-07-11",2e+06
"0fef70cbaf81c9b6b9e0aa5fc3b50829","amplitude","undisclosed",NA,"2013-09-10",NA
"0fef70cbaf81c9b6b9e0aa5fc3b50829","amplitude","venture","1","2015-08-05",9e+06
"6ec338ec248f6a3e88c2a84fb7fd369a","fandealio","seed",NA,"2012-03-01",175000
"6ec338ec248f6a3e88c2a84fb7fd369a","fandealio","seed",NA,"2013-12-25",375000
"6ec338ec248f6a3e88c2a84fb7fd369a","fandealio","seed",NA,"2014-07-15",450000
"6ec338ec248f6a3e88c2a84fb7fd369a","fandealio","seed",NA,"2015-04-08",1200000
"c2f310272f2c5088b06d433cfb5cb0ff","amristar",NA,NA,NA,NA
"59f76ca601f734d0a2d7ff4172814876","amrit-advanced-biotech","angel",NA,"2007-04-01",150000
"59f76ca601f734d0a2d7ff4172814876","amrit-advanced-biotech","angel",NA,"2008-07-01",698097
"59f76ca601f734d0a2d7ff4172814876","amrit-advanced-biotech","venture","1","2009-10-01",2394302
"ba81410b21939b67c3b1ea6fe2e064dd","amsbio",NA,NA,NA,NA
"a717c809520a1e4a7cb47d0b7784fe61","amsco-international",NA,NA,NA,NA
"254c8d0c89234fa1f92155b2d0c2fb83","amsplus",NA,NA,NA,NA
"ee76ca4ee0b74ba3f614f5a7c93fa88f","amstem",NA,NA,NA,NA
"e5f2d14c295f2289053bee68101cd499","amtek-company",NA,NA,NA,NA
"534d857007f34a6d020a57b788158b85","amulet-pharmaceuticals","venture","a","2007-03-05",1700000
"e256a4e9038da5918b1d6532d505c212","amura","venture",NA,"2005-05-01",1840000
"be0202965eb853a98951940d91ab7256","amvac","venture","a","2010-02-11",2800000
"c4f1a0e70e1e6219d4a92c10b4a34e1a","amylin-pharmaceuticals",NA,NA,NA,NA
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","post_ipo_equity",NA,"2010-10-12",13778480
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","post_ipo_equity",NA,"2011-10-28",7e+06
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","venture",NA,"2008-02-07",2357918
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","post_ipo_equity",NA,"2012-02-27",83700000
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","venture","1","2008-08-14",2.1e+07
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","grant",NA,"2009-12-01",24300000
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","venture","1","2009-10-01",41750000
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","venture","1","2007-09-19",7e+07
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","venture","1","2006-10-12",2e+07
"09bbf7ea2dbeced315c1ec95ca78f55a","amyris-biotechnologies","venture","1","2010-07-02",133154025
"196577d10a8254cd60ce794b7fd383ba","ana-data-consulting-inc",NA,NA,NA,NA
"71889b151251deca38da584bff7e245d","anabios","seed",NA,"2011-04-04",1318297
"0bf6636ffcc84de1a63ac3c94f94616d","anaconda-pharma","venture","b","2010-07-19",3240000
"4e0962263f4abfe35de414b198d28e77","anacor-pharmaceutical","venture",NA,"2010-07-30",1.5e+07
"4e0962263f4abfe35de414b198d28e77","anacor-pharmaceutical","grant",NA,"2010-11-04",1500000
"4e0962263f4abfe35de414b198d28e77","anacor-pharmaceutical","private_equity",NA,"2013-04-09",5e+06
"4e0962263f4abfe35de414b198d28e77","anacor-pharmaceutical","venture","1","2009-01-06",5e+07
"4e0962263f4abfe35de414b198d28e77","anacor-pharmaceutical","venture",NA,"2007-02-05",5e+07
"4e0962263f4abfe35de414b198d28e77","anacor-pharmaceutical","venture","1","2005-05-11",2.5e+07
"4e0962263f4abfe35de414b198d28e77","anacor-pharmaceutical","debt_financing",NA,"2013-06-12",4.5e+07
"01629d42c710c96f29d1888f45ad2b1a","anaderm-research-corporation",NA,NA,NA,NA
"6c9c9b6d9af1d3bda9d8f6caab889f7a","anadys","venture",NA,"2009-06-04",17500000
"9a4a15e365ec3793059009d9a87ee78f","anagard",NA,NA,NA,NA
"298df27fae71c788fab52f1bb581c178","anagnostics","venture",NA,"2009-02-27",3790000
"68c466280a91e424b7b458e66709c1ca","analiti-co",NA,NA,NA,NA
"341bf17040dfd8e2e6b40b39313231b1","analiza","seed",NA,"2007-08-22",3e+05
"341bf17040dfd8e2e6b40b39313231b1","analiza","seed",NA,"2008-09-04",3e+05
"8950508096204705f9b73c082910b8d2","analyst-zone",NA,NA,NA,NA
"786dc8ecc001e859508c0817557b6e1d","analyte-logic","venture",NA,"2012-07-26",7e+05
"88e60015b0220b39ed59c742d9f5038c","analytic-alchemy",NA,NA,NA,NA
"bd6e5d1afc7d866693423d38d634cd5a","analytica-inc",NA,NA,NA,NA
"46e12bf466a7d26522fffdf9b463b0ba","analytical-business-solutions-ltd",NA,NA,NA,NA
"0e3dde0e6983f59a53b92de8ee6bf322","analytical-path",NA,NA,NA,NA
"c0c6970f6dff9245226b0947c4bdc5fc","analytically-driven","equity_crowdfunding",NA,"2015-08-19",NA
"11c38005912ee158250f0727ce846bff","analyticmate","seed",NA,"2013-09-01",1420000
"5278e0f0ae74e5fa430602aca8cddedf","analyticon-discovery","venture","c","2005-04-28",3040000
"9581eff79367098856ed3d0eeb748ca1","analytics-egg",NA,NA,NA,NA
"735990a0fac73700777a49f67f538095","analyticsfire",NA,NA,NA,NA
"a02b71c87d4a0c51f8eebb1d0053cca0","analytics-for-life","venture","A","2016-01-06",7165770.5472
"a02b71c87d4a0c51f8eebb1d0053cca0","analytics-for-life","venture",NA,"2015-06-02",1846400
"af9775964a7b523c38618d7c7901f52c","analytics-intelligence",NA,NA,NA,NA
"324f815c132935130fb11c4e8bef113f","analytics-matcher",NA,NA,NA,NA
"589bfe7849fbcf621d7aab9462099fcb","analytics-portfolio",NA,NA,NA,NA
"b7c34e8238e690bd8530d3988a430af5","analytics-pros",NA,NA,NA,NA
"d0b7bbd0afc719fd8f1a2f07b97ce3c8","analytics-training-institute",NA,NA,NA,NA
"bda247fa94c81fdc8ca57f0a980f6450","analytics-vidhya",NA,NA,NA,NA
"9d3f54be267fc8b9334b09a2453ce71b","analyticsmd","venture",NA,"2015-04-14",NA
"9d3f54be267fc8b9334b09a2453ce71b","analyticsmd","seed",NA,"2014-12-01",120000
"c1c91c9bde2749723994a0199c9d19ed","analyticsworks",NA,NA,NA,NA
"fb562e778d947a10226e57e51f738ba6","analytixlabs",NA,NA,NA,NA
"1b4992c25ccbb6b61e96af580f263c32","analyttica",NA,NA,NA,NA
"5a5ca960fdfbc9ea103de1ca8ca0bbd5","analyze-re","venture","A","2013-11-05",1346153
"323d3d6b21b71c499dd5de42df0b180d","analyzee",NA,NA,NA,NA
"cd9c0d228dc71f85199cf21503cf224e","analyzer-cc",NA,NA,NA,NA
"661bddd7277c3b1c95bb2f9fd51d7faa","anametrix","venture","a","2012-10-09",4400000
"661bddd7277c3b1c95bb2f9fd51d7faa","anametrix","undisclosed",NA,"2011-04-06",NA
"661bddd7277c3b1c95bb2f9fd51d7faa","anametrix","venture",NA,"2010-09-03",1150000
"1c948de9ba95eacdd1d4af134fd77015","ananto",NA,NA,NA,NA
"38cfe828096c07d745d5dca5ccacb393","anapa-biotech","venture",NA,"2007-01-25",1e+06
"ac0007c55c66b73aacb51d8ee020c455","anaphore","venture",NA,"2008-04-15",8e+06
"ac0007c55c66b73aacb51d8ee020c455","anaphore","venture","1","2009-06-09",1.3e+07
"ac0007c55c66b73aacb51d8ee020c455","anaphore","venture",NA,"2008-01-31",3300000
"72dae27a5fc3fd9d6adef1910b669e2f","anapsis","seed",NA,"2013-06-01",1e+05
"3f420445bb8d8048dcd1b02441ddfcff","anaptysbio","venture","B","2007-11-08",33900000
"3f420445bb8d8048dcd1b02441ddfcff","anaptysbio","debt_financing",NA,"2013-08-30",2022117
"3f420445bb8d8048dcd1b02441ddfcff","anaptysbio","venture",NA,"2011-10-14",8024394
"3f420445bb8d8048dcd1b02441ddfcff","anaptysbio","venture","a","2006-07-31",2e+06
"3f420445bb8d8048dcd1b02441ddfcff","anaptysbio","venture","D","2015-07-15",4e+07
"ead7f343d856e36271eb37745a0a65fb","anasac",NA,NA,NA,NA
"db56fdb27f681b3e4d080c6d6130a1cd","anavex","private_equity",NA,"2013-07-08",2600000
"db56fdb27f681b3e4d080c6d6130a1cd","anavex","post_ipo_debt",NA,"2014-03-19",1e+07
"71bc615914ca7112aa084a3187fb9c41","anboto",NA,NA,NA,NA
"710133c588c3d20592ea76e7cdd73b3a","ancera","undisclosed",NA,"2013-03-14",NA
"710133c588c3d20592ea76e7cdd73b3a","ancera","debt_financing",NA,"2013-11-25",1277500
"50fc071df21ac2727833052338fe3576","anchor-id-inc","seed",NA,"2014-07-02",3e+05
"50fc071df21ac2727833052338fe3576","anchor-id-inc","angel",NA,"2014-10-01",3e+05
"50fc071df21ac2727833052338fe3576","anchor-id-inc","convertible_note",NA,"2015-08-05",230000
"2365401de9d01fe3a879217bb7a9007a","anchor-therapeutics","venture","b","2010-08-20",1e+07
"294333b8a26f8534dc82c39a8b623eb1","ancoa-software","undisclosed",NA,"2014-12-19",NA
"294333b8a26f8534dc82c39a8b623eb1","ancoa-software","venture","1","2015-09-21",6364942.612
"a00ea02cdde8344647f81d983b9cd332","ancora-pharmaceuticals","venture",NA,"2009-11-09",8e+05
"a00ea02cdde8344647f81d983b9cd332","ancora-pharmaceuticals","venture","1","2007-05-03",NA
"af9a2ff75be3e3f30bb937a7395ca6c8","andale",NA,NA,NA,NA
"37ee7f06a6204b2d0b46affe482d51ec","andalyze","venture","b","2012-01-31",1577608
"37ee7f06a6204b2d0b46affe482d51ec","andalyze","debt_financing",NA,"2014-10-28",2145000
"37ee7f06a6204b2d0b46affe482d51ec","andalyze","debt_financing",NA,"2014-12-05",266372
"37ee7f06a6204b2d0b46affe482d51ec","andalyze","venture","B","2013-04-16",NA
"01139564e36cb94166428dbe0195b8bd","andara-bi",NA,NA,NA,NA
"272b76bba770cecdd8f82224edab6685","andbio","debt_financing",NA,"2014-11-06",NA
"93a2b8d58a63c66d42208fef8b6cbe12","andersonbrecon","debt_financing",NA,"2013-05-13",7.5e+07
"f0aa68c0e6b27cae608b33be841e4387","andiast","seed",NA,"2014-05-02",50000
"f0aa68c0e6b27cae608b33be841e4387","andiast","seed",NA,"2015-09-08",1500000
"ae7f01c8a2712c678a1e1d0afa969b73","andrew-technologies","venture","B","2009-10-09",4800000
"ae7f01c8a2712c678a1e1d0afa969b73","andrew-technologies","venture","A","2006-05-06",410000
"ae7f01c8a2712c678a1e1d0afa969b73","andrew-technologies","venture",NA,"2015-12-09",7800000
"ae7f01c8a2712c678a1e1d0afa969b73","andrew-technologies","venture","C","2011-03-24",6e+06
"ae7f01c8a2712c678a1e1d0afa969b73","andrew-technologies","venture","d","2013-05-30",6261769
"34ca72650acf3ce825f7d43ac0e55b35","andro-diagnostics","venture",NA,"2010-09-27",1307000
"1c1a2aab02ea382106d690d42e047b46","androbiosys","venture",NA,"2009-01-09",5e+05
"5137620a846b1de31893e385b54dcdb4","androjek","venture",NA,"2011-11-17",4e+05
"700ba1b4cf39281b03fbe1b9598dde55","andromeda-biotech-ltd",NA,NA,NA,NA
"9a6267f970be0a3cfe27ad347c132f56","anergis","venture","a","2011-03-28",2e+07
"9a6267f970be0a3cfe27ad347c132f56","anergis","venture","B","2014-12-03",1.5e+07
"cfb8e451518ee10806173276409c74f1","anesiva","venture",NA,"2007-12-18",2.5e+07
"cfb8e451518ee10806173276409c74f1","anesiva","venture",NA,"2009-01-30",3e+06
"cfb8e451518ee10806173276409c74f1","anesiva","debt_financing",NA,"2009-06-04",2e+06
"f8e54757ca5de2e994d593ca0a9ca520","aneumed","venture",NA,"2013-06-05",1110000
"254ac695bc1b7a7a89113f3d0ca167cf","anexon","venture",NA,"2010-10-20",7e+06
"254ac695bc1b7a7a89113f3d0ca167cf","anexon","seed",NA,"2007-12-31",5e+05
"77437695da21c8e1777ac462426f98cc","angelcam","convertible_note",NA,"2014-07-04",155000
"77437695da21c8e1777ac462426f98cc","angelcam","seed",NA,"2014-03-27",44600
"77437695da21c8e1777ac462426f98cc","angelcam","seed",NA,"2014-04-15",1e+05
"1da6f5427fa8e18805107499ee127e1b","angelkings-com",NA,NA,NA,NA
"04b9f052464b905a5494cd1c04852dea","angieslist-com-database",NA,NA,NA,NA
"30bcca8e7e33b44796eb417e1d7659a8","angioblast-systems",NA,NA,NA,NA
"a2bc0f5a5be6aa7726f2f27b65bdcd01","angiochem","venture",NA,"2005-12-12",6e+06
"a2bc0f5a5be6aa7726f2f27b65bdcd01","angiochem","venture",NA,"2005-01-01",807000
"a2bc0f5a5be6aa7726f2f27b65bdcd01","angiochem","venture",NA,"2007-12-01",3e+06
"785a43154aa489e3725b0ff08618cf5f","angiocrine-bioscience","venture",NA,"2013-03-13",3999999
"cbaa80c60f91078bdf1ba91cd1058b75","angion-biomedica","venture",NA,"2015-02-20",4356452
"aac22263ca1ace4869032c9f90bb01f8","angionics-inc",NA,NA,NA,NA
"4c2e9936225a2150653bb57545837ab7","angioscore","venture","e","2007-10-09",3e+07
"4c2e9936225a2150653bb57545837ab7","angioscore","venture",NA,"2011-04-20",1.2e+07
"43f4eba8cab2ba634aea659a05483da2","angmi","product_crowdfunding",NA,"2015-06-17",3536
"a0da6877357fcad569d67f462c2a360e","virante",NA,NA,NA,NA
"c7061b5dd739ac807599db0ca91048f6","anhui-anke-biotechnology-group-co-ltd","venture","A","2005-07-01",NA
"58d69f1eb8f5b277c8c2dc3308778b57","anhui-huaxing-hengda-biotech",NA,NA,NA,NA
"fae7c1ef3f141fa8308df1bd88fbe13b","anika-therapeutics",NA,NA,NA,NA
"a5d9287cd987b87abf9a75c36c07d81e","anima-cell-metrology-ltd",NA,NA,NA,NA
"f212817dd43b350fa4556efbd55da62b","animated-dynamics","grant",NA,"2014-09-02",150000
"90475ea416e393de80535eef4bde3c93","anime-papers",NA,NA,NA,NA
"88e7d2b4b6270c6032333d8ba396fbd3","anivax",NA,NA,NA,NA
"a64484a3b04494aed9fe87f59fe6e36c","ankasa-regenerative-therapeutics","venture","A","2015-06-23",8500000
"3500d34a4fc19cf480953d2664a5fe3b","ankh-genetics","equity_crowdfunding",NA,"2014-10-14",NA
"5cea4de67d87a79e62a385129a07a4a9","annexon","seed",NA,"2011-08-22",999999
"5cea4de67d87a79e62a385129a07a4a9","annexon","venture","1","2014-12-15",3.4e+07
"ed2407ef6161a0aa2d047103ec8bdf1a","annovation-biopharma","venture",NA,"2012-07-26",2e+06
"ed2407ef6161a0aa2d047103ec8bdf1a","annovation-biopharma","venture","1","2012-09-10",8e+06
"ed2407ef6161a0aa2d047103ec8bdf1a","annovation-biopharma","venture",NA,"2011-05-17",375000
"a71cc67d257de50c7f30a94271ade890","anodot","venture","A","2015-12-09",3e+06
"a71cc67d257de50c7f30a94271ade890","anodot","seed","A","2014-05-12",1500000
"0bc8b4930a605d12d86c5472f07b0359","anokion-sa","venture","A","2014-05-09",37500000
"1233f6b39b76c9c95f6561db804bd345","anolytech",NA,NA,NA,NA
"f69a6b993cb02635aa879aec36d0b3a1","anonymous-behaviors",NA,NA,NA,NA
"1f16dd28285d98b6dbbf44f7df127fc9","anosearch",NA,NA,NA,NA
"98131d295209a9f896e5f78e5a914bea","ansun-biopharma","venture",NA,"2015-12-22",1e+07
"7790d301c20b9c2a969bf47085a2e6f5","answergen",NA,NA,NA,NA
"286d594c4e67c64e8409ed9b70feec05","answertoit",NA,NA,NA,NA
"762eccea5e114dd1b8e1933d31a949a3","antara-software-consulting",NA,NA,NA,NA
"df4093ee03b4985dc96b8f8574eb5709","ante-up-fantasy-sports",NA,NA,NA,NA
"c0bfc5b97fcbc31c252b53276c9283f2","antegrin-therapeutics","venture",NA,"2015-10-05",1e+05
"c0bfc5b97fcbc31c252b53276c9283f2","antegrin-therapeutics","seed",NA,"2013-04-02",NA
"229dd56ba1b27b8e61e2299b2878ac71","anteis",NA,NA,NA,NA
"a4d50778bc67f09fe6f4cbd77ef3fca6","antelope-valley-surgery-center",NA,NA,NA,NA
"6b8861e8586c2fed97dfee69c312a7ab","antera-therapeutics","debt_financing",NA,"2015-06-19",265000
"c622b1706bfa259832b492e18c06a071","antezeta",NA,NA,NA,NA
"9d48e4e8b8e8fc4eeb818c817d2474cc","anthelio",NA,NA,NA,NA
"64eee18c1771de37a4432806be7b8743","anthem-marketing-solutions",NA,NA,NA,NA
"aba6833166ec81642d30c5b0c275dcfe","anthera-pharmaceuticals","venture",NA,"2008-08-14",1.9e+07
"aba6833166ec81642d30c5b0c275dcfe","anthera-pharmaceuticals","venture",NA,"2010-09-21",31500000
"d675b719ffd82d1e285a1c1107965a57","anthill","venture",NA,"2009-08-11",2564788
"e51c68596b4acaa376c437199665ebee","anti-microbial-solutions","venture",NA,"2013-02-27",1600000
"1b0db7c1ae8ee673a8819559dfecb142","antibe-therapeutics","post_ipo_equity",NA,"2014-03-31",3015398
"1b0db7c1ae8ee673a8819559dfecb142","antibe-therapeutics","seed",NA,"2013-08-12",55000
"1b0db7c1ae8ee673a8819559dfecb142","antibe-therapeutics","post_ipo_equity",NA,"2015-04-01",786000
"e1dea2657d5a07ff82d4da19448bf86a","antikoerper-online-de",NA,NA,NA,NA
"b9ef18b296039f6f6a2b02dd72e4712e","antibody-adviser",NA,NA,NA,NA
"8cdbdf1d067ecd7d0ebdc3dd6ae4d373","antidot","venture","A","2011-01-01",3500000
"0b332b9ceb3aad945d3540be5a1e6857","antisoma",NA,NA,NA,NA
"b5858b85fc27af8ecbd6e3d1ab8dd0f0","antria","venture",NA,"2013-01-29",1440000
"1b397b1bf110f506e9485b0d08716438","antriabio","venture","A","2015-12-21",2000115
"1b397b1bf110f506e9485b0d08716438","antriabio","debt_financing",NA,"2014-01-14",1420000
"1b397b1bf110f506e9485b0d08716438","antriabio","debt_financing",NA,"2012-08-16",1825000
"1b397b1bf110f506e9485b0d08716438","antriabio","debt_financing",NA,"2013-01-14",825000
"1b397b1bf110f506e9485b0d08716438","antriabio","venture",NA,"2014-04-14",7296453
"1b397b1bf110f506e9485b0d08716438","antriabio","venture",NA,"2015-01-09",7e+06
"1b397b1bf110f506e9485b0d08716438","antriabio","venture",NA,"2015-04-16",2e+06
"a1ef599dca806c2ec1820370be331905","antuit","seed",NA,"2013-08-13",3990440
"a1ef599dca806c2ec1820370be331905","antuit","venture","1","2015-01-22",5.6e+07
"f868ad2257e9db67d7c460a0464cf36e","anulex","venture","e","2010-06-07",18300000
"f868ad2257e9db67d7c460a0464cf36e","anulex","debt_financing",NA,"2010-03-17",3780000
"f868ad2257e9db67d7c460a0464cf36e","anulex","venture","c","2006-07-25",2e+07
"f868ad2257e9db67d7c460a0464cf36e","anulex","venture","d","2009-05-26",10200000
"8a68cac7cc9e5408402b7cd435c39547","anvil",NA,NA,NA,NA
"4a47e69658f9806d6401aaed9fc61579","anvil-media-inc",NA,NA,NA,NA
"d4a7f26eac8fe414a4d4487471ac68fe","anvita-health",NA,NA,NA,NA
"116a26161778cc7a39096bc044b765fa","anychart",NA,NA,NA,NA
"02ce155792ae95d03eb5fedbc1e13f51","anza-therapeutics",NA,NA,NA,NA
"d76f491adcb7fb43f0c1aa3300e7a967","nitrocell-biosciences","venture",NA,"2013-03-21",630000
"d76f491adcb7fb43f0c1aa3300e7a967","nitrocell-biosciences","venture",NA,"2014-08-28",576513
"b0ccb4c5bfb99c53163eeae94d22c98b","aoptix-technologies","venture","c","2007-05-30",1.5e+07
"b0ccb4c5bfb99c53163eeae94d22c98b","aoptix-technologies","venture","d","2009-03-20",12900000
"b0ccb4c5bfb99c53163eeae94d22c98b","aoptix-technologies","venture","e","2012-08-23",4.2e+07
"b0ccb4c5bfb99c53163eeae94d22c98b","aoptix-technologies","venture","F","2015-05-19",19977849
"d9c4b10c2a9eb99e9dc5cd221063c86e","aortx","venture",NA,"2006-12-12",5800000
"ec7d44b431b3217da4e463413e136a6e","aoxing-pharmaceutical","venture",NA,"2010-02-09",5e+06
"1936d78e5a14cde78d5f10313464ac7a","apama-medical","seed",NA,"2010-01-11",1100000
"1936d78e5a14cde78d5f10313464ac7a","apama-medical","venture","1","2013-09-16",3200000
"1936d78e5a14cde78d5f10313464ac7a","apama-medical","venture","1","2015-01-13",17500000
"87bf8c3826a2ccdd394f3b605f0cbae6","apatar",NA,NA,NA,NA
"cc45958c759314a32933e550c53af221","apatech",NA,NA,NA,NA
"b537fb97a64bea9f89241680e0f4aaef","apbeacon",NA,NA,NA,NA
"b1e29af9941a2cbafaeeb7264548b6a6","apellis-pharmaceuticals","venture","D","2016-01-07",3.2e+07
"b1e29af9941a2cbafaeeb7264548b6a6","apellis-pharmaceuticals","venture",NA,"2010-05-21",1700000
"b1e29af9941a2cbafaeeb7264548b6a6","apellis-pharmaceuticals","venture",NA,"2011-06-20",2967500
"b1e29af9941a2cbafaeeb7264548b6a6","apellis-pharmaceuticals","venture",NA,"2014-08-27",17842487
"b1e29af9941a2cbafaeeb7264548b6a6","apellis-pharmaceuticals","venture","C","2014-12-02",3.3e+07
"4698bf38e1b8c2a0651f6e7eee75a1e2","apeptico-forschung-und-entwicklung","venture","a","2010-08-05",3950000
"4c7b1306a1a83d3340cbb6936154b2a8","aperiomics","seed",NA,"2015-04-01",375000
"ab7d195a33d08b0c076910cf9146f73c","aperion-biologics","venture","C","2008-06-24",12430000
"ab7d195a33d08b0c076910cf9146f73c","aperion-biologics","venture",NA,"2011-05-31",4500000
"ab7d195a33d08b0c076910cf9146f73c","aperion-biologics","venture","D","2013-02-13",939942
"f240d0cbef122d6bf56c56500e2100bd","apertus-pharmaceuticals","grant",NA,"2011-01-01",NA
"a9d982a8e6127b412b19699b019b08c5","apervi",NA,NA,NA,NA
"c463cb90ba327446b99420564b957fd5","pervasive-health","debt_financing",NA,"2012-12-11",1593787
"c463cb90ba327446b99420564b957fd5","pervasive-health","venture","1","2013-06-07",1400000
"c463cb90ba327446b99420564b957fd5","pervasive-health","venture","1","2015-01-07",1.8e+07
"9dc9e31289720fae394278974dccfdf2","apex-therapeutics","seed",NA,"2013-06-20",2488899
"9dc9e31289720fae394278974dccfdf2","apex-therapeutics","seed",NA,"2010-10-01",NA
"9dc9e31289720fae394278974dccfdf2","apex-therapeutics","seed",NA,"2015-06-24",275000
"ec34573be0f07ab7ff8e31905e910d8b","apexigen","venture","a","2013-08-06",2e+07
"d2fe4b513c69309fb0f8ebb7be4a76f4","apextwo",NA,NA,NA,NA
"43e38dc395d88cdffd636ce5b0672b9b","aphios","grant",NA,"2012-01-24",2400000
"70b156a2084cd93215edd167d2b43d1c","aphton-corporation",NA,NA,NA,NA
"df2a9a26cc24166380439729325f3829","api-healthcare",NA,NA,NA,NA
"38f980fc57826b7b557520077bc0884f","api-ring",NA,NA,NA,NA
"9e675c126f6c95764e07261af25648f1","api-ai","venture","B","2014-07-18",2600000
"9e675c126f6c95764e07261af25648f1","api-ai","venture","A","2012-05-25",3e+06
"9e675c126f6c95764e07261af25648f1","api-ai","undisclosed",NA,"2014-01-30",NA
"9e675c126f6c95764e07261af25648f1","api-ai","venture","C","2015-08-19",3e+06
"e4dc3e2df117d94263de6410084e5852","apiary","angel",NA,"2011-12-23",120000
"e4dc3e2df117d94263de6410084e5852","apiary","seed",NA,"2013-09-17",1630000
"e4dc3e2df117d94263de6410084e5852","apiary","venture","1","2015-08-18",6800000
"d056a30d3d6cec15cf8593ab95f66b4f","apicube",NA,NA,NA,NA
"bb06173ecb672e07539411d3aa9c44ac","apieron","venture","a","2003-01-01",4600000
"bb06173ecb672e07539411d3aa9c44ac","apieron","venture","b","2005-01-01",1.6e+07
"bb06173ecb672e07539411d3aa9c44ac","apieron","venture","c","2007-06-29",1.7e+07
"bb06173ecb672e07539411d3aa9c44ac","apieron","venture","d","2009-06-02",5900000
"86b37081816439e60bf0dfc68c137b93","apifix","venture","b","2013-10-22",NA
"efad90212d49929965dc59128176aea3","apim-therapeutics","undisclosed",NA,"2011-11-10",NA
"7d394385c32331849b96af3d7b35e338","apimetrics","seed",NA,"2014-09-30",150000
"7d394385c32331849b96af3d7b35e338","apimetrics","seed",NA,"2015-02-17",5e+05
"665c5cc54682f0d4b652ca1926ee9e74","apitope","venture","B","2015-09-29",13456610
"3d41064546bc605d6a34f511187b3f68","apixio","venture","a","2009-12-30",501252
"3d41064546bc605d6a34f511187b3f68","apixio","venture","a","2011-03-23",2785999
"3d41064546bc605d6a34f511187b3f68","apixio","venture",NA,"2012-08-16",5791918
"3d41064546bc605d6a34f511187b3f68","apixio","venture","C","2014-05-27",13500000
"bad9026f5f98e4d2e5bee523f801a1c7","apmetrix","undisclosed",NA,"2013-09-22",NA
"b9007e6aeebf42d6834c73ad90b5aa5a","apofore","venture",NA,"2011-08-01",5e+05
"98330431efef05c4fd83b9db0dcade70","apogenix","venture","c","2012-02-28",1e+07
"d250f5e2549deed0469ad00220f96345","apollo-endosurgery","venture","A","2007-10-08",11500000
"d250f5e2549deed0469ad00220f96345","apollo-endosurgery","venture",NA,"2012-02-06",47600000
"d250f5e2549deed0469ad00220f96345","apollo-endosurgery","debt_financing",NA,"2013-12-18",5e+07
"d250f5e2549deed0469ad00220f96345","apollo-endosurgery","private_equity",NA,"2013-12-18",4e+07
"d250f5e2549deed0469ad00220f96345","apollo-endosurgery","debt_financing",NA,"2009-03-23",3e+06
"d250f5e2549deed0469ad00220f96345","apollo-endosurgery","venture",NA,"2013-07-03",5e+06
"d250f5e2549deed0469ad00220f96345","apollo-endosurgery","debt_financing",NA,"2015-03-10",5e+07
"d250f5e2549deed0469ad00220f96345","apollo-endosurgery","venture","C","2014-08-01",60727392
"b8eee9cb3fb9d6eb181f3366e0b8fe6e","apomio","angel",NA,"2008-02-01",NA
"bcd9014c74e928e43dfb88ad73ff4485","aponia-laboratories","debt_financing",NA,"2011-01-31",782000
"bcd9014c74e928e43dfb88ad73ff4485","aponia-laboratories","venture",NA,"2012-03-06",460000
"bcd9014c74e928e43dfb88ad73ff4485","aponia-laboratories","venture",NA,"2013-01-31",3271712
"bcd9014c74e928e43dfb88ad73ff4485","aponia-laboratories","venture",NA,"2015-03-27",1169025
"0ae864672bd0c9cbfb0887fd3ad67396","apoptos",NA,NA,NA,NA
"966eb701f1f5c767fb63378e5cb3aad3","aposense","venture",NA,"2008-08-20",7300000
"966eb701f1f5c767fb63378e5cb3aad3","aposense","venture",NA,"2010-05-23",3e+06
"966eb701f1f5c767fb63378e5cb3aad3","aposense","venture",NA,"2006-11-09",1.2e+07
"53bd344f78d4a103fe85d6df9b0ac88d","apovax","debt_financing",NA,"2012-11-27",125000
"53bd344f78d4a103fe85d6df9b0ac88d","apovax","debt_financing",NA,"2011-12-07",250000
"5836bc324cc0e2ee8aefe6e577f068b7","app-annie","venture","E","2016-01-13",6.3e+07
"5836bc324cc0e2ee8aefe6e577f068b7","app-annie","venture","b","2012-08-14",6e+06
"5836bc324cc0e2ee8aefe6e577f068b7","app-annie","venture","a","2011-07-07",1e+06
"5836bc324cc0e2ee8aefe6e577f068b7","app-annie","venture","c","2013-09-18",1.5e+07
"5836bc324cc0e2ee8aefe6e577f068b7","app-annie","venture","C","2014-05-28",1.7e+07
"5836bc324cc0e2ee8aefe6e577f068b7","app-annie","venture","D","2015-01-13",5.5e+07
"b7f2c7f33ff3b54403dd93da9d840494","app-enlight",NA,NA,NA,NA
"bfa47cd55474612c8f2ab389d07a23ba","app-insights",NA,NA,NA,NA
"1bc72622561e4c54264d698becc16639","app2you","grant",NA,"2009-07-01",129000
"1bc72622561e4c54264d698becc16639","app2you","grant",NA,"2012-06-26",577000
"1bc72622561e4c54264d698becc16639","app2you","seed",NA,"2009-04-11",40000
"2c07ea202d0fb7be55ed03851c6f0689","appanalytics","seed",NA,"2015-01-16",3e+05
"cefc4686b2b8f99750cf195c564a640a","appboy","venture","A","2013-11-06",5e+06
"cefc4686b2b8f99750cf195c564a640a","appboy","venture","B","2014-10-02",1.5e+07
"cefc4686b2b8f99750cf195c564a640a","appboy","seed",NA,"2011-11-23",1e+06
"cefc4686b2b8f99750cf195c564a640a","appboy","seed",NA,"2012-03-26",1500000
"2f87b4e0c900c48343c33c6a17c65a27","appcard","venture","a","2012-01-01",6500000
"e88ce2e7c8e33f20c149b5294555ea00","appcase",NA,NA,NA,NA
"f8a6542c23ababe6417b4e467670ccaa","appcoach","venture","A","2015-09-01",1e+07
"19502c06fd8eecb8641956d1b48a8022","apperio","seed",NA,"2014-04-30",5e+05
"19502c06fd8eecb8641956d1b48a8022","apperio","seed",NA,"2013-09-06",NA
"599f9384ff91c66f7a8d1af862832644","appfigures",NA,NA,NA,NA
"a8e96458ed4110f31e4caaed50371189","appfirst","venture","a","2011-09-06",4e+06
"a8e96458ed4110f31e4caaed50371189","appfirst","venture",NA,"2009-06-12",1e+06
"a8e96458ed4110f31e4caaed50371189","appfirst","venture","b","2012-12-06",8700000
"a8e96458ed4110f31e4caaed50371189","appfirst","seed",NA,"2010-07-01",1500000
"a8e96458ed4110f31e4caaed50371189","appfirst","debt_financing",NA,"2014-05-23",2650000
"a8e96458ed4110f31e4caaed50371189","appfirst","debt_financing",NA,"2015-02-10",2175000
"e0b015b487d232e573d4c5ae46b1c9d3","appfluent-technology","venture","a","2005-04-04",4100000
"a126bf95cd995b71efa1b826f62bfb84","appforma","seed",NA,"2014-02-25",80000
"a126bf95cd995b71efa1b826f62bfb84","appforma","seed",NA,"2013-03-05",375000
"a126bf95cd995b71efa1b826f62bfb84","appforma","seed",NA,"2013-02-01",1745000
"94561f428f135062df19970abf9cf9ff","appfusions",NA,NA,NA,NA
"626510c269c696dfcafe608968af40ae","appier","venture","B","2015-11-03",2.3e+07
"626510c269c696dfcafe608968af40ae","appier","venture","A","2014-06-18",6e+06
"376ab225e0caa54872ff73c5ccccabd2","appiness","seed",NA,"2015-08-01",768001
"376ab225e0caa54872ff73c5ccccabd2","appiness","grant",NA,"2015-07-20",463628
"0c08139ffeb1c534aae4d92ba3523d10","appistry-inc","venture","D","2011-08-02",8100000
"0c08139ffeb1c534aae4d92ba3523d10","appistry-inc","venture","b","2007-01-01",10500000
"0c08139ffeb1c534aae4d92ba3523d10","appistry-inc","venture","c","2009-01-01",3e+06
"0c08139ffeb1c534aae4d92ba3523d10","appistry-inc","venture","E","2012-05-16",5847751
"0c08139ffeb1c534aae4d92ba3523d10","appistry-inc","venture","a","2005-10-23",8500000
"0c08139ffeb1c534aae4d92ba3523d10","appistry-inc","debt_financing",NA,"2012-09-13",1500000
"0c08139ffeb1c534aae4d92ba3523d10","appistry-inc","debt_financing",NA,"2015-02-20",10250000
"df40fcc755db024f90e4ef0d22c09d34","appkay",NA,NA,NA,NA
"74c84d64345fb8d9f5bfdcfca6580e93","applause","venture","E","2014-01-14",4.3e+07
"74c84d64345fb8d9f5bfdcfca6580e93","applause","venture","C","2010-09-13",1.3e+07
"74c84d64345fb8d9f5bfdcfca6580e93","applause","venture","A","2007-10-01",2300000
"74c84d64345fb8d9f5bfdcfca6580e93","applause","venture","d","2011-12-05",1.7e+07
"74c84d64345fb8d9f5bfdcfca6580e93","applause","seed",NA,"2006-01-01",5e+05
"74c84d64345fb8d9f5bfdcfca6580e93","applause","venture","b","2008-12-01",5e+06
"fd695d7e0c1ef730af2618147b14477c","applera-corporation",NA,NA,NA,NA
"7e7d33d12c216237beeb1cfc3a94d062","applicata",NA,NA,NA,NA
"f795e404c2680b650f7cdc3667fcddd2","applied-algo",NA,NA,NA,NA
"b612bc69c1dda92ea349a5b767922df8","applied-biocode","private_equity",NA,"2012-12-06",1250000
"b612bc69c1dda92ea349a5b767922df8","applied-biocode","venture",NA,"2012-11-26",7000080
"719f76b7e0f650abd304b93d1a24391c","applied-biomath","venture",NA,"2015-05-21",505200
"1b1eb6be6c6c7f6a7bf05b1887f3b21b","applied-biomimetic","undisclosed",NA,"2010-06-01",NA
"d20ff9c2757a238749f7cea3b24461c0","applied-bioresearch","venture",NA,"2012-09-07",250000
"bb8129a7aad6aa3474aee065cc6efa4e","applied-biosystems",NA,NA,NA,NA
"2ce5aa975cfeb43f795834348552799d","applied-brain-research",NA,NA,NA,NA
"20dd4af56ee28dab090f214863ac2dd3","applied-cell-sciences",NA,NA,NA,NA
"a7f3078fd6395d04f2db6d0bc549fd75","applied-cell-technology","venture","A","2013-08-01",NA
"fc2780c80f6bd7cf8d6955e009f9e1a0","applied-direct-services-corporation-adsc",NA,NA,NA,NA
"12530a8120d16de53d83459f528435ad","applied-genetics-technologies-corporation","venture","b","2012-11-19",37500000
"12530a8120d16de53d83459f528435ad","applied-genetics-technologies-corporation","debt_financing",NA,"2012-05-03",750000
"12530a8120d16de53d83459f528435ad","applied-genetics-technologies-corporation","venture","b","2003-11-01",2.7e+07
"12530a8120d16de53d83459f528435ad","applied-genetics-technologies-corporation","venture","c","2009-06-09",11800000
"12530a8120d16de53d83459f528435ad","applied-genetics-technologies-corporation","grant",NA,"2010-09-14",1e+06
"a3b4fb4b906a9c305a1e5fa4dc435d48","applied-genomics",NA,NA,NA,NA
"9ce4dc8a2aaf82910668dd55bedb6565","applied-immune-technologies","venture",NA,"2010-04-26",4e+06
"f46b22d6b5b98abbc81d85ec802c63bd","applied-immunesciences",NA,NA,NA,NA
"7f4b18c90ee99390c2ee21ce04a64f95","applied-logic-nigeria","seed",NA,"2011-07-27",NA
"7f4b18c90ee99390c2ee21ce04a64f95","applied-logic-nigeria","convertible_note",NA,"2010-05-01",NA
"7f4b18c90ee99390c2ee21ce04a64f95","applied-logic-nigeria","seed",NA,"2008-06-01",NA
"438e8484d0208f3f2da6dd6b2e368a1d","applied-matter",NA,NA,NA,NA
"fbf55be481f582297370910a681dc734","applied-molecular-evolution",NA,NA,NA,NA
"71bd6f231b0a4884a3ed121a4698630a","applied-nanotech-holdings",NA,NA,NA,NA
"d2a01765baa3a695fcbafd5e48a6badc","applied-proteomics","venture",NA,"2012-02-06",22500000
"d2a01765baa3a695fcbafd5e48a6badc","applied-proteomics","venture","1","2013-08-20",2.8e+07
"d2a01765baa3a695fcbafd5e48a6badc","applied-proteomics","debt_financing",NA,"2012-04-27",22499993
"557ca174c9ba0ee03c53eaf64bf1a608","applied-spectral-imaging-inc",NA,NA,NA,NA
"2688ff4cd8662818240eb69fc9ee782c","applied-stemcell","venture","b","2010-03-19",1880022
"2688ff4cd8662818240eb69fc9ee782c","applied-stemcell","venture",NA,"2013-03-26",2640741
"5459e9ee645cd27b54388cb84dac7813","applied-technical-systems",NA,NA,NA,NA
"c7833e0267e2f52a41196ab1b9f2a912","applymap","seed",NA,"2014-03-15",90000
"3e9e6bfbcde8641de5c07e29a95d76e1","appnovation-technologies",NA,NA,NA,NA
"82b4d131d5486bba77bf81782c24ac33","appraisalchief-com-appraisal-data-entry-services-india",NA,NA,NA,NA
"1696d0cc83e61edf3e39ec9bb1309cad","apprankcorner",NA,NA,NA,NA
"6f20b9e11ceed34962ad578d5981e562","musichype","seed",NA,"2010-02-01",135000
"6f20b9e11ceed34962ad578d5981e562","musichype","seed",NA,"2010-12-01",450000
"6f20b9e11ceed34962ad578d5981e562","musichype","angel",NA,"2012-02-01",415000
"bc914c1e5a95aecc6b48c99a70f20192","apps-run-the-world",NA,NA,NA,NA
"0f40de2990e2e02b181ac4f912cbf32e","appsbee-solutions",NA,NA,NA,NA
"2244cee540962cc63f66e443ea4364e9","appsignal",NA,NA,NA,NA
"4162c62351df18d95de5a8439e74be9d","appslingr","seed",NA,"2013-07-10",28000
"f8857822e3215c001642cdc76f0c7fdd","appsocially","seed",NA,"2013-04-24",NA
"a5e40f8ac1fd2e05af451ff750bb0219","apptaply",NA,NA,NA,NA
"64326d74eb264ee2f9638717fd016550","apptek",NA,NA,NA,NA
"d78c8e35073a0401a72d2e2d97f438ec","apptics",NA,NA,NA,NA
"55554c88f7f0546cf755b6b6a8aaf5c9","apptopia","seed",NA,"2012-07-26",5e+05
"55554c88f7f0546cf755b6b6a8aaf5c9","apptopia","seed",NA,"2013-02-14",NA
"55554c88f7f0546cf755b6b6a8aaf5c9","apptopia","seed",NA,"2011-10-01",110000
"55554c88f7f0546cf755b6b6a8aaf5c9","apptopia","seed",NA,"2013-08-07",150000
"55554c88f7f0546cf755b6b6a8aaf5c9","apptopia","seed",NA,"2012-04-05",2e+05
"55554c88f7f0546cf755b6b6a8aaf5c9","apptopia","seed",NA,"2013-07-30",565000
"55554c88f7f0546cf755b6b6a8aaf5c9","apptopia","seed",NA,"2011-11-08",105000
"55554c88f7f0546cf755b6b6a8aaf5c9","apptopia","seed",NA,"2013-01-17",137000
"080ea8cb7e9ac6464664d9e9e7ab4ade","appuri","angel",NA,"2014-08-18",261000
"080ea8cb7e9ac6464664d9e9e7ab4ade","appuri","seed",NA,"2013-04-16",NA
"080ea8cb7e9ac6464664d9e9e7ab4ade","appuri","seed",NA,"2015-06-23",2e+06
"8e1edb2fd1e6598850cdde5a2fccb6f6","appuware",NA,NA,NA,NA
"15a39c6c184a503796d5e153329320eb","appweevr","seed",NA,"2011-01-01",3735292
"fa7b4881a30b66ce11415f53bc2add33","appyzoo","seed",NA,"2011-01-01",NA
"fa7b4881a30b66ce11415f53bc2add33","appyzoo","seed",NA,"2011-06-01",NA
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","venture",NA,"2016-01-27",3.5e+07
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","debt_financing",NA,"2012-11-10",4e+06
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","venture",NA,"2011-11-18",25700000
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","venture",NA,"2010-01-26",5500000
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","venture",NA,"2009-05-29",5e+05
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","debt_financing",NA,"2013-12-09",14893829
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","venture",NA,"2010-12-20",3940402
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","venture",NA,"2007-05-18",139000
"cba75a7c6ab76ea139e4a396ba048744","aprecia-pharmaceuticals","debt_financing",NA,"2015-08-31",38750000
"0bb3c3efa2c4ed11ef8b8865adaf69b4","apredica",NA,NA,NA,NA
"a6b3e098c9b05bdc35bceed4186651c6","apricus-biosciences",NA,NA,NA,NA
"fd641ca8619dc4207ef9853022c6a9c6","apriori-2",NA,NA,NA,NA
"c7c3b54a011fce095ec1f5a160d259a4","apropose","seed",NA,"2014-09-11",1875000
"9b30e2033dfc9a2cd2bce90ed8d60363","apsalar","venture","C","2015-11-19",8e+06
"9b30e2033dfc9a2cd2bce90ed8d60363","apsalar","venture","b","2013-08-15",9e+06
"9b30e2033dfc9a2cd2bce90ed8d60363","apsalar","seed",NA,"2010-11-01",8e+05
"9b30e2033dfc9a2cd2bce90ed8d60363","apsalar","venture","a","2011-09-13",5e+06
"482b1a387cfbb3f5b8b53658c543361c","apsara-therapeutics","debt_financing",NA,"2014-02-27",250000
"482b1a387cfbb3f5b8b53658c543361c","apsara-therapeutics","debt_financing",NA,"2014-03-31",750000
"d7b5b66553bdf462f2f718751b58fadc","apse","debt_financing",NA,"2013-10-29",667139
"d7b5b66553bdf462f2f718751b58fadc","apse","seed",NA,"2012-01-01",NA
"d7b5b66553bdf462f2f718751b58fadc","apse","seed",NA,"2015-03-04",350000
"d7b5b66553bdf462f2f718751b58fadc","apse","venture","1","2015-12-01",1e+05
"8e69ee793b97ecb90b3fda5ab26ad986","apstrata","venture",NA,"2010-11-03",1200000
"035743da4a5005c773f3f11d7927f129","apt-pharmaceuticals","venture","A","2007-10-05",2.2e+07
"035743da4a5005c773f3f11d7927f129","apt-pharmaceuticals","venture","a","2008-09-30",3.2e+07
"a7cb722891b0116739d452b72d71941d","apta-biosciences","angel",NA,"2015-07-27",1497771.7045
"a7cb722891b0116739d452b72d71941d","apta-biosciences","angel",NA,"2014-03-17",3078681.1041
"bd2bc0630bd91a4f12c4b13757682ad4","aptacam","undisclosed",NA,"2014-12-01",41250
"8e18be99a0683d1d65c22be673925fef","aptalis","seed",NA,"2011-09-02",170466
"6ecf497547526269563f285859a63c4e","aptamer-group",NA,NA,NA,NA
"e287a96eabbec5498ab91d9973774c18","aptamir-therapeutics","venture",NA,"2015-09-18",3e+06
"5ff70abc3d03043614591fa852df5f1b","aptech-computer-systems",NA,NA,NA,NA
"74b2ab7b0696c2ef61fcd794cac212f3","apthera",NA,NA,NA,NA
"1c33ed2ea0ea2299e0b7cc7b6fec4fa5","aptidata","debt_financing",NA,"2012-01-11",450000
"1c33ed2ea0ea2299e0b7cc7b6fec4fa5","aptidata","angel",NA,"2012-08-28",750000
"7a7a9ed28299d5f35ab859364b5b714c","aptiv-solutions","debt_financing",NA,"2012-04-30",5660000
"edc9e0fea6fc76863f0b45efe6e43618","apu-solutions","debt_financing",NA,"2009-09-08",359742
"fd7af9226c301275e68fd37507d8511e","aqdot","venture","B","2015-09-15",NA
"fd7af9226c301275e68fd37507d8511e","aqdot","venture","a","2013-08-20",NA
"6d80c55cb060df894fcd20d18bc28a45","aqua-pharmaceuticals",NA,NA,NA,NA
"397f92c6b22e4d350ab86f92bdff4ece","aqua-tools","venture",NA,"2010-08-27",8899100
"fef82d7398f3279bdb169241b1ec9e39","aquabounty-technologies","post_ipo_equity",NA,"2014-03-31",1e+07
"fef82d7398f3279bdb169241b1ec9e39","aquabounty-technologies","venture",NA,"2015-07-09",3e+06
"6ce30c3679196d3e684f6ea3e59010d2","aquacote",NA,NA,NA,NA
"30a608688f0aecc2337ed2a592bd2852","aquapharm-biodiscovery","venture","b","2007-07-26",8216758.0781
"30a608688f0aecc2337ed2a592bd2852","aquapharm-biodiscovery","venture","b","2005-08-16",1610000
"30a608688f0aecc2337ed2a592bd2852","aquapharm-biodiscovery","venture","c","2010-04-05",6400000
"a69413c7ae760a46d78c2b628744e6b3","aquaphytex",NA,NA,NA,NA
"475639442520ed14fbbb714a173ba6da","aquarisplus-int","equity_crowdfunding",NA,"2014-06-04",NA
"4e081a4520c1f1c0e25422db7eda64e2","aquarius-biotechnologies","venture",NA,"2013-10-15",327260
"0362e3ed3985f02286c3c72b0fcb935d","aquatic-informatics","undisclosed",NA,"2010-04-01",NA
"2fa9ec8c3bc63c3ad8eea00af1585ac3","aquavit-pharmaceuticals","venture",NA,"2012-12-30",329982
"b2bb15a6f067e071667134b6339a93e1","aqueduct-critical-care","venture",NA,"2015-09-04",3712304
"c35132b58a0e7c7cef463a0aad236f6a","aqueous-biomedical","venture",NA,"2009-08-25",2e+05
"ba708376e275d27425ec54ae10952b3a","aquilon-erp-software",NA,NA,NA,NA
"32052ca8d09488b0f25e554ef1263fbc","aquinox-pharmaceuticals","venture","A","2007-06-12",14500000
"32052ca8d09488b0f25e554ef1263fbc","aquinox-pharmaceuticals","venture","b","2010-06-25",3531483
"32052ca8d09488b0f25e554ef1263fbc","aquinox-pharmaceuticals","venture","c","2013-04-03",1.8e+07
"32052ca8d09488b0f25e554ef1263fbc","aquinox-pharmaceuticals","venture","b","2010-06-17",2.5e+07
"32052ca8d09488b0f25e554ef1263fbc","aquinox-pharmaceuticals","venture",NA,"2011-02-12",4724298
"32052ca8d09488b0f25e554ef1263fbc","aquinox-pharmaceuticals","private_equity",NA,"2011-09-21",3536035
"32052ca8d09488b0f25e554ef1263fbc","aquinox-pharmaceuticals","venture",NA,"2010-04-15",4827549
"c49ef3df768757133225fce03c2941ee","aradigm","venture",NA,"2010-06-29",4108777
"5c46541b4bdd63733ba3405fdbc41ed2","aragen-bioscience",NA,NA,NA,NA
"a96edf9d736efaf98ee71403aea16f19","aragon-pharmaceuticals","venture","d","2012-10-04",5e+07
"a96edf9d736efaf98ee71403aea16f19","aragon-pharmaceuticals","venture","c","2012-03-06",4.2e+07
"a96edf9d736efaf98ee71403aea16f19","aragon-pharmaceuticals","venture","b","2010-04-22",2.2e+07
"a96edf9d736efaf98ee71403aea16f19","aragon-pharmaceuticals","venture","a","2009-05-27",8e+06
"b74bf16bee27364e05043857b9415f5b","aragorn-technologies",NA,NA,NA,NA
"63d88f3785f4b30c4a0a8b388ad72f2e","araim-pharmaceuticals","venture",NA,"2014-11-17",4e+06
"ae741f61caf83a44e9ba3bbfd058c0b6","aranca",NA,NA,NA,NA
"9a2f2db2fc831b73388bced299e22c20","aranex-biotech","venture",NA,"2015-04-30",NA
"a813d17351767617717b45a17ebfa279","aratana-therapeutics","post_ipo_debt",NA,"2015-12-13",4e+07
"a813d17351767617717b45a17ebfa279","aratana-therapeutics","venture","1","2013-01-31",1.2e+07
"a813d17351767617717b45a17ebfa279","aratana-therapeutics","venture","1","2011-01-07",2e+07
"a813d17351767617717b45a17ebfa279","aratana-therapeutics","venture","1","2011-12-07",1.5e+07
"a813d17351767617717b45a17ebfa279","aratana-therapeutics","venture",NA,"2013-10-24",29750000
"60491f4e2d4ddb5898095a757f981e9d","arax-capital-partners",NA,NA,NA,NA
"e1ac2b22b8db968d7559a49ba727629c","arbitrize-llc",NA,NA,NA,NA
"6bafb8183db175f6908621deabd59c02","arbor-pharmaceuticals","venture","b","2010-11-11",34800000
"f772ef7a123f8eceb98edd32a3c2269b","arborgen",NA,NA,NA,NA
"89414218f1a56dabd780dbd74196c4c9","arbormetrix","venture","b","2013-07-16",7e+06
"89414218f1a56dabd780dbd74196c4c9","arbormetrix","venture","b","2014-02-10",1300000
"89414218f1a56dabd780dbd74196c4c9","arbormetrix","debt_financing",NA,"2015-05-21",1437605
"ddd482024621e7fb802d3b6c4834976d","arborvita-associates",NA,NA,NA,NA
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","venture","B","2007-06-12",1.8e+07
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","venture","A","2006-03-03",1.5e+07
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","venture",NA,"2009-10-23",499999
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","venture",NA,"2013-06-17",1250000
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","venture",NA,"2012-10-31",325000
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","venture",NA,"2012-01-05",4549285
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","venture",NA,"2014-02-20",326158
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","venture",NA,"2012-12-28",250000
"570c59c6fff348496a0a2e22bcb80e26","arca-biopharma","post_ipo_equity",NA,"2015-06-25",51650404
"b0dba27dfb93e5e7dadb4c245ed4ad5f","arcadia-biosciences","private_equity",NA,"2015-12-31",2.5e+07
"b0dba27dfb93e5e7dadb4c245ed4ad5f","arcadia-biosciences","private_equity",NA,"2011-11-30",1e+07
"b0dba27dfb93e5e7dadb4c245ed4ad5f","arcadia-biosciences","private_equity",NA,"2008-10-31",1.5e+07
"b0dba27dfb93e5e7dadb4c245ed4ad5f","arcadia-biosciences","private_equity",NA,"2014-05-08",3.3e+07
"b0dba27dfb93e5e7dadb4c245ed4ad5f","arcadia-biosciences","private_equity",NA,"2005-06-15",1.8e+07
"b0dba27dfb93e5e7dadb4c245ed4ad5f","arcadia-biosciences","private_equity",NA,"2010-04-30",2.5e+07
"198bc83b0e293ac5108db820d0c86e50","arcadia-ecoenergies","debt_financing",NA,"2014-06-10",2e+05
"13075f6f9ea87579619d4cea72fe351a","arcametrics-systems-inc","grant",NA,"2012-11-29",NA
"13075f6f9ea87579619d4cea72fe351a","arcametrics-systems-inc","seed",NA,"2013-01-11",350000
"13075f6f9ea87579619d4cea72fe351a","arcametrics-systems-inc","seed",NA,"2012-08-27",50000
"13075f6f9ea87579619d4cea72fe351a","arcametrics-systems-inc","seed",NA,"2013-11-30",140000
"6d61e694926f367d609fbbcf41be50cd","arcarios","seed",NA,"2010-08-25",NA
"22b08fea3249c42ed12bd7b4d7bce277","arch-biopartners","venture",NA,"2014-04-07",140000
"22b08fea3249c42ed12bd7b4d7bce277","arch-biopartners","post_ipo_equity",NA,"2014-08-18",155519
"22b08fea3249c42ed12bd7b4d7bce277","arch-biopartners","post_ipo_equity",NA,"2015-01-22",265000
"71ecc1ed00888bc85d0885a60e5302a7","arch-therapeutics","debt_financing",NA,"2010-09-21",75000
"71ecc1ed00888bc85d0885a60e5302a7","arch-therapeutics","debt_financing",NA,"2013-06-20",370397
"71ecc1ed00888bc85d0885a60e5302a7","arch-therapeutics","venture",NA,"2014-02-07",2850000
"71ecc1ed00888bc85d0885a60e5302a7","arch-therapeutics","convertible_note",NA,"2015-03-17",750000
"71ecc1ed00888bc85d0885a60e5302a7","arch-therapeutics","private_equity",NA,"2015-07-01",3e+06
"c53a543bceb44cb243d45694ad1848e8","archer-gray-productions",NA,NA,NA,NA
"5582091859b89bf5973b6497602baca3","archer-pharmaceuticals","venture",NA,"2008-11-26",2700000
"e15b34b2d3ade3685df1653acd7ef7be","archimedes",NA,NA,NA,NA
"2661680698432a672329097316e69f8a","archimedes-pharma","venture","c","2010-04-05",9.9e+07
"fe9d090e468f4639c992e04aafe7e7f6","archiref",NA,NA,NA,NA
"6431475e351f83de3a2824d145c8b445","arcion-therapeutics","venture","A","2007-12-13",8850000
"6431475e351f83de3a2824d145c8b445","arcion-therapeutics","debt_financing",NA,"2010-02-01",5e+06
"6431475e351f83de3a2824d145c8b445","arcion-therapeutics","debt_financing",NA,"2010-11-02",4e+05
"6431475e351f83de3a2824d145c8b445","arcion-therapeutics","debt_financing",NA,"2010-04-22",1250000
"6431475e351f83de3a2824d145c8b445","arcion-therapeutics","debt_financing",NA,"2012-10-02",1500000
"63cb10a5ca4b9234e0c1920493831529","arck-interactive",NA,NA,NA,NA
"a6b0c949c1efcac59f66e13f9ba8afee","arcot",NA,NA,NA,NA
"5461bf7e1fdad6e6770f8c04d851bb55","arctic-apples",NA,NA,NA,NA
"e196f502c3520df2b7f3a563779b13ee","arcturus-biocloud","convertible_note",NA,"2015-06-15",1e+05
"e196f502c3520df2b7f3a563779b13ee","arcturus-biocloud","convertible_note",NA,"2015-04-23",25000
"e196f502c3520df2b7f3a563779b13ee","arcturus-biocloud","seed",NA,"2015-02-28",1e+05
"e196f502c3520df2b7f3a563779b13ee","arcturus-biocloud","seed",NA,"2015-01-28",2000
"743533d62f52fcdf6856cbaabbd5e7c5","arcxis-biotechnologies","venture","b","2007-10-01",2e+06
"743533d62f52fcdf6856cbaabbd5e7c5","arcxis-biotechnologies","venture",NA,"2010-05-25",1440000
"14f12917c44c25db22cfe0da748a1416","ardea-biosciences",NA,NA,NA,NA
"30e73c7727f30ce1358ee778701b9222","ardelyx","debt_financing",NA,"2010-11-16",5013694
"30e73c7727f30ce1358ee778701b9222","ardelyx","venture","1","2011-08-31",3e+07
"30e73c7727f30ce1358ee778701b9222","ardelyx","venture","1","2015-06-22",77771627
"99d0e44035ecdfa13de407db04e59eca","areametrics","seed",NA,"2015-11-24",NA
"99d0e44035ecdfa13de407db04e59eca","areametrics","angel",NA,"2014-12-01",435000
"41803252c8b5d5d03599256cda93e36e","arena-pharmaceuticals","private_equity",NA,"2010-06-03",35500000
"41803252c8b5d5d03599256cda93e36e","arena-pharmaceuticals","private_equity",NA,"2012-01-11",3.3e+07
"41803252c8b5d5d03599256cda93e36e","arena-pharmaceuticals","private_equity",NA,"2009-06-17",151760000
"ccf28fad8136ad2042e3fdac552be86b","arevo-health",NA,NA,NA,NA
"7a373c9599bc836e6da8adfbfb5bd294","arganteal","venture",NA,"2013-12-15",611076
"4683508ca5d8aadab86f82649bf5bf77","argen-x","venture","b","2011-12-01",43849000
"4683508ca5d8aadab86f82649bf5bf77","argen-x","venture","a","2009-09-10",13600000
"4683508ca5d8aadab86f82649bf5bf77","argen-x","venture","a","2010-02-11",4500000
"4683508ca5d8aadab86f82649bf5bf77","argen-x","grant",NA,"2015-05-19",1694889
"e0605a77843f6e1927bc976e651c6807","argil-data-corp","seed",NA,"2014-07-19",NA
"2295ec574a6b304f121482c4f9836fb0","argo","seed",NA,"2015-01-13",1525000
"c95cbc7c4a36faf9e915496edf8ccb33","argonaut-technologies",NA,NA,NA,NA
"5f231530661021468842f72de5aa1b87","argoncredit","seed",NA,"2014-09-01",1800000
"5f231530661021468842f72de5aa1b87","argoncredit","venture","1","2015-02-18",3e+06
"5f231530661021468842f72de5aa1b87","argoncredit","seed",NA,"2014-04-01",250000
"5f231530661021468842f72de5aa1b87","argoncredit","debt_financing",NA,"2015-05-19",7.5e+07
"336f6129cc0c0186ef411595a7379d56","argos-therapeutics","venture","d","2012-04-24",2.5e+07
"336f6129cc0c0186ef411595a7379d56","argos-therapeutics","debt_financing",NA,"2010-09-21",4852074
"336f6129cc0c0186ef411595a7379d56","argos-therapeutics","debt_financing",NA,"2011-07-29",3500000
"336f6129cc0c0186ef411595a7379d56","argos-therapeutics","venture","e","2013-11-20",17500000
"336f6129cc0c0186ef411595a7379d56","argos-therapeutics","venture","e","2013-08-26",42500000
"336f6129cc0c0186ef411595a7379d56","argos-therapeutics","post_ipo_debt",NA,"2014-09-30",2.5e+07
"336f6129cc0c0186ef411595a7379d56","argos-therapeutics","post_ipo_equity",NA,"2015-04-15",1e+07
"2bb0460b489bbb8723baf3add0153e71","argus-biomedical",NA,NA,NA,NA
"ec638597f501eeb30c7a1e23a0e2e895","argus-insights","angel",NA,"2010-05-01",2e+05
"3c99a5d536599eff5853d2fa5bb6e826","argutus-medical",NA,NA,NA,NA
"628d95faa064ab81c2ff7b2bc7f42139","argyle-executive-forum","private_equity",NA,"2015-06-16",NA
"4290bfb91f89666f4fc931ad67b941ff","argyle","seed",NA,"2010-10-01",325000
"4290bfb91f89666f4fc931ad67b941ff","argyle","venture","1","2011-08-08",1240000
"d9759f67369575fc626fe482b5494577","ari-inc","equity_crowdfunding",NA,"2007-01-26",NA
"68fde85dfe1bacd8e76e177a6a736d30","aria-analytics","venture","b","2007-11-12",350000
"dd7b3915a3babfac930e18ffb3389126","ariadne-diagnostics","seed",NA,"2013-01-01",1e+05
"b0a39df5eab6b7e89c6bfefe0b916377","aridhia-informatics","undisclosed",NA,"2009-03-01",849445
"b0a39df5eab6b7e89c6bfefe0b916377","aridhia-informatics","venture",NA,"2014-12-18",783150
"2c3412ddcd9ce4b3871259f4d4d8a5b3","aridis-pharmaceuticals","debt_financing",NA,"2014-07-17",3500000
"8e99b0ce82cdf7119edb2ed099453b79","ariel-pharmaceuticals",NA,NA,NA,NA
"659b6775a932fb4847978bea7e01016a","arigene",NA,NA,NA,NA
"fc73a3c4b8ccb44450983b34809de300","ariip",NA,NA,NA,NA
"4a1dfa167949a7dc2a0782588091345d","adatao","venture","A","2014-08-07",1.3e+07
"f5c1feacbb4b0b8678a75f6b8c4a9c77","ario-pharma","seed",NA,"2013-12-11",3100000
"bec45741388579cc6322a8a54741c9b8","arion-biotech",NA,NA,NA,NA
"e3a79ca794eba256799a75ed653d8e5c","ariosa-diagnostics-inc","venture","c","2012-01-09",52700000
"e3a79ca794eba256799a75ed653d8e5c","ariosa-diagnostics-inc","venture","A","2009-01-01",2e+06
"e3a79ca794eba256799a75ed653d8e5c","ariosa-diagnostics-inc","venture","B","2010-05-01",12800000
"b7ea78d25e17a537f4286cd0fcbb665d","arisaph-pharmaceuticals","venture",NA,"2013-11-01",1e+07
"a2a7367e4786ac9da34d55ff9f181a2e","arisgen",NA,NA,NA,NA
"71a9afae15b49fc2551620334c92173d","arismore",NA,NA,NA,NA
"098989878a1acbb3f24613f94c26efb3","ariste-medical","seed",NA,"2012-10-30",1275000
"098989878a1acbb3f24613f94c26efb3","ariste-medical","venture",NA,"2015-04-21",4600000
"0dc49e28edaded688257c73052398a09","aristocrat-technologies-inc",NA,NA,NA,NA
"a8c0843082b0109ba46f5793b27bb7ff","arius-research","venture",NA,"2006-03-01",21500000
"a8c0843082b0109ba46f5793b27bb7ff","arius-research","venture",NA,"2005-11-18",2e+06
"a4339e2961bf0bc3b504822314b2149a","arizona-instrument",NA,NA,NA,NA
"7004a9ed74159c17922348f57a8c6642","arjuna-solutions","venture",NA,"2014-05-07",690000
"28adc625d5d10524c98a67afeb630cd2","ark-it-solutions",NA,NA,NA,NA
"c375c8c67e23c3a500e5dcbc5b5184cf","ark-paradigm",NA,NA,NA,NA
"6f6335f9efe5f7ecda753990ff1ebd4d","arkansas-childrens-hospital","grant",NA,"2013-09-20",3500000
"53793e0d2de8448714213fb49b677f57","arkansas-genomics-llc","equity_crowdfunding",NA,"2012-04-19",NA
"f800322f3001da814f74857a3cc813d8","arktos",NA,NA,NA,NA
"8346498e71b95f7fc3c6f7af933de510","arlington-healthcare","debt_financing",NA,"2010-02-24",50000
"d5383750f3b6aeefc59b4bf536a06221","armagen-technologies","venture",NA,"2012-11-27",8492899
"d5383750f3b6aeefc59b4bf536a06221","armagen-technologies","venture","1","2012-11-29",1.7e+07
"2ca1bc9874e9b28439d0814e3c09d926","armgo-pharma-inc","seed",NA,"2011-08-24",1e+06
"4dcdbcce73e662d1f637fd0f46de5d03","armo-biosciences","venture","a","2013-11-25",2e+07
"4dcdbcce73e662d1f637fd0f46de5d03","armo-biosciences","venture","B","2014-05-28",3e+07
"e11fb0609c14afed9a87be7a02640b14","armune-bioscience","debt_financing",NA,"2013-04-29",1399999
"e11fb0609c14afed9a87be7a02640b14","armune-bioscience","debt_financing",NA,"2009-08-11",4e+05
"e11fb0609c14afed9a87be7a02640b14","armune-bioscience","debt_financing",NA,"2010-12-22",250000
"e11fb0609c14afed9a87be7a02640b14","armune-bioscience","venture",NA,"2015-01-20",3537583
"e11fb0609c14afed9a87be7a02640b14","armune-bioscience","venture",NA,"2008-08-25",NA
"cb9d3558bfc2b5a3f10cb074ffe7eb21","arno-therapeutics","venture",NA,"2010-09-14",1.5e+07
"cb9d3558bfc2b5a3f10cb074ffe7eb21","arno-therapeutics","private_equity",NA,"2013-10-30",3.1e+07
"51962a559d658c1fe8c7288963a3565d","aroglyph-inc-",NA,NA,NA,NA
"f779ae870e70e760726b445ad34874cb","aromyx","seed",NA,"2015-05-19",1e+06
"4a1d13145682bffcfda14236f41c90b6","arpeggi","debt_financing",NA,"2013-01-31",195000
"660bf1c403990e30848d1d849c541622","arqule","post_ipo_equity",NA,"2011-01-19",NA
"01da0d1f73158c63199f2946fa02389b","array-biopharma","venture",NA,"2015-03-02",8.5e+07
"0f87b54a016b228e0204c326f0d4aff7","array-bridge","grant",NA,"2012-01-01",NA
"0f87b54a016b228e0204c326f0d4aff7","array-bridge","seed",NA,"2011-01-01",NA
"c3a4d4845c5310b72b2c5b3856e87108","arresto-biosciences",NA,NA,NA,NA
"4c555395ea3d964180e4db3286ef7b86","arria-nlg","venture",NA,"2013-11-14",40269828
"93c9731ab8081870fa157a3a68103795","arrien-pharmaceuticals","venture","a","2011-09-13",2e+06
"3978fc6436257d847d66d02031723a23","arris-pharmaceutical",NA,NA,NA,NA
"a439512ee7641af5b0bb35fa7d42e1a0","arrogene","debt_financing",NA,"2014-03-07",170000
"a439512ee7641af5b0bb35fa7d42e1a0","arrogene","debt_financing",NA,"2011-03-16",496550
"a439512ee7641af5b0bb35fa7d42e1a0","arrogene","venture",NA,"2010-10-12",726550
"a439512ee7641af5b0bb35fa7d42e1a0","arrogene","venture",NA,"2013-06-12",2272250
"a439512ee7641af5b0bb35fa7d42e1a0","arrogene","debt_financing",NA,"2015-01-07",250000
"a7bade9087f9491502e26f3d4ab241ec","arrow-electronics",NA,NA,NA,NA
"11b56aab060c11a8c98808544357ea5f","arrowhead-research","venture",NA,"2009-08-13",2760000
"11b56aab060c11a8c98808544357ea5f","arrowhead-research","post_ipo_equity",NA,"2013-10-14",6e+07
"11b56aab060c11a8c98808544357ea5f","arrowhead-research","post_ipo_equity",NA,"2010-01-29",3222896
"c60a4460d2f321d5b639758ce6944c43","treum",NA,NA,NA,NA
"b925c8d9aa32e31cc7ac408d8a754ee5","arsanis","venture",NA,"2010-09-22",400002
"b925c8d9aa32e31cc7ac408d8a754ee5","arsanis","venture","1","2013-09-03",2e+07
"b925c8d9aa32e31cc7ac408d8a754ee5","arsanis","venture","1","2011-02-28",1e+07
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","venture","B","2007-09-28",13100000
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","debt_financing",NA,"2010-03-19",1e+06
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","debt_financing",NA,"2010-01-20",2050000
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","debt_financing",NA,"2011-09-19",3e+06
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","debt_financing",NA,"2013-08-21",4e+06
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","debt_financing",NA,"2010-08-12",3e+06
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","venture",NA,"2010-05-18",10051308
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","venture",NA,"2009-04-14",8187500
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","debt_financing",NA,"2012-10-04",3e+06
"e7d40d876d16c9e9c7906bee30537688","arsenal-medical-inc","venture",NA,"2015-06-01",1.6e+07
"ccc39fa3f68dc1e3f97fcab0dc73bde4","arsenal-medical","venture",NA,"2011-10-26",3e+06
"ccc39fa3f68dc1e3f97fcab0dc73bde4","arsenal-medical","venture",NA,"2011-09-08",1.2e+07
"ccc39fa3f68dc1e3f97fcab0dc73bde4","arsenal-medical","debt_financing",NA,"2010-01-14",2e+06
"ccc39fa3f68dc1e3f97fcab0dc73bde4","arsenal-medical","debt_financing",NA,"2010-03-01",1e+06
"ccc39fa3f68dc1e3f97fcab0dc73bde4","arsenal-medical","venture",NA,"2010-05-19",1e+07
"7f050370a5c3a7fa337effa9eb6a1cce","art-apta-regenerative-technologies",NA,NA,NA,NA
"48803fcb5c1ffdbec1d2cf6ccce7292b","art-and-technology-holdings",NA,NA,NA,NA
"63cd95362ab9a658324a84f8298e1f91","art-of-bi-software",NA,NA,NA,NA
"a7fb4bf54d097d2296b1856b86adb7f4","arta-bioscience","grant",NA,"2012-01-01",NA
"401db734199e4f6dd50f72db0f501584","artax-biopharma","venture",NA,"2013-09-26",1268256
"401db734199e4f6dd50f72db0f501584","artax-biopharma","venture",NA,"2014-10-12",2007826
"401db734199e4f6dd50f72db0f501584","artax-biopharma","venture","1","2015-09-22",1e+07
"fbc4aff1fd5d27a3c0011be923cb9e02","arteaus-therapeutics","venture",NA,"2012-07-25",1.2e+07
"fbc4aff1fd5d27a3c0011be923cb9e02","arteaus-therapeutics","venture",NA,"2011-10-19",1.8e+07
"26d32eb5df716fe988e8ac77e4f3ae47","artemis-health-inc","seed",NA,"2013-12-26",1200000
"26d32eb5df716fe988e8ac77e4f3ae47","artemis-health-inc","venture",NA,"2014-01-08",795000
"26d32eb5df716fe988e8ac77e4f3ae47","artemis-health-inc","seed",NA,"2013-09-26",NA
"eeee75acdbe377bba8d9c94487165291","artemis-medical",NA,NA,NA,NA
"28c8f5f633ad1df3d8c0af03db6c212e","arterial-health-international","venture",NA,"2010-06-28",90000
"b6e5f53964c221d168bb82d4981628c3","arterial-remodeling-technologies","venture",NA,"2007-11-12",8050704.8026
"b6e5f53964c221d168bb82d4981628c3","arterial-remodeling-technologies","venture",NA,"2010-09-21",8500000
"1facb267ede06b9ee154411c6384f393","artesian-solutions","venture","a","2012-02-09",3176477
"1facb267ede06b9ee154411c6384f393","artesian-solutions","venture","B","2015-06-19",8e+06
"e2476c1a87bc6c23451b0ff9cf938873","arthrosurface","venture","D","2005-02-11",10500000
"d60d6dd723e1803d7984c12806096c72","artielle-immunotherapeutics","venture","a","2004-06-23",NA
"d60d6dd723e1803d7984c12806096c72","artielle-immunotherapeutics","convertible_note",NA,"2010-04-13",185740
"fe616a879c29d3cdf7af43cdc7911cc2","artificial-intelligence-lab-epfl",NA,NA,NA,NA
"bf11837d236c5900eb83d4aab1c09d2e","artisan-mobile","venture","a","2013-06-25",5500000
"bf11837d236c5900eb83d4aab1c09d2e","artisan-mobile","seed",NA,"2012-04-11",1500000
"84a32f04b4068d0fd83f95dbe15b9843","artisan-pharma","debt_financing",NA,"2010-01-20",6e+06
"84a32f04b4068d0fd83f95dbe15b9843","artisan-pharma","venture","1","2006-09-06",3.9e+07
"84a32f04b4068d0fd83f95dbe15b9843","artisan-pharma","debt_financing",NA,"2009-04-28",15381111
"84a32f04b4068d0fd83f95dbe15b9843","artisan-pharma","venture","1","2010-07-20",3e+06
"84a32f04b4068d0fd83f95dbe15b9843","artisan-pharma","venture","1","2010-03-01",2.2e+07
"d9608dc2acfed0bb084d6f1e0108dd3e","artiste",NA,NA,NA,NA
"c44ed5c12143a975608c13beda033bac","artjoker-digital",NA,NA,NA,NA
"2b24d1d421c53b9f5db433b0fafc7239","artpred",NA,NA,NA,NA
"7d1197e3fedd5a9a5542e0bb6f8d0c63","arts-analytics","venture",NA,"2015-10-06",330000
"7d1197e3fedd5a9a5542e0bb6f8d0c63","arts-analytics","seed",NA,"2012-01-01",NA
"d3d2abbaf73046c12682c304710dc3be","artyco-customer-database-marketing",NA,NA,NA,NA
"bf8f63960997d7b203c87eb169934bee","arviem-ag","venture","a","2013-08-01",2254193
"e2b4122c8f2a64972ab177cecb16ca14","arvinas","venture","B","2015-10-21",4.1e+07
"e2b4122c8f2a64972ab177cecb16ca14","arvinas","venture","a","2013-09-26",1.5e+07
"2c3a7ceed89e263735af7d9bdfa3a33e","arvo",NA,NA,NA,NA
"645387af1f523c71719eede39b5f277e","arvys-proteins-inc",NA,NA,NA,NA
"9cb1a61afb3c844d684a3bb0350a4099","aryx-therapeutics","venture",NA,"2008-11-12",21600000
"9cb1a61afb3c844d684a3bb0350a4099","aryx-therapeutics","venture",NA,"2009-11-13",357446
"9cb1a61afb3c844d684a3bb0350a4099","aryx-therapeutics","debt_financing",NA,"2010-08-16",6300000
"56b66ea47380c762c4030d58a242b990","arzeda","seed","a","2009-02-27",NA
"cce498d8053cc03d75ca71d8907515d3","asani-consulting-pvt-ltd",NA,NA,NA,NA
"239733f03679d7754d414124e2e1af60","asc-it-consultancy-services","private_equity",NA,"2010-04-17",5e+07
"a11946e30f2b42b888f4b8a9337411b7","ascalon-international","venture",NA,"2010-05-05",805300
"a11946e30f2b42b888f4b8a9337411b7","ascalon-international","seed",NA,"2011-12-08",1e+05
"7c4af0a58f94e40670c4056019f4f0ff","ascendant-dx","venture",NA,"2014-05-20",2e+06
"a21268515f462003f71241a774ede906","ascendant-mdx","venture","a","2013-06-27",13500000
"d7c657a27c7642a3469b195de4a31f5f","ascendant-strategy-management-group",NA,NA,NA,NA
"a302a7d9e153512b78ca88bacf9982a4","asceneuron","venture","A","2015-09-29",30693206
"acc0a12ca27a3fafe7c077c69459ca06","ascension-orthopedics","venture","D","2008-01-22",2.1e+07
"acc0a12ca27a3fafe7c077c69459ca06","ascension-orthopedics","private_equity",NA,"2011-07-20",18664050
"e3fafb13d000454b91151adcb3f6304c","ascent-healthcare-solutions",NA,NA,NA,NA
"d6dcafd44fa72b1bef2df8d67bcc5422","ascent-therapeutics","venture","a","2007-11-05",18999997
"c3bab67fe3d2cb397474ccbed91ec508","ascenta-therapeutics","venture","C","2007-04-10",5e+07
"c3bab67fe3d2cb397474ccbed91ec508","ascenta-therapeutics","debt_financing",NA,"2010-02-06",1800180
"552d956a87eec7f9c8a88ba642b75d41","ascential-software",NA,NA,NA,NA
"dd5f3112e2b05863008bbbb69b7223d8","ascribe-2","seed",NA,"2015-06-24",2e+06
"1437415a1bbd8061995335cf64e775b4","ash-access-technology","undisclosed",NA,"2004-01-01",NA
"1437415a1bbd8061995335cf64e775b4","ash-access-technology","undisclosed",NA,"2009-01-01",NA
"1437415a1bbd8061995335cf64e775b4","ash-access-technology","debt_financing",NA,"2010-06-04",453000
"81f3b2f7ca96c3e3cad6d51e835f61b1","ashhill-biomedical",NA,NA,NA,NA
"54025799e8ef90835afe26be09b3f76d","asic-insight",NA,NA,NA,NA
"9861ffe92e10d5b3f5728aa875ddaf3f","ask-for-a-concert",NA,NA,NA,NA
"e8c1edff8c71626d0bb5c189ba5e8353","ask-nicely",NA,NA,NA,NA
"060f2b23ccbabed02f48d753afbc5cea","ask-ziggy","venture",NA,"2012-08-14",3500000
"21230d855f0028d367a1fcecf05a1694","askeachother",NA,NA,NA,NA
"4ef0f0576807458e062fa283f4c20146","askmenow",NA,NA,NA,NA
"cefb2094a27c5944579f61ecd23b09cd","fred-kwon","angel",NA,"2014-10-10",350000
"769fede7fdb79de119db088ecd1c7571","askstory",NA,NA,NA,NA
"1dc32ccab4e4589224aabd88e5e5a617","askuity","venture","A","2016-01-11",2e+06
"1dc32ccab4e4589224aabd88e5e5a617","askuity","seed",NA,"2014-05-28",1800000
"1ced71ea5630d88cc47bfa88392531e8","asl-analytical","venture",NA,"2013-07-11",1362512
"1ced71ea5630d88cc47bfa88392531e8","asl-analytical","venture",NA,"2014-08-14",471431
"1ced71ea5630d88cc47bfa88392531e8","asl-analytical","venture",NA,"2015-07-24",539977
"bae013b9c872268807afb65f308f6ca5","aslan-pharmaceuticals","venture","C","2016-01-07",9e+06
"bae013b9c872268807afb65f308f6ca5","aslan-pharmaceuticals","venture","C","2015-12-07",3.4e+07
"bae013b9c872268807afb65f308f6ca5","aslan-pharmaceuticals","venture","a","2011-07-20",1.2e+07
"bae013b9c872268807afb65f308f6ca5","aslan-pharmaceuticals","venture","b","2013-10-10",2.2e+07
"7044d4e3279b8e2069fbdba613abc1c5","asmacure-lte","venture",NA,"2010-02-12",3921207
"7044d4e3279b8e2069fbdba613abc1c5","asmacure-lte","venture","1","2007-05-10",9e+06
"7044d4e3279b8e2069fbdba613abc1c5","asmacure-lte","venture",NA,"2011-05-18",4004534
"7b5aa27c248f19dacf5a9f10011cef49","aspen-marketing-services",NA,NA,NA,NA
"bda580d3e123276866b354f528cfe9a0","aspen-surgical",NA,NA,NA,NA
"e7e20fcf44ebe9e65c0c4c829d1ba157","aspira-networks",NA,NA,NA,NA
"2bc300254d3b337a6fce970686474b88","aspire-bariatrics","venture",NA,"2014-07-01",5025000
"2bc300254d3b337a6fce970686474b88","aspire-bariatrics","debt_financing",NA,"2015-01-29",1.2e+07
"e8ca041c476ae7d4b0d9ab05d64cf146","aspire-ventures",NA,NA,NA,NA
"4b54dce4545b159a67b3e41cf4179455","assalam-world",NA,NA,NA,NA
"ca4ba0eeb6cf3a5b0f2e714bfcd1aaca","assay-depot","venture","a","2011-06-07",1700000
"ca4ba0eeb6cf3a5b0f2e714bfcd1aaca","assay-depot","venture","a","2007-10-08",1800000
"ca4ba0eeb6cf3a5b0f2e714bfcd1aaca","assay-depot","venture","B","2014-03-25",3500000
"64ffab6e7812f6cc0b6b669a349ae668","assaymetrics","venture","b","2011-08-18",NA
"271a05b34282f6f97c2050bcb9bc143b","assembly-pharma","undisclosed",NA,"2014-04-10",NA
"d66a3946252554f663b43ff080b5b0f7","assessfirst",NA,NA,NA,NA
"1e925c5d4da3b470855c78527e93fbf3","assetlink",NA,NA,NA,NA
"e761d0a96eae28e50b68095b161795d4","assistmycase",NA,NA,NA,NA
"d612bcdce7ac8dcd83d06d14eac49cb3","association-for-computational-linguistics",NA,NA,NA,NA
"0a5a903e76828026f7b64c27da8dab48","association-of-international-pharmaceutical-manufacturers",NA,NA,NA,NA
"a7e0c4346724779810427676cff5f947","assured-pharmacy","venture",NA,"2013-02-25",6e+05
"a7e0c4346724779810427676cff5f947","assured-pharmacy","debt_financing",NA,"2011-06-20",7e+05
"a7e0c4346724779810427676cff5f947","assured-pharmacy","debt_financing",NA,"2011-09-06",4e+05
"a7e0c4346724779810427676cff5f947","assured-pharmacy","debt_financing",NA,"2010-12-21",3e+05
"a7e0c4346724779810427676cff5f947","assured-pharmacy","debt_financing",NA,"2011-12-01",740000
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","venture","D","2015-12-21",1.5e+07
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","venture",NA,"2014-05-21",7e+06
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","debt_financing",NA,"2014-05-21",2.5e+07
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","debt_financing",NA,"2012-01-31",8e+06
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","venture","a","2011-01-11",8e+06
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","venture","c","2012-05-30",12500000
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","venture",NA,"2010-07-07",1580725
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","venture","b","2011-03-25",1.1e+07
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","venture","A","2008-06-15",1600000
"18b0d6e1aab539ed377737acf26228dd","assurerx-health","venture",NA,"2014-12-23",3e+07
"91f9426740dd7b45689c439cbd05b2b9","asta-ltd",NA,NA,NA,NA
"efd8cb93f082521c409def778afb3ea5","astellas-pharma",NA,NA,NA,NA
"d370c9159709bd5230427b8665a380e5","asteor-software",NA,NA,NA,NA
"9fe79167c9e5959070e3cdf1f0fcaed6","aster-data",NA,NA,NA,NA
"ff65b5a2e2f41557b091e93dfe88873e","aster-data-systems","angel",NA,"2005-11-01",1e+06
"ff65b5a2e2f41557b091e93dfe88873e","aster-data-systems","venture","1","2007-05-01",5e+06
"ff65b5a2e2f41557b091e93dfe88873e","aster-data-systems","venture","1","2009-02-25",1.7e+07
"ff65b5a2e2f41557b091e93dfe88873e","aster-data-systems","venture","1","2010-09-22",3e+07
"65c95cb7534b4fa5fe021c29ce093f9e","astera-software",NA,NA,NA,NA
"f01524a7a09463568eeb32670420643d","asterand-bioscience",NA,NA,NA,NA
"d7cebeb4c4110c7a9e04cab9b261514d","asteres","venture","b","2004-11-12",NA
"d7cebeb4c4110c7a9e04cab9b261514d","asteres","venture","a","2003-09-23",NA
"d7cebeb4c4110c7a9e04cab9b261514d","asteres","venture",NA,"2008-06-05",4e+06
"d7cebeb4c4110c7a9e04cab9b261514d","asteres","venture","c","2007-11-01",4e+06
"4a6fe316bfd143a91b5553c23c44c503","asterias-biotherapeutics","venture","B","2014-06-17",12500000
"4a6fe316bfd143a91b5553c23c44c503","asterias-biotherapeutics","venture",NA,"2015-02-23",4e+06
"550e9184f38f2780f8c03595cd695392","asterion","venture",NA,"2006-05-15",678000
"66c30684fbc1b861abc90ba1977bfd33","astex",NA,NA,NA,NA
"2339d639581b690d668df11ad904471d","astrazeneca",NA,NA,NA,NA
"6c5c88b694180f3a074f58b1bcc6aa9f","astrazeneca-biotech-laboratory",NA,NA,NA,NA
"c722be0ff7e8ccfbc319fe8dc2752cdb","astronomer","seed",NA,"2015-11-05",NA
"0236e6f7caa7a0d99a4bf55bac04590f","asturix",NA,NA,NA,NA
"d764f83bce927e9eb55e9344125ce26c","astute-medical","venture",NA,"2015-10-14",19999999
"d764f83bce927e9eb55e9344125ce26c","astute-medical","venture","1","2010-05-12",26500000
"d764f83bce927e9eb55e9344125ce26c","astute-medical","debt_financing",NA,"2014-03-06",4984083
"d764f83bce927e9eb55e9344125ce26c","astute-medical","venture","1","2012-06-07",40400000
"d764f83bce927e9eb55e9344125ce26c","astute-medical","venture","1","2008-05-01",6250000
"d764f83bce927e9eb55e9344125ce26c","astute-medical","venture","1","2011-03-08",1.3e+07
"d764f83bce927e9eb55e9344125ce26c","astute-medical","undisclosed",NA,"2014-07-28",1.5e+07
"33f9bea3af037b0e84e211278be39544","asuragen","venture",NA,"2011-08-11",5e+06
"33f9bea3af037b0e84e211278be39544","asuragen","venture","1","2007-12-10",18500000
"33f9bea3af037b0e84e211278be39544","asuragen","venture","1","2006-06-01",4.9e+07
"33f9bea3af037b0e84e211278be39544","asuragen","venture",NA,"2013-03-20",7500000
"13f597fe1464bddf2761612d08ba2708","asyncode","venture",NA,"2014-12-03",NA
"13f597fe1464bddf2761612d08ba2708","asyncode","seed",NA,"2014-02-28",NA
"fd2c7494dc393ed982e3b35e0396c422","ataira-analytics-inc-2",NA,NA,NA,NA
"76e8511f90fe74babe125fdc7ff72e96","atalasoft",NA,NA,NA,NA
"f4d41be3a0eb8bd5af50485c75bbb414","atara-biotherapeutics","venture","b","2013-12-17",38500000
"f4d41be3a0eb8bd5af50485c75bbb414","atara-biotherapeutics","venture","b","2014-01-10",13500000
"dbc4f1fb0e64410c8484156149e43de7","ataxion","venture","a","2014-03-17",1.7e+07
"24681f09c195377e5e3dcf060a38a93f","atcg-dx",NA,NA,NA,NA
"bc570a8cbcc8717544ae916450ed014e","atcontent",NA,NA,NA,NA
"22f3724b532207363ec00d67faade057","atech-flash-technology",NA,NA,NA,NA
"1e8db6ec60864360e1f4a39060fd30d5","atterica-health-inc-",NA,NA,NA,NA
"b397c4f594ea79b167fb296ca60b5e9f","atg-biosynthetics",NA,NA,NA,NA
"93f6273a7f636e5fefa7feeb0d224977","athena-diagnostics",NA,NA,NA,NA
"a6da92084920d4d58dca3968e4f5ef9b","athena-neurosciences",NA,NA,NA,NA
"17565579f4ffde3fd6031775bce71ddf","athenian-venture-partners",NA,NA,NA,NA
"8d8b8ca44a3a65741de45ac9ce74c495","athenix","venture","b","2004-01-20",12500000
"8d8b8ca44a3a65741de45ac9ce74c495","athenix","venture","c","2006-01-06",1.3e+07
"8d8b8ca44a3a65741de45ac9ce74c495","athenix","venture","a","2001-09-10",8e+06
"8d8b8ca44a3a65741de45ac9ce74c495","athenix","venture","d","2008-07-23",1e+07
"52bce693c17844bba4c9671c89875867","atheronova","debt_financing",NA,"2014-03-03",1906500
"52bce693c17844bba4c9671c89875867","atheronova","debt_financing",NA,"2014-09-16",5e+05
"2aa0e5f0c97bbfca043cb30761c943c9","atherotech-diagnostics-lab","venture",NA,"2009-10-16",999131
"f29e80e14703de7005cfe28cf720b47e","athersys","venture",NA,"2012-03-23",9000002
"081785db57aa02a2d7bcb691c7b7592e","athleticode-inc",NA,NA,NA,NA
"cc47405a321907af4683f44759386812","ativa-medical","venture","A","2012-07-26",3368014
"cc47405a321907af4683f44759386812","ativa-medical","debt_financing",NA,"2013-06-05",165000
"cc47405a321907af4683f44759386812","ativa-medical","venture","B","2015-09-17",1.5e+07
"cc47405a321907af4683f44759386812","ativa-medical","debt_financing",NA,"2015-09-17",8199999
"a97bd014a06ade890886fc314651a897","atlanchim-pharma",NA,NA,NA,NA
"39009ed1d201b1ae9537f85f4372d61c","atlantic-bone-screen",NA,NA,NA,NA
"f97c75df0f2988c242dd4c2a813a02d5","atlantic-healthcare","seed",NA,"2013-01-01",NA
"155f490822e600801caa36db3974eb7d","atlantic-motor-labs","seed",NA,"2015-03-24",250000
"5963cd31fd71f80585b8d92c60018a47","atlas-genetics","venture","b","2011-07-18",27184389
"5963cd31fd71f80585b8d92c60018a47","atlas-genetics","venture","B","2014-04-28",28399065
"5963cd31fd71f80585b8d92c60018a47","atlas-genetics","venture","C","2015-01-29",2e+07
"70642a3ab940b2eb942aa9472ed0799a","atlas-spinal-center",NA,NA,NA,NA
"9860dca73113ede7fd4d1e509d2b8998","atlas-spine","venture",NA,"2011-03-18",3500000
"2b69ffdbd15e2ad2641a0dd983a30105","atlas-therapeutics",NA,NA,NA,NA
"1255cc8bd1552a76da4d24c059daf25e","atomation-net","seed",NA,"2015-01-01",8e+05
"1255cc8bd1552a76da4d24c059daf25e","atomation-net","seed",NA,"2014-06-09",7e+05
"745e7846e8cc3757b19b49a4a0115dc9","atomic-infotech",NA,NA,NA,NA
"a9178530a91268a9f795a76f117c1943","atomic-tower",NA,NA,NA,NA
"8e1d751b97a24f3df267a01eb4482fc6","atos-medical",NA,NA,NA,NA
"a1fb19762e17f70d5e09dd3344255372","atossa-genetics","venture",NA,"2013-04-11",1e+06
"a1fb19762e17f70d5e09dd3344255372","atossa-genetics","venture",NA,"2011-06-27",6600000
"a1fb19762e17f70d5e09dd3344255372","atossa-genetics","post_ipo_equity",NA,"2015-05-28",2.5e+07
"b395bbbbddffda80e3661095917f6c42","atox-bio","venture","a","2011-12-19",3250000
"b395bbbbddffda80e3661095917f6c42","atox-bio","venture","E","2014-07-24",2.3e+07
"12927ef6fb9da4237f75f8efa6a31c54","atreaon","venture",NA,"2011-10-27",8e+06
"dd19275c0093d822cba343c7099eddc7","atreca","venture","A","2015-11-04",5.6e+07
"dd19275c0093d822cba343c7099eddc7","atreca","debt_financing",NA,"2011-10-18",160000
"dd19275c0093d822cba343c7099eddc7","atreca","venture",NA,"2012-09-25",6e+06
"dd19275c0093d822cba343c7099eddc7","atreca","debt_financing",NA,"2013-08-29",7e+05
"a2fe0b0c62aca11894b6cba70108e1a2","atrium-medical",NA,NA,NA,NA
"cc79ecfffe860962de342b25c16136f1","atscale","seed",NA,"2013-09-30",2e+06
"cc79ecfffe860962de342b25c16136f1","atscale","venture","1","2015-06-23",7e+06
"17cf762d0d6c5aa40880e67cc9dea22a","attacat",NA,NA,NA,NA
"6b9cbc33560b6b036c5ba0da2e7a1430","attensity","private_equity",NA,"2014-05-14",9e+07
"cd756dae2a19c23b6188e79253a24918","attentio","venture","a","2009-11-24",786000
"53739f902ea150dadc94253aa660c193","attention",NA,NA,NA,NA
"53dc3965dde9435aabe5eaead631e016","attention-point","venture",NA,"2012-11-13",25000
"583351ea29d5fc487f62879d61101f98","attention-sciences","angel",NA,"2009-09-01",NA
"d6f8d09c61cc150e3a0bfe4325ece696","attentive-us","grant",NA,"2015-12-10",109195.9357
"10aa5886be2289430901fe07ae067367","atyr-pharma","venture","d","2013-07-29",4.9e+07
"10aa5886be2289430901fe07ae067367","atyr-pharma","debt_financing",NA,"2013-07-29",1e+07
"10aa5886be2289430901fe07ae067367","atyr-pharma","venture","b","2007-04-18",10500000
"10aa5886be2289430901fe07ae067367","atyr-pharma","venture","c","2010-10-26",2.3e+07
"10aa5886be2289430901fe07ae067367","atyr-pharma","venture","c","2009-09-15",1.2e+07
"10aa5886be2289430901fe07ae067367","atyr-pharma","venture","E","2015-03-31",7.6e+07
"c695c3ec46704d0a4e7cc17df97fe1a1","aubrey","venture",NA,"2009-08-31",3877920
"de9bfc84056612bdfcfd01dc2b2d0da1","audatex",NA,NA,NA,NA
"09b14a636fa0f5474444a6b834b67a39","audentes-therapeutics","venture","C","2015-10-13",6.5e+07
"09b14a636fa0f5474444a6b834b67a39","audentes-therapeutics","venture","a","2013-07-18",3e+07
"09b14a636fa0f5474444a6b834b67a39","audentes-therapeutics","venture","B","2014-12-02",42500000
"67fc1506e079d78e8c496c669d865d9e","audience-point","convertible_note","A","2015-03-12",6e+05
"67fc1506e079d78e8c496c669d865d9e","audience-point","venture","A","2010-10-13",433000
"67fc1506e079d78e8c496c669d865d9e","audience-point","venture","A","2012-09-01",750000
"67fc1506e079d78e8c496c669d865d9e","audience-point","venture","A","2014-05-02",1e+06
"2618ce9b356da646980b3c7baf9d90eb","audiencex",NA,NA,NA,NA
"1b7381fddb7198f4738d6acc1d2ffae5","audigence","venture",NA,"2010-07-26",9500000
"19ffe43e982ce8d2f353a99686d4d1b0","audigist-com",NA,NA,NA,NA
"b828978372cf6585460b9c10fead5f67","audiocure-pharma","seed",NA,"2012-05-29",NA
"a9a73b8bffcbfaf3f97217631867a729","audion-therapeutics","venture",NA,"2015-09-08",9273777
"4963a3220e3d49a4702aee7d9ef321a7","audioscribe","venture",NA,"2012-10-01",749800
"4963a3220e3d49a4702aee7d9ef321a7","audioscribe","venture",NA,"2012-07-01",750000
"fd7c543e7577b776dcf8e018756331be","auditware-systems-limited",NA,NA,NA,NA
"fef52b7090108c0e89ea839362f8ab0a","augmi-labs","seed",NA,"2013-02-14",40000
"374510b90689bf0bcca983c098e9b4c3","augur-2","venture",NA,"2015-09-16",4700000
"779cf114ffff7aa7511850554e5adc12","augustine-temperature-management","venture",NA,"2009-10-30",1356250
"779cf114ffff7aa7511850554e5adc12","augustine-temperature-management","venture",NA,"2012-05-23",915255
"779cf114ffff7aa7511850554e5adc12","augustine-temperature-management","venture",NA,"2010-10-14",30000
"779cf114ffff7aa7511850554e5adc12","augustine-temperature-management","venture",NA,"2015-02-23",4119848
"274b89e16bb979555f59381fcdb461d2","aum-cardiovascular","debt_financing",NA,"2011-07-07",456000
"274b89e16bb979555f59381fcdb461d2","aum-cardiovascular","venture",NA,"2015-07-10",5e+06
"e16a258e2b2e56a0388d7fdc293bd454","au-nalytics","seed",NA,"2011-01-01",820000
"d4f3b1ca89a869aaed0506cbb67fbe7d","aura-biosciences","venture","a","2011-08-26",3e+06
"d4f3b1ca89a869aaed0506cbb67fbe7d","aura-biosciences","venture","a","2010-09-01",1400000
"d4f3b1ca89a869aaed0506cbb67fbe7d","aura-biosciences","debt_financing",NA,"2014-01-08",1335000
"d4f3b1ca89a869aaed0506cbb67fbe7d","aura-biosciences","venture",NA,"2012-12-26",3226728
"d4f3b1ca89a869aaed0506cbb67fbe7d","aura-biosciences","venture",NA,"2014-08-15",4e+06
"d4f3b1ca89a869aaed0506cbb67fbe7d","aura-biosciences","venture","B","2015-03-05",2.1e+07
"7e129a16ff17efbc96dcf37afe97f026","auralytics",NA,NA,NA,NA
"93044ee02a9f55e094623d078a1d118f","auranta",NA,NA,NA,NA
"4f705e92b5885a9c5e3cf51b6594fca0","aurasense-therapeutics","venture",NA,"2015-10-23",14798400
"4f705e92b5885a9c5e3cf51b6594fca0","aurasense-therapeutics","venture","1","2011-12-21",5400000
"4f705e92b5885a9c5e3cf51b6594fca0","aurasense-therapeutics","venture",NA,"2009-12-01",2455000
"4f705e92b5885a9c5e3cf51b6594fca0","aurasense-therapeutics","venture","1","2013-07-31",NA
"4f705e92b5885a9c5e3cf51b6594fca0","aurasense-therapeutics","venture","1","2014-06-17",13600000
"4f705e92b5885a9c5e3cf51b6594fca0","aurasense-therapeutics","venture","1","2015-02-05",4500000
"3fba250b4b5bc4f3f6ebaf10bcdb823e","auraya-group-pty-ltd",NA,NA,NA,NA
"924725a3a7b1d775405c3927e9295a69","aureon-laboratories","venture","B","2005-08-04",2e+07
"924725a3a7b1d775405c3927e9295a69","aureon-laboratories","venture","d","2010-04-14",7e+06
"924725a3a7b1d775405c3927e9295a69","aureon-laboratories","debt_financing",NA,"2010-01-14",2500000
"924725a3a7b1d775405c3927e9295a69","aureon-laboratories","debt_financing",NA,"2010-10-26",4996439
"924725a3a7b1d775405c3927e9295a69","aureon-laboratories","debt_financing",NA,"2009-08-07",4e+06
"924725a3a7b1d775405c3927e9295a69","aureon-laboratories","debt_financing",NA,"2010-08-13",2999961
"924725a3a7b1d775405c3927e9295a69","aureon-laboratories","debt_financing",NA,"2011-09-29",16835103
"5c6abef564f02652aa0a839e88046365","aureus-analytics","angel",NA,"2014-11-14",850000
"ccb8a6c35fdd06ac5acf4f3d31be5db8","aurigma",NA,NA,NA,NA
"7c47f55528f2b8b0585033d50b83297f","aurin-biotech","angel",NA,"2013-12-20",NA
"d89170b8febd8a2c8a35a94e1751b1f4","aurinia-pharmaceuticals","post_ipo_equity",NA,"2014-02-24",5.2e+07
"73e1125165e3cc16948c95505d6a61ff","auriq-systems",NA,NA,NA,NA
"f1ae3988d4658c6e710093ddfeb9b749","auris-surgical-robotics","venture","A","2014-03-31",34377390
"f1ae3988d4658c6e710093ddfeb9b749","auris-surgical-robotics","debt_financing",NA,"2009-06-04",125000
"f1ae3988d4658c6e710093ddfeb9b749","auris-surgical-robotics","venture",NA,"2015-09-23",149549998
"6e8a323fe23c331a2271804a894be9ca","aurobindo-pharma",NA,NA,NA,NA
"9dc4d32b82b7ce8b4e4033eb815c9174","auronix",NA,NA,NA,NA
"994ad7c185f93503467d4ec15b7afdb0","aurora-2",NA,NA,NA,NA
"d3ddb5d461762ecf116c86655218381f","aurora-bioscience",NA,NA,NA,NA
"d896f9c27e1daa718dd9bf98b10e65a2","aurora-health-care",NA,NA,NA,NA
"eaf8fc032d95b34c286904f2c8e23a0a","aurora-pharmaceutical","venture",NA,"2011-11-23",5045000
"eaf8fc032d95b34c286904f2c8e23a0a","aurora-pharmaceutical","venture",NA,"2015-05-27",2412000
"48551b932def19f2534bd4c61328ccf7","aurora-spectral-technologies","venture",NA,"2011-07-18",682500
"48551b932def19f2534bd4c61328ccf7","aurora-spectral-technologies","venture",NA,"2010-10-29",450000
"925471b9fd787283d2dd99238f5ad002","aursos","venture",NA,"2008-04-29",560000
"879b7645b54fd8ff7d157fd0fe418665","aushon-biosystems","venture","A","2006-11-16",7780000
"879b7645b54fd8ff7d157fd0fe418665","aushon-biosystems","venture","B","2008-01-14",4e+06
"879b7645b54fd8ff7d157fd0fe418665","aushon-biosystems","venture",NA,"2011-12-21",2e+06
"879b7645b54fd8ff7d157fd0fe418665","aushon-biosystems","venture",NA,"2012-09-24",5500000
"879b7645b54fd8ff7d157fd0fe418665","aushon-biosystems","venture",NA,"2014-11-26",8013645
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","venture","c","2010-10-13",1.2e+07
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","debt_financing",NA,"2009-10-21",2e+06
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","debt_financing",NA,"2012-01-11",3e+06
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","venture","d","2012-11-08",2.5e+07
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","debt_financing",NA,"2009-05-22",3e+06
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","debt_financing",NA,"2010-02-26",2e+06
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","venture","e","2014-01-08",2e+07
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","debt_financing",NA,"2014-01-08",1.5e+07
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","venture","d","2013-09-10",2992742
"8a99c62e193d86a2d0c892dc8dbdd7a8","auspex-pharmaceuticals","venture",NA,"2010-07-30",13825000
"5e6923d2dca391bf7e0e9af4c6dc761a","austin-logistics-incorporated","venture","C","2008-07-18",NA
"5e6923d2dca391bf7e0e9af4c6dc761a","austin-logistics-incorporated","venture","b","2005-10-28",8e+06
"ae24ecbd29c2b30480959f0736644030","austrianova-biomanufacturing","venture",NA,"2007-06-06",47265574.0066
"5b29926f756b2176e81df621de2a1a0a","autdsig",NA,NA,NA,NA
"08cc341f945b015a737c223762c98c9f","autekbio","venture","a","2007-08-07",1100000
"08cc341f945b015a737c223762c98c9f","autekbio","venture","B","2007-10-22",1e+06
"389d596d44d84706540497c724787fa8","authentica-solutions",NA,NA,NA,NA
"dff9d19b36cfd28526b9d8d6704fcb02","authenticated-digital",NA,NA,NA,NA
"e74e9a16953d0a7790941bbbd988999f","authenticlick","venture","a","2006-02-01",5e+06
"1be9e6cb3af5d3d201af4e8baa7ddff6","authenticom",NA,NA,NA,NA
"e6dc57036c8667caf3875c5f82ce333b","authintic",NA,NA,NA,NA
"07ad17e6452e7433e6fb05ed98e7e5e8","authorrise",NA,NA,NA,NA
"dcf0b8dc41359d7c91fb8f7814a6e98f","autifony-therapeutics","undisclosed",NA,"2011-08-22",8248726
"dcf0b8dc41359d7c91fb8f7814a6e98f","autifony-therapeutics","grant",NA,"2014-06-04",3684289
"dcf0b8dc41359d7c91fb8f7814a6e98f","autifony-therapeutics","venture","1","2015-07-10",12336350
"dcf0b8dc41359d7c91fb8f7814a6e98f","autifony-therapeutics","venture","1","2013-06-04",5500000
"f6762cbe1fafd407b3fec3c1d0d52485","autodeal-com-ph","seed",NA,"2014-06-01",6e+05
"319f541a59a9251e7b70ea01dacb983e","autoden",NA,NA,NA,NA
"14558e3f9979e9d7b26940c58a12c768","autogenomics","debt_financing",NA,"2010-03-25",13125000
"14558e3f9979e9d7b26940c58a12c768","autogenomics","venture","1","2001-11-01",5e+06
"14558e3f9979e9d7b26940c58a12c768","autogenomics","venture","1","2007-03-28",1.2e+07
"14558e3f9979e9d7b26940c58a12c768","autogenomics","private_equity",NA,"2013-01-11",165600
"14558e3f9979e9d7b26940c58a12c768","autogenomics","debt_financing",NA,"2010-06-02",24862654
"9d6252a21a3f2f1aef0e1216bce138b2","autograph","venture","A","2012-04-01",4700000
"9d6252a21a3f2f1aef0e1216bce138b2","autograph","venture","A","2015-05-01",2700000
"c59c68b73d3a61171987e7ff62b81eae","autogrid","venture",NA,"2012-10-29",9e+06
"c59c68b73d3a61171987e7ff62b81eae","autogrid","venture","1","2014-01-27",12750000
"398acaa4906681ee5e6a83a7bbe4d02d","autoimmune",NA,NA,NA,NA
"4911c6fcfdb9fb8911798940a63daf56","automated-call-processing-corporation",NA,NA,NA,NA
"946e028fe203f46e92bc962fb7fa0f78","automated-insights","venture","a","2010-08-01",1300000
"946e028fe203f46e92bc962fb7fa0f78","automated-insights","venture","a","2011-09-01",4e+06
"946e028fe203f46e92bc962fb7fa0f78","automated-insights","venture","B","2014-06-30",5500000
"41814af21d39a851fe6b5e10faaaa78c","automated-marketing",NA,NA,NA,NA
"70ca6f4078092911be18865d13482a8f","automational",NA,NA,NA,NA
"c53e98e0f124432e07f47c13bc04c178","automedics-medical-systems-inc",NA,NA,NA,NA
"575fef97c490d7011ae183ecee538d87","automedx","venture",NA,"2009-06-11",150000
"b66d2069e734666080a5d3ad835fd1e9","automoneyback","seed",NA,"2012-07-31",2e+05
"3130b222931961156006911354450e91","automsoft","venture","a","1999-01-01",2929046
"3130b222931961156006911354450e91","automsoft","venture","b","2002-04-18",5337000
"3130b222931961156006911354450e91","automsoft","venture","c","2004-05-01",2508870
"10b075a8a72ae768be9aa65a215e7262","autonomyworks",NA,NA,NA,NA
"41afc8dcfefd99cecd060cddfc11dd7b","auxoid",NA,NA,NA,NA
"f948371841540dd394376360910d82f4","av-helpdesk-inc",NA,NA,NA,NA
"cada1da1b3797cea5c88a0eb5dbab46e","ava-investment-analytics",NA,NA,NA,NA
"6af90c7893109db817946e755851ca0a","avalanche-biotech","venture",NA,"2013-11-26",5653890
"6af90c7893109db817946e755851ca0a","avalanche-biotech","venture","1","2014-04-22",5.5e+07
"6af90c7893109db817946e755851ca0a","avalanche-biotech","venture",NA,"2014-09-07",9999995
"66bcf298504cba45008b6494cc3f606a","avalon-pharmaceuticals","venture",NA,"2008-10-27",237338
"7f6046a3c7a90ab3da9d5b0cbc3ee0f0","avancen-mod","venture",NA,"2012-07-23",1643849
"ad374eb27550faeeffdf7d2792966c34","avanir-pharmaceuticals","debt_financing",NA,"2012-06-26",3e+07
"eb7baee27a6a94c1b93410081688c486","avansci-bio","seed",NA,"2013-03-13",8e+05
"eb7baee27a6a94c1b93410081688c486","avansci-bio","debt_financing",NA,"2014-05-13",160000
"5401f0c50561782b97c24d23e2524e3d","avanser",NA,NA,NA,NA
"01842d60a353bd2d97c686997922ef5c","avansera","seed",NA,"2013-02-01",106000
"33eead840d4600db34eaf083b3351b0d","avant-credit","venture","E","2015-09-29",3.25e+08
"33eead840d4600db34eaf083b3351b0d","avant-credit","venture","C","2014-07-23",7.5e+07
"33eead840d4600db34eaf083b3351b0d","avant-credit","venture","B","2013-08-14",2e+07
"33eead840d4600db34eaf083b3351b0d","avant-credit","venture","a","2013-05-08",9e+06
"33eead840d4600db34eaf083b3351b0d","avant-credit","debt_financing",NA,"2013-05-08",2.5e+07
"33eead840d4600db34eaf083b3351b0d","avant-credit","debt_financing",NA,"2014-08-21",2e+08
"33eead840d4600db34eaf083b3351b0d","avant-credit","debt_financing",NA,"2014-07-23",1.5e+08
"33eead840d4600db34eaf083b3351b0d","avant-credit","debt_financing",NA,"2014-12-04",3e+08
"33eead840d4600db34eaf083b3351b0d","avant-credit","venture","D","2014-12-04",2.25e+08
"33eead840d4600db34eaf083b3351b0d","avant-credit","debt_financing",NA,"2015-04-13",4e+08
"ea54b12e24269a1cdf03e0538af9945b","avant-diagnostics","convertible_note",NA,"2016-01-22",112500
"b3ce4b86b8e90e9c8424968d89db87ca","avant-healthcare-professionals","debt_financing",NA,"2013-07-30",125000
"e1ae7e52a4d8b39f458f07bb6d8bb5ba","avantari-healthcare",NA,NA,NA,NA
"2c937b4d4845493db16edc048e54a75f","avantbio","debt_financing",NA,"2010-12-22",3e+05
"d0b9b9bc078ae39657512fdd7f808b8c","avanteo-consulting",NA,NA,NA,NA
"86e2dea4e2dc0799ea4ad9bed0459aba","avantic-corporation",NA,NA,NA,NA
"ebc28fea52b9ba15c7698fd1dd0d5330","avantome-illumina",NA,NA,NA,NA
"c12ec15e4e22fadad1df1d35c53fbd65","avantra-biosciences","venture",NA,"2011-10-07",8e+06
"c12ec15e4e22fadad1df1d35c53fbd65","avantra-biosciences","venture",NA,"2010-08-18",7008402
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","venture","b","2012-12-01",NA
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","venture","a","2012-02-14",4100000
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","debt_financing",NA,"2013-12-20",2872388
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","venture",NA,"2012-01-06",3443378
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","grant",NA,"2012-03-19",1500000
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","convertible_note",NA,"2011-06-01",NA
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","convertible_note",NA,"2012-06-01",NA
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","venture","b","2013-06-07",11500000
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","debt_financing",NA,"2014-05-06",3096371
"0c37d40ca86b77ecd8d34f718d3b5b4b","avaxia-biologics","seed",NA,"2012-07-01",NA
"8559e3f64d4f4459d76b40c11fa0887b","avaz","seed",NA,"2014-04-22",550000
"0cb90ad127f65ffe4e578467c01cf759","avecia",NA,NA,NA,NA
"8a3e90ac16e65935c376f2cf33a24b10","avelas-biosciences","venture","b","2014-01-09",6800000
"8a3e90ac16e65935c376f2cf33a24b10","avelas-biosciences","venture","a","2012-12-06",7650000
"8a3e90ac16e65935c376f2cf33a24b10","avelas-biosciences","venture","B","2014-09-10",7400000
"c5a72e2bfb140e099b162f054f09464e","avelis","venture",NA,"2012-08-03",250000
"11bd3035ddf8f8edd96f128ccad9b538","avenel-strategies",NA,NA,NA,NA
"38b852d2efa979d57964a83df07897e1","avenir-medical","venture",NA,"2012-04-24",725000
"38b852d2efa979d57964a83df07897e1","avenir-medical","venture","1","2013-10-02",3213578
"359151313349d536d08f8a44a345dbd9","avention",NA,NA,NA,NA
"f7ed32b99ef022fd3cac11557dd467b4","avenue-a-razorfish",NA,NA,NA,NA
"7c19637e52116d94ddee4c3d96d62833","aveo-pharmaceuticals","venture",NA,"2009-07-21",2e+07
"7c19637e52116d94ddee4c3d96d62833","aveo-pharmaceuticals","venture",NA,"2010-11-03",60750000
"7c19637e52116d94ddee4c3d96d62833","aveo-pharmaceuticals","venture",NA,"2011-05-31",7499997
"7c19637e52116d94ddee4c3d96d62833","aveo-pharmaceuticals","venture",NA,"2010-05-28",2.5e+07
"7c19637e52116d94ddee4c3d96d62833","aveo-pharmaceuticals","venture","1","2007-05-01",5.3e+07
"51ceeb01ee286bbfd44ba410c1d76309","aver-informatics","venture","B","2016-01-05",13600000
"51ceeb01ee286bbfd44ba410c1d76309","aver-informatics","angel",NA,"2013-03-29",1e+06
"51ceeb01ee286bbfd44ba410c1d76309","aver-informatics","seed",NA,"2010-10-27",175000
"51ceeb01ee286bbfd44ba410c1d76309","aver-informatics","angel",NA,"2011-06-29",1300000
"51ceeb01ee286bbfd44ba410c1d76309","aver-informatics","venture","A","2014-05-27",8500000
"a4925af9b0da82e21ad53a99b047201c","averetek",NA,NA,NA,NA
"83e509fda64c3f4026750be321d5085b","avesthagen","venture",NA,"2007-05-07",5530000
"bce82e5fe9fa5ae4a8d6b8b11a006f76","aveva",NA,NA,NA,NA
"b09be91c91a9632e870dc5ed83c46717","avexis","venture","C","2015-01-09",1e+07
"b09be91c91a9632e870dc5ed83c46717","avexis","venture","D","2015-09-08",6.5e+07
"b09be91c91a9632e870dc5ed83c46717","avexis","venture","A","2013-07-27",NA
"b09be91c91a9632e870dc5ed83c46717","avexis","venture","B","2014-04-22",NA
"4d208374b82b9bd9ea8a82c0204e135e","avexxin","undisclosed",NA,"2011-01-10",NA
"1bb7c2735ecd3fa904e548f09fe556af","avi-biopharma",NA,NA,NA,NA
"40524459b59ce935925989c7195df536","avi-networks-inc","venture","B","2014-08-01",20800000
"40524459b59ce935925989c7195df536","avi-networks-inc","venture","A","2012-11-01",12200000
"583139a6f13fb616bc9ca2808f7e61ff","avia-tek",NA,NA,NA,NA
"19dddcc23736fbfd40a098aebdc76a9a","aviata-inc-",NA,NA,NA,NA
"50d46747e77ac8200b05108fb704874f","avid-growing-systems",NA,NA,NA,NA
"9bc8c8acb9e3ba038ff3b0f9cf47d4b8","avid-radiopharmaceuticals","seed",NA,"2005-01-25",5e+05
"9bc8c8acb9e3ba038ff3b0f9cf47d4b8","avid-radiopharmaceuticals","venture","1","2009-05-21",34500000
"9bc8c8acb9e3ba038ff3b0f9cf47d4b8","avid-radiopharmaceuticals","venture","1","2007-05-09",2.6e+07
"9bc8c8acb9e3ba038ff3b0f9cf47d4b8","avid-radiopharmaceuticals","venture","1","2006-01-05",8900000
"7678a3baa4d9babd9ba8e5c16dad82cb","avidbiologics","venture",NA,"2014-09-29",NA
"4a160c993dc1d02410ba99ed0ef53f96","avidbiotics","venture","a","2007-11-07",1e+06
"4a160c993dc1d02410ba99ed0ef53f96","avidbiotics","venture",NA,"2012-07-27",1840173
"4a160c993dc1d02410ba99ed0ef53f96","avidbiotics","venture",NA,"2014-09-18",854128
"69c9233a3759288dc1fd28a7ba29edf8","avidia","venture","c","2006-05-09",43800000
"69c9233a3759288dc1fd28a7ba29edf8","avidia","venture","b","2005-05-06",28500000
"0472da5ee4374542782923d392392c32","avidity-nanomedicines","venture","a","2014-02-18",9067850
"0472da5ee4374542782923d392392c32","avidity-nanomedicines","venture","B","2014-10-07",6e+06
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture",NA,"2007-09-20",11350000
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture",NA,"2006-10-24",1500000
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture",NA,"2007-03-01",130000
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture","1","2013-06-21",1e+07
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture",NA,"2009-10-19",1e+06
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture",NA,"2010-01-15",4200000
"8841798f49b35c0ff199441dc6b1c7d6","aviir","convertible_note",NA,"2007-08-10",1450000
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture",NA,"2008-03-19",1500000
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture",NA,"2008-12-02",7800000
"8841798f49b35c0ff199441dc6b1c7d6","aviir","venture",NA,"2009-08-05",1e+06
"3b2ed778e4e6df56a44cde15167f2dd6","avila-therapeutics","venture","A","2007-08-20",NA
"3b2ed778e4e6df56a44cde15167f2dd6","avila-therapeutics","venture",NA,"2012-01-20",4e+06
"3b2ed778e4e6df56a44cde15167f2dd6","avila-therapeutics","debt_financing",NA,"2009-05-14",5e+06
"3b2ed778e4e6df56a44cde15167f2dd6","avila-therapeutics","venture",NA,"2010-07-07",22500000
"a3e172818098b22e333b11733ba313f9","avitide","venture",NA,"2014-06-09",3435003
"a3e172818098b22e333b11733ba313f9","avitide","venture","1","2015-08-06",7600000
"4a89e7cec03b3e85b875e4d1886dad15","aviture",NA,NA,NA,NA
"38e556ace5cbd0fb916f2dca7c6d3ea4","avlabs",NA,NA,NA,NA
"f7876b3a920921658b7ddbbd0e5ca441","avm-biotechnology","convertible_note",NA,"2009-09-09",225000
"f7876b3a920921658b7ddbbd0e5ca441","avm-biotechnology","debt_financing",NA,"2009-04-30",175000
"f7876b3a920921658b7ddbbd0e5ca441","avm-biotechnology","venture",NA,"2013-06-03",708000
"f7876b3a920921658b7ddbbd0e5ca441","avm-biotechnology","venture","1","2014-04-22",1500000
"9a12dd1d3bcf8b59e0f5a2b735a2d4bd","avogadro",NA,NA,NA,NA
"38dc904655b486d2e319ac11828ce003","avomeen-analytical-services",NA,NA,NA,NA
"276cef05223a133c2fd98eaf03043909","avraham-pharmaceuticals","private_equity",NA,"2013-02-21",5700000
"276cef05223a133c2fd98eaf03043909","avraham-pharmaceuticals","venture",NA,"2011-11-14",3e+06
"276cef05223a133c2fd98eaf03043909","avraham-pharmaceuticals","venture","1","2010-07-13",9e+06
"276cef05223a133c2fd98eaf03043909","avraham-pharmaceuticals","private_equity",NA,"2014-09-17",4500000
"f3f5b710f3defe82455c0c4a35d81a71","avrios","angel",NA,"2014-04-01",NA
"34c38ec04971dafa9e837533f8008c48","avtherapeutics","venture",NA,"2013-12-31",660000
"c57224b803342eb87bf9764d47c595ca","aw-proto-code-inc",NA,NA,NA,NA
"04f76a645f2f2ff140262c0822f42c50","awak","seed",NA,"2011-01-01",6e+06
"d2e23ff54dacc926709f169baa39c144","awalator",NA,NA,NA,NA
"ff4b139ce8ff5a918258a2770b0e0869","awamo","seed","A","2015-08-10",550000
"eb27ba7d642f9fab98a2085bd2f0f167","awaratr-gmatawa-com",NA,NA,NA,NA
"b650720121b96511334aee594fc0d3c1","aware-2",NA,NA,NA,NA
"6a215a08240c6c871cbdf5eae0a19050","snowball-factory","venture",NA,"2011-12-01",4250000
"6a215a08240c6c871cbdf5eae0a19050","snowball-factory","seed",NA,"2010-12-01",1e+06
"e67937b77703e71402f1aced3873d21f","awesome-bi",NA,NA,NA,NA
"815dfeebee62aef7f01f93ebc12fd744","ax-semantics-2",NA,NA,NA,NA
"a459832069787c3531170342191320ca","axela","venture","A","2005-03-08",2847766.5374
"74f3abffff8b9a0e8490aa5c6700d10f","axelacare","venture",NA,"2010-12-22",6.6e+07
"62998fcc8b767e53b7d71f061b3bebee","axelar",NA,NA,NA,NA
"4cbd76c094d8e368a2fdefe9cdba9bed","axerion-therapeutics","venture",NA,"2011-10-13",4e+05
"4cbd76c094d8e368a2fdefe9cdba9bed","axerion-therapeutics","seed",NA,"2010-04-05",750000
"ede93a497c2b12f91472d2c30f1ed2e4","axial-biotech","venture","b","2007-03-27",15300000
"ede93a497c2b12f91472d2c30f1ed2e4","axial-biotech","venture","a","2005-03-01",4100000
"ce36127a4db25160c1e505368652a424","georgia-gulf-corporation",NA,NA,NA,NA
"f6bd0e2fd003d5e9045bfdb1d2208b49","axialmed","seed",NA,"2011-08-10",17408
"be22fb1d62f9f54dca47a6da7aa6f35d","axikin-pharmaceuticals","venture","a","2009-01-22",3e+06
"be22fb1d62f9f54dca47a6da7aa6f35d","axikin-pharmaceuticals","venture","a","2010-08-12",1e+06
"be22fb1d62f9f54dca47a6da7aa6f35d","axikin-pharmaceuticals","venture",NA,"2012-03-30",2e+06
"be22fb1d62f9f54dca47a6da7aa6f35d","axikin-pharmaceuticals","venture",NA,"2015-09-30",6500000
"233d6694200a2d47abe38f78d1e73843","axiogenesis",NA,NA,NA,NA
"e3b4e2a8d04ca8fe7fc5e703cf54a812","axiomx","venture",NA,"2013-10-08",2e+06
"e3b4e2a8d04ca8fe7fc5e703cf54a812","axiomx","venture",NA,"2012-12-06",2e+06
"7d4932133667172bab380a47f1d1bffa","axion-biosystems","venture",NA,"2009-04-30",1000113
"7d4932133667172bab380a47f1d1bffa","axion-biosystems","private_equity",NA,"2012-05-09",3208768
"7d4932133667172bab380a47f1d1bffa","axion-biosystems","venture",NA,"2010-07-16",2100079
"8371bc8d6ea24982a36147d5b23a889a","axogen","venture","C","2007-12-17",12100000
"8371bc8d6ea24982a36147d5b23a889a","axogen","debt_financing",NA,"2011-01-12",3697545
"8371bc8d6ea24982a36147d5b23a889a","axogen","venture","a","2013-08-15",1.8e+07
"8371bc8d6ea24982a36147d5b23a889a","axogen","debt_financing",NA,"2009-06-16",2622234
"8371bc8d6ea24982a36147d5b23a889a","axogen","debt_financing",NA,"2011-06-15",3e+06
"8371bc8d6ea24982a36147d5b23a889a","axogen","post_ipo_equity",NA,"2015-02-05",1.3e+07
"8371bc8d6ea24982a36147d5b23a889a","axogen","post_ipo_equity",NA,"2015-08-28",17500000
"4314200dc133f8c38be1e19b34b33bdb","axon-connected","venture",NA,"2015-01-11",2100000
"b3e4ab46d858fa40e5601200043ad85c","axordia",NA,NA,NA,NA
"9c01d8848a4ecb5d16adbdfe9d38da1e","axsionics","venture","a","2008-07-20",9780000
"17bf71c9cf281e520d92f309afc715a1","axsome-therapeutics","debt_financing",NA,"2013-07-03",1185000
"17bf71c9cf281e520d92f309afc715a1","axsome-therapeutics","debt_financing",NA,"2014-09-23",2025000
"17bf71c9cf281e520d92f309afc715a1","axsome-therapeutics","debt_financing",NA,"2015-01-01",1315000
"17bf71c9cf281e520d92f309afc715a1","axsome-therapeutics","venture",NA,"2015-05-19",2460000
"36e2a4e9c21b55cf8fb03e3600f54621","axsys",NA,NA,NA,NA
"ed45eab94e61e11f27b2d7ae85006a6b","axtria","seed","A","2011-01-10",4318284
"ed45eab94e61e11f27b2d7ae85006a6b","axtria","venture","A","2014-01-09",4822800
"ed45eab94e61e11f27b2d7ae85006a6b","axtria","venture","C","2015-07-07",3e+07
"ed45eab94e61e11f27b2d7ae85006a6b","axtria","venture","B","2015-01-06",5600750
"5c551c9bc770a5e34f4e65ae3528e66d","axxess-pharma","venture",NA,"2014-07-30",2e+06
"0d11248243d746fc9c4b5b52394e8e6c","axxess-unlimited",NA,NA,NA,NA
"79478d29e57f682284914ac3b6997593","axygen",NA,NA,NA,NA
"61a58dd23f57ac8e0a691f7e57a953a4","ayasdi","venture","a","2013-01-16",1e+07
"61a58dd23f57ac8e0a691f7e57a953a4","ayasdi","seed",NA,"2010-09-01",NA
"61a58dd23f57ac8e0a691f7e57a953a4","ayasdi","private_equity",NA,"2012-04-01",10067000
"61a58dd23f57ac8e0a691f7e57a953a4","ayasdi","venture",NA,"2012-05-03",499982
"61a58dd23f57ac8e0a691f7e57a953a4","ayasdi","venture","b","2013-07-16",30600000
"61a58dd23f57ac8e0a691f7e57a953a4","ayasdi","venture",NA,"2013-03-31",182000
"61a58dd23f57ac8e0a691f7e57a953a4","ayasdi","venture","C","2015-03-25",5.5e+07
"886b0b7cd6747705a917434b7936dda2","ayata",NA,NA,NA,NA
"261791ffc31aa5fc06a25ba21071b95a","aylien","venture",NA,"2014-08-05",NA
"261791ffc31aa5fc06a25ba21071b95a","aylien","venture",NA,"2013-06-28",NA
"261791ffc31aa5fc06a25ba21071b95a","aylien","seed",NA,"2011-04-01",5e+05
"261791ffc31aa5fc06a25ba21071b95a","aylien","seed",NA,"2010-12-17",NA
"9d21af41752784681ebc09094cb5c75c","ayoxxa-biosystems","venture","B","2014-07-23",12145503
"9d21af41752784681ebc09094cb5c75c","ayoxxa-biosystems","seed",NA,"2014-12-02",14081347
"9d21af41752784681ebc09094cb5c75c","ayoxxa-biosystems","venture","A","2012-09-20",NA
"3953850cb162f233ddfeb0282956e9d3","az-west-endoscopy-center","venture",NA,"2010-09-22",5e+05
"4e31660021e9ef9389dea8c6d6cd6adf","azalead","venture","B","2015-12-15",5e+06
"4e31660021e9ef9389dea8c6d6cd6adf","azalead","venture","A","2015-03-18",2132476
"16b01d8777ba5ed64c70d7e45f32e3a7","azargen-biotechnologies","venture","B","2016-01-07",3100000
"42b12a6668d34d0ac1b0c545bee66f07","azco-biotech-inc",NA,NA,NA,NA
"4a22eae6d95c367d3f988b227ea4ee40","azelon-pharmaceuticals","venture","a","2011-10-11",4500000
"4a22eae6d95c367d3f988b227ea4ee40","azelon-pharmaceuticals","venture",NA,"2011-08-15",2793488
"4a22eae6d95c367d3f988b227ea4ee40","azelon-pharmaceuticals","venture",NA,"2012-03-16",2422000
"8853e52e999b4ce1c7bbad8f5a1aade4","azevan-pharmaceuticals","venture",NA,"2013-10-18",2205000
"ee13279cfc54fdf8fac8d7adb30fbe13","azot-app",NA,NA,NA,NA
"eca628d0331ef2e685fafe0ea42d866d","azuqua","debt_financing",NA,"2013-08-06",180000
"eca628d0331ef2e685fafe0ea42d866d","azuqua","venture","1","2014-10-08",5e+06
"eca628d0331ef2e685fafe0ea42d866d","azuqua","venture",NA,"2012-12-16",NA
"115c95d960177bd0a5a4840ad032b984","azure-minerals","venture",NA,"2013-11-18",2100000
"5791e295f75c22c86450dbcce34cd01a","b-bridge-international","venture",NA,"2005-03-29",4200000
"9fd276ff1ad71dc52d63921caef6a275","b-secur",NA,NA,NA,NA
"a12e307eaac62a0d352c8b5ae3cc3d80","bsmark","seed",NA,"2011-02-01",NA
"1e34fe9a494446b634b758aaed2a2faa","b12leads",NA,NA,NA,NA
"19a17bc72d7927fb868cdc1ff9315488","b2b-technologies",NA,NA,NA,NA
"374d10e319960f24238df4c98bbc776b","b2m-solutions","venture",NA,"2014-04-28",NA
"10d8c92ed1359f351f38e57c01b4c935","b3-bio","venture",NA,"2010-10-28",5701120
"821c881df80adcaada407fec5648d2a4","babbacombe-cliff-railway",NA,NA,NA,NA
"3142dc19e671a19be5f178a89f97d5f0","babelverse","seed",NA,"2011-05-01",40000
"3142dc19e671a19be5f178a89f97d5f0","babelverse","seed",NA,"2012-09-08",1e+05
"3142dc19e671a19be5f178a89f97d5f0","babelverse","seed",NA,"2013-03-18",50000
"5e36b7b987fe75d4cc360fa8afb5c517","bableonaut",NA,NA,NA,NA
"048f0a4d32409aac20994007a013b615","baby-carrot",NA,NA,NA,NA
"45387ff26d823b68d8e92d95025331d5","backlinksxray",NA,NA,NA,NA
"13565cf5f84c19e2e94ca2bd5d25aaa6","bacmine",NA,NA,NA,NA
"e08616a41a2c2579b83b5d0ba651bfd1","bacterial-barcodes","seed",NA,"2010-04-27",250000
"5a9219b0c1e5db83c4f66013382ae8a2","bacterin-international-holdings","debt_financing",NA,"2010-04-14",3475000
"5a9219b0c1e5db83c4f66013382ae8a2","bacterin-international-holdings","post_ipo_debt",NA,"2014-03-10",4e+06
"5a9219b0c1e5db83c4f66013382ae8a2","bacterin-international-holdings","post_ipo_debt",NA,"2012-08-01",2e+07
"5a9219b0c1e5db83c4f66013382ae8a2","bacterin-international-holdings","debt_financing",NA,"2010-06-21",1086000
"27fbafa2fe2350f6a6c29986c77f62ab","bacterioscan","venture",NA,"2013-05-20",5720000
"27fbafa2fe2350f6a6c29986c77f62ab","bacterioscan","venture","1","2014-08-26",5e+06
"27fbafa2fe2350f6a6c29986c77f62ab","bacterioscan","venture","1","2014-12-10",6e+06
"27fbafa2fe2350f6a6c29986c77f62ab","bacterioscan","convertible_note",NA,"2015-08-07",1700305
"a378fba1567704b03464b96b3e74ce68","bactest","venture",NA,"2012-01-26",1411754
"a378fba1567704b03464b96b3e74ce68","bactest","seed",NA,"2013-01-01",NA
"b69f4aa792e94926a286bfce03c1106e","bad-juju-games","debt_financing",NA,"2014-01-01",5e+06
"9ba7aef2cd27e5577b9da2067f9a3217","bahoui","private_equity",NA,"2013-12-01",NA
"561c38c8e60602ef53ba4cf457c0e5d2","bakdata",NA,NA,NA,NA
"139b3d7fff385f8eb3d4628d5d84c173","ballotready","convertible_note",NA,"2015-06-01",10000
"139b3d7fff385f8eb3d4628d5d84c173","ballotready","grant",NA,"2015-06-15",50000
"139b3d7fff385f8eb3d4628d5d84c173","ballotready","grant",NA,"2015-05-29",30000
"b121c67dcd2d474bb64c0471c305f18d","bam-labs","convertible_note",NA,"2011-12-15",1e+05
"b121c67dcd2d474bb64c0471c305f18d","bam-labs","venture",NA,"2013-02-19",3515781
"b121c67dcd2d474bb64c0471c305f18d","bam-labs","convertible_note",NA,"2012-11-28",1e+06
"b121c67dcd2d474bb64c0471c305f18d","bam-labs","venture",NA,"2009-09-30",1575000
"b121c67dcd2d474bb64c0471c305f18d","bam-labs","venture",NA,"2013-01-23",4060456
"b121c67dcd2d474bb64c0471c305f18d","bam-labs","venture",NA,"2011-03-10",2400000
"b121c67dcd2d474bb64c0471c305f18d","bam-labs","venture",NA,"2014-12-23",3500000
"ab5c6514407397727b7b83687e027883","band-metrics","seed",NA,"2009-09-23",NA
"ab5c6514407397727b7b83687e027883","band-metrics","angel",NA,"2008-11-24",NA
"f80dfaaf766a908ff686819aed8bbe7d","bandandme","seed",NA,"2014-12-31",80000
"f80dfaaf766a908ff686819aed8bbe7d","bandandme","seed",NA,"2014-04-01",70000
"f80dfaaf766a908ff686819aed8bbe7d","bandandme","seed",NA,"2013-07-31",130000
"f80dfaaf766a908ff686819aed8bbe7d","bandandme","seed",NA,"2013-02-28",50000
"4fca34866b9ced3c19702b4087b10550","bang-networks","venture","B","2001-11-05",1.4e+07
"63797e2f2d78df137f05b442a9cb60d0","banner",NA,NA,NA,NA
"4302db66616466df76195818b907d38f","banyan-biomarkers","venture",NA,"2014-02-25",1999999
"4302db66616466df76195818b907d38f","banyan-biomarkers","venture","1","2013-06-20",6e+06
"4302db66616466df76195818b907d38f","banyan-biomarkers","venture",NA,"2015-03-18",1808145
"a90b4e6836e0a18d75a0f0073e4b9857","bap-health-outcomes",NA,NA,NA,NA
"f834c484e038c9989119f57a5ab7e385","baptie-company","undisclosed",NA,"2014-02-19",384036
"717ee102ca206d388db27c6b480fbfb7","bar-club-stats","grant",NA,"2013-03-01",35000
"717ee102ca206d388db27c6b480fbfb7","bar-club-stats","angel",NA,"2014-04-30",70000
"717ee102ca206d388db27c6b480fbfb7","bar-club-stats","seed",NA,"2014-08-01",NA
"061da13205ef73d07720b5eb878de5e3","bar-harbor-biotechnology","venture",NA,"2011-05-20",280000
"061da13205ef73d07720b5eb878de5e3","bar-harbor-biotechnology","venture","1","2015-03-20",180000
"d3acc084ad5bce451f66ee9e5d52674c","bar-o-metrics",NA,NA,NA,NA
"deff9996a1937867ac84e0ef589e9301","barburas",NA,NA,NA,NA
"0da7275e6a8dc38f821b48e92e4d2d65","barcelona-media",NA,NA,NA,NA
"46bbe6ccfb0efb8052aa2dc2d70f3620","barilliance",NA,NA,NA,NA
"2e44c7a3030d2d10add339184ec2e970","barker-kitsen",NA,NA,NA,NA
"76c66ad4843a8d49de90f60e34362035","barofold","venture",NA,"2013-02-20",1700000
"76c66ad4843a8d49de90f60e34362035","barofold","venture","1","2007-05-29",1.2e+07
"76c66ad4843a8d49de90f60e34362035","barofold","venture",NA,"2010-02-23",1200000
"76c66ad4843a8d49de90f60e34362035","barofold","venture",NA,"2006-03-01",2500000
"039757011bcc8491c580c91d88d248b7","barosense","venture",NA,"2006-01-01",6200000
"039757011bcc8491c580c91d88d248b7","barosense","venture","1","2009-08-24",2.7e+07
"039757011bcc8491c580c91d88d248b7","barosense","undisclosed",NA,"2004-12-09",NA
"ac4ac46107d6d8175d4ad48448200f1f","barra-inc",NA,NA,NA,NA
"f1352d5194377ef3e6a8e00518335752","barrix-agro-sciences",NA,NA,NA,NA
"18b1efaaa30f3e14fef5b04f643e5a0f","barvision",NA,NA,NA,NA
"8339cfc63ef44120ecc5756db5f1d6cb","base-pair-biotechnologies",NA,NA,NA,NA
"d140620f09bbdd33baaaecffff1d8bc6","baseclick","venture","b","2011-09-02",1710600
"571d592ee39cdfd9a21e814d03be618b","genophen","venture",NA,"2011-05-03",1500000
"571d592ee39cdfd9a21e814d03be618b","genophen","venture",NA,"2012-05-21",1899997
"571d592ee39cdfd9a21e814d03be618b","genophen","venture",NA,"2013-11-22",2026681
"571d592ee39cdfd9a21e814d03be618b","genophen","venture","1","2015-05-29",3632593
"ee5aae8be644469e1d8c4708cc7c2c2e","basen",NA,NA,NA,NA
"38adaddd19c58c1480416a4825f64063","baseride-technologies","seed",NA,"2014-11-01",6e+05
"51230976331e0c37ea6e1e8357317267","safetna","debt_financing",NA,"2013-06-20",145000
"51230976331e0c37ea6e1e8357317267","safetna","debt_financing",NA,"2015-01-28",1e+05
"f695d0c69dea237d111dfa9b35a19904","basf",NA,NA,NA,NA
"ed57a1f100a68c60f2b581ba3de2bd7b","basilea-pharmaceutica-ltd",NA,NA,NA,NA
"70cc6536b3ac4edee05096e6fe6b4032","basis-technology","private_equity",NA,"2001-04-10",7500000
"70cc6536b3ac4edee05096e6fe6b4032","basis-technology","venture",NA,"2004-03-01",NA
"4cd88900a19f3aeb9fb85076570660f7","basisnote-ag","venture",NA,"2008-08-15",911000
"d7a8db899697081431307ede577a60e5","batch",NA,NA,NA,NA
"2df57eb2bb3f44b5caaea69ca881fb18","batu-biologics","equity_crowdfunding",NA,"2014-08-20",1e+05
"2df57eb2bb3f44b5caaea69ca881fb18","batu-biologics","seed",NA,"2015-06-17",1e+06
"38654c89328f0ee9b5aec021388ea163","bausch-lomb",NA,NA,NA,NA
"15df7be1197a52e5ed6e3e71f195eba8","bavarian-nordic","post_ipo_debt",NA,"2015-05-12",55874661
"63344791570fd294b4ede05b0c6208d9","bavelos-group",NA,NA,NA,NA
"58e8bef3dfcbeec03424fcd921c6fcde","baxter-international",NA,NA,NA,NA
"42eb0095a609fb61364ad1caf901d7ff","bay-city-capital",NA,NA,NA,NA
"89ef7f679c05b724212928c3ac031289","bay-dynamics","venture","A","2014-07-15",8e+06
"58dd9d95ce71193957882d8c3ef7dc75","bay-search-partners",NA,NA,NA,NA
"d598afe6acd5771201b6d50a962f3c88","bay-state-surgical-services","venture",NA,"2015-06-02",105000
"ec3e286fb2d4ace6c480ae2f863f43a6","bay-street-intelligence",NA,NA,NA,NA
"632fa0f376355806d9c2e463deea8c5d","bay31",NA,NA,NA,NA
"a9b649ceedc980f787baed840d684d82","bayard-revistas",NA,NA,NA,NA
"95acbd57b0f8eeb6c8f4c71224afbe4f","bayer-ag-germany",NA,NA,NA,NA
"0268032f5aa64a3c025e596f87af7e0f","bayer-cropscience",NA,NA,NA,NA
"3006504af91d2385d11a29001abd890d","bayer",NA,NA,NA,NA
"5dc88d0f2cbd23ec60dcff1d579a6600","bayes-impact","seed",NA,"2014-07-16",120000
"815a173c0b3cb9496c9383ba0e3ffaaa","bayescamp",NA,NA,NA,NA
"dc2ab7b9377e9d788a574a7b92c4b3ac","bayhill-therapeutics","venture",NA,"2009-07-17",9999999
"986aca13872ea2afd0d1f8ef8cabc413","bayinteractive",NA,NA,NA,NA
"d9cd17959572f46b4a398bd9197337c8","baypoint-benefits",NA,NA,NA,NA
"c2c5d5c2856b8a21b3d24351d97fa0c1","bazifit","seed",NA,"2014-03-20",75000
"c2c5d5c2856b8a21b3d24351d97fa0c1","bazifit","seed",NA,"2015-02-01",25000
"00de8537f48c92ee47c0000206795ee4","bb-biotech-ag",NA,NA,NA,NA
"6ca80632d782e405905c398f738ba134","bbk-worldwide","venture",NA,"2014-09-15",3e+06
"4b295becd9d53463c033c0b7b2e2bbef","bcisim",NA,NA,NA,NA
"ebd4cdcd39c3d905b12d59f50c7de3a8","bcv",NA,NA,NA,NA
"5512637158a5c1d91fe626fc823ed96d","bd-biosciences",NA,NA,NA,NA
"b01f3007d8a8b4145fb9af5a79ea589f","bd-diagnostics-geneohm",NA,NA,NA,NA
"7c5ca20e1869eb525d92ebc09a21fd95","be-limitless",NA,NA,NA,NA
"b8f04826560ad1d97a0a6a1ee73eb6c9","beachhead-marketing",NA,NA,NA,NA
"48bdf0b37def0ebde3d6aa64e6b8d46a","beacon-biomedical",NA,NA,NA,NA
"4dd81d3c43760b79dc724015b7e236d2","beaconifi-mobility-private-limited",NA,NA,NA,NA
"803ba4c424becf93a665b9178a35b0d4","beacons",NA,NA,NA,NA
"aa4d3bbee46d506ca9d10d220d28fca7","beaconsmind-ag","venture",NA,"2015-05-01",213249
"aa4d3bbee46d506ca9d10d220d28fca7","beaconsmind-ag","seed",NA,"2014-12-15",155554
"69452116da65332f426ca37341c6ebcc","beaconwatcher",NA,NA,NA,NA
"dcb7d0d1e684b3c6d607245c36e4a14c","beagle-bioinformatics","seed",NA,"2012-08-14",40000
"58add0b85262c91588112f528e7aea34","beagle-bioproducts","seed",NA,"2012-04-24",380000
"c4ad6be8e059a6268eb555f26dd4ac97","beagle-inc","non_equity_assistance",NA,"2015-03-01",NA
"c4ad6be8e059a6268eb555f26dd4ac97","beagle-inc","seed",NA,"2015-03-01",3e+05
"c4ad6be8e059a6268eb555f26dd4ac97","beagle-inc","venture",NA,"2012-07-07",NA
"8baec57fa162723ddb8c17214a9f720d","bealder",NA,NA,NA,NA
"16ce9c6204637d58efb0dd0ffde07f14","beamery",NA,NA,NA,NA
"a1eeeb00b44a044ed3ba6736e8d93e55","beamly","angel",NA,"2011-06-01",NA
"71a3756f0533b04e709a931b5f3c6b4d","beans-group",NA,NA,NA,NA
"c6685b4c61277be9d6835f1b3af9aff2","beanstalk-data",NA,NA,NA,NA
"de9037de4e0c3b308884528959e03cff","beat-biotherapeutics","seed",NA,"2013-04-16",2500000
"b0973b059ce661b3d6d9b2eaa4f17094","http-about-beauhurst-com-about",NA,NA,NA,NA
"8df9e1fbb72615bd26cfe986f47c763d","beautifeye","seed",NA,"2014-11-01",75321
"8df9e1fbb72615bd26cfe986f47c763d","beautifeye","seed",NA,"2014-12-09",92535
"52edb3b151de1499a954a06abd0dcf9d","beckon-inc","venture","A","2014-02-01",8e+06
"52edb3b151de1499a954a06abd0dcf9d","beckon-inc","seed",NA,"2011-10-01",2e+06
"52edb3b151de1499a954a06abd0dcf9d","beckon-inc","venture","B","2015-01-27",1.3e+07
"ca029f088cc235e79a480aab06c2b58c","becomr",NA,NA,NA,NA
"392fdecde8fb2391e13b980bfa6c818f","becton-dickinson",NA,NA,NA,NA
"c5067bd5ed2765f31097eaf569a18baa","bedatadriven",NA,NA,NA,NA
"f0fe5312221e8a7abda0dfa64a09f278","bedi-oralcare","seed",NA,"2013-08-13",212135
"52d4fc8ef64ef8365cf591321d13703a","bedrock-analytics","convertible_note",NA,"2015-05-11",NA
"52d4fc8ef64ef8365cf591321d13703a","bedrock-analytics","seed",NA,"2015-07-15",NA
"52d4fc8ef64ef8365cf591321d13703a","bedrock-analytics","seed",NA,"2013-04-18",NA
"b2cf1a2fa8a0f62ea937d072c621efff","bedrock-data","venture","A","2015-04-13",3100000
"c3df2ee98b800805fee5af696b9c69ee","bee-control-melbourne",NA,NA,NA,NA
"e94ef713065773307b8ff178b2c3765b","bee-shield","equity_crowdfunding",NA,"2013-10-15",NA
"3bc143e377aa6477a3d0631a23c137dd","beech-tree-labs","venture",NA,"2011-10-27",125000
"3bc143e377aa6477a3d0631a23c137dd","beech-tree-labs","venture",NA,"2010-03-15",1461591
"3bc143e377aa6477a3d0631a23c137dd","beech-tree-labs","venture","1","2010-12-09",7e+06
"3bc143e377aa6477a3d0631a23c137dd","beech-tree-labs","venture",NA,"2015-09-25",124992
"eeb47b4bfed809aa5356a025f045cf1e","beecham-research",NA,NA,NA,NA
"28313e6ce1eda23220c4e93101aef610","beehive-bi",NA,NA,NA,NA
"fb4f94a80696829c4bcd8fcd284d4889","beehiveid","seed",NA,"2013-04-15",50000
"fb4f94a80696829c4bcd8fcd284d4889","beehiveid","seed",NA,"2013-04-14",20000
"fb4f94a80696829c4bcd8fcd284d4889","beehiveid","venture",NA,"2013-11-11",NA
"f53f63e7bb9a563b45f7519a9cb67924","beek",NA,NA,NA,NA
"8a3b9aeac383b0a087ce96abda954741","beeken-biomedical","venture",NA,"2015-03-31",687462
"0a5b7f4320afda5217a01e5f34d40d3d","beeketing","angel",NA,"2015-05-01",70000
"0a5b7f4320afda5217a01e5f34d40d3d","beeketing","angel",NA,"2014-09-01",30000
"0a5b7f4320afda5217a01e5f34d40d3d","beeketing","seed",NA,"2015-10-01",125000
"93383bf4aeffe6237b042ac5c0a660fa","beetlerim-technologies-pvt-ltd",NA,NA,NA,NA
"9a22c0f6a733c111c9197066e31e293f","behaview","angel",NA,"2013-11-01",150000
"9a22c0f6a733c111c9197066e31e293f","behaview","angel",NA,"2014-02-01",1e+05
"f3293f0c2fc9079c4891a3a7b6fe2596","behaviormatrix",NA,NA,NA,NA
"386c5cb212cf5c8a241580f2dc4aa7d2","behaviosec","seed",NA,"2008-01-01",588840
"386c5cb212cf5c8a241580f2dc4aa7d2","behaviosec","venture","1","2011-05-10",1437780
"386c5cb212cf5c8a241580f2dc4aa7d2","behaviosec","venture","1","2014-12-08",6160113
"6850053f1f3cb1a2cef3fdee583ba42a","behold-ai",NA,NA,NA,NA
"182431a6881546c38bdb6230de516834","beigene","venture","A","2014-11-15",7.5e+07
"182431a6881546c38bdb6230de516834","beigene","venture","B","2015-05-12",96600000
"6187d3948faf7ba270ae0210a23e1d37","beijing-taishi-xinguang-technology","venture",NA,"2008-10-23",3e+07
"f877e30366802a98a44a09cde0d8cad1","beijing-tiantan-biological-products",NA,NA,NA,NA
"3c9561bb1c3bad7edb6b26d15385830b","beingwell-healthcare",NA,NA,NA,NA
"1147ed5e5a3a7586f6d1b7604aaf65f1","beintoo","venture",NA,"2012-10-03",2e+06
"1147ed5e5a3a7586f6d1b7604aaf65f1","beintoo","angel",NA,"2011-12-20",550000
"1147ed5e5a3a7586f6d1b7604aaf65f1","beintoo","venture","1","2012-06-22",5e+06
"43e92b6ccb359b4c66e2dcf77969f782","beliefnetworks","venture",NA,"2009-05-22",2086023
"43e92b6ccb359b4c66e2dcf77969f782","beliefnetworks","seed",NA,"2008-12-01",1400000
"4ad000879af757502b404770135042b7","bell-biosystems","seed",NA,"2012-09-30",1500000
"4ad000879af757502b404770135042b7","bell-biosystems","venture","1","2015-04-13",3810250
"739bcd5655634f5e9d7ccf09a6dde2e5","belladati","venture","a","2012-12-15",3e+06
"31493473ace5d5e6d1b0fb114dae5fe4","bellbrook-labs","seed",NA,"2012-06-15",187291
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","debt_financing",NA,"2009-10-20",1250000
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","seed",NA,"2007-10-09",2300000
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","grant",NA,"2007-10-09",1450000
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","venture","1","2009-11-04",4500000
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","venture","1","2012-03-08",2e+07
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","debt_financing",NA,"2010-10-26",1175000
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","venture","1","2014-01-07",14700000
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","venture",NA,"2011-03-25",5700000
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","venture",NA,"2009-03-31",5e+05
"d08d76d4b3f1d08e57d7a3cbb82a4897","bellicum-pharmaceuticals","venture","1","2014-08-27",94357588
"677b192f184c55fb9f0067b3ff0e7697","bellwether-institute","seed",NA,"2013-12-01",NA
"677b192f184c55fb9f0067b3ff0e7697","bellwether-institute","non_equity_assistance",NA,"2014-05-01",NA
"63913ca8f34cb55427df2af704f7aab9","belly","venture","b","2012-05-07",1e+07
"63913ca8f34cb55427df2af704f7aab9","belly","seed",NA,"2011-08-01",375000
"63913ca8f34cb55427df2af704f7aab9","belly","venture","a","2012-01-01",2500000
"63913ca8f34cb55427df2af704f7aab9","belly","venture","b","2013-08-28",12100000
"81342ec204c2d545d78abe798079e4d9","belly-fire-branding",NA,NA,NA,NA
"c9d23c778d0a56c1d596404e7d10d616","beloorbayir-biotech","venture",NA,"2014-03-31",12400000
"e7ab6184e776d7accc33ac6109079e4d","benchling","seed",NA,"2014-02-20",9e+05
"e7ab6184e776d7accc33ac6109079e4d","benchling","seed",NA,"2014-08-18",NA
"e7ab6184e776d7accc33ac6109079e4d","benchling","venture","1","2015-04-16",5e+06
"2c6eabccfba06a5f3ae8469e9ff5ac7b","benchmark-intelligence","seed",NA,"2015-02-26",70000
"6e762e69e0369b19087d25c91d64b467","benesol","venture",NA,"2015-12-10",3144983
"6e762e69e0369b19087d25c91d64b467","benesol","venture",NA,"2011-12-16",95000
"60ec4c5a4cf69e877d315b522ba2cec9","benetrends-financial",NA,NA,NA,NA
"45a95e7512e51d09b24a10964da200f9","beneufit",NA,NA,NA,NA
"8af10722de96c5531d06f55de0a7fb80","benevir-biopharm","venture",NA,"2014-11-26",2e+06
"4c03ce3681e205c40fd61a942e836203","benhauer","venture",NA,"2015-09-30",NA
"4c03ce3681e205c40fd61a942e836203","benhauer","venture",NA,"2014-03-04",1700000
"b1eda2b0011f4ee7c3675626eb36a268","benitec-ltd","post_ipo_equity",NA,"2014-04-15",30826728
"aa4950eaf9013a466db55e02693efb1b","benson-hill-biosystems","venture",NA,"2013-05-21",250000
"aa4950eaf9013a466db55e02693efb1b","benson-hill-biosystems","venture",NA,"2013-08-13",450971
"aa4950eaf9013a466db55e02693efb1b","benson-hill-biosystems","grant",NA,"2014-04-14",30000
"aa4950eaf9013a466db55e02693efb1b","benson-hill-biosystems","debt_financing",NA,"2013-01-04",3e+05
"aa4950eaf9013a466db55e02693efb1b","benson-hill-biosystems","seed",NA,"2014-08-20",50000
"aa4950eaf9013a466db55e02693efb1b","benson-hill-biosystems","convertible_note",NA,"2014-06-09",NA
"aa4950eaf9013a466db55e02693efb1b","benson-hill-biosystems","venture","1","2015-08-26",7300000
"e0a03cb90b14bde919be2eaace42d393","benten-bioservices","venture",NA,"2012-08-23",2944323
"e0a03cb90b14bde919be2eaace42d393","benten-bioservices","debt_financing",NA,"2013-02-01",1315000
"3605885a724e9cd40a9988b3b65905e9","benthic-labs","seed",NA,"2014-07-10",NA
"a12f7f6bb7e270312ac52dc0495e412b","bento-lab",NA,NA,NA,NA
"271d0e739b296b9d37dca179bd1fbb22","bergenbio","venture",NA,"2014-02-05",12172646
"271d0e739b296b9d37dca179bd1fbb22","bergenbio","venture","1","2012-01-09",8800000
"271d0e739b296b9d37dca179bd1fbb22","bergenbio","venture",NA,"2011-03-02",1300000
"271d0e739b296b9d37dca179bd1fbb22","bergenbio","venture",NA,"2013-05-01",6e+06
"c04ecea0aa337dd73cbd673ef48e0c34","berico-technologies",NA,NA,NA,NA
"77bf86e9f0018d10f31124a0e471341f","berkeley-biolabs",NA,NA,NA,NA
"84d545ba8e68842d7e60e0c29fb92d56","berkeley-healthlab",NA,NA,NA,NA
"42e82f4a4587ce4fb6ac3c290e1550fc","berlex-biosciences",NA,NA,NA,NA
"b4edf0c082c44e476b08d4fd801131dd","berlex-pharmaceuticals",NA,NA,NA,NA
"290d0d00e6e8b831ec2f9f0905984d9f","beryllium","venture",NA,"2014-02-25",7500000
"290d0d00e6e8b831ec2f9f0905984d9f","beryllium","venture",NA,"2009-12-07",4000142
"62362eb32d059269480ff006888db5af","bestfit-mobile",NA,NA,NA,NA
"d296396d960229fe07c794384cccb7e9","beta-cat-pharmaceuticals","venture",NA,"2011-01-07",275000
"d296396d960229fe07c794384cccb7e9","beta-cat-pharmaceuticals","venture",NA,"2014-07-08",5e+05
"d296396d960229fe07c794384cccb7e9","beta-cat-pharmaceuticals","venture",NA,"2015-07-02",1039561
"d9546359e0fa5a4aa4f0168c43061db6","beta-innov",NA,NA,NA,NA
"e23f62589892a1283c5fa22c80aa476f","beta-cie",NA,NA,NA,NA
"eee6ec718a64755bbce497d67d151550","betegy",NA,NA,NA,NA
"8f7b68f5413916732c4295c6d432694d","betwire",NA,NA,NA,NA
"749f03674df9a6d3cf056244ebecc023","bevalley","venture","a","2010-03-01",1700000
"616de01c550ae0fa1e7e653d0c952c5b","bevbucks","seed",NA,"2013-06-01",275000
"78505332c7fefdba68efb037d10b15bf","bevy-is---the-smarter-job-network","seed",NA,"2014-12-01",NA
"78505332c7fefdba68efb037d10b15bf","bevy-is---the-smarter-job-network","angel",NA,"2015-07-27",NA
"5eac8c7e732c33680092c2a607ce010e","beyond-intelligence",NA,NA,NA,NA
"a7ad9d2405aa0007a0cca6fec1d0f885","beyond-labs",NA,NA,NA,NA
"587c678e3b8d5f7a8d318459e1e126b2","beyond-the-box","seed",NA,"2013-06-06",NA
"62d3b79138738f31c37683ad9bb4f7a2","beyond-verbal","seed",NA,"2013-07-23",1e+06
"62d3b79138738f31c37683ad9bb4f7a2","beyond-verbal","seed",NA,"2013-05-08",2800000
"62d3b79138738f31c37683ad9bb4f7a2","beyond-verbal","seed",NA,"2014-09-18",3300000
"b3895cf04db1e1acf4169e0d23f49fa0","beyond-vip",NA,NA,NA,NA
"f54ff5fdf53a98bd7c06993c3d859d1b","beyondcore","venture","a","2014-02-18",9e+06
"34a202076251a52ed47afb6a0c0bec66","bfkw","venture",NA,"2013-06-18",280000
"15b11acc7a4828d396741bacfd3ff273","bfs-blue-enterprises",NA,NA,NA,NA
"4a720edfc51122a30766d26751944a28","bg-medicine","venture","a","2001-04-01",23735300
"4a720edfc51122a30766d26751944a28","bg-medicine","venture","a","2004-08-01",5e+06
"4a720edfc51122a30766d26751944a28","bg-medicine","venture","b","2005-03-01",4793990
"4a720edfc51122a30766d26751944a28","bg-medicine","venture","c","2007-05-01",5e+06
"4a720edfc51122a30766d26751944a28","bg-medicine","venture","D","2008-07-17",4e+07
"4a720edfc51122a30766d26751944a28","bg-medicine","debt_financing",NA,"2012-03-01",1.5e+07
"4a720edfc51122a30766d26751944a28","bg-medicine","venture",NA,"2010-04-14",2e+06
"4a720edfc51122a30766d26751944a28","bg-medicine","post_ipo_debt",NA,"2015-05-21",5e+05
"9f597e5f03845a3e631c1bfc0c3c9d73","bglobal",NA,NA,NA,NA
"a0f3b477d353b62305538cbaca49dc60","bhivelab",NA,NA,NA,NA
"416dcc06474b677f021fda1be945380b","endotech-solutions","seed",NA,"2016-01-05",1e+05
"b1dfa85bf0f5cb5d87fef48dba8fccb4","bi-cloud",NA,NA,NA,NA
"8a2910d4e6180cf0b48d9d2478c8de51","bi-sam-technologies","venture","a","2006-05-02",6570000
"05071c9525ada3355b9663155989e1f4","bia-separations","venture",NA,"2015-09-21",1694742
"433813f6e508d65b9fcef89df54fb30f","bialactis",NA,NA,NA,NA
"ac63cf69bd5371b3e90a0eaf30aca2d0","biametrics-gmbh","seed",NA,"2010-09-30",81626
"ac63cf69bd5371b3e90a0eaf30aca2d0","biametrics-gmbh","venture","1","2015-09-21",3490820
"33d0677299bf2e4d661dcc83fe1136bf","bicon-pharmaceutical","private_equity",NA,"2012-03-01",2.5e+08
"33d0677299bf2e4d661dcc83fe1136bf","bicon-pharmaceutical","venture","1","2009-11-01",NA
"d3224a651b28179bf1515d432b84f0bc","bicycle-therapeutics","undisclosed",NA,"2012-12-10",6027784
"d3224a651b28179bf1515d432b84f0bc","bicycle-therapeutics","venture","1","2014-10-14",3.2e+07
"04f0e4e08f6fca0309ece945ad7179fe","bidgely","venture","B","2015-11-02",16600000
"04f0e4e08f6fca0309ece945ad7179fe","bidgely","venture","A","2013-07-01",5e+06
"04f0e4e08f6fca0309ece945ad7179fe","bidgely","seed",NA,"2012-10-22",3e+06
"aa96698ab2f7e6f7285f7f43d0ee61c2","bidprime",NA,NA,NA,NA
"690916860990885cf67ff5040beac1c7","biedermann-motech",NA,NA,NA,NA
"165bebf468d12ab0ae54e890cd5c5845","bosweb-systems",NA,NA,NA,NA
"d5efea9d373893af31b20f76fe5b46ac","big-blue-q",NA,NA,NA,NA
"d91cdb4222f6a3ea5d9f15673fd7bc50","big-cloud-analytics","angel",NA,"2014-10-30",1500000
"68531658e583fa3e7251bb9fe8c20093","big-data-analytics",NA,NA,NA,NA
"2ee95db9cccbba374a5dfc3516595da6","big-data-elephants",NA,NA,NA,NA
"b7196415bb61448476d659e316c5e989","big-data-partnership","venture","A","2014-06-05",2092750
"b7196415bb61448476d659e316c5e989","big-data-partnership","venture","B","2015-05-07",4714577
"2b52e867aae2a2fdb58713a2c1df4c5a","big-data-perspective","seed",NA,"2014-04-02",650000
"231743a2c2146d8a886f2088eb611299","big-data-solutions",NA,NA,NA,NA
"0b449b9332874138067bb6614c32b5e5","big-fat-salary",NA,NA,NA,NA
"94a8d66c140271756d66ea26e0e0f36e","big-insights",NA,NA,NA,NA
"20728893f4942c03aa2a693d861d860d","big-propeller",NA,NA,NA,NA
"ed7afd5a09203afecf1d07995bcb3881","big-red-pin",NA,NA,NA,NA
"5e1659304ed366218121969f06a65970","big-spaceship",NA,NA,NA,NA
"4f06e624a120ee86298847303113b7e2","big-storm",NA,NA,NA,NA
"cfea9153f26fb92667cedc6064643f53","big-gg",NA,NA,NA,NA
"3a7e39c3c6a30a86a8b66e3af92b28ea","bigboards",NA,NA,NA,NA
"95b300d6c9403c9c24f6a6a39a8cadc5","bigdata4analytics",NA,NA,NA,NA
"134c93221041cc2b50daf92b85036847","bigdatagroup",NA,NA,NA,NA
"b0140fee8ec0f9ec891e6148fa350d2a","bigdna","venture",NA,"2007-11-18",614000
"b0140fee8ec0f9ec891e6148fa350d2a","bigdna","venture",NA,"2008-11-03",2413477
"ac62ff5b459862d97080be8abe56f289","bigelow-laboratory-for-ocean-sciences","grant",NA,"2010-09-30",9e+06
"3e6488cc7dfe97d45a3b062c9748a78f","biggerpan",NA,NA,NA,NA
"a3f84e8833f612aa15eebeb585982e04","bigml","seed",NA,"2011-08-31",150000
"a3f84e8833f612aa15eebeb585982e04","bigml","seed",NA,"2013-08-22",1250000
"a3f84e8833f612aa15eebeb585982e04","bigml","venture",NA,"2014-06-25",233000
"4fdd92751b44d443d20a64a59087f027","macrodata-inc",NA,NA,NA,NA
"f2fcb9fbc086b867f732cbf4f4270aaa","big-terminal",NA,NA,NA,NA
"fed505889eb4502d354c1c7d1e8b8199","bigwebstats",NA,NA,NA,NA
"532ee90a0961b72ed40c8f09370e336a","bijoti-inc-","seed",NA,"2014-11-01",NA
"496c3dda4a164cca4a5977ae6e7f5faa","bikanta","seed",NA,"2014-07-16",120000
"c247c04c2860507ecfdcc8d3e286f750","bilbeo",NA,NA,NA,NA
"6651a1c52d7b5b42e01305a347294b58","bill-ray-home-mobility","venture",NA,"2010-06-14",4e+05
"6651a1c52d7b5b42e01305a347294b58","bill-ray-home-mobility","equity_crowdfunding",NA,"2013-11-03",NA
"e26564430c6fa121eb8a90f052552828","billboard",NA,NA,NA,NA
"310a79aaab2e546afd598a9cf4a38593","billguard","venture","b","2011-10-06",1e+07
"310a79aaab2e546afd598a9cf4a38593","billguard","venture","a","2010-05-28",3e+06
"310a79aaab2e546afd598a9cf4a38593","billguard","convertible_note",NA,"2014-09-29",3500000
"2ab4aff57d4205990bc46589cbb293a5","bilytica",NA,NA,NA,NA
"5ffad0864da6e5d678f66e2241afa04f","we-are-cloud","seed",NA,"2009-07-02",1e+06
"5ffad0864da6e5d678f66e2241afa04f","we-are-cloud","venture","1","2013-11-21",4e+06
"40d50fc0ac06f1ecdbe4e524036f5fb5","bimotics",NA,NA,NA,NA
"204c9e8a728dde44e1907d40d0b29054","bina-technologies","seed",NA,"2011-04-21",1100000
"204c9e8a728dde44e1907d40d0b29054","bina-technologies","venture","1","2013-07-30",1750000
"204c9e8a728dde44e1907d40d0b29054","bina-technologies","venture","1","2013-03-27",6250000
"204c9e8a728dde44e1907d40d0b29054","bina-technologies","convertible_note",NA,"2012-03-28",1204545
"50208ae723b948247edd5297a02f1795","binarieslid",NA,NA,NA,NA
"7ff3d1ad1142e8f5785a6e6aac28e0ab","binary-fountain","seed","a","2014-01-22",5700000
"7ff3d1ad1142e8f5785a6e6aac28e0ab","binary-fountain","venture","A","2015-09-28",1.6e+07
"8a6839215dd7f8c25137179b7eb1f8f3","binatix",NA,NA,NA,NA
"7aeb842ec94e7dbe5b991e73bb6a2b42","bind-biosciences","venture","A","2007-02-07",2500000
"81bd02fcf8d278a474964ac4e9649a20","bind-therapeutics","venture","B","2007-11-27",1.6e+07
"81bd02fcf8d278a474964ac4e9649a20","bind-therapeutics","venture","d","2012-02-13",25500000
"81bd02fcf8d278a474964ac4e9649a20","bind-therapeutics","debt_financing",NA,"2011-10-13",4750000
"81bd02fcf8d278a474964ac4e9649a20","bind-therapeutics","post_ipo_equity",NA,"2013-09-20",70500000
"81bd02fcf8d278a474964ac4e9649a20","bind-therapeutics","venture",NA,"2013-02-11",8697684
"81bd02fcf8d278a474964ac4e9649a20","bind-therapeutics","venture","c","2010-06-29",12400000
"53d880015b82964e047ff4985873b546","bink--inc-","seed",NA,"2015-03-09",105000
"964cfc1fa1c27055264e23d237fe6471","binkies",NA,NA,NA,NA
"660ee150c5fea64e0a527b255cec0c73","bio-4",NA,NA,NA,NA
"2e6c8b9346fde305f5c0454c143a999d","bio","equity_crowdfunding",NA,"2011-12-17",NA
"72bd4f6d7d1685552874ac39f71387bc","bio-bureau-biotechnology","angel",NA,"2014-05-08",449775
"f503ed003aa681aba3ed4fcb427a28f2","bio-display-system",NA,NA,NA,NA
"3ded5d90a5a57c0d793c4131d538bced","bio-magnetics",NA,NA,NA,NA
"d1928a1a0e1b82c6de6b8c1d566b457d","bio-solutions",NA,NA,NA,NA
"e80c259e7a9354cdb1888af708d083b6","bio-wellness","venture",NA,"2014-02-25",60000
"e80c259e7a9354cdb1888af708d083b6","bio-wellness","venture",NA,"2011-01-26",402000
"e80c259e7a9354cdb1888af708d083b6","bio-wellness","venture",NA,"2014-02-26",90000
"e80c259e7a9354cdb1888af708d083b6","bio-wellness","venture",NA,"2011-02-07",50000
"e80c259e7a9354cdb1888af708d083b6","bio-wellness","venture",NA,"2011-05-12",150000
"e80c259e7a9354cdb1888af708d083b6","bio-wellness","venture",NA,"2013-06-05",150000
"e80c259e7a9354cdb1888af708d083b6","bio-wellness","venture",NA,"2015-04-20",99000
"c225d370724b5bd28625ce3db940bdad","bio-intervention-specialists","venture","c","2011-01-26",687500
"c225d370724b5bd28625ce3db940bdad","bio-intervention-specialists","venture",NA,"2010-08-16",360000
"d4b10848d8e85ab7cfa2574692a9456d","bio-ivt-group","debt_financing",NA,"2013-07-16",4.5e+07
"a0dbdbcbd6c751ea055feb41688bef5a","bio-key-international","venture",NA,"2013-11-11",3697100
"4c0b3ec9d255aeac01b0a345b04ed869","bio-matrix-scientific-group","debt_financing",NA,"2011-12-15",50000
"a1f380ba0128a284b87e5f81dad6cb3b","bio-nems","debt_financing",NA,"2012-11-11",725000
"a1f380ba0128a284b87e5f81dad6cb3b","bio-nems","debt_financing",NA,"2014-04-07",2e+05
"804ff9f313c9724bdea2bdfa6143d40c","bio-path-holdings","venture",NA,"2013-05-03",453000
"804ff9f313c9724bdea2bdfa6143d40c","bio-path-holdings","venture",NA,"2010-12-22",741000
"804ff9f313c9724bdea2bdfa6143d40c","bio-path-holdings","venture",NA,"2010-06-09",2e+05
"804ff9f313c9724bdea2bdfa6143d40c","bio-path-holdings","venture",NA,"2010-06-02",923000
"68069d7a9608050d90be9fd3d3df34a2","bio-rad-laboratories",NA,NA,NA,NA
"2c6d656f8ac0ae51b3004fc451f4904f","bio-synthesis",NA,NA,NA,NA
"814f986cde6d9f3ca26aacf93a375df5","techne-corporation",NA,NA,NA,NA
"9f6dae2c12ba7726bc30638697972790","bio2-technologies","venture",NA,"2010-07-07",1100064
"1dbe1d9c0ba9b5dfafa407b024e995be","bioabsorbable-therapeutics","debt_financing",NA,"2009-03-13",359705
"0a8a60e60b9eeb1b1b04465dbae95df4","bioactor","venture","A","2011-07-26",2882799
"ee04de1338a95f9b28ad27d02349ada5","bioaegis-therapeutics","seed",NA,"2013-02-08",3e+06
"ee04de1338a95f9b28ad27d02349ada5","bioaegis-therapeutics","debt_financing",NA,"2014-02-07",3732412
"ee04de1338a95f9b28ad27d02349ada5","bioaegis-therapeutics","convertible_note",NA,"2015-04-15",8e+06
"7117f6dcdf6dcb00d76093dacba9ad3a","bioagilytix-labs",NA,NA,NA,NA
"7c3b35de247cdbab3feafcf3e8ecfea3","bioagra",NA,NA,NA,NA
"44a5a21660af89db1b640a145acc057b","bioalabama",NA,NA,NA,NA
"27e5061a18536a5e99a8eda0ec4250b4","bioamber","venture","b","2011-05-04",4.5e+07
"27e5061a18536a5e99a8eda0ec4250b4","bioamber","venture","c","2012-02-22",3e+07
"27e5061a18536a5e99a8eda0ec4250b4","bioamber","debt_financing",NA,"2014-02-19",1e+07
"27e5061a18536a5e99a8eda0ec4250b4","bioamber","debt_financing",NA,"2013-07-18",2.5e+07
"27e5061a18536a5e99a8eda0ec4250b4","bioamber","debt_financing",NA,"2014-06-23",18585460
"27e5061a18536a5e99a8eda0ec4250b4","bioamber","grant",NA,"2014-07-02",7e+06
"473573c87c19518d4b16e618f10f205c","bioanalytical","seed",NA,"2012-08-31",127890
"1fad005cca19c51e4e45942da835e9df","bioanalytix","venture",NA,"2012-08-17",858000
"1fad005cca19c51e4e45942da835e9df","bioanalytix","venture","1","2013-10-24",3750000
"422b6e912066cdd75ffce737ea22fc7d","bioapter","venture",NA,"2007-05-08",2033700
"1598422a8e6a85c4d3313d8f6b75d693","bioarray","seed",NA,"2014-01-01",NA
"9147a1f1ee5715160b4f48fc6592b400","bioarray-therapeutics","venture",NA,"2015-05-01",1468163
"e7ddcbdec68a7a4609dadddd5fb54993","bioassets-development","venture",NA,"2009-09-04",3911759
"002e0b73ab4ebfd50d9ae6df8fede446","bioatla","venture",NA,"2016-01-11",4.5e+07
"002e0b73ab4ebfd50d9ae6df8fede446","bioatla","venture",NA,"2015-07-21",39000001
"002e0b73ab4ebfd50d9ae6df8fede446","bioatla","venture",NA,"2015-06-11",3e+07
"5c5f8f5aea73dd58fe46126e6c5e4fdc","bioatlantis","venture",NA,"2010-06-07",896000
"aeaf7e6ea966241c17e40faa199220c1","bioavenge",NA,NA,NA,NA
"3ad17aba76c1f34475c12e86ec752dbe","bioaxial","seed",NA,"2013-11-27",2700000
"8c5fb075d47fa3ade248a95bdc9b1634","bioaxone-therapeutic","venture","b","2005-05-20",12150000
"f9c9d9365ad883e5d8802badc8ba3ac3","biobat",NA,NA,NA,NA
"e1eec081d8ae6556c28860b82d5dbef5","biobeats","seed",NA,"2013-08-01",650000
"4b3b13b39b4a210184f7e3471cda2d12","biobee",NA,NA,NA,NA
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","venture","A","2007-02-02",8500000
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","venture",NA,"2011-04-29",3e+05
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","venture",NA,"2012-06-01",5159058
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","venture",NA,"2013-02-28",5e+05
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","venture","b","2010-03-17",1e+07
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","debt_financing",NA,"2011-05-23",7e+05
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","debt_financing",NA,"2010-01-27",5e+05
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","debt_financing",NA,"2009-06-18",2500000
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","debt_financing",NA,"2009-12-04",5e+05
"44736cfe71b06f1708207e5bd70ffcad","biobehavioral-diagnostics","seed",NA,"2012-07-17",1454750
"01284278612b51421ce3f98956bab67b","bioblast-pharma","venture",NA,"2014-02-13",4750000
"e6a649b30acbfeaf78e56bf21caf3cf1","biocancell-therapeutic-inc",NA,NA,NA,NA
"75eb03403542334be4b083af61c5b07e","biocare",NA,NA,NA,NA
"57dd4577a711060325ac15e248cf9cee","biocartis","venture","c","2011-11-17",95708000
"57dd4577a711060325ac15e248cf9cee","biocartis","venture","e","2013-11-05",38598000
"57dd4577a711060325ac15e248cf9cee","biocartis","venture","B","2010-04-08",40087836
"57dd4577a711060325ac15e248cf9cee","biocartis","venture","A","2009-10-15",14881026
"57dd4577a711060325ac15e248cf9cee","biocartis","venture","D","2012-12-12",44831977
"57dd4577a711060325ac15e248cf9cee","biocartis","venture","F","2014-09-04",84763024
"57dd4577a711060325ac15e248cf9cee","biocartis","grant",NA,"2014-06-26",2314688
"57dd4577a711060325ac15e248cf9cee","biocartis","secondary_market",NA,"2013-11-01",NA
"516abfe7ee23d825b1e2144b41ca591e","biocatch","seed",NA,"2013-09-01",1e+06
"516abfe7ee23d825b1e2144b41ca591e","biocatch","seed",NA,"2012-03-01",6e+05
"516abfe7ee23d825b1e2144b41ca591e","biocatch","venture","1","2014-06-17",1e+07
"0606febe0854e5bbce3ed3f01aa666eb","biocee","venture",NA,"2011-04-11",2e+05
"0606febe0854e5bbce3ed3f01aa666eb","biocee","venture",NA,"2010-07-14",357070
"a4c12f8a7dfec7f4a31d6a1b7d3a0c4b","biocell-ireland",NA,NA,NA,NA
"f2f86a2c22fb2d0b8472e0edd38a2c4a","biocellection","venture",NA,"2015-04-30",NA
"c77a2888c6c41bf6e0026497402129e8","biocep",NA,NA,NA,NA
"0d3b8963c5f8f4af626dfb37e7ef582a","biocept","venture",NA,"2009-06-30",3000
"0d3b8963c5f8f4af626dfb37e7ef582a","biocept","venture","1","2006-06-23",1e+07
"0d3b8963c5f8f4af626dfb37e7ef582a","biocept","debt_financing",NA,"2011-02-16",1200000
"0d3b8963c5f8f4af626dfb37e7ef582a","biocept","venture","1","2010-03-29",3600000
"0d3b8963c5f8f4af626dfb37e7ef582a","biocept","venture","1","2010-08-12",2299999
"88fb149a3ea73e4930ec03c348a0593f","bioceptive","venture",NA,"2013-12-30",1250000
"88fb149a3ea73e4930ec03c348a0593f","bioceptive","private_equity",NA,"2013-04-23",1100000
"88fb149a3ea73e4930ec03c348a0593f","bioceptive","seed",NA,"2011-08-15",135000
"7fd05d37a417caad42a922566b515134","bioceramic-therapeutics","venture","b","2010-01-17",1900000
"f5fdf1df006d7bb83112ddb4ac51c255","bioceros","grant",NA,"2011-01-21",2300000
"b064e4ec6ffc9cc04576f6b53dcd577e","biocision","venture",NA,"2012-12-04",2500000
"b064e4ec6ffc9cc04576f6b53dcd577e","biocision","venture",NA,"2014-03-12",5847600
"6f897abdc18343a12a8243cda2c82734","biocius-life-sciences",NA,NA,NA,NA
"3cb2a89f1ba5b7390115c1fef0c08cd6","bioclin-therapeutics","venture","A","2014-04-02",6e+06
"3cb2a89f1ba5b7390115c1fef0c08cd6","bioclin-therapeutics","venture","A","2012-12-28",2e+07
"ed2d46befb06953542647d9a3630cff6","bioclinica","venture",NA,"2011-07-11",8714382
"ed2d46befb06953542647d9a3630cff6","bioclinica","venture",NA,"2009-06-17",5e+06
"2872c0e4ddc1009910f3092d1a33c652","bioclones","venture",NA,"2005-06-28",2850000
"14b941a4e595f87420ab0ec560cbd88b","biocompatibles-international",NA,NA,NA,NA
"90dc69a5da845b57ccdf287da3631f35","bioconference-live",NA,NA,NA,NA
"0c92406aec1f62005fd19b5de5064252","bioconnect-systems","venture","A","2007-04-06",8e+06
"0c92406aec1f62005fd19b5de5064252","bioconnect-systems","debt_financing",NA,"2012-01-13",469196
"0c92406aec1f62005fd19b5de5064252","bioconnect-systems","venture",NA,"2013-09-25",9069922
"0c92406aec1f62005fd19b5de5064252","bioconnect-systems","debt_financing",NA,"2012-12-06",1485794
"0c92406aec1f62005fd19b5de5064252","bioconnect-systems","seed",NA,"2006-07-24",NA
"1de18b32ff0bbce3e1a29c299f9e2fc6","bioconsortia","venture","b","2014-04-07",1.5e+07
"385fee1504f6151cd64b955ae21503de","biocontrol","venture",NA,"2007-10-05",1018959.4386
"b9d79191e99f6ca363f71db4a39f4acc","biocrates-life-sciences","venture",NA,"2010-03-25",1600000
"b9d79191e99f6ca363f71db4a39f4acc","biocrates-life-sciences","venture","1","2006-06-23",6270000
"8c02739b0156361d586b0e83bd433c1a","biocritica","private_equity",NA,"2011-05-25",2.5e+07
"10ae51373df7cede844aaaa054f6a07b","biocroi",NA,NA,NA,NA
"86ed41c6a652eb5f4f73bcf8635c46ae","biocryst-pharmaceuticals","venture",NA,"2014-06-23",1900000
"86ed41c6a652eb5f4f73bcf8635c46ae","biocryst-pharmaceuticals","grant",NA,"2014-08-13",4099999
"86ed41c6a652eb5f4f73bcf8635c46ae","biocryst-pharmaceuticals","grant",NA,"2014-08-29",2400000
"bb14c253a9c234716abf51798302467f","biocurex","debt_financing",NA,"2009-08-31",2150000
"55848b9cc1343d250e2733d1a9f657f2","biocurious",NA,NA,NA,NA
"97427298b386c0a89b37f1df68544226","biocurity","venture",NA,"2011-03-16",135000
"f0c090bc2c0cbd43facf3373de8e247e","biocycle","debt_financing",NA,"2016-01-12",9e+05
"f0c090bc2c0cbd43facf3373de8e247e","biocycle","venture",NA,"2012-10-29",1500000
"f0c090bc2c0cbd43facf3373de8e247e","biocycle","debt_financing",NA,"2013-10-11",1500000
"f0c090bc2c0cbd43facf3373de8e247e","biocycle","debt_financing",NA,"2014-04-10",9e+05
"1f408ff9c60766d86298679bb992d500","biodata","venture","b","2012-07-17",NA
"0a232aa1b9d974eaf067f896f85ad203","biodel","venture",NA,"2011-05-13",3e+07
"0a232aa1b9d974eaf067f896f85ad203","biodel","private_equity",NA,"2012-06-29",18500002
"b65f1ce0fc688b056d077d24c53b7657","biodelivery-sciences-international","debt_financing",NA,"2013-07-08",2e+07
"b65f1ce0fc688b056d077d24c53b7657","biodelivery-sciences-international","post_ipo_equity",NA,"2012-11-28",4e+07
"b65f1ce0fc688b056d077d24c53b7657","biodelivery-sciences-international","debt_financing",NA,"2015-06-01",20700000
"8705c49cc31f0c7916cb5122575c9faf","bioderm","venture",NA,"2011-06-22",603850
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","d","2012-08-29",1.2e+07
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","d","2011-07-14",2e+07
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","c","2010-11-05",7100000
"ba512a4f6a4ab85910c659f7097224eb","biodesix","grant",NA,"2010-11-05",1400000
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","b","2009-09-28",1e+07
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","d","2013-04-12",8800000
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","e","2013-12-02",8300000
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","e","2014-01-14",6100000
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","E","2015-01-12",1.2e+07
"ba512a4f6a4ab85910c659f7097224eb","biodesix","venture","E","2015-06-23",1.1e+07
"b546b58ce587a68ed4e53eb62fa14a35","biodesy","venture","B","2016-01-21",1e+07
"b546b58ce587a68ed4e53eb62fa14a35","biodesy","venture","a","2013-10-17",1.5e+07
"b546b58ce587a68ed4e53eb62fa14a35","biodesy","venture",NA,"2009-12-17",350009
"fef487a32505e1767bdcd82db18525dc","biodetego","seed",NA,"2014-03-26",50000
"083e8290e40376be2e7dde57cda1f214","biodigital","venture",NA,"2010-08-06",450000
"083e8290e40376be2e7dde57cda1f214","biodigital","venture","1","2013-09-24",4e+06
"389e6f62fe6e58284e1ab437d7185563","biodirect",NA,NA,NA,NA
"2dbfac10a7f1438a4938daa6905365d2","biodirection","venture","a","2013-08-19",4e+06
"2dbfac10a7f1438a4938daa6905365d2","biodirection","venture",NA,"2014-12-31",1637500
"1ac87e7cebfb420a9277712f0a6c71dd","biodtech","venture",NA,"2010-08-25",575000
"fa8050c8810fef69ca08e7484cb80028","biodynamics-technology-llc-2",NA,NA,NA,NA
"351b7a25ea3ae124aa499cad09a83991","biodynamics-technology-llc",NA,NA,NA,NA
"14707d319ce11de85ac0f3c89d10841f","bioecon","venture",NA,"2011-04-12",1447000
"0ec798d78aa9d345b7f84c80c43ff63d","bioelectronics","seed",NA,"2012-11-09",50000
"de565b02f3f2ac0753385d61c5ed23a2","bioenvision","venture",NA,"2007-04-30",7410000
"0a3f0f96390633293c2110e53d9c7adc","bioexx-specialty-proteins","venture",NA,"2009-06-10",827608
"0a3f0f96390633293c2110e53d9c7adc","bioexx-specialty-proteins","venture",NA,"2009-11-09",3771308
"0a3f0f96390633293c2110e53d9c7adc","bioexx-specialty-proteins","seed",NA,"2011-07-15",2284354
"0a3f0f96390633293c2110e53d9c7adc","bioexx-specialty-proteins","venture",NA,"2010-09-08",1524806
"0a3f0f96390633293c2110e53d9c7adc","bioexx-specialty-proteins","venture",NA,"2010-04-26",1313218
"be87554d14d412c9d4646d2bae5c3096","biofab","seed",NA,"2015-02-02",50000
"be87554d14d412c9d4646d2bae5c3096","biofab","seed",NA,"2014-11-10",50000
"f2efdb7cbd96daf7cb4b2240ec81ed89","biofire-diagnostics","venture",NA,"2013-05-02",4.5e+07
"f2efdb7cbd96daf7cb4b2240ec81ed89","biofire-diagnostics","venture",NA,"2012-09-19",2.5e+07
"f6482428d94618353e5cbb84120b7ab2","biofisica","venture",NA,"2008-02-20",2415000
"f6482428d94618353e5cbb84120b7ab2","biofisica","venture","1","2006-10-31",5e+06
"f6482428d94618353e5cbb84120b7ab2","biofisica","venture",NA,"2008-10-31",NA
"f6482428d94618353e5cbb84120b7ab2","biofisica","venture",NA,"2013-05-17",NA
"f6482428d94618353e5cbb84120b7ab2","biofisica","venture",NA,"2009-06-30",NA
"f6482428d94618353e5cbb84120b7ab2","biofisica","venture",NA,"2014-01-09",NA
"d74e826ad3109b85a1e5bda5b64cadc2","bioform-medical",NA,NA,NA,NA
"a6ecfe12ea19282fb52f71531041ed2d","biofortuna","venture",NA,"2012-01-01",2017328
"a6ecfe12ea19282fb52f71531041ed2d","biofortuna","undisclosed",NA,"2012-04-11",3338591
"a6ecfe12ea19282fb52f71531041ed2d","biofortuna","venture",NA,"2010-05-24",1590000
"6e90a6341ce580cfe1ef445840616360","bioforward",NA,NA,NA,NA
"c5bcf035cf585b2150f5a98362910947","biogait",NA,NA,NA,NA
"9e83fa497c518e8aa0d0c3623c46b171","biogazelle","venture",NA,"2014-10-06",2500000
"aaa4a2155105818e55f9b956a80f4dac","biogen-idec",NA,NA,NA,NA
"2c3b469dbabcbf57723f263aa3d3a622","biogen-waen","venture",NA,"2012-10-31",11247268
"8874b5c327d557f617a7a3498f567c8e","biogenerics","debt_financing",NA,"2011-07-25",3794959
"8874b5c327d557f617a7a3498f567c8e","biogenerics","venture",NA,"2011-03-10",865666
"156701c5a0137a0efdf74534e451881f","biogenex",NA,NA,NA,NA
"2fa718530c278406cd900b88d0d836ce","biogeniq","seed",NA,"2014-10-30",380000
"2fa718530c278406cd900b88d0d836ce","biogeniq","seed",NA,"2015-03-01",6e+05
"9276a1c0ea03ad0b3789bf3204c1aa41","biogenix-research-center---center-for-molecular-biology-and-applied-science",NA,NA,NA,NA
"a900913e170f3ea4cb2b76a5add76faa","biogrid",NA,NA,NA,NA
"00163aaf0889cd3b5c00fc923806d20e","biohealthonomics-inc","equity_crowdfunding",NA,"2013-10-29",NA
"a6ef2c60f160d0a47247736016d116c2","bioheart","venture",NA,"2011-06-28",145000
"a6ef2c60f160d0a47247736016d116c2","bioheart","venture",NA,"2011-03-31",1e+05
"a6ef2c60f160d0a47247736016d116c2","bioheart","venture",NA,"2010-08-12",234020
"a6ef2c60f160d0a47247736016d116c2","bioheart","venture",NA,"2013-06-05",467500
"d9f45f5624a3fae1d9e5b2cf67b7f4f5","biohorizons","private_equity",NA,"2011-06-30",5e+07
"d9f45f5624a3fae1d9e5b2cf67b7f4f5","biohorizons","venture",NA,"2011-11-11",12558512
"d9f45f5624a3fae1d9e5b2cf67b7f4f5","biohorizons","venture",NA,"2012-12-19",1500000
"447a36befa8cad850d1514321c540e4a","bioimagene","venture","D","2008-08-19",2.6e+07
"cbd080837a9dfa7158dfebb664b10c97","bioincept","venture",NA,"2014-04-28",3185000
"918c47dea121add5ff4c6bcf5407c0cf","bioindustrial-innovation-canada",NA,NA,NA,NA
"b5b205a514e841a33433f222f088efca","bioinspire-technologies","seed",NA,"2011-10-05",3124082
"741a334026411229ec42c2bd2ee2575e","bioiq","venture",NA,"2009-09-09",436000
"741a334026411229ec42c2bd2ee2575e","bioiq","venture",NA,"2010-01-28",492942
"db66623eb9e136ddbeb3eca301e9cdef","bioject-medical-technologies","venture",NA,"2009-12-22",1201834
"db66623eb9e136ddbeb3eca301e9cdef","bioject-medical-technologies","venture",NA,"2013-02-11",994550
"db66623eb9e136ddbeb3eca301e9cdef","bioject-medical-technologies","debt_financing",NA,"2013-10-29",680000
"d5bf50574e9bfcaa56fd65ede2bc91b7","biokier","venture",NA,"2011-08-31",340000
"d5bf50574e9bfcaa56fd65ede2bc91b7","biokier","venture",NA,"2009-08-07",199999
"d5bf50574e9bfcaa56fd65ede2bc91b7","biokier","venture",NA,"2013-07-24",1700000
"d5bf50574e9bfcaa56fd65ede2bc91b7","biokier","debt_financing",NA,"2014-08-04",150000
"4d6599af4271d068ca4f4de46ff84324","biokine-therapeutics",NA,NA,NA,NA
"feb2097383bcbbcda6b3df3d706df617","biolase","venture",NA,"2011-07-11",9024004
"feb2097383bcbbcda6b3df3d706df617","biolase","venture",NA,"2014-02-11",5e+06
"feb2097383bcbbcda6b3df3d706df617","biolase","post_ipo_equity",NA,"2014-11-05",3.5e+07
"200c41f69509bcae7f250806cceefd06","biolauncher",NA,NA,NA,NA
"2323c9054834f5ac0e54f58cf333a3ce","bioleap","venture","a","2010-01-12",5e+06
"8b7f3b904e2e72596405461bf927ab98","biolex-therapeutics","venture","c","2007-05-24",3e+07
"8b7f3b904e2e72596405461bf927ab98","biolex-therapeutics","venture","b","2005-09-01",3.6e+07
"8b7f3b904e2e72596405461bf927ab98","biolex-therapeutics","venture","d","2010-10-29",2e+07
"8b7f3b904e2e72596405461bf927ab98","biolex-therapeutics","debt_financing",NA,"2010-02-23",1e+07
"8b7f3b904e2e72596405461bf927ab98","biolex-therapeutics","debt_financing",NA,"2011-06-09",5899709
"8b7f3b904e2e72596405461bf927ab98","biolex-therapeutics","venture","d","2008-10-06",6e+07
"8b7f3b904e2e72596405461bf927ab98","biolex-therapeutics","venture",NA,"2005-01-07",8e+06
"8b7f3b904e2e72596405461bf927ab98","biolex-therapeutics","debt_financing",NA,"2011-12-19",2364417
"c7fa21abce3a8a858895755b6f0e142c","biolife",NA,NA,NA,NA
"3bc50ce1f4fdd44bb4fd67001746ce55","biolight-israeli-life-sciences-investments-ltd","venture",NA,"2014-03-19",4e+06
"3bc50ce1f4fdd44bb4fd67001746ce55","biolight-israeli-life-sciences-investments-ltd","post_ipo_equity",NA,"2015-04-02",6200000
"85e9d847e4e67f47084476d3122bc749","biolin-scientific",NA,NA,NA,NA
"55913185448abbcf302cddf4f347a4a3","biolinerx","post_ipo_equity",NA,"2014-03-07",24100000
"55913185448abbcf302cddf4f347a4a3","biolinerx","post_ipo_equity",NA,"2014-12-17",1e+07
"55913185448abbcf302cddf4f347a4a3","biolinerx","post_ipo_equity",NA,"2015-03-08",2.5e+07
"653087420bcc10edfc39efd8106496aa","biolink",NA,NA,NA,NA
"589302b3376a2cfbb4ab4bd023ef1e78","biological-dynamics","venture","C","2015-11-05",26800000
"fcc0dff80d5899b9b494412cf62b8185","biological-signal-processing",NA,NA,NA,NA
"bf226ba91c8a1293963ee90db7079b3a","biologicsinc","venture",NA,"2010-05-20",821889
"bf226ba91c8a1293963ee90db7079b3a","biologicsinc","venture",NA,"2015-04-15",2.9e+07
"5e7f4ae2289751354e00db28cb846f63","biologics-modular","venture",NA,"2011-07-15",750000
"541b168a53799ab258425978e724925d","biologie-et-industrie",NA,NA,NA,NA
"e0332579fbe1a36489197ed7dbed5a6b","biomup","venture",NA,"2012-10-26",8777440
"e0332579fbe1a36489197ed7dbed5a6b","biomup","venture","1","2015-09-10",35089686
"7306b90652c81fc4d08bbee0e103ca10","biomagnetics-diagnostics",NA,NA,NA,NA
"fe98e81dafe6485da8bcb55912b995ac","biomaps",NA,NA,NA,NA
"5dacc44f7ce76506371ac2d6ccb6ead1","biomarcare-technologies","venture",NA,"2012-03-29",1e+06
"a7a6069d3c963848c5e3cce520e710cf","biomarck-pharmaceuticals","debt_financing",NA,"2012-08-09",266446
"a7a6069d3c963848c5e3cce520e710cf","biomarck-pharmaceuticals","venture",NA,"2009-08-28",7500000
"61b4b830f64eaaefbc425ab1b181e79c","biomarker-strategies","venture",NA,"2009-08-13",439400
"61b4b830f64eaaefbc425ab1b181e79c","biomarker-strategies","venture",NA,"2010-02-18",273178
"61b4b830f64eaaefbc425ab1b181e79c","biomarker-strategies","venture",NA,"2013-12-03",125000
"61b4b830f64eaaefbc425ab1b181e79c","biomarker-strategies","venture",NA,"2011-09-29",2327500
"61b4b830f64eaaefbc425ab1b181e79c","biomarker-strategies","venture",NA,"2010-11-16",2012121
"2003afb90b6b28d7b18a93879bacc85c","biomas",NA,NA,NA,NA
"46ba725e1b3073a56944a8afeaf9beab","biomatik-corporation",NA,NA,NA,NA
"80fac9ff8b60a38b3d86ee5f6a083f81","biomatrica","venture",NA,"2011-02-15",1192160
"80fac9ff8b60a38b3d86ee5f6a083f81","biomatrica","venture",NA,"2012-12-06",5e+06
"80fac9ff8b60a38b3d86ee5f6a083f81","biomatrica","venture",NA,"2012-09-01",3024071
"8efee1e21b83d80af2834ad0b87336e4","biomcn","venture",NA,"2009-03-02",45345600
"83ca5b10aa4eb3aefcd122291c50684c","biomeasure","venture",NA,"2011-12-15",4.5e+07
"02f952ed9f0039cf1c0d638021b234cb","biomec-cardiovascular",NA,NA,NA,NA
"c1dbe00128add90255e4654498cdcbda","biomed-resource",NA,NA,NA,NA
"3cf5cc14caf61d77fd3e8985cd366701","biomed-valley-discoveries-inc",NA,NA,NA,NA
"80d4716d327414a2f070ac3031484e6a","biomedflex","venture",NA,"2009-11-06",250000
"eee0ce1b3bede0763a7844b1c9f74eb8","biomedical-diagnostics-institute",NA,NA,NA,NA
"d0a7b0a14e78b81a5d54883d14a25643","biomedical-enterprises","venture",NA,"2009-06-08",862869
"46f7dfac08848c1ec06fbfdf5fefa124","biomedical-innovation","grant",NA,"2013-10-05",10400000
"43acc63bd0e3f6337c3ff8cdd91c018f","biomedical-structures",NA,NA,NA,NA
"642594fe320292f89ca7af677c8927a2","biomedix-vascular-solution","debt_financing",NA,"2012-11-23",682236
"2814e6abe727e5e23cc17443a304b182","biomedomics","venture",NA,"2014-01-06",690000
"2814e6abe727e5e23cc17443a304b182","biomedomics","venture",NA,"2015-02-23",275752
"2814e6abe727e5e23cc17443a304b182","biomedomics","grant",NA,"2015-09-16",222950
"ba9e6cd4fad7929903d160fcbb29be37","biomeme","debt_financing",NA,"2014-01-29",992799
"ba9e6cd4fad7929903d160fcbb29be37","biomeme","seed",NA,"2013-07-15",NA
"ba9e6cd4fad7929903d160fcbb29be37","biomeme","equity_crowdfunding",NA,"2013-12-23",3e+05
"2a26ffdf21d5db5109718239578d1472","biomerieux",NA,NA,NA,NA
"daa4f18792d3d305df7ca72b8d44e148","biomethodes",NA,NA,NA,NA
"7e604919645897d733e904bf3ea5fb57","biometric-associates","venture",NA,"2013-11-22",240000
"6cbc49f20433abe3a141ae73113aaf7e","biometric-cloud-solutions","convertible_note",NA,"2013-08-21",1e+05
"16859d308386a9273b1725ed19e6cb5d","biometric-imaging",NA,NA,NA,NA
"5660de2650011fcc4cff3df60fdb0dd2","biometrypass",NA,NA,NA,NA
"203533d07f9d0b089d5cf61d1d59c932","biomicro-systems","venture","B","2007-09-27",2020000
"52983b76ec35d9b4b17c0ede2424d1f6","biomimetic-therapeutics","venture",NA,"2009-06-25",2918951
"52983b76ec35d9b4b17c0ede2424d1f6","biomimetic-therapeutics","venture",NA,"2009-04-17",8000004
"1ff22328a34eb607304a61d22d58cf8f","biomimetix-pharmaceutical","seed",NA,"2011-07-26",2e+06
"8e5784aab6509bf538d0db987aa73daa","biomimetx","seed",NA,"2015-01-01",242563
"9bc1dbbab8889a34f6fe2455f60641c4","biomisa-research-group",NA,NA,NA,NA
"a2aea4f9765e5966cf7135d4030e22d3","biomoda","venture",NA,"2010-03-16",1e+06
"a8d1ab5aaffab1055b237923509c3a47","biomode-biomolecular-determination","seed",NA,"2010-12-20",395733
"a8d1ab5aaffab1055b237923509c3a47","biomode-biomolecular-determination","venture","1","2015-03-19",1711156
"84d9aa877eedb46f2b88fb21075a28eb","biomol-international",NA,NA,NA,NA
"12977a408db30f801dbb95d7440ab107","biomonitor","venture",NA,"2008-06-30",4640000
"8fd1195e925891828e212aa0fcba5306","biomoti","seed",NA,"2013-02-18",116185
"5b22da5b626ec0cb41969c2da0b2fb1d","biomotiv","venture",NA,"2013-08-05",2.5e+07
"5b22da5b626ec0cb41969c2da0b2fb1d","biomotiv","venture",NA,"2012-09-05",2.1e+07
"5b22da5b626ec0cb41969c2da0b2fb1d","biomotiv","venture",NA,"2014-08-14",4780000
"5b22da5b626ec0cb41969c2da0b2fb1d","biomotiv","venture",NA,"2015-08-06",30626790
"7518fd852d219699a452c0f84ae784aa","bionanomatrix","venture","A","2008-03-26",5100000
"7518fd852d219699a452c0f84ae784aa","bionanomatrix","venture","b","2012-07-06",1e+07
"7518fd852d219699a452c0f84ae784aa","bionanomatrix","venture","b","2011-03-17",23300000
"7518fd852d219699a452c0f84ae784aa","bionanomatrix","debt_financing",NA,"2010-04-27",782314
"7518fd852d219699a452c0f84ae784aa","bionanomatrix","venture","C","2013-10-02",1e+07
"7518fd852d219699a452c0f84ae784aa","bionanomatrix","debt_financing",NA,"2014-07-01",5000500
"7518fd852d219699a452c0f84ae784aa","bionanomatrix","venture","C","2014-11-20",5.3e+07
"9eeebf703b612c169f49596e6642bb92","bionanoplus","venture",NA,"2011-02-19",817620
"03beb2fce6b4fb3e26d2ad4bf4158828","bionaturis","undisclosed",NA,"2007-09-26",NA
"31c3d4ae4e74eecaa232180004f3eedb","bioncotech",NA,NA,NA,NA
"a6fc2157b76be1b69862d2e0b8bc3619","bioncr-development",NA,NA,NA,NA
"c26042f57c981406717a3bed140e5817","bionex-solutions","venture",NA,"2010-02-24",1004996
"c26042f57c981406717a3bed140e5817","bionex-solutions","seed",NA,"2012-05-01",960000
"0e4be51ec7a11dd432b1af1164c76ea2","bionity",NA,NA,NA,NA
"71d65966d4cc35c091e52bd48f420d84","bioniz","seed",NA,"2013-08-15",599205
"38cd47d03d8a8dd7752cfa1fb89ad08c","bionomics","venture",NA,"2009-09-03",10060000
"38cd47d03d8a8dd7752cfa1fb89ad08c","bionomics","private_equity",NA,"2012-09-27",10409183
"8935987a8068c30f463dfbe1b875c113","bionor-pharma",NA,NA,NA,NA
"87e84e850ec79da09a3c6e65ab443389","bionostics",NA,NA,NA,NA
"aeac57072e644c19475a6974c7fe7702","bionostra","venture","b","2005-10-14",2390000
"0f71a6a6921e504b9d6199cbe2bc6530","bionovo","venture",NA,"2010-07-06",6e+05
"ea017ee659c150f97aec8faa25b5e269","bionumerik-pharmaceuticals","venture",NA,"2010-11-12",1130000
"ea017ee659c150f97aec8faa25b5e269","bionumerik-pharmaceuticals","venture",NA,"2012-11-08",10190500
"c0de1bcf78a01e23bca33133b11539ab","bionure",NA,NA,NA,NA
"86282ba3856ca689b7e66c836bafb485","biom","venture","c","2011-01-13",1.5e+07
"86282ba3856ca689b7e66c836bafb485","biom","venture","b","2009-10-21",2e+07
"86282ba3856ca689b7e66c836bafb485","biom","debt_financing",NA,"2012-07-03",3100000
"86282ba3856ca689b7e66c836bafb485","biom","venture","d","2012-09-13",1.7e+07
"86282ba3856ca689b7e66c836bafb485","biom","venture","E","2015-12-23",17057767
"0268bc8e95afd3cd25c0686752ff5613","bioohio",NA,NA,NA,NA
"37da1c454f4e927272ba3c084b8a464d","bioparaiso","seed",NA,"2012-07-18",40000
"6d6b19c3668f42c9c36ed748ca4547d6","biopassword","venture","C","2007-01-08",1.1e+07
"5927143d139719b8124148b3084208f7","biopharma-manufacturing-solutions","seed",NA,"2013-02-01",400700
"cbff6b45be087e1648733932a57b290d","biopharmacopae","venture",NA,"2011-02-22",2e+06
"cbff6b45be087e1648733932a57b290d","biopharmacopae","venture","1","2008-12-12",NA
"c8d08b48898463c0b45db15e7182e50d","biopharmx","debt_financing",NA,"2014-01-03",5e+05
"c8d08b48898463c0b45db15e7182e50d","biopharmx","venture","1","2015-03-18",7869775
"c8d08b48898463c0b45db15e7182e50d","biopharmx","venture","1","2014-11-10",1.2e+07
"a64debd7575f74f37e491e41fe6bf7e9","biopheresis","venture","a","2005-05-13",8e+06
"971f55ebeb1985c0f9aa18d36be8718b","biophytis","venture","b","2012-10-01",2600000
"ab3dd1d34ee39108e6bde8a7756ae122","biopoly","venture",NA,"2016-01-20",3e+05
"ab3dd1d34ee39108e6bde8a7756ae122","biopoly","venture",NA,"2009-06-15",565510
"ab3dd1d34ee39108e6bde8a7756ae122","biopoly","venture",NA,"2011-05-25",2500000
"3244d5a32b2f36769270875f5530d240","biopontis-alliance",NA,NA,NA,NA
"b562fc983409ef98eead3ff822e1cbc2","biopop",NA,NA,NA,NA
"a19333ac910193bcab5ac6e7c6f9b1d0","biopro-pharmaceutical","venture","a","2005-10-18",5e+06
"6749cc07efedff094efe43faf6f580de","bioprocessors","venture","C","2007-08-06",10010000
"9908775681fb96bc2b4174759d87107c","bioprotein-a-s",NA,NA,NA,NA
"86d754dd7b81680987ed3afd1ae2b112","biopsych-health-systems","debt_financing",NA,"2010-01-13",3e+05
"86d754dd7b81680987ed3afd1ae2b112","biopsych-health-systems","venture",NA,"2011-12-05",75000
"d34ae67ee048c9db9ae265abd50ab7d2","bioptix-inc","venture","a","2009-03-25",3e+06
"d34ae67ee048c9db9ae265abd50ab7d2","bioptix-inc","venture",NA,"2010-10-18",250000
"d34ae67ee048c9db9ae265abd50ab7d2","bioptix-inc","venture",NA,"2014-08-13",1400000
"7b3799ec0394292710e9863da10b3f80","bioquark",NA,NA,NA,NA
"454478c3f36d79d96c06818e410991de","bioquiddity","debt_financing",NA,"2014-10-11",13737000
"c639a7a449ca293eea2d82e3f6bffd18","biorad-laboratories",NA,NA,NA,NA
"3ab5ad47f6c01927fb6978ca9ea16e6a","biorbyt",NA,NA,NA,NA
"1cc36de7ed1a27363e3c086ed1b01c6a","biorealm",NA,NA,NA,NA
"cb17bedffde493c4a9e0f696be619cbd","bioreclamation-holdings",NA,NA,NA,NA
"465ad5cde8799d8409bc6722e34e35da","bioregenerative-sciences","angel",NA,"2010-01-01",NA
"a3123d59ca20eaf9c275c0dc61082804","biorelix","debt_financing",NA,"2010-12-23",2400000
"a3123d59ca20eaf9c275c0dc61082804","biorelix","venture",NA,"2011-09-06",3600000
"a3123d59ca20eaf9c275c0dc61082804","biorelix","venture","1","2010-01-27",5535199
"a3123d59ca20eaf9c275c0dc61082804","biorelix","venture","1","2007-06-11",25800000
"a3123d59ca20eaf9c275c0dc61082804","biorelix","venture",NA,"2012-03-22",2560000
"a3123d59ca20eaf9c275c0dc61082804","biorelix","venture",NA,"2012-04-06",269000
"a3123d59ca20eaf9c275c0dc61082804","biorelix","venture",NA,"2012-01-18",5e+05
"fff2661f96152acb55cd606a0dcade6d","biorem-inc",NA,NA,NA,NA
"abb53f0e365fc5fc3b04aed06344d07a","bioriginal-food-science-corp",NA,NA,NA,NA
"bbc94e273685824741aeec7927d7883b","biosante-pharmaceuticals","venture",NA,"2010-03-04",1.8e+07
"98cf7e2f9dbbd9cae29cd8ea04335f24","biosavita","equity_crowdfunding",NA,"2014-10-17",3e+06
"577be4a3aefc87a64c111711719b64c2","bioscale","venture",NA,"2007-12-31",20689200
"577be4a3aefc87a64c111711719b64c2","bioscale","debt_financing",NA,"2013-02-21",3827004
"577be4a3aefc87a64c111711719b64c2","bioscale","private_equity",NA,"2013-07-09",18800000
"577be4a3aefc87a64c111711719b64c2","bioscale","venture","1","2010-06-14",2.5e+07
"577be4a3aefc87a64c111711719b64c2","bioscale","debt_financing",NA,"2013-03-11",1062028
"577be4a3aefc87a64c111711719b64c2","bioscale","debt_financing",NA,"2012-03-06",5261050
"63766ca2e77e64c7ed1dd500dbec2495","bioscan","debt_financing",NA,"2011-06-10",753250
"63766ca2e77e64c7ed1dd500dbec2495","bioscan","debt_financing",NA,"2010-06-30",1152832
"63766ca2e77e64c7ed1dd500dbec2495","bioscan","venture",NA,"2005-09-12",1e+06
"63766ca2e77e64c7ed1dd500dbec2495","bioscan","debt_financing",NA,"2009-10-08",401217
"a50cfed8f74030e94754de2c4e79e859","bioscentric",NA,NA,NA,NA
"7927b0bd01a0e0a1fca2460251445896","biosceptre","venture",NA,"2014-07-09",4692720
"977d5a53a0572f62a65f26e3de9a2d60","bioscience-advisors",NA,NA,NA,NA
"a5efda35c1945e0fa198e8448202347e","bioscience-vaccines","venture",NA,"2011-07-25",150000
"61a0286b2fe6fa6fd030845ea1af5012","biosculpture-technology","venture","A","2013-08-26",449300
"dc2f60938bf7dca184d2d32179cc1171","bioseed",NA,NA,NA,NA
"287be0b51b211da832d1badebed7eb37","bioseed-capital",NA,NA,NA,NA
"f33793b30a1072a5001940ed191c6fde","bioseek","venture","c","2007-05-23",1e+07
"f79a95b1cdacd4df3d5fba7e4bbac5ac","biosensia","venture",NA,"2008-02-05",2930000
"f79a95b1cdacd4df3d5fba7e4bbac5ac","biosensia","venture",NA,"2011-12-19",1564680
"aa8a866e549e75547af4d91462fc5adc","bioserve-biotechnologies-india",NA,NA,NA,NA
"bf2dc0a18a4558ceb85ea30ffb2eb972","bioservo-technologies","venture",NA,"2007-08-22",216000
"7665814ba380e6ba10b9134a65d2cf39","bioset","debt_financing",NA,"2014-01-06",NA
"7665814ba380e6ba10b9134a65d2cf39","bioset","venture",NA,"2011-05-10",6771486
"e761186d005ff191a59217da5549aceb","biosig-technologies","venture",NA,"2015-11-23",1020000
"e761186d005ff191a59217da5549aceb","biosig-technologies","venture",NA,"2014-04-17",204900
"e761186d005ff191a59217da5549aceb","biosig-technologies","venture",NA,"2014-02-10",791885
"e761186d005ff191a59217da5549aceb","biosig-technologies","venture",NA,"2014-08-22",563000
"e761186d005ff191a59217da5549aceb","biosig-technologies","venture",NA,"2015-01-30",1583100
"e761186d005ff191a59217da5549aceb","biosig-technologies","venture","1","2015-05-19",450000
"f534b94a6b15690ae71b73bc2876a821","biosilta","venture",NA,"2014-06-11",3392314
"1305dbb878db0af3dbd079415b317c79","biosingapore",NA,NA,NA,NA
"f041cda244a7a059f81c0d2bab17a15a","biosite-incorporated",NA,NA,NA,NA
"fc0b67309366c7ca3b3e36d0c380156e","biosolar-australia",NA,NA,NA,NA
"836d276b92414edf4ed324772566e091","biosortia-pharmaceuticals","venture",NA,"2016-01-04",5e+05
"61d7d3b865f11c15fa5cc7c8a5b3d161","biosource-international",NA,NA,NA,NA
"2046c48966c5f68292cd7e17757ab888","biostable","venture","a","2008-12-15",5500000
"7edb21578151c1272145c51e8b0e48ea","biostar-pharmaceuticals","venture",NA,"2009-11-13",3605000
"d18c3dfaf401f178aceb9f143858d043","biostart",NA,NA,NA,NA
"82773cb177403d2296533975a8c8e61e","biostartr",NA,NA,NA,NA
"01c18dd6161824e244032260520357f5","biostevia-sas",NA,NA,NA,NA
"403d314505dc282163a310447cc8321f","biostl","grant",NA,"2014-07-23",3e+07
"f6246e9fa5794820f42e73af290d3e03","biostorage-technologies","venture",NA,"2007-01-10",NA
"f6246e9fa5794820f42e73af290d3e03","biostorage-technologies","venture","1","2007-05-29",8320000
"503ef1e939f5b6338ac8267efb5e77c8","biostratum","seed",NA,"2011-08-19",599999
"5995861329306dccef8367b3b90fca81","biosurplus","venture","a","2012-07-17",2400000
"5995861329306dccef8367b3b90fca81","biosurplus","venture",NA,"2012-05-11",1500000
"c00bd24fe324e6d9e3101dc220a06df3","biosym-technologies",NA,NA,NA,NA
"3ee612dde3e2146c1acc8a05542553b7","biosynexus",NA,NA,NA,NA
"e71fc44e474aa434b3a4569d5333b645","biosyntech","venture",NA,"2009-08-14",1400000
"a2f3a207724ea1bf89017445bf2d97f7","biosyntia","seed",NA,"2015-05-21",1870081
"f81a7127fe97a31ac2c03aae4084d17f","biosystem-development","venture",NA,"2011-07-21",1e+06
"f81a7127fe97a31ac2c03aae4084d17f","biosystem-development","venture",NA,"2010-10-11",978000
"f81a7127fe97a31ac2c03aae4084d17f","biosystem-development","venture",NA,"2009-11-24",1400000
"f81a7127fe97a31ac2c03aae4084d17f","biosystem-development","venture","1","2007-11-01",6e+05
"eb4acade4cd2c75fcd39dba21d1506bc","biosystems-engineering",NA,NA,NA,NA
"f1657828b983a27b6da5004a218f9584","biosystems-international","seed",NA,"2005-04-01",3887700
"f1657828b983a27b6da5004a218f9584","biosystems-international","venture","1","2010-07-19",2700000
"f1657828b983a27b6da5004a218f9584","biosystems-international","venture",NA,"2008-10-29",4600000
"0df4c98adaefa07e8e1a83c1e0bba844","biota-holdings","venture",NA,"2010-04-27",423000
"4e9734e50842ed5dd5786535a292a421","biota-pharmaceuticals-inc",NA,NA,NA,NA
"86f7f554de60f0d2d26934a2190c0691","biota-technology",NA,NA,NA,NA
"ffc37df134122428295d13d7f5c38bc6","biotalent",NA,NA,NA,NA
"56921e5b66ef61b44f09574d1b4648e9","biotec-centre",NA,NA,NA,NA
"6cd5ee4d7e87a7526dbb2a0e04628d7f","biotec-services-international",NA,NA,NA,NA
"cc5b8bd8f6ee543b9ddd67bb7f5b98e0","biotech-igg",NA,NA,NA,NA
"5802a66a2eaa057879a8cec93772c489","biotech-international",NA,NA,NA,NA
"23e57a2e010e6a57dccf0226abfea3da","biotech-medics",NA,NA,NA,NA
"9b5916302c1bf782039a722ab109afa1","biotech-primer",NA,NA,NA,NA
"583861d17514cfb22f632cf50e20f138","biotech-support-group",NA,NA,NA,NA
"522409141b6d01cebfc627e53874e8b2","biotechlikemind",NA,NA,NA,NA
"34ae05a3dc8183b9d63803138354c384","biotechnology-and-biological-sciences-research-council-bbsrc",NA,NA,NA,NA
"0dcb95c2891ac312dd3b188ac8fc2887","biotechnology-general",NA,NA,NA,NA
"f6972826a27b3cad6976099952dd0945","biotesys","venture","a","2007-05-10",608000
"851d3ebf6ebbf1efd6fabca4a71c5162","biothera","venture",NA,"2010-04-12",3500000
"851d3ebf6ebbf1efd6fabca4a71c5162","biothera","venture",NA,"2014-12-10",1588130
"e698519b53bd904c8ee5d30335df2b50","biotherapeutics","venture",NA,"2014-09-23",NA
"e6e4a61293c179ce19a65dfa7a5f29ac","biotheryx","venture",NA,"2014-06-10",1e+06
"e6e4a61293c179ce19a65dfa7a5f29ac","biotheryx","venture",NA,"2014-09-23",150000
"e6e4a61293c179ce19a65dfa7a5f29ac","biotheryx","venture",NA,"2015-05-05",5e+05
"00496f4813ae6bc30d672c94c396b8a7","biotie-therapies","grant",NA,"2013-06-26",143750000
"00496f4813ae6bc30d672c94c396b8a7","biotie-therapies","grant",NA,"2014-07-09",2e+06
"00496f4813ae6bc30d672c94c396b8a7","biotie-therapies","post_ipo_equity",NA,"2015-06-01",6058176
"a198f3786b82b12af5e413849d3bf744","biotime","venture",NA,"2009-05-13",8e+06
"a198f3786b82b12af5e413849d3bf744","biotime","venture",NA,"2010-05-07",8e+06
"a198f3786b82b12af5e413849d3bf744","biotime","venture","1","2014-03-05",3500000
"a198f3786b82b12af5e413849d3bf744","biotime","debt_financing",NA,"2009-04-28",3430000
"a198f3786b82b12af5e413849d3bf744","biotime","post_ipo_equity",NA,"2014-05-05",6400000
"a198f3786b82b12af5e413849d3bf744","biotime","post_ipo_equity",NA,"2014-10-06",3.1e+07
"a198f3786b82b12af5e413849d3bf744","biotime","post_ipo_equity",NA,"2015-05-14",3300000
"675db07cdf780847b5e087b03b6dbed4","biotix","venture",NA,"2011-04-01",2e+06
"675db07cdf780847b5e087b03b6dbed4","biotix","venture",NA,"2012-04-06",2195000
"f5e2eeabfcbd98ebdd6869eb336456eb","biotrace-medical","venture","A","2014-02-25",3491067
"f5e2eeabfcbd98ebdd6869eb336456eb","biotrace-medical","venture",NA,"2015-07-24",1702638
"b175985613d9744a0004907fba96c974","biotrack",NA,NA,NA,NA
"1bfe5ceea736842f1dc86974d206c65a","biotrofix",NA,NA,NA,NA
"b00597acbd7f10de924f4682620f3112","biotrove","venture",NA,"2009-06-04",13313329
"5d3358529a461affb2de45ba3076333a","biovail-crd",NA,NA,NA,NA
"305ccf48cacc7f26cca2bbcb6e8ca58a","biovantage-resources",NA,NA,NA,NA
"7539d769643c6c265339ec52bd5b81c2","biovascular","venture","c","2008-02-07",10870000
"376bb6383ed057140a818f0458b7215e","bioventrix","venture",NA,"2015-12-08",1.4e+07
"8356dc9cf148b02b70242692896fd26d","biovest-international","debt_financing",NA,"2010-10-28",7e+06
"d53c932bed496b928f1538b9edec1c5c","biovest-partners",NA,NA,NA,NA
"5bb412da4daef30dcb9bf99039ae0b71","biovex","venture","E","2007-11-16",3.5e+07
"5bb412da4daef30dcb9bf99039ae0b71","biovex","venture","f","2009-03-30",4e+07
"5bb412da4daef30dcb9bf99039ae0b71","biovex","venture","f","2009-11-10",3e+07
"5bb412da4daef30dcb9bf99039ae0b71","biovex","venture","c","2003-10-06",28314585
"865da24f4027edd324d3732006890d5d","biovidria","venture",NA,"2009-09-02",2e+05
"865da24f4027edd324d3732006890d5d","biovidria","venture",NA,"2010-07-01",150000
"000607fccea0535c6324e83ba07c8cc7","biovigilant-systems","venture","a","2006-05-23",6700000
"bbf2ad694d965ac780730dbbdd9617b0","biovitesse",NA,NA,NA,NA
"80c7c7c485031431a7b0563969b51d77","bioviva-usa","equity_crowdfunding",NA,"2015-07-15",NA
"fd4e41fd02345b347c2501f4b8007779","biowater-technology","venture","A","2013-07-01",6513865
"6c85556c0bffe6ee4d33c3088fe90ba4","biowebspin",NA,NA,NA,NA
"c769298508580d9cbd0cd9e832c8992e","biowish","debt_financing",NA,"2012-04-13",2210000
"c769298508580d9cbd0cd9e832c8992e","biowish","venture",NA,"2013-07-11",11739454
"78f891a7fb425e232f5940d32913282d","biowish-technologies","venture",NA,"2015-08-24",2999999
"55efba05deecb268e217ae47f2bb4c63","bio-world",NA,NA,NA,NA
"a84499c9cd8dfc5b4ae4d6127cbaade6","bioworld",NA,NA,NA,NA
"d4d7d8ffa0449a0a8844ece00b746396","biox-biosciences",NA,NA,NA,NA
"cae583d0df47282de66005e355fa751a","bioxell",NA,NA,NA,NA
"72f5727f70c901c60f86071e7277fa49","bioxodes","seed",NA,"2013-11-26",3345160
"1791b1263e86445d9816b7609b800280","bioxydyn","venture",NA,"2012-10-04",1933105
"a8bffd456c9665be820c209ba777a86a","biozeus",NA,NA,NA,NA
"dc916d672d2a02289ea659718ae02e33","biozone-pharmaceuticals","venture",NA,"2014-01-16",2750000
"dc916d672d2a02289ea659718ae02e33","biozone-pharmaceuticals","seed",NA,"2013-09-04",2e+06
"dc916d672d2a02289ea659718ae02e33","biozone-pharmaceuticals","debt_financing",NA,"2011-03-29",2250000
"dc916d672d2a02289ea659718ae02e33","biozone-pharmaceuticals","debt_financing",NA,"2012-02-24",2300000
"976378885c69da2576ee7172f0c630e5","bipar-sciences","venture","a","2004-12-20",1.3e+07
"976378885c69da2576ee7172f0c630e5","bipar-sciences","venture","b","2007-02-26",3.5e+07
"976378885c69da2576ee7172f0c630e5","bipar-sciences","venture","c","2009-01-12",2e+07
"976378885c69da2576ee7172f0c630e5","bipar-sciences","debt_financing",NA,"2006-06-14",5e+06
"5a0f9f11484f43a0657b8c3d4dba5bcc","bipe-data",NA,NA,NA,NA
"bfbf5b43f2b473ebf243aaee277cd03e","birdeye","venture","A","2016-01-28",8e+06
"85900887f8322abbe86b78c5b3d136b9","birdleaf","seed",NA,"2015-05-31",NA
"ff2e8a288be775a41355d76aed738bf9","birst","venture","d","2012-05-01",2.6e+07
"ff2e8a288be775a41355d76aed738bf9","birst","venture","e","2013-08-20",3.8e+07
"ff2e8a288be775a41355d76aed738bf9","birst","venture","F","2015-03-17",6.5e+07
"78abaf087ffb9db24c798d65d4e83df9","biscayne-pharmaceuticals","seed",NA,"2013-01-25",1500000
"78abaf087ffb9db24c798d65d4e83df9","biscayne-pharmaceuticals","venture",NA,"2014-05-01",2628000
"78abaf087ffb9db24c798d65d4e83df9","biscayne-pharmaceuticals","venture",NA,"2015-01-20",3400000
"3f0a68a174c69aec5d70e5859abc2fe7","bi-science","venture","A","2012-09-01",3500000
"3f0a68a174c69aec5d70e5859abc2fe7","bi-science","debt_financing",NA,"2014-07-01",2e+06
"3f0a68a174c69aec5d70e5859abc2fe7","bi-science","venture","B","2015-01-01",1500000
"ebc9c8345d9bc62338d5ee51cc50c365","bison-analytics",NA,NA,NA,NA
"000a321e5e08d553b65e60548f4b76bd","bistro",NA,NA,NA,NA
"77a3bf91976683d523e5fe8d5d2ca973","bit-software",NA,NA,NA,NA
"afea0f947746cce8cfe7595b0fbf7b53","bit-stew-systems","venture",NA,"2013-12-19",5e+06
"afea0f947746cce8cfe7595b0fbf7b53","bit-stew-systems","debt_financing",NA,"2014-05-27",3500000
"afea0f947746cce8cfe7595b0fbf7b53","bit-stew-systems","venture","1","2015-05-12",17200000
"80c79c2d68d2a893f7fd597a0e654c2b","bitave-lab","venture",NA,"2012-08-23",264993
"c0c979491d2b65d7293f3655b4989c2d","bitbolsa",NA,NA,NA,NA
"059f18cba44e47ed4ad163e623a31203","bitdeli","venture",NA,"2012-06-11",209999
"017b84e919a1d6b3a44b76330b9c1d2e","bitext","seed",NA,"2015-01-29",9e+05
"a16874027594f085f1520cca6f958b8f","bitly","venture","a","2009-03-30",2e+06
"a16874027594f085f1520cca6f958b8f","bitly","venture",NA,"2012-07-10",1.5e+07
"a16874027594f085f1520cca6f958b8f","bitly","debt_financing",NA,"2010-02-18",1500000
"a16874027594f085f1520cca6f958b8f","bitly","venture","b","2010-10-08",1e+07
"a16874027594f085f1520cca6f958b8f","bitly","debt_financing",NA,"2012-03-16",1400000
"a16874027594f085f1520cca6f958b8f","bitly","seed",NA,"2008-01-01",1500000
"a6d8b565da5f9be94d6141242a5d6915","bitple",NA,NA,NA,NA
"4f9324f49569862a4cee2f226856244e","bitponics",NA,NA,NA,NA
"2f71f4a757baf7e4c25d0b15750085ce","bitpost",NA,NA,NA,NA
"d734178b4c26a58e86cdf9902dca7c9e","bitrated",NA,NA,NA,NA
"9af2d1763fd4035447bb29a7616ebff6","bitrec",NA,NA,NA,NA
"6bacee94bb4e0ad9a46fcd588251ff19","bitrockr","seed",NA,"2013-05-01",40000
"867485bbf511dbd53c8dcd8cf647a8cb","bitscopic",NA,NA,NA,NA
"8b56f9009f22cff5af0692b02624e7dc","bitsnbrains",NA,NA,NA,NA
"c58b134af0e22fd597dd30c5ac8c1969","bittle",NA,NA,NA,NA
"83310e643d5c24d3c1e096334067d994","bittwist",NA,NA,NA,NA
"72ce08ecd4f9691b671ce717d390cd94","bitviz",NA,NA,NA,NA
"daa38df49e1875b3746c27e4924123f2","bityota","seed",NA,"2011-08-24",NA
"daa38df49e1875b3746c27e4924123f2","bityota","venture","1","2012-09-21",NA
"daa38df49e1875b3746c27e4924123f2","bityota","venture","1","2012-07-01",1e+07
"764e45736ec97030deb9339e009ffc0a","bivarus","debt_financing",NA,"2014-04-23",375000
"764e45736ec97030deb9339e009ffc0a","bivarus","venture","1","2015-02-11",1900000
"2d4c42e0683e9de3fb49dfbc9e0ae55d","biyo",NA,NA,NA,NA
"16b0f50fe2f6a3d32d74432edee537b8","biz360","venture",NA,"2007-01-01",3800000
"16b0f50fe2f6a3d32d74432edee537b8","biz360","venture",NA,"2008-05-12",1e+07
"ceeb62c59342e0568087653061ba2fd9","bizacuity-solutions-private-ltd",NA,NA,NA,NA
"59847910e1053f2adf82096acf41c4c3","bizboon",NA,NA,NA,NA
"a363ce6969f56f53edac935ccba55a09","bizible","seed",NA,"2011-09-01",330000
"a363ce6969f56f53edac935ccba55a09","bizible","seed",NA,"2012-08-01",18000
"a363ce6969f56f53edac935ccba55a09","bizible","venture","1","2012-11-26",2200000
"a363ce6969f56f53edac935ccba55a09","bizible","venture","1","2014-08-26",8e+06
"d0cd9f8b2b0c1c51a6073b3a6b2f4a1d","bizjournals-com-database",NA,NA,NA,NA
"dd18d70abd2a09baeeeff20c2a2da69e","bizmetrics",NA,NA,NA,NA
"b6096bdae5fb2a4a4a7c1914d3290105","bizmo",NA,NA,NA,NA
"71aa524a42261e3727ef12a677592e19","bizmo-cubes",NA,NA,NA,NA
"d7ef56530ffa1e567fbf33ffa85b2b83","biznex",NA,NA,NA,NA
"08a75bbc1c606b01f28f362b17e036f7","biznik-com-database",NA,NA,NA,NA
"ceaf8734a68aa3a7c6a1cb763c70f664","bizrecommends",NA,NA,NA,NA
"5f8ffec03f2eb29429a8d2c2b2230f08","biztech-consultancy",NA,NA,NA,NA
"7374bf268032b978866e20bb61c1c831","biztweets",NA,NA,NA,NA
"1a5328584cc94cdb18deaa4dd320f08f","bizyhood",NA,NA,NA,NA
"9550c6e5dfbd8fa95666fd2a0efd9066","bkper",NA,NA,NA,NA
"9255a1274c9493dc929bdfb700684bd1","blab","debt_financing",NA,"2013-10-08",342034
"9255a1274c9493dc929bdfb700684bd1","blab","venture",NA,"2013-02-01",2724775
"9255a1274c9493dc929bdfb700684bd1","blab","debt_financing",NA,"2014-08-19",1135033
"9255a1274c9493dc929bdfb700684bd1","blab","venture","1","2014-12-03",8800000
"002e8cbb14f951842b51f728f7b5b738","blabfeed","seed",NA,"2012-07-01",1e+05
"002e8cbb14f951842b51f728f7b5b738","blabfeed","seed",NA,"2014-01-03",50000
"002e8cbb14f951842b51f728f7b5b738","blabfeed","debt_financing",NA,"2015-01-08",30000
"baaa65eacb53a124265fc23a105eea7a","black-veatch","equity_crowdfunding",NA,"2012-09-14",NA
"f1925c604340c8bb45c17c8525f175f3","black-ninja-software",NA,NA,NA,NA
"bea2b063a49e844870edd79e0b5d6027","blackbaud-blkb",NA,NA,NA,NA
"b4c3337332fdee3ab768559a79382a37","blackbox-bi",NA,NA,NA,NA
"698367727ea60bc56dc32c6600583e0d","blackford-analysis","seed",NA,"2012-11-12",1270324
"bc51b81c162b366217594ef1c64ff31c","blacklight-solutions",NA,NA,NA,NA
"2dcc89286231f1cdad96a01d991ababb","blacklocus","seed",NA,"2010-01-01",NA
"2dcc89286231f1cdad96a01d991ababb","blacklocus","venture","1","2011-07-01",2500000
"bd122ca9c6c4a9e9603d6369d4837d4d","blackstone-asia",NA,NA,NA,NA
"ed0629691b6d897bc2c39c87b35863dd","blackwood-seven","undisclosed",NA,"2013-06-30",NA
"ed0629691b6d897bc2c39c87b35863dd","blackwood-seven","undisclosed",NA,"2013-08-13",NA
"ed0629691b6d897bc2c39c87b35863dd","blackwood-seven","undisclosed",NA,"2015-06-04",8406249
"014ede38d530a32abf98f8d80f120d87","bladder-health-ventures","venture",NA,"2009-04-01",2e+05
"014ede38d530a32abf98f8d80f120d87","bladder-health-ventures","venture",NA,"2015-05-20",2e+05
"4d2abf3f4e8b9655100f323494c13de0","blatt-labs",NA,NA,NA,NA
"5dd80da7df520a7029cfbe645e02753a","blaze-bioscience","debt_financing",NA,"2016-01-12",991000
"5dd80da7df520a7029cfbe645e02753a","blaze-bioscience","debt_financing",NA,"2011-10-17",725000
"5dd80da7df520a7029cfbe645e02753a","blaze-bioscience","venture","1","2012-06-08",5e+06
"5dd80da7df520a7029cfbe645e02753a","blaze-bioscience","venture","1","2013-02-22",8500000
"5dd80da7df520a7029cfbe645e02753a","blaze-bioscience","venture","1","2013-12-03",9e+06
"5dd80da7df520a7029cfbe645e02753a","blaze-bioscience","venture","1","1532-06-26",9711998
"3fc7ab2322657495e945896d58d017ff","blazeclan-technologies",NA,NA,NA,NA
"76cd72e646104d0e71a26f349a4c2e24","blazing-db","seed",NA,"2015-06-14",118000
"84302141395a9ff2495078422703f642","bleeble",NA,NA,NA,NA
"b5f1bcb1832d3bed23db8e6589cf1cd8","blend-biosciences","venture",NA,"2011-09-06",2800000
"04c4b20359a7a44cbff37ecfc00370d1","blink-reaction",NA,NA,NA,NA
"5a727ebb83e81d3c4d97ad415827a8e1","blinkfire-analtyics-inc","venture","A","2014-09-23",9e+05
"ca678146fca807a7ffa5218213163fb4","blinkit","non_equity_assistance",NA,"2015-12-01",NA
"ca678146fca807a7ffa5218213163fb4","blinkit","angel",NA,"2014-06-01",NA
"06f6c17635cfacdf171e240d23bc5fac","blippar","seed",NA,"2012-01-03",NA
"06f6c17635cfacdf171e240d23bc5fac","blippar","venture","1","2015-03-09",4.5e+07
"c57f1338dd077060764af25662dba466","bliss-healthcare","venture","a","2011-02-08",5e+05
"6aa085042cfaad8c0f879fdfaea04edc","blitz",NA,NA,NA,NA
"e25ce01db2b1b3279d7925ef37313eeb","bliu-bliu",NA,NA,NA,NA
"bf7c8598b956415fa255837384c6f29e","blockscore","venture",NA,"2013-06-01",25000
"bf7c8598b956415fa255837384c6f29e","blockscore","seed",NA,"2014-06-25",2e+06
"14378bb05e656332f2777cff81c22ddf","blocktrail","seed",NA,"2014-08-18",669209
"b8a68928acc802e321f123c7e0451c82","blocpower","seed",NA,"2014-11-07",NA
"b8a68928acc802e321f123c7e0451c82","blocpower","seed",NA,"2014-02-28",25000
"cabfb54909c102009b6cab6f688e6a71","blogdash",NA,NA,NA,NA
"21fe17f131d5fa133608a129b3323bb6","blomasa",NA,NA,NA,NA
"9e55690873b97e4a2cf183082e04b9ce","blood-cell-storage-inc","debt_financing",NA,"2012-05-14",2375000
"0d45ebd772030686ef1ad0890350a90e","blood-monitoring-solutions-inc","seed",NA,"2014-05-15",50000
"6a895eb9eb5352dd0528c1b8159496d1","blooie","seed",NA,"2011-09-01",16210
"6a895eb9eb5352dd0528c1b8159496d1","blooie","seed",NA,"2012-02-01",142655
"94e614e62360abf0a4285135d65c9cda","bloomage-biotechnology-corporation-limited","venture",NA,"2015-11-06",8.5e+07
"966019cd57cc86629be65f4ba09bef02","bloopark",NA,NA,NA,NA
"3f35c2a32b5072d66b21d49becd770b6","blowfish-digital",NA,NA,NA,NA
"e5e12abe963bd2124039298b96b5e85e","bloxi",NA,NA,NA,NA
"54a9c136d9ba28ec242cfa63d1c69f68","bluapp","seed",NA,"2014-09-03",40000
"c58e4fdd45ee1304181a6cc09192aa3d","blubox-in-making-brands-click","angel",NA,"2015-09-04",1e+05
"c58e4fdd45ee1304181a6cc09192aa3d","blubox-in-making-brands-click","angel",NA,"2014-04-01",NA
"e46523784f06bcfcf435fe7d36cecfd6","blue-belt-technologies","venture",NA,"2009-10-05",1431808
"e46523784f06bcfcf435fe7d36cecfd6","blue-belt-technologies","debt_financing",NA,"2014-10-30",4e+07
"28056363002919792aefe0a45cd24dab","blue-butterfly","venture",NA,"2012-06-14",31124
"28056363002919792aefe0a45cd24dab","blue-butterfly","convertible_note",NA,"2012-07-01",128932
"2dab967a9985bd25a4bc2f606130795a","blue-comet-creative",NA,NA,NA,NA
"9bc8649b7bada844278045c0ae2ae36a","blue-dragon",NA,NA,NA,NA
"1280ae92d379484be18b866ddd8e8ec3","blue-flame-data","venture","a","2005-06-01",6e+06
"5b0c5db00d3fa38b2f201ca28da40676","blue-heron-biotechnology","venture","d","2007-01-16",3680000
"410419f5f4cd961f10ecbf123839f4c7","blue-j-legal",NA,NA,NA,NA
"0a0f750e0c3b218549b7358454673da0","blue-marble-energy","venture","a","2011-02-08",1300000
"0a0f750e0c3b218549b7358454673da0","blue-marble-energy","venture",NA,"2014-07-21",3227125
"8c980274288d23c0237bbb6741457491","blue-moon-works-inc",NA,NA,NA,NA
"f17a1a63ff4ce1705d3e94de929bda39","blue-perch","seed",NA,"2014-01-13",25000
"a38f5ea02101329b44b0ada43b2727e0","bluefather","seed",NA,"2014-03-11",1500000
"e066c72c360b960f088ff7a94dcaf209","blue-ridge","private_equity",NA,"2014-11-10",6e+06
"fbc50d57ebe716a98c90c17598c932a9","blue-sky-biotech","undisclosed",NA,"2011-03-04",NA
"4d68b775a9d490e252705dbb48267f97","blue-triangle-technologies","venture","A","2015-11-02",674000
"4d68b775a9d490e252705dbb48267f97","blue-triangle-technologies","convertible_note",NA,"2013-12-30",195000
"4d68b775a9d490e252705dbb48267f97","blue-triangle-technologies","venture",NA,"2014-08-28",395000
"4d68b775a9d490e252705dbb48267f97","blue-triangle-technologies","venture",NA,"2014-12-16",857750
"b55b93fa1695036d1aa702a55c577051","blue-yonder","undisclosed",NA,"2014-12-16",7.5e+07
"c6f408480beaf5c7b0360d4d0e8ea7f2","blueanatomy","seed",NA,"2013-07-01",NA
"4e0849bb748a9e67ba0b3bbfada6955b","bluebird-bio","venture","d","2012-07-25",6e+07
"4e0849bb748a9e67ba0b3bbfada6955b","bluebird-bio","venture",NA,"2012-10-27",9300000
"4e0849bb748a9e67ba0b3bbfada6955b","bluebird-bio","venture",NA,"2011-04-20",3e+07
"4e0849bb748a9e67ba0b3bbfada6955b","bluebird-bio","grant",NA,"2011-03-16",4200000
"4e0849bb748a9e67ba0b3bbfada6955b","bluebird-bio","venture","b","2010-03-12",3.5e+07
"496fb646ddff912bf72b445be8e41f97","blueconic-2","seed",NA,"2010-08-01",1400000
"496fb646ddff912bf72b445be8e41f97","blueconic-2","venture","1","2015-06-01",1400000
"496fb646ddff912bf72b445be8e41f97","blueconic-2","venture","1","2014-12-01",3500000
"496fb646ddff912bf72b445be8e41f97","blueconic-2","seed","1","2012-10-01",2600000
"bb7a25b3b5e525bef134253d7828b7ef","blueconomics",NA,NA,NA,NA
"28fc27edc681be0cd12dc3f28ce0b08a","triggermail","venture","B","2015-12-02",2.1e+07
"28fc27edc681be0cd12dc3f28ce0b08a","triggermail","seed",NA,"2013-04-02",118000
"28fc27edc681be0cd12dc3f28ce0b08a","triggermail","seed",NA,"2013-07-23",1101452
"28fc27edc681be0cd12dc3f28ce0b08a","triggermail","venture","A","2015-01-22",6e+06
"2c5b4af5675446dc74fbcbc638071173","bluecurve",NA,NA,NA,NA
"782dabf9ea4020ef5fb5b000bc9b3838","bluedata-software","venture","A","2013-02-14",4e+06
"782dabf9ea4020ef5fb5b000bc9b3838","bluedata-software","venture","b","2013-09-24",1.5e+07
"782dabf9ea4020ef5fb5b000bc9b3838","bluedata-software","venture","C","2015-08-25",2e+07
"63764e95624e98a655329a32a72454d1","bluedot","venture","A","2015-01-13",2500000
"241d2f9b7f164e56c84a699da3d43ff6","bluefin-labs","seed",NA,"2009-05-01",1200000
"241d2f9b7f164e56c84a699da3d43ff6","bluefin-labs","grant",NA,"2008-04-01",1150000
"241d2f9b7f164e56c84a699da3d43ff6","bluefin-labs","venture","1","2012-01-24",1.2e+07
"241d2f9b7f164e56c84a699da3d43ff6","bluefin-labs","venture","1","2010-10-01",6e+06
"e17bc562c7a4542eb78f0e2a9eb660b3","blueforce-development",NA,NA,NA,NA
"be5dde3eb884429119570fe7c88b5b98","bluefox","seed",NA,"2015-07-01",NA
"bbc2d24ca616c9ed7b91e1d5af7f199a","bluepearl-veterinary-partners","venture",NA,"2010-01-12",420000
"bc89cf8acad5b9a4bd5642d4ba503a99","blueprint-genetics","venture",NA,"2014-09-01",3900000
"26c220da4a69a1152e0046162534e8fc","blueprint-medicines","venture","a","2011-04-11",4e+07
"26c220da4a69a1152e0046162534e8fc","blueprint-medicines","venture","b","2014-01-07",2.5e+07
"26c220da4a69a1152e0046162534e8fc","blueprint-medicines","venture","C","2014-11-12",5e+07
"bf3896d993fac5f51eb01da5ed3d51bc","blueshift-research",NA,NA,NA,NA
"7e360726aeb72de4f2b9eaf658048f30","bluestreak-2","venture","A","2000-01-20",7e+06
"854dbb6a463d556ceb00a72928274d85","bluetrain",NA,NA,NA,NA
"230070dbf871ef8f8e1c550d2ae1f34c","bluewater-direct",NA,NA,NA,NA
"d18b9f61be9bf8b7bca2787694fd6cb0","blueye-pesquisa-inteligente","seed",NA,"2014-12-01",40000
"7831fe9850daea09b2ffa713c3f35640","blufrog-path-lab-solutions","venture",NA,"2011-10-10",1600000
"bf244212825876432d297496cc458a73","blupanda","venture",NA,"2009-06-15",71798
"d17ba50200b97bba12507c74b4190dc9","blvd-status",NA,NA,NA,NA
"c0339b58c1f6e40eeaf151e35a050541","bmi-assistive-technology",NA,NA,NA,NA
"23665613236741a1bde5f1ee7abf84a2","bmi-imaging-systems",NA,NA,NA,NA
"123d54dd46afb899680abce212a1cc11","bmp-sunstone-corporation","debt_financing",NA,"2009-03-31",6350000
"7bc7fd9826eb05db993e5841f7fa6858","bmrw-associates","seed",NA,"2009-06-01",87000
"7bc7fd9826eb05db993e5841f7fa6858","bmrw-associates","angel",NA,"2010-11-01",4e+05
"7bc7fd9826eb05db993e5841f7fa6858","bmrw-associates","venture","1","2011-05-17",387687
"4f3eb0715148ac4e0b605bff2e3ca5ef","groundcntrl","seed",NA,"2013-03-25",2e+06
"0102c610bf15257c9d57e6dfdd4be0e0","bnotions",NA,NA,NA,NA
"29e5d318bd3a8af725d852fd5b5e99cf","boafx",NA,NA,NA,NA
"6236baa18f5cb80ad64ebb19e5905839","board-international",NA,NA,NA,NA
"c82c8c9d3336f824cb8b537e25b7f40e","boc-sciences",NA,NA,NA,NA
"c1858bd0332b191043464c76b7f28575","boca-pharmacal",NA,NA,NA,NA
"9f1ca6fdda6febb0f7aaf33e550c329f","bocados-de-conocimiento",NA,NA,NA,NA
"13058b0c629dcbaa4294431dd47c7506","bodetree","seed",NA,"2013-04-17",1400000
"13058b0c629dcbaa4294431dd47c7506","bodetree","venture","1","2014-05-13",2e+06
"fdb0fd127eb4f6e91f2877f9a69cae2a","bodhtree-consulting-ltd",NA,NA,NA,NA
"071ee9aa145bc04d1723cbd7123dfccf","bodisen-biotech",NA,NA,NA,NA
"9996108b9a505dc12947afff6f16a40b","body-mint",NA,NA,NA,NA
"1a7ed5f61b3d5e1e5a0f9d0edeb97c1c","body-pass",NA,NA,NA,NA
"4a2c49f279e847546d5c64c5c1eae88d","bodybarista",NA,NA,NA,NA
"18534acea8d63435622228c5b6efb1cd","bodywhat","non_equity_assistance",NA,"2015-09-01",NA
"4c1df8bc0ca21c062be10d7a646a75e8","boehringer-ingelheim",NA,NA,NA,NA
"8a14211f550492031444ff27130bbe37","boldcron",NA,NA,NA,NA
"2f743b845e13e405f21e8b694a19ebb2","boldiq","venture",NA,"2010-11-16",5646324
"2f743b845e13e405f21e8b694a19ebb2","boldiq","venture",NA,"2013-08-23",2e+06
"4357d2a122d333a5d50c2b747ff5d626","boldmind","grant",NA,"2015-09-01",844542.7185
"4357d2a122d333a5d50c2b747ff5d626","boldmind","seed",NA,"2015-05-10",154471.168
"db8634527182f2cc9611f5995123783d","boldr",NA,NA,NA,NA
"cfdd28de4ff2934be204b400db5c515b","boliven",NA,NA,NA,NA
"a825a450492dd9a697dab27cfa4eec5c","volvant","seed",NA,"2014-12-10",2e+05
"a825a450492dd9a697dab27cfa4eec5c","volvant","seed",NA,"2015-01-07",2e+05
"46f73110253397c3d34f97b1fb7be82a","bonapp-2","seed",NA,"2012-08-15",NA
"0f294eaf04d2778cadcaef9680b44b6b","bond","venture",NA,"2015-02-01",NA
"0f294eaf04d2778cadcaef9680b44b6b","bond","seed",NA,"2014-04-01",1e+06
"0f4d177031f43f7a0e89913afc413394","bondable",NA,NA,NA,NA
"039a7b285aca0cba58e9fa65c0ef298b","bondr",NA,NA,NA,NA
"27a5be0ce14a13a98bb71782c5f6acb3","bone-biologics","seed",NA,"2015-05-07",2e+06
"56acbbd1ef53cd8c00f2f6095da4a01f","bone-therapeutics","venture","d","2013-01-28",10351880
"8cd9e6afe7df561e88df105464f1526b","bonfire-associates",NA,NA,NA,NA
"ac7f290311beafa28611692699fa3073","bonoboz-marketing-services-private-limited",NA,NA,NA,NA
"545b1cef6a60d6da2428be9ec84364f4","bonovo-orthopedics","venture","c","2010-12-23",1e+07
"4efb5652f84ab3e62bbe7e3b2fa0d068","bonskai",NA,NA,NA,NA
"dcca112019aef33f3f6ec33cbfd40a61","bonus-biogroup",NA,NA,NA,NA
"2089d9d1c51b8235cbf2d3312c57bf28","bonusbox",NA,NA,NA,NA
"ee37f249ba5395dd3bdb2954a08b68f4","bonzaquote",NA,NA,NA,NA
"392660de3af73c0e85924a121f29633d","bonzerdarg","venture",NA,"2011-06-20",150000
"075d2841f337b33586bc0fcc469994b3","book-of-odds-enterprises","debt_financing",NA,"2010-01-29",2e+06
"b812a46f87b94e7d8e869ebcc346d066","bookigee","angel",NA,"2012-10-23",450000
"b812a46f87b94e7d8e869ebcc346d066","bookigee","venture",NA,"2012-03-27",187500
"ee8660e1ca066d243b3046ebbff07488","booking-social","seed",NA,"2014-11-05",48867
"6cdeade2e5276fdd964d0aebaf10a91f","booklamp",NA,NA,NA,NA
"952a91028697caeb25c1b1ba426983dd","booklr","seed",NA,"2011-01-01",5e+05
"4f06c8d9eac917244464bb21e9aa33a2","bookyacom",NA,NA,NA,NA
"addc4c1db360ca82f8dd354251ce3adc","boomapp","seed",NA,"2015-07-27",NA
"9f04a0e9919e3ba547e314cec44789d7","boomerang-commerce","venture","B","2016-01-14",1.2e+07
"9f04a0e9919e3ba547e314cec44789d7","boomerang-commerce","venture","A","2014-07-16",8500000
"b500e7d8d226fbd57a502931444318a5","boomerang-pharmaceutical-communications",NA,NA,NA,NA
"22d2f732062359fff90d13abfbe25506","boonseo-hyderabad",NA,NA,NA,NA
"90b1e630e1aa2432cc3c29c0036f615e","booshaka","seed",NA,"2012-07-25",1e+06
"90b1e630e1aa2432cc3c29c0036f615e","booshaka","convertible_note",NA,"2014-09-01",2e+06
"e7d1d498b23ef54eda390d980c29943b","boosk","seed",NA,"2012-10-01",10000
"b4655dce7bd24a3597e05b67eca7a1a2","booster-ly","seed",NA,"2014-06-07",170000
"8c81508ca4ec508b9f037ea5ee5e3b67","boostpost",NA,NA,NA,NA
"d12caf0e7f6d89bc0d89a563fd6bf433","boostsolutions",NA,NA,NA,NA
"e39f20ecd52d07ef78e47b75f19f2487","borba",NA,NA,NA,NA
"9cc2ec910cb6550bdd039f2d2b70d76a","border-city-media","convertible_note",NA,"2014-11-01",NA
"8998e61f0b4aa2e0834e2f4da47aee09","boreal-genomics","venture","A","2010-10-01",6499999
"8998e61f0b4aa2e0834e2f4da47aee09","boreal-genomics","venture","c","2013-10-04",1.8e+07
"f7fe96af737d573636022416887c5e87","borean-pharma","venture","a","2005-03-23",5220000
"fcd460589194c69d0a599340baa74ab2","boss-metrics","seed",NA,"2012-02-01",NA
"2238a5b19ab9d1ca38bbe000ccb7e819","boston-biocom",NA,NA,NA,NA
"20fcf59f63cd1a7d72745d963aa99220","boston-biomedical","venture",NA,"2010-06-16",2e+06
"9e3526a77c1fdfca922862041da2e043","boston-heart-lab","venture",NA,"2009-03-23",286000
"9e3526a77c1fdfca922862041da2e043","boston-heart-lab","venture","1","2010-09-21",1e+07
"9e3526a77c1fdfca922862041da2e043","boston-heart-lab","venture","1","2009-05-01",NA
"1feaf74a290621aaaf911d664f10a721","boston-mountain-biotech",NA,NA,NA,NA
"20301ee2ce385f6055af9dd886f8a5db","boston-out-patient-surigal-suites","venture",NA,"2009-05-26",160886
"1c29d5c242cba60d87cb97d9f0f63152","boston-probes-inc",NA,NA,NA,NA
"ae83647f323fb647ac3ebec315d2b989","boston-therapeutics","venture",NA,"2013-08-07",2e+06
"abfbefaf1b8ca2a46982c801a33474fe","bostwick-laboratories","undisclosed",NA,"2011-10-25",NA
"9d22dd7723d924fbca0616243e07d8ac","botanic-innovations","venture",NA,"2012-01-19",790002
"9d22dd7723d924fbca0616243e07d8ac","botanic-innovations","venture",NA,"2011-03-21",1500000
"70e631ccc732848d134b8521a6bb4fc0","botanica-exotica-2","seed",NA,"2013-01-01",NA
"6034f711e22d27c1a34650cf597abf9f","botanocap","venture",NA,"2013-12-23",4200000
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","venture","C","2016-01-07",2196557
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","venture","A","2013-04-13",3600000
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","venture","A","2013-04-03",NA
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","convertible_note",NA,"2013-12-31",NA
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","undisclosed",NA,"2014-01-15",2e+06
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","venture","A","2013-07-30",3700000
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","seed",NA,"2012-10-01",1e+06
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","venture","B","2015-02-09",13500000
"0c5e2a7defe9d98ba877946617dae9ea","bottlenose","venture","B","2014-10-22",1.5e+07
"d3c7b558aceb93e572224787d7b443a6","boundarymedical","debt_financing",NA,"2009-05-26",1250000
"536db69aac1419d914d256e32a32a05e","bourn-hall-clinic","venture",NA,"2014-02-04",5303380
"c7e393951df1a6063f22ae7de19e6e90","bovigen",NA,NA,NA,NA
"88157d08a8bf23395d83ca45c6c7bb73","box-uk",NA,NA,NA,NA
"d7565daeac8359af09078106b06891d6","boxever","venture","B","2016-01-19",1.2e+07
"d7565daeac8359af09078106b06891d6","boxever","seed",NA,"2011-09-01",NA
"d7565daeac8359af09078106b06891d6","boxever","venture","a","2014-03-05",6e+06
"d7565daeac8359af09078106b06891d6","boxever","angel",NA,"2012-04-01",1e+06
"805f6cd0452f212e19f8edc5ae7b2b99","boxfish","venture","b","2014-03-17",7e+06
"805f6cd0452f212e19f8edc5ae7b2b99","boxfish","venture","a","2011-07-30",3e+06
"27dd658d295c23f0f73b1cceb4886c72","boxoffice-metrics",NA,NA,NA,NA
"dbb20124b15a9b3b7c9c2c6f0e187828","boxter",NA,NA,NA,NA
"4429cd88a8d9f1923a821b525c4fe055","boy-scouts-of-america",NA,NA,NA,NA
"c218951335b24fea5bf0828a1297faa0","bp-analytics",NA,NA,NA,NA
"88f60ae916bdd3262dc6607b3506a33e","bp-logix",NA,NA,NA,NA
"97e7ee8e9ba00daa0a382852355f4f2b","bp212-com",NA,NA,NA,NA
"77453ec1276163193ee37715980dba74","bpmonline",NA,NA,NA,NA
"cb65623e027d0655ff757b23c4eadf2d","bqu",NA,NA,NA,NA
"04a348ad239a7d8297a870f02572e074","br3","venture","A","2009-08-01",533807.8292
"c62d87e48fd7d589894178a8daed10ac","braasch-biotech-llc",NA,NA,NA,NA
"37ebf61e8239c36232197d77ec84fa3c","bracco-diagnostic-imaging",NA,NA,NA,NA
"6616013bbadad832a605fc55857b140e","brachysciences",NA,NA,NA,NA
"cd1874e4c6e613e76f720afbb864423d","bracketr","seed",NA,"2014-06-15",25000
"5a11560f6e38471b77942adcad2c11d8","bracketvoodoo",NA,NA,NA,NA
"91e5c8609affe260aabc324958e88333","braclet","venture","A","2015-05-20",NA
"91e5c8609affe260aabc324958e88333","braclet","seed",NA,"2013-02-21",NA
"91e5c8609affe260aabc324958e88333","braclet","seed",NA,"2012-02-13",40000
"91e5c8609affe260aabc324958e88333","braclet","debt_financing",NA,"2014-05-07",3e+05
"91e5c8609affe260aabc324958e88333","braclet","seed",NA,"2015-04-13",NA
"91e5c8609affe260aabc324958e88333","braclet","venture",NA,"2014-11-13",42500
"fe6319148eab608f369634ea0e43cc0a","brafton",NA,NA,NA,NA
"8f464124687f12cd2328c23a47f88e30","bragg-peak-systems","venture",NA,"2011-07-29",2400000
"65d0d9ad359c557e0f64d7e554481aa2","brain","private_equity",NA,"2012-11-27",77766000
"ba6b9c8e0a6dda3558cf52321c0bc056","brain-science",NA,NA,NA,NA
"b6af39203562ae8273cb9eb742673f65","brain-fingerprinting-laboratories",NA,NA,NA,NA
"1dfefbdf1a2b4171e8e7a2c66c55288b","brain-synergy-institute","debt_financing",NA,"2015-12-22",160000
"1dfefbdf1a2b4171e8e7a2c66c55288b","brain-synergy-institute","venture",NA,"2013-11-14",9e+05
"1dfefbdf1a2b4171e8e7a2c66c55288b","brain-synergy-institute","venture",NA,"2013-03-24",1970000
"1dfefbdf1a2b4171e8e7a2c66c55288b","brain-synergy-institute","venture",NA,"2013-10-03",1505802
"1dfefbdf1a2b4171e8e7a2c66c55288b","brain-synergy-institute","debt_financing",NA,"2015-05-07",1500000
"1dfefbdf1a2b4171e8e7a2c66c55288b","brain-synergy-institute","venture",NA,"2015-05-07",7e+05
"27ff4288b27c50cdca34302758d41d3a","brain-tunnelgenix-technologies","venture",NA,"2015-12-14",9100000
"27ff4288b27c50cdca34302758d41d3a","brain-tunnelgenix-technologies","seed",NA,"2013-05-14",1e+05
"27ff4288b27c50cdca34302758d41d3a","brain-tunnelgenix-technologies","product_crowdfunding",NA,"2010-04-16",250000
"27ff4288b27c50cdca34302758d41d3a","brain-tunnelgenix-technologies","venture",NA,"2013-09-17",2213168
"08aa2ac22c26d87d758355d898f55394","braincells","venture","A","2005-07-15",17700000
"08aa2ac22c26d87d758355d898f55394","braincells","debt_financing",NA,"2011-08-01",994727
"08aa2ac22c26d87d758355d898f55394","braincells","venture",NA,"2011-08-01",3999996
"08aa2ac22c26d87d758355d898f55394","braincells","debt_financing",NA,"2012-01-11",1978046
"08aa2ac22c26d87d758355d898f55394","braincells","venture","b","2008-03-01",3e+07
"08aa2ac22c26d87d758355d898f55394","braincells","venture","b","2008-04-01",2e+07
"099d7c385394c3c054c14213eab5b20d","brainceuticals","venture",NA,"2010-09-30",249506
"59b6bd2541ecf64bed12c89b91196537","brain-control",NA,NA,NA,NA
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","grant",NA,"2014-01-29",3e+05
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","convertible_note",NA,"2013-11-01",1e+07
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","debt_financing",NA,"2009-10-30",1593750
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","debt_financing",NA,"2015-09-03",16500000
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","venture",NA,"2010-01-06",385000
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","venture",NA,"2010-03-16",2400000
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","venture",NA,"2009-12-02",970000
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","debt_financing",NA,"2009-07-07",1500000
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","venture","1","2012-12-31",NA
"8f8a456afb0d9b35905f44028c9dc451","brainscope-company","venture",NA,"2015-09-03",2465000
"78a72912c9195018709e7b6e97c07943","brainspace",NA,NA,NA,NA
"71bdcc62e5490893e96434b4e5372b4b","brainstage","venture",NA,"2015-03-26",2200000
"548c890f91ef79400d9e3db949f145aa","brainstorm-cell-therapeutics","grant",NA,"2013-12-12",8e+05
"548c890f91ef79400d9e3db949f145aa","brainstorm-cell-therapeutics","seed",NA,"2012-07-27",206910
"548c890f91ef79400d9e3db949f145aa","brainstorm-cell-therapeutics","venture",NA,"2014-05-09",1632689
"548c890f91ef79400d9e3db949f145aa","brainstorm-cell-therapeutics","post_ipo_equity",NA,"2014-06-13",10500000
"548c890f91ef79400d9e3db949f145aa","brainstorm-cell-therapeutics","grant",NA,"2014-07-24",5e+06
"7a769c3483708e1749370bd32e85ee10","branchbird",NA,NA,NA,NA
"ad4eab0ede25442b8341697227fcd923","brand-a-trend-gmbh","angel",NA,"2013-04-11",5e+05
"ad4eab0ede25442b8341697227fcd923","brand-a-trend-gmbh","seed",NA,"2014-01-01",1101427
"ad4eab0ede25442b8341697227fcd923","brand-a-trend-gmbh","venture","1","2014-11-11",4500000
"c4cca7bcc879d8bad83d2f3455774221","brand-embassy","seed",NA,"2014-02-19",1e+06
"18eb3b9d864c29d6db93431b34dd56ea","brand-navigator",NA,NA,NA,NA
"222524c3a0e86d47e370dbafff893bb2","brand-networks","private_equity",NA,"2013-06-06",6.8e+07
"395462a82fe8ebb0181626a26473b746","gomakeit-labs","seed",NA,"2012-07-17",40000
"0a5db46836f550cbcb60200bc1b6a69f","brandfractal",NA,NA,NA,NA
"4ed9b46827d87b9b3e770d960b8d7ee9","brandguard-software",NA,NA,NA,NA
"5361d0e4175dff2eadf29d1145a09b25","where-2-get-it",NA,NA,NA,NA
"d38ae54d33e2fbd0ff59114f5d814b77","brandmuscle",NA,NA,NA,NA
"5c88369ef1e7b5736ed0f2ead062e6b2","brandskore",NA,NA,NA,NA
"07619a1d8b2a75fa6a748934db40a461","brandtrack",NA,NA,NA,NA
"9462e87512c07646f38f9bf2f39a62b8","brandtree","seed",NA,"2009-01-01",NA
"9462e87512c07646f38f9bf2f39a62b8","brandtree","venture",NA,"2011-08-16",120000
"579c92e9507fa25954aff67e6e6c5aca","brandtribe",NA,NA,NA,NA
"783f55b142ce490f252d6592b31e7540","brandvee","seed",NA,"2015-01-07",75836
"783f55b142ce490f252d6592b31e7540","brandvee","seed",NA,"2015-04-27",151957
"d306f78ad0b14fe53ee3bb558279bce4","brandwatch","venture","C","2015-10-29",3.3e+07
"d306f78ad0b14fe53ee3bb558279bce4","brandwatch","venture",NA,"2012-03-15",6e+06
"d306f78ad0b14fe53ee3bb558279bce4","brandwatch","venture","a","2010-11-01",1500000
"d306f78ad0b14fe53ee3bb558279bce4","brandwatch","angel",NA,"2006-05-01",993280
"d306f78ad0b14fe53ee3bb558279bce4","brandwatch","angel",NA,"2007-12-01",1239465
"d306f78ad0b14fe53ee3bb558279bce4","brandwatch","venture","B","2014-05-22",2.2e+07
"5909a7f232c4ab9c5c49be5dc93cf576","brandwise",NA,NA,NA,NA
"b2ca888f2f09cf636a86710512d7b31d","brandxplorer",NA,NA,NA,NA
"62292df0c8cfdf593c7f62df8d288bfe","brastax",NA,NA,NA,NA
"eaea39b505893a80f29d6f446596d7dd","bravo-health",NA,NA,NA,NA
"27b8eb773e05ffdf4433b800487f4011","breadboard-bi",NA,NA,NA,NA
"23e0d0580e4c642bda7a34585ce33204","breath-of-life","venture",NA,"2010-02-03",750000
"276397629a000d956a1fe0cf41e76035","breathtec-biomedical","venture",NA,"2015-05-29",1125080
"fd697301f3b12f9d25facaa5fb2f6bc5","breed-abbott-morgan",NA,NA,NA,NA
"952cd9ef6a40df74817c34e3e9023d3f","breethe","venture",NA,"2015-09-08",575000
"ebe475acea677db7f7239dd1f7ca354c","brewcharts",NA,NA,NA,NA
"d66fdf35640e12e38183efc819c9dd29","brickell-bay-acquisition","venture",NA,"2010-01-18",52411646
"9400d01de81e21ddd16597f34e8b9b40","brickell-biotech","venture",NA,"2010-07-16",6199987
"9400d01de81e21ddd16597f34e8b9b40","brickell-biotech","venture","1","2013-02-26",7e+06
"9400d01de81e21ddd16597f34e8b9b40","brickell-biotech","debt_financing",NA,"2014-08-14",2214600
"9400d01de81e21ddd16597f34e8b9b40","brickell-biotech","venture","1","2015-02-03",1e+07
"cd05191c488a37af7983e2347c35c5f6","brickstream","debt_financing",NA,"2015-01-30",2e+06
"cd05191c488a37af7983e2347c35c5f6","brickstream","venture",NA,"2012-10-05",4e+06
"cd05191c488a37af7983e2347c35c5f6","brickstream","venture","1","2009-07-13",8798583
"cd05191c488a37af7983e2347c35c5f6","brickstream","venture",NA,"2010-04-22",8670000
"cd05191c488a37af7983e2347c35c5f6","brickstream","venture",NA,"2014-04-15",8700000
"cd05191c488a37af7983e2347c35c5f6","brickstream","debt_financing",NA,"2014-07-08",6e+06
"0837dc80d688a6683626794ffb1370ab","bridg","seed",NA,"2013-04-18",NA
"0837dc80d688a6683626794ffb1370ab","bridg","venture","1","2015-01-06",NA
"0727b79ec70ee95f7eed119d427e2bba","bridge-medical-group",NA,NA,NA,NA
"af88ce601c9c1bacc9722443aebb23a1","bridge-pharmaceuticals","venture","B","2007-02-14",3.5e+07
"af88ce601c9c1bacc9722443aebb23a1","bridge-pharmaceuticals","debt_financing",NA,"2009-08-07",2188388
"34c97a45d10c9709764d0a0fa0a1f636","bridge-usa",NA,NA,NA,NA
"71ffa4efe4169da8ea96fa58a567ddef","bridgecrest-medical","seed",NA,"2014-01-01",NA
"71ffa4efe4169da8ea96fa58a567ddef","bridgecrest-medical","seed",NA,"2014-09-01",30000
"33e3c7b7569f28d447572a0adb4ced3b","bridgei2i-analytics-solutions",NA,NA,NA,NA
"819cde11c0cf7fc58f13969b71f0cf18","bridges",NA,NA,NA,NA
"7b2ef01db26f2421f719198313d022c3","bridgespan-inc",NA,NA,NA,NA
"fbc7c802006c1310294674b573daade1","bridgeu","seed",NA,"2015-11-16",2500000
"fbc7c802006c1310294674b573daade1","bridgeu","seed",NA,"2014-11-01",4e+05
"f4fcc86d9d9766ed047eb1996d47a49d","bridj","seed",NA,"2014-09-04",4e+06
"f4fcc86d9d9766ed047eb1996d47a49d","bridj","venture","1","2015-01-14",7e+06
"30c044c848e0ed87f1f9e77fe9a71cc8","briefmetrics",NA,NA,NA,NA
"5ed0251ba1ccad6b02d25d6cf693519f","bright-forest-media",NA,NA,NA,NA
"fe0d0da86348aaa0c5751549c247674b","bright-north",NA,NA,NA,NA
"51745fc1c5fbbf814e511c2db11c4126","brightbytes","venture","a","2013-07-11",2500000
"51745fc1c5fbbf814e511c2db11c4126","brightbytes","seed",NA,"2013-02-19",750000
"51745fc1c5fbbf814e511c2db11c4126","brightbytes","angel",NA,"2012-03-03",220000
"51745fc1c5fbbf814e511c2db11c4126","brightbytes","venture","b","2014-03-12",1.5e+07
"51745fc1c5fbbf814e511c2db11c4126","brightbytes","venture","C","2015-07-21",3.3e+07
"5feb6981348cdfc00504dcfe73a331ce","brightcove","venture","C","2006-11-09",5.5e+07
"5feb6981348cdfc00504dcfe73a331ce","brightcove","venture","a","2005-03-01",5500000
"5feb6981348cdfc00504dcfe73a331ce","brightcove","venture","B","2005-11-30",16200000
"5feb6981348cdfc00504dcfe73a331ce","brightcove","venture","C","2007-01-17",59500000
"5feb6981348cdfc00504dcfe73a331ce","brightcove","venture","b","2006-09-01",5e+06
"5feb6981348cdfc00504dcfe73a331ce","brightcove","venture","d","2008-05-01",4900000
"5feb6981348cdfc00504dcfe73a331ce","brightcove","venture","e","2014-02-10",39907658
"5feb6981348cdfc00504dcfe73a331ce","brightcove","venture","d","2010-04-05",1.2e+07
"2d0fcf00fe3fb0d47e83385c3b2b397c","brighterion",NA,NA,NA,NA
"8579ee59229a1642cf878057d006a066","brightmetrics",NA,NA,NA,NA
"1a42db1f7c14c26aa2368aa6048fdfc9","brighton-biotech","venture",NA,"2014-11-18",1600000
"bacd99fd731dfa412bd990c82ea464fd","vorstack-corporation","venture",NA,"2011-09-07",NA
"bacd99fd731dfa412bd990c82ea464fd","vorstack-corporation","venture","1","2014-04-29",8400000
"655ebec971d524cbfc1228f364d80dd6","brightqube","angel",NA,"2007-05-01",2e+05
"655ebec971d524cbfc1228f364d80dd6","brightqube","venture","1","2008-05-27",650000
"e565e2b2306cf79bbd93bcb0d0dd5577","brightside-technologies",NA,NA,NA,NA
"8eb9807b2efbbef5853f6384305e055f","bright-sun","angel",NA,"2014-01-13",2e+05
"8946466466a32102781c2785c2a8c3fc","brilliant-arc",NA,NA,NA,NA
"ffd6668aa636c23d6246999d00a0f801","bringshare","venture",NA,"2013-05-14",220000
"ffd6668aa636c23d6246999d00a0f801","bringshare","venture",NA,"2011-09-27",611931
"ffd6668aa636c23d6246999d00a0f801","bringshare","venture","1","2011-03-23",1e+06
"ffd6668aa636c23d6246999d00a0f801","bringshare","undisclosed",NA,"2014-07-07",NA
"ffd6668aa636c23d6246999d00a0f801","bringshare","venture","1","2011-11-01",1e+06
"4cd6aeb9c702c11b2cf41beb2e688904","briskat",NA,NA,NA,NA
"f1f37b642b59be6451279e74f508bbdb","bristol-technology",NA,NA,NA,NA
"258972b92834f6a77da608f51a8e5fbf","bristol-myers-squibb","debt_financing",NA,"2008-11-17",15510000
"530651b27ea9092d29ac584dde960fcd","british-biotechnology-plc",NA,NA,NA,NA
"29912ef8c498877a82599104b4859555","brivas-labs","seed",NA,"2013-08-26",1e+05
"29912ef8c498877a82599104b4859555","brivas-labs","angel",NA,"2013-01-01",1e+05
"29912ef8c498877a82599104b4859555","brivas-labs","private_equity",NA,"2013-11-26",150000
"29912ef8c498877a82599104b4859555","brivas-labs","seed",NA,"2013-09-10",150000
"cdedb111ccc86ffe44c0babaa9c1dce5","broad-hollow-bioscience-park",NA,NA,NA,NA
"ad779d8d9ab8413eb5cacdf1dfb162f7","broad-institute","grant",NA,"2012-01-26",32500000
"ad779d8d9ab8413eb5cacdf1dfb162f7","broad-institute","grant",NA,"2013-11-15",1e+08
"1786bb4119e9bb4c6c39e82823aa8df1","broadforward",NA,NA,NA,NA
"ac6fec6fabe4f45b670da1d058486857","broadpeak-partners",NA,NA,NA,NA
"6ba7ed843f5d1b957d591254dc31cb97","brookings-biospace",NA,NA,NA,NA
"f2d15d8f781176a423aae7173d0b26b5","brooks-bell-interactive",NA,NA,NA,NA
"c739a0889dc0ad8b47c14b9f9102bbe5","brothers-marketing",NA,NA,NA,NA
"1a5f8bb12508a96f084c7825887f9519","brownbook-net-database",NA,NA,NA,NA
"cb9a8d5bf92c10fb0f61afee3ed9b57d","browsera",NA,NA,NA,NA
"cb495e27cdb0c79722b2f97079fadd4b","browz-in","seed",NA,"2015-05-15",93000
"cb495e27cdb0c79722b2f97079fadd4b","browz-in","seed",NA,"2012-10-08",390000
"eed91ecd706285a9bbe949adfce0988e","brthe",NA,NA,NA,NA
"87dbc329206f3ded660fe254af42f5ac","bruder-healthcare","venture",NA,"2009-06-11",5000345
"441ac67297357a714d13ef7492543d59","brytlyt",NA,NA,NA,NA
"b06141048c4ef6b9c05b4492c49d66f1","bsports",NA,NA,NA,NA
"450903942bcd4f9b283c23a17e3e9cf1","btc-global-fund",NA,NA,NA,NA
"6c31ba9bad81230c2151d58807025711","btm-corporation",NA,NA,NA,NA
"e2519f64bdac095b18ba6e6729a65f06","bts",NA,NA,NA,NA
"deefdd8a5c97215e2c083f4327af706f","bubbles-and-beyond","venture","a","2006-07-28",701000
"deefdd8a5c97215e2c083f4327af706f","bubbles-and-beyond","venture","b","2011-03-08",1700000
"baa607d56aeaf2203a575f8ec5bd8647","bubclean",NA,NA,NA,NA
"fafe0cceef09dfe57e2b645a7ab5ee80","bublish-inc-","seed",NA,"2014-03-01",3e+05
"dea7ee9964741ca2c61658b1424d24ef","buck-institute-for-age-research",NA,NA,NA,NA
"96327d03bf1460e2427b9841baa7c29a","buddybounce","venture",NA,"2014-01-01",435823
"96327d03bf1460e2427b9841baa7c29a","buddybounce","seed",NA,"2012-11-01",64414
"96327d03bf1460e2427b9841baa7c29a","buddybounce","seed",NA,"2015-02-01",60156
"acb82a7a996fff24ba46fc7cfca63dce","budurl",NA,NA,NA,NA
"7e918468d4fabec62a80f45b39e4ba5a","buenamarca-com",NA,NA,NA,NA
"587e8e82b62e584662c5219ac317c1a1","buffalo-center-of-excellence",NA,NA,NA,NA
"80c77b18a704f88000d44e6aa7e4d893","bufferstream",NA,NA,NA,NA
"5c22b981890a85d3a77e4fbe6f2477d5","buganalytics",NA,NA,NA,NA
"bf7bb248e030f66d93ad62cfd0be90a5","bugsense","seed",NA,"2011-02-01",1e+05
"968ebdcc23403a01f0fc71b1b04b8793","global-data-machine","convertible_note",NA,"2015-04-02",NA
"968ebdcc23403a01f0fc71b1b04b8793","global-data-machine","seed",NA,"2015-04-01",NA
"64a1eb89b13849a2f00ed6e669b48c23","buildout","undisclosed",NA,"2014-03-10",125000
"441b73bd4aeb46382addbe929defdcad","built-in-menlo",NA,NA,NA,NA
"40e877262794d21a11262d52d1926299","builtwith",NA,NA,NA,NA
"b37c62b4f0d2143468bcd84ab330ef38","bull-basic",NA,NA,NA,NA
"817da25e2ae4e21f7a01bae016037a54","bullbearie",NA,NA,NA,NA
"a40f829a4c21927f0af53b1c36e33dfe","bullet-biotechnology","venture","a","2013-07-09",1135198
"a40f829a4c21927f0af53b1c36e33dfe","bullet-biotechnology","convertible_note",NA,"2015-03-24",699834
"779c48d7160b29c46ef127aaf27341c0","bullitt-foundation",NA,NA,NA,NA
"8fa912385f9f8eda2452d8916f8cbe4e","bullseyeevaluation","angel",NA,"2012-03-01",3700000
"9c7315a35d1740758bf137dbe20892e2","bumebox",NA,NA,NA,NA
"15f42f9bb8a7bd5fcd7472440f2c28e6","bump-com","venture","b","2012-11-06",2300000
"15f42f9bb8a7bd5fcd7472440f2c28e6","bump-com","venture","a","2010-05-04",1e+06
"15f42f9bb8a7bd5fcd7472440f2c28e6","bump-com","venture",NA,"2013-06-26",4e+06
"15f42f9bb8a7bd5fcd7472440f2c28e6","bump-com","venture","b","2011-04-15",1200000
"cac3330346f8d6df46fc0ffe91243e42","bundle-2","seed",NA,"2014-11-26",3e+05
"cac3330346f8d6df46fc0ffe91243e42","bundle-2","angel",NA,"2015-05-25",275144
"b202b74ae8bee6197c0936c374fe7a9a","bureau-labs-inc",NA,NA,NA,NA
"3a2485acd4e414d8ba593cbdb39b61d0","bureau-van-dijk",NA,NA,NA,NA
"465e4819ddd8e4c14bc54507b6d02716","burke-e-porter-machinery",NA,NA,NA,NA
"a0fcbf2017223122a18a2f3baee030ef","burrill-and-co",NA,NA,NA,NA
"c8a28c68d16090b588d0d779e5413b30","we-are-burst","seed",NA,"2015-02-10",76177.3205
"c8a28c68d16090b588d0d779e5413b30","we-are-burst","seed",NA,"2015-05-15",157478
"bee982706ee2ccd3025cdc9e087c5537","burstly","venture",NA,"2011-11-30",5500000
"bee982706ee2ccd3025cdc9e087c5537","burstly","venture","1","2010-03-30",1800000
"86d8d0cb9ef40f4ee9817a9a4f92813b","burt","angel",NA,"2009-05-01",5e+05
"86d8d0cb9ef40f4ee9817a9a4f92813b","burt","seed",NA,"2011-06-30",3e+06
"86d8d0cb9ef40f4ee9817a9a4f92813b","burt","venture","1","2012-10-17",5e+06
"749bc5659aaf37609b3bd30e988c8b71","burwood-back-pain",NA,NA,NA,NA
"77e82ddff3512470b495d0ab20107475","busche-enterprise-division",NA,NA,NA,NA
"d2ce170d1734677ff7dec9162e7ecad2","business-innovation-inc",NA,NA,NA,NA
"df786cf3afc040b40882eaeaa392e268","business-monitor","undisclosed",NA,"2009-09-09",NA
"e0914d2885e9132330941f8a667ddbbd","business-network-designs",NA,NA,NA,NA
"bf2c6d0f39804845c9826943db201138","business-objects-sa",NA,NA,NA,NA
"bcd1dd9b34e2d09346db1ee4757cec99","business-technologies",NA,NA,NA,NA
"820377162ac68dd1a4b2c9d9d26f81a2","business-valuation-resources",NA,NA,NA,NA
"decfd18cedfc1c64c19175b209debaed","businessdb",NA,NA,NA,NA
"1efb5b4863fede0d2b1001ead69ba2da","businessfellows-com",NA,NA,NA,NA
"1da598e6e8ac42645dcd5bb39184ab4c","businesshut",NA,NA,NA,NA
"bbdce5497657ba2985eae89fa80d3ca5","businesstechnologydirect-com",NA,NA,NA,NA
"0f7e7d6c2963be03b468b3a0b9ecd609","busyflow","seed",NA,"2011-08-01",NA
"f6a4cf62a654b332da6f7e8d54ba36a0","butler-shine-stern-partners",NA,NA,NA,NA
"42c258e3cd29943098841b039433af06","buy-sell-rent-asia","angel",NA,"2015-09-01",70000
"37c8f331ca579c82d1d9de63868d2eab","reply-com","venture","b","2007-04-04",6e+06
"37c8f331ca579c82d1d9de63868d2eab","reply-com","venture","c","2007-10-02",4500000
"37c8f331ca579c82d1d9de63868d2eab","reply-com","venture",NA,"2010-06-02",1.5e+07
"37c8f331ca579c82d1d9de63868d2eab","reply-com","private_equity",NA,"2011-07-05",41011402
"37c8f331ca579c82d1d9de63868d2eab","reply-com","debt_financing",NA,"2010-03-29",1079000
"37c8f331ca579c82d1d9de63868d2eab","reply-com","venture","A","2005-03-25",1.7e+07
"37c8f331ca579c82d1d9de63868d2eab","reply-com","venture","D","2014-05-30",NA
"4ec194c436f4bd01df14f1dfc8106d76","buyology",NA,NA,NA,NA
"97da99267752f8cc3f933ad295770786","buytition",NA,NA,NA,NA
"48e4137f598d93acce8be650dca8bb89","buzz-bracket",NA,NA,NA,NA
"db3f9fa329a708647a565c54e3ee626a","buzzdeck",NA,NA,NA,NA
"9964b94296f64acbbfbb50ba93e28031","buzzelement","angel",NA,"2013-12-15",NA
"4993613f6b49509c6f1c19909d6443c1","buzzient","venture","a","2011-08-25",1069585
"4993613f6b49509c6f1c19909d6443c1","buzzient","debt_financing",NA,"2008-04-01",5e+05
"5b2fdaddec926e3cfe99de99b1fd9c28","buzzilla","seed",NA,"2011-07-04",1e+06
"5b2fdaddec926e3cfe99de99b1fd9c28","buzzilla","angel",NA,"2011-07-01",1e+06
"2bb67493f19a17572436de56616fd6f9","buzzinate-information-technology-company","undisclosed",NA,"2011-09-01",NA
"2ca5af4c3ccb53efacaa6364e71157b3","buzzinga",NA,NA,NA,NA
"039c3387458709a175816163fc09227c","buzznumbers",NA,NA,NA,NA
"e02633dc8ee3633787500c87ab205650","buzzoek","seed",NA,"2013-10-14",257320
"bc728e144d8d3b270095ab51f8a269cc","buzzsparks",NA,NA,NA,NA
"9c7c6971fd513edc69c91bb443266d04","buzzstarter","seed",NA,"2013-10-29",NA
"9c7c6971fd513edc69c91bb443266d04","buzzstarter","convertible_note",NA,"2014-05-01",2e+05
"9c7c6971fd513edc69c91bb443266d04","buzzstarter","convertible_note",NA,"2014-07-01",2e+05
"9c7c6971fd513edc69c91bb443266d04","buzzstarter","convertible_note",NA,"2014-09-03",2e+05
"5f4dd93c5aab28e781eec447a234c454","buzzsumo","seed",NA,"2014-04-16",NA
"cfe98ff83d0d721e911d54d4481a97d5","bvf-partners",NA,NA,NA,NA
"304313670dab893a3c789b0a5a5b8e43","bycler","seed",NA,"2014-06-01",40000
"c7427dafadabc3de5b449c09b77d545e","bynder",NA,NA,NA,NA
"bace6559f75f06dd2e4b9d918d717111","byside",NA,NA,NA,NA
"dc9bf83484eb1fa24f46c7e84a10e8d7","c-duck-consultancy-services",NA,NA,NA,NA
"a8931ddd2903fe5b10b709c5b11d412d","c-lecta","venture","c","2008-04-08",NA
"a8931ddd2903fe5b10b709c5b11d412d","c-lecta","venture",NA,"2006-01-20",726000
"a1a01dea58025437eb26840f5b551618","c-e-i-technology",NA,NA,NA,NA
"9b9284a1c6d8a5524a52ce92ab2c75eb","c-it-solutions",NA,NA,NA,NA
"63329f19eb481a28f61b22601cc6770e","c2-therapeutics","venture",NA,"2009-06-16",3017458
"63329f19eb481a28f61b22601cc6770e","c2-therapeutics","venture",NA,"2012-04-06",2388998
"63329f19eb481a28f61b22601cc6770e","c2-therapeutics","venture",NA,"2014-10-08",11628126
"63329f19eb481a28f61b22601cc6770e","c2-therapeutics","debt_financing",NA,"2014-09-22",2550000
"63329f19eb481a28f61b22601cc6770e","c2-therapeutics","debt_financing",NA,"2015-06-18",8e+05
"61ce12c63c0ee5ca502c1bf2955e1190","c3","venture",NA,"2009-12-29",9999998
"61ce12c63c0ee5ca502c1bf2955e1190","c3","venture",NA,"2009-12-15",15810000
"61ce12c63c0ee5ca502c1bf2955e1190","c3","venture","1","2013-05-29",1.5e+07
"82a5a5f1e77c292d8424c03c4b8012d4","c3-jian","venture",NA,"2010-01-05",1.5e+07
"82a5a5f1e77c292d8424c03c4b8012d4","c3-jian","venture","1","2014-03-17",6e+07
"82a5a5f1e77c292d8424c03c4b8012d4","c3-jian","venture",NA,"2012-02-27",3e+07
"afb680f80916a3113cdfb068e207b1bd","c3-metrics","seed",NA,"2011-08-04",1104000
"77d0a7fc9e9f8fb23b46f790044a634b","c4x-discovery","undisclosed",NA,"2009-11-19",NA
"f7ca7e1524727674a1871d0d506ff4b6","c5-insight",NA,NA,NA,NA
"3d83ab23760b581cc19eeabefef622e8","c8-medisensors","venture","c","2012-02-03",2.4e+07
"3d83ab23760b581cc19eeabefef622e8","c8-medisensors","venture",NA,"2010-11-12",10600000
"3d83ab23760b581cc19eeabefef622e8","c8-medisensors","debt_financing",NA,"2009-09-09",2e+05
"3d83ab23760b581cc19eeabefef622e8","c8-medisensors","venture",NA,"2011-12-01",390000
"3d83ab23760b581cc19eeabefef622e8","c8-medisensors","venture","b","2009-05-26",9826800
"3d83ab23760b581cc19eeabefef622e8","c8-medisensors","venture","c","2012-06-12",1.9e+07
"16bf621fd1b4e47821925ae81635bad7","c9-inc","venture","d","2013-09-23",1.2e+07
"16bf621fd1b4e47821925ae81635bad7","c9-inc","venture","a","2004-07-01",2e+06
"16bf621fd1b4e47821925ae81635bad7","c9-inc","venture","A","2005-09-29",8600000
"16bf621fd1b4e47821925ae81635bad7","c9-inc","venture","A","2007-07-25",5e+06
"16bf621fd1b4e47821925ae81635bad7","c9-inc","venture","b","2009-07-15",NA
"16bf621fd1b4e47821925ae81635bad7","c9-inc","venture","c","2010-05-18",8e+06
"2d5c55260966fc8227350c6064859382","cabot-corporation",NA,NA,NA,NA
"68cbcae1c37ee447be1790ba1f78bf8a","cabs-business-intelligence",NA,NA,NA,NA
"a6dfcc05a873da7f600f31c13f0685a9","cadence-biomedical","venture",NA,"2012-01-20",750000
"a6dfcc05a873da7f600f31c13f0685a9","cadence-biomedical","venture","1","2012-04-26",1100000
"a6dfcc05a873da7f600f31c13f0685a9","cadence-biomedical","venture","1","2015-06-25",1200000
"82c05f4eac5e5a8f656721ee037b5cde","cadence-pharmaceuticals","seed",NA,"2008-02-01",NA
"586338d3ee87206ed644c063e4ae42fc","cadi",NA,NA,NA,NA
"072690d5179a94aa405e3661ba9ef6e4","cagenix","venture",NA,"2011-08-05",2328698
"072690d5179a94aa405e3661ba9ef6e4","cagenix","debt_financing",NA,"2010-03-29",1e+06
"072690d5179a94aa405e3661ba9ef6e4","cagenix","seed",NA,"2012-03-01",3e+05
"072690d5179a94aa405e3661ba9ef6e4","cagenix","seed",NA,"2012-11-01",164000
"072690d5179a94aa405e3661ba9ef6e4","cagenix","seed",NA,"2012-09-01",49480
"072690d5179a94aa405e3661ba9ef6e4","cagenix","seed",NA,"2013-09-01",750000
"7582ebfd24e51bcc8332d189df74262d","cahaba-pharmaceuticals","venture",NA,"2009-05-29",831959
"7582ebfd24e51bcc8332d189df74262d","cahaba-pharmaceuticals","debt_financing",NA,"2010-10-20",5e+05
"7582ebfd24e51bcc8332d189df74262d","cahaba-pharmaceuticals","debt_financing",NA,"2013-01-18",205000
"7582ebfd24e51bcc8332d189df74262d","cahaba-pharmaceuticals","debt_financing",NA,"2012-03-23",250000
"89a4f6e4cfb0267470b1dd1dc59ebedf","cains-retail",NA,NA,NA,NA
"bc9c82f49c485186c9cf7cda4e3a0335","caisson-laboratories","venture",NA,"2010-12-20",50000
"c6f87cb459fba70bbd6d5aa790387282","cake-marketing",NA,NA,NA,NA
"17cef662952722d4bf17b84dcb2b0f68","cake-fundraising",NA,NA,NA,NA
"c1ec23487f9371aab228dbf3ae04fa36","calando-pharmaceuticals","venture",NA,"2011-01-18",1e+06
"722da2999b8bfa07405494aca1ca524d","calgene",NA,NA,NA,NA
"d7bda2e7f65d1f48cee7ab42f6acc54e","caliber-interactive",NA,NA,NA,NA
"d8652add75512f290c9768ed3cd87130","caliber-infosolutions","undisclosed",NA,"2009-02-17",NA
"1118442f434d3bd30d369642faae88ae","caliber-media-group",NA,NA,NA,NA
"704fe80945b7bbafd2127b24b0cc3525","caliber-ux",NA,NA,NA,NA
"a6fe8a8a7f803e966649761d2919637f","calibra-medical","venture","B","2008-08-01",3.5e+07
"a6fe8a8a7f803e966649761d2919637f","calibra-medical","venture",NA,"2010-02-23",9300000
"a6fe8a8a7f803e966649761d2919637f","calibra-medical","venture","d","2011-04-15",8100000
"a6fe8a8a7f803e966649761d2919637f","calibra-medical","venture",NA,"2009-11-24",1400000
"a6fe8a8a7f803e966649761d2919637f","calibra-medical","debt_financing",NA,"2011-03-04",1e+06
"b5f09a4a38fd8806f35ba36ca7694c60","calico",NA,NA,NA,NA
"7c1a41e2d3759c0a07e2e0d547d4408e","california-stem-cell","venture","b","2009-12-21",NA
"7c1a41e2d3759c0a07e2e0d547d4408e","california-stem-cell","venture",NA,"2012-02-07",1950000
"62a8ef74a2aa2a6790e0d3b16ea4c37e","caliper-life-sciences","venture",NA,"2010-12-30",10794877
"1fc382a5c1612656149e576d0212ba07","caliper-technologies",NA,NA,NA,NA
"8c580310316e4230812e7f342b1dfe5f","calistoga-pharmaceuticals","venture","A","2008-01-03",5200000
"8c580310316e4230812e7f342b1dfe5f","calistoga-pharmaceuticals","venture","b","2009-05-05",3e+07
"8c580310316e4230812e7f342b1dfe5f","calistoga-pharmaceuticals","venture","a","2007-03-05",2.1e+07
"8c580310316e4230812e7f342b1dfe5f","calistoga-pharmaceuticals","venture","c","2010-06-30",4e+07
"8c580310316e4230812e7f342b1dfe5f","calistoga-pharmaceuticals","venture","A","2009-03-16",1e+06
"ef3d440ad69a8fbb91a886e625dd023c","calithera-biosciences","venture",NA,"2012-04-01",4e+06
"ef3d440ad69a8fbb91a886e625dd023c","calithera-biosciences","venture","1","2013-10-29",3.5e+07
"ef3d440ad69a8fbb91a886e625dd023c","calithera-biosciences","venture","1","2012-05-31",8e+06
"ef3d440ad69a8fbb91a886e625dd023c","calithera-biosciences","venture","1","2010-07-08",4e+07
"ef3d440ad69a8fbb91a886e625dd023c","calithera-biosciences","venture","1","2012-12-31",2e+06
"ef3d440ad69a8fbb91a886e625dd023c","calithera-biosciences","venture","1","2014-07-31",15999998
"82b25da0cf6aec173f8f7a30504ed791","calixa-therapeutics",NA,NA,NA,NA
"8f49199d1a1ee371b33a6e257e570516","calixar","seed",NA,"2012-06-18",1104075
"8f49199d1a1ee371b33a6e257e570516","calixar","venture","1","2015-02-24",1136060
"7b0cb56120aea07e17941a152282e8d6","call-levels","seed",NA,"2015-11-01",5e+05
"c1f151e29e45fd362c25788a7ea4035a","called-it","seed",NA,"2015-12-07",NA
"0437e08d538defc9c3bd58b0d60b8965","called-in",NA,NA,NA,NA
"e9d11ba71acd9a8744c55b898388ecbf","callerkey",NA,NA,NA,NA
"6cc146a1c80ea8cc945e3c4170a4e186","callida-energy","seed",NA,"2013-08-08",25000
"6cc146a1c80ea8cc945e3c4170a4e186","callida-energy","angel",NA,"2014-03-12",40000
"6cc146a1c80ea8cc945e3c4170a4e186","callida-energy","angel",NA,"2012-04-02",40000
"6cc146a1c80ea8cc945e3c4170a4e186","callida-energy","angel",NA,"2013-03-14",17000
"aa33307be536660ac9630902bd8981e7","callidus-biopharma","seed",NA,"2012-07-03",1611154
"aa33307be536660ac9630902bd8981e7","callidus-biopharma","venture","1","2013-05-14",4600000
"eb65a5202a9411cbbf1347a553e9de25","calliope-waterworks-inc",NA,NA,NA,NA
"3a1e7a594b4e3a39241fa0fbca35b221","callpicker",NA,NA,NA,NA
"3afe2df254d5c41fc8dc67f974cd9dec","thecallr",NA,NA,NA,NA
"73e2f600a72e3375c5019168bdcd35f6","callyourprice","undisclosed",NA,"2014-02-01",50000
"4f607f7a804685abc691ca2639a31d10","calmsea","undisclosed",NA,"2011-01-01",NA
"4f607f7a804685abc691ca2639a31d10","calmsea","venture",NA,"2010-09-10",1050000
"4f607f7a804685abc691ca2639a31d10","calmsea","venture",NA,"2012-07-23",1100000
"858d2f06bdc2510e4f1fbc28d782ca70","calorics","venture",NA,"2013-10-02",10231974
"2174c109a406b9e80c5671497079b1bc","calosyn-pharma","venture",NA,"2010-04-13",1863392
"2174c109a406b9e80c5671497079b1bc","calosyn-pharma","venture",NA,"2012-02-29",309685
"2613c7840b96a3c2057bb43a97ee2738","calypte-biomedical",NA,NA,NA,NA
"f78954906bd735eac218abd4b7bbe284","calysta","venture",NA,"2015-01-23",10000
"89d407ac486fa45a99139778f6e2b494","calysta-energy","venture",NA,"2011-05-23",5e+06
"89d407ac486fa45a99139778f6e2b494","calysta-energy","venture","1","2013-12-11",3e+06
"89d407ac486fa45a99139778f6e2b494","calysta-energy","venture","1","2015-01-22",1e+07
"f8176e2cd9d83326861c0a195e158861","cambia-health-solutions",NA,NA,NA,NA
"dc05528dda25056d33b18975723bdddb","cambrian-genomics","seed",NA,"2012-07-01",NA
"dc05528dda25056d33b18975723bdddb","cambrian-genomics","venture","1","2014-11-20",1e+07
"dc05528dda25056d33b18975723bdddb","cambrian-genomics","seed",NA,"2013-09-11",NA
"af0c0d6d58a3f23fdc1408e1d5cb8274","cambridge-antibody-technology",NA,NA,NA,NA
"2a3838ac457fbb5cf1bb4d54f36ea2dd","cambridge-energy-data-lab",NA,NA,NA,NA
"233d4f56d08d71703855b3f5893f849f","cambridge-epigenetix","venture","A","2014-10-29",5500000
"37971ac212b59f8021470b3443d1e99e","cambridge-health-alliance",NA,NA,NA,NA
"00e576acef157e76641466298553a143","cambridge-research-instrumentation",NA,NA,NA,NA
"ffc0fa98c7edd3b576516197bca5f8c6","camden-market-holdings",NA,NA,NA,NA
"b08e458a77f027e5725b7fee91938c43","camio","seed",NA,"2014-02-26",NA
"d51ff904a353d67d849d8192481c0bf7","campaignamp","seed",NA,"2014-02-17",170000
"d51ff904a353d67d849d8192481c0bf7","campaignamp","angel",NA,"2014-07-31",3e+05
"8539b92616fdfa5736dc0fb1a51d3d6c","campaignchain-inc",NA,NA,NA,NA
"d983e0d3bbc71541b1a9feb5325bcadd","campaigndock",NA,NA,NA,NA
"9a9c6f204876de65f037fc26f3acf30a","campalyst","seed",NA,"2011-07-01",NA
"9a9c6f204876de65f037fc26f3acf30a","campalyst","seed",NA,"2012-03-27",NA
"73b4c802ded0a1f8d49a99e02067f527","campionpps",NA,NA,NA,NA
"5f354e1e5c5e6205fd688f54ac6b4405","campus-biotech",NA,NA,NA,NA
"7fd2196767c3d1a540b1fe04fb8c46df","can-stock-photo",NA,NA,NA,NA
"ca9c6724876eb03e6abb6f8918b4b20b","canadian-centre-on-substance-abuse",NA,NA,NA,NA
"abb6b091c6dbe9bd0477c4f8307f0bc2","canadian-financing",NA,NA,NA,NA
"4567ac920a3f47c0477431d1bf6e0ed3","canarias-excelencia-technologica",NA,NA,NA,NA
"8aa393add9a247acbdbbcdfca72bf163","canary-consulting",NA,NA,NA,NA
"e6343254ab8ffd6c6274cf78f7ac6a14","canbridge-life-sciences","venture","B","2015-10-27",1e+07
"e6343254ab8ffd6c6274cf78f7ac6a14","canbridge-life-sciences","venture","A","2014-12-02",1e+07
"264363b6c479c34f0b4da1d25e1ba425","cancer-genetics","venture",NA,"2010-11-01",6618000
"693c5e10a7f04b79082943c149021707","cancer-prevention-pharmaceuticals","debt_financing",NA,"2016-01-27",5e+06
"693c5e10a7f04b79082943c149021707","cancer-prevention-pharmaceuticals","venture",NA,"2013-10-31",4272500
"693c5e10a7f04b79082943c149021707","cancer-prevention-pharmaceuticals","debt_financing",NA,"2009-08-17",1250000
"693c5e10a7f04b79082943c149021707","cancer-prevention-pharmaceuticals","debt_financing",NA,"2011-03-09",550000
"b22f55f429367494e10436c1cfb8813b","cancer-research-technology",NA,NA,NA,NA
"d31a4dd2e4e7dbd753a83c7881272114","cancer-treatment-services-international","venture",NA,"2009-03-31",2e+06
"50da856dc9b2e7c6bcc5d91d8d099f32","cancerguide-diagnostics","venture","A","2010-03-25",2749999
"f37b1ea15d08ee43efc5b77252bfb3b5","canceriq","seed",NA,"2013-06-01",NA
"85b37c5cdcae8a78079b7bb623a1518b","cancervax",NA,NA,NA,NA
"51be150f37f1daa6a874aedb0d7d39fd","canddi","seed",NA,"2010-03-01",29833
"51be150f37f1daa6a874aedb0d7d39fd","canddi","angel",NA,"2012-09-08",5e+05
"51be150f37f1daa6a874aedb0d7d39fd","canddi","seed",NA,"2011-03-01",162761
"ef384cf3d5c5872a43c35caaf8fdd5d1","candela",NA,NA,NA,NA
"48c5720a4a0e86e50cd0d35c9439f664","candiag","venture",NA,"2012-10-11",5e+05
"48c5720a4a0e86e50cd0d35c9439f664","candiag","venture",NA,"2013-09-12",461000
"1fc0531bbe6ad822368495fa181464ea","candid-io","seed",NA,"2013-10-01",210000
"3e3208ce0858ce0148b4927d021cdd9f","candid-cup",NA,NA,NA,NA
"b6f0ba7221f752c586563a0d28669ac4","candidate-metrics",NA,NA,NA,NA
"54b67b7111b22a034c894644e98316a6","candormap","seed",NA,"2014-10-01",NA
"b79e5d0c13476c791e6ec1441f286c72","http-www-candorworks-com-reachus-htm",NA,NA,NA,NA
"fba39b3947032a9ba55fcd067e53de37","canfield-medical-supply","venture",NA,"2014-03-14",2750
"ec3eaa0d92556d7a0c4a00b4f09930f0","canfite-biopharma","debt_financing",NA,"2015-10-02",9000002
"ec3eaa0d92556d7a0c4a00b4f09930f0","canfite-biopharma","post_ipo_equity",NA,"2014-03-11",5e+06
"ec3eaa0d92556d7a0c4a00b4f09930f0","canfite-biopharma","venture",NA,"2014-12-17",8e+06
"ec3eaa0d92556d7a0c4a00b4f09930f0","canfite-biopharma","post_ipo_equity",NA,"2015-09-20",9e+06
"f71a5dd954f37751dc8d85c2eef05a7a","cangene",NA,NA,NA,NA
"9662941f6dcb8625cdf1a4c53236fac1","cannabics-pharmaceuticals",NA,NA,NA,NA
"fa0cd723ed46e08a4e27435a93ad62ae","canny-road",NA,NA,NA,NA
"c66a677637f6301b69389dd218005bb6","canon",NA,NA,NA,NA
"122dffb83780c3a7186da7bf95c3ac94","canon-finetech",NA,NA,NA,NA
"85f483e82408e061b1bf29cad0c2311d","canopy-labs","venture",NA,"2014-03-21",564000
"85f483e82408e061b1bf29cad0c2311d","canopy-labs","seed",NA,"2012-12-13",1500000
"a4b62830e152c58963ab888ff06e5083","cansurround","debt_financing",NA,"2015-05-06",845000
"585ad788ac8b640f190dc05bcecc7bba","cantab-biopharmaceuticals","venture",NA,"2010-01-25",8100000
"4f0fc9a87e026c106391471f27dec72f","cantargia","venture",NA,"2013-07-05",1e+06
"d6d2b36c308a106fc00a0f70c5224207","cantel-medical",NA,NA,NA,NA
"c2929672d2b103606ff2738c1ed8e66e","mashwork","venture","A","2016-01-21",5600000
"c2929672d2b103606ff2738c1ed8e66e","mashwork","venture",NA,"2014-05-06",1500000
"5ab8811e3e892a8cba5a92025715fbf2","cao-points-checker",NA,NA,NA,NA
"c222cfe7577966ee243d0e9f1d845a06","cap-data-solutions","seed",NA,"2015-08-14",161529
"9c05da3d734f49e8ffad2bfe7e7f7520","capazita",NA,NA,NA,NA
"0ed9042c0129f76a59084ee1f8f3219e","capical-gmbh","venture","a","2013-08-01",NA
"0ed9042c0129f76a59084ee1f8f3219e","capical-gmbh","seed",NA,"2011-09-01",NA
"1f5b2b759efab82faa51b4df73eb1c23","capillary-technologies-pvt","seed",NA,"2009-10-06",1e+05
"1f5b2b759efab82faa51b4df73eb1c23","capillary-technologies-pvt","venture","1","2012-09-25",15500000
"1f5b2b759efab82faa51b4df73eb1c23","capillary-technologies-pvt","venture",NA,"2014-02-11",4500000
"1f5b2b759efab82faa51b4df73eb1c23","capillary-technologies-pvt","venture","1","2014-07-16",1.4e+07
"1f5b2b759efab82faa51b4df73eb1c23","capillary-technologies-pvt","venture","1","2015-09-02",4.5e+07
"ac3c3c311b65d9eb3e8355137596b55d","capital-market-exchange",NA,NA,NA,NA
"d0875b6b57e29b76606ba2221c497663","capitol-scientific",NA,NA,NA,NA
"a506f7a7bab6e7c61c0fd9f667374d8f","capnia","debt_financing",NA,"2010-03-19",3309227
"a506f7a7bab6e7c61c0fd9f667374d8f","capnia","venture",NA,"2010-11-19",1892464
"a506f7a7bab6e7c61c0fd9f667374d8f","capnia","debt_financing",NA,"2012-08-14",5017396
"a506f7a7bab6e7c61c0fd9f667374d8f","capnia","venture","1","2004-05-03",1.2e+07
"0209f189b89d57e29cfab915da1ff4e2","capptain","venture","A","2012-03-01",1500000
"266be32a2ae787ff4dcc5672d4a54641","capricor","venture",NA,"2010-01-06",8e+05
"266be32a2ae787ff4dcc5672d4a54641","capricor","venture",NA,"2012-04-13",6e+06
"266be32a2ae787ff4dcc5672d4a54641","capricor","venture",NA,"2013-12-05",26289973
"266be32a2ae787ff4dcc5672d4a54641","capricor","venture","1","2010-12-18",2e+06
"266be32a2ae787ff4dcc5672d4a54641","capricor","venture",NA,"2009-12-31",2800000
"266be32a2ae787ff4dcc5672d4a54641","capricor","venture",NA,"2015-02-03",10002028
"266be32a2ae787ff4dcc5672d4a54641","capricor","seed",NA,"2011-06-27",2500000
"266be32a2ae787ff4dcc5672d4a54641","capricor","venture",NA,"2009-07-08",3400000
"8ba3c4ff4307dd762cf0ad2c23593647","capricornventis-ltd",NA,NA,NA,NA
"3b5f06f1da3f68caf051251cc7cd2538","caprion-pharmaceuticals",NA,NA,NA,NA
"789d0a78632066b5a3bc01f1ca35fb69","caprotec-bioanalytics","venture","b","2010-05-13",5100000
"789d0a78632066b5a3bc01f1ca35fb69","caprotec-bioanalytics","venture","b","2011-05-09",2100000
"789d0a78632066b5a3bc01f1ca35fb69","caprotec-bioanalytics","venture",NA,"2008-01-10",8800000
"90230efa02e71bfc3ba5c952a7768317","capsenta","convertible_note",NA,"2015-09-01",40000
"90230efa02e71bfc3ba5c952a7768317","capsenta","venture",NA,"2015-03-30",170000
"a9bcc01c98fc69f98c758cc7835c28ef","capsidea",NA,NA,NA,NA
"257bd8182c3802eda427e9c2114f4602","capsule-tech","undisclosed",NA,"2012-07-09",NA
"2707e9182f2051ff0e2145cdd9400131","captaindash",NA,NA,NA,NA
"aca783007044ee6bdba5359539ad74d5","captario",NA,NA,NA,NA
"5f0762de737e256e2f8769d0b16d7078","captimo","seed",NA,"2010-08-01",NA
"5f0762de737e256e2f8769d0b16d7078","captimo","angel",NA,"2011-01-24",1200000
"cb302577184765d7df582d9d52a9004f","the-captioning-studio",NA,NA,NA,NA
"9290f8b5ebd0e74e6ba36580e2764847","captora","venture","B","2014-05-20",2.2e+07
"9290f8b5ebd0e74e6ba36580e2764847","captora","venture","A","2013-03-01",5250000
"2def197693a32259d12582caa5265bd0","captricity","venture","C","2016-01-19",3.5e+07
"2def197693a32259d12582caa5265bd0","captricity","undisclosed",NA,"2011-10-01",NA
"2def197693a32259d12582caa5265bd0","captricity","venture","A","2013-05-31",4500000
"2def197693a32259d12582caa5265bd0","captricity","undisclosed",NA,"2012-09-24",NA
"2def197693a32259d12582caa5265bd0","captricity","venture","a","2013-04-01",2400000
"2def197693a32259d12582caa5265bd0","captricity","venture","B","2014-07-15",1e+07
"7f97ffde8d62411ca88a65a587dfdef4","cara-therapeutics","venture","C","2008-07-25",12300000
"7f97ffde8d62411ca88a65a587dfdef4","cara-therapeutics","venture","C","2006-11-28",2.4e+07
"7f97ffde8d62411ca88a65a587dfdef4","cara-therapeutics","venture","b","2005-12-21",4700000
"7f97ffde8d62411ca88a65a587dfdef4","cara-therapeutics","venture","d","2010-07-21",1.5e+07
"7f97ffde8d62411ca88a65a587dfdef4","cara-therapeutics","post_ipo_equity",NA,"2014-12-10",100003
"0ce23f2d357c7fa9cca4dd1fa931b827","caradigm",NA,NA,NA,NA
"f35e4087df5f297c4db232beaf4a7a08","carazo-salas-group",NA,NA,NA,NA
"0d3e127a6dd3bb32e912f59dcedb4e8a","carbon-analytics","seed",NA,"2013-11-26",51842
"2d28f9352dc26597a14dd1de49c120ea","cars-people",NA,NA,NA,NA
"4bd92e53def1087830af0ee40982f0c3","card-scanning-solutions","private_equity",NA,"2013-06-19",NA
"3a806d5e2e100c207e1cee1fd18b3765","cardabel",NA,NA,NA,NA
"aac7f1f159c875ab35c36aeabc0a62d5","cardax-pharma","debt_financing",NA,"2010-09-27",550000
"aac7f1f159c875ab35c36aeabc0a62d5","cardax-pharma","debt_financing",NA,"2014-01-17",2076000
"aac7f1f159c875ab35c36aeabc0a62d5","cardax-pharma","venture",NA,"2008-12-23",6e+05
"aac7f1f159c875ab35c36aeabc0a62d5","cardax-pharma","debt_financing",NA,"2013-06-17",781170
"aac7f1f159c875ab35c36aeabc0a62d5","cardax-pharma","venture",NA,"2015-11-17",466000
"aac7f1f159c875ab35c36aeabc0a62d5","cardax-pharma","venture",NA,"2015-06-30",5e+05
"29edf1d4cc5c31eee45868111035631c","cardeas-pharma","venture","A","2012-03-16",7535988
"29edf1d4cc5c31eee45868111035631c","cardeas-pharma","venture","B","2015-04-10",37500000
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","venture","D","2007-12-30",35500000
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","venture",NA,"2010-11-05",6446863
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","venture",NA,"2012-09-12",5815270
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","debt_financing",NA,"2013-10-15",555000
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","debt_financing",NA,"2013-12-23",1202936
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","debt_financing",NA,"2013-04-01",2376854
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","venture",NA,"2014-04-16",2e+07
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","venture",NA,"2014-10-07",8500000
"6358073b22d9fd3859d8f2758ad721b2","cardiac-dimensions","venture","B","2015-03-11",4.3e+07
"bf7135c0f470b5d0ee1ba274c34c900e","cardiac-insight","venture",NA,"2011-01-07",2e+05
"bf7135c0f470b5d0ee1ba274c34c900e","cardiac-insight","debt_financing",NA,"2011-09-26",315476
"bf7135c0f470b5d0ee1ba274c34c900e","cardiac-insight","venture",NA,"2014-01-23",2e+06
"bf7135c0f470b5d0ee1ba274c34c900e","cardiac-insight","venture",NA,"2011-11-17",699962
"bf7135c0f470b5d0ee1ba274c34c900e","cardiac-insight","debt_financing",NA,"2012-09-25",284811
"bf7135c0f470b5d0ee1ba274c34c900e","cardiac-insight","venture","1","2014-07-21",7e+06
"4a3eeed7f81e1bb5ba0f461d204d003e","cardiacassist",NA,NA,NA,NA
"709029d522546b51a69ee5647cdba8ae","cardialen","venture","A","2014-01-20",2508000
"709029d522546b51a69ee5647cdba8ae","cardialen","angel",NA,"2012-09-01",138000
"709029d522546b51a69ee5647cdba8ae","cardialen","debt_financing",NA,"2009-08-17",337380
"709029d522546b51a69ee5647cdba8ae","cardialen","debt_financing",NA,"2011-12-19",2402000
"709029d522546b51a69ee5647cdba8ae","cardialen","venture","B","2015-03-26",1520000
"009e8957d102c6746c9c98eb11ac8e32","cardiaq","seed",NA,"2009-05-13",750000
"009e8957d102c6746c9c98eb11ac8e32","cardiaq","venture","1","2010-01-12",6500000
"009e8957d102c6746c9c98eb11ac8e32","cardiaq","venture","1","2012-11-29",37300000
"009e8957d102c6746c9c98eb11ac8e32","cardiaq","debt_financing",NA,"2009-05-12",884000
"191df99f68fcac6dfe73fdcda8dab08d","cardinal-path",NA,NA,NA,NA
"356f58c29840973f3620a2e08fb34cfb","cardio3-biosciences","venture",NA,"2012-01-10",3970480
"356f58c29840973f3620a2e08fb34cfb","cardio3-biosciences","grant",NA,"2013-11-25",5789700
"356f58c29840973f3620a2e08fb34cfb","cardio3-biosciences","private_equity",NA,"2013-05-08",24956500
"356f58c29840973f3620a2e08fb34cfb","cardio3-biosciences","venture",NA,"2014-06-16",33872431
"b12b4b4f3a3a2671c978d91726023a14","cardiocell","venture","A","2015-05-26",1060000
"8edea19217df89fd336fbed4764f2768","cardiocom",NA,NA,NA,NA
"f69658932a17743bf8a25fb4b1bfd5a1","cardiodigital",NA,NA,NA,NA
"330c8961a14d350d4336d3e60d254a19","cardiodx","venture","d","2010-05-17",34500000
"330c8961a14d350d4336d3e60d254a19","cardiodx","private_equity",NA,"2012-10-01",5998000
"330c8961a14d350d4336d3e60d254a19","cardiodx","private_equity",NA,"2012-08-27",5.8e+07
"330c8961a14d350d4336d3e60d254a19","cardiodx","venture","b","2006-07-21",1.9e+07
"330c8961a14d350d4336d3e60d254a19","cardiodx","private_equity",NA,"2011-05-11",6e+07
"330c8961a14d350d4336d3e60d254a19","cardiodx","private_equity",NA,"2012-07-01",30509000
"330c8961a14d350d4336d3e60d254a19","cardiodx","private_equity",NA,"2014-07-24",20983348
"330c8961a14d350d4336d3e60d254a19","cardiodx","venture","D","2014-12-18",3.5e+07
"330c8961a14d350d4336d3e60d254a19","cardiodx","venture","D","2015-07-03",5000008
"dff1c866d0e1028c1208c9f4d66266e9","cardiofocus","venture","c","2011-02-28",30600000
"dff1c866d0e1028c1208c9f4d66266e9","cardiofocus","debt_financing",NA,"2009-06-15",5893465
"dff1c866d0e1028c1208c9f4d66266e9","cardiofocus","debt_financing",NA,"2013-05-01",1.1e+07
"dff1c866d0e1028c1208c9f4d66266e9","cardiofocus","debt_financing",NA,"2011-03-21",5e+06
"dff1c866d0e1028c1208c9f4d66266e9","cardiofocus","debt_financing",NA,"2014-05-09",2378923
"dff1c866d0e1028c1208c9f4d66266e9","cardiofocus","private_equity",NA,"2015-01-07",3.2e+07
"ba2fb0d5291109acbb548307416fac85","cardiogen-sciences","seed",NA,"2014-11-06",526000
"982c701f64d1fed22d4da904d28bc5ff","cardiogenics","venture",NA,"2011-02-09",1915575
"982c701f64d1fed22d4da904d28bc5ff","cardiogenics","venture",NA,"2009-07-31",2715000
"8f69dc8dce5a73a008deb17bcb14b6e2","cardiola","venture","e","2009-11-18",4e+06
"8f69dc8dce5a73a008deb17bcb14b6e2","cardiola","venture","e","2009-04-09",2e+06
"7cf80ad7dd52b60c0bcbd68443f40156","cardiome-pharma","post_ipo_equity",NA,"2014-03-11",29214350
"540f9a7a18d7659aa6d39abe42123df3","cardiomind","venture","C","2007-07-03",3.3e+07
"540f9a7a18d7659aa6d39abe42123df3","cardiomind","venture",NA,"2008-03-31",2.2e+07
"f9b91ae1616ee543b25ad9ccbc14c82e","cardiophotonics","debt_financing",NA,"2010-02-10",3e+05
"8fd6dd21815e4a87a16dbe223f26b6f6","cardiorentis","venture","B","2016-01-10",60182956.1868
"96dcadf40bfdb7a1fcd8314d8f7abb4a","cardiosys",NA,NA,NA,NA
"0529d13b36e8be137bbd22597ee11af8","cardiovascular-decisions","venture",NA,"2009-10-18",8e+05
"17e6d00da625977a5069258d73ddb407","cardiovascular-systems","debt_financing",NA,"2010-12-13",1500000
"17e6d00da625977a5069258d73ddb407","cardiovascular-systems","debt_financing",NA,"2013-03-12",13500000
"7c5edc708f3ba67aada49132b34cf976","cardiovip","venture",NA,"2013-04-23",5844999
"5e4f35aefa73005ad0f6fc16299fdd9d","cardiox","venture",NA,"2011-08-31",8e+06
"5e4f35aefa73005ad0f6fc16299fdd9d","cardiox","venture",NA,"2014-04-07",3159813
"5e4f35aefa73005ad0f6fc16299fdd9d","cardiox","venture","1","2009-08-05",786257
"5e4f35aefa73005ad0f6fc16299fdd9d","cardiox","venture",NA,"2009-06-05",3e+05
"5e4f35aefa73005ad0f6fc16299fdd9d","cardiox","convertible_note",NA,"2013-10-23",250000
"5e4f35aefa73005ad0f6fc16299fdd9d","cardiox","debt_financing",NA,"2010-10-14",652959
"5e4f35aefa73005ad0f6fc16299fdd9d","cardiox","venture",NA,"2012-12-28",362745
"5e4f35aefa73005ad0f6fc16299fdd9d","cardiox","seed",NA,"2008-11-07",1e+06
"4d17e9c747e6ea9a84f180e56bd219d3","cardioxyl-pharmaceuticals","venture",NA,"2010-08-02",1.5e+07
"4d17e9c747e6ea9a84f180e56bd219d3","cardioxyl-pharmaceuticals","venture","1","2012-11-13",2.8e+07
"4d17e9c747e6ea9a84f180e56bd219d3","cardioxyl-pharmaceuticals","venture",NA,"2009-08-05",9e+06
"4d17e9c747e6ea9a84f180e56bd219d3","cardioxyl-pharmaceuticals","venture","1","2006-12-06",14500000
"012e039db18c140cd0b96edfb4063e54","cardium-therapeutics","debt_financing",NA,"2009-06-11",750000
"df9bd1491eee99885dcd9546437bdeac","cardo-medical","venture",NA,"2009-10-27",6215250
"f959f2312b888d63231847775d0a951a","cardoz","venture","a","2010-09-16",17592449
"9dbff82190e74fea4675e7a64a5e29b2","cardwee",NA,NA,NA,NA
"02b2f760e6b495434cf5017b62408585","care-analytics","seed",NA,"2015-06-21",1e+05
"239d36871206a9912ed97e5d5caf405a","carecore-national",NA,NA,NA,NA
"e847a9be442d00689b11a5079073d486","carecube","seed",NA,"2015-09-19",NA
"fa852327e17ba10c50f019d9b1bb2ac5","xdx","venture","f","2009-08-05",14400000
"fa852327e17ba10c50f019d9b1bb2ac5","xdx","venture",NA,"2009-10-07",14400000
"fa852327e17ba10c50f019d9b1bb2ac5","xdx","venture","e","2008-06-16",35400000
"fa852327e17ba10c50f019d9b1bb2ac5","xdx","debt_financing",NA,"2011-11-14",2155781
"fa852327e17ba10c50f019d9b1bb2ac5","xdx","venture",NA,"2006-01-05",26500000
"fa852327e17ba10c50f019d9b1bb2ac5","xdx","grant",NA,"2011-01-31",12500000
"fa852327e17ba10c50f019d9b1bb2ac5","xdx","debt_financing",NA,"2012-09-12",1.5e+07
"fa852327e17ba10c50f019d9b1bb2ac5","xdx","debt_financing",NA,"2010-07-12",6041511
"225dca8c5056d435410fa62b795794f5","careevolution",NA,NA,NA,NA
"72a424cb42dc1f3b3af9b61040a557ad","carefamily","venture",NA,"2012-01-13",1250000
"72a424cb42dc1f3b3af9b61040a557ad","carefamily","debt_financing",NA,"2013-10-02",75000
"3d23422165c756d0582b48b7f6aac809","carepeutics","debt_financing",NA,"2011-08-11",5e+05
"c2b040eb85a602e1ab10455ce161d129","carepoint-partners","venture",NA,"2011-01-19",2.7e+07
"3f702efc1c36e87108172c2fe660b5e9","carepoint-solutions","venture",NA,"2012-07-13",214448
"c7cd0b0fe2107fc58adf13c8aa281ec5","careskore",NA,NA,NA,NA
"573bb720d72d614a9c9b715875b83a7c","carestream-health","debt_financing",NA,"2013-06-12",2.4e+09
"83a779a19cad35420bc34e352b4706f2","caretotell",NA,NA,NA,NA
"aae663f97bc3f7105f7f9e652be07269","carex-health-brands",NA,NA,NA,NA
"d7f1847973d7f34f2067285f2609e606","carffeine",NA,NA,NA,NA
"8aad3eaadd554e95673c2fb5c1058b89","thecarforce","seed",NA,"2015-09-21",550000
"8aad3eaadd554e95673c2fb5c1058b89","thecarforce","seed",NA,"2015-05-20",1e+05
"e5cad9b3574e983b919e625ce811d68c","carglass-inc","seed",NA,"2016-01-30",3e+06
"e5cad9b3574e983b919e625ce811d68c","carglass-inc","angel",NA,"2014-10-22",5e+05
"5d10f3565ef6a3d6b713eaa787e1efb5","cargometrics-technologies","venture",NA,"2015-01-05",2144550
"15579d2c79e2ecc9220c4ec99ac47534","cargosense","undisclosed",NA,"2014-08-12",NA
"15579d2c79e2ecc9220c4ec99ac47534","cargosense","seed",NA,"2015-04-28",2500000
"15579d2c79e2ecc9220c4ec99ac47534","cargosense","seed",NA,"2015-08-26",1e+06
"08a670fd2e84d05b26745258f2c178bf","cargospotter","angel",NA,"2013-01-01",264094
"44a6878d42c4acdef8dd11b1bd9d3e0c","caribou-biosciences","venture","A","2014-10-03",2914942
"44a6878d42c4acdef8dd11b1bd9d3e0c","caribou-biosciences","venture","A","2015-03-25",11549904
"30148ef5f88982a0ffe07132081aa351","carigent-therapeutics","venture","A","2007-12-11",2e+06
"142850de3f47c2a12d9c3346b06d4f2c","cariloop","seed",NA,"2015-08-30",170000
"142850de3f47c2a12d9c3346b06d4f2c","cariloop","seed",NA,"2013-09-13",35000
"142850de3f47c2a12d9c3346b06d4f2c","cariloop","seed",NA,"2014-06-04",4e+05
"0a15d9751795796b7da7f621065bc8bb","caris-life-sciences",NA,NA,NA,NA
"4a67eaf59100558099f8ad2f52383c72","carmel-pharma","venture",NA,"2005-12-12",NA
"aacd250a24542755d73af60bb8bf78b8","carmell-therapeutics","seed",NA,"2015-08-14",NA
"aacd250a24542755d73af60bb8bf78b8","carmell-therapeutics","venture",NA,"2008-01-31",130000
"aacd250a24542755d73af60bb8bf78b8","carmell-therapeutics","venture","1","2011-04-18",2400000
"aacd250a24542755d73af60bb8bf78b8","carmell-therapeutics","debt_financing",NA,"2012-12-14",410797
"aacd250a24542755d73af60bb8bf78b8","carmell-therapeutics","venture","1","2014-06-13",1e+06
"aacd250a24542755d73af60bb8bf78b8","carmell-therapeutics","debt_financing",NA,"2014-11-12",303818
"aacd250a24542755d73af60bb8bf78b8","carmell-therapeutics","debt_financing",NA,"2015-08-04",137233
"7d88b54788990acc4aa766f041250be7","carmen","seed",NA,"2015-11-20",141055.329
"54aa8c5a2cfdab721acc1cd98df82561","carmenta-bioscience","seed",NA,"2013-08-07",2e+06
"0c71481094b51b5676b1d63beffa0bd0","carmolex","seed",NA,"2012-05-22",6e+05
"0c71481094b51b5676b1d63beffa0bd0","carmolex","equity_crowdfunding",NA,"2013-10-27",1e+06
"1529905b2767d692ea3698aae9289099","carmot-therapeutics","venture",NA,"2012-07-17",500159
"1529905b2767d692ea3698aae9289099","carmot-therapeutics","venture",NA,"2010-04-23",1549999
"f714ae02bb891c0dd6b28bcba795ac57","carogen","seed",NA,"2013-09-09",150000
"f679338aedf3ca42c755a70a51781e6d","caroline-young",NA,NA,NA,NA
"93f87869e0bef55132bf497d3ab1be92","carolus-therapeutics","debt_financing",NA,"2013-03-05",2250000
"feb168ca67ab6fba40910eb3914d28b9","carp-data-service",NA,NA,NA,NA
"45b2aab71b2fec60d56e080e2aa45417","carpetcleanlondon",NA,NA,NA,NA
"26b92b6b63b6bddbffeee78dbbf6edb7","carprice-ru","seed",NA,"2014-10-28",2e+06
"26b92b6b63b6bddbffeee78dbbf6edb7","carprice-ru","venture","1","2015-07-23",4e+07
"26b92b6b63b6bddbffeee78dbbf6edb7","carprice-ru","venture","1","2014-11-23",6e+06
"afaf44086c736bb922bc56607853393b","carrotfry",NA,NA,NA,NA
"0c46472aeca935884c26f0e9855495a9","carsabi","seed",NA,"2012-01-01",NA
"3789b1d09139c179e854fd9a380d794f","cartela-ab","venture",NA,"2006-04-26",2670000
"1b13a8ac64a68e0b25b5521088c41e78","cartheur",NA,NA,NA,NA
"e721f4733a287e5f97aecfd1cee9d737","cartilix","venture","b","2006-03-01",6350000
"2b983af2391cfeab10df4c5a74f44ac7","cartiva","debt_financing",NA,"2014-01-08",1500000
"2b983af2391cfeab10df4c5a74f44ac7","cartiva","venture","1","2013-07-15",4300000
"2b983af2391cfeab10df4c5a74f44ac7","cartiva","venture",NA,"2014-12-29",1500000
"2b983af2391cfeab10df4c5a74f44ac7","cartiva","venture","1","2015-05-11",8500000
"28fcace0d68f49f038eddeb3dce3cdd2","cartodb","venture","A","2014-09-10",8e+06
"28fcace0d68f49f038eddeb3dce3cdd2","cartodb","venture","B","2015-09-10",2.3e+07
"525caf0a9342acb923cb660795a45937","cartolabs",NA,NA,NA,NA
"60178d5ee1342c1a6a650be76effb1dd","cartouchan",NA,NA,NA,NA
"40d812028769f570702c88bb88161921","cartrescuer","angel",NA,"2013-02-03",120000
"d3cc8115152773be71928704aa2d331f","cartskill",NA,NA,NA,NA
"e9a1d9b9a474befab41944ab3e226928","cartuna","convertible_note",NA,"2015-04-27",5e+05
"89e7436948c8b2bd7995377bc83cbf3d","cas-inc",NA,NA,NA,NA
"9c97d2cabe46add962ca752a6f9b1acf","cascade-prodrug","debt_financing",NA,"2012-02-12",1e+05
"9c97d2cabe46add962ca752a6f9b1acf","cascade-prodrug","venture","1","2013-04-03",1348932
"02b5ca21f3c6e4d10b31d520236c84ba","cascade-strategies-inc-",NA,NA,NA,NA
"742e9b1862942e4ced936e945fda58af","case-base",NA,NA,NA,NA
"1d5a14faa45b124baa1cd28dc5dc5506","case-commons","angel",NA,"2011-01-01",NA
"70706ef5efad51edfc9ec089a26b48f8","casereader","venture",NA,"2011-08-11",2385262
"e567d9eb3023b80365905bc833f96912","cash-credit","private_equity",NA,"2013-08-05",2.5e+07
"f473e5b1ce8c6820898709cbcaaf9b8e","cashforce","venture","A","2016-01-13",1085450.2629
"cd6a3637f0ae9523a111ff18ba64c9cb","cask","venture","B","2015-11-05",2e+07
"cd6a3637f0ae9523a111ff18ba64c9cb","cask","venture","a","2012-11-14",1e+07
"cd6a3637f0ae9523a111ff18ba64c9cb","cask","seed",NA,"2012-01-25",2500000
"62bc8ac56617ab9c8cd94de2f189d971","cassie",NA,NA,NA,NA
"98b765ca0d85d065024ba27191426a41","casterstats","angel",NA,"2009-10-15",631720
"c73a01c5e3c9218530f8846b5ed09a85","castion",NA,NA,NA,NA
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","venture",NA,"2013-05-16",1508000
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","venture",NA,"2010-03-12",1124999
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","venture",NA,"2009-03-20",935899
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","venture",NA,"2013-11-19",1e+06
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","venture",NA,"2012-10-04",1343689
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","venture",NA,"2014-05-05",1e+06
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","venture",NA,"2014-08-13",11800000
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","debt_financing",NA,"2015-04-14",6e+06
"384d059f90fcdcca7563ffc80ecb70d8","castle-biosciences","venture","1","2015-07-27",11700000
"cdeb6fd05e16838014124f3cc5547c3b","castlewood-surgical","venture",NA,"2011-01-13",1e+06
"cdeb6fd05e16838014124f3cc5547c3b","castlewood-surgical","venture",NA,"2012-06-06",408763
"cdeb6fd05e16838014124f3cc5547c3b","castlewood-surgical","venture","1","2010-12-01",NA
"cdeb6fd05e16838014124f3cc5547c3b","castlewood-surgical","venture","1","2011-11-01",NA
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","venture","b","2013-11-14",32400000
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","venture",NA,"2013-02-06",9e+06
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","debt_financing",NA,"2010-01-18",2e+06
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","venture","a","2010-04-21",3.9e+07
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","debt_financing",NA,"2010-01-15",2090000
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","venture","a","2011-12-13",8e+06
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","grant",NA,"2012-04-04",120000
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","venture","a","2010-12-08",14500000
"953c581a329d38f6e1f1fd09f157d38a","catabasis-pharmaceuticals","venture",NA,"2015-03-31",12413736
"ba5f3cb855ff901a103f7f8820d00652","catalent-pharma-solutions",NA,NA,NA,NA
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","venture","b","2006-02-09",3e+07
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","venture",NA,"2012-01-01",7e+06
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","venture",NA,"2013-08-20",400004
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","venture","c","2008-12-03",4e+07
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","venture",NA,"2013-04-01",5072000
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","venture",NA,"2012-09-25",13407658
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","venture",NA,"2014-04-22",5009841
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","venture",NA,"2015-02-03",3224993
"88c3048bca2e8c5431a1637db184dc71","catalyst-biosciences","debt_financing",NA,"2015-06-11",1e+06
"7fed2694e1a183b00edd3d177acc12a0","catalyst-fire",NA,NA,NA,NA
"de03089f43b71d2655554b8974ae0c63","catalystpharma","post_ipo_equity",NA,"2013-09-10",15100000
"b3120c4ffabbafe1f42e57098e6be809","catapult-genetics","venture","a","2005-03-16",2e+06
"8c0acd4bca00c132c02c4949fc43c45c","catapult-partners-llc",NA,NA,NA,NA
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","venture",NA,"2013-10-24",2639000
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","venture",NA,"2014-02-12",1e+06
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","debt_financing",NA,"2011-10-20",680000
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","seed",NA,"2013-04-24",1535000
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","seed",NA,"2011-07-18",127500
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","seed",NA,"2011-09-22",225000
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","debt_financing",NA,"2012-04-25",975000
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","seed",NA,"2012-12-19",3298500
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","venture",NA,"2014-06-13",1500000
"e22a04269b40aad9dbde3c5fc04bbf3f","catasys","venture",NA,"2014-10-01",1500000
"3601626955324d66d7f302f1a8cef54e","catch5",NA,NA,NA,NA
"65a7c86ceb925653e492514c20fb3d34","catchly",NA,NA,NA,NA
"2f402e7222463ccf4ad6d32bd04dec87","catchoom","seed",NA,"2012-05-15",750000
"2f402e7222463ccf4ad6d32bd04dec87","catchoom","seed",NA,"2012-05-15",770580
"aa8e41fdce3df4984bf19a8e2ff6d2e1","catchpoint-systems","venture",NA,"2011-07-01",725000
"aa8e41fdce3df4984bf19a8e2ff6d2e1","catchpoint-systems","venture",NA,"2009-12-09",840000
"aa8e41fdce3df4984bf19a8e2ff6d2e1","catchpoint-systems","venture","1","2013-03-12",3200000
"aa8e41fdce3df4984bf19a8e2ff6d2e1","catchpoint-systems","venture","1","2013-12-10",6000001
"aa8e41fdce3df4984bf19a8e2ff6d2e1","catchpoint-systems","venture","1","2015-07-14",6500054
"aa8e41fdce3df4984bf19a8e2ff6d2e1","catchpoint-systems","debt_financing",NA,"2015-07-29",1e+07
"a34c349b6af0ea8eb1fc23d9e970f6b9","caterna","venture",NA,"2011-01-14",867685
"ba90cde492aafdf2d9ed24200d2d4a11","cathay-industrial-biotech","venture","C","2015-12-14",1.35e+08
"ba90cde492aafdf2d9ed24200d2d4a11","cathay-industrial-biotech","venture","B","2006-12-05",5.2e+07
"4e385cdd8dc2abea70d8f9b3393aea61","catheter-connections","venture",NA,"2012-08-27",1075676
"4e385cdd8dc2abea70d8f9b3393aea61","catheter-connections","venture",NA,"2011-08-08",5286046
"34c47731d7ed4f37da3eb4b5cb41715c","cato-research-ltd",NA,NA,NA,NA
"92ba788ab463685129c42be6a9943773","cats-software",NA,NA,NA,NA
"3c9ab7bce6213dcdd7ac1e7da848dfe9","causal-nexus",NA,NA,NA,NA
"7cbadc7cd0f675dedd5ea0f97199decf","causam-energy",NA,NA,NA,NA
"73752ac224fefdebc59cd6c7e1ff6c30","cause-analytics",NA,NA,NA,NA
"0dd4a5d1c20b9b863744dd8dec32bb58","causeplay","seed",NA,"2010-01-30",35000
"81e29808ce1962dff483e75fd51ce232","cauwill-technologies","seed",NA,"2011-01-01",200430
"5830285bae9fc11deff34abb7efd24e8","cavis-microcaps","venture","A","2005-02-03",5e+06
"c8b5d5a2e32fb22668f99f06a61b6d88","cawcah",NA,NA,NA,NA
"3158a64f4d92a694fb655f23076f057d","cawood-scientific","undisclosed",NA,"2010-12-13",6289540
"79338c2dbc863e5a18843c6ee74fe371","cazena","venture","A","2014-10-20",8e+06
"79338c2dbc863e5a18843c6ee74fe371","cazena","venture","B","2015-07-22",2e+07
"14b6c1f1d7180036481eca340b400913","cazoomi","seed",NA,"2009-09-01",250000
"e998305405c4bae3152204c15aeef86f","cb-biotechnologies","venture",NA,"2009-05-19",2327600
"9ac9678f78a6fe4231beca6a62629a27","cb-insights","venture","A","2015-11-09",1e+07
"9ac9678f78a6fe4231beca6a62629a27","cb-insights","non_equity_assistance",NA,"2015-08-24",1150000
"c5eeafbbf93eed3b2b8e750d1e3c633f","cba-pharma","venture",NA,"2010-04-02",3928115
"c5eeafbbf93eed3b2b8e750d1e3c633f","cba-pharma","venture",NA,"2013-06-05",5300486
"c5eeafbbf93eed3b2b8e750d1e3c633f","cba-pharma","venture",NA,"2015-01-01",1e+05
"b06d27db7cc6ce954a78a3ce028586b7","cblpath","venture",NA,"2010-03-31",3200037
"7a00e2d16980d4aa21bde8f89578c062","ccam-biotherapeutics","venture","a","2012-09-15",NA
"10744d80531204e88f7a315d726b8762","ccbr-synarc","private_equity",NA,"2013-04-09",NA
"1b773c6d4c1b76d2abe17cd369e0a00d","realizeit-by-cckf",NA,NA,NA,NA
"069cb14850e7ec8a85b6d72caae753da","cd-diagnostics","venture","A","2012-09-01",5200000
"069cb14850e7ec8a85b6d72caae753da","cd-diagnostics","venture",NA,"2012-01-16",275000
"069cb14850e7ec8a85b6d72caae753da","cd-diagnostics","debt_financing",NA,"2011-12-02",1335000
"d10582670f818f06e334001cba6c3033","cd-genomics",NA,NA,NA,NA
"442f3666120730365c7e61f6a1be1294","www-cdenchi-com",NA,NA,NA,NA
"cc9587ca46c0d60c401492cd321e2203","cdi-bioscience","venture",NA,"2007-12-10",3e+06
"4b2d7bc0e7c2f792056e2f03fd2daa52","cdi-laboratories","venture",NA,"2015-07-01",1191901
"7050a1750a946275e5803629c777ae60","cdmi",NA,NA,NA,NA
"4e3372769311ddf2fb389d3dde5c9813","cdx-life","venture",NA,"2015-03-06",6917808
"c6ad8088f4c716768c77dfd271ec6918","cearna","venture",NA,"2012-01-11",706388
"e6e26130de483d15ef9609b61d5d58fd","ceb-2",NA,NA,NA,NA
"23fa49d34e5d847effd5a4141e68beb1","cebix","venture","c","2012-10-18",30900000
"23fa49d34e5d847effd5a4141e68beb1","cebix","venture",NA,"2010-09-01",1.6e+07
"23fa49d34e5d847effd5a4141e68beb1","cebix","venture",NA,"2009-10-30",7400000
"23fa49d34e5d847effd5a4141e68beb1","cebix","venture",NA,"2012-03-09",8799305
"23fa49d34e5d847effd5a4141e68beb1","cebix","venture",NA,"2014-11-13",33188333
"44de1f8cdc7a9da24fa50fc9ac4bded6","cedarcone-inc",NA,NA,NA,NA
"b91c5ac5a4a10ed426d3e77368ff7e1f","cee",NA,NA,NA,NA
"630249f2eb5bdc370291bddee4e1a3a1","cel-sci","venture",NA,"2009-08-20",4400000
"fdc5b68517210d4d30952624539281c3","celator-pharmaceuticals","venture","C","2007-08-03",1e+07
"fdc5b68517210d4d30952624539281c3","celator-pharmaceuticals","venture","C","2008-07-29",22500000
"fdc5b68517210d4d30952624539281c3","celator-pharmaceuticals","venture","d","2010-09-01",2e+07
"fdc5b68517210d4d30952624539281c3","celator-pharmaceuticals","venture",NA,"2011-12-28",2576867
"fdc5b68517210d4d30952624539281c3","celator-pharmaceuticals","private_equity",NA,"2013-04-30",39300000
"fdc5b68517210d4d30952624539281c3","celator-pharmaceuticals","venture",NA,"2010-05-10",2500000
"27daa9422ff507e4c0e17432d4a980bb","celcuity","venture",NA,"2015-12-18",2150000
"27daa9422ff507e4c0e17432d4a980bb","celcuity","venture","1","2014-03-24",4e+06
"20c51a680282d5c172789b5cd5bcf9db","celdara-medical","grant",NA,"2015-11-17",1700000
"c09a1976b607b08ed9d8d4bd4bf88386","celect","venture",NA,"2013-12-06",50000
"c09a1976b607b08ed9d8d4bd4bf88386","celect","venture","1","2015-06-25",5e+06
"d56c9ce889ebbd9738051f18dae6f5b6","celerus-diagnostics","venture","c","2009-09-10",3500000
"10ca21289826da149b89671188caa1b1","shanghai-celgen-biopharma-co-ltd","venture",NA,"2009-07-01",NA
"5f6b3568a8a8e215fda780d13d8f91ca","celgene",NA,NA,NA,NA
"6b6e45647439f8f5b03e170687e4c265","celigo",NA,NA,NA,NA
"9d218bc3f52f0f1fa16efc348005ee0e","cell-cure-neurosciences","grant",NA,"2013-12-23",1740000
"9d218bc3f52f0f1fa16efc348005ee0e","cell-cure-neurosciences","grant",NA,"2013-05-16",1500000
"9d218bc3f52f0f1fa16efc348005ee0e","cell-cure-neurosciences","grant",NA,"2015-05-13",1600000
"1d55460bdca2772bff7f4c36141400f1","cell-genesys","venture",NA,"2009-04-08",310000
"b3773b43f8d6a266136776f16ae13b37","cell-guidance-systems","equity_crowdfunding",NA,"2013-10-30",390397
"a67bb8e8e931170644eded00a95469f6","cell-line-genetics",NA,NA,NA,NA
"d15094523abd4840b381debe5cf6040f","cell-medica","grant",NA,"2009-12-31",2200000
"d15094523abd4840b381debe5cf6040f","cell-medica","venture",NA,"2009-09-21",7290000
"d15094523abd4840b381debe5cf6040f","cell-medica","undisclosed",NA,"2012-07-23",26389458
"d15094523abd4840b381debe5cf6040f","cell-medica","venture",NA,"2007-03-30",3740000
"d15094523abd4840b381debe5cf6040f","cell-medica","venture","1","2014-11-25",78382191
"32e6ee7815e52780d9a1f2631ddc62cb","cell-mining","venture","A","2015-12-15",5e+06
"847a51e5f178f66be2a5e0d5cc7d7270","cell-source","convertible_note",NA,"2015-07-28",145000
"d64bb348f15cdb267cb92d74763695d4","cell-therapeutics","post_ipo_equity",NA,"2011-01-13",2.5e+07
"d64bb348f15cdb267cb92d74763695d4","cell-therapeutics","post_ipo_equity",NA,"2010-05-24",2.1e+07
"d64bb348f15cdb267cb92d74763695d4","cell-therapeutics","venture",NA,"2009-08-19",3e+07
"d64bb348f15cdb267cb92d74763695d4","cell-therapeutics","debt_financing",NA,"2013-12-18",5e+06
"d64bb348f15cdb267cb92d74763695d4","cell-therapeutics","venture",NA,"2010-08-04",4060000
"ae465c34f85e7d23b83cb84283e091f9","cell-therapy-2","equity_crowdfunding",NA,"2014-12-09",1077901.2667
"141492644348f2be87668c426e68c888","cell2b",NA,NA,NA,NA
"74c954889b3e50cf17953103013b77c6","cella-energy","debt_financing",NA,"2013-03-28",1150000
"2785e335911f29600d08b01cb9ed40fb","celladon","post_ipo_equity",NA,"2015-11-18",39500000
"2785e335911f29600d08b01cb9ed40fb","celladon","venture",NA,"2012-02-15",4.3e+07
"2785e335911f29600d08b01cb9ed40fb","celladon","venture",NA,"2012-05-08",1e+07
"2785e335911f29600d08b01cb9ed40fb","celladon","debt_financing",NA,"2011-07-13",4e+05
"2785e335911f29600d08b01cb9ed40fb","celladon","debt_financing",NA,"2013-10-25",1097306
"2785e335911f29600d08b01cb9ed40fb","celladon","debt_financing",NA,"2011-12-22",5e+05
"2785e335911f29600d08b01cb9ed40fb","celladon","venture","1","2009-11-01",21800000
"2785e335911f29600d08b01cb9ed40fb","celladon","debt_financing",NA,"2010-10-11",2500000
"2785e335911f29600d08b01cb9ed40fb","celladon","debt_financing",NA,"2009-12-15",3500000
"2785e335911f29600d08b01cb9ed40fb","celladon","venture",NA,"2012-05-08",19466190
"0300694691d7caf4d3c534940539e5fe","cellanyx-diagnostics",NA,NA,NA,NA
"3e3f5da4d92b182adeb567e10f6bbb63","cellara","venture",NA,"2015-05-28",475000
"185e8533679ceecc913c47794807492b","cellartis","venture",NA,"2005-12-13",9540000
"c574a9da11487b9a1a0064be88b2664d","cellay","venture",NA,"2009-06-30",1e+06
"00e12273bfa7d0ac25e2c870ab22c474","cell-biosciences","venture","e","2009-12-21",9249999
"00e12273bfa7d0ac25e2c870ab22c474","cell-biosciences","venture","c","2009-04-10",1e+07
"00e12273bfa7d0ac25e2c870ab22c474","cell-biosciences","venture","d","2009-11-16",1.5e+07
"00e12273bfa7d0ac25e2c870ab22c474","cell-biosciences","venture","b","2006-01-01",2.7e+07
"00e12273bfa7d0ac25e2c870ab22c474","cell-biosciences","venture","f","2010-10-14",2e+07
"00e12273bfa7d0ac25e2c870ab22c474","cell-biosciences","venture",NA,"2009-12-07",4e+06
"488ae8cbf3234abaaed89cf8e5cb9480","cellca","venture",NA,"2006-05-24",11051860
"201c5c865cebb5d541d1b39bf60f8be9","cellcap-technologies","venture",NA,"2012-07-12",115819
"72a4ea6a9ce665c0dea6cb7bb6bd7696","cellcentric","venture",NA,"2013-06-25",6515581
"67b978a253aa5cc3ca2956352e65539c","cellceutix","venture",NA,"2012-05-10",1e+06
"688770ed6943b2b708cbef2efb04fa78","cellcrusher",NA,NA,NA,NA
"32becfa5aa0b800360e16b703874f921","celldex-therapeutics","venture",NA,"2014-10-24",2e+06
"b4228cfad3f361f26d1f537482755658","cellec-biotek",NA,NA,NA,NA
"0bbc98819e136a1bbd63227d0a052c3e","cellectar","venture",NA,"2008-01-08",1.3e+07
"0bbc98819e136a1bbd63227d0a052c3e","cellectar","post_ipo_equity",NA,"2015-10-02",3300000
"0bbc98819e136a1bbd63227d0a052c3e","cellectar","debt_financing",NA,"2010-02-09",2720985
"0bbc98819e136a1bbd63227d0a052c3e","cellectar","debt_financing",NA,"2014-08-19",617500
"0bbc98819e136a1bbd63227d0a052c3e","cellectar","post_ipo_equity",NA,"2011-12-06",NA
"3cfd5c48ed99fee0985e2965a69cc10d","cellectis","venture","A","2000-11-01",3230202
"3cfd5c48ed99fee0985e2965a69cc10d","cellectis","venture","B","2002-05-01",7223476
"3cfd5c48ed99fee0985e2965a69cc10d","cellectis","venture","C","2005-06-01",6913608
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","venture",NA,"2010-02-10",4537908
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","venture","1","2007-04-26",4400000
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","grant",NA,"2011-09-15",16700000
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","venture","1","2005-05-11",1.6e+07
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","debt_financing",NA,"2014-01-22",2190000
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","debt_financing",NA,"2011-08-31",8e+05
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","venture",NA,"2010-12-29",2022678
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","venture",NA,"2012-09-28",2094341
"34ed19fdda76c9f0969b1166c1444e1c","cellerant-therapeutics","grant",NA,"2014-09-11",47500000
"ea505e94bb0ffb0fb4106171374163b3","cellerix","venture","c","2010-01-28",37700000
"ea505e94bb0ffb0fb4106171374163b3","cellerix","venture","b","2009-11-11",40599900
"ea505e94bb0ffb0fb4106171374163b3","cellerix","venture","B","2007-09-01",37125841.1323
"d09b089b34e5474c2334d19ac895fe86","cellgate",NA,NA,NA,NA
"0fe602c8eaa6b8f6d63463ef5e1ad14c","cellix-limited","seed",NA,"2007-02-15",1047627.7779
"95a581d31040df03333bc6ea2ac0fa19","cellmax-2","venture","B","2006-11-15",2e+06
"dcb9cb29c4eaef3a5f516b680868e82b","cellomics-technology","seed",NA,"2012-04-12",150000
"2bad6c82c70fcb3e9683cc5249208f79","cellonx-inc",NA,NA,NA,NA
"1d5a3d29b225d682045163942572e587","cellply","seed",NA,"2014-03-20",2573200
"07a98e72c888978cbfe49f603eee7849","cell-point","venture",NA,"2011-04-27",8076155
"07a98e72c888978cbfe49f603eee7849","cell-point","venture",NA,"2012-05-24",5e+06
"07a98e72c888978cbfe49f603eee7849","cell-point","venture",NA,"2010-03-26",10590250
"3d9813b7b7fb81d3234d2b440ccd270a","cellscape","venture","b","2012-02-01",9300000
"3d9813b7b7fb81d3234d2b440ccd270a","cellscape","venture","a","2010-12-01",1600000
"3d9813b7b7fb81d3234d2b440ccd270a","cellscape","seed",NA,"2009-05-01",NA
"3d9813b7b7fb81d3234d2b440ccd270a","cellscape","venture",NA,"2012-07-01",1100000
"3d9813b7b7fb81d3234d2b440ccd270a","cellscape","venture","b","2013-05-10",NA
"3d9813b7b7fb81d3234d2b440ccd270a","cellscape","venture",NA,"2009-05-06",8e+05
"30a048f421ba6a338e43ba7493d9a360","cellseq-solutions",NA,NA,NA,NA
"9546fae259ea21a8bc6a3145ac622e76","cellspring",NA,NA,NA,NA
"c9737d15f7a9fed5ca98106951a0f706","ucb-celltech-cambridge-uk",NA,NA,NA,NA
"9aeed04bec13fc5944332d3d7ef4ca41","celltex-therapeutics","venture",NA,"2012-07-06",34063000
"c9f66d754feae96763f102ab04cef76d","celltran","undisclosed",NA,"2007-08-21",1983407
"c9f66d754feae96763f102ab04cef76d","celltran","venture",NA,"2005-08-09",4820000
"c9f66d754feae96763f102ab04cef76d","celltran","venture",NA,"2005-02-01",470000
"87cf2bfa9b1db4bc21a7ad0b4b115b00","celltrion-inc",NA,NA,NA,NA
"7653276b287c6ec3cb8f6420de037cce","cellular-bioengineering","venture",NA,"2014-01-01",2e+06
"be2d5897246a160cbcb3136a2d2bc4d1","cellular-biomedicine-group-cbmg","venture",NA,"2013-07-26",3005006
"be2d5897246a160cbcb3136a2d2bc4d1","cellular-biomedicine-group-cbmg","venture",NA,"2014-04-11",6907995
"2e142103b4121bf4e020acc63f1b83b2","cellular-dynamics-international","venture","b","2011-04-07",3e+07
"2e142103b4121bf4e020acc63f1b83b2","cellular-dynamics-international","private_equity",NA,"2012-11-06",21041664
"2e142103b4121bf4e020acc63f1b83b2","cellular-dynamics-international","venture","b","2010-04-27",40600000
"2e142103b4121bf4e020acc63f1b83b2","cellular-dynamics-international","debt_financing",NA,"2013-07-03",2e+07
"1a2b06936195502fbfaa2dbf0aa2d1c9","cellumen","debt_financing",NA,"2009-05-29",621758
"1a2b06936195502fbfaa2dbf0aa2d1c9","cellumen","debt_financing",NA,"2009-10-06",694272
"1a2b06936195502fbfaa2dbf0aa2d1c9","cellumen","venture","1","2007-07-10",8700000
"d6e4b4fb26c5260f431c586ca014d0a4","cellus-medicina-regenerativa-s-a",NA,NA,NA,NA
"f80137710a7990326107d3e05cd1bb3c","cellutions-biosystems","venture","B","2007-06-27",7e+06
"d0afb3be0414a5e06a48aef593848c04","cellvir","venture",NA,"2008-06-16",387000
"1a72b562df2dbe128c1517269ae1aaec","celmatix","venture","A","2013-02-21",19500000
"fd02a0f2533bf7405cf2b56a8fc571a9","celnyx","venture",NA,"2009-08-06",3e+06
"dbdf58af8803516556e1a5ca3d25e766","celon-laboratories","venture",NA,"2010-10-08",15800000
"e83c45fd5f1fd39ea82489f86036dd9a","celonova","venture",NA,"2011-02-15",20841869
"e83c45fd5f1fd39ea82489f86036dd9a","celonova","undisclosed",NA,"2003-03-01",NA
"934b94ec08d8dd46e91a5e1870e18ee5","celox-sales",NA,NA,NA,NA
"0ce4366b778a52905929171db8003304","celsense","debt_financing",NA,"2010-04-07",150000
"0ce4366b778a52905929171db8003304","celsense","venture",NA,"2009-06-03",761300
"0ce4366b778a52905929171db8003304","celsense","venture",NA,"2007-05-24",150000
"0ce4366b778a52905929171db8003304","celsense","venture","1","2007-07-16",720400
"0ce4366b778a52905929171db8003304","celsense","venture",NA,"2010-05-05",684000
"0ce4366b778a52905929171db8003304","celsense","venture",NA,"2012-03-07",125000
"0ce4366b778a52905929171db8003304","celsense","venture",NA,"2014-09-09",267500
"62f7e852b64dbd148a9031fc93c56d6c","celsion","venture",NA,"2011-06-14",8580000
"62f7e852b64dbd148a9031fc93c56d6c","celsion","venture",NA,"2010-06-17",139744
"62f7e852b64dbd148a9031fc93c56d6c","celsion","post_ipo_debt",NA,"2015-06-05",5070000
"24161bc1b4a2e5f11c07df13dc5c9534","celtaxsys","debt_financing",NA,"2009-05-07",2040000
"24161bc1b4a2e5f11c07df13dc5c9534","celtaxsys","venture",NA,"2010-10-27",4231386
"24161bc1b4a2e5f11c07df13dc5c9534","celtaxsys","venture","1","2015-06-08",4e+07
"7c48c6d9c9f98cba184f9b6544a51711","celtic-renewables","venture","B","2014-06-25",2e+06
"99546478b7e1a48a65e3c187e1b481c3","celtic-therapeutics-holdings","private_equity",NA,"2009-10-27",1e+08
"19ae20a5b2fb32947f11390d66ecf2ec","celulas-genetica",NA,NA,NA,NA
"7916665f3a0e0c0be80bbc0ceeaa9aa5","qaim",NA,NA,NA,NA
"fa5038fbd97e5daa1c3de77c4ba661c2","cempra","debt_financing",NA,"2011-08-16",5e+06
"fa5038fbd97e5daa1c3de77c4ba661c2","cempra","private_equity",NA,"2012-10-30",25119996
"fa5038fbd97e5daa1c3de77c4ba661c2","cempra","venture","1","2009-06-02",4.6e+07
"fa5038fbd97e5daa1c3de77c4ba661c2","cempra","venture","1","2006-04-01",2.2e+07
"fa5038fbd97e5daa1c3de77c4ba661c2","cempra","venture","1","2007-07-01",1e+07
"f6571d5f46bc5eac2aa83bacb4f62c6d","cenerx-biopharma","venture","d","2012-02-03",4600000
"f6571d5f46bc5eac2aa83bacb4f62c6d","cenerx-biopharma","debt_financing",NA,"2010-12-09",6e+06
"f6571d5f46bc5eac2aa83bacb4f62c6d","cenerx-biopharma","venture","c","2010-08-13",1.3e+07
"f6571d5f46bc5eac2aa83bacb4f62c6d","cenerx-biopharma","debt_financing",NA,"2010-01-19",3500000
"f6571d5f46bc5eac2aa83bacb4f62c6d","cenerx-biopharma","debt_financing",NA,"2009-06-15",4000001
"f6571d5f46bc5eac2aa83bacb4f62c6d","cenerx-biopharma","debt_financing",NA,"2012-06-18",5153674
"d4f240ea1063a1263bcb25010fa9cb30","cenit-llc",NA,NA,NA,NA
"8fb41c97bd63911c2585c2adf2bd6fc9","center-for-molecular-immunology",NA,NA,NA,NA
"72fc74dea2e0c0495e3dd018e4b33ee4","centerd","venture",NA,"2009-12-29",1900000
"72fc74dea2e0c0495e3dd018e4b33ee4","centerd","angel",NA,"2007-02-01",1e+06
"72fc74dea2e0c0495e3dd018e4b33ee4","centerd","venture","1","2007-10-01",5500000
"72fc74dea2e0c0495e3dd018e4b33ee4","centerd","debt_financing",NA,"2007-05-01",5e+05
"72fc74dea2e0c0495e3dd018e4b33ee4","centerd","convertible_note",NA,"2011-05-03",1500000
"1a37eaafb49e68d4399047b8e09708d9","centerfield-media","venture",NA,"2015-11-05",NA
"8e41dba3cf6bca6be278c4c47bf3ab74","centerline-biomedical","seed",NA,"2015-08-26",1700000
"239f4066d6ae3736c2eac2394dc8dae5","centerrun",NA,NA,NA,NA
"cba19fd643a1037dd31f78617e81d5f3","centerspace-software",NA,NA,NA,NA
"c92c2bd4bb459b29bd7839155bdad714","centerstone-research-institute",NA,NA,NA,NA
"aa0f8e7505111030d424e976ede9820c","centice","venture","b","2007-11-19",11300000
"aa0f8e7505111030d424e976ede9820c","centice","venture",NA,"2011-01-07",1244352
"aa0f8e7505111030d424e976ede9820c","centice","venture","d","2013-03-15",8e+06
"aa0f8e7505111030d424e976ede9820c","centice","venture","c","2010-01-17",6100000
"aa0f8e7505111030d424e976ede9820c","centice","debt_financing",NA,"2012-08-17",2e+06
"aa0f8e7505111030d424e976ede9820c","centice","venture",NA,"2011-06-29",2383581
"aa0f8e7505111030d424e976ede9820c","centice","debt_financing",NA,"2011-03-14",1100000
"aa0f8e7505111030d424e976ede9820c","centice","debt_financing",NA,"2014-01-06",1500000
"aa0f8e7505111030d424e976ede9820c","centice","venture",NA,"2010-05-03",1847326
"aa0f8e7505111030d424e976ede9820c","centice","debt_financing",NA,"2009-03-31",4e+06
"afe9a2bf0bdcc7d531933553828d8256","centiv-services",NA,NA,NA,NA
"9f8b86ea25c9252f2ccf3441afdcc0fb","centocor",NA,NA,NA,NA
"292c79456c21d3815305426f1f29acb4","centogene-ag",NA,NA,NA,NA
"0661e67d5b3da675d68b95761bf08deb","central-new-york-biotech-accelerator",NA,NA,NA,NA
"b0fbd30add68545edd132f7bf1ea95c3","centre-for-sight","venture",NA,"2013-07-03",5e+06
"69bb65f7472f2ad12685279b39b45a23","centrexion",NA,NA,NA,NA
"57809630177415ffeb6eda0200bed63b","centric",NA,NA,NA,NA
"94e9478506b54df5d9e953e2fc9610e8","centrifuge-systems","venture","a","2008-01-31",4500000
"94e9478506b54df5d9e953e2fc9610e8","centrifuge-systems","venture","a","2011-04-18",2e+06
"67fcc79ffad749dd357d66176e11d3ea","centrillion-biosciences","venture","b","2013-04-01",9e+06
"67fcc79ffad749dd357d66176e11d3ea","centrillion-biosciences","venture","a","2010-04-01",7500000
"67fcc79ffad749dd357d66176e11d3ea","centrillion-biosciences","venture","A","2010-07-13",2e+06
"67fcc79ffad749dd357d66176e11d3ea","centrillion-biosciences","venture",NA,"2009-10-01",5800000
"0c7226c4f0d5fa98ffc780242a787250","centripetal-networks",NA,NA,NA,NA
"96226632546125e57fcf2ed6d7375659","centrose","venture",NA,"2014-01-01",1e+05
"96226632546125e57fcf2ed6d7375659","centrose","venture",NA,"2011-09-06",8e+05
"96226632546125e57fcf2ed6d7375659","centrose","debt_financing",NA,"2013-10-02",2e+06
"96226632546125e57fcf2ed6d7375659","centrose","convertible_note",NA,"2016-06-26",1450000
"dc00680104ab2c6b337aa455e51acf35","centruflow",NA,NA,NA,NA
"96105410ad1a13f07b011f4ae2f4c733","century-labs","venture",NA,"2010-05-11",750000
"240928c9dc49cc68941b6c329699c7f6","cephalon",NA,NA,NA,NA
"76807dcd13600f3d84d2a8d33436344a","cepheid",NA,NA,NA,NA
"8f6cced4ef940fee093b4253a572f8fd","ceptaris-therapeutics","debt_financing",NA,"2012-02-21",1.5e+07
"8f6cced4ef940fee093b4253a572f8fd","ceptaris-therapeutics","venture","1","2012-06-05",1e+07
"783ff3261ed1b728b32d78e0cc369d5f","ception-therapeutics","venture","c","2007-01-29",6.3e+07
"783ff3261ed1b728b32d78e0cc369d5f","ception-therapeutics","venture","c","2007-05-31",14700000
"a5eb10a78430152d1926c96c3c8b0ec4","cequent-pharmaceuticals","venture","a","2007-06-18",9e+06
"a5eb10a78430152d1926c96c3c8b0ec4","cequent-pharmaceuticals","venture","b","2009-10-01",3400000
"b83ecba3edb8d416a11eeee78b7b231d","cequr","venture","a","2010-01-05",29600000
"b83ecba3edb8d416a11eeee78b7b231d","cequr","venture","b","2013-09-09",2.7e+07
"b83ecba3edb8d416a11eeee78b7b231d","cequr","venture","C","2015-09-01",1e+08
"e2dbe53a3d15ced012c47104876e49b3","cerafor",NA,NA,NA,NA
"6ec6740949514d8314953a30de1976e4","ceram-hyd","venture","a","2009-12-18",NA
"c8012d9c7a29e6b7ff4356996a3367bf","cerecor","venture","a","2013-09-12",6805883
"c8012d9c7a29e6b7ff4356996a3367bf","cerecor","venture","a","2012-04-05",22137301
"c8012d9c7a29e6b7ff4356996a3367bf","cerecor","venture","B","2014-07-21",3.2e+07
"b54f2b8adba6c2e9246e795dfb206856","ceregene","venture","c","2007-06-22",2.8e+07
"b54f2b8adba6c2e9246e795dfb206856","ceregene","venture","d","2010-11-11",11500000
"48379e8545dac319b2f558286f44c659","cerenis-therapeutics","venture","B","2006-11-13",54061920.8034
"48379e8545dac319b2f558286f44c659","cerenis-therapeutics","grant",NA,"2010-07-26",13836170
"48379e8545dac319b2f558286f44c659","cerenis-therapeutics","venture","c","2010-07-26",51724000
"48379e8545dac319b2f558286f44c659","cerenis-therapeutics","venture","c","2010-10-21",14016000
"48379e8545dac319b2f558286f44c659","cerenis-therapeutics","venture","D","2015-03-31",4119251
"032bd5ce128bc65bb989e98877a05f05","ceres-nanosciences","grant",NA,"2015-06-29",746000
"b6f38f7cfdebe51c47203ef013117d16","cerescan","venture",NA,"2013-01-01",3e+06
"b6f38f7cfdebe51c47203ef013117d16","cerescan","venture",NA,"2013-11-19",607787
"b6f38f7cfdebe51c47203ef013117d16","cerescan","venture",NA,"2012-01-13",2832000
"bee883fec318e5bf78dbf2e55cb57a32","cerevast-therapeutics","venture",NA,"2013-04-22",1479154
"bee883fec318e5bf78dbf2e55cb57a32","cerevast-therapeutics","venture",NA,"2010-01-13",2e+06
"bee883fec318e5bf78dbf2e55cb57a32","cerevast-therapeutics","debt_financing",NA,"2011-10-17",215000
"bee883fec318e5bf78dbf2e55cb57a32","cerevast-therapeutics","debt_financing",NA,"2014-03-26",1780000
"bee883fec318e5bf78dbf2e55cb57a32","cerevast-therapeutics","venture","1","2011-12-12",6564658
"bee883fec318e5bf78dbf2e55cb57a32","cerevast-therapeutics","venture","1","2015-03-06",11400000
"13c282e891dec528b7e0a5691c387c0b","cerimon-pharmaceuticals","venture","a","2010-06-24",1e+06
"13c282e891dec528b7e0a5691c387c0b","cerimon-pharmaceuticals","venture","a","2009-09-09",1500003
"13c282e891dec528b7e0a5691c387c0b","cerimon-pharmaceuticals","venture","a","2010-11-15",232957
"99ba97994c28163259cadc41481bf7ac","cernium","venture",NA,"2007-12-04",1e+07
"99ba97994c28163259cadc41481bf7ac","cernium","venture","1","2005-11-02",7500000
"c00606690ada0dcd43c53ebc205620e3","cernostics","debt_financing",NA,"2009-10-18",393600
"c00606690ada0dcd43c53ebc205620e3","cernostics","venture",NA,"2012-03-08",55000
"c00606690ada0dcd43c53ebc205620e3","cernostics","debt_financing",NA,"2012-08-09",1e+05
"c00606690ada0dcd43c53ebc205620e3","cernostics","venture","1","2013-12-03",1400000
"c00606690ada0dcd43c53ebc205620e3","cernostics","venture",NA,"2015-06-08",1962678
"c00606690ada0dcd43c53ebc205620e3","cernostics","venture",NA,"2010-06-02",2619360
"b20d4885c46899eb539a8358ca919fc5","cerrx","venture",NA,"2013-02-04",2125557
"56c0ae7d278222539db15293b87a2ac2","certicon",NA,NA,NA,NA
"db1a436604faf332c1c9fef1f5b2d2d2","certirx","venture",NA,"2014-04-28",625832
"db1a436604faf332c1c9fef1f5b2d2d2","certirx","venture",NA,"2015-06-04",165000
"b6cd02aed5953d5e723abd538e3c1d8c","cerus-endovascular","seed",NA,"2013-06-06",2272877
"d523354a259a065babb395cecd021835","cervello",NA,NA,NA,NA
"3ec954a2e6fea73316e17407631637c0","cervilenz","venture",NA,"2016-01-20",2500000
"3ec954a2e6fea73316e17407631637c0","cervilenz","venture","1","2012-02-02",8350000
"3ec954a2e6fea73316e17407631637c0","cervilenz","venture",NA,"2010-05-17",3125000
"3ec954a2e6fea73316e17407631637c0","cervilenz","venture",NA,"2011-10-18",3475002
"3ec954a2e6fea73316e17407631637c0","cervilenz","venture","1","2009-05-06",4e+06
"3ec954a2e6fea73316e17407631637c0","cervilenz","venture",NA,"2013-01-04",2e+06
"3ec954a2e6fea73316e17407631637c0","cervilenz","venture",NA,"2012-02-23",2e+06
"3ec954a2e6fea73316e17407631637c0","cervilenz","seed",NA,"2008-08-22",350000
"43ff7a606941196ac4e0509e7876699a","ceterix-orthopaedics","venture","B","2014-05-13",1.8e+07
"43ff7a606941196ac4e0509e7876699a","ceterix-orthopaedics","debt_financing",NA,"2015-05-07",3.5e+07
"294a7e2093d921f171b689ea4f617d77","cevec-pharmaceuticals","venture",NA,"2011-07-25",8628000
"294a7e2093d921f171b689ea4f617d77","cevec-pharmaceuticals","venture","1","2010-02-02",5400000
"78324bfaa5fd5723f0f41391e902d4f1","cfr-pharmaceuticals",NA,NA,NA,NA
"a692970700ba80f08ad233a230fdde85","chai","seed",NA,"2015-05-01",1e+06
"37d5e0fc21aa1cc7c17cd9f341bcafd6","chaikin-analytics","debt_financing",NA,"2013-04-30",845000
"37d5e0fc21aa1cc7c17cd9f341bcafd6","chaikin-analytics","venture",NA,"2013-12-05",1275000
"37d5e0fc21aa1cc7c17cd9f341bcafd6","chaikin-analytics","seed",NA,"2010-07-21",5e+05
"37d5e0fc21aa1cc7c17cd9f341bcafd6","chaikin-analytics","seed",NA,"2011-04-15",1e+06
"37d5e0fc21aa1cc7c17cd9f341bcafd6","chaikin-analytics","venture",NA,"2012-02-08",5e+05
"37d5e0fc21aa1cc7c17cd9f341bcafd6","chaikin-analytics","venture",NA,"2014-12-22",1e+06
"37d5e0fc21aa1cc7c17cd9f341bcafd6","chaikin-analytics","venture",NA,"2015-08-19",475000
"ca63abd40d42690fb3d7c141258b23eb","chainsync","undisclosed",NA,"2014-11-25",5e+05
"af6e9d9459888f890736699cef131582","chalet-tech","seed",NA,"2009-01-01",1500000
"8c09484308db1a5315deec01cd37b0ec","chalk-wire-learning-assessment",NA,NA,NA,NA
"2ae06fff9636dc6a01ea8df503c36fae","chalkrow-ventures","seed",NA,"2014-11-27",NA
"bc107ae0f85c8bd2a054d737cdf27107","chamelic","venture",NA,"2010-08-16",1561320
"06de0b0d9af2c8e4860f3b9d3ab77ba5","champions-oncology","venture",NA,"2010-01-05",2100000
"06de0b0d9af2c8e4860f3b9d3ab77ba5","champions-oncology","venture",NA,"2013-02-07",9300000
"06de0b0d9af2c8e4860f3b9d3ab77ba5","champions-oncology","venture",NA,"2011-04-14",9400000
"06de0b0d9af2c8e4860f3b9d3ab77ba5","champions-oncology","debt_financing",NA,"2014-12-12",2e+06
"06de0b0d9af2c8e4860f3b9d3ab77ba5","champions-oncology","post_ipo_equity",NA,"2015-03-12",1.4e+07
"e0a5842ed206fc0d117c0d73ac3cacc9","changeagain-me-2",NA,NA,NA,NA
"5c2bc44d7b6f405b9cd0e1f5a63b1777","changecorp","seed",NA,"2010-02-01",1e+06
"aae825e4a419455aad1c74337f9049e2","channel-dynamix",NA,NA,NA,NA
"5d79085482a04cf614cec6d6c3663ac2","channel-medsystems","venture","b","2013-05-02",9787000
"5d79085482a04cf614cec6d6c3663ac2","channel-medsystems","debt_financing",NA,"2014-10-15",6e+06
"5d79085482a04cf614cec6d6c3663ac2","channel-medsystems","venture","C","2015-08-31",2.2e+07
"2ed4edb3bd7c8cea68719d68c20b3141","channelmeter","seed",NA,"2013-06-01",NA
"2ed4edb3bd7c8cea68719d68c20b3141","channelmeter","seed",NA,"2014-01-01",1e+05
"2ed4edb3bd7c8cea68719d68c20b3141","channelmeter","seed",NA,"2014-07-31",NA
"2ed4edb3bd7c8cea68719d68c20b3141","channelmeter","seed",NA,"2014-05-31",NA
"8093764913260014a7b6a9f32a314811","channelsight","venture",NA,"2015-10-15",3763106.7297
"7cb64c627665bf69959487c0369767d2","chantest","venture",NA,"2007-08-07",NA
"0affd65dd988bbf0a3898827cac47b2f","chaperone-technologies","venture",NA,"2006-03-06",1e+05
"c06fb149a022e9c2ce652e1e872ea2e9","chargebackops-llc",NA,NA,NA,NA
"fded4b9b6d210a63ad67fe88009cfae3","chargepoint-technology","seed",NA,"2013-10-30",2462283
"8c6e1c8ea0f0ebae8b1243a9cee299eb","chargoon-co-",NA,NA,NA,NA
"4e37aca653ac707517ba7f5b98f57fc1","the-charity-engine","angel",NA,"2011-07-29",325998
"be54d8c2ac5de1b309df5dadc185c401","charles-river-laboratories-international","grant",NA,"2011-09-29",3.4e+07
"634d23bdc176dfb182c073e87448b4ce","charleston-laboratories","venture",NA,"2012-10-02",7415026
"910eb9e3b2893d4d63408eff1e892efb","charlie-app","seed",NA,"2012-12-05",NA
"910eb9e3b2893d4d63408eff1e892efb","charlie-app","seed",NA,"2014-10-23",1750000
"d7fa2e7342ac426ce8df70492035bc7f","charm-analytics",NA,NA,NA,NA
"72f93e098bf6ccbf781021f2b49fbdee","chartbeat","venture","A","2010-09-01",3e+06
"72f93e098bf6ccbf781021f2b49fbdee","chartbeat","venture",NA,"2012-01-06",1e+06
"72f93e098bf6ccbf781021f2b49fbdee","chartbeat","venture","b","2012-04-16",9500000
"72f93e098bf6ccbf781021f2b49fbdee","chartbeat","venture",NA,"2014-05-14",3100000
"72f93e098bf6ccbf781021f2b49fbdee","chartbeat","venture","C","2015-05-06",15500000
"72ca08491d7328c450d770ee87579e6f","chartcube","angel",NA,"2013-05-22",550000
"72ca08491d7328c450d770ee87579e6f","chartcube","venture","1","2014-01-30",NA
"72ca08491d7328c450d770ee87579e6f","chartcube","venture","1","2014-11-06",4e+06
"f01338a1e68754c0a2cae4ef6e8adb92","chart-io","venture","A","2011-10-31",3150000
"f01338a1e68754c0a2cae4ef6e8adb92","chart-io","seed",NA,"2010-06-01",1290000
"f01338a1e68754c0a2cae4ef6e8adb92","chart-io","venture",NA,"2014-01-24",2200000
"f01338a1e68754c0a2cae4ef6e8adb92","chart-io","seed",NA,"2011-02-01",130000
"cec2ea6bb5dd75625012607be458cd0d","chartitright","venture",NA,"2010-09-07",6e+05
"2a27fa3536f4f6fb78f5ca2eff77b77c","chartwise-medical-systems","venture",NA,"2009-08-31",1e+05
"2a27fa3536f4f6fb78f5ca2eff77b77c","chartwise-medical-systems","venture","1","2012-09-20",5e+06
"f6567d9bea56f15d02cdac5e69793e01","chase-pharmaceuticals","venture","a","2010-12-15",1200000
"f6567d9bea56f15d02cdac5e69793e01","chase-pharmaceuticals","venture","B","2014-05-12",2.1e+07
"f6567d9bea56f15d02cdac5e69793e01","chase-pharmaceuticals","venture",NA,"2015-08-20",3e+06
"0f594390c3c35d8f01a11e5486063fb6","chasebook",NA,NA,NA,NA
"65319da5667801312649c7d404f23c57","chatham-therapeutics","seed",NA,"2011-11-10",201000
"f8c1972fd495d9e9c5a9efc66ec870d8","chatmine-technologies",NA,NA,NA,NA
"ab72257d0660ba75eea79e63d48a07b0","chatterbox-analytics","grant",NA,"2012-07-01",172196
"ab72257d0660ba75eea79e63d48a07b0","chatterbox-analytics","grant",NA,"2012-09-01",79248
"611056bd67aa7122afe8a7e775864aaa","chatterbox-labs",NA,NA,NA,NA
"a8e58f4790d2efc4b0c57df7f3288dfd","chatterhound",NA,NA,NA,NA
"6904ae87d80061aa9ccc220ffb83e91c","chattermill","venture",NA,"2015-06-01",NA
"a9d3f4ae1194178e21b841aa52267bc9","chd-bioscience-inc",NA,NA,NA,NA
"42680dcdaf601f620688482205fee772","cheap-seq",NA,NA,NA,NA
"e965f74ac77f0f368c173940e0a80666","chec-pr","equity_crowdfunding",NA,"2015-07-01",NA
"95d731334378b7760f9c09e30cbf4492","checkd-in","seed",NA,"2011-09-13",1e+06
"95d731334378b7760f9c09e30cbf4492","checkd-in","seed",NA,"2012-11-01",3e+05
"95d731334378b7760f9c09e30cbf4492","checkd-in","seed",NA,"2013-09-01",3e+05
"95d731334378b7760f9c09e30cbf4492","checkd-in","seed",NA,"2014-02-25",170000
"eff7aa2dfa6882b0830fd3ebe79077c9","checkmate-pharmaceuticals","venture","A","2015-08-12",2e+07
"f6803b3c78f9883daa5bb8f7b9ea0171","checkpoint-systems",NA,NA,NA,NA
"0c25ce64d48c4b48a905afec144c52c4","cheetah-medical","venture","c","2014-02-24",28849535
"0c25ce64d48c4b48a905afec144c52c4","cheetah-medical","venture","b","2010-04-06",2e+07
"0c25ce64d48c4b48a905afec144c52c4","cheetah-medical","venture","C","2014-06-06",5e+06
"f9550697a4540d288d86c2afc4001212","chelsea-therapeutics-international","venture","A","2005-01-12",14500000
"f9550697a4540d288d86c2afc4001212","chelsea-therapeutics-international","post_ipo_equity",NA,"2013-11-18",7700000
"f9550697a4540d288d86c2afc4001212","chelsea-therapeutics-international","venture",NA,"2010-02-26",16820000
"f9550697a4540d288d86c2afc4001212","chelsea-therapeutics-international","post_ipo_debt",NA,"2015-07-14",4e+05
"a86c57ba62608ab804486fcb4866335e","chelys",NA,NA,NA,NA
"fa7284add6bf034e63e7f82bbc62da49","chemcel-biotech",NA,NA,NA,NA
"89a92083dd4ac600ad483b6d815f0f5a","chemclin","venture","A","2007-05-07",5e+06
"89a92083dd4ac600ad483b6d815f0f5a","chemclin","venture","b","2008-10-01",16500000
"ed3fed7be13f50ed8691f948053d5608","chemel",NA,NA,NA,NA
"77ff65106c1cbed7ff07ae385c6272b9","chemgenex-pharmaceuticals",NA,NA,NA,NA
"78eb22e7c1ff325a82e6e8a0382ffcc8","chemnavigator",NA,NA,NA,NA
"f7a0d337f25f5be2a4aa61b95733dfde","chemo-iberica",NA,NA,NA,NA
"7cf27913e8f76a238e7cd066ad730f4d","chemo-wan-bang-biotech-pharma",NA,NA,NA,NA
"706f11fc7c8974b2cd4e8905c5811278","chemocentryx","venture","B","2004-06-17",3.3e+07
"706f11fc7c8974b2cd4e8905c5811278","chemocentryx","venture","c","2006-08-24",17700000
"706f11fc7c8974b2cd4e8905c5811278","chemocentryx","venture","d","2007-03-22",29840000
"107c36728182d70319392d1219deb36f","chemsw",NA,NA,NA,NA
"4aaa2f94ff38368c82ed3026b01067da","chengdu-rongsheng-pharmaceutical",NA,NA,NA,NA
"c5074f3eedf488f7ce1d15f986b2c7d9","chenguang-biotech-group-co-ltd","venture","A","2009-09-01",7174231
"8350c59e2218768f37d9e779a00d6309","chesapeake-perl","debt_financing",NA,"2010-01-26",265000
"b0fa8c2643db9aa2f6ae400f109a9778","cheshire-impact",NA,NA,NA,NA
"a05d07b47b0947a1346646b7c540e36a","chesson-laboratory-associates-in","venture",NA,"2012-10-10",1588742
"a05d07b47b0947a1346646b7c540e36a","chesson-laboratory-associates-in","debt_financing",NA,"2014-02-28",271923
"a05d07b47b0947a1346646b7c540e36a","chesson-laboratory-associates-in","debt_financing",NA,"2013-06-10",100008
"c09d677e44d227ad0c34f7038491407d","chi-rho-consulting",NA,NA,NA,NA
"2eb687dc3ab9f51d1db831c2e13eaa69","chi2gel","venture",NA,"2010-09-15",658000
"e4af1a6bf77f552c5e340c97e334765e","chiasma","venture","d","2012-07-23",38500000
"e4af1a6bf77f552c5e340c97e334765e","chiasma","debt_financing",NA,"2012-06-08",3e+06
"e4af1a6bf77f552c5e340c97e334765e","chiasma","venture","c","2006-11-15",4.4e+07
"e4af1a6bf77f552c5e340c97e334765e","chiasma","debt_financing",NA,"2009-11-16",2800000
"e4af1a6bf77f552c5e340c97e334765e","chiasma","venture","b","2005-09-12",7700000
"e4af1a6bf77f552c5e340c97e334765e","chiasma","debt_financing",NA,"2011-06-14",1e+07
"e4af1a6bf77f552c5e340c97e334765e","chiasma","venture","E","2015-02-27",7e+07
"0388eb33018216e77e3ee59737651bee","chibwe","seed",NA,"2014-03-10",33390
"55d7ee1264f6cc8b28fabd51157a586e","chicago-website-scraping",NA,NA,NA,NA
"26ed62ef38d37d0dcdc178c2f45eee8c","chicory","seed",NA,"2014-06-02",40000
"26ed62ef38d37d0dcdc178c2f45eee8c","chicory","seed",NA,"2015-01-31",1200000
"6670ae1c5e607f48698b0aea778497a1","chiesi-pharmaceuticals",NA,NA,NA,NA
"7ae64e51cf0ba2a7ec08566dfdad5d36","children-hospital-seattle",NA,NA,NA,NA
"f6f4b97c046cd243ef37cd2ac6b33dc2","childrens-healthcare-of-atlanta","venture",NA,"2014-08-06",552000
"f6f4b97c046cd243ef37cd2ac6b33dc2","childrens-healthcare-of-atlanta","venture",NA,"2015-07-08",249631
"ec9a51f8eeac92c912865cf9f216975f","childrens-mercy-hospital",NA,NA,NA,NA
"17738f611fbc5b268381bbb7ccf8d6a7","childrens-hospital-boston",NA,NA,NA,NA
"8901a51b50ffd364b860bdaeb262dbba","chimerix","venture","e","2009-08-10",16100000
"8901a51b50ffd364b860bdaeb262dbba","chimerix","venture","c","2004-11-04",1.1e+07
"8901a51b50ffd364b860bdaeb262dbba","chimerix","venture","d","2007-02-23",23100000
"8901a51b50ffd364b860bdaeb262dbba","chimerix","venture","f","2011-02-14",4.5e+07
"8901a51b50ffd364b860bdaeb262dbba","chimerix","post_ipo_equity",NA,"2014-11-07",1.22e+08
"3ee84651c32fccf8940e312d5f105425","chimeros","debt_financing",NA,"2010-12-03",750000
"3ee84651c32fccf8940e312d5f105425","chimeros","debt_financing",NA,"2010-06-30",433537
"3ee84651c32fccf8940e312d5f105425","chimeros","debt_financing",NA,"2011-08-10",760945
"3ee84651c32fccf8940e312d5f105425","chimeros","debt_financing",NA,"2010-04-08",444081
"3ee84651c32fccf8940e312d5f105425","chimeros","debt_financing",NA,"2011-04-13",6e+05
"3ee84651c32fccf8940e312d5f105425","chimeros","venture",NA,"2009-10-09",611246
"414665011ac7970e8e351d02673bda97","china-baicaotang-medicine",NA,NA,NA,NA
"5bbcd707f3dde45f1cacf0ead062427e","china-bio-med-regeneration-technology",NA,NA,NA,NA
"55cd973a3ec7f5cdfdb3c793a6a19a0f","china-foundation-center-cfc",NA,NA,NA,NA
"a522b08b41c6132a310eaa639a32298d","china-gene",NA,NA,NA,NA
"53c0ed1712ed511152ffb4e22536f2b8","china-pharmahub","venture",NA,"2010-02-23",492600
"0cad75b58a745d0dc3f6b16d51a2ad23","china-websites-ranking",NA,NA,NA,NA
"f3c70534b74502def6d7bd6169715fed","china-yongxin-pharmaceuticals","debt_financing",NA,"2010-02-06",9e+05
"f3c70534b74502def6d7bd6169715fed","china-yongxin-pharmaceuticals","venture",NA,"2009-10-09",467369
"f8839239782467df833b72bfd3a36473","emeifang-com",NA,NA,NA,NA
"4058dcd95562aa98c01b38824a7391cd","chipscreen","venture",NA,"2015-04-01",7700000
"29521c76a4c355d838f79f11774f7539","chiron-biopharmaceuticals",NA,NA,NA,NA
"f14214f74a6a68a3a068e3834cb340f8","chiron",NA,NA,NA,NA
"48f1b8e9e92e727f5ff87ba8a6c1ce67","chiron-diagnostics",NA,NA,NA,NA
"0b25ac85f67123b37c01a0a08ef40d88","sell-simply","seed",NA,"2012-04-24",1300000
"0b25ac85f67123b37c01a0a08ef40d88","sell-simply","venture","1","2013-07-31",4e+06
"0b25ac85f67123b37c01a0a08ef40d88","sell-simply","venture","1","2013-04-24",2e+06
"0b25ac85f67123b37c01a0a08ef40d88","sell-simply","venture","1","2015-02-24",870000
"58ecc89a6640ea5a1276c1322f5ccd2a","chitika",NA,NA,NA,NA
"9dc0e21eab96c7fe579de226f131f9fe","chlorogen","venture",NA,"2007-09-12",1.5e+07
"9dc0e21eab96c7fe579de226f131f9fe","chlorogen","venture","1","2005-08-12",6e+06
"97c58e01ad168f9eb9e5b77c3cd6cd29","choice-therapeutics","venture",NA,"2011-07-28",582000
"97c58e01ad168f9eb9e5b77c3cd6cd29","choice-therapeutics","venture",NA,"2009-07-02",1372250
"9a269acf62de73a040565342e0211789","choister",NA,NA,NA,NA
"0bb94bf44b546da5bdf8fc6abe69f3b3","chondrial-therapeutics","debt_financing",NA,"2014-03-28",1e+06
"6099f7da552e0e82584b5e01944071ab","choose-digital","private_equity",NA,"2012-03-23",4500000
"02e6caf26a3c0e33d92f0dfaf379e902","choose-growth",NA,NA,NA,NA
"2f361b3bac1b71223b3861596fca2a5f","choosic",NA,NA,NA,NA
"6165a25b219845b588e88710c9d6947d","chroma-therapeutics","venture",NA,"2009-06-23",24500000
"6165a25b219845b588e88710c9d6947d","chroma-therapeutics","venture","1","2006-04-03",5.3e+07
"ec945396217aa79255da6549f5d0c63b","chromadex","venture",NA,"2010-05-27",3674998
"ec945396217aa79255da6549f5d0c63b","chromadex","venture",NA,"2013-10-21",3e+06
"ec945396217aa79255da6549f5d0c63b","chromadex","venture",NA,"2012-02-22",3699998
"ec945396217aa79255da6549f5d0c63b","chromadex","post_ipo_debt",NA,"2014-09-30",5e+06
"ec945396217aa79255da6549f5d0c63b","chromadex","post_ipo_equity",NA,"2014-12-03",750000
"72f0a851f22cbf903f9277c955e344d9","chromance","seed",NA,"2014-01-06",NA
"d612b5cd941a40ae56e8d34d737663de","chromatin","venture","d","2011-10-25",1e+07
"d612b5cd941a40ae56e8d34d737663de","chromatin","venture","e","2014-01-09",3.6e+07
"d612b5cd941a40ae56e8d34d737663de","chromatin","venture",NA,"2006-04-01",1600000
"d612b5cd941a40ae56e8d34d737663de","chromatin","debt_financing",NA,"2014-07-09",12500000
"d612b5cd941a40ae56e8d34d737663de","chromatin","venture","F","2015-01-13",1.2e+07
"70947bbec30a220f5a7469c87fa10f9a","chromotek","venture","a","2010-07-14",510000
"fd637140a3d1aabd49aa5bd2d5a2cb1e","chronix-biomedical","venture",NA,"2012-10-31",1415000
"fd637140a3d1aabd49aa5bd2d5a2cb1e","chronix-biomedical","venture",NA,"2014-04-08",3429767
"fd637140a3d1aabd49aa5bd2d5a2cb1e","chronix-biomedical","venture",NA,"2009-11-03",1487140
"fd637140a3d1aabd49aa5bd2d5a2cb1e","chronix-biomedical","venture",NA,"2011-03-11",2781800
"fd637140a3d1aabd49aa5bd2d5a2cb1e","chronix-biomedical","venture",NA,"2008-08-05",2270000
"fd637140a3d1aabd49aa5bd2d5a2cb1e","chronix-biomedical","venture","1","2010-09-20",1800000
"2ea890aa115b272a03bfbba03b737660","chrono-therapeutics","debt_financing",NA,"2014-03-10",5e+05
"2ea890aa115b272a03bfbba03b737660","chrono-therapeutics","venture","1","2014-06-12",3.2e+07
"2ea890aa115b272a03bfbba03b737660","chrono-therapeutics","venture",NA,"2015-03-04",1e+05
"2ea890aa115b272a03bfbba03b737660","chrono-therapeutics","angel",NA,"2015-08-26",2300000
"a361a0d4d0411e58b9d31ddd2a319d0b","chronos-therapeutics","undisclosed",NA,"2013-12-09",12122011
"9d470742161a936e6b17da742218abb3","chronowake","seed",NA,"2009-03-27",10000
"fa626df3f009c35ee807d24741a2a441","chs-business-associates-llc",NA,NA,NA,NA
"9c2220937e47c228976b911fb0b42013","chundsell-medicals",NA,NA,NA,NA
"2d2e2110e5bf2c28632866fbf946b605","chunlab-inc",NA,NA,NA,NA
"76ea4c39cf77745e248d9678a104868d","churnbee",NA,NA,NA,NA
"e14aaa62bc5f377392a97591b8c0ec77","churnspotter","seed",NA,"2015-02-01",1800000
"b1b0b6ae4b0bd931d030e983200e044a","chute","seed",NA,"2012-07-24",2700000
"b1b0b6ae4b0bd931d030e983200e044a","chute","seed",NA,"2012-06-07",20000
"b1b0b6ae4b0bd931d030e983200e044a","chute","angel",NA,"2011-08-01",NA
"b1b0b6ae4b0bd931d030e983200e044a","chute","venture","1","2013-05-07",7e+06
"b1b0b6ae4b0bd931d030e983200e044a","chute","venture",NA,"2014-12-03",2999997
"f5507d936b0c50081856a61d846cb5be","cians-analytics","angel",NA,"2009-09-01",2e+06
"cc80f9a536958e4759ab56b88028d7bb","ciapple","seed",NA,"2009-06-09",21000
"fe3be07f21c4582e0c98c84003e58c1b","ciba-corning",NA,NA,NA,NA
"22a85d23b85945a3e2eb92bfedf5abff","cidara-therapeutics","venture","A","2014-06-30",3.2e+07
"22a85d23b85945a3e2eb92bfedf5abff","cidara-therapeutics","venture","B","2015-02-11",4.2e+07
"22a85d23b85945a3e2eb92bfedf5abff","cidara-therapeutics","venture",NA,"2014-06-17",30332199
"0e63e6ee06f50a12d733fc0f1889b8f3","ciel-medical","venture",NA,"2014-02-25",732558
"0e63e6ee06f50a12d733fc0f1889b8f3","ciel-medical","venture","1","2015-05-26",324999
"35142dbcd0c1c20a18fabcb4e57931ce","ciesco",NA,NA,NA,NA
"cf5dafc1badcc572cce869ddd6a1bbd5","cignex-technologies",NA,NA,NA,NA
"aef33a9ee09043e522dfa4d8b7683d31","cinchapi",NA,NA,NA,NA
"f912fc9dbd148531e75b934b5563b50f","cinecore","seed",NA,"2013-05-01",NA
"f912fc9dbd148531e75b934b5563b50f","cinecore","equity_crowdfunding",NA,"2015-02-12",240000
"739c548ba9fb51db63fed1a3dde985d0","cinequant",NA,NA,NA,NA
"a776941cf7ca57dac1cd0f5b004c2244","cinetic-media",NA,NA,NA,NA
"37e56ee4b132e6cfa9a64d5a18835fed","cingulate-therapeutics","seed",NA,"2013-11-27",75000
"37e56ee4b132e6cfa9a64d5a18835fed","cingulate-therapeutics","equity_crowdfunding",NA,"2015-07-10",NA
"83c34aae8487cbf48963acda07d947c2","cintell","seed",NA,"2015-04-29",8e+05
"f76636365e10b40bd9e9df34f1b544bb","cintric","seed",NA,"2014-06-25",760000
"f76636365e10b40bd9e9df34f1b544bb","cintric","seed",NA,"2014-07-14",40000
"f76636365e10b40bd9e9df34f1b544bb","cintric","angel",NA,"2014-12-30",95000
"f76636365e10b40bd9e9df34f1b544bb","cintric","debt_financing",NA,"2015-07-15",622567
"f76636365e10b40bd9e9df34f1b544bb","cintric","seed",NA,"2015-08-26",5e+05
"dcb428269388d0ccfeec8d24f78554d2","ciowhitepapers",NA,NA,NA,NA
"6e94ce33204eb5260a9ba5446f3d608a","ciphergen-biosystems",NA,NA,NA,NA
"0b77440760a7873f519de2b9ec86f9d3","cipherhealth","venture","a","2009-10-01",NA
"0b77440760a7873f519de2b9ec86f9d3","cipherhealth","venture",NA,"2012-10-15",NA
"0b77440760a7873f519de2b9ec86f9d3","cipherhealth","venture","B","2013-11-26",NA
"744874114d2c5b2a79eb860095ae4c6b","cipio","angel",NA,"2014-01-04",975609
"744874114d2c5b2a79eb860095ae4c6b","cipio","seed",NA,"2013-07-01",427631
"1a31bc79db5544273263e805a38aa8e9","cipla",NA,NA,NA,NA
"22b9d82e7d020a95b3a93301aa560e17","cirba-inc","venture","a","2006-02-01",5e+06
"22b9d82e7d020a95b3a93301aa560e17","cirba-inc","venture","b","2008-01-28",1.2e+07
"22b9d82e7d020a95b3a93301aa560e17","cirba-inc","venture","c","2012-03-27",1.5e+07
"22b9d82e7d020a95b3a93301aa560e17","cirba-inc","convertible_note",NA,"2014-11-28",6225000
"edc76e285ee745386b9a1983326b1d3a","circassia","venture","B","2008-01-29",21829006.1187
"edc76e285ee745386b9a1983326b1d3a","circassia","venture","d","2011-04-19",9.8e+07
"edc76e285ee745386b9a1983326b1d3a","circassia","venture","c","2009-12-14",24801993
"8ff83cfb81a5f7b41323a72a848d9f1c","circe-biomedical",NA,NA,NA,NA
"2cc5fe1e4f3d173eafc1f2a474293682","circle-biologics","seed",NA,"2012-08-09",1e+05
"2cc5fe1e4f3d173eafc1f2a474293682","circle-biologics","debt_financing",NA,"2012-10-25",616666
"03ed7050d4b5dd2fc3a8be96c01c94ed","circle-pharma","seed",NA,"2014-09-22",NA
"bafc6119deedcb190109e9de7edb605c","circle-street","undisclosed",NA,"2010-07-12",NA
"16c87d40f8b325f11577a5a63ea56e0f","bimax","seed",NA,"2015-10-05",7500
"cbeab0e4f1d8d2854b1780f58197a967","circulator",NA,NA,NA,NA
"da58149aeb3b34dcd5bb93d6a8eeea6e","circulogene-diagnostics","venture",NA,"2015-07-01",1230000
"04417bd06689f107e2fb512c536ac6d9","circulomics-inc","grant",NA,"2015-09-27",1500000
"04417bd06689f107e2fb512c536ac6d9","circulomics-inc","convertible_note",NA,"2012-08-30",75000
"04417bd06689f107e2fb512c536ac6d9","circulomics-inc","grant",NA,"2012-09-17",4e+05
"04417bd06689f107e2fb512c536ac6d9","circulomics-inc","grant",NA,"2012-09-24",4e+05
"04417bd06689f107e2fb512c536ac6d9","circulomics-inc","grant",NA,"2014-04-14",175000
"04417bd06689f107e2fb512c536ac6d9","circulomics-inc","grant",NA,"2014-09-23",225000
"04417bd06689f107e2fb512c536ac6d9","circulomics-inc","grant",NA,"2015-05-13",1500000
"836f5e689fd4feb9f2df8ee9c01c2a32","trycircus",NA,NA,NA,NA
"bca410f6de16682e745d4e7ebae0d2b6","cirle",NA,NA,NA,NA
"5c5e44fa73a13e628048e9b1c98ca999","cirrascale","venture",NA,"2011-02-04",3390000
"5c5e44fa73a13e628048e9b1c98ca999","cirrascale","venture",NA,"2011-02-04",1e+06
"5c5e44fa73a13e628048e9b1c98ca999","cirrascale","debt_financing",NA,"2012-04-13",5376570
"5c5e44fa73a13e628048e9b1c98ca999","cirrascale","venture",NA,"2014-12-30",2005000
"355e80ae2d72227b3ac5045f4d321322","cirtemo","venture","A","2012-12-07",NA
"445415a8c0ecc045da4e1c41a0cc4388","cis",NA,NA,NA,NA
"567ba1812c1e51af1fd95f13be4aa190","cis-biotech","angel",NA,"2013-10-18",4e+06
"64a2a339b80f1fcff0fee1d9cb1e8b71","cisbio-com",NA,NA,NA,NA
"412078e13e9a3ae7b218319dd44ad4b5","cisco-accelerator-for-entrepreneurs",NA,NA,NA,NA
"92090ea967378b601d64d735ac8edc32","canon-research",NA,NA,NA,NA
"9903724d54d75078a30500bfce67b97f","citehealth","angel",NA,"2007-01-01",768000
"6805443b4dfdab0576490cd6fc3012aa","orange-health-solutions","venture","a","2014-04-15",22500000
"ca52adc727eba07efad43f6521de75e6","citrine-informatics","seed",NA,"2014-09-05",NA
"33dbee8f8b4aa9928fbf5dce1d6310ce","citus-data","venture","A","2015-10-20",9500000
"33dbee8f8b4aa9928fbf5dce1d6310ce","citus-data","seed",NA,"2012-06-27",1650000
"33dbee8f8b4aa9928fbf5dce1d6310ce","citus-data","seed",NA,"2013-06-01",2e+06
"6a73b37988afdb9c583c6f9fe0597f26","city-of-biotech",NA,NA,NA,NA
"c1739380ac2f63f7c4c8818a4465a42d","cityblis","seed",NA,"2013-10-29",NA
"c2ee6373f9cf2ee739197f94c2e34bc0","cityfalcon","seed",NA,"2015-03-23",299225
"c219d3a5525926cc34573b1d51b73440","citygro","seed",NA,"2012-05-03",NA
"188af085adbc29f9855ca17924ed799a","citylogix",NA,NA,NA,NA
"36363100ae085bf6c1065ea9e95fbc5e","citymart","seed",NA,"2013-11-06",1e+06
"ae5c071c1da26f44d73a724a05a3f912","cityraven","seed",NA,"2015-06-17",875000
"a0e37ac2b69da5bb6ec374fce9e12c8f","citysearch-com-database",NA,NA,NA,NA
"bc9f3acb9004f4c67b9cf5f94367981c","cityslick-net-database",NA,NA,NA,NA
"918a6f06182580fc7b0744b7bc563f12","citysquares-com-database",NA,NA,NA,NA
"691f2715aa17c195453a508f79eab73f","citystash-holdings","angel",NA,"2014-03-12",450000
"682e8b5ae26e87ede894c9d928f0dc34","civatech-oncology","debt_financing",NA,"2010-03-22",115000
"682e8b5ae26e87ede894c9d928f0dc34","civatech-oncology","venture",NA,"2013-04-23",700313
"682e8b5ae26e87ede894c9d928f0dc34","civatech-oncology","debt_financing",NA,"2009-06-05",1e+05
"682e8b5ae26e87ede894c9d928f0dc34","civatech-oncology","venture",NA,"2009-11-19",1500
"682e8b5ae26e87ede894c9d928f0dc34","civatech-oncology","venture",NA,"2013-06-03",4e+05
"682e8b5ae26e87ede894c9d928f0dc34","civatech-oncology","venture",NA,"2014-04-28",320000
"682e8b5ae26e87ede894c9d928f0dc34","civatech-oncology","venture",NA,"2014-07-29",1500000
"49710e49ffd6ceb8e732c99576b74178","civic-games",NA,NA,NA,NA
"6c640e74cebfcfc9dbdf66c6745a449e","civic-insight",NA,NA,NA,NA
"efd84129a839234061018bafec6f93e3","civicscience","venture",NA,"2012-07-11",2500000
"efd84129a839234061018bafec6f93e3","civicscience","venture",NA,"2013-10-08",1200000
"efd84129a839234061018bafec6f93e3","civicscience","seed",NA,"2011-03-24",1200000
"efd84129a839234061018bafec6f93e3","civicscience","seed",NA,"2008-10-20",NA
"efd84129a839234061018bafec6f93e3","civicscience","seed",NA,"2009-06-04",NA
"efd84129a839234061018bafec6f93e3","civicscience","venture",NA,"2015-03-24",873126
"a775ba74450b12bb094eb912c5024b7f","civis-analytics","undisclosed",NA,"2013-04-01",NA
"b97a74af69a415237d59f9d43850870a","civitas-therapeutics","venture","a","2011-01-10",2e+07
"b97a74af69a415237d59f9d43850870a","civitas-therapeutics","venture","a","2011-05-03",8e+06
"b97a74af69a415237d59f9d43850870a","civitas-therapeutics","grant",NA,"2013-06-18",1e+06
"b97a74af69a415237d59f9d43850870a","civitas-therapeutics","venture","b","2013-09-11",3.8e+07
"b97a74af69a415237d59f9d43850870a","civitas-therapeutics","venture","C","2014-08-25",5.5e+07
"f8ff645e6f4194508f978cb8915cdaa8","claimreturn","debt_financing",NA,"2013-07-25",3e+06
"f8ff645e6f4194508f978cb8915cdaa8","claimreturn","venture",NA,"2012-05-03",2e+06
"3ec9e8464d305eac43ff8ae065dc58e7","clara",NA,NA,NA,NA
"6eca69bde838d716b7b9f442b28ef72a","clarabridge","venture","B","2007-01-23",7200000
"6eca69bde838d716b7b9f442b28ef72a","clarabridge","venture","C","2008-08-12",1.2e+07
"6eca69bde838d716b7b9f442b28ef72a","clarabridge","private_equity",NA,"2013-09-10",8e+07
"6eca69bde838d716b7b9f442b28ef72a","clarabridge","venture",NA,"2010-04-28",4255816
"6eca69bde838d716b7b9f442b28ef72a","clarabridge","debt_financing",NA,"2014-04-23",6e+06
"6a8f03a2483e453796411dee695364e6","clarassance","venture",NA,"2012-09-18",250000
"6a8f03a2483e453796411dee695364e6","clarassance","venture",NA,"2011-11-10",315000
"6a8f03a2483e453796411dee695364e6","clarassance","venture",NA,"2014-06-17",7180523
"14831d432d6f8c673347bbf87a583cea","claremont-biosolutions","venture",NA,"2012-09-01",NA
"e16c0d21e886f8411e75d3831e7b194a","clariant-chemicals",NA,NA,NA,NA
"2739f0d72cad446053235019f73c985a","clarient","venture",NA,"2009-05-19",4e+07
"2739f0d72cad446053235019f73c985a","clarient","venture",NA,"2009-12-31",10912000
"2431cd9450a907c15db4b45d4558041a","clarifai","venture","A","2015-04-28",1e+07
"9b0090c5a3f783ad5d5a9f8156f37b7a","clarify-inc","debt_financing",NA,"2014-08-14",315000
"9b0090c5a3f783ad5d5a9f8156f37b7a","clarify-inc","seed",NA,"2014-10-29",1e+06
"a11a6393ed5c51a6a36d6f348019bd02","clarimedix","debt_financing",NA,"2011-05-17",275000
"c3a4f5b5e8edb17883624731e332b30c","clario-analytics",NA,NA,NA,NA
"7942fb705a836871b4b7663e67ac2a41","clarion-research-group","debt_financing",NA,"2011-11-21",215000
"7942fb705a836871b4b7663e67ac2a41","clarion-research-group","debt_financing",NA,"2010-08-12",490000
"7942fb705a836871b4b7663e67ac2a41","clarion-research-group","debt_financing",NA,"2015-03-02",120000
"20850551636a60a1669fcd6ed6e5d0a4","claritas-genomics","venture","a","2013-12-05",NA
"20850551636a60a1669fcd6ed6e5d0a4","claritas-genomics","venture","B","2015-01-26",1.5e+07
"1fb8de86e3011d57ce0ca51ac00bfdb9","claritics","venture","a","2011-05-12",1500000
"e510d34cc35ae3c026cf9039bab8c668","clarity-synergy-solutions",NA,NA,NA,NA
"bfa78a2d3384e99fa6ce7771c679aef8","clarity-ventures-inc",NA,NA,NA,NA
"691419bfd1c5e0c7065673e907d5daa4","clarityray","seed",NA,"2012-05-18",5e+05
"d75021ae95193651b1b82fa24f170df1","claro-scientific","venture",NA,"2010-04-01",125000
"8865413f891abda114d8f8e26762f960","claron-technology",NA,NA,NA,NA
"c6d481a1f9074563a73bbb9b7d673482","clarus-therapeutics","venture","C","2007-11-27",8e+06
"c6d481a1f9074563a73bbb9b7d673482","clarus-therapeutics","venture",NA,"2014-06-12",31500000
"b1cc475a102d9dddec9feb760bbf4663","clashe",NA,NA,NA,NA
"aac8d3ce79e5f9c2b593bdc00f9aacad","clavis-pharma",NA,NA,NA,NA
"530b7a9d7f86cef093551934340a5f99","clc-bio",NA,NA,NA,NA
"c5dec3691510b2eb8b0c67879edc98a3","clean-teq","post_ipo_equity",NA,"2014-09-18",1300000
"14b9023ebe7e9efaa0269a49ab796456","clear-advantage-collar","seed",NA,"2011-09-20",360000
"50a969dd243739007adbdcac7de025bd","clear-image-technology","seed",NA,"2012-08-20",5e+05
"8a4c50b36d721fcdd3f6618bf4b06600","clear-returns","seed",NA,"2013-05-04",NA
"8a4c50b36d721fcdd3f6618bf4b06600","clear-returns","seed",NA,"2014-06-06",134263
"808ea9bb2756743f5d47be9a7ea6f140","clear-sky-images",NA,NA,NA,NA
"cbcfc27dc8184fc06ae4d6480d999de8","clear-vascular","venture",NA,"2010-08-09",5423014
"cbcfc27dc8184fc06ae4d6480d999de8","clear-vascular","convertible_note",NA,"2009-09-02",1350000
"cbcfc27dc8184fc06ae4d6480d999de8","clear-vascular","debt_financing",NA,"2013-05-30",309408
"796182f4cb8222bed8032d99b7d4496b","clear-water-revival","equity_crowdfunding",NA,"2014-03-01",310063
"6356cd3c226c5767c76dff5cbb376d93","clear-data-analytics","seed",NA,"2013-05-15",1e+05
"99d25553861d77a799406005a933c1bb","clearbit","seed",NA,"2015-03-03",2e+06
"5ad9f71a72b667fc42d4f19ae1bdd5ed","clearbridge-biomedics","venture","b","2013-03-13",7200000
"8c5cf9bc5b2f31e929d2ebe37f1e6685","clearci",NA,NA,NA,NA
"f48be43eba3e3ecad3735843af909f83","clearcode",NA,NA,NA,NA
"ec33473b6bc03516f4ac15b818df958b","cleardata","venture","b","2013-12-05",7e+06
"ec33473b6bc03516f4ac15b818df958b","cleardata","venture","b","2013-08-06",7e+06
"8bbe8cf5fd455439b227199d81f23a13","cleargears",NA,NA,NA,NA
"e7cdc5a62a5c9ae1e14ea61c6616e283","cleargoals",NA,NA,NA,NA
"cff52915c3df488fbcc075ad0b997da5","cleargov",NA,NA,NA,NA
"030f663bfdefe4613b5fa3234838150b","clearpredictions",NA,NA,NA,NA
"8e8db23c8a6fbdbcabcf36a03a927392","clearside-biomedical","venture","C","2015-12-03",2e+07
"8e8db23c8a6fbdbcabcf36a03a927392","clearside-biomedical","venture",NA,"2013-02-12",7899987
"8e8db23c8a6fbdbcabcf36a03a927392","clearside-biomedical","venture",NA,"2012-01-05",4e+06
"8e8db23c8a6fbdbcabcf36a03a927392","clearside-biomedical","venture",NA,"2014-05-12",6e+06
"8e8db23c8a6fbdbcabcf36a03a927392","clearside-biomedical","venture","B","2014-09-02",1.6e+07
"a9e4e6cb2cb860e6a8a540c768af1e65","clearsky-accounting",NA,NA,NA,NA
"41dc5ca16f105be7830719445bd87bc2","clearstoneip",NA,NA,NA,NA
"7115462fac8a6838eb39dc22684485fd","clearstory-data","venture","b","2014-03-31",2.1e+07
"7115462fac8a6838eb39dc22684485fd","clearstory-data","undisclosed",NA,"2012-03-19",NA
"7115462fac8a6838eb39dc22684485fd","clearstory-data","venture","a","2012-12-05",9e+06
"39d806e2e333d1bf7bfe2bb85a249ae1","clearwater-analytics","undisclosed",NA,"2010-12-10",NA
"26e5c5e4eda3aea174bd30a520e2d7b8","clearwave","venture",NA,"2010-08-26",310000
"26e5c5e4eda3aea174bd30a520e2d7b8","clearwave","venture",NA,"2010-05-24",4985884
"ef3cdbe54f234b87f581f2013b9ef405","cleave-biosciences","venture","a","2011-10-11",4.4e+07
"ef3cdbe54f234b87f581f2013b9ef405","cleave-biosciences","venture","a","2013-04-09",1e+07
"f6ef2f6ecfe888e128bc9d4475a0a8b4","cledaso",NA,NA,NA,NA
"7728af035e6bad65eac0a35c4e32e6b7","clemenger-bbdo-and-proximity-melbourne",NA,NA,NA,NA
"0446cfef26170788ef4e7b27d138cf2e","clementia-pharmaceuticals","venture","a","2014-01-09",22500000
"0446cfef26170788ef4e7b27d138cf2e","clementia-pharmaceuticals","venture","A","2015-01-05",1e+07
"0446cfef26170788ef4e7b27d138cf2e","clementia-pharmaceuticals","venture",NA,"2015-06-23",6e+07
"07d4aed81e998c9e20d948a945f77e24","clerio-vision","venture","B","2016-01-04",3187492
"07d4aed81e998c9e20d948a945f77e24","clerio-vision","venture","A","2015-01-13",2e+06
"d07f7c48cae9f23c357f61d95a651967","cleveland-biolabs","venture",NA,"2010-03-05",5e+06
"d07f7c48cae9f23c357f61d95a651967","cleveland-biolabs","venture","1","2009-04-06",3726557
"d07f7c48cae9f23c357f61d95a651967","cleveland-biolabs","venture",NA,"2014-07-03",3500000
"d07f7c48cae9f23c357f61d95a651967","cleveland-biolabs","post_ipo_equity",NA,"2015-02-04",4200000
"d07f7c48cae9f23c357f61d95a651967","cleveland-biolabs","post_ipo_equity",NA,"2015-07-16",2.5e+07
"2c2f7099d472429f8471c8043e428117","cleveland-heartlab","venture","B","2012-10-31",14700000
"2c2f7099d472429f8471c8043e428117","cleveland-heartlab","venture","b","2011-08-22",18400000
"2c2f7099d472429f8471c8043e428117","cleveland-heartlab","venture",NA,"2014-07-09",2751203
"2758e9b2774e0406ffc96b8650259bc9","clever","seed",NA,"2012-10-22",3e+06
"2758e9b2774e0406ffc96b8650259bc9","clever","venture","1","2014-03-25",10300000
"2758e9b2774e0406ffc96b8650259bc9","clever","seed",NA,"2012-06-01",20000
"2758e9b2774e0406ffc96b8650259bc9","clever","venture","1","2014-12-16",3e+07
"6978a8f0eb7fe807fa826e7a81218767","clever-cloud-computing","equity_crowdfunding",NA,"2011-02-16",NA
"254c8915578abf5bd3beeee57fbba95d","cleveranalytics",NA,NA,NA,NA
"35d7fee3aac7b343da2089c4b3bbeac0","cleverlions",NA,NA,NA,NA
"01599deda9c73aa750e1a8da45a2f7c0","clevork",NA,NA,NA,NA
"9131370aaa719b98e68350632a517d99","clicdata","seed",NA,"2015-12-31",6e+05
"9131370aaa719b98e68350632a517d99","clicdata","venture",NA,"2014-06-11",1e+06
"1ae0cfa4079df86ebbe93f700e580c59","click-control-marketing",NA,NA,NA,NA
"fe0ed2fa06968b9bec39c7ef55f555f2","click-labs",NA,NA,NA,NA
"bc99eb3fe15baf98a8087499bcfd2cc9","click-security","venture","b","2013-02-25",17700000
"aa8ae8f1b0c26408bd5467c7b858774c","click-tactics-inc","venture",NA,"2007-09-17",36700000
"aa8ae8f1b0c26408bd5467c7b858774c","click-tactics-inc","venture","1","2004-03-05",3600000
"8969e7b0acc4d472bf879ae28d14c3d8","click-web-seo",NA,NA,NA,NA
"45e954884b6b25b858366b479b119399","click-ru",NA,NA,NA,NA
"d279e2f8698005e3d77c353ecd59d6e4","clickable","angel",NA,"2006-01-01",NA
"d279e2f8698005e3d77c353ecd59d6e4","clickable","venture","1","2011-10-17",1.2e+07
"d279e2f8698005e3d77c353ecd59d6e4","clickable","venture","1","2007-07-01",3e+06
"d279e2f8698005e3d77c353ecd59d6e4","clickable","venture","1","2007-11-20",3e+06
"d279e2f8698005e3d77c353ecd59d6e4","clickable","venture","1","2008-07-30",14500000
"d279e2f8698005e3d77c353ecd59d6e4","clickable","equity_crowdfunding",NA,"2014-12-31",NA
"157a4600d8b5fe1f9b7b84e8280bddb8","clickcue-inc","equity_crowdfunding",NA,"2015-08-07",NA
"2ba56f71486164560c9d15f27f0a4dae","clickdimensions","angel",NA,"2011-11-01",550000
"b05edb59605ed638087ce56f178681c0","clicked-by-design-marketing-solutions",NA,NA,NA,NA
"4425d51c84b10690157eaefc97b01b46","click-fox","debt_financing",NA,"2009-08-28",40000
"4425d51c84b10690157eaefc97b01b46","click-fox","venture","1","2008-04-11",12500000
"4425d51c84b10690157eaefc97b01b46","click-fox","venture","1","2010-11-29",17892602
"4425d51c84b10690157eaefc97b01b46","click-fox","debt_financing",NA,"2009-11-03",450000
"4425d51c84b10690157eaefc97b01b46","click-fox","private_equity",NA,"2012-12-20",10000257
"d2cc555d516416677fd2e74563c1cd77","clickjolt",NA,NA,NA,NA
"a47f7250f51bbd1fc7731750940b8a1f","clickmeter",NA,NA,NA,NA
"8324123dcf93b411cdc99dbc1cd6116c","clickmotive",NA,NA,NA,NA
"9d71eda741e17dbb9aca574567a4e958","clickom",NA,NA,NA,NA
"2550924e757f8bf607156572a51cf0d7","clickon","seed",NA,"2014-01-01",413035
"5207910a224a824e5d9dd14d2739b247","whos-calling",NA,NA,NA,NA
"8ea5203e584e368ba00f709ff224bb47","clickpic",NA,NA,NA,NA
"887166a4bf1c6c594aa48903e61108db","clickst","seed",NA,"2008-01-01",5e+05
"0871b4a1a58585d084de70bef2912ab6","clickstream-technologies",NA,NA,NA,NA
"4fb1ac49eaf73f9ee5b150c0866c4ab9","clicktale","debt_financing",NA,"2013-04-30",3e+06
"4fb1ac49eaf73f9ee5b150c0866c4ab9","clicktale","venture","1","2013-05-01",1.7e+07
"4fb1ac49eaf73f9ee5b150c0866c4ab9","clicktale","venture","1","2007-12-01",3e+06
"4fb1ac49eaf73f9ee5b150c0866c4ab9","clicktale","debt_financing",NA,"2014-04-01",2e+06
"4fb1ac49eaf73f9ee5b150c0866c4ab9","clicktale","venture","1","2015-01-28",3.5e+07
"cbde0434bdc6eabfaff5554a4780f2a6","clicktools",NA,NA,NA,NA
"dcdf29f6f451cf1322a684579b1d9aab","clicktrue","venture","a","2012-07-10",NA
"94afcdc088bc7bedd111a4d223a8012c","get-clicky",NA,NA,NA,NA
"b0fbf97fca00672ce016b6462bca2113","clientmagnet",NA,NA,NA,NA
"fae4a93542d6fa5f180d7bb9928b5daa","clikthrough","venture","a","2009-07-16",1e+06
"fae4a93542d6fa5f180d7bb9928b5daa","clikthrough","angel",NA,"2007-01-01",1e+06
"660694e5673415450cb1fbf76c06bc45","climate-earth-inc",NA,NA,NA,NA
"aafa3987f4fd2ca1898335f3b93a3692","climber-hotel",NA,NA,NA,NA
"7699b57edc93f8ffdaac74542e5fe81f","climeworks","venture","B","2014-04-28",3416466
"ec753ed090f8e50674169e81ecf2e84b","clinic-vitamins",NA,NA,NA,NA
"19764d6cc0e258184d0e73d7cf9a56db","clinical-data","venture",NA,"2011-02-23",101000
"19764d6cc0e258184d0e73d7cf9a56db","clinical-data","venture",NA,"2010-09-20",158611
"0aec3cfe106e4b4d0c264a46451c4dfb","clinical-data-inc-",NA,NA,NA,NA
"946ce04db701193ad00f9261291c1f51","clinical-methods",NA,NA,NA,NA
"aecf58cee995b8341a3890d3b2979d41","clinical-network-services-cns-pty-ltd",NA,NA,NA,NA
"442bdb6b3dd44448cf271dde0e5da0ff","clinicast","seed",NA,"2012-10-01",1e+05
"6c9d406d898b5be4ddf1d16ec0cab3fe","clinipace-worldwide","venture","B","2008-01-14",2600000
"6c9d406d898b5be4ddf1d16ec0cab3fe","clinipace-worldwide","debt_financing",NA,"2011-05-10",4800000
"6c9d406d898b5be4ddf1d16ec0cab3fe","clinipace-worldwide","venture","c","2012-10-26",9e+06
"6c9d406d898b5be4ddf1d16ec0cab3fe","clinipace-worldwide","venture","c","2011-09-27",1.5e+07
"6c9d406d898b5be4ddf1d16ec0cab3fe","clinipace-worldwide","debt_financing",NA,"2014-02-07",3e+06
"6c9d406d898b5be4ddf1d16ec0cab3fe","clinipace-worldwide","debt_financing",NA,"2011-05-09",3354589
"6c9d406d898b5be4ddf1d16ec0cab3fe","clinipace-worldwide","debt_financing",NA,"2014-10-08",4e+06
"6c9d406d898b5be4ddf1d16ec0cab3fe","clinipace-worldwide","venture",NA,"2015-01-15",5e+07
"6a46e915257d19a712bbbd479e3c1cc6","clinnovo-research-labs-pvt-ltd",NA,NA,NA,NA
"d1686996a5d200d04960a45d2b7aa232","clinovo","venture","D","2014-03-03",150000
"380e07be71fd269957b2d881ea473173","clintec-international","undisclosed",NA,"2010-08-19",12514532
"d8b12b456d771fa759388b8d39226d55","clip-fort-ltd-","equity_crowdfunding",NA,"2014-09-18",1200000
"d1ab4f4fd92fafe94e5c4131437d0329","clipping-creations-india",NA,NA,NA,NA
"9bd7e6008975736587f3bf1f37ab7363","clippingimages",NA,NA,NA,NA
"10250126bc9575b516ad110e88b00843","clippod",NA,NA,NA,NA
"2802dea8c2fe29332213563081b9f132","10alike","seed",NA,"2013-01-01",NA
"2802dea8c2fe29332213563081b9f132","10alike","seed",NA,"2014-01-01",NA
"2bda8a961441f9bae2ddc717e8010459","clockwork-solutions",NA,NA,NA,NA
"4b2ce5e4324d51929f1906f6b1635bf7","clogeny-technologies",NA,NA,NA,NA
"a04397aaaff0d9c5a275699a2ff9651c","clogout",NA,NA,NA,NA
"43afa657467922259f14c2ea284c090e","clubvision","angel",NA,"2015-01-01",125000
"43afa657467922259f14c2ea284c090e","clubvision","angel",NA,"2014-06-01",55000
"43afa657467922259f14c2ea284c090e","clubvision","seed",NA,"2012-08-01",50000
"bfeb654de755d1d1abcc694496e60e54","clontech-laboratories-inc","undisclosed",NA,"2001-05-10",NA
"872d5c94f9af07d8a9184ed52b5296eb","cloquo",NA,NA,NA,NA
"2e6e0a04ae04ebaea295f6170eaf123f","gjob",NA,NA,NA,NA
"dc2f4705b6cf70c523ad9ae25f5eabf1","close-up-international",NA,NA,NA,NA
"d8e7418ea8da6ff70febdb90576017fa","closely","venture","a","2014-04-08",3e+06
"d8e7418ea8da6ff70febdb90576017fa","closely","debt_financing",NA,"2009-12-01",395000
"d8e7418ea8da6ff70febdb90576017fa","closely","private_equity",NA,"2011-08-30",3603845
"6649c64522d24010b3d9a327cfd1d54c","closingbell",NA,NA,NA,NA
"f741bf5760709ad12735910ef86c7718","closys","venture",NA,"2009-02-25",498060
"f741bf5760709ad12735910ef86c7718","closys","debt_financing",NA,"2012-06-28",263250
"f741bf5760709ad12735910ef86c7718","closys","venture",NA,"2010-09-14",1491489
"f741bf5760709ad12735910ef86c7718","closys","debt_financing",NA,"2014-08-14",50000
"0deb2ca9c47b5076597644ed46815441","clothes-network",NA,NA,NA,NA
"8465ce5893240247e2ec566de1c733c0","cloud",NA,NA,NA,NA
"99152e5925a39ceeb8b9d34e4d222566","cloud-creatures","angel",NA,"2014-12-01",3e+05
"d09970dabd3c1fec934a526d9dd49329","cloud-fulfilment",NA,NA,NA,NA
"1151dba5ab0c3cf0be284668a0bc1231","app-ninjas","seed",NA,"2014-06-12",50000
"59ff7156aa74da99f46ae6d738d357a7","cloudnsci",NA,NA,NA,NA
"4eaba401ba12ca871771b449b03b13e0","cloudamize","venture",NA,"2015-05-01",NA
"4eaba401ba12ca871771b449b03b13e0","cloudamize","seed",NA,"2013-09-11",1200000
"4eaba401ba12ca871771b449b03b13e0","cloudamize","seed",NA,"2012-12-05",NA
"5eb3a163c225be9631ccd290e91e623a","cloudbash",NA,NA,NA,NA
"6f7287ccf3078fea101045f4eb1cbb03","cloudcherry","seed",NA,"2015-07-01",1e+06
"50403222ba7cc9f934d6a12ae5765c64","cloudcutout","seed",NA,"2015-08-10",5e+05
"f267a617e1cefa6eb4409adb8ff09caf","cloudera","venture","a","2009-03-16",5e+06
"f267a617e1cefa6eb4409adb8ff09caf","cloudera","venture","F","2014-03-18",1.6e+08
"f267a617e1cefa6eb4409adb8ff09caf","cloudera","venture","F","2014-03-31",7.4e+08
"f267a617e1cefa6eb4409adb8ff09caf","cloudera","venture","b","2009-06-02",6e+06
"f267a617e1cefa6eb4409adb8ff09caf","cloudera","venture","d","2011-11-07",4e+07
"f267a617e1cefa6eb4409adb8ff09caf","cloudera","venture","c","2010-10-26",2.5e+07
"f267a617e1cefa6eb4409adb8ff09caf","cloudera","venture","E","2012-12-07",6.5e+07
"f267a617e1cefa6eb4409adb8ff09caf","cloudera","secondary_market",NA,"2014-09-01",NA
"bcc0a92adb01fbf3637894a2b4cdc781","cloudfinder","venture","a","2012-06-01",1232200
"0b3dc7ba307b052f85aadddd5b149958","cloudhouse-technologies-ltd",NA,NA,NA,NA
"41d60ebc243d2310cfb340ed6a46849a","cloudinary","secondary_market",NA,"2015-12-17",NA
"601f91071b8be6e8827a4206861fe902","cloudmade","venture","a","2008-03-17",3784800
"601f91071b8be6e8827a4206861fe902","cloudmade","seed",NA,"2007-01-01",131700
"601f91071b8be6e8827a4206861fe902","cloudmade","venture","B","2010-07-27",12311440.5681
"601f91071b8be6e8827a4206861fe902","cloudmade","convertible_note",NA,"2012-07-06",NA
"8a79ee4e0aaa73235a3ae9dc587ae334","cloudmarked-com","seed",NA,"2012-04-02",2e+05
"68d21ada1287fad4b4659aa653ccc7da","cloudmedx","seed",NA,"2015-05-01",6300000
"0ad1c238f8d459f29cb47ec1e3bd51f7","cloudmeter","venture","a","2012-04-27",5e+06
"0ad1c238f8d459f29cb47ec1e3bd51f7","cloudmeter","debt_financing",NA,"2009-04-01",3e+05
"d04bda1471cd22a6f10a0b1588b1379b","cloudmeter-2","seed",NA,"2014-06-01",40000
"53b0efd002753804bdb87155f51cb625","cloudmoyo",NA,NA,NA,NA
"21bd0df39a90bd6330ee3b1fdee7e4c4","cloudpelican",NA,NA,NA,NA
"0541cefb25dbee6be40635b0b8ac8c4f","cloudphysics","venture","a","2012-08-23",2500000
"0541cefb25dbee6be40635b0b8ac8c4f","cloudphysics","venture","b","2013-08-14",1e+07
"0541cefb25dbee6be40635b0b8ac8c4f","cloudphysics","venture","C","2014-06-23",1.5e+07
"0541cefb25dbee6be40635b0b8ac8c4f","cloudphysics","venture","A","2011-11-18",NA
"8e97ae712bae39d75e4ce796270ac8b8","cloudradigm-pte-ltd","seed",NA,"2013-05-18",5e+05
"8e97ae712bae39d75e4ce796270ac8b8","cloudradigm-pte-ltd","seed",NA,"2015-04-08",250000
"8e97ae712bae39d75e4ce796270ac8b8","cloudradigm-pte-ltd","seed",NA,"2014-08-08",250000
"9438395fe333b28a4d5853d1f5fd0730","cloudrows",NA,NA,NA,NA
"a3ff159d434795fc2fe55ccf3cae6f89","cloudscrape",NA,NA,NA,NA
"056cc1dbc12a354b24db47b360a5a2ea","cloudsnap","seed",NA,"2012-01-01",18000
"056cc1dbc12a354b24db47b360a5a2ea","cloudsnap","seed",NA,"2012-01-01",1e+05
"056cc1dbc12a354b24db47b360a5a2ea","cloudsnap","seed",NA,"2012-08-01",2e+05
"af5f04670e06dcfb95e1b844769a1c4a","cloudspotter-technologies",NA,NA,NA,NA
"380f1a5c34100ea996eeec1ab9fb8fe7","cloudstat",NA,NA,NA,NA
"27444582e2d8145f9d28884445beb05d","cloudthing",NA,NA,NA,NA
"3c8f1ae916f1bd5f280063756ed685de","cloudvelocity","venture","b","2013-07-16",1.3e+07
"3c8f1ae916f1bd5f280063756ed685de","cloudvelocity","venture","a","2012-12-13",5e+06
"3c8f1ae916f1bd5f280063756ed685de","cloudvelocity","venture","C","2015-02-12",1.5e+07
"6a3240aa4e9cfb5b820e37e668f144b9","cloudvertical","seed",NA,"2012-10-02",NA
"db5c80bf284c776e2e98886ee269f1d4","cloudwick",NA,NA,NA,NA
"5fc34e32a7a7cd0688176c03ebc89172","cloudwork","seed",NA,"2011-09-11",1200000
"3a121b0b27c225b9671b3061f2b561db","cloudy-days","debt_financing",NA,"2014-07-09",209050
"13805747e3398d79187748fea96328e0","clovis-oncology","convertible_note",NA,"2011-06-03",2e+07
"13805747e3398d79187748fea96328e0","clovis-oncology","private_equity",NA,"2009-05-26",1.45e+08
"13805747e3398d79187748fea96328e0","clovis-oncology","post_ipo_equity",NA,"2013-11-27",191962756
"e3f005c5ae496f6246d1743acfc463c1","clued-up",NA,NA,NA,NA
"e0252e792d3a1b35408b400e9da90c2a","clustur",NA,NA,NA,NA
"e316f08183bb8234845839892fb9f5ce","clutch","venture","B","2013-08-05",5300000
"e316f08183bb8234845839892fb9f5ce","clutch","venture","B","2015-05-26",5e+06
"fa57a89cf298911b50a13935be2bb63f","clyde-biosciences","venture","A","2015-04-13",2929258
"e4505fa703775ed132ed2934f31cfcd6","cmc-biologics",NA,NA,NA,NA
"acdc8b4a20fd8b1ef5f78d63429773b5","cmd-bioscience","venture",NA,"2012-12-03",775000
"acdc8b4a20fd8b1ef5f78d63429773b5","cmd-bioscience","venture",NA,"2011-02-07",150000
"6c3763013a9c2f268594c5c49ae1ae8f","cml-healthcare",NA,NA,NA,NA
"f7dc9208cd9142c8bdb65e0fee17b465","cmo-2",NA,NA,NA,NA
"2dc686b18dfe5f81aacb18ab7b9cd763","cmo-togo",NA,NA,NA,NA
"60aad0715f694af8b22ca6cfb1271e21","cmp-therapeutics","venture","A","2006-10-27",5700219.1418
"60aad0715f694af8b22ca6cfb1271e21","cmp-therapeutics","venture",NA,"2010-07-29",1960350
"18bfb7fe836591fdd70a449014c091d6","cms-bondedge-an-interactive-data-company",NA,NA,NA,NA
"e765c1f4a466f813ccd2cebc9f2390b7","cmxtwenty","venture",NA,"2010-07-16",1910000
"d4be4b9ebe4623162e77067a4e3c0068","cn-bio-innovations",NA,NA,NA,NA
"16ddec2a4e68460900b8844c084967d7","cn-creative","venture","a","2012-01-26",3137231
"0dc02e451411794642dfcd88fb4c8840","cn-creative-intellicig",NA,NA,NA,NA
"d628d48a4dc3027ea52d7e97ddec0b4d","cnc-broach-tools",NA,NA,NA,NA
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2014-01-30",415000
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2010-10-18",1611688
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2010-08-03",750000
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2010-03-18",1e+06
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2009-09-09",2043000
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2011-11-02",270000
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2012-09-07",3e+05
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2010-03-17",7e+05
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2013-03-12",595000
"ea40b0ca2793ee66af88b0646395f934","cns-response","venture",NA,"2012-12-14",135846
"c016f18db25f8c0e95f1a4968a254de8","cns-therapeutics","venture",NA,"2012-12-21",3050000
"c016f18db25f8c0e95f1a4968a254de8","cns-therapeutics","venture",NA,"2009-08-18",7e+06
"4723fb5b5e3d521bb16413288c2c2426","co-sender",NA,NA,NA,NA
"dc4ec22be5e6238e0c3f52c5bf8ad11f","co2-scorecard-group",NA,NA,NA,NA
"fee15195afcec43ce1cced418d2500da","co2b-in",NA,NA,NA,NA
"33a9e609294f6b5e7edcb2cab105c891","co2stats","seed",NA,"2008-01-01",NA
"0c7ecba7255eb4b9e23b16c22c247e8d","co3-ventures","venture",NA,"2010-07-15",520000
"e042b7a8c3f9d8b8e5fb563c5ea0e66e","coagulation-sciences","debt_financing",NA,"2015-03-13",790000
"fbbc42074fa8c74cfb2e6ecb0d4786f3","coapt-systems","debt_financing",NA,"2009-12-29",3720000
"fbbc42074fa8c74cfb2e6ecb0d4786f3","coapt-systems","venture","1","2007-03-29",22600000
"833ddbe1cbedc5cb0c8b9aa049d3c150","coare-biotechnology","grant",NA,"2013-08-27",220099
"5dde3a67c16d5bca2a2f7917af8995ba","coates-analytics",NA,NA,NA,NA
"ed428c334acfd2d3d4e182a7bf0ce542","coatom",NA,NA,NA,NA
"58764bf638b12d2fa30edd519380ce81","cobalt-technologies","venture","B","2006-11-27",3e+06
"58764bf638b12d2fa30edd519380ce81","cobalt-technologies","venture","d","2011-05-02",2e+07
"58764bf638b12d2fa30edd519380ce81","cobalt-technologies","venture",NA,"2012-10-01",4977000
"58764bf638b12d2fa30edd519380ce81","cobalt-technologies","venture",NA,"2012-04-01",2916000
"58764bf638b12d2fa30edd519380ce81","cobalt-technologies","venture","c","2008-10-20",2.5e+07
"303e58656812d9ec4a932737289bb9e3","cobra-biologics",NA,NA,NA,NA
"f3c65ee58f5365869492f80835eff73c","cocensys",NA,NA,NA,NA
"35a708bccfc3deab8bf5628721af42f6","cochlear",NA,NA,NA,NA
"a957c6dcde5f59eee18d53a298e07527","coco-therapeutics",NA,NA,NA,NA
"73e44c3aa7ca7eadb87d07df085b4de8","cocoon-biotech","debt_financing",NA,"2015-10-06",1809946
"59d22ccea092fa9bdfa3364c11e9c202","cocrystal-discovery","venture",NA,"2011-09-15",7500000
"59d22ccea092fa9bdfa3364c11e9c202","cocrystal-discovery","venture",NA,"2009-10-09",7677581
"6b33403988d6efbb7ef7d4cde0758072","coda-center-for-digital-archaeology",NA,NA,NA,NA
"4dc12e4b5b75ac19ff214a4cb1133929","coda-therapeutics","venture","b","2012-07-24",2e+07
"4dc12e4b5b75ac19ff214a4cb1133929","coda-therapeutics","venture","b","2011-04-18",19200000
"4dc12e4b5b75ac19ff214a4cb1133929","coda-therapeutics","venture","A","2006-10-10",2e+07
"4dc12e4b5b75ac19ff214a4cb1133929","coda-therapeutics","debt_financing",NA,"2011-10-06",6e+06
"4dc12e4b5b75ac19ff214a4cb1133929","coda-therapeutics","debt_financing",NA,"2014-06-10",2510890
"4dc12e4b5b75ac19ff214a4cb1133929","coda-therapeutics","debt_financing",NA,"2015-02-19",1002656
"6065ce59070fefad30c37deb579d913f","codagenix-inc","grant",NA,"2012-07-01",6e+05
"6065ce59070fefad30c37deb579d913f","codagenix-inc","grant",NA,"2014-06-28",1200000
"6065ce59070fefad30c37deb579d913f","codagenix-inc","venture","1","2015-06-12",2e+06
"c644ae145c278dd1aeb44a0391e4ad13","codalytics",NA,NA,NA,NA
"d0b7c3dce9b6309524616edf119d7bf2","codealike","seed",NA,"2011-11-01",50000
"d0b7c3dce9b6309524616edf119d7bf2","codealike","seed",NA,"2012-01-01",50037
"74a395d1e4e1042a2a56a3532f361276","codeglide","seed",NA,"2007-05-01",5e+05
"69e7bc935d5cd6af247d7bb1f70be354","codeq-llc",NA,NA,NA,NA
"49d9734e58b2063844dfbd8b880e4083","codewise","seed",NA,"2012-01-01",1e+06
"c0c4de2242d8d7152474a2b65bc06fa2","codex-oncology",NA,NA,NA,NA
"95b9d9ee07aa94dcaa951413dc460605","codexis","venture","d","2006-08-14",3.7e+07
"3dfde29e7e90700238035944d4f72b01","codiak-biosciences","venture","B","2016-01-26",6.1e+07
"3dfde29e7e90700238035944d4f72b01","codiak-biosciences","venture","A","2015-11-17",3.1e+07
"d9fe5c7bc6689d9f08b9c900a8e5c675","codiki",NA,NA,NA,NA
"8cfaff5c120f180340a42a83ceec2de4","codon-devices","venture","b","2006-12-18",2e+07
"8cfaff5c120f180340a42a83ceec2de4","codon-devices","venture","a","2005-05-30",1.3e+07
"827572d81511c39644ffb72296002a28","coeurative","venture",NA,"2013-05-20",120000
"b58586207498a5c727925ef25b0a4311","cofactor-genomics","angel",NA,"2008-01-01",2e+05
"b58586207498a5c727925ef25b0a4311","cofactor-genomics","seed",NA,"2015-07-31",120000
"675f66b00af3c52ccaa81c8b5d6baf81","cofco","debt_financing",NA,"2014-02-22",3.2e+09
"6b5fd4b3737f9d68ffc96f1827072f70","coferon","venture","b","2012-07-16",1.2e+07
"6b5fd4b3737f9d68ffc96f1827072f70","coferon","debt_financing",NA,"2011-01-06",7104000
"6b5fd4b3737f9d68ffc96f1827072f70","coferon","venture",NA,"2011-05-16",2999975
"6b5fd4b3737f9d68ffc96f1827072f70","coferon","debt_financing",NA,"2011-12-08",216658
"6b5fd4b3737f9d68ffc96f1827072f70","coferon","debt_financing",NA,"2014-05-13",1e+06
"6b5fd4b3737f9d68ffc96f1827072f70","coferon","debt_financing",NA,"2014-10-27",4e+06
"6b5fd4b3737f9d68ffc96f1827072f70","coferon","debt_financing",NA,"2015-08-11",1006067
"7d85420f56b81bbe1b83a6284207a4a8","cofinder",NA,NA,NA,NA
"ab18ed3923f2ee41aedbe9700103c591","cogcubed",NA,NA,NA,NA
"7d08b5c77fe6484ed43d3dba23dd5878","cogenesys",NA,NA,NA,NA
"7bc00016b45f878bedf465e4e8fd76bd","cogenics","venture",NA,"2005-04-21",4500000
"6fa08f3323103cee5e5a424001f40d9b","cogent-healthcare",NA,NA,NA,NA
"dad0aceb88494bd4c1f3a4e3754ed9cd","cogenta-systems","venture",NA,"2009-11-17",1340000
"1427fffdb89e1460d02983df2ca96ad6","cogentus-pharmaceuticals","venture","B","2007-04-03",1.5e+07
"1427fffdb89e1460d02983df2ca96ad6","cogentus-pharmaceuticals","venture","c","2007-12-21",62500000
"4dd0e6ca52fa170f73262c3a4aa546be","coginov",NA,NA,NA,NA
"c2add1909037aca78ba61fe90cf8ba95","cogitativo",NA,NA,NA,NA
"9ca46936d0dc21a1306bc28a59cb1555","cogito","venture","b","2005-02-24",11700000
"e0a8abd40ae119de567a82128a1593f2","cogneesol",NA,NA,NA,NA
"0a0895d5c493106bfb9d7d71b413983b","cognia","venture",NA,"2011-06-22",3224051
"0a0895d5c493106bfb9d7d71b413983b","cognia","undisclosed",NA,"2011-10-21",636035
"0a0895d5c493106bfb9d7d71b413983b","cognia","venture",NA,"2012-11-12",714557
"0a0895d5c493106bfb9d7d71b413983b","cognia","venture",NA,"2015-07-27",NA
"5be8042e546d251ae5267c3784289c5b","cognical-2","venture","A","2014-11-21",1e+07
"faf1296cffc0d2486c64ed1dea93fbdc","cogniciti",NA,NA,NA,NA
"08850f6a2976ec067ed7fd39162decf5","cognicor-technologies","venture",NA,"2013-05-01",781639
"08850f6a2976ec067ed7fd39162decf5","cognicor-technologies","grant",NA,"2012-10-01",96496
"08850f6a2976ec067ed7fd39162decf5","cognicor-technologies","seed",NA,"2014-05-10",NA
"08850f6a2976ec067ed7fd39162decf5","cognicor-technologies","venture",NA,"2011-09-01",152259
"5de0d80592e766b6528452f09e10f50a","cognigen",NA,NA,NA,NA
"7ed0a2ca24810ec18ce4bf546d6ab13b","cognisess","angel",NA,"2015-05-20",NA
"7ed0a2ca24810ec18ce4bf546d6ab13b","cognisess","venture",NA,"2013-07-22",NA
"2e37f47adb7844b04bb86d7889f72f43","cognitics","seed",NA,"2014-06-12",7500
"5800b5c26f6b9210f3775e22d504b4e1","cognition-health-partners","debt_financing",NA,"2012-09-18",1639000
"4e712b0cbc847c79317ec4cc9ef894fe","cognition-technologies","venture",NA,"2011-01-31",2e+05
"4e712b0cbc847c79317ec4cc9ef894fe","cognition-technologies","venture",NA,"2008-07-15",2700000
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","venture","a","2009-07-15",1210000
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","venture","a","2011-01-20",2500000
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","venture","B","2015-07-22",15834018
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","venture",NA,"2013-10-11",138000
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","seed",NA,"2007-11-27",2e+05
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","venture","b","2013-09-13",3e+06
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","venture",NA,"2011-12-06",1823845
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","venture","A","2011-12-01",NA
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","seed",NA,"2012-10-20",NA
"37537965d4621328718c2be2aa22143c","cognition-therapeutics","venture","B","2015-09-08",1.2e+07
"6759b378da3b40578c1d42e540bd782b","cognitive-digital-inc",NA,NA,NA,NA
"421cfdeeb98abe97f2ee44dc30698bc1","cognitive-electronics","venture",NA,"2012-11-14",3400000
"22e3611f68e02b5eb986b590113991a7","cognitive-networks","venture",NA,"2013-06-25",1500000
"22e3611f68e02b5eb986b590113991a7","cognitive-networks","debt_financing",NA,"2013-06-25",2e+06
"22e3611f68e02b5eb986b590113991a7","cognitive-networks","seed",NA,"2012-11-29",2500000
"22e3611f68e02b5eb986b590113991a7","cognitive-networks","venture","1","2014-12-02",14500000
"7533d7b690c5e235f79da290f8e8b783","cognitivescale",NA,NA,NA,NA
"56a1d01e1764420e1dbe75f713713707","cognitivevr",NA,NA,NA,NA
"8b081db00bd3fd292b69bb4d0bc36c65","cognoptix-inc","venture","c","2011-01-07",4600000
"8b081db00bd3fd292b69bb4d0bc36c65","cognoptix-inc","debt_financing",NA,"2014-04-24",390000
"8b081db00bd3fd292b69bb4d0bc36c65","cognoptix-inc","venture","D","2014-09-30",1.5e+07
"d21e7a21c65c433a8dfec84aa45701ea","cognowiz-solutions",NA,NA,NA,NA
"6aab1ad6aa6b969aa64eeb5623f59cee","cogstate-ltd",NA,NA,NA,NA
"48577bcf407b25090ecb432126073a7e","coh","venture",NA,"2011-12-21",4877510
"48577bcf407b25090ecb432126073a7e","coh","venture",NA,"2011-02-28",2321091
"75890334fba8670a05f8e713d9105ec4","cohbar","venture",NA,"2014-02-20",450000
"f1d62f5be5ae4fe16296ae190d4f8e47","coherent-path","seed",NA,"2013-07-10",795000
"f1d62f5be5ae4fe16296ae190d4f8e47","coherent-path","venture","1","2014-06-24",6250000
"5cd2f70ad3a95d44e13fd3c022f06f89","coherus-biosciences","debt_financing",NA,"2013-07-25",28000700
"5cd2f70ad3a95d44e13fd3c022f06f89","coherus-biosciences","private_equity",NA,"2013-01-14",46271280
"5cd2f70ad3a95d44e13fd3c022f06f89","coherus-biosciences","venture","1","2014-05-19",5.5e+07
"5cd2f70ad3a95d44e13fd3c022f06f89","coherus-biosciences","post_ipo_equity",NA,"2015-04-01",1.2e+08
"72cf3d49bcfdd359fa3800d3c95eaf96","cohesion-technologies-inc",NA,NA,NA,NA
"8450e1cf8e1dbd3fd809fc60b7fc1509","cohort-analysis",NA,NA,NA,NA
"88f4c9ce9f2faabf1e7fe7327c9a3402","cohorts-co",NA,NA,NA,NA
"13cc108484d01d30a96a15dd67fa2f9a","coinspot-io",NA,NA,NA,NA
"52b74fbb3a8c6f5df1130dbf1e51907a","cointhink",NA,NA,NA,NA
"bde2a286dd384d2627f415065ff2eb6e","cojoin","debt_financing",NA,"2013-02-25",50000
"bde2a286dd384d2627f415065ff2eb6e","cojoin","angel",NA,"2013-02-01",NA
"610e28f0f4a5e9f892df88d4aa58241b","cola-labs",NA,NA,NA,NA
"7dbed1e6b2f748fdd7e870d4701921d3","cold-crate","seed",NA,"2011-08-25",NA
"b92f476b160a22449eab50bd44b031b5","cold-genesys","venture","A","2014-07-29",13570000
"b92f476b160a22449eab50bd44b031b5","cold-genesys","venture","B","2015-08-05",1e+07
"b7023c80104aa64a831d9ad84c64ecee","coldlight-solutions","angel",NA,"2010-01-01",1e+06
"b7023c80104aa64a831d9ad84c64ecee","coldlight-solutions","venture",NA,"2013-11-08",1e+07
"b7023c80104aa64a831d9ad84c64ecee","coldlight-solutions","undisclosed",NA,"2014-04-08",NA
"df89d56eeb32c3263fb940ae65d93dd0","cole-parmer",NA,NA,NA,NA
"688a05d7e620a5c2a4f7bc05a8512e6e","colectica","grant",NA,"2006-09-30",1e+05
"688a05d7e620a5c2a4f7bc05a8512e6e","colectica","grant",NA,"2011-04-01",150000
"167d5c4ea0e559068b87fd4ea71277a4","coley-pharmaceutical-group","venture",NA,"2005-03-16",1e+07
"22ab59d7a8e6998f41f9d8468fa0ba85","colibr","seed",NA,"2013-03-07",40000
"a891d0360b7240786aa4cc9192c43c8e","collab-u",NA,NA,NA,NA
"8c41f0ca292d2e53917f6b173a24b5fd","collabmobile",NA,NA,NA,NA
"59566877604ef3c2e00abefa73a4c046","collaboratoryx",NA,NA,NA,NA
"aa72405838af4e619e1137635760f5fe","collect",NA,NA,NA,NA
"da5a60a606fabd2d735c69122815dafe","collectivehealth","venture","C","2015-10-20",8.1e+07
"da5a60a606fabd2d735c69122815dafe","collectivehealth","venture","B","2015-03-18",3.8e+07
"da5a60a606fabd2d735c69122815dafe","collectivehealth","venture","A","2014-01-31",6e+06
"eb0c3b400f89532d475759dd4c776d94","collective-intellect","venture","a","2006-02-01",2600000
"eb0c3b400f89532d475759dd4c776d94","collective-intellect","venture","b","2008-04-15",6600000
"eb0c3b400f89532d475759dd4c776d94","collective-intellect","venture",NA,"2009-07-09",3100000
"eb0c3b400f89532d475759dd4c776d94","collective-intellect","venture",NA,"2010-02-17",1687239
"eb0c3b400f89532d475759dd4c776d94","collective-intellect","convertible_note",NA,"2012-12-07",937385
"eb0c3b400f89532d475759dd4c776d94","collective-intellect","convertible_note",NA,"2010-06-09",4e+05
"1135bb09eef3854f1983a53a9a7777d3","collective-i",NA,NA,NA,NA
"75469474562a659d352ec60c72c09035","collegium-pharmaceutical","venture","C","2006-11-03",5500000
"75469474562a659d352ec60c72c09035","collegium-pharmaceutical","venture","D","2008-07-15",2e+07
"75469474562a659d352ec60c72c09035","collegium-pharmaceutical","venture",NA,"2012-02-15",22500000
"75469474562a659d352ec60c72c09035","collegium-pharmaceutical","debt_financing",NA,"2010-03-08",1e+06
"75469474562a659d352ec60c72c09035","collegium-pharmaceutical","venture",NA,"2013-10-02",4000002
"75469474562a659d352ec60c72c09035","collegium-pharmaceutical","venture",NA,"2015-03-10",5e+07
"eb938632f7e2822e080a487dbe721280","colligent",NA,NA,NA,NA
"977061b0edd1ec1222b3c68882fd72f4","colonaryconcepts","venture",NA,"2014-02-14",2100000
"977061b0edd1ec1222b3c68882fd72f4","colonaryconcepts","venture",NA,"2015-02-23",2249640
"503009250e3fc66088f58a47aa4f428c","colony-logic",NA,NA,NA,NA
"cf6d333999d36ff247093f071d130750","color-genomics","venture","A","2015-04-21",1.5e+07
"885d8a3422a5146a370bfc825c41d1f5","colorado-bioscience-association",NA,NA,NA,NA
"695b61dfe3dd5d50b56fed0138f086b6","colourtext",NA,NA,NA,NA
"52b2b38ebfe3cf198c4139d8e0a97ef4","colucid-pharmaceuticals","venture","B","2008-07-01",2.5e+07
"52b2b38ebfe3cf198c4139d8e0a97ef4","colucid-pharmaceuticals","venture","B","2011-08-30",7500000
"52b2b38ebfe3cf198c4139d8e0a97ef4","colucid-pharmaceuticals","venture",NA,"2010-01-26",9199981
"52b2b38ebfe3cf198c4139d8e0a97ef4","colucid-pharmaceuticals","debt_financing",NA,"2011-03-03",2e+06
"52b2b38ebfe3cf198c4139d8e0a97ef4","colucid-pharmaceuticals","venture","C","2015-01-13",37100000
"288f054d25318af96dcda9a44e670900","columbia-laboratories-inc",NA,NA,NA,NA
"4d01dc2c7c856b667508323d84dc3e72","columbus-it",NA,NA,NA,NA
"ca80ab6ebc412e8f5a611473210726ed","columbus-mckinnon",NA,NA,NA,NA
"fae96b82635777a6d84341fd7decf603","colwiz",NA,NA,NA,NA
"0e135a137092d95a54f081895b76335f","combichem-inc",NA,NA,NA,NA
"f1807e859dd728c1216ca8992cbee3a7","combimatrix","venture",NA,"2011-04-07",6700000
"f1807e859dd728c1216ca8992cbee3a7","combimatrix","venture",NA,"2013-05-15",1200000
"f1807e859dd728c1216ca8992cbee3a7","combimatrix","venture","1","2013-12-20",1.2e+07
"f1807e859dd728c1216ca8992cbee3a7","combimatrix","venture",NA,"2014-06-17",52124
"f1807e859dd728c1216ca8992cbee3a7","combimatrix","debt_financing",NA,"2015-02-24",1e+06
"f3316c914143fa54db04800f81c8e6ac","combinature-biopharm","venture","c","2006-05-08",5110000
"3389df835389f600e3a4356d62501cdc","combinent-biomedical-systems","venture","A","2007-05-08",3e+06
"3389df835389f600e3a4356d62501cdc","combinent-biomedical-systems","venture",NA,"2009-12-17",5e+05
"3389df835389f600e3a4356d62501cdc","combinent-biomedical-systems","debt_financing",NA,"2010-09-29",5e+05
"3389df835389f600e3a4356d62501cdc","combinent-biomedical-systems","venture",NA,"2010-12-29",1e+06
"3389df835389f600e3a4356d62501cdc","combinent-biomedical-systems","debt_financing",NA,"2012-01-04",750000
"3389df835389f600e3a4356d62501cdc","combinent-biomedical-systems","seed",NA,"2012-10-02",6e+05
"5f099d4777ab0794529493ef44af8bef","comecer","venture",NA,"2011-03-30",10567500
"1182986da548589c8b445587ecf33234","comenta-tv","seed",NA,"2013-09-01",350000
"1182986da548589c8b445587ecf33234","comenta-tv","seed",NA,"2011-11-25",40000
"1182986da548589c8b445587ecf33234","comenta-tv","seed",NA,"2011-09-01",1e+05
"1182986da548589c8b445587ecf33234","comenta-tv","seed",NA,"2013-05-01",48062
"ef3ec8158b6bd9f949a5256202c7279c","comentis","venture","B","2006-09-28",5e+07
"ef3ec8158b6bd9f949a5256202c7279c","comentis","venture","d","2008-06-05",2e+07
"ef3ec8158b6bd9f949a5256202c7279c","comentis","venture","c","2007-12-03",1.2e+07
"3307164ed50f9c1b10459c612ff71c6e","comet-biorefining","venture",NA,"2015-02-25",NA
"d82863a92cf873ace667a68bfd352387","comit-developers",NA,NA,NA,NA
"63192e2ace9aa604ddb6752e62822389","comjuice",NA,NA,NA,NA
"a4e04163ba640866a3ff524b48647abe","command-line-interactive",NA,NA,NA,NA
"89c8547ba715ae73a1385bbb882b089d","commerce-signals","venture","A","2015-10-26",4e+06
"f3dccffbf047d74a5829ed0f65b32e73","commercequest",NA,NA,NA,NA
"f46ae6e06c5c8ec9a500c08db8375665","commercialization-reactor",NA,NA,NA,NA
"eea0d2b3b91303344c308ace7e7cf442","commit-analytics",NA,NA,NA,NA
"5939ef44142e78d519aa08f23d6e23c1","common-need",NA,NA,NA,NA
"917a04df29b751315c355c328ac5bf58","commons",NA,NA,NA,NA
"3d4fa69144263ec3949e96cfa6f24e95","commonwealth-biotechnologies-inc",NA,NA,NA,NA
"8892ce65098274d393396da264fca01d","commonwealth-computer-research",NA,NA,NA,NA
"8bb91aaa21fd1fa728a0e3ccf10beeb9","communicorp",NA,NA,NA,NA
"8cc9acf017400dc4e7de74be6ab97fd2","communify-health","seed",NA,"2009-05-01",25000
"a7317a0cd88915d5ff2980eece841c70","community-attributes",NA,NA,NA,NA
"f2f9f5b1d08e3958e9b49b45313d4c11","community-informatics","convertible_note",NA,"2013-04-10",125000
"8df696aa241a80e717a94fd72759618f","community-pharmacy","undisclosed",NA,"2011-09-06",NA
"9d7c614d82fb49e21ab4c40e5d664cd0","community-sift","seed",NA,"2013-12-17",235849.0566
"9d7c614d82fb49e21ab4c40e5d664cd0","community-sift","seed",NA,"2015-10-10",577039.9645
"ee561b0a937c9ba8e13db2da66c12c8b","community-veterinary-partners","venture","b","2012-01-23",1131134
"ee561b0a937c9ba8e13db2da66c12c8b","community-veterinary-partners","venture",NA,"2009-12-03",5e+05
"6227922032fc2533e4a7de92ccd27ff1","comodule","seed",NA,"2015-06-29",553982
"6227922032fc2533e4a7de92ccd27ff1","comodule","seed",NA,"2012-08-14",12974
"6227922032fc2533e4a7de92ccd27ff1","comodule","seed",NA,"2014-11-30",NA
"fe6e5f89d6286dd9d5d9d4a31f0b88ac","comove",NA,NA,NA,NA
"8cffdc5b73c4c17b6e241d05fab92923","companion-pharma","seed",NA,"2012-01-01",NA
"8cffdc5b73c4c17b6e241d05fab92923","companion-pharma","grant",NA,"2012-05-01",50000
"8cffdc5b73c4c17b6e241d05fab92923","companion-pharma","grant",NA,"2012-08-01",60000
"5ff8540a51e434e3ca34d81b77095ae1","company-check",NA,NA,NA,NA
"cfcede8123794e34d34041520a39b49e","company-data-trees","venture","a","2011-09-22",NA
"f6af3c029780d6f95cda63c9b420a598","companythread",NA,NA,NA,NA
"563853773fd72989a9467b5bef010d10","compass-therapeutics","debt_financing",NA,"2015-05-29",575000
"563853773fd72989a9467b5bef010d10","compass-therapeutics","venture","1","2015-06-15",4500000
"5991fe25bab02782590f29fb638d42bf","compassto",NA,NA,NA,NA
"c3324b19ba270101f958fda378d7433e","compegps",NA,NA,NA,NA
"a9976a2ee947cf8dda89200c7959f5b2","compendia-bioscience","venture",NA,"2007-11-19",NA
"fee18db3f7bc7bca94dd8aa2d1641db1","compesis",NA,NA,NA,NA
"93c4fe02b3f6eb9bf14dbc49ff9fe2d7","compete","venture","c","2007-08-01",1e+07
"93c4fe02b3f6eb9bf14dbc49ff9fe2d7","compete","venture","a","2000-11-01",6e+06
"93c4fe02b3f6eb9bf14dbc49ff9fe2d7","compete","venture","b","2003-10-06",1.3e+07
"93c4fe02b3f6eb9bf14dbc49ff9fe2d7","compete","venture",NA,"2006-03-09",4e+06
"78ca0ca77e12d072dae653060d841ba6","executive-education-alliance",NA,NA,NA,NA
"1caabc00c9c4a0a3e45cd6731f24ad65","competitor-price-watch",NA,NA,NA,NA
"fef181ac2e1aa0418ac3387a89571a7f","complete-genomics","venture","a","2006-03-28",6e+06
"fef181ac2e1aa0418ac3387a89571a7f","complete-genomics","venture","e","2010-08-19",3.9e+07
"fef181ac2e1aa0418ac3387a89571a7f","complete-genomics","venture","d","2009-08-24",4.5e+07
"fef181ac2e1aa0418ac3387a89571a7f","complete-genomics","debt_financing",NA,"2009-07-02",14490061
"37a03751d9f1656da9a44c4ff87df406","complexa","venture",NA,"2012-06-01",2042458
"37a03751d9f1656da9a44c4ff87df406","complexa","seed",NA,"2013-10-11",2e+05
"37a03751d9f1656da9a44c4ff87df406","complexa","debt_financing",NA,"2013-10-10",3175000
"37a03751d9f1656da9a44c4ff87df406","complexa","venture","1","2014-06-05",14765747
"37a03751d9f1656da9a44c4ff87df406","complexa","seed",NA,"2012-05-23",NA
"37a03751d9f1656da9a44c4ff87df406","complexa","seed",NA,"2013-12-20",NA
"37a03751d9f1656da9a44c4ff87df406","complexa","debt_financing",NA,"2015-06-17",4e+06
"ec87d2b0e9e1a8fbf38a629eac764737","complix","venture","a","2011-02-02",2760600
"ec87d2b0e9e1a8fbf38a629eac764737","complix","venture","a","2010-06-10",6200000
"ec87d2b0e9e1a8fbf38a629eac764737","complix","venture","b","2013-06-26",15439200
"b03de90669c19959443dc7d80584dd0d","composite-apps",NA,NA,NA,NA
"5efdfe4b428f899566236f26a9fe7b75","composure",NA,NA,NA,NA
"7e6d28acd800502bd1fa6c748e29632f","comprehend-systems","seed",NA,"2011-11-08",1200000
"7e6d28acd800502bd1fa6c748e29632f","comprehend-systems","venture","1","2013-07-11",8400000
"7e6d28acd800502bd1fa6c748e29632f","comprehend-systems","venture","1","2014-08-18",2.1e+07
"19e5ee3900e7db11838041839fbcbf34","comprehensive-care","seed",NA,"2011-09-14",1800000
"c075ff20639fb997e04c65aa9f6a4b95","comprendia",NA,NA,NA,NA
"46a07fbf0ab7575a98aea1a32f06b5a7","compressus","venture",NA,"2009-06-11",8147860
"e1ed8e17979db684208efd5451f9b8bf","compucyte",NA,NA,NA,NA
"f0d675e946ef469def18606e81220e89","computomics-gmbh","seed",NA,"2015-10-27",NA
"31d071033aae336cebbe8c0a3c9829bd","coms-interactive","venture","b","2011-11-09",4900501
"31d071033aae336cebbe8c0a3c9829bd","coms-interactive","venture",NA,"2013-06-18",2.1e+07
"b2998883687158ce2fa0b81e4c07375e","comsys-technical-services",NA,NA,NA,NA
"1c56f5180e230a78ae4a97dd2c5b561c","conatix","seed",NA,"2013-03-07",65242.9211
"eb3d39ae7ea4f622024a302fbc08c3de","conatus-pharmaceuticals","venture",NA,"2006-12-26",6600000
"eb3d39ae7ea4f622024a302fbc08c3de","conatus-pharmaceuticals","venture","1","2007-05-09",2.2e+07
"eb3d39ae7ea4f622024a302fbc08c3de","conatus-pharmaceuticals","venture","1","2011-04-12",7500000
"eb3d39ae7ea4f622024a302fbc08c3de","conatus-pharmaceuticals","venture",NA,"2013-06-12",1001551
"eb3d39ae7ea4f622024a302fbc08c3de","conatus-pharmaceuticals","venture","1","2011-02-11",2e+07
"eb3d39ae7ea4f622024a302fbc08c3de","conatus-pharmaceuticals","debt_financing",NA,"2010-10-28",5e+06
"a64cb4a2d8d4ca136418bfd0c162c3da","concentrate",NA,NA,NA,NA
"e3794618ec308bb585088a3fb2d7a405","concentric-medical",NA,NA,NA,NA
"a55470edd42ce06d4e1302268fd32e95","concept",NA,NA,NA,NA
"e62d9f82fe00d01fc397ddc13102c8d1","concept-io","venture","a","2013-07-18",5400000
"e62d9f82fe00d01fc397ddc13102c8d1","concept-io","seed",NA,"2012-01-01",1800000
"ff55046deb6a03d8c385952e53825240","conceptdrop","debt_financing",NA,"2015-07-01",150000
"ff55046deb6a03d8c385952e53825240","conceptdrop","seed",NA,"2012-11-28",25000
"ff55046deb6a03d8c385952e53825240","conceptdrop","venture",NA,"2014-03-09",1e+05
"ff55046deb6a03d8c385952e53825240","conceptdrop","seed",NA,"2012-11-01",NA
"2d394c2bf445658c142ee87609377775","conceptshare",NA,NA,NA,NA
"4e21cc3d5bc22f871d80adc7def2f431","concert-pharmaceuticals","venture","c","2008-04-30",3.7e+07
"4e21cc3d5bc22f871d80adc7def2f431","concert-pharmaceuticals","venture","b","2006-11-30",48500000
"4e21cc3d5bc22f871d80adc7def2f431","concert-pharmaceuticals","venture","a","2006-07-17",1e+07
"4e21cc3d5bc22f871d80adc7def2f431","concert-pharmaceuticals","venture",NA,"2011-06-20",4e+06
"f357ff10b9d2fc29a028826ba744f44b","conchango",NA,NA,NA,NA
"24f2a25087803efa544a257f61d79b0c","concilio-labs","seed",NA,"2014-10-01",5e+05
"e231c24f84ab8169aa60586d5d1893bf","conclusive-marketing","venture",NA,"2006-11-17",8e+06
"e231c24f84ab8169aa60586d5d1893bf","conclusive-marketing","venture",NA,"2011-02-08",5e+05
"e231c24f84ab8169aa60586d5d1893bf","conclusive-marketing","venture",NA,"2012-03-29",1500000
"e231c24f84ab8169aa60586d5d1893bf","conclusive-marketing","venture",NA,"2013-11-01",5e+05
"e231c24f84ab8169aa60586d5d1893bf","conclusive-marketing","venture",NA,"2010-08-20",1500000
"6a310ef6da30552d78e962281881ec32","concord-data-systems",NA,NA,NA,NA
"87b38fec56043a9d98902f97ae73dfd4","concord-innovative",NA,NA,NA,NA
"fbba9ca966ca0995135f0d94fab57a7f","concordia",NA,NA,NA,NA
"ac63cdd0375989123b7dbbe5742b4cf2","concortis-biosystems",NA,NA,NA,NA
"8a7386b17d5f8394264f7b05e9a81a71","condos-ca",NA,NA,NA,NA
"ae72c6aa3b6e5bce44d112a4aeccb228","conductrics","seed",NA,"2012-01-01",NA
"ae72c6aa3b6e5bce44d112a4aeccb228","conductrics","seed",NA,"2012-11-01",210000
"b8c42dc29bea20526b2a03ed965f18bc","conelum","seed",NA,"2013-09-11",257320
"2aa5019ce822c4e5ed4f554b5e0cebd0","conex-med","venture",NA,"2010-11-16",2e+05
"abf4a11c25c3f3ed1b106473bf4e311d","conex-o-de-neg-cios",NA,NA,NA,NA
"2d834ba7b8aa894da5ff4f4d513a0342","conexus-sg",NA,NA,NA,NA
"9ce906094590a67d0432f977955e0a9f","confbook",NA,NA,NA,NA
"01b77f141f889d0ea5a89bc0a896f87f","conference-hound","venture",NA,"2013-01-07",2e+05
"01b77f141f889d0ea5a89bc0a896f87f","conference-hound","seed",NA,"2013-08-14",1e+06
"01b77f141f889d0ea5a89bc0a896f87f","conference-hound","seed",NA,"2011-03-15",145000
"01b77f141f889d0ea5a89bc0a896f87f","conference-hound","seed",NA,"2012-09-15",355000
"01b77f141f889d0ea5a89bc0a896f87f","conference-hound","seed",NA,"2013-09-12",2e+05
"24280cfe70adca6497e6533f74e10727","configo-io-3",NA,NA,NA,NA
"0bb37ea0f6c9caea38585b2c64003143","confirma","venture","C","2008-01-09",17500000
"ca3faa78592b05b5759e838cc6e5f569","conflictbase",NA,NA,NA,NA
"be767d6de8577815a66d3d9dcb08de8c","confluence-discovery-technologies","seed",NA,"2011-01-01",75000
"f9e65e87a7d04801f14f21074b260640","confluence-life-sciences","venture","a","2014-02-19",1e+06
"f9e65e87a7d04801f14f21074b260640","confluence-life-sciences","seed",NA,"2011-04-01",75000
"f9e65e87a7d04801f14f21074b260640","confluence-life-sciences","seed",NA,"2012-07-11",895000
"f9e65e87a7d04801f14f21074b260640","confluence-life-sciences","venture","a","2012-09-17",4e+06
"f9e65e87a7d04801f14f21074b260640","confluence-life-sciences","venture","a","2013-10-24",5e+05
"f9e65e87a7d04801f14f21074b260640","confluence-life-sciences","venture","B","2015-07-28",2400000
"f8bd45480d298e6475270c0d7ec73e38","confluex",NA,NA,NA,NA
"3af41be9d662e47dedc9346f845386af","conformis","grant",NA,"2011-07-12",1400000
"3af41be9d662e47dedc9346f845386af","conformis","venture","1","2009-08-10",5e+07
"3af41be9d662e47dedc9346f845386af","conformis","venture","1","2013-08-02",167700000
"082f044b45ea4cc3aae3f7e506e032dd","congenica","venture",NA,"2014-12-05",1567557
"082f044b45ea4cc3aae3f7e506e032dd","congenica","venture","1","2015-04-14",3232695
"b8bda80dcc9efa6f1ad5ddec846bc13e","conjecto",NA,NA,NA,NA
"f8c9e561c50b77ba2eb31e4375aab2e3","conjuchem-biotechnologies","venture","B","1999-08-01",8500000
"5dbbe0e7f83837f77a15a397337800dc","conjugon","convertible_note",NA,"2013-12-06",595000
"5dbbe0e7f83837f77a15a397337800dc","conjugon","venture",NA,"2006-12-13",3300000
"5dbbe0e7f83837f77a15a397337800dc","conjugon","venture",NA,"2010-05-10",1925000
"fb001da740abd3589e5295f4d1b23cbb","conjure","seed",NA,"2012-07-20",NA
"4fe00d706e1c63eafc0e68ec715d37e6","conker","convertible_note",NA,"2013-02-01",54386
"4fe00d706e1c63eafc0e68ec715d37e6","conker","venture",NA,"2013-08-01",26519
"4fe00d706e1c63eafc0e68ec715d37e6","conker","grant",NA,"2013-09-01",92521
"1e4ed0c055268509b5678cb577d43660","conkwest","venture",NA,"2014-04-17",6504875
"1e4ed0c055268509b5678cb577d43660","conkwest","venture",NA,"2014-12-29",1e+07
"1e4ed0c055268509b5678cb577d43660","conkwest","venture",NA,"2015-01-09",47495481
"1e4ed0c055268509b5678cb577d43660","conkwest","venture",NA,"2015-07-17",78004041
"b2eca9db2bcf1f433e4e8e399886e8c0","connance",NA,NA,NA,NA
"36919576da87ab46d758e6a13e337f24","connectalytics",NA,NA,NA,NA
"3978618f345f0eb246b79555462402a1","connectbiotech",NA,NA,NA,NA
"775ea93d377041822e76b90bc95dcb65","connected-data","venture","a","2013-01-31",6e+06
"775ea93d377041822e76b90bc95dcb65","connected-data","seed",NA,"2012-03-06",745000
"775ea93d377041822e76b90bc95dcb65","connected-data","venture","B","2014-06-02",NA
"d949dde7f105489389a51d362eef5e2f","connecterra-2",NA,NA,NA,NA
"f0079256e5a0bd2e8e6d7b7d08e78976","connectifier","venture","B","2015-10-27",6e+06
"f0079256e5a0bd2e8e6d7b7d08e78976","connectifier","seed",NA,"2012-08-20",1600000
"f0079256e5a0bd2e8e6d7b7d08e78976","connectifier","venture","A","2015-06-16",4099999
"0d28256bf17610753e155272215f789c","connectivity","venture","A","2014-04-24",6350000
"3164bfdd7921962c712fd88ab382e505","connectivity-data-systems","seed",NA,"2010-12-01",NA
"6e0bed2e6314174bec23de2de3272a39","connectors-marketplace",NA,NA,NA,NA
"e4d861152ccf0125648ea10918f55923","connequity-2",NA,NA,NA,NA
"f41b4d4e05352588eeac376747f55b11","connexun",NA,NA,NA,NA
"d2f80996bfe2f809df3e841574473607","connor-group-llc",NA,NA,NA,NA
"aee8039ce0ab7dbdd369c4601545b0d5","connotate","venture","a","2010-06-08",5250000
"aee8039ce0ab7dbdd369c4601545b0d5","connotate","venture","b","2012-04-12",7e+06
"46b0412ef00de1975fa483fd747fc5ae","cono-c","seed",NA,"2014-03-01",24509
"29287c65be302d45e18e48f5ebdae08e","consano","venture",NA,"2014-05-27",3900000
"d4fe2120c3d64f47dffbfc8cd14cd9fe","consensus-orthopedics","venture",NA,"2011-01-11",4e+06
"d4fe2120c3d64f47dffbfc8cd14cd9fe","consensus-orthopedics","venture",NA,"2014-09-30",8e+06
"7f19ca68c33ff788287bbbf8ec6cd63c","consort-medical",NA,NA,NA,NA
"ae440a9447aaeb23d0f1b430a95f9605","consourceum",NA,NA,NA,NA
"dc536c72b5b052fd34167eafa3fd42e9","conspire","seed",NA,"2013-01-14",118000
"dc536c72b5b052fd34167eafa3fd42e9","conspire","seed",NA,"2013-09-18",1017026
"dc536c72b5b052fd34167eafa3fd42e9","conspire","venture",NA,"2014-08-04",2400000
"58166514e3ef2b2bdd78d372718f296a","constant-insight","seed",NA,"2013-01-03",16666
"4d2e51c1ce231a008d0e59dcfc2446a6","constellation-pharmaceuticals","venture",NA,"2015-12-09",5.5e+07
"4d2e51c1ce231a008d0e59dcfc2446a6","constellation-pharmaceuticals","venture","1","2009-08-13",17200000
"4d2e51c1ce231a008d0e59dcfc2446a6","constellation-pharmaceuticals","venture","1","2010-06-07",22250000
"4d2e51c1ce231a008d0e59dcfc2446a6","constellation-pharmaceuticals","venture","1","2011-06-06",1.5e+07
"4d2e51c1ce231a008d0e59dcfc2446a6","constellation-pharmaceuticals","venture","1","2012-01-17",9.5e+07
"4d2e51c1ce231a008d0e59dcfc2446a6","constellation-pharmaceuticals","venture",NA,"2014-08-06",5e+06
"45dfc553837c3b481858e932e1dccc59","constitution-medical-investors","venture",NA,"2010-05-17",1.6e+07
"45dfc553837c3b481858e932e1dccc59","constitution-medical-investors","venture",NA,"2011-03-11",2e+07
"45dfc553837c3b481858e932e1dccc59","constitution-medical-investors","venture",NA,"2012-05-08",12350000
"7e82d7ad4cd208e07bad1c05e95988b1","contact-at-once","venture",NA,"2012-05-08",3e+06
"6c63fb457df4301ba197b0ff5e08ab4f","contactbabel",NA,NA,NA,NA
"9dbd3b3a1b95d18014f7ad98c68bcc9c","contemporary-analysis","seed",NA,"2008-01-01",15798
"7df079384ebfe7e4797cbc6ab9cfb54e","content-analytics","venture","A","2014-09-24",4e+06
"7df079384ebfe7e4797cbc6ab9cfb54e","content-analytics","seed",NA,"2014-01-01",1500000
"7df079384ebfe7e4797cbc6ab9cfb54e","content-analytics","seed",NA,"2013-12-16",NA
"2df0cb68d06ac4da6eda73fed3e8e885","content-fleet","venture","b","2011-09-29",3500000
"2df0cb68d06ac4da6eda73fed3e8e885","content-fleet","undisclosed",NA,"2010-11-18",NA
"b1304fdf0b2009abecf542ce7fdf5cf7","content-savvy","seed",NA,"2013-07-24",992250
"b1304fdf0b2009abecf542ce7fdf5cf7","content-savvy","undisclosed",NA,"2013-05-22",NA
"b1304fdf0b2009abecf542ce7fdf5cf7","content-savvy","undisclosed",NA,"2012-08-10",NA
"1c60a47ee3529d9d0d7ecf16612dec40","content360","seed",NA,"2014-05-01",34623
"1c60a47ee3529d9d0d7ecf16612dec40","content360","convertible_note",NA,"2014-08-01",100533
"1c60a47ee3529d9d0d7ecf16612dec40","content360","seed",NA,"2015-06-01",109565.8271
"74d7942d2d66679a4be6c0a6de3092eb","contentop",NA,NA,NA,NA
"75317684be2e8d5a17f8cedc203707b2","contentwise",NA,NA,NA,NA
"1afe594c3e8454b86ff4e4c42928deb6","context-matters","venture",NA,"2014-04-02",721487
"1afe594c3e8454b86ff4e4c42928deb6","context-matters","venture",NA,"2012-11-07",471422
"1afe594c3e8454b86ff4e4c42928deb6","context-matters","convertible_note",NA,"2011-09-19",345000
"5abb9e5b6ef72e8f89d30fe51dd7ee92","context-relevant","seed",NA,"2012-11-15",1500000
"5abb9e5b6ef72e8f89d30fe51dd7ee92","context-relevant","venture","1","2013-07-16",7e+06
"5abb9e5b6ef72e8f89d30fe51dd7ee92","context-relevant","seed",NA,"2012-06-28",1300000
"5abb9e5b6ef72e8f89d30fe51dd7ee92","context-relevant","venture","1","2014-05-20",2.1e+07
"5abb9e5b6ef72e8f89d30fe51dd7ee92","context-relevant","venture","1","2014-09-25",13500000
"73ac5ffc2ce0adc76d89d9ea266bb7c1","contextbroker","debt_financing",NA,"2012-10-20",267000
"73ac5ffc2ce0adc76d89d9ea266bb7c1","contextbroker","seed",NA,"2012-11-20",111907
"46bb803bfc46a83696c86ee6d4b961c5","contextors","seed",NA,"2015-05-01",4e+05
"46bb803bfc46a83696c86ee6d4b961c5","contextors","seed",NA,"2011-11-01",5e+05
"4333e0ee795984537e195583365e50c3","contextweb","venture","a","2004-06-01",3e+06
"4333e0ee795984537e195583365e50c3","contextweb","venture","b","2005-06-01",9e+06
"4333e0ee795984537e195583365e50c3","contextweb","venture",NA,"2011-09-21",1e+07
"4333e0ee795984537e195583365e50c3","contextweb","venture","d","2008-07-20",2.6e+07
"4333e0ee795984537e195583365e50c3","contextweb","venture","c","2006-09-25",15500000
"49858b8b2222b9031c9d30610297f291","contify",NA,NA,NA,NA
"4e269a2afa531e54773d0b2c9bc0a442","continuum-analytics","debt_financing",NA,"2015-12-15",1e+07
"4e269a2afa531e54773d0b2c9bc0a442","continuum-analytics","venture",NA,"2012-08-14",2500000
"4e269a2afa531e54773d0b2c9bc0a442","continuum-analytics","grant",NA,"2013-02-05",3e+06
"4e269a2afa531e54773d0b2c9bc0a442","continuum-analytics","grant",NA,"2014-12-02",3e+06
"4e269a2afa531e54773d0b2c9bc0a442","continuum-analytics","convertible_note",NA,"2014-01-31",1500000
"4e269a2afa531e54773d0b2c9bc0a442","continuum-analytics","venture","1","2015-07-22",2.4e+07
"c1278536464f54ffd2620ef9a156e3a0","continuum-healthcare","debt_financing",NA,"2015-11-17",13950000
"c1278536464f54ffd2620ef9a156e3a0","continuum-healthcare","debt_financing",NA,"2013-07-23",11500000
"62fc4521511e875ab087cfb1cd2d1e06","continuumrx","venture",NA,"2012-09-20",7e+06
"62fc4521511e875ab087cfb1cd2d1e06","continuumrx","venture",NA,"2015-07-21",13500000
"ea39baefa6681acf5e3ffa2b145eb50c","continuus-pharmaceuticals","debt_financing",NA,"2013-05-22",265000
"ea39baefa6681acf5e3ffa2b145eb50c","continuus-pharmaceuticals","venture","1","2014-06-18",2463659
"b6b1339e6f98557199d2c6cb8177f8e7","contix","seed",NA,"2013-03-31",1585000
"46616436d9ffe2b0bacdddc6c390b12a","contrafect","venture",NA,"2010-08-23",4326603
"46616436d9ffe2b0bacdddc6c390b12a","contrafect","venture",NA,"2011-09-15",12502905
"46616436d9ffe2b0bacdddc6c390b12a","contrafect","debt_financing",NA,"2013-09-04",11963650
"46616436d9ffe2b0bacdddc6c390b12a","contrafect","venture",NA,"2015-06-25",2e+07
"8ba69dce1ac711b4fb0c6a64e0d5c7ae","contravir-pharmaceuticals","venture",NA,"2014-02-14",3225000
"8ba69dce1ac711b4fb0c6a64e0d5c7ae","contravir-pharmaceuticals","post_ipo_equity",NA,"2014-08-22",4742648
"8ba69dce1ac711b4fb0c6a64e0d5c7ae","contravir-pharmaceuticals","venture","1","2014-10-15",9e+06
"273425e52ac206a0ec32383edccdca58","control","seed",NA,"2015-06-09",1500000
"ca01a53bb039d5abb5e78e902313b498","control-delivery-systems",NA,NA,NA,NA
"b9118d85d46c73449039ca51626b98b6","control-ad",NA,NA,NA,NA
"f0b884f828d3f361903987d50000a7d5","controlrad-systems","venture",NA,"2014-03-28",4533081
"f0b884f828d3f361903987d50000a7d5","controlrad-systems","venture",NA,"2012-09-14",5321001
"4621ed68ada26c7a81cfaf8d9b488fcf","contrust",NA,NA,NA,NA
"cd7967adb0e6313de6b4fe7ac2e33102","contygo",NA,NA,NA,NA
"a49b0cea929af60ac4328c56dba6e6e5","conventus-orthopaedics","venture","B","2015-11-13",23428233
"a49b0cea929af60ac4328c56dba6e6e5","conventus-orthopaedics","debt_financing",NA,"2013-03-04",5400000
"a49b0cea929af60ac4328c56dba6e6e5","conventus-orthopaedics","venture",NA,"2013-10-03",11500333
"a49b0cea929af60ac4328c56dba6e6e5","conventus-orthopaedics","debt_financing",NA,"2014-04-22",1e+07
"a49b0cea929af60ac4328c56dba6e6e5","conventus-orthopaedics","venture","A","2014-12-02",2.4e+07
"8023effbdadb50ec9689c48c55cf06d8","convergence-pharmaceuticals","venture","a","2010-10-05",35400000
"4c8bf86969b7c6b053bfac62bc798c9a","convergent-bioscience",NA,NA,NA,NA
"0921cbf36b69ac9eabba3760b08cbdf4","convergent-dental","venture",NA,"2016-01-22",20915171
"0921cbf36b69ac9eabba3760b08cbdf4","convergent-dental","venture",NA,"2011-09-16",2167613
"0921cbf36b69ac9eabba3760b08cbdf4","convergent-dental","venture",NA,"2014-04-16",8e+06
"0921cbf36b69ac9eabba3760b08cbdf4","convergent-dental","venture",NA,"2013-06-12",7395005
"0921cbf36b69ac9eabba3760b08cbdf4","convergent-dental","venture",NA,"2015-03-31",9e+06
"5455ee3972971f2c9ef4d1b107f304e8","convergent-radiotherapy","venture",NA,"2011-12-17",1200000
"f7056a48a891ece677dd3b2e2272325f","convergint-technologies",NA,NA,NA,NA
"6a4d7fbb762ed190ac99e525e7b198aa","convergys-it-company",NA,NA,NA,NA
"08ce33071fad2d3b94d6d705c5131899","conversant-bio","grant",NA,"2015-03-24",50000
"d0cd0eb22ebcbdce4d87943228eb9e2b","conversant-labs","seed",NA,"2015-08-01",550000
"d0cd0eb22ebcbdce4d87943228eb9e2b","conversant-labs","seed",NA,"2014-07-03",25000
"eddd774b8e4ad4d103f75eecceb0edb5","conversion-logic","angel",NA,"2014-08-14",1100000
"eddd774b8e4ad4d103f75eecceb0edb5","conversion-logic","seed",NA,"2015-04-08",4e+06
"f07842d1bc23911a4fc2f1e6017b8f85","conversionista",NA,NA,NA,NA
"b7946583aa91e89c25bbe910ad04483f","conversionx-labs",NA,NA,NA,NA
"384c2a3646ecb432a9b5992754c17d2e","convertable",NA,NA,NA,NA
"95426928bccf4a5f4a19f92400e90394","convince-convert",NA,NA,NA,NA
"8d62c5c97c9402ae06613fecbab7ec6a","convirza","angel",NA,"2012-05-05",2e+06
"8d62c5c97c9402ae06613fecbab7ec6a","convirza","venture","1","2014-05-05",2800000
"8d62c5c97c9402ae06613fecbab7ec6a","convirza","venture","1","2015-06-11",2e+07
"8d62c5c97c9402ae06613fecbab7ec6a","convirza","angel",NA,"2012-01-01",1250000
"8d62c5c97c9402ae06613fecbab7ec6a","convirza","angel",NA,"2010-01-01",3e+06
"74faf08f93bdfbe34089f2e175a2d7f9","conviva","venture","d","2012-02-06",1.5e+07
"74faf08f93bdfbe34089f2e175a2d7f9","conviva","venture","a","2007-04-10",9e+06
"74faf08f93bdfbe34089f2e175a2d7f9","conviva","venture","b","2008-08-25",2e+07
"74faf08f93bdfbe34089f2e175a2d7f9","conviva","venture","c","2010-09-15",1.5e+07
"74faf08f93bdfbe34089f2e175a2d7f9","conviva","debt_financing",NA,"2014-03-10",1e+07
"b23359d330d6dca55da841933ca6388c","convomax",NA,NA,NA,NA
"5fb479c95fd0f6a5d9b044bf8a16293f","convoy-therapeutics","venture",NA,"2012-05-15",2e+06
"e583dc51757407804d648ac9983a1157","convrrt","seed",NA,"2015-03-01",50000
"f6f1a77386ef99febea24db511427e44","coohl",NA,NA,NA,NA
"ceaae99ced4a6229b18f1ac240c48eec","cooknconnect",NA,NA,NA,NA
"600e9d52270b1afa5b1f17dc4ce2c159","cool-energy-island",NA,NA,NA,NA
"b524c73b259d3e2ddafe7f779498ecf3","cooladata","venture","A","2014-05-28",NA
"b524c73b259d3e2ddafe7f779498ecf3","cooladata","venture","A","2013-10-22",7400000
"fec1274e5f33f61e855e40134b8b8a88","coolan","seed",NA,"2015-02-26",NA
"fec1274e5f33f61e855e40134b8b8a88","coolan","seed",NA,"2014-02-13",NA
"fba81c37e99e6ab71269d874d6ef17f9","coolano",NA,NA,NA,NA
"9e6f89b29594a951b87c8679ef448906","coolmoss",NA,NA,NA,NA
"9fad2f1caa8f505698e221e4ceb63c98","coomuna","seed",NA,"2014-05-12",50000
"ac8e5845af5222aa068c0dd7e458d348","cooperatize",NA,NA,NA,NA
"c8d220dee9f2f6c492fa5ad0e8a23384","coopmetrics",NA,NA,NA,NA
"a1852be263a58036ff7523cf99f6a7f7","coosto",NA,NA,NA,NA
"47cb045756d0d24289a433d1b2f7c2f4","copal-partners",NA,NA,NA,NA
"d91d26741764a37f4d51f85933bfc555","copan-diagnostics",NA,NA,NA,NA
"a236f2e9c7d94e7b7cb7d24dc7eec8df","copan-systems","venture","c","2006-03-08",17500000
"a236f2e9c7d94e7b7cb7d24dc7eec8df","copan-systems","venture","a","2009-08-27",3026633
"a236f2e9c7d94e7b7cb7d24dc7eec8df","copan-systems","venture","d","2007-09-17",32400000
"a236f2e9c7d94e7b7cb7d24dc7eec8df","copan-systems","venture",NA,"2009-02-17",18500000
"fbc4a0a51b04d3bb00df4375a0874b92","copictures",NA,NA,NA,NA
"0d1623d24393c0820d39dcc444147453","coral-cea",NA,NA,NA,NA
"b5570824fb199ef99d84b841e35a8e94","coralogix","seed",NA,"2014-08-17",1e+06
"5f607e017491a1b8b35f0277240ec469","corate",NA,NA,NA,NA
"d6ad5a99df03375afcf95a28f583caaf","corax-cyber-security",NA,NA,NA,NA
"9a12b582de36cdf591128062c14d718e","corbett-life-science",NA,NA,NA,NA
"3c03792d68dbae1acb28222a040f8ef8","corcept-therapeutics","private_equity",NA,"2007-08-20",10100000
"3c03792d68dbae1acb28222a040f8ef8","corcept-therapeutics","venture",NA,"2009-10-30",18012959
"3c03792d68dbae1acb28222a040f8ef8","corcept-therapeutics","venture",NA,"2010-04-30",7651215
"3c03792d68dbae1acb28222a040f8ef8","corcept-therapeutics","venture",NA,"2012-04-10",525305
"887b79cd86c843750fe72501a6087d27","cordys-software","private_equity",NA,"2007-04-18",8e+07
"a7be5691ddf9578ad6551a78352723b1","core-analytics",NA,NA,NA,NA
"4468957e7121f6ebfb2be07e622146c0","core-consulting-services-inc",NA,NA,NA,NA
"9b5fcacdb5866f9cc2457164783f36a5","core-diagnostics","venture","A","2012-07-01",5e+06
"3ff39911e750292b5b4a19edbded42fa","core-dynamics","venture","b","2009-05-10",17900000
"f70039195b1b8f8e83a83c857d39c54e","core-essence-orthopaedics","venture","A","2008-07-07",5e+06
"f70039195b1b8f8e83a83c857d39c54e","core-essence-orthopaedics","debt_financing",NA,"2010-10-08",1500000
"f70039195b1b8f8e83a83c857d39c54e","core-essence-orthopaedics","venture","b","2011-03-25",11500000
"f70039195b1b8f8e83a83c857d39c54e","core-essence-orthopaedics","debt_financing",NA,"2012-02-13",432029
"17d25aac2aedaf2b40b348b4cd96f777","core2-group","venture","A","2014-09-02",4300000
"d649d306f4508ef02dc946520bc58076","corebridge",NA,NA,NA,NA
"3a8cf06924f9486f4d0a9ed20639c984","coremetrics","venture","d","2006-03-09",3.1e+07
"3a8cf06924f9486f4d0a9ed20639c984","coremetrics","venture","e","2008-04-04",6e+07
"f51430633a55d46cce683994d1a94976","corethree",NA,NA,NA,NA
"d7deb71c2cee9bdc6f2fd0b20509aece","corgenix","venture",NA,"2010-07-16",1250000
"699ccee48eeed838bbac1086dc1de5fa","corhythm","venture",NA,"2010-10-18",1556500
"699ccee48eeed838bbac1086dc1de5fa","corhythm","venture",NA,"2011-01-11",2256335
"a341a8a06276002c56ea258bcf093344","coridon","venture","A","2010-07-19",3e+06
"634df2c485ce5c5422c4452af25a5155","corimmun","seed",NA,"2007-01-22",879648
"634df2c485ce5c5422c4452af25a5155","corimmun","venture","1","2008-09-20",7187660
"39702a2b98d32593a483669f49faa4b6","corinthian-ophthalmic","venture",NA,"2012-01-27",307440
"39702a2b98d32593a483669f49faa4b6","corinthian-ophthalmic","venture",NA,"2012-01-27",3251500
"39702a2b98d32593a483669f49faa4b6","corinthian-ophthalmic","venture",NA,"2011-12-29",2274850
"39702a2b98d32593a483669f49faa4b6","corinthian-ophthalmic","venture",NA,"2012-06-29",4e+06
"39702a2b98d32593a483669f49faa4b6","corinthian-ophthalmic","debt_financing",NA,"2013-03-11",1638890
"39702a2b98d32593a483669f49faa4b6","corinthian-ophthalmic","debt_financing",NA,"2012-12-19",775000
"b19c2283e934ba54f5f11ef8cd8cf852","corise",NA,NA,NA,NA
"5586abc4f4d28cd8d3e406175a1724ba","cormatrix","venture",NA,"2014-01-17",250000
"5586abc4f4d28cd8d3e406175a1724ba","cormatrix","venture",NA,"2013-10-15",24610032
"5586abc4f4d28cd8d3e406175a1724ba","cormatrix","venture",NA,"2015-01-16",1e+06
"5a62abe93cef770cc8a8f88958a76359","cormedix","venture",NA,"2009-11-13",2619973
"5a62abe93cef770cc8a8f88958a76359","cormedix","debt_financing",NA,"2012-10-04",850000
"5a62abe93cef770cc8a8f88958a76359","cormedix","seed",NA,"2013-10-20",3e+06
"5e354ef43c02633642f0cdbda269da2b","cornerstone-pharmaceuticals","debt_financing",NA,"2014-03-07",3311000
"5e354ef43c02633642f0cdbda269da2b","cornerstone-pharmaceuticals","venture","1","2010-01-26",6100000
"5e354ef43c02633642f0cdbda269da2b","cornerstone-pharmaceuticals","venture",NA,"2008-12-15",6e+06
"5e354ef43c02633642f0cdbda269da2b","cornerstone-pharmaceuticals","debt_financing",NA,"2013-03-11",3768100
"1c3d025a6d53b7753c71716e0b2063eb","cornerstone-therapeutics","debt_financing",NA,"2012-07-02",3e+07
"65809b398e8662b9e2273f6e586ab4cf","cornova","venture","A","2005-04-06",3e+06
"65809b398e8662b9e2273f6e586ab4cf","cornova","venture",NA,"2011-01-07",385000
"65809b398e8662b9e2273f6e586ab4cf","cornova","venture",NA,"2009-12-11",5e+06
"65809b398e8662b9e2273f6e586ab4cf","cornova","venture","b","2010-01-17",2500000
"083829875b99f79714d97196608362c2","ic-infotech-inc",NA,NA,NA,NA
"fe36b1ffa23bfbefb4ca5aad3091f9d8","coronado-biosciences","venture",NA,"2011-01-19",14118534
"fe36b1ffa23bfbefb4ca5aad3091f9d8","coronado-biosciences","venture",NA,"2010-11-03",17700000
"fe36b1ffa23bfbefb4ca5aad3091f9d8","coronado-biosciences","venture","1","2010-07-16",3900000
"fe36b1ffa23bfbefb4ca5aad3091f9d8","coronado-biosciences","venture","1","2011-07-06",25800000
"fe36b1ffa23bfbefb4ca5aad3091f9d8","coronado-biosciences","convertible_note",NA,"2009-08-04",1240000
"5c037f6c8df84793e2fb5985db4b51f9","corpak-medsystems",NA,NA,NA,NA
"387a5616ddef99a619383f69421d00b6","correctional-healthcare-companies","venture",NA,"2011-01-04",4600000
"387a5616ddef99a619383f69421d00b6","correctional-healthcare-companies","venture",NA,"2010-06-22",6053722
"afa1bafa505ea6699082a57a9d7b4284","correctnet","debt_financing",NA,"2010-01-13",3e+06
"afa1bafa505ea6699082a57a9d7b4284","correctnet","venture","1","2008-06-03",370000
"55c4ef44e5300ffe89a71f1f17a45cdc","correlate-io",NA,NA,NA,NA
"7763094ea7072b19fc832c38ae13dc55","correlec","venture",NA,"2006-05-25",1920000
"6ac08d850bf56ad2ed04cb2c432bccb5","correlor-tech","seed",NA,"2012-01-01",NA
"6ac08d850bf56ad2ed04cb2c432bccb5","correlor-tech","venture","1","2014-06-12",NA
"a8a19039decfe42c4e5d940b45eacb9b","correvio",NA,NA,NA,NA
"c6753443351319a4bf9cf75189894ce4","corridor-pharmaceuticals","venture","a","2009-10-02",10750000
"c6753443351319a4bf9cf75189894ce4","corridor-pharmaceuticals","angel",NA,"2008-10-23",2300000
"c6753443351319a4bf9cf75189894ce4","corridor-pharmaceuticals","debt_financing",NA,"2013-01-31",1558429
"c6753443351319a4bf9cf75189894ce4","corridor-pharmaceuticals","venture","a","2010-06-24",13012475
"025ff26c666ac64d4d21399fe502a753","cortec","venture","a","2013-08-01",3859800
"025ff26c666ac64d4d21399fe502a753","cortec","seed",NA,"2011-10-10",3262320
"63cb418a0f81de0d7e4515493405d1f2","cortechs-labs","venture","b","2014-03-18",NA
"2234c80a420f69c410a91e189c0cb3e3","cortex-ag",NA,NA,NA,NA
"243673e3bd505b029e6bc4b7035f242a","cortex-mcp",NA,NA,NA,NA
"99c1af7d3f2c66eff7e55bdb78466c2d","cortex-pharmaceuticals","venture",NA,"2009-08-13",5886291
"99c1af7d3f2c66eff7e55bdb78466c2d","cortex-pharmaceuticals","convertible_note",NA,"2014-04-02",753220
"99c1af7d3f2c66eff7e55bdb78466c2d","cortex-pharmaceuticals","venture",NA,"2010-01-21",1500000
"99c1af7d3f2c66eff7e55bdb78466c2d","cortex-pharmaceuticals","convertible_note",NA,"2014-11-17",238500
"d26b31432cdf0d9f62f390b14d5f50ef","corthera","venture","c","2007-12-20",2.3e+07
"ad037ea36081429d1e67173b8046915c","cept-systems","venture","C","2015-10-29",1800000
"ad037ea36081429d1e67173b8046915c","cept-systems","seed",NA,"2013-11-22",1929900
"ad037ea36081429d1e67173b8046915c","cept-systems","venture","A","2014-11-06",1250000
"3adbe635876b8496ebbe88e7f67a9544","corticon-technologies",NA,NA,NA,NA
"7e684ac27079e39411d9071de285d586","cortria-corporation","venture",NA,"2009-06-30",1841000
"5d459b4bfa914d8d0606c07c167f68f8","corvidae-collective",NA,NA,NA,NA
"52ed2a1a59b9347845c82fc87471da7c","corzen",NA,NA,NA,NA
"37a3a3b4aa8b4a0775da2bd300cf485b","coseer",NA,NA,NA,NA
"30e4226daad7710a2f910c02460ee971","cosmederm-bioscience","venture",NA,"2014-10-13",5e+07
"e71006472fb1f8e415908633f448ad7d","cosmify-inc-",NA,NA,NA,NA
"cf673e233a69f57ddd0a39cb785a0e57","cosmo-pharmaceuticals",NA,NA,NA,NA
"269882ae4e43d48b994677cffc27e659","cosmosid","venture","B","2016-01-27",6e+06
"269882ae4e43d48b994677cffc27e659","cosmosid","venture",NA,"2011-08-19",0
"eb6baacec5d427e59148267713787bb2","costarch-analytical-consulting-private-limited",NA,NA,NA,NA
"beaf06c779008248c8285eb4551f0211","costim-pharmaceuticals",NA,NA,NA,NA
"9b032ad92812660c072bf730818b3277","couchbase","venture",NA,"2011-10-18",1e+06
"9b032ad92812660c072bf730818b3277","couchbase","venture","1","2010-05-18",1e+07
"9b032ad92812660c072bf730818b3277","couchbase","venture","1","2011-08-10",1.4e+07
"9b032ad92812660c072bf730818b3277","couchbase","venture","1","2009-01-01",6e+06
"9b032ad92812660c072bf730818b3277","couchbase","venture","1","2013-08-28",2.5e+07
"9b032ad92812660c072bf730818b3277","couchbase","venture","1","2014-06-26",6e+07
"fe9603b94a0aa1553e4dfb2607cf3576","cougar-biotechnology",NA,NA,NA,NA
"1810976eba96388b2ef23c58bb23c29c","counselytics","seed",NA,"2013-09-01",1e+05
"1810976eba96388b2ef23c58bb23c29c","counselytics","debt_financing",NA,"2015-02-23",750000
"40f567b70d162f64470bc0b447b15129","counsyl","undisclosed",NA,"2010-04-01",11100000
"40f567b70d162f64470bc0b447b15129","counsyl","undisclosed",NA,"2010-03-16",2195000
"40f567b70d162f64470bc0b447b15129","counsyl","venture","1","2014-05-08",41500000
"40f567b70d162f64470bc0b447b15129","counsyl","venture","1","2010-06-01",7500000
"40f567b70d162f64470bc0b447b15129","counsyl","venture","1","2012-03-01",3.4e+07
"40f567b70d162f64470bc0b447b15129","counsyl","venture","1","2012-08-01",7500000
"f163807cb9a364cfa758ff14d220587a","counterest",NA,NA,NA,NA
"10b9428f7f9d51d118e0a10be0bbad08","counterpoint-health-solutions","venture",NA,"2015-07-15",2350479
"be9e856bd10309ffc891f1b0603a4856","cour-pharmaceuticals-development","seed",NA,"2013-04-23",16977
"be9e856bd10309ffc891f1b0603a4856","cour-pharmaceuticals-development","debt_financing",NA,"2014-08-28",5e+05
"d71f7f9466848acdb09991c60a742fc4","courtagen-life-sciences","venture","b","2012-02-10",8e+06
"d71f7f9466848acdb09991c60a742fc4","courtagen-life-sciences","seed",NA,"2010-01-01",NA
"d71f7f9466848acdb09991c60a742fc4","courtagen-life-sciences","seed",NA,"2011-01-01",NA
"d71f7f9466848acdb09991c60a742fc4","courtagen-life-sciences","seed",NA,"2014-06-23",6272598
"d71f7f9466848acdb09991c60a742fc4","courtagen-life-sciences","private_equity",NA,"2015-07-01",2e+07
"3b2589c8a0b7364bce5c4d4b41f8b11e","couture-spot",NA,NA,NA,NA
"3a8dfe830741bd9aa56b830d38ef4a55","covacsis","venture","A","2012-09-24",450000
"3a8dfe830741bd9aa56b830d38ef4a55","covacsis","venture","B","2014-05-29",NA
"3a8dfe830741bd9aa56b830d38ef4a55","covacsis","venture","B","2014-06-24",NA
"381768fe9f9b7c6566ff8af5a896e9a0","covagen","seed",NA,"2009-10-05",NA
"381768fe9f9b7c6566ff8af5a896e9a0","covagen","venture","1","2009-12-01",34200000
"381768fe9f9b7c6566ff8af5a896e9a0","covagen","venture","1","2010-11-29",6300000
"381768fe9f9b7c6566ff8af5a896e9a0","covagen","venture","1","2013-12-09",47200000
"381768fe9f9b7c6566ff8af5a896e9a0","covagen","venture","1","2014-02-20",2805207
"a7c517fdfdeaa00720007c0dbe63733b","covalys-biosciences","venture","C","2006-03-06",NA
"a7c517fdfdeaa00720007c0dbe63733b","covalys-biosciences","venture","b","2005-02-01",2590000
"a8f22d8721898ef919e3834c56d9de5f","covance",NA,NA,NA,NA
"9e375efa5f8fa82eb40f143a2be3476d","covario","undisclosed",NA,"2007-01-25",NA
"9e375efa5f8fa82eb40f143a2be3476d","covario","venture","1","2008-01-01",1.6e+07
"939578a5adae0d291fe357ccb919f3b9","covaron-advanced-materials","seed",NA,"2013-09-11",550000
"939578a5adae0d291fe357ccb919f3b9","covaron-advanced-materials","convertible_note",NA,"2013-03-11",550000
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2009-11-12",360294
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2013-10-04",2368734
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2012-05-22",1936412
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture","1","2013-02-08",3.5e+07
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2010-01-14",868253
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2010-03-04",954909
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2010-10-12",705132
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2014-01-16",18405751
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2011-04-14",890770
"673996ac03c9d6d3b9937c9b98569469","covenant-surgical-partners","venture",NA,"2009-03-27",450600
"877a173e020140694341ad48bcc14b51","covermyid",NA,NA,NA,NA
"002f87157e27c7f571908d2968cf7dc5","covidien",NA,NA,NA,NA
"05d7f0293327931bd0b4c03e833f66a7","covue",NA,NA,NA,NA
"a9688ac038f87e6b3485dec5563099ae","covx",NA,NA,NA,NA
"2441b871238b23212a0700c08c47f727","coworkr","seed",NA,"2012-07-01",2e+05
"d6c21bddf70d9bb24310fb4c6e17760b","cpbid",NA,NA,NA,NA
"5a2a9c2f0bf3b19d38637a39e83d0d17","cpex-pharmaceuticals",NA,NA,NA,NA
"4a9806187f573466bab7171b7d9ace7b","cpgraph",NA,NA,NA,NA
"0ca1d0452fd72a66fab2a50b222ce1aa","cpo-cellular-phenomics-oncology-berlin-buch-gmbh-2",NA,NA,NA,NA
"02e5afbec426b82c3c6efaf2cf401877","cqg",NA,NA,NA,NA
"bea4a4be950ac67fef34ab263bcb1d13","cquotient","venture",NA,"2011-01-03",3e+06
"102ee3bc6dae501f2ab2e6b833ceb0d1","cr-risk-advisory",NA,NA,NA,NA
"60f2a0cbbe3cc4c1faa0d77a372cbf9f","craft",NA,NA,NA,NA
"1dcc9a0f0c0b6371bc7e15c761bdefb5","craft-nation","seed",NA,"2015-03-15",250000
"c0ae9d828a614bbe6a7d15831c5f04f8","craftinity",NA,NA,NA,NA
"4ba35241518841e47aaabfad21ee17a9","craneware","venture",NA,"2011-06-28",6e+06
"dfd705b8da224745fe274d3bccd57026","crate-technology","seed",NA,"2014-04-24",1500000
"fcbd2286fa5305fe028dea6652ea0cc4","crayon-data-pte-ltd","angel",NA,"2013-07-01",2750000
"fcbd2286fa5305fe028dea6652ea0cc4","crayon-data-pte-ltd","venture",NA,"2014-02-18",1188400
"fcbd2286fa5305fe028dea6652ea0cc4","crayon-data-pte-ltd","angel",NA,"2013-09-18",1400000
"5c8aa4229e6052292cc286c87c100df2","creabilis","venture","A","2008-06-06",31145047.6779
"5c8aa4229e6052292cc286c87c100df2","creabilis","venture","b","2011-10-04",2e+07
"c4e00d5c314906a0c687562e6d11b006","creactives","venture",NA,"2013-02-03",1364400
"8d77e146cedef7beb4fbef56a265f84c","crealta-pharmaceuticals",NA,NA,NA,NA
"31d4af42a98a59bdce88f21b3a92983f","creativ","angel",NA,"2012-04-05",750000
"31d4af42a98a59bdce88f21b3a92983f","creativ","angel",NA,"2013-01-01",1500000
"31d4af42a98a59bdce88f21b3a92983f","creativ","angel",NA,"2014-01-01",2e+06
"31d4af42a98a59bdce88f21b3a92983f","creativ","angel",NA,"2015-01-01",750000
"52c5a111db31515909d5744507b739b6","creative-biogene",NA,NA,NA,NA
"bcf2f6db973142b556e4b9c1dd8b911f","creative-bioinformatics-consultants-llc","seed",NA,"2015-03-09",NA
"04c709baffa00a6856ffe8ade165a270","creative-biomolecules",NA,NA,NA,NA
"c897eed6cff7762a32587611e2debd2b","creative-lipi-webtech-pvt-ltd",NA,NA,NA,NA
"cb3c502df116ac18ef89e8037ef6b2cf","creative-reach",NA,NA,NA,NA
"6f9c903336ae9799d7b5e8430d311321","creativebiomart",NA,NA,NA,NA
"184d2038cf465d63fa08584d46d8cac1","creativediagnostics",NA,NA,NA,NA
"b691dcd5d14e76c2ab641edae8678db3","credibility-com",NA,NA,NA,NA
"16db85dcce43b8684242683247148def","credible","venture","A","2015-10-07",11601880
"16db85dcce43b8684242683247148def","credible","seed",NA,"2014-02-28",5e+05
"16db85dcce43b8684242683247148def","credible","seed",NA,"2014-06-17",7e+05
"16db85dcce43b8684242683247148def","credible","seed",NA,"2015-02-19",1500000
"32e01c3c8c5addcca66740b858a230a9","credible-2",NA,NA,NA,NA
"3d101a44518e97ef83e2fc63790c0940","credissimo",NA,NA,NA,NA
"35035c782577be7e826bac27342f34cb","creganna",NA,NA,NA,NA
"186b4b3bd37b0e86d42189ed817ce8da","crescendo-biologics","venture","a","2014-04-03",3030502
"186b4b3bd37b0e86d42189ed817ce8da","crescendo-biologics","venture","a","2010-01-20",7300000
"186b4b3bd37b0e86d42189ed817ce8da","crescendo-biologics","venture","a","2013-12-17",26516900
"186b4b3bd37b0e86d42189ed817ce8da","crescendo-biologics","venture",NA,"2014-12-16",NA
"8fd2beaed3820c6ceca8b59ed524a304","crescendo-bioscience","venture","B","2008-06-27",1.5e+07
"8fd2beaed3820c6ceca8b59ed524a304","crescendo-bioscience","venture","b","2010-07-07",37600003
"8fd2beaed3820c6ceca8b59ed524a304","crescendo-bioscience","debt_financing",NA,"2011-09-20",2.5e+07
"8fd2beaed3820c6ceca8b59ed524a304","crescendo-bioscience","venture","c","2011-09-08",5.6e+07
"8fd2beaed3820c6ceca8b59ed524a304","crescendo-bioscience","venture","d","2013-01-03",2.8e+07
"6f51dffe6b2a75a686c80a99b96d8fe4","cresco-data",NA,NA,NA,NA
"41ef6b8633c00a4ea9e2bb5ea0f3c78f","crest-optics","private_equity",NA,"2013-06-16",514640
"ed5a4f73d280e8d9bd0f4f57e9b5f5ff","crestpointe",NA,NA,NA,NA
"b959de4d7e173698a5c8502d40248e26","crew-factors",NA,NA,NA,NA
"a63890f46f9de5f2df6443694a9ed714","crewspark",NA,NA,NA,NA
"5bfe288197da9c9d1941f25ae7a7d40f","crgt",NA,NA,NA,NA
"fb0d2656cb8b69234428341720ce7f9f","crimson",NA,NA,NA,NA
"5bd1ba45c683d79816196fbbd444f496","crimson-hexagon","debt_financing",NA,"2011-01-06",389188
"5bd1ba45c683d79816196fbbd444f496","crimson-hexagon","venture",NA,"2009-09-09",679518
"5bd1ba45c683d79816196fbbd444f496","crimson-hexagon","venture","1","2011-05-24",5e+06
"5bd1ba45c683d79816196fbbd444f496","crimson-hexagon","venture","1","2012-09-28",5089656
"5bd1ba45c683d79816196fbbd444f496","crimson-hexagon","convertible_note",NA,"2012-09-12",NA
"2d03e105232eedbb61f625459e06001f","crimson-informatics","venture","a","2011-12-22",1800000
"2d03e105232eedbb61f625459e06001f","crimson-informatics","venture","a","2011-09-23",1012000
"4b05a6557940b8507a5b831e0f2d444f","crimsonbase",NA,NA,NA,NA
"b940634df0eda65dd2b294defc223c31","crinetics-pharmaceuticals","venture","A","2015-11-02",4e+07
"b940634df0eda65dd2b294defc223c31","crinetics-pharmaceuticals","grant",NA,"2015-01-30",1500000
"0d16c6c8f8ec18940872e56baa1a7dcc","crisalix",NA,NA,NA,NA
"e378b36409d114cf1f9f5f003b619ad3","crisp-social",NA,NA,NA,NA
"542ef123c9e34f576a9a288f0e85e565","crisply",NA,NA,NA,NA
"be3914e2d93a22792b5f9bf9984cd7b9","crispr-therapeutics","venture","A","2014-04-24",2.5e+07
"be3914e2d93a22792b5f9bf9984cd7b9","crispr-therapeutics","venture","B","2015-04-28",6.4e+07
"978e1fdc55282412d9f34957d3f3d108","critical-biologics-corporation","debt_financing",NA,"2009-07-24",5e+05
"533b415c87f3eb196c50e14a4e620de6","critical-diagnostics","venture",NA,"2013-03-26",2566676
"eba1cb766137a26453de60f8bb25abf4","critical-outcome-technologies","venture",NA,"2013-09-04",45758
"eba1cb766137a26453de60f8bb25abf4","critical-outcome-technologies","undisclosed",NA,"2014-05-06",285000
"eba1cb766137a26453de60f8bb25abf4","critical-outcome-technologies","post_ipo_equity",NA,"2014-08-01",1300000
"eba1cb766137a26453de60f8bb25abf4","critical-outcome-technologies","venture",NA,"2014-09-25",45758
"eba1cb766137a26453de60f8bb25abf4","critical-outcome-technologies","post_ipo_equity",NA,"2015-08-18",13796
"fda8f0c1c60c5d6a4a3ab9101ead909c","critical-pharmaceuticals","venture",NA,"2005-01-31",1400000
"fda8f0c1c60c5d6a4a3ab9101ead909c","critical-pharmaceuticals","venture","1","2007-02-23",1177585
"6237c47f6305eeeb7a9f73bf66274adc","critical-signal-technologies","venture",NA,"2009-09-18",10800000
"83846b93559e6a795928bae743ef0475","critisense","venture",NA,"2005-06-08",1e+06
"83846b93559e6a795928bae743ef0475","critisense","venture",NA,"2006-06-21",1200000
"ae2036d7e75c13b2e7ab998180a53d22","crititech","debt_financing",NA,"2013-01-18",1183000
"ae2036d7e75c13b2e7ab998180a53d22","crititech","venture",NA,"2009-12-10",1050000
"ae2036d7e75c13b2e7ab998180a53d22","crititech","debt_financing",NA,"2012-04-02",3e+06
"3fe8d75b11cbdb44cddeb3818d3bb939","crm-clinical-trials",NA,NA,NA,NA
"0ce1decbcdd8722cd741c40c29dbf4bd","crn",NA,NA,NA,NA
"7971321ca5cae14257fb3bae25c4abc1","cro-analytics","venture",NA,"2014-02-20",25000
"7971321ca5cae14257fb3bae25c4abc1","cro-analytics","seed",NA,"2014-06-18",150000
"96cc4356c4b20cb6a55cd34149320265","crocodile-software",NA,NA,NA,NA
"a443233bc224582a07553f6b402da28e","croda-international-plc",NA,NA,NA,NA
"113ed83c34243291d9089607e8fd4676","croking",NA,NA,NA,NA
"05f46d3ed80639d7355c59aefe3fd3eb","cronimon",NA,NA,NA,NA
"b1cf0417229b5fc69ef2dd2a8ea9723d","cross-country-computer",NA,NA,NA,NA
"63efcade41808a0830a480d156f4c73f","crossroads-extremity-systems","venture",NA,"2015-06-09",1777900
"428ce0d6d6d16f7c5587c4bf0e9ab528","crossroads-systems","seed",NA,"2012-08-17",3e+06
"428ce0d6d6d16f7c5587c4bf0e9ab528","crossroads-systems","venture",NA,"2010-10-22",1e+07
"428ce0d6d6d16f7c5587c4bf0e9ab528","crossroads-systems","private_equity",NA,"2013-04-11",8619991
"428ce0d6d6d16f7c5587c4bf0e9ab528","crossroads-systems","venture",NA,"2014-04-14",4482816
"428ce0d6d6d16f7c5587c4bf0e9ab528","crossroads-systems","debt_financing",NA,"2013-07-25",1e+07
"0882dd4ee3215f2e3b953fb7bc7b8f86","crosstech-partners",NA,NA,NA,NA
"9ac12ece819e1789fb67b032ee20244e","crosstrade-group",NA,NA,NA,NA
"b902b4427e04413d633d6eb66d0d987b","crosswise","seed",NA,"2014-01-08",2e+06
"b902b4427e04413d633d6eb66d0d987b","crosswise","venture","1","2015-08-30",3e+06
"92b98a95e2ca693c2a487b612b2ec7c3","crowd-analyzer","seed",NA,"2013-09-01",24000
"c7d6b362680e878e9ac82f802c6a8878","crowd-convergence",NA,NA,NA,NA
"2e4655581d64606f4c461f99bf227863","crowdfactory","venture","A","2011-01-26",6500000
"2e4655581d64606f4c461f99bf227863","crowdfactory","venture","A","2008-12-01",5535360
"8e6474b4e6dd5fca069fb09b0fb60b30","crowd-prospectus",NA,NA,NA,NA
"7d08ee5f64a9f4c86a3e64d271718407","crowd-rating",NA,NA,NA,NA
"36a5566628e94914695c13fcb6fb8a13","crowd-sense","seed",NA,"2013-05-01",32842
"36a5566628e94914695c13fcb6fb8a13","crowd-sense","seed",NA,"2013-01-01",33011
"cbbbbc7ced025a03513c1c5fe3e17a1f","crowd-vision","undisclosed",NA,"2012-07-30",NA
"3c4ac6f8d86d90edf1ff5e510cacd6e5","crowdanalytix-inc","seed",NA,"2012-05-01",2e+06
"a2832575dbd53ec6e3f09c060b9689ac","crowdbabble","seed",NA,"2013-10-01",25000
"a2832575dbd53ec6e3f09c060b9689ac","crowdbabble","seed",NA,"2015-08-03",95412
"12f9e4a2c448a3e9145943dde186cad3","crowdbooster","seed",NA,"2010-06-01",NA
"12f9e4a2c448a3e9145943dde186cad3","crowdbooster","seed",NA,"2011-01-01",NA
"08e380f492655b4b7eaa92dbeeb119b6","crowded",NA,NA,NA,NA
"a9eecf058cfaf26d8f5663f471351280","crowdfundbeat",NA,NA,NA,NA
"4e413a3a208f65edc5d0e2590aaa2559","crowdfunding-tc",NA,NA,NA,NA
"d9efb97e228aec67aeaa977803b602ee","crowdfynd-inc","seed",NA,"2013-01-31",15000
"d9efb97e228aec67aeaa977803b602ee","crowdfynd-inc","seed",NA,"2012-09-30",75000
"d9efb97e228aec67aeaa977803b602ee","crowdfynd-inc","seed",NA,"2012-12-12",1e+05
"8bf37b9e979a46faeb830cf6105ffde1","crowdnoize",NA,NA,NA,NA
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","debt_financing",NA,"2016-01-22",737500
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","venture",NA,"2012-01-23",5e+05
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","venture",NA,"2011-10-26",5e+05
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","venture",NA,"2012-10-15",5e+05
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","venture","1","2011-04-21",1e+06
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","venture",NA,"2010-07-26",750000
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","debt_financing",NA,"2013-07-16",1520000
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","debt_financing",NA,"2012-04-12",5e+05
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","debt_financing",NA,"2012-12-31",NA
"381b873f6e1d96237ff5f03280d790d5","crowdoptic","venture",NA,"2013-05-17",1e+06
"5c0edc28ddf4bd25da23a55c19db7ebf","crowdscores","angel",NA,"2013-05-28",943481
"5c0edc28ddf4bd25da23a55c19db7ebf","crowdscores","angel",NA,"2014-02-28",1023736
"993acf2e544bb6998ee174e2572281f4","crowdskout","seed",NA,"2014-09-01",1e+06
"98e093db89f9558cf9969c3cc7a9ede2","crowdsystems","venture","A","2014-05-16",1e+06
"98e093db89f9558cf9969c3cc7a9ede2","crowdsystems","seed",NA,"2013-12-24",3e+05
"9827df526fd18061e306e53fec496ef0","crowdtwist","venture",NA,"2014-02-26",21000
"9827df526fd18061e306e53fec496ef0","crowdtwist","seed",NA,"2011-03-15",750000
"9827df526fd18061e306e53fec496ef0","crowdtwist","venture","1","2011-09-19",6e+06
"9827df526fd18061e306e53fec496ef0","crowdtwist","seed",NA,"2011-01-01",NA
"9827df526fd18061e306e53fec496ef0","crowdtwist","debt_financing",NA,"2010-09-16",405000
"9827df526fd18061e306e53fec496ef0","crowdtwist","venture","1","2014-06-26",9e+06
"1f2a1e8003f8e07593fbb740d2c41585","crown-bioscience","venture",NA,"2011-05-01",1e+06
"1f2a1e8003f8e07593fbb740d2c41585","crown-bioscience","venture","1","2014-05-23",26600000
"1f2a1e8003f8e07593fbb740d2c41585","crown-bioscience","undisclosed",NA,"2008-01-01",NA
"1f2a1e8003f8e07593fbb740d2c41585","crown-bioscience","venture","1","2011-05-04",28800000
"1f2a1e8003f8e07593fbb740d2c41585","crown-bioscience","venture","1","2014-05-15",26550000
"e2c636d9429937d9d46d1d320ea7ae9d","crowsnest-labs","seed",NA,"2014-01-01",20000
"e2c636d9429937d9d46d1d320ea7ae9d","crowsnest-labs","seed",NA,"2014-11-14",118000
"da69e8cc1d0b5546e81aa9921f977fa7","crucell","private_equity",NA,"2009-09-28",4.43e+08
"1335370de94760fc8306372a02665643","salescrunch","seed",NA,"2011-01-12",1400000
"b75d318cfaf5778ae7a3c8be5c6a59ac","crux-biomedical","venture","b","2009-01-01",8e+06
"63472ba538ccf62670b342082c4add8c","cruxbot",NA,NA,NA,NA
"a57ce4a37b564311b05b5078ca8abf2e","cruxy",NA,NA,NA,NA
"19f8e4101dd244b5f3d7e1f2eb93d470","cryo-cell-international",NA,NA,NA,NA
"748b6f68b9f36dbd6fce8fa30c15cbc1","cryobanks-international-india",NA,NA,NA,NA
"5f40311c1cd427dd4f4b6b88e288cd80","cryotherapeutics","venture","A","2013-03-21",3869320
"5f40311c1cd427dd4f4b6b88e288cd80","cryotherapeutics","venture","A","2014-05-06",4862326
"739302b2d98beaa1f158db5250935cf5","cryoxtract-instruments","debt_financing",NA,"2012-06-13",8e+05
"739302b2d98beaa1f158db5250935cf5","cryoxtract-instruments","venture","1","2011-06-15",3e+06
"cef130637fba926a09da2bff1f31907b","crysalin","venture","a","2011-01-05",2400000
"c5ca9ceb60339a1c73fad65d4fd97428","crysp","seed",NA,"2015-11-01",36000
"7e00c41cf451216502e52f53826705dc","crystal-decisions",NA,NA,NA,NA
"a0664fcaf67daed971459580b4d96af0","crystalgenomics","venture","A","2012-01-13",2600000
"a0664fcaf67daed971459580b4d96af0","crystalgenomics","venture","B","2014-06-25",12800000
"f2225a167821a5b5058f5287595fb5e7","crystalplex","debt_financing",NA,"2013-05-14",280000
"f2225a167821a5b5058f5287595fb5e7","crystalplex","venture",NA,"2012-10-19",150000
"f2225a167821a5b5058f5287595fb5e7","crystalplex","venture",NA,"2008-01-14",225000
"f2225a167821a5b5058f5287595fb5e7","crystalplex","venture",NA,"2011-06-02",1075000
"f2225a167821a5b5058f5287595fb5e7","crystalplex","venture",NA,"2007-11-08",150000
"f2225a167821a5b5058f5287595fb5e7","crystalplex","debt_financing",NA,"2015-02-24",1014000
"732f89bf46f934a09e36191055b489d5","crystax-pharmaceuticals","undisclosed",NA,"2005-09-30",NA
"33ff74087e63f07e3bc65a295d3927bb","cs-keys","venture","a","2008-01-25",6250000
"33ff74087e63f07e3bc65a295d3927bb","cs-keys","venture",NA,"2006-06-07",285000
"286df81455bdd3ce65eb603ca90139b4","csats","venture",NA,"2015-05-29",2500000
"cfa0374cea6ec346bf0f1475aff0b936","csl",NA,NA,NA,NA
"a24437ebfbc0fcea779ca26f77e6d14c","csrhub",NA,NA,NA,NA
"86e8a639cb1e4b30f6d25f318fb28ea5","cstorepro","seed",NA,"2015-01-20",5.4e+07
"bcb7818e60c1b0adc42be2d75d839b8d","csx-technology",NA,NA,NA,NA
"9c5b591f8c0072931872687529d53a3e","ct-atlantic","venture","a","2009-01-12",8970000
"ad0eade3c8c2012818dd1a4ea8adb8d2","ctd-holdings","venture",NA,"2014-07-23",1725000
"ad0eade3c8c2012818dd1a4ea8adb8d2","ctd-holdings","venture",NA,"2015-09-01",650000
"082aa2dde83bb43f9e64283153e6b0d3","cti-biopharma",NA,NA,NA,NA
"3a5abe0194a2c13b83175a5cc40bc477","cti-molecular-imaging",NA,NA,NA,NA
"c703f17d2aaee23584707d6300335c1b","cti-science","venture",NA,"2014-01-16",271000
"c703f17d2aaee23584707d6300335c1b","cti-science","venture",NA,"2011-08-15",3702210
"6d6a507c4537fb32af464c9d2aafb220","ctmg","venture",NA,"2013-11-06",3020000
"6d6a507c4537fb32af464c9d2aafb220","ctmg","venture",NA,"2009-07-23",1e+06
"6d6a507c4537fb32af464c9d2aafb220","ctmg","venture",NA,"2015-03-04",454684
"d99649de1734bd8c1b783b3943741f02","cttc",NA,NA,NA,NA
"f49b72e744b9e02146a68d66a5276dc0","ctuit-software",NA,NA,NA,NA
"d608b8f95031a1a35c0e021848528948","cube-biotech","venture","a","2012-12-01",NA
"7ee13ee3c75bb54de7749793f3622ca6","cube-design",NA,NA,NA,NA
"677668db79a838143b35fb3143834c37","cube19","angel",NA,"2012-11-06",1750000
"677668db79a838143b35fb3143834c37","cube19","angel",NA,"2014-08-29",1e+06
"9ec8ce452e845bf6a841fa80a41ff545","cubeitz",NA,NA,NA,NA
"14dec4c67ba2388602d2ed96de70253a","cuberon","seed",NA,"2015-08-15",NA
"34d25753749835c5eaa24c401655068c","cubeyou","seed",NA,"2010-01-01",1440600
"34d25753749835c5eaa24c401655068c","cubeyou","venture","1","2012-05-01",4624900
"e79dac987495521e72c635c8b42b6080","cubist-pharmaceuticals",NA,NA,NA,NA
"c86f5190bcbf34df5db095d079dbeaa2","cubresa","seed",NA,"2013-07-01",5e+05
"90d3d1f43db07c70cbc5da0e7c67773a","cue-2","venture",NA,"2015-12-25",NA
"90d3d1f43db07c70cbc5da0e7c67773a","cue-2","venture","1","2014-11-18",7500000
"2afd724a7e49c1f2eca32ba5e527aeb8","cue-ball",NA,NA,NA,NA
"9567afe8c415653a0996b903a3115423","cueball",NA,NA,NA,NA
"62fd1d76cff474d44c3e62ddede0257a","cultiwate",NA,NA,NA,NA
"363cfce82ac6bf0c41c20a2f6caa5805","cultureamp","venture","A","2015-03-04",6300000
"4182eccdeca0cfc9b7b1424437edb9e2","culture-fuels",NA,NA,NA,NA
"b2632e046a0882ad17fc18acf095b871","culture-jam",NA,NA,NA,NA
"8ee813e6930b5329f36cb670093c1fa2","cumberland-pharmaceuticals",NA,NA,NA,NA
"37c37ae5cf6799c17181de9c2602cbb5","cumed","venture",NA,"2010-01-13",4e+06
"00b2fb08ae158cbc6141528b031bcd3b","cuore",NA,NA,NA,NA
"0536ec3825f37af7c6f0af085cb680fb","cupenya","seed",NA,"2015-02-15",6e+05
"4b12d299faa6ccfcd52aa8b79c213671","cup-li",NA,NA,NA,NA
"e82b3700b783febda4224a6a35e67e62","curalate","venture","a","2013-01-15",3e+06
"e82b3700b783febda4224a6a35e67e62","curalate","seed",NA,"2012-05-15",750000
"e82b3700b783febda4224a6a35e67e62","curalate","venture","B","2014-06-06",8600000
"c45d3c86e7f8a71e4340502218b990bf","curatern",NA,NA,NA,NA
"8d0b4d9a1aabcebbe36602447362af3e","curaxian",NA,NA,NA,NA
"c6b332c39a72972b1f32eebf78924934","curaxis-pharmaceutical","venture",NA,"2010-02-17",1526000
"1e465af7ab0291b4a70e06b3fa12f931","curazene",NA,NA,NA,NA
"354424770656190f19eed4234a8d69c4","curedm","venture","b","2006-11-30",2500000
"354424770656190f19eed4234a8d69c4","curedm","venture",NA,"2009-08-10",2100000
"bade01641e9513eb160a3b3f192f0657","curemark","venture",NA,"2014-01-14",18752466
"bade01641e9513eb160a3b3f192f0657","curemark","venture",NA,"2013-10-08",18500000
"bade01641e9513eb160a3b3f192f0657","curemark","venture","1","2009-10-01",6500000
"bade01641e9513eb160a3b3f192f0657","curemark","debt_financing",NA,"2013-02-06",6042000
"bade01641e9513eb160a3b3f192f0657","curemark","venture",NA,"2010-07-16",5220000
"bade01641e9513eb160a3b3f192f0657","curemark","debt_financing",NA,"2015-01-14",5e+06
"bade01641e9513eb160a3b3f192f0657","curemark","venture",NA,"2015-07-13",2e+07
"eb5108d5057e8152e8ff9b8dcdc9ff94","cureon",NA,NA,NA,NA
"4322b9994cac3cbfb2e8e7997ab84d90","cureseq","seed",NA,"2014-07-10",7e+05
"ca0743e41747ba831b4fa373e074f24f","curetech","private_equity",NA,"2013-09-17",4e+06
"cbc5e3d3d8b2b751abc73405b3ec414a","curetis","venture","a","2011-05-17",6376950
"cbc5e3d3d8b2b751abc73405b3ec414a","curetis","venture","a","2011-10-26",13369920
"cbc5e3d3d8b2b751abc73405b3ec414a","curetis","venture","a","2010-05-31",1846050
"cbc5e3d3d8b2b751abc73405b3ec414a","curetis","venture","a","2009-12-03",27972000
"cbc5e3d3d8b2b751abc73405b3ec414a","curetis","venture","B","2014-11-20",18186226
"dd139f9652cc112afdb4aae2d1a08a2a","curevac","venture","F","2015-11-03",1.1e+08
"dd139f9652cc112afdb4aae2d1a08a2a","curevac","venture","b","2006-01-18",26675000
"dd139f9652cc112afdb4aae2d1a08a2a","curevac","venture","d","2012-09-18",104432000
"dd139f9652cc112afdb4aae2d1a08a2a","curevac","venture","c","2010-05-10",34900000
"dd139f9652cc112afdb4aae2d1a08a2a","curevac","venture","E","2015-03-05",5.2e+07
"1034249807ee91d00178209000f10d7c","curis","venture",NA,"2010-02-12",8e+06
"1034249807ee91d00178209000f10d7c","curis","venture",NA,"2011-11-09",8e+06
"1034249807ee91d00178209000f10d7c","curis","venture",NA,"2011-12-23",6e+06
"1034249807ee91d00178209000f10d7c","curis","seed",NA,"2012-03-30",964000
"9acfd8bd40da5f6db79a769aeab58994","curisma",NA,NA,NA,NA
"daed7e13d11ab95c780d96c7afcd1337","curium",NA,NA,NA,NA
"4b336419385a094aba37feb29a36a03b","currenex",NA,NA,NA,NA
"81b752cad647192ae9bc8eceac74bb92","current-analysis",NA,NA,NA,NA
"94c8a566aa9524bb787cc49f3de40093","cursor-insight",NA,NA,NA,NA
"09623a04f86b3b51e89e161b78ace51a","curvo","venture",NA,"2013-07-17",50000
"de0eeef6013918584bd824e0a796aec0","cusac-co",NA,NA,NA,NA
"3c3d5c3096e06a248d6fa6a72def10c1","customer-clever","seed",NA,"2015-06-02",228637
"f3a4f31e82402effbf64f3b0b9d30ae7","customer-labs","seed",NA,"2015-06-18",50000
"dd1e7654bd819cc4246ce6cf5a66d23c","customermatrix","venture","B","2016-01-25",10500000
"dd1e7654bd819cc4246ce6cf5a66d23c","customermatrix","venture","A","2014-12-23",3500000
"dd1e7654bd819cc4246ce6cf5a66d23c","customermatrix","seed",NA,"2013-06-27",2e+06
"ff854f8c7141f347bc8f8235e12c9da5","customerrivet",NA,NA,NA,NA
"f9ab764d184a40557ec22d602a5e39aa","customersat",NA,NA,NA,NA
"37e2a0c619e27f6762306de4d3ae98e6","cfn-customers-first-now",NA,NA,NA,NA
"fa7f589acc6532260c4a3ec4deb4cd8e","customsoft",NA,NA,NA,NA
"8da12f3cc015868a53fe1f96a8ab3765","custopharm","undisclosed",NA,"2015-02-03",NA
"f91e9f255171971c11c1150f094b0492","custora","seed",NA,"2012-01-05",NA
"f91e9f255171971c11c1150f094b0492","custora","seed",NA,"2011-01-01",NA
"f91e9f255171971c11c1150f094b0492","custora","venture","1","2015-04-07",6500000
"86003e42944406ad0f644918f0aad803","cutanea-life-sciences","seed",NA,"2011-09-09",450000
"728c2a4ffe25ca769491e00504622a3e","cutera",NA,NA,NA,NA
"391f309d1832337915d0bbfabe47014b","cutter-consortium",NA,NA,NA,NA
"b6439f9e55602ad23ca21581dd605e28","cuttime-fm",NA,NA,NA,NA
"466ff21de061bc0ca37f07c4c28f4750","argolyn-bioscience","venture","a","2007-06-25",15800000
"f7f4b30add0c5e750e446b496cebed92","cvc",NA,NA,NA,NA
"ec0aceeea84256aa7d1107d68a3133c5","revenue-assurance-cvidya","debt_financing",NA,"2011-02-01",3e+06
"ec0aceeea84256aa7d1107d68a3133c5","revenue-assurance-cvidya","debt_financing",NA,"2009-04-27",5e+06
"ec0aceeea84256aa7d1107d68a3133c5","revenue-assurance-cvidya","debt_financing",NA,"2006-10-29",3e+06
"ec0aceeea84256aa7d1107d68a3133c5","revenue-assurance-cvidya","venture","1","2002-03-01",3e+06
"ec0aceeea84256aa7d1107d68a3133c5","revenue-assurance-cvidya","venture","1","2004-06-01",1e+07
"ec0aceeea84256aa7d1107d68a3133c5","revenue-assurance-cvidya","venture","1","2008-02-01",1.2e+07
"ec0aceeea84256aa7d1107d68a3133c5","revenue-assurance-cvidya","venture","1","2010-01-01",1e+07
"7b1fac6777dd12f3b78c6066a62620b0","cvrx","venture","D","2007-05-10",6.5e+07
"7b1fac6777dd12f3b78c6066a62620b0","cvrx","venture","E","2008-07-30",8.4e+07
"7b1fac6777dd12f3b78c6066a62620b0","cvrx","venture","f","2013-10-30",1.2e+07
"7b1fac6777dd12f3b78c6066a62620b0","cvrx","venture","f","2013-07-10",29600000
"7b1fac6777dd12f3b78c6066a62620b0","cvrx","debt_financing",NA,"2014-09-22",1.5e+07
"e3e1fe3fe40d62173a771cba34f714b3","cw-group",NA,NA,NA,NA
"b7f1a5e05486ad6e34b111919a5cb303","cx-ray","seed",NA,"2014-07-17",120000
"da9ca180cebb1e78bd0c78dbab86aaa9","connexionsasia","venture","A","2015-01-09",8e+06
"bbe2144f6ec2696f3bee8c021b963ff4","cxense",NA,NA,NA,NA
"34da0b579c2b3657ff51a08c33ec6358","cxo-business-intelligence-corporation",NA,NA,NA,NA
"1f0d1a3d0cf1a9d2f04e432654615ae4","cxr-biosciences","venture",NA,"2008-02-25",2555672
"6c8d2f4c46b004b2e03a568e380a063c","cyanotech",NA,NA,NA,NA
"e257a8f513cde2f202a857e6c1d08ccb","cyber-astro-limited",NA,NA,NA,NA
"d2cc21cad8498197324a02bb0b58b893","cyberbills",NA,NA,NA,NA
"a00089818a237d648b0c8f7d9cf0acf0","cyberflow-analytics","seed",NA,"2013-07-16",2e+06
"a00089818a237d648b0c8f7d9cf0acf0","cyberflow-analytics","seed",NA,"2015-05-27",2e+06
"beebc95f93d14bf606913c5a024a0a45","cyberiq-services","venture",NA,"2014-04-01",2100000
"beebc95f93d14bf606913c5a024a0a45","cyberiq-services","venture",NA,"2013-05-09",1190000
"400541276d9d0f458eb31dea75a994a7","cyberlightning-ltd","venture","A","2014-08-12",4200000
"13260388136565c842346cd62759e944","cybervision",NA,NA,NA,NA
"6f127eea38070f5ee3dbcc7d9ab7e5f3","cybo",NA,NA,NA,NA
"854e18d7c3a92f2ac5c284b83204218f","cybranding",NA,NA,NA,NA
"8a5f687e1e4821d124306b7552fdf33e","cybrhome",NA,NA,NA,NA
"07bba124e3fd30427e8a6c367d0b441f","cychreus-technologies",NA,NA,NA,NA
"25951b9f6856399ec1ef0e50e9955940","cyclacel-pharmaceuticals","post_ipo_equity",NA,"2014-04-10",1e+07
"25951b9f6856399ec1ef0e50e9955940","cyclacel-pharmaceuticals","venture",NA,"2010-10-21",15200226
"25951b9f6856399ec1ef0e50e9955940","cyclacel-pharmaceuticals","private_equity",NA,"2012-05-01",3036000
"25951b9f6856399ec1ef0e50e9955940","cyclacel-pharmaceuticals","venture","1","2001-06-01",48218802
"25951b9f6856399ec1ef0e50e9955940","cyclacel-pharmaceuticals","venture","1","2004-01-29",38769109
"25951b9f6856399ec1ef0e50e9955940","cyclacel-pharmaceuticals","undisclosed",NA,"1999-05-01",8063460
"25951b9f6856399ec1ef0e50e9955940","cyclacel-pharmaceuticals","venture",NA,"2005-07-01",8900589
"c350b77e58ae794d7dc278405705740a","cyclica","venture",NA,"2015-08-11",NA
"c350b77e58ae794d7dc278405705740a","cyclica","venture",NA,"2014-12-10",348920.3822
"ad9e6c7d3db96a715c06cdba75e664da","cyclr-automation","grant",NA,"2014-07-04",171587
"3be224992c171b5b086e668ba5f81045","cydan","venture",NA,"2013-04-11",1.6e+07
"3be224992c171b5b086e668ba5f81045","cydan","venture",NA,"2013-10-01",1e+07
"f674b006c8adfd043ac3c386d82b95aa","cydex-pharmaceuticals",NA,NA,NA,NA
"62c38b8e8ed52814a271d8e8760a9fdf","cyfeon-solutions",NA,NA,NA,NA
"2763239ce744aed97979f3c07597c33c","cyfuse-biomedical","venture","B","2015-03-02",1.2e+07
"5856cd15bbdd1d294f7691da32184d04","cygene-laboratories",NA,NA,NA,NA
"4397fd330c174c00f32ca39092caeafb","cygnet-technologies",NA,NA,NA,NA
"5a28dd4ed9fcdfcfa0b7723618df90ce","cylene-pharmaceuticals","venture","B","2005-05-26",26300000
"5a28dd4ed9fcdfcfa0b7723618df90ce","cylene-pharmaceuticals","debt_financing",NA,"2011-08-11",15635924
"5a28dd4ed9fcdfcfa0b7723618df90ce","cylene-pharmaceuticals","debt_financing",NA,"2013-01-22",867000
"5a28dd4ed9fcdfcfa0b7723618df90ce","cylene-pharmaceuticals","venture","c","2007-01-23",4.4e+07
"5a28dd4ed9fcdfcfa0b7723618df90ce","cylene-pharmaceuticals","venture","d","2010-09-24",1.2e+07
"c723d11c71707749b150c09bd728ab2c","cylex","venture","C","2007-03-07",20500000
"c723d11c71707749b150c09bd728ab2c","cylex","venture",NA,"2010-09-07",3300000
"bb00e2c0b72e1f6d458e47d2d9de0b53","cylex-usa-com-database",NA,NA,NA,NA
"208f8efd508e4a4f6c73a386a278971e","cymabay-therapeutics","venture",NA,"2009-11-05",8600000
"208f8efd508e4a4f6c73a386a278971e","cymabay-therapeutics","venture","1","2007-04-19",3.2e+07
"208f8efd508e4a4f6c73a386a278971e","cymabay-therapeutics","venture",NA,"2013-10-11",26833640
"208f8efd508e4a4f6c73a386a278971e","cymabay-therapeutics","debt_financing",NA,"2009-07-21",27747055
"208f8efd508e4a4f6c73a386a278971e","cymabay-therapeutics","debt_financing",NA,"2013-12-11",5e+06
"208f8efd508e4a4f6c73a386a278971e","cymabay-therapeutics","debt_financing",NA,"2015-08-14",324999
"ec8816622e2a3adc4e57afa35c887ffa","cymogen-dx","seed",NA,"2010-07-07",350161
"5feb5607d73278af2def211addfa660b","cynapsus-therapeutics","venture",NA,"2013-03-27",4124454
"5feb5607d73278af2def211addfa660b","cynapsus-therapeutics","venture",NA,"2012-03-28",939505
"5feb5607d73278af2def211addfa660b","cynapsus-therapeutics","venture",NA,"2014-04-21",14546285
"5feb5607d73278af2def211addfa660b","cynapsus-therapeutics","grant",NA,"2014-07-08",5e+05
"5feb5607d73278af2def211addfa660b","cynapsus-therapeutics","venture",NA,"2015-03-31",16602802
"401882e6bf5eeb1969fd6d4b01d62ff1","cynata",NA,NA,NA,NA
"4971ea4dd82f0b78f8a66152a67d245d","cynosure",NA,NA,NA,NA
"d890bd3f58365923bf384c36a4dfcd68","cyntellect","venture","D","2007-07-25",15100000
"d890bd3f58365923bf384c36a4dfcd68","cyntellect","venture","D","2007-09-06",3e+06
"d890bd3f58365923bf384c36a4dfcd68","cyntellect","venture",NA,"2009-11-12",15500000
"d890bd3f58365923bf384c36a4dfcd68","cyntellect","venture","e","2010-07-16",9e+06
"e35874486bc02dfd46d9ae47c0ac2d9f","cynvec","venture",NA,"2015-12-07",1900000
"e35874486bc02dfd46d9ae47c0ac2d9f","cynvec","venture",NA,"2009-03-20",5e+05
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","venture","b","2009-05-20",1718783
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","venture","b","2010-01-11",1968783
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","venture","b","2013-11-25",3284704
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","debt_financing",NA,"2012-05-07",2650000
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","venture","b","2011-11-29",1966802
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","debt_financing",NA,"2011-05-24",1866334
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","venture","a","2008-12-15",675000
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","venture","b","2012-11-26",2992665
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","debt_financing",NA,"2013-10-18",3202814
"784a233405687cdcf8cfe5cd4b841ab7","cynvenio-biosystems","venture","B","2015-06-17",25500000
"1e2e3db9843a52ae675fde4f61408c8c","cyp-design","seed",NA,"2013-10-22",NA
"495edc798c574b11ffce4740fafd2a12","cypher-genomics",NA,NA,NA,NA
"d711897b8b4b3ad6d2df3a9a0e14f613","cypress-bioscience",NA,NA,NA,NA
"4aad19b0bc594da85f7d9a187cb316fd","cyprotex","venture",NA,"2010-08-17",2675263
"f0bfefc19ebd923036b57b2cdaa1fd58","cyram",NA,NA,NA,NA
"c338f72d480cd9570c34334f4dec1135","first-warning-systems","venture",NA,"2015-12-04",3e+05
"c338f72d480cd9570c34334f4dec1135","first-warning-systems","venture","1","2012-08-07",1e+06
"c338f72d480cd9570c34334f4dec1135","first-warning-systems","debt_financing",NA,"2013-07-23",9e+05
"c338f72d480cd9570c34334f4dec1135","first-warning-systems","venture","1","2014-04-22",540000
"c338f72d480cd9570c34334f4dec1135","first-warning-systems","angel",NA,"2014-10-05",1e+06
"c338f72d480cd9570c34334f4dec1135","first-warning-systems","debt_financing",NA,"2014-09-19",2145000
"14c62b351aaccdf9882c59a59d90ef06","cyrenaic-pharmaceuticals",NA,NA,NA,NA
"6da87b865cdf37e64c6746f38792ff55","cyrus-biotechnology","seed",NA,"2015-05-06",850000
"43043076efe0414d88fbffb93ba75b88","cystic-fibrosis-foundation",NA,NA,NA,NA
"6406996cdd040c744561767fdf5abdae","cyteir-therapeutics","venture","A","2015-11-05",5500000
"8324c66b547a31012bffa7be16b338e1","cytel-corporation",NA,NA,NA,NA
"ab7d6a447931894fcaacee2054412a69","cytena","seed",NA,"2015-04-29",1208791
"9d773e0400c47981383198059e6cdf2d","cyterix-pharmaceuticals","venture","a","2011-06-07",9200000
"9d773e0400c47981383198059e6cdf2d","cyterix-pharmaceuticals","venture",NA,"2012-07-01",7290000
"7c3d8873a2157d4c09729b1fcbdc3255","cytheris","venture","b","2006-10-25",30700000
"7c3d8873a2157d4c09729b1fcbdc3255","cytheris","venture","d","2010-06-07",1.5e+07
"d623a1d42e5b8f77b026e2d5f29b1dda","cytheris-sa",NA,NA,NA,NA
"60a6c1beae50ad9d238b4ae44d1b1ff6","cytimmune-sciences","debt_financing",NA,"2010-01-12",1e+06
"60a6c1beae50ad9d238b4ae44d1b1ff6","cytimmune-sciences","venture",NA,"2014-04-15",5410000
"60a6c1beae50ad9d238b4ae44d1b1ff6","cytimmune-sciences","venture","1","2014-05-12",4e+05
"60a6c1beae50ad9d238b4ae44d1b1ff6","cytimmune-sciences","venture",NA,"2014-09-18",689990
"60a6c1beae50ad9d238b4ae44d1b1ff6","cytimmune-sciences","venture",NA,"2015-08-31",747666
"a10e9feb720e87e0126a477f17868452","cyto-wave-technologies","venture",NA,"2013-04-04",965000
"d83bc9704cadaa4dd5daf9d32acf5f2d","cytocentrics","venture",NA,"2008-01-08",1396975
"d83bc9704cadaa4dd5daf9d32acf5f2d","cytocentrics","venture",NA,"2008-01-24",2950000
"d83bc9704cadaa4dd5daf9d32acf5f2d","cytocentrics","venture",NA,"2015-03-26",6637345
"ee29d03e7edb64ee1cc9ab25136a165f","cytochroma","venture","C","2007-01-18",17948717.9487
"ee29d03e7edb64ee1cc9ab25136a165f","cytochroma","venture","C","2008-07-30",44117647.0588
"d985213d500950f4099792424402151a","cytodiagnostics",NA,NA,NA,NA
"0a45c268451b56fb7db3e172d31acafc","cytodyn","venture",NA,"2015-10-05",2693800
"0a45c268451b56fb7db3e172d31acafc","cytodyn","venture","1","2009-10-19",455000
"0a45c268451b56fb7db3e172d31acafc","cytodyn","venture",NA,"2013-09-25",3207260
"0a45c268451b56fb7db3e172d31acafc","cytodyn","seed",NA,"2013-08-12",1200000
"0a45c268451b56fb7db3e172d31acafc","cytodyn","venture",NA,"2013-02-15",5908250
"0a45c268451b56fb7db3e172d31acafc","cytodyn","venture",NA,"2011-12-07",3e+06
"0a45c268451b56fb7db3e172d31acafc","cytodyn","private_equity",NA,"2013-10-24",14500000
"0a45c268451b56fb7db3e172d31acafc","cytodyn","venture",NA,"2009-11-03",250000
"0a45c268451b56fb7db3e172d31acafc","cytodyn","post_ipo_debt",NA,"2015-05-14",3281050
"0a45c268451b56fb7db3e172d31acafc","cytodyn","post_ipo_equity",NA,"2015-07-13",1972500
"c1d17a49a9c7f671985e269aa65af855","cytogel-pharma","venture",NA,"2010-05-17",2200000
"c1d17a49a9c7f671985e269aa65af855","cytogel-pharma","debt_financing",NA,"2014-03-20",240000
"c1d17a49a9c7f671985e269aa65af855","cytogel-pharma","venture",NA,"2015-01-07",2691190
"382ee40b9d9c227b981429b23ebb359e","cytogen-corporation",NA,NA,NA,NA
"08feab48114b89f4664dc62515a94294","cytogene-research-development",NA,NA,NA,NA
"c79e9055df3ea2cd6c42469c87372d36","cytogenix",NA,NA,NA,NA
"9917abe7cb6bffd0642f3d278dd05d02","cytoguide","undisclosed",NA,"2009-06-02",NA
"6a2f093968b22775917e43a283ffed4a","cytomics-pharmaceuticals","venture","B","2006-02-28",11885330.3329
"cd9e853c287bdad5813d8fcdc37be3f0","cytomx-therapeutics","venture","b","2012-07-31",1.1e+07
"cd9e853c287bdad5813d8fcdc37be3f0","cytomx-therapeutics","convertible_note",NA,"2010-03-03",2500000
"cd9e853c287bdad5813d8fcdc37be3f0","cytomx-therapeutics","venture","b","2010-09-23",3e+07
"cd9e853c287bdad5813d8fcdc37be3f0","cytomx-therapeutics","venture","C","2015-01-06",2e+07
"cd9e853c287bdad5813d8fcdc37be3f0","cytomx-therapeutics","venture","D","2015-06-16",7e+07
"265ff5a451d40dc5ede4876823756148","cytonet-gmbh",NA,NA,NA,NA
"823c1fdb2514c2a5d74cb6807576a9ff","cytonics","venture",NA,"2009-05-18",2304760
"823c1fdb2514c2a5d74cb6807576a9ff","cytonics","venture",NA,"2011-03-04",1e+06
"131d01489183cab32941b061ec726d83","cytoo","venture","b","2009-10-01",4700000
"131d01489183cab32941b061ec726d83","cytoo","venture","c","2011-11-25",1e+07
"f3f4a97b0ff6d4a275b80d39411cea17","cytopeia",NA,NA,NA,NA
"db84e9337fa680261f14545cf0e61fe8","cytopia",NA,NA,NA,NA
"a2ee12614fe8d9070f464d0d52fe3b32","cytora","venture","B","2015-10-01",NA
"dd1d2ea9a3a8a3cb35e54ba13ceb2282","cytorex-biosciences",NA,NA,NA,NA
"7164c91309cd9fe8474e8bc50461b134","cytori-therapeutics","venture",NA,"2009-06-30",4251700
"7164c91309cd9fe8474e8bc50461b134","cytori-therapeutics","debt_financing",NA,"2013-07-01",2.7e+07
"7164c91309cd9fe8474e8bc50461b134","cytori-therapeutics","post_ipo_equity",NA,"2014-05-30",1e+07
"7164c91309cd9fe8474e8bc50461b134","cytori-therapeutics","post_ipo_equity",NA,"2014-10-08",13500000
"4e9a53391cf8adf9d8c511801d6c64fe","cytos",NA,NA,NA,NA
"49f68b9c3d29928d6e4a86db5dfba4f2","cytos-biotechnology-ag",NA,NA,NA,NA
"7eb0086eef085ffd3e87e59ef6ba3df0","cytosolv","seed",NA,"2010-02-09",5e+05
"9154ea1303e35d3507dcb3f5f4490382","cytosorbents","debt_financing",NA,"2013-10-11",745000
"9154ea1303e35d3507dcb3f5f4490382","cytosorbents","debt_financing",NA,"2013-08-08",1098000
"f3f5d35dd72f3f47163ae1635693eab7","cytovale","seed",NA,"2013-11-15",NA
"f3f5d35dd72f3f47163ae1635693eab7","cytovale","venture","1","2014-06-10",4300000
"beb7f3d775d5f1c928dbc995aefd6602","cytovance-biologics","venture",NA,"2011-03-15",22500000
"beb7f3d775d5f1c928dbc995aefd6602","cytovance-biologics","debt_financing",NA,"2014-10-28",2e+07
"ac8175d203de095605c396845a876818","cytovia",NA,NA,NA,NA
"92d49d0ad7cdd5cdddaed135a7047ad9","cytoviva","venture",NA,"2009-04-29",685000
"63933d9c30468d26de859bdafea1a5c9","cytox","venture","b","2014-04-03",2272877
"f1ff6cae459c0dd829c033ffba37561b","cytrellis-biosystems","venture",NA,"2015-02-20",7139937
"5550c68f12726c5ac0b71833302e2835","cytyc",NA,NA,NA,NA
"a252ff6107caf1cf3ee54780074be0e6","cyvek","venture","b","2010-02-12",1950000
"a252ff6107caf1cf3ee54780074be0e6","cyvek","venture","d","2013-02-04",5500000
"a252ff6107caf1cf3ee54780074be0e6","cyvek","venture",NA,"2014-04-07",1e+07
"a252ff6107caf1cf3ee54780074be0e6","cyvek","venture","c","2012-05-11",3e+06
"a252ff6107caf1cf3ee54780074be0e6","cyvek","debt_financing",NA,"2014-01-13",1854410
"43aa61d7f70a2a445efcb7c161808b66","cyvenio-biosystems","venture","b","2010-01-11",1968783
"f837e2af82181ef19cb56067f25e7a09","d-square-nv","venture","B","2015-12-29",5464381.341
"f837e2af82181ef19cb56067f25e7a09","d-square-nv","seed",NA,"2007-12-21",194130
"f837e2af82181ef19cb56067f25e7a09","d-square-nv","angel",NA,"2008-07-17",713205
"f837e2af82181ef19cb56067f25e7a09","d-square-nv","venture","A","2010-09-17",3261252.4079
"4359e756b91a03db72594261bc1e5da7","d-a-m-good-media-limited","seed",NA,"2011-06-01",90416
"4359e756b91a03db72594261bc1e5da7","d-a-m-good-media-limited","seed",NA,"2012-01-26",125032
"4359e756b91a03db72594261bc1e5da7","d-a-m-good-media-limited","seed",NA,"2012-09-01",190196
"4359e756b91a03db72594261bc1e5da7","d-a-m-good-media-limited","seed",NA,"2013-07-01",194720
"4359e756b91a03db72594261bc1e5da7","d-a-m-good-media-limited","angel",NA,"2015-01-01",NA
"f2000cef2942d2162bcf0b6cf259abe7","d-c-media-networks-gmbh",NA,NA,NA,NA
"6d2da71a6d505a4e7f1fe176994d3f47","dabizmo",NA,NA,NA,NA
"05a24b0af9d5fc224d39067d750a8d13","dabkick","convertible_note",NA,"2013-07-24",NA
"05a24b0af9d5fc224d39067d750a8d13","dabkick","venture",NA,"2014-08-11",NA
"05a24b0af9d5fc224d39067d750a8d13","dabkick","convertible_note",NA,"2015-06-30",NA
"17d3aece46a01f1cfecd50574e044f4a","dacomed-corporation",NA,NA,NA,NA
"c1924ea32039f2009524c4b338e8511c","dada-nyc",NA,NA,NA,NA
"bf6f2f35eb3c016cad49b76c1f6bfb30","daedalus-data-decisions-and-language",NA,NA,NA,NA
"a5dfb57babda7922747058a77b92e038","daftcode",NA,NA,NA,NA
"d784d4c1724f9b85d3368d991b60bd69","daia-solutions",NA,NA,NA,NA
"7d7004e93273f003336e8ccb2088b9f2","daiichi-sankyo",NA,NA,NA,NA
"ced0f4657a0c7b512b8d4d8c8f07857a","daily-delivery",NA,NA,NA,NA
"dac2b2b99b0887e63232bef5c4afaf44","daily-steak-onmego",NA,NA,NA,NA
"5a4292428b7e1545fce860b914e964c3","dainippon-sumitomo",NA,NA,NA,NA
"4ab6b0ae77a446ab5b96fdd5995d32e5","dairyvative-technologies","venture",NA,"2014-09-02",1e+06
"69cf5e8f3c8c06ecdc924fc54470b7e4","dake",NA,NA,NA,NA
"e8c70cc97d0db6318010d69981371314","dako-denmark",NA,NA,NA,NA
"ddf8845f9027be11e74934cf95d8c008","daktari-diagnostics","venture",NA,"2010-07-02",820000
"ddf8845f9027be11e74934cf95d8c008","daktari-diagnostics","venture","1","2009-10-27",2800000
"ddf8845f9027be11e74934cf95d8c008","daktari-diagnostics","debt_financing",NA,"2011-08-16",1200000
"ddf8845f9027be11e74934cf95d8c008","daktari-diagnostics","venture",NA,"2010-11-05",1800000
"ddf8845f9027be11e74934cf95d8c008","daktari-diagnostics","venture",NA,"2011-12-30",1e+07
"ddf8845f9027be11e74934cf95d8c008","daktari-diagnostics","private_equity",NA,"2014-04-08",19999995
"ddf8845f9027be11e74934cf95d8c008","daktari-diagnostics","venture","1","2015-03-02",15500000
"64382ecba92a523426e12f59420d1424","dancerockit",NA,NA,NA,NA
"d6cfb46fd14cca32ef7ece6e1a228806","dangerous-things",NA,NA,NA,NA
"b57b8b0b6d2640b8da65011a259e8108","gruppo-daniele",NA,NA,NA,NA
"df697060a094c1767a2d00f3a8054721","danisco-a-s",NA,NA,NA,NA
"65a5b3e2e7c1fb00ea29105d51210f3a","dapresy",NA,NA,NA,NA
"5af242bc4395335aac968c057a8cf6f8","daqwest",NA,NA,NA,NA
"8598bac118aa5e4ced7db74ff10d177f","dara-biosciences","post_ipo_equity",NA,"2014-02-13",6e+06
"8598bac118aa5e4ced7db74ff10d177f","dara-biosciences","venture",NA,"2009-06-15",1397000
"969bec88624ac85d95aba579982acb57","daric","angel",NA,"2012-01-01",NA
"5baa9d8e36fc97d9cabf9a2f56d13dde","dark-reading",NA,NA,NA,NA
"1c50bf536f8a02a3f40aa94316dba2df","darkhorse-analytics",NA,NA,NA,NA
"afef6ff0fc9acad726dfb1b356b2c9fd","das-group-of-solutions","undisclosed",NA,"2015-03-20",5118761
"04f5bc94a78d4ea2526b5e47021f95ea","dashburst","equity_crowdfunding",NA,"2014-05-21",15529
"d52117c1dc6979b0ccd564b00520c946","dasheroo","venture","A","2015-05-05",3250000
"d79ed0d2353699c853058a29bee73276","dashgo",NA,NA,NA,NA
"5b92388010744677603c649621863d9f","dashtab-by-bitmatica",NA,NA,NA,NA
"dedb5c815415d170a9c92b5115ec00d2","dashthis","seed",NA,"2014-03-01",NA
"46b6fcdf66fdbfbbf3e53ed33608a332","dat-venture",NA,NA,NA,NA
"c563709739c4ffdfe111cb5c6644f765","data-by-design",NA,NA,NA,NA
"27977bca4f854c9d43c5b999514f890a","data-craft-and-magic","seed",NA,"2013-09-18",33474
"27977bca4f854c9d43c5b999514f890a","data-craft-and-magic","seed",NA,"2014-01-01",34419
"aa38b454ba3788c9e6fe4558d584d4cd","data-explorers",NA,NA,NA,NA
"dcc8bbbfc72136d557f1351d7e478a12","data-extraction-services",NA,NA,NA,NA
"0dcb55f2ca54f1c5b8e313c309585cbc","data-foundations",NA,NA,NA,NA
"122a21ca8d45ff7c6e65e35d6a5f60d0","data-jelly",NA,NA,NA,NA
"1e5c7619cf93e6e1aa12077a18c57d70","data-layers",NA,NA,NA,NA
"ea469120b03ab7eb442ec7720c61621b","data-management-warehousing",NA,NA,NA,NA
"0316a365f1a2283e5c9661b99f6806b3","data-mining-expert-solutions",NA,NA,NA,NA
"960caf3a1dfd1b930b2ec5db42bc78a2","data-mining-systems",NA,NA,NA,NA
"6145a8dfbc2110f5e9b937e9b273d35b","data-razor",NA,NA,NA,NA
"eb0617fbe396902c4af2a61370cdc53c","data-science-central",NA,NA,NA,NA
"a7f48769ad40ad9a8708d67375d72b38","data-scraping-services-3",NA,NA,NA,NA
"8197ff5a633b7fb7aac9be3e6fbcc40d","data-tamer",NA,NA,NA,NA
"1f84b27bfffe121daa70ae36dfb1d532","data-techniques",NA,NA,NA,NA
"57d9e9869ea8f97683dae54e2342a733","databarta",NA,NA,NA,NA
"9c4e78e3196d096754c3e21fead67c3d","database-consultants-incorporated",NA,NA,NA,NA
"76b83cbac479ff5ccb84324d8ef5a058","databean",NA,NA,NA,NA
"e72962bd7f0d3f44cac38f2bb7fcdb54","databerries","seed",NA,"2015-12-10",1858566.7171
"8e88e709e0f5e11f6e236768cdd68a12","databox","angel",NA,"2013-03-01",4e+05
"8e88e709e0f5e11f6e236768cdd68a12","databox","seed",NA,"2015-09-03",3300000
"b70eee8a83db997a509c464724b37278","databricks","venture",NA,"2013-09-25",1.4e+07
"b70eee8a83db997a509c464724b37278","databricks","venture","1","2014-06-30",3.3e+07
"d09546687659fc36eb3a6071b3a4f77b","data-camp","venture",NA,"2015-10-01",1200000
"d09546687659fc36eb3a6071b3a4f77b","data-camp","seed",NA,"2013-12-13",40000
"d09546687659fc36eb3a6071b3a4f77b","data-camp","seed",NA,"2015-07-14",1e+06
"8d2122293d272ba860fcc1925613a0e8","datacapable",NA,NA,NA,NA
"723459b2fa677cdce1280a9bf3b0880d","snehta","venture",NA,"2011-10-18",2800000
"723459b2fa677cdce1280a9bf3b0880d","snehta","seed",NA,"2013-01-23",2100000
"723459b2fa677cdce1280a9bf3b0880d","snehta","seed",NA,"2014-01-01",2e+06
"d42317b4aefab42a9983f8bfbf73d765","datacoup","seed",NA,"2013-01-11",440000
"074c116a22ae34d890fcad5e74347936","datacracker",NA,NA,NA,NA
"99440b9585cfba84c72f9a8f3f3dacb8","datacratic","seed",NA,"2012-07-24",2e+06
"f366a976bdd4ca8b8cbac793c76f80ff","dataculture-inc-","convertible_note",NA,"2015-10-22",125000
"ef0501aa4d152876add4ef878d6fab22","dataddo-com",NA,NA,NA,NA
"21946825bc8a885d1ade2537a59b51dc","datadecision","seed",NA,"2012-07-01",37903
"de1eb669f22856114e7abd23112cc581","datadolphin",NA,NA,NA,NA
"51181de6ae02be611bd0921b77838a3b","dataentryoutsourcced",NA,NA,NA,NA
"fa8e8dc3b442039ac25b80b558b6893d","dataerion",NA,NA,NA,NA
"dde8b2b12e146dce5bae751f740b0b14","datafiniti",NA,NA,NA,NA
"8a224aad06f086f0019e25843324e62d","datafox","venture",NA,"2008-12-01",9e+05
"8a224aad06f086f0019e25843324e62d","datafox","seed",NA,"2013-10-01",1800000
"8a224aad06f086f0019e25843324e62d","datafox","seed",NA,"2014-02-09",NA
"8a224aad06f086f0019e25843324e62d","datafox","seed",NA,"2015-07-22",5e+06
"af3b8a0727aa95a021144c1618e0d45b","datagami",NA,NA,NA,NA
"6b6068c230a0324748201dd14d4cee02","datagnion",NA,NA,NA,NA
"af5aa2166593dd5b9b36bee1bad238d0","datahero","seed",NA,"2012-05-31",1e+06
"af5aa2166593dd5b9b36bee1bad238d0","datahero","seed",NA,"2013-12-10",3150000
"af5aa2166593dd5b9b36bee1bad238d0","datahero","venture","1","2015-05-19",6100000
"79ecc3058bab1cf81a5bdeda98af5388","datahug","seed",NA,"2011-10-28",1500000
"79ecc3058bab1cf81a5bdeda98af5388","datahug","venture","1","2013-05-01",4e+06
"db95d288f0d2e5e714ab158e6b4bf706","dataiku","venture","A","2015-01-19",3700534
"014b4a60382b21760bdadb792878053b","datainsight-io-2",NA,NA,NA,NA
"d605746d060becd26c0cc8ee342c3974","dataium","venture",NA,"2010-09-24",6e+05
"d605746d060becd26c0cc8ee342c3974","dataium","venture",NA,"2010-02-17",148000
"d605746d060becd26c0cc8ee342c3974","dataium","seed",NA,"2012-09-01",30000
"d605746d060becd26c0cc8ee342c3974","dataium","seed",NA,"2012-11-01",1970000
"d605746d060becd26c0cc8ee342c3974","dataium","seed",NA,"2013-09-01",156714
"d605746d060becd26c0cc8ee342c3974","dataium","seed",NA,"2014-02-20",2e+05
"aae0443def8d6acd70ac12a9148e3c33","datakind",NA,NA,NA,NA
"e6720f0b0b91ed69e09a5fcc3816cf0c","datalabs-australia",NA,NA,NA,NA
"d3aa2f72e43b1292d0f3ae888d7df4d4","datalion",NA,NA,NA,NA
"76e6e10f9346e9a95374ca452d762925","datalytics-ie",NA,NA,NA,NA
"4e1c64cad6a06ff1ecbea48aaee8c2c6","datamaglia",NA,NA,NA,NA
"64728f1758bf6c3db4cf88f73de70ab7","datameer","venture","a","2010-04-15",2500000
"64728f1758bf6c3db4cf88f73de70ab7","datameer","venture","b","2011-05-16",9250000
"64728f1758bf6c3db4cf88f73de70ab7","datameer","venture","d","2013-12-17",1.9e+07
"64728f1758bf6c3db4cf88f73de70ab7","datameer","venture","c","2012-09-26",6e+06
"64728f1758bf6c3db4cf88f73de70ab7","datameer","venture","E","2015-08-18",4e+07
"cddf7e5397ac08beaaa0b8f9c8161a73","datamentors","undisclosed",NA,"2014-02-05",NA
"ae021f99adedaeee17e9f2a76c034d3e","datamine-lab",NA,NA,NA,NA
"4a5a1f99423c052c8da39e43d703a8b8","dataminr","secondary_market",NA,"2015-09-30",NA
"4a5a1f99423c052c8da39e43d703a8b8","dataminr","venture","1","2011-07-26",1086000
"4a5a1f99423c052c8da39e43d703a8b8","dataminr","venture",NA,"2010-08-17",1980000
"4a5a1f99423c052c8da39e43d703a8b8","dataminr","venture","1","2012-09-24",16500000
"4a5a1f99423c052c8da39e43d703a8b8","dataminr","venture","1","2013-06-12",3e+07
"4a5a1f99423c052c8da39e43d703a8b8","dataminr","venture","1","2015-03-17",1.3e+08
"d8fb824835da0e359deae0841f2976f3","datamonkey",NA,NA,NA,NA
"edb96fa1807f4c416d6261f07ebfe1e1","datamyne","venture",NA,"2010-01-14",750000
"34bb92d5edbdfb050107937b98f779be","datamyze",NA,NA,NA,NA
"8107a98d6e2ac2eb60eded740fe39026","datanomy",NA,NA,NA,NA
"3d148d4f7c96cc4f05bc9912f6618c79","datanovo-inc-",NA,NA,NA,NA
"f3a44111cf553d017f2381aad24b94a1","datanyze","seed",NA,"2014-08-25",2e+06
"141ddb50615f805665f2ce929808de65","dataotuan-com",NA,NA,NA,NA
"c392b38b806f6e107bb83e7c040ce5f6","datapad-inc","seed",NA,"2013-01-01",1700000
"e75c10a81942dcbdbda6b5dfb70869cc","datapeak",NA,NA,NA,NA
"473bb24e2ccf6283b694394468cfd3ac","dataperx-global",NA,NA,NA,NA
"448339285346ce78ce0121809ee4aae7","datapine","seed",NA,"2013-03-01",NA
"448339285346ce78ce0121809ee4aae7","datapine","venture","1","2013-10-22",NA
"448339285346ce78ce0121809ee4aae7","datapine","seed",NA,"2012-09-01",NA
"448339285346ce78ce0121809ee4aae7","datapine","venture","1","2014-12-01",NA
"448339285346ce78ce0121809ee4aae7","datapine","venture","1","2015-09-21",3e+06
"a6b6aa2e6cc57016cfec0f32805eac3c","data-prophet-pty-ltd-",NA,NA,NA,NA
"ff29e2c399e548cb8c56624319a48b6b","dataquest-2",NA,NA,NA,NA
"24de705b43255a196b3d1d1ef362d2ae","dataracks",NA,NA,NA,NA
"f45151eb1f90464c54a7bb5f808521e9","datarake",NA,NA,NA,NA
"4dfd6f36485c2f3161830aec1bf29b39","dataraker",NA,NA,NA,NA
"418812a193bb1ffc34e8da5ba291b10f","datarati",NA,NA,NA,NA
"34b246df1af30d005e5af0314a1d0234","datarella",NA,NA,NA,NA
"d85e447cb4929be471d76763eeb3a945","datarobot","seed",NA,"2013-01-14",118000
"d85e447cb4929be471d76763eeb3a945","datarobot","seed",NA,"2013-09-16",3300000
"d85e447cb4929be471d76763eeb3a945","datarobot","venture","1","2014-08-15",2.1e+07
"4dc744ca7a4237db20d7261aa3776956","datarpm","seed",NA,"2013-11-14",8e+05
"4dc744ca7a4237db20d7261aa3776956","datarpm","venture","1","2014-03-11",5100000
"03a22135b920bf3ff11a4874a0f332d5","datascience-inc-","venture","A","2015-12-12",2.2e+07
"03a22135b920bf3ff11a4874a0f332d5","datascience-inc-","venture","A","2015-06-02",4500000
"03a22135b920bf3ff11a4874a0f332d5","datascience-inc-","seed",NA,"2014-06-24",1500000
"77fb49f3caabc2d2e3a4350ab2868a33","datascoops",NA,NA,NA,NA
"12c477390bdd14a94a41f2b19b4ec2cd","datascope-analytics",NA,NA,NA,NA
"408379b17ec00d91adcc5c6c83679519","datascore",NA,NA,NA,NA
"063812a1d64bbd7d6fdc6d2480da5358","datashaka",NA,NA,NA,NA
"658e33b07fa5435b9234f84a287bd51e","datasift","venture","a","2012-05-02",7200000
"658e33b07fa5435b9234f84a287bd51e","datasift","venture","b","2012-11-12",1.5e+07
"658e33b07fa5435b9234f84a287bd51e","datasift","venture","c","2013-12-03",4.2e+07
"658e33b07fa5435b9234f84a287bd51e","datasift","seed",NA,"2010-01-01",1500000
"658e33b07fa5435b9234f84a287bd51e","datasift","venture","a","2011-07-11",6e+06
"658e33b07fa5435b9234f84a287bd51e","datasift","secondary_market",NA,"2014-01-24",6192396
"f6310f6e8a69183afca8c95ae06062b1","datasmoothie","seed",NA,"2015-02-05",NA
"0cc1fda20f15197e027a198e7241dcef","datasnap-io","angel",NA,"2014-09-22",1250000
"43f220024a2eb6907797fd5a84803601","datasong",NA,NA,NA,NA
"5ac20062e882dbd2ffc63b3de7657152","dataspora",NA,NA,NA,NA
"376137c8ebb4614fb84cb29a316e1384","datastack",NA,NA,NA,NA
"f5de21a0181df6396fe9037ff3975743","datastorm",NA,NA,NA,NA
"d50fa72abf07e500b90c6f1ca6a6cf7d","dataswft",NA,NA,NA,NA
"644555e8c1ac1495bb4d6412b5310bd2","datatamer",NA,NA,NA,NA
"34e622315c8c4bf51acc18ba1113df2e","datatorrent","venture","a","2013-06-26",8e+06
"34e622315c8c4bf51acc18ba1113df2e","datatorrent","seed",NA,"2012-05-01",750000
"34e622315c8c4bf51acc18ba1113df2e","datatorrent","venture","B","2015-04-28",1.5e+07
"0e73652f22ea720b027eaae309dc6a2f","datatracker","seed",NA,"2012-06-01",16000
"e57957fa4def65b99a28a57680e6740d","datatraks",NA,NA,NA,NA
"1d25a3f178f13366fe236dcd7a60cc0a","datavail","venture","D","2015-12-16",4.7e+07
"1d25a3f178f13366fe236dcd7a60cc0a","datavail","venture","b","2009-12-21",1500000
"1d25a3f178f13366fe236dcd7a60cc0a","datavail","venture","a","2008-01-25",5825000
"1d25a3f178f13366fe236dcd7a60cc0a","datavail","venture","c","2012-09-06",4250000
"1d25a3f178f13366fe236dcd7a60cc0a","datavail","venture",NA,"2014-03-26",2115000
"55f73465b8c1a0958f313c03e72b5c13","datavisor","venture","A","2015-10-13",14500000
"7c98cc1d26abc9e9b5b251b70924442c","datavore",NA,NA,NA,NA
"b558a552e7c0d5bf110e8cbec0e583a5","dataweave",NA,NA,NA,NA
"eb48234a97c0da361f6464d1875ff100","datawiz-io","seed",NA,"2013-12-25",NA
"156169a679a268b13910239dfb2cd6bf","dataxu","venture",NA,"2016-01-25",1e+07
"156169a679a268b13910239dfb2cd6bf","dataxu","venture","1","2009-04-17",7800000
"156169a679a268b13910239dfb2cd6bf","dataxu","venture","1","2013-02-07",2.7e+07
"156169a679a268b13910239dfb2cd6bf","dataxu","venture","1","2010-03-08",1.1e+07
"156169a679a268b13910239dfb2cd6bf","dataxu","venture","1","2014-02-05",1e+07
"8fa358aefe3f7fd88c702bed6be0c0c9","dataxylo",NA,NA,NA,NA
"0409b1ef49a0324a26c313dd8be54f0d","datazar",NA,NA,NA,NA
"69e9f943946e5786e5829c694ef55765","datelligence",NA,NA,NA,NA
"c193bcefa6fad07eb3ee15d3b2ec9565","datelytics",NA,NA,NA,NA
"54f85c87fe1acc318ebdcae688e5bc39","datiphy","venture","A","2015-09-22",7e+06
"714661e9690a8f710dd518db39cf01b9","datknosys",NA,NA,NA,NA
"4a936e7660b129597c804e4091f548a9","datmachine",NA,NA,NA,NA
"bad387dca7cf4eabb153200e2dd18522","graphlab","venture","a","2013-05-14",6750000
"bad387dca7cf4eabb153200e2dd18522","graphlab","venture","B","2015-01-08",18500000
"d5cffa5e78026ca6837241464873d561","datometry","seed",NA,"2014-05-30",1e+06
"f02edb8635df352555d88958c0760ff3","datonics",NA,NA,NA,NA
"355ceda22cb207d661f2e796823f62ef","datoral",NA,NA,NA,NA
"e3bf70654b6ce4392b8a57c5635b7148","datosphera",NA,NA,NA,NA
"ab3e8a0945df8e746de66ac23e152558","datric-inc-",NA,NA,NA,NA
"6f8301725478f3593e2506ababc7da98","datu-health",NA,NA,NA,NA
"2feaeff15401183875e029badd6b5f3e","datumetrics",NA,NA,NA,NA
"47f2a8bb5450b8061fd48c0e8f3f10a0","datumize","seed",NA,"2014-06-20",NA
"47f2a8bb5450b8061fd48c0e8f3f10a0","datumize","seed",NA,"2015-01-01",18192
"e8b1827b9c3d10680d09b79cb30b54a4","daty","seed",NA,"2014-04-01",64330
"a7f9cc46a6898933015cf4b543ce1ae7","daumsoft",NA,NA,NA,NA
"c963efd82c1497304fcd36ac61a07e68","dauria-aerospace","seed",NA,"2011-12-31",NA
"c963efd82c1497304fcd36ac61a07e68","dauria-aerospace","venture","1","2012-01-01",NA
"c963efd82c1497304fcd36ac61a07e68","dauria-aerospace","venture","1","2013-10-01",2e+07
"97b028f543556576387c458c3ac411b5","davita",NA,NA,NA,NA
"945971fa7f8fcc6768bca81fe55c690e","daxtra-technologies",NA,NA,NA,NA
"1a6f9236acd3fc1671b09d53c9760823","daylight-solutions","venture","a","2006-06-28",7500000
"1a6f9236acd3fc1671b09d53c9760823","daylight-solutions","venture","A","2007-07-10",6500000
"1a6f9236acd3fc1671b09d53c9760823","daylight-solutions","venture",NA,"2009-11-17",2e+06
"1a6f9236acd3fc1671b09d53c9760823","daylight-solutions","venture","c","2011-07-11",1.5e+07
"fcea26be500e2422f59b9198f6c1bfe4","daytum",NA,NA,NA,NA
"b59259371e881fba070b8574a17531b9","db---corporate-social-platforms--db-csp-","angel",NA,"2015-03-01",1e+06
"5ad3bf749c403f3803b1f90799c48993","db-best-technologies",NA,NA,NA,NA
"39c6ad061ecc8a810d48b9271bac316e","dbs-h-ltd","seed",NA,"2015-03-01",910000
"9b676356b2911df5c3a472c9aba38fde","dbsync",NA,NA,NA,NA
"8a508561ccab2528ff1d869c9b44391d","dbv-technologies","venture",NA,"2010-12-17",2700000
"8a508561ccab2528ff1d869c9b44391d","dbv-technologies","venture","1","2011-01-05",25500000
"8a508561ccab2528ff1d869c9b44391d","dbv-technologies","post_ipo_equity",NA,"2015-07-21",281500000
"0114429eb6521d7a24a38a630c12cf72","dbvu","seed",NA,"2010-01-28",121857
"9b8377d62ab6068965308f813397219e","dds-strategy",NA,NA,NA,NA
"67c8359f969aa130db0937e49762ffa6","de-burca-consulting",NA,NA,NA,NA
"43f7f54f216c0b2e67c501da7d8bbfe9","deacom-inc",NA,NA,NA,NA
"ded1d2d8669146b86a15efb56bea5594","deak-esport-lp",NA,NA,NA,NA
"c4a076e136ee152441e63d3746fc131c","deal-explorer",NA,NA,NA,NA
"cb16dae849011a9f1383635ec3e75550","dealscorecard",NA,NA,NA,NA
"518d47fe6cfaa4e88f5a1519f4a6b93a","dealscreening-com",NA,NA,NA,NA
"deb8e3188e0167722312f5e5dd39e724","dealyze","seed",NA,"2014-12-01",120000
"f329adab484267eb6387bc4fb30906d1","debateit",NA,NA,NA,NA
"2bcd048f89823e3835fa06a528ab440a","debiotech",NA,NA,NA,NA
"78a7153a0bf5272164095d17f6821689","debtgoner",NA,NA,NA,NA
"bc20303edcd4ec87a9b3728663912a38","debuggify-net",NA,NA,NA,NA
"a295d6edfb2510de9ac26f4c3bfd1675","decibel-insight",NA,NA,NA,NA
"bb3135487d5e389baa82e63e1ccf1e0b","decibel-therapeutics","venture","A","2015-10-15",5.2e+07
"594ee64795207f2e6e1739fcd4c71a43","decide-com","venture","a","2010-01-01",2500000
"594ee64795207f2e6e1739fcd4c71a43","decide-com","venture","b","2011-04-19",6e+06
"594ee64795207f2e6e1739fcd4c71a43","decide-com","venture","c","2013-03-01",8e+06
"5594192af34d0db2a2eaa0ba5c018997","decide-soluciones",NA,NA,NA,NA
"2b642bfad67e55f0533132b6876173bf","decimmune-therapeutics","private_equity",NA,"2013-02-26",2250000
"2b642bfad67e55f0533132b6876173bf","decimmune-therapeutics","venture",NA,"2010-09-27",3200000
"2b642bfad67e55f0533132b6876173bf","decimmune-therapeutics","grant",NA,"2014-10-03",3e+06
"47d0830ec9f929d92bfa0e624f49e8c1","decision-diagnostics","debt_financing",NA,"2013-12-19",12500000
"5151c8695a94c4fb625619f8a642103b","decision-fuel",NA,NA,NA,NA
"6abaa5358c8b54f3124d2e476f734cd5","decision-services-international",NA,NA,NA,NA
"61a72c975b1f7772a9dcbe1d13621684","decision-street",NA,NA,NA,NA
"b2302cfa6d5258fadd8c38b7f779c032","decisioniq",NA,NA,NA,NA
"c70640244f23681c1c91fbaed2103f7c","decisive-analytics-corporation",NA,NA,NA,NA
"b0dd4f51c6070e847dae1162ce2710e1","decisive-bi","angel",NA,"2011-01-15",NA
"f8aa643a5f4fe85708b2adf42c2f680f","decooda",NA,NA,NA,NA
"7ffd5655d647a2c08be8e73b2b1a26be","dectris",NA,NA,NA,NA
"743009e7244ea1df4415e7462e911b87","dedalus-group","private_equity",NA,"2014-01-22",64330000
"a86d2950bddf6c28da0be9c10255e983","deducta",NA,NA,NA,NA
"4720210e65df2c4a92aff08f19482e9d","deep-blue-analytics",NA,NA,NA,NA
"992805f753f11cf996fc3ae214daca80","deep-domain","debt_financing",NA,"2012-12-31",393817
"992805f753f11cf996fc3ae214daca80","deep-domain","convertible_note",NA,"2014-06-27",1e+05
"992805f753f11cf996fc3ae214daca80","deep-domain","venture",NA,"2015-04-23",30000
"992805f753f11cf996fc3ae214daca80","deep-domain","venture",NA,"2015-07-21",260507
"914fcbb9be98f34999becae15b4ff632","deep-genomics","seed",NA,"2015-11-18",3700000
"9d324eda31c11851c718708e721bd9f1","deep-glint","angel",NA,"2013-06-01",1e+06
"9d324eda31c11851c718708e721bd9f1","deep-glint","venture","1","2014-06-01",1.7e+07
"9d324eda31c11851c718708e721bd9f1","deep-glint","venture",NA,"2012-09-01",NA
"8d7315dcff360b021333712907006126","deep-information-sciences-inc","venture","a","2013-01-01",1e+07
"8d7315dcff360b021333712907006126","deep-information-sciences-inc","venture","A","2015-04-22",8e+06
"5cc9687c9a5f698abf42c30c0c4e4eb6","deep-vision",NA,NA,NA,NA
"af651a89fbcf1928133147af8b3a1980","deepdyve","venture","a","2009-10-05",5e+06
"af651a89fbcf1928133147af8b3a1980","deepdyve","venture",NA,"2009-09-02",375000
"26e5d30b196fe9d0728a41bd4ee99942","deepfield","seed",NA,"2011-09-30",1525000
"dff8471056294fc256d05d0000af665d","deepomatic","debt_financing",NA,"2015-09-01",5e+05
"dff8471056294fc256d05d0000af665d","deepomatic","seed",NA,"2015-09-14",950000
"76557ce8245650485a713c4097256d53","vufind","seed",NA,"2012-07-01",5e+05
"76557ce8245650485a713c4097256d53","vufind","angel",NA,"2010-09-01",250000
"76557ce8245650485a713c4097256d53","vufind","seed",NA,"2011-12-01",180000
"e2373995e8e73b608b899ac7b61434bc","deferpanic","seed",NA,"2015-11-01",36000
"65c16107e2b094e2b5daf4375da6ae90","defined-clarity",NA,NA,NA,NA
"b8f16a250b58ec3ce3d6606f4924ed55","definedefforts",NA,NA,NA,NA
"21a4f7cb69b662a1aa78319d8f8d33c8","definicare","venture",NA,"2009-07-20",3e+06
"95474869e2086b0e4f4308faf4673f6f","definiens","venture",NA,"2012-10-01",12877000
"95474869e2086b0e4f4308faf4673f6f","definiens","venture",NA,"2014-06-23",20395398
"d308b866a466f86adcdf5dbf9fa6a362","definigen","venture","A","2013-12-12",2130705
"d308b866a466f86adcdf5dbf9fa6a362","definigen","venture","A","2014-06-02",3820311
"4e6ef3842a3dd4f7a65bac1d92c241ab","deibel-laboratories",NA,NA,NA,NA
"de3216b58a985936841356a5a3bf73ee","deipe",NA,NA,NA,NA
"b3800b455673228fb6bdcd8e11a3759e","dejima",NA,NA,NA,NA
"b060a2710b58a796bf7c8be8e174240e","dekalb-surgical-alliance","venture",NA,"2010-06-18",35000
"251690a0ba1264f1e45153a30cd9217c","dekiba",NA,NA,NA,NA
"7b6a1f490f7831b5001058eaaa6abda4","dekkun","venture",NA,"2011-01-10",1e+07
"b7fe63b973d7053ff928997e3fdb4599","del-mar-pharmaceuticals","venture",NA,"2013-03-07",10500000
"b7fe63b973d7053ff928997e3fdb4599","del-mar-pharmaceuticals","post_ipo_equity",NA,"2015-08-20",2600000
"88d85ae93aab2cca0e8e65490b125795","delcam",NA,NA,NA,NA
"57519c419aef9c03a1b267a747c5d4d8","delcath-systems",NA,NA,NA,NA
"68f3b8ebc258e7cc3aed6d6346de84a1","delenex-therapeutics","venture","a","2011-05-03",19300000
"68f3b8ebc258e7cc3aed6d6346de84a1","delenex-therapeutics","venture","a","2010-11-12",1.4e+07
"68f3b8ebc258e7cc3aed6d6346de84a1","delenex-therapeutics","venture","a","2013-11-06",8e+06
"a68aab0d11adb07d32f0cee58bbbeb7a","delfly",NA,NA,NA,NA
"a137a7833c3a13fb8335f719e61c84d5","delivercarerx","venture",NA,"2015-11-10",10379399
"a137a7833c3a13fb8335f719e61c84d5","delivercarerx","debt_financing",NA,"2014-04-07",3e+05
"9523e3d712de00993b204e802227cfa4","deliverish",NA,NA,NA,NA
"0ce857a76a6aecf63a31adaff1079f32","delmondo",NA,NA,NA,NA
"ace005687bc8daf79b259affe806a384","delpor","venture",NA,"2010-06-16",900492
"ace005687bc8daf79b259affe806a384","delpor","debt_financing",NA,"2013-10-03",470000
"e7792ac6bbe539b9145e14739e2d554b","delta-energy---communications--llc","debt_financing",NA,"2015-10-30",250000
"e7792ac6bbe539b9145e14739e2d554b","delta-energy---communications--llc","debt_financing",NA,"2015-02-06",2e+05
"e7792ac6bbe539b9145e14739e2d554b","delta-energy---communications--llc","debt_financing",NA,"2015-08-04",5e+05
"0d9c99bcabfdff901bffd69f6f369e6e","deltadna","venture","a","2013-07-16",1300000
"0d9c99bcabfdff901bffd69f6f369e6e","deltadna","venture","A","2014-11-03",3e+06
"57eccaee81e2ee5d28660d0cde5813fb","deltagen","venture",NA,"2009-12-21",1500000
"86180168772780ac4ebbbd858f6032b1","deltasight","seed",NA,"2012-03-23",135000
"86180168772780ac4ebbbd858f6032b1","deltasight","seed",NA,"2013-04-01",2e+05
"86180168772780ac4ebbbd858f6032b1","deltasight","seed",NA,"2011-09-19",43000
"d5200654434da561efed322d4f0b7a42","delver-ltd","angel",NA,"2014-02-26",169451
"d5200654434da561efed322d4f0b7a42","delver-ltd","seed",NA,"2013-04-22",47025
"a9124b83929b18d7dfadc297fb1ed942","demand-analytics",NA,NA,NA,NA
"bd22ad580fa73d1d3077a01da5bd6a84","demandbase","venture","d","2013-03-28",1.5e+07
"bd22ad580fa73d1d3077a01da5bd6a84","demandbase","venture","c","2011-05-12",1e+07
"bd22ad580fa73d1d3077a01da5bd6a84","demandbase","venture","b","2008-08-25",8e+06
"bd22ad580fa73d1d3077a01da5bd6a84","demandbase","venture","F","2014-10-13",1.5e+07
"bd22ad580fa73d1d3077a01da5bd6a84","demandbase","venture","E","2014-03-24",1.5e+07
"bd22ad580fa73d1d3077a01da5bd6a84","demandbase","venture","G","2015-07-15",3e+07
"9201648cbb49127f6fae0b41b3ace3a7","demandresults",NA,NA,NA,NA
"d2f429367947750515ec47f9db6374fb","demer",NA,NA,NA,NA
"3f929c40044d870022a961d7ff886f83","demografies","seed",NA,"2015-05-22",5000
"6ce04005e19fdf64418591013ce32d65","demonstranda","seed",NA,"2012-05-15",8000
"6ce04005e19fdf64418591013ce32d65","demonstranda","seed",NA,"2012-07-15",40000
"6ce04005e19fdf64418591013ce32d65","demonstranda","seed",NA,"2013-05-15",17000
"6ce04005e19fdf64418591013ce32d65","demonstranda","seed",NA,"2013-07-15",17000
"8291ea135372b90c59860fd519791fbc","demystdata","venture","a","2012-08-28",NA
"8291ea135372b90c59860fd519791fbc","demystdata","undisclosed",NA,"2013-05-08",NA
"8291ea135372b90c59860fd519791fbc","demystdata","venture","A","2014-05-28",5e+06
"aa85c39b4a8a960ecfef063129816e28","denali-therapeutics","venture","A","2015-05-14",2.17e+08
"291996cfba22dc4f5cb5b4ddf90c5167","denator","venture","d","2011-01-10",1700000
"291996cfba22dc4f5cb5b4ddf90c5167","denator","venture","b","2007-02-01",2160000
"291996cfba22dc4f5cb5b4ddf90c5167","denator","venture","f","2012-04-04",3800204
"291996cfba22dc4f5cb5b4ddf90c5167","denator","venture","a","2006-04-20",664000
"db043c25c9bd125475f8c6db3fad7726","dendreon",NA,NA,NA,NA
"2af64c4d155473648829dafa1e841d50","dendreon-corp-",NA,NA,NA,NA
"7ee3035f8dcb83db14a80728e0b50ffe","denovo-sciences","undisclosed",NA,"2012-05-06",NA
"7ee3035f8dcb83db14a80728e0b50ffe","denovo-sciences","debt_financing",NA,"2013-11-27",1e+06
"7ee3035f8dcb83db14a80728e0b50ffe","denovo-sciences","debt_financing",NA,"2012-04-02",310000
"7ee3035f8dcb83db14a80728e0b50ffe","denovo-sciences","venture",NA,"2014-10-20",2e+06
"7ee3035f8dcb83db14a80728e0b50ffe","denovo-sciences","debt_financing",NA,"2015-09-24",1285000
"ec026613cf7358fe948a62da7dedf810","dens-io",NA,NA,NA,NA
"c18f68ff08714ac88d666dfde639fce6","density",NA,NA,NA,NA
"bfd6180e1f18890fdef194d9deeec08e","dental-kidz","debt_financing",NA,"2012-11-19",2e+05
"e46ffa6c9dcedaf7d00150cde3e7957a","dental-wings",NA,NA,NA,NA
"ca44870bf39e3d476636c188e704e8ef","dentsu-aegis-network",NA,NA,NA,NA
"ff94c8f0e4fc34b5a7f8f3e06b9fac13","denville-scientific",NA,NA,NA,NA
"ea3c09babfe11ddbb4a07241753b24b2","depositphotos","venture","B","2015-12-17",5e+06
"ea3c09babfe11ddbb4a07241753b24b2","depositphotos","venture","a","2011-07-27",3e+06
"fd4d9726deec84f65197a39153f7a696","dermagen","undisclosed",NA,"2008-04-02",NA
"fb996a00f683e22b6b0bfdcd859e8bc0","dermata-therapeutics","venture",NA,"2015-06-12",651305
"6cf68419e6069b36a9426b9ed324d674","dermira","venture","a","2011-10-20",4.2e+07
"6cf68419e6069b36a9426b9ed324d674","dermira","venture","b","2013-06-11",3.5e+07
"6cf68419e6069b36a9426b9ed324d674","dermira","venture","C","2014-08-19",5.1e+07
"0c6c82366d3b9803ab2f0009c24813b5","dermtech-international","venture","b","2013-08-20",5600000
"0c6c82366d3b9803ab2f0009c24813b5","dermtech-international","venture",NA,"2008-03-24",11158700
"0c6c82366d3b9803ab2f0009c24813b5","dermtech-international","debt_financing",NA,"2015-04-14",2441068
"0c6c82366d3b9803ab2f0009c24813b5","dermtech-international","venture",NA,"2015-11-13",4314872
"d333b84a7d225d972ea9ebc380fe0827","desa-kreativ",NA,NA,NA,NA
"a239f99067c2d215b3ceea78227a96a6","descartes-biometrics",NA,NA,NA,NA
"8b93d59511e5bd0ef463ea2c0b80858b","descsoft",NA,NA,NA,NA
"f9fc862392ee15a25bb47818dde390df","desecuritrex-llc","equity_crowdfunding",NA,"2012-05-03",NA
"2526dd8961d95d5638f36edfeac1f43a","desic",NA,NA,NA,NA
"3897bf6911d8f8eb2b78a80d2443d440","designmedix","venture",NA,"2010-06-17",1175000
"3897bf6911d8f8eb2b78a80d2443d440","designmedix","venture",NA,"2013-07-16",7056053
"3897bf6911d8f8eb2b78a80d2443d440","designmedix","grant",NA,"2014-04-15",3e+06
"3897bf6911d8f8eb2b78a80d2443d440","designmedix","venture","1","2014-07-17",1500000
"82dc392c60ec9aa3831b566ee6fe4695","designmind",NA,NA,NA,NA
"d0da12a105c01b15ea0106a7a5eb9a10","deskgod","seed",NA,"2013-02-14",86625
"91b5aa0ee77886aed3fc550d92d67dc9","deskmetrics","seed",NA,"2010-12-20",2e+05
"91b5aa0ee77886aed3fc550d92d67dc9","deskmetrics","seed",NA,"2012-02-10",40000
"91b5aa0ee77886aed3fc550d92d67dc9","deskmetrics","seed",NA,"2012-01-01",40000
"26c5eabf630888e2b2e2005ebdd7eb01","desktime",NA,NA,NA,NA
"837c93159d67782ee62be4b61c80d612","desktop-genetics","venture",NA,"2016-01-11",NA
"837c93159d67782ee62be4b61c80d612","desktop-genetics","seed",NA,"2013-01-22",NA
"837c93159d67782ee62be4b61c80d612","desktop-genetics","venture",NA,"2013-08-31",275000
"837c93159d67782ee62be4b61c80d612","desktop-genetics","grant",NA,"2013-08-31",1e+05
"837c93159d67782ee62be4b61c80d612","desktop-genetics","seed",NA,"2013-08-27",6e+05
"837c93159d67782ee62be4b61c80d612","desktop-genetics","seed",NA,"2012-10-12",80000
"837c93159d67782ee62be4b61c80d612","desktop-genetics","seed",NA,"2012-06-12",12000
"837c93159d67782ee62be4b61c80d612","desktop-genetics","venture",NA,"2015-09-15",2156444
"3b8fcaac5a66411e037deeb9959cc177","destination-beauty",NA,NA,NA,NA
"faa09ae5a0e8e1f3c8d91d4ba428de00","destiny-pharma","venture",NA,"2014-08-04",4709879
"81a32639e25737d102e31d8f08f148cb","detectent","venture",NA,"2010-05-03",32723
"81a32639e25737d102e31d8f08f148cb","detectent","venture",NA,"2009-04-01",13200
"81a32639e25737d102e31d8f08f148cb","detectent","venture",NA,"2011-05-18",12750
"81a32639e25737d102e31d8f08f148cb","detectent","venture",NA,"2014-05-08",21548
"3afb9c05a7d3689b78d109060324a06c","deuterx-llc","seed",NA,"2015-09-30",2800000
"d152611afcd5f636c107d25f06cd0114","devart",NA,NA,NA,NA
"692b5858d113c204f5ce9a4f5679f71b","develo-mobile",NA,NA,NA,NA
"aa4366bbeadebc08a10e4daf486a46a4","deveo",NA,NA,NA,NA
"fe4c00c9c0c40051c8d8782b4de9de8b","devgen",NA,NA,NA,NA
"87d18ac91d96370bb8778e575920930c","device-innovation-group","venture",NA,"2011-02-14",4e+06
"f3add18cd252da78270961dee77c93fa","devicematters",NA,NA,NA,NA
"38818bbe5f6ef9fb9cc3c36e397d0a1f","dewb",NA,NA,NA,NA
"c7d57663938681e46361779a22f8c061","dexela",NA,NA,NA,NA
"2848c39e9ff8cd32d3446efda546adde","deximal",NA,NA,NA,NA
"a8592b0d8e15961fdb9eb18f6635f9c9","dexknows-com-database",NA,NA,NA,NA
"4f1de20dd17a3d845bcc96707d0a7738","dexlab-analytcis",NA,NA,NA,NA
"464cc5fd27793ed99fea459f9219d381","dextro","seed",NA,"2014-06-17",1710000
"8f512abe2fcd6efbd99027cfdef65cfb","dezima-pharma",NA,NA,NA,NA
"388e58898b4daf3187ba69e6a391d75d","dementiaguide",NA,NA,NA,NA
"268941070f7b7cccc5bfae343b55c4bd","dharmacon-inc",NA,NA,NA,NA
"ab328134f9fa590f5c8571247253baab","dhrubo",NA,NA,NA,NA
"37499f719a5cc30e3d3ccda86fabafea","diabetes-care-club",NA,NA,NA,NA
"f4dc031e52545d5f0bcc154627996e3d","diabetica","venture","a","2005-06-15",1210000
"35296af4bcf6bd446795289b46ebeab3","diacarta","venture","A","2015-01-09",8e+06
"f99ca7aac2290c2c24fae3f8628c61f5","diadexus","debt_financing",NA,"2010-06-08",4500000
"f99ca7aac2290c2c24fae3f8628c61f5","diadexus","venture","1","2007-01-12",4e+07
"f99ca7aac2290c2c24fae3f8628c61f5","diadexus","venture","1","2009-02-06",9200000
"f99ca7aac2290c2c24fae3f8628c61f5","diadexus","debt_financing",NA,"2014-08-18",1.5e+07
"e3b8a0183c69da7a97ec5971313dfe07","diaferon","seed",NA,"2007-07-09",927000
"a08aac9bd6489a59622501db575bb4e6","diagenic",NA,NA,NA,NA
"559250d43e0fb1c6e877c5404665fce4","diagenode",NA,NA,NA,NA
"c35f45ff7b0559d2d54366831ff5e18b","diagnoplex","venture","a","2008-12-13",8300000
"c35f45ff7b0559d2d54366831ff5e18b","diagnoplex","venture",NA,"2013-06-07",1400000
"f385f95bdf785d8956b233f9838c51ef","diagnosoft","venture","b","2009-01-01",4e+06
"ab93f4fd61ad1453cd3aba090793f564","diagnostic-biochips","venture",NA,"2013-11-25",150000
"1126dc8df25c5b1fd4c8c7874a560bdf","diagnostic-biosystems","venture",NA,"2015-05-11",NA
"4f3a5b9a9c4fde316021c5f67b75ac84","diagnostic-healthcare","seed",NA,"2013-03-01",1503411
"84c002d99a06dd99fe429f2d7dfc1f7d","diagnostic-hybrids","undisclosed",NA,"2004-08-04",NA
"e249ca602816693f63eb512a8f910432","diagnostic-imaging-international","venture",NA,"2009-03-09",361136
"e249ca602816693f63eb512a8f910432","diagnostic-imaging-international","debt_financing",NA,"2012-12-06",1865000
"e373df8fddc9bfc8361e62c4821dcdb7","diagnostic-photonics","venture","B","2016-01-04",3e+06
"e373df8fddc9bfc8361e62c4821dcdb7","diagnostic-photonics","seed",NA,"2011-09-22",1346510
"e373df8fddc9bfc8361e62c4821dcdb7","diagnostic-photonics","convertible_note",NA,"2014-05-23",NA
"e373df8fddc9bfc8361e62c4821dcdb7","diagnostic-photonics","venture","A","2011-08-12",NA
"e701f36d44516a41d66708300c6e4e3c","diagnostic-product-corp",NA,NA,NA,NA
"2b72e00189daa06998a37168fd0839da","diagnotec",NA,NA,NA,NA
"3c2c27266d2c5572987ca72cb50a785f","dial-800-communications",NA,NA,NA,NA
"c493eacb01f272729679e43424e7a024","dialectica","venture","a","2006-01-01",1780000
"714a6b280e009bb20355df070b8bfcf5","dialedin","seed",NA,"2012-10-01",1500000
"714a6b280e009bb20355df070b8bfcf5","dialedin","seed",NA,"2013-04-01",915000
"714a6b280e009bb20355df070b8bfcf5","dialedin","seed",NA,"2013-12-01",1150000
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","venture","A","2007-08-03",2750000
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","venture","b","2010-12-28",8e+06
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","venture",NA,"2011-01-11",1958268
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","debt_financing",NA,"2009-09-09",1500000
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","venture",NA,"2012-09-12",4e+06
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","venture",NA,"2008-12-01",4600000
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","debt_financing",NA,"2010-01-19",1200000
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","venture","d","2014-01-09",9e+06
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","debt_financing",NA,"2011-12-13",2e+06
"af50251ee42bbbac0d50fcdcccb21e45","ifbyphone","seed",NA,"2005-01-01",1500000
"f5c4678c08e3481a29d687b2d319c366","diamedica",NA,NA,NA,NA
"7c66ce2bbf75a2a1bb01b3122ec7c9dc","diamond-fortress-technologies","seed",NA,"2013-06-15",1700000
"7c66ce2bbf75a2a1bb01b3122ec7c9dc","diamond-fortress-technologies","seed",NA,"2013-04-19",203000
"7c66ce2bbf75a2a1bb01b3122ec7c9dc","diamond-fortress-technologies","seed",NA,"2014-03-20",310000
"7c66ce2bbf75a2a1bb01b3122ec7c9dc","diamond-fortress-technologies","seed",NA,"2015-01-26",5e+05
"62047934f90dded6853f1b1f8d941199","diamond-kinetics","seed",NA,"2014-07-17",1100000
"eb9672975188917a23b63787c8570e92","diamyd-medical",NA,NA,NA,NA
"a73a626c07d2cc181e0c46d2dad19513","dianomi",NA,NA,NA,NA
"a7b42c42f0259683987d08ebfa9b0cc4","diartis-pharmaceuticals","undisclosed",NA,"2011-02-16",NA
"4c9515e558e06de9fa3a98fa2b11e59c","diasome","debt_financing",NA,"2009-04-13",12900000
"f2871c68d3f8ed039d63a713fc80f316","diatech-oncology","private_equity",NA,"2013-06-04",1.8e+07
"9e9a6c6472efcc185a05fc9b1cd72d4c","diatherix-laboratories","venture",NA,"2012-01-04",630030
"9e9a6c6472efcc185a05fc9b1cd72d4c","diatherix-laboratories","venture",NA,"2010-05-17",990000
"4120b1bf6dcdda65a40e6fd145b523d0","diatos","venture","D","2007-07-03",12800000
"40a10f1c2c5fa61d55cf266f6ba72167","diavacs",NA,NA,NA,NA
"a5ab766a1701ea70059d1d3cae679c7a","dibs-3","seed",NA,"2015-03-09",NA
"201d04945c2f00c0e50585494d2e285d","dibz",NA,NA,NA,NA
"487d448de8adc6a71a4ceefa0f71bcbe","dice","seed",NA,"2014-09-01",1700000
"487d448de8adc6a71a4ceefa0f71bcbe","dice","venture",NA,"2015-05-22",100827
"487d448de8adc6a71a4ceefa0f71bcbe","dice","seed",NA,"2015-08-01",2e+06
"b454986f8674079b698095983243d612","dice-molecules","venture",NA,"2015-06-18",3999990
"0abbddb724b406e0c20a8996f365726f","dicedata",NA,NA,NA,NA
"0c7091267f015f937863a6485253f7dd","dicerna-pharmaceuticals","venture","A","2008-07-15",8400000
"0c7091267f015f937863a6485253f7dd","dicerna-pharmaceuticals","venture",NA,"2010-01-04",1.24e+08
"0c7091267f015f937863a6485253f7dd","dicerna-pharmaceuticals","venture","b","2010-10-21",4e+06
"0c7091267f015f937863a6485253f7dd","dicerna-pharmaceuticals","venture","b","2010-08-05",29050628
"0c7091267f015f937863a6485253f7dd","dicerna-pharmaceuticals","venture","c","2013-07-31",6e+07
"aa7a13a45036f895ca58f8ea2538ac9f","dictanova",NA,NA,NA,NA
"20c54ca86055f57235349cc3aec37969","die-pest",NA,NA,NA,NA
"9bf8fe91db81c9c2e9e86da0d17c6d99","diffbot","angel",NA,"2012-05-31",2e+06
"9bf8fe91db81c9c2e9e86da0d17c6d99","diffbot","venture",NA,"2015-06-04",5e+05
"3ee88d9536c2306922a9cb416efe415d","diffinity-genomics","seed",NA,"2011-02-10",680199
"3ee88d9536c2306922a9cb416efe415d","diffinity-genomics","seed",NA,"2012-03-29",678260
"7b63190f49e2910df9067f2d3e5f754a","diffusion-pharmaceuticals","venture",NA,"2007-10-01",4500000
"7b63190f49e2910df9067f2d3e5f754a","diffusion-pharmaceuticals","debt_financing",NA,"2009-12-30",3853990
"7b63190f49e2910df9067f2d3e5f754a","diffusion-pharmaceuticals","debt_financing",NA,"2011-04-27",2197479
"7b63190f49e2910df9067f2d3e5f754a","diffusion-pharmaceuticals","convertible_note",NA,"2013-06-20",5e+06
"7b63190f49e2910df9067f2d3e5f754a","diffusion-pharmaceuticals","venture",NA,"2009-08-26",1803728
"7b63190f49e2910df9067f2d3e5f754a","diffusion-pharmaceuticals","venture",NA,"2012-09-17",5e+06
"7b63190f49e2910df9067f2d3e5f754a","diffusion-pharmaceuticals","convertible_note",NA,"2014-08-29",3472000
"7b63190f49e2910df9067f2d3e5f754a","diffusion-pharmaceuticals","venture",NA,"2015-06-18",4531250
"e4ccb5036738e8c45ee0e3352df41cbc","digaforce",NA,NA,NA,NA
"49f81d97969efbebc3c114bd3f065527","digene-corporation",NA,NA,NA,NA
"ac6006c5381a2c8b97d028826e5c754b","digestive-disease-associates","venture",NA,"2009-09-23",1132416
"acd94c45a1c1b8e62a841382ea917559","digi-intellect-outsourcing-solution",NA,NA,NA,NA
"261786b13db225c63b98c8320152fcea","digi-media-infotech",NA,NA,NA,NA
"9dd389508bf25b3c569c16b4890f9ec1","digifeye","seed",NA,"2014-02-01",NA
"4147e098cda3a9a674c2cf81b72bb3dc","diginome-inc",NA,NA,NA,NA
"ff51c1c6b4edf5bcee27cac99710e58b","digipath","post_ipo_equity",NA,"2014-05-13",2200000
"ff51c1c6b4edf5bcee27cac99710e58b","digipath","post_ipo_equity",NA,"2014-07-23",8199999
"6ccb07d1bccc6cb5b01dc892228a1115","digirad",NA,NA,NA,NA
"8de49d50fcc06a68ab08a80f13672969","digiscend","seed",NA,"2015-06-08",30000
"d7280f70e64435e0178644dd9187d6ab","digital-alchemy",NA,NA,NA,NA
"57bd16b3bc62debab84a199ae47fe1cb","digital-analytics-association",NA,NA,NA,NA
"874ae34d31044cb639e6866c8bf43485","digital-consulting-squared-sarl",NA,NA,NA,NA
"6f0c4ef9b2d94811e496d862612daf0a","digital-dialogue",NA,NA,NA,NA
"4aa680e801491cc93ca54e0c675e3b8a","digital-envoy","venture",NA,"2000-03-07",1200000
"5c2ea4ab57df8829c3c7250ee09e6029","seo-training-in-hyderabad-2",NA,NA,NA,NA
"8c23103a17cba219738a3c46807b9e4c","digital-h2o","convertible_note",NA,"2015-03-09",NA
"8c23103a17cba219738a3c46807b9e4c","digital-h2o","convertible_note",NA,"2014-03-09",1275000
"5a562a8830e8d68adb1c24f428c40c48","digital-health",NA,NA,NA,NA
"84acdbd24c4e42ca05faaadcc1180f0e","digital-lab","grant",NA,"2014-06-17",1e+07
"f76e60816f7c4d87637c235fa58db0e5","digital-luxury-group-dlg",NA,NA,NA,NA
"9e492ecb005f9d5844377d00f767691c","digital-measures",NA,NA,NA,NA
"15ac7aa9802651e4582f1649a8aa6b65","digital-perception","seed",NA,"2013-01-01",26409
"b145e4cc2802d73df5d9f3c35b1ff573","digital-reasoning-systems","venture",NA,"2015-12-18",5e+06
"b145e4cc2802d73df5d9f3c35b1ff573","digital-reasoning-systems","venture",NA,"2011-11-28",4209965
"b145e4cc2802d73df5d9f3c35b1ff573","digital-reasoning-systems","venture",NA,"2010-12-01",NA
"b145e4cc2802d73df5d9f3c35b1ff573","digital-reasoning-systems","seed",NA,"2014-01-08",750000
"b145e4cc2802d73df5d9f3c35b1ff573","digital-reasoning-systems","venture","1","2014-10-09",2.4e+07
"9c03f4db049039f43a833815c91c6e3e","digital-roots",NA,NA,NA,NA
"339abc953f5ef5b8596a12aa37e0e600","digital-shadows","seed",NA,"2013-09-20",NA
"339abc953f5ef5b8596a12aa37e0e600","digital-shadows","seed",NA,"2012-12-12",NA
"339abc953f5ef5b8596a12aa37e0e600","digital-shadows","venture","1","2015-02-11",8e+06
"0b7840261fa03d36b7945cbb4bee1884","digital-solid-state-propulsion","venture",NA,"2011-05-01",NA
"d42d4ae7c0e69d0ee1ffcf60050bf0f1","digital-sonata",NA,NA,NA,NA
"5b9d2f22a9ea382688766e869d246956","digital-surgeons",NA,NA,NA,NA
"86b7bc20c5a2788bc537680cdedde4b4","digital-systems",NA,NA,NA,NA
"1e570cf6288654a6b50db7b2e70fa7f8","digital-trowel","seed",NA,"2008-01-01",NA
"ec6520dcfc9161e570a17a24caf7c822","digitalarmm",NA,NA,NA,NA
"4c40cbd9d368927e426417e6ce4e2771","digitalcoco",NA,NA,NA,NA
"8975281ee63931bc2c5bd6dcf77f9dad","digital-genius-artificial-intelligence","undisclosed",NA,"2014-10-30",250000
"8975281ee63931bc2c5bd6dcf77f9dad","digital-genius-artificial-intelligence","convertible_note",NA,"2015-06-22",3e+06
"8175bee3e46e2292901d24196723d069","digitalguestlist",NA,NA,NA,NA
"3a04cb4fd49338267b309d9dc889cae1","digitalmr","seed",NA,"2013-08-31",1020000
"e05fc43b89533f756f1537c1db590516","digitata",NA,NA,NA,NA
"f8316abb19b9d4d60c681d75ae7bdb0a","digitouch",NA,NA,NA,NA
"ec31e7c32f9f330d486d7c14510de66f","digmydata",NA,NA,NA,NA
"3fff4830a1f927dc844488e307a66d82","digna-biotech","undisclosed",NA,"2007-10-23",NA
"d6719ce2af94f473bbf1db7f18ac4982","dignify-therapeutics","debt_financing",NA,"2014-02-05",50000
"d6719ce2af94f473bbf1db7f18ac4982","dignify-therapeutics","grant",NA,"2014-09-02",159000
"d6719ce2af94f473bbf1db7f18ac4982","dignify-therapeutics","venture",NA,"2015-02-04",3e+06
"729672b598c33b08309592efba2a6923","diligence",NA,NA,NA,NA
"88ca753c098aa228666ebe0067ec4643","dilon-technologies","debt_financing",NA,"2013-12-31",3953200
"88ca753c098aa228666ebe0067ec4643","dilon-technologies","debt_financing",NA,"2011-11-14",1920000
"88ca753c098aa228666ebe0067ec4643","dilon-technologies","debt_financing",NA,"2010-09-07",2954000
"b6a2986df37ae2eb9e38ec62cc3531b2","dilyx-biotechnologies",NA,NA,NA,NA
"734d632d2d6c456a2b9f3c31d7a6d16b","dimatix",NA,NA,NA,NA
"09265c6b11201fa9b7586cccdb34c232","dimension-therapeutics","venture",NA,"2013-11-18",5e+06
"09265c6b11201fa9b7586cccdb34c232","dimension-therapeutics","venture","1","2014-06-23",3e+07
"09265c6b11201fa9b7586cccdb34c232","dimension-therapeutics","private_equity",NA,"2015-02-12",24500000
"09265c6b11201fa9b7586cccdb34c232","dimension-therapeutics","venture","1","2015-04-21",6.5e+07
"5400113098a6e4fee9f27ab726716d00","dimerix-biosciences-pty-ltd","venture","A","2005-09-15",768887.727
"e529dc63244db1bb22f986f4f46e6cdc","dinely",NA,NA,NA,NA
"c98f27c8aab70afa3f8795b97ccdc11c","dinetime",NA,NA,NA,NA
"e3edc7175a9b671c705de00556d87e63","dineyo",NA,NA,NA,NA
"dc36aaacdcc56777df8dc2521b4db809","diobex","venture","b","2007-04-16",2.4e+07
"dc36aaacdcc56777df8dc2521b4db809","diobex","venture","A","2005-09-16",7080000
"7f0f6a5007f09da3e18c3c90d7f765f3","diogenix","seed",NA,"2013-12-05",3200000
"d26b207ed8cca5394b06973339fe8928","diomics","venture",NA,"2014-04-29",1104000
"d26b207ed8cca5394b06973339fe8928","diomics","venture",NA,"2014-05-27",2e+05
"d26b207ed8cca5394b06973339fe8928","diomics","venture",NA,"2014-10-01",250000
"f4e9b47c8ea4f0913b0619f80b7c9c05","dipexium-pharmaceuticals","venture",NA,"2010-07-23",2740000
"f4e9b47c8ea4f0913b0619f80b7c9c05","dipexium-pharmaceuticals","venture",NA,"2013-02-25",930000
"f4e9b47c8ea4f0913b0619f80b7c9c05","dipexium-pharmaceuticals","venture",NA,"2012-03-30",507500
"f4e9b47c8ea4f0913b0619f80b7c9c05","dipexium-pharmaceuticals","venture",NA,"2013-07-22",2750000
"7a8d38bf3003484c232a151ce10ccbc6","diramed","venture",NA,"2010-01-27",295134
"2a4dab1ccf53186f8cbbf4c494b6a66c","direct-access-partners",NA,NA,NA,NA
"16cd2e0a98f36f1c26e7e71a6f0e2bae","direct-impact",NA,NA,NA,NA
"408774748be8414eddd680e7e9d6a89e","direct-one",NA,NA,NA,NA
"51fab2b94adceeeb17f4c2a18136143a","direct-spinal-therapeutics","venture",NA,"2013-09-10",1e+06
"fe933eb7a1bb8ab98bf4f0c4207df7c6","direct-supply",NA,NA,NA,NA
"925cde124862be409c849f361057c5a7","direvo-biotech","venture","d","2010-04-15",8100000
"925cde124862be409c849f361057c5a7","direvo-biotech","venture","c","2007-10-18",16800000
"925cde124862be409c849f361057c5a7","direvo-biotech","venture",NA,"2010-02-01",8347800
"491d642a6899fd3c5a85d2851ee8c89e","discern","venture","A","2015-09-08",2e+07
"85907fc37dc0d75edb51e199a28a0622","discgenics","venture",NA,"2011-10-21",1839000
"63e559082e473ae8d8e20dd6fd004994","discountbox",NA,NA,NA,NA
"4a5e0cc773e472968023ab69d34ea12a","discourse-analytics","angel",NA,"2013-02-01",825000
"4a5e0cc773e472968023ab69d34ea12a","discourse-analytics","convertible_note",NA,"2014-05-01",625000
"dc4ac8b7a8b183a5bbb8b7d792a32c14","discover-dollar-technologies-pvt-ltd",NA,NA,NA,NA
"ab420d70c5c8806bf061366b77a641e2","discoverourtown-com-database",NA,NA,NA,NA
"b830b765aebbb3e7e03613533d44c6f6","discoverx","venture",NA,"2010-11-01",8e+06
"b830b765aebbb3e7e03613533d44c6f6","discoverx","venture",NA,"2009-08-17",5400000
"2d71b8478341200938a1c47675a29055","discovery-laboratories",NA,NA,NA,NA
"93d5942dd49b24872f386dc9f36dc8f4","discovery-machine-inc",NA,NA,NA,NA
"920ca4f66f59a6e35c2bb270d90b9c17","discovery-solutions",NA,NA,NA,NA
"bfb0f026b257a52cb68a590d4a0070be","discoverybiomed","grant",NA,"2015-04-08",1610000
"4a06642f4b58c6066afab575d6b8ca42","dishgo",NA,NA,NA,NA
"f37611664bc7c9daf69c45b75b93b7a9","dispersol-technologies","venture",NA,"2012-01-24",641693
"f37611664bc7c9daf69c45b75b93b7a9","dispersol-technologies","debt_financing",NA,"2013-05-29",611834
"f37611664bc7c9daf69c45b75b93b7a9","dispersol-technologies","venture",NA,"2014-03-10",3021690
"f37611664bc7c9daf69c45b75b93b7a9","dispersol-technologies","venture",NA,"2015-02-03",1e+07
"43361ea263502c33b72028656d7430be","disruption-corporation-2","venture",NA,"2014-11-12",740725
"43361ea263502c33b72028656d7430be","disruption-corporation-2","venture",NA,"2014-07-30",1500000
"43361ea263502c33b72028656d7430be","disruption-corporation-2","seed",NA,"2013-03-29",750000
"e171b1cc7fac2bfd354ab8bbb5b4ea01","disruptiva-franchise-intelligence",NA,NA,NA,NA
"170d5b90c2ab2988eacb1b1628875cec","distilld",NA,NA,NA,NA
"bee539f585446cfea2f3d9ae5c2705ac","distiller",NA,NA,NA,NA
"c949e90133018b420069beb496662cd7","distimo",NA,NA,NA,NA
"79aa111d14a48173220ba1d9f76d25e3","ditto-labs","seed",NA,"2013-07-31",1100000
"79aa111d14a48173220ba1d9f76d25e3","ditto-labs","seed",NA,"2014-05-14",2200000
"79aa111d14a48173220ba1d9f76d25e3","ditto-labs","venture",NA,"2015-07-02",2379742
"79aa111d14a48173220ba1d9f76d25e3","ditto-labs","seed",NA,"2015-08-06",4e+06
"30b778f8922d5f9631940e1ef9a5a8c6","diurnal","venture",NA,"2016-01-06",44600000
"30b778f8922d5f9631940e1ef9a5a8c6","diurnal","venture",NA,"2012-03-19",531746
"30b778f8922d5f9631940e1ef9a5a8c6","diurnal","debt_financing",NA,"2009-12-09",979526
"30b778f8922d5f9631940e1ef9a5a8c6","diurnal","venture",NA,"2014-08-05",10104242
"7f39e7dd7b9c5f3292e58986c64bc834","divergence","venture","c","2009-02-11",11800000
"53fc51d5498e09ec4fc7185e03cddf13","divers-alert-network-dan",NA,NA,NA,NA
"39c96fb0bd922995306e76bc29a52963","diversa-corporation",NA,NA,NA,NA
"b98d56468cf117a41fcd9bc72e50005c","divisadero",NA,NA,NA,NA
"65c3a3d83a8fcf0372761e09926f1735","divisadero-digital-intelligence",NA,NA,NA,NA
"304eb43e8e12aa5e989c628ae965db0c","divtech",NA,NA,NA,NA
"22de7059e83e3cb8c3c85e3aa9270868","diyotta",NA,NA,NA,NA
"b4bf8082a1ca9569a69110b000680d11","dk-new-media",NA,NA,NA,NA
"f615d3a63e6588e00f0f244cec98dad2","dlvr-therapeutics","seed",NA,"2011-10-24",NA
"919c1b04514db52056c663954580632d","dma",NA,NA,NA,NA
"cc7bca0ef576d5113946a3a3097e739f","dmetrics","angel",NA,"2011-01-01",2300000
"cc7bca0ef576d5113946a3a3097e739f","dmetrics","grant",NA,"2013-01-01",1300000
"0b73caf3d5654b28550cacf54f05339f","dmlab",NA,NA,NA,NA
"555d33efa8cc1c98a2ae16b194fbff45","dms-health-technologies",NA,NA,NA,NA
"1d8bb1f67075d2896ec98535c1b1e4ba","dmw-worldwide",NA,NA,NA,NA
"3e48ddab12c7645ae37bb806e604d8aa","dmway-analytics","seed",NA,"2016-01-25",1e+06
"72fb8d5458bd8e07571ce30acd345067","dna-diagnostics-center",NA,NA,NA,NA
"1f8520d9b0b6687016eb64e3483985b0","dna-direct","venture",NA,"2009-11-13",1e+06
"5a646437b070f0ce27d091d468875921","dna-guide","seed",NA,"2012-06-15",250000
"2ef62d36ca1e768ce00cd00cd4b7eb06","dna-plant-tecnology",NA,NA,NA,NA
"15710a6e2e35384dc28233f387222548","dna-seq","seed",NA,"2013-05-24",1e+06
"489f24267da51b9dcfbc18c900b49356","dnaex",NA,NA,NA,NA
"58d007c533092312082da9206ae6becd","dnage","venture","a","2005-04-13",1940000
"2cb95ac24aae0a37b8fc3c0f5f3411b2","dnaiq",NA,NA,NA,NA
"25cad804d7f837fa7fe45ac30537c230","dnanexus","venture","b","2011-10-12",1.5e+07
"25cad804d7f837fa7fe45ac30537c230","dnanexus","venture","c","2014-01-03",1.5e+07
"25cad804d7f837fa7fe45ac30537c230","dnanexus","venture","a","2009-08-03",1550000
"25cad804d7f837fa7fe45ac30537c230","dnanexus","venture","D","2015-04-22",1.5e+07
"38ecf2acef24b38630d9a982654e5055","dnaphone",NA,NA,NA,NA
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","seed",NA,"2012-08-03",885620
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","debt_financing",NA,"2013-06-01",160000
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","seed",NA,"2012-01-30",4500000
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","debt_financing",NA,"2010-01-01",170000
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","seed",NA,"2008-09-01",479193
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","debt_financing",NA,"2006-05-08",176000
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","grant",NA,"2014-02-24",10800000
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","debt_financing",NA,"2013-11-07",1543905
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","debt_financing",NA,"2013-08-27",840000
"337a21cd2f9de16bd33c368b6fdd2f02","dnatrix","venture","1","2014-10-14",2e+07
"7a66096db18d2f56a7fcdf081349fccc","dnc-consulting",NA,NA,NA,NA
"fee5b366f907dcd5a94a69ca832bbdae","dnx-biotherapeutics",NA,NA,NA,NA
"8423727867773389e8a882287299d32c","docalytics","seed",NA,"2013-12-09",540000
"8423727867773389e8a882287299d32c","docalytics","seed",NA,"2013-05-31",20000
"eafe6e811b4872e9f66e152c7f115afa","docitt","seed",NA,"2014-01-01",5e+05
"8945487e97f89016b296ca13e86a4543","docmate-com",NA,NA,NA,NA
"a706ac0160323fb381138da366e52164","docslice",NA,NA,NA,NA
"cd499fb347118890f40ce84319042df2","doctorbase","seed",NA,"2013-08-07",1e+06
"c25ade4c3fadb8255c4404d6622aaa23","doctors-together","debt_financing",NA,"2009-07-14",2525000
"f994244efee880dc8a52fdc96f47e535","doctrackr","seed",NA,"2012-10-02",2e+06
"f994244efee880dc8a52fdc96f47e535","doctrackr","seed",NA,"2012-01-24",NA
"dde2aa5fbee1d6a7aa426e48c0a97ad6","docturnal",NA,NA,NA,NA
"4f92627897d3a05493afa1d68b2a5341","documaster","seed",NA,"2014-11-01",7e+05
"07cab138d71ae97169f7755f67a40e5f","docuware",NA,NA,NA,NA
"2ec5a6aebf4a3d3634667863a3a3925b","docventive",NA,NA,NA,NA
"1fcdf182d9776caa4ba4ae4ea8a187d5","dodge",NA,NA,NA,NA
"f986b2a7d91f9381ab83c0dc21d57434","dodo---biotech-crowdfunding",NA,NA,NA,NA
"e6d95c78cbe6e91024dbc7cd18467439","dojo-madness","seed",NA,"2015-06-10",2250000
"10856895546d70683206f835254827b1","doki-doki-inc",NA,NA,NA,NA
"3180b6500a7c1805b7361b9b1aa5a2a3","dolhun-clinic",NA,NA,NA,NA
"2ff90f0c5fa87872b95a02a3454b5bb1","dollars-sense",NA,NA,NA,NA
"386a97f1771895e32e2faa10c757b47a","dolores-speech-products","venture",NA,"2015-04-07",250000
"807cbe6abf884f256479859153571b5c","dolphin-technologies",NA,NA,NA,NA
"f5808bc74f18f38ae9db0d9eafeb875e","domain-surgical","venture",NA,"2011-01-21",4565000
"f5808bc74f18f38ae9db0d9eafeb875e","domain-surgical","venture",NA,"2011-10-17",1475444
"f5808bc74f18f38ae9db0d9eafeb875e","domain-surgical","debt_financing",NA,"2013-07-11",1233000
"f5808bc74f18f38ae9db0d9eafeb875e","domain-surgical","venture","1","2014-03-06",3.5e+07
"f5808bc74f18f38ae9db0d9eafeb875e","domain-surgical","debt_financing",NA,"2012-06-21",3100000
"995cd2bee229804b86f3fa0310017362","domain-therapeutics","venture",NA,"2012-07-17",2456200
"995cd2bee229804b86f3fa0310017362","domain-therapeutics","grant",NA,"2014-04-14",230000
"995cd2bee229804b86f3fa0310017362","domain-therapeutics","venture","1","2002-02-01",2585033
"995cd2bee229804b86f3fa0310017362","domain-therapeutics","venture","1","2004-05-01",19135704
"995cd2bee229804b86f3fa0310017362","domain-therapeutics","venture","1","2006-10-01",10390925
"995cd2bee229804b86f3fa0310017362","domain-therapeutics","venture","1","2008-12-12",2788484
"a8a16742b4d76251796b019c36cf0a35","domainex","venture",NA,"2008-04-23",718000
"a8a16742b4d76251796b019c36cf0a35","domainex","grant",NA,"2014-07-09",2398574
"a8a16742b4d76251796b019c36cf0a35","domainex","venture","1","2013-02-01",2368857
"30bc8082b82b4c5e53437f0e0b8875e1","domains-index",NA,NA,NA,NA
"b0a4d583df4a1ef3857e06e644500328","dominion-diagnostics","venture",NA,"2010-12-30",8317643
"422daffc34bd8c8b94d20bf5b181f4e6","dominion-semiconductor",NA,NA,NA,NA
"bbaea48d1f4f98c29afef12646196361","domino-data-lab","angel",NA,"2015-04-15",1e+05
"bbaea48d1f4f98c29afef12646196361","domino-data-lab","venture","1","2015-08-04",3e+06
"81203d9640bfe26b555593b812d9c3a0","domize",NA,NA,NA,NA
"47858d54d8aa5166bd66a803ee0f1041","domo","venture","A","2011-07-13",3.3e+07
"47858d54d8aa5166bd66a803ee0f1041","domo","venture","B","2012-01-31",2e+07
"47858d54d8aa5166bd66a803ee0f1041","domo","seed",NA,"2010-11-19",650000
"47858d54d8aa5166bd66a803ee0f1041","domo","seed",NA,"2008-08-01",NA
"47858d54d8aa5166bd66a803ee0f1041","domo","angel",NA,"2011-05-19",1e+07
"47858d54d8aa5166bd66a803ee0f1041","domo","venture","c","2014-02-05",1.25e+08
"47858d54d8aa5166bd66a803ee0f1041","domo","venture","b","2013-03-11",6e+07
"47858d54d8aa5166bd66a803ee0f1041","domo","venture","D","2015-07-22",235037225
"46a4c1b9ad3e6d647c84f1dd85749a7a","donald-danforth-plant-science-center","grant",NA,"2013-12-16",1e+06
"3337763e50fa82c904ce47a50c68cf7e","donationmatch",NA,NA,NA,NA
"5d5d0ed8715cf533394886d6a98b6188","donatix",NA,NA,NA,NA
"f4cceb37aee844c5f5199816ecc3ebb4","donorsearch","grant",NA,"2013-03-14",25000
"2c0510bd11d6a9f2f5bdb40262339805","doochoo","angel",NA,"2012-08-01",535000
"2c0510bd11d6a9f2f5bdb40262339805","doochoo","seed",NA,"2011-01-01",283000
"2c0510bd11d6a9f2f5bdb40262339805","doochoo","seed",NA,"2010-01-29",150000
"1065f44fd22b372a3627b68719217547","doost-inc-","seed",NA,"2013-03-23",NA
"3da009a904eed6651e689cbecd3b7fac","doppel",NA,NA,NA,NA
"5c9d43af9e1866d29e9e001dc7697d42","doppio-group",NA,NA,NA,NA
"692756ccd51f44cf30d62fe04bd05319","dormir","venture",NA,"2010-09-22",1500000
"692756ccd51f44cf30d62fe04bd05319","dormir","venture",NA,"2009-06-03",8e+06
"692756ccd51f44cf30d62fe04bd05319","dormir","venture",NA,"2011-05-17",2e+06
"59b2da1b26ae896b5945296f034a66cd","dorsavi","venture",NA,"2011-08-30",5e+06
"d3eea47875bfafcf58aef85d5d593dc5","dossia",NA,NA,NA,NA
"c0401403bb573424d7e40ce887c7c5d4","dossierview","venture",NA,"2009-12-22",750000
"70531974f7e34f753a60a349d5a6849c","dot",NA,NA,NA,NA
"860f2cb537e6ad9e08c30667553a4ef1","dotaprohub","convertible_note",NA,"2014-06-09",110000
"ad677dd6fe042a84c3bd07598c345d52","dotmiles",NA,NA,NA,NA
"e4e3aa53688338171af4d177bed8fea1","dots-2",NA,NA,NA,NA
"52632198acd9512457ae1d5afba7b59c","dotstudioz","seed",NA,"2014-10-01",830000
"33957f5ca125511321e654d2d0ab4a61","doubledutch","venture","A","2012-04-23",2028000
"33957f5ca125511321e654d2d0ab4a61","doubledutch","venture","B","2012-11-12",3971000
"33957f5ca125511321e654d2d0ab4a61","doubledutch","seed",NA,"2011-04-22",1e+06
"33957f5ca125511321e654d2d0ab4a61","doubledutch","venture","C","2013-09-25",11500000
"33957f5ca125511321e654d2d0ab4a61","doubledutch","seed",NA,"2010-09-14",0
"33957f5ca125511321e654d2d0ab4a61","doubledutch","venture","D","2014-08-21",1.5e+07
"33957f5ca125511321e654d2d0ab4a61","doubledutch","venture","E","2015-08-12",4.5e+07
"b30f0460db74221bb0f361db88dbdd08","doubletab",NA,NA,NA,NA
"d46ae1d399b34c1a2af74c8a20d670ce","douglas-scientific",NA,NA,NA,NA
"3294f635378d448daa26e33754b99d45","dovetail-integrated-systems",NA,NA,NA,NA
"964548a9875169c85817583623b105a4","dovichi",NA,NA,NA,NA
"c3e85b047e14631048be215b2df5c197","dow-agrosciences",NA,NA,NA,NA
"90fb24c4ccfe8101dd12182c925c0032","downcase-consulting",NA,NA,NA,NA
"9c516b98dde0f2b48bf1c5e0601a9eae","dox42",NA,NA,NA,NA
"e8c20a336953650fe162bb6595415920","doxa",NA,NA,NA,NA
"e61f89089efd0a16860844da4bd240b0","doxiq","debt_financing",NA,"2013-08-23",240000
"c531d3c5be2fa66f27ea1012d8811568","dr-jeff-kronson-vascular-surgeon",NA,NA,NA,NA
"18d535bc2525862b3bbda8f0693815a8","dr-lal-pathlabs","venture",NA,"2015-12-07",28600000
"18d535bc2525862b3bbda8f0693815a8","dr-lal-pathlabs","undisclosed",NA,"2010-08-26",NA
"d05ea5c0fe6bfe574295ff92cd0549d2","draftcrunch-2","seed",NA,"2015-10-01",220000
"f909d91951e61083a4a60523470fb3fb","draftpedia",NA,NA,NA,NA
"b05458d8b4f39bfc1d9d49cb836a8cdb","dragon-wealth","seed",NA,"2013-06-01",NA
"b05458d8b4f39bfc1d9d49cb836a8cdb","dragon-wealth","seed",NA,"2015-04-11",15931
"1f196a04033b83874d5b747342f7e7be","dragonfly-data-factory","seed",NA,"2015-06-01",1200000
"35207c2157afcf3ed45f9ec99b27538d","drais-pharmaceuticals","venture",NA,"2010-02-20",2e+07
"e054c055e928cb7417423d755ecb4b5b","drawbridge","venture","a","2012-05-11",6500000
"e054c055e928cb7417423d755ecb4b5b","drawbridge","venture","b","2013-02-21",1.4e+07
"11e42badc1663e2f0655d5a6939033a6","akronet",NA,NA,NA,NA
"d8d3857d6fb813f8c40d89181aa2b249","drawn-to-scale","venture",NA,"2012-03-09",925000
"d587c225e85c5bd730b29392289ce5d5","drd",NA,NA,NA,NA
"23454301e13e4b1e763c79cdb17069b7","dreamcommerce",NA,NA,NA,NA
"c8761a90e14c4cb2d0ca5aed95541f90","dreamerz-foods","venture","b","2007-06-06",1e+07
"4c20de7cd91ce2209a5c3c30cab49674","dreamface-interactive","angel",NA,"2008-01-01",150000
"38a53bd46e1a099c090fdfb6e4f14ed9","dreamise","venture",NA,"2012-11-20",30000
"98fe6deb7294056b942c4f88736f6ce2","dreamnia",NA,NA,NA,NA
"60c999422d7caa8558970a83148bead6","dreampod","venture",NA,"2010-10-09",183498
"d22eff58b99bb38668f38a495fb3866d","dreamsquare",NA,NA,NA,NA
"91b798f8a5e357f12eca47d8cd68066f","dreamups",NA,NA,NA,NA
"f8935181a921589f88acb7b49adfca9c","drected",NA,NA,NA,NA
"f70a4cb6007d63fbf7d3c39e96a26d63","dressometry",NA,NA,NA,NA
"062279f8306cafd92a91da02353951e3","driftt","venture","A","2015-01-13",1.5e+07
"2dfb53a3328066b56cbf373a0a8961cb","driftrock","angel",NA,"2014-03-31",1e+06
"9b2091e5e473030ba70573132696ecbd","drik","venture","a","2013-08-12",5e+05
"5446f8012de4c81ad209cee6b9e97cc2","drillbox",NA,NA,NA,NA
"b571ab46a4c82df7dc97d83dc08e0db9","drillinginfo","private_equity",NA,"2012-03-05",1.65e+08
"b571ab46a4c82df7dc97d83dc08e0db9","drillinginfo","private_equity",NA,"2013-09-16",25125006
"b571ab46a4c82df7dc97d83dc08e0db9","drillinginfo","private_equity",NA,"2015-03-13",1452000
"d51d21465963dc8479090308ed6c90a4","drinkspree",NA,NA,NA,NA
"066fa3f573402ef06770cedbf26164ac","drip-2",NA,NA,NA,NA
"2740bf9e1597387d288423c7dc3b4e85","drip-fish",NA,NA,NA,NA
"6ab4706cbce296da055c447b7e6bce6e","drivefactor","venture",NA,"2013-08-16",3249999
"6ab4706cbce296da055c447b7e6bce6e","drivefactor","venture","1","2011-12-22",1800000
"8249b0c7e37fa685230ed50083d3fbf4","concurrent-inc","venture","a","2013-03-20",4e+06
"8249b0c7e37fa685230ed50083d3fbf4","concurrent-inc","seed",NA,"2011-04-10",9e+05
"8249b0c7e37fa685230ed50083d3fbf4","concurrent-inc","venture","B","2014-06-02",1e+07
"5cc35294ee33490858d9a696b36bd294","driveway-software","angel",NA,"2012-07-30",325000
"5cc35294ee33490858d9a696b36bd294","driveway-software","seed",NA,"2013-08-30",1300000
"5cc35294ee33490858d9a696b36bd294","driveway-software","venture","1","2015-07-31",1e+07
"80ae909329768d7d62e33eef5c7ba7ff","drivingbuddy","seed",NA,"2012-01-01",250000
"eccf93558679440a232c950704b306ef","dro-biosystems","venture",NA,"2006-01-01",237000
"f71a26419595f651e0b7fab7ac5e722e","drox","seed",NA,"2014-10-01",39240.3076
"319cda37fc7fd010a62a5fb8cb720a60","drop-4",NA,NA,NA,NA
"d8d62ab97c16dd03b68fe3d35bc88377","dropquery",NA,NA,NA,NA
"24f0b5bc4e62a41da0e22d73b739c56d","dropsens",NA,NA,NA,NA
"8673c4f14ae7b16f14f47288e9045855","dropthought-inc","venture","a","2013-09-26",2550000
"8673c4f14ae7b16f14f47288e9045855","dropthought-inc","venture","a","2013-04-15",1600000
"8673c4f14ae7b16f14f47288e9045855","dropthought-inc","debt_financing",NA,"2015-01-18",752500
"48fe31f04eef16b5afa3d67b14dc5e35","drs-health","venture",NA,"2011-03-14",281500
"86904a1171a1779f6550c3a1e666cfd0","drthom",NA,NA,NA,NA
"635030be2656a3dd79f4225df163ad05","drug-abuse-sciences","venture","B","2003-01-01",1897818
"635030be2656a3dd79f4225df163ad05","drug-abuse-sciences","venture","A","2001-03-01",46141068
"925a28880444b7e1946abbe2a3e0b78a","drug-innovation-site",NA,NA,NA,NA
"1f274924d681ea0af83cd1b6f7aa5b10","drug-response-dx","venture","a","2013-01-08",NA
"c8ed162ba4f5d381aa782505b3ec5f90","drugdev-org",NA,NA,NA,NA
"94cb228bf85ac34926415c00326d7ceb","drugpatentwatch",NA,NA,NA,NA
"a896f675652c9fdd406c171dac87094d","drumup",NA,NA,NA,NA
"81afee22d356e7bc4e919860aebbf20f","drvr","angel",NA,"2015-03-05",50000
"6608d8ba1999ca80cc8daf460316ab7c","dsapps",NA,NA,NA,NA
"efb70005f2daaaa7a455019ea950a9e2","dsi-renal",NA,NA,NA,NA
"12726050f2ef80a4a133a86c46249fd8","dsm",NA,NA,NA,NA
"cd7c3c3e43f8ea3e7d116fbd1e0674ce","dso-national-laboratories",NA,NA,NA,NA
"db146e9798e2638a1f4e4e44bfe5c913","dtor","venture",NA,"2015-09-04",NA
"bd95604abfb948070eb1f1b6a7a1e613","dual-aperture-international-inc-","venture","A","2014-11-19",5700000
"bd95604abfb948070eb1f1b6a7a1e613","dual-aperture-international-inc-","venture","A","2015-03-17",1400000
"8a4d245fac6f246931e579c8016ed2b6","dualsystems-biotech","venture","c","2013-09-30",NA
"fda1bd8191e80eefca4fa4d57d5b7265","dubbelhelix",NA,NA,NA,NA
"e52962081eaae171b94aa683505f11e3","ducksboard","seed",NA,"2012-04-01",747936
"e52962081eaae171b94aa683505f11e3","ducksboard","venture","1","2014-01-23",NA
"fc7cdecd9da9587f42eefe991ab1dce1","ducktile",NA,NA,NA,NA
"8b4c66e353bad81ba7c4f8f6745b7f9d","ducoin-center-for-advanced-dentistry",NA,NA,NA,NA
"2f301a47331a0bab74d620f492a27e47","duct-tape-marketing",NA,NA,NA,NA
"2cc8c396eeb99cc3be0422c86c19335d","duedil","venture","a","2013-04-12",5e+06
"2cc8c396eeb99cc3be0422c86c19335d","duedil","angel",NA,"2012-08-14",NA
"2cc8c396eeb99cc3be0422c86c19335d","duedil","angel",NA,"2011-11-01",NA
"2cc8c396eeb99cc3be0422c86c19335d","duedil","venture","b","2014-03-03",1.7e+07
"2cc8c396eeb99cc3be0422c86c19335d","duedil","seed",NA,"2011-06-01",NA
"dd18bfccdfcdf8b45bc93a92cec660a9","duer-advanced-technology-and-aerospace","venture",NA,"2010-05-26",2e+06
"b70e402295dfb44c050d9cd1a21e0503","duetto-research","venture","C","2015-12-01",30076604
"b70e402295dfb44c050d9cd1a21e0503","duetto-research","venture","a","2012-12-11",10100000
"b70e402295dfb44c050d9cd1a21e0503","duetto-research","seed",NA,"2012-04-19",2100000
"b70e402295dfb44c050d9cd1a21e0503","duetto-research","venture","B","2014-07-09",2.1e+07
"b70e402295dfb44c050d9cd1a21e0503","duetto-research","venture","C","2015-08-04",3e+07
"f3019ed05ac2383a0a6d5b9a3ec5f4a8","duke-eye-center",NA,NA,NA,NA
"3fb642687f8d4a5b7bf22a02c827382b","duke-medical-school",NA,NA,NA,NA
"e3e332a19ee6aa054c55b42e6e71df97","dukky",NA,NA,NA,NA
"cbd0c04fc7c46420e873eff762a8c75f","dull",NA,NA,NA,NA
"5a3fe5d91092671274ad0ae35c5215f7","dundas-data-visualization",NA,NA,NA,NA
"64691411486e9c45ae8270b5f4544214","dunnhumby",NA,NA,NA,NA
"168414e3cd5d66ddd5292eca9fcd7ed5","duo-design",NA,NA,NA,NA
"7ef0e869e9851c998afe5a62dca7038c","duocort-pharma",NA,NA,NA,NA
"e0e020fb3ccccaebe5f0977400591852","durafizz","venture",NA,"2010-06-30",250000
"906ec6121c1377ef7879071d8a8d981f","durata-therapeutics","post_ipo_equity",NA,"2013-11-07",7e+07
"49341def1efc76d81ab400eb09f6c771","durect-corp","debt_financing",NA,"2014-06-26",2e+07
"aaef2bbb799f0496a1c7277ca260527b","durham-va-medical-center",NA,NA,NA,NA
"b77ea6bc3696cfb625cb6d70582c3322","dusa-pharmaceuticals",NA,NA,NA,NA
"0b5bbc469d6c613cf97175785f9aca4d","dwellaware","seed",NA,"2013-12-15",6e+05
"0b5bbc469d6c613cf97175785f9aca4d","dwellaware","seed",NA,"2014-03-23",1581000
"8049fe12312cc0dcc80c474a95c9e410","dx-urgent-care","venture",NA,"2011-08-15",1950000
"1f994a893c2e4b4b04265996156ab48d","dxna","debt_financing",NA,"2012-11-08",273471
"1f994a893c2e4b4b04265996156ab48d","dxna","venture",NA,"2013-11-20",2500000
"066289421c185c8b43605303ae3e2c09","dxterity","debt_financing",NA,"2012-01-17",2595000
"066289421c185c8b43605303ae3e2c09","dxterity","venture","1","2010-05-11",790000
"066289421c185c8b43605303ae3e2c09","dxterity","venture","1","2009-10-14",56250
"066289421c185c8b43605303ae3e2c09","dxterity","private_equity",NA,"2015-01-12",1e+05
"db9f2af1ab49c719e8b2c196a00e0fa7","dxupclose","venture","a","2012-08-15",1e+06
"2ba71f0670a94f3edbf610540da2606e","dyadic-international","convertible_note",NA,"2015-03-09",2e+06
"d228d1b46f94f8b0a09f04a15d7d695e","dyax",NA,NA,NA,NA
"a003ce13994929db5b38ff615d2d0350","dyli","seed",NA,"2015-01-15",NA
"ddc2e69ac986d0c6ea0bc8cbf1a638a2","dynamic-signal","venture","b","2012-07-16",13300000
"ddc2e69ac986d0c6ea0bc8cbf1a638a2","dynamic-signal","venture","a","2011-02-17",8e+06
"ddc2e69ac986d0c6ea0bc8cbf1a638a2","dynamic-signal","venture","C","2015-09-10",2.2e+07
"482e6aa96f397097885f33762de28c41","dynamic-yield","undisclosed",NA,"2011-11-01",NA
"482e6aa96f397097885f33762de28c41","dynamic-yield","venture","1","2013-04-24",2e+06
"482e6aa96f397097885f33762de28c41","dynamic-yield","venture","1","2014-05-22",12225000
"a1b0c55de76480b11ffd2c4365eda012","dynavax-technologies",NA,NA,NA,NA
"c77404b7fe82046fef166eed0e594311","dynistics",NA,NA,NA,NA
"89dc5f9b7215d57730cf40be53a4e9c5","dyno-mapper",NA,NA,NA,NA
"7b92643addc4c3a44c06da358168bda0","dyomo-corporation",NA,NA,NA,NA
"4f413e5050aaac91410d3277a1ad30d6","dzzom","seed",NA,"2013-11-01",NA
"82f336b841569b81553812055827eea1","prime-view-international","venture",NA,"2010-01-05",238174040
"a528dad840cd4bc76b642a4cfac58fbf","e-rv",NA,NA,NA,NA
"4645a801359bcb3a9afac6fd367cda89","e-brane",NA,NA,NA,NA
"4f20053352751362a5517182a43d0648","e-dialog",NA,NA,NA,NA
"c94810833533de3978c05a3ce010097a","e-mailit",NA,NA,NA,NA
"0a432bb02f2a1d9aae7ccb143c044bee","e-scape-bio","venture",NA,"2015-09-01",20002700
"d94fa4ab9f9c4644f1c22f3a5e237259","e-ye-brain","venture","b","2012-10-09",3300000
"d94fa4ab9f9c4644f1c22f3a5e237259","e-ye-brain","venture","a","2009-11-18",1800000
"d94fa4ab9f9c4644f1c22f3a5e237259","e-ye-brain","venture",NA,"2015-02-03",1470000
"dbf9ff3fc9669abd919a27a19ef23108","e2m-solutions",NA,NA,NA,NA
"349281665fd5876d3871c8a51c086138","e8-security","venture","A","2015-03-10",9800000
"87f2c2262e2c80648cc978648407efcc","eagle-alpha","seed",NA,"2014-02-27",1500000
"87f2c2262e2c80648cc978648407efcc","eagle-alpha","seed",NA,"2014-10-28",1200000
"87f2c2262e2c80648cc978648407efcc","eagle-alpha","seed",NA,"2015-11-02",1800000
"7e1b6cd6e536828e9e478817176de836","eagle-formations-limited",NA,NA,NA,NA
"4dd7c8a56579ca05772cdf39fccddd11","eagle-genomics","seed",NA,"2013-11-21",1515251
"4dd7c8a56579ca05772cdf39fccddd11","eagle-genomics","seed",NA,"2013-11-22",621253
"63ebedbaa3eef1a4ca433e69664bb1be","eagleyemed","venture",NA,"2013-08-08",6e+05
"b048dfa690207a4e138b174596a70f4a","early-charm-ventures",NA,NA,NA,NA
"570653ef47c02043d720cbb72a22e4dc","early-warning-services",NA,NA,NA,NA
"9ad207937d3f8de849463d2c323fcd87","earlysense","venture","c","2010-07-23",1.3e+07
"9ad207937d3f8de849463d2c323fcd87","earlysense","venture","e","2012-11-12",1.5e+07
"9ad207937d3f8de849463d2c323fcd87","earlysense","venture","F","2015-01-20",2e+07
"9ad207937d3f8de849463d2c323fcd87","earlysense","venture","F","2015-04-14",5e+06
"02ae52614e60a45de90231a494c97bfb","earn-part-time",NA,NA,NA,NA
"0525cff3237c248872aea1c0a1d15798","earnest-partners",NA,NA,NA,NA
"ac59dd05651257ceb89706cdde9bc230","earnix","venture","b","2005-09-13",7e+06
"ac59dd05651257ceb89706cdde9bc230","earnix","debt_financing",NA,"2008-09-04",3e+06
"42589d08f84cc43f4bfee5e95fa800ac","earthgen-biofuel",NA,NA,NA,NA
"a5a2dae91feebb65f4020ab1319379d1","earthindicators",NA,NA,NA,NA
"8a14c9d057a39049ca5fbea5df335e4b","earthintegrate",NA,NA,NA,NA
"9f3619c7b330894fd60774fb9d6500ee","ease-vr",NA,NA,NA,NA
"86ce3fb0d86e42b28104bcfefa67449f","easi6",NA,NA,NA,NA
"556ed6fce332ea471d6a30f65425a721","east-vision-systems",NA,NA,NA,NA
"15e39c973502ce5b05ca17b052f836c3","eastern-biotech-and-life-sciences",NA,NA,NA,NA
"faeccf20c1e1a3ee99cc4a35d5ef124e","easton-pharmaceuticals",NA,NA,NA,NA
"ec826d2d391f9d453ad24fea8a00c8aa","easy-insight",NA,NA,NA,NA
"2f8127e1534a294fbb846904e0c8dceb","easy-verification",NA,NA,NA,NA
"67174dee25f90b36bc4b3610bfb7fb46","easy2data",NA,NA,NA,NA
"a28f80d99e03f30bcaf0a2d6832232cc","easyask",NA,NA,NA,NA
"8443f70f73b3407eb2409fabd719e0c6","easyvista",NA,NA,NA,NA
"caaa497d01e2922597c54564b60e61d1","eb-holdings","venture",NA,"2010-08-26",107676692
"af45bbc821aa37483b3d899e2c9ef3a7","ebd-group",NA,NA,NA,NA
"346fb71cbc374711158b7f0dd30af8c5","ebioscience","venture",NA,"2011-02-11",5.5e+07
"c82c6e63c792be316d7861dc26f7327f","ebisa",NA,NA,NA,NA
"8e0f3d0722754aa7a884fe41cda16591","ebr-systems","venture","c","2008-06-12",3.5e+07
"8e0f3d0722754aa7a884fe41cda16591","ebr-systems","venture","d","2011-02-10",5000026
"8e0f3d0722754aa7a884fe41cda16591","ebr-systems","venture",NA,"2005-10-01",2.1e+07
"8e0f3d0722754aa7a884fe41cda16591","ebr-systems","venture",NA,"2015-04-08",2e+07
"89402c67b6cdaa5dbb710f9e9c7fee14","ebridge-software-inc",NA,NA,NA,NA
"0847a4549e2a0e299e1a03a1804eb2d7","ebs-technologies","venture","b","2010-01-14",4345800
"0847a4549e2a0e299e1a03a1804eb2d7","ebs-technologies","venture","B","2015-08-19",1218125.7106
"f8542f89f715933f62b952e99fb0711c","ebureau","venture","c","2009-09-29",1e+07
"f8542f89f715933f62b952e99fb0711c","ebureau","seed",NA,"2004-01-01",8e+06
"f8542f89f715933f62b952e99fb0711c","ebureau","venture","a","2006-03-01",8e+06
"f8542f89f715933f62b952e99fb0711c","ebureau","venture","B","2007-08-01",1.2e+07
"f8542f89f715933f62b952e99fb0711c","ebureau","debt_financing",NA,"2015-04-16",5e+06
"86209ae942c80edc8e7f65b94bd7a2b6","eccrine-systems","grant",NA,"2015-10-01",860000
"86209ae942c80edc8e7f65b94bd7a2b6","eccrine-systems","seed",NA,"2015-02-25",1500000
"8b26a07d55a32fb562c4232a62f55d80","ecelles-carson","seed",NA,"2011-08-01",1500000
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","venture",NA,"2011-01-06",5500000
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","post_ipo_equity",NA,"2013-06-20",12500000
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","angel",NA,"2009-07-29",2e+06
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","venture",NA,"2009-11-13",3e+06
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","venture",NA,"2013-12-19",1e+07
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","venture",NA,"2010-10-21",2455126
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","venture",NA,"2011-02-15",2896500
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","venture",NA,"2009-12-03",562500
"7494367eb916077b1275c4902c9612f1","echo-therapeutics","venture",NA,"2014-12-22",4e+06
"fdc4ca3daa799be01b15d52157e03e1d","echopixel","seed",NA,"2013-11-04",2350000
"fdc4ca3daa799be01b15d52157e03e1d","echopixel","venture",NA,"2013-06-27",1749999
"a6233bbefc43af2ee64a56f9ad320803","echovate","seed",NA,"2015-08-05",5e+05
"e12befd195a136f3a1dd8e27c653af22","echovoice",NA,NA,NA,NA
"f7f5812fe7be110e9db9343c9102a536","echowaves",NA,NA,NA,NA
"0ec8653a748efd5442b81ba2b28a9571","eci-biotech",NA,NA,NA,NA
"792e05280f714118d0f9e156121daf06","ecinity","seed",NA,"2012-04-26",NA
"792e05280f714118d0f9e156121daf06","ecinity","venture","1","2013-04-19",1800000
"2b821d638c5d6881c3ee51b4708c52a0","eclincher","seed",NA,"2013-05-12",NA
"21efa93d5f22767946f772f666088e33","eclinicaldiary",NA,NA,NA,NA
"c88cb026fae690f7a3cc016548fd649e","eclipse-energy",NA,NA,NA,NA
"c87ef2c4585f3548a5b9fcaba809539b","eclipse-market-solutions","angel",NA,"2011-01-01",1200000
"5b3bdf5b47cdd806bc1d5b9e95bc4273","eclipse-therapeutics",NA,NA,NA,NA
"6453e6a6935424359081b52409661237","eclipse-toxicology","venture",NA,"2016-01-21",1278000
"b013d0650d0421cf19ed0133dd22ed35","ecnext","venture","D","2005-09-16",4e+06
"b0ad02b86ed23d95c1926681b83cbd34","eco-innovare",NA,NA,NA,NA
"fb31680b4dd4c7ca58dde3e4e10ee245","ecocode-de",NA,NA,NA,NA
"166709e1e92a6d1d93319135db57f9a7","ecolab",NA,NA,NA,NA
"787b95643dfafb3fe0df76f0377544a4","ecomedia",NA,NA,NA,NA
"8bb0a49514672a994fdb16cfe6abbf7d","ecommerce-cosmos",NA,NA,NA,NA
"1a0a9018002bac429b659a1779e57c81","econda",NA,NA,NA,NA
"95fc9c3645f2c804f555e7125b13b4d9","economic-technology-systems",NA,NA,NA,NA
"ce2d3215ec9a6157116a1d6c398d288c","e-consultancy",NA,NA,NA,NA
"7eb84670319603bb84070fb132699f36","ecoos",NA,NA,NA,NA
"c6f17c8667a350444eaefcc4bad45d7f","ecosys",NA,NA,NA,NA
"83fb7a6ac343cbd22a13e7c0dc6405be","ecovent","angel",NA,"2014-03-31",605000
"83fb7a6ac343cbd22a13e7c0dc6405be","ecovent","seed",NA,"2014-10-14",2200000
"83fb7a6ac343cbd22a13e7c0dc6405be","ecovent","venture","1","2015-07-01",6900000
"138a8a28055dde530ba73065d8f75f3d","ecreeds",NA,NA,NA,NA
"203ca9851ea6cf902db3005d552a1b9b","ecstats",NA,NA,NA,NA
"fe4270a5da2669cbec4b2b277ffcfcca","ecutronic-technologies","venture",NA,"2005-11-15",1550000
"d40474bb7e9c7ae0cca6246c5ce1e9ba","email-data-source","venture","b","2009-05-04",1500000
"d40474bb7e9c7ae0cca6246c5ce1e9ba","email-data-source","venture",NA,"2011-08-23",552167
"9d0c3dfcbfedbd4c4340fd3d37cd1ed4","eddefy",NA,NA,NA,NA
"4d97448ec32f24fa7417e3b098e00b55","eddingpharm-cayman","venture","b","2010-09-17",2.4e+07
"5a4c11ef6a6849d4a6d11a15c9126283","eden-2",NA,NA,NA,NA
"e5ebb0154d3490ff7df88e5ce0fb7e54","eden-therapeutics","seed",NA,"2011-11-30",1e+06
"235cdf325fcd7afa73348f5a7ae7eeb0","edeniq","venture","b","2010-05-11",12400000
"235cdf325fcd7afa73348f5a7ae7eeb0","edeniq","venture",NA,"2012-05-09",3.2e+07
"235cdf325fcd7afa73348f5a7ae7eeb0","edeniq","venture","a","2008-04-21",33120000
"235cdf325fcd7afa73348f5a7ae7eeb0","edeniq","venture",NA,"2013-05-01",6150000
"235cdf325fcd7afa73348f5a7ae7eeb0","edeniq","debt_financing",NA,"2013-07-18",8e+06
"235cdf325fcd7afa73348f5a7ae7eeb0","edeniq","venture",NA,"2015-01-20",1.6e+07
"235cdf325fcd7afa73348f5a7ae7eeb0","edeniq","seed",NA,"2014-11-03",4e+06
"975df3a2a7b00cf71e61916ea13018d6","edge-biosystems",NA,NA,NA,NA
"0cb0b1d42527c6f6b2bd506d00a23d64","edge-networks-pvt--ltd-",NA,NA,NA,NA
"265a4ea9f3e26c1ee960367adf71498b","edge-therapeutics","venture","a","2010-11-08",634500
"265a4ea9f3e26c1ee960367adf71498b","edge-therapeutics","venture","c","2013-06-04",1.8e+07
"265a4ea9f3e26c1ee960367adf71498b","edge-therapeutics","venture",NA,"2011-06-24",219500
"265a4ea9f3e26c1ee960367adf71498b","edge-therapeutics","venture",NA,"2012-09-17",118500
"265a4ea9f3e26c1ee960367adf71498b","edge-therapeutics","debt_financing",NA,"2014-09-08",1e+07
"265a4ea9f3e26c1ee960367adf71498b","edge-therapeutics","venture","C","2014-12-01",16500000
"265a4ea9f3e26c1ee960367adf71498b","edge-therapeutics","venture","C","2015-04-09",5.6e+07
"1d36262afdecacbe5db67ec007f17f24","edgeflip",NA,NA,NA,NA
"fb24d0eaecb048478e4fed148e82de18","edgemont-pharmaceuticals","venture",NA,"2010-12-09",4845795
"fb24d0eaecb048478e4fed148e82de18","edgemont-pharmaceuticals","debt_financing",NA,"2015-05-01",NA
"d3af89bfb9877bb4ba75537ba8d87c19","edgespring","seed",NA,"2010-07-01",1700000
"d3af89bfb9877bb4ba75537ba8d87c19","edgespring","venture","1","2013-05-17",1.1e+07
"100a54b6aa1b356bb14d51e6c9e17a44","edi-knights",NA,NA,NA,NA
"c6983d047d594118929ed6cbfb917bb2","edico-genome","venture","A","2014-07-17",1e+07
"361091a047ff30cffc4158ad9e54e352","edimer-pharmaceuticals","venture","b","2013-07-30",1.8e+07
"de8719d6949507a1270eb5672a3c34aa","edison-agrosciences",NA,NA,NA,NA
"93d65ca35695e0e71b5008418f6382db","edison-pharmaceuticals","venture","B","2007-07-02",4250000
"93d65ca35695e0e71b5008418f6382db","edison-pharmaceuticals","venture","e","2012-01-26",4100000
"93d65ca35695e0e71b5008418f6382db","edison-pharmaceuticals","venture",NA,"2009-04-24",2753514
"93d65ca35695e0e71b5008418f6382db","edison-pharmaceuticals","venture","f","2012-11-26",2e+07
"93d65ca35695e0e71b5008418f6382db","edison-pharmaceuticals","venture",NA,"2010-08-25",250026
"93d65ca35695e0e71b5008418f6382db","edison-pharmaceuticals","venture",NA,"2010-04-15",3024907
"93d65ca35695e0e71b5008418f6382db","edison-pharmaceuticals","private_equity",NA,"2014-03-27",50000135
"39eda1cf422b4fd6c9ea7b295bfc4e69","editas-medicine","venture","a","2013-11-25",4.3e+07
"39eda1cf422b4fd6c9ea7b295bfc4e69","editas-medicine","venture","B","2015-08-10",1.2e+08
"39eda1cf422b4fd6c9ea7b295bfc4e69","editas-medicine","venture",NA,"2015-05-27",4.7e+07
"7e02ba379f23d1ea51e9e5809f7979d9","editd","seed",NA,"2011-06-07",1600000
"7e02ba379f23d1ea51e9e5809f7979d9","editd","venture",NA,"2014-02-11",4400000
"7e02ba379f23d1ea51e9e5809f7979d9","editd","seed",NA,"2010-09-16",NA
"4e2d64936da1aa0bf99dd8fd9e24930d","editoreye",NA,NA,NA,NA
"551afb7a92222d7f6ad47282ca630f7d","edocr",NA,NA,NA,NA
"b36460a5303edf55697238cbb08c8ab2","edori",NA,NA,NA,NA
"7d7832dd8626ee68d04d07a3c09d6910","edp-biotech","venture",NA,"2010-04-12",516000
"7d7832dd8626ee68d04d07a3c09d6910","edp-biotech","debt_financing",NA,"2013-05-13",2e+05
"7d7832dd8626ee68d04d07a3c09d6910","edp-biotech","venture",NA,"2010-01-14",1285000
"7d7832dd8626ee68d04d07a3c09d6910","edp-biotech","venture",NA,"2010-12-16",705000
"5fcd35ccde23b980ebe243cc8de93355","edpuzzle","seed",NA,"2014-01-14",NA
"ee500c49f8adb5c7d621d8fb66614f19","edumedics","venture","A","2015-12-09",4200000
"ee500c49f8adb5c7d621d8fb66614f19","edumedics","debt_financing",NA,"2014-01-21",3e+05
"ee500c49f8adb5c7d621d8fb66614f19","edumedics","venture",NA,"2013-06-03",1052713
"19955dac4dd06349916b760690ca9d18","edusight","grant",NA,"2014-10-16",26615
"19955dac4dd06349916b760690ca9d18","edusight","angel",NA,"2014-08-10",1e+05
"78b4ab2e70450f9544b54a9ef45a347a","edwards-lifesciences",NA,NA,NA,NA
"9d669546c67a54f9c22234da00363ae7","eeme","seed",NA,"2013-11-21",NA
"9d669546c67a54f9c22234da00363ae7","eeme","seed",NA,"2014-12-17",NA
"4f5c95ff57501a558c697b85a98632b6","eepay",NA,NA,NA,NA
"6412cbd6ec9accf2f8fcdf586228e08f","effcon-mxr","venture",NA,"2011-06-29",721566
"4b0a9b0c48ccf796474d9bdaa7e2b0b3","effective-computing",NA,NA,NA,NA
"28c2ffdf8995d30ac0ec7b089cba3f89","effector-therapeutics","venture","B","2015-12-23",4e+07
"28c2ffdf8995d30ac0ec7b089cba3f89","effector-therapeutics","venture","A","2013-05-20",4.5e+07
"c20a6dd7e0205e5a9ec26732cec3d313","efferent-labs-inc",NA,NA,NA,NA
"106ff71ed3e513d4c35efdbd4b696054","efficas","debt_financing",NA,"2009-03-10",3164325
"a80c4b20385e9e7c279beb9096257795","efficiencie",NA,NA,NA,NA
"f93d4362e8bcfd73bc6a2baba3b4956f","efficiency-exchange","seed",NA,"2012-01-25",6e+05
"58a0a62c47ddcf7561fe5790f071cf4d","effilogics","seed",NA,"2013-12-01",339764
"39910d2b804adc07ceab047a9b78d6be","efflorus","venture",NA,"2015-04-17",NA
"70329d1da4441738d5fb82a1e94e09a6","effrx-pharmaceuticals","grant",NA,"2013-10-01",7590940
"70329d1da4441738d5fb82a1e94e09a6","effrx-pharmaceuticals","venture",NA,"2015-01-12",2268535
"13aad8bcb86915b58969aaa0b0c9b576","efinancial-communications","seed",NA,"2013-05-29",NA
"31becda4eab919cea8c8d0a060233284","egalet","venture","B","2007-04-02",27600000
"31becda4eab919cea8c8d0a060233284","egalet","post_ipo_equity","b","2014-02-11",NA
"31becda4eab919cea8c8d0a060233284","egalet","venture","B","2012-03-12",NA
"1651fab583aa3dba50800a88ea662822","egen","venture",NA,"2013-10-25",3917335
"1651fab583aa3dba50800a88ea662822","egen","venture","1","2008-08-04",1.2e+07
"1651fab583aa3dba50800a88ea662822","egen","private_equity",NA,"2009-12-21",7499997
"8b108f2320f460e011c638f50745533d","eggzack","seed",NA,"2011-09-01",NA
"8b108f2320f460e011c638f50745533d","eggzack","seed",NA,"2013-02-01",NA
"8b108f2320f460e011c638f50745533d","eggzack","seed",NA,"2014-02-01",NA
"8b108f2320f460e011c638f50745533d","eggzack","seed",NA,"2014-11-01",NA
"8b108f2320f460e011c638f50745533d","eggzack","seed",NA,"2015-09-01",NA
"735f5fe45309fbf83e636ef4ba59192d","egluu",NA,NA,NA,NA
"896c935ba1910c8d5b8944abafad3ab5","egoscue","seed",NA,"2013-05-09",7000
"896c935ba1910c8d5b8944abafad3ab5","egoscue","seed",NA,"2011-06-21",5550
"c0b5adc5c28fd8923326cefb20f22735","ehavior",NA,NA,NA,NA
"f9e258fb0e01d0715ff5dceec2a964fa","ehr-doctors",NA,NA,NA,NA
"f2dab66537201d9a574038ca535bfbdf","ehr-works","non_equity_assistance",NA,"2015-11-01",NA
"d4d5a0fb83a5e1a278389984644800af","eic",NA,NA,NA,NA
"f02658779c3aef706ecee0438bf29b86","eiger-biopharmaceuticals","venture",NA,"2015-11-18",NA
"f02658779c3aef706ecee0438bf29b86","eiger-biopharmaceuticals","debt_financing",NA,"2015-11-23",6e+06
"f02658779c3aef706ecee0438bf29b86","eiger-biopharmaceuticals","venture","1","2009-02-25",8300000
"f02658779c3aef706ecee0438bf29b86","eiger-biopharmaceuticals","venture","1","2015-02-13",8740630
"8f0339277ab0f78fe81edfb654b4d7f8","eight-wire",NA,NA,NA,NA
"f5854a6a147f88f3395461a4374356f8","einfochips",NA,NA,NA,NA
"8f1109bfcee69b1d50265ab862654476","eirx-therapeutics","venture",NA,"2005-04-06",180000
"20d791ceb72f5de2e84bc59256631ec2","eisai-co",NA,NA,NA,NA
"208548d2b9b87d2598d05a8769288274","eishtec",NA,NA,NA,NA
"86fd8344b427b5d93c51c8898f5f9dc8","eka-software-solutions","venture",NA,"2009-01-01",1e+07
"86fd8344b427b5d93c51c8898f5f9dc8","eka-software-solutions","venture",NA,"2005-01-01",6e+06
"86fd8344b427b5d93c51c8898f5f9dc8","eka-software-solutions","undisclosed",NA,"2013-10-15",NA
"740cbfdf830f9a65065f1fbfea0e0e8f","ekho-inc","seed",NA,"2014-10-01",50000
"740cbfdf830f9a65065f1fbfea0e0e8f","ekho-inc","venture",NA,"2015-05-12",1200000
"966ac861d6541980daea1a5629fe26cd","ekin-labs",NA,NA,NA,NA
"2e6a429aa8e5bcd455238f6a42e6c9d0","ekr-therapeutics","venture","C","2007-08-15",1.3e+07
"c6dae8b48965c0bfcd9ab7f60829b1de","elan-corporation",NA,NA,NA,NA
"84a5f70b8c28a0967b69c8844576a764","elan-diagnostics",NA,NA,NA,NA
"db989b7ac6c66552b89806385878e901","elan-pharmaceuticals",NA,NA,NA,NA
"f6555f7f9f29315f2b74ecf217c8f63e","elara-pharmaceuticals","venture","a","2009-11-26",6910000
"e155c30db761c162f5e457453e2da0d4","elastagen","venture","B","2016-01-07",9202280.2779
"e155c30db761c162f5e457453e2da0d4","elastagen","seed",NA,"2013-07-22",2e+06
"9c4a5b4f37760cf83539964bfa8ca4fd","elastic-io","seed",NA,"2014-02-26",NA
"6fdbd7a785f2889a4eaa5afd6005f1ed","elasticera",NA,NA,NA,NA
"4387465e275918ebe7fea8e3d319262a","elasticscalability",NA,NA,NA,NA
"deecc173b366ede23049bc1448a3a215","elcelyx-therapeutics","venture","E","2015-10-01",4e+07
"deecc173b366ede23049bc1448a3a215","elcelyx-therapeutics","venture","a","2010-03-17",1200000
"deecc173b366ede23049bc1448a3a215","elcelyx-therapeutics","venture","b","2012-12-20",21125008
"deecc173b366ede23049bc1448a3a215","elcelyx-therapeutics","venture","c","2014-02-21",24720101
"deecc173b366ede23049bc1448a3a215","elcelyx-therapeutics","venture","b","2012-08-13",4e+06
"deecc173b366ede23049bc1448a3a215","elcelyx-therapeutics","venture","D","2015-02-23",5800000
"b635b90ce15183a0d5c4dde833c36858","elder-research",NA,NA,NA,NA
"368218e128315b12b9b7b06f365369c7","elearnity",NA,NA,NA,NA
"d55b4651aa21b8167ab52231ac2a1e22","electrochem-tracking",NA,NA,NA,NA
"6e0f2a6ecf2444c57b401efbece80821","electronic-compliance-solutions","debt_financing",NA,"2011-08-04",494409
"6e0f2a6ecf2444c57b401efbece80821","electronic-compliance-solutions","venture",NA,"2013-01-03",370000
"6e0f2a6ecf2444c57b401efbece80821","electronic-compliance-solutions","venture",NA,"2012-08-22",677445
"f75cd353c772a9d28e33ed7faa595eae","elegant-microweb",NA,NA,NA,NA
"7760c98a45fa9748d1265e0d48de303f","elekta-ab",NA,NA,NA,NA
"eef64513effef3883b8538ac5b6f9ce9","eleme-medical","debt_financing",NA,"2010-06-15",6500000
"3799c9d2fc90ef4c74ce2bcf3812af49","element-marketing-group",NA,NA,NA,NA
"f9b6e820df43843c043765be37349049","elemental-consulting",NA,NA,NA,NA
"38dc6c7fbe3ea14199b24a282f78e962","elementive",NA,NA,NA,NA
"938004dc3fadb26e5e7fda80a68599f2","elemica",NA,NA,NA,NA
"05f5e529effe1f8a384e7888ad424972","elevated-media-inc",NA,NA,NA,NA
"7d9fed5168cd1a3b597c6080b8e5f923","elevated-third",NA,NA,NA,NA
"562feaa084eea5a532bb05efa640abff","elevation-pharmaceuticals","venture",NA,"2011-12-16",12400001
"562feaa084eea5a532bb05efa640abff","elevation-pharmaceuticals","venture","1","2010-01-21",3e+07
"562feaa084eea5a532bb05efa640abff","elevation-pharmaceuticals","venture","1","2012-01-04",3e+07
"562feaa084eea5a532bb05efa640abff","elevation-pharmaceuticals","venture","1","2011-09-26",1.7e+07
"30ebc0f12f8b822bab4d8fc2e276ff16","eleven-biotherapeutics","venture","a","2012-05-08",2e+07
"30ebc0f12f8b822bab4d8fc2e276ff16","eleven-biotherapeutics","venture","a","2010-03-09",3.5e+07
"30ebc0f12f8b822bab4d8fc2e276ff16","eleven-biotherapeutics","post_ipo_equity",NA,"2014-11-25",2e+07
"039b95af7b9cb97b9d750db15ede410e","elevio",NA,NA,NA,NA
"394f8a761d046e0307110be0ed48ca76","elfi-tech",NA,NA,NA,NA
"f9ef7e3e320c3e5fd0394d11663d6eeb","eli-lilly",NA,NA,NA,NA
"b0e427e4ec6d69db83ccb89808e32711","eligo-bioscience","seed","A","2015-07-09",2209342
"7cc161a1bf673127c565a699de7cabd4","elina-biosciences-inc",NA,NA,NA,NA
"2eb0caed1b6cbf64ce2f73fbe421884c","elistguy-elg-inc-","equity_crowdfunding",NA,"2015-08-26",NA
"def4f9026f794e7356a9ca11d8f4d5cb","elite-pharmaceuticals","venture",NA,"2009-06-12",1e+06
"def4f9026f794e7356a9ca11d8f4d5cb","elite-pharmaceuticals","venture",NA,"2013-04-23",205038
"def4f9026f794e7356a9ca11d8f4d5cb","elite-pharmaceuticals","post_ipo_equity",NA,"2014-04-15",8e+05
"7e2abc2231cfde816efd5feca53df435","elitra-pharmaceuticals",NA,NA,NA,NA
"b570cc5a17bc27701d50c05020f93562","elixir-bio-tech","convertible_note",NA,"2014-04-22",250000
"fc7296767c787a1d4dc2707320c00b27","elixir-pharmaceuticals","venture","d","2009-05-27",1.2e+07
"fc7296767c787a1d4dc2707320c00b27","elixir-pharmaceuticals","venture","c","2006-11-29",4.6e+07
"06944baf5faf0d647bd4d3cd9bf03783","elodina-inc",NA,NA,NA,NA
"65ce28ec234baf3245828d57a3d41946","elokenz",NA,NA,NA,NA
"9e691d73e87b27e41635ea51540b0b28","eloqua","venture","C","2007-10-01",2.3e+07
"9e691d73e87b27e41635ea51540b0b28","eloqua","venture","b","2006-09-01",12800000
"db00fcfc419e38333b8e3dbabec6fe84","eloxx","venture","a","2013-11-21",NA
"d11dd6743f16839c55f645f85b5fe9ad","elsalys-biotech","venture","a","2013-05-17",2702490
"a722d25005e2bc180f9730452f87b65d","elucid-bioimaging","venture",NA,"2013-01-01",375000
"8c01f79c3fc439a1bae9125b35d71a7e","elucidata",NA,NA,NA,NA
"36f68be6cc73345deb3a202c3207e817","elusys-therapeutics",NA,NA,NA,NA
"66dbc226ba1cb2aea970b8c5092dbb84","elystic",NA,NA,NA,NA
"fd9bdc33c33860c795388d2e1931ff29","em-research-organization",NA,NA,NA,NA
"bcd2cfaa6505733ddba4f756e9d3dab3","emagicone",NA,NA,NA,NA
"3239b158b70e2ff2d0f42697ab1a15de","emagiz",NA,NA,NA,NA
"14ea15b470c6de63260ff7926f56f1f2","email-answers",NA,NA,NA,NA
"0867568d4614a176646ac2fba6545e91","emailage","venture","A","2015-02-26",3800000
"5b6ee01021ab46edf47ba0b8d3a6d56a","emanation-partners",NA,NA,NA,NA
"280959e002f145139b0f371000f81d83","emanio",NA,NA,NA,NA
"3bba277a6c1f0412493f595f18a7452d","emarketer","venture",NA,"2012-01-11",2.5e+07
"363e3ebdbff63f9f5d921ba61f5cb739","emarsys","venture","A","2015-09-15",3.3e+07
"146edab046bc22c803ed474ca910fc2c","emart-solutions",NA,NA,NA,NA
"c5627c4f7d44f2bbce81cd2cd75adec1","emasys-corporation",NA,NA,NA,NA
"ed46baabe26cd146c01ce79523b70507","ematic-solutions","seed",NA,"2015-12-02",1060000
"ed46baabe26cd146c01ce79523b70507","ematic-solutions","angel",NA,"2013-01-07",215000
"aee537a469607dd77bbbfe3ddd188e0a","embeddedanalytics",NA,NA,NA,NA
"6a9505c2515652583342f9c098b89fb3","ember-therapeutics","venture","a","2011-12-15",3.4e+07
"6b471bae8a895deea7f63dcbea987e7b","ember-inc","seed",NA,"2012-10-01",NA
"6d3f46d49500c943a441401aa9ee3424","embera-neurotherapeutics","venture","A","2015-09-11",2e+06
"6d3f46d49500c943a441401aa9ee3424","embera-neurotherapeutics","venture","a","2010-03-10",490000
"6d3f46d49500c943a441401aa9ee3424","embera-neurotherapeutics","venture","a","2011-08-14",4500000
"6d3f46d49500c943a441401aa9ee3424","embera-neurotherapeutics","grant",NA,"2014-07-01",NA
"6d3f46d49500c943a441401aa9ee3424","embera-neurotherapeutics","venture","A","2015-02-26",2e+06
"c1e09a14affe9622eec8473f1ed23660","all-rights","seed",NA,"2012-07-19",NA
"df5a5e19862a20fca84755827724587b","embrex",NA,NA,NA,NA
"177c9d3b0da13a997a95f75495598656","embryotrans-biotech","venture",NA,"2014-09-05",NA
"449d9ffc187b1ed3503377da63d29963","embue","seed",NA,"2013-10-01",250000
"449d9ffc187b1ed3503377da63d29963","embue","seed",NA,"2013-05-22",150000
"449d9ffc187b1ed3503377da63d29963","embue","seed",NA,"2010-08-02",1200000
"449d9ffc187b1ed3503377da63d29963","embue","seed",NA,"2009-11-24",150000
"99149039a326864f9a41b1987e609b05","emcien",NA,NA,NA,NA
"052ee1c4c40e7db461c1ba8a3029c245","emcure-pharmaceuticals",NA,NA,NA,NA
"2d7937a363ac3660755f7f2b37588eaa","emd-millipore",NA,NA,NA,NA
"bb29b7d931fe697f7bb9ad01da6c51f3","emd-serono",NA,NA,NA,NA
"b4192f8361eb5b888b2bdbe091c5837f","emerald-therapeutics","venture","C","2015-06-01",20500000
"b4192f8361eb5b888b2bdbe091c5837f","emerald-therapeutics","venture","A","2010-01-01",7500000
"b4192f8361eb5b888b2bdbe091c5837f","emerald-therapeutics","venture","B","2014-03-01",6e+06
"284257d27b2407030f49fdc6c9129e30","emergency-medical-associates",NA,NA,NA,NA
"e3222df255579cc88ee08f161ffe65a5","emergency-service-partners","venture",NA,"2013-07-16",10296959
"18b3ad7df4a257392bd89e2cb2280bed","emergent-biosolutions","debt_financing",NA,"2015-02-03",2e+06
"a76ddbf24f3e315044255e24f0535d9a","emerginet",NA,NA,NA,NA
"a4ad4e223acf6ee2ee00a77a424be2b1","emerging-media-2","seed",NA,"2013-12-29",350000
"cec74818978186765c5b58f923888fdd","emerus-hospital-partners","venture",NA,"2011-01-18",3e+07
"cec74818978186765c5b58f923888fdd","emerus-hospital-partners","undisclosed",NA,"2015-09-01",NA
"11e04ee99e2dfa7da88b00c3afe0e079","emiliem","venture",NA,"2008-03-04",NA
"8f26ca09f79efe7d00310747b40022e0","eminent-infotech-pvt-ltd-2",NA,NA,NA,NA
"163b3fe754659e6d8967bc8170b6631c","emisphere-technologies","venture",NA,"2011-07-19",7499964
"163b3fe754659e6d8967bc8170b6631c","emisphere-technologies","debt_financing",NA,"2013-05-14",35168880
"163b3fe754659e6d8967bc8170b6631c","emisphere-technologies","venture",NA,"2010-09-08",7065006
"147fbd429630f62fa8c71363aefc528d","emma-solutions",NA,NA,NA,NA
"df619c61fe6952a4585ff55a8fa75bc2","emma","venture",NA,"2015-07-08",5e+06
"9b9768d920b2452a68df3007b2741cb5","emogi","seed",NA,"2014-08-01",1200000
"91eefe2b498dd9b84fdb139128c0631c","emospeech","venture",NA,"2013-02-26",37687
"91eefe2b498dd9b84fdb139128c0631c","emospeech","venture",NA,"2011-11-01",60464
"91eefe2b498dd9b84fdb139128c0631c","emospeech","equity_crowdfunding",NA,"2015-01-28",250000
"91eefe2b498dd9b84fdb139128c0631c","emospeech","grant",NA,"2012-03-01",65000
"91eefe2b498dd9b84fdb139128c0631c","emospeech","grant",NA,"2013-08-01",42244
"91eefe2b498dd9b84fdb139128c0631c","emospeech","seed",NA,"2013-07-01",35117
"9388bf79d352ca416537029cb8d7c570","emot-io",NA,NA,NA,NA
"3e09ccc1ff09ba302747a98237c45366","emoteshare","seed",NA,"2012-01-01",15000
"36060b3b6b763c6f3f898570f5fb2377","emotuit",NA,NA,NA,NA
"9434f60d5213204159eec8bd46d48a31","emozia",NA,NA,NA,NA
"2c77f85ddba0a8f1637617e945863e98","empath",NA,NA,NA,NA
"71b4cdb33448d694d1ada8bbf08a01b3","empaua-gmbh",NA,NA,NA,NA
"534b8b0e429787cbd6ec545cfd70463d","emphasize-outsourcing",NA,NA,NA,NA
"6bd103589c0ac06e25704291048a6f0e","empinfo",NA,NA,NA,NA
"88b1f9c949a24519636c04ad893307d3","empire-genomics","venture","A","2014-07-02",1e+06
"e315c36c6d11498b69cb32ba84ceb3ba","empire-resources",NA,NA,NA,NA
"c72827550dadaa8aad34df2a521099ba","empirical-bioscience","venture",NA,"2011-06-30",NA
"c72827550dadaa8aad34df2a521099ba","empirical-bioscience","venture",NA,"2012-03-22",NA
"44e3476dacef5f2b82690d539966442b","empirical-synergies",NA,NA,NA,NA
"243e4825fb1f4e615485c5800c63320c","empirix",NA,NA,NA,NA
"a61f37a31296fad43e8e9f78d869174a","employma","seed",NA,"2014-01-01",NA
"a61f37a31296fad43e8e9f78d869174a","employma","equity_crowdfunding",NA,"2014-07-25",NA
"1d44b48a64534e33e475823a6451c18c","employtoy",NA,NA,NA,NA
"2082cd1d15c1da28c430381a2ca46943","emporis","venture",NA,"2007-09-06",NA
"e026353fc3768cbb2f4dd242ada47329","empower-campaigns",NA,NA,NA,NA
"05d688f81983314804cb3a2f8006784e","empower-network",NA,NA,NA,NA
"ba96e96f042575768d3bf06c7642e9ab","empower-visi","equity_crowdfunding",NA,"2015-07-23",NA
"f415ba4dfc4798b7f0b5041d23b29abc","empower2adapt","equity_crowdfunding",NA,"2014-07-16",NA
"8a8da11962f94e4d6209f4cee6df3b16","emunamedica","venture",NA,"2010-07-13",2100000
"3fb5345aa084e44229138d1c90ba56d1","enablevue",NA,NA,NA,NA
"f63396fb5f8963a0beb485d0cb452489","enanta-pharmaceuticals","venture",NA,"2013-09-03",9200000
"08fa2811d3824d44e7ff5dd2829d576b","enb-therapeutics","equity_crowdfunding",NA,"2015-05-16",130000
"5a0d73df9c8034f8d4ef7c5db808a638","enbritely-fraud-whistleblowers",NA,NA,NA,NA
"69b51bcccb1f4c79a031e08b3e627de5","encare-biotech","venture","A","2014-11-21",5500000
"3221f44ba37e5aa498da0e707799cb60","enclara-health","debt_financing",NA,"2010-04-06",2021005
"3221f44ba37e5aa498da0e707799cb60","enclara-health","debt_financing",NA,"2009-04-03",2045078
"ef6f13927faba7569797dc619f9f6c0f","encoate","venture",NA,"2007-07-24",5100000
"16ab6911e43f13b7e365da469e5f1c5c","encoded-genomics","seed",NA,"2014-10-15",120000
"4d98fb1f961e1aeffbf490d5e501c762","encore","seed",NA,"2015-07-31",125000
"4d98fb1f961e1aeffbf490d5e501c762","encore","seed",NA,"2013-05-20",30000
"4d98fb1f961e1aeffbf490d5e501c762","encore","seed",NA,"2014-03-18",390000
"e143c4ab600233f4c0454fbf68db9a5e","encore-vision-inc","angel",NA,"2013-12-19",5e+06
"e143c4ab600233f4c0454fbf68db9a5e","encore-vision-inc","venture","1","2015-08-25",2500000
"f52b1378bf338dc216c86e3923236aa4","encycle-therapeutics","venture",NA,"2015-09-30",2130156.2862
"f52b1378bf338dc216c86e3923236aa4","encycle-therapeutics","venture",NA,"2014-11-11",2500000
"24598e02ebc4c523ef165072f5ef07a3","encysive-pharmaceuticals","private_equity",NA,"2007-08-20",13950000
"24598e02ebc4c523ef165072f5ef07a3","encysive-pharmaceuticals","private_equity",NA,"2006-10-19",7.5e+07
"1eefc46005ac38445e732fd20c0b549d","endeavor-pharmaceuticals",NA,NA,NA,NA
"8426016709a1dff35a93f477dfc91f12","endeco",NA,NA,NA,NA
"532f722174133af5de9d76a0b21d6de0","endgenitor-technologies","venture",NA,"2009-07-24",2450000
"eb78c4e6567e203c3d11c71114a215ad","endless-solutions",NA,NA,NA,NA
"c383c7a98211bc77c17bf58305f8a181","endo-health-solutions",NA,NA,NA,NA
"01e4242e7e9923375d2fd8c7858caeef","endobiologics-international","venture",NA,"2010-08-13",250000
"01e4242e7e9923375d2fd8c7858caeef","endobiologics-international","venture",NA,"2010-04-26",1100000
"aa3e327ff3b61b157df346d9f1b25a6e","endochoice","venture",NA,"2013-01-04",4.3e+07
"aa3e327ff3b61b157df346d9f1b25a6e","endochoice","venture",NA,"2011-01-11",4488205
"aa3e327ff3b61b157df346d9f1b25a6e","endochoice","venture",NA,"2010-06-29",7777843
"aa3e327ff3b61b157df346d9f1b25a6e","endochoice","venture",NA,"2009-09-01",3223870
"aa3e327ff3b61b157df346d9f1b25a6e","endochoice","venture","1","2008-05-19",NA
"aa3e327ff3b61b157df346d9f1b25a6e","endochoice","venture","1","2015-03-05",5.7e+07
"6cd1c6a7da3668b7f6820b5c00ddb076","endoclear","venture",NA,"2011-10-25",2400000
"6cd1c6a7da3668b7f6820b5c00ddb076","endoclear","debt_financing",NA,"2011-08-27",5e+05
"6cd1c6a7da3668b7f6820b5c00ddb076","endoclear","venture",NA,"2010-02-15",1950000
"6cd1c6a7da3668b7f6820b5c00ddb076","endoclear","venture",NA,"2014-05-23",782786
"29ffbb35cb75d22d14d73731a812c37c","endocyte","venture","D","2006-11-13",3e+07
"29ffbb35cb75d22d14d73731a812c37c","endocyte","venture","C","2007-03-26",1.5e+07
"29ffbb35cb75d22d14d73731a812c37c","endocyte","venture","c","2010-01-19",2.6e+07
"29ffbb35cb75d22d14d73731a812c37c","endocyte","venture",NA,"2010-08-30",1.5e+07
"29ffbb35cb75d22d14d73731a812c37c","endocyte","debt_financing",NA,"2010-12-27",8100000
"548a48e59c1a78fd81b37a5483cfc765","endologix","venture",NA,"2010-10-27",1.5e+07
"ff4a5c40fd0c052894b2d5d71171df2f","endoluminal-sciences","seed",NA,"2013-07-22",2500000
"8dbdc7358859829d7bbf857fca658b13","endonovo-therapeutics","debt_financing",NA,"2014-08-14",483000
"010a161cea675a08d63c3306756cc0e0","endorphin-me","seed",NA,"2012-09-07",250000
"13a28f58e8fcc173def0ad6b1798887b","endosee","venture",NA,"2014-01-31",1005083
"13a28f58e8fcc173def0ad6b1798887b","endosee","venture",NA,"2013-02-06",1679982
"13a28f58e8fcc173def0ad6b1798887b","endosee","venture",NA,"2011-10-31",887672
"551a836086c4cbe9eee28308179faeb7","endosense","venture","b","2009-10-27",3.6e+07
"551a836086c4cbe9eee28308179faeb7","endosense","venture","c","2012-11-27",40300000
"551a836086c4cbe9eee28308179faeb7","endosense","venture","c","2013-03-06",4300000
"757a7122e60ccd90562a8e54633eb001","endospan","venture",NA,"2015-10-26",1e+07
"7d86b8b8896c7da3348888ac936f14c1","endostim","venture","d","2013-06-05",14100000
"7d86b8b8896c7da3348888ac936f14c1","endostim","venture",NA,"2009-10-01",775000
"7d86b8b8896c7da3348888ac936f14c1","endostim","venture",NA,"2013-01-14",9133808
"7d86b8b8896c7da3348888ac936f14c1","endostim","venture","a","2010-07-19",6e+06
"7d86b8b8896c7da3348888ac936f14c1","endostim","venture",NA,"2009-07-13",550000
"7d86b8b8896c7da3348888ac936f14c1","endostim","venture",NA,"2011-12-05",5548991
"7d86b8b8896c7da3348888ac936f14c1","endostim","debt_financing",NA,"2014-07-10",6364780
"7d86b8b8896c7da3348888ac936f14c1","endostim","venture","E","2015-05-11",2500000
"4f3e27d7cb314c198a951a819f43c282","endotex",NA,NA,NA,NA
"70868338a13277ecaca41c864c453492","endotis","venture","B","2008-01-23",36395929.4792
"40683b6c4f60f5999985232ccf4247dd","endotronix","debt_financing",NA,"2012-08-27",1795000
"40683b6c4f60f5999985232ccf4247dd","endotronix","debt_financing",NA,"2013-06-12",1193200
"40683b6c4f60f5999985232ccf4247dd","endotronix","venture",NA,"2014-04-29",1600000
"40683b6c4f60f5999985232ccf4247dd","endotronix","seed",NA,"2010-10-08",250000
"40683b6c4f60f5999985232ccf4247dd","endotronix","debt_financing",NA,"2015-02-13",2197273
"40683b6c4f60f5999985232ccf4247dd","endotronix","debt_financing",NA,"2015-12-30",2960000
"4d0ef9d469d29f4ed3e3d4e4442cae20","endovention","angel",NA,"2007-06-14",1500000
"cfec0da2eb80c676aa1f83b4eb9c84a9","enduracare-acutecare","venture",NA,"2010-01-13",5e+05
"cfec0da2eb80c676aa1f83b4eb9c84a9","enduracare-acutecare","venture",NA,"2009-09-18",7146823
"50eecd5a804d02ad2163aa1a7018fbed","endurance-biotech","venture",NA,"2015-08-13",5081110
"e003cc5cd1a644b78c35a4fdd5a32283","endymed","post_ipo_equity",NA,"2014-08-03",7e+06
"920bdf2fad29b2607d0f3da3e87558db","enecto",NA,NA,NA,NA
"9ada8b22f83afe0acc823608316f0c50","eneighborhoods",NA,NA,NA,NA
"0e4ccba160df5c6b8be2adf37e4885d9","energenetics-energies","equity_crowdfunding",NA,"2014-12-17",NA
"1c395654816c50d6d82187df4dfae3d7","energesis-pharmaceuticals","seed",NA,"2010-10-21",50000
"274538a56f89f3fe7b82ae763577e7c5","energy-options-inc",NA,NA,NA,NA
"d0367a4041ec289ee183512ad313b35f","energy-solutions-forum-esf","seed",NA,"2014-11-17",NA
"56b1c3fa0df576208497cb7b38f63464","enerplant","equity_crowdfunding",NA,"2013-04-03",NA
"a76c2f4a0160a1c462ac30c6070cbddd","enertiv","seed",NA,"2013-12-03",120000
"a76c2f4a0160a1c462ac30c6070cbddd","enertiv","angel",NA,"2012-10-01",550000
"a76c2f4a0160a1c462ac30c6070cbddd","enertiv","seed",NA,"2014-09-01",1150000
"a76c2f4a0160a1c462ac30c6070cbddd","enertiv","seed",NA,"2011-01-01",120000
"90e663ec35427a3d2b29a42d1803db79","enervee","seed",NA,"2010-07-01",NA
"90e663ec35427a3d2b29a42d1803db79","enervee","angel",NA,"2013-06-01",NA
"90e663ec35427a3d2b29a42d1803db79","enervee","seed",NA,"2014-09-11",1700000
"90e663ec35427a3d2b29a42d1803db79","enervee","venture","1","2015-05-26",3700000
"823d772c47432b1d035c2e0ed1b24438","eneura-therapeutics","venture",NA,"2014-01-06",2212035
"823d772c47432b1d035c2e0ed1b24438","eneura-therapeutics","seed",NA,"2013-08-20",3224999
"823d772c47432b1d035c2e0ed1b24438","eneura-therapeutics","debt_financing",NA,"2014-02-23",1674000
"823d772c47432b1d035c2e0ed1b24438","eneura-therapeutics","venture",NA,"2013-10-02",589990
"823d772c47432b1d035c2e0ed1b24438","eneura-therapeutics","venture",NA,"2014-08-28",5776211
"823d772c47432b1d035c2e0ed1b24438","eneura-therapeutics","debt_financing",NA,"2015-03-12",1.5e+07
"9d169ff40e5466e05d6835cd22ff8026","enevolv","venture","a","2014-03-13",1794845
"7adc9c8cac2eceb1ad433249cfcc2671","enfatica",NA,NA,NA,NA
"41ba9e8891a5c074c467173dc67ba0e4","enfind",NA,NA,NA,NA
"8eb01baad88a4a8c309fc035a6886214","enfuego-technologies-llc",NA,NA,NA,NA
"73c454252d8c9d47e87a02f89ecf459b","engage3-solution",NA,NA,NA,NA
"9aa3411eb3a153ca6b1c09056acf2f05","engageclick",NA,NA,NA,NA
"375425e738708d88c5f5cbb14ebe1de8","engagemaster",NA,NA,NA,NA
"ea754e3892d143af816179864689ebdf","engagement-labs","post_ipo_equity",NA,"2014-02-02",6e+06
"ea754e3892d143af816179864689ebdf","engagement-labs","post_ipo_equity",NA,"2015-03-19",8e+06
"06cfd22f6834683dabe4f9bae42f87d8","engagement-systems",NA,NA,NA,NA
"84b28d69e98657a11572c200f5cd4675","engagesciences","angel",NA,"2012-07-23",3880802
"1031c833e5f06aa23a7a1b75bc13cf71","engagesimply","seed",NA,"2012-12-30",555000
"1031c833e5f06aa23a7a1b75bc13cf71","engagesimply","seed",NA,"2013-06-04",2e+05
"c9b1ad186bf9c5673a2f156a3849ac8c","engagewise",NA,NA,NA,NA
"a0346431370c757f40c3dbc7a5ee46e6","engaging-social",NA,NA,NA,NA
"3eb983d5b411b0ce48e6a34c4fe200e3","engagio-2","venture","A","2015-04-08",1e+07
"1245e91819afbb64586b407e44df80c5","engene","venture","a","2008-03-17",6400000
"1245e91819afbb64586b407e44df80c5","engene","venture","A","2013-08-02",13250000
"1245e91819afbb64586b407e44df80c5","engene","venture","B","2015-01-26",11500000
"d9bc212116601295b420f976b930d378","engeneic","seed",NA,"2011-07-27",1022691
"d9bc212116601295b420f976b930d378","engeneic","venture","1","2015-01-06",1e+07
"d9bc212116601295b420f976b930d378","engeneic","venture",NA,"2015-03-02",7e+06
"d9bc212116601295b420f976b930d378","engeneic","venture",NA,"2015-07-29",2905000
"65bb046e5dafdc34c8f26113e2d7a143","enger",NA,NA,NA,NA
"add1dd79eb1d4683834e1e87d6857230","engineroom-io",NA,NA,NA,NA
"549557703fec23ed0f6c547bcb8a7f1d","englue",NA,NA,NA,NA
"431499afc99f9455a02e007c2e8f1969","engramatic",NA,NA,NA,NA
"0a3795a4b61481e6a7eacc701b0c5e1d","enhanced-automation",NA,NA,NA,NA
"d83c6f42a639e9779291ff86379e804b","enhanced-retail-solutions",NA,NA,NA,NA
"f001500d6b082888405c2ad00d8923d1","enhanceworks","angel",NA,"2013-04-01",3e+05
"105c64873d7869419886ccbd39a0ccff","enigma-technologies","venture","a","2014-01-30",4500000
"105c64873d7869419886ccbd39a0ccff","enigma-technologies","venture",NA,"2012-04-17",815000
"105c64873d7869419886ccbd39a0ccff","enigma-technologies","seed",NA,"2013-02-27",1100000
"105c64873d7869419886ccbd39a0ccff","enigma-technologies","venture","B","2015-06-22",28200000
"b352513500ad1d7a1f9bcd3ca3bd2f9e","eniware-llc",NA,NA,NA,NA
"aa32d49aa74c528690c2ad7eef58b07f","enject","debt_financing",NA,"2009-09-11",1e+06
"b6721c8c3f435399cbfb2014dd4ddc60","enkata-technologies","venture",NA,"2008-02-05",8e+06
"b6721c8c3f435399cbfb2014dd4ddc60","enkata-technologies","venture","1","2006-09-26",4880000
"b6721c8c3f435399cbfb2014dd4ddc60","enkata-technologies","venture","1","2011-10-03",4400000
"991758689e547b81d88d307c253a84ad","enlight-biosciences",NA,NA,NA,NA
"dbf364b12700ca8a07aff6c44aee7289","enlighted","venture",NA,"2010-10-15",1400000
"dbf364b12700ca8a07aff6c44aee7289","enlighted","debt_financing",NA,"2009-07-31",225000
"dbf364b12700ca8a07aff6c44aee7289","enlighted","venture","1","2013-04-18",2e+07
"dbf364b12700ca8a07aff6c44aee7289","enlighted","venture",NA,"2011-10-04",1.4e+07
"dbf364b12700ca8a07aff6c44aee7289","enlighted","venture","1","2014-08-20",2e+07
"cd92c9853b5558c3e1381c98f8b9b0ca","enlitic","venture","B","2015-10-27",1e+07
"cd92c9853b5558c3e1381c98f8b9b0ca","enlitic","seed",NA,"2014-10-28",2e+06
"cd92c9853b5558c3e1381c98f8b9b0ca","enlitic","venture","A","2015-03-12",3e+06
"52d133f07a254d2700ed89ea78bce784","enmain-3",NA,NA,NA,NA
"4a0854e989a32252390cd4c614dfa9b8","enmarkit","seed",NA,"2013-08-29",11700
"862ec8908f22439570dc4fc060480d4d","enobia-pharma","venture","c","2009-08-10",5e+07
"862ec8908f22439570dc4fc060480d4d","enobia-pharma","venture","B","2007-08-01",37711598.7461
"862ec8908f22439570dc4fc060480d4d","enobia-pharma","venture",NA,"2011-08-08",4e+07
"862ec8908f22439570dc4fc060480d4d","enobia-pharma","venture",NA,"2011-04-01",1.5e+07
"862ec8908f22439570dc4fc060480d4d","enobia-pharma","venture","a","2005-01-18",15550000
"b962ce64fb5a1b29d8a236a8e8e8eeac","enodo-software","seed",NA,"2012-03-01",NA
"c959385d92ea8c089d01a19166f51bfd","enovapoint-2",NA,NA,NA,NA
"d0194d30a3f882a3c781bc31601fb1af","ensa","seed",NA,"2015-01-10",5e+05
"08eff74baecf2d63802f068348af5680","ensemble-discovery","venture","B","2007-11-12",1.5e+07
"08eff74baecf2d63802f068348af5680","ensemble-discovery","venture","a","2004-05-12",1.5e+07
"5536d91c8a54c1cc665fee8e2357378e","ensemble-therapeutics",NA,NA,NA,NA
"69b71a025ce9a5764c0b097f1854437c","ensolve-biosystems","debt_financing",NA,"2009-12-01",3e+05
"0540381f6d6acfb4cad12c85e9dc8210","ent-biotech-solutions","venture",NA,"2014-07-14",940000
"0540381f6d6acfb4cad12c85e9dc8210","ent-biotech-solutions","venture",NA,"2015-03-20",5e+05
"2360088c9766aeac58c2d64b14683a7e","entalysis",NA,NA,NA,NA
"f4e0f88b99cd4d5147c501f51d03f6df","entegrion","debt_financing",NA,"2015-11-06",526474
"f4e0f88b99cd4d5147c501f51d03f6df","entegrion","venture",NA,"2009-10-18",257228
"f4e0f88b99cd4d5147c501f51d03f6df","entegrion","debt_financing",NA,"2011-03-31",1500000
"f4e0f88b99cd4d5147c501f51d03f6df","entegrion","debt_financing",NA,"2011-10-07",3e+05
"6adf1a6ab8d19aaded4039b45852e2e7","entelos","undisclosed",NA,"2013-06-21",NA
"6adf1a6ab8d19aaded4039b45852e2e7","entelos","undisclosed",NA,"2001-09-01",NA
"6ff7c0ad8dc74cf0947e3344703ee549","enterest",NA,NA,NA,NA
"365ce9a523593a6c6d5da52750858586","enteromedics","venture",NA,"2009-02-27",15896351
"365ce9a523593a6c6d5da52750858586","enteromedics","venture","1","2004-07-01",NA
"365ce9a523593a6c6d5da52750858586","enteromedics","venture",NA,"2015-07-08",1.6e+07
"f58dc60d45d98adc35c04ad6d4c569b3","enterprise-concept",NA,NA,NA,NA
"cfaaa1fba768f5da2bfa30707011b988","enterprisedb","venture","a","2005-09-07",7e+06
"cfaaa1fba768f5da2bfa30707011b988","enterprisedb","venture","b","2006-08-01",2e+07
"cfaaa1fba768f5da2bfa30707011b988","enterprisedb","venture","c","2008-03-25",1.6e+07
"cfaaa1fba768f5da2bfa30707011b988","enterprisedb","venture",NA,"2009-11-13",8321718
"cfaaa1fba768f5da2bfa30707011b988","enterprisedb","venture",NA,"2011-02-04",6100000
"cfaaa1fba768f5da2bfa30707011b988","enterprisedb","venture",NA,"2010-07-14",7500000
"b8120257e31750dac458283a36aaee15","entest-biomedical",NA,NA,NA,NA
"0af54b50a993d33c76b29e457628e19e","entia-biosciences","debt_financing",NA,"2015-12-07",50000
"0af54b50a993d33c76b29e457628e19e","entia-biosciences","venture","1","2013-11-14",1500000
"0af54b50a993d33c76b29e457628e19e","entia-biosciences","venture",NA,"2015-05-13",205000
"a3554eac143e39316be95d64dd330566","entic","seed",NA,"2014-01-01",4500000
"6cdb03167a436bcbc43b457e1e94ca14","entigen-corporation",NA,NA,NA,NA
"def0cf976553f6da624fbaf8d0a8e5a5","entomopharm","venture","a","2010-08-02",1010000
"def0cf976553f6da624fbaf8d0a8e5a5","entomopharm","seed",NA,"2011-12-22",760000
"def0cf976553f6da624fbaf8d0a8e5a5","entomopharm","undisclosed",NA,"2010-06-10",NA
"def0cf976553f6da624fbaf8d0a8e5a5","entomopharm","seed",NA,"2009-03-09",689654
"dfed7b667ecaee31bde976c8f95c857e","entopsis","seed",NA,"2015-02-17",8e+05
"dfed7b667ecaee31bde976c8f95c857e","entopsis","convertible_note",NA,"2015-03-19",575000
"a55df5d71a68012c435203b8b7785367","entourage-medical-technologies","venture",NA,"2010-01-27",1500000
"a55df5d71a68012c435203b8b7785367","entourage-medical-technologies","venture",NA,"2013-02-08",3251000
"827aa97a9712320aa2e1d8877f79e814","entouragebox",NA,NA,NA,NA
"e203bba46f49bb308d43de908317f628","entrance",NA,NA,NA,NA
"ec7f2c0aad0a0a8a0cb8e76f03567632","entrechem",NA,NA,NA,NA
"0c5ff7d146616891c3f1c26bf48ad6c8","entremed","venture",NA,"2012-01-23",1e+07
"a5a1336f9b9dc25fc5e3101e5ea1cfdc","entrepreneur-handbook","seed",NA,"2013-06-10",40000
"a5a1336f9b9dc25fc5e3101e5ea1cfdc","entrepreneur-handbook","seed",NA,"2014-02-10",125000
"a5a1336f9b9dc25fc5e3101e5ea1cfdc","entrepreneur-handbook","seed",NA,"2015-05-11",185000
"2cf933de8f367bd980e12115af838385","entrepreneurs-world",NA,NA,NA,NA
"c7218e2ddcc12539670a73508e7fec32","entrigue-surgical","venture","A","2007-07-12",6300000
"c7218e2ddcc12539670a73508e7fec32","entrigue-surgical","seed",NA,"2011-11-21",4e+06
"c7218e2ddcc12539670a73508e7fec32","entrigue-surgical","debt_financing",NA,"2009-09-16",3171773
"c7218e2ddcc12539670a73508e7fec32","entrigue-surgical","venture",NA,"2010-05-05",10878234
"eb7d2c213311c17bd74a549c687e1cd4","entropysoft","venture","a","2011-03-16",3500000
"9ec0f107533bf8a58e0435e33594839b","entytle","seed",NA,"2014-07-02",1647000
"9ec0f107533bf8a58e0435e33594839b","entytle","seed",NA,"2015-08-28",405030
"108f0ccf47ca2a2b1bf44a4d5b0ad592","enumeral-biomedical","private_equity",NA,"2013-05-14",1520004
"108f0ccf47ca2a2b1bf44a4d5b0ad592","enumeral-biomedical","venture","1","2011-05-23",1997477
"108f0ccf47ca2a2b1bf44a4d5b0ad592","enumeral-biomedical","debt_financing",NA,"2014-02-10",635000
"108f0ccf47ca2a2b1bf44a4d5b0ad592","enumeral-biomedical","venture",NA,"2012-07-09",2272973
"108f0ccf47ca2a2b1bf44a4d5b0ad592","enumeral-biomedical","venture",NA,"2014-05-07",2016249
"108f0ccf47ca2a2b1bf44a4d5b0ad592","enumeral-biomedical","post_ipo_equity",NA,"2014-08-04",21500000
"94923297161969681908072de7a053e9","enview",NA,NA,NA,NA
"dc0d5af9f2c7fa33edcd85723d625c47","envirogene","undisclosed",NA,"2007-03-26",2941893
"58da87299d88b0664ec5e0db4665c8ff","envirolytic-insights",NA,NA,NA,NA
"25ba5afdae349564c3df89ea0b5f3914","envirotech-innovative-products",NA,NA,NA,NA
"4bbd26b618682942cc3da0f5a5fe3ee5","envisia-therapeutics","debt_financing",NA,"2015-10-19",4600000
"4bbd26b618682942cc3da0f5a5fe3ee5","envisia-therapeutics","venture","1","2013-11-12",2.5e+07
"f79ca45d699df54b6b94cfaef6ba927e","envisr",NA,NA,NA,NA
"0e0490244c45e5e1c0ee56057a3afa5f","envoy-therapeutics","grant",NA,"2012-05-08",1200000
"02933244a494c25f01d13231860cfe4a","enzo-life-sciences",NA,NA,NA,NA
"c1fa590c5e50fecd404e13f27a740f2e","enzon-inc",NA,NA,NA,NA
"ecc11856f9e137cbfa8d2bec9e5cff4d","enzymatics",NA,NA,NA,NA
"2177e4e4c2a316586136d0dc63325dc8","enzymerx","venture",NA,"2008-05-28",1.4e+07
"4b69ba019409efe379e85049278d954a","enzymotec","venture","b","2009-02-02",1.1e+07
"f8ab6952a269fc01b772c716c3bcf2de","enzysurge","venture",NA,"2010-01-11",4100000
"546b4cdaee7c52e3ca1524189c1dc64f","eo2","venture",NA,"2009-08-10",705000
"546b4cdaee7c52e3ca1524189c1dc64f","eo2","venture",NA,"2009-04-01",732500
"546b4cdaee7c52e3ca1524189c1dc64f","eo2","venture",NA,"2010-05-13",2500000
"546b4cdaee7c52e3ca1524189c1dc64f","eo2","venture",NA,"2012-06-28",4290702
"546b4cdaee7c52e3ca1524189c1dc64f","eo2","venture",NA,"2014-04-16",70000
"e28cc7f080629a71ee102fa4bc70f9d6","eon-surgical",NA,NA,NA,NA
"38d2bcb1104e5410549a3e371f987395","eos-ethical-oncology-science",NA,NA,NA,NA
"44a35f6f51735b8af6634a3cfd2077df","eos-data-analytics","seed",NA,"2015-01-08",1e+06
"de2da7a09921877138692ec61a84eb5e","eos-remediation",NA,NA,NA,NA
"9a250e083282123181cc696fc41942e4","ep-vantage",NA,NA,NA,NA
"69d79d7ca7822f209e3452eccac776e3","epartners","venture",NA,"2005-08-22",2.5e+07
"0ae6626692729d95acb3de2ddcec0db1","epharmasolutions",NA,NA,NA,NA
"1614b5682beee85f4e7c72ae9339b5f1","epibiome","seed",NA,"2014-10-15",120000
"3423fe35a523975b664e66ca56b493a9","epibone","grant",NA,"2014-06-12",NA
"3cb4241a37cb62dd9fcbbef45eaf398c","epic-alarm",NA,NA,NA,NA
"4c27509ad79c60e9df9a7e9c7df38cbc","epic-business",NA,NA,NA,NA
"e78c5368af09ca1f0af09ef1074bc4a6","epic-marketing-design",NA,NA,NA,NA
"f559f140c7460ce513a6bd71907edf93","epic-playground","seed",NA,"2012-01-01",NA
"f559f140c7460ce513a6bd71907edf93","epic-playground","seed",NA,"2011-12-01",585000
"92097b22158fc70c56cdde408dc31bb9","epic-research-diagnostics","venture",NA,"2009-08-13",1914997
"92097b22158fc70c56cdde408dc31bb9","epic-research-diagnostics","venture",NA,"2013-08-19",1405000
"feaa5853354fbb81cabc9677b50f914e","epic-sciences","venture","b","2012-11-13",1.3e+07
"feaa5853354fbb81cabc9677b50f914e","epic-sciences","venture","C","2014-07-30",3e+07
"feaa5853354fbb81cabc9677b50f914e","epic-sciences","debt_financing",NA,"2015-06-01",1.5e+07
"1da06dc481170d3d0ab9ec0a7e7680d4","epicom-corporation",NA,NA,NA,NA
"065a9746b677b5d11c174171b36dc40b","epicypher",NA,NA,NA,NA
"701595ca86abab23d0c2fef25e878387","epidata-2",NA,NA,NA,NA
"106a06db5addff724245480cc3514158","epiep","venture",NA,"2013-06-20",4050000
"106a06db5addff724245480cc3514158","epiep","venture","1","2011-07-08",1400000
"106a06db5addff724245480cc3514158","epiep","debt_financing",NA,"2009-07-20",1e+05
"106a06db5addff724245480cc3514158","epiep","venture",NA,"2015-09-23",8626048
"6353232aed97e872b14ca4fc9c2530d1","epigen-biosciences",NA,NA,NA,NA
"4c7cf79a77f6dc412a9bf509de23a152","epigentek",NA,NA,NA,NA
"d21d0bfe2b852112a92c6567a8006f2c","epilogger","seed",NA,"2012-05-01",50809
"faafe81ce11886e5ed025867d63c75ca","epinex-diagnostics","venture",NA,"2016-01-15",2170092
"faafe81ce11886e5ed025867d63c75ca","epinex-diagnostics","venture",NA,"2011-04-29",202756
"faafe81ce11886e5ed025867d63c75ca","epinex-diagnostics","venture",NA,"2013-03-05",318000
"faafe81ce11886e5ed025867d63c75ca","epinex-diagnostics","venture",NA,"2010-08-10",598740
"faafe81ce11886e5ed025867d63c75ca","epinex-diagnostics","venture",NA,"2008-04-17",1174857
"0afe8d6dd3b3afd2ebb432e9eb75d8f7","epiomed-therapeutics","venture",NA,"2013-05-01",2249999
"1c830d1c1fff73725da3855a82b55ead","epiphany","venture","a","2007-03-16",3.6e+07
"e407cc9cf3c2fd2999b36fd798f8f2d6","epirroi",NA,NA,NA,NA
"5b6035f1ac85d3fe94a054cbd4e7c40b","epirus-biopharmaceuticals","venture",NA,"2012-04-01",8083000
"5b6035f1ac85d3fe94a054cbd4e7c40b","epirus-biopharmaceuticals","venture","1","2014-04-16",3.6e+07
"5b6035f1ac85d3fe94a054cbd4e7c40b","epirus-biopharmaceuticals","venture",NA,"2012-07-01",5e+06
"38b77d4160986301c778dd73d8ff698c","episona-inc","seed",NA,"2013-08-01",25000
"2727e160178a7947c8d1e90405c79dcf","epistema","venture",NA,"2015-07-01",NA
"bd9e99b1c369510d3ac8542e7906e920","epitomics",NA,NA,NA,NA
"d738d99e3fa2299309e222f397f06d77","epivax","grant",NA,"2012-04-09",1500000
"d738d99e3fa2299309e222f397f06d77","epivax","seed",NA,"1998-01-01",NA
"d738d99e3fa2299309e222f397f06d77","epivax","grant",NA,"2012-11-01",55000
"d738d99e3fa2299309e222f397f06d77","epivax","grant",NA,"2012-09-05",3e+05
"d738d99e3fa2299309e222f397f06d77","epivax","grant",NA,"2008-11-26",390000
"d738d99e3fa2299309e222f397f06d77","epivax","grant",NA,"2011-01-25",458000
"d738d99e3fa2299309e222f397f06d77","epivax","grant",NA,"2008-07-08",6e+05
"d738d99e3fa2299309e222f397f06d77","epivax","grant",NA,"2007-02-28",368000
"0c4450d8c95f5932cfddd61d02026fc7","epivios","undisclosed",NA,"2012-07-11",NA
"ddfaa78177843a48d6c56a6ec84bb5da","epix-pharmaceuticals",NA,NA,NA,NA
"f202950484683af081bcb0d65b8d5319","epixis",NA,NA,NA,NA
"f72d4de9f06f107d4a6dd7e2fa711f83","epizyme","venture","b","2009-10-07",3.2e+07
"f72d4de9f06f107d4a6dd7e2fa711f83","epizyme","venture",NA,"2011-10-14",4e+06
"f72d4de9f06f107d4a6dd7e2fa711f83","epizyme","venture","b","2009-12-08",8e+06
"f72d4de9f06f107d4a6dd7e2fa711f83","epizyme","venture",NA,"2011-06-23",7500000
"f72d4de9f06f107d4a6dd7e2fa711f83","epizyme","post_ipo_equity",NA,"2014-02-12",1e+07
"59b43f59ace2e0b0646cd20104fb95e9","epoch-biosciences",NA,NA,NA,NA
"10be1a3e46a830371df319fc8a5ae57e","epona-biotech",NA,NA,NA,NA
"f913220db101ae787fd2f3dd40c88c70","epos-media",NA,NA,NA,NA
"f17b14234487fbc6e07f10360773d3db","epsilon-imaging","venture",NA,"2009-06-11",NA
"09c6091cb123b0dd1c645324c6c8d520","epy-io","convertible_note",NA,"2013-09-01",120000
"849c46cff9edc376b1b8c6801786ee43","eqentia",NA,NA,NA,NA
"e914ae20c6739792e0abf4d5a0c15d1e","eqlim","angel",NA,"2014-05-01",425000
"65ae33b0c20165923c4f4da723ba6a4e","equacode",NA,NA,NA,NA
"10e636cb1fa5b7936fe838685aa4c161","equator-technology",NA,NA,NA,NA
"43de408fd4b1d83887a80c56a3fe63ae","equinome",NA,NA,NA,NA
"61c2a153675941ad8c15b3a0bf9d4041","equitymaster",NA,NA,NA,NA
"8690f5206a1e17b965d6c584d31fe6f1","equitymetrix","venture",NA,"2014-01-15",5e+06
"29cce6437200b8d9cb57bc317492b423","equivalentor","seed",NA,"2015-10-10",30000
"0e49f4a117367cb63ee7e8104cda5772","equivio",NA,NA,NA,NA
"4d77f8381a61a1b4814d01f36b5b921e","equon-pharmaceuticals-inc","equity_crowdfunding",NA,"2015-05-27",0
"036a353fede0d7d59bef32b134cb2382","era-biotech","venture","b","2009-09-16",5300000
"036a353fede0d7d59bef32b134cb2382","era-biotech","venture",NA,"2008-06-03",6180000
"036a353fede0d7d59bef32b134cb2382","era-biotech","convertible_note",NA,"2006-12-14",1849837.2584
"9c470aa18571fc1a0d3e167fd09ef17b","eragen-biosciences","venture","a","2006-01-09",1.2e+07
"3bf38774f09f0daebe460cb5201a04a4","erc-eye-care","undisclosed",NA,"2013-12-18",NA
"f5869a1abd2b7af53267821035366a0a","ercole-biotech",NA,NA,NA,NA
"356a8d8063818aa7e703da042c1960c5","ereplacements","angel",NA,"2013-08-01",4e+05
"56c9c962b632c51e0218314492b1e693","ereplicant","seed",NA,"2011-05-29",170000
"794ab9161b023eb83003e038a94f0ab4","erevmax",NA,NA,NA,NA
"e73f4d2fa4f2b8d2403bd01393694295","eribis-pharmaceuticals","undisclosed",NA,"2010-01-26",NA
"e9eea94c8a9b48aa71183d5d9e19aadc","ern","seed",NA,"2013-06-19",1600000
"e9eea94c8a9b48aa71183d5d9e19aadc","ern","seed",NA,"2013-08-02",1e+06
"e9eea94c8a9b48aa71183d5d9e19aadc","ern","seed",NA,"2012-12-20",2e+06
"e9eea94c8a9b48aa71183d5d9e19aadc","ern","seed",NA,"2013-10-06",1e+06
"e9eea94c8a9b48aa71183d5d9e19aadc","ern","seed",NA,"2014-01-01",1e+06
"cc66d4f357a093193fa77eb03e0ca42e","ernst-and-young",NA,NA,NA,NA
"414e45828a000c94b75552074d8d9ce1","erydel","venture","a","2008-12-01",3152000
"9e02c24e18e1cef1d98e07b9891f030b","erytech-pharma","post_ipo_equity",NA,"2015-12-07",27582612.0951
"9e02c24e18e1cef1d98e07b9891f030b","erytech-pharma","venture",NA,"2006-12-22",15830400
"9e02c24e18e1cef1d98e07b9891f030b","erytech-pharma","venture","1","2005-11-03",903075
"9e02c24e18e1cef1d98e07b9891f030b","erytech-pharma","post_ipo_equity",NA,"2014-10-23",38007077
"9e02c24e18e1cef1d98e07b9891f030b","erytech-pharma","venture","1","2010-07-01",6150288
"9e02c24e18e1cef1d98e07b9891f030b","erytech-pharma","venture","1","2011-07-01",5792568
"9e02c24e18e1cef1d98e07b9891f030b","erytech-pharma","venture","1","2013-04-01",19235701
"2e4f0267d3e9215bb1a5443e685fab57","es-cell-international",NA,NA,NA,NA
"d7ecad59e1a9014188f0a0620aa3c277","esanex","private_equity",NA,"2012-06-13",15500000
"16ea8d61e33c2fafe01ce6c4e8d55a52","esbatech","venture","b","2006-08-02",4.1e+07
"16ea8d61e33c2fafe01ce6c4e8d55a52","esbatech","venture","b","2008-08-07",2.2e+07
"0bbb4c9439b82e551b7ef19719cc24ac","escendo",NA,NA,NA,NA
"fb9f5b1f0eaf894d6e30ce24db19f7ab","lin-xiang-qian",NA,NA,NA,NA
"5194a8c018294532cdde4ec28eaf3c18","escoublac","venture","A","2008-01-09",6650000
"839d34bf6b51809f5742fec515c1c47e","escrivo",NA,NA,NA,NA
"fbb134fadbd004048f78d01280a3bfff","esillage","seed",NA,"2013-09-13",132975
"77a67b99f9731054468a56805a6ec134","esistence-virtual-interaction",NA,NA,NA,NA
"6f58315d1ae0a0036a5c38c4a52bbfdd","esmart-systems",NA,NA,NA,NA
"6f7a9f963b140fb354942b6378799ac6","esnf","venture",NA,"2014-04-07",2250000
"4bfc107f8bb489e7dfc3d729532a676a","espafil",NA,NA,NA,NA
"d3d033b1ca65016f685a6f9f006a9884","esperance-pharmaceuticals","venture","b","2011-06-01",7500000
"d3d033b1ca65016f685a6f9f006a9884","esperance-pharmaceuticals","venture",NA,"2010-05-03",9e+06
"d3d033b1ca65016f685a6f9f006a9884","esperance-pharmaceuticals","venture",NA,"2010-05-03",3700245
"5cec97f583eb46a851035b0305db2713","esperion-therapeutics","venture","a","2008-05-01",22750000
"5cec97f583eb46a851035b0305db2713","esperion-therapeutics","venture",NA,"2013-04-25",3.3e+07
"5cec97f583eb46a851035b0305db2713","esperion-therapeutics","post_ipo_equity",NA,"2015-03-24",189900000
"0e27ea20bf3cb39b8bd6afcdff505607","esplorio","seed",NA,"2015-07-23",3e+05
"914b08f4daaa09c0879f72be620a7cd2","esprit-pharma",NA,NA,NA,NA
"ebe20bf01812c80e91d66b419d2df331","ess-magyarorszag",NA,NA,NA,NA
"e0f6618a4e9642485183b6c748ba7f87","essenbioscience","venture",NA,"2014-05-15",NA
"53f8ccaf1a9cfac04133b53762dbd427","essential-testing","venture",NA,"2011-06-17",2e+06
"bd846cd2f182c5ed900c451ca327d2d2","essentialis-inc",NA,NA,NA,NA
"a1f1ff14f607a3bad575316def04e30a","essia-health","venture",NA,"2011-06-28",5e+05
"a1f1ff14f607a3bad575316def04e30a","essia-health","venture",NA,"2013-06-11",6050000
"a1f1ff14f607a3bad575316def04e30a","essia-health","debt_financing",NA,"2015-08-11",2500000
"5471f2a87eee0646b48c099f5a35cf67","estimote","venture","A","2016-01-15",10700000
"5471f2a87eee0646b48c099f5a35cf67","estimote","seed",NA,"2013-03-01",NA
"5471f2a87eee0646b48c099f5a35cf67","estimote","seed",NA,"2013-12-10",3100000
"5c4cf70872da8ae384d90dc2b41909a2","estorian","venture",NA,"2006-04-27",4500000
"35bb154196262d57836c4c670efc2678","esearchvision","seed",NA,"2014-01-01",NA
"6c3b033942ea38c037f22b1cdeb10d83","esvyda",NA,NA,NA,NA
"6f04021713158910822885300326df98","etaal-electronic-transaction-aggregation-analysis-layer",NA,NA,NA,NA
"5d8ef832c4540717f3f9efee17239fac","etapix-global",NA,NA,NA,NA
"af19ce5a1ee2d5250bb6cec63d83da92","etch",NA,NA,NA,NA
"a33f04cf49fc8c99676b052a564f1006","etelecare",NA,NA,NA,NA
"1709edc44e4c37bab033f10f9a7990c2","eternogen","venture",NA,"2015-11-16",5e+06
"1709edc44e4c37bab033f10f9a7990c2","eternogen","venture","1","2013-07-03",1065000
"1709edc44e4c37bab033f10f9a7990c2","eternogen","venture",NA,"2013-07-24",920427
"1709edc44e4c37bab033f10f9a7990c2","eternogen","seed",NA,"2012-01-01",5e+05
"1709edc44e4c37bab033f10f9a7990c2","eternogen","seed",NA,"2014-11-04",2e+06
"3e4d4778acd95dd74c1b8cb67dfeca09","eth-bioenergia",NA,NA,NA,NA
"27f555a9e2eb08d8c750891a1a30ffc6","etherapeutics","private_equity",NA,"2013-02-11",6.4e+07
"27f555a9e2eb08d8c750891a1a30ffc6","etherapeutics","venture",NA,"2009-03-18",2796294
"e45623a84815d2c9e50072db1d34190f","etkitakip-com",NA,NA,NA,NA
"080090636770b87ac5ee45b9e6a2542f","etrackr",NA,NA,NA,NA
"0afbc86780bce566af225e04a34ebe45","etrigue",NA,NA,NA,NA
"f53025ec926570f1fbc692e3ebc24ac6","etubics","venture",NA,"2014-04-30",4400000
"51bd3c6c44512dd609cea0f21bf1553e","eubios-therapeutica-private-limited","venture",NA,"2013-03-22",50000
"51bd3c6c44512dd609cea0f21bf1553e","eubios-therapeutica-private-limited","venture",NA,"2012-12-15",60000
"51bd3c6c44512dd609cea0f21bf1553e","eubios-therapeutica-private-limited","venture",NA,"2010-08-22",490000
"17698a1b54bc3f57598b19fbb9c57213","euclid","venture","C","2016-01-14",2e+07
"17698a1b54bc3f57598b19fbb9c57213","euclid","venture","a","2011-11-03",5800000
"17698a1b54bc3f57598b19fbb9c57213","euclid","venture","b","2013-02-21",17300000
"17698a1b54bc3f57598b19fbb9c57213","euclid","angel",NA,"2010-06-01",5e+05
"43b3065a032d9ffc936fbda68fc4f132","euclidean-life-science-advisors",NA,NA,NA,NA
"d72d39a62e5bc988c9b14369bf08c870","euclises-pharmaceuticals","seed",NA,"2012-05-01",174998
"d72d39a62e5bc988c9b14369bf08c870","euclises-pharmaceuticals","venture",NA,"2015-10-05",1851250
"d72d39a62e5bc988c9b14369bf08c870","euclises-pharmaceuticals","venture","1","2014-09-09",1300000
"d72d39a62e5bc988c9b14369bf08c870","euclises-pharmaceuticals","venture","1","2015-04-07",7e+05
"8af292cea114fc37ec2156184de2ce9f","eucodis-bioscience","venture",NA,"2007-11-20",5910000
"8af292cea114fc37ec2156184de2ce9f","eucodis-bioscience","venture","1","2010-03-17",2700000
"2e8458a037aedfd0134425ccb994fd64","euglena",NA,NA,NA,NA
"ccf7f7f276160cc2c76dd0d379a11604","eunoe-inc",NA,NA,NA,NA
"76803118e6248d458ce8d49aa37e9a0d","eupraxia-pharmaceuticals","angel",NA,"2012-12-21",NA
"79c4229df58c8466276298983fc0ce97","eurand",NA,NA,NA,NA
"d9c74700c96d856f39fe332b8668d5fc","eureka-genomics","venture","a","2010-03-10",3700000
"47d42cd2a6100f43ea7d968fef862132","eureka-mobile-advertising",NA,NA,NA,NA
"17881195986130c22906fcfdd63a9cb1","eureka-therapeutics","venture","C","2014-09-23",2.1e+07
"a108be2a883d1d853943dd11b7b50fe1","eurofins",NA,NA,NA,NA
"c2d17e9582ff350211e7878547aee88d","eurogentec",NA,NA,NA,NA
"65051cd03e7455949e7c02a7b825909d","eurogentec-biologics",NA,NA,NA,NA
"586e03b0ce3bfa041738a20a4a8fe97c","europe-shuttle",NA,NA,NA,NA
"35cef18002ba5731c7a2135ade02b9bf","european-biotechnology-news",NA,NA,NA,NA
"71e7a2c76682caafe812a3baf117e31c","european-federation-of-pharmaceutical-industry-associations",NA,NA,NA,NA
"15d62ae67cf55a2083d59f169b9e79a0","european-star",NA,NA,NA,NA
"06822b565ae087b55e996bf207b9701e","eurordis-rare-diseases-europe",NA,NA,NA,NA
"5e4a2fb411e5be77f53aabeb0488de4e","euroscicon",NA,NA,NA,NA
"6868c0564eda11d0b040dbee45e6e28d","eusa-pharma","venture",NA,"2007-06-28",9100000
"6868c0564eda11d0b040dbee45e6e28d","eusa-pharma","venture",NA,"2006-11-07",18600000
"6868c0564eda11d0b040dbee45e6e28d","eusa-pharma","venture",NA,"2005-07-19",13970000
"6868c0564eda11d0b040dbee45e6e28d","eusa-pharma","venture",NA,"2005-12-13",12530000
"ec36827df46ec9012b39465d0429cd69","euthymics-bioscience","venture","a","2010-07-22",2.4e+07
"ec36827df46ec9012b39465d0429cd69","euthymics-bioscience","venture","a","2014-04-01",10500543
"ec36827df46ec9012b39465d0429cd69","euthymics-bioscience","venture","a","2011-03-09",4e+06
"8b990b10e443388bfc933370602227d5","euvance",NA,NA,NA,NA
"2e9069c4f806fa910669087a0a543036","ev-social","seed",NA,"2011-07-14",40000
"727819af7f4a681001925f204ffc3ffd","ev3-inc","venture",NA,"2009-06-09",34650000
"e426ba9b7add8faff8153498f24c35c0","eval-go",NA,NA,NA,NA
"00d87f58af3510609b2ae47bd620c9dd","evalueserve",NA,NA,NA,NA
"fc37811260621360ac54e843d893b109","evam-technologies",NA,NA,NA,NA
"fcf6a1d033d65a98b276d19fe5cdc2ff","evans-analytical-group",NA,NA,NA,NA
"c974f97bc249339133a22fa372bececf","eve-biomedical","venture","B","2012-12-20",6002724
"c974f97bc249339133a22fa372bececf","eve-biomedical","seed",NA,"2012-04-01",1666700
"9adf33a2cfc3167adab8751d40d637e5","evelo-therapeutics","venture",NA,"2015-11-04",3.5e+07
"9073ea284d900d0f93dd24810bd7f791","event-fabric",NA,NA,NA,NA
"fa4d37e28bfe5231f21edc299ab99e21","eventchocolate",NA,NA,NA,NA
"473ed1aeb095217c7ab1c9f7f0b47182","eventforte","seed",NA,"2013-05-12",3e+05
"473ed1aeb095217c7ab1c9f7f0b47182","eventforte","seed",NA,"2014-06-18",7e+05
"6822c4a338e9e6d9efaf761c2031dc22","event-kloud","seed",NA,"2014-03-03",NA
"6822c4a338e9e6d9efaf761c2031dc22","event-kloud","grant",NA,"2014-10-08",97500
"bdfe2a1924e600e0bb06c06405c12499","eventport",NA,NA,NA,NA
"427cbd484ed44e728e7e022b84dbc966","eventus-diagnostics","venture",NA,"2014-04-15",2720000
"ab04847b21ec32d7a99023c4c0a73c04","ever-team",NA,NA,NA,NA
"1f859b0d2f1c6ddb695bf45286eb3d35","evercompliant","venture","A","2015-05-27",3500000
"1ddddc05c117475032c1ddd0553294b3","everest-it-services",NA,NA,NA,NA
"5e9f9dba293df3b93fe591ea9501442a","evergage","venture","B","2016-01-12",1e+07
"5e9f9dba293df3b93fe591ea9501442a","evergage","seed",NA,"2011-06-09",250000
"5e9f9dba293df3b93fe591ea9501442a","evergage","seed",NA,"2012-05-22",2e+06
"5e9f9dba293df3b93fe591ea9501442a","evergage","venture","A","2014-05-21",4e+06
"9cc472d996a850144817dd44b8e98fbb","everist-genomics","venture",NA,"2012-09-04",3061999
"9cc472d996a850144817dd44b8e98fbb","everist-genomics","venture",NA,"2012-02-03",9479766
"1e7e98f75875090878fccbd6a65c1d4b","everlaw","venture","A","2016-01-14",8100000
"1e7e98f75875090878fccbd6a65c1d4b","everlaw","venture",NA,"2011-02-17",654995
"1e7e98f75875090878fccbd6a65c1d4b","everlaw","venture",NA,"2013-01-09",850000
"00ef51b6188742c1f6ce00daa4da2781","evermede","seed",NA,"2014-01-01",1e+05
"00ef51b6188742c1f6ce00daa4da2781","evermede","seed",NA,"2014-10-31",50000
"f78286dfcca7b19dbf4f72d036310861","pressup","seed",NA,"2015-03-01",77500
"b49cfc5d286e0b9587494054fd0038b7","every-market-media",NA,NA,NA,NA
"796fe81e6dbd9e30934438a6f98a5799","everyday-apps-llc",NA,NA,NA,NA
"509f202610b08e6c036c34991ff87c53","everysk",NA,NA,NA,NA
"61ccd47fa40f30e84cc23baf43e98093","evestment-alliance","venture",NA,"2010-11-18",1.9e+07
"0b57f67e019feaab3cab1755f570a4fd","evestra","convertible_note",NA,"2009-12-14",1800000
"01012aac255d1f3050a597daf1e6ee88","evgen","venture",NA,"2012-07-25",712671
"01012aac255d1f3050a597daf1e6ee88","evgen","venture","1","2011-09-20",NA
"726e4d34761720f2adc20d131683c4ad","eviagenics","venture","a","2011-01-24",1764230
"3d66d5c17b92b6396a93026279d59ed1","evidation-health","venture","A","2014-12-31",6e+06
"1e958b416d5bc31f1cde1c4579a80f96","evident-health","venture",NA,"2012-09-27",1e+05
"7883ed4d0c263423c78d47998faba08b","evimed-online",NA,NA,NA,NA
"67df6426dea64a96013aa65b4991c73b","evoapp","angel",NA,"2010-10-15",5e+05
"67df6426dea64a96013aa65b4991c73b","evoapp","venture","1","2011-01-31",1500000
"67df6426dea64a96013aa65b4991c73b","evoapp","venture",NA,"2012-04-20",1352194
"4f1452a084f92d55ec941163ed2b10a1","evocatal","venture","b","2010-07-06",2515800
"4f1452a084f92d55ec941163ed2b10a1","evocatal","venture","b","2013-06-24",4503100
"4f1452a084f92d55ec941163ed2b10a1","evocatal","undisclosed",NA,"2007-09-01",NA
"4f1452a084f92d55ec941163ed2b10a1","evocatal","undisclosed",NA,"2008-01-01",NA
"744172a8dfa656fa6957ee6beaa87658","evodental","venture",NA,"2012-01-13",613106
"b8e0ed01b94b2599bd5c4b548a6bc021","evogene",NA,NA,NA,NA
"130c6eb11c6561dea745e8b794ab4868","evoke-pharma","venture","A","2007-06-22",3290000
"130c6eb11c6561dea745e8b794ab4868","evoke-pharma","venture",NA,"2010-06-30",6000001
"130c6eb11c6561dea745e8b794ab4868","evoke-pharma","debt_financing",NA,"2014-05-28",4500000
"11116bcfdbbc12382a6f90ccd2d3ac22","evoke-technologies",NA,NA,NA,NA
"969581ee68048211a6213033c009cc3d","evolita","seed",NA,"2013-12-23",550000
"765743b2d1eb1e79ae262e3389413d3d","evolution-laser-clinic",NA,NA,NA,NA
"4f5176148af2ace3bb974b8184717689","evolutionary-genomics","venture","a","2008-04-11",NA
"6a1646b161529f265b9f481a80882057","evolv-on-demand","venture","a","2008-01-29",3450000
"6a1646b161529f265b9f481a80882057","evolv-on-demand","venture","c","2011-04-26",15800000
"6a1646b161529f265b9f481a80882057","evolv-on-demand","venture",NA,"2009-10-30",8247374
"6a1646b161529f265b9f481a80882057","evolv-on-demand","venture","d","2013-03-12",1.5e+07
"f1bc356827a8d1b46e6e588c1a894cb3","evolv-technologies","venture",NA,"2013-08-29",11819107
"e6da6cde6daa47067dc8ae4149ca4798","evolva","venture","B","2009-12-11",27500000
"83e54a307300c95af459892e03217322","evolve-biosystems","venture","A","2015-08-17",9e+06
"76bf7bd7fe1eb5ab14301c99ba920bfe","evolved-analytics-europ",NA,NA,NA,NA
"f714640eb449735efd46c669739e1be1","evolved-capital",NA,NA,NA,NA
"53980d073a4c705bc4e4c1c8d59ed2de","evolveid",NA,NA,NA,NA
"e9712e95d6eb0469180b2f2727a96157","evolvemol","seed",NA,"2011-07-20",40000
"0d24a90f3e1cb00c23b83f5cb8f3b417","evolven",NA,NA,NA,NA
"11ec997387907d806a99addca2f99a7d","evolving",NA,NA,NA,NA
"3590a9f1edf2158310f852e9df0aebd4","evotec-inc","venture",NA,"2013-09-03",4e+07
"3590a9f1edf2158310f852e9df0aebd4","evotec-inc","seed",NA,"2006-07-28",759840
"3590a9f1edf2158310f852e9df0aebd4","evotec-inc","undisclosed",NA,"2004-01-01",NA
"2bf0aa8d076c8254f085c9c937dd14e1","evoz","seed",NA,"2011-07-01",NA
"2bf0aa8d076c8254f085c9c937dd14e1","evoz","venture",NA,"2010-03-01",150000
"2bf0aa8d076c8254f085c9c937dd14e1","evoz","seed",NA,"2011-04-01",NA
"efa2c63c2486e1b5f59a0dc96811bf2f","evozym-biologics","seed",NA,"2011-12-09",6e+05
"56c5cc2b936758344561c8b33b13a273","evs-glaucoma-therapeutics","undisclosed",NA,"2013-09-11",NA
"3c8c015dadd72ef2c169fb4544dd9202","exaalgia-it-solutions",NA,NA,NA,NA
"a939d56f6d4d456b48f5d93f5d079b0e","exabone",NA,NA,NA,NA
"3b93b51fbbab1ef2850730bd5e35b1f8","exacaster","seed",NA,"2011-04-01",150000
"3b93b51fbbab1ef2850730bd5e35b1f8","exacaster","grant",NA,"2012-02-01",380000
"bff2712f2604d8ef32d7e5573f636c3b","exacly-me","angel",NA,"2015-01-01",NA
"9a77c57863ee3df64bb1bbd13d4af758","exact-sciences","venture",NA,"2009-06-15",8200000
"c44b0e6b2144e1efbc7522073e2d18e1","exactech",NA,NA,NA,NA
"6cd88724ab23450ac0ed0326be574bcf","exacttarget","venture",NA,"2006-11-08",7710000
"6cd88724ab23450ac0ed0326be574bcf","exacttarget","private_equity",NA,"2011-04-25",3e+07
"6cd88724ab23450ac0ed0326be574bcf","exacttarget","venture",NA,"2004-07-21",10500000
"6cd88724ab23450ac0ed0326be574bcf","exacttarget","private_equity",NA,"2009-05-06",7e+07
"6cd88724ab23450ac0ed0326be574bcf","exacttarget","private_equity",NA,"2009-12-03",7e+07
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","post_ipo_equity",NA,"2016-01-26",16800000
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","private_equity",NA,"2011-06-29",4910490
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","venture",NA,"2009-05-22",1e+06
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","debt_financing",NA,"2011-11-04",1e+06
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","debt_financing",NA,"2012-11-02",123745
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","private_equity",NA,"2010-10-26",1999995
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","venture","1","2013-10-15",5016977
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","debt_financing",NA,"2013-11-04",2.5e+07
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","debt_financing",NA,"2011-09-27",4910423
"0a6d5bcc437f79b4af7519a484be4b2e","exagen-diagnostics","venture","1","2012-09-10",5300000
"3ffed3ae3a860ab2d9d3ee885f3f8f49","exago",NA,NA,NA,NA
"2dc89b84bf95dd5f1348441080d76483","exaptive","debt_financing",NA,"2013-03-21",80000
"2dc89b84bf95dd5f1348441080d76483","exaptive","debt_financing",NA,"2015-05-08",1600000
"aeb43860d09df103c4405a0a2775da30","exasol",NA,NA,NA,NA
"510a2bcbb5ed8025fd23e854c3e70131","excaliard-pharmaceuticals","venture","a","2007-11-27",15500000
"0630e967594d187847af50e07607ad6c","excedis",NA,NA,NA,NA
"2b3252cbc0de9c6ccdad1eb6354c9137","exceematrix",NA,NA,NA,NA
"327bbc1295e278ac8b15f2dae4133b6d","excel-pharmastudies","venture",NA,"2007-12-01",1e+06
"7867ba7d3a7cb6e2a3d910114f73e465","excelerarx","seed",NA,"2011-10-04",3e+05
"54b8c3757da50b90ffa421e17bc6a928","excelimmune","venture","b","2011-05-31",10500000
"54b8c3757da50b90ffa421e17bc6a928","excelimmune","debt_financing",NA,"2012-01-03",6e+06
"54b8c3757da50b90ffa421e17bc6a928","excelimmune","venture","c","2011-12-20",1.2e+07
"54b8c3757da50b90ffa421e17bc6a928","excelimmune","venture","b","2010-04-14",1e+06
"54b8c3757da50b90ffa421e17bc6a928","excelimmune","venture",NA,"2010-07-07",4500000
"35e579594f6a13f2d0e957b77a8e975e","exco-intouch","debt_financing",NA,"2012-11-15",NA
"35e579594f6a13f2d0e957b77a8e975e","exco-intouch","undisclosed",NA,"2011-09-29",4691322
"35e579594f6a13f2d0e957b77a8e975e","exco-intouch","venture",NA,"2014-12-11",5e+06
"17c502e7feaceed5c760ca1cb56731b0","execusys-inc",NA,NA,NA,NA
"c570e90667148687caf3dca5367a9469","exelate","venture","a","2007-10-01",4e+06
"c570e90667148687caf3dca5367a9469","exelate","venture","b","2010-08-03",1.6e+07
"c570e90667148687caf3dca5367a9469","exelate","venture","c","2012-09-24",1.2e+07
"029766673ec61ad6b2ff5b763bb82028","exelixis",NA,NA,NA,NA
"d33ad1998a0f486f0bd598368f1f65f4","exensa","seed",NA,"2011-12-02",189154
"b40e91ff18e0b45ecdcf196aa0ab08e5","exeros","venture","A","2008-01-01",NA
"b40e91ff18e0b45ecdcf196aa0ab08e5","exeros","venture","b","2006-09-05",1.2e+07
"1e1cd187a0c3640b2aec01c9c534fdd5","exerscrip","seed",NA,"2013-03-28",50000
"8a4f1ab8f5874378e329447ef99b8d72","exiqon","venture",NA,"2005-06-03",2e+07
"8a213a126396973e092478b6aa25cfb1","exitlist",NA,NA,NA,NA
"3c9a94f174b94f9206dd821d7047779f","exmovere","venture",NA,"2010-08-04",574015
"3c9a94f174b94f9206dd821d7047779f","exmovere","venture",NA,"2010-02-23",183151
"3c9a94f174b94f9206dd821d7047779f","exmovere","venture",NA,"2011-03-02",582665
"71cf53ce94f3cbea1ce0eaba21d8a853","exnodes",NA,NA,NA,NA
"131e40261e126dd8f304c255c13a5c1b","exodos-life-science-partners","seed",NA,"2010-08-03",1e+06
"131e40261e126dd8f304c255c13a5c1b","exodos-life-science-partners","venture",NA,"2014-03-12",688249
"131e40261e126dd8f304c255c13a5c1b","exodos-life-science-partners","seed",NA,"2011-11-30",760550
"671c830dd062ddb8195483d8a78c7d47","exogen-bio",NA,NA,NA,NA
"160f1db8a3036f92d70847f305b21c11","exogenesis","venture",NA,"2010-12-01",3190000
"160f1db8a3036f92d70847f305b21c11","exogenesis","venture",NA,"2010-08-10",4563929
"ae6713d90d0c86150683b257813fdc3a","exogensis",NA,NA,NA,NA
"c2d1c733d3d182427cf2d50ee077041f","exogenus-therapeutics","seed",NA,"2015-12-04",859669.6719
"c2d1c733d3d182427cf2d50ee077041f","exogenus-therapeutics","seed",NA,"2015-09-15",113106
"232126e57a4584c9f8eae83387b4a709","exonhit-therapeutics",NA,NA,NA,NA
"b2843690101b82939f44365921454a89","exos","debt_financing",NA,"2008-06-25",2e+05
"b2843690101b82939f44365921454a89","exos","venture",NA,"2010-04-05",925000
"a2c8fa03246baed98c3e8fe340fb8f52","exosect","undisclosed",NA,"2008-02-21",6460581
"a2c8fa03246baed98c3e8fe340fb8f52","exosect","undisclosed",NA,"2008-11-25",2766830
"a2c8fa03246baed98c3e8fe340fb8f52","exosect","venture",NA,"2009-12-17",3223327
"a2c8fa03246baed98c3e8fe340fb8f52","exosect","undisclosed",NA,"2011-10-14",1262642
"a2c8fa03246baed98c3e8fe340fb8f52","exosect","venture",NA,"2012-01-18",2231018
"a2c8fa03246baed98c3e8fe340fb8f52","exosect","undisclosed",NA,"2012-11-02",NA
"a2c8fa03246baed98c3e8fe340fb8f52","exosect","undisclosed",NA,"2013-05-28",3788128
"a2c8fa03246baed98c3e8fe340fb8f52","exosect","undisclosed",NA,"2015-01-16",2430392
"8fb32f8b8877c40652217d66c174158c","exosome-diagnostics","venture","B","2016-01-07",1.6e+07
"8fb32f8b8877c40652217d66c174158c","exosome-diagnostics","venture","a","2010-05-11",2e+07
"8fb32f8b8877c40652217d66c174158c","exosome-diagnostics","venture","b","2014-03-11",2.7e+07
"8fb32f8b8877c40652217d66c174158c","exosome-diagnostics","venture",NA,"2015-07-06",1483973
"8fb32f8b8877c40652217d66c174158c","exosome-diagnostics","venture","B","2015-09-02",17600000
"ed6bc4df3d712ee43c6986e9ec5c9a6b","exovite","venture",NA,"2014-07-22",NA
"5de0001ce7d4baf60c8f6c23bafcb2c7","expanded-io","seed",NA,"2015-07-15",2500000
"00d31306fec55ead00a7500cb6347e14","expasoft",NA,NA,NA,NA
"33fe66a7cc49432b0c050cd5563674f8","experfy","seed",NA,"2015-06-04",1500000
"df535df41d9cee05b259784e5066270e","experian",NA,NA,NA,NA
"7e7d7b7cf8008db44576562dd9ce58fa","experien-footfall",NA,NA,NA,NA
"274a9142f4cc03b42194c151b79ade05","experiture",NA,NA,NA,NA
"f1321d69b1cb932840fd5dd3010209ea","experlytics-ab",NA,NA,NA,NA
"a04c438f47d9b657af98cc9ecaf8c93f","expert-system","venture",NA,"2014-02-18",NA
"60f706ebe7a99b752e48feddca18acc1","expesicor",NA,NA,NA,NA
"1b66e6a3189ef91e9c8f699d7fa57bfa","explain-my-surgery","venture",NA,"2008-11-19",972000
"8b26b96374f7e2203e471584d7ef243f","explore-analytics",NA,NA,NA,NA
"e6af5c665c8ea709e2dcfea5979922e2","explorys","venture","b","2010-08-02",2550000
"e6af5c665c8ea709e2dcfea5979922e2","explorys","venture","c","2011-05-10",11500000
"205151d52100bffde8a47f21d45c3122","expo-max",NA,NA,NA,NA
"136c8db25a70d18b59f5f8ca961c1c67","exponent",NA,NA,NA,NA
"adcadaaaf1a31d6f8808b2f960ee659a","exponential",NA,NA,NA,NA
"992174ebc5913c8b420613affc9e287b","export-abroad",NA,NA,NA,NA
"5ad38bb53fc5b0523d4a3236effef093","expressor-software","venture",NA,"2007-07-01",7500000
"5ad38bb53fc5b0523d4a3236effef093","expressor-software","venture","1","2008-08-27",1e+07
"5ad38bb53fc5b0523d4a3236effef093","expressor-software","venture",NA,"2010-05-20",5550000
"5ad38bb53fc5b0523d4a3236effef093","expressor-software","debt_financing",NA,"2011-12-19",6e+06
"c7c6113c832b0ad6c1553898ce0eba4d","exsulin","debt_financing",NA,"2012-05-30",350000
"c7c6113c832b0ad6c1553898ce0eba4d","exsulin","debt_financing",NA,"2010-08-24",1e+05
"c7c6113c832b0ad6c1553898ce0eba4d","exsulin","debt_financing",NA,"2009-10-01",3e+05
"c7c6113c832b0ad6c1553898ce0eba4d","exsulin","debt_financing",NA,"2010-04-15",120000
"c7c6113c832b0ad6c1553898ce0eba4d","exsulin","venture",NA,"2010-04-15",5692656
"994b9bca06f95f398ecd624e684c450d","extem","venture",NA,"2015-08-19",NA
"994b9bca06f95f398ecd624e684c450d","extem","seed",NA,"2015-01-06",50000
"29aa8d8cf6da49df354851f9e1111914","extend-labs-2","private_equity",NA,"2012-08-16",1900000
"29aa8d8cf6da49df354851f9e1111914","extend-labs-2","debt_financing",NA,"2013-05-17",1225000
"71312aa80da3dbd879b65599a6ac7202","extended-results",NA,NA,NA,NA
"25a5719be57760cd6dcba66f7966da8f","extensity",NA,NA,NA,NA
"cc9fd790e49b30e9ada9e05112f01694","externautics","venture",NA,"2008-06-05",3890000
"e86cb3415077f5132ef66b57dd6f8e02","extractable",NA,NA,NA,NA
"801fd6f0e406e85d4ba1bfe9a6d2893a","extract-alpha","undisclosed",NA,"2015-08-01",41250
"89d7a547ec23dc8ce15965a669566cf3","extraortho","venture",NA,"2010-12-20",3620185
"6b6cb1cde11e93b586e41b7b1e9933f0","brandads","seed",NA,"2011-10-14",180000
"def93c9e22aaacf96bae5114ce37e20b","extremochem",NA,NA,NA,NA
"c4b37d74bd530ce8dbc0123695451aca","eye-pharma","venture",NA,"2014-02-05",145500
"5be7a3c3ee3e45dd5c0878f65b1f2e28","eyeblaster","venture","B","2007-03-21",3e+07
"1e3f824d12adaf6f409a82d5f1045671","eyecyte","venture","a","2008-06-23",3e+06
"e8d55f53a3013cd471ce8093ee7f74c4","eyegate-pharmaceuticals","venture","B","2007-01-17",2e+06
"e8d55f53a3013cd471ce8093ee7f74c4","eyegate-pharmaceuticals","venture","c","2008-03-12",1.5e+07
"e8d55f53a3013cd471ce8093ee7f74c4","eyegate-pharmaceuticals","venture","d","2010-01-08",22600000
"e8d55f53a3013cd471ce8093ee7f74c4","eyegate-pharmaceuticals","venture","d","2011-01-07",5900000
"e8d55f53a3013cd471ce8093ee7f74c4","eyegate-pharmaceuticals","venture","b","2006-11-02",1e+07
"e8d55f53a3013cd471ce8093ee7f74c4","eyegate-pharmaceuticals","debt_financing",NA,"2013-09-26",968971
"e8d55f53a3013cd471ce8093ee7f74c4","eyegate-pharmaceuticals","venture",NA,"2009-03-13",490000
"e8d55f53a3013cd471ce8093ee7f74c4","eyegate-pharmaceuticals","debt_financing",NA,"2014-07-28",994843
"fde9525b9a680f2ad291a3f6748e93a3","eyenetra","venture",NA,"2012-07-27",1e+06
"fde9525b9a680f2ad291a3f6748e93a3","eyenetra","private_equity",NA,"2013-06-28",2e+06
"fde9525b9a680f2ad291a3f6748e93a3","eyenetra","venture","1","2014-07-29",4e+06
"854661e0e549ff84700fa43bcc023fe6","foooblr","venture",NA,"2013-01-01",19791
"ef4eeb331aa8cb7837d71e32bb376830","eyeota","venture","A","2016-01-26",7e+06
"ef4eeb331aa8cb7837d71e32bb376830","eyeota","seed",NA,"2013-05-01",NA
"ef4eeb331aa8cb7837d71e32bb376830","eyeota","seed",NA,"2014-06-01",NA
"21cd067a5d49a8555820658dd1cedeae","eyequant","venture",NA,"2013-10-05",643300
"f2ab513219f4ceb307c0c47d2698f8fb","eyeris",NA,NA,NA,NA
"1e201efd73ac975a63d71e1097367598","eyetap-personal-imaging-lab",NA,NA,NA,NA
"85e72b15e09a3a942012a5f85b66f4d8","eyetech-pharmaceuticals",NA,NA,NA,NA
"fc888b85aaae7bdb37998cf2a31b01ec","eyevensys","seed",NA,"2015-06-30",NA
"fc888b85aaae7bdb37998cf2a31b01ec","eyevensys","undisclosed",NA,"2013-04-11",NA
"f52e42c002d8cb23e6ce3db66dcb5d13","eyeverify","debt_financing",NA,"2014-02-04",624729
"f52e42c002d8cb23e6ce3db66dcb5d13","eyeverify","seed",NA,"2012-05-25",1500000
"f52e42c002d8cb23e6ce3db66dcb5d13","eyeverify","venture","1","2013-05-13",2300000
"f52e42c002d8cb23e6ce3db66dcb5d13","eyeverify","venture","1","2014-08-20",6e+06
"a4dd7e47232a91409d625c090b909fc1","eykona-technologies","undisclosed",NA,"2010-09-24",1870089
"1f81ac427204726cd49bb4bf8f6eeef9","eyso",NA,NA,NA,NA
"a69a6eaf5331c100a41c4db4c06319e5","eywa-media","seed",NA,"2015-09-03",1008334
"a69a6eaf5331c100a41c4db4c06319e5","eywa-media","seed",NA,"2015-10-01",1e+06
"a69a6eaf5331c100a41c4db4c06319e5","eywa-media","angel",NA,"2014-01-30",150000
"a88c5e87d5d879ae4a7a271dd7c1b96c","ez-xbrl-solutions",NA,NA,NA,NA
"86d8bed5436335673938520affc7a944","ezako",NA,NA,NA,NA
"22f80631d87bc5f8d2e7200c208df4cb","ezdia-inc",NA,NA,NA,NA
"91c7f00c107ac4c57b956acafe5f662f","ezlocal-com-database",NA,NA,NA,NA
"1015fea74bc0b031ee44779a241e2098","ezlynx",NA,NA,NA,NA
"2c06216a66253a4d8514cb28c6dee6d2","ezora",NA,NA,NA,NA
"dca5193164bfcc05f374f92a15ae6e23","ezra-innovations","venture",NA,"2013-02-25",2e+06
"dca5193164bfcc05f374f92a15ae6e23","ezra-innovations","venture",NA,"2012-04-23",4280600
"c90fbbbd87c501a920edf1f962e9f318","f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","seed",NA,"2007-01-08",1950900
"c90fbbbd87c501a920edf1f962e9f318","f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","venture","1","2007-11-28",4424100
"c90fbbbd87c501a920edf1f962e9f318","f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","venture",NA,"2011-04-13",21739500
"c90fbbbd87c501a920edf1f962e9f318","f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","venture","1","2013-10-23",9400000
"c90fbbbd87c501a920edf1f962e9f318","f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","venture","1","2010-01-06",11480000
"c90fbbbd87c501a920edf1f962e9f318","f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","venture","1","2007-09-10",8252905.7106
"0276ced6cae44a11079df14f23f12ad7","f-hoffmann-la-roche-ltd",NA,NA,NA,NA
"0a1c3debea34885a071842fd7145b08d","f2g","venture",NA,"2008-08-18",11741755.9206
"0a1c3debea34885a071842fd7145b08d","f2g","venture",NA,"2012-09-05",3e+07
"327e3aab0051aa353ffc8a1323a7da9d","fabrikatyr-analytics",NA,NA,NA,NA
"2a674b9cd556ef9da5cb13b3d4f419c3","fabrixtv",NA,NA,NA,NA
"997dbc78665ecd4cbd978fe30b07857c","fabrus","venture",NA,"2010-11-04",2e+06
"a972592d94ec9926260674dc7ba860af","facecake-marketing-technologies","undisclosed",NA,"2012-09-05",NA
"d23aa571810fc635d287e144a97d0389","faception","seed",NA,"2015-12-27",125000
"88f0d2eb2cb5a46a644c9e0edd16fd97","facerecog",NA,NA,NA,NA
"ca9548cd28ba8b4cfe115ed32c15d572","creativspace",NA,NA,NA,NA
"9f6ac0f029dee7f2ba12dcabb1d4de52","facet-biotech",NA,NA,NA,NA
"e3334888429a7e48760a0946d978b5a6","factabase","seed",NA,"2009-01-01",5e+05
"f0f3b44878978d599e38f9a8d770f7dd","factle-maps",NA,NA,NA,NA
"b1509797f49067bdb63c9da44030e8a4","factlook",NA,NA,NA,NA
"037beddac4f8d2732e50e76e2fcf4d6e","factnexus",NA,NA,NA,NA
"c6eda1e4c526037ac5568af22254f01f","factual","venture","B","2015-12-10",3.5e+07
"c6eda1e4c526037ac5568af22254f01f","factual","seed",NA,"2010-02-03",1e+06
"c6eda1e4c526037ac5568af22254f01f","factual","seed",NA,"2010-03-01",1e+06
"c6eda1e4c526037ac5568af22254f01f","factual","venture","a","2010-12-09",2.5e+07
"7d50acb44238770782eee6d4aea03d95","fair-observer","seed",NA,"2010-08-01",60000
"0a3b6515f6b6125912eb71253937dc02","fairlay","angel",NA,"2014-04-01",NA
"0a3b6515f6b6125912eb71253937dc02","fairlay","seed",NA,"2013-01-01",NA
"d8ff65151a0bd6c4e11b8a762a3b4b86","falcontail-web-design",NA,NA,NA,NA
"a09897252e49c76468fea7ed66032882","quest-to-clean-up-by-fam-ess--llc-","product_crowdfunding",NA,"2014-05-19",8750
"a09897252e49c76468fea7ed66032882","quest-to-clean-up-by-fam-ess--llc-","convertible_note",NA,"2014-05-01",35000
"c5d14a1220f6dbb9ff67301be1b7c490","famoi",NA,NA,NA,NA
"682bce4a803d95853fd5b408069c4190","fan-chirp",NA,NA,NA,NA
"de4b000b1a3425f96ea3563459991794","fan-on-fire",NA,NA,NA,NA
"eb29676e3e521f008faa2e7284b45c9c","fan-analytic",NA,NA,NA,NA
"0d0c5703f5baff4789aeee8dcacbf179","fanbloom","seed",NA,"2015-12-01",10000
"0d0c5703f5baff4789aeee8dcacbf179","fanbloom","seed",NA,"2015-10-15",20000
"63173f4276d67d520ba3177f937fae1f","fanbread","convertible_note",NA,"2014-06-01",8e+05
"63173f4276d67d520ba3177f937fae1f","fanbread","seed",NA,"2015-05-01",1605000
"e1e46d93c4427dcd11970fcfb9e00344","fantain-sports",NA,NA,NA,NA
"524f595b34bf01fbcd1595612e9c0641","faqme",NA,NA,NA,NA
"d50426827acd13e9f29a4ad695397d81","faraday-pharmaceuticals","venture","A","2014-07-23",NA
"2a9d770eedd98183b2edf52adfbe48ec","farallon-biosciences","venture",NA,"2009-05-26",4e+06
"19a02f78e1bb68dae0dafd47da41434d","bdkm",NA,NA,NA,NA
"f739866ea01fe19c709fe49930a50e44","farfield",NA,NA,NA,NA
"2d6da75d4318399fb6628441ff59d59d","farman","seed",NA,"2013-11-18",514640
"7b1d4b4fb61f952de596333d6dc378a7","farmer-s-edge-laboratories","venture","C","2016-01-28",4.1e+07
"7b1d4b4fb61f952de596333d6dc378a7","farmer-s-edge-laboratories","venture","B","2014-11-10",NA
"c9aa178f7a508dc8bd03f059a97b7d71","farmeron","seed",NA,"2012-05-10",1400000
"c9aa178f7a508dc8bd03f059a97b7d71","farmeron","angel",NA,"2010-10-01",15000
"c9aa178f7a508dc8bd03f059a97b7d71","farmeron","seed",NA,"2011-09-29",NA
"c9aa178f7a508dc8bd03f059a97b7d71","farmeron","seed",NA,"2011-10-01",NA
"c9aa178f7a508dc8bd03f059a97b7d71","farmeron","seed",NA,"2014-05-23",2650000
"29d9af64a4d9b783546a34a6eedf0982","farmers-business-network","venture","A","2014-04-10",5600000
"29d9af64a4d9b783546a34a6eedf0982","farmers-business-network","venture","A","2014-06-01",3300000
"29d9af64a4d9b783546a34a6eedf0982","farmers-business-network","venture","B","2015-05-19",1.5e+07
"653409556b37cba9aba58e1b4496c42a","farmis",NA,NA,NA,NA
"76b5010b7f8e52f8f31adfdbaf2b85d7","fashion-metric","seed",NA,"2015-01-19",1e+06
"76b5010b7f8e52f8f31adfdbaf2b85d7","fashion-metric","seed",NA,"2014-09-12",418000
"0aaa33d24610c695dc1b207eafa125f6","fashionhousevn",NA,NA,NA,NA
"d0277ee014c92ea169a5d8ec219e8bfb","fast-europe-ventures",NA,NA,NA,NA
"bedda71ea14c122a23bb3a4e32d5d22a","fastcall411","angel",NA,"2011-09-23",NA
"8e048f29cdd4255258f1253c4d505298","fasterbids","seed",NA,"2015-02-02",35000
"f893639512cf3920708fffb3b97b9c9f","fasthealth","venture",NA,"2009-10-05",48000
"9b76534d6ea6c47faab5fe45144c8a1d","fasttechbpo",NA,NA,NA,NA
"53c63fbae48bb2e3ed8f51cf6dfbe114","fate-therapeutics","debt_financing",NA,"2011-04-20",1e+06
"53c63fbae48bb2e3ed8f51cf6dfbe114","fate-therapeutics","debt_financing",NA,"2013-08-14",2e+07
"53c63fbae48bb2e3ed8f51cf6dfbe114","fate-therapeutics","venture","1","2011-05-05",35988360
"53c63fbae48bb2e3ed8f51cf6dfbe114","fate-therapeutics","venture","1","2007-11-29",1.2e+07
"53c63fbae48bb2e3ed8f51cf6dfbe114","fate-therapeutics","venture",NA,"2012-08-23",9200000
"53c63fbae48bb2e3ed8f51cf6dfbe114","fate-therapeutics","venture",NA,"2015-05-15",8e+06
"f879a54cf20766de993ba2ec3395b453","fathomhq",NA,NA,NA,NA
"991503930b9fe88caadf87e5a8cd9cc5","favebucket",NA,NA,NA,NA
"4b77168601cff4fe38f48c6a83f2d5cb","favrille-inc",NA,NA,NA,NA
"d1944909017bae7334beb169672b2d56","fcul",NA,NA,NA,NA
"5c682141404e7ac3237ace334fbabdc5","fdg-web-inc",NA,NA,NA,NA
"bc7501f6eca61d3610af946af5f8a075","fe3-medical","venture",NA,"2010-10-18",1420500
"bc7501f6eca61d3610af946af5f8a075","fe3-medical","venture",NA,"2011-01-01",3988958
"bc7501f6eca61d3610af946af5f8a075","fe3-medical","venture",NA,"2010-09-28",2800000
"af8cf8c0e9fb0ce04c801d1dd9ea6a74","feature-23",NA,NA,NA,NA
"880c1af3e60172649ef13ed3581a4251","features-analytics",NA,NA,NA,NA
"f47f3ce4c74bb7330a12a662cc0481fd","fed-playbook","seed",NA,"2014-09-29",250000
"937fd0d65842484681bfe2dc3a6914d6","fedger-io","angel",NA,"2014-12-23",NA
"e8c0870a899c5a2aaa44ba89fdf041da","fedora-pharmaceuticals","seed",NA,"2013-05-14",200100
"5e17cc2406c35ceb2075d6d4bb14a723","feedback-ferret",NA,NA,NA,NA
"6e1cdfc3e5f89dc3611c25e36df4b79e","feedback-lite",NA,NA,NA,NA
"da921d7b6fbc64e3d59f42c8545d58e7","feedback-machine","seed",NA,"2012-11-26",40000
"993ca9ac386f7c87b457099f628738ae","feedbackdaddy",NA,NA,NA,NA
"e46df30849713bca9f91ac9f72a6f108","feedbackers-biz",NA,NA,NA,NA
"5f2fc74ac697f7d1a285fa18e1078704","feedbox",NA,NA,NA,NA
"62e1364925e0a24c8132da80002e0df4","feedjit","angel",NA,"2008-01-05",450000
"4ce6cc7bdd29a1798a92baf7929fe8f0","feedodata",NA,NA,NA,NA
"57d6f199676664ced80bca3995e2b160","feedpresso",NA,NA,NA,NA
"f8f06aec8e7b5e4a7a44cfb973de48cb","feedsme",NA,NA,NA,NA
"b0e45b2d6790d4e2beee0b23cba41993","feelter",NA,NA,NA,NA
"f11d167ab37c265f9f0b2d6f199021db","feetme","seed",NA,"2015-02-04",NA
"616ac65e7269de779c3f322b7230aa25","feinstein-kean-healthcare",NA,NA,NA,NA
"c8aea71ec49aa3dbb86825dd91f60195","fem","venture",NA,"2015-03-19",NA
"c8aea71ec49aa3dbb86825dd91f60195","fem","seed",NA,"2015-07-06",120000
"c8aea71ec49aa3dbb86825dd91f60195","fem","seed",NA,"2015-08-03",3e+06
"71c5f2d3ee0a4d907ab97c9dd31084a7","female-algorithm-technologies",NA,NA,NA,NA
"480346dec9206f3f8c68629494b55848","femaledaily-network","venture","A","2014-11-19",1e+06
"480346dec9206f3f8c68629494b55848","femaledaily-network","angel",NA,"2011-12-19",NA
"9eefeae96088f473ac3bedcbffadf831","femta-pharmaceuticals","venture",NA,"2009-07-17",1e+06
"9eefeae96088f473ac3bedcbffadf831","femta-pharmaceuticals","venture","1","2010-10-12",2.2e+07
"9eefeae96088f473ac3bedcbffadf831","femta-pharmaceuticals","venture",NA,"2009-11-13",5e+05
"6a82b4858b962139c8fce61ef2689e73","femto-diagnostics",NA,NA,NA,NA
"a0bfe0a2a879c010604da406185d23a7","fenix-biotech","venture",NA,"2010-09-27",243000
"a9c6e3f5bf2caea505ef7e0a2361db64","fera-pharmaceuticals",NA,NA,NA,NA
"9fc6d60f640dffecbdf1eb94734b713b","ferank",NA,NA,NA,NA
"5b2cd7c7d97567c8049b82bcbade4741","fermentalg","venture","b","2011-01-24",7192630
"5b2cd7c7d97567c8049b82bcbade4741","fermentalg","venture","c","2013-09-17",15439200
"5b2cd7c7d97567c8049b82bcbade4741","fermentalg","seed",NA,"2009-03-01",2870000
"851316ebf98ebe3ca410cca7e24872b9","ferndale-laboratories",NA,NA,NA,NA
"c2942d0d6fe709213d628f2d62fed55a","ferrokin-biosciences","debt_financing",NA,"2012-02-10",3e+06
"c2942d0d6fe709213d628f2d62fed55a","ferrokin-biosciences","venture","1","2010-06-18",1.2e+07
"c2942d0d6fe709213d628f2d62fed55a","ferrokin-biosciences","venture",NA,"2009-11-16",1.5e+07
"1300798244c2f6b228095e1e8bfad1ac","fertile-earth-systems","venture",NA,"2009-02-01",1895337
"3342d960bb763038b9f44fb422c45935","ferx-incorporated",NA,NA,NA,NA
"6be43ca717aa88c997d78b460fff4a37","festivality",NA,NA,NA,NA
"cc3a7dff2a2cc4c49af0f0eb121ca61a","fetch-technologies","venture","b","2011-02-22",4600000
"3066ae69d9ebd1c095d5b9642b20c3e5","ffffound",NA,NA,NA,NA
"6468d70d4f1ec80c2a8188b78287979c","fforward-co-facebook-analysis",NA,NA,NA,NA
"f35c59544e1aea165a7574fae1e83e01","fiberstar","venture",NA,"2013-08-23",5e+05
"f35c59544e1aea165a7574fae1e83e01","fiberstar","debt_financing",NA,"2013-07-18",10640000
"f35c59544e1aea165a7574fae1e83e01","fiberstar","convertible_note",NA,"2015-08-10",70000
"024dc7c383b94ad84a3d3f4189c4ebad","fiberzone-networks","venture","b","2006-03-27",8e+06
"024dc7c383b94ad84a3d3f4189c4ebad","fiberzone-networks","seed",NA,"2003-04-01",3e+06
"024dc7c383b94ad84a3d3f4189c4ebad","fiberzone-networks","venture","c","2011-08-03",1.2e+07
"024dc7c383b94ad84a3d3f4189c4ebad","fiberzone-networks","venture",NA,"2013-02-25",11442442
"024dc7c383b94ad84a3d3f4189c4ebad","fiberzone-networks","venture",NA,"2009-06-15",8343760
"a5a1e0fd10bf10d726f65fd25aeb947b","fibrocell-science","venture",NA,"2011-02-03",4293000
"a5a1e0fd10bf10d726f65fd25aeb947b","fibrocell-science","venture",NA,"2012-05-14",3353000
"a5a1e0fd10bf10d726f65fd25aeb947b","fibrocell-science","venture",NA,"2010-08-04",2702000
"a5a1e0fd10bf10d726f65fd25aeb947b","fibrocell-science","venture",NA,"2010-03-29",8687593
"a5a1e0fd10bf10d726f65fd25aeb947b","fibrocell-science","private_equity",NA,"2012-10-15",4.5e+07
"a5a1e0fd10bf10d726f65fd25aeb947b","fibrocell-science","venture",NA,"2011-08-18",22800000
"bd1ad07d51c679bf3395b112e7904d26","fibrogen","venture","F","2005-02-17",1e+08
"bd1ad07d51c679bf3395b112e7904d26","fibrogen","private_equity",NA,"2012-07-27",6023000
"bd1ad07d51c679bf3395b112e7904d26","fibrogen","venture",NA,"2014-12-10",2e+07
"3993ab9b26da65d223267cb007d31925","fibrotx",NA,NA,NA,NA
"91df8ba956521f7c2437df5934a8926a","fair-isaac-corporation",NA,NA,NA,NA
"158dac91fbe6272ba45fb8e44baa578f","fides",NA,NA,NA,NA
"9e88e38a360f0577d687ab233a4070df","fidesys",NA,NA,NA,NA
"05e8d15046ac0144bf0209f0e9bbc8bd","fidia-advanced-biopolymers",NA,NA,NA,NA
"dcac877d52fb49f5d4b01aef36c85bae","fido-labs","seed",NA,"2013-07-17",1863000
"35858479df8a3da69613f73609d0e019","field-assist",NA,NA,NA,NA
"eda63aff351d969b328bff1bf901e347","fiercebiotechresearch",NA,NA,NA,NA
"f91c1add6a154aa20badc45fea8a6320","fierceinstaller",NA,NA,NA,NA
"aec673f3acd86a2800f7aef91220962c","figureate",NA,NA,NA,NA
"42f61b7ed40c89296d9d464576de748e","fikrimuhal-teknoloji",NA,NA,NA,NA
"3c116978aada658cf7698f1f9bde41a6","filtosh-inc","angel",NA,"2014-06-11",40000
"546ae139c27b533eff3979a7249cd10f","filtr8","seed",NA,"2013-11-01",50000
"1d560fcab3da013e6f5adc1c57392559","fina-technologies","venture","a","2009-12-10",4500000
"d2632e3f28d6bd6072c8b7f0cd68ec78","final","seed",NA,"2015-01-27",1e+06
"98b94eeae12cfb36ac306a88e925099a","finanalytica","venture","B","2009-05-11",2e+06
"98b94eeae12cfb36ac306a88e925099a","finanalytica","venture","A","2007-06-01",5e+06
"e49c4c692b1437cebc6878a474c7384b","financial-crossing",NA,NA,NA,NA
"82e980a3d19841377100e346023b8642","financial-media-exchange-llc","seed",NA,"2014-10-01",250000
"e84da2c29ae92be00d4c27eda15b909c","financial-network-analytics","seed",NA,"2015-01-15",NA
"e84da2c29ae92be00d4c27eda15b909c","financial-network-analytics","seed",NA,"2013-06-01",532000
"7f22b104935ad96f2aaee7f9821b1334","find-any-email",NA,NA,NA,NA
"4fbd6844fe7fcd97c4a08e200ceabdbd","find-my-audience","seed",NA,"2014-10-10",7e+05
"4fbd6844fe7fcd97c4a08e200ceabdbd","find-my-audience","seed",NA,"2015-03-05",3e+05
"4fbd6844fe7fcd97c4a08e200ceabdbd","find-my-audience","seed",NA,"2015-07-16",1200000
"0b420ad28a7519ab365568f48675dfd6","find-your-influence",NA,NA,NA,NA
"cfae520af041aa8cb04c48b25fe5cc67","findie-development-limited",NA,NA,NA,NA
"35ec0eaf966c44c01d6ab2ed3f1f2182","findmelike-2",NA,NA,NA,NA
"8002dcfa4f013db33ba1cdf7b0ccc291","findtheripple","angel",NA,"2014-04-01",49936.7468
"8002dcfa4f013db33ba1cdf7b0ccc291","findtheripple","seed",NA,"2015-01-01",77848
"b00d842f1fa4bda0d465e5050a149931","findyourcloud-com",NA,NA,NA,NA
"2c6a2cd840966ca90339ccb78e7cc54c","fingenius",NA,NA,NA,NA
"d7826af2b3f9bbc529c63c169deb9e99","finhealth",NA,NA,NA,NA
"a95dbba6f24865e06f092e520a085622","finila",NA,NA,NA,NA
"80c52b21c03914304ebae87cb062033e","finney-capita",NA,NA,NA,NA
"39fd3fcbc3a22b3e87d8ecf56cbeb50f","finologic-technologies-private-limited",NA,NA,NA,NA
"6023f77b8432d64767a0fa42eff08be9","finsphere","venture","B","2009-07-21",9e+06
"6023f77b8432d64767a0fa42eff08be9","finsphere","venture","a","2008-06-06",9900000
"6023f77b8432d64767a0fa42eff08be9","finsphere","venture",NA,"2012-01-05",12300000
"6023f77b8432d64767a0fa42eff08be9","finsphere","venture","C","2013-12-19",1820000
"eaff33628256e56d7e9addf9e684154e","fintellix-solutions",NA,NA,NA,NA
"3ccc2169dddca12006a24c1d70aefae6","fio","venture",NA,"2010-09-24",1e+05
"3ccc2169dddca12006a24c1d70aefae6","fio","venture",NA,"2013-02-06",255781
"3ccc2169dddca12006a24c1d70aefae6","fio","venture",NA,"2015-01-28",1e+05
"3acde111003de6600bb9152c82797c1e","firalis","venture","B","2013-07-04",1922561
"601890173e9a6931a1db0b1bd886f941","fire1","venture","a","2014-01-09",NA
"c743cdcd79f88e38e0979061ff0c4ff3","firecart-ecommerce-marketing-automation-software",NA,NA,NA,NA
"9da1133ecd90ce71d9ca0c1bb8934bdd","firefly-bioworks","venture",NA,"2011-10-21",2e+06
"9da1133ecd90ce71d9ca0c1bb8934bdd","firefly-bioworks","grant",NA,"2012-05-24",5e+05
"9da1133ecd90ce71d9ca0c1bb8934bdd","firefly-bioworks","grant",NA,"2013-04-16",120000
"9da1133ecd90ce71d9ca0c1bb8934bdd","firefly-bioworks","debt_financing",NA,"2014-07-21",775000
"6232af3e5a469eeed20d20e10ef64aec","firestop",NA,NA,NA,NA
"380cc47af95b5daa3027832ba54ab134","first-aid-shot-therapy","venture","C","2015-11-18",2.4e+07
"380cc47af95b5daa3027832ba54ab134","first-aid-shot-therapy","venture","b","2014-02-10",NA
"380cc47af95b5daa3027832ba54ab134","first-aid-shot-therapy","venture","a","2013-05-21",NA
"a64a6cc881b6a681fa610d481ca3b4ad","first-china-pharma-group","venture",NA,"2011-04-12",3829000
"acf66ce76259b6186d3799aca540bd03","first-insight","venture","A","2012-11-21",4279267
"acf66ce76259b6186d3799aca540bd03","first-insight","venture","A","2011-05-16",3600000
"acf66ce76259b6186d3799aca540bd03","first-insight","venture","A","2014-02-27",1500000
"acf66ce76259b6186d3799aca540bd03","first-insight","venture","B","2015-03-05",1.4e+07
"bc4b039ddbe84520a1ed2c9c047030a9","first-mile-geo",NA,NA,NA,NA
"34a9e4c62d7807a3ad7e9632d5426529","first-wave","debt_financing",NA,"2012-03-12",130000
"12be9e007228102fda519af6b1859792","firstclick-consulting",NA,NA,NA,NA
"e4471dfd1049c67d0476f683cf931253","firstfuel-software","venture","a","2012-02-23",1e+07
"e4471dfd1049c67d0476f683cf931253","firstfuel-software","venture",NA,"2011-09-22",2400000
"e4471dfd1049c67d0476f683cf931253","firstfuel-software","venture","b","2013-12-10",8500000
"e4471dfd1049c67d0476f683cf931253","firstfuel-software","venture","C","2015-04-08",2.3e+07
"5e3a990da3d25f6b0eb1be47cb2fdd79","firstrain","venture",NA,"2011-08-02",6400000
"5e3a990da3d25f6b0eb1be47cb2fdd79","firstrain","venture",NA,"2010-03-01",7296727
"5e3a990da3d25f6b0eb1be47cb2fdd79","firstrain","venture",NA,"2013-12-22",11778004
"5e3a990da3d25f6b0eb1be47cb2fdd79","firstrain","venture",NA,"2008-01-14",13600000
"5e3a990da3d25f6b0eb1be47cb2fdd79","firstrain","venture",NA,"2006-04-27",18690000
"eeb345b9403fad2eb99713694933725c","firststring-research","venture",NA,"2010-04-15",3237500
"0b15c8885870ff2f00dc845f122743b8","fiscal-technologies",NA,NA,NA,NA
"f0a14a6c847eeed028784f90f1b50c59","fiscals",NA,NA,NA,NA
"d06040d5926bd6cb490f0b6fdda5873c","fishbrain","seed",NA,"2013-09-05",150000
"d06040d5926bd6cb490f0b6fdda5873c","fishbrain","seed",NA,"2014-07-08",2400000
"d06040d5926bd6cb490f0b6fdda5873c","fishbrain","venture","1","2015-07-22",8e+06
"2f8117d1a67122cc7d262a2e0cff6d5c","fisher-scientific",NA,NA,NA,NA
"33e935fa2ce6deb75410f1384adb15cd","fisheye-analytics",NA,NA,NA,NA
"3c414e234518677d6ab492437e74cab4","fision","seed",NA,"2013-10-01",NA
"66e955e3b5aeb47672d5a8ab7a9546e8","fitbase-media",NA,NA,NA,NA
"64f3d818d2645501f06a6c6a86ae89ae","fitbionic","venture",NA,"2013-08-08",2200000
"22b59474bf592fda93a4b9f1bade8a2a","fitch-group",NA,NA,NA,NA
"6c83ef8942b8dd0a007282ebc84a8ab6","fitfully","grant",NA,"2013-11-19",60000
"6c83ef8942b8dd0a007282ebc84a8ab6","fitfully","angel",NA,"2014-07-31",1e+05
"6c83ef8942b8dd0a007282ebc84a8ab6","fitfully","seed",NA,"2015-04-03",450000
"5310f8fa3fca8a9ae6d564049c060529","fitoop",NA,NA,NA,NA
"0a38cd2d2ee5b08ce9ab437c408a5276","fitscript","seed",NA,"2014-10-28",NA
"484fe605cbb3dc7d7281d8fbbf1d7f95","five-cool","seed",NA,"2009-09-01",81191
"bd26266a64915f1b01c63143ee003d38","five-delta","seed",NA,"2013-05-31",3e+05
"0ab8594536cd9289183c7d7391ae0b18","five-point-partners",NA,NA,NA,NA
"ba26bbdf38d54cd0987fc2ea1423ff91","five-prime-therapeutics","undisclosed",NA,"2008-05-20",NA
"ba26bbdf38d54cd0987fc2ea1423ff91","five-prime-therapeutics","venture",NA,"2005-02-08",4.5e+07
"ba26bbdf38d54cd0987fc2ea1423ff91","five-prime-therapeutics","private_equity",NA,"2012-04-20",1e+07
"ba26bbdf38d54cd0987fc2ea1423ff91","five-prime-therapeutics","post_ipo_equity",NA,"2014-03-26",21040488
"ba26bbdf38d54cd0987fc2ea1423ff91","five-prime-therapeutics","venture",NA,"2010-09-15",7499999
"ba26bbdf38d54cd0987fc2ea1423ff91","five-prime-therapeutics","post_ipo_equity",NA,"2013-09-18",6.2e+07
"e90ecc160ec4c31f0069efe0be3f3240","five3-genomics",NA,NA,NA,NA
"a3a9c101641a28d12562574cb8e95eb5","fivenum",NA,NA,NA,NA
"04f3819fc640b2fcf11b16d30c3bb9d1","fivetran","seed",NA,"2013-03-01",NA
"04f3819fc640b2fcf11b16d30c3bb9d1","fivetran","seed",NA,"2013-04-01",NA
"55ead748eb4b5a995c5e3e2cfc9137d1","fivew-capital",NA,NA,NA,NA
"4ecde9ecd419246e5317fc683fbfbc94","fixes-4-kids","venture",NA,"2013-04-10",1675926
"4ecde9ecd419246e5317fc683fbfbc94","fixes-4-kids","venture","1","2012-05-03",NA
"22e16fd9bc08e1884c8469e83a969cb7","fixstream-network","venture","A","2014-06-05",1e+07
"6595f3ceb9935adc1de78831359cece1","fizziology",NA,NA,NA,NA
"b30106085412cf1e9ce0e56fd7ecdb40","fjmoney",NA,NA,NA,NA
"2e7a2100bba9dcf65c3e56775321667e","fk-biotecnologia","venture","A","2000-10-01",338834
"de68169273205791290e2fe0fa6ea0a0","flagship-biosciences",NA,NA,NA,NA
"86511d40658a03d7f4cb3350e54bd9a0","flagtap","seed",NA,"2012-12-05",NA
"86511d40658a03d7f4cb3350e54bd9a0","flagtap","seed",NA,"2013-08-28",150000
"ccc73a8ed0fc47a464369e1532971778","flaii",NA,NA,NA,NA
"84c29c086d4b7d0c39b8168cf0a595ab","flair",NA,NA,NA,NA
"71ed52c4a5493d3694b10e943781b26e","flairsoft",NA,NA,NA,NA
"2db34ba7cc0cf5695139df55e2024ce6","flame-ware-solutions",NA,NA,NA,NA
"3f1a449ba34af8e803decf15f95d4268","flamel-technologies",NA,NA,NA,NA
"75be6005e3a863f8ffc6622dcec6ad8f","flaminem",NA,NA,NA,NA
"3e8227797c32d7b3abc642e833d0da0d","flat-creek-digital",NA,NA,NA,NA
"3e6bb436f2a1523f7425b54e2da5932b","fleet-management-holding","venture",NA,"2010-01-13",31171234
"ae3a12282b1bd0f2ae3f86d9a4427e8a","fleetrover","seed",NA,"2015-05-26",1800000
"845d65d410c7047d502d120632ec2d9d","flex-biomedical","venture",NA,"2011-01-28",866000
"845d65d410c7047d502d120632ec2d9d","flex-biomedical","venture",NA,"2009-06-15",812000
"845d65d410c7047d502d120632ec2d9d","flex-biomedical","venture",NA,"2010-10-19",694101
"845d65d410c7047d502d120632ec2d9d","flex-biomedical","venture",NA,"2012-06-20",881668
"4607582b37a3baebd770f56dd3fcb7b7","flexcell-2","seed",NA,"2014-06-20",489900
"cf2b2a6fa96434ecaa51bb02f380ed63","flexgen","undisclosed",NA,"2009-03-15",NA
"2cc65071ca686795410f6f1ff2c30576","flexion-therapeutics","venture","a","2009-10-01",3.3e+07
"2cc65071ca686795410f6f1ff2c30576","flexion-therapeutics","venture","a","2010-01-29",9e+06
"2cc65071ca686795410f6f1ff2c30576","flexion-therapeutics","post_ipo_equity",NA,"2014-02-12",6.5e+07
"9942508f45daee2f5b38f78461823420","flexreceipts","angel","a","2014-04-08",1400000
"9942508f45daee2f5b38f78461823420","flexreceipts","undisclosed",NA,"2013-10-10",NA
"a0bcfbbd36c078fd5c73092ddc93fe89","flexus-biosciences","venture","B","2014-12-17",3.8e+07
"a0bcfbbd36c078fd5c73092ddc93fe89","flexus-biosciences","venture",NA,"2015-03-20",15200000
"7770c13d05226abb75787730f8f473c7","flexuspine","debt_financing",NA,"2012-09-27",1100001
"7770c13d05226abb75787730f8f473c7","flexuspine","venture",NA,"2011-11-18",2100000
"89721e0f8c4bca8208f861366bcc5457","flightrecorder","angel",NA,"2015-07-17",250000
"89721e0f8c4bca8208f861366bcc5457","flightrecorder","seed",NA,"2014-06-01",50000
"aa2a80fc5b12d210a108296952823b83","flightspeak",NA,NA,NA,NA
"6d72eb605ef19ad1d223970fc059adbd","flightstats","angel",NA,"2003-01-01",1500000
"6d72eb605ef19ad1d223970fc059adbd","flightstats","venture",NA,"2015-01-07",1500000
"15e0e8061e96e76455169190bacc9d87","fliiby","seed",NA,"2015-01-05",0
"f8021aceaff5ced5fc143455704090f5","flimp-media",NA,NA,NA,NA
"44921006ee874b74989087cd42baadb8","flockdata",NA,NA,NA,NA
"9941d62cfbba11604ee5e855f1ffd8db","florida-biomed","venture",NA,"2010-08-31",1550000
"719183847384b31130c16b1875b9a307","flossonic","equity_crowdfunding",NA,"2013-06-04",193679
"686ed4390a2a4765e672dea73928963c","flowco","debt_financing",NA,"2009-11-04",1150000
"686ed4390a2a4765e672dea73928963c","flowco","debt_financing",NA,"2010-06-18",1850000
"8b20b00a6b0d6edf606a7cfa8e572fba","flower-orthopedics","venture",NA,"2014-04-02",2500000
"8b20b00a6b0d6edf606a7cfa8e572fba","flower-orthopedics","venture",NA,"2014-11-26",2200000
"8b20b00a6b0d6edf606a7cfa8e572fba","flower-orthopedics","venture","1","2015-03-23",4500000
"f8daad246c2cc69b89748f5ee4428a75","flowgear","seed",NA,"2010-06-01",130832
"f8daad246c2cc69b89748f5ee4428a75","flowgear","convertible_note",NA,"2014-12-01",550000
"a0f6397f6a02fa8cbd27a0675e4f00d0","flowmetric","venture",NA,"2011-02-14",1501478
"fdb657bac7cf15996dae4dff19649e88","flowsense",NA,NA,NA,NA
"c5210882d404ffc8b56e47859facdc29","flowtale",NA,NA,NA,NA
"5f682040c48e242245ebb4c3f03dc365","flowtown","seed",NA,"2010-08-25",750000
"b5a38a9e2df264cf0da826823ada4109","fluent-ai","seed",NA,"2015-05-01",414016
"f24cafe922cf931f19030c18626bcfb8","fluential","venture","a","2013-11-29",2e+06
"8e7ce9a95f6feaaf405475380a4de469","flugen","venture",NA,"2011-10-06",3276853
"8e7ce9a95f6feaaf405475380a4de469","flugen","debt_financing",NA,"2014-05-30",3228479
"8e7ce9a95f6feaaf405475380a4de469","flugen","venture","1","2015-08-25",1.2e+07
"8a255c9f9c3d9dc9383ce2378ebb1fbb","fluid-imaging-technologies","venture",NA,"2013-01-08",3900000
"f1ddc0dc4ee2f5f1e795a3458e83d0ca","fluidic-analytics","venture","A","2014-12-18",2443430.4092
"908662df2eedef6879faf115b022311f","fluidigm","venture","E","2007-01-08",3.7e+07
"908662df2eedef6879faf115b022311f","fluidigm","debt_financing",NA,"2011-01-21",5003214
"908662df2eedef6879faf115b022311f","fluidigm","venture",NA,"2009-11-19",7500000
"908662df2eedef6879faf115b022311f","fluidigm","venture",NA,"2009-09-01",10700000
"908662df2eedef6879faf115b022311f","fluidigm","venture","e","2007-01-10",1.7e+07
"4c1afa0cf16c1bdc29c6bc07a1d44707","fluimedix",NA,NA,NA,NA
"e7a17920b6afbac6d771d51856963501","flumes","seed",NA,"2011-10-15",78915
"e5d951b16ab3f7bd345d4c1f78045af3","fluoro2-therapeutics","equity_crowdfunding",NA,"2014-10-15",NA
"c513fdea38bac66e1710393138142c2e","fluorofinder","debt_financing",NA,"2014-07-08",1e+06
"109745c22fe33937ea76a41fa07a2d74","fluoropharma","venture",NA,"2012-11-21",1546250
"109745c22fe33937ea76a41fa07a2d74","fluoropharma","debt_financing",NA,"2013-07-08",250000
"109745c22fe33937ea76a41fa07a2d74","fluoropharma","venture",NA,"2011-06-01",3667442
"109745c22fe33937ea76a41fa07a2d74","fluoropharma","debt_financing",NA,"2013-09-27",737500
"109745c22fe33937ea76a41fa07a2d74","fluoropharma","venture",NA,"2014-01-10",877500
"109745c22fe33937ea76a41fa07a2d74","fluoropharma","venture",NA,"2011-07-08",2400000
"109745c22fe33937ea76a41fa07a2d74","fluoropharma","debt_financing",NA,"2014-08-06",1222500
"109745c22fe33937ea76a41fa07a2d74","fluoropharma","debt_financing",NA,"2015-06-09",350000
"1d031bf75817f68adea3e3af2c48992f","flutrends-international","venture",NA,"2011-06-17",3e+05
"05cbb45db8564c700b4387baed47a85a","fluxergy","venture",NA,"2015-04-01",4500000
"67492f7edc6b3d78263cbec5ab6503bd","fluxifi-limited",NA,NA,NA,NA
"44b6cc388ed3f2b6dccaf6e183ecb25e","fluxion-biosciences","venture","b","2007-10-20",7e+06
"44b6cc388ed3f2b6dccaf6e183ecb25e","fluxion-biosciences","venture",NA,"2012-10-01",2e+06
"21f776b905ff2c30cd9fb6a86a9b5246","flx-bio",NA,NA,NA,NA
"872d98a777b3a9748137a45fcb93be1e","flydata","venture",NA,"2013-06-01",925000
"872d98a777b3a9748137a45fcb93be1e","flydata","seed",NA,"2011-09-30",680000
"872d98a777b3a9748137a45fcb93be1e","flydata","venture",NA,"2014-05-27",1450000
"6d55a13e499d1ad72144dcae43b0da89","flyspan-systems",NA,NA,NA,NA
"ce4dd3d433fe8bb35e93201886fdf6b8","flytxt","venture",NA,"2015-06-30",1.1e+07
"ecf9f41115cf4d77e6a643c25b4cefed","flywheel-healthcare","debt_financing",NA,"2011-04-27",1500000
"e2bbb997212d8c90c002b8f6ed522ef3","fm-marketplace",NA,NA,NA,NA
"c57c34bcc2eb074393c706ba19db2497","fme-us",NA,NA,NA,NA
"ea6bb6804a342f9b9aadc1332f7509de","fmp-products","venture",NA,"2010-04-14",480000
"285c3351f0052ed41d9e5f42cef83a9d","fms-hauppauge","venture",NA,"2011-01-04",9031006
"bf19885e110b24fb6aea95539f1dc4a9","fms-midwest-dialysis-centers","venture",NA,"2011-06-21",2891068
"bf19885e110b24fb6aea95539f1dc4a9","fms-midwest-dialysis-centers","private_equity",NA,"2011-11-21",7632343
"f135dc93a82fe122b21d1446ba52c324","fnac",NA,NA,NA,NA
"d23424517607aa84c2b179a87255f254","fobiss",NA,NA,NA,NA
"4956fd33fdb0fb18fe83f0ccfb441f54","focalhub",NA,NA,NA,NA
"b1929a6e2c1e78080a5b86885066f9f1","foghorn-labs",NA,NA,NA,NA
"5d3abf2302701a655e6ab74476b06495","fokus",NA,NA,NA,NA
"2aa09c765b6686d2a9e99c2295a524ae","foldrx-pharmaceuticals","venture",NA,"2010-06-15",2.9e+07
"149808138b9ede8ed59fab6277aead64","foley-hoag-llp",NA,NA,NA,NA
"65b27f8f62d99ff85b16b6ea1851cb68","follica","venture","A","2008-01-04",5500000
"65b27f8f62d99ff85b16b6ea1851cb68","follica","venture","B","2010-11-08",134999
"65b27f8f62d99ff85b16b6ea1851cb68","follica","venture","b","2008-08-12",1.1e+07
"65b27f8f62d99ff85b16b6ea1851cb68","follica","venture","B","2010-06-01",7499999
"e845ad0fda3cdd71a747378ba2a6fd92","follicum","venture",NA,"2012-12-11",649650
"48050b391ddf11148f473818094d2038","follow-the-coin",NA,NA,NA,NA
"41efaa3757bd24ffec72df16110e2549","followanalytics","venture","A","2015-10-15",1e+07
"41efaa3757bd24ffec72df16110e2549","followanalytics","venture",NA,"2015-02-24",3862490
"9b4a0e111db05f3e75b8093656d0665a","folsom-creative",NA,NA,NA,NA
"123a5b2f18da182952f2f70387d06517","fongenie",NA,NA,NA,NA
"fabe9de5bcbfefceab81a7ced3ef0c76","fonteva","venture",NA,"2015-09-30",985498
"fabe9de5bcbfefceab81a7ced3ef0c76","fonteva","equity_crowdfunding",NA,"2015-03-03",NA
"983d7f7f5096029229b700aa98f8ddbc","fooco",NA,NA,NA,NA
"5f4dacb90056aa17e15d04d2c28b8737","food-fertilizer-technology-center",NA,NA,NA,NA
"92fc1b41b36e662ec50d7cd1af4ed03a","food-genius","seed",NA,"2011-06-01",75000
"92fc1b41b36e662ec50d7cd1af4ed03a","food-genius","venture","1","2013-09-17",1e+06
"92fc1b41b36e662ec50d7cd1af4ed03a","food-genius","venture","1","2012-09-11",1200000
"342b7dcd8f95bffa3132822af832a21a","footmarks","seed",NA,"2013-12-02",120000
"342b7dcd8f95bffa3132822af832a21a","footmarks","debt_financing",NA,"2013-05-29",5e+05
"342b7dcd8f95bffa3132822af832a21a","footmarks","seed",NA,"2014-10-13",1850000
"5414819af16113b4f4470369b79528fe","for-arts-sake-media","angel",NA,"2008-01-01",1e+05
"27c4ffa74ca131cd11b79394ead0ea1c","for-robin","grant",NA,"2015-05-04",2e+06
"1388158d4dd5c0197efe53517906d24c","forddirect",NA,NA,NA,NA
"7ac4fccb14529b0527b90e9366d8019c","forecastthis",NA,NA,NA,NA
"f2baf2f62e0d9fe4892b6efe16a9033d","forelight","venture",NA,"2015-04-17",150000
"22c7c52291769f3b982bae3eb44e3050","fores-ee",NA,NA,NA,NA
"24317461454519c3de6bc6a732b7dcce","foresee-results","venture",NA,"2007-04-04",2e+07
"ea19fc29c0386eb2c19e2f8b39369fe2","foresight-biotherapeutics","seed",NA,"2011-07-29",2000290
"ea19fc29c0386eb2c19e2f8b39369fe2","foresight-biotherapeutics","venture",NA,"2013-11-13",1.5e+07
"536b211cfdb422c46dee3a8fcc0abc20","foresight-intelligence",NA,NA,NA,NA
"d8b2a8ce45db62a3a8108fbdec552eb1","forest-chemical-group","seed",NA,"2013-09-07",2573200
"5fbfe133fbbacae2331bdefb9adc7c88","forest-laboratories",NA,NA,NA,NA
"2d83ad2dfe9a5c7cf1d3a92f3d7e7e3a","forest2market","venture","b","2012-01-11",NA
"e962be2ff3402ad36932875b55a70c0a","foretold",NA,NA,NA,NA
"eb31202ad02ef5a46b19f143c4e9f98f","foretuit",NA,NA,NA,NA
"87adcdbfd667c4fea3be2a01a641e763","forever","venture","a","2012-05-01",9e+06
"87adcdbfd667c4fea3be2a01a641e763","forever","venture",NA,"2014-01-10",8573700
"87adcdbfd667c4fea3be2a01a641e763","forever","venture",NA,"2015-04-15",NA
"5003717fc2716d75bbab642d0324128e","forevervogue-com","seed",NA,"2013-01-01",11347
"5003717fc2716d75bbab642d0324128e","forevervogue-com","private_equity",NA,"2013-10-01",8000
"5003717fc2716d75bbab642d0324128e","forevervogue-com","angel",NA,"2013-12-16",21000
"638108bad14ab899a4424638e5018779","forge-life-science","venture",NA,"2014-01-22",2e+05
"a2347ad6039b4852d3fdfce40747468c","forged-elite",NA,NA,NA,NA
"58dd27584ceb46562e1dee0be1b3c132","forkize",NA,NA,NA,NA
"4c17bfd04d5b30b53cabe9d66a96e23c","forma-therapeutics","venture","b","2009-12-17",3e+06
"4c17bfd04d5b30b53cabe9d66a96e23c","forma-therapeutics","venture","a","2008-04-14",4e+06
"4c17bfd04d5b30b53cabe9d66a96e23c","forma-therapeutics","venture","b","2009-12-01",25500000
"4c17bfd04d5b30b53cabe9d66a96e23c","forma-therapeutics","venture",NA,"2012-09-07",1e+07
"0954cfddce8b5af5de560cba65198b53","formatic",NA,NA,NA,NA
"67e95dd33b38641456a228d428b1cfe2","formcept","seed",NA,"2013-06-01",NA
"e52aa26b6d5d42218ecccf2e00104ab8","formisimo","seed",NA,"2015-09-01",674040.2924
"e52aa26b6d5d42218ecccf2e00104ab8","formisimo","seed",NA,"2014-06-02",586451
"e52aa26b6d5d42218ecccf2e00104ab8","formisimo","seed",NA,"2014-05-30",586000
"b5d781d1c5908c96ef78ab71c69db1cf","formjam",NA,NA,NA,NA
"48a50e66903e411a264024e7cc4cfd04","formvertise",NA,NA,NA,NA
"e805765c6f4032b81161985fa09f10b1","foro-digital",NA,NA,NA,NA
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture","A","2007-04-03",5e+06
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture","b","2013-06-17",9300000
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture",NA,"2009-08-10",6e+06
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture",NA,"2009-05-12",12000001
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture",NA,"2011-02-08",6e+06
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture",NA,"2012-08-17",8e+06
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture","c","2014-04-16",1.5e+07
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture",NA,"2014-05-06",1e+06
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","venture",NA,"2014-12-08",2999809
"c135f20c2cd9ae6783156efcb19c9958","forsight-labs","debt_financing",NA,"2015-09-04",1700700
"830d9b282fcfde6b159e12f953593496","fort-sanders-west","venture",NA,"2010-08-31",1e+05
"0ec3c04117376b5b4008d2af7df1a186","forte-consultancy-group",NA,NA,NA,NA
"54f2a4ec850c57963a3ac2a1e669c2dc","forte-wares",NA,NA,NA,NA
"705bd5f728b089f51f8c8f007097ea65","fortebio",NA,NA,NA,NA
"5f42acbbcf046a86ab06a4dfa9910894","forter","venture","a","2014-03-25",3e+06
"5f42acbbcf046a86ab06a4dfa9910894","forter","venture","B","2014-11-11",1.5e+07
"5f42acbbcf046a86ab06a4dfa9910894","forter","venture",NA,"2015-01-01",NA
"6bdf94fd2a73d64943643ff5d63e46bb","forthea-interactive-marketing",NA,NA,NA,NA
"3f0a85a35cc1d63a7c6644716071f355","fortify-infrastructure-services",NA,NA,NA,NA
"b3893d827da710523140150432a9ffe9","fortscale","venture",NA,"2015-11-24",4e+06
"b3893d827da710523140150432a9ffe9","fortscale","seed",NA,"2013-02-01",2e+06
"b3893d827da710523140150432a9ffe9","fortscale","venture",NA,"2014-06-02",1e+07
"4e9d04ff7759602d86e6c73e8f8b7454","fortsec",NA,NA,NA,NA
"6292f806f7e52271d261524bd026bc57","fortunerock-china","venture",NA,"2014-08-25",2.4e+07
"1f45b852b6c220bb83c6f756d4112efa","fortvision-2","seed",NA,"2015-03-01",2e+05
"e4bf83d9482bbd4cd69c06056166ccc5","forward-pharma",NA,NA,NA,NA
"bd3ab6f7484d6d41e75f2980848fea1c","fosteringtech",NA,NA,NA,NA
"caf449d444333cf977e3985fdaffa988","fotegrafik",NA,NA,NA,NA
"995638ef2677b4623d055ee9b8151131","fotoflexer",NA,NA,NA,NA
"7454f8ae83f8845e105f8e08e0a0d285","fotoglif",NA,NA,NA,NA
"4816a5a082e298a3f496e09e7545ad97","fotonation",NA,NA,NA,NA
"c503d5119889426fe02d3df4f6c9d397","fotoviewr",NA,NA,NA,NA
"bd5b2aa5a01a67c971f3859707bd4169","founch","seed",NA,"2014-09-02",20000
"b4905f97cdc50d5ae51f80739293e6bc","found-2",NA,NA,NA,NA
"426383fc53d2af5084f5f2beb25c58a1","foundation-for-innovation-and-technology-transfer",NA,NA,NA,NA
"3b07d7febf117d0b783a6ddf58e6b16c","foundation-radiology-group","venture","a","2009-04-13",1e+07
"3b07d7febf117d0b783a6ddf58e6b16c","foundation-radiology-group","debt_financing",NA,"2013-07-08",6e+06
"3b07d7febf117d0b783a6ddf58e6b16c","foundation-radiology-group","debt_financing",NA,"2014-06-30",2500000
"6beb3ae625eee9a37914c9153c779554","foundationdb","angel",NA,"2011-12-22",5650000
"6beb3ae625eee9a37914c9153c779554","foundationdb","venture","1","2013-11-12",1.7e+07
"a4c8b80a5a1d71a4e36230f9151ece2f","foundcy",NA,NA,NA,NA
"835d3dc91145b0bfb4c180e36d8d9578","founderlift",NA,NA,NA,NA
"17f2fdc57ff1cc9a571c261b94dafc9f","foundry-newco-xii","venture",NA,"2010-01-22",3e+06
"a803a9ba32af47fd4121ee98a6ac873c","fourlt--4lt--llc",NA,NA,NA,NA
"6895451bd13f723af7fae4f1ce002131","foursum-golf",NA,NA,NA,NA
"33e5477fb9da4b81bc8d55861e97199e","foxmetrics",NA,NA,NA,NA
"0603fcbc62b030b5978dd11c18f999b4","foxtrotcode","angel",NA,"2015-04-06",NA
"ed588c4acb9a00d0894024500881cb09","fpt-software","venture",NA,"2010-06-24",5420000
"989651955b951c0d9f66ea25b60365ba","fractal-analytics","venture",NA,"2013-06-24",2.5e+07
"989651955b951c0d9f66ea25b60365ba","fractal-analytics","venture",NA,"2014-08-12",NA
"ac3ee10a43a14fc1ad5365b3ae9cc611","framed-data","seed",NA,"2014-01-01",NA
"ac3ee10a43a14fc1ad5365b3ae9cc611","framed-data","seed",NA,"2014-12-11",2e+06
"57dca2737159af77d6e90a4cac00c490","franklin-data","seed",NA,"2015-06-01",NA
"d04b2931878e35e0a7e991e0c7360b63","frasen","seed",NA,"2013-10-01",6e+05
"d04b2931878e35e0a7e991e0c7360b63","frasen","angel",NA,"2014-09-10",70000
"d04b2931878e35e0a7e991e0c7360b63","frasen","seed",NA,"2014-04-23",40000
"d04b2931878e35e0a7e991e0c7360b63","frasen","angel",NA,"2015-02-10",50000
"3a3f85b81ada7a6e780820223ff2c30a","fraud-net",NA,NA,NA,NA
"48e8b768438c4a39ea0228447b035f7f","fraudexpress",NA,NA,NA,NA
"c4c8dc4dbc9a6af9802275bbd8a24c4d","frederick","angel",NA,"2014-08-01",NA
"4f9aab91957d00c04ef6602ebdeb289e","free-wifi",NA,NA,NA,NA
"d4d0daeeb08dea5973814b1d1cc66893","freebee","seed",NA,"2011-08-18",NA
"d4d0daeeb08dea5973814b1d1cc66893","freebee","private_equity",NA,"2013-11-25",NA
"98ba10ad1865f04931e9bddf91c5c219","freedom-health",NA,NA,NA,NA
"0dcc2bf32209acd1ef436917bc5b21f5","freelancy","equity_crowdfunding",NA,"2014-09-20",NA
"d3ff9b7b9768d3b0a9e80a4137f897c5","freelys",NA,NA,NA,NA
"0a13712b56d2a2ab6bb6dd906d70e5f6","freepik",NA,NA,NA,NA
"1fbc01ac67b589a959296a6f94dbcee5","freight-prophet",NA,NA,NA,NA
"ad13bb490d4ffbd7569b82eaeb11c5b0","freight-right-global-logistics",NA,NA,NA,NA
"3c9400c5d735cfaf66ca8282479759f3","frenchwide",NA,NA,NA,NA
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","venture",NA,"2013-11-14",26820000
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","venture",NA,"2011-07-07",2656095
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","venture",NA,"2011-03-04",653070
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","seed",NA,"2012-03-27",2277466
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","undisclosed",NA,"2013-09-09",2795077
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","undisclosed",NA,"2013-07-13",1091138
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","undisclosed",NA,"2013-11-13",2628823
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","private_equity",NA,"2013-09-03",4122505
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","undisclosed",NA,"2014-02-04",18171496
"0ee9c7a6ddff0f0f213ae23d63f76bcb","fresenius-medical-care","undisclosed",NA,"2010-11-05",30214672
"b4af3f9a78f02ed44da06e7fb8170f83","fresh-coast-lithotripsy","venture",NA,"2013-05-09",20531
"b4af3f9a78f02ed44da06e7fb8170f83","fresh-coast-lithotripsy","venture",NA,"2010-08-31",29160
"b4af3f9a78f02ed44da06e7fb8170f83","fresh-coast-lithotripsy","venture",NA,"2009-10-15",162000
"673dfbf9edc65678a865462f5dbe252e","triggered-messaging",NA,NA,NA,NA
"f6c446e36a43f6bed9cd1c4d6297d14e","fligoo","seed",NA,"2013-03-01",75000
"f6c446e36a43f6bed9cd1c4d6297d14e","fligoo","seed",NA,"2013-03-08",90000
"f6c446e36a43f6bed9cd1c4d6297d14e","fligoo","seed",NA,"2013-12-01",240000
"f6c446e36a43f6bed9cd1c4d6297d14e","fligoo","seed",NA,"2014-06-01",40000
"f6c446e36a43f6bed9cd1c4d6297d14e","fligoo","seed",NA,"2014-09-20",359000
"f6c446e36a43f6bed9cd1c4d6297d14e","fligoo","seed",NA,"2014-12-05",535000
"50567305b68ec8015e4128875383423d","freshlime",NA,NA,NA,NA
"a26d6aaceb42b4c9b2fbb53a903a9ab7","freshmail",NA,NA,NA,NA
"a15cb19fdbb22c6c8b8059c8114853c6","freshoffice","venture","A","2013-10-15",1200000
"b5ee474b53976754258c69df2e7b6ebe","freshplum","seed",NA,"2014-02-13",1044999
"b5ee474b53976754258c69df2e7b6ebe","freshplum","seed",NA,"2011-11-02",1440000
"b5ee474b53976754258c69df2e7b6ebe","freshplum","seed",NA,"2011-06-01",NA
"2e3a663305b344d5e807b7e89d369886","friend2friend",NA,NA,NA,NA
"a01a4e964a068756441ed84c3414639c","friendtipper",NA,NA,NA,NA
"216e39480b5f39d2923933c03c93bac2","fritz-macziol",NA,NA,NA,NA
"9a1628c37d8ef6e4e5f7b197d8616c75","frogmetrics","undisclosed",NA,"2008-06-01",NA
"afda2af1e5dfaf2982c043bad7429b5f","frontier-mea-2","undisclosed",NA,"2013-06-01",380133
"97376b942ba1802788a10e671a66a082","frontier-strategy-group","private_equity",NA,"2010-12-01",11400000
"66717639999924075d6ad9cf9454a654","frost-data-capital",NA,NA,NA,NA
"d2c36acf5974e454907bff9275573e46","fruitfulll","angel",NA,"2013-06-01",760267
"428110189197bdc011a95efeb2b6157e","fst-life-sciences","venture",NA,"2010-09-15",1082192
"466d4f70c5e0beb4a818ee2bb1f454ab","fueldeck",NA,NA,NA,NA
"6f233dc4318880a7c95f561fd7f28888","fuelixir",NA,NA,NA,NA
"13059d6f154e13a827f8bb9c75ddb3ff","fuisz-media","seed",NA,"2014-07-03",2100000
"13059d6f154e13a827f8bb9c75ddb3ff","fuisz-media","venture","1","2015-07-30",1e+07
"22bb4d162336c3b7b98d09900b16f89b","fuji-machine-mfg",NA,NA,NA,NA
"3db338f8323e339941a5e46b7b27b764","fujifilm-teramedica-inc",NA,NA,NA,NA
"cf2d4cc4ed64231969049fc05a912c62","full-genomes-corporation","seed",NA,"2013-09-17",250000
"9788b4b560be6137d8d979f5f2bafebb","full-spectrum-laser","venture",NA,"2014-11-12",1e+07
"af7c5759ce26ab6e9ccf006a81b55f30","fullcube","angel",NA,"2014-10-01",NA
"af7c5759ce26ab6e9ccf006a81b55f30","fullcube","angel",NA,"2015-03-06",NA
"7cf50ea8e6070a3b695bd51d9cba6b54","fuller","undisclosed",NA,"2015-02-27",1900000
"7cf50ea8e6070a3b695bd51d9cba6b54","fuller","seed",NA,"2012-12-18",1200000
"9d89848956249807297852f1a8d2638b","fullerene-solutions",NA,NA,NA,NA
"9a98891f6bac95135537b12282534a18","fullscope-2",NA,NA,NA,NA
"5c24a646e4193af8b072b0bbfa81ebbe","funderbeam","seed",NA,"2015-10-15",746919.6691
"5c24a646e4193af8b072b0bbfa81ebbe","funderbeam","seed",NA,"2014-05-15",685523
"5c24a646e4193af8b072b0bbfa81ebbe","funderbeam","seed",NA,"2013-10-15",135460
"5c24a646e4193af8b072b0bbfa81ebbe","funderbeam","seed",NA,"2013-07-15",26121
"5c24a646e4193af8b072b0bbfa81ebbe","funderbeam","seed",NA,"2015-05-22",553560
"a0c4376a2a9ef8f9302743fc9b37ca77","calltracking",NA,NA,NA,NA
"fd25f69841a2c9380e684da731c96fde","funnelsource",NA,NA,NA,NA
"174e4b7c39a53a050fab93575f8b0775","funnely","seed",NA,"2015-12-17",1e+06
"174e4b7c39a53a050fab93575f8b0775","funnely","seed",NA,"2014-08-10",988000
"d120cd23153aaea7d710b930ad13224e","funxional-therapeutics","venture","b","2010-05-27",12200000
"d0509b4d0ac597377fcfbc1092c43e7a","furiex-pharmaceuticals","debt_financing",NA,"2013-10-01",1.5e+07
"636b042bd47fb44720098a012e1c42fe","fuseit",NA,NA,NA,NA
"1f98c9a5e36f3b4d57cbb9d33af3395b","fusemachines","venture",NA,"2014-07-01",NA
"2222fecdfb6f672d2df595c39dfc56d4","fusion-antibodies","venture",NA,"2007-07-26",2500000
"73bc6fb5cab6b2034905ef94afbc347a","fusion-ventures-llc",NA,NA,NA,NA
"4361b5e3697b325f63e71814d63b865f","fusionops","venture","a","2005-03-01",4e+06
"4361b5e3697b325f63e71814d63b865f","fusionops","private_equity",NA,"2014-01-15",566544
"4361b5e3697b325f63e71814d63b865f","fusionops","private_equity",NA,"2009-11-04",690000
"4361b5e3697b325f63e71814d63b865f","fusionops","seed",NA,"2001-01-01",1400000
"4361b5e3697b325f63e71814d63b865f","fusionops","venture","B","2015-03-26",1.2e+07
"301f92b02a17242179cda852012ba2f0","futura-genetics",NA,NA,NA,NA
"ebda970aae36ab25f97872bfb054b9e1","future-healthcare-of-america","debt_financing",NA,"2013-09-10",1010000
"a943f9bf8643af482e68b1b13a8ef12e","future-image",NA,NA,NA,NA
"8a412b05cddb16c3ae54c730feb2d9ea","future-insight","seed",NA,"2013-03-01",18000
"5db11665cd80a26ed01ab05bd97a029c","future-markets",NA,NA,NA,NA
"f4dd1dd6d9757995ae1523f84be30ae7","future-medical-technologies","undisclosed",NA,"2011-08-08",81837
"a5b7207df88557dd0917165fbe2ea4e2","futureplay",NA,NA,NA,NA
"1e3cb89baa5b33136a356685604ef2aa","futurx",NA,NA,NA,NA
"ee1e57b4293d35c029cd41407636d2f9","fuzzy-io",NA,NA,NA,NA
"9f1a03845abb547d170c4fa83099c48a","fyle",NA,NA,NA,NA
"2b7bef231b3594a4ee62a3584e377c7d","fyoosion-llc","equity_crowdfunding",NA,"2014-12-16",4e+05
"65272e9dff4a48b2243eb0e682fd0ec3","fypio","seed",NA,"2013-10-25",1e+06
"65272e9dff4a48b2243eb0e682fd0ec3","fypio","angel",NA,"2014-12-31",1400000
"a9d9017a355b70229878d7e4ead5c441","fyrebox",NA,NA,NA,NA
"6c017829476448eb5a85fcad979917f8","g-and-a-innovative-solutions","seed",NA,"2015-08-06",3000
"44061d1ef145dbe179c112e0827c3ca8","g-con","venture",NA,"2014-06-24",5e+06
"6007cf6499a8784fa4e704c5ec7d66a5","g-zero-therapeutics","debt_financing",NA,"2013-04-18",457902
"6007cf6499a8784fa4e704c5ec7d66a5","g-zero-therapeutics","venture",NA,"2012-10-12",762884
"d5c4a60b6b0bdef58552063657cb4c53","g-i-windows","debt_financing",NA,"2014-02-26",2393500
"1e1b1e45b062adc7c8f9bf4bf8534f33","g-p-marketing",NA,NA,NA,NA
"89e454b65b935c14d01e9a099f356202","g1-therapeutics","venture","a","2013-10-16",12500000
"89e454b65b935c14d01e9a099f356202","g1-therapeutics","venture","B","2015-02-05",3.3e+07
"e58f057bed3e8e0db12f4dc0ff3bef15","g2-research",NA,NA,NA,NA
"0ff205b1432518a5b5fff49209cb41dc","g2b-pharma","seed",NA,"2013-06-11",235000
"4c99edd5660c008a6e606f797b34e3ae","g4interactive","angel",NA,"2012-02-01",262530
"32e93c488305b52172bce1f090cc867a","g5-classifieds",NA,NA,NA,NA
"24ab17d0d9da3c6495bc8a6e4bc0048e","g7m-electronics",NA,NA,NA,NA
"728e1ba1da036825b5a4bc943581c14b","gaia-herbs","venture",NA,"2010-04-05",7e+05
"728e1ba1da036825b5a4bc943581c14b","gaia-herbs","venture",NA,"2011-01-01",1e+06
"23bca868672e3340af0d816cc16fc9b8","galantos-pharma","venture","c","2010-05-10",5700000
"d0bf3291f6146788abfecd72c8dfae8b","galapagos","grant",NA,"2010-10-28",5127090
"d0bf3291f6146788abfecd72c8dfae8b","galapagos","grant",NA,"2014-01-13",3731140
"d0bf3291f6146788abfecd72c8dfae8b","galapagos","undisclosed",NA,"2001-01-01",NA
"2077b71e91fc6db63ccd4695ac4195cd","galaxy-diagnostics","venture",NA,"2014-08-19",550814
"42ca70d9cf5f961ac45c4bb12d86b65d","galaxy-fireworks-inc",NA,NA,NA,NA
"2cf06515ad91522ad34351069bd14058","galaxyadvisors","seed",NA,"2008-09-15",6e+05
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture",NA,"2011-01-06",3e+06
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture","1","2009-11-10",325000
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture","1","2009-02-12",1800000
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture","1","2009-05-13",9e+05
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture","1","2009-06-30",5e+05
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture","1","2009-10-06",325000
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture","1","2009-11-04",310000
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture","1","2009-12-10",325000
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","venture","1","2010-02-02",325000
"8ffdd798189632ee00cdba64f62f32c1","pro-pharmaceuticals","grant",NA,"2010-02-10",489000
"1eb97e331ea123f3c03eb1b166183d5a","galecto-biotech","venture",NA,"2013-11-01",NA
"8a3d3d2b2beb899e8cc30520ada15446","galena-biopharma",NA,NA,NA,NA
"f72a47e6f1220dac289d11169a8ed0c4","galenea","grant",NA,"2010-10-14",4500000
"f72a47e6f1220dac289d11169a8ed0c4","galenea","venture",NA,"2012-04-26",6e+06
"f72a47e6f1220dac289d11169a8ed0c4","galenea","grant",NA,"2012-09-06",3e+06
"e78602c2e70b6ab0bfcf04616c1e0515","galera-therapeutics","venture","B","2015-10-14",3.7e+07
"e78602c2e70b6ab0bfcf04616c1e0515","galera-therapeutics","convertible_note",NA,"2011-01-01",805000
"e78602c2e70b6ab0bfcf04616c1e0515","galera-therapeutics","convertible_note",NA,"2011-09-01",405000
"e78602c2e70b6ab0bfcf04616c1e0515","galera-therapeutics","venture","a","2012-12-12",1.1e+07
"e78602c2e70b6ab0bfcf04616c1e0515","galera-therapeutics","venture","A","2014-08-07",4700000
"e78602c2e70b6ab0bfcf04616c1e0515","galera-therapeutics","venture","A","2015-03-19",4700000
"75ef063989d97982afb0bd16d45e8148","galleon-pharmaceuticals","venture",NA,"2010-11-23",1e+07
"75ef063989d97982afb0bd16d45e8148","galleon-pharmaceuticals","venture",NA,"2014-01-13",6e+06
"75ef063989d97982afb0bd16d45e8148","galleon-pharmaceuticals","venture",NA,"2013-11-20",1500000
"69c630e2b87a6fe46844773334f4a243","gallop-labs","seed",NA,"2014-12-10",2e+06
"21e190d8376c8646c777a526683d6d77","gallup",NA,NA,NA,NA
"ae5c5eb0cb2e7740b6fd4ef5b59c2859","gallus-biopharmaceuticals","undisclosed",NA,"2011-05-18",NA
"99ba8ab1852c1991bc52ea6ddb36c366","gamamabs-pharma","venture","B","2015-12-15",16476877.4486
"99ba8ab1852c1991bc52ea6ddb36c366","gamamabs-pharma","venture",NA,"2013-09-30",3988460
"bdd217b0ab917038f11f409ec8e121c7","gambleid-llc",NA,NA,NA,NA
"c5e0c7cd881472e5c5ab98505f13f295","gambro",NA,NA,NA,NA
"2d066e891e7c8916a0eaf1b6c8c24a40","gamefilm360",NA,NA,NA,NA
"9c46269b9eb0a043351bc2f56b7c4308","gamera-bioscience",NA,NA,NA,NA
"d0e2289c22562d2b662e73497b7caa50","gamezop",NA,NA,NA,NA
"b4e67041995f75147ae156b5b2b03cc3","gamida-cell","venture","e","2012-05-15",1e+07
"b4e67041995f75147ae156b5b2b03cc3","gamida-cell","venture","d","2006-09-27",1.6e+07
"b4e67041995f75147ae156b5b2b03cc3","gamida-cell","venture",NA,"2014-01-15",4040109
"b4e67041995f75147ae156b5b2b03cc3","gamida-cell","venture","A","2000-05-01",6373389
"b4e67041995f75147ae156b5b2b03cc3","gamida-cell","venture","B","2001-10-01",9677242
"b4e67041995f75147ae156b5b2b03cc3","gamida-cell","venture","C","2005-08-01",3703224
"e8ce9fd18ca85bd1d03b752c07b1aecf","gaming-edge-associates-ltd",NA,NA,NA,NA
"9f9ea551e17f6df4286841047d79b237","gamma-medica","venture","a","2013-07-16",1.6e+07
"9f9ea551e17f6df4286841047d79b237","gamma-medica","venture","B","2014-10-22",11500000
"9f9ea551e17f6df4286841047d79b237","gamma-medica","debt_financing",NA,"2014-10-14",6500000
"375790e23144fcdbac632126226d3821","gamma-soft",NA,NA,NA,NA
"b3a1d5e6fde7aee5a12def6dfee1d263","gamma-service-recycling",NA,NA,NA,NA
"8cf9e542ceb826fc082057bbec5d0454","gamooga",NA,NA,NA,NA
"5fbb4e819d2e681ca45b8c5e3003ae9d","gan-lee-pharmaceutical-co-ltd","venture","b","2011-05-01",30225682
"5fbb4e819d2e681ca45b8c5e3003ae9d","gan-lee-pharmaceutical-co-ltd","venture","a","2010-05-01",16236400
"5fbb4e819d2e681ca45b8c5e3003ae9d","gan-lee-pharmaceutical-co-ltd","undisclosed",NA,"2015-01-01",NA
"3831a9977e086c7037c137cda4cb793b","gandysoft-inc",NA,NA,NA,NA
"89b4a0f660f53634f9ee6e6514bda1df","ganeden-biotech","venture",NA,"2007-11-05",1.2e+07
"3cc11bd3139c9cb4ffbc5a56ff2943aa","gantec","seed",NA,"2012-05-10",777338
"cc14355c8d3948fd4ec7e1cfb852408b","ganymed-pharmaceuticals","venture","C","2007-04-18",33700000
"cc14355c8d3948fd4ec7e1cfb852408b","ganymed-pharmaceuticals","venture","e","2013-11-18",57897000
"5f6c5e4cb1e239d06ab4a0fa5260bf56","gaonic",NA,NA,NA,NA
"8aae164944c6fa79168a47e1f18e7f83","garlik","venture","c","2009-04-23",2340000
"8aae164944c6fa79168a47e1f18e7f83","garlik","venture","b","2007-04-26",11950000
"8aae164944c6fa79168a47e1f18e7f83","garlik","venture",NA,"2008-06-01",5e+06
"8aae164944c6fa79168a47e1f18e7f83","garlik","venture","a","2006-04-24",5400000
"93fa584e376ec386c1b1cb4d0e79cdd5","garnet-biotherapeutics","venture","a","2009-02-03",10400000
"5db0d40c3e34ab598a2228252e599ac3","gars-infotech",NA,NA,NA,NA
"0e730ffa23b1c4ce480a0f4fb3a7da05","gauffin-interactive-ab",NA,NA,NA,NA
"3edc0fdb374bfd74befde4e4d06e704c","gaug-es",NA,NA,NA,NA
"ca464384716960cc99c84ccf61509c5c","gauss-surgical","seed",NA,"2011-12-31",805000
"ca464384716960cc99c84ccf61509c5c","gauss-surgical","seed",NA,"2013-02-01",1421000
"ca464384716960cc99c84ccf61509c5c","gauss-surgical","seed","1","2013-09-01",3126992
"ca464384716960cc99c84ccf61509c5c","gauss-surgical","seed",NA,"2014-10-30",1499997
"ca464384716960cc99c84ccf61509c5c","gauss-surgical","venture","1","2015-08-26",1.2e+07
"bc48464caf097dbdc6e130abd281158f","gavagai",NA,NA,NA,NA
"f557ec65f1b48657d63848c329524899","gazelle-consulting",NA,NA,NA,NA
"bb527d0f0b57e82ec18c1f104d9d6fd5","uberlabs","seed",NA,"2012-10-01",1e+05
"bb527d0f0b57e82ec18c1f104d9d6fd5","uberlabs","seed",NA,"2012-07-15",40000
"bb527d0f0b57e82ec18c1f104d9d6fd5","uberlabs","venture",NA,"2015-02-16",NA
"db2327b1c5d1379f4ab221664b9015b2","gazzang","private_equity",NA,"2012-01-10",2e+06
"db2327b1c5d1379f4ab221664b9015b2","gazzang","venture","1","2010-12-06",3500000
"db2327b1c5d1379f4ab221664b9015b2","gazzang","venture",NA,"2013-01-03",4060000
"11fadb267902e631a78febee76478936","gbi",NA,NA,NA,NA
"3e57391d866c3297f0818e15af52bd2a","gds-ware",NA,NA,NA,NA
"1966843c3293e58c7b2311d8e27d3a97","ge-healthcare",NA,NA,NA,NA
"2cbbef4a02bdbb534303640bf0751a64","gearylsf-group-inc","venture",NA,"2013-12-17",NA
"1d7fd758a630326929b8e4ffdf1d077f","geave",NA,NA,NA,NA
"d79ab6546cfbb1228b7fdace080a0064","gecko-biomedical","venture","A","2013-12-09",15090198.2303
"d79ab6546cfbb1228b7fdace080a0064","gecko-biomedical","venture","B","2015-01-20",1505971
"c995828822eddcd7c7eecab2831e768a","geckoboard","seed",NA,"2011-01-01",3e+05
"c995828822eddcd7c7eecab2831e768a","geckoboard","seed","1","2012-09-28",1500000
"67a3435ee68881887152050de7a31432","geeco-rootiz",NA,NA,NA,NA
"6e0856b4a7e52d769b8f79c7c467d921","geegain-international",NA,NA,NA,NA
"dffd1fd7e823df9d5ef5b142e5cccde3","geeks-technical-support-llc",NA,NA,NA,NA
"9e8108dfe6bfeb8e7d4a1afcfdd38397","geeyee","venture",NA,"2010-04-19",102500
"3721d90009ff710cb2d06159eb2b1b56","gehtsoft-usa-llc",NA,NA,NA,NA
"39e65ccaa9f653bb341398134b158273","gel-del-technologies",NA,NA,NA,NA
"7d01d49b38deb6ddafdaa0418b6c4f15","gelco-information-network",NA,NA,NA,NA
"edca8905ee37b1fc9ff0bcfbab49408e","gelesis","private_equity",NA,"2015-12-18",31500000
"edca8905ee37b1fc9ff0bcfbab49408e","gelesis","venture",NA,"2011-05-12",3600000
"edca8905ee37b1fc9ff0bcfbab49408e","gelesis","venture","1","2008-01-03",1.6e+07
"edca8905ee37b1fc9ff0bcfbab49408e","gelesis","venture",NA,"2011-06-10",2600000
"edca8905ee37b1fc9ff0bcfbab49408e","gelesis","venture","1","2014-05-16",1.2e+07
"edca8905ee37b1fc9ff0bcfbab49408e","gelesis","private_equity",NA,"2015-03-26",2.2e+07
"3024c95695261a3725543d854def3f38","gelo",NA,NA,NA,NA
"a04a006429d98fccbd5ae1b2e6d6fd57","gelzen","venture",NA,"2015-09-04",NA
"73e806b3d7b298d43a82331c15b6a3a3","gem-pharmaceuticals","venture",NA,"2014-03-19",4500000
"5ee34d76c6c75d8547db66cf04025198","gema","venture",NA,"2013-03-27",2665127
"875fdf2eb82b8b934a38ff59d85cf8d4","gemin-x-pharmaceuticals","debt_financing",NA,"2009-06-11",9259078
"875fdf2eb82b8b934a38ff59d85cf8d4","gemin-x-pharmaceuticals","venture","1","2008-07-03",3.8e+07
"875fdf2eb82b8b934a38ff59d85cf8d4","gemin-x-pharmaceuticals","venture","1","2010-04-20",1.6e+07
"875fdf2eb82b8b934a38ff59d85cf8d4","gemin-x-pharmaceuticals","venture","1","2010-08-24",8e+06
"60456563607a55f4c441104e71adcfca","gemmus-pharma","venture","a","2012-06-28",1800000
"60456563607a55f4c441104e71adcfca","gemmus-pharma","venture","B","2014-05-13",3300000
"81ed7ad6bbfe10584557fc6026612a0d","gemphire-therapeutics","debt_financing",NA,"2015-12-22",5451000
"b4eee7ac7e55fcaaf9084d69e08ef8d7","gemstone-biotherapeutics","seed",NA,"2015-06-15",2450000
"343ad6ebcf8102a054ea8a339fe6fec1","gemzies",NA,NA,NA,NA
"137fee38f362a63fa3601670c2ec90fe","gen-probe",NA,NA,NA,NA
"af29c068328e2156070581579ca843c4","gen9","debt_financing",NA,"2012-05-22",395000
"af29c068328e2156070581579ca843c4","gen9","seed",NA,"2011-02-11",1700000
"af29c068328e2156070581579ca843c4","gen9","venture",NA,"2009-06-15",5e+05
"af29c068328e2156070581579ca843c4","gen9","private_equity",NA,"2013-04-24",2.1e+07
"af29c068328e2156070581579ca843c4","gen9","seed",NA,"2011-09-09",1500000
"af29c068328e2156070581579ca843c4","gen9","private_equity",NA,"2014-07-30",2.5e+07
"5474b9eb97c0bb2a5f913089278447b9","genable-technologies-ltd","venture","b","2009-11-10",7483000
"023dbfda5b284329d06337e6c3f29ffc","genaissance-pharmaceuticals",NA,NA,NA,NA
"bfc5fa83c38f71554bcc69caf8d510ef","genalyte","venture","b","2012-03-30",11800000
"bfc5fa83c38f71554bcc69caf8d510ef","genalyte","venture","C","2015-08-18",4.4e+07
"c01eab71fc653ec8a9f7c238a8c0c20e","genapsys","venture","b","2013-11-14",3.7e+07
"c01eab71fc653ec8a9f7c238a8c0c20e","genapsys","venture","a","2013-03-22",8500000
"c01eab71fc653ec8a9f7c238a8c0c20e","genapsys","convertible_note",NA,"2012-05-18",NA
"4aa66eb688f7337649d028c4d711e009","gencell-biosystems","seed",NA,"2014-01-27",3473820
"ecdd757e3923337277c4b577104f3409","gencia","venture",NA,"2010-06-24",3750000
"ecdd757e3923337277c4b577104f3409","gencia","venture","1","2012-02-01",3e+05
"ecdd757e3923337277c4b577104f3409","gencia","venture","1","2013-07-16",680000
"ecdd757e3923337277c4b577104f3409","gencia","venture","1","2012-08-21",1e+06
"b8d2a23b023fe12a124dd025f0dbd797","gencrunch-stpl",NA,NA,NA,NA
"fb5f1be8eb816e34ed50ae1b0fea5328","gendel","venture",NA,"2005-05-25",366000
"fb5f1be8eb816e34ed50ae1b0fea5328","gendel","venture",NA,"2002-01-01",2896631
"e77be67bbbf939fe9d3f5dcde958462b","genderize-io",NA,NA,NA,NA
"4d80c688af2e9655bfd1f234e7a6787e","gene-guru",NA,NA,NA,NA
"694ac18ce72663e7a3ed0dc3b1e80383","gene-oracle-inc",NA,NA,NA,NA
"0f048f03a59c26f11a543baad4efb1ec","gene-solutions","venture",NA,"2015-10-02",639800
"0f048f03a59c26f11a543baad4efb1ec","gene-solutions","private_equity",NA,"2013-02-25",7000
"150a4addecd65d5e78678962a34d6606","geneassess","venture",NA,"2012-07-02",5e+05
"9d33349e3fb4eaa9c42d72f44d334d82","genecapture","venture",NA,"2014-05-30",142000
"c97765a20c76643c86787f2bc9f5f061","genecentric-diagnostics","seed",NA,"2012-01-20",NA
"c97765a20c76643c86787f2bc9f5f061","genecentric-diagnostics","venture","1","2014-07-23",5e+06
"c97765a20c76643c86787f2bc9f5f061","genecentric-diagnostics","venture","1","2015-01-14",2e+07
"a94af202f88115d16c6c1d71d48e3296","genecentrix-inc","grant",NA,"2015-01-09",685300
"6a9ef226c7e63ff7ef6079074b34f2b2","genecord",NA,NA,NA,NA
"92f4bec753e1f4998c0e99797eddd4ec","genecure","venture",NA,"2014-02-21",2e+06
"542f9346c862d84bb961e5197c3a0107","geneexcel","venture","a","2005-03-15",7e+05
"046cf61c2bde1343ecd96d0df6a917da","genegrafts",NA,NA,NA,NA
"d94fe2563ad7d01fbc79a73db31e9d66","geneius","debt_financing",NA,"2015-06-15",3062984
"f90aac644d7655526064fec1d9fb7355","genelabs-technologies","venture",NA,"2007-06-30",9e+06
"f90aac644d7655526064fec1d9fb7355","genelabs-technologies","venture",NA,"2006-06-27",8300000
"07cc77f8b918ca2cc7a882edf9ad4190","genelink","venture",NA,"2011-01-11",465000
"07cc77f8b918ca2cc7a882edf9ad4190","genelink","venture",NA,"2010-02-18",150000
"07cc77f8b918ca2cc7a882edf9ad4190","genelink","venture",NA,"2009-06-12",42500
"07cc77f8b918ca2cc7a882edf9ad4190","genelink","venture",NA,"2012-07-19",215000
"07cc77f8b918ca2cc7a882edf9ad4190","genelink","venture",NA,"2009-11-12",260500
"19d9e57c34b28f2ce5007e26a0f773a3","genelogic",NA,NA,NA,NA
"e404cc7d0feda76f185743e23b438f4b","genelux","venture",NA,"2012-06-06",481268
"f745122c0b782dcf22393fcbbacb829d","genencor-international",NA,NA,NA,NA
"6bdf79209e73a3c823124896bc2a716d","genenews","venture",NA,"2009-12-31",100808
"6bdf79209e73a3c823124896bc2a716d","genenews","debt_financing",NA,"2010-11-30",1354526
"6bdf79209e73a3c823124896bc2a716d","genenews","venture",NA,"2011-06-23",5273385
"6bdf79209e73a3c823124896bc2a716d","genenews","venture",NA,"2007-07-09",172080
"6bdf79209e73a3c823124896bc2a716d","genenews","venture",NA,"2012-12-28",6303211
"6bdf79209e73a3c823124896bc2a716d","genenews","post_ipo_equity",NA,"2014-07-22",6700000
"9fefc106afd32efd674657f3f11d8969","genenta-science","venture","A","2015-01-23",7200000
"9fefc106afd32efd674657f3f11d8969","genenta-science","venture","A","2015-03-05",3800000
"c753860fab3d816a2dc59b26c6b9725b","genentech",NA,NA,NA,NA
"c915d49e1e4723060e6e39031809881b","geneohm-sciences",NA,NA,NA,NA
"84f4e2dd98b77c43675bacff473ee634","genepartner",NA,NA,NA,NA
"30eca85e60a9d451764eb79cab9239a8","genepeeks","debt_financing",NA,"2014-06-30",3e+06
"30eca85e60a9d451764eb79cab9239a8","genepeeks","seed",NA,"2012-10-17",5250000
"25aae963e9a7609e8b082dd2892624a6","geneprot-switzerland-",NA,NA,NA,NA
"4e5429bf33d1be5ae0bc39a17e931ec5","general-genomics",NA,NA,NA,NA
"f75c6f1da21a3b4748ceebc4d06a0a8b","generation-health",NA,NA,NA,NA
"1e35fd96f8756076250599c4c48af433","generation-mobile",NA,NA,NA,NA
"60ec29c84233d69e9645da8c1a4168ca","generationone","venture",NA,"2010-11-18",537710
"dec6ca227275a1278d2b78d0ca28ce4a","generator-research",NA,NA,NA,NA
"9892bd1269e6cade29f73f2c78363f82","generex-biotechnology","debt_financing",NA,"2012-01-25",3600000
"9892bd1269e6cade29f73f2c78363f82","generex-biotechnology","venture",NA,"2012-02-01",2e+06
"9892bd1269e6cade29f73f2c78363f82","generex-biotechnology","venture",NA,"2011-01-25",3e+06
"9892bd1269e6cade29f73f2c78363f82","generex-biotechnology","venture",NA,"2012-08-10",750000
"8f59e820ad41abb8cc51b0b2af5a9cb9","generic-imaging",NA,NA,NA,NA
"331fb68c395768c99610b34539027c30","generico","seed",NA,"2014-01-20",NA
"331fb68c395768c99610b34539027c30","generico","debt_financing",NA,"2013-05-15",435000
"331fb68c395768c99610b34539027c30","generico","venture",NA,"2015-07-28",3759532
"2df6547c8cd049d8e68c2a63e0aaae8a","genesis-biopharma","venture",NA,"2010-09-17",5e+05
"2df6547c8cd049d8e68c2a63e0aaae8a","genesis-biopharma","venture",NA,"2011-01-21",640000
"2df6547c8cd049d8e68c2a63e0aaae8a","genesis-biopharma","debt_financing",NA,"2011-08-09",5e+06
"2df6547c8cd049d8e68c2a63e0aaae8a","genesis-biopharma","venture",NA,"2010-11-08",250000
"2df6547c8cd049d8e68c2a63e0aaae8a","genesis-biopharma","venture",NA,"2013-06-06",1350000
"93d64971be37f9f3c939bf8e5013eb6d","genesis-dna","venture",NA,"2015-09-10",NA
"286586430b5406c862302a9b7745fcb0","genesoft-inc",NA,NA,NA,NA
"1fd6fc3e7f328a912ea6b2bbbd1829da","genesoft-pharmaceuticals",NA,NA,NA,NA
"f9ac757a292ba2bc34072b0b74a9f2b7","genesys","venture",NA,"2012-01-01",NA
"c96e823818cdd575b16adcbea64cf0d8","genetex","private_equity",NA,"2012-03-15",4300000
"93356a8bf3f16d7981439358e127f1a3","genetic-ink",NA,NA,NA,NA
"14b6fa200b6b3dd1d516d96c1030dd86","genetic-microsystems",NA,NA,NA,NA
"172a73f81c43bb4d80a7d88e8fc8e869","genetic-system",NA,NA,NA,NA
"d9eecc81ee88646c4173c2d17499f18a","genetic-technologies-2","debt_financing",NA,"2013-08-28",8e+05
"d9eecc81ee88646c4173c2d17499f18a","genetic-technologies-2","post_ipo_equity",NA,"2015-01-21",19574046
"748f8873036389a7480dffa778e4afa5","genetic-technologies-inc","private_equity",NA,"2013-08-27",NA
"de32ca29ca4f42c9bf49a0b5fab142e6","genetic-therapy",NA,NA,NA,NA
"12b929a80f73a7561a15bc23fa85ea91","geneticme",NA,NA,NA,NA
"b6727e78b2bf2b799ba843f06dc744ed","genetics-institute",NA,NA,NA,NA
"a53de1e8183d6993b5d882e0dccb0d76","genetics-policy-institute",NA,NA,NA,NA
"58e94d40ba837322ed39cadbbac8066d","genetix-fusion","grant",NA,"2013-05-14",50000
"05ad38317e9b120d8c22ff431d9ee197","geneva-biotech",NA,NA,NA,NA
"a68112b8deb4c7b47a578215f1e22ee5","genevolve-vision-diagnostics","debt_financing",NA,"2010-05-03",49000
"7b4b1fc9b0068e73b576a23b5eba64f8","geneweave-biosciences","venture","a","2012-02-28",1.2e+07
"7b4b1fc9b0068e73b576a23b5eba64f8","geneweave-biosciences","seed",NA,"2010-07-26",1e+06
"7b4b1fc9b0068e73b576a23b5eba64f8","geneweave-biosciences","venture","B","2014-06-20",11999998
"faa34efafe45db73356c540a84b3fe04","genewiz","venture",NA,"2015-01-11",NA
"41b99aad269556b7a5f7a228149580f5","genextra",NA,NA,NA,NA
"6f1286b6f74a691183ba8362aded672a","genfit",NA,NA,NA,NA
"cfd3e94f1bf4e543eda86f7b51baa1c2","genia-photonics","venture",NA,"2011-09-01",NA
"c1286cfcd1fb2c26740107f183738e58","genia-technologies","debt_financing",NA,"2013-05-29",10438672
"6cde49740d5fff3f4dbe61ee4bfa0800","genisphere-inc","venture",NA,"2015-10-01",4e+06
"6cde49740d5fff3f4dbe61ee4bfa0800","genisphere-inc","venture",NA,"2014-09-16",2e+06
"0de5676975966574bc4aced5561346a6","genisyss",NA,NA,NA,NA
"3b7db54557ca380e00ce4454657c8c1d","genitope",NA,NA,NA,NA
"22034eb9387ec9a4fb6f2838fe3d1987","genius-com","venture",NA,"2015-11-04",NA
"22034eb9387ec9a4fb6f2838fe3d1987","genius-com","venture","1","2014-07-11",4e+07
"22034eb9387ec9a4fb6f2838fe3d1987","genius-com","venture","1","2012-10-03",1.5e+07
"22034eb9387ec9a4fb6f2838fe3d1987","genius-com","convertible_note",NA,"2011-09-11",1900000
"b15812df65705174123b76fd7ed276de","geniusly",NA,NA,NA,NA
"9623d558d54fa85664863f7be12499c7","genizon-biosciences","venture","d","2007-02-05",8441091
"9623d558d54fa85664863f7be12499c7","genizon-biosciences","venture",NA,"2006-03-29",1.2e+07
"9623d558d54fa85664863f7be12499c7","genizon-biosciences","venture","e","2008-01-01",30810000
"0f81ccf79b9cc3c3be847bf69cfecfe2","genkyotex","venture","c","2011-05-24",20400000
"0f81ccf79b9cc3c3be847bf69cfecfe2","genkyotex","venture",NA,"2008-05-06",3820000
"0f81ccf79b9cc3c3be847bf69cfecfe2","genkyotex","venture","c","2012-07-09",2.6e+07
"0f81ccf79b9cc3c3be847bf69cfecfe2","genkyotex","venture",NA,"2006-01-30",1550000
"0f81ccf79b9cc3c3be847bf69cfecfe2","genkyotex","venture","D","2015-01-07",2.1e+07
"481f042c996b3da7ef4c96e686fbae80","genmab","venture",NA,"2009-10-01",2.3e+07
"481f042c996b3da7ef4c96e686fbae80","genmab","venture",NA,"2010-07-01",1.34e+08
"f2eb3e254a51eed901b7c408c423b9f9","genmedica-therapeutics","venture",NA,"2012-09-26",15414000
"f2eb3e254a51eed901b7c408c423b9f9","genmedica-therapeutics","venture",NA,"2011-10-01",4050900
"cc1ee26c1213eebf0c8d39a4ac495dbb","genmont",NA,NA,NA,NA
"e309311a40756ca4ae9e8718e5d88843","gennius","debt_financing",NA,"2011-12-19",250000
"a9698c248c91cb915069fee348592041","geno","venture",NA,"2009-09-14",2136030
"a9698c248c91cb915069fee348592041","geno","venture",NA,"2011-12-30",7990819
"a9698c248c91cb915069fee348592041","geno","private_equity",NA,"2013-10-03",14570606
"72099240d739ef29297b7a5e8077b7d8","genoa-pharmaceuticals","venture",NA,"2015-08-13",2179480
"c9edd690849ac4d6cdd489edcfdb3f0d","genocea-biosciences","venture","c","2012-10-10",3e+07
"c9edd690849ac4d6cdd489edcfdb3f0d","genocea-biosciences","venture","b","2011-01-03",3.5e+07
"c9edd690849ac4d6cdd489edcfdb3f0d","genocea-biosciences","venture","E","2013-10-15",16085917
"c9edd690849ac4d6cdd489edcfdb3f0d","genocea-biosciences","grant",NA,"2014-09-23",1200000
"c9edd690849ac4d6cdd489edcfdb3f0d","genocea-biosciences","post_ipo_debt",NA,"2014-11-21",2.7e+07
"c9edd690849ac4d6cdd489edcfdb3f0d","genocea-biosciences","venture","B","2009-12-01",25517734
"c9edd690849ac4d6cdd489edcfdb3f0d","genocea-biosciences","venture","C","2010-12-01",20021810
"c9edd690849ac4d6cdd489edcfdb3f0d","genocea-biosciences","post_ipo_equity",NA,"2015-03-17",51700000
"3e4e68222461fc08edb83776f608b1c4","genologics","venture","A","2005-02-03",5e+06
"3e4e68222461fc08edb83776f608b1c4","genologics","venture","c","2009-02-25",5e+06
"3e4e68222461fc08edb83776f608b1c4","genologics","venture","d","2012-02-10",8e+06
"3e4e68222461fc08edb83776f608b1c4","genologics","venture","b","2006-10-31",NA
"3e4e68222461fc08edb83776f608b1c4","genologics","venture",NA,"2010-05-20",1e+06
"3e4e68222461fc08edb83776f608b1c4","genologics","venture",NA,"2009-04-27",1220899
"3e4e68222461fc08edb83776f608b1c4","genologics","debt_financing",NA,"2013-06-05",1767101
"afffde3f2e3329a2d4a1f3305ca51a4a","genomas-2","venture","C","2007-10-19",2500000
"afffde3f2e3329a2d4a1f3305ca51a4a","genomas-2","debt_financing",NA,"2009-04-09",5e+05
"94167ac4ea492b86cf41a980f95a0495","genome","venture",NA,"2007-09-26",250000
"99e30d93fb93cc8994ce83a4d1a70b25","genome-compiler","seed",NA,"2013-10-21",NA
"99e30d93fb93cc8994ce83a4d1a70b25","genome-compiler","venture","1","2015-06-01",5750000
"d396fb28fe74a825a412490f23800638","genome-technology-access-center",NA,NA,NA,NA
"5d026dd6bac587a9a9ab1067e8f9e5e4","genome-therapeutics-corporation",NA,NA,NA,NA
"c69df836b51481201ecf8998cfeacc9b","genomed","venture",NA,"2008-06-03",389000
"3cba75632b7eef2fd918ca8e6a7a94f1","genomedx-biosciences","venture","a","2012-01-09",NA
"3cba75632b7eef2fd918ca8e6a7a94f1","genomedx-biosciences","venture","b","2013-09-30",NA
"3cba75632b7eef2fd918ca8e6a7a94f1","genomedx-biosciences","debt_financing",NA,"2015-09-28",NA
"2d56108a3d1be0ecab91640f6427b85e","genometry","venture","a","2012-09-21",3e+06
"7e28348bebb52cc618c82239730c659a","genomic-expression","convertible_note",NA,"2014-06-25",2e+05
"c55dccd0c3c31c1610473fdfee4c7aee","genomic-solutions-inc",NA,NA,NA,NA
"c25a6ef99128fffe5a73a5ba9e87fcc1","genomic-vision","venture","B","2008-07-25",6274903.5234
"c25a6ef99128fffe5a73a5ba9e87fcc1","genomic-vision","venture","a","2005-12-19",2400000
"e69b269e60eba95470ef5e885ed0980b","genomics","venture",NA,"2014-11-26",16200000
"d3b59100e33bbf09910726be66091bcc","genomics-collaborative-inc",NA,NA,NA,NA
"b364fa75e76bd098db60acaf3b003d7d","genomics-usa","debt_financing",NA,"2013-06-11",837405
"4d05bf72e32aab525a1cbf5fd97b7d3f","genomind","venture","a","2014-04-09",5e+06
"4d05bf72e32aab525a1cbf5fd97b7d3f","genomind","venture","B","2015-09-22",6e+06
"97a719ac70af1ea4ae47e8c93854462b","genomoncology","venture",NA,"2012-06-05",250000
"97a719ac70af1ea4ae47e8c93854462b","genomoncology","undisclosed",NA,"2014-02-05",NA
"97a719ac70af1ea4ae47e8c93854462b","genomoncology","venture",NA,"2012-05-09",1250000
"21a236f1a5854735f27796b0eda9ab3a","genotype-diagnostics","seed",NA,"2011-01-01",NA
"b2dd09d54ebf8f6be129a79ca6c4bfcc","genotyping","venture","A","2015-09-03",1076192.6457
"079ffa4090e7e12a55d24d92c04bd70e","genpharm-international",NA,NA,NA,NA
"044a1f3edfec49feef465c3426634eb3","genprex","venture",NA,"2013-12-26",5e+05
"044a1f3edfec49feef465c3426634eb3","genprex","venture",NA,"2013-12-30",1500000
"044a1f3edfec49feef465c3426634eb3","genprex","venture",NA,"2015-03-04",160000
"1eb455a9cb323f775cc0d4b53b4e420f","genprime","venture",NA,"2013-01-10",160000
"979cf36e95d7fbd7a023785557f7912d","genqual-corporation","venture",NA,"2011-11-21",122000
"84786ff3bc2f5313d02ae9b01af04541","genscript",NA,NA,NA,NA
"89b8c9fb40b863627ecac366b25c84ba","genscript-technology","venture",NA,"2009-05-01",1.5e+07
"0feaf3e735d7deb28eded02e3b102942","genset",NA,NA,NA,NA
"1f3a8bd9916ba59a59d4b967d3c42383","gensia-inc",NA,NA,NA,NA
"63f8ce35767904f9097f7dfcb3dac713","gensight-biologics","venture","a","2013-04-08",41673600
"63f8ce35767904f9097f7dfcb3dac713","gensight-biologics","venture","B","2015-07-23",3.6e+07
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2009-09-18",240000
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2010-06-21",2695000
"924965f1441028962930323dc0132a39","genspera","private_equity",NA,"2013-08-19",5e+06
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2011-03-14",4145578
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2013-04-05",1869000
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2009-06-29",3038000
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2011-05-25",2249750
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2014-06-30",773000
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2014-12-09",280000
"924965f1441028962930323dc0132a39","genspera","venture",NA,"2015-07-27",2513894
"d5cb7e008b91f221e13c1fc5cdba948d","genstruct",NA,NA,NA,NA
"8646aeeedf4038a0ef3884a7e81a78d8","genta",NA,NA,NA,NA
"8219e629ce95338d36c331ca25fb83f3","gentegra-s",NA,NA,NA,NA
"a1e421377d9cdafe93037176ed4e335f","gentek",NA,NA,NA,NA
"8b6da606c8e2189a05739c5d43c2f6b3","genterpret","seed",NA,"2013-09-26",NA
"7b2292bd836a0bf7219c697edddfe802","gentia",NA,NA,NA,NA
"4081c33e50218ecddd558d08b5e7810a","genticel","venture","d","2013-04-24",23670920
"4081c33e50218ecddd558d08b5e7810a","genticel","venture","c","2010-04-05",17700000
"63ab73b2b3763964ee1c12d0fe22160b","gentis","debt_financing",NA,"2010-07-19",548260
"63ab73b2b3763964ee1c12d0fe22160b","gentis","venture","1","2007-06-21",1e+07
"b5d2c81715de55c630ab714896176971","gentium",NA,NA,NA,NA
"455ec353977167387ed07f2a6fff27eb","gentris","private_equity",NA,"2005-04-27",5e+06
"915d2ded78400a8e0c9d4c660308c2db","gentronix","venture",NA,"2007-03-05",1917766
"b775caa51e646e302e4ec9e6d22582f2","genus-oncology","venture","a","2011-05-01",NA
"7c763e7953304d3e006a488791c18dc8","genvault","venture","c","2008-06-09",1.3e+07
"7c763e7953304d3e006a488791c18dc8","genvault","venture",NA,"2007-04-04",1.8e+07
"7c763e7953304d3e006a488791c18dc8","genvault","debt_financing",NA,"2009-11-13",2002000
"7c763e7953304d3e006a488791c18dc8","genvault","debt_financing",NA,"2010-06-16",6801794
"1ce3cf731f8891ff2c847f1295ff1e38","genvec-inc","venture",NA,"2010-01-29",1999999
"b329b51b6f330dcc5863d208cb7bdc34","genzum-life-sciences","venture",NA,"2014-06-20",2e+07
"8b6cbd36dd95fb5ed2af96613809a197","genzyme",NA,NA,NA,NA
"6dfad8c525ac612ed4738cc8e94a1b2d","genzyme-diagnostics",NA,NA,NA,NA
"4325cc1f60947353009b474b3df52738","genzyme-surgical",NA,NA,NA,NA
"abe6807ae9ea1daf9750b2cfa4cdc2ad","geocrop",NA,NA,NA,NA
"73307499e7c44fee8e1e32901b968ef9","geodigm",NA,NA,NA,NA
"2ff43821a8f30d6bb328d95fbfd8aa81","geoedge",NA,NA,NA,NA
"8034fb27c422e872b33717ca91547164","geoeye","private_equity",NA,"2010-09-24",7.8e+07
"91c839590ad0b7bc07d3f4b3c4946518","geofeedia-inc","seed",NA,"2011-07-01",290000
"91c839590ad0b7bc07d3f4b3c4946518","geofeedia-inc","venture","1","2014-10-15",3500000
"91c839590ad0b7bc07d3f4b3c4946518","geofeedia-inc","venture","1","2015-03-05",3e+06
"45aac5aa8d8044b3e9195f11b4a47f44","fortiusone","venture","b","2007-05-01",5450000
"45aac5aa8d8044b3e9195f11b4a47f44","fortiusone","venture","c","2010-08-26",5500000
"45aac5aa8d8044b3e9195f11b4a47f44","fortiusone","venture","a","2005-07-01",550000
"9b8c30b0de38c10df7ed78e14d6b81ea","geonexus",NA,NA,NA,NA
"2f94f518e7530f1ab0b9bfb12e6e6025","officerank",NA,NA,NA,NA
"4bbbfb98e47503c184bc6a33e1617200","geopoll","venture","a","2013-11-06",6600000
"245de3aef38b3142acff17b59aa662eb","georgeson",NA,NA,NA,NA
"6a77ec70c6bb2b1af990d413cb773a02","georgia-state-university-collabtech",NA,NA,NA,NA
"ce6f2a9d56f2f8700c7e211b2fbfcd88","geosenti",NA,NA,NA,NA
"b89781158c1e78305222a4f3adaa5213","geosho","seed",NA,"2011-01-10",388005
"ce9a331de2725d373a1dbf01d3a7ca3f","geostellar","venture",NA,"2015-10-01",1e+06
"ce9a331de2725d373a1dbf01d3a7ca3f","geostellar","convertible_note",NA,"2015-10-01",750000
"ce9a331de2725d373a1dbf01d3a7ca3f","geostellar","venture","1","2012-06-05",1.4e+07
"ce9a331de2725d373a1dbf01d3a7ca3f","geostellar","venture","1","2011-04-05",1500000
"ce9a331de2725d373a1dbf01d3a7ca3f","geostellar","angel",NA,"2015-04-30",2800000
"8ceaf09a2a6b1215c095c57131f31fec","geosurf",NA,NA,NA,NA
"83a13a375ee0d930378984cd1cbe17fd","geotech-consulting-llc",NA,NA,NA,NA
"d195b2e11cc602042d085ae511700917","geovax","venture","b","2013-12-19",1650000
"d195b2e11cc602042d085ae511700917","geovax","venture",NA,"2009-09-30",1500000
"d195b2e11cc602042d085ae511700917","geovax","venture",NA,"2012-01-13",441210
"d195b2e11cc602042d085ae511700917","geovax","venture",NA,"2012-04-02",2200000
"d195b2e11cc602042d085ae511700917","geovax","post_ipo_equity",NA,"2015-02-25",6e+06
"d70e08e24d20a5b2f70216b0520201b6","geppetto-labs",NA,NA,NA,NA
"9d5603f53fa45de495ac1fc71cefee0e","germin8","angel",NA,"2013-01-01",2400000
"9d5603f53fa45de495ac1fc71cefee0e","germin8","venture","1","2014-03-27",3e+06
"aafc08b9ce0f0849745e99eb5e51dbc8","geron-corp","post_ipo_equity",NA,"2014-02-04",96700000
"4840618f41369474ebb2fc28a872be32","get-in","angel",NA,"2008-12-01",NA
"4840618f41369474ebb2fc28a872be32","get-in","angel",NA,"2009-08-01",NA
"70ac50c83a809de4c2a91827c80aa223","get-the-hound",NA,NA,NA,NA
"7974e0bbd414b97829253b4c820e5238","get-way",NA,NA,NA,NA
"73e9e6fd3ab9072a6b68cf8c7a5512fc","getbulb","seed",NA,"2012-02-26",20155
"73e9e6fd3ab9072a6b68cf8c7a5512fc","getbulb","debt_financing",NA,"2012-09-01",63055
"9bcd6852361d7d7b235a9c233c2f3e9d","get-fixr",NA,NA,NA,NA
"c74943128979d98e7b3e6ea87a484153","getfugu","venture",NA,"2009-12-29",8e+05
"f2ad11f9e64b204975adb268cc174db8","gethoneybadger",NA,NA,NA,NA
"8349011a1c4268c27f1583688baadb98","getseated",NA,NA,NA,NA
"0594c055e5a4e54eae2fda4883100100","getsmily","seed",NA,"2014-11-13",622668
"6b2f56a036a96398c3d54819b05546e8","getsnippy","angel",NA,"2013-01-01",80000
"4a65edf8a4eb753a9b14913f1fb94ca1","getter","seed",NA,"2014-11-25",50000
"97a1635a48465b803d71fe5b105508e2","getwell",NA,NA,NA,NA
"feb0d7396515656374cb690c1b7cbbff","gfr-pharmaceuticals",NA,NA,NA,NA
"8a6e5ffeefe001f5cb3813cef2fb1b88","gfta-analytics-gmbh",NA,NA,NA,NA
"6edafcc0ed0c5c5e7852e7aa4fd62afa","ghostery","private_equity",NA,"2010-11-22",9500000
"6edafcc0ed0c5c5e7852e7aa4fd62afa","ghostery","venture",NA,"2010-11-22",9500000
"6edafcc0ed0c5c5e7852e7aa4fd62afa","ghostery","seed",NA,"2009-01-01",NA
"08bc262f410b4e10b1ae7018646cf2f6","gi-dynamics","venture",NA,"2010-01-07",1.5e+07
"08bc262f410b4e10b1ae7018646cf2f6","gi-dynamics","private_equity",NA,"2011-09-15",37504548
"08bc262f410b4e10b1ae7018646cf2f6","gi-dynamics","private_equity",NA,"2013-07-03",57500000
"08bc262f410b4e10b1ae7018646cf2f6","gi-dynamics","post_ipo_equity",NA,"2014-05-06",34300000
"217c063c708ba9b6896853a81cb49de9","gi-track","venture",NA,"2012-09-14",15000
"49b30a1dd5a1d6fe22d4866dadc27bbe","giant-robots-of-destruction",NA,NA,NA,NA
"d346ab57d8f4d29d165a259ca414988f","gicare-pharma","venture","a","2011-07-21",7403435
"638908fdd08038b1f440250dc7fbf1d7","gid-group","venture",NA,"2010-05-20",2499936
"638908fdd08038b1f440250dc7fbf1d7","gid-group","debt_financing",NA,"2014-01-10",2162622
"638908fdd08038b1f440250dc7fbf1d7","gid-group","venture",NA,"2011-12-01",2664272
"6fdafb6a85e30a4a07d09ba9c6575adf","gidoc-integral",NA,NA,NA,NA
"cfda160196be5243d19339257beff129","giftk-derradar",NA,NA,NA,NA
"85356c5db15b9c57e52adf018f13e9fa","giftri-com",NA,NA,NA,NA
"0a3efdd93048261e9b2b1039879d2861","giftyone",NA,NA,NA,NA
"eccbb9d27ee846b3f1d26e0fd7d80907","giga-group",NA,NA,NA,NA
"a6f9f3301fa95fa714a8c8aa92b1efae","gigagen","seed",NA,"2011-12-31",NA
"a6f9f3301fa95fa714a8c8aa92b1efae","gigagen","convertible_note",NA,"2013-10-15",NA
"a6f9f3301fa95fa714a8c8aa92b1efae","gigagen","grant",NA,"2014-07-13",950000
"a6f9f3301fa95fa714a8c8aa92b1efae","gigagen","grant",NA,"2013-09-15",1150000
"a6f9f3301fa95fa714a8c8aa92b1efae","gigagen","grant",NA,"2014-09-06",225000
"a6f9f3301fa95fa714a8c8aa92b1efae","gigagen","grant",NA,"2014-07-09",225000
"a6f9f3301fa95fa714a8c8aa92b1efae","gigagen","grant",NA,"2015-03-05",225000
"a6f9f3301fa95fa714a8c8aa92b1efae","gigagen","grant",NA,"2015-03-23",225000
"9375028715554a6979935b9d67f0a67d","gigawatt","seed",NA,"2014-06-01",40000
"21a352d6a1fbba49bb91aab6df385ce8","gigdog",NA,NA,NA,NA
"46e8888f988012cf8d47a8f6b0d80204","gilead-sciences",NA,NA,NA,NA
"3356b9e8412bbd868edeb2646453f20d","gilon-business-insight","private_equity",NA,"2006-01-01",NA
"d1821caa4c7021a4e559b8e224fd5159","gimme",NA,NA,NA,NA
"b4e8a1a169e46f3c27d569801ae22159","gimmie","seed",NA,"2013-01-11",520000
"b4e8a1a169e46f3c27d569801ae22159","gimmie","venture",NA,"2014-01-13",5e+05
"b4e8a1a169e46f3c27d569801ae22159","gimmie","convertible_note",NA,"2011-08-01",NA
"b4e8a1a169e46f3c27d569801ae22159","gimmie","venture",NA,"2014-11-28",7e+05
"4af79b2069278e0d20907dd157bc36c5","ginger-beard-productions",NA,NA,NA,NA
"80ae667747e50624158d5742efe749ec","ginger-io","seed",NA,"2011-05-01",NA
"80ae667747e50624158d5742efe749ec","ginger-io","venture","1","2012-11-28",6500000
"80ae667747e50624158d5742efe749ec","ginger-io","seed",NA,"2011-03-01",NA
"80ae667747e50624158d5742efe749ec","ginger-io","seed",NA,"2011-10-01",1700000
"80ae667747e50624158d5742efe749ec","ginger-io","venture","1","2014-12-23",2e+07
"6fcf06f8a7907cd9f049748947997160","gingerbrain",NA,NA,NA,NA
"0e731e909a510bb593f2df90b2641620","gingerd","venture","a","2011-10-10",1700000
"0972c0c92b14cce36fb44866d8a13772","gini","grant",NA,"2011-03-01",130000
"0972c0c92b14cce36fb44866d8a13772","gini","angel",NA,"2011-10-15",70000
"0972c0c92b14cce36fb44866d8a13772","gini","angel",NA,"2011-12-01",130000
"0972c0c92b14cce36fb44866d8a13772","gini","seed",NA,"2012-10-22",1500000
"0972c0c92b14cce36fb44866d8a13772","gini","venture","1","2014-12-19",NA
"07a5b5ffa151f341c4cd084b7bfa3abe","ginkgo-bioworks","seed",NA,"2014-07-16",120000
"07a5b5ffa151f341c4cd084b7bfa3abe","ginkgo-bioworks","venture","1","2015-03-18",9e+06
"07a5b5ffa151f341c4cd084b7bfa3abe","ginkgo-bioworks","venture","1","2015-07-23",4.5e+07
"1cf4489e04756b204a5cb9753aa20372","ginzametrics","seed",NA,"2011-10-01",1300000
"1cf4489e04756b204a5cb9753aa20372","ginzametrics","seed",NA,"2010-05-01",14000
"1cf4489e04756b204a5cb9753aa20372","ginzametrics","undisclosed",NA,"2013-12-17",NA
"1cf4489e04756b204a5cb9753aa20372","ginzametrics","seed",NA,"2011-01-31",4e+05
"1cf4489e04756b204a5cb9753aa20372","ginzametrics","convertible_note",NA,"2014-04-27",NA
"3b5601e2ce22d6bec6729d672ce3ee6d","gitbadger",NA,NA,NA,NA
"1806dffbedc1ec129cb027e635e43d57","giteso",NA,NA,NA,NA
"14f0b479167286aa0a2be31221114e2c","gitprime","seed",NA,"2015-04-15",8e+05
"9722eb8a6b1cef012948cdf5a2146234","gitr","venture","a","2012-01-04",1250000
"9722eb8a6b1cef012948cdf5a2146234","gitr","venture",NA,"2012-06-12",1e+06
"9722eb8a6b1cef012948cdf5a2146234","gitr","venture",NA,"2015-05-08",1500000
"4e6b74f39a301d458e6e886418df6566","giusto",NA,NA,NA,NA
"f4a6f4f970ec1dd9d112e30179cdeeb5","givella-llc","seed",NA,"2015-04-01",250000
"e5b30a3023bd5360af4a804b8efb1c40","givemedia",NA,NA,NA,NA
"82902d97d3a1860e074874af9be937ce","givevision",NA,NA,NA,NA
"60c533fdb7deecd74dd8c4d02e769d11","givex",NA,NA,NA,NA
"9ff2f7fab73b19d8730e7dfcd0d57644","gladius-pharmaceuticals","venture","A","2015-06-23",3336438
"7c8837afec2f270bfa32e36fd6f4ac69","gladstone-institutes",NA,NA,NA,NA
"123c91c66523c66ee3a77195909931cd","gland-pharma","private_equity",NA,"2013-11-28",2e+08
"0bba26a4d14ddfcd33bac65a0bcfea94","glassesoff","post_ipo_equity",NA,"2013-08-06",3100000
"0bba26a4d14ddfcd33bac65a0bcfea94","glassesoff","post_ipo_equity",NA,"2014-05-19",5e+06
"0bba26a4d14ddfcd33bac65a0bcfea94","glassesoff","post_ipo_equity",NA,"2014-07-03",1.5e+07
"a07ec9335483dcabbef9accaeca2972d","glassify","seed",NA,"2015-11-01",180000
"a07ec9335483dcabbef9accaeca2972d","glassify","seed",NA,"2015-07-14",70000
"917c07b35359a69f40d73e5414a3835a","glaucopharm",NA,NA,NA,NA
"453e3007fefbd6ecd260fcf61a6e094c","glaxo-group",NA,NA,NA,NA
"f3423b1a0c4905613a2ed80c9bcf0236","gleam","seed",NA,"2013-07-11",1218226
"9a66b9681e3144d3381725faa419adaf","gleanster-research","angel",NA,"2011-01-01",NA
"1e0b31c3e85133cdf22b027567014bff","glen-biotech",NA,NA,NA,NA
"f714c20c62f0472183274d577b7c63ed","glencoe-software","seed",NA,"2015-02-16",8e+05
"4aee508a86be75a2e0fafe98b0249f7f","glenmark",NA,NA,NA,NA
"b18ec3c25010f9c0f92a030bc559d4b6","glenrose-instruments","venture","b","2008-08-08",14880000
"3981d56aa613a43a54e4cfa85a38ec5a","gliacure","venture","A","2012-04-25",2750000
"3981d56aa613a43a54e4cfa85a38ec5a","gliacure","venture","B","2014-08-04",5800000
"3981d56aa613a43a54e4cfa85a38ec5a","gliacure","grant",NA,"2015-03-17",1e+06
"a340e8c71ca331c56544d9842b0bc792","glide-pharma","venture","d","2010-03-17",4300000
"a340e8c71ca331c56544d9842b0bc792","glide-pharma","private_equity",NA,"2013-02-27",21220762
"a340e8c71ca331c56544d9842b0bc792","glide-pharma","venture",NA,"2007-08-13",4640839.3866
"0f172124e9b7624e7303fe065dd3e204","glider","venture",NA,"2012-07-01",350000
"0f172124e9b7624e7303fe065dd3e204","glider","seed",NA,"2012-08-01",NA
"0f172124e9b7624e7303fe065dd3e204","glider","seed",NA,"2013-04-09",1e+06
"0f172124e9b7624e7303fe065dd3e204","glider","seed",NA,"2012-03-07",NA
"241c9024383e35101fce841aee6a1f8c","gliknik","venture","b","2012-10-08",4900000
"241c9024383e35101fce841aee6a1f8c","gliknik","venture",NA,"2011-01-06",3500000
"241c9024383e35101fce841aee6a1f8c","gliknik","venture",NA,"2013-04-26",9825014
"241c9024383e35101fce841aee6a1f8c","gliknik","venture","a","2010-01-13",2887515
"241c9024383e35101fce841aee6a1f8c","gliknik","venture",NA,"2010-09-03",2400000
"241c9024383e35101fce841aee6a1f8c","gliknik","venture",NA,"2011-09-06",2038552
"241c9024383e35101fce841aee6a1f8c","gliknik","venture",NA,"2013-09-03",2835000
"241c9024383e35101fce841aee6a1f8c","gliknik","venture",NA,"2013-05-13",2e+07
"3f74e61a15aec8cf285e00a31d03036e","glints","angel",NA,"2014-03-20",59055
"3f74e61a15aec8cf285e00a31d03036e","glints","seed",NA,"2015-02-11",350741
"afc28045a4f7d1245d7b0c00bb295011","glo-science","venture",NA,"2011-07-20",6268156
"afc28045a4f7d1245d7b0c00bb295011","glo-science","venture",NA,"2011-03-07",1500000
"08fa6a142abdf6808ffa9b7751876c57","global-alliance-for-genomics-health",NA,NA,NA,NA
"7c052534c5f9052ec59a5ab7fb150337","global-analytics","debt_financing",NA,"2013-07-29",3e+07
"7c052534c5f9052ec59a5ab7fb150337","global-analytics","venture",NA,"2009-11-16",1e+07
"3d1b2b8ac2621c237618d9b346c3cc9c","global-biometric-networks",NA,NA,NA,NA
"81222b45dcc40e904aceb46df9e187a9","global-blood-therapeutics","venture","a","2012-06-14",40700000
"81222b45dcc40e904aceb46df9e187a9","global-blood-therapeutics","venture","B","2015-01-06",4.8e+07
"e3dd588e6361a266d15ca94e5b320651","global-debt-registry","venture","A","2015-01-14",7e+06
"d26626189add184168c00c1f2c37a652","global-interactive-marketing-online",NA,NA,NA,NA
"18ce2017e30953d8d134310a499687ec","global-news-intelligence",NA,NA,NA,NA
"c8020a6ef5ce9d30834effa1a5c66427","global-pharm-holdings-group","debt_financing",NA,"2011-11-04",5e+06
"f45745d4727ca16846c97ac360cb3cfc","global-product-data",NA,NA,NA,NA
"1afeb9b9b39158fb7a9822175b2d5229","global-registry-of-biorepositories","venture",NA,"2013-06-27",4.5e+07
"84d3b673af4c819e539481858274021c","global-risk-insights",NA,NA,NA,NA
"33f60fd790da40644cd2d9ae65f25f32","global-stem-cells-group",NA,NA,NA,NA
"c65a2b4a6cb90ac82170bfb04dd3d9c8","global-technology-corporation",NA,NA,NA,NA
"9b7353ab57163f2fc6e565b2c377d0ec","global-trade-alert",NA,NA,NA,NA
"8718367e1202752b2bbdad61d55e5f00","global-vox-populi",NA,NA,NA,NA
"c0cd0b00cd92670ba32122b21b20a644","global-workplace-analytics",NA,NA,NA,NA
"2054c67988998501548baf9f1751b248","globality",NA,NA,NA,NA
"d3a36a31aa564bf0a7149ed2c141cb0d","globalmedia-group","venture","a","2012-10-29",855620
"fd0efee8c0841db67bf4b7f35544ee81","globavir","venture",NA,"2015-11-12",150000
"34d12d229d92287e09e344595c38ee9c","globeimmune","venture","C","2007-09-26",41200000
"34d12d229d92287e09e344595c38ee9c","globeimmune","venture","B","2005-12-16",34300000
"34d12d229d92287e09e344595c38ee9c","globeimmune","venture",NA,"2014-02-13",7500000
"34d12d229d92287e09e344595c38ee9c","globeimmune","grant",NA,"2013-09-04",4e+06
"34d12d229d92287e09e344595c38ee9c","globeimmune","venture","e","2010-01-19",17500000
"34d12d229d92287e09e344595c38ee9c","globeimmune","venture",NA,"2009-05-14",1.3e+07
"34d12d229d92287e09e344595c38ee9c","globeimmune","debt_financing",NA,"2009-03-16",2564710
"34d12d229d92287e09e344595c38ee9c","globeimmune","venture",NA,"2014-03-12",391730
"25aacf3b8d918c4b0e7acda812061141","globus-3",NA,NA,NA,NA
"9c55fcbd4f7416d50ebaee861f340eed","globys-inc",NA,NA,NA,NA
"b213b0317b354599bcedf101ee69f58b","gloria-pharmaceuticals",NA,NA,NA,NA
"832eab474fc978e3b2674cd9c66dbccc","gloucester-pharmaceuticals","venture","d","2009-08-25",2.9e+07
"832eab474fc978e3b2674cd9c66dbccc","gloucester-pharmaceuticals","debt_financing",NA,"2009-04-28",1700000
"832eab474fc978e3b2674cd9c66dbccc","gloucester-pharmaceuticals","debt_financing",NA,"2009-08-12",5e+05
"832eab474fc978e3b2674cd9c66dbccc","gloucester-pharmaceuticals","debt_financing",NA,"2009-07-17",5e+05
"a471ab5828d79bd119affb751bcdcdaa","glowdx","venture",NA,"2015-04-30",NA
"3b053abd5eca75acff406d204217a7d7","glowfi-sh","convertible_note",NA,"2016-01-31",50000
"2a40207c501cfa13412be12266875d27","glowing-plant","product_crowdfunding",NA,"2013-06-08",484000
"2a40207c501cfa13412be12266875d27","glowing-plant","seed",NA,"2014-07-16",120000
"3db4d1c907218408ee1c226caf5c4899","glucoiq","seed",NA,"2015-02-05",20000
"6c61c377806513e40cf69c7d028f0ecf","glucosentient","seed",NA,"2012-11-24",60000
"6c61c377806513e40cf69c7d028f0ecf","glucosentient","venture",NA,"2012-10-12",NA
"d2afe3a80dc95d6113d8d33d7c6cfbdd","glumobilemedia",NA,NA,NA,NA
"b272944a3325e69dc92af70e4465026c","gluu-io","seed",NA,"2014-11-15",NA
"6362854b552c4a18d4e5b54aa7114ee2","glycart-biotechnology-ag","venture","A","2003-11-26",13600000
"4175dde429107de43161c0e6a9a75aba","glycobia","convertible_note",NA,"2010-09-30",5e+05
"0c53cd837f05e8f59440581b4ad5db7d","glycode","venture","b","2010-01-18",4310700
"6f86dbee4bb7dd09588f789e7a726702","glycofi-inc",NA,NA,NA,NA
"21bf3fa06edf988cb003b171e53b6742","glycomimetics","venture","c","2009-12-07",3.8e+07
"21bf3fa06edf988cb003b171e53b6742","glycomimetics","convertible_note",NA,"2010-10-27",38979412
"9541f5111d195b69e8dc5e98ff1e86c0","glycominds","venture",NA,"2005-01-01",1e+06
"a34f93beb750150245b8d29083db9000","glycoregimmune","venture",NA,"2015-04-17",4378000
"13dd29dd0de3fdf74ff1d940a1d63449","glycos-biotechnologies","venture","a","2009-09-29",675296
"13dd29dd0de3fdf74ff1d940a1d63449","glycos-biotechnologies","venture",NA,"2011-09-08",3732218
"13dd29dd0de3fdf74ff1d940a1d63449","glycos-biotechnologies","venture","b","2010-10-20",4220000
"13dd29dd0de3fdf74ff1d940a1d63449","glycos-biotechnologies","venture",NA,"2013-02-28",3e+06
"13dd29dd0de3fdf74ff1d940a1d63449","glycos-biotechnologies","venture",NA,"2008-02-01",2350000
"13dd29dd0de3fdf74ff1d940a1d63449","glycos-biotechnologies","debt_financing",NA,"2013-10-10",375250
"13dd29dd0de3fdf74ff1d940a1d63449","glycos-biotechnologies","venture","a","2009-05-05",5e+06
"13dd29dd0de3fdf74ff1d940a1d63449","glycos-biotechnologies","debt_financing",NA,"2014-02-11",40323
"384e82323a36bb871656c2fdd364c61a","glycosan","venture",NA,"2009-07-30",325000
"384e82323a36bb871656c2fdd364c61a","glycosan","venture",NA,"2010-05-13",625000
"b653524cc7b26d656530bdea8e17c328","glycostasis","venture",NA,"2015-06-11",149998
"0f0de260c5569164e93b264cffd2fc02","glycotech-corporation",NA,NA,NA,NA
"e8951151d8372e9b6b0190d2ef772173","glycotope-biotechnology",NA,NA,NA,NA
"bf88701e12da85b46910c2d379722cae","glyco-vaxyn","venture","A","2007-07-16",9583333.3333
"bf88701e12da85b46910c2d379722cae","glyco-vaxyn","venture","b","2009-03-05",21250000
"bf88701e12da85b46910c2d379722cae","glyco-vaxyn","venture",NA,"2006-07-01",817000
"a7e1bb8dae04f3c22adcf5bf3cd2f79c","glygenix-therapeutics","seed",NA,"2014-03-17",150000
"74b9dc3d70344d6dc6f3dc9f6c6ba82f","glythera","venture",NA,"2010-10-09",792709
"74b9dc3d70344d6dc6f3dc9f6c6ba82f","glythera","venture",NA,"2012-06-21",3140219
"346619e38575982cd84d21bacf623ec7","gm-ryan-international-2",NA,NA,NA,NA
"ec12101b1770b3683ab4e200c44c6b31","propmaven",NA,NA,NA,NA
"dc2c5363f6b5631b9e5b8b3551822e0a","gmid-associates",NA,NA,NA,NA
"c4a1646a508a3746d5737ec4828a5c2b","gnarus-systems","debt_financing",NA,"2010-04-15",3e+05
"8981ec03359c04ca7b97302fcc267327","gneo",NA,NA,NA,NA
"7bc0841729cae11d5d0baf6787ee3595","gnito",NA,NA,NA,NA
"c19be0a98588e4198e9a8c9069be5014","gns-healthcare","venture","C","2015-12-08",1e+07
"c19be0a98588e4198e9a8c9069be5014","gns-healthcare","debt_financing",NA,"2010-11-30",450000
"c19be0a98588e4198e9a8c9069be5014","gns-healthcare","venture",NA,"2012-04-06",5e+06
"c19be0a98588e4198e9a8c9069be5014","gns-healthcare","venture","a","2013-12-23",9939920
"c19be0a98588e4198e9a8c9069be5014","gns-healthcare","venture","b","2014-01-29",1e+07
"c19be0a98588e4198e9a8c9069be5014","gns-healthcare","debt_financing",NA,"2015-03-05",750000
"c19be0a98588e4198e9a8c9069be5014","gns-healthcare","venture",NA,"2015-05-26",8125000
"d37df2e110b2a019df891e3989400d63","gnubio","venture","a","2011-09-01",5e+06
"d37df2e110b2a019df891e3989400d63","gnubio","venture","b","2012-10-02",1e+07
"d37df2e110b2a019df891e3989400d63","gnubio","grant",NA,"2012-09-19",4500000
"d37df2e110b2a019df891e3989400d63","gnubio","venture","a","2010-12-02",3e+06
"2cb9163253cb4a5f00f63cc640ec5bdf","go-baller","seed",NA,"2014-08-01",25000
"13c468a13dd1f4a910df9f16bf2d69c3","go-eco",NA,NA,NA,NA
"66caea04336a4ca42edb09cdd484948c","go-jobs-inc",NA,NA,NA,NA
"c64510cf603d5a353875919862767bb4","go-optimisation",NA,NA,NA,NA
"fa9acd72933eed41d70df25cd52e1d17","goalface-com",NA,NA,NA,NA
"21335edf6c9831895bc5a996b27586b4","gobiquity-inc","venture",NA,"2013-08-14",750816
"ef439874691726194dc02d9708de4e71","peeps-mobile",NA,NA,NA,NA
"680b20a8f33416ff56ca7f909795462b","gochime","angel",NA,"2014-01-01",1500000
"680b20a8f33416ff56ca7f909795462b","gochime","seed",NA,"2011-11-01",NA
"b6ad1b4b981d8f59d0b35dce1c417394","goco-io-inc","venture",NA,"2015-10-30",1809992
"0686fa8c192fe2ac1239af3c62934ac1","goddard-labs","debt_financing",NA,"2014-07-09",1e+05
"6de38b20eeabf7bbba78b7fe45750b7b","godlan",NA,NA,NA,NA
"a498130104fa9e3ffdd5d06962a25852","goepic",NA,NA,NA,NA
"c61a8a83ced5ce5a6fcb03fd87e31e11","go-geo",NA,NA,NA,NA
"cf3d7a8f51b20383de745b4ba287e13b","gohealth-2",NA,NA,NA,NA
"53942afb49d130f0ed1acf8841918599","gohisto",NA,NA,NA,NA
"38761b6d743842bd3756dd9d1652659e","gold-standard-diagnostics","venture",NA,"2013-02-11",1009479
"38761b6d743842bd3756dd9d1652659e","gold-standard-diagnostics","venture",NA,"2010-05-12",775725
"38761b6d743842bd3756dd9d1652659e","gold-standard-diagnostics","venture",NA,"2011-08-25",750000
"a1cfe1fefbea9a5e8bfe269c323fc7a2","golfler-holdings--llc","angel",NA,"2015-02-21",55000
"a1cfe1fefbea9a5e8bfe269c323fc7a2","golfler-holdings--llc","angel",NA,"2015-03-01",67500
"a1cfe1fefbea9a5e8bfe269c323fc7a2","golfler-holdings--llc","seed",NA,"2015-06-14",150000
"3fb9d49570a1b558d2826237bd912819","gomoto","seed",NA,"2014-08-22",7e+05
"d0fa81211f6fa267b81855fdb1b56680","gondola","seed",NA,"2013-09-15",2e+05
"6a07f4d6530159653918148ee106b0d1","good-people-ventures",NA,NA,NA,NA
"1c8b385ce493ea0cd43dec5b38b23a1c","good-start-genetics","venture","a","2010-09-10",1.8e+07
"1c8b385ce493ea0cd43dec5b38b23a1c","good-start-genetics","venture","b","2012-04-02",1.4e+07
"1c8b385ce493ea0cd43dec5b38b23a1c","good-start-genetics","debt_financing",NA,"2013-05-08",2.8e+07
"ae4d81400999d69e6503afff98516cdb","good-technology","secondary_market",NA,"2013-06-01",NA
"ae4d81400999d69e6503afff98516cdb","good-technology","venture","1","2014-02-01",NA
"ae4d81400999d69e6503afff98516cdb","good-technology","private_equity",NA,"2013-12-20",64997000
"ae4d81400999d69e6503afff98516cdb","good-technology","venture","1","2005-03-15",9.5e+07
"ae4d81400999d69e6503afff98516cdb","good-technology","private_equity",NA,"2006-10-01",51300000
"ae4d81400999d69e6503afff98516cdb","good-technology","private_equity",NA,"2014-09-30",8e+07
"ae4d81400999d69e6503afff98516cdb","good-technology","debt_financing",NA,"2007-01-01",NA
"ae4d81400999d69e6503afff98516cdb","good-technology","venture",NA,"2014-04-07",NA
"7d2481a05d2fe38061cf0886da708224","good-co","seed",NA,"2012-12-20",118000
"7d2481a05d2fe38061cf0886da708224","good-co","seed",NA,"2013-11-12",1450000
"7d2481a05d2fe38061cf0886da708224","good-co","seed",NA,"2014-05-01",750000
"e5ebe42a0fcac68a1ef4c5b1e2070409","goodbelly","venture",NA,"2008-08-05",1.6e+07
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","seed",NA,"2009-10-14",2500000
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","seed",NA,"2009-04-01",2500000
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","venture","1","2012-07-25",2.5e+07
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","venture","1","2010-07-21",6500000
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","venture","1","2011-08-18",1.5e+07
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","angel",NA,"2008-07-23",2e+06
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","venture","1","2013-06-12",2.2e+07
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","venture","1","2014-09-10",25699993
"11e04a6364c8dc2e9edaf0be453c8c8f","good-data","undisclosed",NA,"2014-01-01",NA
"876df65df92f74cda3f5fd87f343af1c","goodgut","seed",NA,"2014-10-01",232681.6561
"876df65df92f74cda3f5fd87f343af1c","goodgut","angel",NA,"2016-01-27",667554.327
"753f76cd7d785c550e97be6e04e7f117","goodland-informatics-co-ltd",NA,NA,NA,NA
"108db541d2e1674637e8a1dab069c15f","goodvidio",NA,NA,NA,NA
"b00f542cce66d231351acb723c551137","goodzer","seed",NA,"2012-01-27",650000
"b00f542cce66d231351acb723c551137","goodzer","angel",NA,"2010-07-01",1e+05
"b00f542cce66d231351acb723c551137","goodzer","seed",NA,"2014-10-14",1400000
"9c686ebfe6c32560e31156ecf536d22e","ms-gooroo",NA,NA,NA,NA
"0cd82e9d21f769d17e748832e1dc3c58","gopath-global","venture",NA,"2013-04-30",1571940
"31ec53522f8a48200556fd5fda750346","gordian-surgical","seed",NA,"2015-10-20",1e+06
"8594be7fe354a6af234b9a030f36a846","gosquared","angel",NA,"2011-01-01",NA
"6d274aa67614211cf35e1c25a07f831a","got-ch-technology",NA,NA,NA,NA
"20600038c3316670e96df84a8cb31660","gotham-communications",NA,NA,NA,NA
"29805b25a1bea0f55fab4b4cdc1747bd","gototags","angel",NA,"2011-11-01",1e+05
"29805b25a1bea0f55fab4b4cdc1747bd","gototags","seed",NA,"2015-09-03",3e+05
"6857bc58467bef5eef40eb83c55d9797","gotuitmedia","venture","a","2002-12-01",6e+06
"b8751d9dcb450ffd679eb404b2f2997e","gourmetmiles",NA,NA,NA,NA
"37f21ace23197837c4a1bc18e691f02b","govbrain",NA,NA,NA,NA
"6ad64f202671ac3254bb26eb19c46af1","government-2-0-think-tank",NA,NA,NA,NA
"85c453d7b12a7435a32617972900c25d","govini","venture","C","2015-05-07",2e+07
"e67d28a8af3af5254c2b0ce23d3b5c69","govtribe",NA,NA,NA,NA
"e724f75e8016f7270fc559002bd583b9","gpc-biotech",NA,NA,NA,NA
"0fd3488ab38f1425984157ed3ac24c95","g-predictive-gradient-gmbh","seed",NA,"2012-05-25",130000
"0fd3488ab38f1425984157ed3ac24c95","g-predictive-gradient-gmbh","venture","1","2015-02-05",2850545
"0fd3488ab38f1425984157ed3ac24c95","g-predictive-gradient-gmbh","seed",NA,"2014-01-01",130000
"d5d9a407820bed3be63b5a21590bbf8c","gqr-global-markets",NA,NA,NA,NA
"0f77e5e8054fc7b918f09728e2daf443","grace-2",NA,NA,NA,NA
"6c36abeaae9a57ab2a289e40df4b82be","gracular",NA,NA,NA,NA
"28e5fcc599f80287dd5977756add9930","gradalis","venture","b","2013-01-03",2.4e+07
"391f7aa1d9a0861cc4f810c71b522993","gradberry","seed",NA,"2014-12-01",120000
"391f7aa1d9a0861cc4f810c71b522993","gradberry","seed",NA,"2015-05-01",NA
"de9221e86a445d801be9a23ecca614b4","gradeable","seed",NA,"2013-06-01",18000
"6ceed6659b523a741cec33557d4e3239","gradealyzer",NA,NA,NA,NA
"403e0d7cb052b1879b80eaf0619e0026","gradeedge",NA,NA,NA,NA
"d5cacda8dc4506a4c098d6e4e0b59a4e","gradematic-com","seed",NA,"2012-02-10",40000
"652078d0084654bb3943565328d0f68f","gradient-resources-inc","private_equity",NA,"2010-02-02",1.08e+08
"652078d0084654bb3943565328d0f68f","gradient-resources-inc","private_equity",NA,"2014-08-27",22272724
"5fd6c7e396d2140ea63aa64adaba9a22","grafly",NA,NA,NA,NA
"e247e2aeff9f849f69210129409b511a","graftys","venture","c","2011-04-26",7747010
"0a716b73887fed796b2690d2d0a2dfb9","graham-media-partners",NA,NA,NA,NA
"a32bba47679b08a8770bf09ad6efa661","gram-acquisition","venture",NA,"2013-05-03",818476
"a32bba47679b08a8770bf09ad6efa661","gram-acquisition","venture",NA,"2010-12-28",2437500
"f59a432026f857f308ff10252392e64e","grand-interactive",NA,NA,NA,NA
"7e200564db2f94d3d07e2b1fb08e7069","gram-newco","venture",NA,"2010-12-22",4950000
"7e200564db2f94d3d07e2b1fb08e7069","gram-newco","venture","1","2014-06-09",7583554
"dcfc5f010183a5780bff65982fef62b9","grandata","undisclosed",NA,"2012-07-01",NA
"dcfc5f010183a5780bff65982fef62b9","grandata","seed",NA,"2014-06-24",6e+05
"876ceac9366418896b78fa6308e05ebc","grandhope-biotech",NA,NA,NA,NA
"2510e0d60dda4f976307c9c5c582b85c","granify","convertible_note",NA,"2015-01-31",4737265.9659
"2510e0d60dda4f976307c9c5c582b85c","granify","undisclosed",NA,"2012-08-01",NA
"2510e0d60dda4f976307c9c5c582b85c","granify","seed",NA,"2013-11-06",1500000
"2510e0d60dda4f976307c9c5c582b85c","granify","venture","1","2015-05-26",7298342.7356
"cc687cdf7cafeb7e40c2efa1ceecb5fe","grantiq",NA,NA,NA,NA
"c5aa191cd20248271fbb8b8cca2e7284","granular","venture","A","2014-02-23",6200000
"c5aa191cd20248271fbb8b8cca2e7284","granular","venture","B","2015-09-09",21058523
"e04773eabbad17539032134446e5ee02","grapeword","seed",NA,"2012-12-01",1e+05
"e04773eabbad17539032134446e5ee02","grapeword","seed",NA,"2014-06-01",115000
"77482c2c025df16c7cb3369290997b1e","graph-grail",NA,NA,NA,NA
"16b9665b8b74d42917a4977e10a959c3","graph-ventures",NA,NA,NA,NA
"6d555f2a31e628be8f87b6520ff9fae2","graphalchemist","angel",NA,"2014-11-07",5e+05
"6d555f2a31e628be8f87b6520ff9fae2","graphalchemist","seed",NA,"2012-08-29",NA
"824a2aba8b48e1b80324025dd91bd35c","graphdive","convertible_note",NA,"2011-11-15",1e+06
"824a2aba8b48e1b80324025dd91bd35c","graphdive","seed",NA,"2011-11-15",NA
"824a2aba8b48e1b80324025dd91bd35c","graphdive","venture","1","2013-09-03",2e+06
"36be1f2a0293a5c9c47360f90b23a7be","graphext",NA,NA,NA,NA
"accb547b7b52454f238945548adca619","graphflow","seed",NA,"2014-01-20",225000
"01cc7dc518d417affe0455b4b3d2420d","graphimpact",NA,NA,NA,NA
"39cea8d9ab5cf4748450fc1a2ceb5f81","graphzer",NA,NA,NA,NA
"ff9662c38126c773bdb6d128c76906e9","grassp","angel",NA,"2014-11-01",1500000
"ac5e530015d77b1a518414e9b9c5b209","gravit8-marketing",NA,NA,NA,NA
"cd6c8a93d90a0ae0df1130df992fe6c7","gravityrd","venture","A","2011-09-16",2e+06
"cd6c8a93d90a0ae0df1130df992fe6c7","gravityrd","venture","A","2010-12-31",1e+06
"d4a3b4ccf5db45c9a276e591bdb8a0c3","gravity4",NA,NA,NA,NA
"494f23edb30f0e1e5a0eabcbefde8382","graybug","debt_financing",NA,"2015-12-16",750000
"494f23edb30f0e1e5a0eabcbefde8382","graybug","venture","1","2013-10-29",1500000
"494f23edb30f0e1e5a0eabcbefde8382","graybug","venture",NA,"2014-10-07",750000
"494f23edb30f0e1e5a0eabcbefde8382","graybug","venture","1","2015-03-06",1740000
"a55ddbef3cbfe15a9e111bed9e85a9d3","graylog","seed",NA,"2015-02-04",2500000
"a55ddbef3cbfe15a9e111bed9e85a9d3","graylog","seed",NA,"2013-11-25",1900000
"f60255dfda66bbd82209f2b5503fefa8","graymatter",NA,NA,NA,NA
"843d9b9f0f3b96a8cebbd87643784142","great-basin-corporation","post_ipo_debt",NA,"2016-01-14",20500000
"843d9b9f0f3b96a8cebbd87643784142","great-basin-corporation","venture",NA,"2013-12-11",5797653
"843d9b9f0f3b96a8cebbd87643784142","great-basin-corporation","venture","1","2011-02-14",12100000
"843d9b9f0f3b96a8cebbd87643784142","great-basin-corporation","venture","1","2013-01-07",9500000
"843d9b9f0f3b96a8cebbd87643784142","great-basin-corporation","venture",NA,"2014-04-24",6e+05
"e4ecf87d63d46e16f61edfc84bb79f2c","great-lakes-pharmaceuticals","venture","b","2010-08-23",3100000
"e4ecf87d63d46e16f61edfc84bb79f2c","great-lakes-pharmaceuticals","venture","A","2008-04-09",2400000
"e4ecf87d63d46e16f61edfc84bb79f2c","great-lakes-pharmaceuticals","seed",NA,"2007-08-22",3e+05
"e4ecf87d63d46e16f61edfc84bb79f2c","great-lakes-pharmaceuticals","seed",NA,"2011-10-19",50000
"e4ecf87d63d46e16f61edfc84bb79f2c","great-lakes-pharmaceuticals","venture","B","2014-09-11",11220531
"5d17a98cd9f975b8d3770b5fb079313d","greater-good-analytics",NA,NA,NA,NA
"74dbfad53c669c1e32c167efa73e7ab8","greater-good-ventures",NA,NA,NA,NA
"ae33f70feb91f9db16ae0dd657db18c1","greater-mankato-growth",NA,NA,NA,NA
"709d3b9bf26b31495747cdb8853004fc","greater-than-one",NA,NA,NA,NA
"e792b1e5838db376f9a3c9c49466204a","greathorn","convertible_note",NA,"2015-09-24",275000
"23ea348df0245eef436f19ab3731648f","greatvines-beverage-solutions","seed",NA,"2010-02-08",10000
"5f5a0018ba4ac49e0517cf311b736337","green-grow","venture","B","2014-08-27",6e+06
"6070102ab3f3debcbfbfa1cd9af9ecb6","green-biofactory","seed",NA,"2013-07-25",40000
"5ea8bfcde7b72605898285ddd4fde226","green-biologics","venture","b","2010-07-30",6100000
"5ea8bfcde7b72605898285ddd4fde226","green-biologics","venture","b","2013-12-02",23334872
"5ea8bfcde7b72605898285ddd4fde226","green-biologics","venture",NA,"2007-10-18",3200000
"5ea8bfcde7b72605898285ddd4fde226","green-biologics","venture",NA,"2009-02-04",1464244
"5ea8bfcde7b72605898285ddd4fde226","green-biologics","venture",NA,"2012-05-16",5118945
"5ea8bfcde7b72605898285ddd4fde226","green-biologics","undisclosed",NA,"2013-07-31",3030502
"5ea8bfcde7b72605898285ddd4fde226","green-biologics","venture","C","2015-01-21",4.2e+07
"5ea8bfcde7b72605898285ddd4fde226","green-biologics","debt_financing",NA,"2015-01-21",3.4e+07
"cbda84aa7b7e5e18dfd5dab4eb35ce18","green-cross",NA,NA,NA,NA
"5efb9ec4f65fb1b5374c6ca0d1d25010","green-hills","venture",NA,"2011-06-22",842425
"18ad1851efa207e6f3c540fdbc8b812b","green-materials",NA,NA,NA,NA
"aa924e5de3fe4ac9c7cf008b9e5c36ac","green-wavelength",NA,NA,NA,NA
"3547cc81c3b2d9e5d8f8bacbe6710b9e","greenant",NA,NA,NA,NA
"99a9c8c9cbe230ba69c3d0d28ec15945","greenbean-recycle",NA,NA,NA,NA
"3ab24e9df7f0a75f86af2a114cfdab0c","greenbird-integration-technology","seed",NA,"2010-01-01",144060
"3fcbf2d33a38fe3dc8489221971949f2","greenbone","venture",NA,"2015-09-23",3350245
"b2a4458653e63cbc5196f5c1c2f89613","greencloud","seed",NA,"2013-04-07",1e+05
"cf951eab9f570a9c958e02488b8a3ba1","greenelectric-power-corp","equity_crowdfunding",NA,"2014-05-03",NA
"2630806c4b75395f9eb5f077f92cdb44","greenflash-software",NA,NA,NA,NA
"5ccc06a2fded55448385fe31f37059f6","greenleaf-biofuels",NA,NA,NA,NA
"d70b3943e6703138975edf697835180d","greenlight-biosciences","venture","a","2013-08-12",7e+06
"d70b3943e6703138975edf697835180d","greenlight-biosciences","venture","B","2015-06-17",2e+07
"d70b3943e6703138975edf697835180d","greenlight-biosciences","venture","C","2015-07-22",NA
"3d89ba30a2695d85370223a2ce80e9b4","greenough-communications",NA,NA,NA,NA
"fa51a58ce21f7d81d3f19b1ff09d552e","greenovation-biotech","venture","b","2006-11-25",7062120
"ee3a5f08a2d5dc5c2b9c063f2382867c","greenpeptide-co--ltd-","venture",NA,"2014-08-29",11549774
"35bc39734ced42de2a6eb1cf4d7185b3","greenplum","venture","c","2009-03-17",31899155
"35bc39734ced42de2a6eb1cf4d7185b3","greenplum","debt_financing",NA,"2007-02-06",4e+06
"35bc39734ced42de2a6eb1cf4d7185b3","greenplum","venture","c","2008-01-01",2.7e+07
"35bc39734ced42de2a6eb1cf4d7185b3","greenplum","venture","b","2007-02-01",1.5e+07
"35bc39734ced42de2a6eb1cf4d7185b3","greenplum","venture","a","2006-03-01",1.5e+07
"9bd1f6e8daaa99dba4383edc4a70d640","greensense",NA,NA,NA,NA
"608dd6fa8664ced0fcd58829de0d045f","greenslopes-private-hospital-maternity",NA,NA,NA,NA
"39f82aa12b74f7370c22bbc910b3caeb","greenvote",NA,NA,NA,NA
"5c6d25a7d715d080a5363b6b81d14ea8","greig-biotechnology-global-consulting-inc",NA,NA,NA,NA
"789bbd2e358d94cdf631bb55016cbeed","greyfinn",NA,NA,NA,NA
"91d1e8e13763f58253d4fab35cd98e00","greyson-international","seed",NA,"2012-08-15",115000
"2f8c4d1403be48b6e95d91f2d1288336","gridcraft","seed",NA,"2014-08-07",2200000
"6ef047b7fd393b33cd3cf1bfe7693fa4","gridgain-systems","venture","A","2013-07-29",1e+07
"6ef047b7fd393b33cd3cf1bfe7693fa4","gridgain-systems","seed",NA,"2011-12-05",2500000
"3d2a1a68685a9bb29860ed550eef988a","gridiron-systems","private_equity",NA,"2012-01-01",1.3e+07
"7d3fac11ebc0dd37eb4b9a0a50e72882","gridsum","venture","A","2010-09-06",NA
"7d3fac11ebc0dd37eb4b9a0a50e72882","gridsum","venture","A","2011-07-18",NA
"7d3fac11ebc0dd37eb4b9a0a50e72882","gridsum","venture","B","2013-10-02",NA
"f73fbb7f6f1b5ac2bc0c2cf618a9d293","gridworx-ltd",NA,NA,NA,NA
"0d43f6ab8357012268c221aa4feddd79","grifols",NA,NA,NA,NA
"e0ab892845b365527143be94bfc59d05","grip-qa",NA,NA,NA,NA
"0a4fd6c25f4674bf02c00396fb891b88","gris",NA,NA,NA,NA
"1fa86ced592add623cb76452b516804a","grit-design",NA,NA,NA,NA
"1ccfb712748aa766fded98fdee7278cc","groop","seed",NA,"2014-08-01",50000
"1ccfb712748aa766fded98fdee7278cc","groop","seed",NA,"2015-01-01",NA
"3633181396e45205be5f734dc7d6f140","groove-biopharma","venture","b","2011-12-12",6e+06
"3633181396e45205be5f734dc7d6f140","groove-biopharma","venture","a","2010-04-26",3900000
"88a1cd7f0f619eed9dd62febd9e2343a","ground-up-biosolutions","equity_crowdfunding",NA,"2008-11-24",NA
"f4186d436ed3ca457f00306d6defcc46","groundtruth-io",NA,NA,NA,NA
"350cb81f3bc226f0eb623d8ca615f4b7","groundwork-bioag","venture","B","2015-09-09",NA
"85cd1f5a54a2390193250a09c4ccf69e","group-ib","grant",NA,"2012-09-26",638000
"85cd1f5a54a2390193250a09c4ccf69e","group-ib","venture","1","2012-11-01",3e+05
"77fbc83b7478cc82c61abfd9993a4954","groupe-athena","venture",NA,"2010-03-03",2355000
"613a4ff2bf09aa831515fbd46c1306a0","grouphub","seed",NA,"2015-01-01",2e+05
"613a4ff2bf09aa831515fbd46c1306a0","grouphub","seed",NA,"2015-02-05",20000
"2a1176ad26a3e2bb78b53f0869ee7a95","groupvisual-io","venture","a","2006-10-05",3e+06
"30749fcf312bf519c844d941b928322a","grove-streams","seed",NA,"2011-01-26",5e+05
"4408d0fed48b0468fddddd5dafd6aa4a","grow-2","seed",NA,"2014-12-11",1500000
"5a7e9a3638ba00d4f6a3cd2292ecd30e","grow-fish-anywhere",NA,NA,NA,NA
"54e61102709480f8cfdda8cfb8df2b69","growblox","post_ipo_equity",NA,"2016-01-13",20000
"54e61102709480f8cfdda8cfb8df2b69","growblox","venture",NA,"2014-06-05",2e+06
"63511b630bb7f05dcbbe1c2b65e8cca3","growbuddy","convertible_note",NA,"2015-08-01",NA
"a7cd0aa85f465a52cb3fb6f9906b7c3c","growers-secret","venture",NA,"2011-05-01",525000
"a7cd0aa85f465a52cb3fb6f9906b7c3c","growers-secret","venture",NA,"2011-11-21",1062500
"a7cd0aa85f465a52cb3fb6f9906b7c3c","growers-secret","venture","1","2014-06-24",8e+06
"3109c2341d88a216db0573ad4e5dc7eb","growingio","seed",NA,"2015-07-03",NA
"cd6c03cc518bda673e9f7c1897beed67","grownetics","seed",NA,"2016-01-11",NA
"cd6c03cc518bda673e9f7c1897beed67","grownetics","seed",NA,"2015-08-24",20000
"feddc670aa257880faefae168efd3e8a","growth-intelligence","venture","A","2015-03-06",3400000
"bd77b6dce4bc617e3b8eb2d455accd5c","growth-race-2",NA,NA,NA,NA
"d9641a696b3d29e90bfa32e916133516","growtuity",NA,NA,NA,NA
"f7e039b862243e1808184cfe8fc35972","growyo","seed",NA,"2013-08-28",8000
"5a5b2c53fab88d3a8f11ec8fe8f8f65d","grupo-tv1",NA,NA,NA,NA
"099bdc44f3f469bbb973309046e0cba5","grupo-webb",NA,NA,NA,NA
"d1ee30018751cca1da4220dfc1d5e49e","gruter",NA,NA,NA,NA
"48345bcb02bec853ee2f6d69bd082cba","grypeworld",NA,NA,NA,NA
"c2a3b099575c167cd9fa9e7e3317f51c","grytics",NA,NA,NA,NA
"dc9697f2ce69d17d2b24cb47e21683cc","gsi-global-social-intelligence","seed",NA,"2014-11-28",18710
"93853d8a48b8f3f1c1627c1d3b856082","glaxosmithkline",NA,NA,NA,NA
"1884e1489483d78f0a8514a2b6ef38dc","gt-medical-device-entrepreneurship-association",NA,NA,NA,NA
"3e0861e9eec2f2680e46200f5eef095c","gt-urological","venture",NA,"2010-12-16",4557542
"3e0861e9eec2f2680e46200f5eef095c","gt-urological","venture",NA,"2014-10-02",5e+06
"1e11cda08e7a18c155d6dc6a94b5dc45","gtc-biotherapeutics",NA,NA,NA,NA
"9bb740a2f07909ba21826f69674704d8","gtmhub",NA,NA,NA,NA
"bbe4d6c0b766ff3db79dd3fdf7dd7d22","gtown",NA,NA,NA,NA
"de598f651a77004c02181188696f9569","gtranslate",NA,NA,NA,NA
"17617bc36b02071cf0db4413c2e6c8fe","guarana-design",NA,NA,NA,NA
"466e870dddb5c67d5b44e851c1e442f2","guaranacam",NA,NA,NA,NA
"75ab7a75ee6ff31de65811b5b2f9b16d","guardian-healthcare","venture",NA,"2010-07-15",4552736
"2f00d8827ea501deef8ba0e0a5a79111","guardian-technology-partners",NA,NA,NA,NA
"1fb41cc16a2a291d2f0503a9c5869354","guardion-health-sciences","debt_financing",NA,"2015-05-15",5e+05
"ae30bbeab3b6b9a5b26f0483f2307bc4","guarnerix-inc","seed",NA,"2015-10-19",525000
"95ebb3ab134ff582bd909b15a9847c9a","guava-technologies","venture","D","2003-12-10",NA
"95ebb3ab134ff582bd909b15a9847c9a","guava-technologies","venture","E","2005-11-04",NA
"d5001967050066b0e7e869033260bd3f","guavus","venture","d","2013-01-10",3e+07
"d5001967050066b0e7e869033260bd3f","guavus","venture","b","2011-10-09",2.5e+07
"d5001967050066b0e7e869033260bd3f","guavus","venture","E","2013-04-18",9e+06
"d5001967050066b0e7e869033260bd3f","guavus","venture","c","2012-07-19",1.5e+07
"d5001967050066b0e7e869033260bd3f","guavus","debt_financing",NA,"2014-08-21",2e+07
"d5001967050066b0e7e869033260bd3f","guavus","venture","E","2015-06-25",3e+07
"4f2fbdb6f50261b08e1aa01a273d3080","guesswork",NA,NA,NA,NA
"ee8f5ae9aeb51a7aa521588224d911c8","guidant-vascular-intervetion",NA,NA,NA,NA
"71074111b806496c413d2deecf0ad63a","guide-a-rama",NA,NA,NA,NA
"c64bb3607dedd1b99447d3442024d4d3","guided-therapeutics","venture",NA,"2010-09-10",3055000
"c64bb3607dedd1b99447d3442024d4d3","guided-therapeutics","venture",NA,"2013-06-03",2527001
"c64bb3607dedd1b99447d3442024d4d3","guided-therapeutics","debt_financing",NA,"2014-05-14",3e+06
"c64bb3607dedd1b99447d3442024d4d3","guided-therapeutics","venture",NA,"2015-07-15",2500000
"140386cccd116c3b0f078051e8eb5e44","guideon","seed",NA,"2015-11-17",NA
"e789ff66dfa6a59b5b768a879e69386f","gulf-ideas-fz-llc",NA,NA,NA,NA
"4ca8201885d660a5547f46fb0387c205","gullak",NA,NA,NA,NA
"b95c713106795d6ac2aca2ab801b6164","gumgum","venture","A","2009-07-08",2600000
"b95c713106795d6ac2aca2ab801b6164","gumgum","venture","B","2011-10-24",7e+06
"b95c713106795d6ac2aca2ab801b6164","gumgum","angel",NA,"2007-12-01",225000
"b95c713106795d6ac2aca2ab801b6164","gumgum","venture","A","2008-07-21",1e+06
"b95c713106795d6ac2aca2ab801b6164","gumgum","venture","C","2015-05-28",2.6e+07
"2868aeca47237f6fd37280551be5bce0","zhuhai-guojia-new-macromolecule-material-co-ltd","venture","A","2009-11-01",NA
"2868aeca47237f6fd37280551be5bce0","zhuhai-guojia-new-macromolecule-material-co-ltd","venture",NA,"2013-03-01",1762820
"8f06fe1b345c8e045fa14327a2b0826e","gurucul-solutions",NA,NA,NA,NA
"146360101f05f3643d7adf590a6c9f65","gvk-biosciences","venture",NA,"2007-11-26",2.5e+07
"7d37ace563fb39cee71fde514076b55f","gw-pharmaceuticals","post_ipo_equity",NA,"2015-04-29",179200000
"6138c8427f72e526925b63fa3ff9c592","gyan-lab","seed",NA,"2015-03-31",NA
"5b5b86aa605b27985ddcb081c3b733ff","gymhit","convertible_note",NA,"2015-07-05",350000
"c6383ddd2b28d81166e4313ba2552916","gympp",NA,NA,NA,NA
"b0dcee0902ddd0b7fc4c9b4b3a597105","gynapse",NA,NA,NA,NA
"a95f72555f0075081c8b9ef84f3eab6f","gyros","venture","c","2009-07-06",10400000
"f727a12c330609b90099363a08603e76","h2o-2","seed",NA,"2013-05-22",3e+06
"f727a12c330609b90099363a08603e76","h2o-2","venture",NA,"2013-01-03",1700000
"f727a12c330609b90099363a08603e76","h2o-2","venture","1","2015-11-09",2e+07
"f727a12c330609b90099363a08603e76","h2o-2","venture","1","2014-07-19",8900000
"6fe54d7f2c8f5417a70980760185c4eb","h4y-corp",NA,NA,NA,NA
"5a31c130d85757263679a05b85fec8fa","hlle-httner",NA,NA,NA,NA
"bc8365b84d98a76744b2318ea64d53e1","habcan-lifescience-co-ltd",NA,NA,NA,NA
"393a36da019aa631f3916dc77cdd4a24","habgen-inc",NA,NA,NA,NA
"60db6065154c18a2f7755cbbe5387dc9","hackers-founders","seed",NA,"2012-10-10",225000
"60db6065154c18a2f7755cbbe5387dc9","hackers-founders","private_equity",NA,"2015-01-01",1534025
"60db6065154c18a2f7755cbbe5387dc9","hackers-founders","undisclosed",NA,"2015-06-11",330000
"60db6065154c18a2f7755cbbe5387dc9","hackers-founders","angel",NA,"2015-07-07",70000
"73fb4fbc6dd4598301ed34ae8e9fac23","hackteria",NA,NA,NA,NA
"f491f150bfe70114b16cc32f5de42844","hadabean",NA,NA,NA,NA
"138b9455b857e0d57eb381dd5d06e792","hadapt","venture",NA,"2012-11-08",6700000
"138b9455b857e0d57eb381dd5d06e792","hadapt","venture","1","2011-10-21",9500000
"95bff4c406b99742189f38ada7a95378","hadasit-bio-holdings","post_ipo_equity",NA,"2015-06-28",2e+06
"4118682d98bed111085612fe9b52e24e","hadean","venture",NA,"2014-12-01",NA
"df72f25bccbc651633a675b0a8e7bcc0","hadron-systems","venture",NA,"2011-05-05",5e+06
"c768a295bd992f35ae233a525d328d1e","haemonetics",NA,NA,NA,NA
"22e8eb9c64daf13edf6919703f9939ab","hl-holistic-analytics-laboratory",NA,NA,NA,NA
"778b03c1a390ad1d29cbb360dc559749","halcyon-molecular",NA,NA,NA,NA
"65e04ef9848bdc034a5212e13315221c","halcyon-organics-llc",NA,NA,NA,NA
"ef45bb0dfea236644ff1ea2dd2daddb1","halo-business-intelligence",NA,NA,NA,NA
"98b531f6155c8a42c94f921db12b0dd9","halozyme-therapeutics","debt_financing",NA,"2016-01-05",1.5e+08
"98b531f6155c8a42c94f921db12b0dd9","halozyme-therapeutics","venture",NA,"2011-06-08",6.3e+07
"98b531f6155c8a42c94f921db12b0dd9","halozyme-therapeutics","debt_financing",NA,"2014-01-06",2e+07
"98b531f6155c8a42c94f921db12b0dd9","halozyme-therapeutics","debt_financing",NA,"2013-12-27",3e+07
"c325cb3065e8dff214a1c1544ab84c6f","halscion","venture",NA,"2009-10-23",6000001
"c325cb3065e8dff214a1c1544ab84c6f","halscion","venture",NA,"2011-04-20",3500001
"c325cb3065e8dff214a1c1544ab84c6f","halscion","debt_financing",NA,"2012-06-28",4300000
"54d5647d36e32ec1eb619c149dc1ef80","hana-biosciences","venture",NA,"2009-10-23",16267844
"54d5647d36e32ec1eb619c149dc1ef80","hana-biosciences","private_equity",NA,"2010-06-07",1e+08
"c7fb4e9b4dab13a72708d434ec26809a","handa-pharmaceuticals","venture",NA,"2009-04-01",2042917
"050a56fe6626df6a28c96e32228818c4","handinscan","venture","A","2016-01-06",1450000
"050a56fe6626df6a28c96e32228818c4","handinscan","seed",NA,"2012-12-28",NA
"c524187b3d8d947a5bfe1e6c7e3a67e9","hands-on-telehealth",NA,NA,NA,NA
"e406a4cf91831c97b4da6d60a206349b","handylab","venture","D","2008-08-05",19200000
"ba855ab552853541587279b48741ca48","hangon-images",NA,NA,NA,NA
"f7bedaeeef2c63ca2072fc8c9ca66473","hanover-research",NA,NA,NA,NA
"1708dafdf5b8fd60c69dbdb37cff8c6d","hansa-customer","venture",NA,"2015-06-18",4700000
"5c8086656e1058ab672312eb3e3db8d6","hansa-medical",NA,NA,NA,NA
"3d9dc1e073e93ae72179dc74e9b9c949","hansen-pharma",NA,NA,NA,NA
"fbf9ef2a93ecdd73c1d77ea5d349b161","hanzo-io",NA,NA,NA,NA
"093f81e5916a9c21dae1c5238b82f739","xian-haotian-biological-engineering-technology-co-ltd","venture","A","2004-06-01",1208468
"a661185fc8dc401e949f31891d4a09d0","happy-metrix","angel",NA,"2012-06-15",157450
"2a6a0f0949582f4ff9e96518d1b14581","happyvitals",NA,NA,NA,NA
"9cacaf5aaebe939d95d74db444df3298","hapten-sciences","venture",NA,"2014-01-02",475000
"9cacaf5aaebe939d95d74db444df3298","hapten-sciences","seed",NA,"2012-06-01",7e+05
"9cacaf5aaebe939d95d74db444df3298","hapten-sciences","seed",NA,"2013-06-01",275000
"9cacaf5aaebe939d95d74db444df3298","hapten-sciences","convertible_note",NA,"2015-04-16",250000
"9cacaf5aaebe939d95d74db444df3298","hapten-sciences","convertible_note",NA,"2016-01-12",1225000
"3bc79d26802720bd60faae8a5b5f6f94","harbor-biosciences","seed",NA,"2011-08-12",2825000
"5f9bec9d9cce6630083f1b89e7550f73","harbor-medtech","venture",NA,"2012-05-17",674733
"5f9bec9d9cce6630083f1b89e7550f73","harbor-medtech","venture",NA,"2013-05-31",132000
"5f9bec9d9cce6630083f1b89e7550f73","harbor-medtech","venture",NA,"2015-08-11",3465000
"2238fe5765ba606300491edf2eef0582","harbour-antibodies","venture","a","2013-07-24",3216500
"742496696cd9dd375e140fb021b41a80","hari-seldon-corporation","angel",NA,"2010-08-01",32570
"b960f74ac725b274feca0826bc41cafb","harimata","seed",NA,"2013-11-04",50000
"b960f74ac725b274feca0826bc41cafb","harimata","seed",NA,"2014-05-07",70000
"e0f0f99d70aba8439ac984ab21464f59","harneedi-com",NA,NA,NA,NA
"d55ca6725167be291c20445647e43eb6","harpya",NA,NA,NA,NA
"4f2f48df9f6f500d8385a2eb011cb9f1","hart",NA,NA,NA,NA
"d18ee8895ea1c18d59dcacccd30f4d78","harte-hanks",NA,NA,NA,NA
"78ff9bbf303e6fa4e7a9effe0b69f874","harvard-apparatus-regenerative-technology",NA,NA,NA,NA
"75eccb7552e95d1b8f7ac75c91f6f314","harvard-bioscience",NA,NA,NA,NA
"55767415cd37a9f235845ed4284ed7f4","harvest-precision-components",NA,NA,NA,NA
"041010550de0c1f7f364737b1dffcfb6","hashparade","seed",NA,"2012-08-31",1e+05
"6473e1a1a5f72db12bfb9abe4f5fd7db","hashresearch",NA,NA,NA,NA
"2e6209f5edb6e598ca4342ba50d09f0a","hashtrack","seed",NA,"2014-04-01",NA
"b6c8b9685da10ed947f71b1d8b8784e3","hatch-valley",NA,NA,NA,NA
"c241120a7f91ee0d594ead611a311659","hatchbuck","angel",NA,"2012-10-01",775000
"c241120a7f91ee0d594ead611a311659","hatchbuck","seed",NA,"2014-08-01",2600000
"c241120a7f91ee0d594ead611a311659","hatchbuck","seed",NA,"2015-07-31",1375000
"8741aafa10c3bc7a60bf52ec01667841","hatchmap",NA,NA,NA,NA
"5024186c3ece7f8863cf9eb9a7e54136","hatchtech","venture",NA,"2012-05-01",8100000
"5024186c3ece7f8863cf9eb9a7e54136","hatchtech","venture",NA,"2005-05-30",2200000
"5024186c3ece7f8863cf9eb9a7e54136","hatchtech","venture",NA,"2013-10-31",12330691
"a02c590060be72ce51b7cc38ad8bb2af","havas-edge",NA,NA,NA,NA
"32ce6b97ce1b88bacb79e009b7dee7e0","hawaii-biotech","venture",NA,"2010-01-06",645000
"32ce6b97ce1b88bacb79e009b7dee7e0","hawaii-biotech","grant",NA,"2014-02-05",7400000
"421e6fd79e5d7dd711fc7e4c396006e5","hawaii-medical",NA,NA,NA,NA
"15bd606838a5a4720e2e4d2cd6f2b16a","haystac","seed",NA,"2011-11-28",NA
"de4f0e2c917dc1afd07e0afa37484fc7","haystaqdna",NA,NA,NA,NA
"318b02af46f8f55891205f7f0cb560a4","haystax-technology",NA,NA,NA,NA
"c6e7b785b3925aa1142d415d91b6b823","haywheel",NA,NA,NA,NA
"9a62a778ed90b969c9dd9afb10f38824","hbcs","venture",NA,"2009-10-14",18336720
"60cd8db209708f4e9fa663594cfefabf","hchb-cressey","debt_financing",NA,"2011-03-09",28550000
"dcabe47608f11883f2dbb5e58e40f8c1","hd-biosciences","venture","a","2008-08-08",NA
"5e531ae245ed3df434f4447194ed8ae1","hdl-therapeutics","venture",NA,"2013-02-13",925000
"5e531ae245ed3df434f4447194ed8ae1","hdl-therapeutics","venture","1","2014-12-31",2045000
"70350974cfd04aa6882b236fd86e4e09","hdscores",NA,NA,NA,NA
"2a3cf316abb0a89c6c3f66ef85ab0905","headshift",NA,NA,NA,NA
"dcb3d02e0eedd2d4f6bd4a8149bf98ad","healcerion","venture",NA,"2013-08-07",716867
"2a726f19bb365ca46531b422971e24f5","healint","seed",NA,"2013-11-28",111500
"2a726f19bb365ca46531b422971e24f5","healint","seed",NA,"2014-01-04",250000
"2a726f19bb365ca46531b422971e24f5","healint","seed",NA,"2015-03-27",1e+06
"98fcf0fc99881581931b4dffae6fada1","healionics","venture","b","2008-12-11",2600000
"5303bc535518f9d893db6f1412b3cc2b","healios-k-k","venture",NA,"2013-10-08",29167989
"4aafb89c337b00129e78c76ba16194d3","healor","venture","B","2007-11-27",8e+06
"4aafb89c337b00129e78c76ba16194d3","healor","venture","c","2010-11-04",7500000
"ff80073912d6d9afabdcf672c5c676e2","health-care-dataworks","private_equity",NA,"2013-05-14",4999541
"37783db409d5668124cfef99acce2279","health-catalyst","venture","b","2013-03-01",8e+06
"37783db409d5668124cfef99acce2279","health-catalyst","venture","b","2013-01-08",3.3e+07
"37783db409d5668124cfef99acce2279","health-catalyst","venture","c","2014-01-27",4.1e+07
"37783db409d5668124cfef99acce2279","health-catalyst","venture","a","2011-09-01",NA
"37783db409d5668124cfef99acce2279","health-catalyst","venture","D","2015-03-17",7e+07
"1385784a25539656c716bb9eda5558a3","health-dialog",NA,NA,NA,NA
"90d9c7ef89905191ba609eaf3649e79d","health-discovery","venture",NA,"2009-04-08",475000
"3c959e75f968aa3118838c3e2f6a173d","health-efilings","debt_financing",NA,"2015-06-29",934500
"90961453fc24545105bacce84f8543ce","health-essentials","undisclosed",NA,"2012-10-25",NA
"90961453fc24545105bacce84f8543ce","health-essentials","venture",NA,"2013-08-02",1006102
"f031f18a5ccf5fbd6deccf5400092bd1","health-evillages","seed",NA,"2013-08-27",58000
"b0210b0d843773fa0bfd44b13d468d1c","health-fidelity","venture",NA,"2015-01-09",19264593
"6590a28860e6382150bc3721bcc4351f","beijing-health-guard-biotechnology-co-ltd","venture","A","2008-09-01",2194051
"d94620afb776e07edfc0fcab5c01362f","health-imaging-hub",NA,NA,NA,NA
"f1cea04b5a235f2fe9b5aaf69c432e7a","health-information-designs","undisclosed",NA,"2012-05-21",NA
"79a18711bdb1383e86e22ac9828d39cc","health-integrated","venture",NA,"2013-12-19",3e+06
"79a18711bdb1383e86e22ac9828d39cc","health-integrated","venture",NA,"2012-07-17",1069000
"79a18711bdb1383e86e22ac9828d39cc","health-integrated","venture",NA,"2013-04-19",124628
"79a18711bdb1383e86e22ac9828d39cc","health-integrated","undisclosed",NA,"2003-01-01",NA
"79a18711bdb1383e86e22ac9828d39cc","health-integrated","debt_financing",NA,"2014-06-11",4e+06
"6f3c3d1b22f5b7e3cc8420da15d38250","health-level",NA,NA,NA,NA
"6e5be54fc145c89ee95af9d67b17ec6b","health-market-science","venture",NA,"2005-01-27",4250000
"6e5be54fc145c89ee95af9d67b17ec6b","health-market-science","debt_financing",NA,"2010-02-17",2e+06
"6e5be54fc145c89ee95af9d67b17ec6b","health-market-science","venture","1","2010-08-23",6100000
"6e5be54fc145c89ee95af9d67b17ec6b","health-market-science","venture",NA,"2009-04-29",5589377
"829cf72784c8eb1df8f2cfb9b211cdb9","health-outcomes-sciences","venture","a","2014-03-12",12750000
"829cf72784c8eb1df8f2cfb9b211cdb9","health-outcomes-sciences","venture",NA,"2011-02-17",2998632
"25cbd8acdfff845c8557d81a24cb4f96","health-outcomes-worldwide","undisclosed",NA,"2011-06-30",NA
"ebd8e7cc5e5e735785e9384930b997eb","health-revenue-assurance-holdings","venture",NA,"2013-11-15",5400000
"ef2214a5c718a25e4eea4df07e536b10","health-vectors",NA,NA,NA,NA
"f08e5faaddf469e68f11f636715c6b22","healthcanal",NA,NA,NA,NA
"02211dadd6b0e2b5a80d5a4568353ee9","healthcare-corporation-of-america","private_equity",NA,"2012-10-15",5925000
"02211dadd6b0e2b5a80d5a4568353ee9","healthcare-corporation-of-america","debt_financing",NA,"2014-06-25",3200000
"c43e12146c34d5e2bbefdc41d40faae2","healtheo360","venture",NA,"2012-07-24",3e+05
"971c1b718c73009280726ecf33b55ffb","healthfleet-com","venture",NA,"2013-05-06",723723
"ce80b616e25855b41f8add33ef0a72a3","healthjump","angel",NA,"2015-04-07",1004999
"658c9a2162fbe97848c2604aef7dd3c7","healthnostics",NA,NA,NA,NA
"692920e09adb50d6c6dde3fb50a5e33e","healtho",NA,NA,NA,NA
"7da70706e893670239b7487a9bca7868","healthonomy","venture",NA,"2012-08-08",322500
"3da73c72971231a8b72fdeccfccece5a","healthplan-data-solutions","venture",NA,"2011-08-16",50000
"3da73c72971231a8b72fdeccfccece5a","healthplan-data-solutions","venture",NA,"2015-01-14",1750000
"f7544e42f60aeb2290312de2a790e382","healthscripts-of-america","venture",NA,"2013-09-27",1450000
"f7544e42f60aeb2290312de2a790e382","healthscripts-of-america","venture",NA,"2014-04-08",150000
"f7544e42f60aeb2290312de2a790e382","healthscripts-of-america","venture",NA,"2013-10-31",170000
"f7544e42f60aeb2290312de2a790e382","healthscripts-of-america","venture",NA,"2013-12-26",120000
"f7544e42f60aeb2290312de2a790e382","healthscripts-of-america","venture",NA,"2014-05-19",30000
"f7544e42f60aeb2290312de2a790e382","healthscripts-of-america","venture",NA,"2014-09-10",105000
"198d40a1e8bae2f9a476365113b59b5d","healthsense","undisclosed",NA,"2010-08-25",NA
"198d40a1e8bae2f9a476365113b59b5d","healthsense","venture","1","2012-09-20",7e+06
"198d40a1e8bae2f9a476365113b59b5d","healthsense","venture",NA,"2013-01-07",7e+06
"198d40a1e8bae2f9a476365113b59b5d","healthsense","debt_financing",NA,"2013-12-23",330000
"198d40a1e8bae2f9a476365113b59b5d","healthsense","debt_financing",NA,"2014-04-15",2e+06
"198d40a1e8bae2f9a476365113b59b5d","healthsense","venture",NA,"2009-04-01",1500000
"198d40a1e8bae2f9a476365113b59b5d","healthsense","venture",NA,"2013-05-23",4300000
"198d40a1e8bae2f9a476365113b59b5d","healthsense","venture","1","2014-08-19",1e+07
"bb99dabcb21154370db3f246277e7882","healthsmart-holdings","private_equity",NA,"2012-01-13",15999996
"e364e0edd59a1dc1bdc1aaecbdab2be0","healthspring","venture","b","2013-06-19",3700000
"7c5a23af28a3663c127531d09edf098f","healthsynch","debt_financing",NA,"2012-11-07",325000
"7c5a23af28a3663c127531d09edf098f","healthsynch","debt_financing",NA,"2013-03-22",6e+05
"c7bd94388ed2e530470a7a253bda069b","healthtech-women",NA,NA,NA,NA
"5de1b489c603651dadf926610a3cd446","healthtronics",NA,NA,NA,NA
"b0396aa2c9a2926c9da6f5b79fb76e5f","healthunity","venture",NA,"2006-04-28",2054840
"b0396aa2c9a2926c9da6f5b79fb76e5f","healthunity","debt_financing",NA,"2010-10-22",960000
"b0396aa2c9a2926c9da6f5b79fb76e5f","healthunity","venture",NA,"2010-07-09",8e+05
"e155e3cdaa0cacaade85fdc12fb70103","healthy-bytes","seed",NA,"2015-02-05",20000
"2de2d0f4a95d4c005520f1584f63788a","healthyroad","angel",NA,"2014-08-07",200568.7238
"2de2d0f4a95d4c005520f1584f63788a","healthyroad","seed",NA,"2014-06-01",40000
"6f15a3cf6de1e49d8bb205e8c94c8740","heap","seed",NA,"2013-08-27",2e+06
"295ffa53ba24c3bf3e2fdb42daa2a314","heardable",NA,NA,NA,NA
"6cab94b90e7bc0ff8826caa1cf29b31f","heart-health","venture",NA,"2009-04-24",1310000
"c223d16fba4c8bf816d75c09a6b1e7c9","heart-metabolics","venture","a","2013-01-04",4e+06
"c223d16fba4c8bf816d75c09a6b1e7c9","heart-metabolics","venture","a","2014-04-16",2e+07
"999eb897c1dfdef5dba6bc2196904ab3","heartbeat-software",NA,NA,NA,NA
"0074c1105dd94af129a7cecd2ae1b86c","heartflow","venture",NA,"2011-02-04",20416022
"0074c1105dd94af129a7cecd2ae1b86c","heartflow","debt_financing",NA,"2010-06-14",1e+07
"0074c1105dd94af129a7cecd2ae1b86c","heartflow","venture",NA,"2010-04-19",1600000
"0074c1105dd94af129a7cecd2ae1b86c","heartflow","private_equity",NA,"2014-02-27",104699896
"0074c1105dd94af129a7cecd2ae1b86c","heartflow","venture",NA,"2015-02-13",3.6e+07
"46cc1c1c6c24ca27d4519bf8e2bb0cc4","heartsounds",NA,NA,NA,NA
"7938cae2062101cb4591897e93035a79","heat-biologics","venture","a","2012-05-21",2800000
"7938cae2062101cb4591897e93035a79","heat-biologics","venture",NA,"2009-11-18",249750
"7938cae2062101cb4591897e93035a79","heat-biologics","private_equity",NA,"2013-04-09",5050050
"7938cae2062101cb4591897e93035a79","heat-biologics","post_ipo_debt",NA,"2014-08-25",7500000
"2eb99bdcd2f22fbe5694994807d6da83","heatdata",NA,NA,NA,NA
"47b7d572878cbc607fb861b844c3f4cc","heatmap-inc",NA,NA,NA,NA
"be2b01c971b3f49a8852a2bebeaa7582","heatsync","seed",NA,"2013-01-01",5e+05
"dbb4d8539c5bb411a92401a4b2b70287","heaty",NA,NA,NA,NA
"6e96977d8a917302915383ab94e7a1d5","heaven-2",NA,NA,NA,NA
"e54d7f0b8eafc99bccc1da7898286479","heckyl","angel",NA,"2012-01-01",1e+06
"e54d7f0b8eafc99bccc1da7898286479","heckyl","venture","1","2013-12-10",3500000
"e54d7f0b8eafc99bccc1da7898286479","heckyl","seed",NA,"2013-05-17",250000
"71422bd80d6fb7ab5cafed25f39c45df","hedgeye-risk-management","venture","a","2013-01-23",NA
"be6351d78ef3bd14161d4a19d0a54895","heilongjiang-weikang-bio-tech-group","venture",NA,"2010-02-18",2500000
"be6351d78ef3bd14161d4a19d0a54895","heilongjiang-weikang-bio-tech-group","venture",NA,"2010-12-20",2499994
"ae033e471601cddf6baf08bfbb8946ef","heinrich-group",NA,NA,NA,NA
"3a82074d2bed827e4a1596addd98aef4","heliae","venture",NA,"2012-05-02",1.5e+07
"3a82074d2bed827e4a1596addd98aef4","heliae","venture",NA,"2013-09-03",8e+07
"3a82074d2bed827e4a1596addd98aef4","heliae","venture",NA,"2013-07-09",28400000
"e3a93ff17b1050b63b83b239fdd85f44","helical-it-solutions","seed",NA,"2013-05-10",2500000
"b045124e9c64e2177b9e4a8ac763515b","helicon-therapeutics","venture","f","2009-09-29",5e+07
"0b39d79908e19105d55838e1d1a311d8","helicos-biosciences","venture",NA,"2009-09-28",10000008
"5a400c46d0efebfe8cf06d7f7dfa44e2","helios-innovative-technologies","seed",NA,"2013-04-10",500009
"7346f8075e08e766ce9cadb898dcc495","helius-medical-technologies","venture",NA,"2015-10-26",2e+06
"7346f8075e08e766ce9cadb898dcc495","helius-medical-technologies","venture",NA,"2015-05-07",1825937
"7346f8075e08e766ce9cadb898dcc495","helius-medical-technologies","venture",NA,"2015-07-14",721245
"1b3347baae07785888559e271851f6fd","helix-biomedix","venture",NA,"2011-01-07",5978276
"1b3347baae07785888559e271851f6fd","helix-biomedix","debt_financing",NA,"2010-03-12",2900000
"1b3347baae07785888559e271851f6fd","helix-biomedix","venture",NA,"2013-05-01",5e+05
"00dcf3e7d69170b1fa883d146d02aa1f","helix-biopharma",NA,NA,NA,NA
"905791fc55e00eeede41f9780068f831","helix-medical",NA,NA,NA,NA
"1d7efe4b86220d7031bc1635923aa97e","helix-therapeutics","seed",NA,"2010-01-11",6e+05
"1d7efe4b86220d7031bc1635923aa97e","helix-therapeutics","debt_financing",NA,"2009-03-19",262500
"1d7efe4b86220d7031bc1635923aa97e","helix-therapeutics","venture","1","2010-11-23",2500000
"5b4aa869d7e674aba4a5f523e1286bbb","helixbind","venture",NA,"2014-02-24",1650000
"9c094c68d48495ed110d7900b12c65a9","helixis","venture",NA,"2009-10-21",7333335
"9c094c68d48495ed110d7900b12c65a9","helixis","venture","1","2007-08-30",1e+07
"57eea9ad9220dc7535543621209cb138","hellerstein-consulting",NA,NA,NA,NA
"beee9225f8812f86cd656fedba74dcef","hellosoda",NA,NA,NA,NA
"5a9f48d92ff8f211da75332c087e9b62","helmholtz-zentrum-m-nchen",NA,NA,NA,NA
"61c45b76db5549667eda9f0d9c2aef54","precision-therapeutics","venture","d","2010-06-11",3.3e+07
"61c45b76db5549667eda9f0d9c2aef54","precision-therapeutics","undisclosed",NA,"1998-04-01",NA
"61c45b76db5549667eda9f0d9c2aef54","precision-therapeutics","venture","E","2014-11-13",6e+07
"daf9dd378bce4ad4bac907324421d5be","help-remedies","venture",NA,"2011-01-05",1431003
"563cf40b53084dd77b1ca956ec7787a9","planning-to",NA,NA,NA,NA
"05984de23ce1631262f31c0f0a2cc256","helpaway-com",NA,NA,NA,NA
"01c631947e1ee0c64286865c0b73ecfd","helpest-21",NA,NA,NA,NA
"2f69aa603399e4ef6b1a3ca16c1de730","helppier",NA,NA,NA,NA
"5a6f672634bba60f3d5116eb87e859c2","helynx",NA,NA,NA,NA
"780924c21f6ae3bf02c30b98ad02b3f3","hemacare",NA,NA,NA,NA
"185012bbaed26eb62eeb0efd57b74e6b","hemaquest-pharmaceuticals","venture","A","2007-11-02",2e+07
"185012bbaed26eb62eeb0efd57b74e6b","hemaquest-pharmaceuticals","venture","b","2012-03-12",1.3e+07
"185012bbaed26eb62eeb0efd57b74e6b","hemaquest-pharmaceuticals","venture","b","2010-04-21",1.2e+07
"185012bbaed26eb62eeb0efd57b74e6b","hemaquest-pharmaceuticals","venture",NA,"2012-03-07",6499999
"eb3da156333cc206c8e66df280f23d4d","hemarina","venture","a","2009-02-16",1090000
"eb3da156333cc206c8e66df280f23d4d","hemarina","venture","b","2010-07-02",3700000
"6ad5d7fe2c6670f4e41e3a1882146852","hemasource","venture",NA,"2010-02-18",13488000
"83e10b8f4874a48a41d4bf4722b7abe9","hematris-wound-care","venture",NA,"2009-11-29",3e+06
"b8020b1e7698f7831a9569c0d3460618","general-blood","venture",NA,"2011-07-18",650000
"0955657c2f745bd0be8637190a2a371c","hemera-biosciences","venture",NA,"2013-04-01",1299956
"ff498916c8991bdd3a8b67f18285167e","hemerus-medical",NA,NA,NA,NA
"35d9c90ca7076087d5ee961021edf09c","hemingway-and-associates","private_equity",NA,"2014-01-01",2e+07
"ec557f94eb1144697251257a4190a912","hemmo-pharmaceuticals",NA,NA,NA,NA
"7a5e3a3d44f663d287880923042ee57a","hemobiotech-inc","debt_financing",NA,"2009-11-04",160000
"d4387125e8f9f4ff462353dc9f504161","hemogenyx","seed",NA,"2014-12-12",250000
"047ba907ad86f4e905de9cfbb8cb18e4","hemoshear","venture","d","2012-10-24",4e+06
"047ba907ad86f4e905de9cfbb8cb18e4","hemoshear","venture",NA,"2010-09-13",250000
"047ba907ad86f4e905de9cfbb8cb18e4","hemoshear","venture",NA,"2012-03-26",50000
"047ba907ad86f4e905de9cfbb8cb18e4","hemoshear","venture",NA,"2009-04-15",150000
"047ba907ad86f4e905de9cfbb8cb18e4","hemoshear","venture","C","2014-05-07",8700000
"76a8e6ce201a8483ae2a97f882dde060","hepalife-technologies-inc",NA,NA,NA,NA
"fd541f9feecf2e91bde78af1f78a8e1f","hepalink",NA,NA,NA,NA
"dc74ba055b5f8ca8a85831fcbad68171","hepatochem","venture",NA,"2011-10-14",1e+05
"dc74ba055b5f8ca8a85831fcbad68171","hepatochem","debt_financing",NA,"2012-04-30",330000
"7516f04eb8feff9c74e8197b58c015b4","hepregen","grant",NA,"2010-01-15",5e+05
"7516f04eb8feff9c74e8197b58c015b4","hepregen","grant",NA,"2011-05-25",5e+05
"7516f04eb8feff9c74e8197b58c015b4","hepregen","grant",NA,"2012-06-27",5e+05
"7516f04eb8feff9c74e8197b58c015b4","hepregen","venture","1","2008-09-02",3e+06
"ed7a6520c88185d45c3e7c66276ad047","heptares-therapeutics","seed",NA,"2007-08-10",NA
"ed7a6520c88185d45c3e7c66276ad047","heptares-therapeutics","venture","1","2013-06-27",2.1e+07
"ed7a6520c88185d45c3e7c66276ad047","heptares-therapeutics","grant",NA,"2015-09-28",5500000
"286f5ee1edef93ceec005fd878cf6395","hera-therapeutics","venture",NA,"2013-06-12",501006
"286f5ee1edef93ceec005fd878cf6395","hera-therapeutics","debt_financing",NA,"2014-07-10",1100000
"286f5ee1edef93ceec005fd878cf6395","hera-therapeutics","venture",NA,"2014-12-23",1745019
"286f5ee1edef93ceec005fd878cf6395","hera-therapeutics","venture","1","2015-08-06",1.6e+07
"1aabb250f6898777668b3e1400b2ed4c","herborium-group","venture",NA,"2011-11-14",25000
"5715cd32c173030c42ddc08b824d0a10","hermes-clinical","seed",NA,"2013-01-21",118000
"b9e83450c9bf3c8c386e61b6413e8775","heron-therapeutics",NA,NA,NA,NA
"7ae2d60a0500822e937a6c0ed805cd0e","herta-security",NA,NA,NA,NA
"48902b6d31f4acf7d36410bd97399b3f","heska","private_equity",NA,"2013-03-05",3570000
"c7a01814cb1fc14ea11af901f03e54cf","heureka-software-llc","convertible_note",NA,"2014-10-01",350000
"c7a01814cb1fc14ea11af901f03e54cf","heureka-software-llc","debt_financing",NA,"2015-04-01",750000
"c7a01814cb1fc14ea11af901f03e54cf","heureka-software-llc","non_equity_assistance",NA,"2015-08-01",825000
"293f50b429bf8c6ccf82a018fe70e4d6","heurolabs",NA,NA,NA,NA
"d2dd2b01404d2c34ba6cf4bcd030f8ab","the-hexagon-lavish",NA,NA,NA,NA
"84e9893664380e13238fa891f108fc66","hexagram-49","venture",NA,"2011-09-16",3e+06
"84e9893664380e13238fa891f108fc66","hexagram-49","venture",NA,"2013-11-25",8e+06
"f1796ba83c777a49b009b5382da5dc04","hexa-tech-labs",NA,NA,NA,NA
"ea10327d3b2d7c1aa10dd857eed55f5b","hexcare",NA,NA,NA,NA
"54c9a3ab64c049a18cc1a7c101a4f5f3","hexio","seed",NA,"2008-01-10",20000
"3b100f4a0c46b643719210a1c60e939c","hexis-com-br",NA,NA,NA,NA
"f9294443caebc3fdc1f1345ee9426217","heystaks","venture",NA,"2010-10-28",1385700
"f9294443caebc3fdc1f1345ee9426217","heystaks","venture",NA,"2013-10-30",1029280
"f9294443caebc3fdc1f1345ee9426217","heystaks","venture",NA,"2015-07-28",1654880
"5b32cdb79530a3048f466afa1daf7ec4","heyzap","seed",NA,"2009-01-01",30000
"5b32cdb79530a3048f466afa1daf7ec4","heyzap","seed",NA,"2009-05-27",650000
"5b32cdb79530a3048f466afa1daf7ec4","heyzap","venture",NA,"2009-01-01",15000
"5b32cdb79530a3048f466afa1daf7ec4","heyzap","venture","1","2010-06-23",3e+06
"5b32cdb79530a3048f466afa1daf7ec4","heyzap","venture","1","2012-12-01",4300000
"83c9148920f6dc5fb3c828703fb6b281","hfin-one",NA,NA,NA,NA
"3070fcdcb2f4c984d34efcb50c6f5579","hfs-research",NA,NA,NA,NA
"5f18182f9b756f530849c9ad7b0e9361","hg-data-company","venture",NA,"2012-02-10",160000
"5f18182f9b756f530849c9ad7b0e9361","hg-data-company","venture",NA,"2013-03-13",2e+06
"5f18182f9b756f530849c9ad7b0e9361","hg-data-company","seed",NA,"2010-10-01",1500000
"5f18182f9b756f530849c9ad7b0e9361","hg-data-company","venture",NA,"2012-12-26",599998
"5f18182f9b756f530849c9ad7b0e9361","hg-data-company","venture","1","2014-05-06",2e+06
"fec0e249d34d504953494eadbdcea981","hg-intelligence","venture",NA,"2015-09-01",135000
"fec0e249d34d504953494eadbdcea981","hg-intelligence","seed",NA,"2013-07-01",90000
"fec0e249d34d504953494eadbdcea981","hg-intelligence","venture",NA,"2014-07-01",3e+05
"fec0e249d34d504953494eadbdcea981","hg-intelligence","venture",NA,"2015-06-01",150000
"5c01ad53e635c631912d711767ba7d02","hi-tech-pharmacal",NA,NA,NA,NA
"0e3a304c8ce9e6fb35e1f28d538d7134","health-iq","seed",NA,"2014-12-17",5500000
"a14cf8b35b467d84995403d7c03574a0","hibergene-diagnostics","venture","B","2016-01-19",1635590.4482
"a14cf8b35b467d84995403d7c03574a0","hibergene-diagnostics","seed",NA,"2015-02-02",2260052
"5c62129560119fcef1de3ff8b453a55c","hiberna","debt_financing",NA,"2009-03-13",1e+05
"e5457fab700514ce05da3674370d4324","hibernaut",NA,NA,NA,NA
"0b3988e9e2f267f68feaae0699e40b30","hiconversion","debt_financing",NA,"2015-11-10",280000
"0b3988e9e2f267f68feaae0699e40b30","hiconversion","venture","1","2010-11-23",1500000
"0b3988e9e2f267f68feaae0699e40b30","hiconversion","venture","1","2012-08-09",1300000
"0b3988e9e2f267f68feaae0699e40b30","hiconversion","debt_financing",NA,"2014-02-07",2625000
"87b4c00a0b38e029a341826406915fdc","hideo-2",NA,NA,NA,NA
"61d654cd47345d4f61eefc521821cb7b","high-throughput-genomics","venture","C","2007-10-23",1e+07
"61d654cd47345d4f61eefc521821cb7b","high-throughput-genomics","debt_financing",NA,"2010-08-06",1738500
"61d654cd47345d4f61eefc521821cb7b","high-throughput-genomics","venture","d","2011-02-23",15700000
"61d654cd47345d4f61eefc521821cb7b","high-throughput-genomics","venture","c","2009-07-23",4310000
"71e5ad9f85f5dc224ddf5beb7ea4d104","highland-therapeutics","private_equity",NA,"2013-08-16",6700000
"71e5ad9f85f5dc224ddf5beb7ea4d104","highland-therapeutics","private_equity",NA,"2014-10-16",2.5e+07
"71e5ad9f85f5dc224ddf5beb7ea4d104","highland-therapeutics","debt_financing",NA,"2015-06-24",2.5e+07
"71e5ad9f85f5dc224ddf5beb7ea4d104","highland-therapeutics","private_equity",NA,"2015-06-24",2.5e+07
"5d0f19275165dc928d886469f5dc2d0f","highline-financial",NA,NA,NA,NA
"7c038648790bd822353fab3402c68263","highly",NA,NA,NA,NA
"39b20a78eaee5f7fde1ca2dd84a5bffc","highres-biosolutions","venture",NA,"2015-07-21",2482728
"018c8a7d93824df86a5a76ae2e85af87","highview-healthcare-partners","venture",NA,"2013-05-14",237921
"018c8a7d93824df86a5a76ae2e85af87","highview-healthcare-partners","venture",NA,"2009-06-02",667500
"240dc21486a1aca62507e7bc1657917b","hikkupz-com",NA,NA,NA,NA
"274067a7038b242dc37df2172269bb1e","hill-country-toxicology",NA,NA,NA,NA
"0f6d519eee242ebe14074fc51d5ca531","himark-biogas-inc",NA,NA,NA,NA
"a12827659c28ce6a8dc8ce2cc7e5d893","hindsait-inc",NA,NA,NA,NA
"4b238b21e6edd3c76083f04fd10e72ad","hipbone","angel",NA,"1999-03-01",750000
"68648511269137e6c8288a400a2bb99f","hipcamp","seed",NA,"2014-09-30",2e+06
"8b6dbf8790eb3df955edbf8c700ef8da","hiptype","seed",NA,"2012-08-01",NA
"022a3ebcbb4a7a301dbce037cc46d168","hiq-labs","convertible_note",NA,"2014-03-17",1e+06
"022a3ebcbb4a7a301dbce037cc46d168","hiq-labs","convertible_note",NA,"2014-10-01",1e+06
"022a3ebcbb4a7a301dbce037cc46d168","hiq-labs","venture","1","2015-07-01",3e+06
"ad2027e61abf6ebf0a63c9ce9f43d6a8","hire-ventures","seed",NA,"2015-01-01",1e+05
"e725db7170a5c59acf3deaa9a00c4154","hireiq-solutions","venture","C","2013-09-25",1500000
"e725db7170a5c59acf3deaa9a00c4154","hireiq-solutions","venture","a","2011-03-25",1300000
"e725db7170a5c59acf3deaa9a00c4154","hireiq-solutions","debt_financing",NA,"2010-03-31",287500
"e725db7170a5c59acf3deaa9a00c4154","hireiq-solutions","debt_financing",NA,"2011-03-02",350000
"e725db7170a5c59acf3deaa9a00c4154","hireiq-solutions","debt_financing",NA,"2012-03-30",8e+05
"e725db7170a5c59acf3deaa9a00c4154","hireiq-solutions","venture","B","2012-09-28",1634844
"e725db7170a5c59acf3deaa9a00c4154","hireiq-solutions","debt_financing",NA,"2015-08-27",1e+06
"b6a6a25aef20c2246c2e5f6eab731d4c","hireology","venture","A","2014-02-04",1431776
"b6a6a25aef20c2246c2e5f6eab731d4c","hireology","seed",NA,"2012-06-04",1e+06
"b6a6a25aef20c2246c2e5f6eab731d4c","hireology","seed",NA,"2013-06-28",6e+05
"b6a6a25aef20c2246c2e5f6eab731d4c","hireology","venture","B","2015-05-20",10500002
"33bb935a7d937af674dc524f5f3242bd","hireteammate","seed",NA,"2015-08-01",1500000
"33bb935a7d937af674dc524f5f3242bd","hireteammate","seed",NA,"2015-04-02",NA
"33bb935a7d937af674dc524f5f3242bd","hireteammate","seed",NA,"2015-04-01",NA
"5f5e370dc358262e30af8932c73e7741","hiro",NA,NA,NA,NA
"ee502bea2d05824c83745b8d3c884418","hisamitsu-pharmaceutical",NA,NA,NA,NA
"66e2a16207434ff8f26b08fda5cc1e82","histide","venture","A","2014-11-10",4600000
"d6f387625820fc0122afc5d12d67e6e0","histogen","venture",NA,"2015-06-29",24900000
"2178fd89e493fd6a55c456353b9525e6","histogenics","venture","c","2012-07-23",4.9e+07
"2178fd89e493fd6a55c456353b9525e6","histogenics","venture","b","2008-09-04",13100000
"2178fd89e493fd6a55c456353b9525e6","histogenics","debt_financing",NA,"2011-05-27",34300000
"bab3147a1e5fe613ffef7d68c53dc373","historx","venture","B","2007-10-24",6e+06
"bab3147a1e5fe613ffef7d68c53dc373","historx","venture",NA,"2011-05-27",2600000
"bab3147a1e5fe613ffef7d68c53dc373","historx","venture",NA,"2009-11-23",3160546
"2830e69a6bb3e279bbc5ad4c6203ef7a","histosonics","venture","a","2010-02-22",1.1e+07
"2830e69a6bb3e279bbc5ad4c6203ef7a","histosonics","venture","B","2014-05-19",14172418
"2830e69a6bb3e279bbc5ad4c6203ef7a","histosonics","debt_financing",NA,"2014-12-23",1500000
"2830e69a6bb3e279bbc5ad4c6203ef7a","histosonics","debt_financing",NA,"2015-09-03",3500000
"757442e2191c842ceaaff49859850c06","hit-software",NA,NA,NA,NA
"287507a39f25c0a342fbd6cefba10750","hitch2cloud",NA,NA,NA,NA
"7ff8e1c431f2d942fe3fabd530c87610","hitfox-group","seed",NA,"2011-06-01",NA
"7ff8e1c431f2d942fe3fabd530c87610","hitfox-group","venture","1","2012-05-07",5235670
"55edf5ec1f1f8c44327603687a547719","go-hitlist","seed",NA,"2014-07-18",20000
"cb71b3efeb6cde4779b89df5c65be362","hive-13","seed",NA,"2015-10-15",20000
"d69a3d5c12924880d1d1e4fa8536bd01","ticketlabs","venture",NA,"2015-02-20",NA
"d69a3d5c12924880d1d1e4fa8536bd01","ticketlabs","seed",NA,"2014-07-16",120000
"2aa54ef01e5dba2b339fd146b83ecf32","hive-intelligence",NA,NA,NA,NA
"9a7a09814014a9612c7cd7cdbae1fe4c","hlh-agri-international",NA,NA,NA,NA
"75239bcb7f1769f5465121d2e5e8d759","hlh-agri-r-d",NA,NA,NA,NA
"aaf3a1b9572ab9a78372c3d0df6dbbdd","hms-health","venture",NA,"2009-05-28",1355000
"723e4d19af7d00c68041a9e6ed047683","hnc-software-inc",NA,NA,NA,NA
"d36cf833556bc978b3c69eab7a2bd5b5","hocrox",NA,NA,NA,NA
"8d486cefcab58633864c85d83bb32f18","holaira","venture","D","2014-04-03",4.2e+07
"f9d82ca41ff016716007e137a40af2e1","holganix","venture",NA,"2012-01-19",2e+05
"f9d82ca41ff016716007e137a40af2e1","holganix","seed",NA,"2015-01-20",1e+05
"74c5a0f45ee8d21183faef3e90b6b837","hollywood-os",NA,NA,NA,NA
"64a27b10447497e0883231e9efb9d2b6","hologic","debt_financing",NA,"2010-11-30",4.5e+08
"cf5d9d8c145e92a55553e6307346bd95","holosofx",NA,NA,NA,NA
"380a8faeb4f83025405cd3b9f7b1b956","homebase-io",NA,NA,NA,NA
"b6d2194fcf7abc30c05f62b44002432f","homebiogas",NA,NA,NA,NA
"794a78536a8e9a4074c06c3afe99c384","hutbitat",NA,NA,NA,NA
"bbdf0865eef9e242398b1d10e5a64297","homeland-holdco",NA,NA,NA,NA
"ab2a036aa6cbea56e3fa0b463eeaa1fc","homeostasis-labs","venture",NA,"2011-02-01",225000
"ab2a036aa6cbea56e3fa0b463eeaa1fc","homeostasis-labs","venture",NA,"2010-05-17",897000
"31dba71f9f6ed0df0cd23773dfa53680","homesnap","seed",NA,"2009-07-01",2e+06
"31dba71f9f6ed0df0cd23773dfa53680","homesnap","venture","1","2012-08-06",3500000
"c295fb0333ea3b2240a3d9d905b4bda9","hommes-et-process",NA,NA,NA,NA
"a92815d5f8f158f15eb248a1c1aa2fe9","honeit-inc","undisclosed",NA,"2014-08-15",NA
"2d4f2e368c06a945a4e58bc656258d16","honeytracks",NA,NA,NA,NA
"c716a721013670b5c8da6fbcf4daa693","honeywell-technology-solutions",NA,NA,NA,NA
"56306517a2b1b26772e01b660dd87414","honolulu-data-scraping",NA,NA,NA,NA
"041a604755847ae43399adfc11690bb4","hookfeed",NA,NA,NA,NA
"8d8529eeecd759bf0c785426bb09b37b","hookipa-biotech","venture","a","2011-10-18",9573200
"8d8529eeecd759bf0c785426bb09b37b","hookipa-biotech","venture","b","2013-11-04",25732000
"ff1e62cdfc92ff4a0bd8f86e14f58790","hookit","seed",NA,"2009-05-19",8e+05
"5d8a084e91a9a95b6202590994de93bc","hoonio",NA,NA,NA,NA
"0659accbc67223c64ebc57a53d2869ce","hootsuite","venture","a","2009-12-01",1900000
"0659accbc67223c64ebc57a53d2869ce","hootsuite","venture","B","2013-08-01",1.65e+08
"0659accbc67223c64ebc57a53d2869ce","hootsuite","debt_financing",NA,"2011-09-15",3e+06
"0659accbc67223c64ebc57a53d2869ce","hootsuite","venture",NA,"2012-03-29",2e+07
"0659accbc67223c64ebc57a53d2869ce","hootsuite","venture","D","2014-09-25",6e+07
"432ac4bb240537ed6ee17a9c596cb84b","hoovers-a-d-b-company",NA,NA,NA,NA
"9ff5a3a8081fc56e905a4d7e94e4fe69","hop-skip-connect","venture",NA,"2010-06-08",6015700
"7b53c22382e8324fa70afba91e886d9f","homefront-learning-center","debt_financing",NA,"2013-09-10",2e+05
"7b53c22382e8324fa70afba91e886d9f","homefront-learning-center","venture",NA,"2014-12-05",1180000
"7b53c22382e8324fa70afba91e886d9f","homefront-learning-center","venture",NA,"2015-08-12",1220443
"0e70a9f04322ea13f246b7be1ff2a856","hopes-creek",NA,NA,NA,NA
"9bb4d5b5cda73deef62e0c63fd542089","hoppit","seed",NA,"2012-07-01",5e+05
"a81088117cca422f3f005a1c3f04b01c","horizon-business-funding",NA,NA,NA,NA
"a48d2ad430878c90ca1ad8ec810b7da4","horizon-discovery","venture","C","2011-09-13",11098485
"a48d2ad430878c90ca1ad8ec810b7da4","horizon-discovery","venture","c","2013-06-03",10455234
"a48d2ad430878c90ca1ad8ec810b7da4","horizon-discovery","venture","c","2012-01-16",18600000
"a48d2ad430878c90ca1ad8ec810b7da4","horizon-discovery","venture","a","2008-04-07",298000
"a48d2ad430878c90ca1ad8ec810b7da4","horizon-discovery","venture","c","2010-09-28",9800000
"a3aeaf2570f40f4f72746a20ad4246a0","horizon-therapeutics","venture","C","2007-07-23",3e+07
"a3aeaf2570f40f4f72746a20ad4246a0","horizon-therapeutics","debt_financing",NA,"2009-07-22",1.2e+07
"a3aeaf2570f40f4f72746a20ad4246a0","horizon-therapeutics","debt_financing",NA,"2013-12-09",1.5e+08
"a3aeaf2570f40f4f72746a20ad4246a0","horizon-therapeutics","debt_financing",NA,"2014-06-19",3e+08
"cc28da5960e6211b9aa33a225467e46f","horus-technology","seed",NA,"2016-01-13",9e+05
"8262b820928e4d052ff46d20452ef64b","hostelbench",NA,NA,NA,NA
"dc82472efae7c2b9b05e7ffaae74d815","hot-dot","venture",NA,"2011-09-06",370251
"dc82472efae7c2b9b05e7ffaae74d815","hot-dot","venture",NA,"2013-07-17",3186312
"51a22676fe529f3b48ae0f4ba1ae22c1","hotel-commander",NA,NA,NA,NA
"a30f61d3863e27fc91aab25eb5d31f51","hotelbench-com",NA,NA,NA,NA
"6ada3b8bed0140149007de9f155dc32a","hotelinking",NA,NA,NA,NA
"9cdf9f89db2b10e9ca7805e8d26f4bbd","hotfrog-com-database",NA,NA,NA,NA
"969116b0ec3e5eff8680f29698b9ecbf","hotjar",NA,NA,NA,NA
"6fa8462543525f1574b108fdbbadc630","hotsocket-inc",NA,NA,NA,NA
"17daa716a433dddb1572497958ada92f","hotspots-io",NA,NA,NA,NA
"13606d0e09acc29ce0c58d920ee2f85b","hottolink","venture","C","2012-12-03",NA
"2a40c88908f76c8da8700a482e9a8f83","housecanary","undisclosed",NA,"2015-05-22",NA
"2239b5ae5f218d40b888932aeeffe133","houston-dynamic-displays",NA,NA,NA,NA
"a38435e77d18dd45fa05bcfc94f822c8","houston-technology",NA,NA,NA,NA
"4bde0942b5748c96f56686c55654669b","howdandy",NA,NA,NA,NA
"294d9e1d3ff13663ba1b7032c4de55e3","hp-autonomy",NA,NA,NA,NA
"7b10c70874f6c55c93f8ffa1f8fc0047","hr-cloud",NA,NA,NA,NA
"544d178b4ebe6850dacbf49b244a7a89","hrware",NA,NA,NA,NA
"1c7e4acdb8371919aba08fe199fdb4c8","hs-pharmaceuticals","venture",NA,"2009-03-16",8551655
"05eba33e2f210657cc6918472c55ad3f","hstreaming","seed",NA,"2013-02-14",1e+06
"529919f6c75cd880787fd47ad1e02bb1","htg-molecular-diagnostics","venture","e","2014-02-13",7476879
"529919f6c75cd880787fd47ad1e02bb1","htg-molecular-diagnostics","venture",NA,"2012-11-14",7555498
"529919f6c75cd880787fd47ad1e02bb1","htg-molecular-diagnostics","venture","d","2011-02-24",15700000
"529919f6c75cd880787fd47ad1e02bb1","htg-molecular-diagnostics","venture","d","2011-06-13",5e+05
"529919f6c75cd880787fd47ad1e02bb1","htg-molecular-diagnostics","debt_financing",NA,"2014-08-29",1.6e+07
"a4be801b26bf39e2fd29cac0b08e2332","guangzhou-huafeng-biotech-co-ltd","venture","A","2009-01-01",2929687
"a4be801b26bf39e2fd29cac0b08e2332","guangzhou-huafeng-biotech-co-ltd","venture","B","2009-12-01",NA
"2250442b7a7686b784aa7403a5896008","hub-scan-inc-","seed",NA,"2011-12-01",5e+05
"2250442b7a7686b784aa7403a5896008","hub-scan-inc-","seed",NA,"2013-07-01",5e+05
"cacd7eee119e53ec8eb5205eac47f245","hubble-telemedical","venture","A","2014-02-25",4e+05
"cacd7eee119e53ec8eb5205eac47f245","hubble-telemedical","seed",NA,"2012-06-01",250000
"cacd7eee119e53ec8eb5205eac47f245","hubble-telemedical","seed",NA,"2012-11-01",3e+05
"cacd7eee119e53ec8eb5205eac47f245","hubble-telemedical","seed",NA,"2013-06-01",2e+05
"b847a4ad1dc150db280dd119e65adfc3","hubengage",NA,NA,NA,NA
"01c047e4c1ef98ff185f0254f5b13915","hublo","seed",NA,"2013-01-01",NA
"ccde83ee9b1da933a9f0f6368fb4d9df","hubskip","angel",NA,"2012-09-01",350000
"ccde83ee9b1da933a9f0f6368fb4d9df","hubskip","seed",NA,"2013-07-25",NA
"baa31fb02f4e841c02f46b3c735c45a3","hubstream","debt_financing",NA,"2015-05-29",1e+05
"7dd54ad857003168eea699a5f453aaec","hubvents",NA,NA,NA,NA
"0cb9337c1afaf2755d57f231a12feb5b","huddlehive",NA,NA,NA,NA
"434e6211f3c9793790e39ba612a4b07a","hudson-valley-technology-development-center",NA,NA,NA,NA
"b912e5d1d37079ddd9e6d41a7a57c67b","huffle",NA,NA,NA,NA
"557e6d7cafc5153528cfcdffbb9de46a","huge",NA,NA,NA,NA
"47109fbb71ca572067452cbbe6299f6d","hugo","convertible_note",NA,"2015-02-11",142706
"47109fbb71ca572067452cbbe6299f6d","hugo","grant",NA,"2015-07-24",230248
"b2333270c72e6e989cde8b51c9a14736","hull","seed",NA,"2013-05-13",NA
"f912205db653b72fbe8fe0dcf745ebbc","hulmidi","seed",NA,"2015-01-09",1e+05
"f17b7a0bedf010a0fff0bf4afff72764","humacyte","venture","B","2015-10-20",1.5e+08
"f17b7a0bedf010a0fff0bf4afff72764","humacyte","debt_financing",NA,"2015-01-16",49762373
"5e189ea827ca71cb95823f8fcd4ab60c","human-genome-sciences",NA,NA,NA,NA
"4658dbcdb699a531e830c680b40e7505","human-recognition-systems",NA,NA,NA,NA
"c2f296ac68badb1553838e4f0b9e8d8f","human-record",NA,NA,NA,NA
"1fbe6cb20ce0c2bfaf5f322513f31d12","humancentric-performance","seed",NA,"2012-12-30",4e+05
"23211e5cd13c92437badd83b01742925","humanco","debt_financing",NA,"2013-05-15",75000
"e2495ce8ba08c8d8dd5907e176caa27b","humangeo-group",NA,NA,NA,NA
"67eacfda4ec03d0c4c9e11b5d631c2d8","humanoid","seed",NA,"2010-06-01",NA
"67eacfda4ec03d0c4c9e11b5d631c2d8","humanoid","seed",NA,"2010-12-01",1100000
"4e52e3114e40b3b64b3689ba576b588f","humanrank","seed",NA,"2014-03-01",120000
"dc63593ac23b193b8b3f61a52432b83a","humanyze","seed",NA,"2015-02-24",1e+06
"22c39704043c2e867935125d06e2fd16","humbug-telecom-labs","seed",NA,"2010-01-01",NA
"c49ce7e82ab051be81473b13f85bb47b","humedics","venture","a","2011-10-12",NA
"c49ce7e82ab051be81473b13f85bb47b","humedics","venture","C","2014-11-10",7846067
"c49ce7e82ab051be81473b13f85bb47b","humedics","seed",NA,"2010-03-24",673192
"3f15fa0d979024c5982501a7191a5195","humint-labs",NA,NA,NA,NA
"f11d3ec668001b0d065637caa78de53f","humintio",NA,NA,NA,NA
"1c1ecca9b626568980e702380bb11739","humm",NA,NA,NA,NA
"2163274450b705c67d97c46333a70fa1","hummingbird-technologies-inc-",NA,NA,NA,NA
"e31fe36f83305da6a1284e8a49ac52ff","hupso",NA,NA,NA,NA
"4d3e440dab14c6812fc6773a52c24e76","hurricaneviz",NA,NA,NA,NA
"990dea415d535166fece09b9ab71f10a","husky-seo",NA,NA,NA,NA
"ac93797b403b921b068478f7fa440da9","huvepharma",NA,NA,NA,NA
"443fd5d8b35c889638baff2b8d1ef9e8","huya-bioscience-international","venture",NA,"2009-04-06",5000025
"443fd5d8b35c889638baff2b8d1ef9e8","huya-bioscience-international","convertible_note",NA,"2012-04-02",7613268
"443fd5d8b35c889638baff2b8d1ef9e8","huya-bioscience-international","debt_financing",NA,"2015-04-22",4.8e+07
"0e5a367f59bf7c4789b6cbc63eff6103","hx-diagnostics","venture","b","2009-09-30",4700000
"0e5a367f59bf7c4789b6cbc63eff6103","hx-diagnostics","venture","a","2009-02-17",3100000
"62b162d821f1f684e8ed8c7fb853a2bd","hyasynth-bio","venture",NA,"2015-03-31",NA
"62b162d821f1f684e8ed8c7fb853a2bd","hyasynth-bio","venture",NA,"2014-11-28",NA
"62b162d821f1f684e8ed8c7fb853a2bd","hyasynth-bio","seed",NA,"2014-05-20",60000
"62b162d821f1f684e8ed8c7fb853a2bd","hyasynth-bio","seed",NA,"2015-06-29",520000
"e289396a690e6add93ccad4969de3338","shenzhen-hybio-pharmaceutical-co-ltd","venture","A","2008-03-01",10637130
"e289396a690e6add93ccad4969de3338","shenzhen-hybio-pharmaceutical-co-ltd","venture","B","2009-03-01",3238304
"3b410bf7fd95262c1d258929ded7365b","hybrid-intelligence",NA,NA,NA,NA
"14f372dc579944c35e69b7ac92271150","hybrigenics","venture",NA,"2009-09-14",7320000
"14f372dc579944c35e69b7ac92271150","hybrigenics","venture","1","2000-06-01",8531583
"14f372dc579944c35e69b7ac92271150","hybrigenics","venture","1","2001-12-01",11598857
"4e2f678d5ba465b22d2a729fd6f0f4a1","hybritech-incorporated",NA,NA,NA,NA
"a9af9f616664a2defa66ae92ae632892","hydra-biosciences","venture","C","2008-03-13",3.4e+07
"a9af9f616664a2defa66ae92ae632892","hydra-biosciences","venture","d","2009-01-16",2.2e+07
"a9af9f616664a2defa66ae92ae632892","hydra-biosciences","venture","E","2015-03-31",10507500
"a138851afcb01d4ca26f2fdfe5370361","hydra-dx","debt_financing",NA,"2013-07-18",520000
"a138851afcb01d4ca26f2fdfe5370361","hydra-dx","debt_financing",NA,"2009-09-22",488750
"a138851afcb01d4ca26f2fdfe5370361","hydra-dx","venture",NA,"2009-06-05",785000
"084afe9c792fb23d99cfd2d0bec84a41","hydrocapsule","venture",NA,"2010-08-24",25000
"c3a782915594d8756f3574093be811e5","hydropoint-data-systems","venture",NA,"2010-04-09",8444161
"c3a782915594d8756f3574093be811e5","hydropoint-data-systems","venture",NA,"2012-12-14",750000
"c3a782915594d8756f3574093be811e5","hydropoint-data-systems","venture","1","2004-11-11",11900000
"c3a782915594d8756f3574093be811e5","hydropoint-data-systems","venture","1","2007-02-02",1.9e+07
"d1ed7d023e2dd0f16b214fe804e8f5fe","hygeia-therapeutics","venture",NA,"2010-04-13",1e+06
"be883b92474eeedebf011fa82cfb5439","hygia-health-services","private_equity",NA,"2011-11-17",3499976
"fcb1f606c2f9ab84689fbb4e211236f5","hygieia","debt_financing",NA,"2011-07-29",1500000
"fcb1f606c2f9ab84689fbb4e211236f5","hygieia","venture",NA,"2013-12-13",1375900
"fcb1f606c2f9ab84689fbb4e211236f5","hygieia","debt_financing",NA,"2012-05-15",145000
"fcb1f606c2f9ab84689fbb4e211236f5","hygieia","debt_financing",NA,"2010-02-25",4e+05
"fcb1f606c2f9ab84689fbb4e211236f5","hygieia","debt_financing",NA,"2015-04-14",675000
"7694f0682449ea99c7186b9a1bef0658","hyglos","venture","c","2005-08-23",8990000
"8f77743f1d59c0a481c4071b272ebedc","hype-plan-inc","venture","A","2016-01-15",150000
"fb301098e6229ace9998b04c9192ce3e","hyper-2","seed",NA,"2015-08-26",1100000
"39780663f610987873bfe889d2d7811d","hyperactivate",NA,NA,NA,NA
"93d10220a47be5c89a90a63c5817991a","hypergrowth",NA,NA,NA,NA
"00902b3ec12d6e8e7af388cbfc025747","hyperin",NA,NA,NA,NA
"2e3b4619ec5325857030f89ed4450a32","hyperion","debt_financing",NA,"2009-05-18",1.3e+07
"2e3b4619ec5325857030f89ed4450a32","hyperion","venture","1","2009-06-30",6e+07
"2e3b4619ec5325857030f89ed4450a32","hyperion","venture",NA,"2011-04-18",17471998
"2e3b4619ec5325857030f89ed4450a32","hyperion","debt_financing",NA,"2011-11-04",7500749
"2e3b4619ec5325857030f89ed4450a32","hyperion","debt_financing",NA,"2009-05-14",12988762
"2e3b4619ec5325857030f89ed4450a32","hyperion","debt_financing",NA,"2007-10-05",1.5e+07
"2e3b4619ec5325857030f89ed4450a32","hyperion","venture","1","2007-09-05",4e+07
"adae5b73e077d1311e0964cb216b69ee","hyperloop-data","seed",NA,"2015-03-09",35000
"cf305e5ecd0c753a7e39da8a7267ee87","hyperpublic","seed",NA,"2009-05-09",NA
"cf305e5ecd0c753a7e39da8a7267ee87","hyperpublic","seed",NA,"2010-09-01",1150000
"4224010178280907b6115a522b08b6ff","hyperquality","venture","B","2007-01-23",1e+07
"4224010178280907b6115a522b08b6ff","hyperquality","venture","A","2005-06-12",5500000
"a8cd13831221ec0911fb82d8076f31d4","hyperscience","venture",NA,"2015-07-22",10879675
"348171a14484b66a4f7a80819ff5d2e1","hyperstealth-biotechnology","seed",NA,"2013-06-26",19654
"a86ae3512246d3322cc4d93e22ad57db","hypertension-diagnostics","debt_financing",NA,"2012-03-12",833600
"dfc75c50d2d9f60246cb66a77b77b013","hyperverge","seed",NA,"2015-08-17",1e+06
"a1f3ec4fa3548c22c7d99d9eb7511034","hypetap",NA,NA,NA,NA
"b23bdb5b2355288292fe42a1c2ff9a85","hyprcorp","angel",NA,"2014-06-01",650000
"63632003db035df3dda5243b31b03491","hyprloco","convertible_note",NA,"2014-07-03",NA
"63632003db035df3dda5243b31b03491","hyprloco","seed",NA,"2015-01-15",205000
"63632003db035df3dda5243b31b03491","hyprloco","convertible_note",NA,"2015-07-21",175000
"4ede8e6983d8ae59017be9996cbcfa67","hythiam","venture",NA,"2010-11-12",6948268
"4ede8e6983d8ae59017be9996cbcfa67","hythiam","debt_financing",NA,"2010-10-19",5e+05
"2dd3162c9ad9e5d9adbb827347407c15","hrel","venture","a","2013-04-03",9200000
"10bfb015bcca6593666c3d1e6f83fc12","i-azul",NA,NA,NA,NA
"29b0ad636391798ff3d1286e283c5d9e","i-optics","venture","c","2010-11-01",5848920
"9b8467f0486dab16b69a78d2d3e31ee1","i-pulse","venture",NA,"2010-09-27",45040000
"9b8467f0486dab16b69a78d2d3e31ee1","i-pulse","venture",NA,"2015-01-30",69510024
"0da04d735a1e4219bbcbba3ec0ec3b3d","i-quotient",NA,NA,NA,NA
"98e2ab1c2722d67abcee0fd0f0896bb3","i-stats",NA,NA,NA,NA
"a2d31fd473dbb2be0e406842fea73d9a","i-me","seed",NA,"2015-04-23",2500000
"a2d31fd473dbb2be0e406842fea73d9a","i-me","seed",NA,"2014-09-10",4e+06
"dc05664fcd905e1daaa97fe7434ba0fe","i-predictus","seed",NA,"2014-06-26",4600000
"deeb9c37b0c0d8e215e713829ff77b44","i4giveu",NA,NA,NA,NA
"c491b711beb0249bba9e6fc344d8810b","ia-collaborative",NA,NA,NA,NA
"058c07b8ea6f9fe46bd434479268a20d","iadbox",NA,NA,NA,NA
"192805e5f6786c8073f98da9637710f2","iamip-sverige-ab",NA,NA,NA,NA
"0bc018e43a33a816b3dc8c4ecb294d9a","iamon","seed",NA,"2015-01-15",3e+05
"d4bc4b40bd601e9e0151eeecbf7b3d6a","iaso-pharma","debt_financing",NA,"2010-03-16",3343000
"f2a7941afe3c90cd4f6c01f998d706ba","iasta",NA,NA,NA,NA
"9a1f4990ca75a5375dd9bd14f0b67334","iauro",NA,NA,NA,NA
"5de9af9fdea19e83e6c778dd1b8e5a3d","ibercheck","seed",NA,"2012-01-01",145563
"5de9af9fdea19e83e6c778dd1b8e5a3d","ibercheck","angel",NA,"2013-04-09",195410
"56b12d7d031853227b4d2ba5eedb4c25","ibinom","seed",NA,"2014-12-01",3e+05
"7119ff66c4d0bee481b1a83fa88a482e","ibio","venture",NA,"2009-09-22",3e+06
"7119ff66c4d0bee481b1a83fa88a482e","ibio","venture",NA,"2010-11-13",7065000
"7153f68e1cb0dc8224391d96564fffd7","ibis-biosciences",NA,NA,NA,NA
"026de6a22fd3b3d521a998c5a5c79831","ibisworld",NA,NA,NA,NA
"ff032c124a03925ff1d97d01c083d79c","ibm-watson",NA,NA,NA,NA
"f9977da6b7673ce88bf9c9e29559905c","icad","debt_financing",NA,"2012-01-03",1.5e+07
"279f1fe315611bb213d1aeeda7307545","icagen","venture",NA,"2009-09-21",5e+06
"c76ce9bf39dda502f47b37c20f1afae6","caldera-pharmaceuticals","venture",NA,"2013-09-11",3170000
"c76ce9bf39dda502f47b37c20f1afae6","caldera-pharmaceuticals","venture",NA,"2013-04-29",1550000
"c76ce9bf39dda502f47b37c20f1afae6","caldera-pharmaceuticals","venture",NA,"2011-05-19",1097950
"c76ce9bf39dda502f47b37c20f1afae6","caldera-pharmaceuticals","venture",NA,"2015-01-08",8855000
"3ada4ce233787fdae509ed09e6428dbc","icapital",NA,NA,NA,NA
"a07ad4d071a07885048a90939213464e","icardiac-technologies","venture","A","2006-11-08",4e+06
"a07ad4d071a07885048a90939213464e","icardiac-technologies","venture","B","2007-11-14",NA
"a07ad4d071a07885048a90939213464e","icardiac-technologies","undisclosed",NA,"2014-03-06",NA
"e562cd9e04b937777047c34d19fc47a1","icareu",NA,NA,NA,NA
"52d6ace343705f2ace58402b515c0ea9","icb-international","venture",NA,"2013-04-19",895000
"b9a358344027937e1c945a0509feb874","icenine-biotechnologies",NA,NA,NA,NA
"d9f28a76731c613e5b4eaa3052b5e284","icecreamlabs","angel",NA,"2013-10-01",NA
"d9f28a76731c613e5b4eaa3052b5e284","icecreamlabs","angel",NA,"2014-05-20",NA
"50919fa45c951380d2fa911d322dc413","icenhour-biotech",NA,NA,NA,NA
"cfc23ea7152c8908dc53e30aa1d09718","iceutica","debt_financing",NA,"2010-06-18",2572740
"cfc23ea7152c8908dc53e30aa1d09718","iceutica","venture","1","2005-06-20",1e+06
"cfc23ea7152c8908dc53e30aa1d09718","iceutica","venture",NA,"2011-03-21",1010133
"cfc23ea7152c8908dc53e30aa1d09718","iceutica","venture","1","2007-01-12",5e+05
"26de1fc94bc67bf586aca87925980a78","ichamp","seed",NA,"2015-06-22",125000
"e65dfcc3086713968b528d91e4e8f8aa","icharts","venture","B","2015-12-05",NA
"e65dfcc3086713968b528d91e4e8f8aa","icharts","venture","a","2012-02-29",3100000
"e65dfcc3086713968b528d91e4e8f8aa","icharts","debt_financing",NA,"2014-04-29",2e+06
"e65dfcc3086713968b528d91e4e8f8aa","icharts","venture","B","2014-08-14",4300000
"e65dfcc3086713968b528d91e4e8f8aa","icharts","seed",NA,"2010-01-01",1400000
"e65dfcc3086713968b528d91e4e8f8aa","icharts","convertible_note",NA,"2013-02-27",NA
"929a9428027b430e9a6238578643b67b","ichor-therapeutics","grant",NA,"2013-05-01",450000
"fa8a1fa3b74f9b483a46ba474abe1c5d","ico-therapeutics","venture",NA,"2013-11-21",125914
"fa8a1fa3b74f9b483a46ba474abe1c5d","ico-therapeutics","venture",NA,"2014-02-05",2027393
"fa8a1fa3b74f9b483a46ba474abe1c5d","ico-therapeutics","venture",NA,"2009-12-01",3303118
"a1a088468293e69505756c8ceeeace57","ico-web-solutions",NA,NA,NA,NA
"74affd2c900e0bc830b6562a4faa5f7e","icon-bioscience","convertible_note",NA,"2015-12-03",5316245
"74affd2c900e0bc830b6562a4faa5f7e","icon-bioscience","venture","1","2013-08-29",1.5e+07
"74affd2c900e0bc830b6562a4faa5f7e","icon-bioscience","venture","1","2013-01-01",1.7e+07
"d53af6a6cfe1acd77540ff10c3207ec3","icon-plc-2",NA,NA,NA,NA
"c8ba7ec60adf159c0d36561a8e1e7927","icon-plc",NA,NA,NA,NA
"08f15c9cb17acf12d964b9b180dec042","iconasys-inc",NA,NA,NA,NA
"4e4677ed9924286ec6eac2001e6b9d01","iconic-therapeutics","venture","C","2016-01-11",4e+07
"4e4677ed9924286ec6eac2001e6b9d01","iconic-therapeutics","venture","c","2009-01-17",2500000
"4e4677ed9924286ec6eac2001e6b9d01","iconic-therapeutics","venture","b","2014-04-16",2e+07
"4e4677ed9924286ec6eac2001e6b9d01","iconic-therapeutics","venture",NA,"2011-08-22",NA
"4e4677ed9924286ec6eac2001e6b9d01","iconic-therapeutics","venture","B","2007-04-30",1304901
"4e4677ed9924286ec6eac2001e6b9d01","iconic-therapeutics","venture","A","2004-12-29",4587001
"c84dbfcb8b1a366079dcc991d02da099","iconicloud",NA,NA,NA,NA
"7a80e92c0df4516a3714099402ba6229","iconics",NA,NA,NA,NA
"fc0dc873632523ed17aff2c07238a8c0","iconix-biosciences","venture",NA,"2007-01-24",4e+06
"63182662022f33aeeced0b5c699ce4af","iconosquare",NA,NA,NA,NA
"7196f6e8633710f35b81be322372c972","iconpulse","grant",NA,"2014-06-01",5000
"14905dc146eec4087db5f1c16eee53e4","icontrol-systems","venture",NA,"2015-10-17",2e+07
"5770cec76174b19602a13e6753001dcd","icoria",NA,NA,NA,NA
"c497d2329f3b5e30b864ba5667403af2","icos-corporation",NA,NA,NA,NA
"ba1312c7d92d638bfbf7dafbfe13b532","icosagen",NA,NA,NA,NA
"f513c7f889357f590f247da1a74862bf","icu-metrix","venture",NA,"2013-08-12",116667
"c675b0c3406c142cd9f7f68995940b17","icvrx","convertible_note",NA,"2010-07-08",75000
"0fdea80a3766390f55a36cef878c6e37","icyt-mission-technology","debt_financing",NA,"2009-06-10",1e+06
"c6d0409d19ab99ee618b3ead4d42118f","id-biomedical",NA,NA,NA,NA
"630f62d727efb54758fba9f2ed5e5076","idaciti-inc","seed",NA,"2015-02-02",20000
"97f684c2288d6aae831618a2891ad228","idatamatics",NA,NA,NA,NA
"f6e0766e686d026544b9b217509f0d73","idea-sphere","private_equity",NA,"2011-11-30",2.5e+07
"efa3f844fa1252a9574a509da40ac4c3","ideal-analytics",NA,NA,NA,NA
"10bb3a037175fc0eb28e71d1bb7ad62c","compelation",NA,NA,NA,NA
"a76bcebcf195aad98575b96654b33fa7","idean",NA,NA,NA,NA
"54d55f5494ee39454ffd50a28182cd4c","idearium",NA,NA,NA,NA
"ea001efbdb8c8bd504ad741079225e29","ideastring","angel",NA,"2011-10-01",NA
"ea001efbdb8c8bd504ad741079225e29","ideastring","angel",NA,"2011-12-01",NA
"51d9eeef18746edb7958677eddbd556e","ideata-analytics",NA,NA,NA,NA
"0d2c1e8aceb4cb72edb5082691558922","ideatrotter",NA,NA,NA,NA
"022a9ea19d63a42683dbd0ed335c84b2","idenix-pharmaceuticals","venture",NA,"2011-04-25",5e+06
"022a9ea19d63a42683dbd0ed335c84b2","idenix-pharmaceuticals","venture",NA,"2010-11-23",2e+07
"022a9ea19d63a42683dbd0ed335c84b2","idenix-pharmaceuticals","post_ipo_equity",NA,"2014-01-28",1.07e+08
"549bcbf2c52b6b9b6b6fc24cba17b946","identification-solutions","venture",NA,"2012-05-17",275000
"549bcbf2c52b6b9b6b6fc24cba17b946","identification-solutions","venture",NA,"2013-11-01",225000
"549bcbf2c52b6b9b6b6fc24cba17b946","identification-solutions","venture",NA,"2013-04-10",214550
"549bcbf2c52b6b9b6b6fc24cba17b946","identification-solutions","venture",NA,"2010-09-30",25000
"62e9ae9769434ca7fbad92bc5758deaa","identified-com","venture","A","2010-07-03",NA
"62e9ae9769434ca7fbad92bc5758deaa","identified-com","venture","b","2012-06-05",2.1e+07
"62e9ae9769434ca7fbad92bc5758deaa","identified-com","venture","a","2010-01-01",1500000
"62e9ae9769434ca7fbad92bc5758deaa","identified-com","undisclosed",NA,"2010-02-08",NA
"779240c2df9c676eb87ccb16ef80f8eb","identigen","venture",NA,"2005-09-01",2490000
"c74f9b586f6b5355e82fb6410e4d979f","identityedge",NA,NA,NA,NA
"1c25ed1ab5860b1aae88546693efce3f","identium",NA,NA,NA,NA
"87d7b40094b80a703216f68a9bb21fdb","identytech",NA,NA,NA,NA
"156fd1ceb95378a9239a2ec742d5faa7","ideolo-proximity-marketing-agency",NA,NA,NA,NA
"fb64bde88a47a75d970d7eb40a1a4942","idera-pharmaceuticals","venture","B","2011-11-07",9500000
"fb64bde88a47a75d970d7eb40a1a4942","idera-pharmaceuticals","venture","A","2010-01-19",4300000
"fb64bde88a47a75d970d7eb40a1a4942","idera-pharmaceuticals","post_ipo_equity",NA,"2014-02-10",4e+07
"38b9a6c7e7170f234c97ab579efaf818","idev-technologies","venture","d","2010-10-07",4.6e+07
"38b9a6c7e7170f234c97ab579efaf818","idev-technologies","venture",NA,"2010-05-12",12873985
"38b9a6c7e7170f234c97ab579efaf818","idev-technologies","debt_financing",NA,"2012-03-07",831250
"93093c02ab80a79392b25a8face5b5da","idevelop",NA,NA,NA,NA
"5ff13b5732b6b2a6f61e03a00ed72117","idex-asa",NA,NA,NA,NA
"95a969f1910316ed54736ddb6bad6a87","idexen",NA,NA,NA,NA
"6126157ad6c807939a909b5ef0dd13ec","idi-consulting",NA,NA,NA,NA
"0120f5929340d22dac36f6563aa891f9","idiag","venture",NA,"2007-10-17",3810000
"d452f1fb1d92e5b28f2285a19d453660","idibon","venture",NA,"2013-04-16",1400000
"d452f1fb1d92e5b28f2285a19d453660","idibon","venture","1","2014-10-16",5500000
"ae3a3925c3059b89d76433b3097f87bc","idio","venture","a","2013-06-20",2350000
"ae3a3925c3059b89d76433b3097f87bc","idio","seed",NA,"2006-11-01",250000
"ae3a3925c3059b89d76433b3097f87bc","idio","venture","A","2014-12-02",6200000
"f159059cf01a2adb1b11e8ef20447765","idiro","seed",NA,"2005-01-01",2e+06
"ee000c79c231f8159ed022dd3f93d407","idkliendikaart","seed",NA,"2015-03-10",53941.1178757269
"124f96db17596d9e0251b751aaa0b96e","identitymind",NA,NA,NA,NA
"f250af424ede91b6344a831902e3bc01","idm-pharma-inc",NA,NA,NA,NA
"c998e45a4e014d5c6e1d612defb4c55e","idun-pharmaceuticals","venture",NA,"2015-02-09",2000044
"c998e45a4e014d5c6e1d612defb4c55e","idun-pharmaceuticals","debt_financing",NA,"2015-07-13",1125000
"b6e2ea4bb0c99ae011981f2fcea7c01e","idv-solutions","venture","A","2010-09-01",NA
"b6e2ea4bb0c99ae011981f2fcea7c01e","idv-solutions","venture","B","2012-12-17",NA
"b6e2ea4bb0c99ae011981f2fcea7c01e","idv-solutions","venture","C","2015-01-15",NA
"36feffd78ac9b3bad88993dc4818c98a","ieg",NA,NA,NA,NA
"4105f2649e6c0b404d03abfa0a29865a","ieso-digital-health",NA,NA,NA,NA
"79e3ce97f5486d07ee0b4aaec12db090","ievo",NA,NA,NA,NA
"12bf3c38f8188a677dacdcba3e62e0f1","ifa-systems",NA,NA,NA,NA
"30c8e38d010350ad28528b18b167f216","ifinity","seed",NA,"2014-08-14",1e+06
"37d37e0ec066e137013fc6c036e2b4f8","ifolve",NA,NA,NA,NA
"555073ee4001d04e67cbc15ecef06a9a","iftheycall",NA,NA,NA,NA
"f3b152f8617a25af229e9fd4a7df281c","igd",NA,NA,NA,NA
"52695625039680717e56755877cb716c","igea","venture","a","2008-09-01",NA
"083defc3f71b83e5b61aa34c60a17e7b","igenbio-inc",NA,NA,NA,NA
"cc2ff67f6ed8491ca9f90ed735961d1a","igenica","venture","c","2014-01-28",1.4e+07
"cc2ff67f6ed8491ca9f90ed735961d1a","igenica","venture","b","2010-06-14",2.4e+07
"cc2ff67f6ed8491ca9f90ed735961d1a","igenica","venture","c","2012-06-12",3.3e+07
"cc2ff67f6ed8491ca9f90ed735961d1a","igenica","grant",NA,"2014-08-07",215740
"cc2ff67f6ed8491ca9f90ed735961d1a","igenica","venture",NA,"2015-01-26",5051844
"cc2ff67f6ed8491ca9f90ed735961d1a","igenica","venture",NA,"2015-06-09",1233334
"421a9ce7941bb5422118e08cea67fb01","ignidata","seed",NA,"2015-02-20",77093
"204a00594d42bf6ee52c2333c5ceab22","ignitefeedback","seed",NA,"2015-09-14",3e+05
"3524c45cff03f81336e9284d2d42c55a","searchignite","debt_financing",NA,"2014-04-02",14082872
"3524c45cff03f81336e9284d2d42c55a","searchignite","venture","1","2013-07-10",33994896
"3524c45cff03f81336e9284d2d42c55a","searchignite","venture","1","2014-06-26",2e+07
"3524c45cff03f81336e9284d2d42c55a","searchignite","debt_financing",NA,"2015-05-28",135444
"9b4524d2314b7f602ee3e64bfc0e7d0f","ignyta","post_ipo_equity",NA,"2015-11-16",3e+07
"9b4524d2314b7f602ee3e64bfc0e7d0f","ignyta","venture",NA,"2013-12-03",5.4e+07
"9b4524d2314b7f602ee3e64bfc0e7d0f","ignyta","debt_financing",NA,"2014-01-06",1e+07
"9b4524d2314b7f602ee3e64bfc0e7d0f","ignyta","debt_financing",NA,"2013-02-28",1e+06
"9b4524d2314b7f602ee3e64bfc0e7d0f","ignyta","venture","1","2012-12-31",5500000
"9b4524d2314b7f602ee3e64bfc0e7d0f","ignyta","post_ipo_debt",NA,"2014-10-01",3.1e+07
"9b4524d2314b7f602ee3e64bfc0e7d0f","ignyta","post_ipo_equity",NA,"2015-03-18",4.2e+07
"44b7738ee59b0aeaeef91d3ec68b8102","igy-immune-technologies-life-sciences","venture",NA,"2012-02-22",65100
"dd5a4222d43da214257a20d8247196a7","internet-identity","venture","a","2013-11-05",8e+06
"71cb41eb7c3f11817a7696b476eb744b","iih-nordic",NA,NA,NA,NA
"e699b20c2b884a9cd2b77b8204577e2b","iimedia-research-group",NA,NA,NA,NA
"d8e001212136be715fe5c228f87c2bde","iinside",NA,NA,NA,NA
"11c350d21b35e690dffa6a173165aef1","ijento","venture",NA,"2012-10-29",8e+06
"11c350d21b35e690dffa6a173165aef1","ijento","venture",NA,"2011-09-28",8e+06
"11c350d21b35e690dffa6a173165aef1","ijento","venture",NA,"2010-09-28",1704186
"fa54ebebf772934325b87aaaf58d502d","ijet-international","private_equity",NA,"2013-12-19",NA
"ddbca4e002261ef9da4118613851155a","ikanow",NA,NA,NA,NA
"4dc942a5fd71d5a9f71935b5bd4720bb","ikaria","venture",NA,"2009-10-01",54947203
"4dc942a5fd71d5a9f71935b5bd4720bb","ikaria","venture","1","2005-04-27",1e+07
"4dc942a5fd71d5a9f71935b5bd4720bb","ikaria","venture","1","2007-03-01",2.8e+08
"9468d64a88f2a92472db43fe51b4ba8c","ikegps","venture","a","2005-08-25",1390000
"9468d64a88f2a92472db43fe51b4ba8c","ikegps","venture",NA,"2011-12-01",NA
"4aa26be9e9ff3e4d2303876e1014f807","iken-solutions","undisclosed",NA,"2007-01-01",2e+06
"a6237994f9fd0fad68423981210aaff1","ikerchem","venture",NA,"2007-06-01",380000
"d667bfcf0484ddff7c6e9ee74cc788bf","ikle-co",NA,NA,NA,NA
"ef3bb7d0f3745fc3594c913dd6a5ce42","ikonfete","seed",NA,"2014-06-09",21000
"adc4d2c2ad33e090df334b43d9d1bf17","ikonisys","venture","C","2007-10-17",3e+07
"adc4d2c2ad33e090df334b43d9d1bf17","ikonisys","venture",NA,"2012-08-03",1400000
"adc4d2c2ad33e090df334b43d9d1bf17","ikonisys","venture",NA,"2010-08-04",3805000
"f4d332729562a457ff395b7b2c9e09e1","ikonomo",NA,NA,NA,NA
"c02e9ae70232a0b6bcd0e0573ae1a7f8","ikotech","venture",NA,"2009-04-28",1e+05
"c02e9ae70232a0b6bcd0e0573ae1a7f8","ikotech","convertible_note",NA,"2011-05-08",175000
"48c1bea43c5e6c21da2e113a73c03101","ikroh-seo-uk",NA,NA,NA,NA
"ca984365530d70927a3f71de695fdea1","ilastic",NA,NA,NA,NA
"827c67e6e2c7c7d0e248366a26cb3199","iliad-biotechnologies","venture",NA,"2015-11-13",640000
"c60c257d0f2eeb662f115c0441afdb65","illuminate-solutions","venture","A","2006-07-07",NA
"3acd9615b935533f9e60aa75834b2716","illuminate-ventures",NA,NA,NA,NA
"ce1453d31ab63c605ed0de6320a43668","illuminate360",NA,NA,NA,NA
"293d485c5fb1a62df6320db945156d33","illuminex",NA,NA,NA,NA
"3153e2139ef55b78174f169526865350","illumix-software","venture","a","2008-11-01",3e+06
"1da833c69fc175421c3cda9fa2b9c734","illut-io",NA,NA,NA,NA
"d601b33f34605c5cdbe24ecf9baa89e9","ilnumerics",NA,NA,NA,NA
"eb8a958e34c3857d2482fe35cc020a7c","ilypsa",NA,NA,NA,NA
"bdce3f81575126a5bee7cf16a50fbcef","im3d","seed",NA,"2013-07-01",2573200
"d1172ceafabb83bda72d21d1f302a803","imacor","venture","a","2009-02-21",5450000
"00f3fedced2ba47838f3f54bac5fcf7f","imadac-gmbh",NA,NA,NA,NA
"76c1499e4b52b9dd808ace755733eb28","imagen-biopharma","venture",NA,"2015-06-18",1e+07
"90bb8a3ef7fde041a1c427fd8300e4f8","imagen-biotech","venture","a","2011-10-19",4e+07
"075a58143195b36a3c8da9f90eea97a1","imagesat-international",NA,NA,NA,NA
"94d27c89f63a7a79c085a812266a54bf","imagesurf-net",NA,NA,NA,NA
"3bc58af5568c6898706f5e7c3dcc1d9c","imagevision","seed",NA,"2010-01-01",NA
"3bc58af5568c6898706f5e7c3dcc1d9c","imagevision","venture",NA,"2010-10-22",1250000
"3bc58af5568c6898706f5e7c3dcc1d9c","imagevision","venture",NA,"2014-03-06",2500000
"3bc58af5568c6898706f5e7c3dcc1d9c","imagevision","venture",NA,"2012-03-30",3769000
"ae9a0546399bfe025e6a4c932fd63f6b","imagga","seed",NA,"2011-05-20",71185.8615
"ae9a0546399bfe025e6a4c932fd63f6b","imagga","seed",NA,"2010-01-01",50000
"ae9a0546399bfe025e6a4c932fd63f6b","imagga","seed",NA,"2013-07-01",260000
"ec938d339a069a7b6c4792437c42d6e3","imaginab","venture","a","2012-03-27",12500000
"ec938d339a069a7b6c4792437c42d6e3","imaginab","venture","B","2014-05-08",2.1e+07
"2d0f12e7fda22d088eb2bf654e5411b2","imaging-shop",NA,NA,NA,NA
"971dd9bc2e126ed190ee7018739d0d26","imaging-therapeutics",NA,NA,NA,NA
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","venture",NA,"2009-09-10",536596
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","venture",NA,"2009-03-04",308000
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","venture",NA,"2010-10-26",1e+06
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","debt_financing",NA,"2011-10-11",1e+06
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","venture",NA,"2014-04-15",200697
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","venture",NA,"2009-10-08",1098500
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","debt_financing",NA,"2012-09-20",274450
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","venture",NA,"2014-10-17",430750
"81c46fa8d06ad3b27af3dcded13f2f5f","imaging3","venture",NA,"2015-01-15",53000
"798823a8682c840b54ac885a9d2e87c3","imaginuity-new-media",NA,NA,NA,NA
"e1cc0cf759355481ac4fa61d001d7bb1","imago-biosciences","venture","A","2014-10-31",26500000
"346d921837b1d549518147e12e6b3840","imago-scientific-instruments","debt_financing",NA,"2009-09-11",3e+05
"346d921837b1d549518147e12e6b3840","imago-scientific-instruments","equity_crowdfunding",NA,"2009-05-19",933057
"346d921837b1d549518147e12e6b3840","imago-scientific-instruments","venture",NA,"2006-04-28",3400000
"a5c42a002868ebf15306b7203efdf15f","imalogix","venture",NA,"2012-03-26",285000
"439ea940256f7970fc18f71c491e9309","imanis-life-sciences","venture",NA,"2014-03-24",1e+06
"7b06cff780a9de0ebf698cd3020931cd","imapdata","venture",NA,"2015-11-16",1269624
"7b06cff780a9de0ebf698cd3020931cd","imapdata","private_equity",NA,"2012-07-10",1.5e+07
"7b06cff780a9de0ebf698cd3020931cd","imapdata","venture",NA,"2015-03-03",1500023
"ee3f2958fa9a15abba7051e6da8c3967","imartec",NA,NA,NA,NA
"748989e2b8b4a64734260bd2a2d3d815","imarx-therapeutics","venture",NA,"2005-03-11",7e+06
"a000712e82ae8fa81035f9dc83932199","imath-research",NA,NA,NA,NA
"f14d0afb11a372f0734cfa0d45168141","imaxio","venture","A","2012-04-17",3801616
"f984593607d36397b30d1c1abd8aaafa","imazen",NA,NA,NA,NA
"10fe8f91b0ca0d7567f140881b68cf8f","imbed-biosciences","grant",NA,"2014-07-29",1500000
"10fe8f91b0ca0d7567f140881b68cf8f","imbed-biosciences","debt_financing",NA,"2014-09-08",683275
"66e34caaeff7d06b52b8bb3a4519e22a","imclone-systems",NA,NA,NA,NA
"8c5c3672d4d75686434c510921a0f7c4","imd-companies",NA,NA,NA,NA
"c473d35c8a24f002d8116f23ded26e3f","imedicor","debt_financing",NA,"2015-07-24",1980000
"e5f1268bdfea45c0f723109ac85ca634","imeve","venture","A","2011-04-01",1536885.2459
"2a5804b6edd4d7815157b78faf0dc2c2","immatics-biotechnologies","venture","b","2007-02-08",51964000
"2a5804b6edd4d7815157b78faf0dc2c2","immatics-biotechnologies","venture","D","2013-10-15",16255243
"2a5804b6edd4d7815157b78faf0dc2c2","immatics-biotechnologies","venture","c","2010-09-21",70848000
"2a5804b6edd4d7815157b78faf0dc2c2","immatics-biotechnologies","venture","A","2004-02-11",9867876
"2a5804b6edd4d7815157b78faf0dc2c2","immatics-biotechnologies","venture","D","2014-07-16",29908168
"fc30dccca6b5cece129a58efb8740856","immatics-us","grant",NA,"2015-09-02",19700000
"fc30dccca6b5cece129a58efb8740856","immatics-us","venture",NA,"2015-09-02",40300000
"67d1b2feeecbca66979e080d840226bc","immerss","seed",NA,"2015-03-21",1e+06
"67d1b2feeecbca66979e080d840226bc","immerss","seed",NA,"2013-07-01",1e+06
"bfc8c6b3f0297ad65cb8ce9afc35f6f6","immigraphics",NA,NA,NA,NA
"a2d6258bee43d5649326dcf2e228508b","immpulso",NA,NA,NA,NA
"4b3d8e1b344a04ee0251c7a53f43a04f","immudex",NA,NA,NA,NA
"90cc9c6dcfc4f358525cb26222cc16e4","immumetrix","private_equity",NA,"2013-04-10",6384353
"c8154f47124be87528f749d3674999d4","immune-design","venture","b","2010-07-26",3.2e+07
"c8154f47124be87528f749d3674999d4","immune-design","venture","a","2008-07-07",1.8e+07
"c8154f47124be87528f749d3674999d4","immune-design","venture",NA,"2009-07-16",14000
"c8154f47124be87528f749d3674999d4","immune-design","venture","c","2013-10-30",4.9e+07
"c8154f47124be87528f749d3674999d4","immune-design","venture",NA,"2014-06-12",17500
"423b5c9d331e5fe61cd730571d531fd0","immune-pharmaceuticals","post_ipo_equity",NA,"2014-03-09",11700000
"423b5c9d331e5fe61cd730571d531fd0","immune-pharmaceuticals","post_ipo_debt",NA,"2015-07-29",9500000
"423b5c9d331e5fe61cd730571d531fd0","immune-pharmaceuticals","post_ipo_equity",NA,"2015-07-29",1.2e+07
"927068d999b08725b6dde4e5eaf20dbc","immune-system-therapeutics","venture",NA,"2005-03-10",7e+05
"fe766a1e684fd039f6f05a74636aa393","immune-targeting-systems","venture","A","2007-07-16",7120961.3976
"fe766a1e684fd039f6f05a74636aa393","immune-targeting-systems","venture","a","2010-03-17",13200000
"b0df0de43c840968aef8912ad65cf1a0","tni-biotech","venture",NA,"2013-09-11",2892750
"5bdaa725a8494e3291ef469703508699","immunethep","seed",NA,"2015-04-27",NA
"564215966960c317c266f5a6e3535d90","immunetics","grant",NA,"2011-05-03",2400000
"564215966960c317c266f5a6e3535d90","immunetics","venture",NA,"2012-08-10",629000
"564215966960c317c266f5a6e3535d90","immunetics","grant",NA,"2011-05-25",5e+05
"564215966960c317c266f5a6e3535d90","immunetics","grant",NA,"2012-09-10",3700000
"564215966960c317c266f5a6e3535d90","immunetics","debt_financing",NA,"2014-03-10",835000
"4070871ad224e63898440359776b5dd0","immunetrics","venture",NA,"2006-04-11",150000
"2f197dce85a2b8b786dfad723f1579d5","immuneworks","seed",NA,"2007-10-30",3e+05
"2f197dce85a2b8b786dfad723f1579d5","immuneworks","debt_financing",NA,"2009-07-17",375000
"2f197dce85a2b8b786dfad723f1579d5","immuneworks","venture",NA,"2013-12-26",60000
"f3f02af690c878e09218981d3dadf122","immunex",NA,NA,NA,NA
"33d4d317be8ee7e3f01af35c764119bc","immunexcite","venture","b","2014-01-07",3580000
"33d4d317be8ee7e3f01af35c764119bc","immunexcite","venture","a","2012-01-04",2500000
"5ae517df56d2d9446f805c91945353da","immunexpress","venture",NA,"2014-03-05",6e+06
"1c70b8da3b23841443d94a01fb8d150f","immungene","venture","a","2013-11-07",9e+06
"a1ad24765936fbedba1bafdf924c8db6","immunocore","venture",NA,"2015-07-16",3.2e+08
"8622b6f605d719dc8d021a87ec6f5d02","immunogen","venture",NA,"2011-10-20",3e+06
"8622b6f605d719dc8d021a87ec6f5d02","immunogen","angel",NA,"2011-11-14",1e+06
"8622b6f605d719dc8d021a87ec6f5d02","immunogen","venture",NA,"2011-12-20",2e+07
"8622b6f605d719dc8d021a87ec6f5d02","immunogen","venture",NA,"2011-06-15",2e+06
"dc27b710d616513e512504c1e14cbc1b","immunogenes",NA,NA,NA,NA
"56d909c1290f750c0331110fca08ed36","immunologix","venture",NA,"2010-03-12",2e+05
"56d909c1290f750c0331110fca08ed36","immunologix","venture",NA,"2011-07-20",250948
"56d909c1290f750c0331110fca08ed36","immunologix","venture",NA,"2010-08-13",890168
"277c6fce2178bed1062a47dccfc73cb5","immunome","venture","A","2015-11-16",NA
"277c6fce2178bed1062a47dccfc73cb5","immunome","debt_financing",NA,"2009-09-11",435356
"277c6fce2178bed1062a47dccfc73cb5","immunome","debt_financing",NA,"2013-02-20",445000
"277c6fce2178bed1062a47dccfc73cb5","immunome","debt_financing",NA,"2012-01-04",145000
"277c6fce2178bed1062a47dccfc73cb5","immunome","debt_financing",NA,"2011-06-08",846631
"277c6fce2178bed1062a47dccfc73cb5","immunome","debt_financing",NA,"2014-03-19",735000
"277c6fce2178bed1062a47dccfc73cb5","immunome","debt_financing",NA,"2014-10-14",467500
"277c6fce2178bed1062a47dccfc73cb5","immunome","venture","A","2015-09-18",3634048
"277c6fce2178bed1062a47dccfc73cb5","immunome","debt_financing",NA,"2015-02-11",2e+05
"730d7c77f52047290da3c0a770e85b8d","immunomedics","post_ipo_equity",NA,"2014-05-08",3e+07
"6f3e1f4f64797f451b15cc7fbda57e0b","immunomic-therapeutics","venture",NA,"2010-03-28",6e+05
"6f3e1f4f64797f451b15cc7fbda57e0b","immunomic-therapeutics","venture",NA,"2013-10-17",3e+06
"6f3e1f4f64797f451b15cc7fbda57e0b","immunomic-therapeutics","venture",NA,"2013-06-12",1617000
"6f3e1f4f64797f451b15cc7fbda57e0b","immunomic-therapeutics","venture",NA,"2014-04-24",1028999
"4ba5cc4fad90ca88548dae0dccda6ac2","immunophotonics","venture","A","2014-07-31",NA
"4ba5cc4fad90ca88548dae0dccda6ac2","immunophotonics","venture",NA,"2011-05-27",100123
"4ba5cc4fad90ca88548dae0dccda6ac2","immunophotonics","venture",NA,"2010-05-12",550000
"4ba5cc4fad90ca88548dae0dccda6ac2","immunophotonics","venture","A","2014-09-03",1800000
"4ba5cc4fad90ca88548dae0dccda6ac2","immunophotonics","venture","A","2015-01-26",6e+05
"ad977eb62fa934b593871f6194b22d38","immunoscience-inc",NA,NA,NA,NA
"59da6812ff55d5a4ca95f3f03386ca82","immunostep",NA,NA,NA,NA
"e6f02414045d617871d971f168003594","immunotegg","seed",NA,"2013-12-13",40000
"f36835e1ae191ef869522ebfa8c0f05c","immunovaccine","venture",NA,"2013-11-21",4200000
"f36835e1ae191ef869522ebfa8c0f05c","immunovaccine","post_ipo_equity",NA,"2014-09-05",11200000
"a2d74f700643397b2716b82963781c67","immunovative-therapies","venture",NA,"2012-01-20",1.2e+07
"9e4a21f7cd0558e25cf22569920101da","immurx","venture",NA,"2009-06-04",763434
"e8fde6056a168ddca55802336156f617","immusant","venture","a","2011-12-13",2e+07
"e8fde6056a168ddca55802336156f617","immusant","venture","B","2014-12-22",1.2e+07
"dc5295dceaeb1cb92c6684ebba255ca9","immusoft","grant",NA,"2012-04-21",350000
"dc5295dceaeb1cb92c6684ebba255ca9","immusoft","venture","1","2014-08-21",2374458
"dc5295dceaeb1cb92c6684ebba255ca9","immusoft","debt_financing",NA,"2015-08-18",375000
"85a299b83ce8e8c297a177bdec99b97a","immuta","seed",NA,"2015-07-16",1500000
"b81f02a09168b3001bc5f034034cbac8","immuven","grant",NA,"2012-05-01",1680000
"b81f02a09168b3001bc5f034034cbac8","immuven","seed",NA,"2011-08-15",250000
"b81f02a09168b3001bc5f034034cbac8","immuven","venture",NA,"2011-11-04",NA
"6d7457b35a7addbb499a4c90e7d11f7e","imogul","seed",NA,"2014-05-01",70000
"c0759a0cbc1a175b67c793ecc95efb3b","imoney-group","venture","a","2013-10-24",2e+06
"c0759a0cbc1a175b67c793ecc95efb3b","imoney-group","seed",NA,"2013-06-04",5e+05
"c0759a0cbc1a175b67c793ecc95efb3b","imoney-group","venture","B","2014-09-25",4e+06
"ff03c61d34ddce523f27919290aea486","imosphere","seed",NA,"2012-11-07",1800000
"b94a8392428d464a7bc9613ba486d6e0","impact-lab",NA,NA,NA,NA
"cd5ce4c35c71646935f1b3ca0bdf9066","impact-zone-consultancy--llc",NA,NA,NA,NA
"f32c8d44a4f6624b9a12897e692f7681","impactrx","venture","e","2010-01-11",1200000
"5bcc4ed96f3bed1b9d71f103f216c224","impactspace",NA,NA,NA,NA
"72df3951cfd4f4b3e1bb42bdb203a3bc","impakt-protective","angel",NA,"2013-03-18",490196
"41549431244b2accbc7e7b2e95901aa8","impax-laboratories",NA,NA,NA,NA
"7154b23ac78d1c7c81c0d6341541da4a","impedance-cardiology-systems","venture","b","2006-11-29",5e+06
"463d5f93a6268a5c1802b65a8e7a6f16","impedans","undisclosed",NA,"2015-01-01",NA
"7e42be9be7620c0342b9978fdf4bc9e7","impel",NA,NA,NA,NA
"c4bd3a29e44c067eb8e8920d1241ca99","imperative-health","venture",NA,"2010-01-26",4e+06
"b1a205efde4fb2dad5642f8a6c5e17bf","imperious-group",NA,NA,NA,NA
"2bdceb17dc0d43cc3f15538f1c51e4f9","imperium-health-management","venture",NA,"2013-10-24",3e+06
"2bdceb17dc0d43cc3f15538f1c51e4f9","imperium-health-management","debt_financing",NA,"2011-12-30",155000
"ff3ab7e9bfd0b6e96c2677e0d2c856db","impetus-healthcare-inc",NA,NA,NA,NA
"b6078c462240a1696dd380d499664bb6","impetus-technologies-inc",NA,NA,NA,NA
"995395634f4523865a82c10180b01a56","implanet","venture","d","2010-07-12",10100000
"995395634f4523865a82c10180b01a56","implanet","venture","A","2007-05-01",17722922.5554
"995395634f4523865a82c10180b01a56","implanet","venture","B","2009-06-30",12662502
"995395634f4523865a82c10180b01a56","implanet","venture","C","2010-04-20",10783366
"995395634f4523865a82c10180b01a56","implanet","venture","D","2011-09-01",7649637
"995395634f4523865a82c10180b01a56","implanet","venture","E","2013-11-01",25485288
"4e11fe2eb5a67c1bc6aafd5cd739d729","implicit-bioscience","venture",NA,"2015-11-16",50800
"c8859bc88b0cc8c4d9173fa3ab2f5253","implisense","seed",NA,"2015-02-02",5e+05
"f68805417fb63869a786e27cd6e6c0c5","importgenius",NA,NA,NA,NA
"7c0fe2984ae9b7295106a1b7b2cec0a4","imprimis-pharmaceuticals","private_equity",NA,"2012-05-08",7946180
"7c0fe2984ae9b7295106a1b7b2cec0a4","imprimis-pharmaceuticals","debt_financing",NA,"2015-05-12",1.5e+07
"4f762f5623e28f0b219c512af111954d","improve",NA,NA,NA,NA
"d4ebc950aa8284cf1fe98cc9c7d3eeea","improvely",NA,NA,NA,NA
"ac5220091693af4d2ada3f9f146bc483","imricor-medical-systems","venture",NA,"2010-09-16",1e+05
"ac5220091693af4d2ada3f9f146bc483","imricor-medical-systems","debt_financing",NA,"2009-01-21",2e+05
"ac5220091693af4d2ada3f9f146bc483","imricor-medical-systems","venture",NA,"2010-02-12",3069000
"ac5220091693af4d2ada3f9f146bc483","imricor-medical-systems","venture",NA,"2012-04-17",4120000
"ac5220091693af4d2ada3f9f146bc483","imricor-medical-systems","venture",NA,"2009-04-03",40000
"c5d0355731282723b2feba2de16e7a26","imrsv","debt_financing",NA,"2012-10-22",1e+06
"c5d0355731282723b2feba2de16e7a26","imrsv","seed",NA,"2011-01-01",18000
"c5d0355731282723b2feba2de16e7a26","imrsv","debt_financing",NA,"2011-02-07",20000
"c5d0355731282723b2feba2de16e7a26","imrsv","debt_financing",NA,"2012-11-06",998969
"c5d0355731282723b2feba2de16e7a26","imrsv","debt_financing",NA,"2011-08-08",30000
"c5d0355731282723b2feba2de16e7a26","imrsv","seed",NA,"2011-11-29",140000
"c5d0355731282723b2feba2de16e7a26","imrsv","debt_financing",NA,"2011-09-19",810000
"685d2146aeaa4a164a1018e44e4e783a","imsense",NA,NA,NA,NA
"9adb1a38640f734ea2e0c78943fddd47","imstar-therapeutics",NA,NA,NA,NA
"e9f456bd25b0179186df4e32b2355ef7","imt-innovative-micro-technology","venture","c","2005-01-01",1.7e+07
"e9f456bd25b0179186df4e32b2355ef7","imt-innovative-micro-technology","venture",NA,"2002-01-01",5e+06
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture",NA,"2010-11-18",1029000
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture",NA,"2011-05-06",1846600
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture",NA,"2010-03-31",520000
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture",NA,"2011-03-30",4e+05
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture",NA,"2013-04-02",750000
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture","1","2013-04-02",4000005
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture","1","2011-10-05",4e+06
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture","1","2009-07-22",7e+05
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture",NA,"2015-03-31",427000
"7339b43b7be8af77fa51e687687affad","imthera-medical","venture",NA,"2015-11-10",4667105
"365258189d8793e5d2ed1df816df1ba3","imubit","seed",NA,"2015-02-01",NA
"519ecc1bb1337e6ef3da0dd4896a1bff","imusicfx",NA,NA,NA,NA
"16567ad177175c6c7c0fbb2ec84ef56e","ubee","seed","A","2013-01-13",NA
"43a903a5bfce98f543f9bd1210de178e","in-ovo","venture",NA,"2014-06-18",271199
"5b233637a9042c9b73ebf604e12e73e0","in-three",NA,NA,NA,NA
"a604ca6d6844bd65db251dd95aa69368","in8-mobile",NA,NA,NA,NA
"b8113b632ef16b67958f4931b856fd73","inanovate","venture",NA,"2015-12-17",502408
"39a09698498951a229875f860429828a","inatlas",NA,NA,NA,NA
"01357c3529c4a0cd228c9ee5d51d99ce","inavtas-mobile-business-intelligence",NA,NA,NA,NA
"cc636288f7c0cb431127f716948660b4","inbiomed",NA,NA,NA,NA
"c1b06dedf9ab7c4b5f5f7a6027fc3670","inbiomotion","venture","A","2012-06-28",2492429
"1c40bbafb01cfd5e5007e584b32bce3c","inbiopro-solutions-private-ltd",NA,NA,NA,NA
"bddaed28835cd82a732f347e5493c907","inbound-reach",NA,NA,NA,NA
"3dc9fb72890e27b87e77fc5879c86fe1","inbound-rocket",NA,NA,NA,NA
"46bcfb6cd641061c6faba01a5e2e499f","inboundli",NA,NA,NA,NA
"64c5c5f8735b4579f0d821144412eed2","inboundgeo","seed",NA,"2012-09-10",350000
"64c5c5f8735b4579f0d821144412eed2","inboundgeo","seed",NA,"2011-12-01",585000
"0232f333793796944ff5f60ec3a28920","inboundway",NA,NA,NA,NA
"622284549db54ba8c3153a8af464de79","inbox25",NA,NA,NA,NA
"16a296ca8099b9c136792636b1f82b92","inc-research",NA,NA,NA,NA
"7d47953b59eb34b3d53b380497fba93b","incanthera","venture",NA,"2014-02-02",984913
"e9de0b135675b38eb3462b1da891797f","incaptus-llc",NA,NA,NA,NA
"1300772544767c127eba0cc8fea03f77","incarda-therapeutics","debt_financing",NA,"2012-10-17",310000
"1300772544767c127eba0cc8fea03f77","incarda-therapeutics","venture",NA,"2014-12-19",566977
"1300772544767c127eba0cc8fea03f77","incarda-therapeutics","venture","1","2015-04-28",5e+06
"8d2007d6e63a5a667ed4f26343ee110a","incelldx","venture",NA,"2012-05-14",5999998
"8d2007d6e63a5a667ed4f26343ee110a","incelldx","venture",NA,"2010-06-17",3e+06
"27483ae47525165b09028f30f5ff6278","inception-sciences","venture","a","2013-12-09",1e+07
"27483ae47525165b09028f30f5ff6278","inception-sciences","venture",NA,"2011-11-23",5e+06
"27483ae47525165b09028f30f5ff6278","inception-sciences","venture",NA,"2014-06-27",5e+06
"251fed23d0eb51eed3cac36c91eba582","incisent-labs",NA,NA,NA,NA
"2e990ca812c83f25f2a38bca086129f9","incisive-surgical","venture",NA,"2007-10-12",6e+06
"2e990ca812c83f25f2a38bca086129f9","incisive-surgical","debt_financing",NA,"2009-10-23",1032500
"8e168350b8a928907eddd3a47bead500","incisively-limited",NA,NA,NA,NA
"98f602325d9f71862e0f149bf7f337c4","incite-media-labs",NA,NA,NA,NA
"0b4594ffad24df89d90a57a538780dbf","incline-therapeutics","venture","a","2010-06-28",4.3e+07
"0b4594ffad24df89d90a57a538780dbf","incline-therapeutics","debt_financing",NA,"2009-12-23",440000
"0b4594ffad24df89d90a57a538780dbf","incline-therapeutics","venture","b","2011-09-28",21500000
"4186dba7a3707e2f2a85de6af5763286","inclinix","venture",NA,"2010-09-29",5e+05
"4186dba7a3707e2f2a85de6af5763286","inclinix","venture",NA,"2012-06-13",16700000
"4186dba7a3707e2f2a85de6af5763286","inclinix","venture",NA,"2014-06-19",3396287
"30af654fd02be5f7af6ab9fd8a8741e3","incloudcounsel",NA,NA,NA,NA
"dd704d8300b9565263fdbc44fb32c225","incoming-media","seed",NA,"2013-03-19",1100000
"dd704d8300b9565263fdbc44fb32c225","incoming-media","venture","1","2014-11-04",4900000
"27e847fc681527cdba66f65db2c6eae2","increnta",NA,NA,NA,NA
"c75d2837e1d4279da838b0804fc40b50","incube-labs","venture",NA,"2013-03-18",3e+07
"0996c323392820e0c7f67b9d8a8d85a9","incuron","venture",NA,"2010-04-26",5700000
"3d3dee53c25c187b62b2be6f7dddb511","incyte",NA,NA,NA,NA
"6b929952432b7b4ec239bfc1fc93e684","indee-2","venture",NA,"2015-08-12",NA
"a583184c8d23aa61892bf8125f08608c","indel-therapeutics","venture","b","2011-04-28",1400000
"f2b19b03364cf3d5c03d93ffb232f078","independent-living-systems",NA,NA,NA,NA
"c9b7cdf23cd28bf40371e3408c0a17fd","indestinate-ltd",NA,NA,NA,NA
"24b4b7bc5f97c83ca81d415b001920f0","indevus-pharmaceuticals",NA,NA,NA,NA
"997f616fbe1d8a37a1fe9a342e84e0fb","index-pharmaceuticals","private_equity",NA,"2011-01-21",11319064
"997f616fbe1d8a37a1fe9a342e84e0fb","index-pharmaceuticals","private_equity",NA,"2014-02-25",2e+07
"7752e19f8fae48df6280aa0b1eda9b83","indexed-i-o",NA,NA,NA,NA
"289670d6c5444d37fcc11ec48beb6ff7","i-d-e-a-international-development-expansion-association",NA,NA,NA,NA
"f9249b083774e0b8f5508417e5e13ce9","indextools",NA,NA,NA,NA
"12929b388ebcf7ccefc04b148b17a897","indextron",NA,NA,NA,NA
"33f99b440f952852ee4183b28cccbc86","rejeesh-kochu",NA,NA,NA,NA
"065c691ccfb217db326c5b6ee9d35f70","indicative","seed",NA,"2014-10-14",2e+06
"fb7935e399f46eee8172d2517ff57613","indico-data-solutions","convertible_note",NA,"2014-04-17",20000
"fb7935e399f46eee8172d2517ff57613","indico-data-solutions","convertible_note",NA,"2014-01-01",159000
"fb7935e399f46eee8172d2517ff57613","indico-data-solutions","seed",NA,"2014-11-13",3e+06
"983675c32ee5471f6b57c9e32a0369c1","synbio-axlr8r",NA,NA,NA,NA
"3435c97e01fae1e9f0800202b05252c8","indifi-technologies","seed",NA,"2015-10-01",NA
"517456c6edd788f33c95cd618b39c912","indigo-biosciences","venture",NA,"2011-10-10",682000
"517456c6edd788f33c95cd618b39c912","indigo-biosciences","venture",NA,"2010-09-03",1e+05
"8ca70a15218a3bf2536e6b339f53470c","indipharm","venture",NA,"2010-02-12",2290000
"8ca70a15218a3bf2536e6b339f53470c","indipharm","debt_financing",NA,"2011-05-18",450000
"8ca70a15218a3bf2536e6b339f53470c","indipharm","venture",NA,"2012-03-16",1494843
"8ca70a15218a3bf2536e6b339f53470c","indipharm","debt_financing",NA,"2011-12-07",2e+05
"8ca70a15218a3bf2536e6b339f53470c","indipharm","venture",NA,"2015-04-07",1062500
"d7f579eec8f3a01e6bcb36112e412499","individlabs","seed",NA,"2015-09-10",40000
"6c72c534e8aeeffdc71549a7bc760098","indix","venture","a","2013-04-04",5994730
"6c72c534e8aeeffdc71549a7bc760098","indix","debt_financing",NA,"2011-10-07",250000
"6c72c534e8aeeffdc71549a7bc760098","indix","debt_financing",NA,"2012-04-16",1145200
"6c72c534e8aeeffdc71549a7bc760098","indix","venture","a","2014-03-26",8500000
"6c72c534e8aeeffdc71549a7bc760098","indix","venture","B","2015-06-23",1.5e+07
"c4e041ccf1556ab2e4b48f5ede5964a9","indize",NA,NA,NA,NA
"725d417fbb6ed160e403663bb3a88b01","indri",NA,NA,NA,NA
"2cb89aa761ff3a1b6d6c1219ddd97572","induce-biologics","venture",NA,"2015-03-06",2e+06
"c327bb817635f614a9f7f3d2bf307147","indus-insights","venture","A","2014-08-05",NA
"b089aa1d5b00788808bdd30fb202215e","industrial-microbes","seed",NA,"2014-12-01",120000
"b089aa1d5b00788808bdd30fb202215e","industrial-microbes","seed",NA,"2015-06-01",NA
"5fa1bb507df1f7c868d2b82d5d785b81","industriuscfo",NA,NA,NA,NA
"099ca42020f34f94a2cd34b2f5b9a8a8","ineoquest",NA,NA,NA,NA
"60431ee1e642b0256af86702291c9596","ineos-bio",NA,NA,NA,NA
"87574cc4c6186fc5f65949ebd4b500a7","inetsoft-technology",NA,NA,NA,NA
"b86faea8a2a3556371254c37250c4be9","inevitable-ventures",NA,NA,NA,NA
"8df3e7cd57db4eba664ca54eb1109c80","infacare-pharmaceuticals","venture","C","2013-03-20",3556876
"8df3e7cd57db4eba664ca54eb1109c80","infacare-pharmaceuticals","venture","A","2006-03-10",3e+07
"8df3e7cd57db4eba664ca54eb1109c80","infacare-pharmaceuticals","venture","B","2008-10-28",2.8e+07
"8df3e7cd57db4eba664ca54eb1109c80","infacare-pharmaceuticals","venture",NA,"2014-10-22",1008000
"8df3e7cd57db4eba664ca54eb1109c80","infacare-pharmaceuticals","venture",NA,"2014-12-09",1300000
"8df3e7cd57db4eba664ca54eb1109c80","infacare-pharmaceuticals","venture",NA,"2015-07-08",12100000
"d79ff8b8298602c7932b61d8da06708f","infantium","seed",NA,"2012-10-25",129930
"d79ff8b8298602c7932b61d8da06708f","infantium","grant",NA,"2015-01-01",1819229
"d79ff8b8298602c7932b61d8da06708f","infantium","seed",NA,"2014-01-01",137678
"d79ff8b8298602c7932b61d8da06708f","infantium","convertible_note",NA,"2014-10-01",246591
"c69ffa8b7c6e2179bb1218481d2253be","infermedica","seed",NA,"2013-11-01",160000
"c69ffa8b7c6e2179bb1218481d2253be","infermedica","seed",NA,"2012-06-01",150000
"d4ab0429b51b69ed2018a9dd3d97a38f","infersystems",NA,NA,NA,NA
"9adaeecd06382ec4198e1e3b0e6857f8","infin-markets",NA,NA,NA,NA
"fa42c5001386a97779a00bbdd27a1d94","infinario","seed",NA,"2014-10-01",5e+05
"37e10f6e718abb49fadf75399c3f403a","infinedigital",NA,NA,NA,NA
"974b7b1c81bc9970ebd7b6789d23eb91","infinigraph",NA,NA,NA,NA
"00b4e341ed414a1aff74722e109e2b0b","infinity-pharmaceuticals","venture",NA,"2012-07-19",27500000
"00b4e341ed414a1aff74722e109e2b0b","infinity-pharmaceuticals","venture",NA,"2011-11-29",5e+07
"00b4e341ed414a1aff74722e109e2b0b","infinity-pharmaceuticals","private_equity",NA,"2012-10-15",78540191
"6c678e31e2689aff5543c4f70852208d","inflammatory-response-research","venture",NA,"2014-12-03",860000
"7eecad33a6200f436b32517b37602a7d","inflection","venture","a","2010-09-01",3e+07
"283ab86957c284a23720ac45c6b0b4a3","inflection-biosciences","venture","B","2015-03-09",72000
"283ab86957c284a23720ac45c6b0b4a3","inflection-biosciences","venture","A","2013-06-01",475000
"d4de3ff1db017077f00cb8f6b472f35b","inflexxion","venture",NA,"2015-01-05",NA
"0af180aaf1356112375efc89d824aad3","influencer-in",NA,NA,NA,NA
"58ea406fe156e7dfa0288b4c49326769","influentio",NA,NA,NA,NA
"08e88d9f905a0a4cd15bbb61353fd815","influitive","venture",NA,"2014-05-14",NA
"08e88d9f905a0a4cd15bbb61353fd815","influitive","seed",NA,"2012-08-09",3750000
"08e88d9f905a0a4cd15bbb61353fd815","influitive","venture","1","2012-12-17",7339001
"08e88d9f905a0a4cd15bbb61353fd815","influitive","venture","1","2015-07-08",30500000
"b5397b32fe2cc14c70af79a799dce839","influmedix",NA,NA,NA,NA
"ebbf81a71e73b149eb9081473059c10c","influxdb","seed",NA,"2013-06-05",792000
"ebbf81a71e73b149eb9081473059c10c","influxdb","venture","1","2014-12-08",8100000
"33c8ef661ee9d606055cb1952fdc936f","info-tech-research-group",NA,NA,NA,NA
"910b5b99272e0a8313040b847805a5c6","infoaxon-technologies-limited",NA,NA,NA,NA
"0e5c04e048b177eb87888efadae10575","infobionic","venture","b","2014-04-08",1.7e+07
"0e5c04e048b177eb87888efadae10575","infobionic","convertible_note",NA,"2013-11-19",1205000
"0e5c04e048b177eb87888efadae10575","infobionic","venture","a","2013-03-11",NA
"0e5c04e048b177eb87888efadae10575","infobionic","seed",NA,"2012-12-20",969043
"0e5c04e048b177eb87888efadae10575","infobionic","seed",NA,"2012-12-12",NA
"0e5c04e048b177eb87888efadae10575","infobionic","venture","B","2015-08-05",8e+06
"bf6cdd4687234869d29753b90c43c46a","infobright","venture","a","2006-01-01",3e+06
"bf6cdd4687234869d29753b90c43c46a","infobright","venture","b","2007-09-06",8e+06
"bf6cdd4687234869d29753b90c43c46a","infobright","venture","c","2008-01-01",1e+07
"5ac9b04bf138a79c9f64334a6f20391b","infobuild",NA,NA,NA,NA
"9f16e9145e0a0e923ca440da279dff5b","infocepts-inc",NA,NA,NA,NA
"776857aaf83a0c7b7906155b47cb16aa","infochimps","venture","A","2011-12-13",NA
"776857aaf83a0c7b7906155b47cb16aa","infochimps","venture","A","2011-11-07",NA
"776857aaf83a0c7b7906155b47cb16aa","infochimps","venture",NA,"2013-05-03",NA
"776857aaf83a0c7b7906155b47cb16aa","infochimps","convertible_note",NA,"2012-05-24",NA
"776857aaf83a0c7b7906155b47cb16aa","infochimps","venture",NA,"2011-02-23",NA
"776857aaf83a0c7b7906155b47cb16aa","infochimps","debt_financing",NA,"2012-09-01",1900000
"776857aaf83a0c7b7906155b47cb16aa","infochimps","debt_financing",NA,"2013-03-15",3e+05
"776857aaf83a0c7b7906155b47cb16aa","infochimps","venture","a","2010-11-07",2200000
"776857aaf83a0c7b7906155b47cb16aa","infochimps","debt_financing",NA,"2012-04-19",305000
"776857aaf83a0c7b7906155b47cb16aa","infochimps","angel",NA,"2010-09-14",350000
"98b7b9fe109f8d095fd4831e8aa8ec04","infocomm-investments",NA,NA,NA,NA
"fbff87926dba15fd9213dbc43480da5a","infogami","seed",NA,"2005-08-02",NA
"1e1968eef0682b716f87532438db2043","infogene",NA,NA,NA,NA
"9579d65d4f09910f629bc5bb79da6be3","mabogo",NA,NA,NA,NA
"03509f720954fffffe3b897c268a325c","infographic-database",NA,NA,NA,NA
"10e1b407e72a4e46e7bbe5af2d0f180a","infogrok",NA,NA,NA,NA
"39f6ff4dd943ed83ba2538a15c683cb5","infomart",NA,NA,NA,NA
"32fee66b50163ca1b9758ca825359ee2","infonomi-technologies-co-","seed",NA,"2014-02-01",250000
"b603c3fe6c953a0f7ee1fc1f15de4559","infoprice-2",NA,NA,NA,NA
"690a062a067e2cdf41942f75ed907e78","infopulse-ukraine",NA,NA,NA,NA
"f7f57b9ca13fc72eccc6cd861422ab43","infoready",NA,NA,NA,NA
"d7d89ca70a3f4ca0eed10e854f6d27d5","inform-genomics","venture",NA,"2015-05-13",2600000
"d7d89ca70a3f4ca0eed10e854f6d27d5","inform-genomics","angel",NA,"2011-12-01",NA
"d7d89ca70a3f4ca0eed10e854f6d27d5","inform-genomics","seed",NA,"2011-11-28",1325000
"4e52dfd778c473f91bcaddae550ad2c9","informatica",NA,NA,NA,NA
"ae5d5afdda8ebfba9f0217e2f3956072","information-machine-llc",NA,NA,NA,NA
"e3663bb917fe3e24cd6fffe0887d264a","informationactive",NA,NA,NA,NA
"46ef5a81c9b9613b53d9ec7618359db2","informed-health-technologies","venture",NA,"2015-06-12",240000
"1e8b943b171351d469e20bd72716cfe5","informeddna","seed",NA,"2013-07-08",3e+06
"1e8b943b171351d469e20bd72716cfe5","informeddna","seed",NA,"2008-01-01",485000
"1e8b943b171351d469e20bd72716cfe5","informeddna","angel",NA,"2009-08-01",670000
"1e8b943b171351d469e20bd72716cfe5","informeddna","venture","1","2014-08-06",5e+06
"68d9b46d9eba17306b980e0ca4801b72","inforobica-consulting",NA,NA,NA,NA
"5425dca8b17bc74f2f10975653484fad","inforte",NA,NA,NA,NA
"cbda297b1293904bcfadf9d4acd60697","shoparoo","seed",NA,"2012-08-16",4e+05
"cbda297b1293904bcfadf9d4acd60697","shoparoo","venture","1","2013-05-01",5e+06
"cbda297b1293904bcfadf9d4acd60697","shoparoo","venture","1","2014-06-19",1.6e+07
"246b7e9a56aba417b559f7da94a8e0a3","infoshuk",NA,NA,NA,NA
"8a31aa060f566f3038187c096fcd88d9","infospectrum",NA,NA,NA,NA
"ada637a61c3fd041c90ae3dc9b1faabe","infostroy",NA,NA,NA,NA
"1e1f6cad26cc0f4902ceea50a818eccb","infotrellis",NA,NA,NA,NA
"a576f2b2e81e06e98ff6e221e89458cb","infotrends",NA,NA,NA,NA
"3fc2aa941c5f05f2dc7f2185cd3279b9","infotrie-financial-solutions","seed",NA,"2014-03-31",396825
"1fdd221205cfb440728b71df34afac8a","infotrust",NA,NA,NA,NA
"b34eab42934425cc1dc74e084a0d1382","infotrust-group",NA,NA,NA,NA
"4f9a5e2e7b6f54d3a81216302748931c","infracritical",NA,NA,NA,NA
"9148096b75a644acf97d79351151e6a3","infusionsoft","venture",NA,"2010-08-06",2e+06
"9148096b75a644acf97d79351151e6a3","infusionsoft","venture","1","2007-10-17",9e+06
"9148096b75a644acf97d79351151e6a3","infusionsoft","venture","1","2008-12-19",7900000
"9148096b75a644acf97d79351151e6a3","infusionsoft","venture","1","2013-01-07",5.4e+07
"9148096b75a644acf97d79351151e6a3","infusionsoft","venture","1","2014-10-05",5.5e+07
"5cf258ad8d0f519464b073d36d141b9e","ingage-networks",NA,NA,NA,NA
"bbe615d41b9492ba70388b030e870949","ingen-io","grant",NA,"2015-11-04",109737.7633
"bbe615d41b9492ba70388b030e870949","ingen-io","convertible_note",NA,"2014-04-23",82838
"bbe615d41b9492ba70388b030e870949","ingen-io","seed",NA,"2015-06-09",223902
"f05fd1eb225a8f66bf9e85f05fd93033","ingeniatrics","venture",NA,"2011-02-25",2201920
"b23c784f657a260f6fd5a69c311f5994","ingenios-health","venture",NA,"2012-09-01",NA
"6701722e64e517402fa3284ba7a307b3","ingenious-targeting-laboratory",NA,NA,NA,NA
"042781d0ee29e51298460aa0c1833d9a","ingenisense",NA,NA,NA,NA
"5f3e54c34be44188679341d69e3172df","ingenium-pharamceutical",NA,NA,NA,NA
"f2e1c7c65b92a76a2724d324085e7804","ingenuit",NA,NA,NA,NA
"43e53ba51db1a216cea244282c76197b","ingenuity-systems","venture",NA,"2010-07-01",15400000
"2a3dea1ed863a79841c1642a965de273","ingeny","seed",NA,"2013-11-11",19299
"5dbb864d554374cba4d61fd47d5b91e1","ingollow","seed",NA,"2014-04-17",20000
"05d86d9005e0ff5af01c87f4eb5af5b8","ingram-medical","venture","b","2013-09-05",3e+07
"4c9899f1f3c2e06114cf809eea2f007b","ingrapher",NA,NA,NA,NA
"4ddd75ed63cd778406878156d928df10","ingres",NA,NA,NA,NA
"5459372e9fca33b098eb8ad96f72836e","inhibitex","venture",NA,"2009-10-28",2.3e+07
"a3340421cc7e6fcbe98eb46064d5beef","inhibox","venture",NA,"2006-11-17",1890000
"68bcbddd87f50f14694a2d53ded273cb","inimex-pharmaceuticals","venture","b","2008-06-02",2.2e+07
"68bcbddd87f50f14694a2d53ded273cb","inimex-pharmaceuticals","venture","a","2004-07-06",4500000
"1a5e82aa3c50494667c5e58fffe51e3a","inion",NA,NA,NA,NA
"2c37fb453185e6525bcc1a3acdda8c0b","initial-state-technologies","venture",NA,"2014-03-24",541851
"2c37fb453185e6525bcc1a3acdda8c0b","initial-state-technologies","seed",NA,"2015-02-04",1e+06
"5efa67745d32f6a8e5bf04dc11e052bf","inivata","venture","A","2016-01-26",44908899.0904
"5efa67745d32f6a8e5bf04dc11e052bf","inivata","venture","A","2014-09-23",6540899
"fd4909b855fffc58c20e9091ad496b3c","inixa",NA,NA,NA,NA
"9c584cf5ff82d7e87615561e689f9412","inkat-technologies",NA,NA,NA,NA
"d9dcf778d2870b8b7792e38b37776fdb","inkwire",NA,NA,NA,NA
"08571bf8b8bbb317af9ac5fca9e8aa08","inkwired",NA,NA,NA,NA
"c7cd6d240c1fb77f1fe360997139f607","inlight-solutions","seed",NA,"2012-05-16",350231
"f6a2885bfdec4b263e2cd3ad613a6c9b","innaas","seed",NA,"2015-04-17",107474
"dd5573fcce242d1219421bd64d0c4a7b","innate-immunotherapeutics",NA,NA,NA,NA
"7fbb3ff5abef8f118c9095f5699af04f","innate-pharma","private_equity",NA,"2013-11-20",26117980
"7fbb3ff5abef8f118c9095f5699af04f","innate-pharma","post_ipo_equity",NA,"2014-06-24",67993445
"7fbb3ff5abef8f118c9095f5699af04f","innate-pharma","venture","1","2000-03-20",4366445
"7fbb3ff5abef8f118c9095f5699af04f","innate-pharma","venture","1","2002-01-01",17729815
"7fbb3ff5abef8f118c9095f5699af04f","innate-pharma","venture","1","2004-09-01",18199907
"651e0e6527392043a4c3d5101f367950","innavirvax","venture","b","2012-02-14",4900000
"651e0e6527392043a4c3d5101f367950","innavirvax","venture","C","2015-07-17",3918907
"206ee5af93b27c6dee7a4a9cefdc5fe2","innerchip","angel",NA,"2014-12-01",NA
"185d430b47a384859b4ad9d1f1c32091","innerscope-research","venture","a","2011-09-21",9400000
"913fdcf705b2e92d0fafbf7bb76c1b42","innfocus-inc","venture","C","2015-12-23",33900000
"913fdcf705b2e92d0fafbf7bb76c1b42","innfocus-inc","debt_financing",NA,"2011-05-27",2e+06
"3edacab777f5680dc1ba8fa5426ea714","innocoll-holdings","debt_financing",NA,"2011-04-13",3250000
"3edacab777f5680dc1ba8fa5426ea714","innocoll-holdings","debt_financing",NA,"2010-03-24",4e+06
"3edacab777f5680dc1ba8fa5426ea714","innocoll-holdings","debt_financing",NA,"2010-07-13",5e+06
"3edacab777f5680dc1ba8fa5426ea714","innocoll-holdings","debt_financing",NA,"2012-07-31",2e+06
"3edacab777f5680dc1ba8fa5426ea714","innocoll-holdings","debt_financing",NA,"2009-04-22",4e+06
"3edacab777f5680dc1ba8fa5426ea714","innocoll-holdings","debt_financing",NA,"2011-08-31",3250000
"3edacab777f5680dc1ba8fa5426ea714","innocoll-holdings","debt_financing",NA,"2012-03-01",1100031
"3cc0127ec99f91f498b34fe33fd6a024","innocutis","venture",NA,"2011-04-29",6500000
"c38bb3efff229a277ab0fa321f9dd163","innocyte","venture","a","2012-11-26",NA
"c249001d96939d577c5831699003736f","innogenetics","venture",NA,"2005-10-19",9560000
"276591df8cd14e29df49bde0949c9ad4","innography","venture","b","2010-02-22",3e+06
"276591df8cd14e29df49bde0949c9ad4","innography","venture","b","2014-01-30",3500000
"276591df8cd14e29df49bde0949c9ad4","innography","venture","a","2008-08-01",6500000
"276591df8cd14e29df49bde0949c9ad4","innography","debt_financing",NA,"2014-01-30",3500000
"8454ede81433e200c6be7aad771fb580","innopharma","debt_financing",NA,"2013-11-13",2e+07
"8454ede81433e200c6be7aad771fb580","innopharma","venture",NA,"2012-06-07",8e+06
"8454ede81433e200c6be7aad771fb580","innopharma","venture","1","2011-12-02",1.5e+07
"caa71cbf462a3a80d16001898e120d32","innoquant","seed",NA,"2015-10-10",2037451.3747
"15f34cec7f9e094f97acb92bef912ff9","innoup-farma","venture",NA,"2015-11-08",2153980.9157
"e0e2ed2ae4b5d535ebbe0af4c52fca3c","innovaccer","seed",NA,"2015-05-13",NA
"022bcaf41871046d82dd30bcc1f80105","innovacell","venture",NA,"2012-04-26",10968450
"712a89197df0a67fe2985b7cbac254a0","innovative-acquisitions","private_equity",NA,"2011-10-04",70000249
"78b4bd52ca51847c2d7456fd134fa9f6","innovative-biologics","venture",NA,"2007-10-02",1e+05
"eacd46dfb47e183e34b72a5ad125544b","innovative-biosensors","venture",NA,"2010-03-23",3898078
"eacd46dfb47e183e34b72a5ad125544b","innovative-biosensors","debt_financing",NA,"2009-09-09",1753415
"eacd46dfb47e183e34b72a5ad125544b","innovative-biosensors","venture","1","2005-05-26",3500000
"eacd46dfb47e183e34b72a5ad125544b","innovative-biosensors","venture",NA,"2008-05-01",9500000
"eacd46dfb47e183e34b72a5ad125544b","innovative-biosensors","venture",NA,"2012-03-14",1514728
"e1a1d88a140e5d084de82fbe79904bdb","innovative-cardiovascular-solutions","seed",NA,"2014-12-08",1e+06
"e1a1d88a140e5d084de82fbe79904bdb","innovative-cardiovascular-solutions","venture","1","2014-12-08",4e+06
"e1a1d88a140e5d084de82fbe79904bdb","innovative-cardiovascular-solutions","venture",NA,"2015-07-27",825000
"84a54e27d5ba2236e3e7d554a36398e0","innovative-healthcare","venture",NA,"2010-11-19",4e+05
"84a54e27d5ba2236e3e7d554a36398e0","innovative-healthcare","venture",NA,"2011-05-19",871255
"9c83eb61f51578b022ca2d942b9c231f","innovative-incentives-rewards-pvt-ltd",NA,NA,NA,NA
"3afc1118389c172de839ec3085a9f787","innovative-labs",NA,NA,NA,NA
"a89212cacf44ab125b450b3e484d83f0","innovative-network-solutions",NA,NA,NA,NA
"5af0682fa025e19dbff43bdade524e1f","innovent-biologics","venture","b","2012-11-16",2.5e+07
"5af0682fa025e19dbff43bdade524e1f","innovent-biologics","venture","C","2015-01-22",1e+08
"6f1b6d841191463e9720ac8bf4cc34eb","innovese",NA,NA,NA,NA
"7cdd7e31c7ef9ec93b23908edb1550a9","innovotech",NA,NA,NA,NA
"e6ec90407b260373f41cca19c82dc1b7","innovus-pharmaceuticals","venture",NA,"2014-02-25",1072300
"e6ec90407b260373f41cca19c82dc1b7","innovus-pharmaceuticals","debt_financing",NA,"2012-01-13",174668
"e6ec90407b260373f41cca19c82dc1b7","innovus-pharmaceuticals","debt_financing",NA,"2014-01-07",350000
"9d83fd9e56a643055af94136aff76df1","innuy",NA,NA,NA,NA
"fbb8dc0f2387be885a7114f3b68ef774","inocucor","venture","A","2015-02-03",794035
"fbb8dc0f2387be885a7114f3b68ef774","inocucor","venture",NA,"2013-09-30",1456310
"fbb8dc0f2387be885a7114f3b68ef774","inocucor","venture",NA,"2014-08-15",2383236
"45c06aeb40533ad93a73bc96482b7bb4","inome",NA,NA,NA,NA
"31afdcccabe56037c94083f26b5d05aa","inotek-pharmaceuticals","venture","C","2007-08-23",19300000
"31afdcccabe56037c94083f26b5d05aa","inotek-pharmaceuticals","venture","d","2011-07-19",23600000
"31afdcccabe56037c94083f26b5d05aa","inotek-pharmaceuticals","debt_financing",NA,"2013-09-27",7e+06
"62ff34228d417b08ba065efb6af56098","inotrem","venture","a","2014-03-17",23158800
"039c1dc12540b4c260f9e2fd69e38eb4","inova-solutions",NA,NA,NA,NA
"ba9e13937abe01c28399c4f08721140a","inoveon",NA,NA,NA,NA
"011ea9bc28af8f3f47f694d1bd3a5406","inovio-pharmaceuticals","grant",NA,"2016-01-21",5e+05
"011ea9bc28af8f3f47f694d1bd3a5406","inovio-pharmaceuticals","post_ipo_equity",NA,"2014-03-04",63300000
"011ea9bc28af8f3f47f694d1bd3a5406","inovio-pharmaceuticals","grant",NA,"2015-09-22",4.5e+07
"9c2f0848a3dd0dd4c1ce9983fbf1e848","inplerus",NA,NA,NA,NA
"445b9128ee61c0bb4ed823aff5873a6b","inporia","seed",NA,"2011-05-11",1250000
"c4685a16adf496ea2924d033aa765350","inprenha","venture","A","2014-10-28",2014680.3038
"2ef717939945c0a69b173439828336fc","inpulse-medical","seed",NA,"2013-07-29",80000
"2ef717939945c0a69b173439828336fc","inpulse-medical","seed",NA,"2011-06-01",25000
"2ef717939945c0a69b173439828336fc","inpulse-medical","seed",NA,"2013-05-10",1e+05
"f0ddc05e8bbca2726162b876a82dd45d","inq-biosciences","venture",NA,"2010-03-02",510000
"ea06541d292976e739a84069c6408e3f","inquidia-consulting",NA,NA,NA,NA
"a3908445a860dff6136d1586f3b35806","inrange-systems","seed",NA,"2015-01-18",7123470
"52dc2b83b7260f5c6010bb3720338057","inrix","venture","d","2011-07-24",3.7e+07
"52dc2b83b7260f5c6010bb3720338057","inrix","venture","b","2006-05-23",1e+07
"52dc2b83b7260f5c6010bb3720338057","inrix","venture","a","2005-04-11",6100000
"52dc2b83b7260f5c6010bb3720338057","inrix","venture","E","2014-03-18",10000018
"52dc2b83b7260f5c6010bb3720338057","inrix","venture","c","2007-10-29",1.5e+07
"52dc2b83b7260f5c6010bb3720338057","inrix","secondary_market",NA,"2014-05-01",NA
"52dc2b83b7260f5c6010bb3720338057","inrix","venture","F","2014-09-12",5.5e+07
"52dc2b83b7260f5c6010bb3720338057","inrix","venture","G","2014-11-05",1e+07
"52dc2b83b7260f5c6010bb3720338057","inrix","debt_financing",NA,"2015-02-04",NA
"ff800403d382f27781a05693be51ffbf","insales",NA,NA,NA,NA
"de06f54e6b6413280cecdadc29a79414","inscopix",NA,NA,NA,NA
"90f74b86a65e68f691b06ff3162967c4","insectigen","seed",NA,"2005-11-29",1160000
"b024b2bbee408df8dbde094ccd933119","insero-health","venture",NA,"2012-02-02",1100000
"033c1e8b0fbeb0e5a16c5f6520265f39","insfocus-systems",NA,NA,NA,NA
"fafe1591c11317d11e06b82975a94a88","inside-social","debt_financing",NA,"2013-11-27",640000
"fafe1591c11317d11e06b82975a94a88","inside-social","debt_financing",NA,"2013-10-22",405000
"fafe1591c11317d11e06b82975a94a88","inside-social","seed",NA,"2013-08-05",1200000
"3091638f824a51121255b1ebc83d1fad","sociaplus",NA,NA,NA,NA
"51ecb020ac03350790d4011f2436e250","insidesales-com","venture","a","2012-08-10",4e+06
"51ecb020ac03350790d4011f2436e250","insidesales-com","venture","B","2013-01-08",36550043
"51ecb020ac03350790d4011f2436e250","insidesales-com","venture","C","2014-04-28",1e+08
"51ecb020ac03350790d4011f2436e250","insidesales-com","venture","D","2015-03-18",60649981
"a2327be5d789ec3c3308d092bc08ea20","insight-centre-for-data-analytics",NA,NA,NA,NA
"2f27de046b8a871dc3e4c7c5791efe25","insight-data-science",NA,NA,NA,NA
"043eb5b5945c3935c1d993770c77d752","insight-ecosystems-llc","equity_crowdfunding",NA,"2012-07-31",NA
"425dc0d1c18c1214efc46ad3c323a1b1","insight-genetics","debt_financing",NA,"2015-11-06",3050000
"425dc0d1c18c1214efc46ad3c323a1b1","insight-genetics","grant",NA,"2013-08-27",1500000
"d3a96e8b99f01683231a3ca6ca0c83e9","insight-plus","seed",NA,"2011-09-30",NA
"3f6a0c858ed423f55caa285203b80572","insight-signals",NA,NA,NA,NA
"699a0a9809015cf4f1dd4a316f07d71e","insight-statistics",NA,NA,NA,NA
"c2c1b1b58dac1f2468fd3385465ffa8c","insightexpress",NA,NA,NA,NA
"0adf6e624f961d5c710a496037f7521c","insightfully",NA,NA,NA,NA
"d908292c8a7ab6de355b8a53c8ee5aaa","insightica",NA,NA,NA,NA
"a8ddc020beb4bac9b11f57344f4d8755","insightng","angel",NA,"2015-06-01",108233.4957
"a8ddc020beb4bac9b11f57344f4d8755","insightng","angel",NA,"2014-12-01",333561.5597
"a8ddc020beb4bac9b11f57344f4d8755","insightng","angel",NA,"2013-10-01",519417.4757
"34f9b553b05327ad9d20d3675613d3e7","insightpool","debt_financing",NA,"2016-01-14",3e+06
"34f9b553b05327ad9d20d3675613d3e7","insightpool","seed",NA,"2013-02-06",250000
"34f9b553b05327ad9d20d3675613d3e7","insightpool","seed",NA,"2013-08-29",250000
"34f9b553b05327ad9d20d3675613d3e7","insightpool","venture","1","2014-10-02",4e+06
"3ca899df12b8b0cd362ce93c8eb97b57","insightra-medical","venture","c","2013-10-21",NA
"3ca899df12b8b0cd362ce93c8eb97b57","insightra-medical","venture",NA,"2014-05-02",6e+06
"3ca899df12b8b0cd362ce93c8eb97b57","insightra-medical","venture",NA,"2014-12-15",6125000
"3ca899df12b8b0cd362ce93c8eb97b57","insightra-medical","venture",NA,"2015-06-08",2837500
"3ca899df12b8b0cd362ce93c8eb97b57","insightra-medical","venture",NA,"2015-08-21",5e+06
"e5efad6ad550e1b2d360df39930b53e3","insightsone","venture","a","2012-03-29",4300000
"ed62e0c1993342ffd4b90429c613f423","insightsquared","venture","a","2012-05-14",4500000
"ed62e0c1993342ffd4b90429c613f423","insightsquared","seed",NA,"2011-02-03",1e+06
"ed62e0c1993342ffd4b90429c613f423","insightsquared","venture","b","2013-06-04",8e+06
"ed62e0c1993342ffd4b90429c613f423","insightsquared","venture","C","2014-11-17",13500000
"cc09a5153e15bfc6c88a843648c9436a","insightxm","seed",NA,"2015-07-31",350000
"b2ad6829550d8cd4356be7ef9d360ba1","insignia-health","venture",NA,"2009-10-05",250000
"3a57cf0e4ff74d3b729b02a68ef7fe9a","insilico-db","seed",NA,"2013-03-01",1440000
"3a57cf0e4ff74d3b729b02a68ef7fe9a","insilico-db","seed",NA,"2012-11-05",80000
"a3a90904346fde54b7bcfa82d2862672","insilico-medicine","seed",NA,"2014-04-16",NA
"bb4de8175e095956cf95f03b8e8e5973","insilixa","venture",NA,"2014-10-22",1.3e+07
"d151d8d4e4b330584e765639dbc03d30","insite-vision","private_equity",NA,"2011-07-22",22187064
"d151d8d4e4b330584e765639dbc03d30","insite-vision","debt_financing",NA,"2014-10-24",2381666
"f6b52e67a87f4b1907e1649d8e17d081","insitez",NA,NA,NA,NA
"f212223b1c849dfa040a1b611cd21659","insmed-incorporated","post_ipo_equity",NA,"2014-08-14",1e+08
"f212223b1c849dfa040a1b611cd21659","insmed-incorporated","post_ipo_equity",NA,"2015-03-02",NA
"b056ffacfadf6c61184b987c6e576654","insnap",NA,NA,NA,NA
"04a01ee26ae10e4f0dd1852773d33491","inson-medical-systems","venture",NA,"2009-09-25",642536
"e7304e2bbfd3f84cb7891bed4a2a1069","inspectlet",NA,NA,NA,NA
"34e6b55b9f26f53a9adc1de7c7157a01","insphero","venture","b","2013-06-18",2100000
"34e6b55b9f26f53a9adc1de7c7157a01","insphero","venture","a","2010-08-02",1740000
"34e6b55b9f26f53a9adc1de7c7157a01","insphero","venture","C","2015-07-08",21181504
"9ceb746528f5102a4794cae98bafe411","inspiration-biopharmaceuticals","venture",NA,"2011-03-29",247640946
"9ceb746528f5102a4794cae98bafe411","inspiration-biopharmaceuticals","venture",NA,"2009-07-23",10984600
"83f1c938e3f9b6f22674a679374c0098","inspire-2","seed",NA,"2011-09-07",375000
"fa122557f1f1b2ff748d32120bb0840e","inspire-medical-systems","venture","b","2009-06-29",1.7e+07
"fa122557f1f1b2ff748d32120bb0840e","inspire-medical-systems","venture","E","2014-05-15",4e+07
"831b327409ad2c509817a895d9bf38a2","inspire-pharmaceuticals",NA,NA,NA,NA
"742b921ac611ff0ec21e2215fa0ba8f3","inspiringbeans",NA,NA,NA,NA
"075f97ca2e1be96c41ae18bcbe05b96b","instabase","seed",NA,"2015-06-08",20000
"075f97ca2e1be96c41ae18bcbe05b96b","instabase","seed",NA,"2015-08-31",3750000
"59cfff1665c3a97eb2c0327d5e2d5b0a","instabrand","venture",NA,"2015-02-23",1500000
"59cfff1665c3a97eb2c0327d5e2d5b0a","instabrand","venture",NA,"2015-03-31",2500000
"903a2b0f50ce2a6041b64a63b22bf9b3","instagis","seed",NA,"2013-04-24",NA
"60534549fb0ca419bdac2dabf7538e8b","installmetrix",NA,NA,NA,NA
"feccef4effc6afa06d3db0d48da90810","installtracker","seed",NA,"2015-03-26",1e+06
"2a0bcff5ea83be96014f5c55c0a3982d","instana",NA,NA,NA,NA
"308c463577a6715754d20344b622de59","instanssi",NA,NA,NA,NA
"da25694b969958876d83b7c97b0f0a55","instant-chemistry",NA,NA,NA,NA
"d4bb9dd72d0f464694a07b9a0bdf16bb","instant-labs-medical-diagnostics-corp","convertible_note",NA,"2012-07-13",875000
"121d92624ebb458b07662633f08cf3cf","instapio","seed",NA,"2013-05-29",150000
"ea145ab21bb5222ddcf528608804bd99","instavisit",NA,NA,NA,NA
"2d4eb43eacfc55ac64dff6fcfb91a92c","instica",NA,NA,NA,NA
"a129011578998cd3bf450d8497c457cd","institute-for-health-metrics-and-evaluation",NA,NA,NA,NA
"8b62ca55e9c257583c44292ccbf5ae36","institute-of-clinical-physiology",NA,NA,NA,NA
"1957ffc4cd74d2512617fa9521c5d0e9","instituto-de-medicina-genomica",NA,NA,NA,NA
"33af199b9dea4f0c06aa98be44d46246","instituto-quatroxum",NA,NA,NA,NA
"594622ec47d5721294844ebe3e364386","instream-io",NA,NA,NA,NA
"df82d0c365256b7cdbde3fc15b04e354","instrumec",NA,NA,NA,NA
"f089736a9cf5131e2d57b8fe0c08d7e6","insurance-business-applications","undisclosed",NA,"2013-02-08",NA
"d4eb7ccb60164d4fb5cd1dca776bdb5e","insys-therapeutics","venture",NA,"2011-03-28",2315006
"5537ca3f351cdc12a2457d78cc29055f","intale","seed",NA,"2013-05-01",450000
"5537ca3f351cdc12a2457d78cc29055f","intale","seed",NA,"2015-10-29",2500000
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","venture","b","2007-03-20",5e+07
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","private_equity",NA,"2014-04-01",2e+08
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","debt_financing",NA,"2012-08-30",45791354
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","debt_financing",NA,"2012-11-15",5e+07
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","venture","C","2012-11-16",1.6e+08
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","venture","b","2010-09-08",5e+06
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","venture","b","2010-01-15",9026189
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","venture",NA,"2010-05-14",14488394
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","venture","E","2004-12-01",5e+07
"b887ed5f3c65f807078d7f8fc6eb91e0","intarcia-therapeutics","private_equity",NA,"2015-04-27",2.25e+08
"604f5c207dae71ca7b74d12946dec35d","intavis-bioanalytical-instruments",NA,NA,NA,NA
"ef49db8c225d9018aebaedf7ff2a7e39","intec-pharma","venture","a","2013-08-19",5e+06
"8c63990c84bed1781670b51c15a30cff","integenx","venture","b","2011-02-03",15600000
"8c63990c84bed1781670b51c15a30cff","integenx","venture","c","2011-12-13",4e+07
"8c63990c84bed1781670b51c15a30cff","integenx","venture","a","2006-08-29",4500000
"8c63990c84bed1781670b51c15a30cff","integenx","venture","b","2009-11-12",18100000
"8c63990c84bed1781670b51c15a30cff","integenx","debt_financing",NA,"2014-09-22",1e+07
"335e5fa661f331d484c1d83417eb492b","integeo",NA,NA,NA,NA
"843a5840ee759799dff74376baeff20b","integra-lifesciences-holdings",NA,NA,NA,NA
"145062e5b3c77a8fee318f67889a5b5d","integra4b",NA,NA,NA,NA
"314cd31ef0b508e1361e16ee7f7d2538","integragen","venture",NA,"2012-07-13",2400000
"314cd31ef0b508e1361e16ee7f7d2538","integragen","venture",NA,"2006-11-06",2540400
"314cd31ef0b508e1361e16ee7f7d2538","integragen","venture","1","2005-11-17",9353600
"05ac5fd9bea24a12c94c4887dc48bb1b","integralads","venture","d","2014-01-02",3e+07
"05ac5fd9bea24a12c94c4887dc48bb1b","integralads","venture","c","2012-04-18",1e+07
"05ac5fd9bea24a12c94c4887dc48bb1b","integralads","venture","b","2010-07-06",7250000
"05ac5fd9bea24a12c94c4887dc48bb1b","integralads","venture","a","2009-10-06",2500000
"05ac5fd9bea24a12c94c4887dc48bb1b","integralads","venture","E","2015-07-29",27000070
"05ac5fd9bea24a12c94c4887dc48bb1b","integralads","debt_financing",NA,"2015-07-31",4e+07
"50f0809b1588fa3658c12572525b6d5a","integral-spine-solutions","venture",NA,"2015-06-10",318938
"a6e5477496a2507742b2434697af51df","integrasco",NA,NA,NA,NA
"c79d7772fed87c733f241de410d37bc0","integrated-biopharma","debt_financing",NA,"2012-07-12",5350000
"098d1093e20f6639ee26ea8377909b59","integrated-diagnostics","venture","A","2005-07-14",NA
"098d1093e20f6639ee26ea8377909b59","integrated-diagnostics","venture","a","2009-10-14",3e+07
"098d1093e20f6639ee26ea8377909b59","integrated-diagnostics","venture","a","2012-02-22",1e+07
"098d1093e20f6639ee26ea8377909b59","integrated-diagnostics","seed",NA,"2013-09-20",1500000
"098d1093e20f6639ee26ea8377909b59","integrated-diagnostics","seed",NA,"2013-12-10",3e+05
"098d1093e20f6639ee26ea8377909b59","integrated-diagnostics","venture","B","2014-04-29",30250000
"098d1093e20f6639ee26ea8377909b59","integrated-diagnostics","debt_financing",NA,"2014-04-29",1.7e+07
"02435d454932f0974bcdc0a830fc25dc","integrated-dna-technologies",NA,NA,NA,NA
"6bdb2ea5ee8aa6755127dd7f7abc636f","integrated-medical-management","venture",NA,"2013-08-21",476000
"f50fd4cf06f815b28b1fe1f8ad83bdec","integrated-medical-systems",NA,NA,NA,NA
"bc8737b85bdf78f259b69c54934369c9","integrated-micro-chromatography-systems","venture",NA,"2013-05-14",150000
"99b8f156a6c9491fded14fb58a6ff5ac","integrated-optics",NA,NA,NA,NA
"3814e6f75195e87b299862a08ace59c1","integrated-sales-marketing-automation",NA,NA,NA,NA
"e9cf2aca63121ca5f845ff10ea62dda1","integrated-solar-analytics-solutions","seed",NA,"2013-04-01",1e+05
"3fde1deb8a1a357c933e599f5738c796","integratto-inc",NA,NA,NA,NA
"f70ddbb156df002a45d4b0493ab822e9","integround",NA,NA,NA,NA
"a45ff8b724bee94cb4a2732e996c37a1","interkrin","venture","B","2007-01-12",2.3e+07
"a45ff8b724bee94cb4a2732e996c37a1","interkrin","venture",NA,"2010-06-14",2292809
"a45ff8b724bee94cb4a2732e996c37a1","interkrin","venture","c","2008-08-04",18500000
"a45ff8b724bee94cb4a2732e996c37a1","interkrin","venture",NA,"2009-04-02",21391923
"afeaba8fdb9754dd90914ca6c7730f1b","intelect-medical","venture","B","2007-06-14",7e+06
"5e0bad05bacb63a3457c05bddb39c965","intelen","angel",NA,"2013-04-03",360000
"5e0bad05bacb63a3457c05bddb39c965","intelen","seed",NA,"2010-09-01",250000
"5e0bad05bacb63a3457c05bddb39c965","intelen","angel",NA,"2014-05-19",1500000
"5e0bad05bacb63a3457c05bddb39c965","intelen","grant",NA,"2014-05-11",1e+06
"d4f2c6fe2db65d09f95168362febc483","intelenet-global-services",NA,NA,NA,NA
"01ea5c8da1f0704ce921c569b8b48081","intelescope-solutions","venture",NA,"2015-03-05",8300000
"45839afca662db175db1f2722bc6210b","intelesense-technologies",NA,NA,NA,NA
"fad77275a96c72b77fb1e48ea29c8233","intelgenx","post_ipo_equity",NA,"2013-12-16",3500000
"fad77275a96c72b77fb1e48ea29c8233","intelgenx","venture",NA,"2011-06-17",1730298
"cc076825dec3d01c1d3038b6af7af0cd","inteliace-research","seed",NA,"2006-10-01",1e+05
"360f41894c44c0d975566fc9bbadbf7c","inteliathlete",NA,NA,NA,NA
"5be96cde00cdf31226ba104fcf37b926","intelisoles",NA,NA,NA,NA
"d71b6dbea7a629f92d24e956d461e618","intellect-neurosciences","debt_financing",NA,"2009-09-11",450000
"d71b6dbea7a629f92d24e956d461e618","intellect-neurosciences","debt_financing",NA,"2010-05-13",2320000
"4c62c81ac5bb553573afe40d52ac1c4d","intellia-therapeutics","venture","A","2014-11-18",1.5e+07
"4c62c81ac5bb553573afe40d52ac1c4d","intellia-therapeutics","venture","B","2015-09-01",7e+07
"a219ccb0ee38cfb3b28eb24ca8bab662","intellicell-biosciences","venture",NA,"2011-10-11",340000
"a219ccb0ee38cfb3b28eb24ca8bab662","intellicell-biosciences","venture",NA,"2012-03-27",2475000
"a219ccb0ee38cfb3b28eb24ca8bab662","intellicell-biosciences","venture",NA,"2012-12-03",375000
"2f599fdc53d37a9e558a6c5a552244c1","intellicus",NA,NA,NA,NA
"9624207a1a349cd128377f26b3de5d5a","intellicyt","venture",NA,"2015-10-22",7400000
"9624207a1a349cd128377f26b3de5d5a","intellicyt","venture",NA,"2013-05-06",8e+06
"9624207a1a349cd128377f26b3de5d5a","intellicyt","debt_financing",NA,"2014-06-10",4e+06
"9624207a1a349cd128377f26b3de5d5a","intellicyt","venture",NA,"2015-07-28",5444672
"d965e5e06fd1d4dff7f9c44ce6dc49b1","intelligencenode","seed",NA,"2014-05-01",350000
"d965e5e06fd1d4dff7f9c44ce6dc49b1","intelligencenode","venture","1","2015-05-27",4e+06
"7311cd24002fade49b0f7081d96e260d","intelligenescan","venture",NA,"2010-07-14",1e+05
"92957ca086e14f1d3cb6eb20b895eb41","intelligent-bio-systems","venture","A","2008-03-27",353000
"0aa0a6bc37b492ab7e2f6c9d33223cec","intelligent-data-sensor-devices","undisclosed",NA,"2013-06-01",16500
"08e6e636d1a257ec3050b3ea692a3f0a","intelligent-demand",NA,NA,NA,NA
"6058c28d097ffef51b84ab6b7b8aabcc","intelligent-insites","venture",NA,"2010-12-06",5161000
"6058c28d097ffef51b84ab6b7b8aabcc","intelligent-insites","venture",NA,"2012-01-24",0
"6058c28d097ffef51b84ab6b7b8aabcc","intelligent-insites","undisclosed",NA,"2014-04-17",NA
"1376e54c460788fc06cd0594b223158d","intelligent-optimisations","angel",NA,"2015-11-23",2500000
"1376e54c460788fc06cd0594b223158d","intelligent-optimisations","angel",NA,"2014-06-01",3351243
"1376e54c460788fc06cd0594b223158d","intelligent-optimisations","angel",NA,"2013-09-30",1775768
"1376e54c460788fc06cd0594b223158d","intelligent-optimisations","seed",NA,"2013-05-13",882316
"1376e54c460788fc06cd0594b223158d","intelligent-optimisations","angel",NA,"2015-04-15",1840373
"b23d353e298b548b8c84eae8c40b444b","intelligize","venture",NA,"2010-08-31",2090727
"b23d353e298b548b8c84eae8c40b444b","intelligize","venture","1","2011-05-20",1500000
"b23d353e298b548b8c84eae8c40b444b","intelligize","seed",NA,"2009-12-15",NA
"07b531c8536ad73c91da74d42e1d366c","intelligrape-software",NA,NA,NA,NA
"f6dd906260679577f7c72b4ab9f6b0e8","intellikine","venture",NA,"2011-10-31",4e+06
"f6dd906260679577f7c72b4ab9f6b0e8","intellikine","venture","1","2009-07-22",5.1e+07
"f6dd906260679577f7c72b4ab9f6b0e8","intellikine","venture","1","2007-06-01",3e+07
"91fdd87c2b9cfbc7e3478ab557f6121e","intellimedix","seed",NA,"2015-02-23",2300000
"1c114a8357c45727186902c2508a074a","intellipharmaceutics-international","venture",NA,"2011-02-15",1.2e+07
"bf5f312280c4b3e252aae18d68be4167","intelliworks","venture","d","2009-04-24",2250000
"bf5f312280c4b3e252aae18d68be4167","intelliworks","venture","a","2005-02-14",6e+06
"bf5f312280c4b3e252aae18d68be4167","intelliworks","venture","b","2006-10-10",1e+07
"bf5f312280c4b3e252aae18d68be4167","intelliworks","venture","c","2008-04-07",4e+06
"bf5f312280c4b3e252aae18d68be4167","intelliworks","venture",NA,"2010-07-15",1700000
"906ea6ef0391cae186948be16aeb8f55","intelliworkz-business-solutions",NA,NA,NA,NA
"7cccaf8a1f773a7a437706d3e2fd1b6c","intelnics",NA,NA,NA,NA
"4464923c6ca078ce839a0e1786fd5341","intelomed","venture",NA,"2016-01-26",1855410
"4464923c6ca078ce839a0e1786fd5341","intelomed","venture","1","2013-09-09",4e+06
"4464923c6ca078ce839a0e1786fd5341","intelomed","venture",NA,"2011-05-25",2611000
"4464923c6ca078ce839a0e1786fd5341","intelomed","venture",NA,"2010-01-29",2e+05
"4464923c6ca078ce839a0e1786fd5341","intelomed","venture",NA,"2014-07-24",3850000
"a7036d00daf586a0d0817150991b7ad5","intelytics",NA,NA,NA,NA
"1214c435bed952d112e9d106479e0b69","intema","venture",NA,"2015-04-16",NA
"aadfa744d23807d2d5f1759bb19f0e83","intements",NA,NA,NA,NA
"ae9a782dab35050e99e47e071425224a","intensity-analytics","seed",NA,"2013-07-24",3500000
"f5a9ca0c0476b86e4e99d54d6a4e60f6","intensity-therapeutics","venture",NA,"2014-02-11",1e+06
"f5a9ca0c0476b86e4e99d54d6a4e60f6","intensity-therapeutics","venture",NA,"2015-06-12",5e+05
"d230e67e0ee5145d0fa8d63e2456ae35","intensulabs",NA,NA,NA,NA
"e5a1f4ea9f8ce9474d4c8221510b2442","intent-data",NA,NA,NA,NA
"9292d39c14dbe8c4b75b398bc8e183a6","intent-hq","venture",NA,"2014-05-01",8009622
"9292d39c14dbe8c4b75b398bc8e183a6","intent-hq","undisclosed",NA,"2015-04-01",5187593
"18cdfbee01fa5a2c7f8666b4452d2e2f","intentiva","seed",NA,"2014-01-13",25000
"679db4b6bb284e953cc3ee8b7377d714","interact-io","seed",NA,"2012-12-01",NA
"679db4b6bb284e953cc3ee8b7377d714","interact-io","seed",NA,"2014-02-10",NA
"a07ecf14381420dacee32fcc32eef25c","interactions","venture",NA,"2011-07-26",1.2e+07
"a07ecf14381420dacee32fcc32eef25c","interactions","venture","1","2010-04-13",10450000
"a07ecf14381420dacee32fcc32eef25c","interactions","venture",NA,"2013-05-22",4e+07
"a07ecf14381420dacee32fcc32eef25c","interactions","venture",NA,"2015-04-12",9500000
"086fc9bb216aa2fc07ee171c98dd62ab","interactive-buzz",NA,NA,NA,NA
"8e3f39cb89b687f829730e0fd28125b5","interactive-data",NA,NA,NA,NA
"f455fdcfd44f1d8135d6d4863237cc2f","interactive-design-labs",NA,NA,NA,NA
"efbc57c1f3e3be9081e569a1845db1ae","interactive-motion-technologies","seed",NA,"2011-04-28",3e+05
"d0c677618857f5fb31ef459419353e56","interactives",NA,NA,NA,NA
"ea2fd4cb25d7c7b9c5ca4f4bbfe67b1f","interactivestudios-inc-",NA,NA,NA,NA
"c2ba227fbd12580e3234d1878f9c21ee","interactyx-limited",NA,NA,NA,NA
"5dcd7553210b14521965be5bd88075af","interakt",NA,NA,NA,NA
"5cd975ddca9266d95b7cced2995c0d0c","interana","venture","A","2014-10-07",8199999
"5cd975ddca9266d95b7cced2995c0d0c","interana","venture","B","2015-01-21",2e+07
"d16ca692d694896cf864f2160c2c2007","interarbor-solutions",NA,NA,NA,NA
"da13137cf19cb3688bdf1e295532bae7","intercept-pharmaceuticals","venture","A","2008-07-29",2.5e+07
"da13137cf19cb3688bdf1e295532bae7","intercept-pharmaceuticals","venture","c","2012-08-10",3e+07
"da13137cf19cb3688bdf1e295532bae7","intercept-pharmaceuticals","venture","b","2010-01-25",2.5e+07
"da13137cf19cb3688bdf1e295532bae7","intercept-pharmaceuticals","post_ipo_equity",NA,"2015-04-01",338400000
"8e7f73f6fdc4cf03aa52d881a2f11804","intercloud-systems","post_ipo_equity",NA,"2016-01-22",7500000
"8e7f73f6fdc4cf03aa52d881a2f11804","intercloud-systems","venture",NA,"2013-12-27",11625000
"8e7f73f6fdc4cf03aa52d881a2f11804","intercloud-systems","debt_financing",NA,"2014-07-15",1500000
"8e7f73f6fdc4cf03aa52d881a2f11804","intercloud-systems","venture",NA,"2014-10-20",4345000
"8e7f73f6fdc4cf03aa52d881a2f11804","intercloud-systems","debt_financing",NA,"2014-12-08",2500000
"8e7f73f6fdc4cf03aa52d881a2f11804","intercloud-systems","post_ipo_equity",NA,"2015-05-26",3e+06
"8e7f73f6fdc4cf03aa52d881a2f11804","intercloud-systems","post_ipo_equity",NA,"2015-08-14",2631579
"bbb996ef6e3322f704b93d2c06484368","interconverse",NA,NA,NA,NA
"a00479289bc390b72b01865ea1faa937","intercytex-group","venture",NA,"2003-08-01",1604280
"a00479289bc390b72b01865ea1faa937","intercytex-group","venture",NA,"2005-08-01",21207405
"2f1eb3c12676f229f0ae9831334b6f22","interest-labs",NA,NA,NA,NA
"1be8863b801838061b70b602fc7ac120","interface-biologics","venture","b","2011-01-11",7e+06
"1be8863b801838061b70b602fc7ac120","interface-biologics","venture",NA,"2011-12-08",1e+06
"1be8863b801838061b70b602fc7ac120","interface-biologics","venture","A","2010-01-01",1.9e+07
"1be8863b801838061b70b602fc7ac120","interface-biologics","venture",NA,"2008-12-09",5e+06
"1be8863b801838061b70b602fc7ac120","interface-biologics","venture","B","2015-01-13",NA
"3e855a7ffea40c8d62e388025825d3ba","interfaceware",NA,NA,NA,NA
"d95444e6abef392b915640f88e6b0341","lazygirls",NA,NA,NA,NA
"cd70dd17e037681bdee04407b348576d","interlaced-apple-support-and-repair",NA,NA,NA,NA
"6ae495761dcbe5037cadc0e2e3313a5d","intermedix-corporation",NA,NA,NA,NA
"7cb5eb22ccd0e09c49e2ff35330fa7a3","intermune",NA,NA,NA,NA
"001357404d5a435d7fb02f8029bccfc2","interna-technologies","venture","A","2015-12-15",10500000
"001357404d5a435d7fb02f8029bccfc2","interna-technologies","private_equity",NA,"2013-03-26",NA
"bd4b213707618e47f15c57dba540840b","international-cardio-corporation","venture",NA,"2011-12-21",3e+05
"3cc7d414838f682f9f52502c105d8871","international-network-for-outcomes-research-inor","venture",NA,"2012-06-05",8e+05
"386d92900946e60dee1aac3c7c23906e","international-stem-cell-corporation","private_equity",NA,"2012-03-20",5e+06
"386d92900946e60dee1aac3c7c23906e","international-stem-cell-corporation","venture",NA,"2014-10-23",2500000
"bbd1dac2536a91cfe6af429501e366be","international-trade-centre",NA,NA,NA,NA
"3ca7fdeaff09f6ab4468a893e31f06dc","internet-of-thinkers",NA,NA,NA,NA
"99dd6e6fde4177aee619e0a343cac66d","internet-profiles-corp",NA,NA,NA,NA
"a071f3b78d5943f8d12fbe5a732548e2","interpretomics","angel",NA,"2013-08-13",1600000
"7febd8abfc7cb7a4583fe1a20f83d300","interpublic-group-of-companies-nyse-ipg",NA,NA,NA,NA
"37b222de7a6cad707b8318e36049f255","intersec","venture","B","2014-11-05",2e+07
"9220623d5a3adcfc2b597951dac4898d","interset","venture",NA,"2015-03-18",1e+07
"6f4087d98ae955a97e56bd2cf9d18575","interstate-analytics",NA,NA,NA,NA
"765c15b186b8d9df32e8446392f03103","interthinx",NA,NA,NA,NA
"fef367e8eccbfdefb7735b495c96a9a4","intervalve","venture",NA,"2012-02-09",5986763
"fef367e8eccbfdefb7735b495c96a9a4","intervalve","venture",NA,"2013-07-10",2572292
"fef367e8eccbfdefb7735b495c96a9a4","intervalve","venture",NA,"2014-08-19",2571887
"fef367e8eccbfdefb7735b495c96a9a4","intervalve","debt_financing",NA,"2015-01-21",3e+06
"c17495aa1757b7649e76bd87c9c32474","interventional-spine","venture","C","2007-05-31",2.4e+07
"c17495aa1757b7649e76bd87c9c32474","interventional-spine","debt_financing",NA,"2011-02-03",1308252
"c17495aa1757b7649e76bd87c9c32474","interventional-spine","debt_financing",NA,"2013-02-21",3440857
"b2214f37fa621d0918952771d8ac6269","interworks",NA,NA,NA,NA
"a0afeca7e8791fe3c34fba8b75162c62","intesolv",NA,NA,NA,NA
"c7ad97f1bc8bd5be38dbb98e242902c7","intezyne-technologies",NA,NA,NA,NA
"63afdde95fc992be78a2913bb69de231","inthera-bioscience","seed",NA,"2015-12-14",3735935.3024
"9cd87458de129d6c6a64c15b0468e714","inthrma","seed",NA,"2007-10-01",10000
"598f85d415d51e428dd938440f032a5a","intica-biomedical","debt_financing",NA,"2012-03-15",640000
"950f0988ed3b2485c065de9738e28090","intics-group",NA,NA,NA,NA
"b7b49ca9574bba7b28089ed86bc23bfc","intlock",NA,NA,NA,NA
"bb8eca37b0da7d90c004bb45d782e171","intomics","venture",NA,"2009-07-10",NA
"d7be7add40693bc5b239b1d035aca693","intosoft",NA,NA,NA,NA
"1f2c82feb8c6d0b69f6f0cc55b99df54","intra-cellular-therapies","secondary_market",NA,"2013-09-01",6e+07
"1f2c82feb8c6d0b69f6f0cc55b99df54","intra-cellular-therapies","debt_financing",NA,"2013-05-17",15289893
"e5e873a3dc9c95f7d37ab9e0238269fd","intradigm-corporation","venture","a","2006-11-21",1.6e+07
"e5e873a3dc9c95f7d37ab9e0238269fd","intradigm-corporation","venture","b","2009-01-07",21400000
"898f285c572f881ff8b599542e082307","intralist",NA,NA,NA,NA
"24f3d20aa568cbc8e90bffde8907d574","intrapace","venture",NA,"2011-04-26",116910054
"24f3d20aa568cbc8e90bffde8907d574","intrapace","venture",NA,"2012-04-09",2250000
"24f3d20aa568cbc8e90bffde8907d574","intrapace","venture",NA,"2012-09-04",6201511
"24f3d20aa568cbc8e90bffde8907d574","intrapace","venture",NA,"2013-08-26",3337222
"24f3d20aa568cbc8e90bffde8907d574","intrapace","debt_financing",NA,"2013-03-27",624040
"9b54e6c45534573e51e74dfca222c900","intraxio","seed",NA,"2014-08-21",NA
"7ed1d3a156533423c169521462f39f8c","intrepid-bioinformatics","debt_financing",NA,"2011-08-04",325000
"7ed1d3a156533423c169521462f39f8c","intrepid-bioinformatics","venture",NA,"2010-04-27",550000
"9e54b3b51d87f81167dd025fd5244f8b","intrexon-corporation","venture","c","2009-07-07",1e+07
"9e54b3b51d87f81167dd025fd5244f8b","intrexon-corporation","venture","c","2007-05-16",2.5e+07
"9e54b3b51d87f81167dd025fd5244f8b","intrexon-corporation","venture","b","2005-05-17",5e+05
"9e54b3b51d87f81167dd025fd5244f8b","intrexon-corporation","venture","e","2011-05-31",1e+08
"9e54b3b51d87f81167dd025fd5244f8b","intrexon-corporation","venture","f","2013-05-02",1.5e+08
"9e54b3b51d87f81167dd025fd5244f8b","intrexon-corporation","venture",NA,"2006-03-01",1e+06
"9e54b3b51d87f81167dd025fd5244f8b","intrexon-corporation","post_ipo_equity",NA,"2015-01-28",57500000
"540bd33988498ad7d01293123cbd8507","cloudrupt",NA,NA,NA,NA
"a110b96e875aa825424675d904e152fa","tribunat","seed",NA,"2015-12-30",127000
"a110b96e875aa825424675d904e152fa","tribunat","seed",NA,"2014-06-01",1e+05
"5a9de7679b5cb16e54fc11ef1dc61e7c","intrinsic-medical-imaging","venture",NA,"2012-01-25",3050000
"5a9de7679b5cb16e54fc11ef1dc61e7c","intrinsic-medical-imaging","venture",NA,"2014-02-20",1e+05
"5a9de7679b5cb16e54fc11ef1dc61e7c","intrinsic-medical-imaging","venture",NA,"2012-03-21",585000
"0d353a397b143260076793c664799d67","intromi","private_equity",NA,"2015-04-21",25000
"0e6239c9267032689856e8478b773843","intuitive-biosciences","venture",NA,"2013-04-12",572726
"0e6239c9267032689856e8478b773843","intuitive-biosciences","debt_financing",NA,"2014-08-01",486858
"0e6239c9267032689856e8478b773843","intuitive-biosciences","venture",NA,"2015-06-04",1333888
"d28d4ac087e683a25925b9b43bcb3576","intuitive-business-intelligence",NA,NA,NA,NA
"9abc9ff966ef3340fccb61d7b7a38764","invasc-therapeutics","venture","a","2010-10-08",3100000
"cd1d1a27c7663e7fbca47b7d5d8c7673","invenia",NA,NA,NA,NA
"ead9e75285d617a84db3ad8e980a3389","invenio-imaging","venture",NA,"2015-12-29",1000004
"e356c026147482279abc26e3f0d55d38","invenra","venture",NA,"2013-02-20",3e+06
"e356c026147482279abc26e3f0d55d38","invenra","debt_financing",NA,"2012-01-18",1200000
"e356c026147482279abc26e3f0d55d38","invenra","venture",NA,"2015-01-28",2017640
"e356c026147482279abc26e3f0d55d38","invenra","venture",NA,"2015-08-25",2e+06
"b8ecd159e83a4484ba454659bd909c8f","inventures-turkey",NA,NA,NA,NA
"12d1fc33c2ac0ae34c4585fdc177880e","inveresk-reseaech-group",NA,NA,NA,NA
"2cb6565aed128f04f69e5f606cbfc1c9","inversoft",NA,NA,NA,NA
"be6a95520e3daaa07f4c3a858e15759d","inveschool",NA,NA,NA,NA
"a7c683bfe798c2812a5ba8bba23f60f6","investicare","debt_financing",NA,"2005-08-11",216406
"e802d07d6fc49a800c9fe3ed23368aae","investing-contrarian",NA,NA,NA,NA
"01a4d6ae31db6bd19bb499f929acdfca","investor-group-services-igs",NA,NA,NA,NA
"2adff9aa2f4088c3cb2c065f2e6048bc","investorbit",NA,NA,NA,NA
"3b3191bd4510c5a1a0b66b6f3f990ffa","investy",NA,NA,NA,NA
"3aadff2f7c5f8d6858079f453e9f8a27","invictus-medical","debt_financing",NA,"2013-05-16",480000
"3aadff2f7c5f8d6858079f453e9f8a27","invictus-medical","venture","1","2014-12-16",3800000
"dd83750465fc7e1cc0e2867f787e55eb","invictus-oncology","venture","a","2013-05-28",1880000
"be815e5105de1434d5d0aae0ac040abc","inviragen","venture","a","2009-10-06",1.5e+07
"6af95f68d33337852cb97aa4012e22f8","invisible-media-inc-","seed",NA,"2014-10-01",2e+05
"6af95f68d33337852cb97aa4012e22f8","invisible-media-inc-","seed",NA,"2015-05-19",1e+06
"a6c31f824f0bfa83c29b4b24681b6854","invisible-puppy","seed",NA,"2010-01-01",1e+05
"5515071311c282c93ffb2f848b412415","invisible-sentinel","venture",NA,"2010-12-03",2e+06
"5515071311c282c93ffb2f848b412415","invisible-sentinel","venture",NA,"2009-03-27",1025000
"5515071311c282c93ffb2f848b412415","invisible-sentinel","venture",NA,"2014-01-14",7e+06
"110cc24eb2bd2cd1d3eebd9838a47dba","invitae-corporation","venture","a","2012-11-08",29557113
"110cc24eb2bd2cd1d3eebd9838a47dba","invitae-corporation","venture",NA,"2011-03-29",2299999
"110cc24eb2bd2cd1d3eebd9838a47dba","invitae-corporation","venture","e","2013-12-10",4e+07
"110cc24eb2bd2cd1d3eebd9838a47dba","invitae-corporation","venture",NA,"2010-09-15",3644999
"110cc24eb2bd2cd1d3eebd9838a47dba","invitae-corporation","venture","F","2014-10-13",1.2e+08
"d67cd20638c032632e01e381185cadcc","invitrogen",NA,NA,NA,NA
"4e583e73fd94990dc3e7353bce42b415","invivo-therapeutics","venture",NA,"2010-12-03",1.3e+07
"7736b4b6bf1680a39bfdd6af61c077ed","invivosciences","grant",NA,"2015-10-21",7e+05
"32162c7c06d200d33a478f45fd65bfc8","invizua",NA,NA,NA,NA
"930b5958538cfa61a58107212841c2a5","invo-bioscience","debt_financing",NA,"2009-10-14",545000
"cd7c799440dda45e8cdc6496b4fd2c2e","invoca","venture",NA,"2012-11-21",3250000
"cd7c799440dda45e8cdc6496b4fd2c2e","invoca","venture","1","2009-06-02",3500000
"cd7c799440dda45e8cdc6496b4fd2c2e","invoca","venture","1","2010-11-30",4e+06
"cd7c799440dda45e8cdc6496b4fd2c2e","invoca","venture","1","2014-01-13",2e+07
"1b1c0b9bc6c7e3c4cd7b31522d5bcd85","invoicesharing","seed",NA,"2013-12-02",NA
"1b1c0b9bc6c7e3c4cd7b31522d5bcd85","invoicesharing","seed",NA,"2013-05-31",1500000
"1b1c0b9bc6c7e3c4cd7b31522d5bcd85","invoicesharing","seed",NA,"2014-07-21",20352
"f6367588199a41694fbdad1717f5ecd7","invotek-inc","equity_crowdfunding",NA,"2007-02-18",NA
"8716c5dabfc7154c4eb7ca03320fa5ab","invoy-technologies","venture",NA,"2009-12-30",898000
"cda84ae2835ec2f2e5dec1c9fe1bd59c","invvax","venture",NA,"2015-06-01",NA
"37f257589b91ceaa0bdcd99af463e631","io-biotech","venture","A","2016-01-05",11908757.267
"3532e135e826660024f0a91c8ba16f15","io-datacenters",NA,NA,NA,NA
"0809c863142451a6909e6aa0a3fa2afd","io-therapeutics","venture",NA,"2014-01-02",443501
"89870565de272caba1e78fd948338649","iod-incorporated","venture",NA,"2010-07-13",3.5e+07
"f68d5993bcb8e2d012df9f19409f048c","iodine","venture",NA,"2014-01-01",NA
"f68d5993bcb8e2d012df9f19409f048c","iodine","seed",NA,"2014-02-28",2500000
"5f0405f2b94a78b54abd8b801e445e03","iogenetics","venture",NA,"2014-01-02",1153983
"af3a45afea7ee8fc1b7a904c1a214033","ion-flux",NA,NA,NA,NA
"1c4364e5fb28ae86d3e2afc8d01019c6","ion-global-chinadotcom",NA,NA,NA,NA
"62c48db8df21090e55e053c8df29df4d","ion-healthcare","debt_financing",NA,"2009-04-24",249935
"4b2853e71e9c132c73f34bd6da08a201","ion-torrent","venture",NA,"2009-10-23",22799988
"4b2853e71e9c132c73f34bd6da08a201","ion-torrent","venture","1","2010-03-05",37064376
"48e92bd4539edd4d83278ae0b78dd8dc","ionia-pharmacy","venture",NA,"2012-10-05",5e+05
"48e92bd4539edd4d83278ae0b78dd8dc","ionia-pharmacy","venture",NA,"2013-03-11",250000
"48e92bd4539edd4d83278ae0b78dd8dc","ionia-pharmacy","venture",NA,"2014-07-28",150000
"623ef88ad88b511f646f0256fa770b81","ionic-transport-assays",NA,NA,NA,NA
"6dd3c8071ef292827fddfb99b7be180b","ionix-medical","venture",NA,"2009-09-20",18333503
"a8f78ca1bba5764092bad00c2d20004f","iooota-analytics-for-everything",NA,NA,NA,NA
"5a2b6753d58bb3cefcf5f1a5e3e120de","ioptex-research",NA,NA,NA,NA
"1b85463b91a4718c45a26ac9aaecea7e","iovation","venture","a","2008-03-27",1.5e+07
"1b85463b91a4718c45a26ac9aaecea7e","iovation","venture",NA,"2009-06-24",1e+06
"67e207234d548be0b6bba6891c2468f6","iovox","seed",NA,"2009-01-01",584440
"67e207234d548be0b6bba6891c2468f6","iovox","undisclosed",NA,"2012-10-17",NA
"5f603ee3efb83bb3cbd48845eb2e8165","iowacomputergurus",NA,NA,NA,NA
"bae686d66d7c4bdc90e870c0d9b4484b","ip-street","debt_financing",NA,"2014-01-08",565000
"bae686d66d7c4bdc90e870c0d9b4484b","ip-street","venture",NA,"2014-04-07",3308637
"bae686d66d7c4bdc90e870c0d9b4484b","ip-street","venture",NA,"2010-02-08",1500000
"bae686d66d7c4bdc90e870c0d9b4484b","ip-street","venture",NA,"2012-01-10",2150000
"5d5b150acd004ffaff72299b34e4dc1f","iperceptions","venture","a","2008-12-02",3650000
"5d5b150acd004ffaff72299b34e4dc1f","iperceptions","undisclosed",NA,"2014-12-10",NA
"f7c15817e97d8d54248272c103258e68","ipierian","venture",NA,"2009-07-08",11500000
"f7c15817e97d8d54248272c103258e68","ipierian","venture","1","2013-09-04",3e+07
"f7c15817e97d8d54248272c103258e68","ipierian","grant",NA,"2009-10-01",3700000
"f7c15817e97d8d54248272c103258e68","ipierian","venture","1","2010-11-09",28970000
"c21ec8962c6dd02afb83a01003b8ab0e","ipl",NA,NA,NA,NA
"cb3a38a7d4682569e29876641607b236","iplytics","seed",NA,"2015-10-21",NA
"cb3a38a7d4682569e29876641607b236","iplytics","seed",NA,"2013-09-04",NA
"9bb37c2c0d672b826de35e931c2786f2","ipm-safety-services","seed",NA,"2013-04-26",1e+06
"e739da6148fe290016226892ae97834e","iponweb",NA,NA,NA,NA
"bdf963cbca0633c0e3e4eceb393432b2","ipositioning","venture",NA,"2013-12-30",787000
"59d0ce08930854cd69e4f38084537b07","ipractice-group","venture",NA,"2012-05-13",2290000
"59d0ce08930854cd69e4f38084537b07","ipractice-group","venture",NA,"2010-10-18",227000
"20fdbf4bd974d5091c3a4aa7f239f776","iprecinct",NA,NA,NA,NA
"085b0b3520ab377fcbb5dd9c566e45bc","iprospect-ireland",NA,NA,NA,NA
"503a411b10a0291d95802b70cfbd2139","ips-academia-japan","venture",NA,"2015-02-27",11910020
"42d39085e11b51809a20a02c9b7a21b9","ipsat-therapies","venture",NA,"2006-01-25",3680000
"42d39085e11b51809a20a02c9b7a21b9","ipsat-therapies","venture","1","2005-04-03",9020000
"3907e57959e34f65881f707b9a4fef77","ipselex","seed",NA,"2013-09-05",13000
"3907e57959e34f65881f707b9a4fef77","ipselex","undisclosed",NA,"2014-07-01",41250
"5dbcea4bde53779602d53f2d8020c62f","ipsen",NA,NA,NA,NA
"85cf442181d8c0645667f7ac0a3a8bbb","ipsum-energy","venture","A","2014-08-03",1e+06
"85cf442181d8c0645667f7ac0a3a8bbb","ipsum-energy","undisclosed",NA,"2013-01-01",2e+05
"da7a33430b21f490f8db43a861c29b9b","ipsum-works-sl",NA,NA,NA,NA
"dea366f5704e08ddc362827f731e0a39","ipvive-inc","seed",NA,"2012-03-01",266077
"dea366f5704e08ddc362827f731e0a39","ipvive-inc","seed",NA,"2014-09-30",550000
"dea366f5704e08ddc362827f731e0a39","ipvive-inc","seed",NA,"2015-07-01",115000
"12b1f62e3187c4b9e7d35ae05aaf67a6","ipyxel-creations",NA,NA,NA,NA
"71cc29b4676a5af5729bfd1341651089","iq-engines","venture","b","2012-06-25",3800000
"475bb5115f04e0bc69eac0df0d4b780c","iq-sports-solutions",NA,NA,NA,NA
"6215e62fa39d78d99d1487e6187c6743","iq-technologies","angel",NA,"2010-10-01",3e+06
"b9b5ed92ccd4864f316862312fd3dc43","iqlect","seed",NA,"2015-07-21",2e+06
"d73a92952538ff10c0078d9ead7069c3","iqu",NA,NA,NA,NA
"7e6987fef4d4714597859998e8ee500d","iquanti",NA,NA,NA,NA
"4eb5678899d7f47b2e65047d905b0237","iquity-labs","seed",NA,"2016-01-07",2e+06
"c8f4a00ab39a76e1ed15fc232e7a7cb5","iquum","debt_financing",NA,"2011-01-03",1e+06
"7a74bc00917975a3ca5cc48afae2761a","irecruit","venture","A","2015-01-18",NA
"7a74bc00917975a3ca5cc48afae2761a","irecruit","seed",NA,"2015-12-01",36167.8477
"7a74bc00917975a3ca5cc48afae2761a","irecruit","seed",NA,"2015-04-01",15250.7606
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","venture","E","2014-05-22",1.7e+07
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","venture","c","2011-10-26",7e+06
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","venture",NA,"2010-05-20",1e+07
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","venture","c","2011-05-04",1.5e+07
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","venture",NA,"2012-01-26",22149652
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","debt_financing",NA,"2012-11-13",3498860
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","venture","d","2013-04-10",1.6e+07
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","venture",NA,"2012-11-19",1500000
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","venture","b","2009-05-18",6500000
"aa5c3d9fc9ac60554e3da185ceddae20","irhythm","private_equity",NA,"2012-01-01",12180000
"28c0d91f89d15e5c1a77e2f1a276f084","iri","undisclosed",NA,"2011-04-01",NA
"a4fc88a12e16603763e84527615d4494","iri-group-holdings","venture",NA,"2011-04-28",8.5e+07
"a4fc88a12e16603763e84527615d4494","iri-group-holdings","venture",NA,"2015-07-13",89465605
"260f8f1a4b56d7f63e46d548c1f18eee","iris-tv","seed",NA,"2013-10-04",1700000
"260f8f1a4b56d7f63e46d548c1f18eee","iris-tv","venture","1","2015-06-17",5300000
"53984c473b8e23591c8270ea79cff5f3","irish-cancer-society",NA,NA,NA,NA
"ffabdff8049fe17e44572aac94c50925","iroa-technologies","venture",NA,"2013-04-22",7e+05
"39def725c42ff3491af972c8501df6e1","iroko-pharmaceuticals","debt_financing",NA,"2013-11-21",7.5e+07
"e6328b74a8d51f7230209accd7a51d34","iron-phoenix-technologies",NA,NA,NA,NA
"6f1ec2683ed7c96df731029b945bf320","ironpearl","seed",NA,"2012-06-15",NA
"1e81be5d745513224ec7e57d04e6e70f","ironside",NA,NA,NA,NA
"bb9910b6543c0594214fbf822c1ca489","irx-therapeutics","venture","A","2008-06-04",2.5e+07
"bb9910b6543c0594214fbf822c1ca489","irx-therapeutics","debt_financing",NA,"2014-03-17",15094601
"bb9910b6543c0594214fbf822c1ca489","irx-therapeutics","debt_financing",NA,"2012-05-30",1500000
"bb9910b6543c0594214fbf822c1ca489","irx-therapeutics","venture",NA,"2010-01-06",2211772
"bb9910b6543c0594214fbf822c1ca489","irx-therapeutics","debt_financing",NA,"2010-06-11",8047991
"bb9910b6543c0594214fbf822c1ca489","irx-therapeutics","venture",NA,"2015-08-17",40585742
"301eb7d8fdaea79e179aa90493ce3a9e","is-pharma","venture",NA,"2010-10-07",5700000
"56cf9291c73c0bdaf7a6d77241287b63","isa-pharmaceuticals",NA,NA,NA,NA
"8f16a4442c02c8a05e2a0a707c72bab7","isacglobal",NA,NA,NA,NA
"d7e62b86d521443ed6a854deb4462a36","isalus-healthcare",NA,NA,NA,NA
"e757757525a5ca134670cfb69cfcb074","isarna-therapeutics-gmbh","private_equity",NA,"2005-12-01",1.8e+07
"e757757525a5ca134670cfb69cfcb074","isarna-therapeutics-gmbh","venture","1","2012-01-26",1.1e+07
"e757757525a5ca134670cfb69cfcb074","isarna-therapeutics-gmbh","venture",NA,"2011-07-07",11397600
"e757757525a5ca134670cfb69cfcb074","isarna-therapeutics-gmbh","venture","1","2010-04-05",17500000
"e757757525a5ca134670cfb69cfcb074","isarna-therapeutics-gmbh","venture",NA,"2014-04-24",7600000
"e757757525a5ca134670cfb69cfcb074","isarna-therapeutics-gmbh","undisclosed",NA,"2014-01-07",17800000
"50c0795b1e9d88d780c132415f040eb1","isbgmo-biosafety-conference",NA,NA,NA,NA
"1421dfbc5e681cbbe1ca6cf2da335506","iscience-interventional","venture",NA,"2010-08-11",5087965
"1421dfbc5e681cbbe1ca6cf2da335506","iscience-interventional","venture",NA,"2012-01-27",2759185
"1421dfbc5e681cbbe1ca6cf2da335506","iscience-interventional","venture","1","2009-05-05",20500000
"1421dfbc5e681cbbe1ca6cf2da335506","iscience-interventional","debt_financing",NA,"2011-05-17",5335545
"1421dfbc5e681cbbe1ca6cf2da335506","iscience-interventional","venture",NA,"2011-08-18",3e+06
"a2a65e12f068fb429b38c9e5aaf16714","iscience-surgical","venture","C","2005-03-31",1.5e+07
"b293b59b1ba7318ae3e33fd7bd7d461b","isentio","venture",NA,"2011-01-17",1500000
"4a082a74aee4c8c0e4cfbb69386886b0","isi-emerging-markets",NA,NA,NA,NA
"181f4087be004f5d367d44e520abc611","isi-life-sciences","venture",NA,"2013-04-23",354125
"4e9f1271a8914c7911fb0e0681d606a1","isirona","venture",NA,"2009-10-28",1500000
"1f152a9cdfe7289559f893bf9ec0b11a","isis-biopolymer","venture",NA,"2010-01-06",3999006
"1f152a9cdfe7289559f893bf9ec0b11a","isis-biopolymer","venture",NA,"2010-03-03",3e+06
"feaa36248767a86c8a09c661d8d5fa78","isis-pharmaceuticals","debt_financing",NA,"2012-08-27",201250000
"feaa36248767a86c8a09c661d8d5fa78","isis-pharmaceuticals","venture",NA,"2014-07-02",1.1e+07
"970dace65d211736e939bf9c6097151c","isivi","seed",NA,"2015-12-01",430000
"4ee458f245a38d935db5e8d8321cf8a9","islet-sciences","venture",NA,"2014-02-25",695000
"8541c615bb7cecfa422d404a6c20f1e8","iso-claims-solutions",NA,NA,NA,NA
"e21af32e5a9d8fd9c77c515abcfcdd44","isogenica","undisclosed",NA,"2012-11-29",NA
"eb180314e3acf399ec08ca91de94ba66","isolation-sciences","seed",NA,"2006-07-01",139000
"eb180314e3acf399ec08ca91de94ba66","isolation-sciences","seed",NA,"2008-07-01",48000
"eb180314e3acf399ec08ca91de94ba66","isolation-sciences","seed",NA,"2010-08-01",25000
"9fa9e41c191d88e1ea293660064701ca","isoplexis","venture","A","2014-08-12",1250000
"9fa9e41c191d88e1ea293660064701ca","isoplexis","venture",NA,"2014-08-11",3e+05
"9fa9e41c191d88e1ea293660064701ca","isoplexis","seed",NA,"2014-06-05",1e+05
"9fa9e41c191d88e1ea293660064701ca","isoplexis","venture",NA,"2015-05-29",2350000
"8f391f0d288c75a28de65988df7725fd","isource-transcription",NA,NA,NA,NA
"7b12d4482b25c72f127920cc502c0cce","isowalk","seed",NA,"2012-10-09",250000
"e8a409c1538bda7f2a4d13d08c98aab2","ispecimen","venture","a","2012-09-26",2e+06
"e8a409c1538bda7f2a4d13d08c98aab2","ispecimen","venture","B","2014-09-04",8e+06
"3d109928e5db5071eeb0139bc89cde50","ispot-tv","seed",NA,"2012-07-11",575000
"3d109928e5db5071eeb0139bc89cde50","ispot-tv","venture","1","2013-10-08",5325000
"3d109928e5db5071eeb0139bc89cde50","ispot-tv","venture","1","2015-05-19",21900000
"f905286d126a138581f730d5aafcd573","isquarecube",NA,NA,NA,NA
"b0cff328f61075181717f4815caf151c","israel-air-force",NA,NA,NA,NA
"c309c71c18444dc357becf007a478cd5","israel-tech-challenge",NA,NA,NA,NA
"2444be3238a846f248311b69c30ba6f2","isto-technologies","debt_financing",NA,"2014-03-18",8e+06
"2444be3238a846f248311b69c30ba6f2","isto-technologies","venture",NA,"2013-06-19",2009365
"2444be3238a846f248311b69c30ba6f2","isto-technologies","venture","1","2007-08-03",8800000
"2444be3238a846f248311b69c30ba6f2","isto-technologies","venture",NA,"2009-04-23",5404890
"2444be3238a846f248311b69c30ba6f2","isto-technologies","venture",NA,"2009-12-10",3272961
"2444be3238a846f248311b69c30ba6f2","isto-technologies","debt_financing",NA,"2015-01-06",2460082
"323543c7069c59865fe2f9fe59358128","istock",NA,NA,NA,NA
"7049b3247876a95272e93db16c8dc4b7","istylemyself",NA,NA,NA,NA
"d2d3ba5839250d8021137e997412303d","it-six-golbal-service",NA,NA,NA,NA
"38375161cf17ab08d254f2104edaaf4c","itavio","angel",NA,"2015-02-01",208589
"c37bd4141a1784548360ec0703f991e8","itc","venture",NA,"2010-11-18",72500000
"8a369ba37f44c5b165716754fb97998f","itdatabase","angel",NA,"2007-08-01",NA
"0a027fa2a932253165f9644bd0916dc5","itelligence",NA,NA,NA,NA
"63f7f6a00422d6abc8c156dd937c6fe9","iteos-therapeutics","grant",NA,"2015-12-07",3192633.0535
"2f35b0c0d1094803ccaa26af0bb27a80","itera-international-energy",NA,NA,NA,NA
"3d94cc893573bfc4803a87b529b34ed9","iterable","venture","A","2016-01-21",8e+06
"3d94cc893573bfc4803a87b529b34ed9","iterable","seed",NA,"2013-05-01",NA
"3d94cc893573bfc4803a87b529b34ed9","iterable","seed",NA,"2015-02-09",1200000
"867bc6f7c5e4fb2053632b9cb1eb89ef","iterative",NA,NA,NA,NA
"e6a223904fd39b8c8bfd997df148b369","iteris",NA,NA,NA,NA
"51f3659b504ea8d348fdda58173f095e","ithera-medical","venture","a","2011-11-23",NA
"118d433e490a23ee670402c675538f88","itherx","venture",NA,"2011-11-04",3173595
"118d433e490a23ee670402c675538f88","itherx","venture","1","2010-05-13",2780000
"355401ed265634a896941ef43df5eca8","ito-world",NA,NA,NA,NA
"240048f54548763d6bca4c0e4093878b","itrend-llc",NA,NA,NA,NA
"e8b413b267c9c2c1939810dbd5c77188","its-your-skills",NA,NA,NA,NA
"5653f5cc28908b5c79fef7f581fe6011","itsgr82bme-com",NA,NA,NA,NA
"2bca06b407abcedd67a9206f8f1508e6","itsmyurls","seed",NA,"2013-04-09",75000
"430d1537ddc921636ed8ab71144098f3","itworx",NA,NA,NA,NA
"9bdddb85440b3d7cce589a01ea28711f","iut-institut-fr-umwelttechnologien",NA,NA,NA,NA
"be824bfee78c27065c6d80177d083f57","iv-diagnostics","venture",NA,"2012-06-21",1187674
"be824bfee78c27065c6d80177d083f57","iv-diagnostics","private_equity",NA,"2014-06-05",NA
"0e390a4a8388922bfa996c88325872c6","ivantage-health-analytics","venture",NA,"2011-08-29",8600000
"0e390a4a8388922bfa996c88325872c6","ivantage-health-analytics","private_equity",NA,"2013-06-07",1e+07
"8512fb2ddc1ed103b08e3f8b687e9875","ivao",NA,NA,NA,NA
"e5456838b46f43fea7658fc87d2be09f","iveena","seed",NA,"2015-09-25",1300000
"17cdeaf45c8e98a13165c45028b5628b","ivera-medical","venture",NA,"2013-04-22",2799152
"17cdeaf45c8e98a13165c45028b5628b","ivera-medical","venture",NA,"2011-11-30",1265739
"4209934cf92f9bfda97c503ea3fef50e","iverson-genetic-diagnostics","venture",NA,"2010-05-17",110000
"4209934cf92f9bfda97c503ea3fef50e","iverson-genetic-diagnostics","venture",NA,"2011-12-05",115000
"4209934cf92f9bfda97c503ea3fef50e","iverson-genetic-diagnostics","debt_financing",NA,"2010-03-30",110000
"4209934cf92f9bfda97c503ea3fef50e","iverson-genetic-diagnostics","venture",NA,"2010-02-02",341000
"6465bd68764771f2d5027873d17221b3","ivice-mobile-apps",NA,NA,NA,NA
"4f7fb90c79dbda282f315cfbeac6be4b","ivoucher",NA,NA,NA,NA
"b7daa791bbf49459e9eca8852a07e24b","ixchel-scientific",NA,NA,NA,NA
"061f2537b0a0dd94c7de1b17aeabd4f4","ixchelsis","private_equity",NA,"2013-08-06",NA
"fb3aa1bf49c97dcce4efd66a4686b952","ixreveal",NA,NA,NA,NA
"b3976a033760961518d93a30720e9109","ixsight-technologies",NA,NA,NA,NA
"26f5b808b20bf18425460f0860ad5fe5","iyotta-software",NA,NA,NA,NA
"c3e283c8545f47ced7fb5e1fa347ff3e","izenda","venture","A","2014-08-08",3e+06
"273772dfb2f0d240a74622514d2676f6","izicap","seed",NA,"2014-08-18",NA
"da4493547f17be65289661112d8f659b","izumi-bio","venture","a","2009-04-14",2e+07
"86d3e402b9926001cc3bda075c7b7575","izun-pharmaceuticals","private_equity",NA,"2012-06-19",4083045
"86d3e402b9926001cc3bda075c7b7575","izun-pharmaceuticals","venture",NA,"2014-11-13",1120006
"45b68104885bc3c08f1b03899335cfe4","j-walter-thompson",NA,NA,NA,NA
"0a949b51ba864c58e0be1f84ee0b520e","j-tec",NA,NA,NA,NA
"27f88594f953d8c5634b77d31450ce3f","j-craig-venter-institute","grant",NA,"2013-09-18",2400000
"27f88594f953d8c5634b77d31450ce3f","j-craig-venter-institute","grant",NA,"2014-06-05",2.5e+07
"a4f3572a6b19901c7af01c07ca9cdf9a","j-d-power",NA,NA,NA,NA
"0a351b635faa85278a5e6a157c35603b","j-k--machine-tools",NA,NA,NA,NA
"34651429a07e82ca1bc70f54b897994f","j-j-solutions","venture",NA,"2015-07-17",9580181
"d6efef309fdd53673b26a6f3b189f2c5","j2p-usa",NA,NA,NA,NA
"5c8cf7040cb933d79fda2bd5cc3c1297","jackdb",NA,NA,NA,NA
"fc6810008b427a4bb5020487e81638b3","jackson-square-group","seed",NA,"2010-07-16",NA
"35849e11e60e6b16a18bc2cc4e681324","jaco","seed",NA,"2015-02-01",NA
"6aa8aca241adb7f9f0d432302da06c40","jadetrack","seed",NA,"2014-10-09",312500
"f234f4b346d40bd3b1ec903ed53bd447","datezr","seed",NA,"2014-08-01",NA
"2054f4a5b25865cb9d767d55b13aef34","jaincotech",NA,NA,NA,NA
"32eabc52882d7c8045e17ce2438d222f","jaleva-pharmaceuticals","venture",NA,"2011-05-31",454462
"24fff92d97c302bfca388f2ba85cfe2b","jamcloud",NA,NA,NA,NA
"ad56f1c43c2ed2a235e9d951063677c0","jamplify","angel",NA,"2013-02-20",6e+05
"ad56f1c43c2ed2a235e9d951063677c0","jamplify","seed",NA,"2012-05-20",15000
"645ee8741439177b769f930c92758cce","janssen-biotech",NA,NA,NA,NA
"b53aa8de7ebd4a1738a731d3121ddaec","janus-biotherapeutics","venture",NA,"2011-08-19",1100000
"b53aa8de7ebd4a1738a731d3121ddaec","janus-biotherapeutics","venture",NA,"2011-03-16",5e+05
"acc8934c954d4167f6197de6db14e87d","janvest-technologies-llc",NA,NA,NA,NA
"7130dbfce5ec4dcfa00a154c2acb5658","japan-private-detective",NA,NA,NA,NA
"28644452edec2d727eb5cd2e0a836d80","jaspersoft","venture",NA,"2011-07-14",1.1e+07
"28644452edec2d727eb5cd2e0a836d80","jaspersoft","venture","1","2005-07-19",8e+06
"28644452edec2d727eb5cd2e0a836d80","jaspersoft","venture",NA,"2008-12-10",12500000
"28644452edec2d727eb5cd2e0a836d80","jaspersoft","venture","1","2007-08-19",1.2e+07
"fcc696beb89bf34535769cc0b4e4d223","jastr",NA,NA,NA,NA
"ec8c2b156f24872265fbe71a2ca1315c","javelin-pharmaceuticals",NA,NA,NA,NA
"3110fa1a6d8c61e531ec04751135fea6","javeline",NA,NA,NA,NA
"7c3038ac6c5a4f45604e85c103a990ca","javlin",NA,NA,NA,NA
"90b9bf4a3eb663a1f68ff25351666f65","jaxified",NA,NA,NA,NA
"496da8e63f21835132973bfd6e122aaa","jazz-pharmaceuticals","venture",NA,"2009-07-08",6999998
"496da8e63f21835132973bfd6e122aaa","jazz-pharmaceuticals","debt_financing",NA,"2009-12-07",1.2e+08
"41d414891f0979e05fa103b6e954ccc6","jb-therapeutics","venture",NA,"2012-04-11",662000
"60b3e708f5082c73df78486b41d8834c","jclarity",NA,NA,NA,NA
"bac3add6110094cedfb09183dc2aa13f","jcn-newswire",NA,NA,NA,NA
"c2ff40be79cf3b12a645db0a5c3e90f6","jda-assessoria-imobiliria",NA,NA,NA,NA
"06007772fdc881e2e6d96cea78590a37","jdp-therapeutics","venture",NA,"2010-10-12",3e+05
"06007772fdc881e2e6d96cea78590a37","jdp-therapeutics","venture",NA,"2013-06-05",2e+05
"06007772fdc881e2e6d96cea78590a37","jdp-therapeutics","venture",NA,"2011-05-09",175000
"48bac6101ffc73bf7e62312146475d3b","je-capital-fund",NA,NA,NA,NA
"26e80ddea1368cd03966875aca78be32","jealo-us",NA,NA,NA,NA
"b87d5e547f1d44a92339478ee0fac973","jedox","venture","a","2008-01-01",5126827
"b87d5e547f1d44a92339478ee0fac973","jedox","venture","b","2009-01-01",7694280
"b87d5e547f1d44a92339478ee0fac973","jedox","venture","b","2008-06-18",3090000
"b9ac98b0aaa4c8e5bae3ed4923e90cb2","jeeri-neotech-international","venture",NA,"2014-04-22",9900000
"b9ac98b0aaa4c8e5bae3ed4923e90cb2","jeeri-neotech-international","seed",NA,"2014-04-28",2512832
"4aa6c2a131be5c1e064e914903b0f30c","jeeves-2",NA,NA,NA,NA
"00d4675740d9344a8930bfcc56751f01","jefto",NA,NA,NA,NA
"9f20b8665e69e71cb51fcfcd2b0b7b27","jellybooks",NA,NA,NA,NA
"b55192908b8611974ca474a53ee771e8","jellycloud","venture","a","2008-05-16",6600000
"bb716743c0bd65341ca5c14b0b32d355","jenken-biosciences","undisclosed",NA,"2007-07-14",142716
"718d5a3f9a4ea12940a54f0c839dcc09","jennerex-biotherapeutics","venture","c","2009-09-18",5500000
"718d5a3f9a4ea12940a54f0c839dcc09","jennerex-biotherapeutics","venture",NA,"2011-08-11",8600000
"718d5a3f9a4ea12940a54f0c839dcc09","jennerex-biotherapeutics","venture","d","2010-10-24",8600000
"718d5a3f9a4ea12940a54f0c839dcc09","jennerex-biotherapeutics","seed",NA,"2011-10-13",1750006
"718d5a3f9a4ea12940a54f0c839dcc09","jennerex-biotherapeutics","private_equity",NA,"2013-05-23",21600000
"b8abc300eb29ef5dfa60019d3cfbd45d","jet-interactive",NA,NA,NA,NA
"57eca90833f292faaf0feceb6c517f90","jethrodata","seed",NA,"2013-02-27",4500000
"57eca90833f292faaf0feceb6c517f90","jethrodata","venture","1","2015-06-09",8100000
"fe49ab91aa98874b38cb51a75719f287","jetlore","venture",NA,"2014-06-30",NA
"fe49ab91aa98874b38cb51a75719f287","jetlore","venture",NA,"2015-07-14",NA
"fe49ab91aa98874b38cb51a75719f287","jetlore","venture","1","2013-06-30",7e+06
"14561ac81f959f0600d9dd7b5c2acea8","jgb-biopharma-consulting",NA,NA,NA,NA
"15f6373e0bfc3ab33124af11b6288b0d","jhl-biotech","venture","B","2014-06-19",3.5e+07
"15f6373e0bfc3ab33124af11b6288b0d","jhl-biotech","venture","C","2015-05-11",45600000
"b4bcf5b5bdab8069a623e21a87a457a8","jiangsu-institute-of-microbiology",NA,NA,NA,NA
"b2f07ec8d9c2b1756b52901882d6563c","jiffle","venture",NA,"2015-08-13",4e+06
"b2f07ec8d9c2b1756b52901882d6563c","jiffle","venture",NA,"2012-12-01",2e+06
"12b3691843ee4a4875bc46df9f9f7b07","jigsaw-academy","venture","A","2015-12-09",3e+06
"229ab9df841593ca010ff20f9741258b","jilin-jinbao-pharmaceutical",NA,NA,NA,NA
"16d10944d088dcc2b500b41a34066ac9","jinfonet-software",NA,NA,NA,NA
"d48982e88abf5f50588d9ac6ba1cd389","jinhua-pharmaceutical",NA,NA,NA,NA
"59ccb77be3647c2b956738cdf7c89cc2","jios-aerogel-limited",NA,NA,NA,NA
"3a15505f48f10afab3bc3806f1f690fd","jirafe","seed",NA,"2010-12-20",NA
"3a15505f48f10afab3bc3806f1f690fd","jirafe","venture","1","2012-06-26",7e+06
"26b80e0d299e49048e9328288136f766","jitterbit","venture","B","2016-01-26",2e+07
"26b80e0d299e49048e9328288136f766","jitterbit","venture","A","2012-10-05",NA
"26b80e0d299e49048e9328288136f766","jitterbit","venture","A","2013-12-09",NA
"9917fa1fd4bb584a09b6dc9f9b3f2448","jiva-discovery",NA,NA,NA,NA
"099972bbfb62dcd80e3ed4b9adeacb40","jivox","seed",NA,"2008-03-10",2700000
"099972bbfb62dcd80e3ed4b9adeacb40","jivox","venture",NA,"2011-11-01",8200000
"099972bbfb62dcd80e3ed4b9adeacb40","jivox","venture","1","2008-06-16",10700000
"099972bbfb62dcd80e3ed4b9adeacb40","jivox","venture","1","2014-02-04",5800000
"099972bbfb62dcd80e3ed4b9adeacb40","jivox","venture",NA,"2010-06-14",0
"3c80ef22cd08fcd6a95ccf11ca803b73","jj-pharma","venture",NA,"2009-09-05",255002
"4234c61a814e1ec0aaa9f48706d9485b","jmea","venture",NA,"2010-12-20",189704
"cb44c0ccd0f25c71d1bbf66696fcda10","jnetdirect",NA,NA,NA,NA
"cd1635bc7b836159c89f32f9b0c1ae95","jnetdirect-biosciences",NA,NA,NA,NA
"ee23f8778110773874bf87cce418c669","joberate","seed",NA,"2015-12-04",1350000
"ee23f8778110773874bf87cce418c669","joberate","convertible_note",NA,"2015-01-09",3e+05
"ff14ead2ad43878a72846ab772da188d","jobscan",NA,NA,NA,NA
"eee7877248fa5c19dfa70284847d1acf","jobsmunk",NA,NA,NA,NA
"adc372a416ce8af4b17a954d31b9903f","careersmore-com","angel",NA,"2013-09-01",5e+05
"d867f5cc46dcf761882d85b3655f9e78","jobsync","venture","a","2011-11-15",1634000
"d867f5cc46dcf761882d85b3655f9e78","jobsync","convertible_note",NA,"2013-07-15",381000
"2c0680b93f6a8f50ea72656743d4df69","jobtarget",NA,NA,NA,NA
"2e1ac0099875054031566a4972f656af","jobtitled",NA,NA,NA,NA
"9ae76a0432263252724c83873be35024","jobzology",NA,NA,NA,NA
"eac94e8b821ec7629853eb4af1678a6f","johnson-matthey-medical",NA,NA,NA,NA
"3db17d4068e62d21bcb615c9bda4aca2","johnson-research-labs",NA,NA,NA,NA
"217a84b5525c5922789c06aa9f531fda","johnson-strategic-communications",NA,NA,NA,NA
"e40356d3dfb2646c5b953e3de0a44ecb","join-the-clicks",NA,NA,NA,NA
"2685dbab19a5d01a66d06d3ab8f4dc71","jokkspot",NA,NA,NA,NA
"6ee0de0e526337c077477145c908a6ad","jolicharts",NA,NA,NA,NA
"6018e3d48f93da538be619c14c8bdc34","jombay","venture",NA,"2015-10-27",NA
"7a9bdfc302b9de2c2e2d1a9ebb967e87","jomie",NA,NA,NA,NA
"4ad35a650b54a97aaecfd3ff693b0e17","joola",NA,NA,NA,NA
"0ac6a179872bc431fdc3eb44b68e152a","joomah-inc","seed",NA,"2014-02-12",1e+05
"d50274f2780d931f76756f1b5728bf66","jottr","seed",NA,"2015-06-26",1100000
"d50274f2780d931f76756f1b5728bf66","jottr","non_equity_assistance",NA,"2015-06-26",110000
"082b3ea81b833e8749a307073fcb59a3","joule-biotechnologies",NA,NA,NA,NA
"3dfa3bf3834a38df54768243611afd10","joulo",NA,NA,NA,NA
"35998e837a9ac4e628883722c1a486ed","jounce-therapeutics","venture","a","2013-02-14",4.7e+07
"35998e837a9ac4e628883722c1a486ed","jounce-therapeutics","venture","B","2015-04-23",5.6e+07
"3efc9d7f5c4efe2ce91a58b9c2e9d783","journeypure","debt_financing",NA,"2015-11-17",9e+05
"3efc9d7f5c4efe2ce91a58b9c2e9d783","journeypure","convertible_note",NA,"2014-05-13",75000
"3efc9d7f5c4efe2ce91a58b9c2e9d783","journeypure","venture",NA,"2014-12-03",1500450
"3efc9d7f5c4efe2ce91a58b9c2e9d783","journeypure","venture","1","2015-05-28",1431000
"c1d5e4395b4813f68976cb1fb7d835f6","journie",NA,NA,NA,NA
"a97d597b6276807685bbaab18d64e2a4","jpc-technologies",NA,NA,NA,NA
"b218030f1b8f05ee1018bffacc2250d1","judicata","venture","a","2013-05-28",5800000
"b218030f1b8f05ee1018bffacc2250d1","judicata","venture",NA,"2012-12-11",2e+06
"46f5d9a6dfa3038d65ec994fad1911c7","judith-solutions",NA,NA,NA,NA
"db9361d995e673a54ca92a3d4c06be02","juice-analytics","seed",NA,"2013-09-01",5e+05
"a2d519d407956d2264464e2bc8bbae70","juji-inc",NA,NA,NA,NA
"29aebdfaf28c557ccbc948d916e52d14","jumpgate-technologies",NA,NA,NA,NA
"bea32c33115a01bc6864388862865049","jumpshot","venture","A","2015-05-13",2.2e+07
"639578a43d4cdee2d4c0790f31453189","jumptime","debt_financing",NA,"2012-06-28",250000
"639578a43d4cdee2d4c0790f31453189","jumptime","venture",NA,"2010-12-09",2e+06
"3c3ff5f6d18cc161b0deccb4d1bb75a7","junction","seed",NA,"2015-07-01",5e+05
"f79794b785d21ebefa8367ae83ac395b","juneau-biosciences","debt_financing",NA,"2011-07-20",1e+06
"f79794b785d21ebefa8367ae83ac395b","juneau-biosciences","venture",NA,"2013-12-04",25000
"f79794b785d21ebefa8367ae83ac395b","juneau-biosciences","venture",NA,"2009-03-27",2600000
"f79794b785d21ebefa8367ae83ac395b","juneau-biosciences","venture",NA,"2011-03-01",3761000
"f79794b785d21ebefa8367ae83ac395b","juneau-biosciences","venture",NA,"2012-06-13",5e+05
"ff4290912166c3b5409d6e779fee09f5","juno-therapeutics","venture","a","2013-12-03",1.2e+08
"ff4290912166c3b5409d6e779fee09f5","juno-therapeutics","venture","A","2014-04-24",5.6e+07
"ff4290912166c3b5409d6e779fee09f5","juno-therapeutics","venture","B","2014-08-05",1.34e+08
"ff4290912166c3b5409d6e779fee09f5","juno-therapeutics","venture",NA,"2015-07-14",849803496
"fc08ab78958e5a41767983862b7efd73","jurispect","seed",NA,"2015-03-25",2e+06
"9c7996704c75702a8c7d12b7e01d8bcb","juristat","grant",NA,"2013-07-01",50000
"9c7996704c75702a8c7d12b7e01d8bcb","juristat","grant",NA,"2013-10-03",50000
"9c7996704c75702a8c7d12b7e01d8bcb","juristat","seed",NA,"2013-06-28",160000
"9c7996704c75702a8c7d12b7e01d8bcb","juristat","seed",NA,"2014-07-22",257000
"9c7996704c75702a8c7d12b7e01d8bcb","juristat","grant",NA,"2014-04-11",1e+05
"9c7996704c75702a8c7d12b7e01d8bcb","juristat","seed",NA,"2015-01-05",1200000
"a3f54219d9657f1e6ff6ed9de0d223b0","jurojinx-ag","seed",NA,"2015-08-03",1e+05
"e28b4e93a3d748b38a32d74c0bb7fa2c","just-drive-media",NA,NA,NA,NA
"28337c94c893f1b38f5213cd0e54ac88","just-internet-group",NA,NA,NA,NA
"3305efad1ac11fef1da971a85a865bc3","just-media",NA,NA,NA,NA
"562700c81bf41d421720a81cb8edbd78","just-biotherapeutics","venture","A","2015-09-21",1.5e+07
"173fc984ae76a658d56edc9f695ef8ba","justcare",NA,NA,NA,NA
"33805b6aebcd7c24d41df408d6e26f1e","justluxe",NA,NA,NA,NA
"d9cae2e79a6d32213fb8509f1e85d2ab","justly-2",NA,NA,NA,NA
"26d6eeaf32e54c5b16fc872366c492b5","justone-database-inc","angel",NA,"2011-01-28",450000
"26d6eeaf32e54c5b16fc872366c492b5","justone-database-inc","seed",NA,"2012-04-01",950000
"26d6eeaf32e54c5b16fc872366c492b5","justone-database-inc","seed",NA,"2013-06-01",1250000
"26d6eeaf32e54c5b16fc872366c492b5","justone-database-inc","seed",NA,"2014-05-30",1e+06
"26d6eeaf32e54c5b16fc872366c492b5","justone-database-inc","seed",NA,"2014-12-31",5e+05
"38b96d155c9212b2bb03f77c163e121c","justright-surgical","venture",NA,"2012-06-07",5556123
"38b96d155c9212b2bb03f77c163e121c","justright-surgical","debt_financing",NA,"2013-09-25",4e+06
"38b96d155c9212b2bb03f77c163e121c","justright-surgical","venture",NA,"2011-02-15",4200000
"38b96d155c9212b2bb03f77c163e121c","justright-surgical","venture",NA,"2014-05-16",7500000
"ff0499a50595c3961d6a1d5593100de0","justrite-manufacturing","venture",NA,"2014-02-20",14800000
"93d8b657253959cb7eee9165fce1b728","justvisual",NA,NA,NA,NA
"c28bf3484d6fbb78306b37f5cb9ce4cc","jut-inc","venture","B","2013-11-07",2e+07
"8fdabe9ac613997864acfc3486b62192","juvaris-biotherapeutics","venture","b","2010-04-12",12500000
"8fdabe9ac613997864acfc3486b62192","juvaris-biotherapeutics","venture","A","2007-01-05",15880000
"8fdabe9ac613997864acfc3486b62192","juvaris-biotherapeutics","debt_financing",NA,"2010-10-26",750000
"8fdabe9ac613997864acfc3486b62192","juvaris-biotherapeutics","grant",NA,"2007-08-02",9e+06
"8fdabe9ac613997864acfc3486b62192","juvaris-biotherapeutics","venture","b","2010-01-27",2.5e+07
"e88783fa8007930c2ec9bb89b0fdac30","juventas-therapeutics","venture","b","2012-07-16",22200000
"e88783fa8007930c2ec9bb89b0fdac30","juventas-therapeutics","seed",NA,"2008-09-30",3e+05
"e88783fa8007930c2ec9bb89b0fdac30","juventas-therapeutics","venture",NA,"2013-11-20",5e+06
"e88783fa8007930c2ec9bb89b0fdac30","juventas-therapeutics","venture","B","2015-05-12",13500000
"510b68ad6c60ad3f66555450c1e4f67b","jyte",NA,NA,NA,NA
"2727ebe3e281236c6d80915bd3245db6","k-measure",NA,NA,NA,NA
"966ac39fa97c12c4d985af42f2f512dd","k-pax-pharmaceuticals","convertible_note",NA,"2011-03-16",3e+05
"966ac39fa97c12c4d985af42f2f512dd","k-pax-pharmaceuticals","venture",NA,"2014-10-14",1460000
"9f5ca9fc89f8bf6f1b4a774734370e18","k2-digital",NA,NA,NA,NA
"41c7079788376c1cb73cc49e09d7562e","k2-partnering-solutions",NA,NA,NA,NA
"db4f7fac7b529e59a0ff431ecff882e9","k5launch",NA,NA,NA,NA
"4eb380eb81c038ac5752a9a2b7a50eca","k94-discoveries","seed",NA,"2013-09-24",3e+05
"c58ee2c159199378676eaa3225555269","kaazing","venture","a","2008-04-29",1e+06
"c58ee2c159199378676eaa3225555269","kaazing","venture",NA,"2013-04-17",1.5e+07
"c58ee2c159199378676eaa3225555269","kaazing","venture","b","2010-06-11",4015021
"c58ee2c159199378676eaa3225555269","kaazing","venture",NA,"2012-06-20",1.7e+07
"3893bbad4275d15b0c48a7fa454dde02","kaddy",NA,NA,NA,NA
"27f0d96c481046720a5d1df15fe9164e","kadimastem",NA,NA,NA,NA
"411d4a512e2f7b38477357450872d061","kadmon-pharmaceuticals","venture",NA,"2010-07-09",10835000
"411d4a512e2f7b38477357450872d061","kadmon-pharmaceuticals","venture",NA,"2012-08-30",4744220
"411d4a512e2f7b38477357450872d061","kadmon-pharmaceuticals","venture",NA,"2014-08-06",5690000
"86b22462b69ef05bfbc39c11a38e48fb","kadmus-pharmaceuticals","debt_financing",NA,"2009-07-03",3e+05
"3d7c33b6bcf0c63ab87ebe65f986547f","kaggle","venture","A","2015-09-04",1750000
"3d7c33b6bcf0c63ab87ebe65f986547f","kaggle","venture","a","2011-11-02",1.1e+07
"b6135653854b38f45a2eb2fc9a17bd6e","kahr-medical","venture","B","2015-12-13",1.2e+07
"b6135653854b38f45a2eb2fc9a17bd6e","kahr-medical","seed",NA,"2012-06-10",2600000
"b6135653854b38f45a2eb2fc9a17bd6e","kahr-medical","seed",NA,"2013-09-09",2350000
"d237d8376ff4d4064d4cb34214ad954f","kahuna","venture","a","2014-02-26",1.1e+07
"d237d8376ff4d4064d4cb34214ad954f","kahuna","seed",NA,"2013-10-08",2e+06
"d237d8376ff4d4064d4cb34214ad954f","kahuna","seed",NA,"2012-06-06",NA
"d237d8376ff4d4064d4cb34214ad954f","kahuna","venture","B","2015-08-19",4.5e+07
"5fc82be8be0de99c34284af477c68cbf","kai-pharmaceuticals","venture","b","2006-05-02",3.5e+07
"ea03298fb848de6b69998114c5ddf4e9","kaiima","venture","A","2011-04-05",1.8e+07
"ea03298fb848de6b69998114c5ddf4e9","kaiima","private_equity",NA,"2013-09-03",6.5e+07
"8b2fed9851c6e63ca61bfaff09153c19","kailos-genetics","venture",NA,"2011-12-05",1900000
"86205927bac0bd775f184887ea006f76","kaiser-permanente","grant",NA,"2014-08-05",7400000
"50db902b3ffffcd6d3bed7bc411bc97f","kaitek-labs",NA,NA,NA,NA
"e59d9d7fdcd4c86b89405a0f3235db2b","kaizen-platform","venture","B","2016-02-01",8e+06
"e59d9d7fdcd4c86b89405a0f3235db2b","kaizen-platform","venture","a","2014-03-30",5e+06
"e59d9d7fdcd4c86b89405a0f3235db2b","kaizen-platform","seed",NA,"2013-08-20",8e+05
"e59d9d7fdcd4c86b89405a0f3235db2b","kaizen-platform","venture","A","2015-04-24",4e+06
"022e9e39e76992297e1ef6bd4e6c0241","kala-pharmaceuticals","venture","a","2009-12-24",2e+06
"022e9e39e76992297e1ef6bd4e6c0241","kala-pharmaceuticals","private_equity",NA,"2012-03-14",7243205
"022e9e39e76992297e1ef6bd4e6c0241","kala-pharmaceuticals","venture","a","2013-02-28",11500000
"022e9e39e76992297e1ef6bd4e6c0241","kala-pharmaceuticals","venture","b","2010-11-10",3e+06
"022e9e39e76992297e1ef6bd4e6c0241","kala-pharmaceuticals","venture","B","2014-04-23",22500000
"022e9e39e76992297e1ef6bd4e6c0241","kala-pharmaceuticals","venture",NA,"2015-08-19",6999999
"f4df2a478febf9f4ebad07457987d051","kaleo","debt_financing",NA,"2012-05-29",1.5e+07
"f4df2a478febf9f4ebad07457987d051","kaleo","debt_financing",NA,"2014-04-07",1.5e+08
"b5b995349d085864c256c7cee63d8e9f","kalidex-pharmaceuticals","venture",NA,"2012-01-01",6500000
"b5b995349d085864c256c7cee63d8e9f","kalidex-pharmaceuticals","debt_financing",NA,"2010-11-10",250628
"b5b995349d085864c256c7cee63d8e9f","kalidex-pharmaceuticals","venture",NA,"2011-03-09",8249998
"b2e249bdf4fb18b2ea77003812557933","kalido","venture","d","2007-11-26",1e+07
"b2e249bdf4fb18b2ea77003812557933","kalido","venture","e","2009-05-08",5100000
"b2e249bdf4fb18b2ea77003812557933","kalido","venture","c","2005-10-04",13500000
"d2c1b875f607c06b6a9e0ea63e4001c3","kalion","seed",NA,"2013-11-01",NA
"d2c1b875f607c06b6a9e0ea63e4001c3","kalion","venture","1","2015-03-01",NA
"4bc7da8a925d7304e60cdf088d40d05e","kalistick","venture","a","2010-09-07",1300000
"32100767db5cee7d22c76bbcca92abe5","kallyope","venture","A","2015-12-10",4.4e+07
"2db897ef849d780c376301b8cd1f1397","kalobios-pharmaceuticals","venture","D","2008-09-23",2e+07
"2db897ef849d780c376301b8cd1f1397","kalobios-pharmaceuticals","venture","B","2005-03-16",2e+07
"2db897ef849d780c376301b8cd1f1397","kalobios-pharmaceuticals","private_equity",NA,"2012-04-01",1.7e+07
"2db897ef849d780c376301b8cd1f1397","kalobios-pharmaceuticals","venture","d","2008-12-22",1.2e+07
"5ea5bae122899733f8108178c4f68a4d","kalood",NA,NA,NA,NA
"28607b446f46208b16a21334d1c0570a","kalos-therapeutics","debt_financing",NA,"2013-02-12",19999
"7dd26818843ad7921675b7dae4d2da2d","kaltura","venture","a","2007-05-01",2100000
"7dd26818843ad7921675b7dae4d2da2d","kaltura","debt_financing",NA,"2010-02-24",1e+06
"7dd26818843ad7921675b7dae4d2da2d","kaltura","venture","b","2008-06-20",2.1e+07
"7dd26818843ad7921675b7dae4d2da2d","kaltura","venture","d","2012-11-21",2.5e+07
"7dd26818843ad7921675b7dae4d2da2d","kaltura","venture","C","2011-02-14",2e+07
"7dd26818843ad7921675b7dae4d2da2d","kaltura","venture","e","2014-02-11",4.7e+07
"8e482a064e7423a8cb50b01e80b1b40b","kalvista-pharmaceuticals","venture","a","2011-08-23",13207305
"8e482a064e7423a8cb50b01e80b1b40b","kalvista-pharmaceuticals","venture","B","2015-07-22",3.3e+07
"9d051215b2adfc93f14ccda0abab4071","kalypsys","venture","C","2006-11-29",1e+08
"40335e1d099baee1aa5057eb9c8ad057","kalyra-pharmaceuticals","private_equity",NA,"2013-08-21",6e+06
"5921d7ae9a6d6984c6edb226f0887dfd","kamada",NA,NA,NA,NA
"7dec9b2b2137a86a0360bfecfb038d36","kameleoon","venture",NA,"2015-11-30",2118023.3194
"7dec9b2b2137a86a0360bfecfb038d36","kameleoon","angel",NA,"2012-06-01",371696.5469
"12f9251962cdf028c339db3e0a4dd5e2","kampyle","venture","a","2009-01-01",1e+06
"a6a3b3aa2450f68bf3f881c280b8a59a","kanartek",NA,NA,NA,NA
"733220ea850006d3608b7807e6fded40","kanavape",NA,NA,NA,NA
"d0c844069f730da8a22495ec602fa7a0","kane-biotech","venture",NA,"2009-05-03",42467
"f1489116fdc9a51660e2a40dd8a13379","kaneq-bioscience","undisclosed",NA,"2013-01-22",NA
"3dc7dd7816ba40a187947513edbbd874","kangchern-environmental-science-technology",NA,NA,NA,NA
"c12081205fbd27fff51e8bd9597735af","experience-project","venture","b","2008-05-13",3e+06
"c12081205fbd27fff51e8bd9597735af","experience-project","venture","a","2008-02-01",902545
"c12081205fbd27fff51e8bd9597735af","experience-project","venture","c","2011-01-01",1700000
"c12081205fbd27fff51e8bd9597735af","experience-project","venture","c","2012-07-27",3874993
"c12081205fbd27fff51e8bd9597735af","experience-project","seed",NA,"2007-02-15",NA
"c12081205fbd27fff51e8bd9597735af","experience-project","venture","d","2013-11-05",4046002
"0ef5de0363ee024f86f764c781b285b6","kannalife-sciences","venture","a","2013-03-07",1500000
"0ef5de0363ee024f86f764c781b285b6","kannalife-sciences","undisclosed",NA,"2015-05-01",NA
"e87ffd5dca3d53b2a94d960a2ebc2aad","kanyos-bio","venture",NA,"2015-06-12",10399876
"e87ffd5dca3d53b2a94d960a2ebc2aad","kanyos-bio","venture",NA,"2015-06-12",6009268
"f409efc452d84f52a7af2bb7b90d6ed0","kaonetics-technologies-inc","equity_crowdfunding",NA,"2012-03-27",NA
"843bdd56d8b3a9495118888c26880223","kaoxee",NA,NA,NA,NA
"1ef40158021bbf0eab4c1946d76dbb64","kapa-biosystems",NA,NA,NA,NA
"7cea059c970dc69039f6268786af7e71","kapow-technologies","venture","c","2008-03-06",11600000
"7cea059c970dc69039f6268786af7e71","kapow-technologies","venture","b","2005-02-01",6643770
"7cea059c970dc69039f6268786af7e71","kapow-technologies","debt_financing",NA,"2010-01-13",1500000
"689c2008a6f45f81c66dcb947d57b194","kaptivo",NA,NA,NA,NA
"f334f8ced90852108fb7a0eec3cb85b7","karmadata",NA,NA,NA,NA
"33aa52a929137d89f9b47f9d198a1e42","karmagenes",NA,NA,NA,NA
"cbd64eee5807a7e78b873d044b6e5d46","karmakey","seed",NA,"2010-05-11",15000
"ad05bf795b48a24ddfbd931947a0bc7e","karmapulse",NA,NA,NA,NA
"799d142f2d6ba6725ff3e617d20e889b","karmasphere","venture","A","2010-03-24",5e+06
"799d142f2d6ba6725ff3e617d20e889b","karmasphere","venture","B","2011-09-30",6e+06
"799d142f2d6ba6725ff3e617d20e889b","karmasphere","venture","C","2012-12-14",3499999
"799d142f2d6ba6725ff3e617d20e889b","karmasphere","venture","C","2013-09-12",1500000
"f796e91cce0d901c89a22b51503874e3","karmic-lifesciences",NA,NA,NA,NA
"98e572be48ee199d6faaaed19a1ceac1","karo-bio",NA,NA,NA,NA
"7933655fc2e8ab442a3a1b4746905ab5","karolinska",NA,NA,NA,NA
"46bd8c5184cea4efe6e86c452110ef2b","kartinka",NA,NA,NA,NA
"d3e9aabed410e202f82df31b0b5d3f98","karuna-pharmaceuticals","debt_financing",NA,"2011-06-09",6e+05
"5a747b0a7480457f6e8c1ce703e8032e","karus-therapeutics","venture","b","2012-09-06",7600000
"61f8cbb47d4b09ccdd4d2d235eb9acad","karyon-ctt",NA,NA,NA,NA
"ba4bd8515e700f98562a368083277aee","karyopharm-therapeutics","venture","a","2011-11-02",1e+07
"ba4bd8515e700f98562a368083277aee","karyopharm-therapeutics","venture",NA,"2013-05-01",20500000
"ba4bd8515e700f98562a368083277aee","karyopharm-therapeutics","venture","a","2010-11-03",2e+07
"ba4bd8515e700f98562a368083277aee","karyopharm-therapeutics","venture","b","2013-07-31",1.9e+07
"ba4bd8515e700f98562a368083277aee","karyopharm-therapeutics","venture",NA,"2013-01-01",2e+07
"ba4bd8515e700f98562a368083277aee","karyopharm-therapeutics","venture","b","2013-05-20",48200000
"ba4bd8515e700f98562a368083277aee","karyopharm-therapeutics","post_ipo_equity",NA,"2014-06-30",1.11e+08
"15b88ad25d8e0c33c64159d127f78199","kaspersky",NA,NA,NA,NA
"298f74f1003df6ecf72dbbb0cac94a11","kastus-antimicrobial-technologies",NA,NA,NA,NA
"9b54e98c7c2ca997acb9ceeaa1efeeab","katby-n",NA,NA,NA,NA
"761b7859709cc3288024f586803a98d5","kauplus-social-commerce",NA,NA,NA,NA
"c3e84e6ece7b9ec8f1672791542f832d","kavalia","venture",NA,"2010-05-11",215000
"b8256d54755bbd4ca14963b4e2e2efb9","kavo-brazil",NA,NA,NA,NA
"a4d34c88ee7d7621da4618e3f56668f3","kawo",NA,NA,NA,NA
"7d044ca4cedd7c7058a6620e4e501246","kayxo",NA,NA,NA,NA
"82bc47944cd41b013adb2174a2a83f16","kbb-partners",NA,NA,NA,NA
"fe47204233748af86a5396f3e7be95cb","kbi-biopharma","venture",NA,"2009-09-22",9600000
"c1efd716038730d0ec39267a45f8e4b7","kcas",NA,NA,NA,NA
"93f93d3388f273b29521c45e04b2be32","kci-medical",NA,NA,NA,NA
"a309b8ee83d5854dae4f1e71aa4daf61","keclon","seed",NA,"2012-03-19",NA
"eac4a68e03ffe3ac8cfbafba249d4f0f","keen","seed",NA,"2012-01-01",118000
"eac4a68e03ffe3ac8cfbafba249d4f0f","keen","seed",NA,"2012-06-10",750000
"eac4a68e03ffe3ac8cfbafba249d4f0f","keen","seed",NA,"2013-10-23",2350000
"eac4a68e03ffe3ac8cfbafba249d4f0f","keen","venture","1","2014-07-01",11300000
"eac4a68e03ffe3ac8cfbafba249d4f0f","keen","seed",NA,"2013-10-06",NA
"d82523af788d7b396a79e42baec2992b","keenjar","venture",NA,"2014-02-03",87000
"80c00d696cd46e449aec9812e412f2f6","keepify",NA,NA,NA,NA
"57a2d6ded6e797e082743a5f6c5c61ce","keeptrax","seed",NA,"2015-03-31",1e+06
"2693d6676c09eadf974c5a649265c8b3","keepvision","seed",NA,"2015-02-01",30000
"c7127c4dc301335ab42f14128a54d005","kellbenx","venture",NA,"2015-12-07",3211000
"c7127c4dc301335ab42f14128a54d005","kellbenx","venture",NA,"2011-04-21",2500000
"c7127c4dc301335ab42f14128a54d005","kellbenx","venture","1","2013-07-29",1e+07
"c7127c4dc301335ab42f14128a54d005","kellbenx","venture",NA,"2012-02-02",1e+06
"69167f525784b0da305c2c889013f3eb","keller-medical","venture",NA,"2009-03-23",4e+05
"378db6d30ccc4e4fb81cbd6abd974d27","kelyniam-global",NA,NA,NA,NA
"61e8eddc57412d77151e0e195100e618","kemeta","venture",NA,"2007-08-17",NA
"10890dca69c091c283dcffc245e61a6e","kempharm","venture",NA,"2010-07-22",6852006
"10890dca69c091c283dcffc245e61a6e","kempharm","debt_financing",NA,"2013-05-30",762000
"10890dca69c091c283dcffc245e61a6e","kempharm","venture",NA,"2009-08-27",3489385
"10890dca69c091c283dcffc245e61a6e","kempharm","debt_financing",NA,"2014-06-04",6e+07
"10890dca69c091c283dcffc245e61a6e","kempharm","venture",NA,"2015-03-04",4e+06
"5b5f873562c59a666e8242571ac3317a","kennect",NA,NA,NA,NA
"17b9de6a2309ef70de3834151b5307f0","kensee","seed",NA,"2014-12-25",NA
"931e48a150d3f047ef2356917aa305a5","kensey-nash-corporation",NA,NA,NA,NA
"646e87fdecf8896bdb2020087179e56b","kenta-biotech","venture","b","2009-03-12",1e+07
"3fbda18dffd4d11e4be04ab8670bf9b5","kepion",NA,NA,NA,NA
"ab4598879582798ec413142675ee020c","keraderm","venture",NA,"2013-10-30",50000
"ab4598879582798ec413142675ee020c","keraderm","venture",NA,"2011-04-18",619200
"ab4598879582798ec413142675ee020c","keraderm","venture","1","2010-01-17",2500000
"1b130a9b8d10e42f74338808e9df674a","kerafast","venture","a","2012-04-11",2988252
"eb7b798787c4829113cf51bd901a80c9","keranetics","venture",NA,"2012-01-13",4714000
"eb7b798787c4829113cf51bd901a80c9","keranetics","venture",NA,"2010-06-28",4149225
"eb7b798787c4829113cf51bd901a80c9","keranetics","venture",NA,"2015-03-26",1655000
"653ee4e4da73faf8014d258bf223f345","keraplast-technologies","venture",NA,"2009-06-19",2371149
"653ee4e4da73faf8014d258bf223f345","keraplast-technologies","venture",NA,"2010-05-27",2500000
"55ddcfa3f142786c36dedb40671720c3","kereos","debt_financing",NA,"2009-06-15",887126
"55ddcfa3f142786c36dedb40671720c3","kereos","seed",NA,"2012-01-13",1127730
"55ddcfa3f142786c36dedb40671720c3","kereos","venture",NA,"2010-05-06",5675098
"6a4f4dc596dcb1498e23c78a16d50c31","kericure","debt_financing",NA,"2013-06-10",8e+05
"30e7be8fa0a0bc5ba900728b3ad3fc06","keryx-biopharmaceuticals",NA,NA,NA,NA
"669551aea1a8abc93b8165cce809709b","ketera","venture",NA,"2007-01-08",1.4e+07
"f588c7168e9ec0b6ab43ab75560da3e4","kevy",NA,NA,NA,NA
"6da10f7db1e490d820d438e3c9752f5f","kew-group","venture",NA,"2014-02-06",16070505
"6da10f7db1e490d820d438e3c9752f5f","kew-group","venture","1","2014-12-16",16798000
"835e3958c99e8f922640bafb4ec831a9","kextil","seed",NA,"2010-06-01",120000
"835e3958c99e8f922640bafb4ec831a9","kextil","angel",NA,"2011-04-01",250000
"835e3958c99e8f922640bafb4ec831a9","kextil","seed",NA,"2013-12-27",460000
"835e3958c99e8f922640bafb4ec831a9","kextil","seed",NA,"2013-03-14",NA
"a9c480b8e0e71c46451ea5c4995149c9","key-surgical",NA,NA,NA,NA
"f48c445ea8ecd873a63196c83d7956b6","key3media","debt_financing",NA,"2003-02-07",3e+07
"ffbb90a6f6b7cd20ef1b513ed7f0ce2c","keyence",NA,NA,NA,NA
"8e68761ba75d917304721b35c3e2b965","keyinsite",NA,NA,NA,NA
"75ad406745a725e6097848f6e394ad98","keyneurotek-pharmaceuticals","venture","c","2009-04-07",10869100
"232467692b8c6e4cfae2c188f029755f","deviceanywhere",NA,NA,NA,NA
"53b0fb038c69da836381b09b56441aa5","keypoint-technologies-usa",NA,NA,NA,NA
"e6b615680a65c67782d48596e42e7582","keytrac",NA,NA,NA,NA
"177106e1c206fc7b0f29db6230ac916c","keywordenvy",NA,NA,NA,NA
"13f717db289d916ede24d1f3c8a76d87","keywordfirst",NA,NA,NA,NA
"21419d069777173782312f53cb9d84d7","khalbil",NA,NA,NA,NA
"96a65367220507f267cb40a6954afe82","kiadis-pharma","venture",NA,"2007-06-26",20190146.3113
"96a65367220507f267cb40a6954afe82","kiadis-pharma","venture",NA,"2012-11-20",12809000
"986fb246ad57047dde520434e4f7a069","kiana-analytics","convertible_note",NA,"2015-04-30",1e+06
"e7e57f3ba49889a5e7264f4edc242365","kibron",NA,NA,NA,NA
"86dfa0d3cfdf6e92889f8a1c665a7857","kickdynamic",NA,NA,NA,NA
"6a86a82ba32a955b8b0e65b4d04d4961","kickfactory",NA,NA,NA,NA
"d9fbeb7533b2f8000a6ac91af5964730","kickfire","venture","b","2008-07-31",2e+07
"7e7ac74ec1f12a27dd459d09c495cb56","kifi","undisclosed",NA,"2014-05-20",10200000
"7e7ac74ec1f12a27dd459d09c495cb56","kifi","seed",NA,"2013-01-01",1e+06
"6a4a1c0ecec7f619365ec1a875cbfc19","kiha-software","venture","a","2010-10-28",2e+07
"439f74dabad1003664690c638ad3fe01","kilobaser","venture",NA,"2015-02-17",NA
"439f74dabad1003664690c638ad3fe01","kilobaser","venture",NA,"2014-05-02",NA
"e266d2f5c9dcd87658953322a45e235a","kimerick-technologies","seed",NA,"2013-08-26",55420
"e266d2f5c9dcd87658953322a45e235a","kimerick-technologies","seed",NA,"2013-08-01",75000
"a9cd71e69e8b6076b488f32fdba7dea1","kimono","seed",NA,"2014-01-01",NA
"3f7129912824f556a12040dfc07f8b52","kinaxo-biotechnologies","venture","A","2007-05-09",NA
"b70b8947d9f9f0c54438cb1e2d6f0c4a","kindex-therapeutics","venture","A","2015-03-09",5500000
"723c3b76307b444eec719e89e5ee1245","kindful","seed",NA,"2013-04-14",250000
"bc5f55ef0a995602a175a7c151f3e2ef","kindred-biosciences","venture",NA,"2012-11-19",1e+06
"bc5f55ef0a995602a175a7c151f3e2ef","kindred-biosciences","venture",NA,"2013-08-31",5309755
"cf2901751f463c8cadde09ced9bec614","kineta","venture","B","2015-12-02",7e+06
"cf2901751f463c8cadde09ced9bec614","kineta","undisclosed",NA,"2014-03-13",NA
"cf2901751f463c8cadde09ced9bec614","kineta","venture",NA,"2012-08-08",5757742
"cf2901751f463c8cadde09ced9bec614","kineta","venture",NA,"2010-01-07",942455
"cf2901751f463c8cadde09ced9bec614","kineta","venture",NA,"2010-07-14",709318
"cf2901751f463c8cadde09ced9bec614","kineta","venture",NA,"2013-10-08",760497
"cf2901751f463c8cadde09ced9bec614","kineta","venture",NA,"2014-05-16",1627498
"cf2901751f463c8cadde09ced9bec614","kineta","venture","B","2015-01-20",7e+06
"da5831da3ca827ab39959935167f182f","kinetic-analysis-corporation",NA,NA,NA,NA
"bef6dc1b4d9981591fca269bee67028d","kinetic-concepts",NA,NA,NA,NA
"3cabba4b2e81ffdcf8b3bfad06a0e5e6","kinetic-fin",NA,NA,NA,NA
"2c5daa1e36a1ad72a40f7e7f59736225","kinetic-trading-strategies","venture","a","2010-12-31",2999000
"dea74b3aaeea7564a166de4bd134c83f","kinetic-information-systems",NA,NA,NA,NA
"e1038e8f319a6997ce2f77a67c6a28e7","kinetic-social","debt_financing",NA,"2011-10-01",3e+06
"e1038e8f319a6997ce2f77a67c6a28e7","kinetic-social","debt_financing",NA,"2012-08-01",3e+06
"e1038e8f319a6997ce2f77a67c6a28e7","kinetic-social","venture","1","2013-05-07",8e+06
"e1038e8f319a6997ce2f77a67c6a28e7","kinetic-social","venture","1","2014-04-15",1.8e+07
"e1038e8f319a6997ce2f77a67c6a28e7","kinetic-social","venture","1","2015-07-21",17500000
"263fa2b9392392ab3a6b0b012dd5bb79","kinex-pharmaceuticals","private_equity",NA,"2014-03-05",4e+07
"263fa2b9392392ab3a6b0b012dd5bb79","kinex-pharmaceuticals","venture",NA,"2011-04-25",4674600
"263fa2b9392392ab3a6b0b012dd5bb79","kinex-pharmaceuticals","venture",NA,"2012-08-06",5e+06
"263fa2b9392392ab3a6b0b012dd5bb79","kinex-pharmaceuticals","venture",NA,"2010-02-03",4075000
"263fa2b9392392ab3a6b0b012dd5bb79","kinex-pharmaceuticals","venture",NA,"2013-12-23",3e+05
"263fa2b9392392ab3a6b0b012dd5bb79","kinex-pharmaceuticals","venture",NA,"2015-05-20",48099980
"6fcbf85101543bc40619b3fdf5b39bb6","king-pharmaceuticals",NA,NA,NA,NA
"fd50a71e30be331cededf4fc94145a89","kingspoint-as",NA,NA,NA,NA
"a4db7f9a921796f77a3ae9bbef86d157","kip-biotech","debt_financing",NA,"2010-09-07",1e+06
"a4db7f9a921796f77a3ae9bbef86d157","kip-biotech","convertible_note",NA,"2009-12-11",250000
"8a57b870e10dced51003f39b0f4594f2","kira",NA,NA,NA,NA
"0d88eda8fefea74dab9c12f2dae70fe1","kiran-solutions-pvt-ltd",NA,NA,NA,NA
"4f458acbfa994a51f9df0ffb362b4cca","kirax","venture",NA,"2012-09-12",540760
"7a95ad6766c74d7725e124328ce79767","kirix-corporation",NA,NA,NA,NA
"56f2cd1a653cdb6d8258f133817f7c24","kirkland-partners","venture",NA,"2014-04-07",7476000
"f2fed0ad86f950ce95f2a91e05f2415f","kiss-metrics","venture","b","2013-07-18",7e+06
"f2fed0ad86f950ce95f2a91e05f2415f","kiss-metrics","venture","a","2009-07-28",2800000
"f2fed0ad86f950ce95f2a91e05f2415f","kiss-metrics","seed",NA,"2008-05-13",1e+06
"8aca61fb5e1005b32628d132182cf509","kite-ly","seed",NA,"2013-06-01",4e+05
"9f6a3202bac86687e31615523fc34bc3","kite-pharma","debt_financing",NA,"2012-12-20",250000
"9f6a3202bac86687e31615523fc34bc3","kite-pharma","venture","1","2011-03-09",1.5e+07
"9f6a3202bac86687e31615523fc34bc3","kite-pharma","venture","1","2013-05-15",2e+07
"9f6a3202bac86687e31615523fc34bc3","kite-pharma","venture",NA,"2014-04-28",5e+07
"8a51a389dbf088fbdbfb0ea29ae37652","kitedesk","seed",NA,"2015-04-20",4e+06
"2585fd85b56676939e8d7a60b995a1ab","kitenga","grant",NA,"2010-01-04",2e+05
"a982988da07908f627b74e514262952e","kites","seed",NA,"2013-01-01",5e+05
"b05fe6b2ce1ff2cd263294e94e199fdf","kitlocate","seed",NA,"2013-05-01",750000
"b05fe6b2ce1ff2cd263294e94e199fdf","kitlocate","venture",NA,"2014-07-21",NA
"5944c498003716bdf64256413e410ca2","kitovet",NA,NA,NA,NA
"39b18213875b7dbb8ed73d63347483e2","kitt-ai",NA,NA,NA,NA
"9c2ca15ce0867c957e356ec8fefb99c0","kivera",NA,NA,NA,NA
"9e17987bed9c84397bc1e9a15a68968f","kiwi-wearable-technologies","seed",NA,"2014-04-01",45180
"9e17987bed9c84397bc1e9a15a68968f","kiwi-wearable-technologies","seed",NA,"2015-09-08",2500000
"9dd8592db8f4506f13572c08c24aba64","kiwigrid","undisclosed",NA,"2013-07-01",NA
"280df65e9ef8a8ce7f3e49421226caca","kixie","seed",NA,"2014-11-01",NA
"3e2c0b82b06ef6f6fee678be0ae14e0b","kiyatec","venture","a","2012-05-23",NA
"3e2c0b82b06ef6f6fee678be0ae14e0b","kiyatec","venture",NA,"2014-12-08",180000
"e69c5e6d0094aff7d8eacb77315ae42a","kkt",NA,NA,NA,NA
"32a4479c71ac78368b6504c90d7b6725","klaggle",NA,NA,NA,NA
"dd048d1b3b97293602ff6949e8c54395","klangoo","seed",NA,"2014-01-01",NA
"4280b2438702531e2f2dd6b444c9ef3e","klassdata",NA,NA,NA,NA
"21fc4564df044106e450473c956303dc","klaushofer",NA,NA,NA,NA
"38394ee1b32a124c66c8018850beff8c","klee-group",NA,NA,NA,NA
"347d5c13e81fe77993d6c26160041836","kleenresource","equity_crowdfunding",NA,"2015-04-10",NA
"7de2cfae6a743e2dee787bdccc56ccf9","klink-com",NA,NA,NA,NA
"c50e22425e2ada60126b74f8d5b67ce1","klipfolio","seed",NA,"2014-02-16",1545454
"c50e22425e2ada60126b74f8d5b67ce1","klipfolio","venture","1","2015-02-25",6200000
"a0054f28655f3992bf972dccf527df3b","klobomedia-2",NA,NA,NA,NA
"2d83c13f86213e671354c118a2df4226","enterprise-signal",NA,NA,NA,NA
"074f47546ee9b81fdecd14675f244ef5","klout","venture","C","2011-11-04",NA
"074f47546ee9b81fdecd14675f244ef5","klout","venture","B","2010-12-21",NA
"074f47546ee9b81fdecd14675f244ef5","klout","venture","B","2012-02-27",NA
"074f47546ee9b81fdecd14675f244ef5","klout","venture","B","2010-08-05",NA
"074f47546ee9b81fdecd14675f244ef5","klout","undisclosed",NA,"2013-08-23",NA
"074f47546ee9b81fdecd14675f244ef5","klout","venture","b","2011-01-10",8500000
"074f47546ee9b81fdecd14675f244ef5","klout","seed",NA,"2009-07-01",NA
"074f47546ee9b81fdecd14675f244ef5","klout","venture","c","2012-01-01",3e+07
"074f47546ee9b81fdecd14675f244ef5","klout","venture","a","2010-04-28",1500000
"074f47546ee9b81fdecd14675f244ef5","klout","undisclosed",NA,"2012-09-28",NA
"2749a559ef4605e740d6adb2f1c739c6","klue","seed",NA,"2015-05-01",1400000
"2749a559ef4605e740d6adb2f1c739c6","klue","seed",NA,"2015-04-01",NA
"7a0d7d9c16f7d460180ea3662a1af84a","klustera",NA,NA,NA,NA
"b420ff5a754682d71379025ae87bb3c7","knecta",NA,NA,NA,NA
"0a09324c69234636afd2bf12b6765fcb","kneon",NA,NA,NA,NA
"ecf6bd479ea80e57ba86e4fa265971c9","knetik-media","seed",NA,"2011-01-01",250000
"ecf6bd479ea80e57ba86e4fa265971c9","knetik-media","seed",NA,"2014-04-01",1200000
"ecf6bd479ea80e57ba86e4fa265971c9","knetik-media","equity_crowdfunding",NA,"2015-01-20",NA
"ecf6bd479ea80e57ba86e4fa265971c9","knetik-media","seed",NA,"2013-10-04",3e+05
"ecf6bd479ea80e57ba86e4fa265971c9","knetik-media","seed",NA,"2014-05-01",850000
"5e92b54c6f2dd606bd5fc6744cb62c0f","kneto",NA,NA,NA,NA
"b2167c4ce759085e155d7c74a76522d0","knewton","venture","F","2015-10-30",42250017
"b2167c4ce759085e155d7c74a76522d0","knewton","venture","b","2009-04-07",6e+06
"b2167c4ce759085e155d7c74a76522d0","knewton","venture","d","2011-10-13",3.3e+07
"b2167c4ce759085e155d7c74a76522d0","knewton","venture","a","2008-05-21",2500000
"b2167c4ce759085e155d7c74a76522d0","knewton","venture","c","2010-04-19",12500000
"b2167c4ce759085e155d7c74a76522d0","knewton","venture","e","2013-12-01",5.1e+07
"61f1e95b8e4473daf54421f6beb1288a","knf-technologies","equity_crowdfunding",NA,"2014-10-13",NA
"ea0d232ce459d72721f79b0b529f5f89","knight-therapeutics","post_ipo_equity",NA,"2014-04-10",1.8e+08
"9ef162c4adeb7decfe72dfda33ec633f","knime",NA,NA,NA,NA
"67e67a67ab14d536b6d33de03e67bbc7","knipbio","grant",NA,"2013-10-29",50000
"67e67a67ab14d536b6d33de03e67bbc7","knipbio","venture","1","2015-01-20",1585523
"a96c0e82d7731812793944d598443c02","knoda","debt_financing",NA,"2013-11-21",2e+05
"a96c0e82d7731812793944d598443c02","knoda","angel",NA,"2014-05-28",50000
"a96c0e82d7731812793944d598443c02","knoda","seed",NA,"2014-01-01",4e+05
"5c17604368583f6273d15e9b80b5bbc6","knoema",NA,NA,NA,NA
"00b87fc94b8522bbe1782f22f1056b49","knoldus-software-llp",NA,NA,NA,NA
"8ed5d43df7ac28e8b5d001b2612eb5ad","knome","venture","B","2011-08-02",5e+06
"8ed5d43df7ac28e8b5d001b2612eb5ad","knome","venture","D","2014-01-21",1.3e+07
"8ed5d43df7ac28e8b5d001b2612eb5ad","knome","venture","C","2013-10-31",5800000
"8ed5d43df7ac28e8b5d001b2612eb5ad","knome","venture","A","2010-05-03",5e+06
"87898333ac74934ddfd6e701c731d549","nnopp-biosciences-llc","venture","b","2008-01-22",1e+07
"87898333ac74934ddfd6e701c731d549","nnopp-biosciences-llc","venture","a","2006-01-01",1e+07
"87898333ac74934ddfd6e701c731d549","nnopp-biosciences-llc","venture",NA,"2010-01-13",8500001
"87898333ac74934ddfd6e701c731d549","nnopp-biosciences-llc","venture",NA,"2010-09-03",6e+07
"87898333ac74934ddfd6e701c731d549","nnopp-biosciences-llc","debt_financing",NA,"2015-07-08",14942729
"87898333ac74934ddfd6e701c731d549","nnopp-biosciences-llc","venture",NA,"2014-12-11",5e+06
"d8ca9ffd960313acb5aaa3b68f9852b0","knot-6-3",NA,NA,NA,NA
"f9fdfa6509a8c1014fdff604e21668f7","knotch","seed",NA,"2013-11-14",1500000
"f9fdfa6509a8c1014fdff604e21668f7","knotch","convertible_note",NA,"2014-03-10",NA
"a8caa9de395378492739a7d37eda4586","know-keep-your-genes",NA,NA,NA,NA
"a8f8586dd29ce22f581bf56f08ade28e","knowclick",NA,NA,NA,NA
"73b9bef83ca315a6a8a99bb12c1806b8","knowit-2",NA,NA,NA,NA
"1a68a0b1f96f1b59e436baad24b143ec","knowledge-flow",NA,NA,NA,NA
"ca956e069f949fba12d5de4197d3084c","knowledge-foundry",NA,NA,NA,NA
"4a9ba54ad0e042df0f7547ad602a5b9c","knowledgeblue",NA,NA,NA,NA
"e3373e0dfa6d97d50e0ed996ed30414f","knowledgemill","venture","a","2012-03-01",2391663
"9b6a9af89843331fdc0caf825134c3fb","knowledgent",NA,NA,NA,NA
"a4f55ee3e92de8fe61546a2f0a40fa2e","know-normal","debt_financing",NA,"2013-01-10",3e+05
"a4f55ee3e92de8fe61546a2f0a40fa2e","know-normal","venture",NA,"2013-11-22",1127622
"a4f55ee3e92de8fe61546a2f0a40fa2e","know-normal","debt_financing",NA,"2015-05-04",2e+05
"3300aaf2e5df25a0f25aa4b37c7fc92c","knowsis",NA,NA,NA,NA
"c465d08d6f2b0fbfcb7a95a11e4066a2","knozen","seed",NA,"2013-11-01",2250000
"78eaab1dd9019b69d44a06cf934bafbe","knuman",NA,NA,NA,NA
"8978d5d8709ab15eb98900f295cc9b2c","knyou","seed",NA,"2014-08-01",650000
"9a92179f309dc4d2474defe24b66aa38","koalify","seed",NA,"2012-01-01",9803
"df928356ac89d9992261893b7069e0d5","koddi",NA,NA,NA,NA
"887e3d378e680e9cd82c5313d4b77cb1","kodiak-sciences","venture","B","2016-01-12",3.4e+07
"8e8e5d3d8911d7d2162124899b4fd5e6","koemei","convertible_note",NA,"2013-12-01",435000
"8e8e5d3d8911d7d2162124899b4fd5e6","koemei","angel",NA,"2012-12-01",9e+05
"c9886879f1c3453c18cb32810d326d25","koffeeware","angel",NA,"2007-08-31",NA
"9316daaa58da1cf66421a2af0fb66436","koggee",NA,NA,NA,NA
"667fdba9baea299da2565a2164e19cc0","kognitio","undisclosed",NA,"2011-01-17",NA
"60af900ca414cdb7ab41891cf2e8531b","kolabtree",NA,NA,NA,NA
"b660c93ac7a676e1311de6215035571f","kolltan-pharmaceuticals","venture","b","2010-01-20",1e+07
"b660c93ac7a676e1311de6215035571f","kolltan-pharmaceuticals","venture","a","2009-10-12",5e+06
"b660c93ac7a676e1311de6215035571f","kolltan-pharmaceuticals","venture",NA,"2010-09-16",6e+06
"b660c93ac7a676e1311de6215035571f","kolltan-pharmaceuticals","venture","a","2008-07-31",4e+07
"b660c93ac7a676e1311de6215035571f","kolltan-pharmaceuticals","venture","c","2012-03-08",2.5e+07
"b660c93ac7a676e1311de6215035571f","kolltan-pharmaceuticals","venture","d","2014-03-19",6e+07
"5be21592ad7ed72caef81d6aadd4f2f1","kolor",NA,NA,NA,NA
"985074b69e54375ac8343dd4e4714b9e","komiko",NA,NA,NA,NA
"1c0635a6094477a691843f3c298bba76","komli-media","venture","c","2011-01-19",1.5e+07
"1c0635a6094477a691843f3c298bba76","komli-media","venture","d","2012-06-12",3.9e+07
"1c0635a6094477a691843f3c298bba76","komli-media","venture","b","2010-07-14",6e+06
"1c0635a6094477a691843f3c298bba76","komli-media","private_equity",NA,"2013-10-24",3e+07
"1c0635a6094477a691843f3c298bba76","komli-media","venture","a","2008-01-01",7e+06
"8922ad175aeba35d1fb1e43874c7e6d8","kompas-2",NA,NA,NA,NA
"acaf1ea7786933e042f5aad593ca978f","kompetoo",NA,NA,NA,NA
"45bd27b3dda4b80610c21f8992bb028d","kompyte","venture",NA,"2015-10-08",449399.4899
"45bd27b3dda4b80610c21f8992bb028d","kompyte","seed",NA,"2014-07-15",65269
"9125a9e6da7c6a76b31f0b10fe23d93b","konan-medical-usa",NA,NA,NA,NA
"6e5972d86d81c42c6c1623e90669c749","konduto",NA,NA,NA,NA
"21c8060f1a51a9588da9e751952e0a51","koneksa-health",NA,NA,NA,NA
"b94235ca630636ee0d42b921b3674bd6","konnected-interactive",NA,NA,NA,NA
"1a868dd1b486d2c24157cc8dab00b3c7","konolabs-inc-","seed",NA,"2014-11-27",1e+05
"1a868dd1b486d2c24157cc8dab00b3c7","konolabs-inc-","seed",NA,"2015-01-30",110000
"1a868dd1b486d2c24157cc8dab00b3c7","konolabs-inc-","seed",NA,"2015-04-02",150000
"2dd3505daf7d47e5233c5932574aa211","kontera","venture","b","2007-08-01",10300000
"2dd3505daf7d47e5233c5932574aa211","kontera","venture","a","2006-07-01",7e+06
"2dd3505daf7d47e5233c5932574aa211","kontera","venture","D","2012-10-01",1340000
"2dd3505daf7d47e5233c5932574aa211","kontera","venture","D","2013-07-25",2e+06
"2dd3505daf7d47e5233c5932574aa211","kontera","venture","c","2009-07-23",15500000
"ee0b8107c22a9830c689d3a95a1633ff","kontest","seed",NA,"2014-03-19",833549
"88078d2c5c75fa4eefb53e3b6ae04f18","kontexa",NA,NA,NA,NA
"98391502a264f4dc352bdf35d497421c","kontexto",NA,NA,NA,NA
"25d0dc5f34c71ef72acffc7cc60d1cc4","kontup",NA,NA,NA,NA
"965653f25db5ae55799095540896df18","konux","seed",NA,"2015-04-01",2155846.1157
"3f077dbd0bf8539f62554181473ea1d5","konveen",NA,NA,NA,NA
"d277985f3e244362b8b3731d32d9934b","kooaba","venture","a","2010-08-26",2920000
"edc763ae6fc13de68577df507f48a94a","koodbee",NA,NA,NA,NA
"a3cb885ad73041028afbfe4bb838b544","koollearning","seed",NA,"2012-11-01",750000
"d4979c27ba973b714252c29d3e1f96a7","koordinates",NA,NA,NA,NA
"08a3b3d7560492ca7bfdbe8f1087ea20","kopi-incorporation-limited",NA,NA,NA,NA
"4a159a258b0d0ce01fb180bcfdc2a80b","korl8",NA,NA,NA,NA
"c81183348b4bcc1d1e42de95e7bd5cea","koronis-pharmaceuticals","venture","D","2007-06-28",2e+07
"c81183348b4bcc1d1e42de95e7bd5cea","koronis-pharmaceuticals","venture",NA,"2012-01-09",1e+06
"c81183348b4bcc1d1e42de95e7bd5cea","koronis-pharmaceuticals","debt_financing",NA,"2015-09-24",55000
"802c02a0ed85b7342157d9e1d77f3eaa","korrelate",NA,NA,NA,NA
"759f9316e9df2c935246aa21ae41279c","kosan-biosciences","venture",NA,"2006-07-19",3e+06
"cc90560b8e036ca17bf4cdf970c80ed9","kosherstock-images",NA,NA,NA,NA
"4688e1a1c4a350033c621af1c8db30be","koshika-life-sciences-academy",NA,NA,NA,NA
"6058212a8d13ab8a82f71fea895dfd4d","kosmos-biotherapeutics","venture","a","2010-04-04",3.19e+08
"9de63a574ce17d4ceee2bb4ced597d41","koverse-inc",NA,NA,NA,NA
"98878efc4300800529eb8faffe50389d","kpi-management-solutions",NA,NA,NA,NA
"0f15b4380aeeffe1b22b7f61eabb2fcf","kpi-watchdog",NA,NA,NA,NA
"4791bb732effbd6fbdcd232f7d2ed445","kpmg",NA,NA,NA,NA
"f67eb8171a0f5d4d7f6cb36e6c5f1ead","kraig-biocraft-laboratories",NA,NA,NA,NA
"46e8acd68e699cae74d1edd8bb0e22b9","kranem","debt_financing",NA,"2012-02-10",78500
"46e8acd68e699cae74d1edd8bb0e22b9","kranem","debt_financing",NA,"2012-11-14",427778
"46e8acd68e699cae74d1edd8bb0e22b9","kranem","venture",NA,"2012-11-06",150000
"ea48e7608f66988353154a964bd5ec44","kreatech-diagnostics","venture",NA,"2009-11-18",3e+06
"ea48e7608f66988353154a964bd5ec44","kreatech-diagnostics","venture","1","2010-01-31",2700000
"299d94925cd6ea15465a671a43ef9401","kreditech","debt_financing",NA,"2015-01-22",2e+08
"299d94925cd6ea15465a671a43ef9401","kreditech","venture","1","2014-06-24",4e+07
"299d94925cd6ea15465a671a43ef9401","kreditech","debt_financing",NA,"2013-09-15",5e+06
"299d94925cd6ea15465a671a43ef9401","kreditech","debt_financing",NA,"2014-01-27",1e+07
"299d94925cd6ea15465a671a43ef9401","kreditech","venture","1","2012-12-17",4e+06
"299d94925cd6ea15465a671a43ef9401","kreditech","angel",NA,"2012-03-04",NA
"299d94925cd6ea15465a671a43ef9401","kreditech","venture","1","2013-04-22",3e+06
"299d94925cd6ea15465a671a43ef9401","kreditech","seed",NA,"2012-06-01",1e+06
"299d94925cd6ea15465a671a43ef9401","kreditech","venture","1","2015-09-28",9.2e+07
"cddbab9528da222029b179db2ef7ea33","kremsa-digital",NA,NA,NA,NA
"8ef3e681480a07b735857ccd960ed609","kribl",NA,NA,NA,NA
"29e425feaf09299a08fb608c71ee19a4","kricket",NA,NA,NA,NA
"c5c9a23c80615c01601197e936ebccb3","krishidhan-seeds","venture",NA,"2010-05-07",3e+07
"8874b3d289a9a53a2af906f6584c4eb5","kromatid","debt_financing",NA,"2013-09-10",50000
"61499e838da734f6bc5ba7c64dc66fb4","krossover","venture",NA,"2013-01-07",3e+05
"61499e838da734f6bc5ba7c64dc66fb4","krossover","angel",NA,"2010-07-01",295000
"61499e838da734f6bc5ba7c64dc66fb4","krossover","debt_financing",NA,"2011-11-14",3500000
"61499e838da734f6bc5ba7c64dc66fb4","krossover","angel",NA,"2013-08-27",3834330
"61499e838da734f6bc5ba7c64dc66fb4","krossover","angel",NA,"2012-03-01",4600000
"61499e838da734f6bc5ba7c64dc66fb4","krossover","angel",NA,"2009-11-01",330000
"61499e838da734f6bc5ba7c64dc66fb4","krossover","venture","1","2015-07-20",16300000
"de8cb9fef90a96cf6aef355b07a0cdd6","krowdster",NA,NA,NA,NA
"51a8fe67d3c6070f6fe83ee7f85fdd7c","krux","venture","B","2014-06-11",3.5e+07
"51a8fe67d3c6070f6fe83ee7f85fdd7c","krux","venture","A","2011-09-11",1.3e+07
"51a8fe67d3c6070f6fe83ee7f85fdd7c","krux","seed",NA,"2010-05-01",2e+06
"f9f03a2cfc2638ec5d7ab9077d41238c","kryptoncloud","seed",NA,"2015-06-05",2700000
"d5a8728978cc326e8ecdc134e189d91c","kuaizi-tech","venture","A","2014-03-13",NA
"d5a8728978cc326e8ecdc134e189d91c","kuaizi-tech","angel",NA,"2013-03-28",NA
"dc15ef0c382145af6a632511a83f6f1a","kuehnle-agrosystems","venture",NA,"2010-01-21",1271600
"dc15ef0c382145af6a632511a83f6f1a","kuehnle-agrosystems","venture",NA,"2011-01-07",356440
"dc15ef0c382145af6a632511a83f6f1a","kuehnle-agrosystems","venture",NA,"2011-12-31",250000
"dc15ef0c382145af6a632511a83f6f1a","kuehnle-agrosystems","venture",NA,"2012-01-05",398813
"dc15ef0c382145af6a632511a83f6f1a","kuehnle-agrosystems","venture",NA,"2012-09-21",289455
"05006873c41565d263aab224298ec24f","kuldat","seed",NA,"2013-02-01",5e+05
"05006873c41565d263aab224298ec24f","kuldat","venture",NA,"2015-07-02",1500000
"9a8025f0419c0bbf15bb2366bfa90491","kulira-technologies",NA,NA,NA,NA
"9ba61d547e7971751bf2053ecd2aed3a","kun-run-biotechnology","venture",NA,"2010-05-13",8e+06
"a21b1d1890dfcb7e828d2f7b5f36a7ab","kunshan-riboquark-pharmaceutical-technology","venture","a","2014-01-13",7446285
"79b367a70a58715dd102fc29bf974152","kuona","grant",NA,"2013-01-01",40000
"79b367a70a58715dd102fc29bf974152","kuona","angel",NA,"2014-11-07",120000
"79b367a70a58715dd102fc29bf974152","kuona","seed",NA,"2013-09-01",40000
"39971e001bd395b9c001adb1ea650d71","kurobe-pharmaceuticals","venture",NA,"2013-06-04",5e+06
"75511df3ed811506f3d5eb1b7668a631","kuros-biosurgery","venture",NA,"2015-11-11",4972254.8181
"75511df3ed811506f3d5eb1b7668a631","kuros-biosurgery","venture","1","2005-01-01",5448400
"75511df3ed811506f3d5eb1b7668a631","kuros-biosurgery","venture",NA,"2005-10-01",4335120
"75511df3ed811506f3d5eb1b7668a631","kuros-biosurgery","venture",NA,"2015-08-18",15350000
"947f36c4bdd1a1245added9e89c04fb3","kutenda","seed",NA,"2009-01-01",NA
"7d790c81b0c87a4c41ebe46c1b628a1d","kuznech","angel",NA,"2011-08-01",1200000
"7d790c81b0c87a4c41ebe46c1b628a1d","kuznech","seed",NA,"2011-08-01",25000
"7d790c81b0c87a4c41ebe46c1b628a1d","kuznech","seed",NA,"2012-08-20",7e+05
"7d790c81b0c87a4c41ebe46c1b628a1d","kuznech","grant",NA,"2012-06-01",12000
"7d790c81b0c87a4c41ebe46c1b628a1d","kuznech","grant",NA,"2012-10-01",18000
"84f138a6db883d11c256eea80588af6e","kvantum","angel",NA,"2013-01-01",1e+06
"9c2c20e68c4721d41669e8db24b1facf","kwanzoo",NA,NA,NA,NA
"0c9e9de9d8aacad86862f33d957fa055","kwelia","seed",NA,"2011-09-08",20000
"0c9e9de9d8aacad86862f33d957fa055","kwelia","seed",NA,"2012-04-10",40000
"56fc90ea57d71869be15ef081e042a67","kxen","venture","d","2010-06-16",8e+06
"3bf878eb62e95466527f0065dac56148","kybalion","seed",NA,"2013-02-14",40000
"93b42779a0200f186cd9378b6ccf0d51","kyiv-polytechnic-institute",NA,NA,NA,NA
"4a3555496e2574b9c8e7e00cae6da104","kylin",NA,NA,NA,NA
"a49fd6008ac56fa0d38c6b7a1b668636","kylin-therapeutics","venture",NA,"2009-03-04",2e+06
"a49fd6008ac56fa0d38c6b7a1b668636","kylin-therapeutics","venture",NA,"2009-11-09",57896
"49d7e498080c05d024cc1e3e18b06915","kymab","venture","a","2010-07-12",30400000
"49d7e498080c05d024cc1e3e18b06915","kymab","venture","B","2014-05-16",4e+07
"49d7e498080c05d024cc1e3e18b06915","kymab","venture","B","2015-05-06",5e+07
"be49651363cc01204f5f07d48acf6eb2","kynance-consulting",NA,NA,NA,NA
"0e07413a8ec5feb23bb4fc194aa04ca5","kyndi","venture",NA,"2015-07-14",1099474
"0e07413a8ec5feb23bb4fc194aa04ca5","kyndi","angel",NA,"2014-09-14",NA
"81e1bb20bfb09bcfc4d28d356c89c959","kyowa-hakko-kirin",NA,NA,NA,NA
"b5e8449880024849c6cf14f9e9f372cd","kypha","debt_financing",NA,"2015-11-13",2100000
"b5e8449880024849c6cf14f9e9f372cd","kypha","venture",NA,"2014-01-14",398375
"b5e8449880024849c6cf14f9e9f372cd","kypha","venture",NA,"2012-01-19",206000
"b5e8449880024849c6cf14f9e9f372cd","kypha","venture",NA,"2013-08-08",750000
"b5e8449880024849c6cf14f9e9f372cd","kypha","venture",NA,"2014-07-29",NA
"b5e8449880024849c6cf14f9e9f372cd","kypha","venture",NA,"2014-11-21",3500000
"eb452e692d9c4cb6bb08c12864009c14","kyras-therapeutics","venture","A","2015-12-11",NA
"b2708779b5d947400accc339e60c6df6","kyron","seed",NA,"2013-10-24",3e+06
"1b50aa605932df39cdf560bd6fa02930","kyruus","venture",NA,"2011-11-08",3e+06
"1b50aa605932df39cdf560bd6fa02930","kyruus","venture","1","2013-01-02",1.1e+07
"1b50aa605932df39cdf560bd6fa02930","kyruus","private_equity",NA,"2014-05-20",11250000
"1b50aa605932df39cdf560bd6fa02930","kyruus","venture","1","2011-06-01",8e+06
"1b50aa605932df39cdf560bd6fa02930","kyruus","venture","1","2015-09-18",2.5e+07
"9d2eb6335b7fbb0e41e4462ed5d88a1b","kythera-biopharmaceuticals","venture","c","2008-05-19",3e+07
"9d2eb6335b7fbb0e41e4462ed5d88a1b","kythera-biopharmaceuticals","venture","b","2006-07-24",3e+07
"9d2eb6335b7fbb0e41e4462ed5d88a1b","kythera-biopharmaceuticals","venture",NA,"2005-09-16",1e+06
"9d2eb6335b7fbb0e41e4462ed5d88a1b","kythera-biopharmaceuticals","venture","d","2011-09-19",37400000
"68a118107089847c5b9df771a256bb73","kyto","seed",NA,"2013-01-01",NA
"9e932a007ab649a7aec8bdbbedbb7359","kzn-growth-fund",NA,NA,NA,NA
"3909fa246b4ebebd1bb838c74f171fef","l-d-earthmoving",NA,NA,NA,NA
"f022b78195ae95f136bf4511ca652c1b","l2c","undisclosed",NA,"2012-05-23",NA
"f022b78195ae95f136bf4511ca652c1b","l2c","venture",NA,"2010-01-22",4005616
"f022b78195ae95f136bf4511ca652c1b","l2c","seed",NA,"2007-10-07",NA
"5413b01c9e4229badbbb23eb487a6ab4","l4---laboratorium-marketingowe",NA,NA,NA,NA
"3a43d72cf87e9eea945d8fa7f2f732fa","la-factoria-de-proyectos",NA,NA,NA,NA
"f4b3230673ba6f755dcb4722a2b79168","la-generale-multimedia-sarl",NA,NA,NA,NA
"b7c62a8eee873405b7a10a05d852bc79","la-jolla-pharmaceutical-co","venture",NA,"2011-04-18",5183999
"b7c62a8eee873405b7a10a05d852bc79","la-jolla-pharmaceutical-co","venture","1","2013-10-09",17755714
"7e2d5c78725e1c93b92727d41964f963","laliste",NA,NA,NA,NA
"18a350fca81e8d8db3e22b0ce49b8463","la-reunion-virtuelle","seed",NA,"2008-03-01",75835
"18a350fca81e8d8db3e22b0ce49b8463","la-reunion-virtuelle","seed",NA,"2008-10-01",70405
"3d1227534d1909016c6e7f9a84d7eb46","lab-automate-technologies","seed",NA,"2012-10-23",50000
"a5ca8da3e6f8228c1d99b8b7a2f30b5b","lab-fellows",NA,NA,NA,NA
"0242450cdfc276166682e3b8a2254084","lab-tech-support",NA,NA,NA,NA
"f4bd12aaba7816ba3226e924aad56739","lab21","venture",NA,"2010-10-27",837800
"edfd9f2234d2c2697952ef5fe40ef55a","lab4motion-solutions-ltd","seed",NA,"2011-02-11",150000
"edfd9f2234d2c2697952ef5fe40ef55a","lab4motion-solutions-ltd","seed",NA,"2013-09-01",210000
"edfd9f2234d2c2697952ef5fe40ef55a","lab4motion-solutions-ltd","debt_financing",NA,"2015-05-01",140000
"ed171fdc3b01f1104c52cb011ebccbff","lab7-systems","debt_financing",NA,"2013-06-29",210000
"ed171fdc3b01f1104c52cb011ebccbff","lab7-systems","debt_financing",NA,"2012-06-15",5e+05
"254907f8216b42d2016da4ddefbbdcf9","laboratory-corporation-of-america",NA,NA,NA,NA
"1706561860a276f77ee6c180e6cc9529","labcyte","grant",NA,"2011-11-08",196000
"1706561860a276f77ee6c180e6cc9529","labcyte","venture","1","2013-01-08",5300000
"1706561860a276f77ee6c180e6cc9529","labcyte","debt_financing",NA,"2015-05-05",1.7e+07
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","venture",NA,"2015-10-01",NA
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","convertible_note",NA,"2015-07-16",NA
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","convertible_note","1","2015-08-28",NA
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","seed",NA,"2013-03-07",6e+05
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","grant",NA,"2012-06-01",50000
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","seed",NA,"2012-09-18",50000
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","grant",NA,"2013-04-05",1e+05
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","venture","1","2014-10-14",1527921
"53166eab339df4a5b7d0b10ca5c83ffa","foodessentials","venture","1","2014-12-22",2170000
"ada745c21d98b520d568d4bebcea0ffe","labformatix-inc",NA,NA,NA,NA
"7cdb6319ddd7b9ab66230db992ead73c","labfriend-pty-ltd",NA,NA,NA,NA
"996ea73b0a70fd16cd46f4f54acc1fda","labgenius",NA,NA,NA,NA
"e3aaea476215757fe7ed9be72ca12cbf","labii",NA,NA,NA,NA
"67621111ca5ce81d0439b8bf689f9653","labnow","debt_financing",NA,"2010-05-11",605000
"67621111ca5ce81d0439b8bf689f9653","labnow","venture","1","2007-11-13",2e+07
"67621111ca5ce81d0439b8bf689f9653","labnow","venture","1","2004-09-29",1.4e+07
"67621111ca5ce81d0439b8bf689f9653","labnow","debt_financing",NA,"2009-04-06",783350
"bcfb7e5f68ebae0b23ec55c88e9c67f3","labochema","undisclosed",NA,"2012-01-08",NA
"1059edff6f29b833f3ef4df6dc4d8c92","labomar","venture",NA,"2012-06-14",6903050
"2fee1e68c352fc527d1e43a48c3569be","labome",NA,NA,NA,NA
"ff423897dfa61c4866ef49194e387c7b","labopharm",NA,NA,NA,NA
"4c5fc52360b2f5cc85198afc491b6128","labor-market-pulse",NA,NA,NA,NA
"1f5cb6b9a7b9978876a1153c66b64a26","laboratorios-andromaco",NA,NA,NA,NA
"1004c7bd2c88e75bf1a956d1e82bd5c4","laboratory-management-services",NA,NA,NA,NA
"434b16f01ba3d79a9986cddce4aecefb","laboratory-partners","venture","d","2008-01-14",1.6e+07
"434b16f01ba3d79a9986cddce4aecefb","laboratory-partners","venture",NA,"2009-05-14",8e+06
"434b16f01ba3d79a9986cddce4aecefb","laboratory-partners","venture",NA,"2010-05-10",5e+06
"40c778cfe6f6f398647fc791d2493acc","labroots","debt_financing",NA,"2008-10-27",25000
"0de62f122bba63498c5c9a4985007ee6","labrys-biologics","venture","a","2013-01-03",3.1e+07
"0de62f122bba63498c5c9a4985007ee6","labrys-biologics","venture",NA,"2012-12-28",14588234
"a5a410a8957336b25d3aaf54a4121759","labster",NA,NA,NA,NA
"5960a3ed99a911c0e8c2d16a851fcf53","labtec",NA,NA,NA,NA
"8d2c7a711b87b2e90b5565001ebdefa1","ladder-2",NA,NA,NA,NA
"91dd9c7803cc60659d7d0f3764ecefd0","ladder-digital","seed",NA,"2015-01-19",NA
"cb8010ef0c8145951d9e01fd2ca2b5c0","laforge","seed",NA,"2014-11-14",1100000
"cb8010ef0c8145951d9e01fd2ca2b5c0","laforge","venture",NA,"2015-08-05",524998
"16e66951904e2b2b8571c4b2b0f64cdb","lagiar","seed",NA,"2013-02-13",40000
"be2ce4b29f27a032a2d010a2aeb5ad13","lagniappe-health","private_equity",NA,"2013-09-10",7865646
"fbca8bc1dcda6683f12b920169f7406e","lakemaster-corporation",NA,NA,NA,NA
"35c5919c3e60f12ef4c89948917234f1","lakewood-amedex","venture","C","2014-06-18",5500000
"6e1a931dcb2d6c8883c1ce741959b7a3","lambda-labs",NA,NA,NA,NA
"e18ab6f1778729ca39e326f7bac59f50","lambda-therapeutic",NA,NA,NA,NA
"2e9f166ed814bd27418e441c16aa2739","lambdoop-solutions-sl",NA,NA,NA,NA
"fe886795e5471a07dbea3b384ce655b3","lamellar-biomedical","venture","a","2013-01-07",5301059
"cd62062863df1d80d17d5c7d6a9affc7","lamplight-analytics","seed",NA,"2015-09-02",1500000
"11a1de4fd58e78d24230ac3619d95ec2","lana",NA,NA,NA,NA
"9ad0e3380b4bddc8357b4e69207e3ec2","landauer",NA,NA,NA,NA
"f65df38e02be14b3feece1a09c5b41b2","landec-corporation",NA,NA,NA,NA
"5058a7e639cf00e6e4c88651535d3cc1","mixgenius","seed",NA,"2013-06-01",1451612
"5058a7e639cf00e6e4c88651535d3cc1","mixgenius","seed",NA,"2012-10-01",305073
"5058a7e639cf00e6e4c88651535d3cc1","mixgenius","convertible_note",NA,"2014-05-01",2181818
"5058a7e639cf00e6e4c88651535d3cc1","mixgenius","venture","1","2015-06-29",6200000
"b96cd3a36af5443939677bff03be4dc9","langcorr",NA,NA,NA,NA
"774c08e681f1aa189cf5ae33145386a9","langproving-com",NA,NA,NA,NA
"bed435c15280fdf1e076b13e185198a6","lankau-consulting-llc",NA,NA,NA,NA
"bc93b88ca3f26f5e3692fcf3fd892bda","lanoba",NA,NA,NA,NA
"7c2639a9729fb41f9dc8782a13e5e9d4","lanthio-pharma","venture","a","2012-11-28",6187680
"7c2639a9729fb41f9dc8782a13e5e9d4","lanthio-pharma","debt_financing",NA,"2014-05-21",4933432
"cda8bcfec083c610607a8f08bc9c851c","lanx","venture",NA,"2009-07-24",43500
"cda8bcfec083c610607a8f08bc9c851c","lanx","venture",NA,"2012-10-10",1006018
"cda8bcfec083c610607a8f08bc9c851c","lanx","venture","1","2013-05-13",1.5e+07
"cda8bcfec083c610607a8f08bc9c851c","lanx","venture",NA,"2013-03-07",507088
"dc218b705a5207c2fdbd8d73798cca60","lanyon","venture",NA,"2009-12-03",1e+07
"d2dee4fc2d11f97f154f33b663a90139","lapuck-laboratories",NA,NA,NA,NA
"c92c13ae32a06cc64a49967ce79d5c3c","larada-sciences","venture",NA,"2011-08-11",400469
"c92c13ae32a06cc64a49967ce79d5c3c","larada-sciences","venture",NA,"2009-08-11",1828880
"c92c13ae32a06cc64a49967ce79d5c3c","larada-sciences","venture",NA,"2014-03-27",4e+05
"26e1cde7e723a50bc680a26b158c0430","larapharm","venture",NA,"2014-04-02",1500000
"f5a8afcc2803628f306ab1c40559e58a","laros",NA,NA,NA,NA
"e8e8da6564ed0a3f860f685716126d04","lascco",NA,NA,NA,NA
"8cac8ecc3ac0143567e0ed21e52d434e","laser-skin-clinic",NA,NA,NA,NA
"e4e46553482a55d3193c8db1711ac19a","laserfiche",NA,NA,NA,NA
"faf5b960e357a50eecff888ff66c585e","lasergen","venture","a","2011-08-30",5e+06
"a7b39b6db3d48c229fff99819e94ff44","laserleap","seed",NA,"2013-01-01",NA
"3082a3166e498fd09faed3ff494a3fe0","latentview-analytics",NA,NA,NA,NA
"f57b4aca1ae792d7423fdaa2b7f11f36","lateral-2","seed",NA,"2014-05-01",415485
"f57b4aca1ae792d7423fdaa2b7f11f36","lateral-2","seed",NA,"2014-12-03",NA
"4c3bbfb7c1befaa6b897f02b159d5493","lathrop-parc-redwood-city","venture",NA,"2009-06-16",1600000
"4c3bbfb7c1befaa6b897f02b159d5493","lathrop-parc-redwood-city","debt_financing",NA,"2012-10-15",8727000
"78fc8dcbebc82aab8b0cd6813c2dd193","latio","seed",NA,"2014-02-15",10000
"1e87aa655a9bba9549920aa07920c24d","latitude-digital-marketing",NA,NA,NA,NA
"1e456a2dd71a896e01b6f95342bb9a17","lattice-engines","venture","B","2011-06-07",1.5e+07
"1e456a2dd71a896e01b6f95342bb9a17","lattice-engines","venture","C","2012-11-23",2e+07
"1e456a2dd71a896e01b6f95342bb9a17","lattice-engines","venture","a","2008-05-27",1700000
"1e456a2dd71a896e01b6f95342bb9a17","lattice-engines","venture","D","2015-06-10",2.8e+07
"91a1c06870258f61ca05259f110ef330","laud-social",NA,NA,NA,NA
"7462f4b75684b2d2989825e4fd4ee819","launchcloud",NA,NA,NA,NA
"8d8b0f2d8c1b47c76c8f4160238874c5","launchcyte","venture",NA,"2010-10-12",493697
"8d8b0f2d8c1b47c76c8f4160238874c5","launchcyte","debt_financing",NA,"2010-01-06",1021293
"5a93e98218878510d9e6588ff68ff866","launchly",NA,NA,NA,NA
"d71b73c9c8ab1fa5ef07f06ef47593c7","launchtrack","angel",NA,"2012-09-12",92500
"d71b73c9c8ab1fa5ef07f06ef47593c7","launchtrack","seed",NA,"2013-10-29",360000
"d71b73c9c8ab1fa5ef07f06ef47593c7","launchtrack","seed",NA,"2014-08-01",690000
"937a910b0adb22223f2edf8f4140b58f","laundromatch",NA,NA,NA,NA
"bfee16aaa5d5b6cae89325fbc2413157","laurantis-pharma","venture",NA,"2012-09-04",7094556
"68fcca37c86794c07cea744df6d67e0c","laureate-pharma","debt_financing",NA,"2010-10-07",2e+07
"dd8597d05107fe12f328efea9d8ccdfb","lavaboom",NA,NA,NA,NA
"793d6a62d8a8fdac0b79361e49959e38","lavoisier-bv",NA,NA,NA,NA
"dd976cea970355506801d4845deff703","lawgeex","venture",NA,"2015-10-01",NA
"100d3586dc86a52e9d3c29c22d7a7b49","lawyerboom",NA,NA,NA,NA
"3e8e84ae1f208d29e729677898e3677e","lawsuit-jackpots",NA,NA,NA,NA
"e4c23b114286486d59b9e7994ddd52e1","layerbio","debt_financing",NA,"2014-07-01",205000
"5b27a83b3157386993792d5c10fe6f94","layerx-technologies-inc",NA,NA,NA,NA
"26c174920664bfce3de33869e7ba1e77","lazarus-therapeutics","venture",NA,"2010-08-02",1e+05
"0d372de503a09fa29e2e6743dc613df7","lcm-technologies","equity_crowdfunding",NA,"2013-10-07",NA
"27b498802a227ba391d207409924b9ac","ldger","seed",NA,"2014-03-01",NA
"b2de013d5923216c9a464f030a62dbbd","ldrly",NA,NA,NA,NA
"ddad34225565cb408a9f6bed6996ce41","lead-forensics",NA,NA,NA,NA
"a8f38cce2261168c92e10059bd6842df","lead-generator",NA,NA,NA,NA
"79c8b62994c7a9c505234df2a2929b46","lead-method","convertible_note",NA,"2015-08-03",1e+05
"6f2f7840598faafbc2e75af4768e2bcc","lead-therapeutics","venture","a","2007-11-05",1.7e+07
"6f2f7840598faafbc2e75af4768e2bcc","lead-therapeutics","debt_financing",NA,"2009-06-03",3e+06
"17216319424bd92dc57a0fd0cfbddd3b","lead-wizards","grant",NA,"2015-06-01",5855.21916670863
"dabddd73384ef98858f40f4fb9aab786","leadboxer","seed",NA,"2015-12-21",543622.045
"dabddd73384ef98858f40f4fb9aab786","leadboxer","seed",NA,"2014-08-01",80426.4389
"0f0cf62f1a9b5af4ccb7d20982943fc4","leadformix",NA,NA,NA,NA
"5048e4685437677ccd149a2366683673","leadgenesys",NA,NA,NA,NA
"4100bb6d33b22b21023226a96d960bc4","leadgnome-inc",NA,NA,NA,NA
"f19276cab11c6339c1a57b7c4e941c92","leadlander",NA,NA,NA,NA
"e0dc6a482a6538ac6ed14aaf3f605002","leadmd-com",NA,NA,NA,NA
"fcc8ca3d9f4f85d339deabd1c5701cbf","leadpath",NA,NA,NA,NA
"78e7bee95c4b674bc1408ef176447bbe","leadpro247",NA,NA,NA,NA
"0feba80c1769a804f1ec9242e508304c","leadqual",NA,NA,NA,NA
"bd5580e79d7a4736c5ee98365facf8bb","leads-origins",NA,NA,NA,NA
"b6b498056d74533f5648bd18b3f830e6","leadsolve",NA,NA,NA,NA
"de90dd27b9da6eea4deaccb8103765ec","leaf","venture",NA,"2013-09-30",2e+07
"de90dd27b9da6eea4deaccb8103765ec","leaf","angel",NA,"2012-01-01",6e+06
"0280f020a79cbab0be7ed310eba3d2d9","leagit",NA,NA,NA,NA
"b63c02c95a3c8310c214c2c9016753f4","lean-analytics",NA,NA,NA,NA
"140467a68cfdb4d2c7bfea8146f9f082","dialogikdigital",NA,NA,NA,NA
"7b82246ea6d0e08a81d68461962a56a3","leanciti",NA,NA,NA,NA
"440df013193344bfa560d17f250e1d82","leanda",NA,NA,NA,NA
"5851d2a71163dbc002b99e56e9b397cc","leanplum","angel",NA,"2013-02-13",825000
"5851d2a71163dbc002b99e56e9b397cc","leanplum","venture","1","2014-07-28",4800000
"5851d2a71163dbc002b99e56e9b397cc","leanplum","venture","1","2015-08-05",11600000
"4a4fa4a2dac574fba32b7c0e43ea2d73","leantegra","seed",NA,"2015-12-28",132000
"4a4fa4a2dac574fba32b7c0e43ea2d73","leantegra","seed",NA,"2014-12-14",593000
"4a4fa4a2dac574fba32b7c0e43ea2d73","leantegra","seed",NA,"2015-08-19",325000
"76a9bffef7d1d5a948f395d41e961027","leanxcale",NA,NA,NA,NA
"3c52a11d10362443c4806942a450b008","leap-medical","seed",NA,"2010-03-25",1010000
"c7b1b4ae73a96b61595bd84cce4add31","leapforce","seed",NA,"2008-12-14",2e+05
"abf19c90e403a93b72b9eb9296654b5b","leapfrog-on-line","venture","a","2008-09-17",3e+07
"7e5b4caf555127e60ec3e0dced904b8a","shroudbase",NA,NA,NA,NA
"82d45c09d9af61f1375c74f8537a8d20","mindops","grant",NA,"2014-02-19",25000
"82d45c09d9af61f1375c74f8537a8d20","mindops","seed",NA,"2014-04-01",44000
"82d45c09d9af61f1375c74f8537a8d20","mindops","angel",NA,"2015-01-07",260000
"fa342122a3b600e2154563bd50d22bbd","learndatamodeling",NA,NA,NA,NA
"0d7cbbaf0b7bb5a63b7bc4885ea05bb0","learning-machine",NA,NA,NA,NA
"4042d24944075092b06ba85f89724537","learnmetrics","seed",NA,"2013-02-13",150000
"4042d24944075092b06ba85f89724537","learnmetrics","seed",NA,"2014-01-22",NA
"98ab689dcf1e14ec61de1fbdb378f081","learnnovators",NA,NA,NA,NA
"73e9e438e33213c9aef7f3511000323d","learnsprout","seed",NA,"2013-04-23",5e+05
"73e9e438e33213c9aef7f3511000323d","learnsprout","venture","1","2014-05-13",4200000
"82b2f05e2ccee00e8f2727d2615c1f39","lectus-therapeutics","undisclosed",NA,"2007-09-05",6030177
"82b2f05e2ccee00e8f2727d2615c1f39","lectus-therapeutics","venture","1","2006-02-13",14257949
"dac84107f5e4bb56fd7bbb569971e68b","led-grow-master-global",NA,NA,NA,NA
"452d6bfc8f14f571e0a04a315ce2576a","led-medical-diagnostics","venture",NA,"2015-03-09",499196
"311254268f8b1001a4be5393e2ebcb24","ledge","venture",NA,"2014-11-28",344000
"d7d74cc4901873d072958b4c9c813f29","ledswim",NA,NA,NA,NA
"7b1999a08b429895ffccd4deeb14b167","lee-biosolutions",NA,NA,NA,NA
"ea9eba6f2e12c251599a76cec58c7b3a","lee-enterprises-consulting",NA,NA,NA,NA
"c6a396514a1e92218165451ee1ba358f","leente",NA,NA,NA,NA
"282d1133a14e3d130d229f40f7f3ed8d","leetix",NA,NA,NA,NA
"90991d1980a23ab2cb8388a8891fcdf3","leftronic","seed",NA,"2010-11-17",5e+05
"90991d1980a23ab2cb8388a8891fcdf3","leftronic","undisclosed",NA,"2010-10-01",NA
"4f4d822783fab3fb0810ca41dc7a1422","legal-robot",NA,NA,NA,NA
"626053e9d07e9a9dd56ff97b735f0630","legal-shine","seed",NA,"2014-02-01",NA
"626053e9d07e9a9dd56ff97b735f0630","legal-shine","seed",NA,"2014-11-01",313837
"626053e9d07e9a9dd56ff97b735f0630","legal-shine","seed",NA,"2015-03-01",55957
"3dc0cc954da865dddec128d43b70959f","legalogic",NA,NA,NA,NA
"eb8f8255d4fe5d2db8e4bc1dd1051ef1","legalpad","seed",NA,"2013-10-01",20275
"2e317e2be4062e1a3fcd52b8bc6fb985","legup","seed",NA,"2014-03-17",60000
"2e317e2be4062e1a3fcd52b8bc6fb985","legup","convertible_note",NA,"2015-06-13",NA
"4ae88c22e9fcd72a01549ab5f5c08014","leica-biosystems",NA,NA,NA,NA
"44d82a65c7373ba2e20b05cdec99be34","leica-biosystems-st-louis",NA,NA,NA,NA
"eee841d0e8a4e12f31f96dfb9b770daa","leica-microsystems",NA,NA,NA,NA
"488a2213d927060c681089fdf7087ecc","leighton-interactive",NA,NA,NA,NA
"d251eda7bf7607d2eb70e8f06dd04fc9","leiki",NA,NA,NA,NA
"e1b3b6872eecd636dff07db3c18d2c49","lela-inc-2","angel",NA,"2013-01-01",1.2e+07
"d5e56193514417099f4e6da4021865e4","lemonaid-inc",NA,NA,NA,NA
"7208445c84071d680a62c383ec57a223","lemonfish-technologies","venture",NA,"2013-09-30",3e+06
"2d422ea987dc33641dbfa674feb95ce1","lending-alpha",NA,NA,NA,NA
"06023d163aa05906070c490c78243ca0","lenticular-research-group","debt_financing",NA,"2015-08-11",330000
"9ea36f34a2e50c0552d1e5c6bf3c3e80","lentigen","grant",NA,"2010-11-04",1200000
"ff06465849d433c009d4bc3aab055bce","leonardo-biosystems","venture",NA,"2011-11-14",1250000
"ff06465849d433c009d4bc3aab055bce","leonardo-biosystems","debt_financing",NA,"2010-05-18",1250000
"6f95616c2bce0cddfb4d2e603763b423","leukocare","venture",NA,"2015-07-22",NA
"30f09cba011ea15ebe30b13226342a29","leukodx","venture",NA,"2009-09-17",377000
"30f09cba011ea15ebe30b13226342a29","leukodx","debt_financing",NA,"2010-06-28",115000
"30f09cba011ea15ebe30b13226342a29","leukodx","venture",NA,"2012-04-18",1600000
"30f09cba011ea15ebe30b13226342a29","leukodx","venture",NA,"2010-08-02",250000
"30f09cba011ea15ebe30b13226342a29","leukodx","venture",NA,"2014-06-16",7e+06
"cc4d0ea26220313cfb4cbc2fe481ef76","lev-pharmaceuticals","venture",NA,"2007-11-08",2e+07
"cc4d0ea26220313cfb4cbc2fe481ef76","lev-pharmaceuticals","venture",NA,"2006-10-23",2.1e+07
"5a68bb232ce4b3588cb0228986ad3473","level-up-analytics",NA,NA,NA,NA
"d83c36a71492e971e08585c69f3642de","levelg",NA,NA,NA,NA
"7f1cddf7b7345d7e2f80764e01bb73f0","levelwing",NA,NA,NA,NA
"147611729831089d8bb0e767790d1cc2","lever-systems",NA,NA,NA,NA
"7b93609837aa310cc20f96140bd30a61","levers",NA,NA,NA,NA
"b22ff5682c10fe3f4feee8ab20695235","leversense","debt_financing",NA,"2010-12-03",399000
"b22ff5682c10fe3f4feee8ab20695235","leversense","debt_financing",NA,"2009-07-13",260000
"28e7b7a82bb6f78c4f767990df80de11","leviathan-system",NA,NA,NA,NA
"5f0ab469078992bcddf559f3e085ea6b","levicept","venture","A","2014-10-07",16046384
"5f0ab469078992bcddf559f3e085ea6b","levicept","grant",NA,"2014-10-08",3866789
"3ea2bb3ebd174181fdd401e4ab74c13a","lewis-and-clark-pharmaceuticals","venture",NA,"2012-11-20",1e+05
"3ea2bb3ebd174181fdd401e4ab74c13a","lewis-and-clark-pharmaceuticals","venture",NA,"2013-10-21",375000
"52335884d9a0320e8a3bd61fb8eb7bd3","lexalytics",NA,NA,NA,NA
"879b4f04f0fa80c73a109ff943fff07d","lexer","angel",NA,"2014-04-04",NA
"38ec6997c193fcbe40845ce1aa450b34","lexicon-branding-inc",NA,NA,NA,NA
"23d281d12baaca5fbbc065fdb1ec9ddb","lexicon-genetic",NA,NA,NA,NA
"ac37f95047c903d9c8426d2c23be85d9","lexicon-pharmaceuticals","private_equity",NA,"2012-08-08",3.5e+07
"ac37f95047c903d9c8426d2c23be85d9","lexicon-pharmaceuticals","private_equity",NA,"2010-03-15",75040000
"ac37f95047c903d9c8426d2c23be85d9","lexicon-pharmaceuticals","post_ipo_equity",NA,"2014-11-25",1.3e+08
"ac37f95047c903d9c8426d2c23be85d9","lexicon-pharmaceuticals","venture",NA,"2014-12-12",4662780
"78dd4c599c6d00a735d3e4fc65e45727","liaison-technologies","seed",NA,"2013-02-25",727627
"78dd4c599c6d00a735d3e4fc65e45727","liaison-technologies","venture","1","2012-04-10",3e+07
"78dd4c599c6d00a735d3e4fc65e45727","liaison-technologies","venture",NA,"2014-04-14",1.5e+07
"78dd4c599c6d00a735d3e4fc65e45727","liaison-technologies","undisclosed",NA,"2015-03-13",NA
"2717b8a42cf89a251515a07b65278a54","liber-118",NA,NA,NA,NA
"3ec8d840c7ee23a5c194f233fdb6bc89","libi-software-technology",NA,NA,NA,NA
"5447787f5f5d85688e1de742f3006e1a","lidskaner",NA,NA,NA,NA
"2102ba83763ee06d4e0445e94aac27c1","life-magnetics",NA,NA,NA,NA
"8c81eb94cc7063eef6ef592dd1cb8125","life-recovery-systems","venture",NA,"2009-05-29",640000
"002177128d7e07b42ba0dd81d405bdf3","life-sciences-group-inc",NA,NA,NA,NA
"376fe82cfc100b89e9732563b3946bc6","life-scientific",NA,NA,NA,NA
"088ae0b26af89a600619999cde3a7a84","life-technologies",NA,NA,NA,NA
"c63e8a8847feefc9b9289b0a376a71a7","lifebeam","seed",NA,"2013-06-17",2700000
"46786c6f6ad4039e8258e14643349795","lifebond","venture","c","2011-05-23",2e+07
"46786c6f6ad4039e8258e14643349795","lifebond","venture","b","2009-06-03",8e+06
"46786c6f6ad4039e8258e14643349795","lifebond","venture","D","2015-08-05",2.7e+07
"77d79ecb5098ee462498c4566da43465","lifecell",NA,NA,NA,NA
"255902146939afa0fa40dbd206fe9c8c","lifecode","venture","A","2015-02-19",20500000
"80e1cff7c1b1b9650dac922362d97969","lifecycle","seed",NA,"2015-12-02",20000
"80e1cff7c1b1b9650dac922362d97969","lifecycle","seed",NA,"2015-10-30",10000
"80e1cff7c1b1b9650dac922362d97969","lifecycle","seed",NA,"2015-09-01",20000
"80e1cff7c1b1b9650dac922362d97969","lifecycle","seed",NA,"2014-07-18",20000
"a14b915d48ccae44afd39ecdc529d278","lifelabs",NA,NA,NA,NA
"787e29021c2be8f999ac6981a778f6cc","lifelife","seed",NA,"2014-09-19",NA
"41235c2819056b3811943c206e5f6b7f","lifemap-sciences",NA,NA,NA,NA
"fa3f927417a48bbf8e77034925c98819","lifepass",NA,NA,NA,NA
"a7d3f8020242832d3586054c1914486c","lifesci-advisors",NA,NA,NA,NA
"ec835e6d56c72d49c00d967458d38b14","lifesciences-british-columbia",NA,NA,NA,NA
"db0de992ab9d1cd5399c1b2bb21fcbc5","lifeshare-technologies","debt_financing",NA,"2013-02-19",625000
"db0de992ab9d1cd5399c1b2bb21fcbc5","lifeshare-technologies","convertible_note",NA,"2014-06-06",NA
"0a737ba392c28039009ff08a246bbd09","lifespan",NA,NA,NA,NA
"b2ff12c5a13698fd3225a4bb0f2c159c","lifesync-holdings","debt_financing",NA,"2009-08-06",3e+05
"2657dcede1ede16e1d325710f03cbd04","lifetime-health-diary",NA,NA,NA,NA
"5a64d89a160b4f87c9facf76cf3c8b3a","lifetime-oy","grant",NA,"2015-07-02",402731
"5a64d89a160b4f87c9facf76cf3c8b3a","lifetime-oy","seed",NA,"2011-07-01",12309
"5a64d89a160b4f87c9facf76cf3c8b3a","lifetime-oy","seed",NA,"2012-07-31",12289
"fcb0abeb745e7de415da3885aa716fa1","lifewave","venture",NA,"2013-12-31",618178
"031a7b2ff2e5d901119bcaaf44cad3c8","lift-3d",NA,NA,NA,NA
"654ad5480a9c321017b5a82e2b3b4e1b","lift12","seed",NA,"2013-09-01",560000
"a647ed80b8055ebf5f8184fd3343e23b","liftmetrix","seed",NA,"2014-05-30",2e+06
"8f67d796c0ebf4eb4362f1acd85fd703","liftoff-mobile","venture","A","2015-02-03",5e+06
"da8fbe3324972f4b1663c0f2a2d33b48","ligadata",NA,NA,NA,NA
"d90d9ad2e33fcd5f466efb2399962076","ligand-pharmaceuticals","post_ipo_equity",NA,"2014-08-14",2.25e+08
"bfef2ad0c2c60de8e36ad74fae65d6a5","ligandal-technology","convertible_note",NA,"2010-01-14",64000
"73fa162861a878413fa28f0641d2c1cb","light-chaser-animation","venture","B","2014-06-20",2e+07
"8cbfd1a0a3e6e23e7c7af7189a8dd86e","light-sciences-oncology","venture","C","2008-07-17",40100000
"8cbfd1a0a3e6e23e7c7af7189a8dd86e","light-sciences-oncology","venture","A","2005-10-11",3.5e+07
"8cbfd1a0a3e6e23e7c7af7189a8dd86e","light-sciences-oncology","debt_financing",NA,"2011-06-10",6256000
"8cbfd1a0a3e6e23e7c7af7189a8dd86e","light-sciences-oncology","venture",NA,"2012-01-23",1255674
"8cbfd1a0a3e6e23e7c7af7189a8dd86e","light-sciences-oncology","venture",NA,"2009-11-01",3.5e+07
"8cbfd1a0a3e6e23e7c7af7189a8dd86e","light-sciences-oncology","venture","b","2007-07-11",3e+07
"8cbfd1a0a3e6e23e7c7af7189a8dd86e","light-sciences-oncology","venture","A","2005-12-14",3.2e+07
"8cbfd1a0a3e6e23e7c7af7189a8dd86e","light-sciences-oncology","venture",NA,"2013-12-23",350000
"c51151d68146ab8622d7887465a73d9f","lightapp-technologies",NA,NA,NA,NA
"ca6b132bb3d1a01125401dc3667f2ec4","lightspeed-genomics","venture","A","2012-09-19",5082474
"4017b6f4767ebe1d4ffae2debe36188f","lightwave",NA,NA,NA,NA
"24357ef467e870c760e41eeb1c53f4bf","ligo-scientific-collaboration",NA,NA,NA,NA
"10b37c27d4a9e6017fb14b9b67ed1297","ligocyte-pharmaceuticals","debt_financing",NA,"2011-06-21",5500000
"10b37c27d4a9e6017fb14b9b67ed1297","ligocyte-pharmaceuticals","venture","1","2009-08-14",29490335
"10b37c27d4a9e6017fb14b9b67ed1297","ligocyte-pharmaceuticals","debt_financing",NA,"2010-04-22",6572305
"10b37c27d4a9e6017fb14b9b67ed1297","ligocyte-pharmaceuticals","venture",NA,"2012-06-28",2e+06
"4ff0e59c0858063145b1fed3758faa6b","ligon-discovery","seed",NA,"2009-11-19",1e+06
"4ff0e59c0858063145b1fed3758faa6b","ligon-discovery","venture",NA,"2009-05-15",5e+05
"7214baf34b03bfbb1d79162e6c3b907a","liifmed",NA,NA,NA,NA
"c1a6c3e0fefb9d3fde4ad5daf5b7be65","like-a-bird-apps",NA,NA,NA,NA
"25e030da771a995614733da6671129aa","likealyzer",NA,NA,NA,NA
"05ec2e6bb3bbba8acf9fca68f9eff73f","likehack","seed",NA,"2012-09-01",150000
"05ec2e6bb3bbba8acf9fca68f9eff73f","likehack","debt_financing",NA,"2012-12-19",1e+05
"05ec2e6bb3bbba8acf9fca68f9eff73f","likehack","seed",NA,"2012-09-19",45208
"8a4630f10aae4da2d71bfde1127468d9","likely-co","venture",NA,"2012-11-24",1600000
"871e3c93a5cfc267e4bd2c8b1cd95402","lilt","debt_financing",NA,"2015-05-18",650000
"e42adecb5d09ba4322c8c5104e89dcd0","lime-technology",NA,NA,NA,NA
"b69f1d58b311a0241637a3cc7acdae7e","limelight-platforms-inc-","seed",NA,"2016-01-13",3100000
"596e66b5a3b23cf6174caa78db4e0405","limerick-biopharma","venture",NA,"2008-06-11",15200000
"596e66b5a3b23cf6174caa78db4e0405","limerick-biopharma","venture","1","2009-07-15",1.5e+07
"596e66b5a3b23cf6174caa78db4e0405","limerick-biopharma","debt_financing",NA,"2010-11-03",9939415
"596e66b5a3b23cf6174caa78db4e0405","limerick-biopharma","debt_financing",NA,"2012-01-30",480000
"596e66b5a3b23cf6174caa78db4e0405","limerick-biopharma","venture","1","2009-06-13",1500000
"77b6384e3fc5fe94a06af8a3c777d829","limespot-solutions","seed",NA,"2013-08-01",115000
"77b6384e3fc5fe94a06af8a3c777d829","limespot-solutions","convertible_note",NA,"2015-03-05",50000
"77b6384e3fc5fe94a06af8a3c777d829","limespot-solutions","convertible_note",NA,"2015-05-29",50000
"77b6384e3fc5fe94a06af8a3c777d829","limespot-solutions","seed",NA,"2014-01-15",370000
"77b6384e3fc5fe94a06af8a3c777d829","limespot-solutions","seed",NA,"2014-09-15",240000
"93caea8d9d9f3c70b224a10ddc469407","linalis",NA,NA,NA,NA
"ff8f7e39ce6d13c868ecc2a9e982d946","linc-global","venture",NA,"2014-01-01",NA
"ff8f7e39ce6d13c868ecc2a9e982d946","linc-global","venture",NA,"2014-07-01",NA
"800590185ac09db9e17523d5af97fb0e","lince-labs-amniofilm","seed",NA,"2012-08-22",40000
"9c552a698615a7e504431206cd2df67e","lineagen","venture",NA,"2008-12-31",5800000
"9c552a698615a7e504431206cd2df67e","lineagen","venture","1","2011-11-04",1.6e+07
"9c552a698615a7e504431206cd2df67e","lineagen","debt_financing",NA,"2010-06-22",1100000
"9c552a698615a7e504431206cd2df67e","lineagen","debt_financing",NA,"2013-04-25",11594064
"9c552a698615a7e504431206cd2df67e","lineagen","venture","1","2010-08-30",10800000
"9c552a698615a7e504431206cd2df67e","lineagen","venture","1","2013-12-18",3500000
"9c552a698615a7e504431206cd2df67e","lineagen","venture","1","2015-01-26",12170000
"37d94721b8ac2468677f3de420263251","linehire",NA,NA,NA,NA
"039155dce15f2c1586bdd526f8de3767","linguamatics",NA,NA,NA,NA
"9e428a0cdb6e8fac159d97d8ba428fe7","linguanext","venture","a","2014-01-13",NA
"fb65c4c546addd21e886086b3887de64","linkplug-limited-time-free-account",NA,NA,NA,NA
"990ae21a5a545eaa954d0df1a2312a22","linkage-biosciences","venture",NA,"2012-10-01",1545000
"990ae21a5a545eaa954d0df1a2312a22","linkage-biosciences","venture",NA,"2012-01-01",1954000
"990ae21a5a545eaa954d0df1a2312a22","linkage-biosciences","venture",NA,"2009-09-30",2044228
"990ae21a5a545eaa954d0df1a2312a22","linkage-biosciences","seed",NA,"2007-10-16",1e+06
"990ae21a5a545eaa954d0df1a2312a22","linkage-biosciences","venture","1","2011-09-09",2100000
"990ae21a5a545eaa954d0df1a2312a22","linkage-biosciences","venture","1","2009-02-04",2e+06
"990ae21a5a545eaa954d0df1a2312a22","linkage-biosciences","private_equity",NA,"2013-05-08",2e+06
"52d0654db3a3927c240f6480ee377b36","linkedwellness",NA,NA,NA,NA
"aa6dae7f82e2c4872aeb36b354a83696","linkexchange",NA,NA,NA,NA
"db9e92815e9ff754d4be8ab7c85847b3","linkfire","angel",NA,"2014-04-01",119926
"db9e92815e9ff754d4be8ab7c85847b3","linkfire","seed",NA,"2015-09-16",2596962
"a25d6967b8e6b6ed926f21091298aa7d","linkfluence","venture","b","2014-03-07",4200000
"a25d6967b8e6b6ed926f21091298aa7d","linkfluence","venture","b","2013-09-12",4500000
"a25d6967b8e6b6ed926f21091298aa7d","linkfluence","venture","a","2010-12-25",2500000
"c125610b58377c45821d14f849f3345f","linknexus",NA,NA,NA,NA
"71e678bf166d7f2cdec4765b92612a33","linkredirector",NA,NA,NA,NA
"ac0e90102e9cd378db4c5415642e13fc","linkrisk",NA,NA,NA,NA
"3b9efc1dd3347e5d50d6e7eacc3f0678","lintao-sa",NA,NA,NA,NA
"33325dbce341ebdb415d0f81e6cd8fd5","lion-bioscience-ag",NA,NA,NA,NA
"36e664872f226ed8e1c586127f99fa8f","lion-biotechnologies","post_ipo_equity",NA,"2013-10-31",2.3e+07
"c06d0ef42adf65ed28cdcd419a530ffb","lionizer365",NA,NA,NA,NA
"3f600301dbf80b17c091abfd9abfea6e","lionsharp-solutions","seed",NA,"2013-08-01",33149
"3f600301dbf80b17c091abfd9abfea6e","lionsharp-solutions","seed",NA,"2013-04-01",32059
"3f600301dbf80b17c091abfd9abfea6e","lionsharp-solutions","seed",NA,"2013-12-01",452000
"05d9771f7234ce3c321e1d9d12d5cbc0","lipella-pharmaceuticals","venture",NA,"2011-01-28",251424
"05d9771f7234ce3c321e1d9d12d5cbc0","lipella-pharmaceuticals","venture",NA,"2008-04-24",240000
"05d9771f7234ce3c321e1d9d12d5cbc0","lipella-pharmaceuticals","venture",NA,"2006-12-05",120000
"19a57c1f9ee1bbea5d2e27a54693f2b2","lipidviro-tech",NA,NA,NA,NA
"a2d55716d391781ffc8148dad6c7f6f7","liplasome-pharma","venture","b","2005-03-01",8010000
"582b664af266ac3ee58a0199d27f5788","lipocalyx","seed",NA,"2011-09-22",NA
"610535d5121dff6da292992b11a7fdf9","lipocine",NA,NA,NA,NA
"71d55dd79d96d352f860f2940e0ddb10","lipomics-technologies",NA,NA,NA,NA
"ebb4f3373bab8a111cef372b0854713b","lipopharma",NA,NA,NA,NA
"1c7610b2314f2382702399c0a4e3bf50","liposonix","venture","C","2004-07-11",2.7e+07
"1c7610b2314f2382702399c0a4e3bf50","liposonix","venture","B","2002-10-11",9935003
"1c7610b2314f2382702399c0a4e3bf50","liposonix","venture","B","2004-04-09",1e+06
"b4e7c6e5aef5d491b2554e6a1a41f3dc","lipper-thomson-reuters",NA,NA,NA,NA
"cac6361ae1dbfbc7118b48534b0169ba","liquatex",NA,NA,NA,NA
"2c346c9ccbe42bd4e42dcbce48eac831","liquid","seed",NA,"2014-04-30",1e+06
"69a26f36f8b29def7b5062e08482cd5b","liquid-biotech","seed",NA,"2015-12-02",2e+06
"caa7337e5c58e7d2ba96c39c6e3f7c55","liquid-bronze","private_equity",NA,"2013-06-11",NA
"c35e3749dc2635e5872fe4a65e5305d9","liquid-labs",NA,NA,NA,NA
"61a71aa58622743a554168516ee1d7cc","liquid-newsroom",NA,NA,NA,NA
"c65d8883d898844f01d1fe3dd11a110c","listenfirst-media",NA,NA,NA,NA
"70af6d2f4f23c94a04f748857284ed95","listenlogic",NA,NA,NA,NA
"aa52c386b885ae76446bbda958080ae7","listenloop","angel",NA,"2014-11-13",1985000
"86d20266ff83c0c3e7c89a7375657d4e","litebi","angel",NA,"2009-10-20",748550
"5c3ffac6358cfd7cd163ef2d8ab3ec8a","litesprite","debt_financing",NA,"2014-07-28",1e+05
"daf4fc8cb1b5ecbb1689f631f242b185","lithera","venture","c","2014-02-12",8e+06
"daf4fc8cb1b5ecbb1689f631f242b185","lithera","venture","c","2012-12-19",20600000
"daf4fc8cb1b5ecbb1689f631f242b185","lithera","venture","c","2013-07-18",6700000
"0159b37d98036b97bcd7141822d0916c","lithient",NA,NA,NA,NA
"3f1b15e85fd9488ecba083972c56682a","liveaction","venture","A","2014-09-04",5350000
"3f1b15e85fd9488ecba083972c56682a","liveaction","seed",NA,"2013-06-01",5e+05
"309f07b1770bb03173f059d696c1f757","liveassay",NA,NA,NA,NA
"ad929740c849d09916cafd67f77e122d","capturetocloud","venture",NA,"2012-07-11",4700000
"fad827cd0f089209e75f80de8b1565d1","liveleaf","venture",NA,"2013-09-10",3850000
"fad827cd0f089209e75f80de8b1565d1","liveleaf","debt_financing",NA,"2015-05-15",2250000
"30074da16f78e4409f2549ef483d7999","liventa-bioscience","venture",NA,"2012-12-10",1e+06
"30074da16f78e4409f2549ef483d7999","liventa-bioscience","venture",NA,"2011-09-28",250000
"30074da16f78e4409f2549ef483d7999","liventa-bioscience","venture",NA,"2013-02-07",1233332
"30074da16f78e4409f2549ef483d7999","liventa-bioscience","venture",NA,"2014-10-03",150000
"43b05caf29eab42bb7c737bae096ca5b","liveramp","undisclosed",NA,"2011-09-06",1e+06
"43b05caf29eab42bb7c737bae096ca5b","liveramp","undisclosed",NA,"2007-06-01",NA
"43b05caf29eab42bb7c737bae096ca5b","liveramp","venture","1","2010-10-25",1.5e+07
"43b05caf29eab42bb7c737bae096ca5b","liveramp","venture","1","2013-04-01",NA
"769ec0ab977c88e8a3c8d16825343f76","liverpool-chirochem-limited","equity_crowdfunding",NA,"2015-08-09",883132.1754
"b26e4be4ad9abe97df394cbb688cdf0d","livestories","seed",NA,"2014-11-14",1110000
"b26e4be4ad9abe97df394cbb688cdf0d","livestories","seed",NA,"2015-04-21",1e+06
"88bd2e6e15d6d63a501271bbfb5665cc","livetechnology-holdings--inc-","venture","A","2002-05-14",12500000
"f806627cf2e817fcb0479ca1010f6766","living-cell-technologies","venture",NA,"2011-01-11",637630
"f806627cf2e817fcb0479ca1010f6766","living-cell-technologies","venture",NA,"2011-01-18",5640573
"32d136f4c7b8cef8a4d352b72b0e4848","living-proof","venture","c","2013-02-21",3e+07
"32d136f4c7b8cef8a4d352b72b0e4848","living-proof","venture","a","2008-08-25",7e+06
"32d136f4c7b8cef8a4d352b72b0e4848","living-proof","venture","b","2011-03-14",1.6e+07
"da9b9dcd46122b4b2bc24c296f64db2f","livingwell-health","venture",NA,"2010-04-03",3e+06
"e5f7e08a30d08c8babced45a0d91d28a","lixte-biotechnology-holdings","venture",NA,"2010-01-27",1787500
"eca5c396e0bc6b0faa9b229cf177287b","ljl-biosystems",NA,NA,NA,NA
"93285cb07fd2ef3098bfcd9398f32128","lmi-vet","equity_crowdfunding",NA,"2014-11-07",NA
"c883635a2f4037501ec4b1099db96741","loadcost",NA,NA,NA,NA
"05282e41eb9975ce5584c143faf7c5f5","loc-enterprises","venture","a","2013-10-31",7e+05
"05282e41eb9975ce5584c143faf7c5f5","loc-enterprises","seed",NA,"2013-05-31",1835300
"5812ad6b74e7488b4750f860730b0105","loc8te",NA,NA,NA,NA
"ade9a2d5ed84c36d4682dd124075e051","localbase","seed",NA,"2010-11-01",250000
"ade9a2d5ed84c36d4682dd124075e051","localbase","seed",NA,"2009-07-01",750000
"23f399542e8439d3e35c739dc7d6ac74","localsense","debt_financing",NA,"2012-04-02",1e+05
"45f02a478d40a69386dc118033c825f9","localsocial",NA,NA,NA,NA
"269ebc3250a787c9d1a8431103dd1e44","locarise",NA,NA,NA,NA
"bb96b1cd5751ee5b3761817aa3031a4b","locatee",NA,NA,NA,NA
"a2fca7524dfc4fb921f10c6cc6abfc99","cadio","grant",NA,"2010-08-01",180000
"a2fca7524dfc4fb921f10c6cc6abfc99","cadio","grant",NA,"2011-08-30",498000
"a2fca7524dfc4fb921f10c6cc6abfc99","cadio","grant",NA,"2010-10-21",1e+05
"a2fca7524dfc4fb921f10c6cc6abfc99","cadio","grant",NA,"2012-07-07",1e+05
"a2fca7524dfc4fb921f10c6cc6abfc99","cadio","angel",NA,"2010-08-31",3e+05
"0989538a382162b88f4a6a2d6f9e52c2","location3-media",NA,NA,NA,NA
"da31c631b0227a7a6fe470e34893a4f6","locationary","venture",NA,"2011-07-28",2500000
"50bdd45d68ee0542661161431150575f","locobuzz",NA,NA,NA,NA
"b1f34744a6d452c8281848b18e8cb1b2","locomatix",NA,NA,NA,NA
"76b04f1b04abf820ab2872b24eb65553","locomizer","seed",NA,"2013-07-22",75762
"76b04f1b04abf820ab2872b24eb65553","locomizer","seed",NA,"2013-01-01",162107
"76b04f1b04abf820ab2872b24eb65553","locomizer","convertible_note",NA,"2014-09-17",162475
"0d8069a7e3f525ea948d22c347dff1a3","locomotus",NA,NA,NA,NA
"72866727a91d42485f593c31dafe4c8a","locus-labs","angel",NA,"2011-07-10",3e+05
"b3dbc8f157c24a5bd2c2a3a1a3204cc8","locus-pharmaceuticals","venture","E","2006-11-13",2.5e+07
"b3dbc8f157c24a5bd2c2a3a1a3204cc8","locus-pharmaceuticals","venture","E","2007-02-14",30200000
"b3dbc8f157c24a5bd2c2a3a1a3204cc8","locus-pharmaceuticals","debt_financing",NA,"2010-07-08",1683875
"3282099228989d8073540bdd5ad34b36","locust-walk-partners",NA,NA,NA,NA
"ff46f2b95e96b11a3755471a936b073b","lodo-therapeutics","venture","A","2016-01-11",1.7e+07
"663f948f3ab7237238d07a26c65450e2","loex",NA,NA,NA,NA
"7e287cabc460d950299a979bf72844fe","logandroll",NA,NA,NA,NA
"13b51ca71759bba03b397998846628f8","logbase-inc",NA,NA,NA,NA
"33d7d9fd9cf1b850f90ac98d156e118a","logdog","venture",NA,"2014-11-14",NA
"33d7d9fd9cf1b850f90ac98d156e118a","logdog","venture","1","2015-07-16",3500000
"2714c63f12841b570419443bc05fa48d","logdrill-ltd",NA,NA,NA,NA
"a3250a5884a7b133d0fe39f2bff529b8","logentries","seed",NA,"2012-07-17",1100000
"a3250a5884a7b133d0fe39f2bff529b8","logentries","venture","1","2013-09-30",1e+07
"a3250a5884a7b133d0fe39f2bff529b8","logentries","seed",NA,"2010-02-01",NA
"9d05ca0c2974667a807ce0a3ebb1915f","logfuze","seed",NA,"2015-02-18",2e+05
"b945f1b5d0ef15c966551548268630dc","loggr",NA,NA,NA,NA
"93913aca20e098364b7e0427bbc70526","logi-analytics","venture",NA,"2008-10-01",3e+06
"93913aca20e098364b7e0427bbc70526","logi-analytics","private_equity",NA,"2011-11-29",1e+07
"93913aca20e098364b7e0427bbc70526","logi-analytics","private_equity",NA,"2013-10-15",27500000
"93913aca20e098364b7e0427bbc70526","logi-analytics","venture",NA,"2007-12-10",5e+06
"93913aca20e098364b7e0427bbc70526","logi-analytics","venture",NA,"2010-10-27",2499999
"de0a09baf759d4a37f4b8d2db3e68ba9","logic-technology",NA,NA,NA,NA
"659569e0253e8708db151a8a6b2cf2fa","logical-therapeutics","venture","B","2007-06-13",3e+07
"659569e0253e8708db151a8a6b2cf2fa","logical-therapeutics","venture","c","2010-05-27",16900000
"659569e0253e8708db151a8a6b2cf2fa","logical-therapeutics","venture",NA,"2009-08-04",32537580
"6213ca7b97c06a6e6d0c3298fcde6bb8","logicbio-therapeutics","venture",NA,"2016-01-20",3999911
"f3c012f8e467ea5322c90d33086689a9","logicmantra-solutions",NA,NA,NA,NA
"37eed5a73e054ecb5438a93aeda74c88","logicpond",NA,NA,NA,NA
"f4564981ce6d3e7d9af82f17f04f8bdf","loginext-solutions","seed",NA,"2015-04-07",6e+05
"f4564981ce6d3e7d9af82f17f04f8bdf","loginext-solutions","venture","1","2015-09-22",1e+07
"b71798b680e4fa1a2b716f3fa0766e1b","logz-io","venture","A","2015-10-05",8e+06
"b71798b680e4fa1a2b716f3fa0766e1b","logz-io","venture",NA,"2015-02-17",1200000
"562d56275b32d10705540b76e8a48534","lokad",NA,NA,NA,NA
"b4b6babd545bd00bcd848007241a6907","lokango",NA,NA,NA,NA
"ee4de52c6ffa56d4036f50f1b1072957","lolabox","seed",NA,"2013-04-01",NA
"8d2a7f7f8e3497efb5f3b1a6f56d4ac3","london-speech-therapy",NA,NA,NA,NA
"dece1738f1973dcc7d5ff754f55127e7","lonestar-heart","venture","b","2012-10-10",2e+07
"dece1738f1973dcc7d5ff754f55127e7","lonestar-heart","venture","a","2010-06-16",10150000
"dece1738f1973dcc7d5ff754f55127e7","lonestar-heart","venture","c","2013-11-18",2396585
"dece1738f1973dcc7d5ff754f55127e7","lonestar-heart","venture",NA,"2009-07-22",13571573
"dece1738f1973dcc7d5ff754f55127e7","lonestar-heart","debt_financing",NA,"2014-09-04",1000100
"623d7b2bd1b3a106ac8bfce7a2f0d288","longenex",NA,NA,NA,NA
"164eb0d9326e8de5fe664ab813f2af19","longevity-biotech","grant",NA,"2012-04-26",350000
"164eb0d9326e8de5fe664ab813f2af19","longevity-biotech","debt_financing",NA,"2011-04-12",170000
"5c4b0b0b2aa2b49cfa9c965fef994ff1","longs-peak-analytics",NA,NA,NA,NA
"f00a9caa0a58d217d438ec67de8158b9","longview-solutions",NA,NA,NA,NA
"ffb823d63722f9b8d9b26e72aae880ee","lonza-bioscience",NA,NA,NA,NA
"dbc84d2ae44a6a4ffc1343db24381936","lonza-group",NA,NA,NA,NA
"a7a8e371d9317735b247d8ac3b5eb4b0","lookbookspro",NA,NA,NA,NA
"467b150e87cefb2ce663b3da7db5c197","lookeen",NA,NA,NA,NA
"d684f10be13f9d40f995aca4520c247b","looker","venture","C","2016-01-14",4.8e+07
"d684f10be13f9d40f995aca4520c247b","looker","seed",NA,"2013-03-06",2e+06
"d684f10be13f9d40f995aca4520c247b","looker","venture","a","2013-08-13",1.6e+07
"d684f10be13f9d40f995aca4520c247b","looker","venture","B","2015-03-11",3e+07
"f745e5579ac163fb822f424ea895658d","looktracker","seed",NA,"2013-07-15",50000
"89f534fbb6b0edfae9963fe7d656784b","loom-systems",NA,NA,NA,NA
"53533c399c716ef7920c06a33d70333f","loop-ai-labs",NA,NA,NA,NA
"d83a6a33e452e59e1c5410780c6a7ed4","loopback","seed",NA,"2013-06-11",6e+05
"edb4b1d539d032bda1a5c76edc8f3234","loopd-via","seed",NA,"2014-10-13",1e+06
"edb4b1d539d032bda1a5c76edc8f3234","loopd-via","seed",NA,"2015-06-22",1500000
"44aadedd1607de751bca5caa5cd21f92","loopme","seed",NA,"2013-01-16",5e+05
"44aadedd1607de751bca5caa5cd21f92","loopme","venture","1","2015-12-16",7e+06
"193f1e31cf3a0ea29fa066ed68ec8af1","lophius-biosciences","venture",NA,"2011-07-19",1982400
"193f1e31cf3a0ea29fa066ed68ec8af1","lophius-biosciences","venture","1","2010-05-17",1970000
"193f1e31cf3a0ea29fa066ed68ec8af1","lophius-biosciences","venture",NA,"2014-05-08",2778639
"193f1e31cf3a0ea29fa066ed68ec8af1","lophius-biosciences","seed",NA,"2008-10-02",6e+05
"e459a4fcdd7d6d146fcced6b4ed22c28","lorus-therapeutics","post_ipo_equity",NA,"2014-04-24",28250000
"e9b1f549be3034ad9f9551c986926043","los-angeles-web-scraping",NA,NA,NA,NA
"f712a89bc4dca8d02b9dde8caeec66a5","shinestar-web-solutions",NA,NA,NA,NA
"b1fd92cfbad36c987919573870315034","lotus-tissue-repair","venture","a","2011-06-30",2.6e+07
"c31b51b848ec924860bd81e8283447c5","loudcloud-systems","venture",NA,"2010-02-18",5e+06
"c31b51b848ec924860bd81e8283447c5","loudcloud-systems","private_equity",NA,"2012-06-27",9999990
"f217c098c0ce90ce41bc01e875b8d3a3","loxo-oncology","venture","a","2013-10-03",3.3e+07
"f217c098c0ce90ce41bc01e875b8d3a3","loxo-oncology","venture","B","2014-05-06",2.4e+07
"32cf89a6c00792e93ab1c16bc94507b5","loyalis","angel",NA,"2014-06-23",NA
"32cf89a6c00792e93ab1c16bc94507b5","loyalis","seed",NA,"2015-03-20",NA
"3010badb6a6e72459122e8f1a0d451a2","loyalty-refunds",NA,NA,NA,NA
"ba1e4b6b576dbfbcb8e4e16bc30689f9","loyaltylion","seed",NA,"2012-09-03",18852
"ba1e4b6b576dbfbcb8e4e16bc30689f9","loyaltylion","seed",NA,"2014-04-23",370000
"90678967c164198970ac09f75df30a66","loyl-me",NA,NA,NA,NA
"0d0206305c83f28a73efd8cb32ec8625","loylap","seed",NA,"2013-09-01",NA
"e3ee62211ffda9fad6af17adf043fece","lpath","venture",NA,"2010-12-01",4884700
"e3ee62211ffda9fad6af17adf043fece","lpath","post_ipo_equity",NA,"2014-09-19",12500000
"e3ee62211ffda9fad6af17adf043fece","lpath","venture",NA,"2014-10-07",12527521
"25a5e03c5d6c4392587838820a762292","lq3-pharmaceuticals","venture","A","2014-09-10",1e+07
"4120252b380bacf71481987098a526be","ls-plasma","equity_crowdfunding",NA,"2014-12-30",5000
"97912d91703f80a334a2de0d62ab7546","ls9","venture","c","2009-10-29",2.5e+07
"97912d91703f80a334a2de0d62ab7546","ls9","venture","a","2007-03-01",5e+06
"97912d91703f80a334a2de0d62ab7546","ls9","venture","b","2007-10-09",1.5e+07
"97912d91703f80a334a2de0d62ab7546","ls9","venture","d","2010-12-20",3e+07
"1592f8cd504ac16b64b3ec540a340332","ltu-technologies",NA,NA,NA,NA
"7489b2eb085844149f346d2a674168d2","lubb-tex","venture",NA,"2010-08-31",4100000
"74e3d017eb9af7747a4ed8b0c601a08c","lubio-science",NA,NA,NA,NA
"87e8d667b4b11788c43b1e24b201ca9c","luca-technologies","venture","b","2007-10-10",2e+07
"87e8d667b4b11788c43b1e24b201ca9c","luca-technologies","venture","c","2008-12-23",75900000
"87e8d667b4b11788c43b1e24b201ca9c","luca-technologies","venture",NA,"2006-09-22",3e+06
"496d7b7ce70ed681e714926f37fce2d7","federated-sample","venture","a","2011-11-08",2800000
"496d7b7ce70ed681e714926f37fce2d7","federated-sample","venture",NA,"2015-02-19",399451
"67650169b68077bf7f9784b1a48c93b8","lucid-technologies-and-solutions",NA,NA,NA,NA
"4f17359b313046e9c5032443c67af049","lucidel",NA,NA,NA,NA
"470b236f20929715e51782c4f2574547","lucidera","venture","B","2007-08-01",15600000
"67d5da33283529111fcdc16cb17f549c","lucidiate-limited",NA,NA,NA,NA
"2e0b6c08ba919a7b4410b0b5c6248a0e","lucidius-group",NA,NA,NA,NA
"a36e9aa1660970176e599e73437d27e0","lucidworks","private_equity",NA,"2012-02-03",5999999
"a36e9aa1660970176e599e73437d27e0","lucidworks","venture","1","2010-03-10",1e+07
"a36e9aa1660970176e599e73437d27e0","lucidworks","venture","1","2009-01-27",6e+06
"a36e9aa1660970176e599e73437d27e0","lucidworks","venture","1","2009-06-18",NA
"a36e9aa1660970176e599e73437d27e0","lucidworks","venture","1","2013-05-13",1e+07
"a36e9aa1660970176e599e73437d27e0","lucidworks","venture","1","2015-11-18",2.1e+07
"1d072663394eab7ff360970f5f69ffd4","lucigen","venture","A","2015-01-13",1950000
"54ec31c95ea03cc9349f4eb6a4b9f346","lucky-orange",NA,NA,NA,NA
"eb2d9f16b2a1f1622f23143a9e8e4e21","lucky-oyster","debt_financing",NA,"2013-12-03",867949
"eb2d9f16b2a1f1622f23143a9e8e4e21","lucky-oyster","angel",NA,"2012-10-18",575000
"eb2d9f16b2a1f1622f23143a9e8e4e21","lucky-oyster","debt_financing",NA,"2015-03-23",150000
"696c48afc5339a607806446c57408d5e","lucky-sort","seed",NA,"2012-04-01",5e+05
"deedf296ad95b3efa50fadd2b5f3f29b","ludesi","undisclosed",NA,"2006-09-20",3438286
"4495152711b98f47f7572966672e103a","lugiron-software","seed",NA,"2009-04-01",NA
"cf5514b9f5032b4476161fe4c850dbe7","luigi-s-box",NA,NA,NA,NA
"4797906c141ddc2e63505f1ee0302929","lumacyte","venture",NA,"2014-05-13",30080
"4797906c141ddc2e63505f1ee0302929","lumacyte","seed",NA,"2014-06-04",512080
"4797906c141ddc2e63505f1ee0302929","lumacyte","equity_crowdfunding",NA,"2014-03-29",822480
"a8028c65e2478d34b67e91f4cce66343","kv-pharmaceutical","venture",NA,"2010-12-06",7552506
"a8028c65e2478d34b67e91f4cce66343","kv-pharmaceutical","debt_financing",NA,"2011-04-01",2.25e+08
"a8028c65e2478d34b67e91f4cce66343","kv-pharmaceutical","private_equity",NA,"2011-03-04",32337500
"a8028c65e2478d34b67e91f4cce66343","kv-pharmaceutical","seed",NA,"2012-06-18",210000
"2d9ed1bb06f9a59036580459a8cf1609","lumavita","venture","A","2008-09-04",16216216.2162
"2d9ed1bb06f9a59036580459a8cf1609","lumavita","venture","a","2009-06-24",5500000
"28ec3d35a724548a9f75ba9c22e2bf96","lumen-biomedical","venture",NA,"2009-10-10",675000
"09ec29c0d3d7991e0d4da3d8158e69e7","lumena-pharmaceuticals","debt_financing",NA,"2012-05-24",2550150
"09ec29c0d3d7991e0d4da3d8158e69e7","lumena-pharmaceuticals","venture","1","2014-03-11",4.5e+07
"09ec29c0d3d7991e0d4da3d8158e69e7","lumena-pharmaceuticals","venture","1","2013-05-08",2.3e+07
"b00481b6b27739ef60bac4aa3ee1406f","lumendata",NA,NA,NA,NA
"dce34a389a7e4726e9062c9612c905e5","lumenis","private_equity",NA,"2006-09-01",1.2e+08
"4775acbb63e57730c89e1d383badbe8f","lumenogix",NA,NA,NA,NA
"69a096bc652f287f29b480994309386e","lumense","venture","b","2013-11-14",2650000
"69a096bc652f287f29b480994309386e","lumense","seed",NA,"2012-05-15",1e+06
"e228147c37028359e71e7f6420c958bf","lumesis","venture","a","2012-02-22",2500000
"e228147c37028359e71e7f6420c958bf","lumesis","seed",NA,"2013-04-01",1981872
"e228147c37028359e71e7f6420c958bf","lumesis","venture",NA,"2014-06-04",1999999
"e228147c37028359e71e7f6420c958bf","lumesis","venture","B","2014-06-06",2e+06
"1eaf78039ef9d8b039953976fe45fdfe","lumi","product_crowdfunding",NA,"2012-07-29",268000
"1eaf78039ef9d8b039953976fe45fdfe","lumi","seed",NA,"2014-12-01",120000
"653f853581b06c4a54acae92d15331bf","shanghai-lumi-information-technology-limited-company","venture","A","2012-11-01",NA
"653f853581b06c4a54acae92d15331bf","shanghai-lumi-information-technology-limited-company","undisclosed",NA,"2010-04-01",6e+06
"0d0261ba961a343296a2f2eabad13b5a","lumiary","angel",NA,"2014-02-01",1e+05
"0d0261ba961a343296a2f2eabad13b5a","lumiary","convertible_note",NA,"2014-11-25",5e+05
"50d2a50cf1f06bfdd1dc630ab1ff8e3b","lumiata","venture","a","2014-01-08",4e+06
"50d2a50cf1f06bfdd1dc630ab1ff8e3b","lumiata","venture","A","2014-09-11",6e+06
"80c324e79a1d9f7fee27405ac9d989c5","lumidatum",NA,NA,NA,NA
"37e6768ac2a1d70aee5b8feca24602cf","lumific","seed",NA,"2014-01-30",1e+05
"37e6768ac2a1d70aee5b8feca24602cf","lumific","seed",NA,"2014-07-01",2e+05
"37e6768ac2a1d70aee5b8feca24602cf","lumific","undisclosed",NA,"2014-03-24",50000
"921519781ff6f786fa8ba1473d25f06a","lumina-decisiion-systems",NA,NA,NA,NA
"5a3cc1c4a35c6710975c739562486a50","luminacare-solutions","seed",NA,"2013-01-01",75000
"49211c4e936a89157a0d2c830606c8e7","luminate-io",NA,NA,NA,NA
"be6f191807e15db102d68ec4656f54fa","luminessence-inc",NA,NA,NA,NA
"dae9dcbbb5a18adf8ae656e18a4bdcbd","luminex",NA,NA,NA,NA
"8ab6f9908b6cd1cdf0b01f56a0d44e42","luminous-medical","debt_financing",NA,"2010-09-03",500001
"8ab6f9908b6cd1cdf0b01f56a0d44e42","luminous-medical","venture",NA,"2010-10-21",3938310
"e2cdc410b08e9ee5ea2f4efde5a18d43","lumity-inc","venture","A","2015-09-15",1.4e+07
"94c629901ffc3946c0dacccbb333c048","lumolink",NA,NA,NA,NA
"09395f280031a29f6f9f755d39ee2fb9","lumora","venture",NA,"2007-01-11",NA
"09395f280031a29f6f9f755d39ee2fb9","lumora","venture","1","2011-05-26",2446977
"d14cfc0b5bc90e4d341bbfbdecc47219","lumos-pharma","venture","a","2014-02-04",1.4e+07
"d14cfc0b5bc90e4d341bbfbdecc47219","lumos-pharma","grant",NA,"2015-05-05",5500000
"22f0c97e3878a9e7e31b82e9e9e55c91","luna-innovations","venture",NA,"2010-01-21",7115002
"22f0c97e3878a9e7e31b82e9e9e55c91","luna-innovations","venture",NA,"2014-04-24",6e+06
"43f045c9a6a5e5c9d867734ce13c2542","lundbeckfond-ventures",NA,NA,NA,NA
"3f2f5d6a1dfdcba480268571f62062dc","cldi-inc","venture",NA,"2015-11-03",2e+06
"3f2f5d6a1dfdcba480268571f62062dc","cldi-inc","angel",NA,"2014-06-09",98109.1104
"0f240adf0846f1add0dc7c2d1e1173bd","lupin",NA,NA,NA,NA
"f57f2b4b283d40e659cfbad6492a2f12","lutheran-life-communities",NA,NA,NA,NA
"1aae6c30e2fafe468e42c537659dda50","lux-bio-group","venture",NA,"2011-12-09",805000
"1aae6c30e2fafe468e42c537659dda50","lux-bio-group","venture",NA,"2014-02-12",675000
"e3e1009fa0420fa41bb8f5d6fec072c7","lux-biosciences","venture","b","2009-10-01",5e+07
"e3e1009fa0420fa41bb8f5d6fec072c7","lux-biosciences","debt_financing",NA,"2011-07-14",6e+06
"e3e1009fa0420fa41bb8f5d6fec072c7","lux-biosciences","debt_financing",NA,"2009-06-15",9200000
"e3e1009fa0420fa41bb8f5d6fec072c7","lux-biosciences","debt_financing",NA,"2010-12-20",5e+06
"e3e1009fa0420fa41bb8f5d6fec072c7","lux-biosciences","debt_financing",NA,"2012-03-06",1.6e+07
"e3e1009fa0420fa41bb8f5d6fec072c7","lux-biosciences","debt_financing",NA,"2011-12-12",4e+06
"bbaf5e6fceef3fff20389df5b30ff8f9","luye-pharma",NA,NA,NA,NA
"bd681c15a2ff838ff6eee8a02ce099d1","lvl-analytics",NA,NA,NA,NA
"9be468e67ee9be7629a6764758bf0fac","lxr",NA,NA,NA,NA
"351a061b4402546df6bc2c02505436ef","lycera","debt_financing",NA,"2014-04-07",4e+06
"351a061b4402546df6bc2c02505436ef","lycera","venture","1","2009-05-05",3.6e+07
"351a061b4402546df6bc2c02505436ef","lycera","debt_financing",NA,"2013-10-21",5e+06
"351a061b4402546df6bc2c02505436ef","lycera","venture","1","2015-06-22",29892748
"359a2ad0adf9deb24e2a4a3c0ee1c85c","lygos",NA,NA,NA,NA
"eebd3b67978b430479034d3da561d448","lyks","seed",NA,"2013-10-22",NA
"a5485739ce12a3fbf9ee7bdbce4c507e","lymbix","venture",NA,"2011-04-05",1398369
"a5485739ce12a3fbf9ee7bdbce4c507e","lymbix","angel",NA,"2011-03-01",1443541
"a5485739ce12a3fbf9ee7bdbce4c507e","lymbix","seed",NA,"2010-02-11",236484
"a5485739ce12a3fbf9ee7bdbce4c507e","lymbix","seed",NA,"2010-07-01",469673
"932da0e4eb08e2e778bbc7cdea1ffe23","lynaslogic",NA,NA,NA,NA
"c7818850bd3150cfde85e0d29b43a21b","lyncean-technologies","venture",NA,"2015-11-23",3165749
"c7818850bd3150cfde85e0d29b43a21b","lyncean-technologies","debt_financing",NA,"2012-01-06",170000
"c7818850bd3150cfde85e0d29b43a21b","lyncean-technologies","debt_financing",NA,"2013-03-29",1e+06
"c7818850bd3150cfde85e0d29b43a21b","lyncean-technologies","venture",NA,"2011-05-11",1020000
"bfcd2fd7e5487b538ec8cc08355bbe81","lynx-therapeutics-inc",NA,NA,NA,NA
"4af6e9231ed48748bca272b9e900d4c0","lypro-biosciences","venture",NA,"2010-09-06",177950
"65618799dc68c4d8cb3540ae31e7b691","lyra-research",NA,NA,NA,NA
"2cb8ab6c251e8c4b25af0535ab6713a6","lysogene","venture","A","2014-05-21",2.2e+07
"30014bb91330de57c12fff6f31903892","lysosomal-therapeutics","seed",NA,"2014-05-12",4800000
"30014bb91330de57c12fff6f31903892","lysosomal-therapeutics","venture","1","2015-02-03",2e+07
"080459f052e34a57ddde0e90494a2b83","lytics","seed",NA,"2012-10-08",NA
"080459f052e34a57ddde0e90494a2b83","lytics","seed",NA,"2013-08-09",2200000
"080459f052e34a57ddde0e90494a2b83","lytics","debt_financing",NA,"2013-07-19",1e+05
"080459f052e34a57ddde0e90494a2b83","lytics","venture","1","2014-10-22",7e+06
"2781a4c9c63c1dcb1b7c1f95dbc90386","lytix-biopharma","venture",NA,"2009-01-19",10400000
"e136187f3eb9a1e60daa63f26a76a83b","lyxia-corporation","seed",NA,"2013-06-30",1600000
"e136187f3eb9a1e60daa63f26a76a83b","lyxia-corporation","venture","1","2014-09-01",17100000
"5da0324b44bd73a43017e81e0eb9bce6","lyxia",NA,NA,NA,NA
"699ee3967f8e9c981ab1f6d2716c832e","m-paani",NA,NA,NA,NA
"95186fde57bec44d2b80519f2423d0f0","m2-scientifics",NA,NA,NA,NA
"d681c1133edd530ef29262f43e88a7eb","m2g","venture",NA,"2011-02-22",1331000
"972a59175e213e2ada58cbe37ef6a141","m2mloger",NA,NA,NA,NA
"d36d798188f918064b937662c6ccc51a","m2p-labs","undisclosed",NA,"2011-05-30",NA
"d36d798188f918064b937662c6ccc51a","m2p-labs","venture",NA,"2006-07-04",768000
"d36d798188f918064b937662c6ccc51a","m2p-labs","undisclosed",NA,"2013-11-07",NA
"5faae740f95093e436d39391381e0bed","m2s",NA,NA,NA,NA
"ed21b556274e6be8c524537daacc37c1","m3-accounting-analytics",NA,NA,NA,NA
"74f18c3b33fd5f08ed1851e123910099","m3-biotechnology","venture",NA,"2015-11-20",3500000
"2a45685691e2f765355d4ee49a0b89df","m4jam","undisclosed",NA,"2015-02-20",NA
"394867a13a047249b80f081b9407ddc8","m5-network-security",NA,NA,NA,NA
"953b7781d2394e12e1d1ca9b4edd97cd","m7-database-services",NA,NA,NA,NA
"8205916d192696f23069bd51de95f824","maalka",NA,NA,NA,NA
"3bc74126175349c750a85cfd810339be","maana","angel",NA,"2013-02-10",585000
"3bc74126175349c750a85cfd810339be","maana","seed",NA,"2013-07-17",2610000
"3bc74126175349c750a85cfd810339be","maana","venture","1","2015-05-21",14200000
"2a56877d42e3b49b822a1d7259949834","maaxmarket",NA,NA,NA,NA
"d10b39516abf37fda1bb34a2e6f2d52e","mabaya","seed",NA,"2015-12-15",2250000
"d10b39516abf37fda1bb34a2e6f2d52e","mabaya","seed",NA,"2014-01-01",1200000
"beaaf6a137d1f147744ab164d6adb8b1","mabb",NA,NA,NA,NA
"fcd748eaa83b3aafd98b5df233a25d6a","mablyte","undisclosed",NA,"2013-04-30",232239
"9344ca92d2b57363e17fa144e9d81f5d","mabspace-biosciences-co","venture","A","2015-10-29",1.5e+07
"4cf61330a1659808025321e56a0b3b2e","mabvax-therapeutics","venture",NA,"2014-02-25",12050998
"4cf61330a1659808025321e56a0b3b2e","mabvax-therapeutics","venture","1","2012-11-20",5250000
"4cf61330a1659808025321e56a0b3b2e","mabvax-therapeutics","venture",NA,"2009-09-02",500010
"4cf61330a1659808025321e56a0b3b2e","mabvax-therapeutics","grant",NA,"2013-09-25",1750000
"4cf61330a1659808025321e56a0b3b2e","mabvax-therapeutics","private_equity",NA,"2014-07-09",3e+06
"4cf61330a1659808025321e56a0b3b2e","mabvax-therapeutics","post_ipo_equity",NA,"2015-04-06",11600000
"80ab4600497cc80518a589ac360e57fd","macellum","seed",NA,"2015-05-16",17136
"2417260d5a852d43c104dd36d1858c1a","mach-one",NA,NA,NA,NA
"3cf1bbc0b990de856fefbccb1145b689","machinalis",NA,NA,NA,NA
"8f9438146cdd4238af4b1d5e9c7b0d44","machine-publishers",NA,NA,NA,NA
"cf2caa73ed36e873a9340fa6d41c8af8","machine-to-machine-intelligence-m2mi-corp",NA,NA,NA,NA
"01c6fd52ad0ec60d60aa0d1e830db408","machinepulse",NA,NA,NA,NA
"22785971d3bf4e9f63d5ac71aaffca6a","machineshub",NA,NA,NA,NA
"8c7553367d15e65e2c710678f4382864","machinify","venture","A","2015-01-23",NA
"c69f577a086b8d9a05b297a9c009f64a","machool-technologies-ltd","seed",NA,"2014-10-17",62107
"c69f577a086b8d9a05b297a9c009f64a","machool-technologies-ltd","angel",NA,"2015-03-17",312858
"c69f577a086b8d9a05b297a9c009f64a","machool-technologies-ltd","seed",NA,"2014-02-20",25000
"3e6d52afcd5c9ff20abbadb23253decf","macquarie-health-services",NA,NA,NA,NA
"db0ae503c92d4276fd5a63b0869f178d","macrocure","undisclosed",NA,"2012-05-14",NA
"db0ae503c92d4276fd5a63b0869f178d","macrocure","private_equity",NA,"2011-04-01",1.3e+07
"a88589a4aa06622b2e4e22629387cf5c","macrofuel",NA,NA,NA,NA
"91efe631e7e04dfa1f5e5f101dd2d765","macrogenics","private_equity",NA,"2011-01-31",12016500
"91efe631e7e04dfa1f5e5f101dd2d765","macrogenics","venture","1","2006-05-17",4.5e+07
"6303f10204237340941e9146b173a7ae","macroglossa",NA,NA,NA,NA
"e6142747c5c5fcecbaa1ec0217602390","macroimpact",NA,NA,NA,NA
"fc9fe8ef38c8293d21ec1dce9f6eb721","macromeasures","seed",NA,"2015-06-08",40000
"3986f405e4d5e83f68d4eb078ecf0fe2","macromicro",NA,NA,NA,NA
"3881e35ba13551d6262068325e8c02c8","macrovue","seed",NA,"2014-05-31",1e+05
"fadfee45f4a1c95a62de39976d7e94e1","macspeech",NA,NA,NA,NA
"7280fd8a34c52a0561ebfb05f1d96696","macuclear","venture",NA,"2012-01-03",1e+06
"e3b3aea14af8abe42287ca35926d4ad5","madam-therapeutics",NA,NA,NA,NA
"592143f9f517e50d151f69519dd5643b","made-in-w-inc","angel",NA,"2014-02-10",3e+05
"592143f9f517e50d151f69519dd5643b","made-in-w-inc","undisclosed","1","2015-10-01",NA
"c7da2ef176b7fef695c5145dd9c37a0d","genomcore","seed",NA,"2015-02-01",101662
"c7da2ef176b7fef695c5145dd9c37a0d","genomcore","convertible_note",NA,"2015-06-01",109565
"5f5993df30c2d12a59da77d26c2e69cd","madeira-therapeutics","venture",NA,"2011-04-13",420000
"1970e2f538c87c0ab19baa4731e9d81a","madeo-technologies-inc-","seed",NA,"2014-03-21",1e+05
"713c31b03365026d91d60cd59afa6cdd","madeup","seed",NA,"2014-10-22",NA
"a5545b2b37503caa9dc9329fa9253f43","madison-vaccines","venture","A","2015-03-10",3e+06
"a5545b2b37503caa9dc9329fa9253f43","madison-vaccines","venture","a","2014-01-13",8e+06
"e41973d2a74f39521e5737c60e124732","madronish-therapeutics","equity_crowdfunding",NA,"2014-09-16",NA
"54f9b02f2224d73395c9ba5f884a7036","magellan-bioscience-group","venture",NA,"2012-09-17",25000
"fe91af82465f1c6e86e6b324808df2fd","magellan-global-health","venture",NA,"2010-11-22",50000
"ba1208b2f45ed9f375d9a3992a0f01b2","magellan-health-services",NA,NA,NA,NA
"71d2dbfc539eb6f716f0d3c26a6a499b","magellan-laboratories",NA,NA,NA,NA
"fc020ffa758578049d8ff4e2d08de0a3","magen-biosciences",NA,NA,NA,NA
"23cd67841fde8914f541cceb8e577689","magic-wheels","venture","a","2010-02-17",285075
"e35e1f0a13062151c9e35f4159ee9a8e","magicboard",NA,NA,NA,NA
"6e9cb36b43cea44a7ca65ea4b1563f28","magma",NA,NA,NA,NA
"f3a73c60e6c7a9c3f7052d28bac81890","magna-pharmaceuticals","venture",NA,"2014-01-10",1005536
"9a7abd97d12d0eaa42cefe47377d8f96","magneceutical-health","equity_crowdfunding",NA,"2014-05-30",225000
"9a7abd97d12d0eaa42cefe47377d8f96","magneceutical-health","venture",NA,"2011-11-17",3665000
"295951a11bb7b78a9e3c7cf2f1329561","magnegas-corporation","post_ipo_equity",NA,"2014-03-25",5e+06
"cdeaaec2739a18e96136c2f2b01ea390","magnet-360","venture","A","2011-02-01",NA
"cdeaaec2739a18e96136c2f2b01ea390","magnet-360","venture","B","2013-02-04",NA
"8cc327bf4fe68bcf717e6ca753237038","magnet-works",NA,NA,NA,NA
"4b4411317d6f679cbd181991961c89a3","deliradio-concert-network","venture","a","2013-10-08",9350000
"cb8a7cb0766d7649b7d6cc51e657f1c6","magnus-life-science","seed",NA,"2014-10-07",24833177
"b49f1da1b211e9f45a11145367c4947e","maia-intelligence",NA,NA,NA,NA
"bfe5c546f1c40ddcb3b13032da56db8f","mail-print",NA,NA,NA,NA
"122d19c4bb333d073cd1ac0b18a6996d","maillands-technologies",NA,NA,NA,NA
"2f85a3c89f029fc04fa277d91b266fc3","maillift","seed",NA,"2013-10-07",50000
"2f85a3c89f029fc04fa277d91b266fc3","maillift","venture",NA,"2013-07-25",70000
"2f85a3c89f029fc04fa277d91b266fc3","maillift","seed",NA,"2013-05-31",20000
"2f85a3c89f029fc04fa277d91b266fc3","maillift","seed",NA,"2014-06-18",150000
"808898937d1cca6a11111becace0900f","mailparser",NA,NA,NA,NA
"78b9a5c1a8630d94ffec91ec0431d6b5","mailplants",NA,NA,NA,NA
"d57f20fe2129dca6c2e9ff59a5200094","main-street-hub","seed",NA,"2011-10-01",2600000
"d57f20fe2129dca6c2e9ff59a5200094","main-street-hub","venture","1","2014-01-14",1.4e+07
"d57f20fe2129dca6c2e9ff59a5200094","main-street-hub","seed",NA,"2012-04-01",2800000
"d57f20fe2129dca6c2e9ff59a5200094","main-street-hub","venture","1","2013-03-01",1600000
"d57f20fe2129dca6c2e9ff59a5200094","main-street-hub","debt_financing",NA,"2015-02-22",2e+07
"d57f20fe2129dca6c2e9ff59a5200094","main-street-hub","venture","1","2015-07-16",2.5e+07
"00778f392a49db9a8aa337c9e89aea89","maindatagroup",NA,NA,NA,NA
"962267e7f1871096b930a502e224c159","mainkeys-inc","seed",NA,"2011-01-11",15000
"e41b8a862b40b74605360ea6f3ab520a","mainmetrics",NA,NA,NA,NA
"f75cc907b1a72c3e67453fee6319874a","majestic-data",NA,NA,NA,NA
"85e307fc8713f869a68fdaa41f66a1ff","mak-scientific-llc",NA,NA,NA,NA
"065672334a4f145154e927409e47b2bd","makamatch",NA,NA,NA,NA
"dd756d3fe9ee17ad11ebae471d6638b2","makazi-group",NA,NA,NA,NA
"2e98b3dd0e28e615af9e5eb9c066fc96","make-positive",NA,NA,NA,NA
"85eb9394a77bc3ee86407903b30fe3f3","makesbridge",NA,NA,NA,NA
"1a5356dfc5cb927a18dbd3e0808fb775","mako-surgical","venture","c","2007-02-06",3e+07
"1a5356dfc5cb927a18dbd3e0808fb775","mako-surgical","post_ipo_equity",NA,"2008-02-07",1e+05
"1a5356dfc5cb927a18dbd3e0808fb775","mako-surgical","post_ipo_equity",NA,"2008-10-31",4e+07
"6d35bdb1bcd9fc15a5e56188c441b599","makucell","venture",NA,"2013-10-01",NA
"6d35bdb1bcd9fc15a5e56188c441b599","makucell","debt_financing",NA,"2012-10-09",1668447
"f1d5d17c8aeb38c409f7d2edd6bb1360","m-laga-open-innova",NA,NA,NA,NA
"5dbb0eac72361f3b4552ed31cf2cf96e","malaysian-biotechnology-corporation",NA,NA,NA,NA
"ebcb263c26b97ab83f0bd9d64d1b048a","malaysian-technology-development-corporation",NA,NA,NA,NA
"1b1fea94419c445141b2dc60dfc6f2a9","mall-connect","venture","A","2016-01-11",1091274.1717
"d32ed6e6f4f655c85e117a4cd4fed856","mallinckrodt",NA,NA,NA,NA
"716c962975dd8007e203160734cb0b5a","mallinckrodt-veterinary",NA,NA,NA,NA
"c5c2212b2688c8e9eeb2f55b4cc4918b","malltip","seed",NA,"2013-11-30",NA
"fd295ea578032086c67be9a4eb571398","maluuba","grant",NA,"2013-01-01",1e+06
"fd295ea578032086c67be9a4eb571398","maluuba","venture","1","2016-01-20",9e+06
"fd295ea578032086c67be9a4eb571398","maluuba","seed","1","2012-02-01",2e+06
"6620872f465700f0b89ce86b34b15d19","malvern-media",NA,NA,NA,NA
"25dcc79ada30168b5af3e2ffb6c790fa","mambo",NA,NA,NA,NA
"1dbd458c95ca9b876d78ee067f10cb18","mammothdb","seed","A","2015-05-19",1800000
"11af12544fccc0124c9478a35487a9b7","manage-com",NA,NA,NA,NA
"996d1bc3ac6302d6e7582a26eae23b60","management-health-solutions","venture","b","2010-04-27",7e+06
"1a639172858ca3f4fe66837f0877ba04","managility",NA,NA,NA,NA
"5545e59022e9074d0a2c371025c7f640","manas-technology-solutions",NA,NA,NA,NA
"f6ab4dd402f1cbff3f2dca8301c55318","manchester-pharmaceuticals",NA,NA,NA,NA
"d27291cdbe85daf8c689f93fff464727","manhattan-pharmaceuticals","venture",NA,"2010-03-03",2547500
"a59d8336d8c06c087124c3f32dbd7b1e","manipal-acunova","venture","b","2009-12-02",NA
"221e02b39eab7318fac95dadc6f885f9","manitoulin-holdings",NA,NA,NA,NA
"f9d7cae8813332633e362b0cbe3393cb","manix-solutions",NA,NA,NA,NA
"77935671fc53c7768e4db535bebdae27","mannkind-corporation","debt_financing",NA,"2013-08-16",4e+07
"77935671fc53c7768e4db535bebdae27","mannkind-corporation","debt_financing",NA,"2013-07-01",1.6e+08
"c28df747acbfdbb4678dbac989c12e68","mansa-systems",NA,NA,NA,NA
"1be97639c4d57255acc8fae8b4dd3539","manta-tools","grant",NA,"2013-01-01",1e+06
"628332fd5d9d5c375de04c4d80e17e88","manta-com-database",NA,NA,NA,NA
"2855ed6a32b708bcd474fcdd1776d910","manthan-software-services","venture","D","2015-02-04",6e+07
"c69068968effeff26ad54f53031aa38d","manthan-systems","venture","c","2012-02-15",1.5e+07
"c69068968effeff26ad54f53031aa38d","manthan-systems","venture","b","2009-11-20",1.5e+07
"c69068968effeff26ad54f53031aa38d","manthan-systems","venture","b","2009-12-09",1.5e+07
"c69068968effeff26ad54f53031aa38d","manthan-systems","venture",NA,"2007-06-20",2e+06
"c69068968effeff26ad54f53031aa38d","manthan-systems","venture","d","2013-01-01",4e+06
"c69068968effeff26ad54f53031aa38d","manthan-systems","venture","a","2007-03-01",5700000
"c69068968effeff26ad54f53031aa38d","manthan-systems","private_equity",NA,"2015-03-20",NA
"13c7898ac7ec4906aee4d5b16792b21e","manticore-technology",NA,NA,NA,NA
"591a14e64a1db5753de87a1d79f5fe8c","mantis",NA,NA,NA,NA
"141169c872db1aaf986239ca5b3d5131","manyeta","seed",NA,"2011-06-23",NA
"d794f04c82400a5331675d7dc35de275","map-pharmaceuticals","venture","d","2007-03-28",5e+07
"e4be65bd7272ca9b96bb155a9410b687","mapd","seed",NA,"2014-10-14",2e+06
"81a8058b863f74930679723baeeb0ec6","mapegy",NA,NA,NA,NA
"fdc0dbdff32d8f85cc756bad10193051","mapmypage",NA,NA,NA,NA
"81fb1935093b95e4d4add73ae7a6e8e5","mapp-biopharmaceutical",NA,NA,NA,NA
"b462228939cb65ed4c02e3052ee6ce20","mappedin","seed",NA,"2015-03-31",1510000
"b462228939cb65ed4c02e3052ee6ce20","mappedin","seed",NA,"2012-07-01",1510000
"b462228939cb65ed4c02e3052ee6ce20","mappedin","seed",NA,"2014-06-30",375000
"5a2807cb3afe7ad47db720fcfe374a7a","mapquest-com-database",NA,NA,NA,NA
"ba0e5e9884bc89618a97a6b062f3e56b","mapr-technologies","venture","a","2009-07-22",9e+06
"ba0e5e9884bc89618a97a6b062f3e56b","mapr-technologies","venture","b","2011-08-30",2e+07
"ba0e5e9884bc89618a97a6b062f3e56b","mapr-technologies","venture","c","2013-07-26",34999994
"ba0e5e9884bc89618a97a6b062f3e56b","mapr-technologies","private_equity",NA,"2014-06-30",8e+07
"ba0e5e9884bc89618a97a6b062f3e56b","mapr-technologies","debt_financing",NA,"2014-06-30",3e+07
"7c4134b05975624cf99e568245e14b6f","maprecruit-com",NA,NA,NA,NA
"6f05dbc97835c44a40dd1d6aacb84a5f","maps-capital-management",NA,NA,NA,NA
"5e6483b1e2ac815ae8b313a248987b14","mapthatpad",NA,NA,NA,NA
"27d9439f8f6068aa8e8b85daaa74508c","marcadia-biotech","venture","a","2007-05-15",1.5e+07
"27d9439f8f6068aa8e8b85daaa74508c","marcadia-biotech","venture",NA,"2006-03-01",1e+06
"d48ea66eb525c938651641c4d15c1ceb","marerua-ltd","angel",NA,"2013-01-01",9e+05
"d48ea66eb525c938651641c4d15c1ceb","marerua-ltd","seed",NA,"2014-01-01",532000
"e46d5642a67a6e62e0ceb17bfc27de53","mariana",NA,NA,NA,NA
"5e65c6b1fd85dfd6df48850c89971112","marina-biotech","post_ipo_equity",NA,"2014-02-24",6e+06
"5e65c6b1fd85dfd6df48850c89971112","marina-biotech","post_ipo_equity",NA,"2015-08-12",1100000
"61d09131183407457698c41d32516604","marine-life-research","debt_financing",NA,"2014-01-04",3e+06
"0ecf36441c21650b4e0a71ebba2d9e4e","mariner-2",NA,NA,NA,NA
"4ab8baf641d0130eb657d0a1e27147eb","marinus-analytics","convertible_note",NA,"2015-12-23",150000
"fe162dcb8475f00f0c3aaa14032c6abf","marinus-pharmaceuticals","venture","b","2009-05-03",2e+07
"fe162dcb8475f00f0c3aaa14032c6abf","marinus-pharmaceuticals","venture","c","2013-01-07",2.1e+07
"fe162dcb8475f00f0c3aaa14032c6abf","marinus-pharmaceuticals","venture",NA,"2012-12-19",11435690
"e00b4f980efaeb6abf7b85556fe73473","mariposa-biotechnology","seed",NA,"2013-06-18",2427823
"9481554a914882b34974ce91c05ff420","mark-red",NA,NA,NA,NA
"1c6353feae4f39bb66c22df837d9997b","markentive",NA,NA,NA,NA
"084fc98a85e30dbedae5ed22590611bb","market-and-media-research",NA,NA,NA,NA
"c9d1d2994d7ee270e6240859bb4521ab","market-brew",NA,NA,NA,NA
"d8f63776a0c04f499c74b146444f75a0","market-force-information","venture","B","2007-03-06",3.2e+07
"d8f63776a0c04f499c74b146444f75a0","market-force-information","debt_financing",NA,"2011-09-27",1.5e+07
"6d7ef638f19c2a3813f5e1df38727459","market-meme",NA,NA,NA,NA
"7f6a9b38ada316efaeb8b35d9cfd3820","market-reports-online",NA,NA,NA,NA
"880378805c881fccf093ffdc084dfc8e","market-sketch",NA,NA,NA,NA
"1fb11f5b9e71e6fa82c9fd7074902c04","market2lead",NA,NA,NA,NA
"70b186672fcd88e57426c2a9d97a6c10","market6","venture","a","2006-06-06",5500000
"5fbf7c771880c821ccf5a95e9bf01776","market76","venture",NA,"2011-04-07",849158
"f7b64238e87df6d113c5ebaa95497160","marketanalysis-com",NA,NA,NA,NA
"19cb96e5cf8ad47a24376000392640f1","marketapi",NA,NA,NA,NA
"de1163c9039a456010b0b9feff8c13fc","marketbridge","seed",NA,"2000-01-01",5e+06
"de1163c9039a456010b0b9feff8c13fc","marketbridge","debt_financing",NA,"2013-09-01",3e+06
"0e2bb1c904871abeff53138de60049a8","marketbright","undisclosed",NA,"2010-04-13",NA
"0e2bb1c904871abeff53138de60049a8","marketbright","venture","1","2008-08-01",NA
"b8090ce3fc60b0027d288bddc07b1d25","marketchorus",NA,NA,NA,NA
"939a8834a62d54e892d6062bfc85dc6d","marketecture","seed",NA,"2010-01-01",320000
"939a8834a62d54e892d6062bfc85dc6d","marketecture","angel",NA,"2011-01-01",160000
"939a8834a62d54e892d6062bfc85dc6d","marketecture","debt_financing",NA,"2011-01-01",80000
"939a8834a62d54e892d6062bfc85dc6d","marketecture","debt_financing",NA,"2012-01-01",183000
"939a8834a62d54e892d6062bfc85dc6d","marketecture","angel",NA,"2013-01-01",1e+05
"939a8834a62d54e892d6062bfc85dc6d","marketecture","debt_financing",NA,"2013-01-01",630000
"ef94cf3e1d51feb66439cf7cfac1827d","marketer365",NA,NA,NA,NA
"e5bddda755051733e9fb8c7ad7baf572","marketing-analytics",NA,NA,NA,NA
"19aac4f0eeef7f45791508d2cb7e350c","marketing-evolution",NA,NA,NA,NA
"781d6fe12057c0e07270cc1789bc74ba","marketing-operatives",NA,NA,NA,NA
"3504b84526b48eab68ca3a925b03f2ed","aimcrm",NA,NA,NA,NA
"68f019a356a8abac03a863d3baaab40c","marketing-podcasts",NA,NA,NA,NA
"6ac31d20316a78fce7a0a84a555eb019","marketing-resource-management",NA,NA,NA,NA
"e820a1b118d90d096ad6eed65c0097b4","marketing-sciencelab",NA,NA,NA,NA
"08b468a030cb4b9fae390fd10673632d","marketing-ai","venture","A","2015-11-04",2e+06
"b25182b24e27fcfd046ccf677ec58dbb","marketingstick",NA,NA,NA,NA
"2e43d4044b3edecb63f50e4a4d553e9f","marketingvitals-com",NA,NA,NA,NA
"39f16719c9b13008f91fe8bd831f5027","marketly-llc",NA,NA,NA,NA
"6b1a20f53bcbfffa85b92a49f33b95d1","marketlytics",NA,NA,NA,NA
"ef1c2c583a8ce6809c537e8f85c4177a","marketmuse","seed",NA,"2014-02-05",95000
"ef1c2c583a8ce6809c537e8f85c4177a","marketmuse","seed",NA,"2015-09-15",1e+05
"ef1c2c583a8ce6809c537e8f85c4177a","marketmuse","angel",NA,"2013-10-30",30000
"ef1c2c583a8ce6809c537e8f85c4177a","marketmuse","angel",NA,"2014-01-05",20000
"9bb34518db4f7bcff9f15da5fafd937f","marketo","venture","c","2009-09-22",1e+07
"9bb34518db4f7bcff9f15da5fafd937f","marketo","venture","a","2006-10-01",5400000
"9bb34518db4f7bcff9f15da5fafd937f","marketo","venture","f","2011-11-16",5e+07
"9bb34518db4f7bcff9f15da5fafd937f","marketo","venture","b","2008-08-12",8e+06
"9bb34518db4f7bcff9f15da5fafd937f","marketo","venture","d","2010-04-27",1e+07
"9bb34518db4f7bcff9f15da5fafd937f","marketo","venture","e","2010-11-17",2.5e+07
"ee8534667e08aa0fc3e221c3ef494e3e","marketo-japan","venture","a","2014-03-25",4600000
"61d93d89bbd799f055f9d701e07b0ce2","marketresearch-com",NA,NA,NA,NA
"56b9f087ccfa171874313ada44aaac87","marketshare","venture",NA,"2011-04-14",3.2e+07
"56b9f087ccfa171874313ada44aaac87","marketshare","debt_financing",NA,"2011-09-22",5e+06
"56b9f087ccfa171874313ada44aaac87","marketshare","venture",NA,"2013-04-16",3.8e+07
"56b9f087ccfa171874313ada44aaac87","marketshare","debt_financing",NA,"2012-03-19",3e+06
"56b9f087ccfa171874313ada44aaac87","marketshare","venture",NA,"2014-12-19",1e+07
"56b9f087ccfa171874313ada44aaac87","marketshare","venture",NA,"2015-05-04",8e+06
"37fc57db49fa0c2ebe3aac8bf440ede0","marketvibe","seed",NA,"2010-08-05",NA
"53888d2622a42876f04e90404836eb62","marketwatch",NA,NA,NA,NA
"aab5877f07d86c7cc5934d4a87f5aeb1","marketyze","seed",NA,"2012-10-01",1600000
"5f1ea44b17205d4de675d53f34e34efe","markodojo",NA,NA,NA,NA
"5b7201f72c48757b33f9fbb395660982","marktab",NA,NA,NA,NA
"9d703db2698de7c9b171a25f922e8b46","marlabs-inc",NA,NA,NA,NA
"4438d4f88b9d150d95cfbdb8cbe097d7","maroon-biotech",NA,NA,NA,NA
"0685c1d6137df59f855b0fe88e8b4a5d","marquee","seed",NA,"2012-03-01",NA
"6b5b60634a23d54ead3858d198984a1e","doomoro","seed",NA,"2014-09-01",7e+05
"fe818f839f2ce757b8132b04d12f112d","marriage-material","seed",NA,"2014-08-22",NA
"d83ced70a386e30f6f3d28bf29a34a65","marrone-bio-innovations","venture","A","2007-05-02",3750000
"d83ced70a386e30f6f3d28bf29a34a65","marrone-bio-innovations","venture","B","2008-08-14",1e+07
"d83ced70a386e30f6f3d28bf29a34a65","marrone-bio-innovations","debt_financing",NA,"2012-04-20",1e+07
"d83ced70a386e30f6f3d28bf29a34a65","marrone-bio-innovations","venture","c","2011-06-01",25400000
"d83ced70a386e30f6f3d28bf29a34a65","marrone-bio-innovations","debt_financing",NA,"2014-06-05",1e+07
"d83ced70a386e30f6f3d28bf29a34a65","marrone-bio-innovations","debt_financing",NA,"2015-08-21",4e+07
"88315ad78caaecfd1aeeb4897def23f5","mars-bioimaging","venture","a","2014-02-24",5e+05
"485d30310a7ee307d4ed9d242d2b8405","martek-biosciences",NA,NA,NA,NA
"df9b256423d18d4865dc27b57f22812b","martell-biosystems",NA,NA,NA,NA
"66d7b77dcf60bddb176b1c43a2f39b99","marval-pharma","debt_financing",NA,"2011-11-02",1516515
"66d7b77dcf60bddb176b1c43a2f39b99","marval-pharma","venture","1","2010-01-19",2500000
"66d7b77dcf60bddb176b1c43a2f39b99","marval-pharma","venture",NA,"2012-07-31",2500000
"b9ac613a596e65454f08d29d3c1b1f0a","marvia",NA,NA,NA,NA
"3b01c79875f3091081b01d34a25e9a33","marvin-mobile-security",NA,NA,NA,NA
"39d3e0f7b92442cef0bb1b4bc8d909e4","maryland-psychiatric-research-center",NA,NA,NA,NA
"7e0da9ab534c9e6b9d0e81d0fbc738f3","masflight",NA,NA,NA,NA
"d83e8405341fa4bc76e468798a9885ca","your-analytics-site",NA,NA,NA,NA
"89ea3dab6e0d84dec2a428a26986e7d7","mashery","angel",NA,"2007-01-01",NA
"89ea3dab6e0d84dec2a428a26986e7d7","mashery","venture","1","2007-05-08",1200000
"89ea3dab6e0d84dec2a428a26986e7d7","mashery","venture",NA,"2012-07-23",1e+07
"89ea3dab6e0d84dec2a428a26986e7d7","mashery","venture","1","2010-02-24",5500000
"89ea3dab6e0d84dec2a428a26986e7d7","mashery","venture","1","2011-05-04",1.1e+07
"89ea3dab6e0d84dec2a428a26986e7d7","mashery","venture","1","2008-10-29",7e+06
"8611105f417869d50aefc1e70bebe644","mashfeed",NA,NA,NA,NA
"5712c83abee8c274da837a71a1382846","masimo",NA,NA,NA,NA
"52bd45c49113c8720a0acaf05bea0552","mass-big-data",NA,NA,NA,NA
"2eff0a99d91db2791a66c16893ebfa7f","massachusetts-biotechnology",NA,NA,NA,NA
"5182847a6ea16c0ea958c3c3add6d9e5","massachusetts-life-sciences-center","grant",NA,"2011-02-23",3400000
"89e3b3133607fd12cdf9fc5ab51132eb","massbio",NA,NA,NA,NA
"8a3a482cfc6319d797f7664acc9f80b3","massbiologics",NA,NA,NA,NA
"183692b0b175b12589ce2badd9f56b55","masschallenge","grant",NA,"2015-03-12",1500000
"1f1cae07b0e3744fcb95a037da956e90","massive-alliance",NA,NA,NA,NA
"45f2922e213d0c0e6c20c18066d69de3","massive-analytic","undisclosed",NA,"2015-05-12",2023220
"9b287110af96cec2a2c4de9f7d3ca6d0","mast-therapeutics",NA,NA,NA,NA
"c496d492b9b2550b045622371eb6a104","mastercard-smart-path-accelerator",NA,NA,NA,NA
"f391ba21310456e2114961df2c0621b3","mastermind-software-and-consulting",NA,NA,NA,NA
"d7b871b109efe869fce0a708bc12ec39","mastodon-c","seed",NA,"2012-07-01",19567
"f399e517691f364ba810d6e573925183","match-media",NA,NA,NA,NA
"307888c8a27dc5a61c8328e8fbbbcfaa","matchbox-io","seed",NA,"2015-02-01",20000
"b653fc693ee6e6ab96273da53c15e4ba","matchdrobe",NA,NA,NA,NA
"a7735c755e3626b73976e2b2c1cf650e","matchmatix",NA,NA,NA,NA
"67164fef0164509ba499b2aa7470d454","matchpoint","seed",NA,"2012-01-31",5e+05
"74e239f6a6afbabd8651948218ae44eb","mathbased-inc",NA,NA,NA,NA
"18bfec67c05693e54edc844438ffd9a6","mati-therapeutics","venture",NA,"2013-04-15",1310000
"18bfec67c05693e54edc844438ffd9a6","mati-therapeutics","venture",NA,"2014-10-07",150000
"d961598a54cb0def2cdd3f8be85e4a77","matinas-biopharma","venture",NA,"2013-05-17",1000001
"d961598a54cb0def2cdd3f8be85e4a77","matinas-biopharma","venture",NA,"2013-08-07",7593750
"d961598a54cb0def2cdd3f8be85e4a77","matinas-biopharma","venture",NA,"2015-04-13",1e+07
"1c0cd0cafaec2c83a0bbf6b0abff351c","matricore","seed",NA,"2015-03-31",16227
"1692eabb839cebb349bdbfd05e29700a","matrix-marketing-group",NA,NA,NA,NA
"9f11850249e0cb3a3bb3e1dce6ee7065","matrix-bio","venture",NA,"2011-02-02",140000
"e334533e2bec96eeff253f8d0413c688","matrixvision","angel",NA,"2014-07-11",50000
"e334533e2bec96eeff253f8d0413c688","matrixvision","seed",NA,"2013-11-30",70000
"e334533e2bec96eeff253f8d0413c688","matrixvision","seed",NA,"2014-06-23",1e+05
"09d29cbfc3480d56c0574edd39f6d6f5","maui-imaging","venture",NA,"2010-04-19",980000
"09d29cbfc3480d56c0574edd39f6d6f5","maui-imaging","venture",NA,"2015-01-29",5721000
"9478af284dd3e686e97a83ab5fe1d743","mautic",NA,NA,NA,NA
"20aa8c7ddbbd981140c26c0f3189ff5b","maven-biotechnologies","grant",NA,"2010-10-04",1960000
"7fba72c1000926b8c24378c54156186d","maven7","seed",NA,"2014-02-27",739795
"7fba72c1000926b8c24378c54156186d","maven7","venture","1","2015-06-08",1558000
"f61512ffd02ee4b88ed419399a43aad1","mavens-biotech",NA,NA,NA,NA
"d78285fc06ae93ac9fde3b59386ad06c","mavensocial","seed",NA,"2012-04-10",945000
"d78285fc06ae93ac9fde3b59386ad06c","mavensocial","angel",NA,"2013-12-30",1e+06
"d78285fc06ae93ac9fde3b59386ad06c","mavensocial","venture",NA,"2015-02-10",2e+05
"8f5ee2adc4531802596713d6610855df","maverick-2",NA,NA,NA,NA
"67be0fd8a71dd6bd718fb67e5f3f4c61","maverix-biomics","venture","a","2014-01-07",6e+06
"910192b63ea5ede231bcb5d48b736e01","mavrx","venture","A","2015-11-24",1e+07
"910192b63ea5ede231bcb5d48b736e01","mavrx","venture",NA,"2012-12-01",NA
"910192b63ea5ede231bcb5d48b736e01","mavrx","seed",NA,"2013-12-31",80000
"910192b63ea5ede231bcb5d48b736e01","mavrx","seed",NA,"2014-08-01",NA
"6149a24faf100d9150db630c7ee52a86","max-endoscopy","seed",NA,"2010-03-09",250000
"6149a24faf100d9150db630c7ee52a86","max-endoscopy","seed",NA,"2010-10-27",135000
"6149a24faf100d9150db630c7ee52a86","max-endoscopy","undisclosed",NA,"2007-01-01",NA
"08576ffc434ac805672767d995f8cb19","maxcyte","venture",NA,"2009-08-31",1500000
"08576ffc434ac805672767d995f8cb19","maxcyte","venture",NA,"2014-12-16",1700000
"c7d6c32fafd568e452317596e25f11fd","maximax-marketing-design",NA,NA,NA,NA
"dab81e032578f6415bb4720311e77e28","maxivax",NA,NA,NA,NA
"d896febb2b5b3f78a67825353adb4213","maxivet",NA,NA,NA,NA
"4511d294d7719277a0fac1446a796b87","voodoo-alerts-2","seed",NA,"2014-10-08",5e+05
"42131d941fdf06f5f34b861be4071372","maxmind",NA,NA,NA,NA
"3f9eb249cb8f2c52d6c398d092ad47ad","maxroy-com",NA,NA,NA,NA
"162cd260f59e164f6d53930833acd86d","maxtraffic","debt_financing",NA,"2013-09-01",66086
"ca0fbae9cbdbdb5ca22b0f361e16237b","maxygen",NA,NA,NA,NA
"7ba2f461cea72cfd8d0c04552038378d","maxymiser","venture","a","2009-01-20",2777360
"7ba2f461cea72cfd8d0c04552038378d","maxymiser","venture","b","2012-01-05",1.2e+07
"7ba2f461cea72cfd8d0c04552038378d","maxymiser","private_equity",NA,"2013-06-05",NA
"0414cc8eb629fbb1a171d293a587116a","maya-medical","debt_financing",NA,"2010-07-15",7e+05
"0414cc8eb629fbb1a171d293a587116a","maya-medical","venture",NA,"2011-03-11",2370582
"0414cc8eb629fbb1a171d293a587116a","maya-medical","debt_financing",NA,"2011-12-30",2810000
"0414cc8eb629fbb1a171d293a587116a","maya-medical","debt_financing",NA,"2012-03-26",1040000
"d0ef9e48c14d6e11baee3c316007a151","mayne-pharma","seed",NA,"2012-10-12",2705000
"162fd133ff6af3dbf4348a18e514b359","mayo-clinic-rochester","grant",NA,"2013-09-19",8800000
"162fd133ff6af3dbf4348a18e514b359","mayo-clinic-rochester","grant",NA,"2014-10-13",9300000
"a7d119c3a4c727be8506a038895fbca7","mayomo",NA,NA,NA,NA
"73fd853b62dbf941a0e0c916f2aefa8b","mazira",NA,NA,NA,NA
"4071d9203dfebe82efdd064136ab4d33","mazliah-analytics",NA,NA,NA,NA
"73323a80341b79cdf893168e66b95992","mazor-robotics",NA,NA,NA,NA
"063ec6374cde6f7237c203b6cae1a077","mbf-therapeutics","debt_financing",NA,"2010-03-15",345000
"5222d8a10ddec31800052ba98567a4e5","mbio-diagnostics","venture","a","2011-01-06",1997424
"5222d8a10ddec31800052ba98567a4e5","mbio-diagnostics","venture","B","2015-05-21",6300000
"2121547e48032045b40fc2964fdc6586","mbt",NA,NA,NA,NA
"966a9500578c22194b01a52702ab59b5","mcginley-innovations","seed",NA,"2012-10-24",505000
"966a9500578c22194b01a52702ab59b5","mcginley-innovations","venture",NA,"2013-12-23",8e+05
"1c41f4ce92b4371f717b69f7b8386dd0","mckesson",NA,NA,NA,NA
"47999c66c9f56488150474d47a530159","mcneil-pharmaceuticals",NA,NA,NA,NA
"893e0a58255832d501e044cde29c8535","mcule",NA,NA,NA,NA
"77f689790c2e7040095344ddd0a0a4cc","md-on-line","venture",NA,"2011-05-18",1.2e+07
"abb45377f8f27e518c57bfd87b67215e","md-solarsciences","venture",NA,"2013-06-14",2227004
"616f574269216ef9abb431a1f947784b","mda",NA,NA,NA,NA
"094bb5ab0fb157cab604089345c91885","mdl-information-systems-symyx-technologies",NA,NA,NA,NA
"8b65cd127fedfe51fa0a7606773744ab","m-labs","seed",NA,"2013-11-13",1250000
"a5e45618268cdd90f58504b888148288","mds",NA,NA,NA,NA
"35575a56edad4a48a0fab93c3dc95fa7","mds-sciex",NA,NA,NA,NA
"138d174d9b753a42c1932a644c475024","mdxhealth","venture","a","2013-06-25",23600000
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","seed",NA,"2012-05-15",75000
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","venture","1","2013-12-01",750000
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","seed",NA,"2011-08-01",18000
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","seed",NA,"2012-06-01",50000
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","seed",NA,"2012-07-03",25000
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","seed",NA,"2012-09-16",50000
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","venture","1","2013-04-01",750000
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","venture",NA,"2014-11-17",474959
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","convertible_note",NA,"2012-12-06",349994
"a62f39e58156a56d1a19dbeb7b56f507","meal-ticket","venture",NA,"2014-01-02",560000
"d0e71a9dc323f7a9298f3380f4426f32","meaningo","seed",NA,"2009-01-01",150000
"791721d691804873871f9867ba86fb21","measurabl","seed",NA,"2014-09-02",2049999
"791721d691804873871f9867ba86fb21","measurabl","venture",NA,"2015-01-11",2300000
"d031ff81d32d82d0acc264740e7234e3","measure-map",NA,NA,NA,NA
"bf0405710326a384f3ceceead16d6175","measured-search",NA,NA,NA,NA
"7b2e32a62b99b20eaaa5012a9c303655","measureful","seed",NA,"2013-02-08",NA
"7b2e32a62b99b20eaaa5012a9c303655","measureful","seed",NA,"2013-06-10",NA
"7b2e32a62b99b20eaaa5012a9c303655","measureful","seed","1","2013-11-14",NA
"a58c9c139efb8c16e19d9d6aa615fbef","measurence","seed",NA,"2015-01-01",255000
"e5314069fc236cd8df860a88df0f8ac9","mecenato","seed",NA,"2013-02-01",20000
"2867d37ce420391265b75902cf14719f","med-access","seed",NA,"2009-07-03",10000
"69ab96678cadc11b45ff734a6cec405c","med-pharmex",NA,NA,NA,NA
"b068a0984bd429f8759554281e2d2a8d","meda",NA,NA,NA,NA
"08cbcc73bf549956a29257c3b3baf240","medafor","convertible_note",NA,"2009-09-09",1e+05
"08cbcc73bf549956a29257c3b3baf240","medafor","seed",NA,"2012-09-27",15000
"405c6579fce0ff766870aa0236bafde7","medallia","venture","b","2013-02-01",2e+07
"405c6579fce0ff766870aa0236bafde7","medallia","venture","A","2012-09-27",3.5e+07
"405c6579fce0ff766870aa0236bafde7","medallia","venture","C","2014-08-18",5e+07
"405c6579fce0ff766870aa0236bafde7","medallia","venture","D","2015-07-21",1.5e+08
"857431a4af8598d7f72ed14f797d5492","medallion-analytics-software","venture",NA,"2011-01-11",250000
"857431a4af8598d7f72ed14f797d5492","medallion-analytics-software","venture",NA,"2011-08-02",1100000
"857431a4af8598d7f72ed14f797d5492","medallion-analytics-software","private_equity",NA,"2013-05-16",1221000
"857431a4af8598d7f72ed14f797d5492","medallion-analytics-software","venture",NA,"2012-07-12",295772
"857431a4af8598d7f72ed14f797d5492","medallion-analytics-software","venture",NA,"2010-05-05",4e+05
"857431a4af8598d7f72ed14f797d5492","medallion-analytics-software","venture",NA,"2014-01-29",1500000
"857431a4af8598d7f72ed14f797d5492","medallion-analytics-software","seed",NA,"2011-07-25",NA
"857431a4af8598d7f72ed14f797d5492","medallion-analytics-software","seed",NA,"2010-09-23",NA
"aa4f802079ba7b66aef0d928b418dc12","medalogix","seed",NA,"2012-06-17",3e+05
"aa4f802079ba7b66aef0d928b418dc12","medalogix","venture","1","2014-08-22",5e+06
"9595059827da43d8a0d55cd48e528237","medarchon","venture",NA,"2013-05-03",225000
"9595059827da43d8a0d55cd48e528237","medarchon","private_equity",NA,"2014-08-27",1577640
"7c511b31f766c55e90317639748baf0c","medarex",NA,NA,NA,NA
"549e7d283fe2376ba6fb5d7786944c3d","medarkive","seed",NA,"2014-03-01",28437
"549e7d283fe2376ba6fb5d7786944c3d","medarkive","seed",NA,"2014-06-15",28848
"9805e8c3261ba49dc8edcee25982e5b2","medarray",NA,NA,NA,NA
"b6f227350a0bdc44ba4d7bfcc3083a60","medasense-biometrics-ltd--2",NA,NA,NA,NA
"01a283fabbfefc88b0721082d3d5fc8d","medavail","venture",NA,"2011-01-13",7082152
"01a283fabbfefc88b0721082d3d5fc8d","medavail","venture","1","2014-10-16",3e+07
"f67d51074dc9392088babb1c27e210d6","medaxion","venture",NA,"2015-12-29",973014
"f67d51074dc9392088babb1c27e210d6","medaxion","venture",NA,"2010-08-06",756702
"f67d51074dc9392088babb1c27e210d6","medaxion","seed",NA,"2012-08-16",800959
"f67d51074dc9392088babb1c27e210d6","medaxion","seed",NA,"2013-07-30",375000
"f67d51074dc9392088babb1c27e210d6","medaxion","seed",NA,"2011-09-20",1043343
"f67d51074dc9392088babb1c27e210d6","medaxion","venture",NA,"2014-06-02",787472
"f67d51074dc9392088babb1c27e210d6","medaxion","venture",NA,"2015-06-26",1312330
"29a72209602d6fc97807e5c7cedc8314","medbiomarkers",NA,NA,NA,NA
"a154d77c96a43b7f19c58053764f766c","medcell-bioscience",NA,NA,NA,NA
"335befd0ad610922050320f577a5a3b8","medcity-news","seed",NA,"2010-12-30",250000
"335befd0ad610922050320f577a5a3b8","medcity-news","seed",NA,"2008-12-01",60000
"742b89737b12e01c085ac613c54b25bc","medco-health-solutions",NA,NA,NA,NA
"2d28de68286cc33536dc096567120350","medday","venture","a","2013-04-10",10468800
"94b8cce7c384a23124994dc6215f76b3","medeanalytics","venture","c","2008-07-29",5e+07
"6e674e7f360781b98db3678e2a27d39d","mederi-therapeutics","debt_financing",NA,"2013-12-23",1e+07
"6e674e7f360781b98db3678e2a27d39d","mederi-therapeutics","venture","1","2013-12-23",8500000
"e2a563b6ca97a982398d86bee0ba7a70","medeview",NA,NA,NA,NA
"3f637c5dcd5010ceeb6669a8999b655d","medexpress-urgent-care","private_equity",NA,"2010-09-01",NA
"9b3b64221efb65fc753d2af202fe07a5","medgenesis-therapeutix","venture",NA,"2012-01-10",5e+06
"91efcb93d6d2b92eae8a83c1a949b421","medgenics","debt_financing",NA,"2010-06-08",430370
"91efcb93d6d2b92eae8a83c1a949b421","medgenics","debt_financing",NA,"2009-06-16",265000
"91efcb93d6d2b92eae8a83c1a949b421","medgenics","debt_financing",NA,"2010-09-22",4001500
"91efcb93d6d2b92eae8a83c1a949b421","medgenics","private_equity",NA,"2012-07-02",9529196
"91efcb93d6d2b92eae8a83c1a949b421","medgenics","post_ipo_equity",NA,"2014-11-26",2.1e+07
"91efcb93d6d2b92eae8a83c1a949b421","medgenics","grant",NA,"2015-06-14",3400000
"dded482b2095f4eca5c93214168f3abb","medhab","venture",NA,"2014-01-05",772979
"dded482b2095f4eca5c93214168f3abb","medhab","venture",NA,"2010-10-21",255000
"dded482b2095f4eca5c93214168f3abb","medhab","venture",NA,"2012-10-11",23542
"dded482b2095f4eca5c93214168f3abb","medhab","equity_crowdfunding",NA,"2011-08-04",NA
"dded482b2095f4eca5c93214168f3abb","medhab","venture",NA,"2015-05-08",25000
"f69dc985443afc7d7e242d5270465e2c","medhost",NA,NA,NA,NA
"85633049d672aa7330692564d7f433fa","media-analytics",NA,NA,NA,NA
"666cab49ccab4cd6369020048bf0db08","media-armor","seed",NA,"2011-05-01",250000
"666cab49ccab4cd6369020048bf0db08","media-armor","venture","1","2012-02-10",1530000
"846ba26f894773c08c23756e95f7ad6f","media-bakery",NA,NA,NA,NA
"13a39eefe083b64e19e5d7b4fb21e28d","media-injection",NA,NA,NA,NA
"e08230ff75b0b43f3cc7be5f3b485467","media-junction",NA,NA,NA,NA
"d9572bfd8488aba67a0331383919547d","media-salvation",NA,NA,NA,NA
"55f5215a0f36635b924a62300caee049","media-thirst",NA,NA,NA,NA
"924f9831e197623a0b266321b799d8f0","media-whale",NA,NA,NA,NA
"e90db6b80000fcf587279373682060fa","media-x-at-stanford-university",NA,NA,NA,NA
"8877373e8f4e66edcc65ba1e1cf07655","mediabeacon",NA,NA,NA,NA
"59aa4822086e742b054d3dc7af4f174c","mediacloud",NA,NA,NA,NA
"98187285170f095c5dcaaf245405dc79","mediacode",NA,NA,NA,NA
"01e42adf3368d49535ec132cce0d11ca","mediafed",NA,NA,NA,NA
"817730764837be609f5300692ac493ef","mediametric",NA,NA,NA,NA
"70798eba96229bbc169c34858a0d0418","mediamobz",NA,NA,NA,NA
"472fbd7b4ed11221d6b16651fdab9d19","medianama",NA,NA,NA,NA
"a142215bfc46c090fd1a56b429280bc1","medianest","seed",NA,"2014-09-01",NA
"7905ae42899b09c787bb2dca9366b57d","medianet-software",NA,NA,NA,NA
"f78c00237ec9c99e44b8da417c480734","mediaomics","seed",NA,"2013-07-10",528336
"d04eb74d1b4909fe55339090d199d3df","mediascope",NA,NA,NA,NA
"417d6c4a78bc922a9682d50d9f7cc3fe","mediashake",NA,NA,NA,NA
"f4901b12a2a4154f07638af351016148","mediaspa",NA,NA,NA,NA
"a9118773c27bd2114a3294bd118c9dda","mediasynced",NA,NA,NA,NA
"32de702ab3a9b09ca2a379903d19e3b9","mediatech-solutions",NA,NA,NA,NA
"d3b9af427d5de66ecdcf7e8a1dd91f68","mediator",NA,NA,NA,NA
"19a468b742cea057e90801efc91bd6dc","mediatrac",NA,NA,NA,NA
"31d632b7ba9e016c6058ddc91eb14710","mediavision",NA,NA,NA,NA
"9ce6f97bc244526be25df1d52beabdef","medibeacon","venture","a","2013-08-01",3500000
"9ce6f97bc244526be25df1d52beabdef","medibeacon","venture",NA,"2013-01-01",NA
"9ce6f97bc244526be25df1d52beabdef","medibeacon","debt_financing",NA,"2015-06-10",5058000
"9ce6f97bc244526be25df1d52beabdef","medibeacon","venture","B","2015-08-27",22400000
"d230ffd0f4f1afa1cf288b721bde5915","medic-vision","venture","c","2010-01-08",1e+06
"06b2b26da8e55e87c9e2c1f143967034","medicago","private_equity",NA,"2011-09-27",2.5e+07
"06b2b26da8e55e87c9e2c1f143967034","medicago","venture",NA,"2010-05-13",1e+07
"58415d043e0e9ec82d3534e818488adf","medical-account-services",NA,NA,NA,NA
"14c9240971401a53560be5734d69383e","medical-communications-group",NA,NA,NA,NA
"32246001ece1de8b14eac3018a9cabdc","medical-connections","venture",NA,"2010-08-26",51050
"7666206da469905c23de5cfaf6b13015","medical-data-systems",NA,NA,NA,NA
"aa29927234d0a0cda53d853e0c89d9fb","medical-delta",NA,NA,NA,NA
"8de7c970068d5c39952108fde9a28eca","medical-device-innovations","venture",NA,"2011-11-30",701696
"c4df76b2b65139e65b17d52cdfe67730","medical-distribution-solutions",NA,NA,NA,NA
"fa497898b1ad61a68eabab9e941139a5","medical-predictive-science-corporation","debt_financing",NA,"2010-01-27",1250000
"aa3dbfa913880ee1ebeaa29ffc290c82","medical-prognosis-institute",NA,NA,NA,NA
"a0efeedd6d9f19dcb1fc492b5756435f","medical-simulation","debt_financing",NA,"2013-08-02",13388302
"a0efeedd6d9f19dcb1fc492b5756435f","medical-simulation","debt_financing",NA,"2012-04-25",3055971
"80681f5c6dda318a2bed1962913f49de","medical-technologies-international","venture",NA,"2010-02-17",475000
"590aebbe4d576a1fc5faeecdf39d61b1","medical-teknologix",NA,NA,NA,NA
"9845953e625da5bb9d53cad6f7104e96","medical-sphere",NA,NA,NA,NA
"c1dc483d9f1ef3156d40165d3e87e813","medicamatch",NA,NA,NA,NA
"08ceef84d2c39819167c5d42c88df946","medican-enterprises",NA,NA,NA,NA
"77107d1ac8df815a42c6fbc94f358d1d","medichanical-engineering","undisclosed",NA,"2010-11-26",NA
"77107d1ac8df815a42c6fbc94f358d1d","medichanical-engineering","seed",NA,"2013-08-29",634306
"48b140dce81648cd2fe538d852f66d21","medicina","undisclosed",NA,"2013-12-19",9091508
"5cddf3a1cbe32b5cc324608ea3d5a307","medicinal-genomics",NA,NA,NA,NA
"ad5081b7ff6601e019d7ce944d739a0b","medicinova","venture",NA,"2012-08-20",2e+07
"72c74487ee0706c44d893b16f667436a","medicis-pharmaceutical",NA,NA,NA,NA
"eb18bb4ac62cd0fac0de65997dcdd2b8","medictouch",NA,NA,NA,NA
"6b2db27d070ec6cd9a556bd63811ba4c","medicure",NA,NA,NA,NA
"77bc60887168010bcd4b700732138d82","medifacts-international","venture","A","2005-01-27",1.6e+07
"77bc60887168010bcd4b700732138d82","medifacts-international","venture",NA,"2009-07-01",5e+06
"6a4de86064398c1bc9ee27899ac5c80c","medifocus","post_ipo_debt",NA,"2013-12-19",3500000
"6a4de86064398c1bc9ee27899ac5c80c","medifocus","post_ipo_debt",NA,"2014-03-11",2e+06
"9c09d284e4bda024cae3c50972d76b20","iguard",NA,NA,NA,NA
"d84d91f5cb4f4e0cba6b38132b2943b3","medihealth",NA,NA,NA,NA
"86b800e576cc972dd8a443d86ddbcfa9","medimetrix-solutions-exchange","venture",NA,"2010-11-18",1282936
"86b800e576cc972dd8a443d86ddbcfa9","medimetrix-solutions-exchange","venture",NA,"2011-07-06",1270000
"86b800e576cc972dd8a443d86ddbcfa9","medimetrix-solutions-exchange","seed",NA,"2012-05-11",67530
"0faa852208b449fb5d92f33a1bcef49f","medimmune",NA,NA,NA,NA
"803564ba28492e170e7ed7aae47f12a8","medio","venture","B","2006-11-16",3e+07
"803564ba28492e170e7ed7aae47f12a8","medio","venture","A","2005-10-15",1.1e+07
"cc60dbe50f17fb21a628b7079b5ce670","medipropharma","undisclosed",NA,"2010-01-06",NA
"cc60dbe50f17fb21a628b7079b5ce670","medipropharma","venture",NA,"2009-11-13",645000
"ed7cee2e92c72652c82ae36ff0d1b7ac","mediquest-therapeutics","debt_financing",NA,"2010-03-23",970481
"ed7cee2e92c72652c82ae36ff0d1b7ac","mediquest-therapeutics","venture",NA,"2010-10-26",3683631
"ed7cee2e92c72652c82ae36ff0d1b7ac","mediquest-therapeutics","venture","1","2006-06-15",1.6e+07
"ed7cee2e92c72652c82ae36ff0d1b7ac","mediquest-therapeutics","venture","1","2009-06-16",2.3e+07
"f3bef85b9a7d559d561da67a779cc643","mediquire",NA,NA,NA,NA
"52d23169a3bf9c4e607f6b11405ea4bf","medisens","venture",NA,"2011-04-06",5e+05
"52d23169a3bf9c4e607f6b11405ea4bf","medisens","venture",NA,"2009-03-30",350000
"52d23169a3bf9c4e607f6b11405ea4bf","medisens","venture","1","2015-01-13",2615062
"46717bd03f5c11293b0375d90465f7fb","medisse","undisclosed",NA,"2009-12-11",NA
"1823b073eed0ad9521a3c5011ce5a266","medistem",NA,NA,NA,NA
"e99b9886d03bf5753c703d5ea48424fe","medisyn-technologies","venture",NA,"2005-02-17",1500000
"2b6bfa4ec9a7d7d2b979f22442e2f8aa","medisync-bioservices","debt_financing",NA,"2010-08-16",625000
"3887bb24d7b530758ce19005396ef85f","medisys-health-group",NA,NA,NA,NA
"362797fbe877ed45fd3d72c9e2fdce97","meditope-biosciences","venture","a","2013-07-26",3600000
"6349dacc846e3ace24363ef2de69992e","meditrina-pharmaceuticals-inc","venture","A","2007-04-05",4400000
"6349dacc846e3ace24363ef2de69992e","meditrina-pharmaceuticals-inc","debt_financing",NA,"2010-12-27",50000
"ab4457cae784120770fedf41eb0be778","medivance","venture","D","2007-07-27",2.3e+07
"ab4457cae784120770fedf41eb0be778","medivance","venture",NA,"2009-06-25",8070000
"c352348d5c10193c4d0c8b1eb00bb724","medivation",NA,NA,NA,NA
"6dbb6c1e97d792331b5c6a50575940ce","medivo","venture","b","2013-06-17",1.5e+07
"6dbb6c1e97d792331b5c6a50575940ce","medivo","venture","a","2011-11-17",7e+06
"6dbb6c1e97d792331b5c6a50575940ce","medivo","convertible_note",NA,"2011-08-18",745000
"5081d7cf84e09a6acf0f12b0a300863c","mediwound","private_equity",NA,"2013-06-23",1.8e+07
"eef3521e7a17a503bb9a500cf41bd226","medlink","venture",NA,"2010-11-15",1250000
"63388dbe9bc05fc5a3e26daf34b90ab9","mednet-healthcare-technologies",NA,NA,NA,NA
"977c392efa2468444a579ffe0bcfbfd0","medop","debt_financing",NA,"2010-05-24",2500000
"ffacc616237d43ac2af348b2c1756bd9","medpace",NA,NA,NA,NA
"e1486db6ba4d29b41f9c07b443263a60","medplexus","venture",NA,"2009-07-27",2486458
"2e124ebcf8485d5f5e0fca45e5a7a4be","medpro","debt_financing",NA,"2010-09-08",2.5e+07
"2e124ebcf8485d5f5e0fca45e5a7a4be","medpro","debt_financing",NA,"2012-09-27",727000
"6d8b463e35195069f43a6da243df333e","medrad",NA,NA,NA,NA
"07ddb043c1ebb33adfa9a4558f62e260","medrespond",NA,NA,NA,NA
"d90225d2faf912b4e29788da8462000c","medrobotics","venture","G","2015-11-07",2.5e+07
"d90225d2faf912b4e29788da8462000c","medrobotics","debt_financing",NA,"2013-03-22",1e+07
"d90225d2faf912b4e29788da8462000c","medrobotics","venture","B","2012-08-13",8e+06
"d90225d2faf912b4e29788da8462000c","medrobotics","venture","A","2011-11-21",11700000
"d90225d2faf912b4e29788da8462000c","medrobotics","venture","d","2012-12-20",33600000
"d90225d2faf912b4e29788da8462000c","medrobotics","venture","E","2014-05-14",2.6e+07
"d90225d2faf912b4e29788da8462000c","medrobotics","venture","F","2014-10-21",2e+07
"b2b1fc5b8cb66a99b2b9f4c9d5bf642d","medscape",NA,NA,NA,NA
"df9d82fb672ecfe993f2893d914b70ed","medspot",NA,NA,NA,NA
"4402039ff6f66e1c1540196587eee3d6","medstartr","seed",NA,"2012-08-28",50000
"f491744daa8c3f49dc96137610401e8f","medtel24-inc","venture",NA,"2011-07-20",1050000
"f491744daa8c3f49dc96137610401e8f","medtel24-inc","venture",NA,"2012-09-24",209804
"ddcbea0ddc8c3efaa2bb33e82e0df98f","medtrec",NA,NA,NA,NA
"09ecd0bb448d9c4319630747fa6f3d6c","medtrics-lab","debt_financing",NA,"2015-03-18",102002
"d5b9d6ac97a81abfc1385c548d4acb38","medtronic",NA,NA,NA,NA
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","private_equity",NA,"2013-06-27",9e+05
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","venture",NA,"2006-08-28",4e+06
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","undisclosed",NA,"2003-10-31",NA
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","undisclosed",NA,"2003-11-18",NA
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","undisclosed",NA,"2004-10-31",NA
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","undisclosed",NA,"2005-10-31",NA
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","undisclosed",NA,"2008-05-27",NA
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","undisclosed",NA,"2000-11-23",NA
"d8f106f77096ee38971682a7bd3ce205","medusa-medical-technologies","undisclosed",NA,"2001-08-16",NA
"11b8917e01e45ea3c5c376f5d0974163","medusind-solutions",NA,NA,NA,NA
"fcec656d993aaa6c8d2171f16e1bcb7b","medwhat","seed",NA,"2015-03-01",NA
"fcec656d993aaa6c8d2171f16e1bcb7b","medwhat","seed",NA,"2014-02-18",560000
"fcec656d993aaa6c8d2171f16e1bcb7b","medwhat","grant",NA,"2011-04-15",30000
"002f2e1d7e59cc9c0d33e7f19f567739","meerkat-2",NA,NA,NA,NA
"46fb24f74109aa40a54104eabb25241e","meet-zebra",NA,NA,NA,NA
"52248921cac1532945014764242869c8","meetalytics",NA,NA,NA,NA
"a84339010c763c62c69b57d63e97bc13","meetuniv","venture",NA,"2015-05-19",950000
"f4d35bfd951d2e7278c1d4c731a0c90e","mega-palestras",NA,NA,NA,NA
"12f6db3b5340c13445d6f2079f3f997d","megalytics","seed",NA,"2015-01-05",NA
"41fd552da7d2e500457bb1042d4bf2d7","megaventory",NA,NA,NA,NA
"87abaf46eb393c47ccab1a1e2a3af5e4","mei-pharma","venture",NA,"2011-05-31",1113344
"048e2371943b8bc3c2a7cc10f6f23767","melbourn-scientific",NA,NA,NA,NA
"26bc6e904186d6b7da4e629b0a02a627","melee-media",NA,NA,NA,NA
"291c4a092959708573c612f9a349c9d6","melinta","venture",NA,"2009-01-25",2.5e+07
"291c4a092959708573c612f9a349c9d6","melinta","venture",NA,"2012-02-07",3e+06
"291c4a092959708573c612f9a349c9d6","melinta","venture",NA,"2012-11-29",67500000
"291c4a092959708573c612f9a349c9d6","melinta","venture",NA,"2011-01-11",2e+07
"291c4a092959708573c612f9a349c9d6","melinta","venture",NA,"2014-02-10",7e+07
"291c4a092959708573c612f9a349c9d6","melinta","debt_financing",NA,"2015-02-09",3e+07
"291c4a092959708573c612f9a349c9d6","melinta","venture","1","2015-06-10",6.7e+07
"5629d732518ade44920226d35fe005e6","melior-discovery","debt_financing",NA,"2009-07-24",250000
"5629d732518ade44920226d35fe005e6","melior-discovery","seed",NA,"2005-01-25",5e+05
"5629d732518ade44920226d35fe005e6","melior-discovery","venture",NA,"2009-09-24",825000
"5629d732518ade44920226d35fe005e6","melior-discovery","venture",NA,"2013-02-06",1741599
"5629d732518ade44920226d35fe005e6","melior-discovery","venture","1","2006-04-05",2500000
"ef69b806912aa0a3d45ec08868245833","melior-pharmaceuticals","venture","d","2011-10-10",375000
"643ca5d2c19d4dfb326c3f4550df8e36","melissadata-com",NA,NA,NA,NA
"4f52d17c878bb8dbf8faf33f98ea610e","melon-power","grant",NA,"2012-05-22",16000
"0c4285939258c6990f68c2704eb14d1d","melss-crm",NA,NA,NA,NA
"efa59b14888c55aa81f48633181f363f","melstevia","private_equity",NA,"2013-04-30",50000
"efa59b14888c55aa81f48633181f363f","melstevia","seed",NA,"2012-12-30",25000
"4d28773897a7333c647d2f9af37a199b","membean",NA,NA,NA,NA
"64314326e2a6a406d3b27be8009e8eaa","mememe","venture","a","2011-04-01",1465920
"64314326e2a6a406d3b27be8009e8eaa","mememe","venture",NA,"2012-01-01",665383
"64314326e2a6a406d3b27be8009e8eaa","mememe","undisclosed",NA,"2010-07-01",NA
"83ff5b51eaf2a83dd87404dac9d4fa8a","memento-security",NA,NA,NA,NA
"6d2473032406291b955ec53b86b2095b","memo-therapeutics","venture","A","2015-07-22",2300000
"3ed814cfee3dff3c892071591ae65b0b","memobead-technologies","venture",NA,"2005-11-01",720000
"0b123bb4e87f5edc3200816aa343c8cd","memory-pharmaceuticals","venture",NA,"2007-03-29",1e+07
"0b123bb4e87f5edc3200816aa343c8cd","memory-pharmaceuticals","venture",NA,"2005-09-21",3.1e+07
"430f94de0dc245708487aa23040ec472","memsql","venture","b","2014-01-22",3.5e+07
"430f94de0dc245708487aa23040ec472","memsql","venture","a","2013-01-18",5e+06
"430f94de0dc245708487aa23040ec472","memsql","seed",NA,"2011-07-12",5e+06
"430f94de0dc245708487aa23040ec472","memsql","undisclosed",NA,"2014-09-26",NA
"da5254ca163838a0ff2c09da50c0230c","menasocial","seed",NA,"2013-10-01",2e+05
"bc0da6075eb3e6969476cfd2b8f76969","menarini",NA,NA,NA,NA
"ad63f681a18066c1252a578384250b8e","mendel-biotechnology","venture","f","2011-11-09",11846950
"ad63f681a18066c1252a578384250b8e","mendel-biotechnology","private_equity",NA,"2007-06-13",8387128
"2ea63449c9a93ae7207a5509b6fb5c4f","menogenix","seed",NA,"2012-07-31",5e+05
"2ea63449c9a93ae7207a5509b6fb5c4f","menogenix","convertible_note",NA,"2014-08-14",405000
"afad2a78a62feb8f1d3cf5b452261c7b","mensia-technologies","grant",NA,"2015-11-03",3961834.3293
"afad2a78a62feb8f1d3cf5b452261c7b","mensia-technologies","seed",NA,"2013-11-04",5e+05
"d267c31b5c91ec3ce71181cb6a0025ee","mentalix-inc",NA,NA,NA,NA
"3b151d5f5c1dc89492aee48ea95463b9","mentat-innovations",NA,NA,NA,NA
"f157cb79d8586b3f96de944aebc6f120","mentimeter","seed",NA,"2015-12-27",125000
"f157cb79d8586b3f96de944aebc6f120","mentimeter","seed",NA,"2014-06-07",5e+05
"1d249d3d8bb1ccffe509b30689699e28","mentinova","venture",NA,"2013-01-28",5e+05
"3cb4f01900fc6aee567fb7234dcb0673","mention-llc",NA,NA,NA,NA
"d0df63fd327fc7c25b5f747ae7435f92","mentionmap-analytics",NA,NA,NA,NA
"109f246600df161489f47c4172e8f2f2","mentionmapp",NA,NA,NA,NA
"ba3b52d6c2eba23c5a5c2f43a7ed8407","mentis-technology","venture",NA,"2010-09-08",3e+06
"970e7ecd8d9dbdde19b52909a56fb142","mentorlogic",NA,NA,NA,NA
"ec03a71ea0208ccf1a469ebd965aa75a","meocare",NA,NA,NA,NA
"03ff106c3251e8c71da2615394b566df","mercator-medsystems","venture","b","2013-05-30",6500000
"e77dda17af6f4440f77b88c0bcd31a82","merchantatlas","venture","A","2014-03-13",3e+06
"e77dda17af6f4440f77b88c0bcd31a82","merchantatlas","angel",NA,"2013-01-24",1300000
"e77dda17af6f4440f77b88c0bcd31a82","merchantatlas","angel",NA,"2010-12-01",1e+06
"e77dda17af6f4440f77b88c0bcd31a82","merchantatlas","angel",NA,"2011-11-29",1e+06
"e77dda17af6f4440f77b88c0bcd31a82","merchantatlas","venture","A","2013-01-24",2366048
"60dc056ff5ebf44de1f58ba715eed8e6","merchant-service-group-llc",NA,NA,NA,NA
"18957cf21b782cdf71a0835a7986fd76","merchantcashinadvance",NA,NA,NA,NA
"e7cc64a1885b2c93956838c83f5a70d9","merchanttribe",NA,NA,NA,NA
"8d5f893c0c4cbc68aa4e2cb6c0c86994","merchii",NA,NA,NA,NA
"2f9b212ad3aaa8c26317516127c8ba88","merck-co-inc","venture",NA,"2016-01-21",5e+06
"a3383085f4ba31b9fbe1963854a0b12c","merck-kgaa",NA,NA,NA,NA
"4da20648ad9454d137af4ca9c6ff2129","merclain",NA,NA,NA,NA
"da13415e9d6fec985a1f10104df6a149","mercury-pharma-group",NA,NA,NA,NA
"5a0ae97ef16d4d3728f680cb022d0258","mercury-touch-ltd","seed",NA,"2014-07-17",40000
"5a0ae97ef16d4d3728f680cb022d0258","mercury-touch-ltd","venture","1","2014-09-08",NA
"5a0ae97ef16d4d3728f680cb022d0258","mercury-touch-ltd","seed",NA,"2014-08-11",40000
"19a5d10ee4ab83a9401d531a1674d6b9","merganser-biotech","venture","A","2015-02-19",2.8e+07
"c292b1b7b4bd31963cc10da343ebfdcb","merge-healthcare",NA,NA,NA,NA
"347bd00c8eb035d714d47680fc54dc2e","mergeflow",NA,NA,NA,NA
"078c46e116f7394dd294548ece9a7a9f","mergepay",NA,NA,NA,NA
"e4cc715ab18c06f2ae77e542238154a9","mergermarket",NA,NA,NA,NA
"822bc0639e560ca51ed70be2333c7dd4","merial-limited",NA,NA,NA,NA
"2aec7c53848cb100dbdb3818a0e19621","meridian-bioscience-inc",NA,NA,NA,NA
"547b99db84678f2faefda193c1cfa2a5","meritage-pharma","venture","A","2008-06-16",22500000
"547b99db84678f2faefda193c1cfa2a5","meritage-pharma","venture",NA,"2009-08-27",29972053
"547b99db84678f2faefda193c1cfa2a5","meritage-pharma","venture",NA,"2011-11-17",6500002
"2e0ba33d282b2ccdaf19826a9408c40d","merkley-newman-harty",NA,NA,NA,NA
"b7e1992cc87e65425f1813bede1b855f","merlion-pharmaceuticals","venture","c","2010-10-11",7e+06
"625b032cd3a9019dfbce76b0eaa3626e","merrimack-pharmaceuticals","private_equity",NA,"2011-04-14",7.7e+07
"625b032cd3a9019dfbce76b0eaa3626e","merrimack-pharmaceuticals","venture","1","2002-01-01",NA
"625b032cd3a9019dfbce76b0eaa3626e","merrimack-pharmaceuticals","grant",NA,"2010-11-08",2440000
"625b032cd3a9019dfbce76b0eaa3626e","merrimack-pharmaceuticals","undisclosed",NA,"2006-03-28",NA
"5af1f344fd75730900492f96195be878","mersana-therapeutics","venture","a","2012-07-31",2.7e+07
"5af1f344fd75730900492f96195be878","mersana-therapeutics","debt_financing",NA,"2010-02-26",2500000
"5af1f344fd75730900492f96195be878","mersana-therapeutics","venture","a","2014-04-08",14505371
"5af1f344fd75730900492f96195be878","mersana-therapeutics","debt_financing",NA,"2012-04-18",1e+07
"5af1f344fd75730900492f96195be878","mersana-therapeutics","venture",NA,"2005-11-08",2.1e+07
"5af1f344fd75730900492f96195be878","mersana-therapeutics","venture","B","2015-03-02",3.5e+07
"40b4426e8d1ce53a2645802f7fa3d541","mersen",NA,NA,NA,NA
"88132a7141b982dec508e38b663d6618","merus","venture","b","2010-01-29",30306220
"88132a7141b982dec508e38b663d6618","merus","venture","b","2013-10-03",39884600
"88132a7141b982dec508e38b663d6618","merus","venture","C","2015-04-26",79139323
"c50b60b504a8ecf00ace8f283ce9f612","merus-labs","post_ipo_equity",NA,"2014-03-14",2e+07
"e9c76726af428846dc0c18bcdd589775","meryx","debt_financing",NA,"2015-07-03",2500000
"32ec7ec3b5fa78bd0f2b27de0296bfa1","merz",NA,NA,NA,NA
"d0e2be3b57a79a39086ff1ad165afcf7","meshsensors",NA,NA,NA,NA
"48bc1afa8f5d8ae10aa9b7be26a6a0c4","minesage",NA,NA,NA,NA
"1e8fdce4bc6df898b0788cd4a9c2f577","mesoblast",NA,NA,NA,NA
"e451b6a3a8605ca68f0797b343c770b6","mesoica",NA,NA,NA,NA
"f10f42612b41f5093f730c6bf4c962e3","message-business",NA,NA,NA,NA
"f3802ab744752e0e22da8e7ea90c8984","messagegears","debt_financing",NA,"2010-07-01",625000
"d284d4b17bd2be8144103fbc3769b028","messagehandler",NA,NA,NA,NA
"5a46a3e683cd715ccb78dc1da0841ac6","meta-data-analytics-360","venture",NA,"2014-03-14",5e+05
"5a46a3e683cd715ccb78dc1da0841ac6","meta-data-analytics-360","equity_crowdfunding",NA,"2015-05-04",NA
"d80fb4154d895e69c457851d128b2b24","meta-matter-llc",NA,NA,NA,NA
"773bb3fc584b54a2342c84e6825bc119","metabolic-solutions-development","debt_financing",NA,"2015-09-25",16135409
"773bb3fc584b54a2342c84e6825bc119","metabolic-solutions-development","venture","1","2010-10-24",23500000
"773bb3fc584b54a2342c84e6825bc119","metabolic-solutions-development","venture",NA,"2014-02-05",98191
"773bb3fc584b54a2342c84e6825bc119","metabolic-solutions-development","venture",NA,"2011-08-11",6810000
"bcec4258bd9617147a10da2c57defc79","metabolistics",NA,NA,NA,NA
"1bb0cc62addda5336daee544981f0ffa","metabolix","grant",NA,"2011-05-05",6e+06
"1bb0cc62addda5336daee544981f0ffa","metabolix","post_ipo_equity",NA,"2014-08-04",2.5e+07
"d8e2c2967e01341ad6d47867229d9990","metabolomic-diagnostics","venture",NA,"2014-12-09",NA
"d8e2c2967e01341ad6d47867229d9990","metabolomic-diagnostics","venture",NA,"2013-09-28",NA
"d8e2c2967e01341ad6d47867229d9990","metabolomic-diagnostics","venture",NA,"2014-01-02",964950
"d8e2c2967e01341ad6d47867229d9990","metabolomic-diagnostics","seed",NA,"2015-02-11",849444
"d8e2c2967e01341ad6d47867229d9990","metabolomic-diagnostics","venture",NA,"2013-06-28",NA
"f7c8bdf1f72b1949a3513c54d631226f","metabolomx","grant",NA,"2011-10-24",1140000
"966dca4f9767f88c34edbc57100a39a8","metabolon","venture","e","2014-01-06",14999980
"966dca4f9767f88c34edbc57100a39a8","metabolon","venture","d","2011-08-29",13100000
"966dca4f9767f88c34edbc57100a39a8","metabolon","venture","b","2006-01-18",8e+06
"966dca4f9767f88c34edbc57100a39a8","metabolon","venture",NA,"2008-04-30",5270577
"966dca4f9767f88c34edbc57100a39a8","metabolon","venture","c","2009-12-07",6e+06
"966dca4f9767f88c34edbc57100a39a8","metabolon","venture",NA,"2015-03-09",5049994
"65bc5d0ad4beb7abb12040a493fe6904","metacell","seed",NA,"2014-08-01",1e+05
"f8671c341c3229364955db56e30cf47b","metacog-inc","seed",NA,"2014-09-24",2e+06
"6a71e40239d2f420b4cd7c1da4bb818d","metacrine","venture","A","2015-08-05",3.6e+07
"be8a9dc6ad4abcae09ce5303dd5add3c","metacrux-consulting",NA,NA,NA,NA
"7f284cce0de9c6dfc9ddabe5c9ea3220","metacure","venture","b","2009-05-10",2e+07
"c1d7d48db25f3d434f6c8096b0330c5a","metafor-software","seed",NA,"2012-11-05",NA
"ca8fbaa760e917edbbb392ccc98ec5a8","metaform","venture","A","2007-02-01",2881355.9322
"7f49e40ff996d1f6b3bd7a133aad89dc","metafused","seed",NA,"2015-08-21",3e+05
"7f49e40ff996d1f6b3bd7a133aad89dc","metafused","angel",NA,"2013-06-01",NA
"7f49e40ff996d1f6b3bd7a133aad89dc","metafused","angel",NA,"2014-04-01",NA
"7f49e40ff996d1f6b3bd7a133aad89dc","metafused","grant",NA,"2014-03-09",4e+05
"4300e3df86893bc0f48618c2e391dd10","metagenomix","seed",NA,"2010-04-13",7e+05
"ef319a567d2c5737f9c78f08adb9872f","metagoo",NA,NA,NA,NA
"6b99eabd28c1ca9c71cd9712e241f759","metamark-genetics","venture","b","2010-08-13",2.2e+07
"6b99eabd28c1ca9c71cd9712e241f759","metamark-genetics","private_equity",NA,"2012-11-15",9109287
"6b99eabd28c1ca9c71cd9712e241f759","metamark-genetics","venture","b","2012-11-05",1.3e+07
"6b99eabd28c1ca9c71cd9712e241f759","metamark-genetics","venture",NA,"2009-05-06",2650000
"6ba9086c70f74a0a319d2a8799ce2941","metamarkets","venture","b","2012-04-26",1.5e+07
"6ba9086c70f74a0a319d2a8799ce2941","metamarkets","seed",NA,"2010-06-01",2500000
"6ba9086c70f74a0a319d2a8799ce2941","metamarkets","venture","a","2011-05-31",6e+06
"6ba9086c70f74a0a319d2a8799ce2941","metamarkets","venture","b","2013-12-22",5e+06
"6ba9086c70f74a0a319d2a8799ce2941","metamarkets","venture","C","2015-02-24",1.5e+07
"8712ce71b4d6db955a1d5c5ed5fb883d","metamed","angel",NA,"2012-09-01",5e+05
"e6eddff401fbe656b87d380fad4dae7e","metamind","venture",NA,"2014-12-05",8e+06
"d551f306432c9b4b7ad3174836643ae0","metamug",NA,NA,NA,NA
"2bc71ce89c9e69ee124cd1f0bef32f0a","metanautix","venture","A","2014-08-05",7e+06
"2bc71ce89c9e69ee124cd1f0bef32f0a","metanautix","venture",NA,"2015-07-14",NA
"e65a3136b1f3b7738baf294ece51de5f","metanet-ivs",NA,NA,NA,NA
"d0db004c20d20ab7020118a2196c9117","metaome","venture",NA,"2013-09-09",NA
"015aebec89bd7645695f7a4e35b58b3b","metascale",NA,NA,NA,NA
"d755b93a85ff3c8c997ba0fa97cb3927","metasquare",NA,NA,NA,NA
"c871052bd99048ae49c96af5120b682f","metastat","venture",NA,"2012-05-11",880000
"c871052bd99048ae49c96af5120b682f","metastat","venture",NA,"2013-12-24",1487000
"c871052bd99048ae49c96af5120b682f","metastat","venture",NA,"2014-01-01",2450000
"c871052bd99048ae49c96af5120b682f","metastat","debt_financing",NA,"2014-06-20",215000
"c871052bd99048ae49c96af5120b682f","metastat","venture",NA,"2014-07-08",5735427
"c871052bd99048ae49c96af5120b682f","metastat","venture","1","2015-01-06",3500000
"c871052bd99048ae49c96af5120b682f","metastat","venture",NA,"2015-03-20",1300000
"c871052bd99048ae49c96af5120b682f","metastat","post_ipo_debt",NA,"2015-08-14",1200000
"3be7f30c06c6406f389212bf53ee8e85","metatron-2",NA,NA,NA,NA
"38f2d4571d388d0bced6642866eae4a0","metecol",NA,NA,NA,NA
"298ba8ae3afad16c0401f2a4e2eb3c3a","meteo-logic","venture","a","2013-09-03",3e+06
"cfbc8f7f69430fbf03f6b4a8631885fb","meteor-solutions","angel",NA,"2010-01-01",NA
"5c6bd1af9a3dcef62981ba2810c24d24","meteorix",NA,NA,NA,NA
"f9704aaddefaacf2d89257da4096d55d","metgen","venture",NA,"2013-02-11",2946020
"7a5b86dcc695646501fbb1bbbf8c6e50","metheor-therapeutics","venture",NA,"2015-10-30",90000
"7a5b86dcc695646501fbb1bbbf8c6e50","metheor-therapeutics","seed",NA,"2011-08-30",185000
"7ea57b88df868850327f66c50911c1ee","method-mill",NA,NA,NA,NA
"723e72d019abc81df51dcee08e85c8c0","methylgene","venture",NA,"2012-11-21",26125730
"723e72d019abc81df51dcee08e85c8c0","methylgene","venture",NA,"2011-09-11",34500000
"99092f55a39e04b4c5da4c63cfd305da","metia",NA,NA,NA,NA
"df9af8831b8414bc8cf4c1f6171d5b91","metra-biosystems",NA,NA,NA,NA
"cd88aebb5fecd290cc5bd802ec98fd9f","metric-arts",NA,NA,NA,NA
"425351e317b3e76c2213e21273424779","metric-insights","seed",NA,"2013-12-01",NA
"425351e317b3e76c2213e21273424779","metric-insights","seed",NA,"2015-03-04",3758835
"ccab011f29306bd4388a4c4d0689a180","metric-review",NA,NA,NA,NA
"cf537b486d7d25ef7c3f801c1b5b60c1","metricle--inc-",NA,NA,NA,NA
"35418f82b347fe000bc3b86a4cd0b65c","metricly","seed",NA,"2010-01-01",NA
"d4bf6d733cb91da1334f77d48463153b","metricsbot",NA,NA,NA,NA
"a7b6f3aa679534121b6592fc733f0c7d","metricscat","seed",NA,"2014-09-16",20000
"a7b6f3aa679534121b6592fc733f0c7d","metricscat","seed",NA,"2014-08-30",NA
"81b6bda6809db872e0dabe0aca725b91","metricstory","seed",NA,"2015-12-09",1450000
"81b6bda6809db872e0dabe0aca725b91","metricstory","seed",NA,"2015-03-23",118000
"fdd60640af1a264d8638323b5fc074b8","metricus",NA,NA,NA,NA
"989bfc9504af19524e01580b4d8a1797","metrify",NA,NA,NA,NA
"9e2d7ba15f6098dd8718f8959a5cbd9f","metrigen",NA,NA,NA,NA
"396d908b67b379134b4397cea2d14aca","metrik-studios","seed",NA,"2012-11-23",40000
"3acf4eb524f60b5ad1059325d5c2c904","metrikea","undisclosed",NA,"2014-09-12",NA
"1e3789bb632f464b0611db5683f33877","metristo",NA,NA,NA,NA
"daab869a88e0531c8e96020b065fe871","metrixlab","venture",NA,"2008-10-20",NA
"66c43b1f591ecf91ffb114ad46aee26f","metronome-labs",NA,NA,NA,NA
"ef48deed8e4e3e64030adf2b58d2e74a","mettler-toledo-international-inc",NA,NA,NA,NA
"3eef4cc112388c32abc147ae651a4aae","metwit","seed",NA,"2012-08-30",25000
"3ccbf67d50634aa32836994ce98e5c36","mevion-medical-systems","venture","C","2007-10-08",6900000
"3ccbf67d50634aa32836994ce98e5c36","mevion-medical-systems","venture",NA,"2012-01-24",4.5e+07
"3ccbf67d50634aa32836994ce98e5c36","mevion-medical-systems","private_equity",NA,"2012-01-12",2.5e+07
"3ccbf67d50634aa32836994ce98e5c36","mevion-medical-systems","private_equity",NA,"2013-06-25",5.5e+07
"3ccbf67d50634aa32836994ce98e5c36","mevion-medical-systems","venture",NA,"2011-03-18",11500000
"3ccbf67d50634aa32836994ce98e5c36","mevion-medical-systems","venture",NA,"2009-01-01",3.3e+07
"3ccbf67d50634aa32836994ce98e5c36","mevion-medical-systems","private_equity",NA,"2014-08-04",2e+08
"3ccbf67d50634aa32836994ce98e5c36","mevion-medical-systems","private_equity",NA,"2015-08-11",58835853
"28d531ddef719260eba962475bc0051c","mevoked",NA,NA,NA,NA
"244e10e7bf27fec60426d3013a7ebdde","mevvy","seed",NA,"2013-06-05",30000
"244e10e7bf27fec60426d3013a7ebdde","mevvy","seed",NA,"2012-06-06",40000
"4b2f92e45d8f0d1a78f1745c1a730770","mezzo-labs",NA,NA,NA,NA
"4813be46bb42345cbe1ec3de88331fe7","mgb-biopharma","venture","A","2010-03-31",3030000
"4813be46bb42345cbe1ec3de88331fe7","mgb-biopharma","grant",NA,"2014-06-09",2184359
"4813be46bb42345cbe1ec3de88331fe7","mgb-biopharma","venture","B","2014-09-17",6400000
"1848e6993115712c685ea4dafd5918d6","mgi-pharma",NA,NA,NA,NA
"1b5692a2825b7c2be4976c2198e5154e","mgv","grant",NA,"2012-06-01",10000
"f77d72dfe1f919efc3ff334237cc742d","mgvs",NA,NA,NA,NA
"02e2ffd9f0122cca06c76d0bde9fb91f","mhoto",NA,NA,NA,NA
"30d9f299007e68766d45a38b00d747f4","mi-digital",NA,NA,NA,NA
"960011c41786e999a72078d5a68dc783","mi-c3",NA,NA,NA,NA
"de8c776422d7c70027e26cc191afe82d","mic-network","seed",NA,"2013-03-01",1800000
"de8c776422d7c70027e26cc191afe82d","mic-network","angel",NA,"2013-10-27",3200000
"de8c776422d7c70027e26cc191afe82d","mic-network","venture","1","2014-04-28",1e+07
"de8c776422d7c70027e26cc191afe82d","mic-network","venture","1","2015-06-02",1.7e+07
"0082524051f505c432857276e35f4e0a","micar21","equity_crowdfunding",NA,"2014-12-16",NA
"9f66e8c3e8fef0dbb0f31f88f6a2186c","micell-technologies","venture","b","2009-10-01",1.5e+07
"9f66e8c3e8fef0dbb0f31f88f6a2186c","micell-technologies","venture",NA,"2007-07-12",7e+06
"9f66e8c3e8fef0dbb0f31f88f6a2186c","micell-technologies","venture",NA,"2009-12-03",300055
"9f66e8c3e8fef0dbb0f31f88f6a2186c","micell-technologies","debt_financing",NA,"2009-07-29",5e+06
"948bf9606789423809e2aa6e70200c81","micelle-laboratories",NA,NA,NA,NA
"873a96e8575addb84fb0ac8891ccbde6","michelson-diagnostics","venture","a","2010-10-13",2692759
"873a96e8575addb84fb0ac8891ccbde6","michelson-diagnostics","venture",NA,"2010-01-06",1100000
"873a96e8575addb84fb0ac8891ccbde6","michelson-diagnostics","undisclosed",NA,"2012-03-13",948321
"873a96e8575addb84fb0ac8891ccbde6","michelson-diagnostics","venture","a","2014-01-13",3250000
"873a96e8575addb84fb0ac8891ccbde6","michelson-diagnostics","venture","B","2015-02-16",2848191
"e37fa2878d9f76a0a74b442eef48cd16","michigan-endoscopy-center","venture",NA,"2009-10-23",350000
"e37fa2878d9f76a0a74b442eef48cd16","michigan-endoscopy-center","venture",NA,"2015-01-13",517758
"8797a07c843f8c847a25127accada1b1","micreos","undisclosed",NA,"2012-05-23",NA
"52c498363b0173966b2f4798a4bf9568","micrima","venture",NA,"2008-04-22",3990000
"52c498363b0173966b2f4798a4bf9568","micrima","venture",NA,"2012-09-12",965149
"52c498363b0173966b2f4798a4bf9568","micrima","undisclosed",NA,"2006-03-08",824888
"de8d9926c33efb00afd9234d99b4bda1","microarrays","venture",NA,"2010-08-27",1e+06
"f764a2c9e4822b1f1300e7775007d97f","microbia","venture","E","2007-03-01",5e+07
"9823ecdf38817ce9c27941395dfeb1d6","microbial-systems",NA,NA,NA,NA
"dbc6929b53ec00c797528fbb6a57032b","microbide",NA,NA,NA,NA
"e5d8d6d0ead8c6de0430e140af659438","microbiome-therapeutics","seed",NA,"2013-12-20",1300000
"e5d8d6d0ead8c6de0430e140af659438","microbiome-therapeutics","debt_financing",NA,"2015-06-24",743445
"0ed7a3276a6215fc9dbbda2a2df71300","microbion","venture",NA,"2009-10-26",414000
"0ed7a3276a6215fc9dbbda2a2df71300","microbion","venture",NA,"2011-09-15",932664
"0ed7a3276a6215fc9dbbda2a2df71300","microbion","venture",NA,"2013-04-03",1246025
"0ed7a3276a6215fc9dbbda2a2df71300","microbion","venture",NA,"2010-08-11",199374
"0ed7a3276a6215fc9dbbda2a2df71300","microbion","venture",NA,"2016-01-22",5861141
"8230e03372cd3309b714c573bfd1f1fb","microbix-biosystems","convertible_note",NA,"2014-02-20",1500000
"8230e03372cd3309b714c573bfd1f1fb","microbix-biosystems","venture",NA,"2009-09-23",88124
"8230e03372cd3309b714c573bfd1f1fb","microbix-biosystems","venture",NA,"2010-03-29",296283
"8230e03372cd3309b714c573bfd1f1fb","microbix-biosystems","venture",NA,"2011-08-18",248010
"b2e3bfc7721b025a7b7b21821d5f2c47","microblink",NA,NA,NA,NA
"bf535df5a9d167ebfbc9ef953de24fc2","microchemistry-ltd",NA,NA,NA,NA
"78ab693b56bb36d5e23c1627ab8642ce","microcure-ltd",NA,NA,NA,NA
"db752167f86d51c51dd1e2f2ab22dbb8","microdermis","debt_financing",NA,"2015-12-29",1387500
"db752167f86d51c51dd1e2f2ab22dbb8","microdermis","venture",NA,"2012-09-04",2376720
"db752167f86d51c51dd1e2f2ab22dbb8","microdermis","venture",NA,"2010-10-25",1500000
"db752167f86d51c51dd1e2f2ab22dbb8","microdermis","convertible_note",NA,"2011-05-13",375000
"db752167f86d51c51dd1e2f2ab22dbb8","microdermis","venture",NA,"2014-11-25",40000
"db752167f86d51c51dd1e2f2ab22dbb8","microdermis","debt_financing",NA,"2015-08-27",375001
"f15c8cb35db1d4abb37cce54346289bd","microdimensions","seed",NA,"2014-03-07",NA
"e0a4435235f189c7145632b673124ab6","microfusin-informtica",NA,NA,NA,NA
"f04fcb9054334c308184f1713f8ca9a4","microgen-biotech",NA,NA,NA,NA
"164f6ef42364c52435b46a0a5dd2bf31","microland","venture",NA,"2006-08-09",1.1e+07
"164f6ef42364c52435b46a0a5dd2bf31","microland","venture",NA,"2005-01-14",7300000
"bf8e78f3b469dd2e4d036bddc7348afe","microlin-bio",NA,NA,NA,NA
"6e8ca56c76953561ea1f31d389c15530","microlytic","undisclosed",NA,"2011-12-01",NA
"f70adc243bc3396aea79532211e6381e","micromed-cardiovascular","debt_financing",NA,"2011-01-31",4083500
"f70adc243bc3396aea79532211e6381e","micromed-cardiovascular","debt_financing",NA,"2011-09-08",3752323
"f70adc243bc3396aea79532211e6381e","micromed-cardiovascular","venture",NA,"2011-12-13",3185680
"4e7254e022dc6c486e49eedabe7d3b90","micromedia-imaging-systems",NA,NA,NA,NA
"1603d3f7474373afe1d8628f0f0b06c4","micromedics",NA,NA,NA,NA
"c2d087bc8b56555aab7a8ac7ad66537f","micromet",NA,NA,NA,NA
"4521266fdc40b837f50f1848622d22ac","micromuscle","venture",NA,"2006-11-22",NA
"7ccfc438228c059506f64b27f5d4fe30","micron-technologies",NA,NA,NA,NA
"19a77cb783dcc99a711bbf4c40bfd811","micronet",NA,NA,NA,NA
"df662bd049d044cc107674c11275d226","micronics",NA,NA,NA,NA
"552f939088e3add55df2d7b7b4a886af","micronotes","venture",NA,"2009-11-30",301076
"b4303a3372bc9bf7df69552b42b166d3","microphage","debt_financing",NA,"2009-05-31",8514449
"b4303a3372bc9bf7df69552b42b166d3","microphage","debt_financing",NA,"2011-10-19",6e+06
"22b599cc040814edceeeb18a7c974433","micropharma","seed",NA,"2013-01-24",851242
"72f9ed0b60e41f52e299c30e59b7a8b2","microporous-products",NA,NA,NA,NA
"8685a9cd7358de2c65f568b5cd54e1ea","microquant","venture",NA,"2013-03-22",740000
"d7a1e88805ff92abd04f7e13f03e7c3c","microrganic-technologies","venture",NA,"2013-10-01",49997
"d7a1e88805ff92abd04f7e13f03e7c3c","microrganic-technologies","venture",NA,"2014-09-05",380000
"21cd4938d3d4123ba4e45a4136d52044","microsaic","venture",NA,"2013-05-28",6515581
"963f0b25d90113c929c46c752e0fa67a","microscopy-innovations","venture",NA,"2015-03-19",749998
"9ca58d4201f0b4d1f8669c34d5127cbc","microsoft-assistance",NA,NA,NA,NA
"002dba78a5db27e4feb9eb432b51fdfc","microsoft-research",NA,NA,NA,NA
"232a54d3a68f8e7ae56955ea1258fe6d","microsonic-systems","venture",NA,"2010-09-16",1259000
"232a54d3a68f8e7ae56955ea1258fe6d","microsonic-systems","venture",NA,"2009-07-10",665006
"9e06f9809ecfd8b6e1ff6e597206b6f6","microstim","seed",NA,"2009-02-05",640000
"9e06f9809ecfd8b6e1ff6e597206b6f6","microstim","venture",NA,"2011-10-06",1990350
"9e06f9809ecfd8b6e1ff6e597206b6f6","microstim","venture",NA,"2013-09-17",643300
"8f10370bcac8f71452a2153643015744","microtest-diagnostics","grant",NA,"2003-01-01",16121445
"8f10370bcac8f71452a2153643015744","microtest-diagnostics","venture","1","2012-01-01",3098048
"24ff6ef7238a87303bac9382bb3a39ea","microthings",NA,NA,NA,NA
"2bcedc4eb22970735a875e1a5189a470","microvi-biotechnologies","venture","a","2009-01-01",NA
"2bcedc4eb22970735a875e1a5189a470","microvi-biotechnologies","grant",NA,"2014-01-01",1500000
"2bcedc4eb22970735a875e1a5189a470","microvi-biotechnologies","venture",NA,"2014-12-01",5e+06
"2bcedc4eb22970735a875e1a5189a470","microvi-biotechnologies","venture","B","2015-01-15",NA
"17b7b759f593c064283c365223837663","microzap",NA,NA,NA,NA
"e57e00755e11eb9c1ef1e6d011572162","micurx-pharmaceuticals","venture","A","2007-06-25",1e+07
"e57e00755e11eb9c1ef1e6d011572162","micurx-pharmaceuticals","venture","b","2013-08-22",2.5e+07
"46ec40dd83bf8b50dd8adadf517c53de","mid-america-consulting-group","venture",NA,"2010-05-04",6367916
"292f92d146ef3ed9f74aa548d7a7113f","middle-peak-medical","venture","a","2013-10-28",3e+06
"292f92d146ef3ed9f74aa548d7a7113f","middle-peak-medical","venture","a","2013-06-26",8500000
"a2d01d6283d57a9e7dcea06b11c07991","middlegate","venture",NA,"2013-05-06",896000
"a2d01d6283d57a9e7dcea06b11c07991","middlegate","debt_financing",NA,"2014-08-05",1e+05
"9bf06a03088a47132d35cfbad297759e","milestone-pharmaceuticals","venture",NA,"2011-06-13",1.3e+07
"9bf06a03088a47132d35cfbad297759e","milestone-pharmaceuticals","venture","1","2015-06-15",1.7e+07
"48d3c42118974b13620dd4cc5549fbaf","milestone-scientific","post_ipo_equity",NA,"2013-11-19",150000
"48d3c42118974b13620dd4cc5549fbaf","milestone-scientific","venture",NA,"2014-05-20",1e+07
"48d3c42118974b13620dd4cc5549fbaf","milestone-scientific","grant",NA,"2015-07-06",4200000
"c879c1af1e3deb7b479cd87679f27e23","milestone-pod","seed",NA,"2015-01-25",1400000
"c879c1af1e3deb7b479cd87679f27e23","milestone-pod","seed",NA,"2013-12-16",350000
"bdf79d85832cd374a8c9de27486cda05","militarymobile",NA,NA,NA,NA
"b698939e21cd8e3d3c3a6aa6f0dcd58e","millbrook-inc",NA,NA,NA,NA
"8d4f0a984e4b3af6b18ee86539119a69","atterocor","venture","B","2016-01-05",6.2e+07
"8d4f0a984e4b3af6b18ee86539119a69","atterocor","venture","a","2012-08-03",1.6e+07
"8d4f0a984e4b3af6b18ee86539119a69","atterocor","private_equity",NA,"2013-02-26",8522872
"b38b78a72932b0ecf843121ffefe68ef","millenium-biologix","venture",NA,"2006-08-18",1180000
"b38b78a72932b0ecf843121ffefe68ef","millenium-biologix","venture",NA,"2005-11-18",1.3e+07
"036b82b44193a0e9276b732dcbb35a9f","millennium-biotechnologies","debt_financing",NA,"2009-11-10",4601838
"665761ab008621c09fbb14675c3f1ae5","millennium-laboratories","debt_financing",NA,"2010-08-13",1.96e+08
"68a2b0834431a8f59d53c40eef2b4407","millennium-pharmaceuticals",NA,NA,NA,NA
"99aac107962a8c22d7d460764fe33a37","millennium-pharmacy-systems","private_equity",NA,"2007-06-13",4e+07
"99aac107962a8c22d7d460764fe33a37","millennium-pharmacy-systems","venture",NA,"2011-03-24",7074808
"6bb1ddadd0681ef9e08fbfc98113498d","millepah",NA,NA,NA,NA
"b6ee2c213ead60a3b451d976f9c8ff70","millipore",NA,NA,NA,NA
"34bedbcab9e751d6e149fa32b9f22b43","millipore-india",NA,NA,NA,NA
"797352786b137272ff1eb4f9e6ce623f","milo-biotechnology","venture",NA,"2012-02-14",250000
"64893ae68e6abe96b910a6986c3b7c7e","milople",NA,NA,NA,NA
"19602f4dd0b2cd065faae7da29572f69","miltenyi-biotec",NA,NA,NA,NA
"c0e083d0fca3b11f9b313b68917e5dc4","mimedx",NA,NA,NA,NA
"9b1511dd7a4972b387882b27eb53b6cf","mimetogen-pharmaceuticals","venture",NA,"2005-10-31",848000
"9b1511dd7a4972b387882b27eb53b6cf","mimetogen-pharmaceuticals","venture","1","2011-02-25",2e+06
"9b1511dd7a4972b387882b27eb53b6cf","mimetogen-pharmaceuticals","venture",NA,"2013-07-18",8e+05
"ee62fe191e7ee5663f211fbbb6ea2f41","minatx",NA,NA,NA,NA
"5645a53d7bf2dd795e056c906bf3e793","mind-the-byte","equity_crowdfunding",NA,"2015-10-22",265894.1045
"0bb6306b859f05f3f615e9349b39635c","mind-your-analytics",NA,NA,NA,NA
"e8548815e7e68f5004f7bdea7846a599","mind-matrix",NA,NA,NA,NA
"38a7c122a18cb9c6996b80f4572cb7bf","mind-nrg","venture","a","2011-01-11",2e+06
"38a7c122a18cb9c6996b80f4572cb7bf","mind-nrg","venture","b","2013-09-04",7719600
"38a7c122a18cb9c6996b80f4572cb7bf","mind-nrg","venture","a","2010-10-27",13803000
"0287c9388e4efb06934aef3800e2470b","minder-it-solutions",NA,NA,NA,NA
"e43c50e1369cce99decf52670b6b2c99","mindframe-inc","venture","a","2012-05-18",6500000
"e43c50e1369cce99decf52670b6b2c99","mindframe-inc","convertible_note",NA,"2012-01-05",1999900
"e43c50e1369cce99decf52670b6b2c99","mindframe-inc","venture",NA,"2010-08-16",7087672
"08cad025306bf8cd336043c68b941fa3","mindgenius",NA,NA,NA,NA
"299ae6ea727cfd86bc5df6cebf773825","mindmeld","venture","A","2014-12-18",1.3e+07
"299ae6ea727cfd86bc5df6cebf773825","mindmeld","undisclosed",NA,"2014-07-18",NA
"299ae6ea727cfd86bc5df6cebf773825","mindmeld","convertible_note",NA,"2013-07-22",NA
"299ae6ea727cfd86bc5df6cebf773825","mindmeld","venture",NA,"2012-10-04",2400000
"03f7a4b241faaf7818a294a37e4a578d","mindray-medical-international",NA,NA,NA,NA
"51bbe4a24167bcf98bc3f43830334479","mindset-rx","venture",NA,"2010-11-30",1e+05
"15d6d849636d077612f891e071e0b915","mindset-systems",NA,NA,NA,NA
"6a5aeb8cf0436758b4a4acf55cfdb575","mindseye-solutions",NA,NA,NA,NA
"ee79ae796a05d43bc0023b5b592b202a","mindshare-medical","seed",NA,"2014-05-01",525000
"ee79ae796a05d43bc0023b5b592b202a","mindshare-medical","seed",NA,"2015-02-09",728709
"b8fa48577358772ad276021762eb6d8a","mindvalley",NA,NA,NA,NA
"03275426bb0e4c0450f24638ccbbd980","mineful","seed",NA,"2011-09-23",25000
"523433b8927afe1afdb8ecd9d3d31d0c","minerva-biotechnologies","venture",NA,"2010-02-23",1605632
"523433b8927afe1afdb8ecd9d3d31d0c","minerva-biotechnologies","venture",NA,"2010-11-17",4600000
"523433b8927afe1afdb8ecd9d3d31d0c","minerva-biotechnologies","venture",NA,"2014-10-24",2e+06
"ef6aed4757762c4a6c8fbca1dccc4fed","minetta-brook","seed",NA,"2013-01-14",NA
"ef6aed4757762c4a6c8fbca1dccc4fed","minetta-brook","debt_financing",NA,"2012-11-30",163000
"ef6aed4757762c4a6c8fbca1dccc4fed","minetta-brook","seed",NA,"2013-07-23",2e+06
"ef6aed4757762c4a6c8fbca1dccc4fed","minetta-brook","debt_financing",NA,"2014-03-27",50000
"ef6aed4757762c4a6c8fbca1dccc4fed","minetta-brook","debt_financing",NA,"2014-11-24",250000
"ef6aed4757762c4a6c8fbca1dccc4fed","minetta-brook","venture",NA,"2015-06-12",1626000
"f0835990c51757d3288a4a15bd9c3ff9","minewhat","seed",NA,"2012-11-08",NA
"f0835990c51757d3288a4a15bd9c3ff9","minewhat","convertible_note",NA,"2014-01-21",NA
"f0835990c51757d3288a4a15bd9c3ff9","minewhat","convertible_note",NA,"2015-04-06",NA
"0de61c491c600e81469091e97884c58a","minhash","seed",NA,"2015-05-12",NA
"9d98d2ab3a5dead0a53ece9f2d110b31","miniera",NA,NA,NA,NA
"e0258a45cf798d669475853ba4dfa74c","minimus-spine","venture",NA,"2011-01-11",1000324
"e0258a45cf798d669475853ba4dfa74c","minimus-spine","venture",NA,"2012-11-15",1039926
"68e28b89f44c7bc3511400b1e582002d","minivax","venture",NA,"2013-05-02",110000
"0b736e3be5cb780f7f1905d8218d9bc7","minneapolis-data-scraping",NA,NA,NA,NA
"35ef58dad3f357849305e0a74d276135","minoryx-therapeutics","venture","A","2015-10-14",22101545.5892
"35ef58dad3f357849305e0a74d276135","minoryx-therapeutics","venture","a","2013-04-04",1922700
"35ef58dad3f357849305e0a74d276135","minoryx-therapeutics","venture",NA,"2015-01-23",1825108.9362
"47c464fced5abdcc1c2a9a66e1c9c820","mint-labs","seed",NA,"2013-04-01",51295
"47c464fced5abdcc1c2a9a66e1c9c820","mint-labs","grant",NA,"2013-12-01",217449
"47c464fced5abdcc1c2a9a66e1c9c820","mint-labs","grant",NA,"2015-04-01",269480
"47c464fced5abdcc1c2a9a66e1c9c820","mint-labs","convertible_note",NA,"2015-02-01",293692
"5d0a957d5ed83ef93896c8dd06365307","mintigo","venture","c","2013-10-17",1e+07
"5d0a957d5ed83ef93896c8dd06365307","mintigo","venture","b","2011-09-21",9e+06
"0c2b5a0f27e1f2184ad0369c04b47747","minubo","seed",NA,"2013-09-27",1286600
"0c2b5a0f27e1f2184ad0369c04b47747","minubo","seed",NA,"2014-12-11",1600000
"9126ef56c60213f0169e3cf379cca0c9","mips",NA,NA,NA,NA
"0e9c0195adc9a6f62c1b3db38985a44b","mira-dx","venture","a","2010-07-01",4e+06
"502c4024fa060394f775872b603118dc","mirabosystems",NA,NA,NA,NA
"4e1ea49e57395c84dd82b5b75bbeb196","miraclecord","debt_financing",NA,"2012-02-09",2e+05
"bea18c9ddd09a862477952222cf0e878","mirador-biomedical","venture","b","2011-07-08",1500000
"eb85b87be6f4b0c7e63cc974a7e961fd","miragen-therapeutics","venture","C","2015-11-10",4.1e+07
"eb85b87be6f4b0c7e63cc974a7e961fd","miragen-therapeutics","venture","b","2012-04-24",2e+07
"eb85b87be6f4b0c7e63cc974a7e961fd","miragen-therapeutics","convertible_note",NA,"2012-01-03",6e+06
"eb85b87be6f4b0c7e63cc974a7e961fd","miragen-therapeutics","venture","a","2008-05-19",8e+06
"eb85b87be6f4b0c7e63cc974a7e961fd","miragen-therapeutics","venture","b","2009-06-03",4e+06
"eb85b87be6f4b0c7e63cc974a7e961fd","miragen-therapeutics","venture","B","2014-06-27",7e+06
"eb85b87be6f4b0c7e63cc974a7e961fd","miragen-therapeutics","venture","B","2015-02-18",8500000
"eb7ebd21f8dc33f9c699885f28558e3c","mirexus-biotechnologies","venture","A","2015-10-08",3447562.5733
"eb7ebd21f8dc33f9c699885f28558e3c","mirexus-biotechnologies","venture",NA,"2014-03-13",350000
"dc130fc8d430b542d676d3f3a6df9537","mirimus","venture","a","2011-03-03",2e+06
"56b70a2289cdd4efd3a2d83f15e3eede","mirna-therapeutics","grant",NA,"2014-05-21",16765000
"56b70a2289cdd4efd3a2d83f15e3eede","mirna-therapeutics","grant",NA,"2010-06-18",10297000
"56b70a2289cdd4efd3a2d83f15e3eede","mirna-therapeutics","grant",NA,"2009-12-16",5e+06
"56b70a2289cdd4efd3a2d83f15e3eede","mirna-therapeutics","venture","1","2012-10-24",34500000
"56b70a2289cdd4efd3a2d83f15e3eede","mirna-therapeutics","venture","1","2015-04-30",41800000
"56b70a2289cdd4efd3a2d83f15e3eede","mirna-therapeutics","venture","1","2011-08-23",1500000
"a37bb0af6d17813f4fc8e53e38ef44f7","miromatrix-medical","venture","B","2015-08-28",23284490
"a37bb0af6d17813f4fc8e53e38ef44f7","miromatrix-medical","venture",NA,"2012-07-20",5312856
"82a5ed07ad2aca9a014677c2a4c45748","mirror42","venture","a","2007-12-01",1200000
"d6c9e23a89c04ad2ca440587e486084f","mirsani",NA,NA,NA,NA
"7555f110dd98520814d2efe0cf111649","mirtle-medical","venture","a","2013-05-30",250000
"7555f110dd98520814d2efe0cf111649","mirtle-medical","debt_financing",NA,"2014-06-12",150000
"1bd8db9c66ff23e6b307394449982262","mirus-bio",NA,NA,NA,NA
"93c1644fee7883a6a406fe4d06cf4a12","mish-guru","seed",NA,"2014-05-01",18000
"93c1644fee7883a6a406fe4d06cf4a12","mish-guru","seed",NA,"2014-12-15",28500
"93c1644fee7883a6a406fe4d06cf4a12","mish-guru","angel",NA,"2015-06-06",NA
"f1e95c308e8375858af9e6330453efea","mishmash-i-o",NA,NA,NA,NA
"051d315ba87f3c5d9380f40988cfb2ca","mission-therapeutics","venture",NA,"2011-08-25",1e+07
"051d315ba87f3c5d9380f40988cfb2ca","mission-therapeutics","venture","1","2013-11-18",30305028
"051d315ba87f3c5d9380f40988cfb2ca","mission-therapeutics","grant",NA,"2015-09-25",2895017
"e18e85283e7719a642a6dea840107a48","mit-department-of-biological-engineering",NA,NA,NA,NA
"2e294d3267cb097693ef52bf19ca011c","mitchell-international",NA,NA,NA,NA
"44a9d2a32b9a7ae707111d6b55a8b128","mithridion","venture","A","2007-03-01",2200000
"44a9d2a32b9a7ae707111d6b55a8b128","mithridion","venture",NA,"2009-01-21",2908499
"44a9d2a32b9a7ae707111d6b55a8b128","mithridion","venture","c","2011-01-11",1250000
"6ed5497553e085e9312158ae7fb6c79f","mitochon-pharmaceuticals","seed",NA,"2014-11-05",3e+05
"618fa3afa99baaff416fcc21b88de77a","mitochon-systems","debt_financing",NA,"2010-04-05",640000
"09873260db74c2e9e77e38226a221e08","mitogenetics","venture",NA,"2014-03-03",1485000
"21cce1419c5aad1136fd6475a04535a8","mitokyne","venture",NA,"2013-10-04",5222321
"583efad03a850d57a9dd85f547f6a847","mitomics","debt_financing",NA,"2013-09-26",2077050
"583efad03a850d57a9dd85f547f6a847","mitomics","convertible_note",NA,"2010-12-09",766666
"583efad03a850d57a9dd85f547f6a847","mitomics","venture",NA,"2015-06-26",1e+05
"7a40b8c7c4f714099c61515742916db3","mitoprod","venture",NA,"2005-05-17",170000
"7a40b8c7c4f714099c61515742916db3","mitoprod","venture",NA,"2006-07-04",2046560
"5c8698fa158d306e84129bff14e4996b","mitotix",NA,NA,NA,NA
"17cd15b72687a568eb220bf2cda99a14","mitra-biotech","venture","a","2010-01-01",2200000
"17cd15b72687a568eb220bf2cda99a14","mitra-biotech","venture","b","2013-10-24",4911591
"66f6e16cac4b1cbe60e28873a44f7c75","mitraspan","venture",NA,"2012-07-13",499999
"66f6e16cac4b1cbe60e28873a44f7c75","mitraspan","venture",NA,"2014-08-06",2200000
"864c233e4ddb023381b1a1b626a6deb6","mitrassist","angel",NA,"2013-07-01",1e+06
"82669160969a92daeb443ef775925ed8","mitsubishi-tanabe-pharma",NA,NA,NA,NA
"2a2f8eba8aaa6a8d298035bc80dd4af2","mixrank","debt_financing",NA,"2015-04-30",250000
"2a2f8eba8aaa6a8d298035bc80dd4af2","mixrank","seed",NA,"2011-11-18",1500000
"08e0031f507ae0695bd6365a434cd502","mize-inc",NA,NA,NA,NA
"4b564e2c2e8f067204cc6cf5d5c880e2","mkg-media-group",NA,NA,NA,NA
"87bc519e0545d00d191bae990166060b","mknowledge",NA,NA,NA,NA
"961b9f1dd9be20161e5013a5ea243360","mnemosyne-pharmaceuticals","venture","a","2012-02-16",5400000
"961b9f1dd9be20161e5013a5ea243360","mnemosyne-pharmaceuticals","venture","a","2013-06-21",6e+06
"b205123a08c56ee6507b77726606d6d0","mnubo-inc","seed",NA,"2012-06-07",NA
"b205123a08c56ee6507b77726606d6d0","mnubo-inc","venture","1","2015-05-14",6e+06
"004202e58e638af76271f100e4943b0f","mobclix","seed",NA,"2008-09-01",NA
"7ab7ff7221dc7b7cb8cc848ebbc8628d","mobdb",NA,NA,NA,NA
"3b95d5155e193620962b34a1a6b24ed1","mobee","seed",NA,"2012-11-19",1100000
"3b95d5155e193620962b34a1a6b24ed1","mobee","venture","1","2015-08-25",5e+06
"141bbedb88915c861d78b0da08ada546","mobikon-asia","venture","A","2015-10-08",NA
"141bbedb88915c861d78b0da08ada546","mobikon-asia","venture","A","2012-07-13",1700000
"141bbedb88915c861d78b0da08ada546","mobikon-asia","venture","B","2015-07-14",2300000
"387da9f20971662ca4020dae8d17feb4","mobile-action","seed",NA,"2014-07-23",805000
"387da9f20971662ca4020dae8d17feb4","mobile-action","seed",NA,"2015-04-30",2e+06
"76d0fca4eedb0f6eabe39e23869bfaa0","mobile-acuity",NA,NA,NA,NA
"cf6a560243027612d0c81b6fb5e2d3fd","mobile-agent-technologies",NA,NA,NA,NA
"04fd322418a0d9520129bb2cbd270438","mobile-customer-connect",NA,NA,NA,NA
"622cdd94b77647489f9322dbcba0076a","mobile-interactiva",NA,NA,NA,NA
"442f3add77790a554359a1b20b7b4f4e","mobile-system","seed",NA,"2012-12-14",1e+06
"442f3add77790a554359a1b20b7b4f4e","mobile-system","grant",NA,"2014-06-17",4e+05
"442f3add77790a554359a1b20b7b4f4e","mobile-system","seed",NA,"2014-04-04",1e+06
"442f3add77790a554359a1b20b7b4f4e","mobile-system","undisclosed",NA,"2015-02-24",NA
"5a9561f41619f4f1953a5ce216ad9390","claymx",NA,NA,NA,NA
"9b69bd411eb775a48e54c6a35aab261f","mobiledevhq","seed",NA,"2012-08-01",NA
"9b69bd411eb775a48e54c6a35aab261f","mobiledevhq","undisclosed",NA,"2009-02-01",NA
"9b69bd411eb775a48e54c6a35aab261f","mobiledevhq","seed",NA,"2012-12-20",650000
"8acfcddec43e0156b9ec7b9027a9941c","mobileoct","seed",NA,"2014-09-01",NA
"3e7f009b49916b5ee7745d422aee02ec","mobileroi","seed",NA,"2010-05-01",1e+06
"3e7f009b49916b5ee7745d422aee02ec","mobileroi","venture","1","2011-02-25",5e+06
"fd11ff002819c19c9fd615d9a4b77a15","mobilerq","seed",NA,"2013-09-11",8e+05
"fd11ff002819c19c9fd615d9a4b77a15","mobilerq","venture",NA,"2014-06-24",1200000
"fd11ff002819c19c9fd615d9a4b77a15","mobilerq","debt_financing",NA,"2015-06-17",805000
"43ac9159a36fe490076b1b22f9fcf4d0","mobilewalla","venture","a","2013-01-12",4e+06
"43ac9159a36fe490076b1b22f9fcf4d0","mobilewalla","debt_financing",NA,"2014-05-27",1e+06
"43ac9159a36fe490076b1b22f9fcf4d0","mobilewalla","debt_financing",NA,"2015-08-03",3362914
"11db27892e3152633971368e0de0b4af","mobileye-vision-technologies","private_equity",NA,"2006-05-11",1.5e+07
"11db27892e3152633971368e0de0b4af","mobileye-vision-technologies","private_equity",NA,"2007-10-12",1e+08
"11db27892e3152633971368e0de0b4af","mobileye-vision-technologies","private_equity",NA,"2013-07-07",4e+08
"8173df3315d8f3261e65378e95e3fbef","mobillify",NA,NA,NA,NA
"8049d693731387b13ba19bc461df8c38","mobillions",NA,NA,NA,NA
"db8c1a14f99e805455ef1174219161c3","mobit","seed",NA,"2013-11-10",206611
"db8c1a14f99e805455ef1174219161c3","mobit","seed",NA,"2014-07-08",218910
"db8c1a14f99e805455ef1174219161c3","mobit","seed",NA,"2014-09-14",203656
"db8c1a14f99e805455ef1174219161c3","mobit","seed",NA,"2014-11-12",468626
"85b3b44d4035902c3bf3502d58c12cd6","mobitargets",NA,NA,NA,NA
"602e7d2960f01bb47c1f743fd056c91a","mobius-therapeutics","venture","A","2007-08-01",3500000
"602e7d2960f01bb47c1f743fd056c91a","mobius-therapeutics","venture","b","2013-10-10",5e+06
"602e7d2960f01bb47c1f743fd056c91a","mobius-therapeutics","undisclosed",NA,"2011-02-04",NA
"487853bdcf492396a5430c6e04c05027","mobiuslogic-inc",NA,NA,NA,NA
"cca145be6920ac4575e3343a8f7e25e7","mobolt",NA,NA,NA,NA
"fb30183b0d0364aa2156c5c1b4debc78","mobosurvey",NA,NA,NA,NA
"7d3002d1f7ca83c8bebac8863158f674","mode-analytics","debt_financing",NA,"2014-02-12",375000
"7d3002d1f7ca83c8bebac8863158f674","mode-analytics","seed",NA,"2013-10-17",550000
"7d3002d1f7ca83c8bebac8863158f674","mode-analytics","seed",NA,"2014-06-17",2e+06
"7d3002d1f7ca83c8bebac8863158f674","mode-analytics","venture","1","2015-08-20",7500000
"b47be92a2a84934d05798d0331e5738c","mode-diagnostics","venture","b","2013-05-31",NA
"b47be92a2a84934d05798d0331e5738c","mode-diagnostics","venture","c","2014-01-31",NA
"693f584e1bb764d4f2787603bb0b1630","modelsheet-software",NA,NA,NA,NA
"2108ecabc8fdfb85f69ad724ccd3aec9","modelshop","seed",NA,"2015-05-01",6e+05
"8618cdfb2b4d1ef5d5ad0ce26a91f55f","moderasyon",NA,NA,NA,NA
"416361c1aa7c8fce1ab15d03b0f433bc","moderna-therapeutics","grant",NA,"2016-01-12",2e+07
"416361c1aa7c8fce1ab15d03b0f433bc","moderna-therapeutics","private_equity",NA,"2013-11-20",135000044
"416361c1aa7c8fce1ab15d03b0f433bc","moderna-therapeutics","venture",NA,"2012-12-06",4e+07
"416361c1aa7c8fce1ab15d03b0f433bc","moderna-therapeutics","venture",NA,"2014-01-14",2.5e+07
"416361c1aa7c8fce1ab15d03b0f433bc","moderna-therapeutics","grant",NA,"2013-10-02",24600000
"416361c1aa7c8fce1ab15d03b0f433bc","moderna-therapeutics","private_equity",NA,"2015-01-05",4.5e+08
"d9d226fa1b3e14f8886d287eb3724eaf","modeural",NA,NA,NA,NA
"f15f018da53308d0244d3200e204340f","modeural-2","seed",NA,"2015-03-31",NA
"a4cc4fcd1a8fa504e34a83984d89cb8d","modgen",NA,NA,NA,NA
"cd1554be154e2f36da2058fe14cbd90d","modiface","angel",NA,"2007-04-01",5e+05
"cd1554be154e2f36da2058fe14cbd90d","modiface","venture","1","2012-01-01",3750000
"03c04071d7c0e05a5ba3abcc632a4bbd","modulation-therapeutics","undisclosed",NA,"2013-02-14",NA
"caaab0dbe1638e447cbeaa6a3af4affe","moerae-matrix","venture","b","2013-01-10",5534612
"921cd73e4ad092778e2d0600d34ba084","mofiler",NA,NA,NA,NA
"cad2283c2792462caebe8b95a11d002a","mogene","grant",NA,"2013-09-30",1500000
"d23e868123279a6f55b92692ab57179e","mohound","seed",NA,"2013-07-10",28000
"3bb04bb68cad383f779f6cdf37543c6d","mojave-networks","venture",NA,"2013-11-18",5e+06
"8722339e675d87a5a6fe49a55070f7a3","mojave-therapeutic",NA,NA,NA,NA
"ed79a879e1b9216a455a0397d1153c4d","moksha8-pharmaceuticals","venture","A","2008-06-02",3.9e+07
"ed79a879e1b9216a455a0397d1153c4d","moksha8-pharmaceuticals","private_equity",NA,"2012-10-22",1.25e+08
"ed79a879e1b9216a455a0397d1153c4d","moksha8-pharmaceuticals","venture","c","2010-10-05",3e+07
"ed79a879e1b9216a455a0397d1153c4d","moksha8-pharmaceuticals","debt_financing",NA,"2009-12-01",5e+06
"ed79a879e1b9216a455a0397d1153c4d","moksha8-pharmaceuticals","venture","b","2009-12-01",25071696
"a37f3ad3010991807c30c627798675ec","molcure","angel",NA,"2013-06-01",46263
"a37f3ad3010991807c30c627798675ec","molcure","debt_financing",NA,"2013-02-07",106986
"a37f3ad3010991807c30c627798675ec","molcure","seed",NA,"2013-07-31",34600
"a37f3ad3010991807c30c627798675ec","molcure","seed",NA,"2013-07-01",10200
"a37f3ad3010991807c30c627798675ec","molcure","venture","1","2014-09-27",1833883
"d38c506d6566d93305ab22a18244e0c2","molecubes","seed",NA,"2016-01-07",2049349.7809
"81f5af5f6afce3459b76d2cb1cca68ef","molecula-maxima",NA,NA,NA,NA
"66eac58879d1772558c7c5f5f0221880","molecular-assemblies",NA,NA,NA,NA
"caf4f8d2e5cbadd2d75824a2438fcd2f","molecular-biometrics","venture","b","2010-01-12",12500000
"caf4f8d2e5cbadd2d75824a2438fcd2f","molecular-biometrics","venture","A","2008-11-10",1.2e+07
"3f74ea1b748d4a3180c80d2f595004a7","molecular-biosystems",NA,NA,NA,NA
"bdaa99b055dcbdef7a565b502db4a28a","molecular-detection","venture",NA,"2013-12-01",NA
"bdaa99b055dcbdef7a565b502db4a28a","molecular-detection","venture",NA,"2010-06-18",1399590
"bdaa99b055dcbdef7a565b502db4a28a","molecular-detection","venture",NA,"2012-03-07",1500000
"bdaa99b055dcbdef7a565b502db4a28a","molecular-detection","venture",NA,"2009-06-16",250000
"bdaa99b055dcbdef7a565b502db4a28a","molecular-detection","venture","1","2009-12-01",4700000
"bdaa99b055dcbdef7a565b502db4a28a","molecular-detection","venture","1","2012-04-16",1900000
"c515cf3a45a761bf2b976fa278a75449","molecular-devices",NA,NA,NA,NA
"8d62668fa1df47bce3a41ba908dacf7e","molecular-imaging-research","venture","a","2012-03-07",9900000
"8d62668fa1df47bce3a41ba908dacf7e","molecular-imaging-research","venture","a","2011-05-09",7e+06
"8d62668fa1df47bce3a41ba908dacf7e","molecular-imaging-research","venture",NA,"2013-10-02",3500000
"8d62668fa1df47bce3a41ba908dacf7e","molecular-imaging-research","venture",NA,"2014-12-23",1535000
"c9904c0f023b556482a059c4c3b61b2b","molecular-matrix","debt_financing",NA,"2015-01-26",80000
"79be121f8eef291676d7cb11c2a45441","molecular-partners","venture","b","2009-12-16",44200000
"79be121f8eef291676d7cb11c2a45441","molecular-partners","venture","a","2007-08-14",15560000
"a609e674cd48019575cacb158f8de6d2","molecular-probes",NA,NA,NA,NA
"4463c64aac9c38f50265580909d8b2a8","molecular-profiles",NA,NA,NA,NA
"24670afdab52ad53e8ae628edab8f901","molecular-reflections-corporation",NA,NA,NA,NA
"551c1037cc3f7b8c77ba9abf7c53ed13","molecular-response",NA,NA,NA,NA
"29809a8c92f975548b3b9b1287d84812","molecular-sensing","seed",NA,"2014-08-18",5e+05
"29809a8c92f975548b3b9b1287d84812","molecular-sensing","seed",NA,"2012-03-01",125000
"29809a8c92f975548b3b9b1287d84812","molecular-sensing","seed",NA,"2012-06-01",1350000
"29809a8c92f975548b3b9b1287d84812","molecular-sensing","seed",NA,"2013-06-01",1e+05
"29809a8c92f975548b3b9b1287d84812","molecular-sensing","venture","1","2013-09-01",450000
"29809a8c92f975548b3b9b1287d84812","molecular-sensing","venture","1","2013-11-15",1500000
"29809a8c92f975548b3b9b1287d84812","molecular-sensing","venture","1","2014-07-23",2670000
"231a5349dc4f8e9c9276653aef611e49","molecular-templates","venture","C","2013-10-08",8500000
"231a5349dc4f8e9c9276653aef611e49","molecular-templates","grant",NA,"2013-10-08",10600000
"231a5349dc4f8e9c9276653aef611e49","molecular-templates","venture","a","2009-05-03",2500000
"231a5349dc4f8e9c9276653aef611e49","molecular-templates","venture",NA,"2011-04-15",1409621
"231a5349dc4f8e9c9276653aef611e49","molecular-templates","venture",NA,"2014-07-03",7e+06
"231a5349dc4f8e9c9276653aef611e49","molecular-templates","venture","C","2014-09-15",3500000
"203bcb663068008b0189222a1e4e6b4e","molecular-therapeutics",NA,NA,NA,NA
"0615227a79acc1a9771f524586d870be","molecularmd","private_equity",NA,"2013-05-20",2500000
"0615227a79acc1a9771f524586d870be","molecularmd","venture","1","2012-04-02",6e+06
"a82e4956aab1840ee155e5fa8423e481","moleculera-labs","debt_financing",NA,"2012-10-30",324000
"a82e4956aab1840ee155e5fa8423e481","moleculera-labs","seed",NA,"2013-10-03",1840000
"a82e4956aab1840ee155e5fa8423e481","moleculera-labs","venture",NA,"2013-10-18",2958936
"a82e4956aab1840ee155e5fa8423e481","moleculera-labs","venture",NA,"2015-05-19",1060000
"9fb23572cb121635da149c48dc2d56d6","moleculin","venture",NA,"2012-08-22",3184757
"9fb23572cb121635da149c48dc2d56d6","moleculin","venture",NA,"2013-04-24",1527465
"9fb23572cb121635da149c48dc2d56d6","moleculin","venture",NA,"2011-03-11",1165000
"9fb23572cb121635da149c48dc2d56d6","moleculin","venture",NA,"2011-12-12",4490309
"9fb23572cb121635da149c48dc2d56d6","moleculin","debt_financing",NA,"2014-05-16",491010
"4e5bc1f263b9536aaaa757a648ca273a","molino-de-ideas",NA,NA,NA,NA
"b41b5c04df260fdcfe82a58f86f2f656","mologic","venture",NA,"2015-10-27",4596738.3588
"ccebb65d37e5e0ef000ec6244de2cdcb","molplex","seed",NA,"2010-06-01",145621
"ccebb65d37e5e0ef000ec6244de2cdcb","molplex","venture",NA,"2012-09-25",568261
"9105eaeddccb4490ba4961888e3fdad8","molport","seed",NA,"2010-12-10",132338
"9105eaeddccb4490ba4961888e3fdad8","molport","venture",NA,"2013-04-22",633462
"51c56401fa0ef73168f215f78a621ac1","momentface-sro","grant",NA,"2014-08-01",37532
"51c56401fa0ef73168f215f78a621ac1","momentface-sro","debt_financing",NA,"2014-09-03",26274
"51c56401fa0ef73168f215f78a621ac1","momentface-sro","venture",NA,"2013-07-27",10230
"b74f16a6df1a7cb03696345bad6c0b06","momentfeed","venture","B","2015-09-30",2737305
"b74f16a6df1a7cb03696345bad6c0b06","momentfeed","seed",NA,"2013-02-12",1800000
"b74f16a6df1a7cb03696345bad6c0b06","momentfeed","venture","a","2013-12-11",5500000
"b74f16a6df1a7cb03696345bad6c0b06","momentfeed","seed",NA,"2011-07-11",1200000
"70ec28b002af68e103ea97c931dce108","momentum-bioscience","undisclosed",NA,"2011-09-26",357060
"15164927f5745770d6dc57123e90ea44","mona-2","convertible_note",NA,"2015-09-24",1e+05
"e650080320d7c46ec50eb5808650d351","mondevices","seed",NA,"2014-11-05",16335
"881b552a41ece40a798df26669e2e3bf","mondovo",NA,NA,NA,NA
"539b348c76cfd645d0a56c925bb08825","moneero","equity_crowdfunding",NA,"2013-07-10",160000
"539b348c76cfd645d0a56c925bb08825","moneero","private_equity",NA,"2014-04-05",280000
"97f22bd72fd2cade9db06ba9fe81ba57","money-net",NA,NA,NA,NA
"4635307288e07b1f558d81a04535cbf1","moneyspyder","seed",NA,"2006-07-01",183687
"c709540d3be424bd403b21bb5d37cdc5","moneythor",NA,NA,NA,NA
"e0ca117e343973f7cc7e9fa0bf2a5a10","mongoose-metrics",NA,NA,NA,NA
"9f87db1e44f162ef97bf6be8b00f1d9d","mongosluice","venture",NA,"2014-08-26",30000
"9f87db1e44f162ef97bf6be8b00f1d9d","mongosluice","seed",NA,"2014-07-01",NA
"e9736e43b9670fdc4d72089bab1f8cdd","moni-ai",NA,NA,NA,NA
"37ba4a86bf6cfc4df5b4333817789ba0","monica-healthcare","seed",NA,"2015-02-04",3e+06
"730a0b57cd3363d596b5a2d4a99c8331","monitic-io",NA,NA,NA,NA
"1f4d4a0ef340ca9ee771bfb7747258c5","monitor-360",NA,NA,NA,NA
"c1eebde32d82fc13d29d7fb456856c19","monja",NA,NA,NA,NA
"8934c83a7a0e125b0aab7ef9fd01d7bc","monkey-analytics","seed",NA,"2010-03-01",NA
"313b0e8b1085333ba36e94eb61f2a3e8","monkeylearn","convertible_note",NA,"2015-08-18",125000
"313b0e8b1085333ba36e94eb61f2a3e8","monkeylearn","seed",NA,"2014-07-11",3e+05
"313b0e8b1085333ba36e94eb61f2a3e8","monkeylearn","seed",NA,"2015-05-27",250000
"7bd949e76d3ceed1abb54261b9debfea","monograf-me",NA,NA,NA,NA
"026e0ca5e678e7321e82e3592838a800","monogram-biosciences",NA,NA,NA,NA
"ed5dd51de71ffd31619889a267ad86d7","monolibre","seed",NA,"2014-03-01",25000
"db4131b9e83805772326e72a959dbbb3","monsanto",NA,NA,NA,NA
"c74a2b41081c72d450a551789f584445","monster-arts","venture",NA,"2011-01-24",1e+07
"a2f64afbf2472a97641814b5fb16cc7a","monstro",NA,NA,NA,NA
"e3ea4564e0048b5ed5b041a08ba0ce2c","montage-healthcare-solutions","seed",NA,"2012-04-13",999984
"763ef20eeb0e90510d900ff140a5f668","mood-international",NA,NA,NA,NA
"d0b52a26065ab1a220dc271380cedc95","mooditor",NA,NA,NA,NA
"429e430b20369113cb467dadf8117f0c","moodstocks",NA,NA,NA,NA
"e3eae386837734f879ebc851ef598475","moodsy","undisclosed",NA,"2014-07-31",10000
"7a0b840c51d90aa36ed4fa08e5605b1b","moodwire",NA,NA,NA,NA
"e2e22f133f883e363521a08ff597e37d","moodys",NA,NA,NA,NA
"0ff37a0cf693da9cc335b6cdddd20db9","moogsoft","venture","a","2013-05-29",7e+06
"0ff37a0cf693da9cc335b6cdddd20db9","moogsoft","venture","B","2014-10-21",14300000
"7c9643b0d0d3621b31650570d943402a","moonmetrics",NA,NA,NA,NA
"b81d7fcc66e325a1bfc2d03018462829","moontoast","venture","b","2013-01-14",5e+06
"b81d7fcc66e325a1bfc2d03018462829","moontoast","venture",NA,"2009-06-17",780000
"b81d7fcc66e325a1bfc2d03018462829","moontoast","seed",NA,"2012-01-05",6e+06
"b81d7fcc66e325a1bfc2d03018462829","moontoast","venture","b","2014-02-09",4500000
"b81d7fcc66e325a1bfc2d03018462829","moontoast","venture",NA,"2014-05-28",1718631
"477069b3d499082d25a0ae5ddf767bae","moosend",NA,NA,NA,NA
"30f73fd78b0480c82986f453b7819175","mopapp","seed",NA,"2010-01-01",360150
"30f73fd78b0480c82986f453b7819175","mopapp","seed",NA,"2011-04-01",70705
"f16481776f886c21b7ab62378a1ee44b","mopinion",NA,NA,NA,NA
"8d72dbac1b72fa48cd82fb3d33644145","moqod",NA,NA,NA,NA
"d5c80b5d75a1f36f64276b7fe9745948","more2","venture",NA,"2015-09-29",1.7e+07
"33ff596e63da0e4fc85d0a9bccfdcf68","morethancure",NA,NA,NA,NA
"859acd65d2ae96e0b6656c17ff40894e","morguefile",NA,NA,NA,NA
"aebfcbd1e67681a1693c27b203d3ccf2","morningside-analytics","seed",NA,"2013-12-30",1100000
"39bcecd1d63688d97b60b7a8ffb1e9c6","morningside-technology-advisory-llc",NA,NA,NA,NA
"c8534443dd26c7db19e2e675076854d5","morphochem-ag",NA,NA,NA,NA
"4e0eaa1607fd99459a3273f4b83fca0d","morphogen-ix","seed",NA,"2016-01-18",2139688.3663
"dcc150f243de4f3d68b02b370ff3e74a","morphosys","private_equity",NA,"2013-09-19",1.26e+08
"59125a9be52d13c3a5b3f9c53051d19b","morria-biopharmaceuticals","venture",NA,"2013-02-01",931000
"59125a9be52d13c3a5b3f9c53051d19b","morria-biopharmaceuticals","venture",NA,"2012-12-12",1503000
"88b19f27af575323ea1a0deed3fea60c","morris-innovative","venture",NA,"2009-10-05",1175735
"851ca104f17fe051a24c5891d0ac86f9","morrow-lane-llc",NA,NA,NA,NA
"ab3ad2642c12fd3b09a2b7ce5b4989a4","morvus-technology","venture","a","2010-02-11",3300000
"cf8c85416326dd391ae20b8b246ab53b","mosaic-biosciences","venture","a","2011-11-08",1e+06
"cf8c85416326dd391ae20b8b246ab53b","mosaic-biosciences","venture",NA,"2014-02-10",2274000
"25dc0b72b9146bc97a4e17bc5b3edf32","mosaicoon","venture",NA,"2013-06-28",NA
"25dc0b72b9146bc97a4e17bc5b3edf32","mosaicoon","venture",NA,"2012-12-28",NA
"a5d1022a749b9400b14585e4eda76efd","mosanto-agriculture-product",NA,NA,NA,NA
"6705c76e43ad360b4e42ff8cfcb9d35c","mosimtec",NA,NA,NA,NA
"3d544b06e9c6fe963326257c544941db","mostlikely","venture",NA,"2011-01-13",1591333
"3d544b06e9c6fe963326257c544941db","mostlikely","venture",NA,"2011-06-01",1600000
"3d544b06e9c6fe963326257c544941db","mostlikely","venture",NA,"2013-01-22",6489578
"3d544b06e9c6fe963326257c544941db","mostlikely","angel",NA,"2012-06-12",1200000
"3d544b06e9c6fe963326257c544941db","mostlikely","venture",NA,"2010-12-08",560000
"b8da2fecd13313a2cc35efbeb1da55c1","mostro","seed",NA,"2014-03-01",5e+05
"22f26aa80922cca16fff328426ebfd06","motalen",NA,NA,NA,NA
"e9b6f716ee94cebba49cc95ae61b7870","motar",NA,NA,NA,NA
"8ba6f424b2cc96cde726b89418df5217","mothernode",NA,NA,NA,NA
"926628a842b2b9ff7789c8cd4e07f4d5","motif-biosciences","venture","c","2007-04-05",1e+06
"926628a842b2b9ff7789c8cd4e07f4d5","motif-biosciences","venture",NA,"2006-03-02",1870000
"ee803f24c78fa82d2fd04810591eb30a","motility-count","undisclosed",NA,"2011-09-11",NA
"ee803f24c78fa82d2fd04810591eb30a","motility-count","seed",NA,"2014-03-27",646551
"8e6d72acf0cdf2aab71ff443e009eb60","motionloft","angel",NA,"2010-09-01",NA
"8ce208e9ac65f274921fdc940d1b5eba","motista","private_equity",NA,"2014-11-30",6e+06
"8ce208e9ac65f274921fdc940d1b5eba","motista","venture","1","2011-04-12",5800000
"adff3709ee071e4d7b9f04a230ad7a8f","motivequest",NA,NA,NA,NA
"179fa2e70553337804945517a5581962","motosmarty","grant",NA,"2014-12-20",5e+05
"ccaf7e99d6a4a5323a5c97cc01d82c90","motus-global",NA,NA,NA,NA
"d5143a837a455b002977edf64663c411","mountain-drones","seed",NA,"2015-02-01",25000
"0362dd1c8d76f1cb4be980191e68a12d","mountainview-capital-holdings","private_equity",NA,"2007-11-07",6.5e+07
"10bd8ad70df878617513f7eaa7534f5e","mouseflow",NA,NA,NA,NA
"14c98333b934cdbf315b9e563cddf9f8","mousera","venture","A","2014-10-29",8800000
"14c98333b934cdbf315b9e563cddf9f8","mousera","venture","A","2015-06-09",20000004
"8efaefd3e5a0bf899c62f9261f340d36","mousestats",NA,NA,NA,NA
"779612c43bd47d8d44eb62951eb3498b","mousetrace",NA,NA,NA,NA
"23b5008caeacbcda7c8ffcb333d855b9","move-guides","venture","B","2015-10-07",15600000
"23b5008caeacbcda7c8ffcb333d855b9","move-guides","seed",NA,"2013-12-04",1800000
"23b5008caeacbcda7c8ffcb333d855b9","move-guides","angel",NA,"2012-07-01",624194
"23b5008caeacbcda7c8ffcb333d855b9","move-guides","venture","A","2014-10-09",8199999
"211e541f191b6a579448b825d84c289f","move-in-history","equity_crowdfunding",NA,"2014-08-21",NA
"7e08caea0e567b42d62122dc2cb7cec4","64clicks",NA,NA,NA,NA
"4647caa7b53f4650016c32f0048315a9","movelo",NA,NA,NA,NA
"7d49d371d36293016b652dc9046c91c9","movement-2",NA,NA,NA,NA
"bcbe7bd6fa3d8728513cd5e1d2859ca4","movetis","venture","a","2007-01-08",63729400
"bcbe7bd6fa3d8728513cd5e1d2859ca4","movetis","private_equity",NA,"2009-12-03",127500000
"7e4d2b064f7c69b4e4749e110d87fc6c","moviegalaxies",NA,NA,NA,NA
"00668fe0f0b40383ccdfdad9f7b26eae","around-knowledge","seed",NA,"2012-12-10",2500000
"d110240a595b0d9c0d055d7493a5fbd6","moximed","venture",NA,"2012-01-01",1770000
"d110240a595b0d9c0d055d7493a5fbd6","moximed","venture","1","2011-12-05",45837656
"d110240a595b0d9c0d055d7493a5fbd6","moximed","venture","1","2015-05-07",3.3e+07
"1771a8670a49f9e9a28cfe0b326d570d","mozenda","seed",NA,"2010-08-24",5e+05
"1771a8670a49f9e9a28cfe0b326d570d","mozenda","seed",NA,"2009-05-01",1e+06
"313838ed8104cb23c55c89fc8ef9d178","mozzo-analytics","seed",NA,"2013-05-01",NA
"51617908e3204032c18ceddb34a4df44","mpex-pharmaceuticals","venture","b","2005-08-09",3.2e+07
"740ae495a8b84a061f35536d9ada82f9","mpga-technologies",NA,NA,NA,NA
"2b8f4f19192959686b4483814808ecf1","mpoint-media","seed",NA,"2014-09-22",9e+05
"2b8f4f19192959686b4483814808ecf1","mpoint-media","seed",NA,"2015-01-01",3e+05
"53e8e614aa6b160f229835317f97b1f2","mpower-communications",NA,NA,NA,NA
"ad63da2d5e435b1c2867ed95c5f4b1e0","mpowered-technical-solutions",NA,NA,NA,NA
"1671a4f4094c8b7f13a20c734915dc88","mps-biopharm",NA,NA,NA,NA
"cf71d5656b1a3d8839151c2ea959842b","mr-gabriel","seed",NA,"2015-07-13",650000
"5c414b312b8230ef3957548e719b1539","mry",NA,NA,NA,NA
"e692bb419af04c99b355731b562c1ba9","msi-methylation-sciences","venture","a","2011-09-29",18380250
"e692bb419af04c99b355731b562c1ba9","msi-methylation-sciences","venture",NA,"2015-03-24",19783
"4d46d2cdd541588606c2e66b00470884","msm-protein-technologies","venture",NA,"2012-10-25",250000
"8be0feb40974ab71f7a3f225010c1cde","mtech",NA,NA,NA,NA
"b26c5a48deaf39caf660ea76d2e19d72","mtelligence",NA,NA,NA,NA
"ca9021c62113a2b87244e72b92a183b8","mtm-laboratories","venture","c","2009-10-05",57002400
"ca9021c62113a2b87244e72b92a183b8","mtm-laboratories","venture","a","1999-08-30",1672640
"ca9021c62113a2b87244e72b92a183b8","mtm-laboratories","venture","b","2003-09-01",13158000
"ca9021c62113a2b87244e72b92a183b8","mtm-laboratories","venture","c","2010-11-08",9741900
"076f1e1c480f05b8238cb52079f60d17","paradigm-creatives",NA,NA,NA,NA
"585709d46d3987103b6f3f97bef84c96","mu-sigma","venture","c","2011-06-06",2.5e+07
"585709d46d3987103b6f3f97bef84c96","mu-sigma","venture",NA,"2011-12-28",1.08e+08
"585709d46d3987103b6f3f97bef84c96","mu-sigma","private_equity",NA,"2013-02-05",4.5e+07
"5e6e1edd330b3332ade016bf0b060f9b","mucimed","venture",NA,"2011-06-08",2e+05
"1f9addc35e861f00589f13493fca328e","mucosis","venture",NA,"2016-01-20",6206874.0222
"5327431e35e5a9b2fb440dbb11ae25b1","muffle",NA,NA,NA,NA
"2d2d51fd455ad1754e6e9a8266cd59a6","webfluenz",NA,NA,NA,NA
"3cc1990d0c364d9032b7d910971eae79","multibind-biotec","venture",NA,"2006-04-10",762237
"3cc1990d0c364d9032b7d910971eae79","multibind-biotec","undisclosed",NA,"2008-01-01",NA
"ebce2fce5b0e26413c5ec9142b65b53d","multibrain",NA,NA,NA,NA
"d03093d355b298456e61e2e8b83c2aca","multiplica",NA,NA,NA,NA
"17e4bd1ef97af814e83de16ff17eff14","multiplicom","venture",NA,"2011-04-27",2933600
"17e4bd1ef97af814e83de16ff17eff14","multiplicom","venture",NA,"2013-02-11",7365050
"f714f179106c14236ed114fcb500c534","multispan","venture","b","2007-10-01",6e+05
"9f8c52af880e1bd0fdfff018c259cfbe","multistat","venture","A","2008-01-11",NA
"53055aab0de38a8901876238521a7ec9","mum-software",NA,NA,NA,NA
"db7fe6be66b2d2fd536f0eb88d999555","munc-key-therapeutics",NA,NA,NA,NA
"d2ec290fec670d6f46c846c45f728bcc","munogenics-inc","equity_crowdfunding",NA,"2012-06-08",NA
"b4826c5f8b5485499538025d3cf18d3d","mural-consulting",NA,NA,NA,NA
"129cfcd750407f88befe744d8beeaa2f","murdock-martell-inc",NA,NA,NA,NA
"4a0d9437465c1ed6f5c094e74de7c2ac","murigen","venture","A","2007-01-09",3906250
"861360e7a21f17970cca28a84391d4a1","murm-io",NA,NA,NA,NA
"4a1963255c9b26d9750f8bfdcf61ae4e","mursix",NA,NA,NA,NA
"82a14fe334ecbbe234058d7c2dc09179","cloudtactix",NA,NA,NA,NA
"f7e72679c429d90f27d44dc1ed2ed954","museotainment",NA,NA,NA,NA
"703c9dbdf2ed366bc6281cbc3a3e2384","musicmetric","venture","a","2010-12-07",NA
"703c9dbdf2ed366bc6281cbc3a3e2384","musicmetric","angel",NA,"2008-12-01",599275
"703c9dbdf2ed366bc6281cbc3a3e2384","musicmetric","venture",NA,"2013-01-23",4756750
"4fc1a7a7b11db99767b0579373cd2683","musicperk",NA,NA,NA,NA
"45dee6bc71ab323b850b2942d29e6ea8","musicplay-analytics","seed",NA,"2014-07-18",20000
"99eb16fe2fc247bf02b91ee551b89e38","muso",NA,NA,NA,NA
"5419e61e784214b702640f6f36d950fa","muster-media",NA,NA,NA,NA
"911286729cca4ba18b50a1fb661e1ff5","mutualmind","angel",NA,"2012-08-01",3e+05
"911286729cca4ba18b50a1fb661e1ff5","mutualmind","angel",NA,"2010-05-17",150000
"0d26196bc6f3cf06ed430ba6a1ce6203","muufri","seed",NA,"2014-09-30",2e+06
"0d26196bc6f3cf06ed430ba6a1ce6203","muufri","venture",NA,"2014-05-02",60000
"d6efb8c0c3d56be0cfbd4f1e4894c652","muzic-technologies",NA,NA,NA,NA
"0ca3e0be1d295ff0d309a89f1f94d3a8","muzieo-media",NA,NA,NA,NA
"547b34a8f2d10381c59ffa6884c28e49","mve-partners",NA,NA,NA,NA
"e6b967e8c0edcdfb441b9a147de13a97","mwh-agrology-india-pvt-ltd",NA,NA,NA,NA
"5389fcb457eeca61d460230f1d1933e5","mwi","debt_financing",NA,"1999-01-01",1e+05
"5389fcb457eeca61d460230f1d1933e5","mwi","debt_financing",NA,"2003-01-01",180000
"5389fcb457eeca61d460230f1d1933e5","mwi","debt_financing",NA,"2007-01-01",70000
"420fbb866f1563203d443966e227e6ef","mworks",NA,NA,NA,NA
"467834988c645beb555b0fc777570079","mxbiodevices","venture",NA,"2014-02-10",210000
"d837fd03b8ced8881568066f33fc97e9","mxresearch",NA,NA,NA,NA
"e414c2d54037b64779778428f86b981b","my-diabetes-home",NA,NA,NA,NA
"d4780f154f37489b65e5622c9091abc0","my-free-digital-photos",NA,NA,NA,NA
"4d2989472f3572582e8395ab524811bd","my6sense","seed",NA,"2008-01-01",5e+05
"4d2989472f3572582e8395ab524811bd","my6sense","venture","1","2010-05-01",2500000
"4d2989472f3572582e8395ab524811bd","my6sense","venture","1","2013-06-27",2e+06
"4d2989472f3572582e8395ab524811bd","my6sense","venture","1","2012-06-01",2500000
"2303c8ca8cdd1e3a0de80a735f302486","myagonism-com","seed",NA,"2013-03-15",71000
"2303c8ca8cdd1e3a0de80a735f302486","myagonism-com","seed",NA,"2015-03-15",160000
"2303c8ca8cdd1e3a0de80a735f302486","myagonism-com","angel",NA,"2013-09-01",80000
"2303c8ca8cdd1e3a0de80a735f302486","myagonism-com","angel",NA,"2015-04-15",170000
"4dadaf9144352fdfcd7a7c586acf4a87","mybesthealthplan",NA,NA,NA,NA
"afeef62bd899250dda37fedeece076cc","mycare","seed",NA,"2012-02-02",1e+06
"afeef62bd899250dda37fedeece076cc","mycare","venture",NA,"2012-10-11",750000
"afeef62bd899250dda37fedeece076cc","mycare","venture",NA,"2012-01-26",999999
"844bbeef8469b28e39a11004913b850f","mychances",NA,NA,NA,NA
"4b0d8d29b0c1dcb7aead883d1a647694","mycityvenue",NA,NA,NA,NA
"a2670cdf73e5a10b93182782dd8dcb14","mycodev-group","seed",NA,"2015-05-06",5e+05
"1cf30481e151f0555c0d6f83f77f789d","mycogen",NA,NA,NA,NA
"39d6b76845683adae70bbc93a90475da","mycollegestat",NA,NA,NA,NA
"9fc91951607ba6cea9e2767297ba83d3","mycollife",NA,NA,NA,NA
"c65ae6dca42ceea4ca3a9cff3bf16726","mycordbank-com","convertible_note",NA,"2013-12-08",2e+06
"7846c3061a17e1729a009ff3bf986b09","creopoint","angel",NA,"2010-02-01",NA
"3ed06173577da477bda694fed1825652","mycroft-business-solutions","seed",NA,"2014-08-01",50000
"3ed06173577da477bda694fed1825652","mycroft-business-solutions","grant",NA,"2015-05-01",60000
"03322f28b98988f9d7240e1a27fd1957","mydials",NA,NA,NA,NA
"a5aa0051205a37c723b9ac1d7a941d1f","mydocket","venture","a","2013-03-06",3600000
"a5aa0051205a37c723b9ac1d7a941d1f","mydocket","venture","B","2014-06-09",1e+06
"9135e91ddb125e4ba3b5d72f59f7b8f9","myeasydocs","seed",NA,"2014-09-24",1e+06
"b11e59557a63324cabcd9372e8890e20","myfeelback","private_equity",NA,"2014-09-18",1300000
"b11e59557a63324cabcd9372e8890e20","myfeelback","seed",NA,"2012-03-29",1e+05
"d9048950b107f2645ba29b74c104d635","myfrenchstartup",NA,NA,NA,NA
"f1c6e59333ab7a95c0e624c5618e952d","touch212-solutions",NA,NA,NA,NA
"f6117746650fa4e588b71aa6f533265e","mygon",NA,NA,NA,NA
"0e3a32e3386462a43c49030e44784219","myk-applications",NA,NA,NA,NA
"2633d294c77eac5667c3a1644501ce5f","myknowtions","convertible_note",NA,"2015-08-15",NA
"b358eb182dfd0124348b692d8b89a1d7","mylan-inc",NA,NA,NA,NA
"29e5233b86446d15f54e0d9df25840c7","mymatrixx","venture",NA,"2010-05-17",180000
"9ea530eb586601f8da48850f9d398821","mymedleads-com","seed",NA,"2010-04-01",350000
"234859ee9cb203d94a1a227aa75233da","myokardia","venture",NA,"2012-10-04",4e+06
"234859ee9cb203d94a1a227aa75233da","myokardia","venture","1","2012-09-20",3.8e+07
"234859ee9cb203d94a1a227aa75233da","myokardia","venture",NA,"2014-08-22",1e+07
"234859ee9cb203d94a1a227aa75233da","myokardia","venture","1","2015-04-30",4.6e+07
"896f86661976445ca5c24c7746b20b76","myomo","venture",NA,"2009-12-18",616765
"896f86661976445ca5c24c7746b20b76","myomo","venture",NA,"2013-10-08",7e+06
"896f86661976445ca5c24c7746b20b76","myomo","venture","1","2015-05-13",5e+06
"77f70ce31ef4d3be40a1fae4399ef836","myoscience","venture","B","2008-07-11",10400000
"77f70ce31ef4d3be40a1fae4399ef836","myoscience","venture","d","2012-03-21",3.3e+07
"77f70ce31ef4d3be40a1fae4399ef836","myoscience","venture","c","2011-03-17",3.9e+07
"77f70ce31ef4d3be40a1fae4399ef836","myoscience","venture","e","2013-09-12",2.5e+07
"06103cbc1082c752391c7116baea02f8","myouvies",NA,NA,NA,NA
"2a08eb6e29f516cb8d1caa9b481b2d75","myr","venture",NA,"2011-05-12",707650
"2a08eb6e29f516cb8d1caa9b481b2d75","myr","venture",NA,"2014-10-31",8813715
"30e50d74f107582e28be2fcbf02df941","myrefers","seed",NA,"2013-09-01",2e+05
"30e50d74f107582e28be2fcbf02df941","myrefers","angel","1","2014-10-15",4e+05
"deceb57519ae41a149ecfb6fa93d65f7","myrexis-inc",NA,NA,NA,NA
"1da1af759afa6f1d0214b23dd22ed3d0","myriad-genetics",NA,NA,NA,NA
"3eaeefad4d8d71e20959a2c053e2df28","myriad-pharmaceuticals",NA,NA,NA,NA
"bbe3d7c96efc2006691381b16255ebff","myriant-technologies","venture",NA,"2011-01-24",6e+07
"bbe3d7c96efc2006691381b16255ebff","myriant-technologies","grant",NA,"2009-12-08",5e+07
"c6da0aea455ea8d97bac5c115d78c534","myskin","venture",NA,"2014-03-14",275000
"02aa7eb6728147dc2e715e3a351bc0bc","mysollars",NA,NA,NA,NA
"3759f4a14c828e211b38e161c61884ec","mysteryvibe","seed",NA,"2015-02-25",230000
"3759f4a14c828e211b38e161c61884ec","mysteryvibe","seed",NA,"2015-03-25",330000
"3759f4a14c828e211b38e161c61884ec","mysteryvibe","seed",NA,"2015-12-15",6e+05
"3759f4a14c828e211b38e161c61884ec","mysteryvibe","angel",NA,"2015-09-01",6e+05
"3759f4a14c828e211b38e161c61884ec","mysteryvibe","seed",NA,"2014-05-16",225000
"3759f4a14c828e211b38e161c61884ec","mysteryvibe","angel",NA,"2014-12-01",330000
"3759f4a14c828e211b38e161c61884ec","mysteryvibe","angel",NA,"2015-06-01",330000
"870147cc98c6e89beba7669f8c9f244e","mystockvectors",NA,NA,NA,NA
"6818f97cd807690003a51c3cf51bbf50","mystorey",NA,NA,NA,NA
"edfa0c857811879fcf7d97737ce171cc","mysurf",NA,NA,NA,NA
"853d4d1a576bc54d2444ff67b85eb0b5","mytomorrows","venture",NA,"2014-02-19",2200000
"853d4d1a576bc54d2444ff67b85eb0b5","mytomorrows","venture",NA,"2012-01-01",3800000
"853d4d1a576bc54d2444ff67b85eb0b5","mytomorrows","venture",NA,"2014-11-06",5610972
"3ab0c0f87415b1f8183c4428b23c446a","myvideoport-com",NA,NA,NA,NA
"cfb742c354a416926f647c0a6a19f5dc","myweboo",NA,NA,NA,NA
"d4cfe5b557f89a6e6694fc906db9ae2e","n-of-one-therapeutics","venture",NA,"2013-12-16",1700000
"d4cfe5b557f89a6e6694fc906db9ae2e","n-of-one-therapeutics","debt_financing",NA,"2012-04-30",748955
"6ebf678eea1a96b3ce85b7aaf52befac","n-io-innovation-limited-2",NA,NA,NA,NA
"86daa0059258e2d0d37a568965637bdc","n-thing","seed",NA,"2014-09-01",NA
"860e66ae4213ceb8b57375f8dd1d0c84","n2n-global",NA,NA,NA,NA
"252680aa94f9ca53ec5efadaa4916ed1","n2n-solutions-pvt-ltd",NA,NA,NA,NA
"352d9436fd3f0b5a29fdaf4c1dc66d49","n42","seed",NA,"2014-05-01",NA
"14378dadbfb57519481e8f692e8f334b","nabi-biopharmaceuticals","grant",NA,"2009-09-29",1e+07
"aade4ceb4197df278654d7b0522a5cca","nabriva-therapeutics","venture","B","2015-04-07",1.2e+08
"6ce519aa6649039dd0461e12beae2757","nabsys","venture","b","2010-03-10",7e+06
"6ce519aa6649039dd0461e12beae2757","nabsys","venture",NA,"2009-01-27",2750000
"6ce519aa6649039dd0461e12beae2757","nabsys","venture","d","2013-03-13",35049975
"6ce519aa6649039dd0461e12beae2757","nabsys","venture","c","2011-09-14",1e+07
"6ce519aa6649039dd0461e12beae2757","nabsys","venture","a","2009-05-05",4e+06
"6ce519aa6649039dd0461e12beae2757","nabsys","venture","E","2014-08-28",25500000
"4e6181e69a0d83e9cf40d2e4c5d3e47a","nadel-phelan",NA,NA,NA,NA
"5305cadbac0467ebaefb4350806ce08d","nader-tawil",NA,NA,NA,NA
"680a9a48b247596e9756d3f32010531e","nagase-co",NA,NA,NA,NA
"735f4cd3886e2d7f913d5aa40e3e4981","nagpurkar-hearing-services",NA,NA,NA,NA
"4584415e9848d78fa91d128cad6e9c31","nairamarket",NA,NA,NA,NA
"63f6e3464601ee994847eaced0aa705a","naiscorp-information-technology-services","venture","b","2009-08-15",2e+06
"63f6e3464601ee994847eaced0aa705a","naiscorp-information-technology-services","venture","a","2006-08-15",1e+06
"de7d35f09ddb416e971b812e262a196a","naked-data",NA,NA,NA,NA
"b295ab6758260bae1e13d9eeae2902cf","naked-lime",NA,NA,NA,NA
"00db752612f0e85857d55abb5453ceb6","nakkeb",NA,NA,NA,NA
"9bcf6e2399c8698fe05d9d547e8ce9ae","nalainstitute",NA,NA,NA,NA
"9301509a04d976c85929a60efad1f062","nalari-health","venture",NA,"2011-12-02",1e+05
"4829715a289d5f9a6c388c94efcd15b1","nalini-networks",NA,NA,NA,NA
"5867522ead0999440afe8542d87fc6ff","nanaya",NA,NA,NA,NA
"7c9a39c25187f954ed065bf9cb84042a","nandi-proteins","undisclosed",NA,"2006-02-24",1154102
"7c9a39c25187f954ed065bf9cb84042a","nandi-proteins","venture","1","2014-10-28",1100000
"c9d5340396194ba52208c0036eb06439","nanigans","venture","a","2011-08-09",3e+06
"c9d5340396194ba52208c0036eb06439","nanigans","venture","a","2013-04-23",5850000
"c9d5340396194ba52208c0036eb06439","nanigans","venture","B","2015-03-25",2.4e+07
"bfe8e35b30137aebbdbe522f31d5d6b4","nano-defense-solutions","venture",NA,"2014-09-25",3e+05
"0c9ffffd5d8568d742d5c07193250971","nano-precision-medical","venture",NA,"2014-03-24",2e+06
"bebdca8ef35c4617f89274cc79419d39","nano-terra","venture",NA,"2011-04-26",2300000
"bebdca8ef35c4617f89274cc79419d39","nano-terra","debt_financing",NA,"2011-02-24",750000
"bebdca8ef35c4617f89274cc79419d39","nano-terra","venture","1","2010-12-14",1.7e+07
"bebdca8ef35c4617f89274cc79419d39","nano-terra","venture",NA,"2014-10-23",6388098
"aa727f11eadb944f525fc53149a13a59","nano3d-biosciences","venture",NA,"2010-06-04",250000
"e59ba3a3e30b28520b354c7e46005914","nanoantibiotics","seed",NA,"2013-07-02",5e+05
"94b51e6c59473f625ae2c4b493e94aed","nanobi","venture",NA,"2014-02-03",NA
"b440a934ea8c738fdf5b99857108db5f","nanobio","private_equity",NA,"2006-10-21",3e+07
"b440a934ea8c738fdf5b99857108db5f","nanobio","venture","1","2009-07-08",2.2e+07
"b440a934ea8c738fdf5b99857108db5f","nanobio","venture","1","2012-11-28",1.1e+07
"b440a934ea8c738fdf5b99857108db5f","nanobio","grant",NA,"2010-11-30",6e+06
"1d4d295094d84b9e8079d5f820b1f504","nanobiodesign","venture",NA,"2007-07-09",1e+06
"f9c9aa1ee935b0e0bc355e30248c8ee3","nanobiotix","venture","c","2010-05-05",1.1e+07
"f9c9aa1ee935b0e0bc355e30248c8ee3","nanobiotix","grant",NA,"2013-07-04",3602480
"4cd9ba3db87b1fbbd7b85adfa4084ec7","nanocarrier-co","venture",NA,"2015-09-18",78036873.0361
"4cd9ba3db87b1fbbd7b85adfa4084ec7","nanocarrier-co","undisclosed",NA,"2012-01-26",46555627
"0a22e58755be26e9d2b591a7dda90a6d","nanocellect","venture",NA,"2016-01-22",1750000
"0a22e58755be26e9d2b591a7dda90a6d","nanocellect","grant",NA,"2013-10-21",7e+05
"88bf5ed678033078a25d218c8198921e","nanocellect-biomedical","venture",NA,"2016-01-22",1750000
"0c99fea59174da17dfc79b26b87e3567","nanocor-therapeutics","venture","B","2007-09-10",6250000
"d363b99ecb930abcf78a511cd442ee7d","nanoelectra",NA,NA,NA,NA
"de8b0f717761cb2e3bf2714b2c22ce7c","nanofiber-solutions","debt_financing",NA,"2013-12-12",1500000
"de8b0f717761cb2e3bf2714b2c22ce7c","nanofiber-solutions","seed",NA,"2012-04-23",NA
"196bdd34d66644b90e6c90171ce8f163","nanogen",NA,NA,NA,NA
"e3c466372b949dc48a7f73d70683b226","nanohorizons","venture","B","2008-06-04",6700000
"e3c466372b949dc48a7f73d70683b226","nanohorizons","venture",NA,"2011-01-05",2101767
"1b923b7cb415a83ccbcc53b27c877907","nanoink","venture",NA,"2008-03-21",1.2e+07
"1b923b7cb415a83ccbcc53b27c877907","nanoink","venture","1","2012-01-06",8.8e+07
"6b67d77157c1f2b523d5be5382e9113a","nanolive","undisclosed",NA,"2014-04-01",3049871
"d8b80b9cdb933398844b8b788c0e73d1","nanologix",NA,NA,NA,NA
"7aeb31dabf79797100fa11f7e1aa38b6","nanoly",NA,NA,NA,NA
"7c0f8e7155210e570be9ac762a770eec","nanomed-pharameceuticals","venture",NA,"2009-04-01",3049998
"0c849e3e18aa83cc6c2afbb0d4c6fecd","nanomed-targeting-systems",NA,NA,NA,NA
"95cca9893316aa7ee895122218d62373","nanomedex-pharmaceuticals","venture",NA,"2009-06-08",5e+05
"2cc910f569f1ed25578f332f5c800793","nanomedical-diagnostics","debt_financing",NA,"2016-01-22",6e+05
"2cc910f569f1ed25578f332f5c800793","nanomedical-diagnostics","venture",NA,"2015-04-22",NA
"2cc910f569f1ed25578f332f5c800793","nanomedical-diagnostics","venture","1","2015-10-13",1600000
"577c5f652b3a15047da878171b45b07e","nanomr","venture","b","2011-07-19",1.3e+07
"577c5f652b3a15047da878171b45b07e","nanomr","debt_financing",NA,"2010-10-29",2e+06
"577c5f652b3a15047da878171b45b07e","nanomr","venture","a","2008-06-27",5500000
"577c5f652b3a15047da878171b45b07e","nanomr","debt_financing",NA,"2013-07-09",2623512
"577c5f652b3a15047da878171b45b07e","nanomr","debt_financing",NA,"2013-12-20",2400000
"7e458abcdf6efa689465588ed444fe39","nanopharmaceuticals","venture",NA,"2014-02-03",2622500
"7e458abcdf6efa689465588ed444fe39","nanopharmaceuticals","venture",NA,"2015-01-06",5e+05
"f7d250a4878d4c97f6c74ad90d1e249e","nanopore-diagnostics","seed",NA,"2016-01-20",6e+05
"3dc12dc33949fd76db27fff1451f9387","nanorete","venture",NA,"2012-12-21",1188277
"3dc12dc33949fd76db27fff1451f9387","nanorete","venture",NA,"2015-05-23",50000
"99aee2d8ad0a49812111de25726ebc5e","nanoscale-biomagnetics",NA,NA,NA,NA
"c593bc236292d1abbcf615cb739f857f","nanosphere","post_ipo_equity",NA,"2013-09-19",30200000
"c593bc236292d1abbcf615cb739f857f","nanosphere","post_ipo_debt",NA,"2015-05-29",4070000
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","venture",NA,"2005-04-27",3800000
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","venture","1","2011-11-07",2e+07
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","debt_financing",NA,"2011-06-30",2500000
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","venture",NA,"2013-05-13",150000
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","venture","1","2007-06-26",8500000
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","debt_financing",NA,"2012-04-03",1.5e+07
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","venture","1","2009-06-14",3e+07
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","venture","1","2012-12-03",15300000
"d73376706b13f892a41676c64edb9a87","nanostring-technologies","venture",NA,"2010-02-12",1.5e+07
"61c0db9873729b52e59d78cd692e2ba1","nanosyn",NA,NA,NA,NA
"a4980732d4d948b9bbd999a7f0bbe455","nanotherapeutics","debt_financing",NA,"2014-06-03",3e+07
"a4980732d4d948b9bbd999a7f0bbe455","nanotherapeutics","debt_financing",NA,"2014-09-24",8e+06
"a4980732d4d948b9bbd999a7f0bbe455","nanotherapeutics","debt_financing",NA,"2015-03-18",28500000
"48731bc6c229732eb65257fe19618439","nanotherics","venture","a","2008-05-07",NA
"48731bc6c229732eb65257fe19618439","nanotherics","undisclosed",NA,"2010-09-28",1742189
"eb78e86becc2a65f5911af821219a41f","nanoviricides","venture",NA,"2011-07-27",2500000
"eb78e86becc2a65f5911af821219a41f","nanoviricides","venture",NA,"2012-02-09",5e+06
"eb78e86becc2a65f5911af821219a41f","nanoviricides","venture",NA,"2014-01-21",2e+07
"eb78e86becc2a65f5911af821219a41f","nanoviricides","debt_financing",NA,"2013-02-06",6e+06
"eb78e86becc2a65f5911af821219a41f","nanoviricides","venture",NA,"2012-06-29",5e+06
"eb78e86becc2a65f5911af821219a41f","nanoviricides","post_ipo_equity",NA,"2014-09-08",7500000
"a786bf389c2ab19df4e177e3646d8443","nanovis","venture",NA,"2015-12-14",750000
"e0a409e21e4c7a4e7bec68e70b41eb7a","nanovision-diagnostics","venture",NA,"2015-01-10",1500000
"6614724ba4f310efa3ba18be5a60ea8f","nansen",NA,NA,NA,NA
"1bba41d9c7fd2f5d1e3b9acaed8077cb","nantomics",NA,NA,NA,NA
"09a125444754f9f28417844aad898351","naoh",NA,NA,NA,NA
"b0c2bc8f0fea77d75a7c2d6055c796ac","napo-pharmaceuticals","venture",NA,"2009-05-12",5e+05
"b0c2bc8f0fea77d75a7c2d6055c796ac","napo-pharmaceuticals","venture",NA,"2011-10-27",3087500
"b0c2bc8f0fea77d75a7c2d6055c796ac","napo-pharmaceuticals","venture",NA,"2011-06-22",2996869
"b0c2bc8f0fea77d75a7c2d6055c796ac","napo-pharmaceuticals","venture",NA,"2010-10-27",3360000
"b0c2bc8f0fea77d75a7c2d6055c796ac","napo-pharmaceuticals","debt_financing",NA,"2014-06-06",137500
"474a0daf9431548f3a113f255eb1d0e0","narada-robotics",NA,NA,NA,NA
"d9d4d429227a96191e88bd521923fb9e","narrative","product_crowdfunding",NA,"2012-12-01",550000
"d9d4d429227a96191e88bd521923fb9e","narrative","seed",NA,"2012-07-03",675000
"d9d4d429227a96191e88bd521923fb9e","narrative","venture","1","2013-10-03",3e+06
"d9d4d429227a96191e88bd521923fb9e","narrative","venture","1","2014-09-04",8e+06
"f1202c4a8a1a1bef2f468ac24fe92f5c","narrative-science","venture",NA,"2013-04-05",550000
"f1202c4a8a1a1bef2f468ac24fe92f5c","narrative-science","venture","1","2013-09-10",11500000
"f1202c4a8a1a1bef2f468ac24fe92f5c","narrative-science","venture","1","2011-01-01",6e+06
"f1202c4a8a1a1bef2f468ac24fe92f5c","narrative-science","seed",NA,"2010-04-22",1350000
"f1202c4a8a1a1bef2f468ac24fe92f5c","narrative-science","debt_financing",NA,"2012-07-02",3e+06
"f1202c4a8a1a1bef2f468ac24fe92f5c","narrative-science","venture","1","2014-11-28",1e+07
"0ff018d9593609d52fff870295f53de6","narrative-visualization","seed",NA,"2015-06-01",40000
"aaebc6680ed2e214ce03d82a9e89cf73","narrativedx","seed",NA,"2014-06-18",50000
"aaebc6680ed2e214ce03d82a9e89cf73","narrativedx","seed",NA,"2015-06-15",8e+05
"aaebc6680ed2e214ce03d82a9e89cf73","narrativedx","seed",NA,"2015-06-08",650000
"aaebc6680ed2e214ce03d82a9e89cf73","narrativedx","debt_financing",NA,"2015-07-29",718000
"34bd991372f3ba9c715dd3872694d528","narrativewave-inc","seed",NA,"2014-08-05",650000
"34bd991372f3ba9c715dd3872694d528","narrativewave-inc","seed",NA,"2015-04-23",575000
"18d858afbc41bb3e3578e0d3de0ddf08","narwhaler-llc",NA,NA,NA,NA
"a26c044967a323b9de9e4ad5ea7f673f","nascent-bioscience-llc",NA,NA,NA,NA
"782c0be5bf5db1f004fac35c4ba05126","nascent-biologics","venture",NA,"2014-10-10",542500
"782c0be5bf5db1f004fac35c4ba05126","nascent-biologics","post_ipo_equity",NA,"2015-02-19",1200000
"782c0be5bf5db1f004fac35c4ba05126","nascent-biologics","grant",NA,"2015-02-26",225000
"3b62234830e50ab877f1b9868a91ea47","nascent-surgical","venture",NA,"2010-12-30",223000
"3b62234830e50ab877f1b9868a91ea47","nascent-surgical","venture",NA,"2015-01-02",105000
"3b62234830e50ab877f1b9868a91ea47","nascent-surgical","venture",NA,"2015-08-14",35000
"141e695dfae0309e3079b0238d70fbd0","nastel",NA,NA,NA,NA
"990892aa57fd74e0c1cfa07a76c8fc58","natera","venture","E","2013-05-01",54600000
"990892aa57fd74e0c1cfa07a76c8fc58","natera","venture","b","2009-01-07",6e+06
"990892aa57fd74e0c1cfa07a76c8fc58","natera","venture","d","2012-01-06",2e+07
"990892aa57fd74e0c1cfa07a76c8fc58","natera","venture","a","2008-12-05",4e+06
"990892aa57fd74e0c1cfa07a76c8fc58","natera","venture","c","2010-11-01",1.2e+07
"990892aa57fd74e0c1cfa07a76c8fc58","natera","grant",NA,"2011-04-27",2e+06
"990892aa57fd74e0c1cfa07a76c8fc58","natera","venture","F","2015-04-06",55500000
"e4d9b7360abbeb5b600ad07dec6ad402","natero","venture","a","2014-04-07",3334176
"5e1430d54c3b059b9bad4849695285d4","nathean-technologies",NA,NA,NA,NA
"0dd8095833e8b8f2d2a04d4852dffc53","natifs",NA,NA,NA,NA
"70bd3e77cd5b43c8c2a980f0d231b92a","national-business-brokerage",NA,NA,NA,NA
"41a1d6a65b548b37de2dc66238657234","national-capital",NA,NA,NA,NA
"ddbac37adb45505d8e1bb00b1dae170f","national-center-for-education-statistics",NA,NA,NA,NA
"e212a35d46246935b3c915be3e489682","national-research-corporation",NA,NA,NA,NA
"80600c6159abd08ca4e4e41b39c416b3","national-science-foundation--sbir-sttr-program",NA,NA,NA,NA
"8ba83b4f4229c5d889926790bf104c8c","native-ads-inc-",NA,NA,NA,NA
"5f550e07cdf583bb9a7e32b19344873a","native-rank",NA,NA,NA,NA
"2e482b65a327ee5dc0ce9d1349a7eddd","nativis","venture",NA,"2015-12-24",250000
"2e482b65a327ee5dc0ce9d1349a7eddd","nativis","venture",NA,"2014-02-10",9161414
"2e482b65a327ee5dc0ce9d1349a7eddd","nativis","venture",NA,"2015-06-23",725000
"8f8bbe4eea591580046e9e7dc367ff3f","therapeutics-international","venture",NA,"2010-04-05",1400000
"4925999ef9510d1d88b2834bb562692a","natta",NA,NA,NA,NA
"65e26db39f733e861a3adedfe1d78512","naturalia-france",NA,NA,NA,NA
"892c08c94cd52732a10dc6f8ccd2112c","nature-one",NA,NA,NA,NA
"ce5268ebf36966a8eb47717978268dd6","nature-technology",NA,NA,NA,NA
"a41889cd4af42f7dc0c94167006c9542","natures-sunshine-products",NA,NA,NA,NA
"a378b01f06fe7f6ef084e2a1d79e1c02","natus-medical",NA,NA,NA,NA
"00d7b7ae118d9a32cd6c0260231331ef","nau-media-corporation",NA,NA,NA,NA
"5a47bc5aa98a6a5d484fc201b5f05764","naurex","debt_financing",NA,"2011-02-04",1106600
"5a47bc5aa98a6a5d484fc201b5f05764","naurex","venture","1","2011-05-11",1.8e+07
"5a47bc5aa98a6a5d484fc201b5f05764","naurex","venture","1","2012-12-17",3.8e+07
"5a47bc5aa98a6a5d484fc201b5f05764","naurex","venture","1","2014-05-06",2.5e+07
"5a47bc5aa98a6a5d484fc201b5f05764","naurex","venture","1","2014-12-03",79999999
"612210890ef2f8c79ad026eb5b17e41b","nautilus-biotech","venture",NA,"2007-04-30",11300000
"612210890ef2f8c79ad026eb5b17e41b","nautilus-biotech","venture",NA,"2005-03-03",9529400
"042fa59031d6324faf48725d64ec8b2c","nautilus-neurosciences","venture",NA,"2010-04-12",8e+06
"042fa59031d6324faf48725d64ec8b2c","nautilus-neurosciences","venture","1","2010-04-12",17755532
"6994a0485f10afcdcc99da290b8d8aac","navegg","seed",NA,"2010-07-01",NA
"6994a0485f10afcdcc99da290b8d8aac","navegg","venture","1","2011-02-14",NA
"34e1a99ed48987848a311fc7c9b7c07f","navia-systems",NA,NA,NA,NA
"fb9ba72133c57096daefd1cffacd5242","navidea-biopharmaceuticals","post_ipo_debt",NA,"2014-03-06",3e+07
"fb9ba72133c57096daefd1cffacd5242","navidea-biopharmaceuticals","venture",NA,"2014-01-21",2500000
"fb9ba72133c57096daefd1cffacd5242","navidea-biopharmaceuticals","post_ipo_debt",NA,"2015-05-11",6e+07
"40faad3b405d9e5706179563526da1ed","navigatormd","venture",NA,"2010-04-03",50000
"3f9a0b1e2b8cdefe931347bc12f57519","navigenics","venture","c","2010-02-04",1.8e+07
"3f9a0b1e2b8cdefe931347bc12f57519","navigenics","venture",NA,"2007-11-07",2.5e+07
"bb25183e1f9fb2b1c3f04c5702fed7c9","navilyst-medical",NA,NA,NA,NA
"87d37c70c6ecb7393e28ef183904bf74","navilytics",NA,NA,NA,NA
"f684778d3125e505b4e3102e215f7366","naviscan","venture","C","2007-05-03",1.5e+07
"f684778d3125e505b4e3102e215f7366","naviscan","debt_financing",NA,"2011-10-17",830000
"f684778d3125e505b4e3102e215f7366","naviscan","convertible_note",NA,"2010-06-10",2500001
"f684778d3125e505b4e3102e215f7366","naviscan","venture",NA,"2012-12-19",1e+06
"8154ffb0b849b073839ec78ad8ce17da","navitor-pharmaceuticals","venture","B","2015-12-18",3.3e+07
"8154ffb0b849b073839ec78ad8ce17da","navitor-pharmaceuticals","venture","A","2014-06-19",23500000
"abdb0aea199c2d0dfa680d372e60e961","nazar","seed",NA,"2014-02-01",1e+05
"02a30d3d2e66416d692aec21bc479da7","nbe-therapeutics","venture","A","2015-03-24",3097541
"fe480d323938ecc77135bea6d1cbbda2","nc-associates",NA,NA,NA,NA
"7c8f5d07eb75f8980c0b1dbd01c8ff65","nc4",NA,NA,NA,NA
"5ee80a6a77d43d672c16b668b1ed65b3","nchannel","venture",NA,"2015-12-04",351677
"5ee80a6a77d43d672c16b668b1ed65b3","nchannel","venture",NA,"2012-04-09",768851
"5ee80a6a77d43d672c16b668b1ed65b3","nchannel","venture","1","2013-04-30",2400000
"5ee80a6a77d43d672c16b668b1ed65b3","nchannel","debt_financing",NA,"2015-06-15",1403986
"5ee80a6a77d43d672c16b668b1ed65b3","nchannel","seed",NA,"2011-07-01",450000
"5a1c4ff06053b5ab585ebb4288d11bec","ncmborz",NA,NA,NA,NA
"01e77632e94ca13a184bc2cc4fb6ac02","ncoasource",NA,NA,NA,NA
"f0d23d906afdd0974a1dd95641f2c7cf","ncrease","convertible_note",NA,"2015-05-04",25000
"68f3bb39fa51cc96af523e0050ad88f0","ncsrt","venture","A","2007-09-24",5e+06
"25ce4c1f9b2d5e9f34e566c22833489a","ncube","seed",NA,"2015-05-01",3826452
"4f8857b27ccff5a146d02328923fb8aa","ncyclo-corp","venture",NA,"2014-02-21",1e+06
"4f8857b27ccff5a146d02328923fb8aa","ncyclo-corp","venture",NA,"2014-09-30",NA
"4553eec526e354d438d6906cbee0ff50","nd-acquisitions","debt_financing",NA,"2010-10-05",1501115
"4553eec526e354d438d6906cbee0ff50","nd-acquisitions","venture",NA,"2009-05-20",5473606
"4553eec526e354d438d6906cbee0ff50","nd-acquisitions","private_equity",NA,"2011-09-22",12224529
"4553eec526e354d438d6906cbee0ff50","nd-acquisitions","debt_financing",NA,"2011-03-10",5e+06
"4553eec526e354d438d6906cbee0ff50","nd-acquisitions","venture",NA,"2014-07-11",11031858
"4553eec526e354d438d6906cbee0ff50","nd-acquisitions","venture",NA,"2015-03-18",3849424
"2601c06ab77d5d63b4cb96e225c4f756","nds-surgical-imaging",NA,NA,NA,NA
"9bb1c018dc6ec0d88e6ad98e7d921194","ndssi-holdings","venture",NA,"2011-01-13",3700000
"9bb1c018dc6ec0d88e6ad98e7d921194","ndssi-holdings","venture",NA,"2010-05-17",3118726
"9bb1c018dc6ec0d88e6ad98e7d921194","ndssi-holdings","venture",NA,"2011-07-07",4500000
"2f0d330f7a060aaec8f178522ab03f35","nearco","venture","B","2014-10-15",1.9e+07
"2f0d330f7a060aaec8f178522ab03f35","nearco","venture","A","2012-11-28",6500000
"d48e60360da8bab8d9910ae67272eb41","nearbuy-systems","venture",NA,"2011-07-21",1e+06
"d48e60360da8bab8d9910ae67272eb41","nearbuy-systems","venture",NA,"2012-01-26",1532328
"d48e60360da8bab8d9910ae67272eb41","nearbuy-systems","venture",NA,"2012-11-23",749999
"e96d95b3211ded23a722e7805310687d","neardesk","equity_crowdfunding",NA,"2013-03-20",203085
"e96d95b3211ded23a722e7805310687d","neardesk","equity_crowdfunding",NA,"2013-09-04",77878
"e96d95b3211ded23a722e7805310687d","neardesk","equity_crowdfunding",NA,"2014-07-04",1715874
"d1f93fcb5a8b0f6558ce12a492cde7f1","nearstream",NA,NA,NA,NA
"6335400155b6c56ce5acf7e9d4048aa2","nebotrade","venture",NA,"2005-03-28",3e+05
"65a7c570e86820432943cfea97d1ceca","nebulab","venture",NA,"2015-10-01",110000
"65a7c570e86820432943cfea97d1ceca","nebulab","seed",NA,"2014-04-01",25000
"65a7c570e86820432943cfea97d1ceca","nebulab","seed",NA,"2015-01-01",118000
"fc05d82a2ee0354f9e6433812b490085","nectar-online-media","seed",NA,"2014-02-01",1e+06
"fc05d82a2ee0354f9e6433812b490085","nectar-online-media","seed",NA,"2012-07-01",3e+05
"70864fabf114c13e941728b71b9ca9d6","ned-biosystems","venture",NA,"2015-10-27",1507500
"09b8eb33bd1b41657e8422968f20456c","nediyor","seed",NA,"2012-08-07",140449
"7c4e1c6aeb8594b18a4889a5ee6930f9","nedstat",NA,NA,NA,NA
"497bd4633dfca7f0dd45edb29a762c02","needlefound",NA,NA,NA,NA
"d91a1c65a46f4a46f592f28395e2282d","needtagger",NA,NA,NA,NA
"d08d0058c20c6af1c6826d8386f1a35c","neevo",NA,NA,NA,NA
"f53585daee6acc0f50d618b988dd958b","neighbormd","seed",NA,"2012-01-06",2080112
"f53585daee6acc0f50d618b988dd958b","neighbormd","seed",NA,"2012-11-01",818886
"f53585daee6acc0f50d618b988dd958b","neighbormd","seed",NA,"2013-03-01",4e+05
"0e891d7a0977826274f10456804738b2","neil-dhillon",NA,NA,NA,NA
"3a7272dcaf888247ee5bec7dba0fe76a","nektar-therapeutics","venture",NA,"2013-08-28",2.5e+07
"188ab704072e0c08cfc4baf016b3eba7","nellone-therapeutics","venture",NA,"2008-06-04",1500000
"d6061fb97f761c3dd92831e9dfe57527","neo-technology","seed",NA,"2009-10-28",2500000
"d6061fb97f761c3dd92831e9dfe57527","neo-technology","venture","1","2012-11-02",1.1e+07
"d6061fb97f761c3dd92831e9dfe57527","neo-technology","venture","1","2011-09-21",10600000
"d6061fb97f761c3dd92831e9dfe57527","neo-technology","venture","1","2015-01-15",2e+07
"2fde95491fd09b0bdb65f30976f32bce","neo-ogilvy",NA,NA,NA,NA
"9756825c668df6187d83c92d077834a2","neoantigenics","undisclosed",NA,"2014-04-13",NA
"9756825c668df6187d83c92d077834a2","neoantigenics","venture",NA,"2015-02-24",3025713
"a0dcd8e2c3db4d2f5a1a4d5718190f08","neochord","venture","b","2011-07-29",5074000
"a0dcd8e2c3db4d2f5a1a4d5718190f08","neochord","venture","a","2009-06-16",3359055
"a0dcd8e2c3db4d2f5a1a4d5718190f08","neochord","debt_financing",NA,"2013-10-25",3e+06
"a0dcd8e2c3db4d2f5a1a4d5718190f08","neochord","venture","C","2015-06-09",2e+07
"4d14a15120ae65a3745d4eec63635580","neodiagnostix","venture",NA,"2009-10-24",1509997
"d7aa389fe026ef8038ed5dc41e8534f5","neodyne-biosciences","venture",NA,"2008-06-16",1e+06
"d7aa389fe026ef8038ed5dc41e8534f5","neodyne-biosciences","venture",NA,"2010-08-05",5764177
"1e4247e81069905836e51dc2fe2fdf79","neofi-solutions",NA,NA,NA,NA
"0bf596c07b237382ac686184dc745049","neofluidics-llc","seed",NA,"2015-04-02",216000
"0bf596c07b237382ac686184dc745049","neofluidics-llc","angel",NA,"2014-09-21",135000
"0bf596c07b237382ac686184dc745049","neofluidics-llc","angel",NA,"2014-08-29",50000
"79aab5685d7c9a500b50fe73c0c74ff4","neogenix-oncology","venture",NA,"2009-05-15",1.5e+07
"79aab5685d7c9a500b50fe73c0c74ff4","neogenix-oncology","venture",NA,"2010-09-30",846225
"dfb769f4cd0d5346ce1bd2e915b4edab","neogenomics-laboratories","venture",NA,"2009-03-30",5e+05
"a38ddc2ff42b7457b79bf5622a659659","neoguide-systems","venture","B","2003-11-18",1.4e+07
"a38ddc2ff42b7457b79bf5622a659659","neoguide-systems","venture","c","2006-09-29",2.5e+07
"0265962d7b59221d6781ec90f6fecfff","neokami-2","convertible_note",NA,"2014-08-01",NA
"0265962d7b59221d6781ec90f6fecfff","neokami-2","seed",NA,"2015-07-08",1100000
"b8b12beed9c3bb875341d1eeab87f562","neomed-institute","grant",NA,"2014-08-25",1.2e+07
"3d2c22ed4f11821b8811f50668ff9138","neomend","venture","C","2007-07-14",6e+06
"3d2c22ed4f11821b8811f50668ff9138","neomend","venture","d","2011-08-03",2e+07
"3d2c22ed4f11821b8811f50668ff9138","neomend","debt_financing",NA,"2009-05-15",2702727
"3d2c22ed4f11821b8811f50668ff9138","neomend","venture","d","2010-01-27",3e+07
"3d2c22ed4f11821b8811f50668ff9138","neomend","debt_financing",NA,"2009-10-14",3e+06
"5658ffaddfb23454cb0fd6fe8249b5b2","neon-creative-labware",NA,NA,NA,NA
"3d707d74712776173d3f0cc7af035ad9","neon-crm",NA,NA,NA,NA
"4b18d7623a4ddc67485d37bf205021ce","neon-mobile","non_equity_assistance",NA,"2013-09-24",120000
"4b18d7623a4ddc67485d37bf205021ce","neon-mobile","undisclosed",NA,"2014-09-09",1e+05
"c7238a872a5d9f30a85c2f8418bb8369","neonc-technologies","venture",NA,"2012-08-14",150000
"f983c9a26ec0f7eb12c69b04bbcda697","neoprospecta","seed",NA,"2014-08-18",1769107
"f983c9a26ec0f7eb12c69b04bbcda697","neoprospecta","angel",NA,"2013-02-15",254668
"52befd5f3443b1b9ac81b330c10c1d7c","neoreach","seed",NA,"2013-11-10",3e+05
"52befd5f3443b1b9ac81b330c10c1d7c","neoreach","seed",NA,"2014-08-27",2900000
"520b73617fbe2867205eb4606492d0bd","neos-therapeutics","venture",NA,"2011-06-09",13554505
"520b73617fbe2867205eb4606492d0bd","neos-therapeutics","venture","1","2014-03-04",15500000
"520b73617fbe2867205eb4606492d0bd","neos-therapeutics","venture","1","2009-11-24",24100000
"520b73617fbe2867205eb4606492d0bd","neos-therapeutics","venture","1","2014-04-23",2500000
"520b73617fbe2867205eb4606492d0bd","neos-therapeutics","debt_financing",NA,"2014-04-23",2e+07
"520b73617fbe2867205eb4606492d0bd","neos-therapeutics","venture",NA,"2015-02-19",20624355
"5196bce6424ec95b50e8da45624e2a11","neostem","venture",NA,"2009-04-13",1.1e+07
"5196bce6424ec95b50e8da45624e2a11","neostem","venture",NA,"2014-05-19",3.8e+07
"dfc04ed184140a48cb99cd0a38c9968e","neotropix","venture",NA,"2009-05-15",1400000
"39fd2cf3f67b814826af9b59a0120e67","neovacs","venture",NA,"2007-07-17",17902300
"39fd2cf3f67b814826af9b59a0120e67","neovacs","venture",NA,"2015-06-29",8309742
"b9372128fedcbc11f0ec9d2849e44744","neovise",NA,NA,NA,NA
"40057ce6750310066d59c5e460a4f922","nephrogenex","post_ipo_equity",NA,"2015-11-13",5500000
"40057ce6750310066d59c5e460a4f922","nephrogenex","venture",NA,"2010-07-21",1e+06
"40057ce6750310066d59c5e460a4f922","nephrogenex","venture","1","2007-07-06",3300000
"40057ce6750310066d59c5e460a4f922","nephrogenex","post_ipo_equity",NA,"2014-11-20",1.2e+07
"0403bf78df5b1317bfde188ecc06ae11","nephron-pharmaceuticals",NA,NA,NA,NA
"cf3370b526f62f47c8b365cfb71cb92a","nephrx-corporation","venture",NA,"2010-02-10",6219317
"42672805dcd9e1188d77a24648afe20d","neptune-technologies-bioressource","post_ipo_equity",NA,"2014-03-05",2.5e+07
"42672805dcd9e1188d77a24648afe20d","neptune-technologies-bioressource","venture",NA,"2011-05-17",6125000
"42672805dcd9e1188d77a24648afe20d","neptune-technologies-bioressource","venture","1","2013-08-27",5e+06
"118b5df8765e9e755608e8e7a851d609","nerdphone",NA,NA,NA,NA
"68d575d23ff71418006882ff1b171483","nereus-pharmaceuticals","venture","D","2005-10-19",42600000
"68d575d23ff71418006882ff1b171483","nereus-pharmaceuticals","venture","D","2007-08-09",4.5e+07
"68d575d23ff71418006882ff1b171483","nereus-pharmaceuticals","venture","e","2010-06-25",2e+07
"f44e9e0b5a501e896485a3fee6583def","neri","grant",NA,"2011-10-25",4.5e+07
"f5c05e57d563db3582106f26d6a250d2","nerites","venture","A","2008-02-15",5700000
"f5c05e57d563db3582106f26d6a250d2","nerites","debt_financing",NA,"2009-06-11",1669779
"f5c05e57d563db3582106f26d6a250d2","nerites","debt_financing",NA,"2010-02-03",6e+05
"1cab0bfe84e6ec5039d68924adbc42b2","nerium-biotechnology","venture",NA,"2011-03-31",288537
"87ebecb38867e99843ff2b69df156836","nerveda","venture",NA,"2010-04-12",14135454
"43ffa2acde2033d7811c51a23832c779","nervve-technologies","seed",NA,"2012-08-21",3e+05
"43ffa2acde2033d7811c51a23832c779","nervve-technologies","venture",NA,"2013-12-01",NA
"43ffa2acde2033d7811c51a23832c779","nervve-technologies","venture","1","2014-10-20",5e+06
"1f8c827ef43565a271ff3cb22c5860fa","nestegg","seed",NA,"2015-03-31",16227
"4abae211b6dac0b2acd4a677a1697d67","nestiny-inc","angel",NA,"2016-01-07",350000
"174eef9f56122e08dfadfbdd6de803ce","net-results",NA,NA,NA,NA
"688864430aaf08607fd6bd84caa921df","netbase","venture","B","2007-12-01",6500000
"688864430aaf08607fd6bd84caa921df","netbase","venture","C","2013-01-15",9600000
"688864430aaf08607fd6bd84caa921df","netbase","venture","C","2010-03-02",7200000
"688864430aaf08607fd6bd84caa921df","netbase","venture","C","2012-06-01",13100000
"688864430aaf08607fd6bd84caa921df","netbase","venture","a","2005-06-01",5e+06
"688864430aaf08607fd6bd84caa921df","netbase","venture","D","2014-07-15",10200000
"688864430aaf08607fd6bd84caa921df","netbase","venture","E","2015-03-12",2.4e+07
"688864430aaf08607fd6bd84caa921df","netbase","venture","E","2015-04-29",9e+06
"83d874a46ea66449b604760f31d41ca4","netemic",NA,NA,NA,NA
"11548d4962716bf8ed91d5047ba13b80","netexpo",NA,NA,NA,NA
"6eb4f403bc67562354000e2e7155e08f","netfactor","venture","a","2008-01-01",2e+06
"76dfc7a85c5aad999fc770fe317c0538","netgoogly-com",NA,NA,NA,NA
"0f0592f5806c4f9308a2d915e3e4c5cf","netherlands-forensics-institute",NA,NA,NA,NA
"72660746a859614a011e048ac0e48fe4","nethub-media","angel",NA,"2012-10-01",166000
"72660746a859614a011e048ac0e48fe4","nethub-media","seed",NA,"2011-10-01",48925
"72660746a859614a011e048ac0e48fe4","nethub-media","venture",NA,"2012-12-01",55663
"72660746a859614a011e048ac0e48fe4","nethub-media","convertible_note",NA,"2013-01-01",180834
"480111eaeb95eacb6c53de6f277f1c4e","neticle-technologies",NA,NA,NA,NA
"4b023b5d8c5bf9fd9cfe6de4673aa822","netis-systems",NA,NA,NA,NA
"f5d5cc983a41c33f9e459f43b75ff69d","netnui-com","seed",NA,"2012-07-18",40000
"9229fc0ecad04ac074c1091fad07fba7","netonomy",NA,NA,NA,NA
"d3b05a24c6ab9ad9d390638543066f4d","netowl",NA,NA,NA,NA
"16e536cb1fb3025976002c2ead699517","netprospex","venture",NA,"2006-09-01",NA
"16e536cb1fb3025976002c2ead699517","netprospex","venture","1","2009-10-26",2e+06
"16e536cb1fb3025976002c2ead699517","netprospex","venture","1","2008-02-01",NA
"16e536cb1fb3025976002c2ead699517","netprospex","venture","1","2008-05-23",NA
"16e536cb1fb3025976002c2ead699517","netprospex","venture","1","2012-06-06",7e+06
"16e536cb1fb3025976002c2ead699517","netprospex","venture","1","2014-04-08",1.3e+07
"16e536cb1fb3025976002c2ead699517","netprospex","venture","1","2010-12-07",5500000
"74310fa56a85cf3d4866fc7c96306024","netra-systems-inc","convertible_note",NA,"2015-08-03",5e+05
"74310fa56a85cf3d4866fc7c96306024","netra-systems-inc","seed",NA,"2014-07-01",1e+05
"74310fa56a85cf3d4866fc7c96306024","netra-systems-inc","seed",NA,"2015-06-04",18000
"5d3b9aa9e280f81d8e37bb81e32e8427","netscientific","venture",NA,"2013-09-16",45457543
"98f20c8dd5a4119f0b84bb16484157ad","nettime-solutions",NA,NA,NA,NA
"49e367e4715ff1f53653edf5ce381389","netwave",NA,NA,NA,NA
"69cce0bcb78ceff19afb323abd466d4f","networked-insights","venture","a","2010-04-20",5e+06
"69cce0bcb78ceff19afb323abd466d4f","networked-insights","venture","c","2013-10-18",9400000
"69cce0bcb78ceff19afb323abd466d4f","networked-insights","venture","b","2011-09-29",2e+07
"69cce0bcb78ceff19afb323abd466d4f","networked-insights","venture","a","2007-11-07",4e+06
"69cce0bcb78ceff19afb323abd466d4f","networked-insights","venture","D","2014-12-10",8800000
"19d2e5174a6755dbd3a3c3d966eec260","networqx",NA,NA,NA,NA
"1c81e39154471a9c1273c70f65427b13","neudesic",NA,NA,NA,NA
"2103f58ba8e846aa1ef1e12b02b9edc9","neumedicines",NA,NA,NA,NA
"8df5ea390b20613455a400fdc2c9ae64","neumedics","venture",NA,"2008-05-14",87950
"038abd2805356de100dff129499a52ce","neumitra","seed",NA,"2012-06-01",20000
"038abd2805356de100dff129499a52ce","neumitra","seed",NA,"0010-02-10",NA
"9ee25d271df04f957a2411904d608d96","neumodx-molecular","venture","b","2014-04-01",2.1e+07
"f579b28be67d004384ae4b731d3bebca","neural","convertible_note",NA,"2015-01-29",NA
"a795fe55805eadcc6b0d4a2f6e671f48","neural-id",NA,NA,NA,NA
"702fdc4ccf8ffbbf6000baeb4cf84c70","neuralstem","venture",NA,"2010-01-05",1500000
"702fdc4ccf8ffbbf6000baeb4cf84c70","neuralstem","venture",NA,"2013-04-10",1778000
"0a037ef943cf7377504ea5b3e006d401","neuraltus-pharmaceuticals","venture","a","2009-03-26",1.7e+07
"0a037ef943cf7377504ea5b3e006d401","neuraltus-pharmaceuticals","venture","b","2012-01-31",9600000
"0a037ef943cf7377504ea5b3e006d401","neuraltus-pharmaceuticals","venture",NA,"2012-04-01",1501000
"0a037ef943cf7377504ea5b3e006d401","neuraltus-pharmaceuticals","venture","a","2012-05-30",11125649
"b7abfe744a6805c6bdac8f60b3bb6324","neuraxon","venture","B","2007-08-20",3.2e+07
"b7abfe744a6805c6bdac8f60b3bb6324","neuraxon","debt_financing",NA,"2009-12-30",8750000
"b7abfe744a6805c6bdac8f60b3bb6324","neuraxon","venture",NA,"2012-05-01",782171
"b7abfe744a6805c6bdac8f60b3bb6324","neuraxon","debt_financing",NA,"2010-09-30",1.4e+07
"c0e8a55e9702685e038f06d3e8b3da50","neurecall","seed",NA,"2015-01-26",24115
"c0e8a55e9702685e038f06d3e8b3da50","neurecall","grant",NA,"2015-06-08",12060
"c0e8a55e9702685e038f06d3e8b3da50","neurecall","seed",NA,"2014-09-30",92840
"c0e8a55e9702685e038f06d3e8b3da50","neurecall","grant",NA,"2015-07-28",19215
"8cc9edc133c2b57adf659e4867d6e698","neurelis","debt_financing",NA,"2010-02-03",1700000
"8cc9edc133c2b57adf659e4867d6e698","neurelis","debt_financing",NA,"2011-10-03",1083950
"8cc9edc133c2b57adf659e4867d6e698","neurelis","venture",NA,"2015-07-16",1500000
"d5e1dc877ebba0487d75174e10ab60d7","neuren-pharmaceuticals","venture",NA,"2013-10-21",21500000
"9e941950a46413eb8aeb7927165bc843","neurence","venture",NA,"2015-02-23",4e+06
"9bcc3b1dc4ad2405ea8f637576f6f993","neurimmune-holding",NA,NA,NA,NA
"307328b3a048a007ef673ed1ec99cf3d","neuroco",NA,NA,NA,NA
"abff60ff405704f94255d751dcad2bd0","neurocrine-biosciences","venture",NA,"2009-12-17",1e+07
"bbf3d8029d379096d08250b4a40194bc","neurodon","equity_crowdfunding",NA,"2014-11-14",NA
"e9621160f418a544b0417d65f02184a2","neurodyn","venture","a","2013-02-06",1001402
"e9621160f418a544b0417d65f02184a2","neurodyn","venture","A","2015-03-12",1408880
"b8f0a15b5600d5f62413f2129136746d","neurodyne-medical",NA,NA,NA,NA
"530b1abf3da486372e7f1860cf6e7473","neurogen-corp",NA,NA,NA,NA
"7c4e41259f3f0efede8cbe43eb99fb87","neurogenetic-pharmaceuticals","grant",NA,"2015-11-15",2500000
"7c4e41259f3f0efede8cbe43eb99fb87","neurogenetic-pharmaceuticals","venture",NA,"2010-07-12",1144878
"7c4e41259f3f0efede8cbe43eb99fb87","neurogenetic-pharmaceuticals","undisclosed",NA,"2012-01-04",NA
"7c4e41259f3f0efede8cbe43eb99fb87","neurogenetic-pharmaceuticals","venture",NA,"2014-01-09",1e+05
"7c4e41259f3f0efede8cbe43eb99fb87","neurogenetic-pharmaceuticals","debt_financing",NA,"2012-10-02",250000
"7c4e41259f3f0efede8cbe43eb99fb87","neurogenetic-pharmaceuticals","debt_financing",NA,"2015-03-12",50000
"fe1e058df6c25bef651998875996bf52","neurogesx","venture",NA,"2008-01-09",2.5e+07
"fe1e058df6c25bef651998875996bf52","neurogesx","venture","1","2005-12-01",2e+07
"fe1e058df6c25bef651998875996bf52","neurogesx","venture",NA,"2011-08-03",20209229
"fe1e058df6c25bef651998875996bf52","neurogesx","venture",NA,"2012-02-02",2999382
"fe1e058df6c25bef651998875996bf52","neurogesx","venture",NA,"2012-03-29",975000
"70a47dd4425a58876e52c1f83af953c9","neuroinitiative",NA,NA,NA,NA
"39e1fca4976f338b4781e4a79ba4de82","neurointerventional-therapeutics","venture",NA,"2009-06-30",85000
"5a216fc25ecc82ab9fca67712a244d4b","neurolink","venture",NA,"2010-10-18",1617000
"5a216fc25ecc82ab9fca67712a244d4b","neurolink","venture",NA,"2011-01-11",2261759
"dd3092852d0ea18f81a3b36eabc2c110","neurolixis-inc","venture",NA,"2013-07-18",15000
"7b9fb5aab6cef73fb24821575dbffe52","neurologix","venture",NA,"2010-12-06",7e+06
"7fec2334ecaa3fc84064aa7e929d8ad2","neuromed-pharmaceuticals","venture","E","2007-08-22",53300000
"8da350c31a6c6f0ed5c964e9e519bf1f","neuromore","seed",NA,"2016-01-07",3e+05
"8da350c31a6c6f0ed5c964e9e519bf1f","neuromore","seed",NA,"2015-09-01",5e+05
"f91dde3ebed1aac5548f1ca19406101b","neuron-systems","venture","a","2008-08-08",8960000
"0e9f7b21dce625b9b25061ae61446ef7","neuron-therapeutics","venture","A","2015-12-01",23500000
"0e9f7b21dce625b9b25061ae61446ef7","neuron-therapeutics","venture",NA,"2014-12-23",7644339
"fa34dc03afc1c76190b7c79cc8dad1da","neuronascent","venture",NA,"2008-01-23",50000
"fa34dc03afc1c76190b7c79cc8dad1da","neuronascent","venture",NA,"2015-03-18",1200000
"26e9f31a8999b0f7b7f47b3c746b33b5","neuronetics","venture","d","2009-10-27",3e+07
"26e9f31a8999b0f7b7f47b3c746b33b5","neuronetics","venture","e","2011-05-16",3e+07
"26e9f31a8999b0f7b7f47b3c746b33b5","neuronetics","seed",NA,"2001-08-22",NA
"26e9f31a8999b0f7b7f47b3c746b33b5","neuronetics","venture","F","2015-04-27",34300000
"b188c5fc45e3b80695fc3cf735117481","neuronex","venture","a","2010-10-07",1500000
"b188c5fc45e3b80695fc3cf735117481","neuronex","debt_financing",NA,"2011-05-09",399999
"da755d56cb4a4ec516edec7513a4a1ec","neurontools",NA,NA,NA,NA
"3d03d832243e4503815a0d76a6fdfc1e","neurop","debt_financing",NA,"2014-02-24",155000
"3d03d832243e4503815a0d76a6fdfc1e","neurop","seed",NA,"2008-04-20",NA
"3ac8f9441278635a50ef93ba0ce9bb29","neuropace","venture",NA,"2013-07-09",1.8e+07
"3ac8f9441278635a50ef93ba0ce9bb29","neuropace","venture",NA,"2011-08-31",4.9e+07
"27c3700e67078722576b8753bbfac490","neurophage-pharmaceuticals","venture","b","2012-03-08",9e+06
"27c3700e67078722576b8753bbfac490","neurophage-pharmaceuticals","venture","c","2013-05-06",6400000
"27c3700e67078722576b8753bbfac490","neurophage-pharmaceuticals","venture","b","2011-03-01",12400000
"27c3700e67078722576b8753bbfac490","neurophage-pharmaceuticals","venture","d","2014-03-25",1.7e+07
"27c3700e67078722576b8753bbfac490","neurophage-pharmaceuticals","venture","D","2015-01-14",1e+07
"aefc4d889c30314d932ac8afed5960f5","neuroptics","seed",NA,"2011-11-30",5e+05
"aefc4d889c30314d932ac8afed5960f5","neuroptics","venture",NA,"2014-04-21",1246627
"7450a73fc4f489807573fc6b1f9a0f68","neuropure","venture","a","2007-03-20",5e+05
"d4d00efe8ce87f2dbac82afe9781d426","neuroquest","undisclosed",NA,"2013-05-13",NA
"34840a202fac518c065bcf973ce4e481","neurosearch","venture",NA,"2009-08-17",14330000
"490a930bdc3b3b248eea203782b7a98e","neurosigma","venture",NA,"2011-02-15",5e+05
"490a930bdc3b3b248eea203782b7a98e","neurosigma","debt_financing",NA,"2011-03-10",1210000
"5218d501fc53a4b4af1f2863f68a614a","neurosky","venture","a","2013-11-01",NA
"5218d501fc53a4b4af1f2863f68a614a","neurosky","undisclosed",NA,"2013-11-04",NA
"048e1005b6ab23fd44f3c7ad8d98874f","neurosyntek","equity_crowdfunding",NA,"2015-09-14",NA
"79225ca0a6f912a0e3c0dfbf113ff594","neurotar",NA,NA,NA,NA
"da674fbd1bc6a494a7b674ae2f5758e2","neurotec-pharma","venture",NA,"2011-02-19",4496910
"d468da86a0c47df858eb5ad16713a1d7","neurotech","venture","b","2006-11-16",3.5e+07
"f0ad9627a36113003c351a4384f1738e","neurotherapeutics-pharma","debt_financing",NA,"2009-01-06",3200000
"f0ad9627a36113003c351a4384f1738e","neurotherapeutics-pharma","venture","1","2010-05-20",4.3e+07
"f0ad9627a36113003c351a4384f1738e","neurotherapeutics-pharma","venture",NA,"2011-12-15",1.2e+07
"df6b4ea982300ce0ad0ba386cee1e5ee","neurotrack-technologies","venture","A","2016-01-27",6500000
"df6b4ea982300ce0ad0ba386cee1e5ee","neurotrack-technologies","seed","A","2013-09-26",2e+06
"df6b4ea982300ce0ad0ba386cee1e5ee","neurotrack-technologies","seed",NA,"2013-05-22",90000
"df6b4ea982300ce0ad0ba386cee1e5ee","neurotrack-technologies","debt_financing",NA,"2014-12-29",1e+06
"6cc7db7fb69f11c5a40bb9ff7cdcc1be","neurotron-biotechnology","venture","c","2013-12-27",16500000
"e7eec65e4950909d4891c9f05476cdf3","neurotronik","venture","a","2013-06-13",13100000
"a8eb98268bc0ce4e4a35648eba7e86aa","neurotrope-bioscience","venture","a","2013-09-02",21900000
"005172e8ec7f43a2823f420ad9aef096","neurovance","venture","A","2015-06-29",6499995
"005172e8ec7f43a2823f420ad9aef096","neurovance","venture",NA,"2012-02-03",478064
"005172e8ec7f43a2823f420ad9aef096","neurovance","venture",NA,"2012-10-11",10500543
"005172e8ec7f43a2823f420ad9aef096","neurovance","venture","a","2014-04-03",6300000
"005172e8ec7f43a2823f420ad9aef096","neurovance","venture","A","2015-03-26",5500000
"1f37e6e02b703b51b19d7d0498843f49","neurovigil","seed","A","2011-05-01",NA
"1f37e6e02b703b51b19d7d0498843f49","neurovigil","venture","A","2015-05-01",NA
"d1dfb899222f2a689d1ba7a56e7f5641","neurovive-pharmaceutical","post_ipo_equity",NA,"2015-02-12",3300000
"d1dfb899222f2a689d1ba7a56e7f5641","neurovive-pharmaceutical","post_ipo_equity",NA,"2015-05-27",7462732
"9b98a18e03edb6158a06c50a4c0ddb09","neustar",NA,NA,NA,NA
"9dcbe6451f9e35c47d3503642e9eae82","neustring","undisclosed",NA,"2009-11-17",NA
"958e9c8ae77ae370b9fe55581f2565e3","neutrinobi",NA,NA,NA,NA
"045a6966fdea27f924b2e0fa9801b2e6","neutron-creations",NA,NA,NA,NA
"722be60cb46a876cad70f070e839b17b","nevro","venture",NA,"2011-07-19",5.8e+07
"722be60cb46a876cad70f070e839b17b","nevro","venture","1","2013-03-07",4.8e+07
"36db9f3568ac31920ff6be6a7faa46c5","new-century-hospice","venture",NA,"2010-10-12",1.2e+07
"36db9f3568ac31920ff6be6a7faa46c5","new-century-hospice","venture",NA,"2011-03-31",1e+06
"36db9f3568ac31920ff6be6a7faa46c5","new-century-hospice","seed",NA,"2011-10-04",1296337
"36db9f3568ac31920ff6be6a7faa46c5","new-century-hospice","venture","1","2010-10-13",2e+07
"612f7871b32c54b400585fca4e1f3cf9","new-context",NA,NA,NA,NA
"0e8f1c683e46fa20e7efcb3737194a1a","new-frontier",NA,NA,NA,NA
"5a180012b942192180197b9ca8227c86","new-haven-pharmaceuticals","debt_financing",NA,"2015-10-07",6300000
"5a180012b942192180197b9ca8227c86","new-haven-pharmaceuticals","venture","1","2012-10-29",6e+06
"5a180012b942192180197b9ca8227c86","new-haven-pharmaceuticals","debt_financing",NA,"2013-04-26",2e+06
"5a180012b942192180197b9ca8227c86","new-haven-pharmaceuticals","venture",NA,"2014-10-23",11786611
"6b44d29e99261bdb80a26c6a342661e1","new-kcbx","venture",NA,"2012-10-11",2085094
"49a0dd1dbca4c35c60573dc3b8a6976d","new-life-solutions","venture",NA,"2015-04-30",9136632
"965f49ef77b2b83aa08ea90004d72cf3","new-ortho-polymers",NA,NA,NA,NA
"c65065c2b07290285fc27323935a15d2","new-port-richey-surgery-center","seed",NA,"2011-09-01",178486
"8e5825f925dd1ed2817141255fc8c0ea","new-relic","venture","a","2008-04-01",3500000
"8e5825f925dd1ed2817141255fc8c0ea","new-relic","venture","b","2008-11-12",6e+06
"8e5825f925dd1ed2817141255fc8c0ea","new-relic","venture","c","2010-10-14",1e+07
"8e5825f925dd1ed2817141255fc8c0ea","new-relic","private_equity",NA,"2013-02-05",8e+07
"8e5825f925dd1ed2817141255fc8c0ea","new-relic","venture",NA,"2011-11-16",1.5e+07
"8e5825f925dd1ed2817141255fc8c0ea","new-relic","private_equity",NA,"2014-04-28",1e+08
"1af21e80b2c8e1c2aec7f975fe6f4cfc","new-wave-foods","venture",NA,"2015-10-29",NA
"1af21e80b2c8e1c2aec7f975fe6f4cfc","new-wave-foods","venture",NA,"2015-09-17",NA
"2dc0892a214b5137d9f12e91dc73469f","new-zealand-private-investigtor",NA,NA,NA,NA
"20f161c635d5e4a1cffbc0610aa33397","newbrandanalytics","private_equity",NA,"2013-05-08",3999999
"20f161c635d5e4a1cffbc0610aa33397","newbrandanalytics","venture","1","2011-11-10",2.6e+07
"20f161c635d5e4a1cffbc0610aa33397","newbrandanalytics","venture",NA,"2014-04-29",5032735
"ef5e68000ae4e94fdb06cbb17de3ef30","newbridge-pharmaceuticals","venture","b","2010-09-20",1.2e+07
"fd3adeaf7f15872ba28ad27bae86ef04","newcleus",NA,NA,NA,NA
"e885db8532298f0bc4fa13084f1abebd","newco-2",NA,NA,NA,NA
"cb5715c551b7bb19d0b4677c0695c757","neweast-biosciences",NA,NA,NA,NA
"1c1d66abc70cb86b7ebd21320119eb83","newgen-payment","angel",NA,"2015-05-25",NA
"0d2e1a6f37e6768fa9904d0bf67804b1","newleaf-symbiotics","venture","a","2013-01-09",7e+06
"0d2e1a6f37e6768fa9904d0bf67804b1","newleaf-symbiotics","venture","B","2014-09-15",1.7e+07
"1f8c0734db7c2bbc3c92875500f5ed62","newlink-genetics","venture","c","2008-01-31",1.7e+07
"1f8c0734db7c2bbc3c92875500f5ed62","newlink-genetics","venture","d","2009-07-21",7500000
"1f8c0734db7c2bbc3c92875500f5ed62","newlink-genetics","venture",NA,"2008-02-08",20714105
"30bbbfb3f098e4c36ca31fe9bcdff72d","newlio",NA,NA,NA,NA
"1c628c2cfd6f0448e538dc0eadaa40bd","newmo","venture",NA,"2014-11-05",950000
"2d6c64aa6893dd9fe3997a1a3b3fc0e8","newquest",NA,NA,NA,NA
"e1ffdd7373f4ddee73fa24fcc10bb69b","news-jelly","seed",NA,"2014-12-01",45043
"459da366026b80a50f01bb4ce3792568","newsanglr",NA,NA,NA,NA
"3a7d4f42cf58425acd75e2693f571b8d","newsbrewer",NA,NA,NA,NA
"5324a6623ae9f371cf131b67e18c1452","newscurve",NA,NA,NA,NA
"ef21496f5ef6d5e92df223d9dec99784","newsense",NA,NA,NA,NA
"ec10cc1b18a03c858856346c9c4b4526","newsit","seed",NA,"2012-03-08",5e+05
"991383c69285082d1ccf4cb05a27ba6b","newsjelly",NA,NA,NA,NA
"526e98ba9408419d4f5d7930433a452e","newsmaven","seed",NA,"2013-06-06",57324
"0e7dc8def7dcfd7a7dea52d8ab3d4b9d","newstree",NA,NA,NA,NA
"ac268a1a16fb649e7238632ecd366adf","newsummitbio","undisclosed",NA,"2011-01-01",NA
"ac268a1a16fb649e7238632ecd366adf","newsummitbio","venture","1","2005-10-01",NA
"4a2ec944acbafe73cf2d307cc39c9f8e","newswhip","angel",NA,"2012-07-09",NA
"4a2ec944acbafe73cf2d307cc39c9f8e","newswhip","seed",NA,"2013-09-12",1100000
"4a2ec944acbafe73cf2d307cc39c9f8e","newswhip","seed",NA,"2011-09-01",NA
"4a2ec944acbafe73cf2d307cc39c9f8e","newswhip","venture",NA,"2015-05-28",1600000
"2e67fd691b0899963b904ceac01ec85a","newton-insight","seed",NA,"2011-12-06",NA
"8fbb2ec18577c94b22cf99e40700ba78","nexabion-solutions",NA,NA,NA,NA
"8195961b99902e1e4a8d5cfc988c6c6e","nexalogy","angel",NA,"2011-09-30",574392
"d5d23d7b9665fe381175690000faf98f","nexbio","venture",NA,"2011-11-10",9900000
"d5d23d7b9665fe381175690000faf98f","nexbio","venture",NA,"2013-05-29",5e+06
"6e23a3135b7763d716261b159fac1e6d","nexd-io",NA,NA,NA,NA
"32236cd1cea0a1e14a2d8103da4bde60","nexeption","venture","a","2014-01-02",21500000
"82a032fe8c1b0dd6615eba06a5239229","social-iq-networks","venture","a","2013-04-09",3500000
"82a032fe8c1b0dd6615eba06a5239229","social-iq-networks","seed",NA,"2011-09-30",250000
"82a032fe8c1b0dd6615eba06a5239229","social-iq-networks","angel",NA,"2011-07-01",3e+05
"82a032fe8c1b0dd6615eba06a5239229","social-iq-networks","seed",NA,"2012-08-20",250000
"a21a15ce43bc563da839f502629e7941","nexgen-medical-systems","debt_financing",NA,"2011-01-11",690000
"a21a15ce43bc563da839f502629e7941","nexgen-medical-systems","debt_financing",NA,"2011-08-11",350000
"a21a15ce43bc563da839f502629e7941","nexgen-medical-systems","debt_financing",NA,"2012-07-13",5e+05
"505f595c55f171902b8acd6b07214b3d","nexgenix-pharmaceuticals","venture","B","2007-07-16",3900000
"3910e6018e3e76eb5dd292b189f67d1a","nexidia","venture",NA,"2006-08-08",1.3e+07
"3910e6018e3e76eb5dd292b189f67d1a","nexidia","venture","1","2010-10-18",2.3e+07
"3910e6018e3e76eb5dd292b189f67d1a","nexidia","debt_financing",NA,"2010-07-01",1286288
"3910e6018e3e76eb5dd292b189f67d1a","nexidia","venture",NA,"2012-09-12",2481049
"3910e6018e3e76eb5dd292b189f67d1a","nexidia","venture",NA,"2009-12-09",501477
"bba9f3cfe5e7c828faefb44b80c1022f","neximmune","seed",NA,"2011-06-07",1000
"bba9f3cfe5e7c828faefb44b80c1022f","neximmune","debt_financing",NA,"2013-12-27",250000
"bba9f3cfe5e7c828faefb44b80c1022f","neximmune","venture",NA,"2014-07-18",3e+06
"bba9f3cfe5e7c828faefb44b80c1022f","neximmune","debt_financing",NA,"2015-02-13",1962000
"24ece842e6d0a8bbf3709f787997c7eb","nexis-vision","debt_financing",NA,"2011-08-12",6e+06
"24ece842e6d0a8bbf3709f787997c7eb","nexis-vision","debt_financing",NA,"2013-12-30",750000
"e4ac82ab716233a724bfc75f3dd8154f","nexmed","debt_financing",NA,"2010-03-10",2300000
"7494c36d64e1811151befc2910e705a6","nexosis","angel",NA,"2015-03-06",60000
"7494c36d64e1811151befc2910e705a6","nexosis","convertible_note",NA,"2015-07-10",660000
"1da05f8ce49b38775729ed47a836dae6","next-big-sound","seed",NA,"2009-08-06",NA
"1da05f8ce49b38775729ed47a836dae6","next-big-sound","venture",NA,"2010-02-17",449997
"1da05f8ce49b38775729ed47a836dae6","next-big-sound","seed",NA,"2009-12-03",1e+06
"1da05f8ce49b38775729ed47a836dae6","next-big-sound","venture","1","2012-01-03",6500000
"61e2389dc37defccd36f262a8ef698c8","next-pixar-web",NA,NA,NA,NA
"48ea927ad01358a84753fbd9f0a435cd","next-points","seed",NA,"2012-12-11",38979
"ef9820b4d44b2bdd5901671897d0a2b8","next-safety","venture",NA,"2010-09-24",135000
"071f6096e38a3f22f04b60e193c5f3b0","next-stop-solutions",NA,NA,NA,NA
"a48985a6ba4b5c517abf9629b481fc61","nextan",NA,NA,NA,NA
"d233cf22ccd8d96929432863ee63efb5","nextcare","venture",NA,"2011-01-11",4300000
"d233cf22ccd8d96929432863ee63efb5","nextcare","venture",NA,"2010-01-08",3199999
"d233cf22ccd8d96929432863ee63efb5","nextcare","venture",NA,"2009-04-24",280000
"d233cf22ccd8d96929432863ee63efb5","nextcare","venture",NA,"2010-10-05",2500000
"f3f06a436e36c006386c6a5eb91fa8a4","nextcode-health","venture","a","2013-10-23",1.5e+07
"f71ad10833c87e0c97c91f7074a84012","nextcure","venture","A","2016-01-06",6.7e+07
"02cc0e1059a224225b023cb01aaca655","nextgxdx","venture",NA,"2015-10-02",1500000
"02cc0e1059a224225b023cb01aaca655","nextgxdx","venture","1","2014-03-05",2949029
"02cc0e1059a224225b023cb01aaca655","nextgxdx","angel",NA,"2013-03-05",1e+06
"02cc0e1059a224225b023cb01aaca655","nextgxdx","seed",NA,"2010-01-01",NA
"02cc0e1059a224225b023cb01aaca655","nextgxdx","venture",NA,"2014-10-14",2226000
"8422d06e4fac79d9f4c92d5695fd1eb8","nextprotein",NA,NA,NA,NA
"891efdaf5081bc7693daacb4dd149601","nextray",NA,NA,NA,NA
"641c13594186612272011ccb043cf2e8","nextuser","seed",NA,"2013-11-10",1650000
"d11796b5c5909c1bd8a9716e243ee15d","nextwave-pharmaceuticals","venture","B","2007-02-14",4e+07
"d11796b5c5909c1bd8a9716e243ee15d","nextwave-pharmaceuticals","venture","c","2011-01-11",4.5e+07
"d11796b5c5909c1bd8a9716e243ee15d","nextwave-pharmaceuticals","venture",NA,"2012-10-01",1819000
"d1116cef9b56d8ace95bb0f06dccb0bd","nexus-bi",NA,NA,NA,NA
"232fce3ba1e0db75ba997c5c9bf38656","nexus-biosystems","venture",NA,"2009-06-29",5e+06
"202e7d404f6910c69b02ffbcb7886249","nexus-dx","venture",NA,"2009-09-28",9e+06
"fd1930d05262f2eebeca6f89b131a3cc","nexus-research-intelligence","debt_financing",NA,"2012-05-04",280000
"3938888ebac27e26548b788ed2eb23c3","nexvet","venture",NA,"2013-10-28",7e+06
"3938888ebac27e26548b788ed2eb23c3","nexvet","venture","1","2014-04-16",31500000
"3938888ebac27e26548b788ed2eb23c3","nexvet","grant",NA,"2013-08-23",1500000
"54fde63c38e361543be6f67cecd152dd","nexvisionix",NA,NA,NA,NA
"1301beb1c9ec7570c72a7c77529ebab8","nflabs","seed",NA,"2014-08-25",NA
"1301beb1c9ec7570c72a7c77529ebab8","nflabs","venture","1","2014-12-22",1500000
"7f03ee2dcffaef51801f6b180e6a69f2","nflate-inc",NA,NA,NA,NA
"59c1c384bbf0bb2b132cda35c6cb852b","nfusion-group",NA,NA,NA,NA
"387a6487b906e941d27b3e0eaff8b6be","ngame","venture",NA,"2013-11-25",680000
"387a6487b906e941d27b3e0eaff8b6be","ngame","venture","1","2014-11-14",1e+07
"0333d67c4c78c0293833914ab8d88869","ngdata","venture","B","2015-10-28",10200000
"0333d67c4c78c0293833914ab8d88869","ngdata","seed",NA,"2012-10-03",2500000
"0333d67c4c78c0293833914ab8d88869","ngdata","venture","a","2013-09-24",3300000
"0333d67c4c78c0293833914ab8d88869","ngdata","undisclosed",NA,"2014-12-19",2456740
"28e929b70301f90f8470850de6a10221","ngen",NA,NA,NA,NA
"b7f109fa48fbbc809c16108dff9b4cf8","tcland-expression","venture","a","2007-12-19",11795700
"5dfc069c4a9e6ea639de877ac2e25183","ngm-biopharmaceuticals","venture","A","2008-02-12",25550000
"5dfc069c4a9e6ea639de877ac2e25183","ngm-biopharmaceuticals","venture","b","2011-11-07",55389000
"5dfc069c4a9e6ea639de877ac2e25183","ngm-biopharmaceuticals","venture",NA,"2013-05-07",1.3e+07
"5dfc069c4a9e6ea639de877ac2e25183","ngm-biopharmaceuticals","venture","a","2009-12-22",26550000
"5dfc069c4a9e6ea639de877ac2e25183","ngm-biopharmaceuticals","venture","c","2013-07-18",5e+07
"5dfc069c4a9e6ea639de877ac2e25183","ngm-biopharmaceuticals","venture","D","2015-03-26",57500000
"5dfc069c4a9e6ea639de877ac2e25183","ngm-biopharmaceuticals","venture","E","2015-03-25",105999996
"535e473a850d6f93271f56363946bdfb","ngtronix-industries","seed",NA,"2015-03-01",30000
"e694c829a3b259621b85a75b8640a8bc","nibrt",NA,NA,NA,NA
"df020cfe17c5809eccaa016ef329e670","nicepeopleatwork","venture",NA,"2012-03-28",1333700
"bd339fb97605f5c555ab3f4b58df7482","niche-protein",NA,NA,NA,NA
"32332aa9a11ca840b805c518eb2f48f9","nico","venture","c","2009-07-26",1e+07
"32332aa9a11ca840b805c518eb2f48f9","nico","venture",NA,"2012-07-20",6572736
"92ff885b0679e8880f88bea75f020bc6","nicox","post_ipo_equity",NA,"2009-11-18",1.49e+08
"a6291b635d80a4095ac05fbaacaef5fc","nightingale","seed",NA,"2014-07-16",120000
"a6291b635d80a4095ac05fbaacaef5fc","nightingale","seed",NA,"2015-03-24",660000
"a6291b635d80a4095ac05fbaacaef5fc","nightingale","seed",NA,"2013-07-23",NA
"da2ceff2f94771d5fb14228d08f50a4f","nightley-inc",NA,NA,NA,NA
"6c751a8c699ac44dc7b5ac2b2ff7a7d0","night-out","venture",NA,"2013-07-11",150000
"6c751a8c699ac44dc7b5ac2b2ff7a7d0","night-out","seed",NA,"2012-05-01",125000
"87a6f36dd196a66aa30575e1f17fdd6b","nightstarx","venture","B","2015-11-07",3.5e+07
"87a6f36dd196a66aa30575e1f17fdd6b","nightstarx","venture",NA,"2014-02-04",18183017
"0bee0404c72a16ae0a0d9790e23034e8","niiki-pharma","debt_financing",NA,"2010-03-11",3800000
"0bee0404c72a16ae0a0d9790e23034e8","niiki-pharma","debt_financing",NA,"2009-01-06",5e+06
"0bee0404c72a16ae0a0d9790e23034e8","niiki-pharma","venture",NA,"2011-08-10",1688500
"f42a1eafac8511469fc3b722d82fbc69","nik-software",NA,NA,NA,NA
"abb2fdfa41e717d4158f61341c673b9c","nikom-technology",NA,NA,NA,NA
"9744c3b4f2a870564650a1513995a8c0","nilimedix",NA,NA,NA,NA
"c97137e35272e75997426bfde618fb33","nimbata",NA,NA,NA,NA
"6b5abf0c452a53b9d20030bb6562020d","nimble-apps-limited","angel",NA,"2010-01-01",1872780
"7246584d7a10dea65c3224a4ee748f12","nimblepitch",NA,NA,NA,NA
"eadf63df16bd1fbacfd0a3b754f1226d","nimbus-concepts","venture",NA,"2011-12-07",142500
"9bf2bf73fd91f5861824d2046944a8cf","nimbus-discovery","seed",NA,"2011-03-10",1500000
"9bf2bf73fd91f5861824d2046944a8cf","nimbus-discovery","venture","1","2011-06-28",2.4e+07
"9bf2bf73fd91f5861824d2046944a8cf","nimbus-discovery","venture",NA,"2010-04-29",3500000
"9bf2bf73fd91f5861824d2046944a8cf","nimbus-discovery","venture","1","2015-03-19",4.3e+07
"458a286de602e5a0dc3e4ff31517f121","ningbo-renjian-pharmaceutical","venture",NA,"2011-09-28",9400000
"ba6f62bee36353ccd0519e14954d0bfe","ninja-digital",NA,NA,NA,NA
"9a95bbb4bfe71d53c1d3da648f5a47a5","ninjametrics","venture",NA,"2012-12-01",NA
"9a95bbb4bfe71d53c1d3da648f5a47a5","ninjametrics","venture","1","2013-11-11",2800000
"9a95bbb4bfe71d53c1d3da648f5a47a5","ninjametrics","venture","1","2015-06-03",2880152
"6aea19c6d5230e96afe444667893f291","ninja-outreach",NA,NA,NA,NA
"fdc5c5a71ac5e1fc80624de3bd9a085a","niqotin",NA,NA,NA,NA
"bd39d15388fa31e219c13beab5d84b6b","nira-wireless",NA,NA,NA,NA
"2f774218e3f0aec86d2ad8299d049ba3","nirmidas-biotech","seed",NA,"2014-08-18",2e+06
"30cfc9ed20a2c77a2c366eecf018b350","niti-surgical-solutions","venture","f","2009-08-11",18500000
"9caac42f424a74f8b5c9f6e3f052ca3a","nitric-bio","debt_financing",NA,"2012-01-20",1020000
"9caac42f424a74f8b5c9f6e3f052ca3a","nitric-bio","venture","1","2006-03-31",1.4e+07
"9caac42f424a74f8b5c9f6e3f052ca3a","nitric-bio","debt_financing",NA,"2010-07-14",1750000
"9caac42f424a74f8b5c9f6e3f052ca3a","nitric-bio","debt_financing",NA,"2009-04-01",1688739
"7847d324ba1c383474a91b4750851265","nitrio","undisclosed",NA,"2014-07-01",NA
"7847d324ba1c383474a91b4750851265","nitrio","seed",NA,"2015-09-11",NA
"5272649ccc3103e468aaa2e53f8a3e1d","n30-pharmaceuticals","venture","b","2010-07-12",1e+07
"5272649ccc3103e468aaa2e53f8a3e1d","n30-pharmaceuticals","venture","B","2014-11-19",3e+07
"c6754cc019b1b3dddbd45492e905194f","niveus-medical","debt_financing",NA,"2013-08-02",365000
"c6754cc019b1b3dddbd45492e905194f","niveus-medical","venture","1","2011-09-15",2e+06
"c6754cc019b1b3dddbd45492e905194f","niveus-medical","venture",NA,"2014-08-14",1840538
"339f3746552f69870294f3ee6eb9b3a2","nkt-therapeutics","venture",NA,"2010-08-25",4e+06
"339f3746552f69870294f3ee6eb9b3a2","nkt-therapeutics","venture","1","2009-03-16",8e+06
"86042f011f8b808145b78672f9f01430","nlife-therapeutics","venture",NA,"2012-02-21",6611000
"86042f011f8b808145b78672f9f01430","nlife-therapeutics","venture",NA,"2014-06-20",2718942
"86042f011f8b808145b78672f9f01430","nlife-therapeutics","grant",NA,"2014-09-24",350000
"9656b1c16514c934e487a0cf964d2083","nlogic-canada",NA,NA,NA,NA
"961efa6eccd46f7b83f9777b702465bb","nlp-logix","debt_financing",NA,"2012-11-08",150000
"961efa6eccd46f7b83f9777b702465bb","nlp-logix","venture",NA,"2014-05-01",175319
"c79d88e6d9d74bc864f484a258535c20","nlt-spine","venture",NA,"2012-03-06",5700000
"7bbb5837029aafd9770da217dea764d8","nm-incite",NA,NA,NA,NA
"a18c44a1a7d85fa990a01534a95fb784","nmt-medical","venture",NA,"2010-03-01",5759760
"40cd52c12879834d004893237f64287e","everyfit",NA,NA,NA,NA
"ee357d70745feb4860b3057ac4af5e57","noble-biomaterials-inc","venture","b","2012-02-10",8e+06
"ee357d70745feb4860b3057ac4af5e57","noble-biomaterials-inc","venture","C","2013-07-01",NA
"7af61da732a3524fde3c8f41a0821be6","noble-digital",NA,NA,NA,NA
"2b43b1f4ca0d96cdd69e7b9ccd50d3ee","noble-life-sciences","seed",NA,"2013-01-01",1e+05
"2b43b1f4ca0d96cdd69e7b9ccd50d3ee","noble-life-sciences","seed",NA,"2010-12-14",235000
"8375c5670d9c3678040e346f65e9b985","noble-metrics",NA,NA,NA,NA
"a13c1801c3ca1ad5772446ffac1a4917","nobly-point-of-sales","angel",NA,"2014-09-01",NA
"92c002694f3db874618d37f8a6c4c160","nodality","debt_financing",NA,"2011-08-08",9999999
"92c002694f3db874618d37f8a6c4c160","nodality","venture","1","2010-01-13",1e+07
"92c002694f3db874618d37f8a6c4c160","nodality","venture","1","2010-01-17",3500000
"92c002694f3db874618d37f8a6c4c160","nodality","venture",NA,"2010-03-22",2e+06
"92c002694f3db874618d37f8a6c4c160","nodality","venture","1","2006-08-17",1540000
"3bc8ba46dab8b598f0e2d2ed352d99ac","nodally-technologies",NA,NA,NA,NA
"5466345f93006e6c911387ac5b215d1e","nodeable","venture","a","2011-07-26",2e+06
"52ab184b6979c88b3705491bac0bd3da","nodeprime","seed",NA,"2013-10-04",1500000
"52ab184b6979c88b3705491bac0bd3da","nodeprime","seed",NA,"2015-09-30",7e+06
"6537ba98fbd3943a05d2f228ab893ffe","nodequery",NA,NA,NA,NA
"6a42715e0485f201154f5f2cabebee72","nodexus","seed",NA,"2014-12-01",NA
"82f98e72dab106ca68a052c2b6a46c24","noglo",NA,NA,NA,NA
"9f2b43c03ab37de0dcc43e1373244504","nohla-therapeutics","venture",NA,"2015-12-03",2.1e+07
"2f0cb44341651b1e55aaa412f1eab268","noiz-analytics","seed",NA,"2010-08-31",163000
"90b74210e09dd062706a4d60155eac82","nokia-growth-partners",NA,NA,NA,NA
"c35922f3cd918ac48d17fe60854d99b7","noknoker","seed",NA,"2011-11-01",50000
"c35922f3cd918ac48d17fe60854d99b7","noknoker","angel",NA,"2012-12-12",350000
"c35922f3cd918ac48d17fe60854d99b7","noknoker","seed",NA,"2011-12-01",49751
"c35922f3cd918ac48d17fe60854d99b7","noknoker","convertible_note",NA,"2012-06-01",314901
"872ded0f8e5a6776ad9d440fd5843492","nolexis","seed",NA,"2014-10-01",75000
"ae002bdc259388f6ab33e64abed9ffde","nom","seed",NA,"2013-11-30",4000
"b5929f83db060b69649441ac369195a9","nomi","seed",NA,"2013-02-11",3e+06
"b5929f83db060b69649441ac369195a9","nomi","venture","1","2013-10-16",1e+07
"1872e4475407d44abaf2d31bf1f6f405","nominum","venture","d","2005-03-22",1.6e+07
"1872e4475407d44abaf2d31bf1f6f405","nominum","venture","c","2003-02-20",1e+07
"1872e4475407d44abaf2d31bf1f6f405","nominum","venture","b","2002-05-06",1e+07
"1872e4475407d44abaf2d31bf1f6f405","nominum","venture","a","2000-05-11",5e+06
"ecba4a08e14a40070890acb3cca382b3","nomit","seed",NA,"2015-08-28",40000
"ecba4a08e14a40070890acb3cca382b3","nomit","venture",NA,"2014-02-13",93677
"10dc2488a4be2f276f7f5ab1c3c1e761","nomnom-insights","undisclosed",NA,"2015-07-06",218000
"1243e8352fa1953d7e6d8ed4bdbd2b19","noninvasive-medical-technologies","venture",NA,"2009-09-10",6258682
"1c3f7f33af2ffec12ed268452d725fd9","nono","private_equity",NA,"2013-05-24",9776044
"39de7d0c858247165d877f8599a14e1b","nonovice-com",NA,NA,NA,NA
"70f8383895ce263333c1b0db6d226920","noobsys",NA,NA,NA,NA
"3a7e672619dcb64db876951f15cb76d8","nookster","seed",NA,"2014-07-27",NA
"9880f6d50602e2f984393a3c44f5d622","noomiz",NA,NA,NA,NA
"eeecf1153fba4d2508ffec0d2a702091","nooq",NA,NA,NA,NA
"f6509d8999e50c7a97b5700145489681","nor1","private_equity",NA,"2012-10-01",1.2e+07
"f6509d8999e50c7a97b5700145489681","nor1","venture","1","2009-09-02",8100000
"f6509d8999e50c7a97b5700145489681","nor1","venture","1","2012-12-19",9e+06
"f6509d8999e50c7a97b5700145489681","nor1","venture",NA,"2010-05-20",NA
"7a9feacf764d79ccc760f347f1b61588","nora-therapeutics","venture","b","2014-04-17",1.8e+07
"7a9feacf764d79ccc760f347f1b61588","nora-therapeutics","venture",NA,"2010-06-02",2932000
"5f52e3838a3647e829a6257979dc6abc","nordic-agency",NA,NA,NA,NA
"7e0e289647956b47935b16452f750c75","nordion",NA,NA,NA,NA
"9107cbfa5e1757314b3c42933c49d916","nordson",NA,NA,NA,NA
"45f342b305930631da1e61c39853892d","normoxys","venture","b","2010-05-24",17500000
"45f342b305930631da1e61c39853892d","normoxys","debt_financing",NA,"2010-03-24",1050000
"45f342b305930631da1e61c39853892d","normoxys","venture",NA,"2009-04-29",4506708
"45f342b305930631da1e61c39853892d","normoxys","debt_financing",NA,"2011-11-21",6e+05
"45f342b305930631da1e61c39853892d","normoxys","convertible_note",NA,"2011-06-24",1500000
"960bac43fd1665a6e03ea1fd310d734a","north-carolina-biotechnology-center","debt_financing",NA,"2015-02-03",1683000
"960bac43fd1665a6e03ea1fd310d734a","north-carolina-biotechnology-center","grant",NA,"2015-02-03",350000
"a8c0621101d7ed2b03179125d0ec3444","naborly","seed",NA,"2014-12-15",75000
"a8c0621101d7ed2b03179125d0ec3444","naborly","seed",NA,"2014-12-05",25000
"c3046ae632e358951a9eddbd129267ba","north-shore-innoventures","grant",NA,"2011-08-16",211500
"c3046ae632e358951a9eddbd129267ba","north-shore-innoventures","grant",NA,"2013-06-25",1e+05
"c2c6d74a406d562d7f692e8dba9a4b02","north-rica-risk-countermeasure-associated",NA,NA,NA,NA
"ff219e606ee695800ab6c73ec69c0768","northbay-solutions",NA,NA,NA,NA
"4ffab675a674d9c6d6f846cccd07907d","northern-frac-proppants",NA,NA,NA,NA
"72cccfdd85e03a2693ae88f48fe3a197","northridge",NA,NA,NA,NA
"a411a9949881d956e6aa64adf1f4495b","northrop-grumman",NA,NA,NA,NA
"211dfcbf4731bee8645ca4c11f3ef993","northstar-biosciences","venture",NA,"2011-09-30",163800
"b67f854d774f785b6dc39ca10b689e19","northwest-biotherapeutics","venture",NA,"2010-12-09",395000
"b67f854d774f785b6dc39ca10b689e19","northwest-biotherapeutics","post_ipo_equity",NA,"2013-11-26",2.7e+07
"b67f854d774f785b6dc39ca10b689e19","northwest-biotherapeutics","post_ipo_equity",NA,"2014-10-07",11500000
"b67f854d774f785b6dc39ca10b689e19","northwest-biotherapeutics","post_ipo_equity",NA,"2014-11-20",3.5e+07
"b67f854d774f785b6dc39ca10b689e19","northwest-biotherapeutics","post_ipo_equity",NA,"2015-04-03",4e+07
"1c6cd87fd3021193eb0435731e32f6f1","nortis","venture",NA,"2014-03-26",1242250
"1c6cd87fd3021193eb0435731e32f6f1","nortis","venture",NA,"2014-07-11",1e+06
"1c6cd87fd3021193eb0435731e32f6f1","nortis","venture",NA,"2015-03-19",408845
"0e6eaa5c932b5a42115dd7bcfcf48e49","nosopharm","venture",NA,"2013-11-07",1119342
"ea4e3f63e73d0a91da81bebd6bda640b","nosto","seed",NA,"2013-04-17",2800000
"ea4e3f63e73d0a91da81bebd6bda640b","nosto","venture","1","2014-07-15",5500000
"cd392955f4abbd5b8a2071188870b92b","not-provided-count",NA,NA,NA,NA
"746b3a5ca906523955d82f8e295c260f","notable-labs-2","seed",NA,"2014-12-01",NA
"746b3a5ca906523955d82f8e295c260f","notable-labs-2","venture",NA,"2015-09-01",NA
"09538dbd5f016ad31cc715025991f980","notey","seed",NA,"2015-02-17",1600000
"3a7aadb18090bb2b2566e1b6fe57f01b","notice-technologies","angel",NA,"2010-04-01",NA
"9cdf523e30555a46321bd6f65924b202","nousco","venture",NA,"2014-01-21",940262
"0a3d071b5e11b30f6c729cb7cfb1d3c1","nova-lignum","venture",NA,"2014-04-29",NA
"604ea070b35a9948f49cd075b6311380","novabiotics","venture",NA,"2015-01-19",7569850
"bcd1daec57b90462544b61b44e09b54b","novacta-biosystems","venture",NA,"2008-01-16",6869075.4224
"bcd1daec57b90462544b61b44e09b54b","novacta-biosystems","venture",NA,"2009-07-07",21260581
"bcd1daec57b90462544b61b44e09b54b","novacta-biosystems","venture",NA,"2007-07-23",829000
"e769dd14f43f20826e1bc03b2267a7ee","novadigm-therapeutics","venture",NA,"2013-02-20",20588274
"e769dd14f43f20826e1bc03b2267a7ee","novadigm-therapeutics","venture","1","2013-10-03",1.4e+07
"25e614bbd9b6bb5ad4eff6089c9f204b","novadiol","debt_financing",NA,"2014-07-11",1095000
"0cc90450a8fd156b5750d4c0abb7da3b","novadip-biosciences","venture","A","2015-09-10",31390134
"039f1231b47c17a13918bb7b9a92195d","novalact","seed",NA,"2015-11-05",80000
"039f1231b47c17a13918bb7b9a92195d","novalact","seed",NA,"2015-11-16",314000
"039f1231b47c17a13918bb7b9a92195d","novalact","seed",NA,"2014-06-01",40000
"43afe4ce90c7b8a41c234652fa195b64","novalar-pharmaceuticals","venture","D","2007-11-02",3e+07
"43afe4ce90c7b8a41c234652fa195b64","novalar-pharmaceuticals","debt_financing",NA,"2010-07-16",1000999
"dc7f6c7e9b7e558091992b16de5be8c2","novalign-orthopaedics",NA,NA,NA,NA
"3921a1ab0755addc0d8011430b0fd688","novaliq","venture","e","2013-04-13",18142280
"da79d8458c6d67b492edfad3c699d5ae","novalyst-discovery",NA,NA,NA,NA
"6948842240cccff978d73855fd8e475c","novan","venture",NA,"2015-12-30",32840304
"6948842240cccff978d73855fd8e475c","novan","venture","1","2011-10-14",6e+06
"6948842240cccff978d73855fd8e475c","novan","venture",NA,"2011-01-18",3999992
"6948842240cccff978d73855fd8e475c","novan","venture",NA,"2013-02-28",1.1e+07
"6948842240cccff978d73855fd8e475c","novan","venture",NA,"2009-07-01",2e+06
"6948842240cccff978d73855fd8e475c","novan","debt_financing",NA,"2014-03-10",3500000
"6948842240cccff978d73855fd8e475c","novan","venture",NA,"2014-08-29",10325093
"6948842240cccff978d73855fd8e475c","novan","venture",NA,"2015-03-30",5e+07
"70e9297ec40a5679edcf5287d6577ca2","novartis",NA,NA,NA,NA
"2880ae9ff36232c516d6430e124c3f89","novashare-solutions","seed",NA,"2014-05-17",NA
"33fe808479a1c1e7fda995b4e2702a0d","novasom","debt_financing",NA,"2011-01-21",8077411
"33fe808479a1c1e7fda995b4e2702a0d","novasom","venture","1","2011-06-27",3.5e+07
"33fe808479a1c1e7fda995b4e2702a0d","novasom","debt_financing",NA,"2014-06-06",3e+06
"e51c4ed348d55f08edddc909d1884a3f","novast-laboratories","venture",NA,"2012-06-12",2e+07
"4d105bb536a9cf1a160ce71fd4162544","novasys","venture",NA,"2008-05-16",49500000
"21f22b182b55b14cebbb121a9dffe153","novatarg-therapeutics","grant",NA,"2015-09-29",3200000
"59b44603703100b1179c49c3da5ca0cd","novathera",NA,NA,NA,NA
"b51d7200b2c53e4f6ab12511f9cf08bf","novatris","venture",NA,"2001-01-01",1570886
"b63a0a8ca70a6585ecae270449faa08f","novavax-ab","venture",NA,"2008-06-27",5020000
"0a7e8e889d765641f76d1f4b468e31a6","novaweb",NA,NA,NA,NA
"493fd93b8872a9c5ebe76bd92747ba9d","novawind",NA,NA,NA,NA
"dcb74f1ce63feb085e3e591ab1b9e6b2","novawise","seed",NA,"2013-06-12",48318
"895bff53facb88eb372f37de19e80c20","novel-therapeutic-technologies","private_equity",NA,"2011-12-19",7.5e+07
"8a565b39e7acb26ac030bf48c159f669","novelix-pharmaceuticals","venture",NA,"2009-10-23",253103
"c795cfe0e72570a53b462185d45ca29c","novelmed","grant",NA,"2013-09-11",1430000
"0fe0bc41a948e605bd77f4aa1d809cc4","novelos-therapeutics","venture",NA,"2011-04-11",5100000
"0fe0bc41a948e605bd77f4aa1d809cc4","novelos-therapeutics","venture",NA,"2009-09-09",3500000
"0fe0bc41a948e605bd77f4aa1d809cc4","novelos-therapeutics","venture","1","2009-10-25",32250000
"0fe0bc41a948e605bd77f4aa1d809cc4","novelos-therapeutics","venture",NA,"2014-02-07",4e+06
"0fe0bc41a948e605bd77f4aa1d809cc4","novelos-therapeutics","venture",NA,"2009-11-19",9e+06
"9566b3d97f94b6963a0d1225dc1affd8","novelrank",NA,NA,NA,NA
"4696326e182eec15d0f753ddd4a3b8a6","noven",NA,NA,NA,NA
"b4369927e134f48348914b607dffb84b","novertur",NA,NA,NA,NA
"eda89f0d8a2633e12eb6cb3cc24009ad","novexel",NA,NA,NA,NA
"6640a29b63e90810e7db7a9658448235","novim",NA,NA,NA,NA
"3dd7ddde139de8d7347095494c492651","novimmune","venture","C","2016-01-11",29800000
"3dd7ddde139de8d7347095494c492651","novimmune","grant",NA,"2012-10-15",7782600
"3dd7ddde139de8d7347095494c492651","novimmune","venture","B","2014-02-17",6.6e+07
"3dd7ddde139de8d7347095494c492651","novimmune","venture","a","2000-05-01",1.4e+07
"3dd7ddde139de8d7347095494c492651","novimmune","venture","b","2006-06-01",4.6e+07
"3dd7ddde139de8d7347095494c492651","novimmune","venture","c","2009-05-12",54800000
"3dd7ddde139de8d7347095494c492651","novimmune","venture","d","2010-12-17",22413980
"22563b384e5fa75446192c7156166657","novira-therapeutics","seed",NA,"2011-07-26",2500000
"22563b384e5fa75446192c7156166657","novira-therapeutics","venture","1","2014-02-11",2995233
"22563b384e5fa75446192c7156166657","novira-therapeutics","venture","1","2013-03-24",2.5e+07
"22563b384e5fa75446192c7156166657","novira-therapeutics","debt_financing",NA,"2014-12-24",9e+06
"f4514e501eccb7f2140bd07ea79162ad","novita-pharmaceuticals","venture",NA,"2011-01-01",2e+06
"b3f3032ff5161339a10eb5c624d70a51","novita-therapeutics","seed",NA,"2011-07-29",750000
"b3f3032ff5161339a10eb5c624d70a51","novita-therapeutics","angel",NA,"2010-01-15",NA
"b3f3032ff5161339a10eb5c624d70a51","novita-therapeutics","venture",NA,"2013-10-21",3155000
"b3f3032ff5161339a10eb5c624d70a51","novita-therapeutics","venture",NA,"2009-11-17",250000
"b3f3032ff5161339a10eb5c624d70a51","novita-therapeutics","venture",NA,"2010-06-10",590000
"7b15d6a307a8a937c09c560fd0886b1e","novo-nordisk",NA,NA,NA,NA
"a9112e899651284516602c1dbec8b187","novocor-medical-systems","venture","a","2013-08-30",961000
"9eaf8f724c519b4f514d70e2dc3f6f3a","novodynamics","venture",NA,"2003-01-01",NA
"011f77054b13bcbcc262be2d7393a93c","novogen","private_equity",NA,"2013-07-03",4530000
"66768597da1d0562641497eaaa68586f","novopedics","venture",NA,"2013-04-19",5e+05
"3e69212fdb1ffc6e183eb00af68edc1e","novopyxis","venture",NA,"2014-07-22",343000
"178540d3902aed5898b73183d927834d","novoron-bioscience","grant",NA,"2015-12-22",680000
"bc7cd32ddc71dbe1279c7de4ec95e8b7","novosco",NA,NA,NA,NA
"82e3a06d6ea82df19c6e1b58f3e405f1","novospec",NA,NA,NA,NA
"5af7e2c22d20fdec7b02f50368b670a8","novowave-ltd",NA,NA,NA,NA
"d4a0bf9b1d8024b8da7ba7511c5e710a","novozymes",NA,NA,NA,NA
"ca875ed72dc6697c00c2e61b23687d4e","novus","undisclosed",NA,"2013-06-10",NA
"4d92964e3bc6e4d44526b8a8cf3a92fa","novx","venture","C","2008-05-02",7800000
"613d32c6ab3c75f6943b06ccc9713567","now-in-store","seed",NA,"2013-04-15",49342
"e90071479ffa629c09d16df9fae1dc21","nowdiscover",NA,NA,NA,NA
"00f6489cbe55df46f7e12628f6f67ae0","nowledgedata","venture","a","2012-12-01",1e+06
"88d73c1cdce9c1efb4f0e6ae6d8bd790","noxxon-pharma","venture","C","2007-05-03",50287453.9598
"88d73c1cdce9c1efb4f0e6ae6d8bd790","noxxon-pharma","venture","d","2010-05-27",40441500
"88d73c1cdce9c1efb4f0e6ae6d8bd790","noxxon-pharma","venture","d","2010-10-13",2791600
"f9c1348839f0b71f7eb3897f38297f8c","npario","venture",NA,"2011-05-06",5e+06
"f9b9f135ed9647f640de64d382c8c08f","npm-pharma",NA,NA,NA,NA
"e5051e24e4c6a6a110ddb75bd8093053","nps-pharmaceuticals",NA,NA,NA,NA
"02238db83c9951ef44a95a9282964b3d","nrgene",NA,NA,NA,NA
"5137d7fb3b3011e0e21fbc159074f36e","nsgene","venture",NA,"2005-05-02",5140000
"5137d7fb3b3011e0e21fbc159074f36e","nsgene","grant",NA,"2013-11-25",545000
"ce6c8b43b6efbed96a06979ad1579ca4","nsttvideo",NA,NA,NA,NA
"5ea32953fb20a60445a82ccb1f5ad0ac","ntera-studio",NA,NA,NA,NA
"e00af79b6dd054cd703e8f8f19d808b0","ntirety","venture","b","2008-03-26",1e+06
"44ec7ce1e40ddd2c2d8949045498220c","ntt-comware",NA,NA,NA,NA
"798363b7d065f2893b87c38f85cce795","nu-med-plus","seed",NA,"2012-03-01",87653
"798363b7d065f2893b87c38f85cce795","nu-med-plus","venture",NA,"2014-05-01",121500
"798363b7d065f2893b87c38f85cce795","nu-med-plus","venture",NA,"2015-04-22",30000
"626ca9e651a6197ef3dd6a5871f9a310","nu-pulse","venture",NA,"2011-05-19",550000
"626ca9e651a6197ef3dd6a5871f9a310","nu-pulse","venture",NA,"2014-06-23",2749800
"6f0b9fb4683a972d9743bb8817d9ea97","nuagebi",NA,NA,NA,NA
"546e7ca5dc0a30074581c8c57cafc484","nube-technologies",NA,NA,NA,NA
"a4f973610d38066d42f45f08e16cabd8","nubimetrics","convertible_note",NA,"2013-08-01",1e+05
"a4f973610d38066d42f45f08e16cabd8","nubimetrics","convertible_note",NA,"2014-11-01",394561
"49499cf1b55e06028c624d406b2683b5","nucana-biomed","venture","a","2011-11-29",10529448
"49499cf1b55e06028c624d406b2683b5","nucana-biomed","venture","b","2014-04-10",5.7e+07
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","venture","c","2012-08-02",5e+06
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","venture","b","2012-02-02",3400000
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","venture","b","2011-10-11",3400000
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","venture",NA,"2012-05-03",555000
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","seed",NA,"2013-02-20",1066970
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","venture","b","2011-08-19",3e+06
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","venture",NA,"2009-06-10",8903450
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","venture",NA,"2012-04-12",1900000
"da6ad19c1ece8abaf5fc10023f1148ca","nuclea-biotechnologies","debt_financing",NA,"2010-12-17",425000
"1db8fb76f867319cd14785c1405216c7","nucleic-acid-diagnostics",NA,NA,NA,NA
"a45f09b88960cc3e68d4b5ebefb9866c","nucleix",NA,NA,NA,NA
"945099465c5081ae51191af281e066b4","nuconomy","seed",NA,"2007-04-01",3e+05
"945099465c5081ae51191af281e066b4","nuconomy","venture","1","2008-02-01",3e+06
"99a694b99ffa4c7333006bdc67040250","nudata-security",NA,NA,NA,NA
"75ec4896c0cd99120ad1d1a7af5ec1f8","nudge-6",NA,NA,NA,NA
"71e104508245314dd29367752583cbc3","nudge-now",NA,NA,NA,NA
"1148333dfad7438fee099f7ca8bd9bba","nudgespot","seed","A","2015-05-21",650000
"5e6e4963cad3e3b80467254fba6d215a","nuevolution","venture",NA,"2012-06-19",13880900
"1f8f4d0a1c0a7735b06a551246ca122a","nuevora","venture","a","2012-05-07",2250000
"78026a9a207722531cdc20ecae5a0421","nugen-technologies","seed",NA,"2010-03-31",1500001
"78026a9a207722531cdc20ecae5a0421","nugen-technologies","venture","1","2011-08-30",3499999
"78026a9a207722531cdc20ecae5a0421","nugen-technologies","debt_financing",NA,"2014-09-26",6179995
"bb2aed818724090aff2ed75f0857d64c","nugit",NA,NA,NA,NA
"6d27f63409a99588222555ebe925a483","nulabel","venture","D","2016-01-19",3285452
"6d27f63409a99588222555ebe925a483","nulabel","venture",NA,"2011-01-04",1525000
"6d27f63409a99588222555ebe925a483","nulabel","venture",NA,"2013-12-31",3023097
"6d27f63409a99588222555ebe925a483","nulabel","venture",NA,"2011-08-19",1e+06
"6d27f63409a99588222555ebe925a483","nulabel","seed",NA,"2009-06-01",NA
"6d27f63409a99588222555ebe925a483","nulabel","seed",NA,"2010-11-01",NA
"6d27f63409a99588222555ebe925a483","nulabel","venture","a","2011-08-01",NA
"6d27f63409a99588222555ebe925a483","nulabel","venture","a","2012-01-01",NA
"6d27f63409a99588222555ebe925a483","nulabel","venture","b","2013-02-01",NA
"6d27f63409a99588222555ebe925a483","nulabel","venture","B","2014-01-01",NA
"d174a22f6dfb6559e55e6229c9639cdb","numab-ag",NA,NA,NA,NA
"6096fa8736af5c4b37c8d5cefa2ebb61","numares-gmbh","venture",NA,"2009-12-21",5747200
"6096fa8736af5c4b37c8d5cefa2ebb61","numares-gmbh","venture","1","2012-02-13",9500000
"6096fa8736af5c4b37c8d5cefa2ebb61","numares-gmbh","venture",NA,"2011-10-10",9515100
"6096fa8736af5c4b37c8d5cefa2ebb61","numares-gmbh","venture",NA,"2006-10-10",2510000
"6477b02e98ca41dd487fe7c792f60421","numbers-today",NA,NA,NA,NA
"91c6016ffd85c3c0ea4ff09f9802a200","nume-health","venture","a","2011-07-26",675000
"91c6016ffd85c3c0ea4ff09f9802a200","nume-health","venture","a","2012-05-16",1500000
"c2ed107961151196303c40096cbdc9b0","numedii","venture","a","2013-06-26",3500000
"c2ed107961151196303c40096cbdc9b0","numedii","venture","A","2015-08-17",2e+06
"8c7b7bb5a56b007d833a9d51bb682cf1","numerai",NA,NA,NA,NA
"77dbd349505c4e188addf4b65bcb8f5b","numerate","venture","b","2009-03-01",5500000
"77dbd349505c4e188addf4b65bcb8f5b","numerate","venture","C","2014-06-06",8240487
"2efa962d8d12b0d12ab77be1b2269863","numerify","venture","C","2015-10-22",37500000
"2efa962d8d12b0d12ab77be1b2269863","numerify","venture","a","2013-10-02",8e+06
"2efa962d8d12b0d12ab77be1b2269863","numerify","venture","B","2014-09-24",1.5e+07
"68377cc151b8f20a23459260a205378f","numira-biosciences","venture","A","2007-03-21",2500000
"68377cc151b8f20a23459260a205378f","numira-biosciences","venture",NA,"2009-07-16",3282738
"68377cc151b8f20a23459260a205378f","numira-biosciences","seed",NA,"2013-03-07",NA
"185022a67e403437d84ba85e717dbd4c","cryptocrumb",NA,NA,NA,NA
"303ed5d12e1bf32ec28ecf2c66da2c56","cytomedix","venture",NA,"2010-10-08",1.3e+07
"303ed5d12e1bf32ec28ecf2c66da2c56","cytomedix","debt_financing",NA,"2011-07-26",1300000
"303ed5d12e1bf32ec28ecf2c66da2c56","cytomedix","private_equity",NA,"2012-02-08",2.1e+07
"303ed5d12e1bf32ec28ecf2c66da2c56","cytomedix","private_equity",NA,"2013-02-19",27500000
"303ed5d12e1bf32ec28ecf2c66da2c56","cytomedix","venture",NA,"2010-04-22",3650000
"303ed5d12e1bf32ec28ecf2c66da2c56","cytomedix","debt_financing",NA,"2013-12-10",3e+06
"303ed5d12e1bf32ec28ecf2c66da2c56","cytomedix","venture",NA,"2011-05-04",325000
"303ed5d12e1bf32ec28ecf2c66da2c56","cytomedix","post_ipo_debt",NA,"2014-06-26",3.5e+07
"f98644fec533841fa19a93ce12c9d48b","nuoctave-inc",NA,NA,NA,NA
"94ef30242577c950089c81a9b449688a","nuokang-bio-pharmaceutical",NA,NA,NA,NA
"dbe5f70806de4c1be38f523b1ec9c13f","nuon-therapeutics","venture","b","2008-04-28",2.7e+07
"dbe5f70806de4c1be38f523b1ec9c13f","nuon-therapeutics","venture",NA,"2010-03-17",6050000
"dbe5f70806de4c1be38f523b1ec9c13f","nuon-therapeutics","venture","a","2007-07-20",5e+06
"dbe5f70806de4c1be38f523b1ec9c13f","nuon-therapeutics","venture",NA,"2010-08-12",1e+07
"c7e7bdd2e7f38637397e297ba99058d9","nuovo-biologics","venture",NA,"2011-04-18",1e+06
"555fb9d76b1f662fd56d2fd9dcf3d81c","nuovonet-t-i",NA,NA,NA,NA
"955fb60809c82ff348dcfb5b96b49abc","nupathe","venture","B","2008-07-24",3e+07
"955fb60809c82ff348dcfb5b96b49abc","nupathe","debt_financing",NA,"2011-06-14",1e+07
"955fb60809c82ff348dcfb5b96b49abc","nupathe","private_equity",NA,"2012-10-23",2.8e+07
"955fb60809c82ff348dcfb5b96b49abc","nupathe","debt_financing",NA,"2010-04-23",10062500
"955fb60809c82ff348dcfb5b96b49abc","nupathe","venture","A","2006-09-12",1.5e+07
"4c1fca74db9ae74ca768f42eee0b6aaf","nupotential","venture",NA,"2014-03-05",375000
"4c1fca74db9ae74ca768f42eee0b6aaf","nupotential","debt_financing",NA,"2013-06-12",350000
"b9b09b1715b78396e1ffb16d350d1c98","nuretix-research-labs-llc",NA,NA,NA,NA
"b412b6919466314260447c3ce721574e","nuritas","venture","A","2015-10-27",3200000
"b412b6919466314260447c3ce721574e","nuritas","seed",NA,"2014-04-11",128660
"6216e9808c247d3ab3fad68af7429f42","nurix","seed",NA,"2012-05-17",3100000
"6216e9808c247d3ab3fad68af7429f42","nurix","venture","1","2014-05-22",25100000
"ad5bb2c041bcadc344194bb50d771c84","nuro-pharma","venture",NA,"2013-06-19",79992
"ad5bb2c041bcadc344194bb50d771c84","nuro-pharma","debt_financing",NA,"2012-07-11",658392
"f257866bde4621c42dbe29b17e1b22cd","nuron-biotech","private_equity",NA,"2014-02-12",22705658
"f257866bde4621c42dbe29b17e1b22cd","nuron-biotech","private_equity",NA,"2013-01-03",3e+07
"26339c599351d1db0d3450e435e84ee5","nurotron-biotechnology","undisclosed",NA,"2011-09-01",NA
"26339c599351d1db0d3450e435e84ee5","nurotron-biotechnology","venture","1","2013-12-01",16236400
"90893eef398977d9d3768dbdeb4bb2c7","nurture",NA,NA,NA,NA
"44c1f64f3b2f2907cc39ec4b35eea397","nurun-ant-farm-interactive",NA,NA,NA,NA
"bc13bd9a65ac3e98c156f7b0bd1aab49","nusirt","seed",NA,"2012-06-01",6e+05
"bc13bd9a65ac3e98c156f7b0bd1aab49","nusirt","seed",NA,"2012-09-01",2083353
"bc13bd9a65ac3e98c156f7b0bd1aab49","nusirt","venture","1","2014-03-01",3500000
"bc13bd9a65ac3e98c156f7b0bd1aab49","nusirt","venture","1","2014-06-01",1800000
"bc13bd9a65ac3e98c156f7b0bd1aab49","nusirt","venture","1","2015-05-13",6e+06
"dca6515e612294d6e9e0b9bc2a1d0de3","nutech-medical","venture",NA,"2011-02-01",325000
"db4fb23678044b56ed7829f9249967d5","nutek-orthopaedics","seed",NA,"2012-07-17",4e+05
"db4fb23678044b56ed7829f9249967d5","nutek-orthopaedics","venture",NA,"2009-04-30",3074998
"08dcd0b2216f219d5677097cd73ad113","nutmeg-2",NA,NA,NA,NA
"d52655c8b799969ad48a282fe67952bf","nutra-pharma",NA,NA,NA,NA
"332a932db14766d806f12c2b3688a896","nutramed","debt_financing",NA,"2014-01-05",12500000
"f3c04a4e93109a09ee69c8f9fae2ad7e","nuvasive","private_equity",NA,"2011-10-19",40462984
"1941019ea8b4b26317c3f38edfeb6f1a","nuvelo",NA,NA,NA,NA
"5441bbf67fb6aa7529b55144088305a0","nuvem-beta",NA,NA,NA,NA
"08de30528f28c97722b703f46abb2d1c","nuvento-systems-pvt-ltd",NA,NA,NA,NA
"560957628096d0ec0d9af543f7073b9f","nuvilex","venture",NA,"2013-12-27",1136000
"c540a84588411647f0f58eb91eff46b5","nuvision-2","seed",NA,"2015-07-31",590000
"94946ec3021e6c582ae630e5c59d40fa","nuvo-research","post_ipo_equity",NA,"2014-04-01",3100000
"3a1c28cc149f9fe61316c6c9ff9c54f9","nuvolabase",NA,NA,NA,NA
"612eed6f600e3f87a77001d013537052","nvigen","venture","b","2014-03-18",1116749
"612eed6f600e3f87a77001d013537052","nvigen","seed",NA,"2014-02-18",NA
"0a3baa6325aa04d46f643cccf748901b","nvision-medical","venture","A","2013-04-25",NA
"0a3baa6325aa04d46f643cccf748901b","nvision-medical","venture",NA,"2012-02-07",135000
"64743b6f5dd64197207a4f0bd91af0be","nvmdurance","seed",NA,"2013-09-17",321650
"64743b6f5dd64197207a4f0bd91af0be","nvmdurance","undisclosed",NA,"2012-01-01",NA
"64743b6f5dd64197207a4f0bd91af0be","nvmdurance","venture",NA,"2014-08-05",8e+05
"c3f12e9690a67180b3a78fc9153a953f","nx-pharmagen","angel",NA,"2012-01-01",3500000
"c3f12e9690a67180b3a78fc9153a953f","nx-pharmagen","debt_financing",NA,"2013-06-24",773000
"c3f12e9690a67180b3a78fc9153a953f","nx-pharmagen","venture",NA,"2015-03-12",1807974
"9e6feb999eb46dadff7f57e4e90ef373","nxstage-medical",NA,NA,NA,NA
"6a28dec0aae7d1610524554c96e21ef1","nycomed-salutar",NA,NA,NA,NA
"0ce3fd6e3563412ec209dbeb9d9023ea","nymirum","venture",NA,"2009-05-22",550000
"cee45a3a3937e0717d57085db36c7349","o-connor-kelly",NA,NA,NA,NA
"583a0f0564010a4b7f20023ac5bae606","oakley-networks","venture","B","2006-10-21",1.2e+07
"583a0f0564010a4b7f20023ac5bae606","oakley-networks","venture",NA,"2005-12-13",1.6e+07
"3aee51448345c614a0d186cff3458337","oakmore-labs",NA,NA,NA,NA
"2f0c7bcb1b352c3680abd0374f75deaa","oakwood-worldwide",NA,NA,NA,NA
"46ddad0db92f8188bc2e21aa17a80acf","oasmia-pharmaceutical","post_ipo_equity",NA,"2015-10-23",9e+06
"46ddad0db92f8188bc2e21aa17a80acf","oasmia-pharmaceutical","venture",NA,"2010-07-22",10198952
"836c7923347fa2596ef4c77b2cfe4385","obatech","seed",NA,"2013-08-29",11700
"4fac8fb95287d0baf3a01bbc9cdbabc1","obi-pharma",NA,NA,NA,NA
"8324ef9b71215fbb53aa7fe7d8952ee9","objective-analysis",NA,NA,NA,NA
"6bc6d9b09d28e36d6e6667e80b0ffa67","objective-logistics","debt_financing",NA,"2012-07-12",1400000
"6bc6d9b09d28e36d6e6667e80b0ffa67","objective-logistics","venture",NA,"2011-11-30",1500000
"6bc6d9b09d28e36d6e6667e80b0ffa67","objective-logistics","seed",NA,"2010-11-19",8e+05
"6bc6d9b09d28e36d6e6667e80b0ffa67","objective-logistics","venture","1","2013-07-18",5300000
"e2699e43179dad551a7fb9ff762122ac","oblaksoft",NA,NA,NA,NA
"6cb35cc3b2583c56a65fb0a7a7a2becb","obn",NA,NA,NA,NA
"a38c948005c29182b553fc2f20af1702","observepoint","venture",NA,"2016-01-25",2e+06
"a38c948005c29182b553fc2f20af1702","observepoint","venture","1","2015-03-31",6500000
"42dd49093bbc5bf9cead01b5d7f5d8a2","observit",NA,NA,NA,NA
"d40dbb76e1871fed660cd6dd58b39bc3","obsessory",NA,NA,NA,NA
"198d5dba586b94e69ac1efb2f96d3621","obseva","venture","B","2015-11-23",6e+07
"198d5dba586b94e69ac1efb2f96d3621","obseva","venture","a","2013-08-29",32936960
"e1c5c793dd895aba6de411b4b9e26e2e","obvious-engineering","seed",NA,"2014-01-14",150000
"e1c5c793dd895aba6de411b4b9e26e2e","obvious-engineering","seed",NA,"2014-02-01",NA
"c2fd9f1733b5807ef0291cb60e2d3857","ocata-therapeutics","post_ipo_debt",NA,"2015-08-19",1e+07
"9bd5120937af43ff56fc117c59c42aea","oceana-therapeutics","venture",NA,"2009-05-26",3e+06
"bd431c43f3121f145d593388bad6eaf7","ocelus","venture","b","2010-01-20",812931
"a3bb54b359fd98c430f370fb14dbc6e3","ocera-therapeutics","venture",NA,"2013-11-06",2.8e+07
"a3bb54b359fd98c430f370fb14dbc6e3","ocera-therapeutics","debt_financing",NA,"2012-03-30",1500150
"a3bb54b359fd98c430f370fb14dbc6e3","ocera-therapeutics","post_ipo_debt",NA,"2015-08-03",2e+07
"15bb48bae83818f0a58c98a370a45b85","ocimum-biosolutions","venture","c","2011-01-18",8e+06
"7263b2ed22a8929ce8a4d042c3674fcc","oco","venture","c","2007-01-30",1e+07
"c92e91b19cb7fc32174b54c414065fa1","ocoos","angel",NA,"2013-11-02",450000
"c92e91b19cb7fc32174b54c414065fa1","ocoos","seed",NA,"2012-04-02",760000
"d7ead9e25343dd4d1fa047862f074f51","ocs-homecare","debt_financing",NA,"2010-01-19",1199998
"d7ead9e25343dd4d1fa047862f074f51","ocs-homecare","venture",NA,"2009-04-02",506575
"b79ff478421efa348d046f4597463f59","octagen",NA,NA,NA,NA
"8cd39697dd9e04011466d8af57bda487","octamer","venture",NA,"2009-09-18",820800
"4aa266e21884f8683799e808e68ddf66","octano",NA,NA,NA,NA
"7484ac9acce0e19e64ccc8aa5920101e","octapharma-plasma",NA,NA,NA,NA
"116798da7ffc876e1901f4188828ade1","octavarium",NA,NA,NA,NA
"3b3747a6a438512e56b0ee5d05dbb702","octoleaf",NA,NA,NA,NA
"8616a8eb7e7dc9208eb9db87655e5e47","octoly","seed",NA,"2015-10-14",1200000
"0e020ce32dc5cb3883981c59771ee700","octopusocial","seed",NA,"2013-10-18",120000
"7fa1d4af04fca93ea91d2da1628fcbf8","octreopharm-sciences","venture",NA,"2011-04-12",7235000
"08c8072e49752754b2e6593118abdf6f","ocucure-therapeutics","venture",NA,"2015-10-06",2e+05
"08c8072e49752754b2e6593118abdf6f","ocucure-therapeutics","venture",NA,"2010-06-17",825000
"08c8072e49752754b2e6593118abdf6f","ocucure-therapeutics","venture",NA,"2014-02-26",125000
"08c8072e49752754b2e6593118abdf6f","ocucure-therapeutics","venture",NA,"2011-06-21",3e+05
"08c8072e49752754b2e6593118abdf6f","ocucure-therapeutics","venture",NA,"2013-07-01",2e+05
"527be6330fa6e4fd9aa6ece2f78d75f7","ocular-concepts",NA,NA,NA,NA
"381bc8f0b319b87e6c029647c68dd2f6","ocular-therapeutix","venture","d","2013-01-28",23800000
"381bc8f0b319b87e6c029647c68dd2f6","ocular-therapeutix","venture","c","2011-01-12",6e+06
"381bc8f0b319b87e6c029647c68dd2f6","ocular-therapeutix","venture",NA,"2009-07-01",6e+06
"381bc8f0b319b87e6c029647c68dd2f6","ocular-therapeutix","venture","d","2011-02-03",1.4e+07
"381bc8f0b319b87e6c029647c68dd2f6","ocular-therapeutix","venture","c","2009-06-24",1.5e+07
"381bc8f0b319b87e6c029647c68dd2f6","ocular-therapeutix","venture","e","2013-06-10",8500000
"2494d67d3d5fbbd4287c8068bc063426","oculeve","venture",NA,"2014-03-16",16649997
"2494d67d3d5fbbd4287c8068bc063426","oculeve","venture",NA,"2012-10-01",7565000
"2494d67d3d5fbbd4287c8068bc063426","oculeve","debt_financing",NA,"2012-05-14",5e+05
"2494d67d3d5fbbd4287c8068bc063426","oculeve","venture",NA,"2013-03-21",7590476
"b094c59d2b590161b1402965be9ecf19","oculir",NA,NA,NA,NA
"09ad06dd3b5aba69c3a642aa59b43d1e","oculus360","venture",NA,"2016-01-22",3685856
"09ad06dd3b5aba69c3a642aa59b43d1e","oculus360","seed",NA,"2013-09-16",1499999
"9447ab5279def605833431c71e0fc511","oculusai",NA,NA,NA,NA
"4294f06b0f037bd61ba1859408887c6a","ocusciences","venture",NA,"2009-05-01",NA
"d5737accb1a7ef56a09f8996fbae0ebd","ocutri",NA,NA,NA,NA
"f89d427e72683e42579c47410a47534c","odesia",NA,NA,NA,NA
"83ff98cff294ef5ebbf0e178df014ecd","odessa-technologies-inc",NA,NA,NA,NA
"a0c54b64ebddff8298dc8249e9b6389e","odim",NA,NA,NA,NA
"c5da644da74ae035920d964e177fb6a7","odimax","seed",NA,"2011-09-01",24000
"c5da644da74ae035920d964e177fb6a7","odimax","seed",NA,"2012-02-01",135000
"7df3325dc0d5cc939086b424a5c68c9f","odin-biotech-partners","venture",NA,"2014-09-09",6e+05
"e7ff3b0927d952af47939b78a86c043d","odysci",NA,NA,NA,NA
"e70837801386ac4c90d6185bca8a0af2","odyssey-thera","venture",NA,"2013-02-14",2800000
"e70837801386ac4c90d6185bca8a0af2","odyssey-thera","venture",NA,"2010-03-17",3500000
"597890f1afb275891d3f0ce58a3681fd","oem-company",NA,NA,NA,NA
"1aad21d81d3031986b50ca7790663928","oerlikon",NA,NA,NA,NA
"09073bf5d429c4af928e9649ff1245db","offerial","seed",NA,"2013-09-01",118956
"62c025ce9eee8386238386d44caebbc7","offerpop","venture","b","2012-12-17",5700000
"62c025ce9eee8386238386d44caebbc7","offerpop","venture","a","2010-10-20",1348791
"62c025ce9eee8386238386d44caebbc7","offerpop","venture","a","2011-09-09",2500000
"62c025ce9eee8386238386d44caebbc7","offerpop","venture","C","2014-06-02",1.5e+07
"c67d63d8943831292bb42c605c2f515f","offersavvy","seed",NA,"2014-01-27",525000
"c67d63d8943831292bb42c605c2f515f","offersavvy","seed",NA,"2013-10-23",425000
"c67d63d8943831292bb42c605c2f515f","offersavvy","seed",NA,"2014-05-27",1e+05
"c67d63d8943831292bb42c605c2f515f","offersavvy","angel",NA,"2014-05-01",250000
"19f5d8796220b30e6c3e79dfa696ff37","www-officetimer-com",NA,NA,NA,NA
"3cca95ba87a33b55fc5ab0664e7f1ef2","offsite-care-resources","venture",NA,"2011-10-07",1258507
"b2c195a6c6f70aa78e6985b3a00d7f78","ogggy-com",NA,NA,NA,NA
"36e259a81da2cddc19a63226ce905721","oggii",NA,NA,NA,NA
"32e58f4bfcc1fdf7ebbb20335c36f4bd","ogilvy-new-york",NA,NA,NA,NA
"0d1431b830575352e0432dd8ae417e54","ogma-conceptions",NA,NA,NA,NA
"a6a72b516693d726a2c62225bca0d4a2","ohmeda",NA,NA,NA,NA
"83684cc2c8c89623620e50f30e765233","oh-my-green","seed",NA,"2014-01-04",NA
"8dc2d077060b58fa276aaabd6ac6d9cb","ohmztech",NA,NA,NA,NA
"692a048296ccaefb358b26fdc33ee5bc","ohr-pharmaceutical","venture",NA,"2014-01-16",569581
"692a048296ccaefb358b26fdc33ee5bc","ohr-pharmaceutical","venture",NA,"2013-10-11",376915
"692a048296ccaefb358b26fdc33ee5bc","ohr-pharmaceutical","venture",NA,"2014-12-29",50000
"0d0927634b2af1a0458f34c8b74174d4","ojd-introl",NA,NA,NA,NA
"d7f45e57af184745dcc912a48686091c","okairos","venture","b","2010-09-14",20500000
"2bb3f9b325e14cf4d200a6cca2e89d4d","okapi-sciences",NA,NA,NA,NA
"7544b220b0ea02dda5ea00364acc44f5","oklahoma-medical-research-foundation","grant",NA,"2014-08-21",14500000
"fd8dd1611b5f756ee3d25ab62a467f90","l-app",NA,NA,NA,NA
"342700c437408add6d012e87af1a51c6","oleapark",NA,NA,NA,NA
"78dbb770d428cf2ba8c489cd9df6a00e","olepoints",NA,NA,NA,NA
"6e8b2fd4936e651a248bfbff9f9f7b4b","olerace-cosmetics-inc",NA,NA,NA,NA
"426ce9fb539da8af23db055ea8d7ce4a","olerup-ssp",NA,NA,NA,NA
"1c1a106db240f4b417732b6ace0b221b","olfactor-laboratories","venture",NA,"2010-06-18",50000
"15234c18c9ee160af733da79834b3936","oligasis","venture",NA,"2009-07-13",1836044
"da4554a02255ed48f8fc6634f29f1895","oligomerix","venture","a","2012-04-23",2e+06
"da4554a02255ed48f8fc6634f29f1895","oligomerix","grant",NA,"2013-09-11",1700000
"da4554a02255ed48f8fc6634f29f1895","oligomerix","venture","b","2013-05-22",2800000
"da4554a02255ed48f8fc6634f29f1895","oligomerix","venture",NA,"2015-04-15",NA
"76be3c96b801b4f687c517abf10cd2fd","olista","venture","b","2006-04-26",1e+07
"76be3c96b801b4f687c517abf10cd2fd","olista","venture",NA,"2008-10-28",1.4e+07
"c696ebc8e7bfe1cc96e4214e18353a36","ollert",NA,NA,NA,NA
"565f103288ad5182b1e057527a98a6f7","oma",NA,NA,NA,NA
"8a1ec7a82b33aa6fb60adea84b3a5d47","omeros","private_equity",NA,"2007-01-11",9e+06
"8a1ec7a82b33aa6fb60adea84b3a5d47","omeros","post_ipo_debt",NA,"2014-03-05",3.2e+07
"8a1ec7a82b33aa6fb60adea84b3a5d47","omeros","venture","1","2007-02-12",6.3e+07
"8a1ec7a82b33aa6fb60adea84b3a5d47","omeros","post_ipo_equity",NA,"2014-03-20",37800000
"b88cbd5046bb5b9e45edc7dfc19fc172","ometria","venture",NA,"2013-02-01",6e+05
"b88cbd5046bb5b9e45edc7dfc19fc172","ometria","seed",NA,"2014-03-25",1500000
"b88cbd5046bb5b9e45edc7dfc19fc172","ometria","seed",NA,"2014-09-22",5e+05
"b88cbd5046bb5b9e45edc7dfc19fc172","ometria","seed",NA,"2015-09-28",2277166.5975
"e38c8727eb7a9b120faa09d692abe29e","omics-publishing-group",NA,NA,NA,NA
"a06b5d562140dca3ec9df59f150f75fb","omicsis","seed",NA,"2015-03-10",179594.566
"a06b5d562140dca3ec9df59f150f75fb","omicsis","seed",NA,"2014-08-04",289589
"a0771365a6905f54e885cb337f4663a8","omixon",NA,NA,NA,NA
"9955ffda2699b9e814d1395133c558a7","omni-bio-pharmaceutical","venture",NA,"2011-06-14",3079875
"9955ffda2699b9e814d1395133c558a7","omni-bio-pharmaceutical","debt_financing",NA,"2012-06-01",687500
"9955ffda2699b9e814d1395133c558a7","omni-bio-pharmaceutical","venture",NA,"2010-02-10",1985650
"9955ffda2699b9e814d1395133c558a7","omni-bio-pharmaceutical","venture",NA,"2011-09-28",2800000
"9955ffda2699b9e814d1395133c558a7","omni-bio-pharmaceutical","venture",NA,"2013-06-11",1540000
"f64e73537be39043aa222cdeca9a6f39","omni-buddy",NA,NA,NA,NA
"ffcd53d9b0baba2dfd995c746b9c8d58","omni-hospitals","venture","a","2013-08-07",9800000
"b8ca1b972a660255776a058188efd4e3","omnia-molecular",NA,NA,NA,NA
"7b6395e9fe25a4703ba778a87cb504ea","omniata","venture","a","2014-03-12",5200000
"7b6395e9fe25a4703ba778a87cb504ea","omniata","seed",NA,"2013-01-01",1600000
"d9015d7a37501dfc6fadd97bc4cd49ad","omniderm","debt_financing",NA,"2015-06-25",NA
"2cca3f21734f2140fd00b83e047d9c77","omniearth","seed",NA,"2014-08-29",NA
"2cca3f21734f2140fd00b83e047d9c77","omniearth","undisclosed",NA,"2014-02-18",NA
"2cca3f21734f2140fd00b83e047d9c77","omniearth","venture","1","2015-05-05",5e+06
"95a8a9ac0931e8227ca502c22aba6da0","omniforce","undisclosed",NA,"2013-08-27",NA
"7346a99a7a98ab7a09b4734306e5fcec","omnilytics","venture",NA,"2010-12-03",5e+05
"7346a99a7a98ab7a09b4734306e5fcec","omnilytics","seed",NA,"2013-07-09",2e+05
"1950722cb7e71eaa4927d07c74c8c712","omniox","private_equity",NA,"2013-08-07",3e+06
"1950722cb7e71eaa4927d07c74c8c712","omniox","venture",NA,"2014-06-23",6603710
"1950722cb7e71eaa4927d07c74c8c712","omniox","grant",NA,"2014-10-09",5800000
"348ef13a967c226b730ecba6c0a826fa","omniperception","venture",NA,"2005-05-12",NA
"163472145ac3cd3fb74d15950e8a7926","omnivec","venture",NA,"2013-05-06",550000
"dc60530ecdee85ac09152b9147f1aa5f","omrix-biopharmaceuticals","venture",NA,"2005-03-31",4840000
"66c9b5d3ffa561c16e49fd143276dda6","omthera-pharmaceuticals","debt_financing",NA,"2013-02-28",17600000
"66c9b5d3ffa561c16e49fd143276dda6","omthera-pharmaceuticals","venture","1","2010-03-30",6500000
"66c9b5d3ffa561c16e49fd143276dda6","omthera-pharmaceuticals","venture","1","2011-03-14",33900000
"66c9b5d3ffa561c16e49fd143276dda6","omthera-pharmaceuticals","venture",NA,"2009-11-27",2158333
"4a38e73c96ddd13db666968328fdcb7f","on-demand-therapeutics","debt_financing",NA,"2010-03-18",3e+05
"4a38e73c96ddd13db666968328fdcb7f","on-demand-therapeutics","venture","1","2009-08-13",830000
"4a38e73c96ddd13db666968328fdcb7f","on-demand-therapeutics","venture","1","2011-06-17",2624369
"2c30a59fbfdd868a218dff3712962682","on-target-laboratories","venture",NA,"2014-03-11",1.5e+07
"229f68c24339e72c409fa8b5aefd24fa","on-q-ity","venture","b","2012-02-28",5e+06
"229f68c24339e72c409fa8b5aefd24fa","on-q-ity","venture","a","2009-12-14",2.6e+07
"927b6b9e34afc1de06183a5500d06e77","onalytica",NA,NA,NA,NA
"a91621249d4995f4ac9f250cf7d41ae4","oncgnostics","seed",NA,"2012-04-17",NA
"a91621249d4995f4ac9f250cf7d41ae4","oncgnostics","venture","1","2015-01-29",NA
"03f9aee910c421c5c1e4910713d6211e","oncimmune","undisclosed",NA,"2007-10-01",NA
"c63bd2e964965babd0bd34c1b1cd7af7","oncirc-diagnostics","venture",NA,"2010-03-23",5e+05
"56e84a3588f3fd60f305b952e9d9f167","oncodesign","venture","c","2008-05-22",4710000
"f80c0bcc91eb53548a83dc5589b1a1c0","oncodiagnostic-laboratory",NA,NA,NA,NA
"441f662f205440941ce903e631b85af5","oncoethix","venture","b","2013-07-08",1.9e+07
"e40888a59f630234998bd9d57a4adf17","oncofactor-corporation","venture","a","2011-08-02",2100000
"e40888a59f630234998bd9d57a4adf17","oncofactor-corporation","venture",NA,"2013-09-03",1e+06
"0b573db94d55bb66623d0ac494142a30","oncofusion-therapeutics","debt_financing",NA,"2013-03-01",525000
"fe0c379d9f7b0e7d6f67bed8d61f78f8","oncogenex","venture",NA,"2010-01-04",1e+07
"ea45214eb55e506b5d441e9eb921a017","oncohealth","venture","a","2011-05-03",1600000
"ea45214eb55e506b5d441e9eb921a017","oncohealth","angel",NA,"2011-01-01",1250000
"ea45214eb55e506b5d441e9eb921a017","oncohealth","seed",NA,"2012-07-01",6e+05
"15bca75a162949bf56da3620a7e90625","oncoholdings","venture",NA,"2010-10-15",182500
"a3de27a4a84fe7216b977c902a378fb4","oncolix","venture",NA,"2011-08-17",50000
"a3de27a4a84fe7216b977c902a378fb4","oncolix","venture",NA,"2011-10-10",1500000
"a3de27a4a84fe7216b977c902a378fb4","oncolix","venture",NA,"2012-04-24",2400000
"a3de27a4a84fe7216b977c902a378fb4","oncolix","venture",NA,"2015-01-22",4508704
"d92a6e06ee75dd2842fddcbc82c6d3bb","oncology-services-international","private_equity",NA,"2013-08-21",3400000
"141869e6372fb3cd7a007956155799d8","oncolytics-biotech","venture",NA,"2010-10-28",2.4e+07
"700be9edd399a8140d7e83b33662f6bb","oncomark","venture",NA,"2015-09-21",2700000
"5e01ed0b693b43e1ac5f3e9c74f0d5a4","oncomed-pharmaceuticals","venture",NA,"2011-04-28",2e+07
"5e01ed0b693b43e1ac5f3e9c74f0d5a4","oncomed-pharmaceuticals","venture","1","2008-11-04",1.54e+08
"5e01ed0b693b43e1ac5f3e9c74f0d5a4","oncomed-pharmaceuticals","venture",NA,"2013-12-06",22249996
"07a930652ab8cc9d2e26fdb20adbe731","onconova-therapeutics","venture",NA,"2015-10-23",1500000
"07a930652ab8cc9d2e26fdb20adbe731","onconova-therapeutics","venture",NA,"2011-01-06",11690190
"07a930652ab8cc9d2e26fdb20adbe731","onconova-therapeutics","venture",NA,"2012-08-14",5e+07
"07a930652ab8cc9d2e26fdb20adbe731","onconova-therapeutics","venture",NA,"2010-03-04",19226287
"07a930652ab8cc9d2e26fdb20adbe731","onconova-therapeutics","venture",NA,"2012-05-10",7050000
"5e15769b3eda4fd89bbe606d7f545da8","oncopep","venture","a","2012-02-13",5e+05
"5e15769b3eda4fd89bbe606d7f545da8","oncopep","venture","a","2012-04-26",2500000
"5e15769b3eda4fd89bbe606d7f545da8","oncopep","venture","a","2011-04-15",4500000
"5e15769b3eda4fd89bbe606d7f545da8","oncopep","venture","B","2014-08-28",6900000
"eae755e8129059e4d98596e3a3384e21","oncopeptides","venture","a","2013-05-21",NA
"470415606773d436bcfcecd15b90f155","oncore-biopharma","debt_financing",NA,"2014-10-03",1e+06
"65bb4bfe1fb40dec8cc43c68c0a4f664","oncorps","venture",NA,"2015-10-05",2300000
"30db025b2f3944bf9af677ca25c46748","oncos-therapeutics","venture","c","2010-04-30",5500000
"5500b8cbc5127cbc9e901a44043af641","oncothyreon","private_equity",NA,"2011-04-29",4e+07
"5500b8cbc5127cbc9e901a44043af641","oncothyreon","private_equity",NA,"2010-09-24",14900000
"5500b8cbc5127cbc9e901a44043af641","oncothyreon","private_equity",NA,"2013-05-30",1e+07
"74ee9fca0b44bbad9f19bf5fcf4bd958","oncotree-dts","seed",NA,"2012-01-13",2400000
"74ee9fca0b44bbad9f19bf5fcf4bd958","oncotree-dts","debt_financing",NA,"2011-12-27",2400000
"74ee9fca0b44bbad9f19bf5fcf4bd958","oncotree-dts","debt_financing",NA,"2012-04-04",750000
"5ac39b9606755689ab4edf8ba996955b","oncovista-innovative-therapies","venture",NA,"2015-11-03",NA
"5ac39b9606755689ab4edf8ba996955b","oncovista-innovative-therapies","venture",NA,"2010-11-12",6.5e+07
"dd4e5635977d3829c12f15a7ec9c46a3","0ndine-biomedical-inc","seed",NA,"2009-09-11",43360
"dd4e5635977d3829c12f15a7ec9c46a3","0ndine-biomedical-inc","venture",NA,"2009-12-21",719491
"bc4bfaf0b9c154dec26d9366bc59cd91","one-call-medical",NA,NA,NA,NA
"f01d75ed4bbba772b6b593ba92c93019","one-eighty-marketing",NA,NA,NA,NA
"6b74e4a5865451ef991719759192414d","one-match",NA,NA,NA,NA
"562832fb86aca0860ec7745cfca707ba","hubbard-one",NA,NA,NA,NA
"cb15235c38d764750a2ac3b426712239","one-world-lab","debt_financing",NA,"2014-12-01",25000
"cb15235c38d764750a2ac3b426712239","one-world-lab","debt_financing",NA,"2015-06-15",71500
"0a92eabfcdff92612bbbcdbc8ff97947","oneavenue",NA,NA,NA,NA
"e6506697d65bb7a4b175b11d9a9690f8","oneclickretail",NA,NA,NA,NA
"5ebd49370d51befe74261c51ca0630d7","onedepth",NA,NA,NA,NA
"f389b9fa62a11959726c48b542e7d8af","oneeleven",NA,NA,NA,NA
"6eb0d4680f7bfa0cc254665af6d85286","onefold","seed",NA,"2014-02-05",720000
"6eb0d4680f7bfa0cc254665af6d85286","onefold","convertible_note",NA,"2014-02-28",210000
"6eb0d4680f7bfa0cc254665af6d85286","onefold","convertible_note",NA,"2014-05-19",120000
"dcf502218fe41fa728239919dbb02430","oneighty-c-technologies","venture",NA,"2013-05-15",360000
"dcf502218fe41fa728239919dbb02430","oneighty-c-technologies","venture",NA,"2014-01-12",25000
"72620bec67162055790a7737da8a9042","onemedplace",NA,NA,NA,NA
"f72e8f7c011cbc445c4790879e47374c","oneome","venture",NA,"2015-05-18",1040832
"7209594bf87f37d6a1d63388abc7bc80","onepastfive-gmbh",NA,NA,NA,NA
"7a311a5ed865ad366b499f524c918459","internet-media-labs","seed",NA,"2011-08-01",175000
"7a311a5ed865ad366b499f524c918459","internet-media-labs","seed",NA,"2012-12-21",1300000
"ca0993c407bfb408e7c948a6407c7d97","oneredcar",NA,NA,NA,NA
"b3c7953999789b11a3c0494661efbcac","onesaas",NA,NA,NA,NA
"20fbc2cd3aca88a8110605b734c367af","onespin-solutions","undisclosed",NA,"2012-05-31",NA
"20fbc2cd3aca88a8110605b734c367af","onespin-solutions","venture","1","2005-05-24",1.8e+07
"51c748c3b7ea8949c2a750ad7d140200","onfarm","seed",NA,"2012-06-01",3e+05
"51c748c3b7ea8949c2a750ad7d140200","onfarm","seed",NA,"2015-09-01",NA
"51c748c3b7ea8949c2a750ad7d140200","onfarm","equity_crowdfunding",NA,"2014-04-10",8e+05
"51c748c3b7ea8949c2a750ad7d140200","onfarm","seed",NA,"2013-06-07",NA
"5abd8bac4c1981793e5f54de8b3a71a0","onkaido-therapeutics","venture",NA,"2014-01-14",2e+07
"5df167b388a7f135c2ce97ca684ef424","onkure","seed",NA,"2013-06-04",599705
"5df167b388a7f135c2ce97ca684ef424","onkure","debt_financing",NA,"2015-07-07",495000
"4b1387f962d1e8efda94e0d493e23fb7","onl-therapeutics","seed",NA,"2014-07-02",501810
"4b1387f962d1e8efda94e0d493e23fb7","onl-therapeutics","grant",NA,"2014-11-12",1370000
"fab54afd6418e6e15b5a9204f87806b6","online-marketing-people",NA,NA,NA,NA
"7f6af79507958116401ce6ce15a0e03e","onmobile",NA,NA,NA,NA
"0663ac783d861b615521cacc926821e5","onnuridmc-inc-","seed",NA,"2014-11-01",2e+06
"3741fd820ab404853fd14eb095bd2b8d","onovative","angel","A","2014-07-14",4e+05
"3741fd820ab404853fd14eb095bd2b8d","onovative","venture","A","2015-12-04",1200000
"0b88082cbb3b3d293cbd846b7d009c54","onramp-bioinformatics-inc-","seed",NA,"2014-11-15",NA
"0b88082cbb3b3d293cbd846b7d009c54","onramp-bioinformatics-inc-","convertible_note",NA,"2015-08-01",NA
"c0dd29db70c1272cb5bfad5458c576e0","onscreens",NA,NA,NA,NA
"b393ed51aed3c0b4943a5b86ca7fd2f5","onsophic-fka-exlibrix",NA,NA,NA,NA
"b1e1454c99a72ace3c0217dde0b14a0a","ontame-io",NA,NA,NA,NA
"e121555a079f350d8d38af42f3217ffd","ontology-systems",NA,NA,NA,NA
"980983e591762da50d7843c9f4f36897","ontopit",NA,NA,NA,NA
"85d338b8c1d296b84c6e57c960854878","ontotext","venture","A","2008-01-01",NA
"3fa1d3f211a639aadf1fd5c383183eee","ontrack-diabetes",NA,NA,NA,NA
"4782cddda1274ab99c966b21b7eb57b0","ontrack-imaging","venture",NA,"2010-10-14",1e+05
"80101131bd34989ab3a2613095f14a6a","ontraport","venture",NA,"2013-01-01",NA
"7b7ea06a7151328150db7afbca0bcdf2","onvedeo",NA,NA,NA,NA
"8dceda076ff3be58368798c30712ffc1","onward-behavioral-health","private_equity",NA,"2012-02-28",9250150
"9f5c70395e2a11a758406c8167192477","onyara",NA,NA,NA,NA
"2e958c6a7a1cb50d4fb2a3407204da83","onysus",NA,NA,NA,NA
"5e0d0caf2e27553ff1233a57a735fa7f","onyu","equity_crowdfunding",NA,"2014-02-18",NA
"bccb8dab6aa07de4fd655f15626a263d","onyvax","venture","c","2006-05-08",14906222
"b241aba65c5634767ef0026ea8921ddb","onyx-pharmaceuticals",NA,NA,NA,NA
"b158507f2ba425acefb33745d1e5d8ac","onyx-beacon",NA,NA,NA,NA
"007991711b0821b3f02cb98f1643a8fd","oopsly",NA,NA,NA,NA
"2c05d390132b21ef20198c6590719fb7","ooxesis-biotech",NA,NA,NA,NA
"55272742915869f131a1364322caff54","ooyala","venture","c","2009-10-12",1e+07
"55272742915869f131a1364322caff54","ooyala","venture","b","2007-12-18",8500000
"55272742915869f131a1364322caff54","ooyala","venture","a","2007-06-01",1500000
"55272742915869f131a1364322caff54","ooyala","venture","d","2010-09-09",2.4e+07
"55272742915869f131a1364322caff54","ooyala","venture",NA,"2011-09-13",NA
"55272742915869f131a1364322caff54","ooyala","venture","e","2012-06-18",3.5e+07
"55272742915869f131a1364322caff54","ooyala","venture","f","2013-12-11",4.3e+07
"c869ad59bb3e011c3de0edddb8135f6f","opal-therapeutics","venture","a","2005-10-31",6e+06
"97f6c0fd0e964ec35f508f66e9e19613","opalia-pharma",NA,NA,NA,NA
"d1858fcc760695d06b6fc3ff8eb35f82","opani",NA,NA,NA,NA
"fb15e1aa5e094c9f2822d6c356c8fe0e","opara","seed",NA,"2012-02-26",20118
"281677a03b3b3f7dc6b21bc1ea58690b","opeepl","angel",NA,"2013-02-01",NA
"d05c3f520a9469b0b13f069ec22548ac","open-box-technologies","seed",NA,"2005-11-30",150000
"d05c3f520a9469b0b13f069ec22548ac","open-box-technologies","venture","1","2006-06-01",2300000
"79a0311d1149851487abd4515bcca6a4","ocx",NA,NA,NA,NA
"f2a7b13bf73e6b624857c7d0a28c61e7","open-harbor","venture","B","2001-11-19",1e+07
"60972be964c5b4d0ebd15f7b2d3a42cf","open-health-network","convertible_note",NA,"2014-01-15",2e+05
"f8bf0f77b0c918b4a398c61b2a28a4c1","open-insight",NA,NA,NA,NA
"cb3d93feb2c2219aa53cef5b350308c6","open-plus",NA,NA,NA,NA
"3ab3ca908343af3f79c5bac1c2213a75","open-source-food","seed",NA,"2007-12-25",10000
"7460cab391e9885518895bc4c747e6c0","open-web-analytics",NA,NA,NA,NA
"c160ec8cf002a5e2700c39eb34947fdc","open42",NA,NA,NA,NA
"3dd569fb5c63485d3b8facb2041a64d3","openamplify",NA,NA,NA,NA
"aff8b62ea5011a2b942abad12305a8c7","openbci",NA,NA,NA,NA
"4b6e93db6bf92bc002da0f8775ab9f0b","openbiome",NA,NA,NA,NA
"02bfa45fa678403375774397b14091b3","openconnect-systems-inc",NA,NA,NA,NA
"4fcd8d88048b60899eea06bc26eb8bd1","opencredo",NA,NA,NA,NA
"a81e886ea81d2c13e55bd4a67735663b","opengov","venture","B","2015-10-15",2.5e+07
"a81e886ea81d2c13e55bd4a67735663b","opengov","venture",NA,"2013-07-03",4e+06
"a81e886ea81d2c13e55bd4a67735663b","opengov","venture","A","2012-06-11",3e+06
"a81e886ea81d2c13e55bd4a67735663b","opengov","venture","B","2014-05-15",1.5e+07
"44e1706f0c41d0f26a118f5b721c9536","creativecloud","seed",NA,"2011-11-09",4e+05
"44e1706f0c41d0f26a118f5b721c9536","creativecloud","seed",NA,"2013-03-04",875000
"44e1706f0c41d0f26a118f5b721c9536","creativecloud","seed",NA,"2012-09-15",225000
"44e1706f0c41d0f26a118f5b721c9536","creativecloud","non_equity_assistance",NA,"2015-03-01",NA
"44e1706f0c41d0f26a118f5b721c9536","creativecloud","venture",NA,"2014-04-01",NA
"6c78434e993a59a906535026a74f04a4","openhouse-inc","venture","A","2015-11-19",13500000
"239f419c8d5eb4bd1c68ea6d8c66bfcf","opening",NA,NA,NA,NA
"082005ea4d9e41096890824749353630","openinvo",NA,NA,NA,NA
"92f3abadf332a36efe860c6fede4a6f7","openmail",NA,NA,NA,NA
"cbdfd277fc86d785a0165d4d93ac43c8","openoox",NA,NA,NA,NA
"689e23dceb42bdaa3fc4304531add773","openplain",NA,NA,NA,NA
"de63530b816cf0bd36ae3309eff83302","openrisk","seed",NA,"2015-09-01",NA
"ad2db7918925f18a5148f927f62cdd03","openspan","venture","a","2006-12-04",8e+06
"ad2db7918925f18a5148f927f62cdd03","openspan","venture",NA,"2005-01-01",1e+07
"ad2db7918925f18a5148f927f62cdd03","openspan","venture","c","2008-07-14",1.3e+07
"ad2db7918925f18a5148f927f62cdd03","openspan","venture",NA,"2011-02-01",NA
"abb30566ddce8ee90d3bcaf09c08d335","opentracker",NA,NA,NA,NA
"70952af554e82cb4f56f8afc5c9229a7","opentrons","venture",NA,"2014-11-24",NA
"70952af554e82cb4f56f8afc5c9229a7","opentrons","venture",NA,"2015-10-20",NA
"70952af554e82cb4f56f8afc5c9229a7","opentrons","seed",NA,"2014-07-14",25000
"70952af554e82cb4f56f8afc5c9229a7","opentrons","undisclosed",NA,"2014-09-02",NA
"2a1615901a3d454922e1dbefa967230c","openweathermap",NA,NA,NA,NA
"79e0d8e2b82625ca9ba6b79336e20722","opera-solutions","private_equity",NA,"2013-05-09",3e+07
"79e0d8e2b82625ca9ba6b79336e20722","opera-solutions","private_equity",NA,"2011-09-14",8.4e+07
"79e0d8e2b82625ca9ba6b79336e20722","opera-solutions","venture","1","2014-10-23",8199999
"bbdad75f241bcba83f5ba6851cf5747f","operative-2",NA,NA,NA,NA
"29280107ee28c6eeb0e2f607b63a01bc","operativearts",NA,NA,NA,NA
"c6e0d82ab307e13be8bfa4125bb60670","opex-software-inc",NA,NA,NA,NA
"6c7af7aed4d51452a2727b3b046484d0","opexa-therapeutics","venture",NA,"2009-04-25",1101000
"6c7af7aed4d51452a2727b3b046484d0","opexa-therapeutics","debt_financing",NA,"2013-02-19",650000
"6c7af7aed4d51452a2727b3b046484d0","opexa-therapeutics","debt_financing",NA,"2012-07-27",4085000
"ac28832a96feba22ba34d900d92f2ddf","opgen","venture","B","2005-01-27",5e+06
"ac28832a96feba22ba34d900d92f2ddf","opgen","debt_financing",NA,"2012-02-16",3532442
"ac28832a96feba22ba34d900d92f2ddf","opgen","venture","c","2012-03-07",1.7e+07
"ac28832a96feba22ba34d900d92f2ddf","opgen","venture","a","2007-09-12",23600000
"ac28832a96feba22ba34d900d92f2ddf","opgen","debt_financing",NA,"2010-01-15",4052000
"ac28832a96feba22ba34d900d92f2ddf","opgen","debt_financing",NA,"2014-04-07",3999864
"ac28832a96feba22ba34d900d92f2ddf","opgen","venture","b","2010-09-28",1.7e+07
"ac28832a96feba22ba34d900d92f2ddf","opgen","debt_financing",NA,"2010-05-10",4018522
"ac28832a96feba22ba34d900d92f2ddf","opgen","debt_financing",NA,"2014-07-17",1079917
"ac28832a96feba22ba34d900d92f2ddf","opgen","debt_financing",NA,"2015-02-23",1243999
"bc90893f3d06b8c8a6711d3672629678","ophiuchus-technologies",NA,NA,NA,NA
"0a618f521f365b1908b83c1d410dc09f","ophthonix","venture","D","2006-12-14",35100000
"0a618f521f365b1908b83c1d410dc09f","ophthonix","venture",NA,"2010-09-27",5393752
"0a618f521f365b1908b83c1d410dc09f","ophthonix","debt_financing",NA,"2010-03-18",3113636
"0a618f521f365b1908b83c1d410dc09f","ophthonix","debt_financing",NA,"2011-10-20",14046415
"0a618f521f365b1908b83c1d410dc09f","ophthonix","convertible_note",NA,"2011-06-10",2100000
"0a618f521f365b1908b83c1d410dc09f","ophthonix","venture","C","2005-10-11",1.7e+07
"e5d691ffbe11baa005e3f26dc4bd37b2","ophthotech","venture","A","2007-08-13",3.6e+07
"e5d691ffbe11baa005e3f26dc4bd37b2","ophthotech","private_equity",NA,"2013-05-29",5e+07
"e5d691ffbe11baa005e3f26dc4bd37b2","ophthotech","private_equity",NA,"2013-05-25",1.25e+08
"e5d691ffbe11baa005e3f26dc4bd37b2","ophthotech","venture","b","2009-12-15",3e+07
"e5d691ffbe11baa005e3f26dc4bd37b2","ophthotech","post_ipo_equity",NA,"2014-01-24",41700000
"52ea9f01ea7230eb88aef4082d6679e4","opi-open-intelligence","venture",NA,"2014-07-01",1e+06
"35f01ac28fdea6242a4775cb3dc96ad9","opiniator",NA,NA,NA,NA
"da5d62635d809157c1f5344e80b0736e","opinion-research-corporation",NA,NA,NA,NA
"7d594dd784413abd68a4f1f56c97f2cf","opinionlab","venture",NA,"2013-03-11",1.5e+07
"116010facbd85021b3414a27dfcb111d","opinit-inc",NA,NA,NA,NA
"e83468298cee4100c1f9b288cf80a6b7","opk-biotech",NA,NA,NA,NA
"960e178436746acc9822e815f7fff81b","opko-health","debt_financing",NA,"2013-02-15",1.75e+08
"960e178436746acc9822e815f7fff81b","opko-health","venture",NA,"2009-06-03",3.1e+07
"d84b071233590c289365631a3505e3bc","opnia","angel",NA,"2014-05-01",240000
"febd0d0b15383200656743028c0837bc","opprtunity","angel",NA,"2013-05-30",1e+05
"94988ec7c16239f3edfe0449d478d494","oppstreet",NA,NA,NA,NA
"a1a8d3031694757d4cc957728bffeb5a","opsona","venture","c","2013-04-29",43272900
"a1a8d3031694757d4cc957728bffeb5a","opsona","venture","b","2009-06-16",4600000
"a1a8d3031694757d4cc957728bffeb5a","opsona","venture","c","2013-10-02",3859800
"550dd00ddbe4354dcc0b2a8220d924b1","vssod-corporation",NA,NA,NA,NA
"626861aafb30375b4fbbc91d2935f151","optherion","venture","A","2007-10-09",3.7e+07
"626861aafb30375b4fbbc91d2935f151","optherion","debt_financing",NA,"2009-09-16",5e+06
"0f5e3b92c772c515acab70966508a0ac","optics","venture",NA,"2010-01-21",3.8e+07
"8c629430dcc9c67a8bfb1948950cc6bb","optics-for-hire",NA,NA,NA,NA
"9bbaf5405994029a3346501ad2d1fb89","optier","venture",NA,"2007-06-05",1.5e+07
"9bbaf5405994029a3346501ad2d1fb89","optier","venture",NA,"2007-07-23",NA
"9bbaf5405994029a3346501ad2d1fb89","optier","venture","1","2006-03-06",7e+06
"9bbaf5405994029a3346501ad2d1fb89","optier","debt_financing",NA,"2008-09-23",1.5e+07
"9bbaf5405994029a3346501ad2d1fb89","optier","venture","1","2008-09-23",47500000
"9bbaf5405994029a3346501ad2d1fb89","optier","venture","1","2013-08-13",8e+06
"9bbaf5405994029a3346501ad2d1fb89","optier","venture","1","2003-09-16",8600000
"9bbaf5405994029a3346501ad2d1fb89","optier","venture","1","2004-02-04",7500000
"9bbaf5405994029a3346501ad2d1fb89","optier","venture","1","2005-08-10",9500000
"25ecf529d2907859cad0c861f8c9a854","optigo-networks",NA,NA,NA,NA
"a6c522d21e1dc977882502a839f8a0f2","optii-solution","venture","A","2015-09-02",2e+06
"a6c522d21e1dc977882502a839f8a0f2","optii-solution","seed",NA,"2013-08-28",1347305.3892
"927db064e9e1434cca806b362492b358","optimal-digital-marketing",NA,NA,NA,NA
"1811cf30d9b928bdf96c5da0b469446a","optimalize-me","seed",NA,"2013-11-01",60000
"b4b9d96f46ba70989c12ec879250e686","optimata","venture",NA,"2008-02-13",1500000
"504f3407a130e59cf96512c293898a53","optimedica","venture","A","2005-05-26",NA
"504f3407a130e59cf96512c293898a53","optimedica","venture","c","2008-03-26",1.6e+07
"504f3407a130e59cf96512c293898a53","optimedica","venture",NA,"2009-08-05",30235886
"504f3407a130e59cf96512c293898a53","optimedica","venture","e","2013-05-10",3.5e+07
"bc98f9fcc1fb1478c81701e58b3e23b7","optimer-pharmaceuticals","venture",NA,"2005-03-02",1.2e+07
"bc98f9fcc1fb1478c81701e58b3e23b7","optimer-pharmaceuticals","venture","1","2005-12-14",22200000
"ed493ac66f7709937bcc13ff5b3fd2a8","optimise-connect-ltd",NA,NA,NA,NA
"c65179cfd3ec6a124b553d95bb3d382c","optimizerx","venture",NA,"2010-06-08",3e+06
"997bccedd1ec643180be4931b42fa411","optimum-biometric-labs",NA,NA,NA,NA
"f66f23f8b0e3e93dfd5b9975974864a2","optimus-digital",NA,NA,NA,NA
"6c58ea0ae418a340a48732f45751e877","optinose","venture","D","2015-10-06",3e+07
"6c58ea0ae418a340a48732f45751e877","optinose","venture","C","2010-06-07",48500000
"6c58ea0ae418a340a48732f45751e877","optinose","venture","C","2014-08-05",3.5e+07
"19986151b4a27bc16064e512bc5556b1","optiscan-biomedical","venture",NA,"2005-10-10",3.6e+07
"19986151b4a27bc16064e512bc5556b1","optiscan-biomedical","private_equity",NA,"2010-04-14",31500000
"19986151b4a27bc16064e512bc5556b1","optiscan-biomedical","private_equity",NA,"2012-11-02",2523099
"19986151b4a27bc16064e512bc5556b1","optiscan-biomedical","private_equity",NA,"2013-02-07",30733658
"b615be9730c77dc8dcecb74af12eb243","optmed","venture",NA,"2011-04-29",6009950
"b615be9730c77dc8dcecb74af12eb243","optmed","venture",NA,"2012-01-23",321849
"b615be9730c77dc8dcecb74af12eb243","optmed","venture",NA,"2009-09-01",2e+06
"b615be9730c77dc8dcecb74af12eb243","optmed","venture",NA,"2013-06-11",124000
"b615be9730c77dc8dcecb74af12eb243","optmed","venture",NA,"2012-08-22",257321
"b615be9730c77dc8dcecb74af12eb243","optmed","venture",NA,"2014-07-02",75000
"b615be9730c77dc8dcecb74af12eb243","optmed","debt_financing",NA,"2015-03-17",2e+05
"b615be9730c77dc8dcecb74af12eb243","optmed","venture",NA,"2015-08-11",2e+05
"8f428d2286128fadad784b9d983623e9","optofluidics","seed",NA,"2015-05-06",75000
"fee54cc99308c9fc90b22601dfeb6464","optum",NA,NA,NA,NA
"e3396d48bb8f1bbe06615de1ca3c4ebe","optuminsight",NA,NA,NA,NA
"00b478a5e75c17fc2295fd487341e9e3","opus-healthcare-solutions",NA,NA,NA,NA
"46428fe8ae83fccadd0d8cf17b6943d1","o-ra","seed",NA,"2014-03-01",6e+05
"ef901a71449a77a941fb65295e5a0b81","oragenics","venture",NA,"2012-08-10",2538185
"ef901a71449a77a941fb65295e5a0b81","oragenics","venture",NA,"2010-01-13",3e+06
"ef901a71449a77a941fb65295e5a0b81","oragenics","venture",NA,"2013-10-15",9900000
"ef901a71449a77a941fb65295e5a0b81","oragenics","venture",NA,"2010-08-11",2e+06
"ef901a71449a77a941fb65295e5a0b81","oragenics","venture",NA,"2012-06-15",5798001
"ef901a71449a77a941fb65295e5a0b81","oragenics","debt_financing",NA,"2012-03-23",11237011
"5125c2d18a1c29ec9be72185d1370d07","oramed-pharmaceuticals","venture",NA,"2015-12-01",5e+07
"5125c2d18a1c29ec9be72185d1370d07","oramed-pharmaceuticals","venture",NA,"2011-04-13",3356000
"5125c2d18a1c29ec9be72185d1370d07","oramed-pharmaceuticals","venture",NA,"2013-01-03",31500
"5125c2d18a1c29ec9be72185d1370d07","oramed-pharmaceuticals","venture",NA,"2012-09-27",1e+06
"58981ebc182defc0f5e259f1a5f9cbbc","orange-harp",NA,NA,NA,NA
"97cb0902e064415be4ddcc035223f36c","orange-pi",NA,NA,NA,NA
"9db85cd1731d25e75a1a0153bd9e271d","orapharma-topco-holdings",NA,NA,NA,NA
"40e38bdb679aa7d6f42ecd46bbc7dbce","oratel-diagnostics",NA,NA,NA,NA
"a15dba672a27a45fec4e5d665cece378","oraya-therapeutics","venture","b","2008-01-11",1.8e+07
"a15dba672a27a45fec4e5d665cece378","oraya-therapeutics","debt_financing",NA,"2009-04-22",3000030
"a15dba672a27a45fec4e5d665cece378","oraya-therapeutics","venture","c","2009-07-20",4.2e+07
"a15dba672a27a45fec4e5d665cece378","oraya-therapeutics","venture","a","2007-06-18",4e+06
"a15dba672a27a45fec4e5d665cece378","oraya-therapeutics","venture","D","2014-05-14",25132051
"a15dba672a27a45fec4e5d665cece378","oraya-therapeutics","grant",NA,"2014-08-05",215000
"df077b61d662931551daf321485925f1","orb-intelligence",NA,NA,NA,NA
"ac0d43f913028deb242652ac1a4500f4","orbeus","seed",NA,"2014-05-20",1466387
"ac0d43f913028deb242652ac1a4500f4","orbeus","venture","1","2014-09-01",NA
"8c6209cc812aaa0c697f3af1d7e055dc","orbis-biosciences","venture",NA,"2009-05-06",250000
"8c6209cc812aaa0c697f3af1d7e055dc","orbis-biosciences","equity_crowdfunding",NA,"2012-09-14",NA
"8c23e2ba66676ffc721876da1207d9aa","orbital-insight-inc","seed",NA,"2014-02-21",NA
"8c23e2ba66676ffc721876da1207d9aa","orbital-insight-inc","venture","1","2015-03-16",8700000
"dcf22c4b6749def4f290bb19414777a0","orbitera-inc","seed",NA,"2015-06-03",2e+06
"1e8fb506e28a14bb5f9918bfd0170b88","orchard-capital-ventures",NA,NA,NA,NA
"1be7eca48384eee63f32b7d7afb04d4d","orchestrate-orthodontic-technologies","seed",NA,"2012-04-19",782625
"a7bb2e2496d3bffc894e73e37e29f11d","orchid-cellmark",NA,NA,NA,NA
"da077cecb428625381abfbc8ec8f136c","orchid-orthopedic-solutions",NA,NA,NA,NA
"c8c899e65b475644fd3a1ab92618fdaf","orchid-robotics",NA,NA,NA,NA
"f97630e000a44d4ab21acb7db6e9455d","orega-biotech","venture",NA,"2010-09-01",3710000
"996e711c773f1a5519efea4a3a6a9188","orexigen-therapeutics","venture","C","2006-11-22",3e+07
"996e711c773f1a5519efea4a3a6a9188","orexigen-therapeutics","post_ipo_equity",NA,"2015-09-11",6e+07
"b8083a2658f74e703af38803afa4f86c","orexo","post_ipo_equity",NA,"2014-08-29",50600000
"b8083a2658f74e703af38803afa4f86c","orexo","venture","1","2003-01-17",22261405
"c0300b8927bc39c9219b0e74a10d462a","organ-preservation-alliance",NA,NA,NA,NA
"944db5ba2bab60ebdebf547cf79bc33b","organic-fresh-food-group",NA,NA,NA,NA
"8a04c27ead15e6a5c28a1c5316866554","organic-society","seed",NA,"2011-12-06",40000
"d3d0ef78367c05b7d74bab037e25b3f3","organovo-holdings","venture","a","2011-11-02",3489760
"d3d0ef78367c05b7d74bab037e25b3f3","organovo-holdings","private_equity",NA,"2012-03-19",15200000
"d3d0ef78367c05b7d74bab037e25b3f3","organovo-holdings","seed",NA,"2013-01-04",7662675
"d3d0ef78367c05b7d74bab037e25b3f3","organovo-holdings","secondary_market",NA,"2015-06-19",4e+07
"94325bb14dfafb86414277eeee0ff825","orgenesis","post_ipo_equity",NA,"2015-12-16",1e+07
"94325bb14dfafb86414277eeee0ff825","orgenesis","private_equity",NA,"2013-05-14",1300000
"94325bb14dfafb86414277eeee0ff825","orgenesis","grant",NA,"2014-11-26",2015000
"efcf3c1c00396851dcd06f900aebe886","oricane",NA,NA,NA,NA
"bdf88bb6a7a1233e528a5e02ebd6a848","oricula-therapeutics","undisclosed",NA,"2014-04-10",NA
"c3b5dc738a0342f2a85d021366b7d5cf","oridion",NA,NA,NA,NA
"67cc508017add8aa6609c03d6bfa1348","oriel-therapeutics","venture",NA,"2007-11-16",26500000
"425ee150a66dc8b3b0c218fc5aed8093","origami-logic","venture","a","2012-11-13",9300000
"425ee150a66dc8b3b0c218fc5aed8093","origami-logic","venture","b","2014-01-29",1.5e+07
"425ee150a66dc8b3b0c218fc5aed8093","origami-logic","venture","C","2015-09-29",2.5e+07
"d8f1c861568617b75901368827f21c9c","origammi",NA,NA,NA,NA
"4404a470c1171ea4e49c3c3224b8c582","origen-therapeutics","grant",NA,"2007-10-03",2e+06
"4404a470c1171ea4e49c3c3224b8c582","origen-therapeutics","venture",NA,"2010-08-12",3743342
"da3f4e76678ed998afdbcafeb01741f7","origene-technologies","private_equity",NA,"2012-09-04",1.5e+07
"da3f4e76678ed998afdbcafeb01741f7","origene-technologies","venture","1","2013-03-21",21300000
"da3f4e76678ed998afdbcafeb01741f7","origene-technologies","venture","1","2010-03-24",1.6e+07
"da3f4e76678ed998afdbcafeb01741f7","origene-technologies","private_equity",NA,"2014-03-10",2e+05
"da3f4e76678ed998afdbcafeb01741f7","origene-technologies","venture",NA,"2015-06-09",17051983
"866ba078597ead32dcd6a6c1c200b721","origin-biomed","venture",NA,"2007-07-10",3800000
"e2daeb700e72dd4bd0ed8f3effdd8af3","orion-digital-marketing",NA,NA,NA,NA
"da75ec3f755fa03002bd5d2717d04db7","orion-health",NA,NA,NA,NA
"79f91e06794a91233de723963ad739a1","orion-high-technologies",NA,NA,NA,NA
"71c36913cd08abb0150edc4bf7889b5b","orior-creative",NA,NA,NA,NA
"042171c447ce60e40c6be71d11a101f0","orkiv",NA,NA,NA,NA
"4eb3eb661a75b1539497f684d26e93d3","orkney","venture","A","2013-03-29",NA
"4eb3eb661a75b1539497f684d26e93d3","orkney","debt_financing",NA,"2014-06-30",NA
"4eb3eb661a75b1539497f684d26e93d3","orkney","venture",NA,"2014-08-29",866233
"e9e10475a4c3013c8da943008dd26584","oros","venture",NA,"2010-07-22",1030000
"8ab1dde910a703f05db020aac87a0429","orpalis-gdpicture",NA,NA,NA,NA
"0ed420f84c22d624c034e86153cad3b6","orphazyme","venture","a","2011-09-07",2e+07
"0ed420f84c22d624c034e86153cad3b6","orphazyme","seed",NA,"2011-02-14",NA
"0ed420f84c22d624c034e86153cad3b6","orphazyme","venture","B","2015-01-09",2.4e+07
"65e64fbd552db173309857aed9756f8a","orpix",NA,NA,NA,NA
"e0106adba1b5e4896b5535dbda1957f4","orpro-therapeutics","venture",NA,"2013-12-18",1327498
"4411447a982764478c7e04933863c75b","orqis-medical","venture","D","2007-03-27",1.2e+07
"4411447a982764478c7e04933863c75b","orqis-medical","debt_financing",NA,"2008-11-20",1193787
"6e7e1d779071a03c40d482b60400022d","orreco","venture",NA,"2015-03-12",1061822
"bd93235abfeba5c8cb14720f30bcdf50","orteq","undisclosed",NA,"2011-01-08",NA
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","debt_financing",NA,"2016-01-06",4e+06
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture","1","2015-08-31",NA
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture","1","2013-06-27",NA
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture","1","2011-05-06",NA
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture","1","2010-11-24",NA
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture",NA,"2009-04-24",500010
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture",NA,"2009-11-11",3500000
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture","1","2010-01-31",2e+06
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture","1","2010-12-08",2e+06
"8c58d3cc73b51d83d7a73c793cff25ae","ortho-kinematics","venture",NA,"2014-04-22",6292611
"587fb60b3af049cb320d799f59b26d06","orthobond","venture","a","2011-10-21",2147092
"7ef9e96391eb29de2cc19d14d4ad1f81","orthofix-international-n-v",NA,NA,NA,NA
"969d4277d28f33b50ca0648456c3516e","orthogem","undisclosed",NA,"2011-04-22",NA
"0e6ae3dbe5361b88e2b45805a8772a92","orthohub","venture",NA,"2013-04-22",109000
"593d52af9cbbdf742e149f118261d99b","orthologic-corp",NA,NA,NA,NA
"d6db49b1ad4e39ecbfd9b13a86870640","orthomimetics","venture","A","2006-12-01",9812643.9188
"16336910cce7e17e7956123db3aa4e1d","orthopaedic-synergy","debt_financing",NA,"2010-09-08",3641000
"16336910cce7e17e7956123db3aa4e1d","orthopaedic-synergy","venture",NA,"2014-04-30",42500000
"302f626b09a68f7c9dfa0aed0dd94747","orthopediactrics","venture",NA,"2010-06-18",51875
"302f626b09a68f7c9dfa0aed0dd94747","orthopediactrics","debt_financing",NA,"2008-01-13",12500000
"6c18155ff8c3c64557425ea1d6f2974c","orthos","undisclosed",NA,"2010-08-05",1327461
"6cf19253d78f6e4c922e8e4cdf95710f","orthoscan","debt_financing",NA,"2010-03-09",825000
"6cf19253d78f6e4c922e8e4cdf95710f","orthoscan","venture","1","2008-10-06",7500000
"46ec386c0f09a236a07225817deab2b5","orthospace","venture",NA,"2015-05-19",8e+06
"87140ef2a8fab7bb6bc5400f359f2385","ortivus",NA,NA,NA,NA
"000e0a0375e78b1d9c462a9ad0e68ab5","oryzon-genomics","venture","C","2015-10-29",18735810.3789
"000e0a0375e78b1d9c462a9ad0e68ab5","oryzon-genomics","venture","b","2008-03-12",17024700
"f76e38327b204b34a927849dabcba9f0","orzota",NA,NA,NA,NA
"dc553a0d31172c89fcd388acb14ac618","os-rise",NA,NA,NA,NA
"ea89a37ae5617aaa1df5bf318d2b37ef","oscadi","seed",NA,"2013-07-01",651386
"37769870d19b4af920b134a9b2126ed6","oseberg","private_equity",NA,"2016-01-14",1e+07
"8d5e8921528e2d85e1d90b0d79dc4d6b","osf-global-services",NA,NA,NA,NA
"843108fb0ac29d973d9b6c001d680315","osg-records-management","venture",NA,"2009-03-19",1e+06
"843108fb0ac29d973d9b6c001d680315","osg-records-management","venture",NA,"2006-07-25",2500000
"b4bb00fe9e2c5a8fc2084efecf1e461b","osint-solutions",NA,NA,NA,NA
"08fe73bca9a1fad2a22e55a190d9dc91","osiris-therapeutics","private_equity",NA,"2005-06-09",5e+07
"08fe73bca9a1fad2a22e55a190d9dc91","osiris-therapeutics","post_ipo_equity",NA,"2014-04-09",1.5e+07
"8bbab3eb9e1d407bc1238514be80c6dc","osprey-data","seed",NA,"2013-09-13",525000
"8bbab3eb9e1d407bc1238514be80c6dc","osprey-data","seed",NA,"2014-11-14",3905802
"c47a34c726a84d411bbd7efdf8f41c98","osprey-pharmaceuticals-usa","venture","A","2008-09-03",1.1e+07
"c47a34c726a84d411bbd7efdf8f41c98","osprey-pharmaceuticals-usa","venture",NA,"2007-01-30",9e+06
"c47a34c726a84d411bbd7efdf8f41c98","osprey-pharmaceuticals-usa","venture",NA,"2009-05-18",5892744
"c47a34c726a84d411bbd7efdf8f41c98","osprey-pharmaceuticals-usa","venture","a","2009-05-01",NA
"da28037bfffb7e0d7c37a20758d701e3","ossdsign-ab","venture",NA,"2015-11-04",10564310.2386
"da28037bfffb7e0d7c37a20758d701e3","ossdsign-ab","venture",NA,"2013-07-15",2059161
"0bfd4d1cf3b8efa0a5ee537b4a7cff0e","ossianix","undisclosed",NA,"2012-01-03",NA
"b2d6068c1fb232cb497409474dced1f5","osteopathy-quebec","seed",NA,"2014-11-20",NA
"e1165ba97274531eed94cf95ac2a1f57","ostial-solutions","venture",NA,"2010-09-08",1892560
"e1165ba97274531eed94cf95ac2a1f57","ostial-solutions","debt_financing",NA,"2011-05-17",137530
"ecd5c26fac78e6aaff774c3c46014dd9","osurv","seed",NA,"2012-03-21",20000
"f53af9442155362eb11e3cac977cb6be","othera-pharmaceuticals","debt_financing",NA,"2009-08-04",10619994
"46afcba6b37417d6d2d59ba155d7f9c4","otherlevels",NA,NA,NA,NA
"8f0ab7fd01b7419526762f971169710c","otiiplanet",NA,NA,NA,NA
"d827996e20dcbb5ea62e5243b9ee9f93","oto",NA,NA,NA,NA
"0fd9ad960985c8c69ee297e728c88ea8","otologic-pharmaceutics","venture","a","2014-04-03",4100000
"86c4dece48dd6475e3f33d2ac84f6599","otologics",NA,NA,NA,NA
"d964e925a2127649cec99b19642e399e","otonomy","venture","c","2013-09-04",45900000
"d964e925a2127649cec99b19642e399e","otonomy","venture","b","2010-08-30",38500000
"d964e925a2127649cec99b19642e399e","otonomy","venture","a","2010-06-11",1e+07
"d964e925a2127649cec99b19642e399e","otonomy","venture","D","2014-04-30",4.9e+07
"dfb84f892a260c5e9f1d308ea869df5b","otosense","seed",NA,"2015-02-15",NA
"dfb84f892a260c5e9f1d308ea869df5b","otosense","angel",NA,"2014-04-01",NA
"dfb84f892a260c5e9f1d308ea869df5b","otosense","venture","1","2015-01-30",NA
"dfb84f892a260c5e9f1d308ea869df5b","otosense","venture","1","2015-06-29",1200000
"52f574987f2c98148e88408a5fe7909d","otsuka-pharmaceutical",NA,NA,NA,NA
"42f7c9bb41deb1e6445525f263d0735f","ouro-botics","venture",NA,"2014-12-12",NA
"daf747050102b738b9d4d5b9e924013a","ouroboros","venture","A","2007-07-18",1170000
"daf747050102b738b9d4d5b9e924013a","ouroboros","debt_financing",NA,"2009-03-24",666667
"2c12b3d4c683016dec240ba31e8a331c","outboundengine","venture","A","2012-09-01",6800000
"2c12b3d4c683016dec240ba31e8a331c","outboundengine","venture","B","2014-12-11",1.1e+07
"f0640485037133b70bcf76de57e3f5d4","outfie",NA,NA,NA,NA
"71ef1be61b120b366af0d3a28594f16f","outflank",NA,NA,NA,NA
"9c8dadb3c62dfd1e614f7c8bbda11a45","outleads","non_equity_assistance",NA,"2014-09-28",NA
"9c8dadb3c62dfd1e614f7c8bbda11a45","outleads","venture",NA,"2015-03-15",NA
"2faf44ed62452250254e52e78f5ef8ef","outline","grant",NA,"2011-02-01",NA
"2faf44ed62452250254e52e78f5ef8ef","outline","seed",NA,"2013-02-25",NA
"2faf44ed62452250254e52e78f5ef8ef","outline","grant",NA,"2012-09-01",7000
"2faf44ed62452250254e52e78f5ef8ef","outline","grant",NA,"2012-04-01",15000
"2faf44ed62452250254e52e78f5ef8ef","outline","seed",NA,"2013-09-09",850000
"2faf44ed62452250254e52e78f5ef8ef","outline","grant",NA,"2012-04-06",20000
"ab06cd5ab1ff5d8a5b0d891e36524876","outmarket",NA,NA,NA,NA
"e89929346c33be0bf0d57445d1a947c9","quotadeck-com-odesk-elance-for-salespeople","seed",NA,"2014-09-19",1e+06
"26a4a187cfb03842d203e1924b992b04","outsourcing-service-provider",NA,NA,NA,NA
"c267e7b97b884c9edd4d9f7bf9b69e50","outsourcing-services-india",NA,NA,NA,NA
"c54efe4b972afb5724b9a344cdb397a5","ovagene-oncology","debt_financing",NA,"2012-03-13",516375
"c54efe4b972afb5724b9a344cdb397a5","ovagene-oncology","seed",NA,"2012-03-05",1605474
"c54efe4b972afb5724b9a344cdb397a5","ovagene-oncology","equity_crowdfunding",NA,"2013-10-20",NA
"d9aa49b6078121e8f6f68eab0ffc8c3e","ovalis","venture",NA,"2010-07-01",493036
"d9aa49b6078121e8f6f68eab0ffc8c3e","ovalis","venture","1","2010-07-01",1361841
"d9aa49b6078121e8f6f68eab0ffc8c3e","ovalis","venture","1","2007-01-13",6600000
"528d6d0eb92cf751ef911811009df7e8","ovascience","venture","a","2011-10-11",6e+06
"528d6d0eb92cf751ef911811009df7e8","ovascience","venture","d","2013-03-28",34999920
"528d6d0eb92cf751ef911811009df7e8","ovascience","venture","b","2012-04-03",3.7e+07
"528d6d0eb92cf751ef911811009df7e8","ovascience","venture","c","2012-08-07",4e+06
"198f32d94ab9191344885b04ec031d21","ovation-pharmaceuticals",NA,NA,NA,NA
"a4cc71d656808a8de01545f6dd8bd3fc","over-the-counter-data-otcd",NA,NA,NA,NA
"74ac5ee2eac550b367d647f39ddfad05","overbrook-scientific",NA,NA,NA,NA
"25104cff1a2de61ec73f4485933c7f3a","overgrad",NA,NA,NA,NA
"d738b4fd0de7b66b273d6b69064cddc3","islanddatacorporation","venture",NA,"2009-10-01",2500000
"d738b4fd0de7b66b273d6b69064cddc3","islanddatacorporation","venture","1","2007-03-05",5e+06
"d738b4fd0de7b66b273d6b69064cddc3","islanddatacorporation","venture","1","2008-07-02",6e+06
"d738b4fd0de7b66b273d6b69064cddc3","islanddatacorporation","venture","1","2010-04-19",7e+06
"db4da46afd05125e804354e58852dca5","ovizio","venture",NA,"2015-11-16",8605790.2625
"7cbc358e6773aa6c289db44984ff72f3","ovuline","seed",NA,"2012-08-23",NA
"7cbc358e6773aa6c289db44984ff72f3","ovuline","grant",NA,"2011-03-01",NA
"7cbc358e6773aa6c289db44984ff72f3","ovuline","seed",NA,"2013-01-07",1400000
"7cbc358e6773aa6c289db44984ff72f3","ovuline","seed",NA,"2013-10-08",1100000
"7cbc358e6773aa6c289db44984ff72f3","ovuline","venture",NA,"2015-05-22",3219992
"a2e4e952ff7744b1e510dfcd97a0a27e","owl-biomedical","venture",NA,"2012-01-23",3e+06
"199f2c082ad5b28adccfc733344a13dd","owlin","seed",NA,"2012-12-11",250000
"20eae51d008eb536d824c93507484ed9","owloo",NA,NA,NA,NA
"2c570d2101375b1e361993c8efb9fd2b","own-the-arena-consulting",NA,NA,NA,NA
"dda067079083f4512c45228524475cab","ownermetric",NA,NA,NA,NA
"56a23c4bf523e81a007305903da4d893","oxagen","venture","c","2009-11-24",26700000
"c1d669ed28c2f26d43b65eac2c1b507a","oxen-enterprises-llc",NA,NA,NA,NA
"d3dd0909df9c9460ae5879dfb8dc073e","oxford-biochronometrics","convertible_note",NA,"2013-09-01",198260
"145b481d8c3fa860763aa86289d62e6b","oxford-biomedica",NA,NA,NA,NA
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","venture",NA,"2005-03-22",996524
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","venture",NA,"2006-03-02",1047079
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","undisclosed",NA,"2007-01-04",3889597
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","undisclosed",NA,"2008-08-15",1303945
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","venture",NA,"2009-02-24",1160668
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","venture",NA,"2010-03-23",1119924
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","undisclosed",NA,"2010-05-27",1025066
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","venture",NA,"2010-08-20",1098450
"00a953969e93e381b55779c1161f0c67","oxford-biotherapeutics","debt_financing",NA,"2015-07-30",1e+07
"320094b8df82422a94fada2b135bcf43","oxford-biotrans","seed",NA,"2013-10-01",909150
"320094b8df82422a94fada2b135bcf43","oxford-biotrans","venture","1","2015-08-04",3901677
"02708d086df14912859f12741e3c7c3e","oxford-economics",NA,NA,NA,NA
"cfbbff57ce7c57a6e64086a3fc9e5053","oxford-genetics","seed",NA,"2013-07-30",227287
"1fde072d6ef33c836cb3f50460c61fe3","oxford-glycosciences",NA,NA,NA,NA
"fd3add4c8f75be9c19a1bd57ab334bf2","oxford-immunotec","venture","c","2007-10-29",4e+07
"fd3add4c8f75be9c19a1bd57ab334bf2","oxford-immunotec","venture",NA,"2012-06-18",2.8e+07
"fd3add4c8f75be9c19a1bd57ab334bf2","oxford-immunotec","venture","d","2010-05-04",2.6e+07
"fd3add4c8f75be9c19a1bd57ab334bf2","oxford-immunotec","venture","b","2005-08-10",12550010
"6086f9315a49f257ae7ae8dd5eb7f65b","oxford-phamascience-group","undisclosed",NA,"2013-10-31",6061005
"6086f9315a49f257ae7ae8dd5eb7f65b","oxford-phamascience-group","undisclosed",NA,"2011-11-02",1762373
"3775bd0f298b483dc03968037dfbd184","oxigene","venture",NA,"2010-03-26",7500000
"5abb3fde5da5ac800b82799f92b95f7f","oxigene-inc",NA,NA,NA,NA
"f033e96da188800e565792a467499ac3","oxitec","undisclosed",NA,"2012-02-14",12577090
"f033e96da188800e565792a467499ac3","oxitec","venture",NA,"2005-06-08",2387838
"f033e96da188800e565792a467499ac3","oxitec","undisclosed",NA,"2007-10-30",3099612
"f033e96da188800e565792a467499ac3","oxitec","venture",NA,"2009-12-18",3005153
"f033e96da188800e565792a467499ac3","oxitec","venture",NA,"2011-03-29",5542270
"f033e96da188800e565792a467499ac3","oxitec","venture",NA,"2014-06-24",1e+07
"1c8a937dc2c217c94c512f73902d88d4","oxthera","undisclosed",NA,"2007-06-29",21894082
"1c8a937dc2c217c94c512f73902d88d4","oxthera","venture",NA,"2005-07-11",20908870
"1c8a937dc2c217c94c512f73902d88d4","oxthera","undisclosed",NA,"2014-04-16",10521261
"23d788d352e125b74ff7a0136d64db23","oxygen-biotherapeutics","post_ipo_equity",NA,"2013-07-22",5400000
"23d788d352e125b74ff7a0136d64db23","oxygen-biotherapeutics","venture",NA,"2009-06-09",5250000
"ce687b4f47c11b5bf2123f15578ce5d7","oxyrane-uk","venture","d","2011-11-17",26500000
"3e42c5da0fc45a2f1b8ad0733f556d9a","oy-lx-therapies","venture",NA,"2009-01-14",2630000
"782df730e18cb13ec72142cb8286d784","oyagen","venture",NA,"2009-09-17",1029709
"782df730e18cb13ec72142cb8286d784","oyagen","venture","1","2010-09-24",3e+06
"782df730e18cb13ec72142cb8286d784","oyagen","venture","1","2012-10-11",1742315
"782df730e18cb13ec72142cb8286d784","oyagen","grant",NA,"2013-09-16",150000
"dc2aec79df59cf0588a6be1f8ee33f1a","oyc-europe",NA,NA,NA,NA
"39ae0f9e01f1e2df5970a7b29b2d6890","oye","seed",NA,"2013-09-04",20000
"79cbbb7d9d7f8d79418062df0122f2c2","ozone-media-solutions","venture","A","2008-07-07",4e+06
"79cbbb7d9d7f8d79418062df0122f2c2","ozone-media-solutions","venture","b","2012-09-01",1500000
"79cbbb7d9d7f8d79418062df0122f2c2","ozone-media-solutions","venture","a","2008-04-01",2300000
"248b7f025b1a0e662ce7dcc23c084c72","ozone-online",NA,NA,NA,NA
"eb42bdf0c4966f3970a21c40ed1e33c9","p-lemmens-company","undisclosed",NA,"2011-10-13",NA
"763b2cf745544c721c85a4c9c02a7e69","p2-science","venture","a","2014-04-06",1e+06
"763b2cf745544c721c85a4c9c02a7e69","p2-science","seed",NA,"2013-03-17",2e+05
"763b2cf745544c721c85a4c9c02a7e69","p2-science","venture",NA,"2011-11-23",150011
"763b2cf745544c721c85a4c9c02a7e69","p2-science","seed",NA,"2013-05-19",650000
"35da1d307693d58d811b983e9973f52f","paari-chem-resources-pvt-ltd",NA,NA,NA,NA
"75c4bb2d50aadf29a94851ec9c886ae5","100paces",NA,NA,NA,NA
"84f79f338faa5814194f3310d3b7ccc2","pacgen-biopharmaceuticals","seed",NA,"2011-03-31",12288
"351b9403b20a51bd98ca728f19dfe924","pacgenomics","venture","A","2015-01-10",1500000
"351b9403b20a51bd98ca728f19dfe924","pacgenomics","venture","A","2015-01-12",3e+06
"8dacdf05486c47ff661e8f55e0ac0c31","pachyderm","seed",NA,"2014-12-01",120000
"8dacdf05486c47ff661e8f55e0ac0c31","pachyderm","seed",NA,"2015-06-10",2e+06
"92fb79272fe3fc4907f27156a05d0eaf","pacific-biosciences","debt_financing",NA,"2013-02-11",20500000
"92fb79272fe3fc4907f27156a05d0eaf","pacific-biosciences","venture","1","2009-10-01",6.8e+07
"92fb79272fe3fc4907f27156a05d0eaf","pacific-biosciences","venture","1","2010-07-14",1.09e+08
"92fb79272fe3fc4907f27156a05d0eaf","pacific-biosciences","venture","1","2007-01-15",5e+07
"92fb79272fe3fc4907f27156a05d0eaf","pacific-biosciences","venture","1","2005-08-31",7720000
"e77388be34851a388128f77c5d57d600","pacira-pharmaceuticals",NA,NA,NA,NA
"06177f71579a72dcb2266043ecaeb913","packaging-coordinators-inc",NA,NA,NA,NA
"8afd63f7767aacc7e51d088b904fa70c","packetsled","angel",NA,"2013-06-01",3e+06
"02634f52250821946409bf339835ba02","pacsdrive",NA,NA,NA,NA
"98c2cd38d08e810ff4d0c6ded0cb9759","padicode",NA,NA,NA,NA
"8c974fa3edeb31fea56f8c6c25e40377","padinmotion","seed",NA,"2013-01-14",NA
"8c974fa3edeb31fea56f8c6c25e40377","padinmotion","venture",NA,"2013-12-17",360000
"3778cc07af2746597238ba7d19dfefe3","pagedna",NA,NA,NA,NA
"0a7f15183c1f38d074943de905daf442","pagefreezer","angel",NA,"2009-01-30",5e+05
"4ec56f1e4b69bf17b5106f0861ffa2eb","pageviral-inc",NA,NA,NA,NA
"39c04b952948bd150f319d0ac8cf41cd","pain-therapeutics","grant",NA,"2015-09-21",1700000
"d15a451a736c7b6ffa59e8132114aef0","paion-ag","venture",NA,"2014-01-02",4097400
"d15a451a736c7b6ffa59e8132114aef0","paion-ag","venture",NA,"2014-02-20",4349671
"d15a451a736c7b6ffa59e8132114aef0","paion-ag","venture",NA,"2014-07-30",6745985
"617951820c0d435e70718ed9fa60ec91","paladin-labs",NA,NA,NA,NA
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","private_equity",NA,"2015-12-23",200029998
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","private_equity",NA,"2015-12-09",125830003
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","private_equity",NA,"2015-10-21",104830011
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","venture","1","2012-05-16",5.6e+07
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","venture","1","2011-05-05",5e+07
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","venture","1","2010-06-25",9e+07
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","private_equity",NA,"2014-09-12",444184042
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","secondary_market",NA,"2011-01-01",NA
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","secondary_market",NA,"2013-01-01",NA
"4b9df2994ef21fad607e278d90eb69ab","palantir-technologies","seed",NA,"2005-09-01",NA
"e524f4d15edb830c83593f7dd1ca98af","palatin-technologies","venture","a","2012-07-13",3.5e+07
"e524f4d15edb830c83593f7dd1ca98af","palatin-technologies","post_ipo_equity",NA,"2014-12-24",2e+07
"e524f4d15edb830c83593f7dd1ca98af","palatin-technologies","post_ipo_debt",NA,"2014-12-24",1e+07
"5ebb218da1dd7cd0797ca195b7485b50","paletly",NA,NA,NA,NA
"a50021705824967417aad7954046eb1e","palindromx","undisclosed",NA,"2007-05-04",198608
"f7de00609be958021d1a2006fcde607c","palingen","venture",NA,"2010-07-02",1302789
"aea96b186aeaef00df00baa1f17265fe","palkion","venture",NA,"2009-08-17",2500000
"0b9b1b7c8ecf19169081ac41c7e4cac6","palladian-software",NA,NA,NA,NA
"539969897e716484196fab648a8ec603","palladium-life-sciences","venture",NA,"2013-07-10",1800000
"04b4803c185eb25ce421ec1a74c83342","palm-international-inc",NA,NA,NA,NA
"fdddd1d89f502f1688ee35be5d097597","palo-alto-data",NA,NA,NA,NA
"04d7469949798d07b5d7ee9f81e30f40","palobiofarma",NA,NA,NA,NA
"41819f335d68ee286bc7b562aca39ba5","paloma-pharmaceuticals","debt_financing",NA,"2009-09-02",5e+05
"41819f335d68ee286bc7b562aca39ba5","paloma-pharmaceuticals","venture",NA,"2010-09-10",1200000
"4e1246f09b55e7a76323f12c50a47b91","panacea-pharmaceuticals","venture","E","2015-12-08",1.5e+07
"0b84cd65514a228f5c411209b4bf1730","panacela-labs","venture",NA,"2015-12-24",2902600
"0b84cd65514a228f5c411209b4bf1730","panacela-labs","venture","1","2011-10-07",3.7e+07
"46d38875d97659ef3ac49efc31efb880","panamplify","seed",NA,"2015-11-13",1100000
"c396d3b90411ef8c22471686467a658c","panjiva","seed",NA,"2006-01-01",4e+05
"c396d3b90411ef8c22471686467a658c","panjiva","venture","1","2008-01-01",5200000
"c396d3b90411ef8c22471686467a658c","panjiva","seed",NA,"2012-05-18",NA
"ec8cd1dbe008fd60b399b2f91cf8cd1d","panoptes-pharma","seed",NA,"2015-11-02",NA
"8b150964acd79b486b04305dd62394d9","panoptica","venture","a","2011-01-04",3e+07
"8b150964acd79b486b04305dd62394d9","panoptica","venture","b","2014-04-15",4.5e+07
"3dd712f80f6d2a6ea0074f503cc823b0","panorama-education","seed",NA,"2013-03-01",NA
"3dd712f80f6d2a6ea0074f503cc823b0","panorama-education","seed",NA,"2014-01-14",NA
"3dd712f80f6d2a6ea0074f503cc823b0","panorama-education","seed",NA,"2013-10-21",4e+06
"3dd712f80f6d2a6ea0074f503cc823b0","panorama-education","venture","1","2015-08-04",1.2e+07
"f043085d9d3fa466b8cf86e9e80d9cfd","panorama-software",NA,NA,NA,NA
"ba0ba53d2802a02cea7945bbc2e04af3","pansense-pharmaceutical-co-ltd",NA,NA,NA,NA
"2c79637a828ea7a4c557e20561ff0171","pantec-biosolutions","venture","A","2007-12-07",5591715.9763
"204401591e2607061329dc50b98b7e27","paper-hunter","undisclosed",NA,"2014-05-02",2000
"9115b54a65d961fafa787f29dd621796","paper-otter",NA,NA,NA,NA
"43e12ddcf6f6812159c8e910aab75190","paperlinks","seed",NA,"2011-08-02",NA
"b9c571754f40a9487b5b36e154c0c8b2","papershare","seed",NA,"2011-07-01",1800000
"b9c571754f40a9487b5b36e154c0c8b2","papershare","debt_financing",NA,"2013-09-04",6e+05
"ec8c6e0783eff0c14a19bb869045d3fa","paquin-healthcare-companies","venture",NA,"2014-01-01",187500
"b59c23375992aa847d580f5940430fc0","parabole-llc",NA,NA,NA,NA
"cda5e6b880a24f584d213897b6027c8a","paraccel","venture","c","2009-06-30",2.2e+07
"cda5e6b880a24f584d213897b6027c8a","paraccel","venture",NA,"2012-04-25",2e+07
"cda5e6b880a24f584d213897b6027c8a","paraccel","venture","e","2011-08-04",1e+07
"cda5e6b880a24f584d213897b6027c8a","paraccel","venture",NA,"2010-12-30",10491709
"cda5e6b880a24f584d213897b6027c8a","paraccel","venture","b","2007-12-10",2.2e+07
"cda5e6b880a24f584d213897b6027c8a","paraccel","undisclosed",NA,"2011-07-07",NA
"bbb06182719219854ab4e94f25540a6c","paracelsus-labs","debt_financing",NA,"2010-06-23",135000
"ce8c89dbd0e8c8a53603b05dfe9d69a3","paradigm-holdings","venture",NA,"2009-03-16",6206000
"a97e98f208fb110ad4866240b2f6ead6","paradigm4","venture","A","2015-11-30",NA
"8fd51a1f5d3af52d7372ed3bfc8fbdd8","paradoxes",NA,NA,NA,NA
"5a45f457b94d4ef3e425c836a74588bd","paragon-bioservices","venture","A","2014-10-28",1.3e+07
"5a45f457b94d4ef3e425c836a74588bd","paragon-bioservices","venture","A","2015-08-18",2e+06
"756c7c92653f6f525a99eb479f1e33f3","paragonix-technologies","debt_financing",NA,"2013-12-18",1100000
"d1b68f202debc42140f179b28daead55","paralign-me",NA,NA,NA,NA
"caf033b7c50ad02421afc37e62b49d2e","parallel-machines","venture","B","2015-03-12",NA
"caf033b7c50ad02421afc37e62b49d2e","parallel-machines","venture",NA,"2015-11-03",NA
"6361af3b69d96e34d6589d8c1bfa4951","parallocity","venture","a","2010-11-11",NA
"6361af3b69d96e34d6589d8c1bfa4951","parallocity","venture","a","2005-07-03",NA
"6361af3b69d96e34d6589d8c1bfa4951","parallocity","venture","A","2012-01-04",NA
"0dccdd04b35e7720f7acb8f150ded57d","parametric-dining","seed",NA,"2012-11-01",220000
"0dccdd04b35e7720f7acb8f150ded57d","parametric-dining","debt_financing",NA,"2013-09-03",1e+05
"c3b5505074150d8d23d5952b87719e7f","paranta-biosciences","venture",NA,"2015-10-01",4933781.6026
"57266ea88465e42b329b4c4f6fc4e987","parasol-therapeutics","venture",NA,"2009-11-30",3200000
"57266ea88465e42b329b4c4f6fc4e987","parasol-therapeutics","venture","1","2009-05-10",3250000
"5bfa80d449b62b6648f7ff6568e1cb74","parastructure","seed",NA,"2013-03-01",2500000
"5c2bae14c7918dd7f06299021db2270f","parata-systems",NA,NA,NA,NA
"954da077ba18f99e6b02b3b5ccc457c7","paratechs",NA,NA,NA,NA
"4c6e4eda041afa37cf49e3176012296e","paratek-pharmaceuticals","venture","H","2007-10-26",4e+07
"4c6e4eda041afa37cf49e3176012296e","paratek-pharmaceuticals","debt_financing",NA,"2014-07-18",9.3e+07
"4dbb65febe487ba2f91cd235cd4da54c","parcell-laboratories","venture",NA,"2014-05-18",5e+05
"c6a3b94dca8a9708466e182d87483c80","parchment","venture",NA,"2005-04-05",NA
"c6a3b94dca8a9708466e182d87483c80","parchment","venture","1","2011-12-11",5999994
"c6a3b94dca8a9708466e182d87483c80","parchment","venture","1","2014-03-19",34999994
"c6a3b94dca8a9708466e182d87483c80","parchment","venture","1","2011-01-21",4500000
"c6a3b94dca8a9708466e182d87483c80","parchment","venture","1","2012-04-10",1550000
"c6a3b94dca8a9708466e182d87483c80","parchment","venture",NA,"2015-03-18",4500000
"6af687dd371d494573cd1cf14184f634","pardot",NA,NA,NA,NA
"d00051f77a6ff71b7bd341ab5f287e2d","parentplus","venture",NA,"2007-12-13",1e+05
"c567020d86e7b1784dae8111934eadfa","parentsconcern",NA,NA,NA,NA
"a921327ef41748283671880d2d707296","pareto-biotechnologies","undisclosed",NA,"2013-11-14",NA
"7e15f07fd980a0b64e88d16fe7e44221","parexel",NA,NA,NA,NA
"8883c882feaf0086cb04546b690afc7a","parexel-international",NA,NA,NA,NA
"2a208d4c922413fe8c653852ac3a877d","parim","seed",NA,"2014-01-10",329380
"2a208d4c922413fe8c653852ac3a877d","parim","seed",NA,"2015-02-25",154789
"c6f595b6fea2e2f151394c682c713b92","paringenix","debt_financing",NA,"2013-02-19",7e+05
"c6f595b6fea2e2f151394c682c713b92","paringenix","venture",NA,"2010-08-04",4394613
"b48cd1bf51097be4945c0bf47fbbddb7","parion-sciences","grant",NA,"2014-09-16",3e+06
"2182b7cccee7facc01c57c66125b688b","pariveda-solutions",NA,NA,NA,NA
"f2dc7cf24d270f56d00e3e20ad22f00b","parker-software",NA,NA,NA,NA
"ba4590f47f18527508140778465b4030","parkerwhite-brand-interactive",NA,NA,NA,NA
"e5387947e04b5f1cc7f0a301f6785dfd","parkinsor","undisclosed",NA,"2009-01-01",NA
"31bfbd25063dc874645fbb6b83f8d89b","parklet","seed",NA,"2015-02-09",1500000
"c720b2b49ccf027761d7ab7e68182fc1","parking-in-motion","angel",NA,"2011-09-23",897000
"c720b2b49ccf027761d7ab7e68182fc1","parking-in-motion","venture","1","2012-10-31",7400000
"2f2abdfe0298702aec8b229c3c7b6115","parle","non_equity_assistance",NA,"2015-09-01",60000
"7efa3d73c727dcb4765e554c601fda5f","parllay",NA,NA,NA,NA
"b6bf8964cbcdff041943d47341375133","parnative",NA,NA,NA,NA
"3e9fa4770678c36266a1354afd3a4e03","parsely","venture","A","2012-12-21",NA
"3e9fa4770678c36266a1354afd3a4e03","parsely","venture","A","2011-11-28",NA
"3e9fa4770678c36266a1354afd3a4e03","parsely","venture","a","2013-08-26",5232753
"3e9fa4770678c36266a1354afd3a4e03","parsely","venture","A","2010-12-01",8e+05
"3e9fa4770678c36266a1354afd3a4e03","parsely","seed",NA,"2009-05-01",20000
"3e9fa4770678c36266a1354afd3a4e03","parsely","undisclosed",NA,"2015-03-02",NA
"4bb67d6645fd9b1e7cbea1c3b830df77","parsoli-motors",NA,NA,NA,NA
"1dc1199aebc0f3dd5d3ea2ce9732be0b","parstream","venture","a","2012-08-14",5600000
"1dc1199aebc0f3dd5d3ea2ce9732be0b","parstream","venture","b","2013-10-17",8e+06
"2d184163c1132008e19bb2e7f54c76c9","particle-sciences",NA,NA,NA,NA
"44afc3497b37f3040e60525da939d460","partikula","venture",NA,"2015-02-13",550000
"65a46946b93d64e0ae49e06d431e80e5","parts","seed",NA,"2015-11-20",NA
"65a46946b93d64e0ae49e06d431e80e5","parts","seed",NA,"2015-05-08",NA
"19b0b2360cf6878a5b6729a1aeae84ee","parzival",NA,NA,NA,NA
"57713e017cb641d1fee0709ee1bcb338","pas-analytik","venture",NA,"2010-10-15",774895
"8fdc9f705fcd6478a7d77032a60009df","passkit","venture","A","2012-12-10",1200000
"8fdc9f705fcd6478a7d77032a60009df","passkit","venture","A","2014-12-01",9e+05
"2b9a88dc6ab983f410d2ff5a3d079bab","passmark-security",NA,NA,NA,NA
"2f0838a06e58dd79db80433bee2675d4","passur-aerospace","venture",NA,"2011-05-13",1e+07
"16697505088846bbde144001a413a0a0","patara-pharma","venture","A","2015-10-12",2.6e+07
"16697505088846bbde144001a413a0a0","patara-pharma","debt_financing",NA,"2014-01-01",1800000
"16697505088846bbde144001a413a0a0","patara-pharma","venture",NA,"2014-09-15",10550000
"0baf8e4d387eed08f34e5a1d4ca83b71","patentko",NA,NA,NA,NA
"61307a36e343aa213b1cfcccd1de35cd","path-1","venture",NA,"2005-01-26",2780000
"61307a36e343aa213b1cfcccd1de35cd","path-1","venture",NA,"2005-04-26",2380000
"61307a36e343aa213b1cfcccd1de35cd","path-1","venture",NA,"2005-12-06",1990000
"61307a36e343aa213b1cfcccd1de35cd","path-1","debt_financing",NA,"2006-04-26",1e+06
"61307a36e343aa213b1cfcccd1de35cd","path-1","venture",NA,"2006-08-30",4e+05
"9284712fd2d031f4b6adb8174fca5708","pathintelligence","venture","a","2007-01-01",1e+06
"9284712fd2d031f4b6adb8174fca5708","pathintelligence","private_equity",NA,"2012-04-01",NA
"eac33645e44381fd0f6322ee787dc007","path-logic","debt_financing",NA,"2010-03-26",2500000
"61e4533da45b86322a6d10ab5a228694","path4ward",NA,NA,NA,NA
"38087c944fab94bde4bcdd35f151c8bb","patheer","convertible_note",NA,"2015-06-01",NA
"56cc4deb1e8f1d89d3ecdcc500bb965f","patheon",NA,NA,NA,NA
"3e279b6539ccac23018cbc14027f6414","pathfinder-cell-therapy",NA,NA,NA,NA
"28286e5889a0e2c0acf19a4e04a2caec","pathfinder-technologies","venture","a","2008-10-16",NA
"28286e5889a0e2c0acf19a4e04a2caec","pathfinder-technologies","seed",NA,"2012-06-01",2708333
"28286e5889a0e2c0acf19a4e04a2caec","pathfinder-technologies","seed",NA,"2013-06-01",1243879
"28286e5889a0e2c0acf19a4e04a2caec","pathfinder-technologies","venture",NA,"2010-05-27",3024162
"28286e5889a0e2c0acf19a4e04a2caec","pathfinder-technologies","seed",NA,"2012-03-01",250000
"28286e5889a0e2c0acf19a4e04a2caec","pathfinder-technologies","seed",NA,"2013-03-01",2e+05
"28286e5889a0e2c0acf19a4e04a2caec","pathfinder-technologies","seed",NA,"2014-02-27",50000
"06bf0f1fe6dbadce26b8683a510fd00b","pathflow","seed",NA,"2013-08-25",140496
"06bf0f1fe6dbadce26b8683a510fd00b","pathflow","undisclosed",NA,"2013-01-01",NA
"1810aa04934add063e3db00a8e640834","pathgroup","debt_financing",NA,"2010-01-12",19500000
"9019df8bd18f54a3f8681849bae35e9e","pathogen-removal-and-diagnostic-technologies",NA,NA,NA,NA
"18c77d39ec4b109b7459993e04d39c89","pathogen-systems","venture",NA,"2012-01-12",1e+06
"18c77d39ec4b109b7459993e04d39c89","pathogen-systems","convertible_note",NA,"2013-07-13",905000
"2f7dcd330b0ed626ea8609224bd20e5c","pathogenetix","venture","b","2011-08-01",4e+06
"2f7dcd330b0ed626ea8609224bd20e5c","pathogenetix","venture","b","2011-11-01",7500000
"2f7dcd330b0ed626ea8609224bd20e5c","pathogenetix","venture","c","2013-10-30",1e+07
"2f7dcd330b0ed626ea8609224bd20e5c","pathogenetix","debt_financing",NA,"2010-01-19",1e+06
"2f7dcd330b0ed626ea8609224bd20e5c","pathogenetix","venture",NA,"2010-12-13",1510453
"849d405b2af5f1c1e5d873545160cbf0","pathology-holdings","venture",NA,"2009-10-20",24654366
"e2720e7099d6fdc8911c7bd69b42e18a","pathoquest","venture","b","2013-07-11",4960000
"b64f01ad240bff4f2d322d6af0997110","pathsensors","debt_financing",NA,"2013-04-18",168894
"b64f01ad240bff4f2d322d6af0997110","pathsensors","convertible_note",NA,"2012-09-11",1755000
"b64f01ad240bff4f2d322d6af0997110","pathsensors","seed",NA,"2014-12-30",5e+05
"b64f01ad240bff4f2d322d6af0997110","pathsensors","venture","1","2010-12-10",NA
"44a7fcdc0f7f845a6d876f25617df01d","pathsight",NA,NA,NA,NA
"6b63cf5a902357652e951acaa48d4a42","pathway-diagnostics",NA,NA,NA,NA
"2d6a636db02529bc183b462856ddf4bc","pathway-genomics","venture","E","2016-01-05",4e+07
"81f772349db842a6a96b0a1026cffbc0","pathway-pharmaceuticals","seed",NA,"2014-04-16",NA
"498c1df5ce8d53db9107f048ac2b68a1","pathway-therapeutics","debt_financing",NA,"2013-03-05",4e+05
"498c1df5ce8d53db9107f048ac2b68a1","pathway-therapeutics","venture","1","2008-06-18",9600000
"498c1df5ce8d53db9107f048ac2b68a1","pathway-therapeutics","venture","1","2009-10-09",2400000
"498c1df5ce8d53db9107f048ac2b68a1","pathway-therapeutics","venture","1","2010-08-10",4500000
"498c1df5ce8d53db9107f048ac2b68a1","pathway-therapeutics","venture","1","2011-05-25",7500000
"df8a51a4f958aed6e007684c074586c9","pathwork-diagnostics","venture","B","2008-09-05",2e+07
"df8a51a4f958aed6e007684c074586c9","pathwork-diagnostics","venture","c","2010-10-06",3e+07
"df8a51a4f958aed6e007684c074586c9","pathwork-diagnostics","venture",NA,"2006-07-06",1.1e+07
"df8a51a4f958aed6e007684c074586c9","pathwork-diagnostics","venture","a","2005-10-01",2500000
"5a5f1a90e75a51a1b1b43cb9758211d6","patient-home-monitoring","venture",NA,"2015-11-06",275875
"5a5f1a90e75a51a1b1b43cb9758211d6","patient-home-monitoring","debt_financing",NA,"2014-08-12",7500000
"5a5f1a90e75a51a1b1b43cb9758211d6","patient-home-monitoring","venture",NA,"2015-05-20",557344
"ace7e86b9afe71e00aba960a1a59cc3d","patientsville-com",NA,NA,NA,NA
"394216bd2acf7e45515df00331ff5066","patina-marketing",NA,NA,NA,NA
"d1d1a7b6388fadc89e90c46c40a33e98","patriot-technologies",NA,NA,NA,NA
"403f47fd2ecc057bcd179a64744d470b","patrys",NA,NA,NA,NA
"8e89c0c570d0c713ba643cd26455cfa9","patsnap","venture","B","2015-12-17",1e+07
"8e89c0c570d0c713ba643cd26455cfa9","patsnap","venture","A","2014-08-28",3602901.5367
"26314be43411e52ae63de4d8e24dc225","pattern-genomics","seed",NA,"2013-03-21",150000
"1bde71d05632174e146f3bfbaa716e39","pattern-insight","venture","A","2008-01-31",3e+06
"8a2ff942c78d9b3599dfd54cdac87b78","pattern-inc",NA,NA,NA,NA
"61453d51e3804286179be16ceb6446e0","patterneq-inc",NA,NA,NA,NA
"1901a598cdb97b3eda0882eae54b2634","pattypets","seed",NA,"2015-10-13",80000
"55def9889ef4a8bd2cc7d0f277016589","distributed-systems",NA,NA,NA,NA
"ebf5dada6f9f9d89083e636109c44f3e","paxata","venture","b","2013-10-28",8e+06
"ebf5dada6f9f9d89083e636109c44f3e","paxata","debt_financing",NA,"2012-11-14",1492752
"ebf5dada6f9f9d89083e636109c44f3e","paxata","venture","C","2015-09-09",1.8e+07
"85956c6700fff276f095894378ab779f","paxvax","private_equity",NA,"2015-12-08",1.05e+08
"85956c6700fff276f095894378ab779f","paxvax","venture",NA,"2009-11-09",2e+06
"85956c6700fff276f095894378ab779f","paxvax","venture","1","2013-12-04",2.2e+07
"85956c6700fff276f095894378ab779f","paxvax","debt_financing",NA,"2013-10-31",2500000
"85956c6700fff276f095894378ab779f","paxvax","debt_financing",NA,"2010-10-11",35106472
"85956c6700fff276f095894378ab779f","paxvax","debt_financing",NA,"2014-04-18",6e+06
"85956c6700fff276f095894378ab779f","paxvax","venture","1","2014-07-28",1.2e+07
"85956c6700fff276f095894378ab779f","paxvax","debt_financing",NA,"2014-07-28",5e+07
"3a2dbff85d032b21b105fd31afaab4c5","payboard",NA,NA,NA,NA
"6041f3fb5ef8eb90fa9b319787c71f6e","payment-ninja",NA,NA,NA,NA
"8ab6c3ac793af4f5675f7694a20faae5","paynet-inc",NA,NA,NA,NA
"192293650b3b2613ef4253221cb56ff6","payoda-technologies",NA,NA,NA,NA
"5852a74201179c53809389a873c2d226","paysketch",NA,NA,NA,NA
"eca1db96ad499b55165b24f4b61089ab","paytango","seed",NA,"2013-01-01",7e+05
"e5fe8d91b9c7b0ba58e3a81c5bb787bb","paytouch","angel",NA,"2013-09-01",207093
"e5fe8d91b9c7b0ba58e3a81c5bb787bb","paytouch","venture",NA,"2013-12-17",1286600
"e5fe8d91b9c7b0ba58e3a81c5bb787bb","paytouch","seed",NA,"2009-09-01",69068
"e5fe8d91b9c7b0ba58e3a81c5bb787bb","paytouch","seed",NA,"2010-12-01",34528
"e5fe8d91b9c7b0ba58e3a81c5bb787bb","paytouch","seed",NA,"2011-02-01",49721
"e5fe8d91b9c7b0ba58e3a81c5bb787bb","paytouch","debt_financing",NA,"2012-01-01",570376
"e5fe8d91b9c7b0ba58e3a81c5bb787bb","paytouch","grant",NA,"2012-01-01",80096
"e5fe8d91b9c7b0ba58e3a81c5bb787bb","paytouch","debt_financing",NA,"2013-01-01",252693
"11a14eac00b6b148c7d9f72d7e619d4e","paytunes","seed",NA,"2015-11-04",NA
"5301e41d3d9da9ada878b8477df7a536","pazien-inc","venture",NA,"2014-05-21",2999989
"911b0a8ac5a8faa0873f0d8d25154385","pb-b-ltd-",NA,NA,NA,NA
"272d23b52cd1d829bd521f3a1342db10","pbs-bio","venture",NA,"2010-01-27",338132
"fbd526df4fc6d1f133640df44a4e5e06","pbt-payment-solutions",NA,NA,NA,NA
"f4aa9fc1a51e8406adac5c791c01a611","pbxdom","seed",NA,"2015-01-01",150000
"1348bdc5ebf67295bb5ea2497470c648","pbxplus",NA,NA,NA,NA
"c948e2e32ef4cbe03de0f45f700339e0","pca-audit","seed",NA,"2012-07-01",50038
"c948e2e32ef4cbe03de0f45f700339e0","pca-audit","grant",NA,"2014-03-01",93344
"83fbb3c6b4546fd166c24ab70aa534da","pci-strategic-management-2",NA,NA,NA,NA
"d3ecf99f917f94b205daeae26117c5a5","pcovery",NA,NA,NA,NA
"25a5b387f831b7d0b1c55eb7ef7e8b51","pd-rx-pharmaceuticals",NA,NA,NA,NA
"be3028f0642975476be0114f477d1949","pdc-biotech","venture","a","2010-02-01",5500000
"baab3d2475528ff8c924da1ee4f255a2","pdg-world-marketing",NA,NA,NA,NA
"a6caf3cb9facb1753e47591ea84f93c7","pdl-biopharma",NA,NA,NA,NA
"bfc696c6a711dd1d49b7870f044233c5","peak-scientific",NA,NA,NA,NA
"cb70980483c1b10a56569ddca4cf1c74","peakemployee",NA,NA,NA,NA
"6881f122211040645f6f6110130f2a78","peaksource-vision",NA,NA,NA,NA
"7e99846d1c0981c528979ec7a6ef8a08","peakstone-corporation",NA,NA,NA,NA
"289801f0ae509cebfa231bf780fd2655","pear-analytics","angel",NA,"2009-08-15",2e+05
"d80ac1599f2763bad8b420f31f9917c7","pear-therapeutics","venture",NA,"2015-03-19",NA
"561d7df853e72782b6ce049bc1a1ae9b","pearl-therapeutics","venture","A","2007-09-07",15500000
"561d7df853e72782b6ce049bc1a1ae9b","pearl-therapeutics","venture","c","2010-10-19",6.9e+07
"561d7df853e72782b6ce049bc1a1ae9b","pearl-therapeutics","private_equity",NA,"2012-10-01",23273200
"561d7df853e72782b6ce049bc1a1ae9b","pearl-therapeutics","venture","d","2012-11-13",6.5e+07
"561d7df853e72782b6ce049bc1a1ae9b","pearl-therapeutics","venture","c","2010-03-05",1.5e+07
"561d7df853e72782b6ce049bc1a1ae9b","pearl-therapeutics","venture","a","2008-07-03",1.8e+07
"561d7df853e72782b6ce049bc1a1ae9b","pearl-therapeutics","private_equity",NA,"2013-04-01",41726900
"a609170eebfc13b9c734eddd745fc227","peaxy-inc","venture","B","2015-09-30",1.5e+07
"a609170eebfc13b9c734eddd745fc227","peaxy-inc","venture","A","2013-08-16",1.7e+07
"ee5d1fe3aae766e9235b42967ffac1c8","peckforton-pharmaceuticals","venture",NA,"2012-03-02",1587246
"37a12abb9e1a1788bd6575f512333a71","pediapharm",NA,NA,NA,NA
"5d5e7d5c055033a00357d96220e7b180","pediatric-bioscience","venture",NA,"2014-01-08",766837
"5d5e7d5c055033a00357d96220e7b180","pediatric-bioscience","debt_financing",NA,"2014-12-15",670921
"5d5e7d5c055033a00357d96220e7b180","pediatric-bioscience","debt_financing",NA,"2015-03-18",1680000
"162f451c77265f4086e67adf4a8b2b52","peekabuy-inc","seed",NA,"2013-05-01",NA
"162f451c77265f4086e67adf4a8b2b52","peekabuy-inc","venture","1","2014-01-01",NA
"936c7b6dfc3bd9d1ecf6f65486f0189d","peer60","seed",NA,"2013-11-25",750000
"80fbf51bf7cc7c26f6960e5e8eb46012","peerindex","venture","a","2009-07-01",NA
"80fbf51bf7cc7c26f6960e5e8eb46012","peerindex","venture","a","2012-03-19",3e+06
"80fbf51bf7cc7c26f6960e5e8eb46012","peerindex","equity_crowdfunding",NA,"2014-10-06",799671
"07be09cef7325394149835f3856c52b6","peeriq","venture",NA,"2014-09-19",NA
"07be09cef7325394149835f3856c52b6","peeriq","seed",NA,"2015-04-09",6e+06
"07be09cef7325394149835f3856c52b6","peeriq","seed",NA,"2015-09-14",2500000
"9323931ed435ed581f27124d812f0b20","peerpong","venture",NA,"2010-02-09",2800000
"c07f4a7b9f85c8a5c26ff480a528001b","peerreach","seed",NA,"2012-11-23",310000
"67b2f86e9c13badaca1c4cd035e07e3c","peersay",NA,NA,NA,NA
"3f1d1e87b3c277aee3f5483b80e44bb9","peervue",NA,NA,NA,NA
"2e4236317e3d1a5f4ac8b189f3ce1476","pegaspace",NA,NA,NA,NA
"9ab2e1a186bba116088e8e7e391585dd","pegasus-biologics","venture","C","2007-05-10",2e+07
"9ab2e1a186bba116088e8e7e391585dd","pegasus-biologics","debt_financing",NA,"2009-06-06",1047369
"1918484d2b441276e1e4a87ffdcf2c81","pelikan-technologies","venture",NA,"2009-01-01",2.5e+07
"1918484d2b441276e1e4a87ffdcf2c81","pelikan-technologies","venture","1","2007-12-06",6.9e+07
"3c9d74aa31b2958bbcba2be09db52726","pellepharm","venture",NA,"2014-07-21",476200
"3c9d74aa31b2958bbcba2be09db52726","pellepharm","venture",NA,"2014-10-24",1250000
"3c9d74aa31b2958bbcba2be09db52726","pellepharm","venture",NA,"2015-04-22",1750000
"3c9d74aa31b2958bbcba2be09db52726","pellepharm","venture",NA,"2015-05-11",118625
"3c9d74aa31b2958bbcba2be09db52726","pellepharm","venture",NA,"2015-07-24",4550000
"a652ed65b832af63a6671a1313f7836c","pellucid-analytics","debt_financing",NA,"2013-12-20",451156
"a652ed65b832af63a6671a1313f7836c","pellucid-analytics","debt_financing",NA,"2014-05-01",30000
"a5686f712657e4283895c5e3b3dabdfb","peloton",NA,NA,NA,NA
"09c1e064226a341c4e6b0a9e9e4a990b","peloton-therapeutics","venture","a","2011-07-27",1.8e+07
"c9eee68e66397d585175213b81126ea6","pembient","seed",NA,"2015-01-16",50000
"45a5b71b74d49a8557a016755345eab5","pendo-io","venture","A","2015-10-28",1.1e+07
"45a5b71b74d49a8557a016755345eab5","pendo-io","seed",NA,"2014-11-04",1e+06
"45a5b71b74d49a8557a016755345eab5","pendo-io","undisclosed",NA,"2014-01-01",NA
"45a5b71b74d49a8557a016755345eab5","pendo-io","convertible_note",NA,"2015-03-20",1250000
"f70d1ce8279f60a89b5e4748556615c7","penn-medicine","grant",NA,"2013-10-04",1.2e+07
"46a75996ca5884b7899f4c77558f5dc2","penny-stocks-lab",NA,NA,NA,NA
"1221d6e7d8bf1f1553e40caee90c4492","penpath","convertible_note",NA,"2014-01-01",50000
"5006ef3c2eb3326460df00cfd69ae543","penrith","venture",NA,"2011-01-11",3120192
"7846e9c258050e9a377a49bb1bf59701","penser-consulting-limited",NA,NA,NA,NA
"a86835bb3ace1bba9abf3085f8faac36","pentagon",NA,NA,NA,NA
"221f24fb8b7a36c07c84311cd99efcb3","pentaho","venture",NA,"2011-10-20",5e+06
"221f24fb8b7a36c07c84311cd99efcb3","pentaho","venture","1","2012-10-30",2.3e+07
"221f24fb8b7a36c07c84311cd99efcb3","pentaho","venture","1","2006-07-13",2.4e+07
"221f24fb8b7a36c07c84311cd99efcb3","pentaho","venture","1","2005-12-08",1.3e+07
"221f24fb8b7a36c07c84311cd99efcb3","pentaho","venture",NA,"2010-03-29",6995394
"0ab953928dbe793330aa43a58a937ed6","penumbra","seed",NA,"2012-11-02",121230
"0e784674f6535388271af6addd1bf098","penwest",NA,NA,NA,NA
"ad0153c7407638db2e7934050d46aa1d","penzata","seed",NA,"2014-04-21",5e+05
"ad0153c7407638db2e7934050d46aa1d","penzata","seed",NA,"2014-11-12",675000
"aad2af72dd0566fdf23447cf146b2e17","peonut","undisclosed",NA,"2013-08-16",89522
"9eb1a07dece2d8d797d0639a7de960f6","people",NA,NA,NA,NA
"1dff56203bea022bf913d71f6247dfe3","people-acquisition-retention",NA,NA,NA,NA
"a5a45816e0a91dc37643f511d46296f7","people-pattern","venture","a","2013-12-30",4500000
"a589b5a8805d99773dc40974a74dd598","people10-technologies-inc","private_equity",NA,"2014-10-22",1633386
"50e5764e26a49ed0e45fb7accfe6d594","peoplehq","seed",NA,"2014-10-01",2e+06
"517145074c34e8fdbcf40ab6f37c1198","peoplevine",NA,NA,NA,NA
"cf64a34a4b9483363aec797836e67adb","pep-therapy","venture",NA,"2015-04-27",1413319
"fe1a8002651afd88a526bc564231ac02","pepperprint","seed",NA,"2010-03-31",676000
"ece110eda428df00f91d47025d21b521","pepscan","venture","b","2006-09-19",8857800
"ece110eda428df00f91d47025d21b521","pepscan","venture","a","2005-07-08",5952000
"82a771709e596f040dd0bbd0f80b7eac","peptilogics","venture",NA,"2016-01-21",416761
"83d3832331652cd29cf4edb344d0fb4b","peptimmune","venture","D","2008-07-17",8900000
"83d3832331652cd29cf4edb344d0fb4b","peptimmune","venture","C","2005-06-09",18660000
"3bf6771d68a4e26b1167b61803a3a52d","peptineo","seed",NA,"2014-08-05",NA
"4777c166319e141fbc44e3f3129c3bbd","peptivir","venture",NA,"2010-11-18",3e+05
"24371aa65c20614fd7590f096ecd2698","perception-research-systems",NA,NA,NA,NA
"d7b3087c56cdeb842f6c82687540382d","perch","seed",NA,"2012-11-28",1400000
"5040533fbb39fcd7d6f711ec583ee3aa","perchbox",NA,NA,NA,NA
"f789da14de6b500fd7620a552ae35401","percivia",NA,NA,NA,NA
"4c5cca93e43f926662c2037436d30769","percollate",NA,NA,NA,NA
"441e1725ccf30ca0593ce51c537d6d15","pereira-stryker",NA,NA,NA,NA
"1b98b335372a18f248bb5f31462ece11","perez-forensic-strategies","debt_financing",NA,"2014-11-11",350000
"f06e2351a7d881144a443f4a6004f8f6","perfect-channel","venture","A","2015-12-08",1504777.6691
"f06e2351a7d881144a443f4a6004f8f6","perfect-channel","venture","A","2014-07-10",3427846
"aae9065c0e3e511d4db6b679c4d4f773","perfect-market","venture","c","2010-03-01",6e+06
"aae9065c0e3e511d4db6b679c4d4f773","perfect-market","venture","d","2011-01-18",9e+06
"aae9065c0e3e511d4db6b679c4d4f773","perfect-market","venture","a","2008-07-09",15600000
"48cf9b24bc412b1fd75ec122564405df","perfect-pitch-technology",NA,NA,NA,NA
"4167670fcb38a46c4274831a7fd04089","perfect-price","seed",NA,"2015-12-01",2049999
"e16c812433018613b7a586dc22b3293d","perfecta",NA,NA,NA,NA
"1192494b31f7ffe9becf06b21e80b85c","perfectus-biomed","seed",NA,"2013-06-19",151525
"1192494b31f7ffe9becf06b21e80b85c","perfectus-biomed","seed",NA,"2015-04-28",304913
"186f0b6c8b15e577d002167070b693a7","perfint-healthcare","venture","d","2013-01-01",1.4e+07
"186f0b6c8b15e577d002167070b693a7","perfint-healthcare","venture","c","2011-12-01",8e+06
"186f0b6c8b15e577d002167070b693a7","perfint-healthcare","venture","b","2010-07-01",7200000
"186f0b6c8b15e577d002167070b693a7","perfint-healthcare","venture","a","2007-12-01",3500000
"306b6a00c2dbabba5bf005eb92d766a2","perfocal","non_equity_assistance",NA,"2015-05-20",15568
"5e91dfc93c2cdfe5ac1f5476e3c5678f","performable","venture","a","2010-01-15",3e+06
"c57570c60f6027d4bef3e954f6aacc74","performance-genomics","private_equity",NA,"2013-09-09",240384
"fa9bc834d634c615d7aa8a3b05a3899e","performance-indicator","venture",NA,"2015-11-06",6500000
"fa9bc834d634c615d7aa8a3b05a3899e","performance-indicator","venture",NA,"2014-03-18",4735000
"b9ade74dff6bb6e31e8b0d7bf1228243","performance-plants","seed",NA,"2008-07-22",1.3e+07
"bb3ca81bfc3940c1bde6cab479214c5b","performance-sherpa","seed",NA,"2015-11-01",NA
"a866c681d70c5a9aa0405cef31041754","perfusix","seed",NA,"2013-05-22",8e+05
"50720acc3e82e67bda51bc00bd9e2b31","pergo-rides",NA,NA,NA,NA
"3ac063fb859e69d5240c187f8509fc49","perioseal-inc","equity_crowdfunding",NA,"2009-09-29",NA
"cd3006f9ee89ae4d3e3fe74564a36ad6","periphagen","venture",NA,"2014-04-01",6500000
"6e795eec612e7498aebe59002d5bd869","periscope-inc","venture","A","2015-10-22",9500000
"6e795eec612e7498aebe59002d5bd869","periscope-inc","seed",NA,"2012-12-26",NA
"6e795eec612e7498aebe59002d5bd869","periscope-inc","seed",NA,"2012-11-01",NA
"d0fcb2ae43cf4ec7a86e1443e3f07348","periscopic",NA,NA,NA,NA
"59725dacdcb4b615cbded3c78f65689e","perks",NA,NA,NA,NA
"07b31273586d0da8313227e05b607d76","perle-bioscience","product_crowdfunding",NA,"2013-09-26",2e+06
"5b5172a4502ec8f6e4ae9ef2bf288317","perlegen-sciences","venture","d","2005-02-28",7.4e+07
"e50b13db5c5b158c870286b35922c58a","perlstein-lab","seed",NA,"2015-04-10",2500000
"e50b13db5c5b158c870286b35922c58a","perlstein-lab","seed",NA,"2014-07-31",2500000
"e50b13db5c5b158c870286b35922c58a","perlstein-lab","seed",NA,"2014-10-31",2200000
"84cb9fc8c0da649df94118db2df69277","perma",NA,NA,NA,NA
"d2e342ca381dc9d4f4fade7087b79b04","permeon-biologics","venture",NA,"2011-12-30",2500000
"ef6f8e9a09c035f0fee747d0b5b05538","pernix-therapeutics-inc","post_ipo_debt",NA,"2014-02-06",6.5e+07
"ef6f8e9a09c035f0fee747d0b5b05538","pernix-therapeutics-inc","post_ipo_equity",NA,"2013-01-08",3.4e+07
"d9a07fe8977d9429509dc62abfeae416","perora","seed",NA,"2013-09-16",NA
"bd8ad0e4420dcddd0a722aadd79c084b","perosphere","venture","B","2015-10-23",2123355
"bd8ad0e4420dcddd0a722aadd79c084b","perosphere","venture",NA,"2011-12-16",1034124
"bd8ad0e4420dcddd0a722aadd79c084b","perosphere","debt_financing",NA,"2014-07-03",1500000
"0ea732c495051e85b7a587c1e947b6a9","perpetto","venture",NA,"2013-10-23",41206.7158
"0ea732c495051e85b7a587c1e947b6a9","perpetto","seed",NA,"2015-06-01",54782.9136
"829f5a173739703b78fc55a66da5828a","perpetual-biotechnologies",NA,NA,NA,NA
"3bad0c9b8c2db41c8c0549935769136a","perpetually-com",NA,NA,NA,NA
"4fe574115097b28203b44e82de50b29f","perppl",NA,NA,NA,NA
"1256041533e19d4c7314f71db33b8e5b","perrigo",NA,NA,NA,NA
"5ee84dce19d93aa040118172338983fc","persado","venture","a","2013-02-13",1.5e+07
"5ee84dce19d93aa040118172338983fc","persado","venture","B","2015-01-22",2.1e+07
"440205fb8268ce41d537c8abfda8fce5","perseid-therapeutics",NA,NA,NA,NA
"b27b6567ec53103d5cabc08e7dc3fe69","perseptive-biosystems",NA,NA,NA,NA
"cf1fbbb866651d2cd1a90339fa59544c","persistent-systems",NA,NA,NA,NA
"845ad8554b6c895668106417c408b35e","personal-genome-diagnostics-pgd","angel","A","2014-04-02",2800000
"845ad8554b6c895668106417c408b35e","personal-genome-diagnostics-pgd","seed",NA,"2010-10-01",1e+05
"845ad8554b6c895668106417c408b35e","personal-genome-diagnostics-pgd","venture","A","2015-10-28",21400000
"55b77ea5bee159a4ce567a27b7d0cd55","personal-genome-project",NA,NA,NA,NA
"0e928845a3a2207b6c7473e6a9ebbe38","personalis","venture","b","2013-10-07",2.2e+07
"0e928845a3a2207b6c7473e6a9ebbe38","personalis","venture","a","2011-08-15",2e+07
"0e928845a3a2207b6c7473e6a9ebbe38","personalis","venture","C","2015-01-13",3.3e+07
"c150f8240643c2a03703225a9f33dcea","personyze",NA,NA,NA,NA
"4e06d65b17ff325351ccfd39bdd60d75","perspica-networks","venture","A","2015-06-16",4e+06
"6eba1e4306631b13f6c38435a5290557","pertrac-financial-solutions","venture",NA,"2005-07-27",6.3e+07
"7c0d6d402670cca2a289a395c0b12e3a","pervasis-therapeutics","venture",NA,"2008-01-15",9750000
"7c0d6d402670cca2a289a395c0b12e3a","pervasis-therapeutics","venture","1","2009-08-31",17380000
"7c0d6d402670cca2a289a395c0b12e3a","pervasis-therapeutics","venture","1","2005-08-26",12400000
"c949ab7de57c23a1b57fce0fbe8a6b2b","perzonalization",NA,NA,NA,NA
"73f7de7f16e203edff8b2d81fef97f7c","pet-wireless","angel",NA,"2013-12-31",410000
"73f7de7f16e203edff8b2d81fef97f7c","pet-wireless","convertible_note",NA,"2015-06-15",350000
"7c16e6cb8a897c1737452fe73f2f8617","petasecure-inc",NA,NA,NA,NA
"39f0cba137360eb37d92ad0e121f9b47","pevesa","venture",NA,"2013-04-04",2050880
"a873531f7c19fa56711f4e5c3e87b3c9","pevion-biotech","venture","A","2007-08-13",29160000
"9afbe9d2e911415da9d2805a1b7961b4","pew-research-center",NA,NA,NA,NA
"1481d8b2d20d6bee0d578e6981ca809c","pfenex","venture","a","2009-12-09",2.4e+07
"e5ef1346b47702d64353145d9331ddd0","pfitr--llc","convertible_note",NA,"2015-07-15",50000
"e5ef1346b47702d64353145d9331ddd0","pfitr--llc","seed",NA,"2014-08-01",336000
"e5ef1346b47702d64353145d9331ddd0","pfitr--llc","seed",NA,"2014-11-30",75000
"e5ef1346b47702d64353145d9331ddd0","pfitr--llc","convertible_note",NA,"2015-01-30",150000
"e5ef1346b47702d64353145d9331ddd0","pfitr--llc","angel",NA,"2014-07-22",NA
"e5ef1346b47702d64353145d9331ddd0","pfitr--llc","seed",NA,"2013-12-31",186000
"2eadc665593ac9345088a7490b7aa47d","pfizer",NA,NA,NA,NA
"3e575c796148672e2fc78035ee580e1d","phacil",NA,NA,NA,NA
"80a8802561e2c2051fe8d92ecb13eabb","phagelux","venture","A","2015-06-09",1e+07
"824120b6bf7406213dc1bd34847363e5","phagenesis","venture","a","2010-09-01",3080440
"824120b6bf7406213dc1bd34847363e5","phagenesis","venture","b","2011-10-04",9226700
"824120b6bf7406213dc1bd34847363e5","phagenesis","venture","b","2013-05-22",1.7e+07
"b6a6e71c7c6a3a01880af8404ba02994","phalanx-biotech",NA,NA,NA,NA
"cd9fca12ad83c8d00d1a07ef9cfa52e1","pharma-two-b","venture","b","2012-10-23",8e+06
"e219f6591f5c0b58d388baa2b2697f33","pharma-ventures",NA,NA,NA,NA
"6bbd750fab382fd3e05d356003fedd5b","pharmababa-com",NA,NA,NA,NA
"7357a21b79b82dacde36283b2a7604ec","pharmabcine","venture","a","2009-09-16",6e+06
"f1881bc001f6f03018ceace066ad1c88","pharmaca","venture","D","2005-05-13",7500000
"f1881bc001f6f03018ceace066ad1c88","pharmaca","venture",NA,"2009-08-13",6555000
"f1881bc001f6f03018ceace066ad1c88","pharmaca","private_equity",NA,"2008-03-26",2e+07
"f1881bc001f6f03018ceace066ad1c88","pharmaca","venture",NA,"2009-03-09",6138778
"ad5bef8fc04bff004b3e31d2cccbf0da","pharmacadence-analytical-services",NA,NA,NA,NA
"708d0d823b7196e3f138b2a7e7d82dcb","pharmaceutic-litho---label-company","undisclosed",NA,"2014-10-16",NA
"696575d262ce91b4297f478cfa22e96c","pharmaceutical-companies",NA,NA,NA,NA
"ccbf13471f53c56e1396b128f5b22113","pharmaceutical-product-development-inc",NA,NA,NA,NA
"9e9c904de1a00ae7d83b4779012774fb","pharmacia-biotech",NA,NA,NA,NA
"ba20c016d6f3b8e2deff4e60e3cdfe5c","pharmacopeia","venture",NA,"2005-07-27",7630000
"9e8bf0c16435561f92252d1269b9350d","pharmacophotonics","debt_financing",NA,"2013-04-30",930000
"9e8bf0c16435561f92252d1269b9350d","pharmacophotonics","venture",NA,"2011-05-17",2880756
"9e8bf0c16435561f92252d1269b9350d","pharmacophotonics","venture",NA,"2013-03-08",2399233
"9e8bf0c16435561f92252d1269b9350d","pharmacophotonics","debt_financing",NA,"2015-08-13",875000
"413aeb5ae0817b496a67723b9d3f2cae","pharmacy-development","debt_financing",NA,"2009-04-07",15000
"4989448035bf82ffae86330794d742c4","pharmacyclics",NA,NA,NA,NA
"8cde8f118a56285b8c2f334ec3d50a66","pharmacyte-biotech","post_ipo_equity",NA,"2016-01-15",1e+06
"2b08823b06174d1343f9d302c9e9dc52","pharmaderm",NA,NA,NA,NA
"ceefd10abe3b60172a6bc982621fc45a","pharmadiagnostics","venture","b","2010-01-21",3700000
"5cb67640bb045ddffdadb97c64f0f7c7","pharmagen","debt_financing",NA,"2013-09-04",105500
"5cb67640bb045ddffdadb97c64f0f7c7","pharmagen","debt_financing",NA,"2013-06-28",63000
"b23242ed3b74a0ecaafbbfea43bfe51c","pharmain","venture",NA,"2014-05-16",1500000
"d22fb096e66e345bafc576f4497ee563","pharmajet","venture",NA,"2016-01-21",6010941
"d22fb096e66e345bafc576f4497ee563","pharmajet","venture",NA,"2012-08-23",2798591
"d22fb096e66e345bafc576f4497ee563","pharmajet","venture",NA,"2011-03-23",4223475
"d22fb096e66e345bafc576f4497ee563","pharmajet","debt_financing",NA,"2013-04-12",2500000
"d22fb096e66e345bafc576f4497ee563","pharmajet","venture",NA,"2013-07-02",5210601
"d22fb096e66e345bafc576f4497ee563","pharmajet","venture",NA,"2011-11-23",3354297
"d22fb096e66e345bafc576f4497ee563","pharmajet","venture",NA,"2010-03-30",9141724
"d22fb096e66e345bafc576f4497ee563","pharmajet","debt_financing",NA,"2015-06-04",3743375
"c011f6af28ae6b21339a88a4ca4a4ebe","pharmakea-therapeutics","venture","a","2013-10-07",1e+07
"6ce2cbf13ea32c6a2c5cfb1916471f78","pharmalink","venture",NA,"2012-01-04",5092768
"6ce2cbf13ea32c6a2c5cfb1916471f78","pharmalink","venture","1","2013-10-03",14429158
"2b5dbb26229b2473c7371a3f0415d116","pharmamar-zeltia-group",NA,NA,NA,NA
"8b491ec7f63968611e0735030fa5a755","pharmapod","seed",NA,"2012-02-01",NA
"c5c8046b013f7e02471736152bddc775","pharmaron-holding","private_equity",NA,"2015-12-14",2.8e+08
"c5c8046b013f7e02471736152bddc775","pharmaron-holding","venture","1","2011-02-24",4e+07
"9789947394a810680a4c1d40aec4ab31","pharmathene","secondary_market",NA,"2009-07-27",19300000
"91cb2faa327f4cc06564f4c16d63366a","pharmatrophix","venture",NA,"2010-03-15",179936
"91cb2faa327f4cc06564f4c16d63366a","pharmatrophix","venture",NA,"2013-10-25",250000
"91cb2faa327f4cc06564f4c16d63366a","pharmatrophix","grant",NA,"2008-02-11",3e+05
"91cb2faa327f4cc06564f4c16d63366a","pharmatrophix","debt_financing",NA,"2012-09-11",8e+05
"91cb2faa327f4cc06564f4c16d63366a","pharmatrophix","debt_financing",NA,"2015-11-20",10300000
"33c5be56c922aa643f8f899136388786","pharmaxis","venture",NA,"2009-06-04",1394437
"38cd107f9a45dfe9905f1967ab28c6c4","pharmedica",NA,NA,NA,NA
"b7a7f5406b93ea6fde763b0724331540","pharminex","venture",NA,"2011-04-18",4134572
"b7a7f5406b93ea6fde763b0724331540","pharminex","venture",NA,"2010-04-06",4025000
"b7a7f5406b93ea6fde763b0724331540","pharminex","venture",NA,"2013-01-24",3147857
"8f86d9dba16ba9da474a1951fc5fdfa1","pharming-group",NA,NA,NA,NA
"779dc8016ef94ce7b174abf8c70b6ae8","pharminox","undisclosed",NA,"2011-07-08",2391737
"2f00864085ddf2375d2139546b171b2a","pharmstandard",NA,NA,NA,NA
"3b1ba179bb317648ae06cb8a233f6db2","pharnext","venture",NA,"2012-02-09",10630400
"3b1ba179bb317648ae06cb8a233f6db2","pharnext","venture","1","2010-06-14",5800000
"3b1ba179bb317648ae06cb8a233f6db2","pharnext","venture","1","2011-09-08",3511000
"1b9603584958722fbeb7b70640f3adf0","phase-5-group--llc","angel",NA,"2015-09-28",1e+06
"1b9603584958722fbeb7b70640f3adf0","phase-5-group--llc","angel",NA,"2015-04-01",398800
"1b9603584958722fbeb7b70640f3adf0","phase-5-group--llc","angel",NA,"2014-05-01",1200000
"e545295260ced38ba312798341e4e6c7","phase-holographic-imaging","venture",NA,"2009-03-24",870000
"3805a3d7e4f1153ae842a849f7064725","phase2-technology",NA,NA,NA,NA
"2cbd6139b5f9ec07be5529ab2a08945d","phasebio-pharmaceuticals","debt_financing",NA,"2009-11-12",1e+06
"2cbd6139b5f9ec07be5529ab2a08945d","phasebio-pharmaceuticals","venture","1","2010-01-07",2.5e+07
"2cbd6139b5f9ec07be5529ab2a08945d","phasebio-pharmaceuticals","venture","1","2012-06-05",2.3e+07
"2cbd6139b5f9ec07be5529ab2a08945d","phasebio-pharmaceuticals","venture","1","2007-10-24",6600000
"2cbd6139b5f9ec07be5529ab2a08945d","phasebio-pharmaceuticals","venture","1","2012-06-18",48524067
"2cbd6139b5f9ec07be5529ab2a08945d","phasebio-pharmaceuticals","venture","1","2015-03-12",4e+07
"6daa5555348c456cefa1ab9995a90ae2","phaserx","debt_financing",NA,"2015-12-29",4e+06
"6daa5555348c456cefa1ab9995a90ae2","phaserx","venture","1","2008-02-28",20216583
"6daa5555348c456cefa1ab9995a90ae2","phaserx","debt_financing",NA,"2012-02-14",3600037
"6daa5555348c456cefa1ab9995a90ae2","phaserx","venture","1","2009-08-26",302654
"6daa5555348c456cefa1ab9995a90ae2","phaserx","debt_financing",NA,"2013-10-02",1400014
"6daa5555348c456cefa1ab9995a90ae2","phaserx","debt_financing",NA,"2012-12-21",1500016
"717c54c1f4e26ffdd09efaa165871c85","phemi-health-systems","seed",NA,"2014-03-24",2800000
"717c54c1f4e26ffdd09efaa165871c85","phemi-health-systems","venture","1","2015-08-11",9317624.0568
"5a9946a19368ce5d6ae992cb5b6c36a2","phenex-pharmaceuticals","venture","c","2010-09-21",7872000
"5a9946a19368ce5d6ae992cb5b6c36a2","phenex-pharmaceuticals","venture","a","2005-10-11",5049240
"58e23a1d269272bad9194ae367a04753","phenomix","venture",NA,"2010-03-10",5955935
"58e23a1d269272bad9194ae367a04753","phenomix","venture","1","2007-03-08",5.5e+07
"f1b05cf6dc69c6bdc9e46646e829bea2","phico-therapeutics","undisclosed",NA,"2011-06-11",1630571
"b8f8a019bbbd706cbc43e5fb14588538","phlexglobal","undisclosed",NA,"2011-03-31",NA
"ff611fde5c182689401be47df6036603","phloronol","venture",NA,"2010-11-27",8160000
"ff611fde5c182689401be47df6036603","phloronol","venture",NA,"2011-07-17",1e+05
"973b6431fa5a43a35d7f8b84b89123d1","phluant","venture","A","2010-06-18",1500000
"f6a94be181c2260e185595eeef6c6e29","phocabby","seed",NA,"2013-11-18",650000
"402ada96cf9b67e33696d25fe2bfe6e8","twentyfour",NA,NA,NA,NA
"4198fccd14689b9e9cd8ab3c66af746c","phoenix-biotechnology","venture",NA,"2010-12-29",3300664
"4198fccd14689b9e9cd8ab3c66af746c","phoenix-biotechnology","venture",NA,"2014-06-23",852000
"f2cfe094fbc0d14a1e4167a94c76a810","phoenix-marketing-international",NA,NA,NA,NA
"5fd158ea10543fe8b9147f2de992fec4","phonexia",NA,NA,NA,NA
"42d12b45c6b82167fdd71ea41f33e024","phoremost","seed",NA,"2015-03-11",3800000
"c2cd70ec2449456ec7b8ff7be6445d86","phosimmune","venture",NA,"2014-08-12",NA
"28ebe4997527cb21875de24da5e7438c","phosphate-therapeutics","venture",NA,"2012-03-05",13881000
"8e834358b57ca4acb509cebce9741abf","photetica","venture",NA,"2012-07-18",25000
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture",NA,"2016-01-27",1723848
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","undisclosed",NA,"2009-02-16",NA
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture","1","2006-05-01",10500000
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture","1","2005-03-01",3e+06
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture","1","2008-05-25",1e+07
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture","1","2006-11-10",4500000
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture","1","2008-02-17",NA
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture","1","2009-12-22",NA
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture","1","2013-02-28",NA
"f53cb4de236e0b1bdee87104a8b018f9","photobucket","venture",NA,"2014-08-14",3186432
"0923ab6f30b74f9c7e55e684f7d56e20","photomerchant",NA,NA,NA,NA
"34a0b635e6e629b502d8d71deae19ccd","photonbunk",NA,NA,NA,NA
"40ff37550e4bbe33d2a8bc8c81b859df","photonics-healthcare","undisclosed",NA,"2013-10-21",NA
"b972299ab9e7266820226c7930a2d9ca","photothera","venture","c","2006-04-21",30500000
"b972299ab9e7266820226c7930a2d9ca","photothera","venture","d","2009-05-22",5e+07
"63ca8b181a3449bb7d8f294ba65d3780","photoweaver",NA,NA,NA,NA
"48593467e183a4e1772bd8c074666e74","phrixus-pharmaceuticals","debt_financing",NA,"2013-10-09",1e+05
"48593467e183a4e1772bd8c074666e74","phrixus-pharmaceuticals","venture",NA,"2007-07-17",NA
"95b9f762d063d959ef577d60fd63608a","phthisis-diagnostics","venture",NA,"2012-05-01",285000
"95b9f762d063d959ef577d60fd63608a","phthisis-diagnostics","venture","1","2012-06-29",450000
"95b9f762d063d959ef577d60fd63608a","phthisis-diagnostics","venture","1","2011-04-21",435000
"59ea7cd3561769a9e8ae52b0156ef0d9","phylagen",NA,NA,NA,NA
"9960bf7ecd94b68d9ce435c869918a1c","physicians-endoscopy","undisclosed",NA,"2013-09-03",NA
"9960bf7ecd94b68d9ce435c869918a1c","physicians-endoscopy","venture",NA,"2010-04-30",1250000
"10eda05547e5f29cb5ae5e57e9804221","physicians-immediate-care","seed",NA,"2013-04-29",350000
"10eda05547e5f29cb5ae5e57e9804221","physicians-immediate-care","venture",NA,"2012-07-26",NA
"ad353032c91e36e7b5bdb616f0f3a14c","physicians-laboratories","venture",NA,"2014-04-01",135000
"0c4825dc717479412c9a27c09d0d697b","phytech","venture","A","2015-12-28",NA
"0c4825dc717479412c9a27c09d0d697b","phytech","venture",NA,"2012-03-31",2e+06
"0c4825dc717479412c9a27c09d0d697b","phytech","venture",NA,"2014-04-30",1e+06
"88d1a4b8fbeec567128ab9c1e9bcd5a5","phytelligence",NA,NA,NA,NA
"a5d795d70734044f5f9253e87e5eab82","phytoceutica","venture",NA,"2010-12-01",2e+06
"f967ae147015f0ecc18b6cb4d87a8417","phytoceuticals",NA,NA,NA,NA
"dde3f16ed233577e46842ff3039ecddd","phytomedics","venture","B","2007-06-11",9e+06
"0f5190c33fbbc5f9e540336f20dbf79e","phytonix-corporation",NA,NA,NA,NA
"277470827873194f558e6fbc0fae8aac","phyture-biotech","venture",NA,"2015-01-19",1156416
"004a54002048bd3243874b7d3db21dde","pialgo-technologies","seed",NA,"2013-02-20",35000
"a62c0e393d3ff99f92f461da7138db4f","pica9--inc-",NA,NA,NA,NA
"730cb75cf6650c81bae496741fa203b6","picalike-gmbh",NA,NA,NA,NA
"27a31decefbb0d58699bb2f3e65e1dea","picchio-pharma",NA,NA,NA,NA
"4a6140fea46a02f4bfd7cff9315e3ccd","picfair","seed",NA,"2014-06-08",520000
"69c0dc7423073f563b85429e951f307f","picjew-photos",NA,NA,NA,NA
"423800de769c106c64155d149a3c13e0","pickntell",NA,NA,NA,NA
"1709e02253e9724d2cf83830506a6712","pico-3",NA,NA,NA,NA
"25a2a6a15022a9fcecca3338a13a9785","picooc-technology","venture","B","2014-02-14",2.1e+07
"25a2a6a15022a9fcecca3338a13a9785","picooc-technology","venture","A","2014-01-01",4e+06
"25a2a6a15022a9fcecca3338a13a9785","picooc-technology","venture",NA,"2012-09-01",NA
"86c4ad81f52a4007bbad9319801b9201","picscout",NA,NA,NA,NA
"f2be604acb4c68f3fc2283803af456f3","picsorlinks",NA,NA,NA,NA
"59dc61ad89dd79a8f75579c469d7c902","pict","seed",NA,"2012-03-01",NA
"59dc61ad89dd79a8f75579c469d7c902","pict","seed",NA,"2013-04-26",1400000
"b0f366ff5b6ae06c7de9fe54575743d9","pictacular",NA,NA,NA,NA
"771fbe66078004833f1f6d46cd3fdd58","picus-security","angel",NA,"2013-04-30",2e+05
"3199f42454232730e0d6558f5a6497a6","piedmont-bioproducts","undisclosed",NA,"2007-04-18",NA
"0aee272015fb1be8e066ff8772513b7f","piedmont-pharmaceuticals","venture","B","2007-11-12",8500000
"0aee272015fb1be8e066ff8772513b7f","piedmont-pharmaceuticals","venture",NA,"2009-04-09",5e+06
"0c6e7ee4328a722155f2fa890428f650","pier-systems",NA,NA,NA,NA
"ef2b9f868ce9ed85561b3b57b760c176","pieriandx","venture","A","2016-01-07",9250000
"32207ba10cf1e1855b5fe448dc492386","pieris-proteolab","venture","b","2006-11-01",6390000
"32207ba10cf1e1855b5fe448dc492386","pieris-proteolab","venture","B","2008-03-27",39300760.8627
"32207ba10cf1e1855b5fe448dc492386","pieris-proteolab","undisclosed",NA,"2014-11-26",8232745
"32207ba10cf1e1855b5fe448dc492386","pieris-proteolab","post_ipo_equity",NA,"2014-12-18",12200000
"5dc0efb6fe20d9dbbee489f179366a3f","pierre-fabre",NA,NA,NA,NA
"2082fb2ac1800999f68e913c6040407b","pierry-software","venture",NA,"2016-01-21",1e+06
"2082fb2ac1800999f68e913c6040407b","pierry-software","seed",NA,"2016-01-07",NA
"d429d1167478bbfe3303852f82a282f4","piesync","venture",NA,"2016-01-21",1600000
"12d7981097d8ef381b9704b127dc93b3","piiixl",NA,NA,NA,NA
"a6a814137fabba2c7e25e539dc20a943","pijajo-com","seed",NA,"2012-08-01",NA
"265d0b52ff31a029d11a66d9be01c428","pili","venture",NA,"2015-04-30",NA
"613f1dc24c9c0369543d9e5b61a487e9","pillar-technologies",NA,NA,NA,NA
"10ec186c2f86bcbdcab43108e54dd088","pilot-ai-labs","seed",NA,"2015-11-12",NA
"e70765949489d537604696b84960c438","pilot44",NA,NA,NA,NA
"e550be9e649e4761a50949165d126868","groupflix","seed",NA,"2015-12-27",125000
"c4ccc2c591aa89fc85e466a7bdab9535","pilus-energy",NA,NA,NA,NA
"ee8c65de884aa9baaa4f265c7d68ad9e","pimovation-pty-ltd","seed",NA,"2014-06-10",NA
"ee8c65de884aa9baaa4f265c7d68ad9e","pimovation-pty-ltd","seed",NA,"2014-06-01",46549
"d3a2b15fc82892cdbbab5e8423173ddd","pin-your-client","seed",NA,"2014-07-19",9786
"64f36594bc28450e4d7b4e94304e8072","pinalyzer",NA,NA,NA,NA
"a95515a46050804ed42ce454d95f5cac","pincaption",NA,NA,NA,NA
"5e4893e08b7399191cec8f105a6542c5","pinch-media","venture",NA,"2010-01-06",560001
"5e4893e08b7399191cec8f105a6542c5","pinch-media","seed",NA,"2008-05-01",NA
"5e4893e08b7399191cec8f105a6542c5","pinch-media","seed",NA,"2009-06-01",NA
"54b33314738ec95a172377e1401aae12","pinclout",NA,NA,NA,NA
"c8499925287cff4c296ed2c4726de808","pindrop-security","venture","C","2016-01-28",7.5e+07
"c8499925287cff4c296ed2c4726de808","pindrop-security","seed",NA,"2012-05-01",1e+06
"c8499925287cff4c296ed2c4726de808","pindrop-security","venture","a","2013-06-19",1.1e+07
"c8499925287cff4c296ed2c4726de808","pindrop-security","venture","B","2015-02-18",3.5e+07
"ad1dfae649d74ea6b7bcc200e8cb7061","pine-biotech",NA,NA,NA,NA
"802e3f874ed68ebf5709dcd7d8552e5c","pinfishing-com",NA,NA,NA,NA
"99c911048592049f628560897a58b05c","pingkast",NA,NA,NA,NA
"c71b9459e25b551cff30d7905c3ccebd","pingthings","seed",NA,"2014-04-21",775000
"c71b9459e25b551cff30d7905c3ccebd","pingthings","seed",NA,"2015-01-15",2e+06
"c71b9459e25b551cff30d7905c3ccebd","pingthings","venture",NA,"2015-04-23",1e+06
"2e680bbb6210b1004b416eb9f7d714e6","pinkelstar","venture",NA,"2010-09-15",5e+05
"fc6d59c39a3895155fc3f2497bf02aa3","pinnacle-biologics","venture",NA,"2011-12-30",1500000
"8a21a0a2375d75964e3bc1d1eb790a80","pinnacle-pharmaceuticals","venture",NA,"2011-07-27",8015002
"605b4410afe089603afe28322c3bd990","pinnacle-spine","venture",NA,"2011-11-14",250000
"019a2a66447904f81d2bd59f4778307f","pinota",NA,NA,NA,NA
"f54c125158e697285ce84ec1bcb8b0fc","pinpoint-systems-corporation",NA,NA,NA,NA
"c1e6c9ec3fff7c34a86230f380549ca8","pinreach",NA,NA,NA,NA
"c64444c8c2a74ec6bb5e516651ab9b38","pinscriptive-inc","seed",NA,"2015-02-24",615000
"4e13151078d611af0d42e6a998659888","pinster",NA,NA,NA,NA
"9e2afadec1721a79b79a0eed5d673258","pinta-biotherapeutics","venture",NA,"2013-12-10",2503048
"9e2afadec1721a79b79a0eed5d673258","pinta-biotherapeutics","venture",NA,"2013-04-01",4294000
"9e2afadec1721a79b79a0eed5d673258","pinta-biotherapeutics","venture",NA,"2013-03-31",1005000
"9e2afadec1721a79b79a0eed5d673258","pinta-biotherapeutics","venture",NA,"2014-01-13",6311156
"9e2afadec1721a79b79a0eed5d673258","pinta-biotherapeutics","venture",NA,"2013-12-10",17998555
"7ecf5960cb52ce224d3b7b752d92a28b","pioneer-hi-bred",NA,NA,NA,NA
"3121133123b6592e826dcc13bdab297a","pipeline-biomedical-holdings","private_equity",NA,"2012-11-14",3200000
"3121133123b6592e826dcc13bdab297a","pipeline-biomedical-holdings","venture",NA,"2013-03-02",8e+06
"42b886d428e0d267a86552936ed727c7","pipelinedb","seed",NA,"2014-05-31",NA
"38e37c3836958f83b989de73483f0c02","pipelinerx","venture",NA,"2014-03-17",5e+06
"38e37c3836958f83b989de73483f0c02","pipelinerx","venture",NA,"2010-06-25",515000
"38e37c3836958f83b989de73483f0c02","pipelinerx","venture",NA,"2015-07-07",9100000
"a4ae36fe15286961c407787136bc6096","zapstitch","seed",NA,"2014-05-01",1e+05
"a4ae36fe15286961c407787136bc6096","zapstitch","seed",NA,"2015-05-12",2e+06
"5eaa941e134e12d04ad2cc76e697f276","pipeslab",NA,NA,NA,NA
"072c52f379d5fa6a836daee3de734197","pipewave-inc",NA,NA,NA,NA
"109c54e1c498cb50cd34b35d54a2b777","pipl",NA,NA,NA,NA
"8c0a39c0b285eaa089b38e9bd3aa1da0","piqora","seed",NA,"2012-07-31",1400000
"8c0a39c0b285eaa089b38e9bd3aa1da0","piqora","seed",NA,"2013-04-01",2100000
"8c0a39c0b285eaa089b38e9bd3aa1da0","piqora","venture","1","2014-04-23",7700000
"03ec792eeecc7fd649125cde973f930a","pique-therapeutics","venture",NA,"2009-06-04",535500
"d9c188d39b10082e514a7e91aa3d4b76","piqur-therapeutics","venture","a","2014-04-08",3.6e+07
"d9c188d39b10082e514a7e91aa3d4b76","piqur-therapeutics","venture","A","2015-07-16",1.9e+07
"c85ca813157fe305d8902d323929e485","piramal-healthcare",NA,NA,NA,NA
"d1159db0ac92ba0e2bc6c594dacd68d0","pirate-index",NA,NA,NA,NA
"36c8c5fe3f5c16b6fffbe1148bcd0b1d","pirate-metrics",NA,NA,NA,NA
"52da4021fcd4e9169ac05f10a2edd1da","pirendo",NA,NA,NA,NA
"4945007122ed170eb470cef1c93aa463","pitchbook-data","venture","B","2016-01-27",1e+07
"4945007122ed170eb470cef1c93aa463","pitchbook-data","venture","a","2009-09-25",3800000
"d7cdef3e05a166778540e76c0e344d36","pitchero",NA,NA,NA,NA
"682a6bc9eb6df955d1cb132238f973b7","pitchswag-ltd",NA,NA,NA,NA
"c288e8cb8422d5ca13c7cef98822fea8","pitstop","seed",NA,"2015-06-09",120000
"81e1d450cbd4b782992783274aaa29cb","pittsburgh-data-scraping",NA,NA,NA,NA
"51a8fdc5abbd52defb21c2ba4e32230b","pivot-bio","venture","A","2016-01-22",8121509
"4cdeeb3b58b8cbf8c4188b048460f396","pivotal-analytics",NA,NA,NA,NA
"432528daa02b7144266354a8f1e629fa","pivotal-chicago",NA,NA,NA,NA
"359d5dab8cbb3ae266398cf8fd07f240","pivotal-research",NA,NA,NA,NA
"2f58b12d645f99db374dfc5972d34a9c","pivotal","private_equity",NA,"2013-04-24",1.05e+08
"881ce034779b1762b7f2fce223a4d24e","pivotal-therapeutics","post_ipo_debt",NA,"2014-03-04",7498349
"3e0070a9ec9f64d151abf56ac65d4b72","pivotlink-formerly-seatab","venture","B","2007-10-10",9e+06
"3e0070a9ec9f64d151abf56ac65d4b72","pivotlink-formerly-seatab","venture","a","2007-02-15",3500000
"3e0070a9ec9f64d151abf56ac65d4b72","pivotlink-formerly-seatab","venture",NA,"2011-07-22",8085068
"3e0070a9ec9f64d151abf56ac65d4b72","pivotlink-formerly-seatab","debt_financing",NA,"2013-03-01",2e+06
"3e0070a9ec9f64d151abf56ac65d4b72","pivotlink-formerly-seatab","venture","c","2009-02-10",1e+07
"3e0070a9ec9f64d151abf56ac65d4b72","pivotlink-formerly-seatab","venture",NA,"2012-01-17",1.3e+07
"1b26db0072f08d8e4d6447a48c3259f6","pivotstream","seed",NA,"2013-06-24",279706
"3ea01a358a940198946bb6a409ab8aa1","piwik",NA,NA,NA,NA
"ad27f3d7b1cc7af18deaa13875d26c8d","piwik-pro",NA,NA,NA,NA
"358ee7095af24c881e3ebb3d908693b3","pix4d","seed",NA,"2012-07-18",2400000
"18137cb3fa83724d02388ba39c69d6d6","pixalate","venture","a","2013-12-10",4600000
"18137cb3fa83724d02388ba39c69d6d6","pixalate","seed",NA,"2013-01-23",150000
"4232e04ad2cfb7203082ba8f169efa5f","pixbi",NA,NA,NA,NA
"b3164d5744fa4117544bc703a45ce731","pixbuf","seed",NA,"2015-12-21",60000
"53c1b1f4d5e5afa29db67665e1abc383","pixel-forensics",NA,NA,NA,NA
"dcc03f19ebd495821ac9ae6350d49cef","pixelnetica",NA,NA,NA,NA
"1ae3c5de5cc3d751e93187292fb01139","pixlcloud",NA,NA,NA,NA
"1bae85c7960f28f1f511eb5b199d68a8","pixoneye","seed",NA,"2015-02-15",77014
"1bae85c7960f28f1f511eb5b199d68a8","pixoneye","seed",NA,"2015-05-15",43739
"dd36bc0b15725b22e4cba09a43215326","pixsy-image-search",NA,NA,NA,NA
"f5d8ea8512606bd40549817432537c58","pixtago",NA,NA,NA,NA
"0b33079269f4489adad9277611e9cd12","pkj-ventures",NA,NA,NA,NA
"a59836c67431431c561382247daa21b9","place-i-live","seed",NA,"2013-01-01",264094
"a59836c67431431c561382247daa21b9","place-i-live","seed",NA,"2012-01-01",14242
"49576903770e8071489157c1eb04d440","placeknow",NA,NA,NA,NA
"6f7d3b847b7ca0e892c802c0ae857e6e","placemeter","seed",NA,"2013-11-01",1700000
"6f7d3b847b7ca0e892c802c0ae857e6e","placemeter","angel",NA,"2013-04-02",18000
"6f7d3b847b7ca0e892c802c0ae857e6e","placemeter","angel",NA,"2012-07-01",125000
"6f7d3b847b7ca0e892c802c0ae857e6e","placemeter","venture","1","2014-09-18",6e+06
"65379174086a49579ae46940b71bfc51","placester","venture","C","2015-11-24",2.7e+07
"65379174086a49579ae46940b71bfc51","placester","seed",NA,"2013-04-29",2500000
"65379174086a49579ae46940b71bfc51","placester","debt_financing",NA,"2009-07-07",1e+05
"65379174086a49579ae46940b71bfc51","placester","venture",NA,"2011-08-30",826212
"65379174086a49579ae46940b71bfc51","placester","venture","A","2014-04-22",5500000
"65379174086a49579ae46940b71bfc51","placester","venture","B","2015-04-07",1.5e+07
"f1a9be4deea3e972bc51505bd1fddeab","plain-text-offenders",NA,NA,NA,NA
"3cb672caa1f63c9b8981f9169f6ca306","plan-to-start-2",NA,NA,NA,NA
"aa48e161fd1e65d7bdcc35bfb7c3f266","plan2profit-agri",NA,NA,NA,NA
"c16ee985e8304c4deff234be76ca8174","plandai-biotechnology","post_ipo_equity",NA,"2014-02-10",15300000
"c6a3b4203098019642c881f287cb3894","planday","venture",NA,"2014-05-06",3750000
"a0fa30ca70a56e5b5fd3c01b88b9af09","plandex",NA,NA,NA,NA
"c48c8aec235d0454054f1abe1b950fa5","planet-biotechnology","debt_financing",NA,"2009-02-03",350000
"c48c8aec235d0454054f1abe1b950fa5","planet-biotechnology","debt_financing",NA,"2010-12-29",411000
"ceac61ee75e366da10c2b47b918c187a","marinexplore","seed",NA,"2012-10-17",NA
"463fe831ad294b269d2ca028608f0bda","planet3","venture","A","2015-09-09",1e+07
"486de828faed961cde70f21a0159be02","plantiga","seed",NA,"2012-02-12",250000
"eea7f543638805b9e9abb7e14757265a","plantresponse-biotech","venture","A","2015-11-26",6055037.1004
"5a6695d41dbe4df449f9518c821400f2","plasma-computing-group",NA,NA,NA,NA
"de88ed76861f9f1fc23fa0544318a174","plasmonix","venture","a","2013-11-13",231069
"de88ed76861f9f1fc23fa0544318a174","plasmonix","debt_financing",NA,"2012-06-07",298264
"de88ed76861f9f1fc23fa0544318a174","plasmonix","venture",NA,"2011-06-21",1217417
"de88ed76861f9f1fc23fa0544318a174","plasmonix","venture",NA,"2013-07-03",3e+05
"de88ed76861f9f1fc23fa0544318a174","plasmonix","venture",NA,"2015-07-07",543857
"82e9a0832d158dd1c51f25fe13860a3a","plastic-duniya",NA,NA,NA,NA
"e052c14f6e316864848ea5ecdd94d999","plasticell","venture",NA,"2011-01-31",5566500
"e052c14f6e316864848ea5ecdd94d999","plasticell","venture",NA,"2007-11-23",1418703
"8a4b7c8492b79fcfb80afc031e951485","plasticity-labs","seed",NA,"2016-01-15",174270.6772
"8a4b7c8492b79fcfb80afc031e951485","plasticity-labs","seed",NA,"2013-03-01",1e+05
"8a4b7c8492b79fcfb80afc031e951485","plasticity-labs","seed",NA,"2014-01-27",5e+05
"8a4b7c8492b79fcfb80afc031e951485","plasticity-labs","angel","1","2014-08-28",687837.8048
"8a4b7c8492b79fcfb80afc031e951485","plasticity-labs","seed",NA,"2013-11-30",150000
"46f85563b5457dc23497d10036a2c61a","plate-iq","seed",NA,"2015-08-08",5e+05
"9535e84cfa06ef64842c5de90d08330e","platesmart",NA,NA,NA,NA
"1b47edbc234104392a940d7323aa394d","platfora","venture","C","2015-12-08",3e+07
"1b47edbc234104392a940d7323aa394d","platfora","venture","b","2012-11-13",2e+07
"1b47edbc234104392a940d7323aa394d","platfora","venture","a","2011-09-08",7200000
"1b47edbc234104392a940d7323aa394d","platfora","venture","c","2014-03-19",3.8e+07
"23def9c37b25b032520c25d3988ecfc4","platformz-llc","seed",NA,"2015-03-15",NA
"5c3ba5cda63b64f1884c2b9ab3dc8725","platypus-tv","seed",NA,"2014-05-01",25000
"4d8e7afcdab43772a5470cc6180335ff","plaxd","seed",NA,"2012-05-01",1e+05
"f9c6c364d8e7c0fe29aa30a543119dc6","playax",NA,NA,NA,NA
"fedd8da841d69e234ccec32bfbd5720e","playermate","seed",NA,"2015-03-09",NA
"a41e20433a814466f412324e5cf0854a","playfuldroid",NA,NA,NA,NA
"61be791bfc077c84864d55073056d4dc","playir",NA,NA,NA,NA
"5d1094e1dcfdf158cee5c4f7e06b693d","playmob","angel",NA,"2011-07-01",20861
"5d1094e1dcfdf158cee5c4f7e06b693d","playmob","angel",NA,"2011-04-01",200524
"5d1094e1dcfdf158cee5c4f7e06b693d","playmob","venture",NA,"2012-03-08",788162
"5d1094e1dcfdf158cee5c4f7e06b693d","playmob","undisclosed",NA,"2013-09-09",1173862
"5d1094e1dcfdf158cee5c4f7e06b693d","playmob","venture",NA,"2014-04-01",NA
"0c5030a8b922d26199905b77a9c12299","playpass-ltd","angel",NA,"2013-10-17",339300
"0c5030a8b922d26199905b77a9c12299","playpass-ltd","angel",NA,"2014-07-01",820359
"0c5030a8b922d26199905b77a9c12299","playpass-ltd","seed",NA,"2012-12-06",1e+05
"0c5030a8b922d26199905b77a9c12299","playpass-ltd","seed",NA,"2015-02-28",1200000
"38890a3fbd04bc24acb103e6e4da9ed2","playthe-net","venture","A","2014-05-12",2201279
"38890a3fbd04bc24acb103e6e4da9ed2","playthe-net","seed",NA,"2014-05-16",4500000
"36e5de9968c04dfa83d9cb4b7abcda26","swfstats",NA,NA,NA,NA
"7627a9d5bffb43b6b9cff59a9c3e5ad6","plc-diagnostics","venture",NA,"2011-04-11",128691
"7627a9d5bffb43b6b9cff59a9c3e5ad6","plc-diagnostics","debt_financing",NA,"2009-12-07",55000
"22ee00e0de0106f04559c1ea0e4a64ba","plectix-biosystems","venture",NA,"2008-02-15",6916666
"3895a0eb888d74133de0dfd975c90dcc","pledger","convertible_note",NA,"2015-09-01",1e+05
"3895a0eb888d74133de0dfd975c90dcc","pledger","seed",NA,"2014-05-01",2e+05
"3d89e32a321cb7984fcc18caed634de4","plehn-analytics","venture",NA,"2012-01-19",150000
"053465f5f56084ce8696f4efcbc090f2","plexpress","seed",NA,"2009-05-18",2500000
"61d94327b0f2a5ae36ea1da8aa3b5302","plom-io",NA,NA,NA,NA
"fc4f5491b5103cdc06552673ba05f91b","plored","seed",NA,"2013-10-22",80000
"fc4f5491b5103cdc06552673ba05f91b","plored","non_equity_assistance",NA,"2015-01-01",25000
"c32b6e4eb00ab5c73a23cb69f278d15b","plotly","seed",NA,"2013-08-26",1428571
"c32b6e4eb00ab5c73a23cb69f278d15b","plotly","venture","1","2015-06-03",5500000
"b99251e77b6e6147672eef3b34c067fe","plotonic",NA,NA,NA,NA
"0a54e8b2d667dfd3f9701e93befa1846","plotwatt","venture",NA,"2010-12-09",714998
"0a54e8b2d667dfd3f9701e93befa1846","plotwatt","venture","1","2012-07-02",3e+06
"0a54e8b2d667dfd3f9701e93befa1846","plotwatt","seed",NA,"2011-06-23",1e+06
"708875ed2af8fb31c6c36d7e2ee4ad95","plugbuy","seed",NA,"2014-09-24",104364.234
"ed6638de0bfe942ac0c42fe00bc770d5","pluggio",NA,NA,NA,NA
"c4bac88ee8ae996d8556ccf6bd505731","plum-voice",NA,NA,NA,NA
"a3a694e02b2a5f8b6718369bde9568d0","plurilock-security-solutions","grant",NA,"2013-11-13",253000
"d0159679eee327d1f067eff6a6614c9f","pluriomics","venture","A","2014-10-24",5059192
"9121408cc5f167a6ae22212307b6f48b","pluriselect","venture",NA,"2009-03-16",780000
"527cf7d5e52688d47cc47ed1ee6c42b9","pluristem-therapeutics","venture",NA,"2010-05-13",250000
"527cf7d5e52688d47cc47ed1ee6c42b9","pluristem-therapeutics","venture",NA,"2010-10-13",1220003
"527cf7d5e52688d47cc47ed1ee6c42b9","pluristem-therapeutics","grant",NA,"2015-06-17",2900000
"527cf7d5e52688d47cc47ed1ee6c42b9","pluristem-therapeutics","post_ipo_equity",NA,"2015-06-28",1.7e+07
"b069d963b5f78ebe3f2981608a5278e1","plusclouds",NA,NA,NA,NA
"40a4cc980a1fdcb25d0ce9ed43b3d6bc","pluss-polymers","venture",NA,"2013-07-08",2400000
"84666de430d47ce683de9f0aa0da8216","plx-pharma","venture",NA,"2009-01-06",3106961
"84666de430d47ce683de9f0aa0da8216","plx-pharma","venture",NA,"2013-07-08",9e+06
"84666de430d47ce683de9f0aa0da8216","plx-pharma","venture",NA,"2011-10-05",2893965
"84666de430d47ce683de9f0aa0da8216","plx-pharma","venture",NA,"2010-08-09",2000020
"84666de430d47ce683de9f0aa0da8216","plx-pharma","venture",NA,"2013-03-19",8273297
"078e2403f8352b7bb070286164bf952c","plytix","seed",NA,"2015-01-01",18192
"078e2403f8352b7bb070286164bf952c","plytix","seed",NA,"2015-09-10",560538
"ee322308eec35b9c140ffb9caf901ed5","pm-digital",NA,NA,NA,NA
"bb84343e54c3d2bdf26b352ff3c0823e","pmd-solutions","seed",NA,"2013-09-01",1e+05
"e3ed4e4ab84a34697463b1f32c7d9d5d","pmedianetwork","seed",NA,"2012-06-01",NA
"4923a5f151a1f1e4a5ee28d41b1b4d18","pml-microbiologicals",NA,NA,NA,NA
"c5cd003a6e008ef9b6f0e86b1b71d159","pna-innovations","venture",NA,"2015-05-06",1200000
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","undisclosed",NA,"2011-08-02",3250745
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","seed",NA,"2009-02-01",NA
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","undisclosed",NA,"2009-08-01",NA
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","angel",NA,"2009-09-01",NA
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","grant",NA,"2009-06-01",78635
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","grant",NA,"2009-02-01",71370
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","grant",NA,"2010-03-01",372918
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","angel",NA,"2010-08-01",156042
"91dc98c7db477d9a566ff054abe17e2f","pneumacare","venture",NA,"2013-10-30",1515251
"2dd62539543cd261ff2235ffb3e21923","pneumoflex-systems","debt_financing",NA,"2010-06-30",930000
"e8fb8e59cecabe2f0680361fc1c4bab0","pnp-therapeutics","venture",NA,"2013-09-25",212000
"e8fb8e59cecabe2f0680361fc1c4bab0","pnp-therapeutics","venture","1","2007-06-07",925000
"e8fb8e59cecabe2f0680361fc1c4bab0","pnp-therapeutics","venture","1","2012-06-27",673000
"e8fb8e59cecabe2f0680361fc1c4bab0","pnp-therapeutics","venture",NA,"2014-10-01",394000
"7a2937d591f601b57f0521d4fc197b87","pocketwhale",NA,NA,NA,NA
"8cded10bbd3be6f33dcf72367e5fb604","podimetrics","venture",NA,"2016-01-19",3789933
"8cded10bbd3be6f33dcf72367e5fb604","podimetrics","seed",NA,"2013-03-27",2500000
"8cded10bbd3be6f33dcf72367e5fb604","podimetrics","debt_financing",NA,"2014-10-28",1200000
"b4e95773963af4349719e948d900e5fa","podium-digital",NA,NA,NA,NA
"88b66fd91be308f107bc5b3fc6d78390","point-biomedical","venture","G","2007-07-09",4300000
"88b66fd91be308f107bc5b3fc6d78390","point-biomedical","venture","e","2008-01-01",2.5e+07
"51feb56d30d715abd840720b71669565","point-carbon",NA,NA,NA,NA
"90f15c999a3dd85c1867d0c39d40b094","point-inside","debt_financing",NA,"2011-08-16",805000
"90f15c999a3dd85c1867d0c39d40b094","point-inside","convertible_note",NA,"2010-10-20",575000
"90f15c999a3dd85c1867d0c39d40b094","point-inside","venture",NA,"2012-08-02",3200000
"90f15c999a3dd85c1867d0c39d40b094","point-inside","venture",NA,"2009-10-23",7e+05
"6e019ba378fa5b5f6eee5bb67470075c","pointcare","venture",NA,"2008-04-24",NA
"6e019ba378fa5b5f6eee5bb67470075c","pointcare","venture",NA,"2010-09-23",1765594
"bbf648e6b26b7b04e11abeb4df706a01","pointcare-genomics","grant",NA,"2015-10-30",3e+05
"f683f302b3af7c3a350275fe6a30efed","pointcross-life-sciences",NA,NA,NA,NA
"bc8c5455a973bc1d8199f31267e1d7aa","pointillist",NA,NA,NA,NA
"2acd17a5dc31a0215f95d42ff46c16fc","points-planet",NA,NA,NA,NA
"41eae28e021443f60d69918e49d8fd0d","pointslocal",NA,NA,NA,NA
"a7ee45254f92a70724404a676e6c74b2","poke-new-york",NA,NA,NA,NA
"6db1e334c71dd6d4e6ea4281d3bc1186","polarrose","venture","A","2006-11-15",5100000
"d82ce3d6e891fa4fee9d4b72f4a8e7a7","polaris-biopharma-consulting",NA,NA,NA,NA
"8490dcfa58959ce06084e0093b45a47d","polaris-health-directions","venture",NA,"2014-04-08",750000
"e27e1dfe336790cefa5dcab45e8dd0ea","poliana","seed",NA,"2013-08-07",15000
"6b018c636e894efda334ef8b98a99819","polimetrix","venture","A","2006-11-20",4530000
"6b018c636e894efda334ef8b98a99819","polimetrix","venture","a","2004-03-15",3e+06
"eb20c6f1d2f347f83160f204e55b2b3e","politapoll","convertible_note",NA,"2014-06-18",40000
"a2e4787719ff78ff3e71ebdf9f82545c","poll-authority",NA,NA,NA,NA
"8b994e0cc00c875d2715a18bd0d90374","pollstr",NA,NA,NA,NA
"d7f339d541f7e4d25d922beab4117bfb","polyactiva","venture","B","2013-02-19",9836167.0944
"7d6a6e782142a530ffb495fa705db074","polybiotics","venture",NA,"2010-05-07",175000
"51f684b0434c31c0d00c008ab03418c4","polymedix","venture",NA,"2010-04-01",1.4e+07
"59155215298c61358a3d42693f20b15c","polynova-is-a-start-up-medical-device-company","seed",NA,"2014-06-12",1e+05
"43156215018f01f8cb5af219c915283d","polyphor",NA,NA,NA,NA
"7324eb6a84743518f2ad0db92eef8f37","polypid","venture","b","2012-01-23",2e+06
"7324eb6a84743518f2ad0db92eef8f37","polypid","venture","a","2010-01-01",1400000
"32021d6571b0a9c0736b006e64c1d72d","polyplus-transfection","venture",NA,"2011-01-11",3237000
"903f433efaac839d85fe427248cbf2a4","polysciences",NA,NA,NA,NA
"1a68566f370761e9913957c97747cafc","polytherics","venture","c","2010-04-15",4e+06
"1a68566f370761e9913957c97747cafc","polytherics","venture",NA,"2013-07-26",20455894
"1a68566f370761e9913957c97747cafc","polytherics","undisclosed",NA,"2011-09-07",3437061
"1a68566f370761e9913957c97747cafc","polytherics","venture",NA,"2007-06-20",4572594.9145
"aca8f2da1d2bd375f8b731221df323e5","ponchar-com",NA,NA,NA,NA
"c90001b7b467ac82112d47a14571dea7","pongr","debt_financing",NA,"2010-07-06",25000
"ef53561904d156b1488802f6ee0e179b","pono","venture",NA,"2012-03-19",1500000
"c50b6c85deb728e24811e26d6fd9a3ae","pontis","venture","b","2007-02-12",1.5e+07
"c50b6c85deb728e24811e26d6fd9a3ae","pontis","venture","C","2009-02-10",19650000
"c0856440344be1ca108c485017762bdd","popcorn-metrics","seed",NA,"2013-11-06",NA
"74975fb18fb3accaf5ce0d5d8493d424","pope",NA,NA,NA,NA
"afd319b6d35876aa500a1d740c31bc25","popmarker",NA,NA,NA,NA
"f79e3c5cec5b77c8540b74839a434507","popmatters",NA,NA,NA,NA
"81e512d7a8bea1dd5211e5eb69408c1a","popmetrics",NA,NA,NA,NA
"c00afd528092e49e2b78e09704b6b16b","popular-pays","seed",NA,"2013-10-01",2e+05
"c00afd528092e49e2b78e09704b6b16b","popular-pays","seed",NA,"2014-12-01",120000
"c00afd528092e49e2b78e09704b6b16b","popular-pays","seed",NA,"2015-04-01",NA
"c00afd528092e49e2b78e09704b6b16b","popular-pays","seed","1","2015-07-23",2e+06
"78f3138952c42360385851b37daf1c4b","population-diagnostics","venture","a","2011-08-29",5360344
"d5ebe1a75e889f5eb4c0cd8820bf4ad1","population-genetics-technologies","venture","a","2008-02-19",7414904
"d5ebe1a75e889f5eb4c0cd8820bf4ad1","population-genetics-technologies","venture","b","2011-10-18",5700000
"d5ebe1a75e889f5eb4c0cd8820bf4ad1","population-genetics-technologies","venture","C","2009-04-01",2983238
"d5ebe1a75e889f5eb4c0cd8820bf4ad1","population-genetics-technologies","venture","D","2010-12-01",2482442
"d5ebe1a75e889f5eb4c0cd8820bf4ad1","population-genetics-technologies","venture","F","2012-09-01",1578260
"d5ebe1a75e889f5eb4c0cd8820bf4ad1","population-genetics-technologies","venture","G","2013-03-01",470676
"e8923c414ead6aca2f8b553cef863179","populr","seed",NA,"2011-10-01",425000
"e8923c414ead6aca2f8b553cef863179","populr","seed",NA,"2012-12-02",NA
"e8923c414ead6aca2f8b553cef863179","populr","seed",NA,"2013-07-29",NA
"e8923c414ead6aca2f8b553cef863179","populr","seed",NA,"2013-01-16",475000
"e8923c414ead6aca2f8b553cef863179","populr","seed",NA,"2014-04-09",75000
"9d652cf60cb431aa8053ba138c3e88e3","popuri",NA,NA,NA,NA
"3811d0849bd873d3d5a5e82820f1f290","portaero",NA,NA,NA,NA
"0305528ac89be6bb1aef3e9868bbe6d0","portent-interactive",NA,NA,NA,NA
"7951df2c069ac65b100317b69ad85840","portent-io","seed",NA,"2015-01-30",2e+05
"6bf888dc84889bc7a2a334589444e46c","porter-sail","angel",NA,"2014-06-03",250000
"6bf888dc84889bc7a2a334589444e46c","porter-sail","angel",NA,"2014-12-01",361800
"6bf888dc84889bc7a2a334589444e46c","porter-sail","seed",NA,"2015-12-07",1227000
"965ec49dffc00a843b1432d49d5748a6","portfolio-defense",NA,NA,NA,NA
"357fd07d01db84010e660652c9a3b59b","portola-pharmaceuticals","venture","C","2007-05-07",7e+07
"357fd07d01db84010e660652c9a3b59b","portola-pharmaceuticals","venture","d","2011-11-21",8.9e+07
"357fd07d01db84010e660652c9a3b59b","portola-pharmaceuticals","venture","c","2009-06-15",60099999
"357fd07d01db84010e660652c9a3b59b","portola-pharmaceuticals","private_equity",NA,"2011-12-07",8999999
"76abb49d3092c1f7c531b25678278987","portsmouth-regional-ambulatory-surgery-center","venture",NA,"2011-12-20",534672
"76abb49d3092c1f7c531b25678278987","portsmouth-regional-ambulatory-surgery-center","venture",NA,"2014-03-24",508478
"76abb49d3092c1f7c531b25678278987","portsmouth-regional-ambulatory-surgery-center","venture",NA,"2015-03-25",640387
"9c707bf5d3c90e6913a617327e2ecd5c","pose-2",NA,NA,NA,NA
"0e457bab6ece077d445f93d757fd68d2","poseida-therapeutics","venture","A","2015-12-23",23033232
"56bc82b3ae3ab563660bf489ce87a1d7","poshlight",NA,NA,NA,NA
"1acd3791afabedf48f1c0ff263ba6058","posiba","seed",NA,"2013-12-18",5e+05
"1acd3791afabedf48f1c0ff263ba6058","posiba","angel",NA,"2014-06-30",2500000
"3d5ac1fa27d309ec33df0e91540636ca","posit-science","venture","c","2009-04-27",5600000
"3d5ac1fa27d309ec33df0e91540636ca","posit-science","venture",NA,"2009-05-13",296054
"3d5ac1fa27d309ec33df0e91540636ca","posit-science","venture",NA,"2009-12-14",5e+05
"9ab95431f8ab4654c9257e432fe42961","positron","venture",NA,"2012-11-13",1500000
"43b270b1e24c728c3c92bd9f01b6798b","post-affiliate-pro-expert",NA,NA,NA,NA
"8e1d053d963058fae0ce719097c3d465","postheads",NA,NA,NA,NA
"f6549a35222800836c638303ecc441a8","posthelpers","seed",NA,"2010-01-01",250000
"cfebd043199b37581b8b84f69cd975a0","aiderss","undisclosed",NA,"2009-01-06",NA
"0719bba87517e26dc87695383cf0b66e","postrocket","seed",NA,"2011-11-01",NA
"0719bba87517e26dc87695383cf0b66e","postrocket","seed",NA,"2012-05-31",610000
"8b4f9abb934e53c38c3e999cbfeeb0be","posyt",NA,NA,NA,NA
"afb9b049891723a0226457afbf786c1e","potbotics","debt_financing",NA,"2015-08-06",2355200
"240805d015fdc06711d133f96639a308","potelo-softwares",NA,NA,NA,NA
"65aa85842c6f6fcd3becf813661b938f","potentiametrics-inc-","venture",NA,"2015-03-12",625000
"a4c60664edb3bab6123f0883f6d5280a","potomac-research-group","venture","A","2012-01-09",NA
"04499c9a98dac30ae0c85c2c7937d5a6","power-medical-interventions",NA,NA,NA,NA
"682f0d66e9dea9d40c9c02129e8ce0f6","powerbrand",NA,NA,NA,NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2014-04-07",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2014-03-11",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2014-02-05",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2013-11-12",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2013-09-27",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2013-02-25",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2012-12-19",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2011-10-20",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2011-05-13",NA
"e18fdbfccbee2e14668a406484d43fa5","powerhouse-dynamics","venture",NA,"2011-04-14",NA
"937057eff20c5d5c9c6d1c8f80e39f41","powerpanels",NA,NA,NA,NA
"678fba1e90afeb848a13a8f1512d88d5","powerreviews","venture",NA,"2010-03-01",1100000
"678fba1e90afeb848a13a8f1512d88d5","powerreviews","venture","1","2005-12-01",6250000
"678fba1e90afeb848a13a8f1512d88d5","powerreviews","venture",NA,"2011-05-04",1e+07
"678fba1e90afeb848a13a8f1512d88d5","powerreviews","debt_financing",NA,"2011-03-23",2840312
"678fba1e90afeb848a13a8f1512d88d5","powerreviews","venture","1","2007-09-01",1.5e+07
"678fba1e90afeb848a13a8f1512d88d5","powerreviews","venture",NA,"2009-12-16",4930000
"678fba1e90afeb848a13a8f1512d88d5","powerreviews","venture","1","2014-07-10",3.5e+07
"4b4c63c6f172836f01490964793964fc","powerup-io",NA,NA,NA,NA
"5bb2cb1b9e48eef188f1d5c9aa240c74","powervote",NA,NA,NA,NA
"866c146c4c46e298d8c5b392feba124e","powerweave-software-solutions",NA,NA,NA,NA
"ca4bcbfb9ce0025817598d7e5ec6cf4a","powr-of-you","seed",NA,"2015-01-28",75692
"ca4bcbfb9ce0025817598d7e5ec6cf4a","powr-of-you","seed",NA,"2014-01-10",60000
"8db733b2d476104c2d012ba3caf3875e","poxel","venture","a","2010-08-27",20300000
"8db733b2d476104c2d012ba3caf3875e","poxel","venture","B","2014-09-09",13500000
"dc70d2a55e3cafb4773a564b8d2a4dc8","ppd",NA,NA,NA,NA
"b2b0e6bf8d0d4a65f18609b10388db38","practical-ehr-solutions","venture",NA,"2011-07-05",250000
"4b8f6e2c8601e93cd37d2416d2263678","practiceignition","angel",NA,"2014-02-21",585585
"4b8f6e2c8601e93cd37d2416d2263678","practiceignition","venture",NA,"2012-12-31",110000
"4b8f6e2c8601e93cd37d2416d2263678","practiceignition","seed",NA,"2014-12-24",1003705
"16019d7171485e4804922e5eb0cc8463","practice-unite","seed",NA,"2012-09-01",5e+05
"16019d7171485e4804922e5eb0cc8463","practice-unite","debt_financing",NA,"2014-06-13",70000
"16019d7171485e4804922e5eb0cc8463","practice-unite","venture",NA,"2015-12-04",550000
"26914d5eb4227d73caf46458e1fc6081","practicenext-digital",NA,NA,NA,NA
"26465e411c7153ade83d9b41ed5636d9","practichem",NA,NA,NA,NA
"fa52bddc596ad7519a629f302353e83d","pradama","venture",NA,"2009-11-20",250000
"b6ec91948b3a21fe2f4839679e78d17c","praecis-pharmaceuticals",NA,NA,NA,NA
"ec256c09d931a1223c3cf81db1ff6f7f","praescient-analytics",NA,NA,NA,NA
"6cff201c0b50a9d351e2f91c3562f57c","pragsis-bidoop",NA,NA,NA,NA
"c132daf8401d60072e90afa3013a4e61","pramata","venture","A","2015-12-15",1e+07
"91c8e31ad59fa1dc021e14926ecb12f1","prana-biotechnology",NA,NA,NA,NA
"b34a55d08810b0d8b14d25522f31fdbf","prayas-analytics","seed",NA,"2015-09-15",1e+06
"b34a55d08810b0d8b14d25522f31fdbf","prayas-analytics","seed",NA,"2015-06-01",NA
"e4c6c142d9e13e66dff825022378d607","prc-clinical",NA,NA,NA,NA
"f72f3d78f5dd8aad0e28d704a8b8da0e","pre-diagnostics","venture",NA,"2015-11-16",1615682.8953
"7a4909c11e04b905a55c1aad706ff40e","preact","seed","a","2014-04-18",4600000
"7a4909c11e04b905a55c1aad706ff40e","preact","seed",NA,"2013-03-01",750000
"7a4909c11e04b905a55c1aad706ff40e","preact","venture",NA,"2015-07-08",5127146
"e07aa21061934218104671b613bea26e","preadly",NA,NA,NA,NA
"b4730733d8dac46231a583be4c358dc5","preceptiv","seed",NA,"2013-02-01",157923
"b08a408ba4659fccab9495664465cc4a","precipio-diagnostics","venture","b","2013-10-28",1800000
"b08a408ba4659fccab9495664465cc4a","precipio-diagnostics","venture","a","2011-10-04",1075000
"281e3277b9e1a1086e591c3ee94996b1","precise-light-surgical","venture",NA,"2013-10-15",4500000
"7d673786e7aaa48842d91767948e9ec0","precise-software","convertible_note",NA,"2013-01-18",NA
"7d673786e7aaa48842d91767948e9ec0","precise-software","convertible_note",NA,"2012-11-20",NA
"7d673786e7aaa48842d91767948e9ec0","precise-software","venture","1","2010-08-03",NA
"7d673786e7aaa48842d91767948e9ec0","precise-software","venture","1","2008-03-06",NA
"7d673786e7aaa48842d91767948e9ec0","precise-software","venture",NA,"2009-05-08",16395
"7d673786e7aaa48842d91767948e9ec0","precise-software","venture","1","2012-04-17",6e+06
"7d673786e7aaa48842d91767948e9ec0","precise-software","venture",NA,"2009-01-14",760604
"f916dd49d6fc67a881a313dec5231f8d","precision-biologics","venture",NA,"2015-10-19",5e+07
"f916dd49d6fc67a881a313dec5231f8d","precision-biologics","venture",NA,"2014-04-02",795000
"c01699029715924584c9a843ec7ba1ae","precision-biopsy","venture","B","2015-10-05",33600000
"c01699029715924584c9a843ec7ba1ae","precision-biopsy","venture","a","2011-11-08",2500000
"06d64313d64df74df14e989bedc436f9","precision-biosciences","venture","A","2015-05-11",25600000
"c3b524a9b36b203a1f6c00be2c19ba21","precision-bioservices",NA,NA,NA,NA
"182600bd2201ed4e05f99bebc2ea7ae7","precision-dermatology","venture",NA,"2010-11-30",19000001
"182600bd2201ed4e05f99bebc2ea7ae7","precision-dermatology","debt_financing",NA,"2013-09-23",6.7e+07
"182600bd2201ed4e05f99bebc2ea7ae7","precision-dermatology","venture",NA,"2012-04-25",29400001
"a293c21deb523439789c055aae88b32a","precision-nanosystem","venture","A","2015-09-29",13400000
"7021d1874688674cfd769cc39ca68fb1","precision-toxicilogy","debt_financing",NA,"2015-04-01",14500000
"a6b24dd179cdc27a79ad87d02bdf7717","precisioncyber-llc",NA,NA,NA,NA
"0497fe6ede511936347fb6d8a3da68e8","precisionpoint-software","venture",NA,"2006-12-20",1970000
"2e1254bf35422bb69bacaaabd6a9e29c","precog","venture","a","2012-05-24",2e+06
"2e1254bf35422bb69bacaaabd6a9e29c","precog","seed",NA,"2011-10-05",750000
"2e1254bf35422bb69bacaaabd6a9e29c","precog","seed",NA,"2011-08-01",18000
"2e1254bf35422bb69bacaaabd6a9e29c","precog","undisclosed",NA,"2013-03-06",50000
"48f9cfc32e94b5709e4dd49784409836","predicsis","seed",NA,"2014-02-11",1300000
"3e323dc6170d4404c91531a47bc4c95e","predictable-ly",NA,NA,NA,NA
"4eb55726fb1dba569ca2cb039f7cfc47","predictful",NA,NA,NA,NA
"834726c83dca7168fac0f38cb7cdd0cd","predict-hq",NA,NA,NA,NA
"e63cfe12619205ac3e2f6b7e772531bf","prediction-institute",NA,NA,NA,NA
"9818419573b4629a4a405687a77ebe54","predictionio","seed",NA,"2013-11-13",150000
"9818419573b4629a4a405687a77ebe54","predictionio","seed",NA,"2014-07-17",2500000
"e9594417d73654a5d25e20afb9f66148","predictive",NA,NA,NA,NA
"aa085e1749cf975d7ef071f6eca16cfc","predictive-analytics",NA,NA,NA,NA
"6b1e2694525095d28fac496e975cbda7","predictive-biosciences","venture","b","2008-10-16",21750000
"6b1e2694525095d28fac496e975cbda7","predictive-biosciences","venture","a","2006-12-18",1e+07
"6b1e2694525095d28fac496e975cbda7","predictive-biosciences","venture","c","2010-06-18",2.5e+07
"0784344f16dffc68c473922b1daa56bc","predictive-pop",NA,NA,NA,NA
"3b15859de45a92f91c7871a1e2fd32f5","predictivedb",NA,NA,NA,NA
"fea9e769c4af68036a56b95ef093d7ad","predictivez","angel",NA,"2011-01-01",1e+05
"4741e0b36f77ec4c836d58b45a600537","predictly-tech-labs",NA,NA,NA,NA
"c11f1ce03d7ba4b3456a07a0859fe0f6","predictry","seed",NA,"2014-05-05",230000
"bdb7f574e3b363dfd29696c66dd1b81b","predictus-biosciences","venture",NA,"2011-01-12",5e+05
"dafb8117a91a1d12c3733a96db48b561","predikt","seed",NA,"2014-06-13",NA
"3bad194988fbf7b0af2553c5ec565cb7","predpol","seed",NA,"2012-07-08",1300000
"3bad194988fbf7b0af2553c5ec565cb7","predpol","venture",NA,"2014-07-11",2375000
"d9ca724b06bec638af5321843d4f09e6","pregenen",NA,NA,NA,NA
"8f3c14b5648ad4775a42347480ee7482","preglem","venture","A","2007-06-27",26016260.1626
"8f3c14b5648ad4775a42347480ee7482","preglem","venture","B","2007-12-04",31952662.7219
"7295f7beafc7e5e28d496885ad560228","prehash-ltd","seed",NA,"2013-10-01",80788
"2d4123351025c5319e8b8489aded2b25","premaitha-health",NA,NA,NA,NA
"eedc39ae1e4bc6be37c3e486a02f4777","prematics","venture","c","2009-04-07",10786338
"0e95ce29386f251662800d9c5df8af79","premier-biomaterials",NA,NA,NA,NA
"8291119051f2283703beba75a65ad76d","premier-biomedical","debt_financing",NA,"2015-12-30",1600000
"8291119051f2283703beba75a65ad76d","premier-biomedical","venture",NA,"2011-06-08",57000
"e5bf9f075e06d50b78fe3387647ca3d9","premierguide-inc",NA,NA,NA,NA
"4f680a26074bb8fa7fa4e5cfb5f0c30d","premise","venture","A","2013-06-14",NA
"4f680a26074bb8fa7fa4e5cfb5f0c30d","premise","venture","B","2014-03-13",1.1e+07
"4f680a26074bb8fa7fa4e5cfb5f0c30d","premise","seed",NA,"2012-05-01",NA
"4f680a26074bb8fa7fa4e5cfb5f0c30d","premise","venture","C","2015-09-24",5e+07
"b9381e96b58e8619156422fc2a3abec2","premonix","angel",NA,"2011-08-01",250000
"b9381e96b58e8619156422fc2a3abec2","premonix","seed",NA,"2010-01-28",25000
"b9381e96b58e8619156422fc2a3abec2","premonix","seed",NA,"2010-05-11",18900
"862640935c5f8cb35721d9114001d6ca","prenetics","seed",NA,"2014-12-03",2650000
"ae81f017fc2cb73581083bd41b139ff4","presage-biosciences","venture",NA,"2011-08-04",1566295
"ae81f017fc2cb73581083bd41b139ff4","presage-biosciences","seed",NA,"2009-11-01",NA
"ae81f017fc2cb73581083bd41b139ff4","presage-biosciences","venture","1","2010-06-18",4e+06
"ae81f017fc2cb73581083bd41b139ff4","presage-biosciences","venture",NA,"2013-03-13",8e+06
"d11e23c0d696209e7cc93af2bbb881f0","prescience-ai",NA,NA,NA,NA
"77dc2e8923d7177fab81568b0a4ee276","prescribe-wellness","private_equity",NA,"2012-08-09",1025000
"f931de27f48d792a4a5da11a829374cf","prescription-corporation-of-america","debt_financing",NA,"2012-10-15",5925000
"210fc71a88d83ec65205f8b7e3bf465e","presence-aware-tech",NA,NA,NA,NA
"02dac2e2b087135e29c022121323419d","presenceid","seed",NA,"2005-03-03",4500000
"bdb9874fdcef7299ef5742b7e69267c9","presidio","venture",NA,"2009-07-10",2.7e+07
"bdb9874fdcef7299ef5742b7e69267c9","presidio","debt_financing",NA,"2011-07-27",3000050
"bdb9874fdcef7299ef5742b7e69267c9","presidio","venture",NA,"2012-10-01",7977900
"bdb9874fdcef7299ef5742b7e69267c9","presidio","venture",NA,"2012-11-02",14377542
"bdb9874fdcef7299ef5742b7e69267c9","presidio","venture","1","2007-08-29",2.6e+07
"bdb9874fdcef7299ef5742b7e69267c9","presidio","venture","1","2014-06-16",21827981
"e1a22f497ad686e4038785192e6f97ac","press-army",NA,NA,NA,NA
"da6e5b127c0303a7087bc04e9b96580c","pressking",NA,NA,NA,NA
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","post_ipo_equity",NA,"2016-01-26",5010000
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","venture","1","2011-04-13",825720
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","venture",NA,"2010-04-01",1667766
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","seed",NA,"2012-02-07",8e+05
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","venture","1","2009-11-18",1200000
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","venture",NA,"2009-02-20",1805270
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","post_ipo_equity",NA,"2014-03-09",630000
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","venture",NA,"2012-04-09",5e+05
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","venture",NA,"2012-07-03",1200000
"c965489d02fcedb3d29f4dbd4a012ae1","pressure-biosciences","private_equity",NA,"2013-06-14",2e+06
"a93fb5a711b2b278b06bdf37ab63701d","prestodiag","venture","A","2015-07-24",NA
"a93fb5a711b2b278b06bdf37ab63701d","prestodiag","angel",NA,"2013-03-28",NA
"1d73fc7fbe7a6ca7b3bc6150a2ef87ef","prestwick-pharmaceuticals-inc","venture",NA,"2007-08-27",2e+07
"1d73fc7fbe7a6ca7b3bc6150a2ef87ef","prestwick-pharmaceuticals-inc","venture","1","2006-10-22",6e+07
"e286b7f90a0167ffbae9563da8a3251c","preteckt","convertible_note",NA,"2016-01-21",3e+05
"e286b7f90a0167ffbae9563da8a3251c","preteckt","convertible_note",NA,"2015-05-04",25000
"3bb09fa03d0c68fc87cde7adf1896fa1","prevacus","debt_financing",NA,"2013-01-28",1658000
"3bb09fa03d0c68fc87cde7adf1896fa1","prevacus","seed",NA,"2013-02-28",NA
"2f690fff53acd03bfc36e454f3894e2a","prevent-io",NA,NA,NA,NA
"e6c01f9249a7f689ab3c996f57e06a3b","prevention-pharmaceuticals","debt_financing",NA,"2011-01-11",650000
"be97470c6713b9c60f1360648a4c1e54","previsio",NA,NA,NA,NA
"cc09a90ef55c66fe35356630b7ae02a8","prevtec-microbia","venture",NA,"2015-03-12",4700000
"cc09a90ef55c66fe35356630b7ae02a8","prevtec-microbia","venture",NA,"2015-09-21",2500000
"3b4d002a4a7459e424929bfab6501c54","prexa-pharmaceuticals","venture",NA,"2011-04-29",3200000
"3b4d002a4a7459e424929bfab6501c54","prexa-pharmaceuticals","venture","1","2011-05-11",7e+06
"6e86aa272b432c5f751678fb1870df7e","prgx",NA,NA,NA,NA
"ab648577b60af70bd1bd8770bde51a7a","price-intelligently",NA,NA,NA,NA
"cb620929c60909761ee1fdfcdd3489f6","price-trakker",NA,NA,NA,NA
"8bea66083a7ec27f2af30ce08d4ff976","pricewaterhousecoopers-llp",NA,NA,NA,NA
"dd55d4da1d74b31cf936cfb4f4a6ddd7","pricing-assistant","seed",NA,"2013-09-23",675866
"688531be740f637bc489b9c827db6fd9","pricing-engine","seed",NA,"2013-03-27",1e+06
"688531be740f637bc489b9c827db6fd9","pricing-engine","convertible_note",NA,"2012-01-01",2e+05
"688531be740f637bc489b9c827db6fd9","pricing-engine","angel",NA,"2011-06-06",25000
"688531be740f637bc489b9c827db6fd9","pricing-engine","venture",NA,"2014-10-03",1e+05
"e4ff22c303438fb83c98a2680708ce2a","prima-biomed",NA,NA,NA,NA
"0a647c88d50acf8457e5fa83cb1c40c1","primadiag","equity_crowdfunding",NA,"2014-12-02",205380.0224
"286be80ef79b794503ef366b9a225a70","primary-vision",NA,NA,NA,NA
"c17e8c241951c0232ea61a661b10c1c9","prime-genomics","debt_financing",NA,"2014-01-14",324685
"c17e8c241951c0232ea61a661b10c1c9","prime-genomics","seed",NA,"2013-07-16",NA
"c17e8c241951c0232ea61a661b10c1c9","prime-genomics","seed",NA,"2011-12-27",192000
"2edc59d614d55af641f4946319f3aaf8","primegen-biotech","venture","B","2016-01-25",1030000
"4847f638b3aa1138d4ac2e0540f7931d","primeloop","seed",NA,"2014-01-24",3e+05
"4847f638b3aa1138d4ac2e0540f7931d","primeloop","undisclosed",NA,"2013-06-10",175000
"4847f638b3aa1138d4ac2e0540f7931d","primeloop","undisclosed",NA,"2014-01-02",50000
"ce53c8787a06409666b46b76c3635665","primeradx","venture","B","2008-01-09",1.2e+07
"ce53c8787a06409666b46b76c3635665","primeradx","venture","c","2009-10-30",2e+07
"ce53c8787a06409666b46b76c3635665","primeradx","debt_financing",NA,"2009-09-02",1151129
"be2f77d828fee10276ae5555de8a5994","primerlife",NA,NA,NA,NA
"85cef6eb31416d382b5bf8902195b27b","primesource-healthcare-systems","debt_financing",NA,"2013-08-26",5500000
"0a3718076c59ec031b0cf5a6354a38ef","primesyn-lab",NA,NA,NA,NA
"d68d25cad74bf6f61502a14eec308fe7","primetag-2",NA,NA,NA,NA
"33a3a554dd7128335757dc221b18b755","primis-marketing-group","venture",NA,"2003-06-19",NA
"2c6b83216f2af1ded5042ff3b74f8a16","primordial","venture",NA,"2013-12-03",180000
"567cc6648e23ae198deef08e33a18eb2","primordial-genetics","venture",NA,"2014-05-09",414800
"567cc6648e23ae198deef08e33a18eb2","primordial-genetics","venture",NA,"2015-08-05",625219
"a052b89e2a2261539ff143c24f7f4868","primorigen-biosciences","venture","a","2006-08-10",2500000
"f0dbcf08c422e84b8e19353f21fed2b7","primrose-therapeutics","venture",NA,"2010-08-17",752550
"0283b3a5a53208d1255118d40b31e07a","leapyear-innovations",NA,NA,NA,NA
"cecb59da5ff9a0e904d196d446c4f2f1","principia-biopharma","venture","a","2012-10-29",12500000
"cecb59da5ff9a0e904d196d446c4f2f1","principia-biopharma","venture",NA,"2011-02-10",12116666
"cecb59da5ff9a0e904d196d446c4f2f1","principia-biopharma","venture","B","2014-04-22",5e+07
"cecb59da5ff9a0e904d196d446c4f2f1","principia-biopharma","venture",NA,"2015-08-10",15285151
"70bcb7a54da3cd5f9cb7b82dc3d9f973","principia-pharmaceutical-corporation",NA,NA,NA,NA
"80dfe5a5d90be51bef9cb2f445f6bf2b","printingforless-com",NA,NA,NA,NA
"d9a085aba6228eeb5a7185afd5121870","prinum",NA,NA,NA,NA
"2dd985f020535ea2696723574bdac396","prionics-ag",NA,NA,NA,NA
"6c0eb77a09eb7cfb05e628262ab31c07","prior-knowledge","seed",NA,"2012-02-01",1400000
"3ca612a81cd3a40a948f9a26a418f281","priori-data",NA,NA,NA,NA
"fdd362ca59d1f04566483f41ae2fc980","pris",NA,NA,NA,NA
"470b43ce82d8a542796e18bf53ce0fa4","prism-analytical-technologies","venture","a","2010-10-14",NA
"64100fd8aeb227b64424fb43bdaa0ce8","prism-pharmaceuticals","venture","c","2013-06-13",1.5e+07
"be669a7d74676862060defeca09260ab","prism-skylabs","venture","a","2012-10-16",7499700
"be669a7d74676862060defeca09260ab","prism-skylabs","seed",NA,"2011-09-01",1500000
"be669a7d74676862060defeca09260ab","prism-skylabs","venture","b","2013-10-22",1.5e+07
"4a733516f65e11ec78bdc929ae1ba079","prismic-pharmaceuticals","seed",NA,"2013-02-20",1200000
"679252cfa2fd63f7ed0bab57c5566920","prismtech","venture",NA,"2010-02-22",2320000
"8c17d49ae01454a534d5842e412307ea","pristech-analytics",NA,NA,NA,NA
"b3ace07336c334f692dbf2fa539edc9c","privacy-analytics","venture",NA,"2012-11-01",1375000
"b3ace07336c334f692dbf2fa539edc9c","privacy-analytics","seed",NA,"2014-07-21",3500000
"995509f8ac16870ae73823b957208b1d","privacybank-com",NA,NA,NA,NA
"b761554f969d712c4d17c2df141042ac","privaris","debt_financing",NA,"2010-06-16",2672922
"b761554f969d712c4d17c2df141042ac","privaris","venture","1","2005-11-01",15700000
"b761554f969d712c4d17c2df141042ac","privaris","debt_financing",NA,"2009-05-29",1012361
"b761554f969d712c4d17c2df141042ac","privaris","debt_financing",NA,"2009-11-20",2076915
"b761554f969d712c4d17c2df141042ac","privaris","debt_financing",NA,"2009-08-12",1534295
"b761554f969d712c4d17c2df141042ac","privaris","debt_financing",NA,"2011-04-14",3172009
"b761554f969d712c4d17c2df141042ac","privaris","debt_financing",NA,"2011-02-17",2964369
"10836ab5f89e2c0babc1fc991fe98b39","private-formula-international-holdings",NA,NA,NA,NA
"6190178ff0b0a112de25693f9fc425cd","privco",NA,NA,NA,NA
"93590077a83592a1c26d7646d36bfc69","privy-2","venture",NA,"2011-09-08",157500
"93590077a83592a1c26d7646d36bfc69","privy-2","seed",NA,"2013-07-03",1700000
"93590077a83592a1c26d7646d36bfc69","privy-2","seed",NA,"2011-10-24",NA
"93590077a83592a1c26d7646d36bfc69","privy-2","seed",NA,"2012-07-31",NA
"da5a6bc08c016df58059cad15d86ddbb","pro-ace-heating-cooling",NA,NA,NA,NA
"0ec7c479a082cfda3e6ca23289599d25","pro-cure-therapeutics","venture",NA,"2007-11-08",1158535
"0ec7c479a082cfda3e6ca23289599d25","pro-cure-therapeutics","venture",NA,"2010-04-13",1080000
"eb07107f7439e40179a60c3bcdcfd2f7","proa-medical","venture",NA,"2010-08-19",105000
"eb07107f7439e40179a60c3bcdcfd2f7","proa-medical","venture",NA,"2013-05-07",1085533
"eb07107f7439e40179a60c3bcdcfd2f7","proa-medical","venture",NA,"2013-10-18",320998
"eb07107f7439e40179a60c3bcdcfd2f7","proa-medical","venture",NA,"2013-07-02",281427
"eb07107f7439e40179a60c3bcdcfd2f7","proa-medical","venture",NA,"2012-12-06",169995
"eb07107f7439e40179a60c3bcdcfd2f7","proa-medical","venture",NA,"2014-06-26",1e+05
"eb07107f7439e40179a60c3bcdcfd2f7","proa-medical","venture",NA,"2015-08-18",504865
"eb07107f7439e40179a60c3bcdcfd2f7","proa-medical","venture",NA,"2015-09-24",544282
"fbc988ff48347baa59c6ee528182a915","proacta","venture","B","2007-02-07",3.5e+07
"fbc988ff48347baa59c6ee528182a915","proacta","debt_financing",NA,"2010-02-17",3000445
"fbc988ff48347baa59c6ee528182a915","proacta","debt_financing",NA,"2011-12-15",5e+05
"cc100bf60a443323c185762d8daf6593","probe",NA,NA,NA,NA
"10803590185abee6f4ab905a775d5874","probiodrug","venture","b","2009-11-02",5.4e+07
"10803590185abee6f4ab905a775d5874","probiodrug","venture",NA,"2012-01-04",19422000
"0e4f73e7ba89931b210432b7c293b1f0","probity","venture",NA,"2009-04-01",1275000
"fa5200a2f63a2e83bd1b4eb636ea4cb5","procarta-biosystems","venture",NA,"2008-06-06",631000
"fa5200a2f63a2e83bd1b4eb636ea4cb5","procarta-biosystems","venture",NA,"2007-11-12",1510777
"5b09006b16b29d17aeab9d7221088613","procept-biorobotics","debt_financing",NA,"2015-07-17",7667625
"5b09006b16b29d17aeab9d7221088613","procept-biorobotics","undisclosed",NA,"2015-07-07",4.2e+07
"5b09006b16b29d17aeab9d7221088613","procept-biorobotics","venture","1","2015-07-21",4.2e+07
"17462dd2d1ae3b79c44feb77f1d490ac","procertus-biopharm","venture","A","2007-05-10",2300000
"17462dd2d1ae3b79c44feb77f1d490ac","procertus-biopharm","venture","a","2011-04-05",1700000
"e6a7aa7630c2d42c0e19e990afcb20fc","process-digital-audio",NA,NA,NA,NA
"7265eb7e20c37df0b0ce211b7265b74d","process-stream",NA,NA,NA,NA
"2da0e7c5a0e91efd14732b4699cec317","prochon-biotech","venture",NA,"2010-01-20",3950000
"98b88940582cf071d086e8ef592f14df","proclarity-corporation","venture",NA,"2002-07-09",7750000
"fbbd803c8fdaca22d5e6a8478c69136d","procogia",NA,NA,NA,NA
"cd3e7cc8bb7e65da38c202affad352f5","procure-treatment-centers","private_equity",NA,"2006-12-20",3.5e+07
"cd3e7cc8bb7e65da38c202affad352f5","procure-treatment-centers","venture",NA,"2011-02-01",4e+07
"9af9923e3432efae73b7f9dfc9f4dfc3","product-chart",NA,NA,NA,NA
"fc52a4b0346339c1efef5325e7bc666e","product-reviews",NA,NA,NA,NA
"cfacf53f7b34b04e5dbc6844efb81925","product2market",NA,NA,NA,NA
"666544245cf85ede9be7651131436244","productbio","seed",NA,"2014-08-01",1e+05
"e1ef2c368b555a258d62e0e54aab16ed","productboard","seed",NA,"2015-04-18",NA
"77e660096944e18499e8dd9c76b6af31","productscope360",NA,NA,NA,NA
"2abcb90c639df4d335307570c7027f7c","productsup",NA,NA,NA,NA
"996af867a1bbcefa20165c35d619eb34","prodvigator-ua",NA,NA,NA,NA
"cca6617ff1251cd9787fb5d5e7c92a1f","profectus-biosciences","grant",NA,"2015-12-09",4600000
"cca6617ff1251cd9787fb5d5e7c92a1f","profectus-biosciences","grant",NA,"2010-10-06",4400000
"cca6617ff1251cd9787fb5d5e7c92a1f","profectus-biosciences","venture",NA,"2014-04-18",7291206
"cca6617ff1251cd9787fb5d5e7c92a1f","profectus-biosciences","venture",NA,"2007-06-15",3e+06
"cca6617ff1251cd9787fb5d5e7c92a1f","profectus-biosciences","grant",NA,"2011-12-14",5400000
"cca6617ff1251cd9787fb5d5e7c92a1f","profectus-biosciences","grant",NA,"2014-10-31",9500000
"dc78668ed2b587b2d3ce065e0bbf1411","profectus-health-research","debt_financing",NA,"2013-03-21",480000
"f42ad2c5c89a936202e050840abd2c80","professional-advantage",NA,NA,NA,NA
"270058e3543fb0cd1ecfeb834982df8e","profex","venture","a","2008-08-28",15500000
"7110ab200b98529722c1baa00d5afc2f","profibrix","venture","A","2007-03-27",1.1e+07
"7110ab200b98529722c1baa00d5afc2f","profibrix","venture","b","2009-08-24",11400000
"7110ab200b98529722c1baa00d5afc2f","profibrix","venture","b","2011-08-05",10600000
"2b05cd554753fe9a9aed3dbc60295e6c","profility","venture",NA,"2015-05-08",1687820
"89fae4d02df2fd9c553501b9b42b705f","profit-street","seed",NA,"2015-01-08",370000
"9af7052c19046dacc9a1179ef75bc19a","profit-ly",NA,NA,NA,NA
"2ec29a5cd7c0d68c95e8fcd3e114af12","profitail",NA,NA,NA,NA
"64179d2dfa9cb42788b3181fed427ae5","profitect","venture","b","2009-10-26",5500000
"64179d2dfa9cb42788b3181fed427ae5","profitect","venture",NA,"2014-04-28",NA
"64179d2dfa9cb42788b3181fed427ae5","profitect","venture",NA,"2015-07-08",NA
"fd85dd0c99d8358555350e8e9ab78273","profitero","venture","a","2011-12-18",979800
"fd85dd0c99d8358555350e8e9ab78273","profitero","venture","A","2010-09-09",63556.0904
"fd85dd0c99d8358555350e8e9ab78273","profitero","venture",NA,"2014-06-04",8e+06
"436a2f14322453df26d8d2f40f76392b","profoundis-labs","seed",NA,"2013-12-17",40000
"436a2f14322453df26d8d2f40f76392b","profoundis-labs","venture",NA,"2014-07-22",NA
"4a7771186efa3a3de499ba690872a8b6","profusa","debt_financing",NA,"2012-08-30",1200000
"4a7771186efa3a3de499ba690872a8b6","profusa","venture",NA,"2013-09-10",2759821
"4a7771186efa3a3de499ba690872a8b6","profusa","venture","1","2015-12-16",13200000
"7cc087553696183281fa644878670fd8","proge",NA,NA,NA,NA
"048374a549e627f8eee710b26ed884e9","progen-pharmaceuticals-limited",NA,NA,NA,NA
"8a1615e5149f80e174a363cb24d8d2a3","progenesis-technologies","venture",NA,"2010-07-15",1e+05
"8328fabc34a9a6bc096d49257a1b6ea5","progenics-pharmaceuticals-inc",NA,NA,NA,NA
"4aee675b40925ecdfadd261d160f2669","progenitor-labs",NA,NA,NA,NA
"3713ab19ed3b8055a246a0506c78c896","prognomix","venture",NA,"2007-03-29",4100000
"ba0bb554fd06a585fb3e9bbb44acf85c","prognosdx-health","debt_financing",NA,"2011-05-17",10000
"20488c9b66cfc6bc437c1a9bc35bdc17","prognolytics",NA,NA,NA,NA
"75dfea55f639d708083ef067e41400b9","prognoz",NA,NA,NA,NA
"195d353e89409d69c08179cfa13a291d","progressive-care","venture",NA,"2011-12-12",150000
"f61f63e0c499345fa8e932ecaa8e68fc","progrids",NA,NA,NA,NA
"fb97067b966f8e08438ca87f0845ac2c","maha-knows",NA,NA,NA,NA
"62fddfd46c3df46846d2c3b136fa29b6","projectbrainsaver-limited",NA,NA,NA,NA
"eb50dc6f47ea5c9eb8baa7a42023a7ca","projectial",NA,NA,NA,NA
"d38f753e7737db4d9f4b19e4e1cc7099","projectioneering","venture",NA,"2010-03-15",883000
"6f6b37922b3a4aaa9fa36e7315276b8a","projectvision-inc",NA,NA,NA,NA
"c68e5844ea524614fb2fd249c35342c0","prolacta-bioscience","venture","d","2011-11-03",1.5e+07
"c68e5844ea524614fb2fd249c35342c0","prolacta-bioscience","private_equity",NA,"2011-08-09",5783892
"c68e5844ea524614fb2fd249c35342c0","prolacta-bioscience","venture","C","2007-05-23",1.2e+07
"c68e5844ea524614fb2fd249c35342c0","prolacta-bioscience","venture","b","2006-11-21",540000
"59768f94304e62fd985ecbe57e5faf79","prolific-interactive",NA,NA,NA,NA
"171ecc3da90790795e03449d8a1897e5","prolinx-inc",NA,NA,NA,NA
"103145a6e8498e104c200bd59516179d","prollie","venture","a","2012-12-13",5e+05
"f784ab7a23ebbe7e66ee708185859ffa","prolong-pharmaceuticals","venture",NA,"2010-10-14",3e+07
"908a7ff13ac6425c4150685d14fccce9","prolor-biotech","venture",NA,"2009-08-06",2e+06
"908a7ff13ac6425c4150685d14fccce9","prolor-biotech","private_equity",NA,"2010-03-25",24399991
"11fa1c6e77bbb43c389d74abe85fbf75","prome-brasil",NA,NA,NA,NA
"9831c4856521b3af49f032f674a89db7","promedior","venture","d","2012-10-15",3e+06
"9831c4856521b3af49f032f674a89db7","promedior","debt_financing",NA,"2011-10-17",6500000
"9831c4856521b3af49f032f674a89db7","promedior","venture","d","2012-03-07",21500000
"9831c4856521b3af49f032f674a89db7","promedior","venture","c","2010-03-17",1.2e+07
"9831c4856521b3af49f032f674a89db7","promedior","venture","a","2006-05-24",1.4e+07
"9831c4856521b3af49f032f674a89db7","promedior","venture",NA,"2009-02-25",6e+06
"2263945a336081b8ba66914fdf7a699c","promentis-pharmaceuticals","venture","b","2014-01-17",2900000
"2263945a336081b8ba66914fdf7a699c","promentis-pharmaceuticals","debt_financing",NA,"2013-04-01",750000
"2263945a336081b8ba66914fdf7a699c","promentis-pharmaceuticals","venture",NA,"2009-08-31",1687000
"292cb55138c66e448d4dbe235f291b30","prometei","seed",NA,"2015-07-01",1e+05
"c8bf0ef07a0b01a69791c7745c5eb8f6","promethean-2","venture",NA,"2010-01-13",3684991
"f5e2d1624eae047a8893c31ee399f614","prometheon-pharma","convertible_note",NA,"2014-08-15",1e+06
"f5e2d1624eae047a8893c31ee399f614","prometheon-pharma","convertible_note",NA,"2015-01-28",1e+05
"eea0bc765f15d76febe93369fc47fa71","promethera-biosciences","venture","a","2010-02-02",7300000
"eea0bc765f15d76febe93369fc47fa71","promethera-biosciences","venture","b","2012-03-28",31475320
"eea0bc765f15d76febe93369fc47fa71","promethera-biosciences","venture","C","2014-11-25",31444456
"003b7da77e0a1ebec32c19210e9dcbdd","prometheus-laboratories","debt_financing",NA,"2010-01-07",2.6e+08
"83c7fe9e1cda52b5079e7d5de1a54e29","prometic-life-sciences","venture",NA,"2013-11-20",5100000
"83c7fe9e1cda52b5079e7d5de1a54e29","prometic-life-sciences","post_ipo_equity",NA,"2014-08-01",2e+07
"f644ec2b76a0019e0fcee30b724b8f73","promimic","venture",NA,"2011-02-10",1541809
"a738d4358304fb3d2bcd3e283db26763","promip-agro-biotecnologia","venture","A","2014-08-04",1770360.6225
"d7c792cad241e095d539799359688ae8","promis-neurosciences","venture",NA,"2015-08-17",150341
"80fa3d48735780ae98e64aef353a6749","promojam","angel",NA,"2008-07-01",5e+05
"80fa3d48735780ae98e64aef353a6749","promojam","venture","1","2012-03-21",1200000
"7eb1f8a595b0c94e5b56d419a637334e","promosome","venture","c","2011-01-25",4100000
"7eb1f8a595b0c94e5b56d419a637334e","promosome","venture","b","2008-10-27",9600000
"75740b296d6cd78e6e329fd6828f52ae","promoter-io","convertible_note",NA,"2013-09-01",187000
"75740b296d6cd78e6e329fd6828f52ae","promoter-io","seed",NA,"2014-12-01",850000
"83531bc2dd23130a99232803f2a7e6a4","promotion-king",NA,NA,NA,NA
"2c2573bf03db323df8a3b99e16afa29f","promotools",NA,NA,NA,NA
"829261cb9678faf1bb5ecd1b34b739fd","promovention",NA,NA,NA,NA
"11746a777eda6aaf91d53e5f40c6a0f7","promptcare","debt_financing",NA,"2009-05-20",876150
"46e38aad840f74551114ade49504c7cd","promuc","undisclosed",NA,"2014-03-04",350001
"9d52c43c8fa7d9db5d6a2b00c58a02a4","pronai-therapeutics","venture","c","2014-01-13",1.2e+07
"9d52c43c8fa7d9db5d6a2b00c58a02a4","pronai-therapeutics","venture","A","2010-12-27",1691410
"9d52c43c8fa7d9db5d6a2b00c58a02a4","pronai-therapeutics","debt_financing",NA,"2013-06-04",4300993
"9d52c43c8fa7d9db5d6a2b00c58a02a4","pronai-therapeutics","venture","D","2014-04-21",59500000
"9d52c43c8fa7d9db5d6a2b00c58a02a4","pronai-therapeutics","debt_financing",NA,"2015-03-27",2739049
"48d2d42c5a57eb92271238130096d3f3","proneuron-biotechnologies",NA,NA,NA,NA
"fee61adc08ccfc07c25cb5dec33d8efb","pronota","venture","c","2012-12-12",1825600
"fee61adc08ccfc07c25cb5dec33d8efb","pronota","venture","c","2012-01-20",4774706
"fee61adc08ccfc07c25cb5dec33d8efb","pronota","venture","a","2006-04-19",7800000
"fee61adc08ccfc07c25cb5dec33d8efb","pronota","venture","a","2006-08-22",10600000
"fee61adc08ccfc07c25cb5dec33d8efb","pronota","grant",NA,"2006-10-09",2200000
"fee61adc08ccfc07c25cb5dec33d8efb","pronota","grant",NA,"2007-07-10",2800000
"fee61adc08ccfc07c25cb5dec33d8efb","pronota","venture","b","2009-06-29",7360000
"fee61adc08ccfc07c25cb5dec33d8efb","pronota","venture","b","2009-10-30",1950000
"2cb931a6264161302a71db66fcd773a9","pronova-solutions","venture",NA,"2012-11-13",7500000
"2cb931a6264161302a71db66fcd773a9","pronova-solutions","venture",NA,"2014-10-11",3e+07
"2cb931a6264161302a71db66fcd773a9","pronova-solutions","convertible_note",NA,"2014-11-17",2702460
"35b7cb29eb849f55e464b6d7bdeb45e2","pronoxis","undisclosed",NA,"2009-06-01",NA
"8f1da61994ae0b4247f471e9c1ccfe0b","pronutria","venture","B","2013-12-11",NA
"8f1da61994ae0b4247f471e9c1ccfe0b","pronutria","venture","a","2013-10-22",10800000
"8f1da61994ae0b4247f471e9c1ccfe0b","pronutria","venture","C","2015-05-28",3.9e+07
"c34a9bddc25f8f94535f9783a1a569aa","proofhq",NA,NA,NA,NA
"006a24cb340bbdd699c391c44d612db9","proofpoint-systems",NA,NA,NA,NA
"eb1823e75fdd102406f3ac3951444eb0","prooftag",NA,NA,NA,NA
"2499ff3620d33215965ada5dd938193a","proonto","seed",NA,"2014-01-01",NA
"2499ff3620d33215965ada5dd938193a","proonto","seed",NA,"2015-06-03",NA
"2499ff3620d33215965ada5dd938193a","proonto","seed",NA,"2014-06-01",860000
"f6df107665a13838a1715460bd26e1c4","propagenix","venture",NA,"2014-04-22",2300000
"8c68b9ed13f21e39565f66256ddfa65d","propanc","venture",NA,"2012-06-04",30000
"95eeb8b998c6aae7960e22c9df432e0c","propel-x","seed",NA,"2015-06-01",1500000
"c06c58cd988615e7a1233640c5eed86d","propelad-com","angel",NA,"2012-09-30",250000
"c06c58cd988615e7a1233640c5eed86d","propelad-com","venture",NA,"2014-07-16",650000
"c06c58cd988615e7a1233640c5eed86d","propelad-com","seed",NA,"2013-11-01",54513
"12bc353578ef32235f58b45083008969","propequity",NA,NA,NA,NA
"2bd637eec8cbe0530e44dae6ea7fd380","prophecis",NA,NA,NA,NA
"b3f52af99bcec9cd261c79ece9aff69b","prophesee","angel",NA,"2015-12-09",5e+05
"6a3421a90d97de06d8f99e631f13805f","proposalrocket",NA,NA,NA,NA
"44134263b33b38d74d3d76295d3648d4","proprius-pharmaceuticals","venture","A","2007-01-08",1.1e+07
"67c854aad80fdef345413b12fdd11c7b","proqr-therapeutics",NA,NA,NA,NA
"531ebef5cbada5ace138d8c45a1707e3","proretina-therapeutics","venture",NA,"2010-09-24",509656
"366c1f28f88c0e6aabf115181fb09fb4","prosensa","venture","A","2007-02-01",1.8e+07
"366c1f28f88c0e6aabf115181fb09fb4","prosensa","venture",NA,"2012-01-25",29766600
"366c1f28f88c0e6aabf115181fb09fb4","prosensa","venture","b","2008-12-17",25306200
"366c1f28f88c0e6aabf115181fb09fb4","prosensa","grant",NA,"2014-07-02",2e+05
"b98a2461230baac8990e84fd762e8a3f","prosensa-therapeutics-b-v",NA,NA,NA,NA
"6ab19eeae24e0a237a92a47af86c98ab","prosetta","venture","D","2015-12-04",3.1e+07
"6ab19eeae24e0a237a92a47af86c98ab","prosetta","venture","b","2012-07-24",2039850
"6ab19eeae24e0a237a92a47af86c98ab","prosetta","venture","a","2007-05-21",2e+06
"84bb0eb30ba814fc570c72c791ef44bc","prosolia",NA,NA,NA,NA
"1bfdc02da30e5e99fc494d764d34b577","prosonix","venture","b","2012-05-24",26808752
"1bfdc02da30e5e99fc494d764d34b577","prosonix","venture","b","2011-07-06",18240509
"a26bf538d5f5f5c36b8c7765edfcdbc9","prospecting-io",NA,NA,NA,NA
"2370af5c7efa760bbf2e37d960ee322f","prospira-paincare",NA,NA,NA,NA
"e26a549628e47eb3a9d69971a5b8f073","prostagene","venture",NA,"2015-03-10",4e+05
"9898f5733afe74d3f236c2beb2ead593","prostrakan",NA,NA,NA,NA
"7f6ba04e49edbb9ea0dea0048600d9af","protab","venture","a","2010-04-23",4e+06
"13a9354a7733c6a946b89f1a470dabab","protaffin-biotechnologie","venture","A","2008-01-21",1970591.9561
"13a9354a7733c6a946b89f1a470dabab","protaffin-biotechnologie","venture","a","2007-05-04",3599646.8271
"13a9354a7733c6a946b89f1a470dabab","protaffin-biotechnologie","venture",NA,"2006-01-01",1560000
"b147ca4767a42f62f449d6d0562717b5","protagenic-therapeutics","seed",NA,"2010-09-16",375000
"b147ca4767a42f62f449d6d0562717b5","protagenic-therapeutics","seed",NA,"2013-02-15",642789
"5cb27a08ba4e6198cbfa7a91f4b0fc6e","protagonist-therapeutics","venture","b","2013-09-19",4e+06
"5cb27a08ba4e6198cbfa7a91f4b0fc6e","protagonist-therapeutics","venture","a","2006-09-19",9e+06
"5cb27a08ba4e6198cbfa7a91f4b0fc6e","protagonist-therapeutics","venture","b","2013-06-04",1.4e+07
"5cb27a08ba4e6198cbfa7a91f4b0fc6e","protagonist-therapeutics","venture","C","2015-07-16",4e+07
"a639f5ae51f7ef0c3b11357854076163","protalex","convertible_note",NA,"2014-01-23",2828000
"a639f5ae51f7ef0c3b11357854076163","protalex","debt_financing",NA,"2009-11-11",3e+06
"886cfb5828972ddea43a85bc96da0444","protalix-biotherapeutics","venture",NA,"2015-10-14",1e+07
"cdfe68879d01d56145032d8213a8b5f8","protea-biosciences-group","debt_financing",NA,"2011-05-05",1050000
"cdfe68879d01d56145032d8213a8b5f8","protea-biosciences-group","debt_financing",NA,"2013-07-29",439500
"cdfe68879d01d56145032d8213a8b5f8","protea-biosciences-group","debt_financing",NA,"2013-10-30",275000
"cdfe68879d01d56145032d8213a8b5f8","protea-biosciences-group","venture",NA,"2009-08-12",180000
"cdfe68879d01d56145032d8213a8b5f8","protea-biosciences-group","debt_financing",NA,"2012-12-14",915000
"cdfe68879d01d56145032d8213a8b5f8","protea-biosciences-group","debt_financing",NA,"2014-04-17",6e+05
"cdfe68879d01d56145032d8213a8b5f8","protea-biosciences-group","venture",NA,"2014-10-11",4426528
"cdfe68879d01d56145032d8213a8b5f8","protea-biosciences-group","debt_financing",NA,"2015-06-05",2e+06
"362335e7450e59e6068f8d4450ba7e82","protech-ltd",NA,NA,NA,NA
"2d6ea42be42f0ed1566061089c1fad1f","protectimmun-gmbh-2","seed",NA,"2011-05-04",NA
"f5e0ae7fdf587097e5d1c763ebdc0edf","protg-biomedical","seed",NA,"2014-01-31",5e+05
"b068f7cd6dc60b44d7e5006ea5b16c83","protegrity",NA,NA,NA,NA
"f24096279a11a7ffc4cd4ea3c41796b0","protein-design-labs",NA,NA,NA,NA
"d6c72f0a945bf036a712493e6d8b54d8","protein-forest","debt_financing",NA,"2009-04-22",3010000
"d6c72f0a945bf036a712493e6d8b54d8","protein-forest","debt_financing",NA,"2009-07-08",1250000
"d6c72f0a945bf036a712493e6d8b54d8","protein-forest","debt_financing",NA,"2009-11-06",750000
"d5d3af0b4f8a521a6088a9722fc4a960","protein-lounge","seed",NA,"2011-06-14",1000
"fb7af987b8b73a12d11bca27a9a9b1c1","protenders","seed",NA,"2011-02-01",1e+06
"fb7af987b8b73a12d11bca27a9a9b1c1","protenders","seed",NA,"2009-01-01",250000
"9d41f4b18571058a682dbbca0bb31496","protenus","venture",NA,"2016-01-26",2605000
"9d41f4b18571058a682dbbca0bb31496","protenus","seed",NA,"2014-01-10",NA
"9d41f4b18571058a682dbbca0bb31496","protenus","seed",NA,"2014-04-02",50000
"9d41f4b18571058a682dbbca0bb31496","protenus","angel",NA,"2014-09-22",1200000
"9d41f4b18571058a682dbbca0bb31496","protenus","seed",NA,"2015-01-07",1e+05
"ee6b65ae2f8761b5bf07f073c385a948","proteolix",NA,NA,NA,NA
"182df772924aa221eccecfcff5d7fc32","proteomedix","venture","b","2014-04-09",3345160
"182df772924aa221eccecfcff5d7fc32","proteomedix","venture","A","2012-01-12",2680292
"182df772924aa221eccecfcff5d7fc32","proteomedix","venture","B","2015-01-28",1112860
"4151d33ed06fca4d2e1fddf1d7f8f664","proteon-therapeutics","venture",NA,"2011-08-12",15200000
"4151d33ed06fca4d2e1fddf1d7f8f664","proteon-therapeutics","venture","1","2007-09-06",1.2e+07
"4151d33ed06fca4d2e1fddf1d7f8f664","proteon-therapeutics","venture","1","2009-05-28",5e+07
"4151d33ed06fca4d2e1fddf1d7f8f664","proteon-therapeutics","venture",NA,"2014-02-19",4338660
"4151d33ed06fca4d2e1fddf1d7f8f664","proteon-therapeutics","venture","1","2014-05-16",4.5e+07
"681e186a55c1e9f76befda7a282f12a9","proteonomix","seed",NA,"2012-03-21",3804991
"6c01fd61b1974064bcfde2475db2e6a1","proteopure","venture",NA,"2005-09-07",1e+05
"6c01fd61b1974064bcfde2475db2e6a1","proteopure","venture",NA,"2006-03-21",1e+05
"6c01fd61b1974064bcfde2475db2e6a1","proteopure","venture",NA,"2006-10-27",50000
"6c01fd61b1974064bcfde2475db2e6a1","proteopure","venture",NA,"2006-10-04",40000
"d9c6e663ee62d2db033220f3dd1007da","proteostasis-therapeutics","venture","a","2008-08-25",70623000
"d9c6e663ee62d2db033220f3dd1007da","proteostasis-therapeutics","debt_financing",NA,"2014-08-15",3012271
"d9c6e663ee62d2db033220f3dd1007da","proteostasis-therapeutics","venture","B","2015-09-08",3.7e+07
"513df112ba1150e405b4b756fd900c0c","proteotech","debt_financing",NA,"2009-04-28",519401
"513df112ba1150e405b4b756fd900c0c","proteotech","venture",NA,"2011-06-28",10021378
"707fb775d9b86d1484dcaabc613668d7","proteros-biostructures","venture",NA,"2007-08-22",7016360
"2045de88c90e682bc27821cfe74dfd25","proterro","venture","A","2012-12-01",3500000
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","venture",NA,"2009-12-31",25449979
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","debt_financing",NA,"2014-01-21",31600000
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","venture","1","2013-05-01",62500000
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","venture","1","2014-06-02",1.72e+08
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","venture","1","2001-05-01",NA
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","venture","1","2003-12-19",NA
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","venture","1","2006-01-01",NA
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","venture","1","2008-07-10",NA
"eba0467df4f6b60964aecaf0e22b7c0a","proteus-biomedical","venture",NA,"2012-05-16",17500000
"f059afdd694f1e04cd7caeebb6b0571d","prothena",NA,NA,NA,NA
"7cbd17170a399043260f072a2c9199d2","prothera-biologics","venture",NA,"2012-09-05",750000
"d5bfb7e6b99ca3c92d671e658f89b04f","protiva-biotherapeutics","venture",NA,"2007-07-06",3300000
"d5bfb7e6b99ca3c92d671e658f89b04f","protiva-biotherapeutics","venture","1","2006-07-13",4950000
"eebb2ff53207d5726afcb9ab70204b89","protix-biosystems","venture",NA,"2015-02-03",NA
"df652b5500bfa8e435a43a6693c0dc05","protolytic","venture",NA,"2015-02-27",1e+05
"59744c44200dd015648c1451f51bed0f","protom-international","debt_financing",NA,"2013-03-01",860000
"59744c44200dd015648c1451f51bed0f","protom-international","convertible_note",NA,"2009-04-30",936000
"06662b9994ff60264ab15015a51abeea","proton-therapy","venture",NA,"2009-11-13",3013326
"06662b9994ff60264ab15015a51abeea","proton-therapy","venture",NA,"2011-05-19",1015685
"95e0c6492914a6d5ce0372fb1dd59fb6","prourocare-medical","convertible_note",NA,"2011-07-28",125000
"95e0c6492914a6d5ce0372fb1dd59fb6","prourocare-medical","convertible_note",NA,"2013-11-05",2e+05
"95e0c6492914a6d5ce0372fb1dd59fb6","prourocare-medical","debt_financing",NA,"2013-04-02",50000
"95e0c6492914a6d5ce0372fb1dd59fb6","prourocare-medical","venture",NA,"2012-04-26",1e+05
"95e0c6492914a6d5ce0372fb1dd59fb6","prourocare-medical","venture",NA,"2010-09-28",875000
"3896b60677d583b86975d923786ca5a7","provectus-pharmaceuticals","venture",NA,"2009-06-30",2712000
"3896b60677d583b86975d923786ca5a7","provectus-pharmaceuticals","venture",NA,"2009-08-07",4507176
"3896b60677d583b86975d923786ca5a7","provectus-pharmaceuticals","venture",NA,"2014-04-17",3373250
"f260fc3ffa1bef4ce25c530d7c9b07d1","proved",NA,NA,NA,NA
"297564e40673fa9a293db127efa2fb95","provenance-biopharmaceuticals","venture","a","2011-12-22",8e+06
"3c3378d8f9464d8436c6a979f0336571","proventix-systems","venture",NA,"2009-04-15",550000
"3c3378d8f9464d8436c6a979f0336571","proventix-systems","venture",NA,"2011-06-22",835000
"3c3378d8f9464d8436c6a979f0336571","proventix-systems","venture",NA,"2011-06-22",1603823
"3c3378d8f9464d8436c6a979f0336571","proventix-systems","undisclosed",NA,"2014-03-20",NA
"3c3378d8f9464d8436c6a979f0336571","proventix-systems","debt_financing",NA,"2012-07-27",1e+06
"3c3378d8f9464d8436c6a979f0336571","proventix-systems","debt_financing",NA,"2013-08-12",1382431
"5659caecc68dc15aa45557c6ac5f7741","provesica","venture",NA,"2010-12-20",6179090
"adf60ed45fb13356cb8bd8ba280f7fb6","provia-laboratories","venture",NA,"2014-12-15",325000
"db8d0cbef90162bd185e505e9b98c829","providence-surgery","seed",NA,"2011-09-27",45000
"454d98efdccd95f94b8f5415e5ebf902","providencetherapy","debt_financing",NA,"2012-07-02",25000
"8fa1c0150c1b288034bedb628e3f81d1","provision-diagnostic-imaging","venture",NA,"2015-03-11",1736410
"90fca0a1cf8ea980bd5ec2e20dc3e6e5","provista-diagnostics","venture","a","2012-03-07",5e+06
"90fca0a1cf8ea980bd5ec2e20dc3e6e5","provista-diagnostics","venture","a","2013-04-17",6e+06
"90fca0a1cf8ea980bd5ec2e20dc3e6e5","provista-diagnostics","venture","a","2012-09-18",2500000
"90fca0a1cf8ea980bd5ec2e20dc3e6e5","provista-diagnostics","venture","b","2014-04-16",6e+06
"90fca0a1cf8ea980bd5ec2e20dc3e6e5","provista-diagnostics","venture",NA,"2015-03-16",3870986
"90fca0a1cf8ea980bd5ec2e20dc3e6e5","provista-diagnostics","venture",NA,"2015-08-03",6046254
"64f8ec6e08982b54f3fc105d82e8b1b5","provivi","venture",NA,"2015-03-13",1e+06
"64f8ec6e08982b54f3fc105d82e8b1b5","provivi","venture","1","2015-09-03",7471104
"667a76ed100aab51287c6a11b690ea74","prowess-smartdeploy",NA,NA,NA,NA
"82c7eb43933f503c0dcd46f8924e5b0f","proxeon","venture",NA,"2009-02-02",2410000
"95132aff78558b8b1c92197c966a3c8a","proximagen","venture",NA,"2011-09-29",1.6e+07
"95132aff78558b8b1c92197c966a3c8a","proximagen","venture",NA,"2009-06-05",80500000
"8c316ee49b92bf19d388e5541c83fafc","proximic","venture","a","2006-05-05",2060000
"8c316ee49b92bf19d388e5541c83fafc","proximic","venture","a","2007-01-01",3951000
"8c316ee49b92bf19d388e5541c83fafc","proximic","venture","b","2008-05-01",NA
"8c316ee49b92bf19d388e5541c83fafc","proximic","venture","c","2010-12-08",4400000
"860627c5fce73f8dfe2269ffe4d7dba3","proximus-io",NA,NA,NA,NA
"4e5db5b57dfefa2dd37a0ecc0f175cea","proxloop",NA,NA,NA,NA
"3fe9d0c70ff9e5ac2d74b6dd3e7e73bb","proxsys","undisclosed",NA,"2007-03-12",NA
"f6c85ac94f24a5e29b7e9d6db1fc59e2","prozyme","debt_financing",NA,"2011-10-14",321414
"4e7e164fee0b2823557d7653c5ef65ad","prsm-healthcare","seed",NA,"2013-09-19",50000
"4e7e164fee0b2823557d7653c5ef65ad","prsm-healthcare","venture",NA,"2012-05-25",55000
"76388161a7e74a54c862fe393fdfd2eb","prvdr",NA,NA,NA,NA
"353897ecf68a1c4a830ebc9ac631e0a4","prx-consulting","convertible_note",NA,"2015-10-01",20000
"353897ecf68a1c4a830ebc9ac631e0a4","prx-consulting","seed",NA,"2012-03-15",50000
"353897ecf68a1c4a830ebc9ac631e0a4","prx-consulting","seed",NA,"2014-04-08",80000
"353897ecf68a1c4a830ebc9ac631e0a4","prx-consulting","seed",NA,"2012-01-15",50000
"62793ac7ec5be86a72184a54eb21096a","pryde-marketing",NA,NA,NA,NA
"c53497bedcee2dec393f178597526f10","productstructure",NA,NA,NA,NA
"7bdbcd3155b4e4ec2cd3ca5a5dc4639f","ps-biotech","undisclosed",NA,"2013-09-02",NA
"7bdbcd3155b4e4ec2cd3ca5a5dc4639f","ps-biotech","venture","1","2014-11-25",NA
"74f97e6d5a8f807e0739b5f32bb29466","psivida","venture",NA,"2012-07-18",4e+07
"74f97e6d5a8f807e0739b5f32bb29466","psivida","post_ipo_equity",NA,"2013-07-19",10800000
"74f97e6d5a8f807e0739b5f32bb29466","psivida","post_ipo_equity",NA,"2014-03-13",7e+06
"dffb5d08302c8c51eb0f0c0932cb8864","pss-herbs-india",NA,NA,NA,NA
"01267dd4edb041894fa09f17542d0ecb","pssc-labs",NA,NA,NA,NA
"4a47d3225a9a277617a6fb67ca5d8a20","psyche",NA,NA,NA,NA
"3d1ea5df67cb20f77312c61bd37af2c5","psychemedics-corporation",NA,NA,NA,NA
"6f3d5c54e8e3847d9024d34ad0224f0d","psylin-neurosciences","venture",NA,"2009-07-29",5e+06
"65d5e53096cf1b19408387bdaf80d73d","psynova-neurotech","venture",NA,"2006-03-16",3930701
"6bd8db5d29ebe24882608267fa4a5aa2","ptc-therapeutics","private_equity",NA,"2009-12-22",5e+07
"6bd8db5d29ebe24882608267fa4a5aa2","ptc-therapeutics","private_equity",NA,"2012-07-23",3e+07
"6bd8db5d29ebe24882608267fa4a5aa2","ptc-therapeutics","private_equity",NA,"2013-05-15",4500000
"6bd8db5d29ebe24882608267fa4a5aa2","ptc-therapeutics","grant",NA,"2009-12-02",1e+06
"6bd8db5d29ebe24882608267fa4a5aa2","ptc-therapeutics","private_equity",NA,"2013-03-07",6e+07
"6bd8db5d29ebe24882608267fa4a5aa2","ptc-therapeutics","private_equity",NA,"2011-12-23",5e+06
"6bd8db5d29ebe24882608267fa4a5aa2","ptc-therapeutics","private_equity",NA,"2005-11-10",26600000
"6bd8db5d29ebe24882608267fa4a5aa2","ptc-therapeutics","convertible_note",NA,"2015-08-14",1.5e+08
"9b0076703e6be34a97c867eedff4f18c","ptengine-jp",NA,NA,NA,NA
"11a2cd5eef2a822477227631639b46ff","public-good-software","debt_financing",NA,"2014-04-10",325000
"11a2cd5eef2a822477227631639b46ff","public-good-software","seed",NA,"2015-01-28",1600000
"ba55ffce11e921ce56cebb3ac839c53c","public-insight-corporation","seed",NA,"2013-04-08",1e+05
"ba55ffce11e921ce56cebb3ac839c53c","public-insight-corporation","venture",NA,"2014-09-25",520000
"8fa581392ea6971397994a189498afce","publicfast","seed",NA,"2013-12-13",3e+05
"606476b58576e927585d6d7d2ebcc814","publicitweet",NA,NA,NA,NA
"531c3a97b26f0b45e6138d76ddfd27e3","publishdrive",NA,NA,NA,NA
"46d37fde49f66cd0bd006522e090fe6d","publishthis","venture","a","2011-01-01",5e+06
"46d37fde49f66cd0bd006522e090fe6d","publishthis","seed",NA,"2011-12-01",2738628
"26374c802323629a7fd0d7a69236e510","pubmatic","venture","b","2009-03-16",3500000
"26374c802323629a7fd0d7a69236e510","pubmatic","venture","c","2010-04-15",7500000
"26374c802323629a7fd0d7a69236e510","pubmatic","venture","D","2012-06-06",3.2e+07
"26374c802323629a7fd0d7a69236e510","pubmatic","venture",NA,"2014-02-06",1.3e+07
"26374c802323629a7fd0d7a69236e510","pubmatic","venture","a","2008-01-01",7e+06
"26374c802323629a7fd0d7a69236e510","pubmatic","secondary_market",NA,"2015-06-19",NA
"ec42613397dd3628aaeb4e6976e639a9","puget-energy",NA,NA,NA,NA
"570a42c632e23659c2f277171a058cd0","pugmarks-me",NA,NA,NA,NA
"4bcf14811badf14e8b05595175d89bce","pulmatrix","debt_financing",NA,"2013-02-25",20500000
"4bcf14811badf14e8b05595175d89bce","pulmatrix","venture","1","2009-11-02",30200000
"4bcf14811badf14e8b05595175d89bce","pulmatrix","venture","1","2009-03-11",3500000
"4bcf14811badf14e8b05595175d89bce","pulmatrix","venture","1","2011-08-15",1.4e+07
"4bcf14811badf14e8b05595175d89bce","pulmatrix","grant",NA,"2010-12-14",5700000
"4bcf14811badf14e8b05595175d89bce","pulmatrix","private_equity",NA,"2015-06-16",1e+07
"cfac173b37247c970a4e9c70a5f051db","pulmokine","seed",NA,"2015-03-03",1e+06
"9bab228f727cf3682d444c90a3afe9dc","pulmonetic-systems",NA,NA,NA,NA
"337184e3cdfbb75965ff229ed92b77fd","pulmonx","venture",NA,"2010-01-19",11500000
"337184e3cdfbb75965ff229ed92b77fd","pulmonx","venture","1","2010-03-08",3.2e+07
"337184e3cdfbb75965ff229ed92b77fd","pulmonx","private_equity",NA,"2012-01-31",1e+07
"337184e3cdfbb75965ff229ed92b77fd","pulmonx","venture","1","2007-05-07",2e+07
"337184e3cdfbb75965ff229ed92b77fd","pulmonx","debt_financing",NA,"2014-09-17",2e+07
"b5c322589baa272a2ab60b4e05e1674b","pulmotect",NA,NA,NA,NA
"858f43c4dc2316f6d0c35a18858b752d","pulsar-education",NA,NA,NA,NA
"a27e837205ff04f8da3c27e80ea0f8a5","pulse-8-inc","venture","a","2013-12-30",1135000
"a27e837205ff04f8da3c27e80ea0f8a5","pulse-8-inc","undisclosed",NA,"2014-08-06",NA
"fae097939266829f6ccd18f1cc0b5b03","pulse-insights",NA,NA,NA,NA
"56ac0afbe5e33cc0c2087e0398630def","pulsepoint","venture",NA,"2011-05-26",9477054
"56ac0afbe5e33cc0c2087e0398630def","pulsepoint","debt_financing",NA,"2010-05-07",1008401
"56ac0afbe5e33cc0c2087e0398630def","pulsepoint","venture",NA,"2013-01-01",3e+06
"56ac0afbe5e33cc0c2087e0398630def","pulsepoint","debt_financing",NA,"2015-09-29",3e+07
"5dc8cfe64839073dd8c3fc2426a7d528","pulzze-systems-inc","seed",NA,"2015-01-01",150000
"7ce5bb09f734255b4f9a9c6e31cabf58","puma-biotechnology","post_ipo_equity",NA,"2014-02-16",129300000
"7ce5bb09f734255b4f9a9c6e31cabf58","puma-biotechnology","venture",NA,"2011-10-12",70000249
"7ce5bb09f734255b4f9a9c6e31cabf58","puma-biotechnology","post_ipo_equity",NA,"2015-01-27",2.18e+08
"0046a8930dfa0e728c5a314e4bc31746","pummelvision-com",NA,NA,NA,NA
"db03e014b68fc7cda086ce56796682dd","pump","seed",NA,"2013-09-06",40000
"2c112c1fb844cb8b617c1652c15e162d","punch-cyber-analytic-group",NA,NA,NA,NA
"785db72e1b17eb9933df9af319a50b90","punchme",NA,NA,NA,NA
"f51f2db61b4c6fcbddac40dd2b0b6faa","punchtab","venture","a","2011-11-08",4400000
"f51f2db61b4c6fcbddac40dd2b0b6faa","punchtab","seed",NA,"2011-05-31",850000
"f51f2db61b4c6fcbddac40dd2b0b6faa","punchtab","venture",NA,"2014-04-30",6250000
"7a4abfa6718bfdf34b9c5884387b8afb","pupil",NA,NA,NA,NA
"f36ab9dfae5fd86d2a7d15f5ed1ab90a","purdue-pharma",NA,NA,NA,NA
"d02699b44f1eefcea863cbcf78145404","pure-bioscience","venture",NA,"2010-11-09",2376000
"d02699b44f1eefcea863cbcf78145404","pure-bioscience","venture",NA,"2012-07-16",650250
"d02699b44f1eefcea863cbcf78145404","pure-bioscience","venture",NA,"2011-12-24",225000
"68d6874713e4c96bf1b406bace8fd027","pure-blue-technologies",NA,NA,NA,NA
"952281f4cf847551467c0d3994827c50","pure-life-renal","venture",NA,"2015-06-01",NA
"952281f4cf847551467c0d3994827c50","pure-life-renal","debt_financing",NA,"2013-06-04",5e+05
"952281f4cf847551467c0d3994827c50","pure-life-renal","venture","1","2014-05-09",2e+07
"3576dadff2eec6354a1dde405798450b","purebrands","venture",NA,"2010-12-20",750000
"1519425734c094c5b1a5878e3e46db2b","purepredictive","venture",NA,"2014-03-05",1720000
"1519425734c094c5b1a5878e3e46db2b","purepredictive","debt_financing",NA,"2014-11-12",1550000
"1519425734c094c5b1a5878e3e46db2b","purepredictive","debt_financing",NA,"2015-08-10",3842900
"4d818f25d38667ed5d80e365adbb329d","purespeech",NA,NA,NA,NA
"bdfd52cd4c1b370508bffa488a0b9bbb","puretech-2",NA,NA,NA,NA
"7656f71c53d60685e62bd4624e8001da","puridify","venture","A","2015-10-21",3405256.4777
"7656f71c53d60685e62bd4624e8001da","puridify","seed",NA,"2014-05-29",1424811
"a11097700a472ab15a96f4e011d72ae8","purigen-biosystems","debt_financing",NA,"2013-04-19",830000
"a11097700a472ab15a96f4e011d72ae8","purigen-biosystems","debt_financing",NA,"2014-08-05",2e+05
"66e871a38c610db016680201cdb70e1c","purkinje-farms","equity_crowdfunding",NA,"2014-11-15",5000
"f13e0cb4eb5ebabf2ebcb9eaa90f9104","purple-politics",NA,NA,NA,NA
"546c75dabc27313bc593794014b7f966","purple-blue-bo","venture","a","2009-08-18",NA
"09db76ac40d3f28b3130e2b7ade09141","purple-orange-llc",NA,NA,NA,NA
"2310aeecf1f101b161b0d4ee578c0853","purplebricks","venture","B","2015-12-04",87262660.6084314
"2310aeecf1f101b161b0d4ee578c0853","purplebricks","venture","A","2014-08-18",13364740
"05fea0810943761b67c11fb3c4b6ba39","pursway","venture","A","2010-02-09",8500000
"05fea0810943761b67c11fb3c4b6ba39","pursway","venture","B","2011-10-03",1400000
"05fea0810943761b67c11fb3c4b6ba39","pursway","venture","B","2013-10-03",7200000
"d25ed6be8cf194c0eb2dd10547b41729","purthread-technologies","venture",NA,"2013-11-04",7e+06
"d25ed6be8cf194c0eb2dd10547b41729","purthread-technologies","venture",NA,"2013-01-18",2076957
"9892d558f4e3d92f62f3923e6e57c46e","pushstartr",NA,NA,NA,NA
"d64f5a5e26fd9a66f52bb0da43fca20c","push-technologies",NA,NA,NA,NA
"d7995a29505a3d2415c7fa4b8772c3ef","pushwizard",NA,NA,NA,NA
"7bbe4de800213b5632e1007fb62aaf43","putney","venture","b","2009-11-02",6700000
"7bbe4de800213b5632e1007fb62aaf43","putney","venture",NA,"2010-11-05",2843756
"7bbe4de800213b5632e1007fb62aaf43","putney","venture","c","2011-09-29",2.1e+07
"7bbe4de800213b5632e1007fb62aaf43","putney","debt_financing",NA,"2014-04-24",3e+06
"7bbe4de800213b5632e1007fb62aaf43","putney","venture",NA,"2014-06-23",16056308
"e15d2cb048dbecac27f10f49314b1856","pxradia","venture",NA,"2014-04-07",50000
"cf9dc7b409e56cd01d8c200e05ecb8d4","pya-analytics","private_equity",NA,"2014-01-30",5e+05
"e4fc3eeef7ccdcf45b7527db3f23117e","pykih",NA,NA,NA,NA
"bb7a64305f5f769f23a9f6d047d6abac","pyng-medical","venture",NA,"2015-12-02",105582
"bb7a64305f5f769f23a9f6d047d6abac","pyng-medical","venture",NA,"2011-01-11",599820
"bb7a64305f5f769f23a9f6d047d6abac","pyng-medical","venture",NA,"2012-07-05",170000
"bb7a64305f5f769f23a9f6d047d6abac","pyng-medical","venture",NA,"2013-10-03",588118
"417ff952f515c4219e624d4e1782266b","pyramid-analytics","venture","B","2015-10-20",3e+07
"417ff952f515c4219e624d4e1782266b","pyramid-analytics","venture","a","2013-03-18",11500000
"d459294ebe8bf42d440bc1cf75c8b831","pyrosequencing-biotage-since-2003",NA,NA,NA,NA
"54f804854f0d543c635f9c50333c87f4","q-care-international","venture",NA,"2014-02-18",3800000
"54f804854f0d543c635f9c50333c87f4","q-care-international","venture",NA,"2015-04-30",3850000
"51cb0c1af89584bf847edda659f3b56f","q-chip","venture",NA,"2006-02-15",574000
"51cb0c1af89584bf847edda659f3b56f","q-chip","venture","1","2011-05-20",6e+06
"51cb0c1af89584bf847edda659f3b56f","q-chip","undisclosed",NA,"2010-09-18",3125336
"9f226de2750204430dece65182abb47b","q-holdings","venture","b","2008-02-15",8e+06
"9f226de2750204430dece65182abb47b","q-holdings","venture","a","2012-07-27",4018047
"da8cc1f1dfc25c3375995ac79ab55c78","q-med",NA,NA,NA,NA
"d22dbfcccf0fc3e848d2cfa13fe3f022","q4-web-systems","venture",NA,"2014-09-01",5e+06
"019d60f3cab6cdf9d71ba64b99885e96","california-institute-for-quantitative-biosciences",NA,NA,NA,NA
"f90bb9f2bceeef57d5d592f273f7015b","qbox-io","debt_financing",NA,"2015-03-11",120000
"f90bb9f2bceeef57d5d592f273f7015b","qbox-io","venture",NA,"2014-03-18",30000
"f90bb9f2bceeef57d5d592f273f7015b","qbox-io","seed",NA,"2013-08-29",428333
"f90bb9f2bceeef57d5d592f273f7015b","qbox-io","seed",NA,"2015-08-26",2400000
"aacab62a61c0ff9528cf104ab6b867f4","qdatum","venture",NA,"2014-08-11",NA
"c65aa861f3abc0eea12e1942199da8ef","qelzal",NA,NA,NA,NA
"3fbf66bf3ec9f2e19463020fcacd0fe8","qfer-me-marketing-platform-for-restaurants-and-cafes",NA,NA,NA,NA
"80412b41d0b471c044d76d2c974afd86","qfx-solutions-ltd",NA,NA,NA,NA
"cac03be57f6b8d2d2d15eb7b73de970d","qiagen",NA,NA,NA,NA
"ece3b83ac824b285174ac256bb781f6f","qieon-research",NA,NA,NA,NA
"1d6fb3d894cc5e6fa3792f60bd29b67f","qleeq",NA,NA,NA,NA
"81e73a280d7be48166e36ce87c68bd32","qlik-technologies",NA,NA,NA,NA
"6d4d141669de4fcff00c7f110ee18d0e","qlika","seed",NA,"2013-03-15",20000
"6d4d141669de4fcff00c7f110ee18d0e","qlika","seed",NA,"2013-10-23",1700000
"7594940ccecce902e4dc92c97b7aafe6","qliktech","venture",NA,"2004-12-06",12500000
"11605687ec6164114ef0aac7a90cc83f","qlikview",NA,NA,NA,NA
"f6e3cbedd5ddffe55dc119084f29ece5","qlt",NA,NA,NA,NA
"56da2096ca1cf1700ab50fa5bcaf38c9","qlt-usa",NA,NA,NA,NA
"cf5eff57af39e6773afbd2555a47675a","qlucore","angel",NA,"2012-08-01",650000
"44bef008e9e5b5e9ab28ca1c59fb395d","qlusters","venture","c","2007-08-08",10360000
"221150d24e1773aaf9ad208834156822","qm-scientific","angel",NA,"2014-08-15",1e+05
"c76999be36f451d52731e7eb56fc3358","qmedic","grant",NA,"2013-10-02",3e+06
"c76999be36f451d52731e7eb56fc3358","qmedic","angel",NA,"2015-05-22",1100000
"0e742ae71d42856c2b6336124fe58119","qmetrix",NA,NA,NA,NA
"ab9d9d7f7f9be401dc30c1bd36598a58","qmonix",NA,NA,NA,NA
"2dacf1c44c9021a062ff7268c764635e","qoints-inc",NA,NA,NA,NA
"4b2a5307a781e6f19f3f656fb3e6604d","qordoba","seed","a","2014-01-29",1500000
"4b2a5307a781e6f19f3f656fb3e6604d","qordoba","undisclosed",NA,"2011-06-01",NA
"598b8a5bac8e2f86081ad5f7adafaaa8","qr-pharma","venture","A","2015-03-16",NA
"598b8a5bac8e2f86081ad5f7adafaaa8","qr-pharma","debt_financing",NA,"2010-01-15",150000
"598b8a5bac8e2f86081ad5f7adafaaa8","qr-pharma","seed",NA,"2013-06-20",350000
"598b8a5bac8e2f86081ad5f7adafaaa8","qr-pharma","venture",NA,"2012-01-17",110000
"598b8a5bac8e2f86081ad5f7adafaaa8","qr-pharma","debt_financing",NA,"2010-04-26",706103
"598b8a5bac8e2f86081ad5f7adafaaa8","qr-pharma","venture",NA,"2015-01-05",5e+05
"598b8a5bac8e2f86081ad5f7adafaaa8","qr-pharma","venture","A","2015-05-26",5700000
"09c32b1ba75f090d6a0b040bd355f913","qr4-technologies",NA,NA,NA,NA
"a6630fba3f70c5594c2561c540fd7643","qruso","seed",NA,"2012-04-13",NA
"ee4d31e270fb83a715eccacf5aed848f","qrxpharma","debt_financing",NA,"2009-12-30",12397760
"ee4d31e270fb83a715eccacf5aed848f","qrxpharma","post_ipo_equity",NA,"2013-12-13",11600000
"ee4d31e270fb83a715eccacf5aed848f","qrxpharma","venture","1","2003-04-30",5e+05
"fd7fe438a00ec87c09ea6a38bab3ce8d","qseap-technologies-pvt-ltd",NA,NA,NA,NA
"c3c5f7af0a832a2603e6eda2e6e4802b","qsearch",NA,NA,NA,NA
"2a4dba85191261b54506b39875079961","qstream","venture","a","2013-09-27",2800000
"2a4dba85191261b54506b39875079961","qstream","debt_financing",NA,"2013-08-12",505000
"2a4dba85191261b54506b39875079961","qstream","venture","A","2015-01-13",4e+06
"64b0e776e070673a78c4801630fdc6dd","qu-stay-curious","convertible_note",NA,"2015-02-04",50000
"26729cb4d783aea780341a2838fa54d9","quad-technologies","venture","A","2015-11-05",3e+06
"0e8cafc9091308accb0083e8609a637a","quadmetrics",NA,NA,NA,NA
"59da53eb4f7933b3029f6162ca72b375","quadpharma","venture",NA,"2012-11-20",1e+06
"32ca1cc172cf26629d39e5a8644a165f","quadroi","seed",NA,"2012-05-31",NA
"32ca1cc172cf26629d39e5a8644a165f","quadroi","seed",NA,"2012-02-01",160000
"5170f7c41d1b1e0febd6104cdb547112","quaero-corporation","seed",NA,"2014-05-31",2600000
"5170f7c41d1b1e0febd6104cdb547112","quaero-corporation","seed",NA,"2015-08-24",1500000
"aa527f22c907ff4ad7bb0d0fe8c940a0","qual-canal","seed",NA,"2012-10-01",50000
"aa527f22c907ff4ad7bb0d0fe8c940a0","qual-canal","seed",NA,"2014-07-14",1e+05
"dccf6de24e935c53d67a85dcc445faef","qualia-hr",NA,NA,NA,NA
"96072fb36eb08cbb45b70d1ad9188cb6","quality-systems","venture",NA,"2011-04-11",11394037
"96072fb36eb08cbb45b70d1ad9188cb6","quality-systems","venture",NA,"2010-02-12",1.2e+07
"e9b6610364db4fc6581e829f894da605","quandl","venture","A","2014-11-13",5400000
"d52c98a17024f043e0b9e947ddbc0c56","quandx","venture",NA,"2015-12-10",3e+06
"d52c98a17024f043e0b9e947ddbc0c56","quandx","venture","1","2014-01-14",950000
"d52c98a17024f043e0b9e947ddbc0c56","quandx","venture","1","2013-03-01",3e+05
"f5af6358770c2d6cde88b6cea9942332","quantabytes",NA,NA,NA,NA
"c857a91235ac09c6489dc27b41656f3e","quantagen-biotech","seed",NA,"2010-10-19",11500
"230a6951596c234e1d4b298422bbe35f","quantal",NA,NA,NA,NA
"65901c894735e3fe570aa81a418cbdb5","quantalife","debt_financing",NA,"2011-07-22",3557182
"65901c894735e3fe570aa81a418cbdb5","quantalife","venture",NA,"2009-06-03",7955437
"65901c894735e3fe570aa81a418cbdb5","quantalife","venture","1","2010-12-13",17200000
"3a6d302860936246cc1b76dd0e004e3c","quantapore","venture",NA,"2014-05-21",3.5e+07
"54cd0cbcee80e9ca425e579ed8c53b3a","quantave",NA,NA,NA,NA
"c494b39f565163e7d9b31ec84fc21139","quantdeck-systems",NA,NA,NA,NA
"e98859381d33a29ebbcc3c8999c66f95","quantec-geoscience","venture",NA,"2006-12-11",3e+06
"a5b50aa2d5f0f78e0553c7ed20b92bdb","quanterix","venture",NA,"2010-10-12",2500000
"a5b50aa2d5f0f78e0553c7ed20b92bdb","quanterix","venture",NA,"2011-08-19",6e+06
"a5b50aa2d5f0f78e0553c7ed20b92bdb","quanterix","venture","1","2008-08-25",1.5e+07
"a5b50aa2d5f0f78e0553c7ed20b92bdb","quanterix","venture","1","2012-11-15",18500000
"a5b50aa2d5f0f78e0553c7ed20b92bdb","quanterix","debt_financing",NA,"2012-03-06",1999999
"de2fd23094752ca1421c8685472a5cb4","insidevault","venture",NA,"2015-09-17",10300000
"4a661be94d4daa50139608004af4a564","quantico-trends","seed",NA,"2015-11-30",4e+05
"4a661be94d4daa50139608004af4a564","quantico-trends","convertible_note",NA,"2015-02-01",25000
"4a661be94d4daa50139608004af4a564","quantico-trends","convertible_note",NA,"2014-09-01",25000
"8a969f78ce786d9bdd0801f544911393","quantified-impressions","debt_financing",NA,"2013-12-04",550000
"b6ec6cd3ede742d2cccc1baf1b28036e","quantified-skin","undisclosed",NA,"2014-01-01",60750
"b6ec6cd3ede742d2cccc1baf1b28036e","quantified-skin","undisclosed",NA,"2013-08-19",1e+05
"b6ec6cd3ede742d2cccc1baf1b28036e","quantified-skin","undisclosed",NA,"2013-07-01",120000
"8f94b7fff094aac3c04463e27559f6f6","quantifind","venture",NA,"2009-10-15",NA
"8f94b7fff094aac3c04463e27559f6f6","quantifind","venture",NA,"2014-07-22",1.2e+07
"1d0a61f9f9d01a750bcd4ffb6ae5c1ad","quantihealth","seed",NA,"2015-10-12",3200000
"13fde7f5898b5f14c46e5bb1b2955bc2","quantinum",NA,NA,NA,NA
"01c5901b2c695a2fba07397c4dfb5228","quantisense","venture",NA,"2009-10-19",99875
"98ef86ea4714b049063728ac87105355","quantitative-medicine","angel",NA,"2013-02-21",325000
"1369c9f9ff6f83ab40433a2d7e4b2f47","quantivo","venture","a","2008-01-09",7100000
"1369c9f9ff6f83ab40433a2d7e4b2f47","quantivo","debt_financing",NA,"2009-12-16",2300000
"979753e355e794ee3e90cf3dd8612d11","quantmind",NA,NA,NA,NA
"f4ece870f645c7c68a72478ad3922d2f","quantomic--llc",NA,NA,NA,NA
"587bd16c55fa00581896b92c6bc56d18","quantros","private_equity",NA,"2013-07-31",NA
"c9cc671715ac9ce17f81057e304a3f75","quantrx-biomedical","venture",NA,"2009-08-14",406039700
"f058338c0bc7030819d25867cf2d1b9a","quantstock",NA,NA,NA,NA
"7a00944b4cea69e9d4318266b52c3aad","quantum-biosystems","venture","B","2015-02-09",20500000
"644de57ba872a12dff2be68cc6adac5d","quantum-business-analytics",NA,NA,NA,NA
"70b15e7a80912e9c7fcca3828da9b997","quantum-consumer-solutions",NA,NA,NA,NA
"54b82ad58b8bcfdfeb2e400973fe90df","quantum-immunologics","venture",NA,"2010-09-25",1633201
"54b82ad58b8bcfdfeb2e400973fe90df","quantum-immunologics","venture",NA,"2009-06-18",3703530
"54b82ad58b8bcfdfeb2e400973fe90df","quantum-immunologics","venture","1","2009-09-15",2200000
"ea233f9b9f5110dd82e44537a06bd814","quantum-leap-innovations",NA,NA,NA,NA
"388ef86351c6747a41a8f82ae2677350","quantum-ops","venture","a","2012-06-28",1050000
"a07e9fbc91cf13f3d50706b4cd255a2f","quantumdx-group","grant",NA,"2013-10-18",1790000
"a07e9fbc91cf13f3d50706b4cd255a2f","quantumdx-group","venture",NA,"2014-06-02",8420000
"a07e9fbc91cf13f3d50706b4cd255a2f","quantumdx-group","grant",NA,"2012-09-26",5700000
"a07e9fbc91cf13f3d50706b4cd255a2f","quantumdx-group","grant",NA,"2011-09-01",1788142
"a07e9fbc91cf13f3d50706b4cd255a2f","quantumdx-group","grant",NA,"2012-11-05",2240932
"a07e9fbc91cf13f3d50706b4cd255a2f","quantumdx-group","private_equity",NA,"2011-01-01",2100000
"3937388992ba0427eae32be54dce6922","quantumgraph",NA,NA,NA,NA
"466cd271258daecc43c6f712f56eaa16","quantzig",NA,NA,NA,NA
"350ba1cceabced2ff30ea0ec321bd188","quark-pharmaceuticals","venture","e","2008-07-04",2.7e+07
"350ba1cceabced2ff30ea0ec321bd188","quark-pharmaceuticals","venture",NA,"2010-06-01",1e+07
"305dbb1bb16b2d135aa4869e6e06a4ed","quarrio-corp",NA,NA,NA,NA
"7aab11d29b355f9a2cefc3c921f4bb19","quarryio",NA,NA,NA,NA
"8320cdc1762abdf2b1bdc0e0915c3ef7","quartet-medicine-","venture","A","2015-10-07",6e+06
"8320cdc1762abdf2b1bdc0e0915c3ef7","quartet-medicine-","venture","A","2014-10-23",1.7e+07
"9d122b4de1dca0d6ef6c1b7845e571bd","quasi-convex-union",NA,NA,NA,NA
"a8473ed9a3dfe1097d1c8ab0125be7df","quatrx-pharmaceuticals","venture","E","2007-05-22",4.4e+07
"a8473ed9a3dfe1097d1c8ab0125be7df","quatrx-pharmaceuticals","convertible_note",NA,"2009-04-24",14025045
"6c6d738a983308857f2847b90d024f5d","qubit","angel",NA,"2010-10-01",1350000
"6c6d738a983308857f2847b90d024f5d","qubit","venture","1","2012-12-04",7500000
"6c6d738a983308857f2847b90d024f5d","qubit","venture","1","2014-09-29",2.6e+07
"b7747dda94b12a1a3779471e0e1c4a18","qudos-visuals",NA,NA,NA,NA
"e31ff2d5ae1623c66c3492948b530466","query-hunter","seed",NA,"2011-12-01",NA
"72ddf687a74fa2eb04682465fe0d4ac4","queryio",NA,NA,NA,NA
"0c05161afa59f025a5e55d25c9f4203b","querysurge",NA,NA,NA,NA
"6421c63fb059b9c7f26b79da07102eb8","quest-groups",NA,NA,NA,NA
"7e30b100d14cd1111e351c9745b50a06","questcor-pharmaceuticals",NA,NA,NA,NA
"444a598648a53ae8daf9253da0b464ef","questex-media-group",NA,NA,NA,NA
"25311d6cfc7ee476592dffaabcb025c7","quibble-genomics",NA,NA,NA,NA
"70d79030b2ec1af056adf34da5e37357","quickbuyer",NA,NA,NA,NA
"ac30adbfc9a22dd9475c41ef1320385a","quicklizard",NA,NA,NA,NA
"8c136435f8878c710efb5912818fe8ca","quicklogix","seed",NA,"2015-11-01",60000
"aad5b71efcd4cf21a353030dde0abb07","quickshow",NA,NA,NA,NA
"d5735c506c8b2d91efc01b6dbfbb24d5","quid","venture","C","2011-07-25",2.4e+07
"d5735c506c8b2d91efc01b6dbfbb24d5","quid","venture","D","2015-03-19",3.9e+07
"d5735c506c8b2d91efc01b6dbfbb24d5","quid","convertible_note",NA,"2013-12-31",3500000
"b101c345fcd53980654b72604f6f37c7","quidel",NA,NA,NA,NA
"be8e53f8331fe8482808d9ad8b9dce72","quidgest",NA,NA,NA,NA
"ecc7fcd60bc39a0e61d6d39e680febcc","quill-2","grant",NA,"2014-05-16",2e+05
"ecc7fcd60bc39a0e61d6d39e680febcc","quill-2","seed",NA,"2015-02-01",18000
"ec21500359082c5a86c48abc0eb7385d","quincy-bioscience","venture",NA,"2010-12-20",5181090
"009490374a103d17b9bbfdd81a671835","quinnova-pharmaceuticals","venture","A","2006-11-28",13600000
"009490374a103d17b9bbfdd81a671835","quinnova-pharmaceuticals","convertible_note",NA,"2010-09-28",3e+05
"009490374a103d17b9bbfdd81a671835","quinnova-pharmaceuticals","venture","B","2009-10-28",17400000
"702375b011369654159b9b7ec37490a5","quintessence-biosciences","private_equity",NA,"2012-06-26",1486000
"b8ae0a3794878f450bca83761974bd86","quintiles","debt_financing",NA,"2009-12-21",5.25e+08
"b8ae0a3794878f450bca83761974bd86","quintiles","grant",NA,"2013-06-12",1e+06
"710187776bb06372720f083bb594b3be","quintype","venture",NA,"2015-09-23",3250000
"9d3dee3026e73b2ecccd960fe702929c","computable-genomix","seed",NA,"2010-12-24",230000
"9d3dee3026e73b2ecccd960fe702929c","computable-genomix","venture","1","2013-01-01",2500000
"9d3dee3026e73b2ecccd960fe702929c","computable-genomix","seed",NA,"2012-06-01",1e+05
"9d3dee3026e73b2ecccd960fe702929c","computable-genomix","seed",NA,"2013-06-01",1275750
"9d3dee3026e73b2ecccd960fe702929c","computable-genomix","seed",NA,"2013-11-01",1249500
"9b08499a25a576aaed8d65011d93c302","quorum-3",NA,NA,NA,NA
"816f2cbd8844e9aa9b255cff39f63628","quorum-intelligence",NA,NA,NA,NA
"9bb558188c03fbd508366f7c56fae9fb","quotient-biodiagnostics","venture",NA,"2012-03-06",11200000
"9bb558188c03fbd508366f7c56fae9fb","quotient-biodiagnostics","private_equity",NA,"2013-02-26",5e+06
"9bb558188c03fbd508366f7c56fae9fb","quotient-biodiagnostics","seed",NA,"2014-11-27",2.7e+07
"9be405e64cd90769ea63a9ef635dbd94","quotient-clinical","private_equity",NA,"2008-09-03",62661128.6164
"10f3b58b45304527a762931ca7a90c05","quovo","venture","A","2013-12-12",1400000
"10f3b58b45304527a762931ca7a90c05","quovo","venture","A","2015-07-08",3800000
"fee7bfca29734b28b2ac35605ccce7e0","qurater","seed",NA,"2013-03-01",50000
"e445d8360166cfa62ab04625b7e5fae1","quri","venture","C","2015-10-14",1.7e+07
"e445d8360166cfa62ab04625b7e5fae1","quri","debt_financing",NA,"2009-02-09",282500
"e445d8360166cfa62ab04625b7e5fae1","quri","venture","a","2012-01-03",4275735
"e445d8360166cfa62ab04625b7e5fae1","quri","venture","b","2013-10-02",10200000
"5fca942edcb22ece34bfaf7420bc25a1","qvella-corporation","venture","A","2015-10-29",2e+07
"36217381519cce9c051068626bc46b90","qvinci-software","venture",NA,"2015-10-30",3400000
"0eea1c96286296ad92376306e964f6b4","qwalytics","seed",NA,"2014-01-13",25000
"0eea1c96286296ad92376306e964f6b4","qwalytics","seed",NA,"2014-03-18",NA
"0d3654246352fb9554f05b2dd434ec01","qwell-pharmaceuticals","venture","a","2009-01-06",7e+06
"533cbb97e3dcf8ff5f33cbb4cfa90cd4","qwiksense","seed",NA,"2013-11-11",100338
"533cbb97e3dcf8ff5f33cbb4cfa90cd4","qwiksense","grant",NA,"2012-12-31",19812
"533cbb97e3dcf8ff5f33cbb4cfa90cd4","qwiksense","grant",NA,"2013-03-23",25912
"533cbb97e3dcf8ff5f33cbb4cfa90cd4","qwiksense","angel",NA,"2014-11-04",87617
"533cbb97e3dcf8ff5f33cbb4cfa90cd4","qwiksense","angel",NA,"2015-05-15",56991
"e7e1c5f9730a06ff9d710db88f26aa49","qxbranch",NA,NA,NA,NA
"c4ef92b1c65b67ea2927a06887320031","r-fn",NA,NA,NA,NA
"06366e52702dd70be6c7939a603e59f6","r-ga",NA,NA,NA,NA
"a0fc8bef16eff21281479831c4bf25a8","r18-communication-and-technology",NA,NA,NA,NA
"040700800f88fd33e897f2deca4630af","r3dstar-biomedical",NA,NA,NA,NA
"1dc8a28dd8c687a2f679b7bb75685677","r3intell",NA,NA,NA,NA
"26c76cbb8330c532da7ff19b16319107","r3r",NA,NA,NA,NA
"15a0389874d9bfd0d974a20ea7f8d3f4","ra-pharmaceuticals","venture","a","2012-05-16",8600000
"15a0389874d9bfd0d974a20ea7f8d3f4","ra-pharmaceuticals","venture",NA,"2010-02-25",10333082
"15a0389874d9bfd0d974a20ea7f8d3f4","ra-pharmaceuticals","venture","B","2015-07-23",58500000
"21947daa0eef239c669284b5fe78a3a6","racal-radar-defence-systems",NA,NA,NA,NA
"23f8d8f994060b31ab9e2af02e57c571","race-against-the-machine",NA,NA,NA,NA
"d2d4293f6749c0fa92e59f56fa612c4f","radar-do-futuro",NA,NA,NA,NA
"8420299d511cbb6ea105cea71ac7d529","radar-logic-inc-",NA,NA,NA,NA
"cbd878ee62fe678307d38e2156880ee7","radial-analytics","venture",NA,"2015-01-06",400040
"2ed3badf7893da30f5a0dfa6e54ab671","radico","venture",NA,"2013-12-03",1824993
"d2c28b941bafbb8c2b86be6c080e332c","radico-health",NA,NA,NA,NA
"26754eb646557e9f1905c7c73abfafb6","radient-pharmaceuticals","debt_financing",NA,"2011-02-14",8437500
"230f05ac0ad55348b3715b35ca74798d","radient-technologies","venture",NA,"2015-07-01",1395606.2465
"230f05ac0ad55348b3715b35ca74798d","radient-technologies","debt_financing",NA,"2013-07-15",2229092
"230f05ac0ad55348b3715b35ca74798d","radient-technologies","venture","1","2012-09-06",406039
"230f05ac0ad55348b3715b35ca74798d","radient-technologies","debt_financing",NA,"2014-05-27",350113
"230f05ac0ad55348b3715b35ca74798d","radient-technologies","venture",NA,"2015-02-09",40287
"230f05ac0ad55348b3715b35ca74798d","radient-technologies","venture",NA,"2015-10-30",550632
"d7711fa8c45b5206cbc6a643465a50b9","radio-advertising-bureau",NA,NA,NA,NA
"039361d6f8b217e6cb3eca454f9d8f0e","radioactive-south-east-asia",NA,NA,NA,NA
"cf5845aed324926b15f60255eaa8b089","radiorx","private_equity",NA,"2013-04-17",20450011
"5e00c6064888a1cf664fc7683e97f9f4","radisphere",NA,NA,NA,NA
"d35c6601f65730ce8d06adb89e0e18d4","radisphere-national-radiology-group","venture",NA,"2010-11-16",27500005
"d35c6601f65730ce8d06adb89e0e18d4","radisphere-national-radiology-group","debt_financing",NA,"2012-03-19",1.5e+07
"7fcc0a080997b9af46e99c125ac3ba03","radius-intelligence-inc","venture","A","2013-01-23",8400000
"7fcc0a080997b9af46e99c125ac3ba03","radius-intelligence-inc","venture","b","2014-01-09",1.3e+07
"7fcc0a080997b9af46e99c125ac3ba03","radius-intelligence-inc","seed","A","2009-09-19",2750000
"7fcc0a080997b9af46e99c125ac3ba03","radius-intelligence-inc","undisclosed",NA,"2012-03-01",NA
"7fcc0a080997b9af46e99c125ac3ba03","radius-intelligence-inc","venture","C","2014-09-23",54700000
"7fcc0a080997b9af46e99c125ac3ba03","radius-intelligence-inc","venture","F","2015-07-29",5e+07
"b243356fd93e1dba0ee8c9cd1c6a506e","radius-health","venture",NA,"2014-06-09",NA
"b243356fd93e1dba0ee8c9cd1c6a506e","radius-health","venture","1","2011-07-26",6.6e+07
"b243356fd93e1dba0ee8c9cd1c6a506e","radius-health","private_equity",NA,"2011-12-16",21400000
"b243356fd93e1dba0ee8c9cd1c6a506e","radius-health","venture","1","2007-04-02",57500000
"b243356fd93e1dba0ee8c9cd1c6a506e","radius-health","venture","1","2008-11-20",1.5e+07
"b243356fd93e1dba0ee8c9cd1c6a506e","radius-health","private_equity",NA,"2013-04-25",4.3e+07
"b243356fd93e1dba0ee8c9cd1c6a506e","radius-health","venture","1","2007-09-17",1e+07
"06e47973b9414c2c22df9b69f9875559","radlogics","seed",NA,"2011-01-01",850000
"06e47973b9414c2c22df9b69f9875559","radlogics","venture","1","2014-08-15",2e+06
"74758a17740e66fd8819e37a2dbab03e","radoop",NA,NA,NA,NA
"370561ded6154006c301566e78839c87","radpharm","venture","B","2007-11-28",1e+07
"cc01881b2589dc90ee2c7c3119ef6daf","rainbirdsoft-limited",NA,NA,NA,NA
"8e6f6af0e047b12fea82bd8c7515bf29","rainbow-biosciences",NA,NA,NA,NA
"bdc8273f17e6bded5b459d40d31d8f7f","rainbow-hospitals","venture",NA,"2013-08-13",19500000
"d4f2ef0f4c7efc943f7d62e3da6eb1fc","raindance-technologies","venture","B","2007-04-17",23660000
"d4f2ef0f4c7efc943f7d62e3da6eb1fc","raindance-technologies","venture","d","2011-01-25",37500000
"d4f2ef0f4c7efc943f7d62e3da6eb1fc","raindance-technologies","venture",NA,"2009-04-24",6000528
"d4f2ef0f4c7efc943f7d62e3da6eb1fc","raindance-technologies","debt_financing",NA,"2013-09-22",3.5e+07
"d4f2ef0f4c7efc943f7d62e3da6eb1fc","raindance-technologies","venture","e","2013-04-29",2e+07
"d4f2ef0f4c7efc943f7d62e3da6eb1fc","raindance-technologies","venture","e","2014-03-03",16500000
"93d5e45af1f38e534a4cd7fd489da0e7","rainmaker-labs",NA,NA,NA,NA
"417f4a23cb1e2a02dad960191f62a89a","rainstor","venture","c","2012-10-05",1.2e+07
"417f4a23cb1e2a02dad960191f62a89a","rainstor","venture","b","2010-03-10",7500000
"417f4a23cb1e2a02dad960191f62a89a","rainstor","venture",NA,"2011-07-08",1799998
"417f4a23cb1e2a02dad960191f62a89a","rainstor","venture",NA,"2009-02-10",4e+06
"417f4a23cb1e2a02dad960191f62a89a","rainstor","convertible_note",NA,"2012-03-09",984827
"5f1c711cd8de7e9dbe3b1a41b572516f","raintree-oncology-services","venture","b","2012-04-24",11100000
"5f1c711cd8de7e9dbe3b1a41b572516f","raintree-oncology-services","venture",NA,"2012-08-10",22787517
"f1eaa6800d6c58077c10ce29b9a84d45","raise-partner","angel",NA,"2012-11-30",5187192
"c5988b4580b0c6d815b739be936bb893","raity",NA,NA,NA,NA
"3c7cdb743a73c6c47e2586785297557e","rajganga-agro",NA,NA,NA,NA
"57d7e41f2c7d64c6fc78bf30128263b0","raland-technologies-llc",NA,NA,NA,NA
"441d65fd91b6c652406dbbacddd5a0c0","rallyteam","non_equity_assistance",NA,"2015-03-01",NA
"441d65fd91b6c652406dbbacddd5a0c0","rallyteam","convertible_note",NA,"2014-06-15",20000
"441d65fd91b6c652406dbbacddd5a0c0","rallyteam","venture",NA,"2014-01-22",NA
"441d65fd91b6c652406dbbacddd5a0c0","rallyteam","venture",NA,"2015-08-28",NA
"016ac118c063329b937dbd8589117a25","rallyverse",NA,NA,NA,NA
"e93c8651cd60dfd52ecabefabee634b9","ramp-2",NA,NA,NA,NA
"388b2b24dadf37366f6bb335d3a8ac1b","ramp","venture","B","2007-06-12",1e+07
"388b2b24dadf37366f6bb335d3a8ac1b","ramp","venture","c","2009-05-11",8250000
"388b2b24dadf37366f6bb335d3a8ac1b","ramp","venture","c","2012-09-27",1.5e+07
"388b2b24dadf37366f6bb335d3a8ac1b","ramp","venture",NA,"2010-11-15",3500000
"d04b6720a12dc9f9a099645e2f08d535","ramp-technology-group",NA,NA,NA,NA
"24a4a9ef3f912a2be738816293ab025d","ramp-up-tech",NA,NA,NA,NA
"7bac7f7aa78d56c70ecb6b77e248658b","rana-therapeutics","venture",NA,"2011-11-30",2660000
"7bac7f7aa78d56c70ecb6b77e248658b","rana-therapeutics","venture","1","2012-01-18",20700000
"7bac7f7aa78d56c70ecb6b77e248658b","rana-therapeutics","venture","1","2015-07-30",63812231
"5a2b2fe5d90196e21dcc5155942c17cf","randstad-technologies-portugal",NA,NA,NA,NA
"c1466096ef9dfda28c600e1401dfb9fa","rangespan","venture",NA,"2012-12-07",5e+06
"3fa6b7af2f17fd4a862b0b83f9942bd9","rani-therapeutics","venture","b","2013-08-28",NA
"3fa6b7af2f17fd4a862b0b83f9942bd9","rani-therapeutics","venture","C","2015-05-26",15486363
"716aa68f43ffe2369d05b7f8c23d4a03","rankhammer",NA,NA,NA,NA
"318dd6431b1e98ac1dcc3d62c830ccb8","ranking-alive",NA,NA,NA,NA
"89be2f793ccf890b18198b622e108445","rankinity",NA,NA,NA,NA
"b07b65fc020b6722f339058253334556","rankmeme",NA,NA,NA,NA
"6737364562d380da6b5765b09c098b13","rankpop",NA,NA,NA,NA
"4c99e19d2abf52fd0346d6c84a86f115","rankquarrel",NA,NA,NA,NA
"f6385ea6d9c136eedbc9d0d9679e0f00","ranktab","seed",NA,"2015-01-30",25000
"f6385ea6d9c136eedbc9d0d9679e0f00","ranktab","angel",NA,"2015-03-01",62500
"f6385ea6d9c136eedbc9d0d9679e0f00","ranktab","seed",NA,"2015-06-01",1e+05
"c8c99f15a7675683a6e072ce7a3df158","rapid-consulting-services",NA,NA,NA,NA
"9ee87a5815e9264075784096611abd9e","rapid-diagnostek","venture",NA,"2012-06-06",4635000
"9ee87a5815e9264075784096611abd9e","rapid-diagnostek","debt_financing",NA,"2013-08-01",850000
"9ee87a5815e9264075784096611abd9e","rapid-diagnostek","venture","1","2010-01-29",4e+06
"9ee87a5815e9264075784096611abd9e","rapid-diagnostek","debt_financing",NA,"2015-03-10",3318748
"4cc6fe8d3a2bc327e00869024ecb95a2","rapid-micro-biosystems","debt_financing",NA,"2012-04-27",2500000
"4cc6fe8d3a2bc327e00869024ecb95a2","rapid-micro-biosystems","venture","1","2009-08-06",18600000
"4cc6fe8d3a2bc327e00869024ecb95a2","rapid-micro-biosystems","venture","1","2013-06-26",32600000
"4cc6fe8d3a2bc327e00869024ecb95a2","rapid-micro-biosystems","venture",NA,"2010-09-22",6700000
"4cc6fe8d3a2bc327e00869024ecb95a2","rapid-micro-biosystems","venture",NA,"2014-04-11",6001413
"4cc6fe8d3a2bc327e00869024ecb95a2","rapid-micro-biosystems","debt_financing",NA,"2015-03-18",6e+06
"4cc6fe8d3a2bc327e00869024ecb95a2","rapid-micro-biosystems","venture","1","2015-04-29",2.5e+07
"ab8e25ba770a6e5605298291b9ead9a6","rapid-pathogen-screening","debt_financing",NA,"2010-02-09",1.5e+07
"ab8e25ba770a6e5605298291b9ead9a6","rapid-pathogen-screening","venture",NA,"2012-10-10",6790950
"ab8e25ba770a6e5605298291b9ead9a6","rapid-pathogen-screening","debt_financing",NA,"2013-07-22",6250000
"ab8e25ba770a6e5605298291b9ead9a6","rapid-pathogen-screening","debt_financing",NA,"2014-10-13",2.8e+07
"6195067cda39336807c084b06e166558","rapidblue-solutions","angel",NA,"2011-01-24",2035650
"fce24bb6f249c8c76c19a7efe293c388","rapidminer","venture","C","2016-01-05",1.6e+07
"fce24bb6f249c8c76c19a7efe293c388","rapidminer","venture","a","2013-11-04",5e+06
"fce24bb6f249c8c76c19a7efe293c388","rapidminer","venture","B","2015-02-18",1.5e+07
"278adc502baa5d7ec2ee77786a94b6db","rapidscaler",NA,NA,NA,NA
"afa8fb7c71125354b4d17b7bbe90b521","rapporter",NA,NA,NA,NA
"ac06182d78f4d8a567496271d5329bac","raptor-pharmaceuticals","venture",NA,"2009-09-14",2386000
"ac06182d78f4d8a567496271d5329bac","raptor-pharmaceuticals","venture",NA,"2010-08-09",1.5e+07
"ac06182d78f4d8a567496271d5329bac","raptor-pharmaceuticals","convertible_note",NA,"2014-07-01",6e+07
"ac06182d78f4d8a567496271d5329bac","raptor-pharmaceuticals","debt_financing",NA,"2014-07-01",1e+07
"ba2ed99ebe7d95d7f974e9060ab82d7e","rarecyte","undisclosed",NA,"2012-08-21",NA
"1ad2fad05e86d9ef5740fc80e32c6fc6","rarelogic","seed",NA,"2014-07-01",469044
"6b119cdce3ede0add4c763a31d55ef43","ras-labs","debt_financing",NA,"2015-09-01",345000
"6b119cdce3ede0add4c763a31d55ef43","ras-labs","debt_financing",NA,"2015-08-04",1e+06
"c65998c3c1aa0571a1eb127ab682893a","raspberry-express",NA,NA,NA,NA
"30193cc57eb841c8e0643aa1cab13c09","rating-vc",NA,NA,NA,NA
"8fc195f19b2a869199526ce97c18e0f9","ratingsintel",NA,NA,NA,NA
"3c1078e38ef1d92a39ec1935409c186c","ratio","venture",NA,"2010-07-09",343000
"f8c00f36fc4ea0da025d4b5848624379","rational-interaction",NA,NA,NA,NA
"23e7875fb0e4ac87739c197d417755ca","raveil",NA,NA,NA,NA
"8c8936604697fb643c73dbeaf27926a6","ravel",NA,NA,NA,NA
"5a2afe1226ccc9ea90565959baed3d42","ravel-law","venture","a","2014-02-03",8100000
"5a2afe1226ccc9ea90565959baed3d42","ravel-law","seed",NA,"2012-07-01",1100000
"c36e570ef972be7579da09a45bc00067","ravelin","seed",NA,"2015-03-12",NA
"c36e570ef972be7579da09a45bc00067","ravelin","venture",NA,"2015-09-29",1973629.2765
"002e7723ca64a785590c198524743de5","raven-biotechnologies","venture","d","2005-10-12",48300000
"c2ef8a14498160c4ad24f2f4af9332f9","raven-s-eye",NA,NA,NA,NA
"355ef1494f505ae83b450ff6be509670","ravenpack",NA,NA,NA,NA
"86c7c158b6e76bdaa6357a87bb400548","rawdata","seed",NA,"2012-01-01",1400000
"cc40bb11800e025a0342f06370934201","rcsi",NA,NA,NA,NA
"b0eeb704b1ffa625f787672b6a63a91e","rct-logic","venture",NA,"2010-09-20",506000
"b0eeb704b1ffa625f787672b6a63a91e","rct-logic","venture",NA,"2012-08-15",175001
"b0eeb704b1ffa625f787672b6a63a91e","rct-logic","venture",NA,"2013-04-29",150000
"90ed73069530964cad5c9d1ac2849c9c","reinfer-io","convertible_note",NA,"2015-05-20",83877
"7a7e41c791900113fe737a3e66fcb53b","re-invention",NA,NA,NA,NA
"c8c34a618c4ddf6d3f6a023438fbbccf","re-vu",NA,NA,NA,NA
"ce5ff093a8d21780a584c4bf49458427","reach-influence","venture","C","2014-10-14",4810000
"ce5ff093a8d21780a584c4bf49458427","reach-influence","seed",NA,"2015-01-07",5e+06
"fdfd907557e70e03dacad4ac1354e30a","reach-health","venture","a","2010-09-27",5e+06
"fdfd907557e70e03dacad4ac1354e30a","reach-health","venture",NA,"2014-04-07",2140271
"fdfd907557e70e03dacad4ac1354e30a","reach-health","private_equity",NA,"2013-06-27",4400000
"fdfd907557e70e03dacad4ac1354e30a","reach-health","debt_financing",NA,"2013-06-27",3e+06
"fdfd907557e70e03dacad4ac1354e30a","reach-health","venture","b","2012-04-17",4e+06
"fdfd907557e70e03dacad4ac1354e30a","reach-health","venture",NA,"2015-09-09",1500000
"9a43bb67e592832e46111529fe316a43","reach-ly","angel",NA,"2011-08-04",NA
"9a43bb67e592832e46111529fe316a43","reach-ly","debt_financing",NA,"2013-06-21",66143
"9a43bb67e592832e46111529fe316a43","reach-ly","seed",NA,"2014-03-27",206777
"a803d8dc19adf4978e77916687c475bb","reach7","seed",NA,"2014-04-30",101014
"a803d8dc19adf4978e77916687c475bb","reach7","seed",NA,"2014-07-07",686016
"70f1393b210a5a3ecbb260f4630168d5","reachpod-inovaktif-bilisim","seed","b","2014-01-31",170000
"70f1393b210a5a3ecbb260f4630168d5","reachpod-inovaktif-bilisim","seed","B","2014-04-01",50000
"70f1393b210a5a3ecbb260f4630168d5","reachpod-inovaktif-bilisim","seed","B","2014-10-03",420000
"c701aa6892cf0d156fd531943893f8f5","react-mobile",NA,NA,NA,NA
"e24f2235bbfaf2868e4eaeb2314af906","reactful","seed",NA,"2013-04-15",20000
"6d9760aa2e3fb00a74a50dc0c2958ce3","reactive-search",NA,NA,NA,NA
"6a1f0fd80404a9d98e4f85d00d12c3fe","reactor-2",NA,NA,NA,NA
"8f86177639ae57f1c772d01109448452","reactor-inc","seed",NA,"2013-07-01",1100000
"8f86177639ae57f1c772d01109448452","reactor-inc","seed",NA,"2013-02-13",750000
"29f1bd7a356820bc9378e6b91ae8465c","ready-to-market",NA,NA,NA,NA
"9cbb422ee45ed3b065f144191a934f52","readygraph",NA,NA,NA,NA
"3d474c83f6f77dae37a5d5a9e911cfe5","real-capital-analytics",NA,NA,NA,NA
"bed4ea27f4260c3dea51c639f87dc92a","real-magnet",NA,NA,NA,NA
"17ec612c90665f249447cd1cc4401621","real",NA,NA,NA,NA
"7aa193a7ef74ba31c49a030147eae64e","real-time-genomics","venture","a","2009-03-01",3e+06
"1b851126be3e1fb274fddac919aa9d6a","real-time-innovations",NA,NA,NA,NA
"0fe2c925a150676b27c9536e5cecb4b4","realbio-technology","convertible_note",NA,"2009-12-04",1125000
"0fe2c925a150676b27c9536e5cecb4b4","realbio-technology","venture",NA,"2013-10-18",484750
"bf9d497405d15b5d2cb95ea17d9c2b61","realeyes","venture","A","2013-03-11",5700000
"bf9d497405d15b5d2cb95ea17d9c2b61","realeyes","grant",NA,"2012-11-15",160000
"bf9d497405d15b5d2cb95ea17d9c2b61","realeyes","grant",NA,"2011-01-28",770000
"bf9d497405d15b5d2cb95ea17d9c2b61","realeyes","seed",NA,"2011-01-28",3e+05
"bf9d497405d15b5d2cb95ea17d9c2b61","realeyes","grant",NA,"2011-09-05",330000
"bf9d497405d15b5d2cb95ea17d9c2b61","realeyes","grant",NA,"2015-04-17",826000
"bf9d497405d15b5d2cb95ea17d9c2b61","realeyes","debt_financing",NA,"2015-05-29",2500000
"387f607c51f8d408c795e9f3226282fb","pickeez",NA,NA,NA,NA
"a5a48171b42af68002ce51d60ff82f17","realitycheck","seed",NA,"2013-05-07",180000
"985426b249208f8fbb31141299b7c0d4","realm-systems",NA,NA,NA,NA
"bf80d4598cc8a9f8fd248910d837dd89","realmassive","venture","A","2015-05-14",8e+06
"bf80d4598cc8a9f8fd248910d837dd89","realmassive","seed",NA,"0015-01-01",NA
"d9bd449e3076332a1397bd2427557425","realmed",NA,NA,NA,NA
"3f7b507e957d69a80c7655ce353eed6e","realspeaker-inc","grant",NA,"2013-03-20",50000
"3f7b507e957d69a80c7655ce353eed6e","realspeaker-inc","grant",NA,"2012-08-02",15463
"5b3a4662d0e3a61c82d7a173fc472ede","realtidbits",NA,NA,NA,NA
"61dd95db599af43f9178cde11ea1393b","realtimeimage","venture","B","2000-01-27",8e+06
"61dd95db599af43f9178cde11ea1393b","realtimeimage","venture",NA,"1999-11-30",NA
"646908e5f89256e2c6abcc142520318b","realtracker",NA,NA,NA,NA
"6802a558e2da6f45a5453fffb6c2cec6","realtycloud",NA,NA,NA,NA
"f748fbb60f78b34d4270e8237c5bc5df","realtytrac-com",NA,NA,NA,NA
"2decf4c353f04241a89204b423f22c70","realytics",NA,NA,NA,NA
"b916ff63775f6ec96f9af6548d6a6f96","reamaze","seed",NA,"2012-06-01",NA
"fc1ea7ec4c2f8108da71043437698c97","reametrix","venture","A","2005-01-14",3550000
"fc1ea7ec4c2f8108da71043437698c97","reametrix","venture",NA,"2009-11-24",2100000
"d416008a1b05f555f268ccee145ca3ef","reapplix","venture",NA,"2010-09-03",1309068
"d416008a1b05f555f268ccee145ca3ef","reapplix","seed",NA,"2011-03-04",380000
"d416008a1b05f555f268ccee145ca3ef","reapplix","seed",NA,"2009-03-09",339174
"76a404a6ba5a36dba53c78e24c3889b7","reaqta","seed",NA,"2014-04-01",8e+05
"c2fabdb678a16e74978fe12bfa159ba7","reata-pharmaceuticals","venture","E","2007-07-08",2.5e+07
"c2fabdb678a16e74978fe12bfa159ba7","reata-pharmaceuticals","private_equity",NA,"2011-07-13",3e+08
"c2fabdb678a16e74978fe12bfa159ba7","reata-pharmaceuticals","venture",NA,"2010-02-26",1972000
"c2fabdb678a16e74978fe12bfa159ba7","reata-pharmaceuticals","venture",NA,"2009-09-25",16977840
"c2fabdb678a16e74978fe12bfa159ba7","reata-pharmaceuticals","private_equity",NA,"2010-07-12",7.8e+07
"19efd809bf8265ec63d0648598622151","rebiotix","venture",NA,"2011-11-07",2780000
"19efd809bf8265ec63d0648598622151","rebiotix","venture","1","2014-08-04",2.5e+07
"fb46cc38d28c940d3e164da952d5178a","recent-media",NA,NA,NA,NA
"d7090b969a2d285c512c6ea1c50ce3be","recept-holdings","private_equity",NA,"2011-12-27",10154182
"c838d6e8e19f930bac8d49d4f96a4765","recepta-biopharma","venture",NA,"2007-06-15",2500000
"694fceb9bc4142184791bfebe98ca21d","receptiviti","venture",NA,"2015-08-20",690000
"7b873a90a7c6765d5f023d801c7e37f4","receptos","venture",NA,"2009-05-22",7673456
"7b873a90a7c6765d5f023d801c7e37f4","receptos","venture",NA,"2012-02-03",10806610
"7b873a90a7c6765d5f023d801c7e37f4","receptos","venture","1","2009-11-23",2.5e+07
"7b873a90a7c6765d5f023d801c7e37f4","receptos","venture",NA,"2012-03-13",3e+07
"ff7d64ed94fd658c1fc67df4497d2543","recipharm","post_ipo_equity",NA,"2016-01-27",3.2e+07
"ff7d64ed94fd658c1fc67df4497d2543","recipharm","post_ipo_debt",NA,"2014-09-19",210384730
"285d607bfb7754fdaeb676b3daa356f4","reclick","non_equity_assistance",NA,"2014-11-01",30000
"285d607bfb7754fdaeb676b3daa356f4","reclick","angel",NA,"2015-05-11",65000
"0c4ca2b58f61a52531a5bf46fadeaa77","recognia","undisclosed",NA,"2007-09-24",NA
"be2200ac874bcdd34088704fbb61a1a4","apploop",NA,NA,NA,NA
"d169cd40b65b958d968f7858f9222981","recombine","venture","a","2014-03-04",3300000
"f121f12cea1fc27a8b55acfe39ce53f5","recombinetics","venture",NA,"2015-11-20",2770250
"f121f12cea1fc27a8b55acfe39ce53f5","recombinetics","venture",NA,"2013-08-08",35000
"f121f12cea1fc27a8b55acfe39ce53f5","recombinetics","venture","1","2013-06-28",2e+06
"f121f12cea1fc27a8b55acfe39ce53f5","recombinetics","venture",NA,"2014-10-30",540800
"03d2653face6a9101c7365a104a5cff0","recombitex",NA,NA,NA,NA
"336afba0e0beef7d630fde3a784f6149","record-evolution",NA,NA,NA,NA
"a2a88e80e7e5483b7e78d1142c1cc47b","recordati",NA,NA,NA,NA
"6c4affe232e455023e6c15ceb74d2529","recorded-future","venture","a","2009-07-01",2200000
"6c4affe232e455023e6c15ceb74d2529","recorded-future","venture","b","2010-06-01",6700000
"6c4affe232e455023e6c15ceb74d2529","recorded-future","venture","c","2012-01-01",1.2e+07
"6c4affe232e455023e6c15ceb74d2529","recorded-future","venture","D","2015-04-16",1.2e+07
"d9116c428b604497d795fe1f35ce0ee2","recourse-technologies",NA,NA,NA,NA
"d78ffe3f895c4ec2d6fe40ec1974ef9c","recruitics",NA,NA,NA,NA
"aad7c7f1a3f7124bd5c1fbc621da5bad","recruitingscience",NA,NA,NA,NA
"60c52141f21cc885deeabce7c00e351a","recyte-therapeutics","venture",NA,"2011-01-03",4e+06
"60c52141f21cc885deeabce7c00e351a","recyte-therapeutics","venture",NA,"2011-02-02",2300000
"60c52141f21cc885deeabce7c00e351a","recyte-therapeutics","venture",NA,"2011-03-24",3600000
"75e37ec6b2136f80a06e9be92c422c1c","red-foundry","venture","a","2010-11-03",1100000
"a79b844c352fb6d655e656fd8f2d70dc","red-pepper-group",NA,NA,NA,NA
"1b5dc4c5cf18785ce8e5e06b8b86c914","red-zebra","venture","A","2014-04-01",1664558
"e24472051e43daef9ee911510d41bb79","red-ehs",NA,NA,NA,NA
"e3db3a25ad8156eecb159e50417792b2","redbiotec","venture",NA,"2010-04-20",420763
"e3db3a25ad8156eecb159e50417792b2","redbiotec","undisclosed",NA,"2014-11-27",1445205
"e3db3a25ad8156eecb159e50417792b2","redbiotec","venture",NA,"2009-03-26",NA
"1758862a414ff5b1039614f50cea51ef","redbird","angel",NA,"2014-05-01",1038714
"1758862a414ff5b1039614f50cea51ef","redbird","seed","1","2015-04-01",2155846
"1758862a414ff5b1039614f50cea51ef","redbird","seed",NA,"2015-05-27",NA
"eea0862beeab84491aa2a2fd1c3be6ea","redd-intelligence",NA,NA,NA,NA
"7f3105d651eeaacdf4c24436d577afab","reddrummer","debt_financing",NA,"2012-10-25",3500000
"9f6f766c719e8c6f47cb050dc872de4e","redfoodie",NA,NA,NA,NA
"c79f5491919d4a8e5696e51f6c60ea19","redhill-biopharma","post_ipo_equity",NA,"2013-12-31",8500000
"c79f5491919d4a8e5696e51f6c60ea19","redhill-biopharma","venture",NA,"2010-11-08",1e+07
"c79f5491919d4a8e5696e51f6c60ea19","redhill-biopharma","post_ipo_equity",NA,"2014-01-22",11700000
"c79f5491919d4a8e5696e51f6c60ea19","redhill-biopharma","post_ipo_equity",NA,"2015-07-20",4e+07
"ac76f6e6275d9ab55b35682268995000","redlattice-inc",NA,NA,NA,NA
"46c6312d5ceb5ba773dfa4026935302a","redlen-technologies","venture","A","2015-06-09",2418061.3059
"46c6312d5ceb5ba773dfa4026935302a","redlen-technologies","venture",NA,"2010-02-09",7800000
"46c6312d5ceb5ba773dfa4026935302a","redlen-technologies","venture",NA,"2014-03-06",5500000
"bc093f368556451374108be4e99577d7","redlink",NA,NA,NA,NA
"64b95b59780922ef74954a040e25cb26","redmica","debt_financing",NA,"2012-03-01",1e+05
"76bbbf4b1616e983919fa65e65eb5f9e","redoak-logic","venture",NA,"2010-12-22",250000
"1d24394f1590ff247c8eb36a34809d78","redowl-analytics","debt_financing",NA,"2013-09-18",2750000
"1d24394f1590ff247c8eb36a34809d78","redowl-analytics","grant",NA,"2013-04-16",1e+05
"1d24394f1590ff247c8eb36a34809d78","redowl-analytics","venture","1","2014-06-24",4600000
"1d24394f1590ff247c8eb36a34809d78","redowl-analytics","venture","1","2015-07-13",1.7e+07
"66e96ed0f867eb42acd0c61b98ff339f","redox-diagnostics",NA,NA,NA,NA
"ad6332d0e957175d71247ba3f934645d","redox-pharmaceutical","venture",NA,"2010-01-06",123200
"57c497327b1628fbab7e651b62c1fb52","redpath-integrated-pathology","venture","A","2006-12-20",6500000
"57c497327b1628fbab7e651b62c1fb52","redpath-integrated-pathology","debt_financing",NA,"2012-08-03",588218
"57c497327b1628fbab7e651b62c1fb52","redpath-integrated-pathology","debt_financing",NA,"2013-04-09",612500
"57c497327b1628fbab7e651b62c1fb52","redpath-integrated-pathology","venture",NA,"2011-05-16",1600000
"5256179a0705cce1b5dce32db9c22dff","redpoint-global","venture",NA,"2012-11-07",6400000
"5256179a0705cce1b5dce32db9c22dff","redpoint-global","venture",NA,"2014-07-14",5249999
"e11a4003bcb7a6b6629e3caf3371da66","redpoint-international","debt_financing",NA,"2010-12-20",50000
"305110894c6677f460955dbe1f9d20ca","redscarf",NA,NA,NA,NA
"70d658151affab7ad3d5d4fe08a74aca","redtree-people","undisclosed",NA,"2012-10-17",80837
"6ba63ce9bbad887106455737fce204cf","reduce-data","seed",NA,"2013-02-01",5e+05
"a33f301119fea9b5317f54ca897ceef1","redvision-system","venture",NA,"2009-03-12",6800000
"a33f301119fea9b5317f54ca897ceef1","redvision-system","venture","1","2013-11-13",5e+06
"a33f301119fea9b5317f54ca897ceef1","redvision-system","venture","1","2003-11-01",NA
"fdf1d5d1e810502b62f5c5abe84981c8","redwood-bioscience","venture",NA,"2010-04-26",3e+05
"fdf1d5d1e810502b62f5c5abe84981c8","redwood-bioscience","debt_financing",NA,"2010-03-03",450000
"fdf1d5d1e810502b62f5c5abe84981c8","redwood-bioscience","venture",NA,"2013-04-22",8648300
"fdf1d5d1e810502b62f5c5abe84981c8","redwood-bioscience","undisclosed",NA,"2011-06-27",NA
"fdf1d5d1e810502b62f5c5abe84981c8","redwood-bioscience","venture","1","2014-01-28",2499999
"395e50fd45e8a26170de6abf196cb54a","redzebra-ltd",NA,NA,NA,NA
"be71eefc66ed429765192e64891f42a0","reef-digital-agency-pty-ltd",NA,NA,NA,NA
"fb784160259677b0de723138aefcf297","yesreeli",NA,NA,NA,NA
"2c6f33897f4a86c9bc44ee0e031a93f2","reembed","seed",NA,"2013-11-21",107879
"a1ecae7ab79f304adf7362b67740aacf","refactored-materials",NA,NA,NA,NA
"88758730146609575966ed57dc82980d","refgene",NA,NA,NA,NA
"1d24181009941902713e59c98c41c7d0","refinepro",NA,NA,NA,NA
"9dc37fe68b270b935198f6a85135e146","reflektive","seed",NA,"2015-10-08",3600000
"ea162a69cc195ef5e8de3550a45b6d54","reflow-medical","venture","a","2012-05-28",499997
"ea162a69cc195ef5e8de3550a45b6d54","reflow-medical","venture","a","2011-06-15",9e+05
"b3c25b336c0610dc471de9a9133f6f63","reframed-tv","seed",NA,"2014-01-01",201777
"b3c25b336c0610dc471de9a9133f6f63","reframed-tv","seed",NA,"2014-07-21",NA
"1e7563f57775f8789450b8b3942c0460","regado-biosciences","post_ipo_equity",NA,"2014-01-31",2e+07
"1e7563f57775f8789450b8b3942c0460","regado-biosciences","venture","1","2009-12-17",4e+07
"1e7563f57775f8789450b8b3942c0460","regado-biosciences","venture","1","2007-03-27",2.3e+07
"1e7563f57775f8789450b8b3942c0460","regado-biosciences","venture","1","2012-12-17",5.1e+07
"1e7563f57775f8789450b8b3942c0460","regado-biosciences","post_ipo_equity",NA,"2013-08-22",4.3e+07
"28418beae3cb10cc1d409241083c5225","regdesk","seed",NA,"2014-10-24",NA
"f72738a0d27583f01e29b0fdf3352204","regen-biologics","venture",NA,"2009-01-30",7051572
"7cd42551a84476a962df55f9d62ef68f","regen-lab",NA,NA,NA,NA
"9c6949d8db7428c8b1877c3fe60fa42b","regenastem","equity_crowdfunding",NA,"2013-10-03",5e+05
"2d2174579b295c2d3956aa50010634e6","regenerate","venture",NA,"2010-10-22",2300000
"629521e961cbf7a6db7a18b2d25e67fb","regenerative-medical-solutions","seed",NA,"2013-06-20",850000
"629521e961cbf7a6db7a18b2d25e67fb","regenerative-medical-solutions","venture",NA,"2014-02-10",595000
"f6edb6663dd6fc235c1a8bdb9c2a1a37","regeneron-pharmaceuticals",NA,NA,NA,NA
"e3aafc1378e8c311c317f4f6cc32edcf","regenerx","venture",NA,"2011-01-07",950000
"e3aafc1378e8c311c317f4f6cc32edcf","regenerx","venture",NA,"2009-10-23",1e+06
"e3aafc1378e8c311c317f4f6cc32edcf","regenerx","venture",NA,"2009-05-13",6e+05
"c886bef01377968a654f5135c36fcc15","regenesance","seed",NA,"2010-12-01",NA
"89fb50ea9423eb9e70676728ff7b20b5","regenmedtx","venture",NA,"2015-08-05",4366667
"0e72024480a410f7e8c508de23b50033","regenobody-holdings-inc","equity_crowdfunding",NA,"2010-08-09",NA
"15a39529cf1ecde29653cd19f66a9f29","regentis-biomaterials","venture","c","2012-05-14",1e+07
"e2b83af53afb8bf094aefd7612312a3e","regenx-biosciences","venture",NA,"2013-11-07",7891875
"e2b83af53afb8bf094aefd7612312a3e","regenx-biosciences","venture","1","2015-01-21",3e+07
"e2b83af53afb8bf094aefd7612312a3e","regenx-biosciences","venture","1","2015-05-20",70500000
"7ad37cee0e532141c3f1d711c83df858","regimmune-corporation","venture","b","2008-02-01",6e+06
"7ad37cee0e532141c3f1d711c83df858","regimmune-corporation","venture","d","2014-02-14",9200000
"7ad37cee0e532141c3f1d711c83df858","regimmune-corporation","venture","a","2007-02-21",4200000
"7ad37cee0e532141c3f1d711c83df858","regimmune-corporation","seed",NA,"2006-08-15",1600000
"fa6945394ff54615ec4ef7885c2ba09c","regis-mckenna-inc",NA,NA,NA,NA
"8c538b01a2b720cdb505d263223ed345","registrat-mapi","debt_financing",NA,"2009-06-15",1500000
"8e81ea2baf73cc0604685c4bcb3e3d06","registratura-ru",NA,NA,NA,NA
"9228bf7da2935781d512b5c5a57b82b6","regradar",NA,NA,NA,NA
"216cb546ef9d8a3b0535f392f13c969b","regsourceconsulting",NA,NA,NA,NA
"6e3d5643eb024c9c3514e4062bd844ab","regular-io",NA,NA,NA,NA
"69545c6e2ab088ab274e616b1df7b02c","regulus-therapeutics","debt_financing",NA,"2012-10-23",2.5e+07
"69545c6e2ab088ab274e616b1df7b02c","regulus-therapeutics","venture",NA,"2014-02-06",9999992
"25f4e00114aa5f1bbc86a8caea102d92","rehabtek",NA,NA,NA,NA
"2d236d8655ca3968eecd176c5d9c4228","reichhold","debt_financing",NA,"2014-02-04",3.5e+07
"0adc52b9d5d350cf0e36a5465d4ac1a0","reidin-com",NA,NA,NA,NA
"3794b11970f405e435cfe991f176646b","reinnervate","venture","b","2011-12-20",2734165
"3794b11970f405e435cfe991f176646b","reinnervate","venture","a","2010-05-28",2e+06
"b7a558198069ce5850e80dddb16b8f03","reintent",NA,NA,NA,NA
"44956beae7c874d0df64274c429f7fea","rejoiner",NA,NA,NA,NA
"961f8674144f32a41d2e85e78e6c9b32","relatas",NA,NA,NA,NA
"8d28e3bba48022f0561d18b467401b8a","relaterocket",NA,NA,NA,NA
"3f5171ce1ccb513cad700dff883c5905","relationship-analytics","seed",NA,"2013-04-05",1e+05
"3f5171ce1ccb513cad700dff883c5905","relationship-analytics","seed",NA,"2013-05-16",25000
"785c5d3f8f1ffca28afb47753545e0ae","relationship-capital-partners",NA,NA,NA,NA
"71b612ac5d07595e6d60fb9de6a0de0e","relativ-ai","seed",NA,"2012-07-01",NA
"370f95dbfc2e39308000b79818375b8f","relattio",NA,NA,NA,NA
"e44f45aba5897de9325d317cb8d3b12b","relead","seed",NA,"2011-10-15",NA
"9c30e0cb238682aed5de7cb014e55afe","relecura",NA,NA,NA,NA
"d1a49b1a7a9867c0ab83422afb4534c0","relevare-pharmaceuticals","debt_financing",NA,"2012-06-18",750000
"faa02ea0b34812e241314833138c4dae","relevvant","convertible_note",NA,"2011-04-01",675000
"21afbf3062717fcff1bd314a1a01e09c","reliant-technologies","venture","e","2007-04-19",1.5e+07
"89279101f5a2758b3d9e1e6388b8d65b","relievant-medsystems","venture","B","2006-10-22",5050000
"89279101f5a2758b3d9e1e6388b8d65b","relievant-medsystems","venture","c","2009-07-07",2e+07
"89279101f5a2758b3d9e1e6388b8d65b","relievant-medsystems","venture","d","2012-03-28",3e+07
"18daef83fddfb6f7bd025839d10ef505","relink-group-as","seed",NA,"2013-11-26",570000
"18daef83fddfb6f7bd025839d10ef505","relink-group-as","seed",NA,"2014-06-01",460000
"18daef83fddfb6f7bd025839d10ef505","relink-group-as","convertible_note",NA,"2014-11-24",110000
"18daef83fddfb6f7bd025839d10ef505","relink-group-as","seed",NA,"2015-06-01",2e+05
"9a39f0be4bd3456fcb5f38d383e2f091","reliot",NA,NA,NA,NA
"7f589b6aac99b900e94a49c47cd01610","relmada-therapeutics","venture","a","2012-07-24",3e+06
"7f589b6aac99b900e94a49c47cd01610","relmada-therapeutics","venture","a","2013-10-01",8e+06
"7f589b6aac99b900e94a49c47cd01610","relmada-therapeutics","debt_financing",NA,"2013-06-07",180000
"7f589b6aac99b900e94a49c47cd01610","relmada-therapeutics","venture",NA,"2014-05-22",15051110
"b46bfa13097573c5b91350605c0e5096","relox-medical","venture",NA,"2010-03-29",7e+05
"fe8ce43ebf9ed9051eb8bc6a6eb03dd3","relypsa","venture","a","2007-10-29",3.3e+07
"fe8ce43ebf9ed9051eb8bc6a6eb03dd3","relypsa","venture","b","2011-08-08",70129747
"fe8ce43ebf9ed9051eb8bc6a6eb03dd3","relypsa","venture",NA,"2012-10-01",2600100
"fe8ce43ebf9ed9051eb8bc6a6eb03dd3","relypsa","venture","c","2012-08-14",8e+07
"fe8ce43ebf9ed9051eb8bc6a6eb03dd3","relypsa","venture","b","2010-09-13",7e+07
"fe8ce43ebf9ed9051eb8bc6a6eb03dd3","relypsa","debt_financing",NA,"2010-05-03",4000040
"fe8ce43ebf9ed9051eb8bc6a6eb03dd3","relypsa","private_equity",NA,"2012-07-01",62400000
"fe8ce43ebf9ed9051eb8bc6a6eb03dd3","relypsa","debt_financing",NA,"2014-06-02",3.5e+07
"03c13a4492f1d318b6fc55bbb8870b13","remedi",NA,NA,NA,NA
"04f70684f4ff1f05ac7e6e3db0f30984","remedy-pharmaceuticals","venture",NA,"2015-12-01",9e+06
"04f70684f4ff1f05ac7e6e3db0f30984","remedy-pharmaceuticals","venture",NA,"2010-09-22",4e+05
"04f70684f4ff1f05ac7e6e3db0f30984","remedy-pharmaceuticals","venture",NA,"2012-07-06",4083809
"04f70684f4ff1f05ac7e6e3db0f30984","remedy-pharmaceuticals","venture",NA,"2014-02-26",1024440
"04f70684f4ff1f05ac7e6e3db0f30984","remedy-pharmaceuticals","seed",NA,"2012-03-06",792506
"21d0c7da9138f467347ab1b05eb9aca7","remindcloud",NA,NA,NA,NA
"b784ca75e37f6656766d275e1881bc29","reminiz","venture",NA,"2014-01-01",NA
"1d5a40815a0e9250dbca34d3b4fba01e","remitdata","venture",NA,"2011-04-06",3e+06
"1d5a40815a0e9250dbca34d3b4fba01e","remitdata","seed",NA,"2013-03-20",2500000
"1d5a40815a0e9250dbca34d3b4fba01e","remitdata","venture",NA,"2015-08-17",3000100
"285ca1102e94a4f6bed8615937654228","remitt",NA,NA,NA,NA
"5431218f85001e39659ade9b54647e92","remote-insight",NA,NA,NA,NA
"af39063a86fcf5b265477a5a6adb835b","remotemedical","venture","a","2013-05-22",8e+06
"bca79bfbeb3dab33bc83a8bea1c209ac","remoterep-com",NA,NA,NA,NA
"2a0bacdd1022560906b198c495959668","rempex-pharmaceuticals","venture","b","2011-11-09",67500000
"9be717979ca2d0917e13dab5c1e84ca3","remsoft",NA,NA,NA,NA
"3afce335d253b5d208f4edfd05e72afd","renamed-biologics","venture",NA,"2006-09-07",4e+07
"466836e0f35b903596766939911a3ac4","renavance-pharma","debt_financing",NA,"2009-07-01",5e+05
"117616384548665ee6145057c0b02ef3","renesys",NA,NA,NA,NA
"edb49991f584d58218c569849ef56207","reneuron-group","venture",NA,"2010-02-22",7300000
"edb49991f584d58218c569849ef56207","reneuron-group","venture",NA,"2013-07-22",38411624
"edb49991f584d58218c569849ef56207","reneuron-group","grant",NA,"2013-07-22",11924235.2438
"edb49991f584d58218c569849ef56207","reneuron-group","venture",NA,"2015-07-10",105148268
"222e493c50e6a32bba53b4622b92b32d","renewdata","venture",NA,"2009-08-13",6140625
"222e493c50e6a32bba53b4622b92b32d","renewdata","private_equity",NA,"2012-07-31",5260109
"7d0d82fd2045eb8da3ab268b750091eb","renglo",NA,NA,NA,NA
"06df278ae327c241b84a73bd49de5914","renglo-sys",NA,NA,NA,NA
"e5a081050ff43a9b7b3757c0cff94abb","reniac","seed",NA,"2013-07-10",28000
"6fa427aa191eb0a07ba6f6ffa2e0cc05","accelastudy",NA,NA,NA,NA
"a485a0c6b45f77390eb9637c4239383a","rennovia","venture","a","2009-03-01",16333333
"a485a0c6b45f77390eb9637c4239383a","rennovia","debt_financing",NA,"2009-06-19",2500000
"a485a0c6b45f77390eb9637c4239383a","rennovia","venture","b","2014-02-16",23320658
"a485a0c6b45f77390eb9637c4239383a","rennovia","venture",NA,"2013-02-27",8e+06
"a485a0c6b45f77390eb9637c4239383a","rennovia","venture","a","2013-01-02",28383533
"78d041eb020f324669a6ad5a3c8e9945","renova-therapeutics","venture","C","2014-10-18",7520000
"a7ea01bbb19d9bc3885a62cdcf6ce53d","renovar","venture","b","2006-11-30",1200000
"d60932702610cbeefb3c92fae8f2ce75","renovis-surgical-technologies","venture",NA,"2013-04-23",725000
"d60932702610cbeefb3c92fae8f2ce75","renovis-surgical-technologies","venture",NA,"2012-02-13",3470600
"d60932702610cbeefb3c92fae8f2ce75","renovis-surgical-technologies","venture",NA,"2014-05-14",2e+06
"9de5aefbde32c74a5d0901730e2548c4","rental-history-reports",NA,NA,NA,NA
"5233041457dbd22853886562ed138134","rentallect",NA,NA,NA,NA
"61f3ec653cf9d8960d36a8a4f2cc4a19","rentlytics","venture","A","2016-01-14",9180000
"61f3ec653cf9d8960d36a8a4f2cc4a19","rentlytics","venture",NA,"2014-04-25",NA
"61f3ec653cf9d8960d36a8a4f2cc4a19","rentlytics","seed",NA,"2014-11-24",4e+06
"094f75c6145218239a65a85b96c75d69","reonomy","debt_financing",NA,"2015-06-17",4500000
"094f75c6145218239a65a85b96c75d69","reonomy","venture","1","2014-03-18",3700000
"094f75c6145218239a65a85b96c75d69","reonomy","seed",NA,"2013-03-01",1150000
"094f75c6145218239a65a85b96c75d69","reonomy","venture","1","2015-01-05",1.3e+07
"73670432b7931d8fbb06178efddef4b3","repairogen","seed",NA,"2014-01-03",460000
"0b07fca1dba21309e9f44e0885349239","replenish","venture",NA,"2009-07-15",10249632
"9a9b3d034a16dda63b20f6add6ef42af","replication-medical","debt_financing",NA,"2009-11-30",2e+05
"9a9b3d034a16dda63b20f6add6ef42af","replication-medical","venture",NA,"2011-04-25",409999
"9a9b3d034a16dda63b20f6add6ef42af","replication-medical","venture",NA,"2010-07-01",1100000
"48fe041ebbe8d3956241c9cbbc57b0c4","replicel-life-sciences","venture",NA,"2012-04-25",594050
"48fe041ebbe8d3956241c9cbbc57b0c4","replicel-life-sciences","venture",NA,"2015-07-02",143033
"65e59b68f5a3557e202b0e30ad5197e5","repligen","grant",NA,"2010-12-15",1400000
"65e59b68f5a3557e202b0e30ad5197e5","repligen","venture",NA,"2014-06-18",4e+06
"bec4a40edcbe47664bfa1c2e325971cc","replo",NA,NA,NA,NA
"373c3b12393b52740cb4d9e0dedd8580","report-buyer",NA,NA,NA,NA
"050ff0af2926b0652fd4ac9a1faf3597","reporty",NA,NA,NA,NA
"53faec1f7eea064a9fb82c9e54120a57","repositive-ltd","seed",NA,"2015-03-26",297137
"53faec1f7eea064a9fb82c9e54120a57","repositive-ltd","grant",NA,"2015-03-26",148568
"b11ff27da6742d2e7bbbef64aa7954a4","reppify","seed",NA,"2009-10-15",250000
"fc14bf8810cf1da3cf254463b30edd90","repregen","venture",NA,"2010-11-16",1600000
"90b94f6d0c3efe5880f78dccebe05ead","reprocell",NA,NA,NA,NA
"d49214920f7c1e78bf86d65d1b68b038","reproductive-biology-and-endocrinology",NA,NA,NA,NA
"78a7bc46e9a4e9422fbc1b3060f5ce0d","reproductive-research-technologies","venture",NA,"2010-05-24",720000
"7c8d4aa61ee6b323c076cdca56e994aa","repros-therapeutics","venture",NA,"2009-11-12",5897313
"7c8d4aa61ee6b323c076cdca56e994aa","repros-therapeutics","private_equity",NA,"2012-09-19",23601997
"f68d48ff6eb8ac3837d5e96085de7042","reprosource",NA,NA,NA,NA
"7ec1acd05881632de1a85b30ca8cf17f","repu-com","seed",NA,"2010-08-20",110000
"7ec1acd05881632de1a85b30ca8cf17f","repu-com","debt_financing",NA,"2010-12-01",50000
"373beae0ec6fc9f631d406acc3882de9","repunch","seed",NA,"2013-06-01",NA
"373beae0ec6fc9f631d406acc3882de9","repunch","debt_financing",NA,"2013-11-08",35000
"2285c52182ff828d6b9a110a4bcaf37e","repustate",NA,NA,NA,NA
"d16e43a7a85a15b330163bb5532710d8","reputada",NA,NA,NA,NA
"f05ec4c823926d64cdf75236631db177","reputation-protect",NA,NA,NA,NA
"48a17caf57c781b508189af7c16d29db","reputation-x","angel",NA,"2016-01-28",NA
"831be5aed7c5f6c8343dd1c9a381d1e4","research-pharmaceutical-services",NA,NA,NA,NA
"1ff19beed819a2007b444e280e60d6e3","reset-therapeutics","venture",NA,"2013-12-03",14796231
"1ff19beed819a2007b444e280e60d6e3","reset-therapeutics","debt_financing",NA,"2015-10-08",9100000
"e12f37fc337b6f13146a6175475afe04","resistentia-pharmaceuticals","venture","c","2006-09-26",13960000
"42f7b3b96fc5d3b85b55bf939bc1accb","resmed",NA,NA,NA,NA
"723ef21e85f476a755c025be999dce08","resmio","seed",NA,"2013-06-25",NA
"723ef21e85f476a755c025be999dce08","resmio","grant",NA,"2011-11-11",136328
"723ef21e85f476a755c025be999dce08","resmio","seed",NA,"2014-01-01",1652141
"723ef21e85f476a755c025be999dce08","resmio","grant",NA,"2015-01-19",723628
"8eb48d0b4dea9f53a27cadec606fe76f","resnap","seed",NA,"2013-08-01",66299
"8eb48d0b4dea9f53a27cadec606fe76f","resnap","seed",NA,"2015-02-19",450000
"a28e9b38cd3a9ddddc00b305b96124f1","resolve-therapeutics","venture","b","2012-11-01",5800000
"a28e9b38cd3a9ddddc00b305b96124f1","resolve-therapeutics","venture","a","2011-05-17",2e+06
"a28e9b38cd3a9ddddc00b305b96124f1","resolve-therapeutics","debt_financing",NA,"2012-04-25",1083334
"de970b339f023e81fb17c7a136acef21","resolvyx-pharmaceuticals","venture","A","2005-12-02",1.7e+07
"de970b339f023e81fb17c7a136acef21","resolvyx-pharmaceuticals","venture",NA,"2010-11-09",2500000
"de970b339f023e81fb17c7a136acef21","resolvyx-pharmaceuticals","debt_financing",NA,"2010-06-18",1200000
"77dd54a035b8324852bfcaebdd695d3b","resonant-sensors-inc","equity_crowdfunding",NA,"2011-04-20",NA
"49b05685dc9d664ae398e634f040166c","resonate-networks","venture","b","2012-02-22",2.2e+07
"49b05685dc9d664ae398e634f040166c","resonate-networks","angel",NA,"2009-05-06",2e+06
"49b05685dc9d664ae398e634f040166c","resonate-networks","venture","a","2010-06-23",5e+06
"49b05685dc9d664ae398e634f040166c","resonate-networks","debt_financing",NA,"2014-06-30",NA
"919f904565c7ae8902daa9487bbaccde","respirics","debt_financing",NA,"2009-09-11",375000
"919f904565c7ae8902daa9487bbaccde","respirics","venture","1","2005-09-27",NA
"919f904565c7ae8902daa9487bbaccde","respirics","venture",NA,"2010-08-27",146257
"919f904565c7ae8902daa9487bbaccde","respirics","venture",NA,"2010-05-04",3726283
"fc042a45f6fa3b824b2a037f99f53738","response-biomedical","venture",NA,"2009-05-29",3119136
"fc042a45f6fa3b824b2a037f99f53738","response-biomedical","venture",NA,"2013-10-15",3119136
"fc042a45f6fa3b824b2a037f99f53738","response-biomedical","private_equity",NA,"2012-01-05",4937100
"fc042a45f6fa3b824b2a037f99f53738","response-biomedical","venture",NA,"2010-08-12",7724990
"fc042a45f6fa3b824b2a037f99f53738","response-biomedical","debt_financing",NA,"2014-02-12",2500000
"fc042a45f6fa3b824b2a037f99f53738","response-biomedical","debt_financing",NA,"2011-12-01",265238
"b4668ec5f56a6686b0f87a0854323757","response-genetics-inc","post_ipo_debt",NA,"2014-08-05",1.2e+07
"327637b85255b2aab98a8c62a07fea7a","response-mine-interactive",NA,NA,NA,NA
"e14c597595f4176e3bc5f66346fffc7a","responsebase","venture",NA,"2001-06-22",NA
"776adf6eee4bdd1f58113384e5ec4537","responster","seed",NA,"2013-01-10",45000
"776adf6eee4bdd1f58113384e5ec4537","responster","seed",NA,"2014-10-15",3e+05
"776adf6eee4bdd1f58113384e5ec4537","responster","seed",NA,"2015-08-28",1e+05
"d173a07ca7956247e3d04f6448f2ba38","ressac-media",NA,NA,NA,NA
"245c44a573bbd777740a3a64d8ccbc96","docmato",NA,NA,NA,NA
"94f0261e50ff6cbdfd1a4626659e855e","restat",NA,NA,NA,NA
"161f697fd18a05ec36b1f2672077de04","restoration-robotics","venture","c","2011-08-03",4.1e+07
"161f697fd18a05ec36b1f2672077de04","restoration-robotics","debt_financing",NA,"2011-06-09",1999999
"161f697fd18a05ec36b1f2672077de04","restoration-robotics","venture","b","2007-08-13",2.5e+07
"161f697fd18a05ec36b1f2672077de04","restoration-robotics","venture","C","2014-11-10",4.5e+07
"62bd4f347ac91bfedaaac54385e4154a","restore-flow-allografts","venture",NA,"2013-06-12",750000
"7810eb1f05334b987d2e5245bc093f91","resulticks",NA,NA,NA,NA
"4650d777fa3604bb5ce329133f065db9","resverlogix","private_equity",NA,"2013-08-14",1600000
"4650d777fa3604bb5ce329133f065db9","resverlogix","venture",NA,"2010-03-29",2.5e+07
"4650d777fa3604bb5ce329133f065db9","resverlogix","seed",NA,"2011-12-01",1841995
"4650d777fa3604bb5ce329133f065db9","resverlogix","post_ipo_equity",NA,"2014-06-11",2300000
"4650d777fa3604bb5ce329133f065db9","resverlogix","post_ipo_debt",NA,"2014-07-03",3e+07
"b20a90b421e1c2a5f03793e5633639c9","resyn-biosciences",NA,NA,NA,NA
"632461364b4ec1d2b7473364de5804f4","retail-iq",NA,NA,NA,NA
"b31846b397d84a2ce82891de9ee8f947","retail-optimization","debt_financing",NA,"2010-06-17",644942
"b31846b397d84a2ce82891de9ee8f947","retail-optimization","venture","1","2007-04-26",1e+06
"b31846b397d84a2ce82891de9ee8f947","retail-optimization","venture","1","2008-12-10",1200000
"986f56c8ff0e5d92f9b2991ae781852e","retail-pro","seed",NA,"2012-07-18",40000
"161f4b59814089ac406f04bb40b97878","retail-solutions","venture","c","2010-09-28",15200000
"161f4b59814089ac406f04bb40b97878","retail-solutions","venture","A","2004-10-10",9400000
"161f4b59814089ac406f04bb40b97878","retail-solutions","venture","B","2005-11-01",8800000
"64ca0dd7b6a36545ad4316e935c37ac3","retechnica","undisclosed",NA,"2014-01-01",NA
"d9b84b1008bb7d99e40b5c24d3376fdf","retel-technologies","seed",NA,"2009-08-06",NA
"d9b84b1008bb7d99e40b5c24d3376fdf","retel-technologies","seed",NA,"2009-12-02",1e+06
"ec621a9fdb12c1d5ce0a43bf22299850","retention-science","seed",NA,"2013-08-29",2500000
"ec621a9fdb12c1d5ce0a43bf22299850","retention-science","venture","1","2014-08-05",7e+06
"5b90ce4200e8c873ebe9b4b6df07009d","rethink-autism","venture","B","2011-04-01",NA
"5b90ce4200e8c873ebe9b4b6df07009d","rethink-autism","venture",NA,"2014-06-03",1e+07
"5b90ce4200e8c873ebe9b4b6df07009d","rethink-autism","venture","C","2014-08-18",1e+07
"c8cf923399c52a81c05938fbcc7ab325","retica-systems","venture","B","2007-07-10",7400000
"f458afea85c3445500122c623b2ee79c","retina-implant","venture",NA,"2011-03-02",1.8e+07
"8d01715bf05678661d8f3e417e1230ec","retinad-vr","angel",NA,"2015-05-20",5e+05
"8d01715bf05678661d8f3e417e1230ec","retinad-vr","angel",NA,"2015-09-16",NA
"6b60d704737768345966957edee2d2ea","retrophin","post_ipo_equity",NA,"2013-08-16",2.5e+07
"6b60d704737768345966957edee2d2ea","retrophin","post_ipo_debt",NA,"2014-07-01",4.5e+07
"6b60d704737768345966957edee2d2ea","retrophin","convertible_note",NA,"2014-07-01",4.6e+07
"6654e57d360aeb1d859bff18b9cdcf3a","retroscreen-virology",NA,NA,NA,NA
"9502164abdcd6f00fe791dc4ac417150","retrosense-therapeutics","seed",NA,"2011-10-07",75000
"9502164abdcd6f00fe791dc4ac417150","retrosense-therapeutics","venture","1","2015-01-08",6e+06
"9502164abdcd6f00fe791dc4ac417150","retrosense-therapeutics","venture",NA,"2011-03-04",NA
"9502164abdcd6f00fe791dc4ac417150","retrosense-therapeutics","venture","1","2015-11-12",6e+06
"af038e30aee85d6f1cd24b939555e69f","retrovirox","grant",NA,"2015-03-12",3e+06
"828293825438c4226735fc0578efff77","retsku","seed",NA,"2014-01-06",40000
"38273a2cb4d01377b1787eddedceaabf","reunify","angel",NA,"2010-06-01",NA
"38273a2cb4d01377b1787eddedceaabf","reunify","private_equity",NA,"2011-11-01",NA
"eee99d3d3e7e933d265cdb0314355517","revalesio","venture",NA,"2012-06-19",10650000
"eee99d3d3e7e933d265cdb0314355517","revalesio","venture",NA,"2014-05-05",13500000
"4c77f087b9eee6276786d5749950ef2f","revaltics-inc",NA,NA,NA,NA
"1b0e907cec826c003c76aa7fc6277cd2","revance-therapeutics","venture","C","2007-12-12",43200000
"1b0e907cec826c003c76aa7fc6277cd2","revance-therapeutics","venture","d","2009-12-28",25620000
"1b0e907cec826c003c76aa7fc6277cd2","revance-therapeutics","venture","e","2013-04-02",3.3e+07
"1b0e907cec826c003c76aa7fc6277cd2","revance-therapeutics","venture","d","2011-06-10",4.5e+07
"1b0e907cec826c003c76aa7fc6277cd2","revance-therapeutics","venture",NA,"2013-10-24",1e+07
"512b14030a813f80b6776185f86c6783","revantha-technologies","seed",NA,"2012-07-10",150000
"d68699f74516e78e727920aa1a46dc5f","reveal-6","seed",NA,"2015-09-01",NA
"f9d73935a7d2e70998964715c57c96ba","reveal-design-automation","venture",NA,"2011-04-18",NA
"64c20d9e9529804bfe24dd81a22e735b","revealytics",NA,NA,NA,NA
"9030a47eb32c7680ac1ac1ed9c6af97a","revel","seed",NA,"2015-01-01",1500000
"876a762db8be5ee7bdcd90b3f2403252","revel-systems","venture","a","2011-05-24",3700000
"876a762db8be5ee7bdcd90b3f2403252","revel-systems","venture","b","2013-06-26",10100000
"876a762db8be5ee7bdcd90b3f2403252","revel-systems","venture","C","2014-11-11",1e+08
"876a762db8be5ee7bdcd90b3f2403252","revel-systems","grant",NA,"2014-12-02",1200000
"876a762db8be5ee7bdcd90b3f2403252","revel-systems","venture",NA,"2015-01-01",NA
"876a762db8be5ee7bdcd90b3f2403252","revel-systems","venture","C","2015-08-18",13500000
"be5d466a17f5ea9dadaa91c07dab42c4","revelation","venture","a","2008-07-05",1100000
"be5d466a17f5ea9dadaa91c07dab42c4","revelation","venture",NA,"2010-04-19",1270000
"99c684208aec8b5e86effa3724cb0f2b","revelator","seed",NA,"2015-01-31",5e+05
"99c684208aec8b5e86effa3724cb0f2b","revelator","seed",NA,"2015-10-25",8e+05
"99c684208aec8b5e86effa3724cb0f2b","revelator","seed",NA,"2015-03-11",650000
"c31a12f47abeacb84d5208493500d242","reven-pharmaceuticals","debt_financing",NA,"2014-01-29",1833055
"c31a12f47abeacb84d5208493500d242","reven-pharmaceuticals","venture",NA,"2015-02-19",4440594
"b4473425e968d4777239f672b576e1df","revenew","venture","b","2013-10-30",5e+06
"b4473425e968d4777239f672b576e1df","revenew","venture",NA,"2014-12-02",2638575
"6333029fe4e9a68af6efbf064bd8431b","revenue-river-marketing",NA,NA,NA,NA
"de26094414c31431f6b5bab61171818d","reverb-technologies","venture",NA,"2009-07-08",3700000
"de26094414c31431f6b5bab61171818d","reverb-technologies","venture","1","2008-01-01",1e+06
"de26094414c31431f6b5bab61171818d","reverb-technologies","venture","1","2011-07-25",1599996
"de26094414c31431f6b5bab61171818d","reverb-technologies","venture","1","2010-09-01",6490000
"de26094414c31431f6b5bab61171818d","reverb-technologies","venture","1","2013-04-01",NA
"5dbbad11f8bb3cce4b1bb5d8d16d1abf","reverse-medical","venture","b","2010-04-07",1.4e+07
"5dbbad11f8bb3cce4b1bb5d8d16d1abf","reverse-medical","debt_financing",NA,"2009-07-01",1500000
"7d0c9c6976c761473cdafafcf23d00ac","revily","venture",NA,"2014-10-15",675000
"5b1ebc0e2490294a1e2902603e4b4a11","reviral","venture",NA,"2014-12-03",1e+06
"495f1f18b10942767d4637e96dfc2f0f","revision-optics","venture","D","2007-04-30",2.5e+07
"495f1f18b10942767d4637e96dfc2f0f","revision-optics","venture","E","2013-07-29",5.5e+07
"495f1f18b10942767d4637e96dfc2f0f","revision-optics","venture","E","2013-04-16",14999998
"495f1f18b10942767d4637e96dfc2f0f","revision-optics","venture","d","2010-07-20",3.5e+07
"bf5380527c4f2615393ea0d805117ee0","revision-therapeutics","venture",NA,"2011-12-05",5e+05
"bf5380527c4f2615393ea0d805117ee0","revision-therapeutics","venture",NA,"2010-04-23",2870231
"09673593230057742bf0028f281823b6","reviticell-holdings","equity_crowdfunding",NA,"2015-06-01",NA
"09673593230057742bf0028f281823b6","reviticell-holdings","venture",NA,"2016-01-20",1600383
"3afbbdc0265bd68e23f48eaa602a183a","reviva-pharmaceuticals","venture","b","2012-08-20",7624840
"3afbbdc0265bd68e23f48eaa602a183a","reviva-pharmaceuticals","venture","C","2013-03-21",1.2e+07
"3afbbdc0265bd68e23f48eaa602a183a","reviva-pharmaceuticals","venture","D","2014-07-02",15831541
"6e7cf80bfb799133ca354d2361834b12","revive-defibrillation-systems",NA,NA,NA,NA
"520ca4666890a0cf2348f4afeb60c916","revmetrix","seed",NA,"2015-02-19",2200000
"14b7357a74424b9b3398c0f1529a773f","revolution-computing","venture","c","2010-10-18",13395398
"14b7357a74424b9b3398c0f1529a773f","revolution-computing","debt_financing",NA,"2009-04-03",1500000
"14b7357a74424b9b3398c0f1529a773f","revolution-computing","venture","b","2009-10-20",16000001
"14b7357a74424b9b3398c0f1529a773f","revolution-computing","venture","a","2008-01-22",NA
"14b7357a74424b9b3398c0f1529a773f","revolution-computing","venture",NA,"2013-01-02",7800000
"01e413e64bf87481e1d4a56e25a3286b","revolution-bioengineering","seed",NA,"2014-09-09",NA
"56a7b7f393080f55bb737dd25731a5f0","revsocial-llc","seed",NA,"2014-12-08",NA
"b8879a7008fd79f33f0892ce8ae543c7","revstream",NA,NA,NA,NA
"fc52800c9a8ce7310b1401ed3badd576","rex-pet-health","seed",NA,"2014-07-22",25000
"fc52800c9a8ce7310b1401ed3badd576","rex-pet-health","seed",NA,"2015-03-01",120000
"830cfa20b8272747497a6464a6a14c88","rexahn-pharmaceuticals","private_equity",NA,"2013-10-13",5e+06
"442efd0d4a9ab986dbd825173ab196db","rezora","seed",NA,"2009-08-06",18000
"88759446f90684df6c708425a57e1eeb","rfeyed","seed",NA,"2012-02-06",40000
"13d8b11b60eb3602a0a16c639d33c53c","rfs-pharma","venture",NA,"2014-12-08",5e+06
"3504efc6d3da1966358f0ad0aabb7156","rfxcel",NA,NA,NA,NA
"114339a9743aabdc55749ef43dc77385","rgenix","seed",NA,"2013-09-30",2500000
"114339a9743aabdc55749ef43dc77385","rgenix","venture",NA,"2015-08-18",8e+06
"d77ff8974155cfb87c357311fe1c658f","rhein-biotech-nv",NA,NA,NA,NA
"37487145c59dab97bf80bc3aded1dfb2","rhenovia-pharma","venture","b","2014-02-12",694764
"c67baef15ee121bbc21c16a6d31e8b68","rheonix","venture",NA,"2015-10-20",28600000
"c67baef15ee121bbc21c16a6d31e8b68","rheonix","venture","1","2010-05-24",12600000
"c67baef15ee121bbc21c16a6d31e8b68","rheonix","venture",NA,"2012-02-09",6e+06
"c67baef15ee121bbc21c16a6d31e8b68","rheonix","venture","1","2013-12-19",1.2e+07
"c67baef15ee121bbc21c16a6d31e8b68","rheonix","venture",NA,"2010-01-14",11524758
"c67baef15ee121bbc21c16a6d31e8b68","rheonix","undisclosed",NA,"2013-12-13",2e+06
"c67baef15ee121bbc21c16a6d31e8b68","rheonix","debt_financing",NA,"2014-01-15",2e+06
"c67baef15ee121bbc21c16a6d31e8b68","rheonix","venture",NA,"2014-06-11",1.4e+07
"84f9f560e98698d4fd06adb67f9741e2","rhetorical-group-plc","undisclosed",NA,"2001-11-01",6303109
"86cad44071afb5066d9ad10a40dffadf","rhino-security-labs",NA,NA,NA,NA
"07a962770967a7f387eb3923aa802d38","rhinocyte","convertible_note",NA,"2015-10-07",250000
"07a962770967a7f387eb3923aa802d38","rhinocyte","debt_financing",NA,"2012-10-22",525000
"07a962770967a7f387eb3923aa802d38","rhinocyte","venture","1","2006-08-07",930000
"07a962770967a7f387eb3923aa802d38","rhinocyte","debt_financing",NA,"2009-10-15",1130000
"07a962770967a7f387eb3923aa802d38","rhinocyte","debt_financing",NA,"2011-11-18",1114721
"07a962770967a7f387eb3923aa802d38","rhinocyte","venture",NA,"2014-07-11",750000
"528ab8135f384bc55b04c668b2301def","rhiza-labs","venture",NA,"2015-12-04",1500000
"528ab8135f384bc55b04c668b2301def","rhiza-labs","venture","1","2014-06-17",3e+06
"528ab8135f384bc55b04c668b2301def","rhiza-labs","convertible_note",NA,"2015-07-30",1500000
"2234ef3037a689f6ef965da190dbc990","rhodes-edge",NA,NA,NA,NA
"660f61674582196ed08d1a56bbecbacf","rhumbix-inc-","angel",NA,"2014-08-01",1e+06
"660f61674582196ed08d1a56bbecbacf","rhumbix-inc-","venture","1","2015-09-04",6134517
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","venture",NA,"2012-06-04",9500000
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","venture","1","2012-11-27",8e+06
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","venture","1","2010-03-15",2.1e+07
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","venture","1","2010-09-08",1.9e+07
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","venture","1","2013-07-31",1.1e+07
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","grant",NA,"2013-09-10",1400000
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","venture","1","2012-06-13",2.5e+07
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","venture","1","2015-08-13",4e+07
"cf7d70f92b78afdd10fa949453c20f57","rhythm-pharmaceuticals","grant",NA,"2015-09-24",1e+06
"aa4548a31e979572a42639030754188f","riboxx","equity_crowdfunding",NA,"2015-01-12",1184422
"aa4548a31e979572a42639030754188f","riboxx","seed",NA,"2009-12-11",NA
"aa4548a31e979572a42639030754188f","riboxx","venture","1","2011-03-02",NA
"aa4548a31e979572a42639030754188f","riboxx","venture","1","2012-11-15",NA
"936b13cdb50257cb0525937d1160d634","ribozyme-pharmaceuticals",NA,NA,NA,NA
"44bb134008a79259e65f73db3e5b03a8","ricerca-biosciences",NA,NA,NA,NA
"ce1fdfeee0c890ab316497387253f061","richrelevance","venture","b","2007-12-20",4200000
"ce1fdfeee0c890ab316497387253f061","richrelevance","venture","d","2010-05-05",1.2e+07
"ce1fdfeee0c890ab316497387253f061","richrelevance","venture","e","2012-05-01",2e+07
"ce1fdfeee0c890ab316497387253f061","richrelevance","venture","f","2013-11-27",2e+07
"ce1fdfeee0c890ab316497387253f061","richrelevance","venture","c","2009-07-17",12500000
"ce1fdfeee0c890ab316497387253f061","richrelevance","venture","e","2012-08-14",8e+06
"ce1fdfeee0c890ab316497387253f061","richrelevance","debt_financing",NA,"2009-05-13",4032065
"ce1fdfeee0c890ab316497387253f061","richrelevance","venture","a","2007-06-19",1100000
"09ac338355d264b0094d275ce8ad0dc9","richter-group",NA,NA,NA,NA
"c060153cdd427d9564bf0c499ccabe94","ridge-diagnostics","venture",NA,"2010-06-11",577000
"c060153cdd427d9564bf0c499ccabe94","ridge-diagnostics","venture",NA,"2013-04-18",250000
"c060153cdd427d9564bf0c499ccabe94","ridge-diagnostics","venture","1","2012-03-07",NA
"b8f99aecd5f3dcd14a3ea9c23f8a84fa","rift-recon",NA,NA,NA,NA
"cdc11a49d09b48ced1ab30f3c09c2cbc","rigel-pharmaceuticals","venture",NA,"2011-05-27",1.3e+08
"6c1d56076dbf065a7fbdef216410f669","right-on-interactive","angel",NA,"2010-04-01",655000
"6c1d56076dbf065a7fbdef216410f669","right-on-interactive","angel",NA,"2011-11-22",750000
"33ea39825be53f36eab51f4e3e0759f1","right-relevance","convertible_note",NA,"2014-03-01",730000
"4a964e3581b1d2fc7be43c139d1b11ee","rightbid",NA,NA,NA,NA
"bf253611054f8fbd17385c5b0b2c8bfc","rightsify",NA,NA,NA,NA
"076ac3aaab73999f58afbe22d69635a4","rightster",NA,NA,NA,NA
"b31a859e7b470ab53bbe0e9e77476a46","rigor",NA,NA,NA,NA
"8161cca523b4116cd7197a756e9741a6","rillate",NA,NA,NA,NA
"1a0810113c3e9c2f4d969e348624dc24","rinat",NA,NA,NA,NA
"b7b29b78e48a1a9512ba77bbce35a43d","rincon-pharmaceuticals","venture",NA,"2005-11-15",4700000
"7f8def7389cde9c37e356bc109fb1e60","ringostat","seed",NA,"2013-02-01",150000
"05416d70d455b375b39a1128a0110d25","rinku",NA,NA,NA,NA
"857fd44c379304bee74c879ddbbcbc95","riogin","undisclosed",NA,"2014-04-08",NA
"82c7e88c2a54f0fff0bf26540c495d44","ripvanwafels","seed",NA,"2011-10-01",182000
"5563724e7354b4fca228c2973c1cbcc2","ripehouse",NA,NA,NA,NA
"3223dc8f5fbb2915a0588e6e723dd989","ripl-io","undisclosed",NA,"2014-05-01",55000
"a31239d509e6a6e76bf7ab34fb677756","ripple-platform",NA,NA,NA,NA
"28b69c48ac9ab268ac065ac76074695e","ripplelocal",NA,NA,NA,NA
"fc0e2f3ea8ff00637a60d21c640da788","rippleshot","undisclosed",NA,"2015-12-07",1200000
"fc0e2f3ea8ff00637a60d21c640da788","rippleshot","seed",NA,"2015-02-07",8e+05
"46857faa7536489681c5125ce1fa82d2","riptide-io","venture","A","2015-12-01",3e+06
"46857faa7536489681c5125ce1fa82d2","riptide-io","debt_financing",NA,"2014-07-28",2e+05
"d9dc53b277b2d8c7ab87345ab5bf3157","rise-interactive",NA,NA,NA,NA
"bb210945d87ea4c1d7d479447e9afd74","rise-science",NA,NA,NA,NA
"f19274a5f38366825c34b423f584451f","risk-ident",NA,NA,NA,NA
"535b7e851c8e6727a2aad17195aa7b1c","risk-management",NA,NA,NA,NA
"46d90536a0c7f07eb75c22c5e46f44e9","riskbi",NA,NA,NA,NA
"93fa50647a61bc509892afd72e5aad90","riskgap",NA,NA,NA,NA
"656b1c28b9bc14c06e16a7f249cd5aba","riskified","seed",NA,"2013-07-08",1650000
"656b1c28b9bc14c06e16a7f249cd5aba","riskified","venture","1","2014-02-01",4e+06
"6a4dbbc59e1ee8f8d59acabe7dec8c20","riskmatch",NA,NA,NA,NA
"168493a600540314f6c53023e0b31374","riskmetrics-group",NA,NA,NA,NA
"f62d92972205a84c8722ecda45947a7d","risksystem",NA,NA,NA,NA
"f8e81486476e5d09c847a52f2564ebb0","rival-iq","seed",NA,"2013-01-15",70000
"f8e81486476e5d09c847a52f2564ebb0","rival-iq","venture",NA,"2014-01-09",860000
"f8e81486476e5d09c847a52f2564ebb0","rival-iq","seed",NA,"2014-01-01",NA
"f8e81486476e5d09c847a52f2564ebb0","rival-iq","venture",NA,"2014-11-13",1e+06
"e2c0f743620a053dfbe34655a84a0322","rivalfox","seed",NA,"2014-05-27",NA
"99e80f99133b235f53b861a0a7f044bb","river-cities-technology-llc","seed",NA,"2015-02-02",NA
"d4a4744e6ca5b3cd861ccc17043e0b26","riverbed-marketing",NA,NA,NA,NA
"2a36f0b09172df2f108e542607b3da66","riverlabs-gmbh",NA,NA,NA,NA
"7121a28ef030af41dc4a0f935f0bacbb","riwi","seed",NA,"2012-12-12",212697
"c5d0acbbfef57dca3ddcfee50818b6ad","rjmetrics","debt_financing",NA,"2012-01-03",1200000
"c5d0acbbfef57dca3ddcfee50818b6ad","rjmetrics","venture","1","2013-05-15",6250000
"c5d0acbbfef57dca3ddcfee50818b6ad","rjmetrics","venture","1","2014-09-15",16500000
"de9e591e5383b224d665d30eaf3dc8c7","rl-clean-power-pvt-ltd",NA,NA,NA,NA
"6f723920de55bc24b1c6c747251a20c6","rnrounds",NA,NA,NA,NA
"7f3739c4b91931af8db259076405d355","roam-analytics","venture","A","2015-07-01",9590000
"7f3739c4b91931af8db259076405d355","roam-analytics","venture",NA,"2013-12-26",1749998
"2cbd8cad2d7820fce9777728eae8c32a","mellmo","angel",NA,"2009-09-23",4e+06
"2cbd8cad2d7820fce9777728eae8c32a","mellmo","venture",NA,"2010-12-21",1e+07
"2cbd8cad2d7820fce9777728eae8c32a","mellmo","venture",NA,"2009-11-12",4349999
"2cbd8cad2d7820fce9777728eae8c32a","mellmo","venture","1","2011-09-15",3e+07
"7984f7f0235cb849d8374b7e4fe6485a","robertnemec-com",NA,NA,NA,NA
"2ba402deb0925449616b631b8bdf54de","robertson-global-health-solutions","venture",NA,"2010-10-26",9e+05
"2ba402deb0925449616b631b8bdf54de","robertson-global-health-solutions","venture",NA,"2011-08-31",545000
"8997b2417b6822cad3e381e797e9d7c6","robin-systems","convertible_note",NA,"2014-09-01",4300000
"8997b2417b6822cad3e381e797e9d7c6","robin-systems","seed",NA,"2013-12-31",2400000
"8997b2417b6822cad3e381e797e9d7c6","robin-systems","venture","1","2015-10-06",1.5e+07
"4ed201afc9220f5285b2a94052279513","robonica-srl","seed",NA,"0015-04-15",NA
"24772e7164653364528f14b9a4b2fefd","robot-owl",NA,NA,NA,NA
"f8cc956b13aa8a99a56860f6ed3ffbf3","robot-recruit",NA,NA,NA,NA
"0637cbc12bd4faaded4605c1795e93db","robotronica","grant",NA,"2013-08-01",155000
"393a50c8102c5fb00c75f88756e297d8","roche",NA,NA,NA,NA
"e8caf0120e939e94c5474589dd4b1ba0","roche-boehringer-mannheim",NA,NA,NA,NA
"020cfb72eca0caffeea7bde3a3915646","roche-diagnostics",NA,NA,NA,NA
"859225cf443e62d1b0f9c7a64065ef49","roche-molecular-systems",NA,NA,NA,NA
"2384b0f73516d20500edc3f46f30a3d0","rochester-bioventure-center",NA,NA,NA,NA
"faee177cf274ede30e03ce992eb0bcc9","rochester-medical-corporation",NA,NA,NA,NA
"9c11ef6320d33624d8e9a7cc970931fb","rock-it-oil",NA,NA,NA,NA
"a0da8bd41a97b513595cd39d8557f862","rockdex",NA,NA,NA,NA
"be22906eb1e5b67094552bdb7b889a8a","rocket-pharmaceuticals","venture",NA,"2016-01-15",16425000
"6132a598b7b711388bbf6dea281fd2b4","rocket-colombia","seed",NA,"2013-10-01",250000
"6132a598b7b711388bbf6dea281fd2b4","rocket-colombia","convertible_note",NA,"2014-03-01",550000
"516997121ca2746332e0e63984808131","rocketgraph","seed",NA,"2014-12-16",5e+05
"c96025a8a2ba7223ee290e434578bb95","rocketium",NA,NA,NA,NA
"b023e205d8cd6e7d001d49c1bdc4a0f6","rocketroi","undisclosed",NA,"2015-06-01",547829.1357
"e431c6700e7ae0ce9197b42c177e9a04","rockwell-medical","debt_financing",NA,"2013-06-18",2e+07
"e431c6700e7ae0ce9197b42c177e9a04","rockwell-medical","venture",NA,"2014-10-15",1.5e+07
"280c8e4a6205637b5035fa72dcf0ebcf","rocky-mountain-biosystems","venture",NA,"2011-01-07",256000
"79e798f809ce6b6934bce79a0f451317","rodati","seed",NA,"2014-06-01",1e+06
"155b68949d409c01e78a58645b99acc2","rodenburg-biopolymers","private_equity",NA,"2013-08-29",NA
"c8696c373ff7dd92bf31508c98a4a5ff","rodin-therapeutics","venture","B","2016-01-06",17300000
"c8696c373ff7dd92bf31508c98a4a5ff","rodin-therapeutics","seed",NA,"2013-06-27",NA
"c8696c373ff7dd92bf31508c98a4a5ff","rodin-therapeutics","venture","A","2014-05-29",12900000
"780b050b85507fa11f6559ac22f0193b","rodo-medical","venture",NA,"2011-02-14",1620431
"d615cc09cc31812f4765e188ec22f0d4","rodos-biotarget","venture",NA,"2013-04-17",3413540
"d615cc09cc31812f4765e188ec22f0d4","rodos-biotarget","seed",NA,"2009-05-07",NA
"31d82c34e9cc38793e2b509e56fa4c8a","rogers-cowan",NA,NA,NA,NA
"c521104cff2b1ca50425d82a451a3047","rogue-resolutions",NA,NA,NA,NA
"d6e022f750627db148ebca5dc2b516b7","roi","undisclosed",NA,"2010-06-26",NA
"d6e022f750627db148ebca5dc2b516b7","roi","seed",NA,"2011-06-24",1e+06
"4992184af47add4bd34132fbe72dfbce","roi-influencer-media",NA,NA,NA,NA
"3ea5ff9e689355c1a94c47cad0ffe9f8","roi-revolution",NA,NA,NA,NA
"34458ad6bf3d74df6a5cd0b7acd6f0eb","roi-dna",NA,NA,NA,NA
"7dd236639b102c8fdfebd7b7e58d1c23","roichecker-com",NA,NA,NA,NA
"f19add1d3eef385b93c07b01b4eb8905","roka-bioscience","venture","c","2011-07-28",2e+07
"f19add1d3eef385b93c07b01b4eb8905","roka-bioscience","venture","d","2012-01-08",47500000
"f19add1d3eef385b93c07b01b4eb8905","roka-bioscience","venture","e","2013-12-05",16996657
"f19add1d3eef385b93c07b01b4eb8905","roka-bioscience","venture","e","2013-06-27",24999999
"3d60f3880d9e0c6e29c45613acd91502","role-models-medical",NA,NA,NA,NA
"f35aff06d0e7ba3ecd7a3f6713d4019e","rollbar","seed",NA,"2013-04-01",2e+05
"f35aff06d0e7ba3ecd7a3f6713d4019e","rollbar","seed",NA,"2012-09-01",235000
"10903634536092035e2c573ac61b35c1","rollout",NA,NA,NA,NA
"055d608f97c098bef0ca759f452d5b31","romanz-media-group",NA,NA,NA,NA
"eb6e7035ddbefd80d5b7dedeb1478999","romark-laboratories","venture",NA,"2011-01-05",23111817
"eb6e7035ddbefd80d5b7dedeb1478999","romark-laboratories","venture",NA,"2011-11-18",9647700
"eb6e7035ddbefd80d5b7dedeb1478999","romark-laboratories","venture",NA,"2014-06-16",14999520
"eb6e7035ddbefd80d5b7dedeb1478999","romark-laboratories","venture",NA,"2014-07-08",1900000
"22c53cc6bd58bacd54148e08444df772","romir",NA,NA,NA,NA
"9b77d648c8bdb54a5dc626ea28f82327","ronser-bio-tech-sdn-bhd",NA,NA,NA,NA
"710f28dcbfbd6ab9a0c71e5f1ca50057","roofingesher",NA,NA,NA,NA
"5024061fd414703e4ef0995984050e1b","rook-security",NA,NA,NA,NA
"6ad978e64f0b9078e920cc5df4166fd8","room-biotic",NA,NA,NA,NA
"e7790c33c0de73c4c97177dc56dd9738","room-choice","seed",NA,"2014-04-06",1e+05
"e7790c33c0de73c4c97177dc56dd9738","room-choice","seed",NA,"2015-05-13",899100
"50eac12530e8616369cf55c140c82388","roosterbio","venture",NA,"2014-01-14",1e+05
"50eac12530e8616369cf55c140c82388","roosterbio","seed",NA,"2014-02-25",250000
"f010a8a0ad51aef0f1b58682fc950f08","rorotika-technologies-pty-ltd",NA,NA,NA,NA
"c0901c75c35ce8c7cd6ab48d47f173dd","rosalind","grant",NA,"2013-03-01",25000
"1db299295726811a6ae2d674564026ec","roselabs",NA,NA,NA,NA
"1e13202cfa09b11bc58922bea49c3f7f","rosenthalanalysis",NA,NA,NA,NA
"9f39f4b4be92f9688b1f5c7dfd73a92d","rosetta-biosoftware",NA,NA,NA,NA
"d5456422a532099c1e52ea5ac19ec317","rosetta-genomics","venture","A","2011-10-19",1518751
"d5456422a532099c1e52ea5ac19ec317","rosetta-genomics","private_equity",NA,"2012-02-09",1750000
"d5456422a532099c1e52ea5ac19ec317","rosetta-genomics","product_crowdfunding",NA,"2011-03-07",2500000
"d5456422a532099c1e52ea5ac19ec317","rosetta-genomics","venture","A","2011-03-07",2725000
"6a56cd310b8abe8cdfb84805e1ada502","rosetta-green",NA,NA,NA,NA
"580332b933306730bd43553d0faccd7e","rosetta-inpharmatics",NA,NA,NA,NA
"4c241afcb278fa90e1d0e603d8283be5","rosoka-software",NA,NA,NA,NA
"8f78962d2d9cf91d8d47e43148c9751e","rosslyn-analytics","venture",NA,"2010-01-18",3748964.1458
"8f78962d2d9cf91d8d47e43148c9751e","rosslyn-analytics","undisclosed",NA,"2012-05-29",NA
"8f78962d2d9cf91d8d47e43148c9751e","rosslyn-analytics","venture",NA,"2013-12-11",3182028
"49a28987e3dbf0de2fdc01933ca50c86","rothenberg-ventures",NA,NA,NA,NA
"b0ddf0b4e7eadb1d91624330d6ac6b49","rothman-healthcare","venture",NA,"2011-01-11",410000
"b0ddf0b4e7eadb1d91624330d6ac6b49","rothman-healthcare","seed",NA,"2012-07-16",893738
"1df5192effa6310d164f636ed2a7a5ff","rottapharm",NA,NA,NA,NA
"b90aace8e59ab0c8fc3601b8c1332c96","roundforest-ltd",NA,NA,NA,NA
"d1cd19cba4c078b920c478604c99db86","roundteam",NA,NA,NA,NA
"6383d77c08a23632ff094d777d002ccc","route",NA,NA,NA,NA
"83e9bea9c6aa56c9170af9fa5dfa0d87","roxro-pharma","venture","b","2007-06-12",42700000
"7bc8d978a466995d8842de496d1e51ab","royal-gate-inc",NA,NA,NA,NA
"c47330dce838ea4024ba3ddaa222ca14","royal-health-care",NA,NA,NA,NA
"43d5d0f72d227b5b4b99b3ce9e5393b3","rpm-sustainable-technologies","seed",NA,"2013-03-22",NA
"6b9a9c57f120106ae501abffe763c2b6","rqmicro",NA,NA,NA,NA
"af522039cfbeb082549cfd7af0670801","rqx-pharmaceuticals","venture","A","2011-02-01",7e+06
"f5315b3cbb4c18289b812f2103cdb761","rre-ventures",NA,NA,NA,NA
"e2605a362b4240b096cebe40ff12c5d3","rs-synthesis",NA,NA,NA,NA
"e35c32309b615ffb345da7b5bbe1daa4","rsa",NA,NA,NA,NA
"53e3ba83bf65ad941a3b94e6043fe9a0","rsb-spine","venture",NA,"2010-02-23",30649
"4d5c943aaadf6900bf111dad98c26da1","rti-biologics",NA,NA,NA,NA
"4f9b15efe3538f9dfa3fdbfc9b3bca2c","rtp-corporation",NA,NA,NA,NA
"6aea49f7b5477099821790ff4ccdea36","rts-labs",NA,NA,NA,NA
"766e12ea689f789202d9cb55c46b0a95","rtsheet",NA,NA,NA,NA
"40657fb38b244c9f13cd3358e060fdeb","rttech-software","venture","A","2015-02-24",3e+06
"40657fb38b244c9f13cd3358e060fdeb","rttech-software","seed",NA,"2012-05-01",750000
"368f331397b22f29dec739abfda23934","rubicon-genomics","venture",NA,"2015-07-15",2e+06
"d6eac16a61cd45f91ee4fbc6b7ee11fe","rubikey-intelligence-knowledge",NA,NA,NA,NA
"e9da5f7c39f9bf1fd7d1e94a067e52d2","rubikloud","seed",NA,"2013-11-18",1500000
"e9da5f7c39f9bf1fd7d1e94a067e52d2","rubikloud","venture","1","2015-01-19",7e+06
"85aaa9d4c8edfe273aaca2b2eddaf80a","rubius-therapeutics","venture","A","2015-12-09",2.5e+07
"ebe0a6b3ac05734eb41f248bbf9f074d","ruckus-marketing",NA,NA,NA,NA
"8cce40c77e722dda0a5d3496d0b601c5","rudrasoft",NA,NA,NA,NA
"54d23e51c44d3fce32605a913cf3ed71","rufus-leonard",NA,NA,NA,NA
"a39aeda07b36b5e20193343ec4e09eea","ruifu-biological-medicine-science-and-technology-shanghai-co-ltd","venture","A","2007-04-01",NA
"96f222400e685f98cd7a7059584aa41c","ruiyi","venture","b","2014-03-27",1.5e+07
"96f222400e685f98cd7a7059584aa41c","ruiyi","debt_financing",NA,"2014-06-11",4e+06
"6d464315fae503564fd7b2a99a857930","ruler-analytics",NA,NA,NA,NA
"1670d54a12fae0e3d26bea7e31f8d2ca","rules-based-medicine","venture","A","2007-10-15",2.5e+07
"ec8cdc88e2087338375c880b85e51b0d","rulex",NA,NA,NA,NA
"ed4a04d74a0165ccac21ebbe51574079","rumble-inc",NA,NA,NA,NA
"b5ae1c86e7ea12f38024b39ca39bff85","rumble-inc-2",NA,NA,NA,NA
"e72938055e94f00318ce104185d4131d","rundown-app","seed",NA,"2013-07-15",2e+05
"ba731794b746bceda934c97a20960839","runecast",NA,NA,NA,NA
"f2aa1f8d8afa8870740385c2518936c8","runnr-me",NA,NA,NA,NA
"2cdce11addfa09665757b1b02075007c","runteq","angel",NA,"2016-01-06",93859.2327
"2cdce11addfa09665757b1b02075007c","runteq","debt_financing",NA,"2012-05-01",66070
"2cdce11addfa09665757b1b02075007c","runteq","equity_crowdfunding",NA,"2014-03-01",48888
"2cdce11addfa09665757b1b02075007c","runteq","equity_crowdfunding",NA,"2014-11-01",58499
"2cdce11addfa09665757b1b02075007c","runteq","debt_financing",NA,"2014-12-01",130805
"2cdce11addfa09665757b1b02075007c","runteq","undisclosed",NA,"2012-03-31",59952.0384
"e018936eb2c3620219251a6133a8bbcd","ruro",NA,NA,NA,NA
"71c3516c08c1f23fbeb9bd7ea722b134","rush-hour",NA,NA,NA,NA
"3a7debb3c29a635ab98601d684e88c41","rutherford-chemicals",NA,NA,NA,NA
"46ecbf03e1017b5977ab140b11bcab86","ruthigen",NA,NA,NA,NA
"5f0b96d7f449e8390e733b0588e00590","rxadvance","venture","a","2014-03-03",NA
"736ca4e15629ead33da6a7282b666488","rxbio",NA,NA,NA,NA
"21b60bb9d8549c2718e1c5f1fdffe910","rxgen",NA,NA,NA,NA
"49724b38cc60166edfd3307d2d8dd4ec","rxi-pharmaceuticals","grant",NA,"2012-10-05",3e+05
"49724b38cc60166edfd3307d2d8dd4ec","rxi-pharmaceuticals","post_ipo_equity",NA,"2014-04-24",2e+07
"b0bab73cef405ad5c797c43efa0ff5e3","rxlogix-corporation",NA,NA,NA,NA
"3d54ec19094847b28e7b4c236aa08951","rxmp-therapeutics","seed",NA,"2014-07-30",3e+05
"b0004c85a076431910c7a96030b367e3","rxresults","venture",NA,"2010-03-19",150000
"b0004c85a076431910c7a96030b367e3","rxresults","venture",NA,"2014-09-04",4e+06
"e5824495d73ae25ee5c40271da7e18ea","rymed-technologies","venture",NA,"2009-08-13",842500
"e5824495d73ae25ee5c40271da7e18ea","rymed-technologies","debt_financing",NA,"2012-08-02",6132825
"e5824495d73ae25ee5c40271da7e18ea","rymed-technologies","debt_financing",NA,"2011-02-18",8e+05
"e5824495d73ae25ee5c40271da7e18ea","rymed-technologies","venture",NA,"2010-08-19",160000
"0bfdcc3e0b8e5e51e42f507df01d5479","rythm",NA,NA,NA,NA
"4c6a5de35ba80b6e2b0cf2345b96070f","s-cap-consultancy","venture","B","2014-12-30",350000
"ac7fb64dadfa79cd8cf48dfdf562d1fe","s-bio","private_equity",NA,"2009-01-21",112500000
"ac7fb64dadfa79cd8cf48dfdf562d1fe","s-bio","venture",NA,"2008-10-20",2.6e+07
"ac7fb64dadfa79cd8cf48dfdf562d1fe","s-bio","private_equity",NA,"2010-09-23",5e+06
"8a6dfbfc5b786c74db04ed13b37af17f","s2c","venture","C","2014-10-14",4600000
"ea350cc2ce91661a1593c07e5c46d18e","solapa4","seed",NA,"2015-12-19",1200000
"ea350cc2ce91661a1593c07e5c46d18e","solapa4","seed",NA,"2014-03-01",25000
"ea350cc2ce91661a1593c07e5c46d18e","solapa4","undisclosed",NA,"2013-06-14",1e+06
"ea350cc2ce91661a1593c07e5c46d18e","solapa4","seed",NA,"2015-01-20",NA
"08f32401defc58b1bf4e802f6e12e92d","sa-ignite","venture",NA,"2011-01-11",270000
"08f32401defc58b1bf4e802f6e12e92d","sa-ignite","venture",NA,"2012-08-29",1596494
"08f32401defc58b1bf4e802f6e12e92d","sa-ignite","venture",NA,"2014-04-28",116115
"cc5a8e4e552f657fa8e4c05fe20708fa","saama-technologies","venture","A","2015-06-02",3.5e+07
"aca478dc9d1d5b0dfa6065525095151a","saas-metrics",NA,NA,NA,NA
"f09ae0412042b9e69f246055ab4c8c42","saba",NA,NA,NA,NA
"3b3dff28d65244204339ff5d53d20b73","sabia","venture",NA,"2012-08-21",295000
"3b3dff28d65244204339ff5d53d20b73","sabia","venture","1","2012-10-04",NA
"3ba7b751eb8ea1d1be08ab289e8b3787","sabirmedical","venture",NA,"2010-09-16",6539000
"35d59d41156850a1910ce17628464bae","sabre-hospitality-solutions",NA,NA,NA,NA
"47037e1992c3061794e6529d33393c7a","sabrtech","seed",NA,"2012-09-01",455267
"47037e1992c3061794e6529d33393c7a","sabrtech","seed",NA,"2015-02-09",59956
"f7e414595829e287f67a3c3ec3d778c7","sacramento-data-scraping",NA,NA,NA,NA
"bcdac2013df8914acc8c4399ab1cb146","saex-group-inc","angel",NA,"2011-02-01",370000
"bc25e7d999d798c05eebe5e3e44151ea","safepath-medical","debt_financing",NA,"2012-07-10",119000
"bc25e7d999d798c05eebe5e3e44151ea","safepath-medical","venture",NA,"2011-10-12",3e+05
"bc25e7d999d798c05eebe5e3e44151ea","safepath-medical","venture",NA,"2015-07-13",30000
"47f4e8351ed078807bd7c5353d099cd0","sage-labs",NA,NA,NA,NA
"c5f2f067b69d48e4f71c6d765110a3d3","sage-middle-east",NA,NA,NA,NA
"9b98fbe09811b513b6c8c87ad6bdae89","sage-payment-solutions",NA,NA,NA,NA
"f51c693e30cbf0e05b3db298b1c99954","sage-science","venture",NA,"2011-09-29",2e+06
"f51c693e30cbf0e05b3db298b1c99954","sage-science","venture",NA,"2010-12-02",2020000
"4c055bb9cf8047009fc2c18cbf18961b","sage-therapeutics","venture","a","2011-10-18",3.5e+07
"4c055bb9cf8047009fc2c18cbf18961b","sage-therapeutics","venture","c","2014-03-13",3.8e+07
"4c055bb9cf8047009fc2c18cbf18961b","sage-therapeutics","venture","b","2013-10-16",2e+07
"4ac29325c1be2607507bcb8f6e4e5743","sagemetrics","venture","B","2002-05-12",6e+06
"4ac29325c1be2607507bcb8f6e4e5743","sagemetrics","venture","A","2000-03-30",6e+06
"f14b3a6552d965fab4b28be04969539b","sagence-group","venture","a","2011-12-12",NA
"378504f2a3ae574b77c213eea65eff3f","sagent","angel",NA,"2015-05-30",250000
"70a4475ad5f1c72d0dd2980561b35dac","sagent-pharmaceuticals","venture","A","2007-09-27",5.3e+07
"70a4475ad5f1c72d0dd2980561b35dac","sagent-pharmaceuticals","venture","A","2008-09-04",3e+07
"70a4475ad5f1c72d0dd2980561b35dac","sagent-pharmaceuticals","venture","b","2010-04-08",4e+07
"70a4475ad5f1c72d0dd2980561b35dac","sagent-pharmaceuticals","venture","a","2009-06-14",3e+07
"37ec27df4476c10b586a8cb57555f04b","sagetis-biotech","venture","b","2011-07-22",2e+06
"ac73446c46d90ea4ad4050d1da0072ef","sagewell",NA,NA,NA,NA
"d247794d5c31b7dc615e4d64e11ca3a0","saggezza-inc",NA,NA,NA,NA
"e32306feefa5a6290e2c1f260deba7d1","saguaro-group","private_equity",NA,"2011-07-14",27396000
"6c5060a698e806ef8a6305ada43c73ea","sai-wireless",NA,NA,NA,NA
"c69fab84944a16e26c84b8cb15b9984b","sailthru","seed",NA,"2010-07-26",1e+06
"c69fab84944a16e26c84b8cb15b9984b","sailthru","venture","1","2013-02-11",1.9e+07
"c69fab84944a16e26c84b8cb15b9984b","sailthru","venture","1","2013-12-17",2e+07
"c69fab84944a16e26c84b8cb15b9984b","sailthru","venture","1","2011-09-01",8e+06
"8908df06ced001df3a03d67263b6fd25","sainstore-inc",NA,NA,NA,NA
"f85f396af6855cdb74b537dbe773db2d","saje-pharma","venture",NA,"2012-05-15",50000
"8e5428656274717f347f8832e0a3dc59","sakkini","seed",NA,"2015-02-15",NA
"7e0a07d3cbaaebc58e1a0c8ab8796943","saladax-biomedical","private_equity",NA,"2013-03-05",22400000
"7e0a07d3cbaaebc58e1a0c8ab8796943","saladax-biomedical","venture","1","2010-03-30",8400000
"7e0a07d3cbaaebc58e1a0c8ab8796943","saladax-biomedical","debt_financing",NA,"2011-06-21",9e+06
"7e0a07d3cbaaebc58e1a0c8ab8796943","saladax-biomedical","venture",NA,"2009-10-02",7923399
"c18ca01fe96d69828b6424d65d4d5874","salary-fairy",NA,NA,NA,NA
"d2e2abbd54acf92bbae02a7ee826dfe1","salecycle",NA,NA,NA,NA
"093a62ed374616d20ba30215d60c7ac1","salemove","venture","A","2015-07-09",5100000
"093a62ed374616d20ba30215d60c7ac1","salemove","seed",NA,"2012-06-04",25000
"bda13d2fbe32df759348aa6442211b89","sales-orders",NA,NA,NA,NA
"df0a1f0210bab1be44c9c340f0507e66","sales-development-services",NA,NA,NA,NA
"c1a87d13a297b825f16818de28b0c8f5","sales-flow-technologies",NA,NA,NA,NA
"cde29b50d3826aa2b3184c560aec3940","sales-nucleus",NA,NA,NA,NA
"236fbc544cd672369812ca393e2d8330","sales-secret-llc",NA,NA,NA,NA
"b3916cf597504681cf0aea3fbe481c6a","salesformics",NA,NA,NA,NA
"40524ad2b9149f16bfbc8a69d399736a","salesframe",NA,NA,NA,NA
"5b66fd30753e827cf908a6f962d73af1","salesfuel",NA,NA,NA,NA
"5bec81f27d770a2d82084aa6c253dade","salesmanago",NA,NA,NA,NA
"e5e5a4919c29491f68951c769e94bd4d","salespredict","seed",NA,"2013-08-21",1e+06
"e5e5a4919c29491f68951c769e94bd4d","salespredict","venture","1","2014-05-12",4099999
"8a857661a03779c77991b1c21bd54f0b","salesprepper",NA,NA,NA,NA
"95ab11725701b3c3cda2c334b905800b","salesquest",NA,NA,NA,NA
"bbc08859c89d16d49335fcb4f0df2b1b","salexis-com",NA,NA,NA,NA
"b8affcc7c2834ab13ee1a35e152ea2ed","salezeo","venture",NA,"2014-02-20",1929900
"53bb671c1b00af273fd2ca4dc78bc19a","salg---services-analyzer-and-lead-generator",NA,NA,NA,NA
"b87ce898c7283a32dbbe81c4838e5d89","salgomed","venture",NA,"2012-06-14",205000
"5ffd75bcc341673fabf950ff8316d5db","salient-management-company",NA,NA,NA,NA
"a2061df4770014d7ba7901af37597f8d","salient-pharmaceuticals","venture",NA,"2010-01-29",2e+06
"a2061df4770014d7ba7901af37597f8d","salient-pharmaceuticals","non_equity_assistance",NA,"2011-08-18",NA
"8e95535ef86e820a23b7978f8df689df","saling-silang",NA,NA,NA,NA
"d415764efc4ef64c6ad7805995b982ce","salmedix-inc","venture","C","2005-10-19",4.5e+07
"b818673bb0687d0b12bda9632b1b020a","saltbox-services-llc",NA,NA,NA,NA
"044ec52571338ed081465629ec142628","salter-labs",NA,NA,NA,NA
"13ff845248d9680263a2a0108b0e4e62","salucro-healthcare-solutions","venture",NA,"2012-07-05",567605
"a1e70d9a16b8dd9cf3dde478a8e0c834","saludfcil","undisclosed",NA,"2013-05-08",NA
"a22333ceb6af6218ba4e45fcdadb1676","salus-novus-inc","seed",NA,"2009-12-01",250000
"a22333ceb6af6218ba4e45fcdadb1676","salus-novus-inc","venture","1","2011-01-01",5e+05
"3813e63bfc6664e608734f3200824a5c","salutaris-medical-devices","debt_financing",NA,"2012-09-05",1099128
"3813e63bfc6664e608734f3200824a5c","salutaris-medical-devices","debt_financing",NA,"2011-10-14",7e+05
"3813e63bfc6664e608734f3200824a5c","salutaris-medical-devices","venture",NA,"2009-12-10",2055074
"3813e63bfc6664e608734f3200824a5c","salutaris-medical-devices","venture",NA,"2010-01-29",1300000
"3813e63bfc6664e608734f3200824a5c","salutaris-medical-devices","venture",NA,"2010-12-10",350000
"3813e63bfc6664e608734f3200824a5c","salutaris-medical-devices","debt_financing",NA,"2014-07-17",305000
"3813e63bfc6664e608734f3200824a5c","salutaris-medical-devices","venture",NA,"2015-03-25",1220000
"7c78240a163438f2e0fc5cf42d551d1e","salveo-specialty-pharmacy","venture",NA,"2011-06-09",250000
"7c78240a163438f2e0fc5cf42d551d1e","salveo-specialty-pharmacy","venture",NA,"2011-10-10",1.9e+07
"eb08a812205d72b6aca7c7f7e1bd6c24","salviol","venture","A","2015-07-08",7167668
"97bb5c1af7e378fb519ca0a645bd0b9f","sama",NA,NA,NA,NA
"72de596a4e58d1bae73ecefad4f21290","samba-tech","venture","A","2016-02-03",3e+06
"72de596a4e58d1bae73ecefad4f21290","samba-tech","venture","a","2008-06-01",3e+06
"c2ebae444111c896b4b7324059fcd2aa","samepoint",NA,NA,NA,NA
"7b1fb5be7dc6a6dd503a2f8d0dc4b437","social-asset-measurements",NA,NA,NA,NA
"2d634f2106921a5469f969426b3dc7f1","sami-health","debt_financing",NA,"2012-10-04",143578
"b28b1057ba84a6264d86042c0ff85549","sample-labs",NA,NA,NA,NA
"474c244bf611cc80a65c819596391462","novophage","venture","B","2013-10-09",6500000
"474c244bf611cc80a65c819596391462","novophage","venture","a","2011-05-31",5750000
"474c244bf611cc80a65c819596391462","novophage","venture","B","2014-11-14",2500000
"bd80cc9bc6471124ef5da8351545d59b","sampling-technologies","venture",NA,"2010-01-18",2e+06
"be834db9dd3d70eebe47aff5b28db60e","samuel-zell-robert-h-lurie-institute-for-entrepreneurial-studies",NA,NA,NA,NA
"96f46d5edd07dcad09436c7702907e70","san-francisco-ltd",NA,NA,NA,NA
"b6dedddd4f06cf22b9d332c879d9ba1c","sand",NA,NA,NA,NA
"8bdf7785e45511943ed877cde8b0e28b","sand-hill-exchange-2","seed",NA,"2014-10-01",NA
"e73ab8d06dffa9a62c0409dfd665df3b","sandcube",NA,NA,NA,NA
"9fdd40dc8bf57e8b1beb22701bfde198","sandtable",NA,NA,NA,NA
"2232f485bb96c3c0c88b548cdffeb2f0","sangamo-biosciences","post_ipo_equity",NA,"2013-09-24",74200000
"b8108f44046245777c8dff6833b3c41b","sangart","venture","F","2007-04-04",5e+07
"b8108f44046245777c8dff6833b3c41b","sangart","venture","f","2009-03-12",1e+08
"b8108f44046245777c8dff6833b3c41b","sangart","venture",NA,"2011-04-19",5e+07
"b8108f44046245777c8dff6833b3c41b","sangart","private_equity",NA,"2012-05-24",100774578
"b8108f44046245777c8dff6833b3c41b","sangart","venture","g","2012-05-24",5e+07
"b8108f44046245777c8dff6833b3c41b","sangart","venture",NA,"2010-10-13",15098381
"98a1036500f2ae0f578befc864ae334a","sangon-biotech","venture","a","2010-07-01",6200000
"b4326af3c1c535b9c869d2106f132e87","sangui-biotech-international",NA,NA,NA,NA
"65692649f8584b1a2d09f648ca6c97c3","sanguine-biosciences","seed",NA,"2013-02-23",2e+06
"65692649f8584b1a2d09f648ca6c97c3","sanguine-biosciences","venture","1","2014-11-25",4e+06
"65692649f8584b1a2d09f648ca6c97c3","sanguine-biosciences","venture",NA,"2015-06-01",NA
"ab2b8c3b663ce8a12d4ad2434c7afff8","sanifit","venture","C","2015-09-08",40834314
"f01341260ccff2e61ec1b378188e9f75","sano-intelligence","seed",NA,"2012-01-01",20000
"f01341260ccff2e61ec1b378188e9f75","sano-intelligence","seed",NA,"2013-01-07",3750000
"f01341260ccff2e61ec1b378188e9f75","sano-intelligence","seed",NA,"2015-06-19",6500000
"1b9c97f0c15ed9cb5606c2fd31f0892c","sanofi-aventis",NA,NA,NA,NA
"4c16a1dab80bfdcccf68ca21491d2da3","sanofi-pasteur",NA,NA,NA,NA
"d16853859efe0d4288e4017ab91b4b82","sanovas","venture",NA,"2015-10-05",285699
"d16853859efe0d4288e4017ab91b4b82","sanovas","debt_financing",NA,"2010-07-23",350000
"d16853859efe0d4288e4017ab91b4b82","sanovas","debt_financing",NA,"2011-07-22",2081000
"d16853859efe0d4288e4017ab91b4b82","sanovas","venture",NA,"2012-09-19",6448822
"f2b25e09b3fb19030f78583d0951b6a2","santa-maria-biotherapeutics","venture",NA,"2014-01-13",6311156
"33fb5705a324e5ff8a2c585080dec1f6","santaris-pharma","venture","C","2007-12-30",30000735.3121
"33fb5705a324e5ff8a2c585080dec1f6","santaris-pharma","venture",NA,"2012-06-21",1.2e+07
"8523b17be9a8d0d36de1aa2ea7cadcfa","novagali-pharma","venture",NA,"2000-01-01",3825516
"8523b17be9a8d0d36de1aa2ea7cadcfa","novagali-pharma","venture","1","2003-11-01",5808662
"8523b17be9a8d0d36de1aa2ea7cadcfa","novagali-pharma","venture","1","2004-09-01",11162610
"8523b17be9a8d0d36de1aa2ea7cadcfa","novagali-pharma","venture","1","2006-04-01",31521519
"8523b17be9a8d0d36de1aa2ea7cadcfa","novagali-pharma","venture","1","2009-09-26",22013286
"a0cd67b9222891897e4602a913d084d9","santh-cleanenergy-microgrid","venture","a","2013-11-01",10000
"bf941eee23c41a6dfe1e87f071a0618a","santhera-pharmaceuticals-holding","private_equity",NA,"2013-10-30",11141000
"bf941eee23c41a6dfe1e87f071a0618a","santhera-pharmaceuticals-holding","post_ipo_equity",NA,"2014-08-15",14769257
"12eb9205baddc0d6808549b1c2b5c4b1","santosolve","venture",NA,"2007-11-07",7e+06
"12eb9205baddc0d6808549b1c2b5c4b1","santosolve","venture","1","2010-01-31",5500000
"8c84a9e50bc60019925c92d9c47f5414","sanwa-biotech",NA,NA,NA,NA
"3b538a59c93e6b62500a0277216838f8","sap-labs-grc",NA,NA,NA,NA
"b7e0d447d52dabb56724f8fce256ad60","sap-startup-focus",NA,NA,NA,NA
"f7303677396a51fd3abbc7b7df2786a6","saphetor",NA,NA,NA,NA
"a0413fb6c5a7a171ee6e32674bf30d6e","saphium",NA,NA,NA,NA
"49806f65a06461dc46516e07a2d4ce79","sapinda-group",NA,NA,NA,NA
"562024095e62d5d39659e3abe91cc6f2","saplo","grant",NA,"2009-06-05",190000
"562024095e62d5d39659e3abe91cc6f2","saplo","seed",NA,"2010-05-27",5e+05
"562024095e62d5d39659e3abe91cc6f2","saplo","seed",NA,"2012-05-31",150000
"a9e47ba4d970d9d96f8c65e8084a9402","saqtech",NA,NA,NA,NA
"f9d1673f610f06ed57eb7c0921888b7c","sarcode-corporation","venture","A","2007-01-24",2.5e+07
"f9d1673f610f06ed57eb7c0921888b7c","sarcode-corporation","venture","b","2011-07-18",4.4e+07
"f9d1673f610f06ed57eb7c0921888b7c","sarcode-corporation","venture",NA,"2006-12-01",2.9e+07
"6a7e37814b8b816e1aa1548ec33da428","sardegna-ricerche",NA,NA,NA,NA
"d69ef57e2b24f68ff17b81a75421210c","sarentis-therapeutics","venture",NA,"2009-11-10",3609654
"d69ef57e2b24f68ff17b81a75421210c","sarentis-therapeutics","debt_financing",NA,"2015-07-08",750000
"33f34ca48f3dd7daba35effc5911b379","sarepta-therapeutics","post_ipo_debt",NA,"2015-06-26",4e+07
"f55790caa13533e24ef9631074cca52c","sareum-holdings",NA,NA,NA,NA
"a515c5ccbcb83ad9753a57886f91c8bd","sas-institute",NA,NA,NA,NA
"9ec17ec7c9f1f2d7fcca427f64cd5cfb","satalia",NA,NA,NA,NA
"41c4e21ae5c1ce891685239f071b3e35","satinos",NA,NA,NA,NA
"1e301e875a54f96697b0f89851c86b2c","satisfi",NA,NA,NA,NA
"c31fdde0928b1eb83ef897a36a671141","satisfly",NA,NA,NA,NA
"2474a2cb4dd1719c6055c4e3ef8ea668","satismeter",NA,NA,NA,NA
"5aae074e79c69ea0fcb0ef87d35e960c","satmap",NA,NA,NA,NA
"e958696ced7c49b52bda8da0f605189b","satoris","venture","b","2008-03-25",5200000
"337c36e4b83a263e97fc5425086a6ec1","founder-and-ceo-2",NA,NA,NA,NA
"99181d27d731cc470ad74bf0425e0239","savara-pharmaceuticals","venture",NA,"2012-12-01",NA
"99181d27d731cc470ad74bf0425e0239","savara-pharmaceuticals","venture","1","2013-06-26",14300000
"99181d27d731cc470ad74bf0425e0239","savara-pharmaceuticals","venture","1","2015-12-09",18544474
"dc6bb8afbbe3d5e74d056702c2df9b45","savi-technology","venture",NA,"2015-11-23",15006088
"16e5e25bffa907e489f713b63cae5a82","saviant-consulting","angel",NA,"2013-03-15",250000
"4b2a2829317b10ee5334f1c43bd57dba","savicell-diagnostics",NA,NA,NA,NA
"8e86342cb78c70be25666d4233b128da","savient-pharmaceuticals",NA,NA,NA,NA
"5c45ca29d00a845a7fe9c7ca1c5a0a78","savyon-diagnostics",NA,NA,NA,NA
"ee82cd4fb356812b6be9bb77baa057d1","sawittoku-chemical-laboratories",NA,NA,NA,NA
"2dc2882954d9b641e97539b7d667ff00","saygent","seed",NA,"2011-05-19",1e+06
"2dc2882954d9b641e97539b7d667ff00","saygent","venture","1","2012-08-18",1e+06
"09c8972f8c807db79b867963990840c7","sayhello-llc","angel",NA,"2012-03-04",3e+05
"10c3f4c610fdad9fde3f36ae22a858c0","saylent-technologies","venture","a","2007-03-01",NA
"10c3f4c610fdad9fde3f36ae22a858c0","saylent-technologies","venture",NA,"2014-10-23",2e+06
"9b015f471f5a706aa28bc4804dd6f681","saypay-technologies-inc-",NA,NA,NA,NA
"3816fcda579fdaab721d1336e355d7f3","scalable-network-technologies",NA,NA,NA,NA
"f6d8e65a02442d2eb6b058e902b3d361","scalearc","venture","C","2016-01-19",2e+07
"f6d8e65a02442d2eb6b058e902b3d361","scalearc","venture","c","2013-01-10",12300000
"f6d8e65a02442d2eb6b058e902b3d361","scalearc","venture","b","2011-12-20",5330000
"f6d8e65a02442d2eb6b058e902b3d361","scalearc","private_equity",NA,"2011-12-28",6080000
"e67cc4921243a94a3d77cebe4c09814a","scalebase","venture","b","2012-10-17",10500000
"e6e30d2b4d455ab27f36b220f8906bd1","scaled-inference","seed",NA,"2014-01-01",5600000
"e6e30d2b4d455ab27f36b220f8906bd1","scaled-inference","venture","1","2014-10-01",8e+06
"87520cbe7167683e46b666ef755a2b8c","scaled-recognition",NA,NA,NA,NA
"7536bee20f80320445ade9fb36af2a69","scaled-risk",NA,NA,NA,NA
"05f490a468216f4bee9d5c3b3a72f449","scalyr","seed",NA,"2015-04-22",2100000
"ec82b5adc3ccafd45e57ac58d2366e5b","scanalytics","seed",NA,"2013-07-07",5e+05
"ec82b5adc3ccafd45e57ac58d2366e5b","scanalytics","seed",NA,"2013-01-04",20000
"ec82b5adc3ccafd45e57ac58d2366e5b","scanalytics","non_equity_assistance",NA,"2014-08-12",NA
"ec82b5adc3ccafd45e57ac58d2366e5b","scanalytics","venture",NA,"2014-01-22",NA
"0f955be3b912c1b8cbac2bc18b106b39","scancash",NA,NA,NA,NA
"0538af25026da4e2030ac23b0120c30d","scancell","venture",NA,"2004-04-27",2327975
"0538af25026da4e2030ac23b0120c30d","scancell","venture",NA,"2005-05-25",2283201
"da7cbf86c8f3a243a8adb973453f09b4","scannibal","convertible_note",NA,"2016-01-01",NA
"da7cbf86c8f3a243a8adb973453f09b4","scannibal","seed",NA,"2015-06-01",20000
"43af64be707aa5fdead9fecd8a11b9c6","scantherma",NA,NA,NA,NA
"1ca49ca37ba7505423b1296bcee6ca0d","scarab-genomics-llc",NA,NA,NA,NA
"876444ba2fccab4453bbde9605db86da","scarab-research",NA,NA,NA,NA
"c545207bd0efc21495d70dad89ca6ab3","sence7","venture","B","2001-07-12",11300000
"c545207bd0efc21495d70dad89ca6ab3","sence7","venture","C","2004-06-16",7500000
"b65cb552aded9e0c8c4ac6b2b924f987","schering",NA,NA,NA,NA
"550834b58011e00e353e2dd8694789e8","schlumberger-technologies",NA,NA,NA,NA
"3698e1ce58b48ea863bcb21eb87c54e7","schmetrics",NA,NA,NA,NA
"9831ba6666e389a86adc44d5b4d7e808","scholar-rock","venture","B","2016-01-04",3.6e+07
"9831ba6666e389a86adc44d5b4d7e808","scholar-rock","venture","A","2014-09-15",2e+07
"d1bf679b0efa70a0e458011c170a5c6d","schoolcontrol","seed",NA,"2012-10-01",49682
"d1bf679b0efa70a0e458011c170a5c6d","schoolcontrol","venture",NA,"2013-12-01",97912
"d1bf679b0efa70a0e458011c170a5c6d","schoolcontrol","grant",NA,"2014-12-01",28704
"17d17a238981b32755a334813a098838","schoolrunner","venture",NA,"2015-03-23",1500000
"93b10e3fce19db48706af6509178fe30","schoolzilla","venture","A","2015-10-30",3500000
"93b10e3fce19db48706af6509178fe30","schoolzilla","venture","A","2014-09-05",4e+06
"93b10e3fce19db48706af6509178fe30","schoolzilla","seed",NA,"2013-05-08",1e+06
"41dfd792e3ec703039bb124743446d08","schramm",NA,NA,NA,NA
"592e5a200c0b50a4c9b7e3cd2d9f0df2","schrodinger","venture",NA,"2012-12-12",2e+07
"592e5a200c0b50a4c9b7e3cd2d9f0df2","schrodinger","venture",NA,"2010-04-29",1e+07
"592e5a200c0b50a4c9b7e3cd2d9f0df2","schrodinger","venture",NA,"2015-06-19",2.2e+07
"2ab3af61bbb4a26efb0c809b8f899865","schwartz-biomedical",NA,NA,NA,NA
"6ee6810e6f3b6a8fd12f19403d1c1d58","scicasts","seed",NA,"2014-04-24",250000
"9909971cd10d358b0eef52198e16572c","sciclone-pharmaceuticals",NA,NA,NA,NA
"43c2d902a4c9f9631eeffa0899cdf988","scicrop",NA,NA,NA,NA
"af08b8e876021a85c118ac4b8df237f7","scicrop-2","seed",NA,"2015-02-01",2e+05
"c05c0caca38f760940a0e0ae5c49d125","science-behind-sweat","seed",NA,"2012-03-19",50000
"69de71ac7c99357266753db93aae1a5c","science-rockstars",NA,NA,NA,NA
"8414c368b0b6ebda05ed97607903514f","sciencix",NA,NA,NA,NA
"dd5ae7df20acd94c60d8f55edf0ce59e","scienion","venture",NA,"2006-07-18",5638950
"eefc6dda39a21ed8ca7a9886b1af962c","scientific-digital-imaging-sdi","seed",NA,"2013-06-21",1287963
"44517796df12284f01f3b418ea0b0dbf","scientific-protein-labs",NA,NA,NA,NA
"c7313cbdc4c01fb4cbbc80523a172dab","scifluor-life-sciences","venture","a","2011-08-02",5e+06
"c7313cbdc4c01fb4cbbc80523a172dab","scifluor-life-sciences","venture","B","2015-04-21",3e+07
"18eb206cee38f19cb27a55525b7088ad","scigen-israel",NA,NA,NA,NA
"09fa1a4c8287232c1dee9e76e9eb72aa","scikik",NA,NA,NA,NA
"80e180cc342af7e44435060d11eb2ff4","scil-proteins","venture",NA,"2011-02-02",33127200
"ac639cdd56a04f92ee8fd0db5f6820f3","scio-health-analytics","venture","a","2008-05-16",NA
"ac639cdd56a04f92ee8fd0db5f6820f3","scio-health-analytics","venture",NA,"2009-10-22",15929754
"f5597994f75a27a478a3291c131f5882","scioderm","debt_financing",NA,"2013-03-25",1e+06
"f5597994f75a27a478a3291c131f5882","scioderm","venture","1","2013-04-26",1.6e+07
"f5597994f75a27a478a3291c131f5882","scioderm","venture","1","2014-12-18",2e+07
"38c16ad11d679a95fa448f7631978273","scion-pharmaceuticals",NA,NA,NA,NA
"b5310dc406f9907aa0377e18de087ea2","sciona","venture",NA,"2007-06-08",3400000
"b5310dc406f9907aa0377e18de087ea2","sciona","venture","1","2006-04-03",9900000
"14e0300446536168f0e1c8f98e82851b","scl","venture",NA,"2005-11-03",5325912
"dfa5849413d82fa12a688260473a827c","sclera",NA,NA,NA,NA
"94b38259e66f081e8eb4d7d686051a07","scoop-it","venture",NA,"2013-07-30",2600000
"94b38259e66f081e8eb4d7d686051a07","scoop-it","venture","1","2009-06-04",8400000
"a25112e9d2729e6bec9d83dd75bc29f0","scoopinion","grant",NA,"2011-09-15",330000
"89f0cab0790ad55dff9f67d729f3b1f2","scope-investigations",NA,NA,NA,NA
"fb4a55709e210b10354585bf7b45c71f","scopio","seed",NA,"2015-11-20",103000
"fb4a55709e210b10354585bf7b45c71f","scopio","product_crowdfunding",NA,"2014-12-04",32000
"5fcfd2e01140fa3fcc48dd66d05c40cd","scopix","venture",NA,"2012-07-02",4821292
"5fcfd2e01140fa3fcc48dd66d05c40cd","scopix","venture",NA,"2012-07-01",821000
"20721a892ad781f19d50f3206df5b1dd","scoredata-corporation",NA,NA,NA,NA
"185b732fa4f62506112d6c2e22d026ad","scorise",NA,NA,NA,NA
"e4ecdc1497eb30e10f93f75fd958a5dd","scorto",NA,NA,NA,NA
"55637b8f0d57a32bc28ae169dc41b2f5","scout-analytics","venture",NA,"2011-03-14",1991652
"55637b8f0d57a32bc28ae169dc41b2f5","scout-analytics","debt_financing",NA,"2013-01-28",1e+06
"55637b8f0d57a32bc28ae169dc41b2f5","scout-analytics","venture","1","2006-12-01",NA
"07d14be50582664056cbc8baa6bd6ff3","scranton-gillette-communications","venture",NA,"2010-08-09",1550000
"5fae24576b949826d715ddb35529a7ba","scrapehero",NA,NA,NA,NA
"bcc6659fd72cb84c3661f037b658fa9b","scraperwiki","venture",NA,"2012-02-03",1e+06
"bcc6659fd72cb84c3661f037b658fa9b","scraperwiki","seed",NA,"2009-12-01",198810
"e3b84fc2e284b1f05c68ddcb1ce16f95","scrapinghub",NA,NA,NA,NA
"d2387b5c50f1a901dc125b35afbc49e1","scrazzl",NA,NA,NA,NA
"743d2c92ca111b1a8b38d89058404396","screen","venture",NA,"2011-11-16",29000
"9957a268937299eef8fbce8e781d4d71","screendragon",NA,NA,NA,NA
"e07743e8d3354acbb810bd7b07cf26a9","scribblelive","seed",NA,"2010-01-01",NA
"e07743e8d3354acbb810bd7b07cf26a9","scribblelive","venture","1","2013-06-19",8e+06
"e07743e8d3354acbb810bd7b07cf26a9","scribblelive","venture","1","2011-11-10",3920529
"e07743e8d3354acbb810bd7b07cf26a9","scribblelive","venture","1","2014-10-02",1.2e+07
"e07743e8d3354acbb810bd7b07cf26a9","scribblelive","venture","1","2015-09-23",3.5e+07
"348f9be5328e7807c7104d96de4a9ab4","scribe-software","undisclosed",NA,"2006-01-01",NA
"ad73cefe8ddae34cd2f33413eeb14378","scripsamerica","venture",NA,"2013-11-07",200537
"ad73cefe8ddae34cd2f33413eeb14378","scripsamerica","debt_financing",NA,"2014-12-10",4e+06
"654af610c6c1f1fbcc25c6cfa39bc020","scriptbook","seed",NA,"2014-09-09",NA
"f4d1ff0d78b67a0aa53323b389c3fe5d","scriptive",NA,NA,NA,NA
"53b5849b3673545177a33125c0ff22f8","scriptrx","venture",NA,"2011-02-25",1e+06
"6c8e77445fae774a38f5ff03fd8e77f0","scrobl",NA,NA,NA,NA
"ed792cafe2e8641a00a7d8070314db8e","se-holding","venture",NA,"2010-02-14",4800000
"ed792cafe2e8641a00a7d8070314db8e","se-holding","venture",NA,"2010-07-15",637500
"fac5e6a04bf12a43436a1644fc21622b","sea4us",NA,NA,NA,NA
"b4500e84c3fa598182151209dd60a9ef","seadev-fermensys","venture",NA,"2007-11-06",4370000
"ecdb8c00d90ee80f8acb675233eef5cd","seahorse-bioscience","venture",NA,"2012-05-22",9400000
"ecdb8c00d90ee80f8acb675233eef5cd","seahorse-bioscience","venture","1","2010-03-08",5e+06
"ecdb8c00d90ee80f8acb675233eef5cd","seahorse-bioscience","private_equity",NA,"2013-04-01",11346594
"ecdb8c00d90ee80f8acb675233eef5cd","seahorse-bioscience","venture","1","2009-03-09",6e+06
"73aea552d2846b091ce7a31d19c55528","seajas",NA,NA,NA,NA
"db9869b425c7b654b8f75476bd778c00","seak",NA,NA,NA,NA
"4dc2b32a0024e74bb6455ce1dc1b9fde","sealantium-medical",NA,NA,NA,NA
"c4772af974b83c59055401ecd1196a16","seanalytes",NA,NA,NA,NA
"9714742f62a28fbb007bc0694b0f60b1","search-discovery",NA,NA,NA,NA
"b5963ecdfd6ec41adeefcfeec892fcdc","seach2go",NA,NA,NA,NA
"03529c512408993bbbf11c8e33eb5143","searchbox","angel",NA,"2010-09-01",980392
"fc39b7a281d058766ad4e8b7b6c17e2a","searchd",NA,NA,NA,NA
"5a5349ffe940b52b3b2e91099eb10064","searchmetrics","venture",NA,"2015-08-01",5485724.3168
"5a5349ffe940b52b3b2e91099eb10064","searchmetrics","venture",NA,"2014-03-20",19658241.9256
"5a5349ffe940b52b3b2e91099eb10064","searchmetrics","venture",NA,"2014-09-22",6418952.1702
"5a5349ffe940b52b3b2e91099eb10064","searchmetrics","venture",NA,"2010-01-29",NA
"5a5349ffe940b52b3b2e91099eb10064","searchmetrics","venture",NA,"2010-12-23",NA
"608f2209373a51a41489321a0aadbac8","searchspace","undisclosed",NA,"2004-09-01",20467015
"17765852b4f7f54cefd077227e55ad88","seaside-therapeutics","venture",NA,"2009-09-17",3e+07
"11441a37ab91a9bd16b8d671cc92087e","seasonal-charts",NA,NA,NA,NA
"a597888f6048669b58dc1d7dc210b3a3","seattle-biomedical-research-institute","grant",NA,"2013-08-15",1.6e+07
"a597888f6048669b58dc1d7dc210b3a3","seattle-biomedical-research-institute","grant",NA,"2014-03-10",1e+07
"74a43ce8306c1f4188fd5673b6385b20","seattle-genetics","post_ipo_equity",NA,"2014-01-17",9e+06
"74a43ce8306c1f4188fd5673b6385b20","seattle-genetics","post_ipo_equity",NA,"2011-02-02",1.55e+08
"3a0d785d673e569682c649c602019abf","seaurchin-io",NA,NA,NA,NA
"976d5e52a48d2dfca48037c4c8337f05","seb-consulting",NA,NA,NA,NA
"cdae11aaab7d584c5d19bbc943c14f48","secant-therapeutics","venture",NA,"2011-01-19",150000
"767f294b954c3018a179440a15bbf3d1","second-genome","private_equity",NA,"2011-08-09",4999999
"767f294b954c3018a179440a15bbf3d1","second-genome","venture","1","2012-04-01",2500000
"767f294b954c3018a179440a15bbf3d1","second-genome","venture","1","2013-06-05",11500000
"9ebeb507728eb2abb337bef47c2958ef","second-measure","seed",NA,"2015-06-01",120000
"07fc1ffcfb1c1bc181e84d184199e60c","second-spectrum",NA,NA,NA,NA
"381842b09944a23fd0f39c7e0de09b79","secondsync",NA,NA,NA,NA
"e518115bae4aedce5746da50ad5329fa","secret-sauce-partners",NA,NA,NA,NA
"17b370d3f02e9f2cb0a80563d991db37","securelogix",NA,NA,NA,NA
"fb5c11d59c403285958d399615d2d0d4","secureware",NA,NA,NA,NA
"a5c35bae63614c7b3537995b61f2f68a","securimobile",NA,NA,NA,NA
"faf2a7c7c969ade00748d93b595d01ee","securionpay","seed",NA,"2014-10-01",NA
"faf2a7c7c969ade00748d93b595d01ee","securionpay","seed",NA,"2015-08-14",NA
"1b75020516d727922bedee2255dd8886","securisyn-medical","venture",NA,"2014-09-16",2851000
"1b75020516d727922bedee2255dd8886","securisyn-medical","venture",NA,"2012-10-11",50000
"894f83ea1f91eb234b40bb965c1aa415","securus-medical-group","venture","a","2011-08-01",750000
"894f83ea1f91eb234b40bb965c1aa415","securus-medical-group","venture","b","2013-10-29",6500000
"894f83ea1f91eb234b40bb965c1aa415","securus-medical-group","seed",NA,"2012-07-25",250000
"323d34ef923cf0741cecb0060a3d642f","sedia-biosciences","seed",NA,"2013-05-21",284998
"323d34ef923cf0741cecb0060a3d642f","sedia-biosciences","grant",NA,"2014-02-12",1e+06
"323d34ef923cf0741cecb0060a3d642f","sedia-biosciences","grant",NA,"2014-08-19",2e+05
"978507ca195775d180c223faf16bd5ea","sedicii",NA,NA,NA,NA
"07a042dd0032a19093058e1cad7afafc","seditious-technologies",NA,NA,NA,NA
"69fa5d4a5842689c3c4673b250966473","seeburger-inc",NA,NA,NA,NA
"fb25d92ae15955d1901457a83a4cc327","seecontrol","venture","a","2005-07-14",4500000
"fb25d92ae15955d1901457a83a4cc327","seecontrol","venture",NA,"2012-10-23",617500
"a484fe23d4c8d5fe806fe16d1a14b4ca","seed-scientific-2",NA,NA,NA,NA
"edd0bb1b5f6302914e4c225ababa956e","seederboard",NA,NA,NA,NA
"d1100a45f25cf0df1f162bb0cdd64356","seeflight",NA,NA,NA,NA
"7b5361a37d45acbc31883d73a1367abd","seeker","angel",NA,"2013-08-01",94986
"7b5361a37d45acbc31883d73a1367abd","seeker","seed",NA,"2013-12-23",196069
"7b5361a37d45acbc31883d73a1367abd","seeker","seed",NA,"2013-01-01",81053
"7d7f3591f8214c41dce01ef70e502923","seekintoo",NA,NA,NA,NA
"63b473d267c81e9b3dde70c6c845c8a3","seeloz-inc","angel",NA,"2013-02-28",250000
"63b473d267c81e9b3dde70c6c845c8a3","seeloz-inc","seed",NA,"2014-07-31",2450000
"da134364167e1bd8c913235ab3d722ed","seen","convertible_note",NA,"2012-11-19",635000
"da134364167e1bd8c913235ab3d722ed","seen","seed",NA,"2014-11-03",1250000
"da134364167e1bd8c913235ab3d722ed","seen","venture",NA,"2014-09-23",2097567
"da134364167e1bd8c913235ab3d722ed","seen","seed",NA,"2013-12-01",635000
"69b74f07b7e45b87f098c124c432fc11","seeq","venture",NA,"2015-11-13",4189731
"69b74f07b7e45b87f098c124c432fc11","seeq","venture","1","2013-11-05",6e+06
"69b74f07b7e45b87f098c124c432fc11","seeq","debt_financing",NA,"2013-05-30",2e+06
"d1c3ae2435318e63d382829e069d1117","seer-interactive",NA,NA,NA,NA
"5934de6a8d52752d5cf7387414a26449","seerene","seed","A","2015-12-08",5e+06
"31c23ab984572fd10c3ff620999f3b67","seevibes","seed",NA,"2012-02-28",2e+05
"31c23ab984572fd10c3ff620999f3b67","seevibes","seed",NA,"2014-05-26",1e+06
"2dd7fba9016f02f47a418f51dace5723","seevolution","angel",NA,"2012-10-08",NA
"2dd7fba9016f02f47a418f51dace5723","seevolution","angel",NA,"2011-06-29",530000
"92a337b382119848d4df8ce36172d8f1","seewhy","venture",NA,"2011-08-05",8e+05
"92a337b382119848d4df8ce36172d8f1","seewhy","venture",NA,"2012-01-19",2250000
"92a337b382119848d4df8ce36172d8f1","seewhy","venture","1","2005-07-25",3500000
"92a337b382119848d4df8ce36172d8f1","seewhy","venture","1","2011-04-21",NA
"92a337b382119848d4df8ce36172d8f1","seewhy","venture","1","2009-05-05",4500000
"92a337b382119848d4df8ce36172d8f1","seewhy","venture",NA,"2011-05-13",667000
"92a337b382119848d4df8ce36172d8f1","seewhy","venture","1","2009-12-16",2e+06
"7f6f09b4f59f7bb0abc4d92fd130ac50","seg",NA,NA,NA,NA
"b2172011db2585f1304336ba134c0262","segment-io","venture","B","2015-10-09",2.7e+07
"b2172011db2585f1304336ba134c0262","segment-io","seed",NA,"2013-01-15",6e+05
"b2172011db2585f1304336ba134c0262","segment-io","venture","A","2014-10-08",1.5e+07
"b2172011db2585f1304336ba134c0262","segment-io","seed",NA,"2014-10-07",2e+06
"4516a857ee8b01f2432602cd895538b8","segment-interactive",NA,NA,NA,NA
"b5aec3dcc8c59b6084b7ef83e98a66ab","segmentify",NA,NA,NA,NA
"4b578d030c4dca5609c77ddfc2eb0137","segone-inc","seed",NA,"2013-09-13",5e+05
"4b578d030c4dca5609c77ddfc2eb0137","segone-inc","seed",NA,"2014-05-12",125000
"0f55a0b63493013056d38656db728d6e","segovia-consulting",NA,NA,NA,NA
"957598b9494bea567f1f7e5a85723d45","seguro-surgical","venture",NA,"2010-07-01",125000
"957598b9494bea567f1f7e5a85723d45","seguro-surgical","debt_financing",NA,"2010-07-01",1152832
"7ff5a654c0c74739561dedb95f6c949f","seismos","venture","A","2015-04-08",4e+06
"136f9a18ea892b09944445b2ec5ea5db","seiva-technologies",NA,NA,NA,NA
"fa3545a74109ae3de61f4ee6782db3d2","selah-genomics","venture","A","2013-06-11",9e+05
"80299494b3e28effeb9c072a77c83469","seldar-pharma","venture",NA,"2013-12-11",12999000
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","venture","b","2009-02-25",15100000
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","venture","d","2012-02-13",2.2e+07
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","venture","D","2011-10-27",47250000
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","grant",NA,"2010-08-17",3e+06
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","venture","c","2010-04-05",1.5e+07
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","grant",NA,"2014-06-17",8100000
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","private_equity",NA,"2014-10-15",2e+07
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","venture",NA,"2014-08-28",4450000
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","grant",NA,"2014-12-23",3200000
"f7db74f0c392c0f815defe6a07fae548","selecta-biosciences","venture",NA,"2015-04-22",5942306
"c5cd274486bc653edd4befa38ff41e5a","selerity","angel",NA,"2008-12-29",5020000
"c5cd274486bc653edd4befa38ff41e5a","selerity","venture","1","2013-02-13",3e+06
"c5cd274486bc653edd4befa38ff41e5a","selerity","debt_financing",NA,"2015-09-25",2300000
"b84e5dacb63e78ccaa49af10acc9a9b8","selexagen-therapeutics","seed",NA,"2011-08-01",597387
"1189c22a3ddd799806e58e96b87c527b","selexys-pharmaceuticals-corporation","debt_financing",NA,"2011-11-04",5e+06
"1189c22a3ddd799806e58e96b87c527b","selexys-pharmaceuticals-corporation","venture","1","2015-02-23",43196831
"1189c22a3ddd799806e58e96b87c527b","selexys-pharmaceuticals-corporation","venture","1","2012-09-20",2.3e+07
"1189c22a3ddd799806e58e96b87c527b","selexys-pharmaceuticals-corporation","debt_financing",NA,"2009-07-02",3435000
"b48fa57757586a151e889e5c276225c8","selfdrvn-enterprise-pte-ltd","seed",NA,"2015-07-01",370000
"22690dceb49634391d947578a2815308","selfecho","venture",NA,"2016-01-27",603144
"a7427d5fb6e5d347d9abd405a10bc89f","selfscore","seed",NA,"2014-12-01",1e+06
"a7427d5fb6e5d347d9abd405a10bc89f","selfscore","venture","1","2015-06-27",5250000
"a7427d5fb6e5d347d9abd405a10bc89f","selfscore","seed",NA,"2013-12-01",1e+06
"70e56d0b3d8f22af91dc58c5d215faa1","selleckchem",NA,NA,NA,NA
"3a5a586845939da4c90b3e609e5c5121","selventa","venture",NA,"2011-11-29",5e+06
"3a5a586845939da4c90b3e609e5c5121","selventa","venture",NA,"2010-05-17",5e+05
"ffdf3fa6b3f52e2247cedccb304732fa","semandex-networks",NA,NA,NA,NA
"b153b2bba665afc837cb0bee838a5dce","semant-io","seed",NA,"2014-06-01",40000
"6f0dc69c1c67f1e62c1c8c8576ea64fd","semantic-press",NA,NA,NA,NA
"6ece40aaa0194709b89ece39efc4c0ec","semantic-research-inc",NA,NA,NA,NA
"3a2cf575837475efa92b53ed8ec68e27","punkt-netservices","seed",NA,"2014-01-31",NA
"0061397b435395387b1b477c457ecebd","semantictool",NA,NA,NA,NA
"8c5eef66d190dc4348856feed4d66c0e","semantifi","venture","a","2008-09-16",2200000
"8c5eef66d190dc4348856feed4d66c0e","semantifi","debt_financing",NA,"2010-08-20",1e+06
"46e37b9afa98c05c16504b746cdb64f4","semantile","seed",NA,"2015-12-28",NA
"a4df46909051ce0eaacbddc0abcd4be7","semantra","venture","c","2008-07-22",3e+06
"a4df46909051ce0eaacbddc0abcd4be7","semantra","venture",NA,"2006-09-01",2300000
"a4df46909051ce0eaacbddc0abcd4be7","semantra","venture","b","2007-08-15",3800000
"20b931766f5041cae09e1f7aa7a1a49f","semantria","seed",NA,"2011-02-01",NA
"8efd2eccf03daa5e7f11ed50e22eab11","semanttica",NA,NA,NA,NA
"6deced4e20ac736424dff81ba2e2fe1e","sematext",NA,NA,NA,NA
"174f9a356e7814d0e2a9bd5e2858c8bf","semba-biosciences","venture",NA,"2010-12-22",875000
"174f9a356e7814d0e2a9bd5e2858c8bf","semba-biosciences","debt_financing",NA,"2010-05-11",120000
"174f9a356e7814d0e2a9bd5e2858c8bf","semba-biosciences","grant",NA,"2012-09-24",225000
"174f9a356e7814d0e2a9bd5e2858c8bf","semba-biosciences","venture",NA,"2015-01-05",511175
"4210f0db8929c90978f6d74d2726bcdd","semdirector","venture","A","2007-03-05",5950000
"d3ef14eedffa69eb8c691b365f76a2f2","semeon-analytics",NA,NA,NA,NA
"bc1b8b2e4a45583ec697937e33a8c7a8","semetric","venture",NA,"2013-01-23",4700000
"13a940118791807968fb6f9408356525","seminis",NA,NA,NA,NA
"79baf27ce79b666ad6e5633f7643877c","semiosbio-technologies","seed",NA,"2013-07-23",474000
"9f52478d64c07b8d14eb751dc3f5ffba","semler-scientific","post_ipo_equity",NA,"2015-03-11",498600
"2de484c46268e477db38a23897e9fc4f","semma-therapeutics","venture","A","2015-03-24",4.4e+07
"ee93e8042a7083b3709a9d51eea40f0f","semnur-pharmaceuticals","venture",NA,"2013-08-16",6e+06
"2d24c79e91217183e3bad2180c9b9195","semprus-biosciences","grant",NA,"2011-10-19",1e+06
"2d24c79e91217183e3bad2180c9b9195","semprus-biosciences","venture","1","2008-12-14",8e+06
"2d24c79e91217183e3bad2180c9b9195","semprus-biosciences","venture","1","2010-12-13",1.8e+07
"c2343768ee3d278a27fc4a84f575feb1","sems-technologies",NA,NA,NA,NA
"03c449cfa3919d6e48e4e888c4300999","senaptec","debt_financing",NA,"2014-09-04",1e+05
"d01be584356d9cf122bdd062987db645","sendloop",NA,NA,NA,NA
"7583d8fee89d8406415fac3e8ad382e4","senesco-technologies","private_equity",NA,"2013-12-12",25200000
"7583d8fee89d8406415fac3e8ad382e4","senesco-technologies","venture",NA,"2010-03-29",11500000
"7583d8fee89d8406415fac3e8ad382e4","senesco-technologies","private_equity",NA,"2013-10-01",1725000
"7f40004338a93239e411070be0ca8d51","senex-biotechnology","debt_financing",NA,"2011-05-10",2e+05
"7f40004338a93239e411070be0ca8d51","senex-biotechnology","debt_financing",NA,"2013-08-08",4e+05
"9bc786526a54433ef94ac4c8332818d7","senhwa-biosciences","venture","b","2013-12-12",1.7e+07
"4ff5e5697197393ff83f13543401bb5e","senior-wellness-solutions","seed",NA,"2012-10-02",172442
"4ff5e5697197393ff83f13543401bb5e","senior-wellness-solutions","venture",NA,"2012-02-16",263333
"7258d69fb45a46814987a95c725e6210","senomyx",NA,NA,NA,NA
"82a3838fe36735326cc081f4ec63be79","senostic","seed",NA,"2016-01-25",NA
"900491540432e9dbc69e5b6071a6662a","sensai-corporation","seed",NA,"2015-03-31",1300000
"8f96833962c936ab1ca7a6870ed852c2","sensation-io","angel",NA,"2014-06-01",545263.7032
"e8f00e3224f49664274767cd23567188","sense-4-things",NA,NA,NA,NA
"74cc53278a1753d5498998945cdd0f4f","sense-networks","venture","a","2008-04-01",3e+06
"74cc53278a1753d5498998945cdd0f4f","sense-networks","venture","b","2009-06-26",6e+06
"cc4819da97c2ed3e8a154a0229294810","sense-platform","debt_financing",NA,"2014-04-03",6e+05
"cc4819da97c2ed3e8a154a0229294810","sense-platform","angel",NA,"2013-02-01",160000
"cc4819da97c2ed3e8a154a0229294810","sense-platform","seed",NA,"2014-10-01",1100000
"9a709836ad2979e991f4352ab38f88c5","sense-ly","seed",NA,"2013-07-10",28000
"9a709836ad2979e991f4352ab38f88c5","sense-ly","seed",NA,"2014-09-22",1250000
"9a709836ad2979e991f4352ab38f88c5","sense-ly","venture","1","2015-06-19",2500000
"7435e4cf98271cb70a7971fe4270e61f","sensedoc",NA,NA,NA,NA
"4f952cc9f423e18e0b9c2bfb2d191c6d","senseforth-technologies-private-limited",NA,NA,NA,NA
"f0d858e397ac1cb5ecd81fa990f9d93a","senseihub",NA,NA,NA,NA
"87056db616f3388b75e23763df7f7af2","sensevery",NA,NA,NA,NA
"a8cd68fe8b14019d9e319b2909bb9e8a","sensewaves",NA,NA,NA,NA
"efcad5482180aef2244a19c700c0e1f3","senseye",NA,NA,NA,NA
"a72fbff3b47ceae5edfdb3093da7af55","sensible-medical-innovations","venture",NA,"2013-11-11",2e+07
"2210698bd969cda2ec46378637823f6f","sensigen","venture",NA,"2007-05-15",250000
"8f3f301ae9272703570766e3312556fe","sensing-dynamics","seed",NA,"2015-03-01",399857
"d77a9a34d9b08bf5fb0f91eaeb7dbab5","sensipass","seed",NA,"2013-05-20",NA
"d77a9a34d9b08bf5fb0f91eaeb7dbab5","sensipass","undisclosed",NA,"2013-11-28",NA
"d77a9a34d9b08bf5fb0f91eaeb7dbab5","sensipass","seed",NA,"2015-03-03",NA
"d77a9a34d9b08bf5fb0f91eaeb7dbab5","sensipass","seed",NA,"2013-08-01",NA
"d77a9a34d9b08bf5fb0f91eaeb7dbab5","sensipass","undisclosed",NA,"2015-06-17",NA
"7ddb638f046b4cb247dfd23c779d8ac6","sensiple-software-solutions-pvt-ltd",NA,NA,NA,NA
"890a622791e6bc995dd77e6bce1cb7ab","sensis-corporation",NA,NA,NA,NA
"fea1f08511d4906c03c7a6bd7781d955","sensometrix",NA,NA,NA,NA
"08fb7a17bce88bc6fd3eb70316a6ae8f","sensor-medical-technology","venture",NA,"2013-11-14",720000
"08fb7a17bce88bc6fd3eb70316a6ae8f","sensor-medical-technology","venture",NA,"2012-08-31",5500000
"a0bf3cdad6cd26c114e71c2e5e3b490b","sensor-platforms",NA,NA,NA,NA
"cfd6fbd985332466bbcc55ed52e526ff","sensoraide","seed",NA,"2013-11-21",40000
"cfd6fbd985332466bbcc55ed52e526ff","sensoraide","seed",NA,"2015-06-30",16674
"a0d9f677ce1b5219e97c6e4283bb3c48","sensorion","venture",NA,"2012-04-26",991125
"a0d9f677ce1b5219e97c6e4283bb3c48","sensorion","undisclosed",NA,"2015-01-21",4636695
"faca409e74bbadd790d198dfd9809614","sensory-analytics","convertible_note",NA,"2008-12-01",1e+06
"2a2e941bfd7f27d9c7fd513cd29151a1","sensory-health-systems",NA,NA,NA,NA
"bccf83d78652d5e6b531075c2657108b","sensory-medical","venture","c","2014-03-12",5e+05
"bccf83d78652d5e6b531075c2657108b","sensory-medical","venture",NA,"2013-06-11",750000
"bccf83d78652d5e6b531075c2657108b","sensory-medical","venture","D","2015-09-03",1500000
"b5ffc629b146097a038e85087c55b1c6","sensq-2",NA,NA,NA,NA
"8bf026d53a8b5b3d4004be2371970b77","sensulin","seed",NA,"2013-02-28",330000
"f40e1648cc8b0ed4ec8112c1a015636f","sensus-b-v",NA,NA,NA,NA
"97bc2814b4ccbda74f013e475887631f","sente-inc","venture","a","2009-01-31",698000
"97bc2814b4ccbda74f013e475887631f","sente-inc","debt_financing",NA,"2010-09-26",94000
"97bc2814b4ccbda74f013e475887631f","sente-inc","venture","b","2011-04-15",50000
"97bc2814b4ccbda74f013e475887631f","sente-inc","venture","b","2013-05-22",2.1e+07
"97bc2814b4ccbda74f013e475887631f","sente-inc","venture","C","2014-06-02",5e+06
"05b240a7a0cdc4e96313f0ddbae89f39","sentenai","seed",NA,"2016-01-21",1800000
"b90e7ca7c03a40478f5971030b39b0bd","argus-labs","venture","B","2015-11-17",5200000
"b90e7ca7c03a40478f5971030b39b0bd","argus-labs","angel",NA,"2012-06-01",246440
"b90e7ca7c03a40478f5971030b39b0bd","argus-labs","seed",NA,"2013-04-22",653054
"b90e7ca7c03a40478f5971030b39b0bd","argus-labs","seed",NA,"2014-04-28",692086
"b90e7ca7c03a40478f5971030b39b0bd","argus-labs","venture","A","2015-01-21",2e+06
"3e4a8c183beaae84906451567d59f5a3","sentido-comn-internet",NA,NA,NA,NA
"ee8d79a09dbc921bf4b4633a3991a666","sentient-technologies-consultants",NA,NA,NA,NA
"94d5c4abde3112ee142383a292fc6f93","sentilant",NA,NA,NA,NA
"98b90e71391ce4e23d7ae671e46aea40","sentio-solutions-inc","seed",NA,"2015-09-10",75000
"5a70d0ad379e87c735aee040f8eb5975","sentiquant",NA,NA,NA,NA
"87fb71cfff4719a2b1cbfed619a0b761","ara-labs","seed",NA,"2014-02-10",486905
"7f849d5701e9ea63d634b3ff94a83ad7","sentrian","venture","A","2014-11-10",8e+06
"7f849d5701e9ea63d634b3ff94a83ad7","sentrian","venture",NA,"2014-05-21",NA
"7f849d5701e9ea63d634b3ff94a83ad7","sentrian","seed",NA,"2014-03-31",1366000
"7f849d5701e9ea63d634b3ff94a83ad7","sentrian","seed",NA,"2013-10-18",NA
"7f849d5701e9ea63d634b3ff94a83ad7","sentrian","seed",NA,"2013-01-29",NA
"b1e9423fd452c96a75e36d186edf9675","sentry",NA,NA,NA,NA
"9f8aeb24bb1961557b75226dff77bf60","senzagen-ab",NA,NA,NA,NA
"085f39363635e30394f01f26b4ca5763","seo-seo-detective-com",NA,NA,NA,NA
"0abba9cec248013a6759a20c9a87bd31","seo-intelligence",NA,NA,NA,NA
"c066193d360b8d4c5a7164026c95807b","seoq","seed",NA,"2012-05-15",150000
"201f6ca55947290b73c413602559d7d3","seo-takeaways",NA,NA,NA,NA
"7af881a602ccd6071a76f6bf7457192b","seo-trfico",NA,NA,NA,NA
"1955053234a849e66139fb0f93b3a10c","seo-web-analyst",NA,NA,NA,NA
"f8176f03b5ddaecf5882249d59101c51","seobats",NA,NA,NA,NA
"d5870a26be6c52a6eff8df1ae16d9fc9","seoclarity",NA,NA,NA,NA
"425ffa8da4ad02e17ca5210b8d4e419a","seofuture",NA,NA,NA,NA
"1e2046efd162d021241e94f061449092","seomic",NA,NA,NA,NA
"c040386a7838dc5518a020632e03abf8","seon-security",NA,NA,NA,NA
"c1a1b2c2b5f4a496b28a3fdd70e9e5f8","sepmag-technologies","seed",NA,"2009-02-25",1151550
"6db4c1b4e53c9dfa9ebdda2d9d76f9a0","sepracor",NA,NA,NA,NA
"32e9c86cb871ab1b0646983df04f0f40","seqcentral",NA,NA,NA,NA
"027a9a0d42536e608742536e0ea84aff","seqll","venture","A","2014-09-18",1e+06
"4937fa69f4692e6cb9d5b5197a3bd327","sequana-therapeutics",NA,NA,NA,NA
"b01b719a4088a97408140ab75707fad8","sequaz",NA,NA,NA,NA
"3dd4d1876cf12c5dfd72736b737699c2","sequel-pharmaceuticals","venture","A","2007-09-27",2e+07
"3dd4d1876cf12c5dfd72736b737699c2","sequel-pharmaceuticals","debt_financing",NA,"2010-09-07",1367579
"3dd4d1876cf12c5dfd72736b737699c2","sequel-pharmaceuticals","debt_financing",NA,"2009-08-11",3005455
"3dd4d1876cf12c5dfd72736b737699c2","sequel-pharmaceuticals","debt_financing",NA,"2010-12-22",1e+06
"5df02dcef12c195e242bf2765a611098","sequella","venture",NA,"2011-08-10",550000
"5df02dcef12c195e242bf2765a611098","sequella","venture","1","2008-06-15",720097
"5df02dcef12c195e242bf2765a611098","sequella","venture","1","2009-08-06",1500000
"5df02dcef12c195e242bf2765a611098","sequella","debt_financing",NA,"2010-02-16",2e+06
"5df02dcef12c195e242bf2765a611098","sequella","debt_financing",NA,"2011-06-03",1e+06
"5df02dcef12c195e242bf2765a611098","sequella","venture","1","2013-07-17",3.8e+07
"5df02dcef12c195e242bf2765a611098","sequella","venture",NA,"2013-10-01",555000
"5df02dcef12c195e242bf2765a611098","sequella","debt_financing",NA,"2014-10-10",3100000
"4bebf1c289cbad70e8f3f2e1f238466f","sequence-bio","seed",NA,"2015-10-19",1e+06
"bd36faa4c24e0bdab6012a2246164562","sequencing-com",NA,NA,NA,NA
"a85b844faaa5f30eec0e5ad58991bbdb","sequenom","venture",NA,"2009-12-29",1512015
"a85b844faaa5f30eec0e5ad58991bbdb","sequenom","venture","1","2010-05-21",51605250
"a85b844faaa5f30eec0e5ad58991bbdb","sequenom","debt_financing",NA,"2012-09-24",1.3e+08
"28f95f38051b5bc384104f6413d93b06","sequenta","venture",NA,"2012-01-01",8460000
"28f95f38051b5bc384104f6413d93b06","sequenta","venture","1","2010-12-08",1.3e+07
"28f95f38051b5bc384104f6413d93b06","sequenta","venture","1","2013-07-02",2e+07
"28f95f38051b5bc384104f6413d93b06","sequenta","venture",NA,"2014-10-20",NA
"ae41cac51c6922b295233e0bb5e832d5","sequentia-environics",NA,NA,NA,NA
"abe2875e6cdacd854d8828128cfe00bb","sequoia-pharmaceuticals","venture","c","2007-01-09",3.5e+07
"abe2875e6cdacd854d8828128cfe00bb","sequoia-pharmaceuticals","venture","b","2005-03-20",2.2e+07
"abe2875e6cdacd854d8828128cfe00bb","sequoia-pharmaceuticals","debt_financing",NA,"2009-06-09",3800000
"d6ed57064f1763e8e0667d6e746dbaed","sera-prognostics","venture","a","2011-01-04",1400000
"d6ed57064f1763e8e0667d6e746dbaed","sera-prognostics","private_equity",NA,"2012-11-21",10229985
"d6ed57064f1763e8e0667d6e746dbaed","sera-prognostics","venture","a","2011-11-15",19300000
"d6ed57064f1763e8e0667d6e746dbaed","sera-prognostics","venture",NA,"2014-03-14",4500000
"d6ed57064f1763e8e0667d6e746dbaed","sera-prognostics","venture",NA,"2014-06-12",9156865
"d6ed57064f1763e8e0667d6e746dbaed","sera-prognostics","venture","B","2014-11-18",5e+06
"d6ed57064f1763e8e0667d6e746dbaed","sera-prognostics","venture","B","2015-01-07",2e+07
"b5e757b4bb3dfcbeaffbdb3299c070d3","seracare-life-sciences","private_equity",NA,"2012-04-24",8.2e+07
"7dbaf8ed02295fcf4ac9733cdb849293","seraf",NA,NA,NA,NA
"1a13f29ff640dce152617f832fe17273","seragon-pharmaceuticals","venture","a","2013-10-16",3e+07
"7650f3a4c5aafc2aa5313e3775e8ff8d","serascience",NA,NA,NA,NA
"c6529ed2ecba9d5923f1c576ecaf4224","serefind",NA,NA,NA,NA
"8480e3614b24ceb6192ad658771f6bd6","foviance",NA,NA,NA,NA
"4c8f0018a6a1d07ba902e28eb51f115a","serendip-media",NA,NA,NA,NA
"875f07a10cbb77d8336e262debde3e70","serene-oncology","venture",NA,"2012-11-26",270000
"875f07a10cbb77d8336e262debde3e70","serene-oncology","convertible_note",NA,"2011-04-07",1500000
"3eb81f0ea68441032ece8af3c5babc01","serenex","venture","D","2007-06-28",2.6e+07
"3eb81f0ea68441032ece8af3c5babc01","serenex","venture","C","2005-10-06",3e+07
"cde0b801e81118846f7b6b58817846da","serenytics",NA,NA,NA,NA
"47c22265a50b9e6489991a70acace7de","seres-health","venture","A","2012-11-27",NA
"47c22265a50b9e6489991a70acace7de","seres-health","venture","B","2014-05-23",NA
"47c22265a50b9e6489991a70acace7de","seres-health","venture","C","2014-12-02",4.8e+07
"47c22265a50b9e6489991a70acace7de","seres-health","venture","D","2015-01-06",6.5e+07
"0ba739ce5bf78fa0563acc3dc65f32cd","seresco",NA,NA,NA,NA
"ea037502ad11748fd19993aa3a9edefe","serial-metrics",NA,NA,NA,NA
"683bd1eb9556c98843bf168480430dda","serica-technologies","venture","C","2007-02-28",1.2e+07
"94063c9287a5d6070f22ebded4589194","serina-therapeutics","venture",NA,"2011-06-01",9500000
"94063c9287a5d6070f22ebded4589194","serina-therapeutics","private_equity",NA,"2012-10-02",11150080
"94063c9287a5d6070f22ebded4589194","serina-therapeutics","seed",NA,"2012-09-21",2e+06
"94063c9287a5d6070f22ebded4589194","serina-therapeutics","venture",NA,"2015-03-18",4855000
"9d557b6f18037b9e83f9fae764917873","worldone","venture",NA,"2013-04-03",3.5e+07
"9d557b6f18037b9e83f9fae764917873","worldone","venture",NA,"2011-09-08",2.5e+07
"8d5fd75d4383c3bed28ed86c80925bbc","sernova","venture",NA,"2012-04-12",85077
"61fe2c28b69d8a6d3fc8554ece089657","serologicals-corporation",NA,NA,NA,NA
"06167820412c38bed66a2164e6db5284","serometrix","debt_financing",NA,"2012-06-27",227979
"c6cbc8210a793018eeaced0956161dd3","serono",NA,NA,NA,NA
"1ab19f8cadadaf657d516d834f7a9c70","serono-international",NA,NA,NA,NA
"41d9cf053e4ab8245daa83fe39a0551a","serpstat",NA,NA,NA,NA
"dc053364a3cedd09b699fd26aa1825bc","serpyou",NA,NA,NA,NA
"5cb02b96db238a16567c1fa7730d99b4","serro-solutions",NA,NA,NA,NA
"2fdd789f7022cf63d2c589331a1b3d62","serstech","venture","b","2013-06-01",1821193
"9a818616035662f34a241abe25531cb7","servant-health-group","venture",NA,"2009-04-01",270000
"158fd78f18349db0a304529e0280cc53","servhawk","venture",NA,"2011-10-12",2e+05
"29b15e60d997e5aa012a848425019496","servicepower",NA,NA,NA,NA
"71aeab5d2c3bc6bfbcc6bb27f496ccd3","servio","venture","a","2010-08-13",5100000
"71aeab5d2c3bc6bfbcc6bb27f496ccd3","servio","venture","b","2013-03-06",4256180
"b36b242b01c461a7577868fe62d653ed","sessionbox","convertible_note",NA,"2013-06-10",NA
"0ba4515f41f97747ad250052a844caf4","sessionm","venture","b","2012-05-08",2e+07
"0ba4515f41f97747ad250052a844caf4","sessionm","venture","a","2011-05-21",6500000
"0ba4515f41f97747ad250052a844caf4","sessionm","venture","C","2015-05-05",1.2e+07
"d2c6464a4dbb8232ee2700745bd462b4","setgo","undisclosed",NA,"2012-06-05",NA
"e25302a4d297b9af8ea50d951e07c5ca","setpoint-medical","debt_financing",NA,"2009-05-26",4e+06
"e25302a4d297b9af8ea50d951e07c5ca","setpoint-medical","debt_financing",NA,"2012-04-13",3300000
"e25302a4d297b9af8ea50d951e07c5ca","setpoint-medical","venture",NA,"2010-10-19",5000001
"e25302a4d297b9af8ea50d951e07c5ca","setpoint-medical","venture","1","2013-08-08",30607151
"e25302a4d297b9af8ea50d951e07c5ca","setpoint-medical","venture","1","2015-09-08",4.3e+07
"23290ec53847db87c32c0846904553d3","setuserv","venture",NA,"2014-03-24",160000
"ad1c0513f4510e7e3cb0239a509f07da","seven-lakes-technologies","venture","A","2015-03-03",2e+07
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","venture",NA,"2015-12-22",2060000
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","debt_financing",NA,"2010-05-04",1500000
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","debt_financing",NA,"2012-06-01",2e+05
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","venture","1","2011-05-11",4500000
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","debt_financing",NA,"2013-04-01",157500
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","grant",NA,"2011-12-16",3280000
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","debt_financing",NA,"2012-04-10",750000
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","venture","1","2012-06-13",1e+07
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","venture",NA,"2014-04-10",930000
"5c6247b36da66525d7f31f8778528ca3","seventh-sense-biosystems","debt_financing",NA,"2010-10-14",2100000
"e2b0b477734f97ac24e1c6be8091b6c1","sexybookmarks",NA,NA,NA,NA
"ad491a09d14d3085ccc1026b594c907d","seywan",NA,NA,NA,NA
"a5ec9879cf2b4dd673804c09e8d62cb0","sf-interactive","venture",NA,"1999-12-14",1e+07
"cfa9ef678aec207bc0421a68fb668a3e","sfg-media-group",NA,NA,NA,NA
"5e967645139ac2ca03edd16e24956e1e","sfj-pharmaceuticals","venture",NA,"2012-10-01",5e+05
"5e967645139ac2ca03edd16e24956e1e","sfj-pharmaceuticals","private_equity",NA,"2012-04-01",3.5e+07
"5e967645139ac2ca03edd16e24956e1e","sfj-pharmaceuticals","private_equity",NA,"2013-04-01",1.3e+07
"5e967645139ac2ca03edd16e24956e1e","sfj-pharmaceuticals","private_equity",NA,"2012-07-01",2.1e+07
"5ff01e9d04cd09f97a251099b4d4f9b2","sg-austria",NA,NA,NA,NA
"fb5b727e0336908313b9e01eeeb336fe","sg2-2",NA,NA,NA,NA
"d77cae746c57c5757ef5238981b8be6a","sgaim",NA,NA,NA,NA
"9e4fb4face8425c46e2bc31f18791f43","sg-biofuels","venture","b","2012-01-17",1.7e+07
"9e4fb4face8425c46e2bc31f18791f43","sg-biofuels","venture","a","2010-09-14",9400000
"9e4fb4face8425c46e2bc31f18791f43","sg-biofuels","venture","C","2014-09-09",1.1e+07
"c0e7be304a007270ae7a9870630bd615","sgx-pharmaceuticals","venture",NA,"2007-11-20",2.5e+07
"92021e1405954f74f238c6cef8eb75d3","shaanxi-aierfu-tissue-engineering-company",NA,NA,NA,NA
"332b1fbec7dba395df880064094e0a4b","shady-grove-fertility","venture",NA,"2012-06-24",250000
"82cfc09e8114fdfa5e9ce96bbcef5ecd","shake-on","angel",NA,"2015-09-01",112363.3381
"a2e8fb77c8d9bcadabc98ecffe106f6d","shaldor",NA,NA,NA,NA
"898396addbe0741f6badf357f122a4f2","shaman-inc",NA,NA,NA,NA
"04ead9d969f5215cbdbe0fb5e5d69d08","shambhavi-impex",NA,NA,NA,NA
"c5895047d7bf9fa887245ba59851d6dc","shamrock-structures",NA,NA,NA,NA
"54772f78c5f1dad7c0ee9a8f0f4de412","shanghai-fosun-pharmaceutical",NA,NA,NA,NA
"bc938e379f061c4e4b30c707b12c9855","shangpharma",NA,NA,NA,NA
"13e7ad2958adb74a4063db5140bb6ce0","shantha-biotechnics",NA,NA,NA,NA
"9cba723e9512aafc91f629ca5bccb0ac","shape-medical-systems","venture",NA,"2012-06-21",8320993
"19e890403d3ffaf266707e4fb9eecf36","shape-pharmaceuticals","venture",NA,"2010-10-12",3e+06
"4af9ceaa3f1f350a2e7317aa1dfa7947","share-practice","seed",NA,"2013-07-01",NA
"4af9ceaa3f1f350a2e7317aa1dfa7947","share-practice","seed",NA,"2014-03-25",1300000
"4af9ceaa3f1f350a2e7317aa1dfa7947","share-practice","seed",NA,"2013-02-28",750000
"4af9ceaa3f1f350a2e7317aa1dfa7947","share-practice","venture",NA,"2013-04-01",25000
"4af9ceaa3f1f350a2e7317aa1dfa7947","share-practice","angel",NA,"2012-11-01",750000
"4af9ceaa3f1f350a2e7317aa1dfa7947","share-practice","seed",NA,"2013-08-01",1300000
"fd7407af095132fa017879ddfa777ec6","shareable-social-2","seed",NA,"2014-07-15",18000
"2fe16f59d5f06cd76b2b67f81e719c63","shareablee","venture","A","2014-05-12",6e+06
"294cb4db8c2661baa1b9644384c7dc43","shareaholic","angel",NA,"2009-09-01",355000
"294cb4db8c2661baa1b9644384c7dc43","shareaholic","venture","1","2012-06-28",3e+06
"294cb4db8c2661baa1b9644384c7dc43","shareaholic","seed",NA,"2011-11-10",2100000
"294cb4db8c2661baa1b9644384c7dc43","shareaholic","venture","1","2014-10-01",2300000
"f90fb44f99c1ad6917431453ac8733f2","shared",NA,NA,NA,NA
"b94cc274a06afde5320a7414ab1230ac","visibli","seed",NA,"2011-03-03",5e+05
"6089f81e17d57737df70e04b84eab8ab","sharedvue",NA,NA,NA,NA
"91657ecddf67c30893fe0d5f4d7d46b6","shareroot","post_ipo_equity",NA,"2016-01-13",3500000
"91657ecddf67c30893fe0d5f4d7d46b6","shareroot","seed",NA,"2015-11-03",1400000
"ff6fef56b6b42f77aa64c291f3fd0c64","sharetracker","undisclosed",NA,"2014-03-26",NA
"ac5758fc189b3687e650b1f273f748d1","sharint",NA,NA,NA,NA
"0984f5fe8fb010dc4c6d08130e7574d4","sharklet-technologies","venture",NA,"2009-07-08",1170000
"0984f5fe8fb010dc4c6d08130e7574d4","sharklet-technologies","venture",NA,"2012-12-18",2004554
"0984f5fe8fb010dc4c6d08130e7574d4","sharklet-technologies","equity_crowdfunding",NA,"2014-12-26",NA
"c1b747896b4487feff11a83aaed8c8ab","sharp-edge-labs","seed",NA,"2013-07-09",250000
"c1b747896b4487feff11a83aaed8c8ab","sharp-edge-labs","venture",NA,"2012-01-05",1e+05
"c1b747896b4487feff11a83aaed8c8ab","sharp-edge-labs","venture","1","2014-08-19",6e+05
"8d49c8024e22cefab91b48c14c4df646","sharpspring",NA,NA,NA,NA
"538439c3693e0c5476e3f6c4c237370c","shaser","venture",NA,"2009-04-24",855614
"538439c3693e0c5476e3f6c4c237370c","shaser","venture",NA,"2010-03-31",2999999
"9ab447ef9e350daad8b3d8deced7af4d","shazura",NA,NA,NA,NA
"ac8acde0f6392ca5beb458d8d073bc27","sheepdoginc-ca",NA,NA,NA,NA
"dcdd4abf25dfd2874dba0935e153d1fb","sheepla",NA,NA,NA,NA
"7d5abdf0da1f01962f0c688bb6b8a484","shelfie","seed",NA,"2014-07-18",20000
"9850bd99e4aa56a2ffdefb808e2d7811","sherpa",NA,NA,NA,NA
"26587edbc8cdb76a00e76f882deb0d28","sherpa-digital-media","undisclosed",NA,"2015-08-07",NA
"26587edbc8cdb76a00e76f882deb0d28","sherpa-digital-media","undisclosed",NA,"2013-12-19",NA
"0965c54510ac6c10580d78107a41c4b2","sherpa-2","seed",NA,"2015-05-11",7e+05
"db0276d54db8a6fb79bf06ef38151844","shield-therapeutics","venture","a","2011-06-01",11814560
"792e0ac7ba3a81a109c7c567cbc5a8bd","shiftfwd",NA,NA,NA,NA
"34843d896c0f97bfb8533a8ea792bff8","shinbone-networks",NA,NA,NA,NA
"cf4d4f0aa876a8c3ea0634e383f574dd","shinystat",NA,NA,NA,NA
"159577615c764bf033ccb425e0c535cf","sciele-pharma",NA,NA,NA,NA
"df1340ff65087de7fdf2e3032d147e58","shipster","seed",NA,"2015-03-31",NA
"320b8779f992ffd521705281705fe72f","shire",NA,NA,NA,NA
"62c88e516f8c92e5bb21dbad605d23f3","shl-systemhouse",NA,NA,NA,NA
"575bb9d0f5e4cd1bd907c1d182ebbea1","shock-concepts",NA,NA,NA,NA
"9f97f53794cbe7854a9d929046fba992","shoejitsu",NA,NA,NA,NA
"fccec438f65cae462e008d93d0bfd533","shoes-dsire",NA,NA,NA,NA
"9a267a7d418e912c148e8ae34a46bfe5","shoork","seed",NA,"2012-09-26",129006
"8d18677d5a8ba80d26455155d7e2e209","shop-ur-meds",NA,NA,NA,NA
"644c67cb20379043b90d257ca82e10e1","shopalive-sa",NA,NA,NA,NA
"450613643b074ed1f08bff6a60ad598c","shopalytic","seed",NA,"2014-01-06",40000
"2c11c6df2ec5a1fc16c530f3620450ad","shopback-2",NA,NA,NA,NA
"f4e553bdcd425764328c0b7900a685bd","shopbox",NA,NA,NA,NA
"fbe3698fab07f385bdd1a6b174953080","shopconnect",NA,NA,NA,NA
"55858fe700bbf1cc3f00ab61c75c7182","shopian",NA,NA,NA,NA
"41f5a4769418935d4b8e72ebe1eab169","shopify","venture","b","2011-10-17",1.5e+07
"41f5a4769418935d4b8e72ebe1eab169","shopify","venture","A","2010-12-13",7e+06
"41f5a4769418935d4b8e72ebe1eab169","shopify","venture","C","2013-12-11",1e+08
"76bde17e28095f5383cf07ff732ea20d","shopitize","seed",NA,"2011-08-01",1638906
"76bde17e28095f5383cf07ff732ea20d","shopitize","seed",NA,"2013-04-25",1531549
"6419af563afdeacc37295309a3e16474","shoplogic","seed",NA,"2011-10-01",250000
"af119582d28f739a67735917475aca9e","shopparity","seed",NA,"2014-01-23",NA
"1cd7dd89ff320c06243715e03976fdfb","cashorcard-pos","convertible_note",NA,"2013-09-06",127673
"1cd7dd89ff320c06243715e03976fdfb","cashorcard-pos","convertible_note",NA,"2014-01-15",188356
"1cd7dd89ff320c06243715e03976fdfb","cashorcard-pos","angel",NA,"2014-05-22",136807
"fe7b8673542600251b69d401520c894f","shopper-studio",NA,NA,NA,NA
"c72cd2a3494e1997d2f925b6a2474f2b","shopperception","seed",NA,"2012-07-01",2e+05
"c72cd2a3494e1997d2f925b6a2474f2b","shopperception","seed",NA,"2014-01-01",720030
"c72cd2a3494e1997d2f925b6a2474f2b","shopperception","seed",NA,"2013-10-30",NA
"0e505af8f038aa66d1a2c539722006a7","shoppertrak",NA,NA,NA,NA
"19c41e9bcf701ade1cd71a7927342ad0","shoppist",NA,NA,NA,NA
"10535eecaccf3c0a80bc3643628cb259","shopsense","seed",NA,"2015-11-19",NA
"10535eecaccf3c0a80bc3643628cb259","shopsense","seed",NA,"2013-09-12",NA
"590c2a3d6aaadbfa0fec0914387e3561","shopsy","seed",NA,"2013-03-27",1e+05
"d45177ab6518f84e32468b0d3f7b65a3","shop-tech-pty-ltd",NA,NA,NA,NA
"f67f1b9d8c82af26be2a3a3b3e98054e","shopventory","venture",NA,"2013-10-11",1e+06
"f67f1b9d8c82af26be2a3a3b3e98054e","shopventory","seed",NA,"2013-05-13",NA
"f67f1b9d8c82af26be2a3a3b3e98054e","shopventory","seed",NA,"2013-10-10",1030000
"efd058b15f77c65ed714d1b0e19d16b5","shot-shop","seed",NA,"2013-05-24",215661
"efd058b15f77c65ed714d1b0e19d16b5","shot-shop","seed",NA,"2013-11-26",264165.598
"efd058b15f77c65ed714d1b0e19d16b5","shot-shop","debt_financing",NA,"2013-12-05",340454
"efd058b15f77c65ed714d1b0e19d16b5","shot-shop","undisclosed",NA,"2013-12-05",344000
"8ee3a81dfc1cbd2eb861a4d44cddbe19","briton-t-swiercinsky",NA,NA,NA,NA
"1072662170d1005a28f0b58f8ba0710b","shoutcrowd-media",NA,NA,NA,NA
"92bfe2337572189734f2aa9b5b7aef07","showcase-corp",NA,NA,NA,NA
"0ea6912b4bd925b3b22af9afc4ba25d4","shryne",NA,NA,NA,NA
"b05df9466827df9d5da79b59f3270636","shuanglong-tonghua-chemical",NA,NA,NA,NA
"4ea4adc7075aa191902eae91981946f6","trinity-pharma-solutions","venture","a","2014-04-07",4e+06
"4ea4adc7075aa191902eae91981946f6","trinity-pharma-solutions","venture","a","2013-12-17",1.5e+07
"c31bda330b9f33c68830781abd15137e","sia-aerospace",NA,NA,NA,NA
"7172a90226b6ebc567ac87c51c098d19","sialix","venture","b","2012-10-10",2e+06
"7172a90226b6ebc567ac87c51c098d19","sialix","venture","b","2014-02-27",2464207
"7172a90226b6ebc567ac87c51c098d19","sialix","venture","b","2014-02-05",1200000
"7172a90226b6ebc567ac87c51c098d19","sialix","venture",NA,"2014-07-14",526998
"7172a90226b6ebc567ac87c51c098d19","sialix","venture",NA,"2015-04-10",2000176
"eb6f7e1422ae84495b7feb269b2ad8c5","sibdocity",NA,NA,NA,NA
"a46e00fb99f73af7d927cdde1a58c325","sibia-analytics",NA,NA,NA,NA
"83e09b44721df23e5818863ec9d5710d","sibia-neurosciences",NA,NA,NA,NA
"d5276de92ad8849b28a8edfdadaa778c","sideband-networks","seed","a","2014-02-12",6e+06
"5b0581042dd580901e7efc83bb432d4c","sideris-pharmaceuticals","seed",NA,"2013-04-19",599000
"5b0581042dd580901e7efc83bb432d4c","sideris-pharmaceuticals","venture","1","2013-10-22",3.2e+07
"40bd1e282a7f13f5a07daf7913b0bce9","sidewalk","seed",NA,"2013-05-13",NA
"5025e9b29b12754c7e424247dd6f967e","sierra-atlantic-hitachi-consulting-corp","secondary_market",NA,"2010-06-01",7e+05
"6daa046b952760e25804af44e9e46437","sierra-surgical","venture","b","2008-07-27",14500000
"6daa046b952760e25804af44e9e46437","sierra-surgical","venture","a","2007-08-15",7100000
"b875c62a43e19f25874a93d781c3cce9","sifdata",NA,NA,NA,NA
"35d16eac0ba40ff4aacbd932721550c1","sift-science","venture","a","2013-03-19",4e+06
"35d16eac0ba40ff4aacbd932721550c1","sift-science","seed",NA,"2011-09-01",1600000
"35d16eac0ba40ff4aacbd932721550c1","sift-science","venture","B","2014-05-14",1.8e+07
"5b98f526cfe7d91748aed86905e8fdba","siftynet","seed",NA,"2013-09-20",20250
"5b98f526cfe7d91748aed86905e8fdba","siftynet","seed",NA,"2013-12-01",20385
"09a10be0bb2f82e15c19a70d5fc67f6e","siga-technologies",NA,NA,NA,NA
"7acc3d324bee867731ca12850b57e556","sight-machine","venture","A","2015-02-09",5e+06
"4e2f16e09c5f7d1cfd490e127eb89412","sight-io",NA,NA,NA,NA
"ad83a4f57ad07763cf5530ec8fe3c52f","sightcorp",NA,NA,NA,NA
"15bfc86401fdc8feeb367e75d7e62814","sightec",NA,NA,NA,NA
"6c7a4e23ca99e4a5e9be52c63ee36886","sightline-innovation-inc",NA,NA,NA,NA
"75ada5c62d5612e09d85a9e938b56581","sigma-infosolutions",NA,NA,NA,NA
"585a408fa977f5aa6924e6439ec9eb82","sigma-labs","venture",NA,"2011-04-29",1142500
"585a408fa977f5aa6924e6439ec9eb82","sigma-labs","post_ipo_equity",NA,"2013-08-01",1200000
"ec78e52c07b30e190640e847f7521029","sigma-pharmaceuticals","venture",NA,"2009-09-23",18215562
"7c4971106faa0d94da70d627ead3b412","sigma-aldrich",NA,NA,NA,NA
"2514c96e7f1b2558979c1c97bab310ba","sigmascreening","venture","a","2010-10-06",NA
"6dff66998e3053073b0ec1d2c5e18a5e","sigmento","seed",NA,"2015-12-01",NA
"93ab0b429bb3012d61e2f1bdcae34034","sigmoid-pharma","venture",NA,"2014-09-29",6339385
"f28b0d16ad3a1242eafa27a9887c5d7e","sign2pay","angel",NA,"2015-01-23",696864
"6d977b1bbeb82f7f9adfbadedc2defd8","signal-media-ltd","seed",NA,"2015-10-09",1400000
"6d977b1bbeb82f7f9adfbadedc2defd8","signal-media-ltd","seed",NA,"2015-03-31",1800000
"a81dc398bec5f1f03d1c5f4a0b7e2470","signals-intelligence-group","venture","B","2015-10-26",1.5e+07
"3d14d5b7599bf500d1c1f26fd94ab146","signalshare",NA,NA,NA,NA
"a4fca22386da2a8465fd00f6f429af3a","signature-bioscience",NA,NA,NA,NA
"32d547ae105253ca3a09a87b51eb0712","signature-therapeutics-inc","venture","a","2011-12-16",1e+07
"42c3b0da6ae3ddb7622898183ad0cb76","signder",NA,NA,NA,NA
"64fc529566ab622a1bc69e0a1a6d34d3","significo-research",NA,NA,NA,NA
"f100320ad1d347d6cacbbe05ac073412","signl",NA,NA,NA,NA
"a577321eebc2decc213d8e109f8252c4","signosis",NA,NA,NA,NA
"c4c8c6bee2f994417d13baee3ff2b556","signostics","venture","C","2015-11-17",3.5e+07
"c4c8c6bee2f994417d13baee3ff2b556","signostics","venture","b","2010-04-07",5e+06
"c4c8c6bee2f994417d13baee3ff2b556","signostics","venture","a","2009-09-15",4e+06
"b6c646df9a1ee4690b313c6773c8a49c","signpath-pharma","venture",NA,"2011-10-04",580000
"b6c646df9a1ee4690b313c6773c8a49c","signpath-pharma","venture",NA,"2014-06-05",4355500
"b6c646df9a1ee4690b313c6773c8a49c","signpath-pharma","venture",NA,"2014-11-26",320000
"736a4f254434301adfadfc7f468c134b","signpost","venture","a","2012-05-01",3750000
"736a4f254434301adfadfc7f468c134b","signpost","venture",NA,"2010-10-25",1250000
"736a4f254434301adfadfc7f468c134b","signpost","venture","b","2013-11-19",1e+07
"736a4f254434301adfadfc7f468c134b","signpost","undisclosed",NA,"2010-03-25",1050000
"736a4f254434301adfadfc7f468c134b","signpost","venture","C","2015-04-28",20500000
"e795d29ab19c143feeb4fe4f5b594a9b","signum-biosciences","venture",NA,"2011-07-25",4e+06
"e795d29ab19c143feeb4fe4f5b594a9b","signum-biosciences","grant",NA,"2013-11-15",1600000
"5a233399aeb1d55497664fcbd7da566a","sigopt","seed",NA,"2014-12-01",120000
"5a233399aeb1d55497664fcbd7da566a","sigopt","seed",NA,"2015-06-16",2e+06
"1bcbc2e18b3188faf565dc4c958cca8d","silence-therapeutics","venture",NA,"2015-04-08",58200000
"09b12b02ec21c156d256c1f2a6762b0b","silenseed","venture",NA,"2014-04-08",5e+05
"75ce7ea51d3ae4a810fd88625b35bbb8","silentale","seed",NA,"2013-12-01",2e+06
"a26f53cdd2495b750d7b0eed01f6d7e7","silere-medical-technology","debt_financing",NA,"2009-09-09",120000
"21d57cb4ebb94b6ef56744a4aa2d5480","silicolife",NA,NA,NA,NA
"52c4101a83d0535db4e776bd4722c5f2","silicon-kinetics","venture",NA,"2013-03-25",2872821
"52c4101a83d0535db4e776bd4722c5f2","silicon-kinetics","debt_financing",NA,"2009-04-27",250000
"79b5043a52cfedc6f79d087c8d47d35d","silicon-valley-connect",NA,NA,NA,NA
"5367f0f66a40fa24d96506dbd2b67769","silicon-valley-data-science","venture","a","2013-08-30",3e+06
"84ca4ead3b48d734ef2ed8808c591858","silicon-valley-software-group",NA,NA,NA,NA
"644613d9bfa35e73fd4461ba26c7d4c2","silobreaker",NA,NA,NA,NA
"e9a5d0a7ddff9f8c6c3c4600868a0b90","silommedical",NA,NA,NA,NA
"377e6885f4702b7c27035d2b255a27c5","silver-imp",NA,NA,NA,NA
"a4f2e428c369152ac5da6a55ad68c9ac","silver-tail-systems","venture","a","2008-09-26",2100000
"a4f2e428c369152ac5da6a55ad68c9ac","silver-tail-systems","venture","b","2011-06-06",2e+07
"a4f2e428c369152ac5da6a55ad68c9ac","silver-tail-systems","undisclosed",NA,"2011-09-22",NA
"dbe891a9db0b70de643d2a31824a80d3","silvergate-pharmaceuticals","venture",NA,"2011-05-20",3015000
"dbe891a9db0b70de643d2a31824a80d3","silvergate-pharmaceuticals","venture",NA,"2014-09-11",1e+06
"fed75f2ef84951d0a5a5e664774cd281","silverpop","venture","B","2000-09-28",3e+07
"fed75f2ef84951d0a5a5e664774cd281","silverpop","venture",NA,"2008-04-24",1.5e+07
"fed75f2ef84951d0a5a5e664774cd281","silverpop","venture",NA,"2013-04-24",2.5e+07
"cdd3267853e5c4f40c776e48e84970a8","silvon-software-inc",NA,NA,NA,NA
"4403ff986279028bab7f9528da8cd312","simba-digital-marketing",NA,NA,NA,NA
"ccf9f58521f37e229498b733a15ac770","simba-technologies",NA,NA,NA,NA
"9bb9ec5056b8732b00e606459b6e6937","simcere-pharma",NA,NA,NA,NA
"bc865a69c2553803dba3262ec7e64d01","similartech",NA,NA,NA,NA
"96e873c9ebd5a5a77d0530a12448490e","similarweb","venture","E","2015-10-26",2.5e+07
"96e873c9ebd5a5a77d0530a12448490e","similarweb","seed",NA,"2009-02-01",NA
"96e873c9ebd5a5a77d0530a12448490e","similarweb","venture","b","2013-01-29",2500000
"96e873c9ebd5a5a77d0530a12448490e","similarweb","venture","D","2014-11-25",1.5e+07
"96e873c9ebd5a5a77d0530a12448490e","similarweb","venture","C","2014-02-24",1.8e+07
"96e873c9ebd5a5a77d0530a12448490e","similarweb","venture","b","2013-09-24",3500000
"96e873c9ebd5a5a77d0530a12448490e","similarweb","venture","a","2010-05-31",1100000
"4b728e2975642632cdf6906c2635b451","simility","angel",NA,"2014-07-01",8e+05
"4b728e2975642632cdf6906c2635b451","simility","seed",NA,"2015-10-23",1500000
"4b728e2975642632cdf6906c2635b451","simility","seed",NA,"2015-08-25",3450000
"072a9e8879b249fcf01e4efb44dbcbdf","simitless",NA,NA,NA,NA
"06cb49141465edfb94ebb462609e2958","simple-disability-insurance","seed",NA,"2015-11-01",NA
"06cb49141465edfb94ebb462609e2958","simple-disability-insurance","convertible_note",NA,"2016-01-20",250000
"77ee12f33b4a3b8382e769a6d74d9209","simple-energy","venture","a","2013-02-19",2016500
"77ee12f33b4a3b8382e769a6d74d9209","simple-energy","seed",NA,"2011-09-01",9e+05
"77ee12f33b4a3b8382e769a6d74d9209","simple-energy","venture","b","2014-01-27",6e+06
"77ee12f33b4a3b8382e769a6d74d9209","simple-energy","seed",NA,"2011-08-01",NA
"e1e3f868700a7b99f5c27d3a5b1acee1","simplereach","seed",NA,"2011-10-01",NA
"e1e3f868700a7b99f5c27d3a5b1acee1","simplereach","seed",NA,"2012-06-15",1600000
"e1e3f868700a7b99f5c27d3a5b1acee1","simplereach","venture","1","2014-07-22",9e+06
"85536087c3d120b0f25075807df0d89d","simplex-3","seed",NA,"2014-05-28",1e+06
"85536087c3d120b0f25075807df0d89d","simplex-3","grant",NA,"2015-03-01",4e+05
"d529085b542df4d6d52ba577c01b83f9","simplicant",NA,NA,NA,NA
"66a5e9680f1a8b74211de88b251be1d7","simplifier-corporation","seed",NA,"2015-02-01",110000
"3f407a191cf241dbda152f373a6f3e23","simplify360",NA,NA,NA,NA
"3a785e57dec24ad17647766d7f2d656e","simply-connected",NA,NA,NA,NA
"f1c0ad8acdb995abf0f7e3ce4a94d732","simply-good-technologies","seed",NA,"2012-01-24",18000
"bd62bbdeb86443b0c169898a0c76debf","simply-measured","venture","b","2013-01-22",8e+06
"bd62bbdeb86443b0c169898a0c76debf","simply-measured","angel",NA,"2011-08-01",750000
"bd62bbdeb86443b0c169898a0c76debf","simply-measured","venture","c","2014-03-18",2e+07
"bd62bbdeb86443b0c169898a0c76debf","simply-measured","seed",NA,"2010-01-01",250000
"42910aa952dea22de34869b7053a983f","simplycast","venture","a","2009-12-01",956411
"42910aa952dea22de34869b7053a983f","simplycast","undisclosed",NA,"1999-07-02",NA
"42910aa952dea22de34869b7053a983f","simplycast","undisclosed",NA,"2000-04-24",NA
"42910aa952dea22de34869b7053a983f","simplycast","undisclosed",NA,"2002-12-31",NA
"42910aa952dea22de34869b7053a983f","simplycast","undisclosed",NA,"2009-08-14",NA
"42910aa952dea22de34869b7053a983f","simplycast","undisclosed",NA,"2013-02-25",NA
"42910aa952dea22de34869b7053a983f","simplycast","venture","B","2014-09-23",2300000
"c4b2558fa886e3e398609e91e2c295fc","simqly","seed",NA,"2015-03-01",24950.9801
"5750909752eb6535e7b7401dbdfad612","simris-alg","seed",NA,"2015-10-24",3134565.1057
"5750909752eb6535e7b7401dbdfad612","simris-alg","seed",NA,"2012-01-01",1292352
"5750909752eb6535e7b7401dbdfad612","simris-alg","seed",NA,"2013-01-01",537634
"5750909752eb6535e7b7401dbdfad612","simris-alg","seed",NA,"2014-01-01",2112894
"5750909752eb6535e7b7401dbdfad612","simris-alg","seed",NA,"2015-02-01",1300000
"5750909752eb6535e7b7401dbdfad612","simris-alg","seed",NA,"2015-04-30",569522
"b35321c13f160f51ea13724ee4adffd2","simularity","seed",NA,"2015-09-20",40000
"b35321c13f160f51ea13724ee4adffd2","simularity","seed",NA,"2014-10-31",110000
"0576ad9aa45c0ed020bdeee9e29f7120","sinapis-pharma","venture","a","2009-11-17",510000
"0576ad9aa45c0ed020bdeee9e29f7120","sinapis-pharma","venture",NA,"2010-05-19",311163
"0576ad9aa45c0ed020bdeee9e29f7120","sinapis-pharma","venture",NA,"2014-04-24",271120
"1dd83c6ccf6b318e3754100cd6af13e4","sindicetech",NA,NA,NA,NA
"9ebb7f195be66f740aeaa6c9fe2fd04f","sinewave-ventures",NA,NA,NA,NA
"81361804ea2c9339179460d01ce69bcc","single-cell-technology","debt_financing",NA,"2012-12-20",323777
"0729f28a8d6cc8f4c7abde0eead206db","singly","venture","a","2012-04-23",7e+06
"0729f28a8d6cc8f4c7abde0eead206db","singly","seed",NA,"2013-05-08",NA
"0729f28a8d6cc8f4c7abde0eead206db","singly","seed",NA,"2011-02-01",1950000
"841442fa05177c898aa681744af1f319","singular-net","seed",NA,"2014-07-17",5e+06
"8303e97db232c23af7f7c3a9ab57d775","singular-intelligence",NA,NA,NA,NA
"66e3775381a9f15ba97ca9ee75c83a9f","singulex","venture",NA,"2011-08-05",9651335
"66e3775381a9f15ba97ca9ee75c83a9f","singulex","venture","1","2006-07-17",9350000
"66e3775381a9f15ba97ca9ee75c83a9f","singulex","debt_financing",NA,"2013-09-26",4e+07
"66e3775381a9f15ba97ca9ee75c83a9f","singulex","venture","1","2009-01-12",1.9e+07
"66e3775381a9f15ba97ca9ee75c83a9f","singulex","venture","1","2007-06-07",1.9e+07
"66e3775381a9f15ba97ca9ee75c83a9f","singulex","venture","1","2013-06-28",1.5e+07
"66e3775381a9f15ba97ca9ee75c83a9f","singulex","venture","1","2012-03-15",15335540
"86128752750f51b3f1b5cf599f874eca","sinitex",NA,NA,NA,NA
"d032461b76c291464abf9884ccb210fe","sinkronigo",NA,NA,NA,NA
"fdb7fb04fc156cff5a91607055d02d67","sino-biological",NA,NA,NA,NA
"f565ce59f9b8602c983d0fc91a74d0a6","sinocare",NA,NA,NA,NA
"737ce62370b31cc78ba66e3aa6a684b8","sinocom-pharmaceutical","venture","a","2009-12-15",1.5e+07
"5dcc404c093172243b92ccdfa1f41023","sinovac-biotech","grant",NA,"2014-04-24",9600000
"677b6a6ff149924e815a808f80d54d35","siperian","venture","e","2008-01-22",2.5e+07
"771a4d92e5604b384ddd0e628c284468","sire-life-sciences",NA,NA,NA,NA
"5ec716d08a5d9b86d274f242f18d8514","sirenum",NA,NA,NA,NA
"f99edc8e1bda76cbf68f57ece17ec8e4","sirigen","venture",NA,"2010-10-01",6050871.5572
"f99edc8e1bda76cbf68f57ece17ec8e4","sirigen","venture",NA,"2008-04-30",3933430
"f99edc8e1bda76cbf68f57ece17ec8e4","sirigen","undisclosed",NA,"2009-05-14",2480852
"f99edc8e1bda76cbf68f57ece17ec8e4","sirigen","venture",NA,"2010-04-20",883621
"f99edc8e1bda76cbf68f57ece17ec8e4","sirigen","venture",NA,"2010-08-09",478793
"f99edc8e1bda76cbf68f57ece17ec8e4","sirigen","venture",NA,"2011-10-13",1177030.6394
"f99edc8e1bda76cbf68f57ece17ec8e4","sirigen","undisclosed",NA,"2012-02-17",3151707.4375
"825d85ec1f329767e2b4e799a1c86272","sirion-biotech","undisclosed",NA,"2011-06-27",NA
"825d85ec1f329767e2b4e799a1c86272","sirion-biotech","venture",NA,"2013-03-08",NA
"196175f194e740b29632ac092ff85ace","sirion-holdings","venture",NA,"2009-10-22",27684009
"196175f194e740b29632ac092ff85ace","sirion-holdings","debt_financing",NA,"2009-08-05",1500001
"65977a4c5f5086ac642c817fcbe3a66a","sirion-therapeutics","venture","B","2007-04-10",4.5e+07
"3160fe6bc7ffbcd27dde07645f0e5822","sirna-therapeutics","venture",NA,"2005-07-05",2.8e+07
"3160fe6bc7ffbcd27dde07645f0e5822","sirna-therapeutics","venture",NA,"2003-04-23",4.8e+07
"a143d19853db36b5c35fa106930ae642","sirnaomics","venture",NA,"2015-11-11",NA
"a143d19853db36b5c35fa106930ae642","sirnaomics","undisclosed",NA,"2007-12-26",NA
"63de803a0aed1dac49ad0ab513c51b57","sirona-biochem","venture",NA,"2013-03-19",24295
"52b1bf484441b9e363af1b098d7bc911","sironrx-therapeutics","venture","a","2011-08-16",3400000
"52b1bf484441b9e363af1b098d7bc911","sironrx-therapeutics","venture",NA,"2011-02-07",5e+05
"aec32c7047bba5e95c2f5f1a0573db0f","bioformix","venture","a","2012-03-13",13600000
"aec32c7047bba5e95c2f5f1a0573db0f","bioformix","venture","B","2015-04-30",NA
"aec32c7047bba5e95c2f5f1a0573db0f","bioformix","debt_financing",NA,"2015-04-30",NA
"5ee3b905109199a253f07294031522c6","sirs-lab","venture",NA,"2006-12-14",13213123.274
"6a55ac325b0c14d10ac1daf5325e147e","sirtris-pharmaceuticals","seed",NA,"2004-01-01",5e+06
"6a55ac325b0c14d10ac1daf5325e147e","sirtris-pharmaceuticals","venture","1","2004-12-01",1.3e+07
"6a55ac325b0c14d10ac1daf5325e147e","sirtris-pharmaceuticals","venture","1","2005-03-08",2.7e+07
"6a55ac325b0c14d10ac1daf5325e147e","sirtris-pharmaceuticals","venture","1","2006-04-19",3.7e+07
"c253bc28128c3fa1d87cd8b570246893","sisaf","seed",NA,"2013-10-18",757625
"26928e1e099ce60a80d1431e2f8f88d7","siscapa-assay-technologies","venture",NA,"2014-04-11",1e+06
"26928e1e099ce60a80d1431e2f8f88d7","siscapa-assay-technologies","venture",NA,"2012-08-23",562000
"ffd6f48b1f7add43b087a0a1c1521a1b","sisense","venture","D","2016-01-07",5e+07
"ffd6f48b1f7add43b087a0a1c1521a1b","sisense","venture","a","2010-07-13",4e+06
"ffd6f48b1f7add43b087a0a1c1521a1b","sisense","venture","B","2013-04-03",1e+07
"ffd6f48b1f7add43b087a0a1c1521a1b","sisense","venture","C","2014-06-12",3e+07
"c13648732c265fe85f57fc286408bf23","sispyme",NA,NA,NA,NA
"40217ce94375fc13384e45287a75b8f0","sistel-networks",NA,NA,NA,NA
"1131ac63a640efb167fabb4ad1358c54","sistemi-technologies",NA,NA,NA,NA
"d84cf6a1bc2e597f86f8fee4cf167f70","sistemic","venture","a","2010-03-17",1e+06
"48d4583897a47aef5f38b491142d0ef3","sistrix-gmbh",NA,NA,NA,NA
"f3fabd1050529fa4568ef381dd905360","sisu-labs",NA,NA,NA,NA
"97dc4266c35276394702635f5d357725","sitari-pharmaceuticals","venture","a","2013-11-22",1e+07
"29f30691846354c3acdb531674d0d4e2","siteanalysis-biz",NA,NA,NA,NA
"b5472a9a46c2ec8576222736588fd575","sitecore","venture",NA,"2011-12-01",NA
"c41f21f23f1972d247cbbfdd47e45216","siteimprove","venture",NA,"2015-12-22",5.5e+07
"247f1f4375d5f97fdf34e704e8317c3b","site-morph",NA,NA,NA,NA
"92cf206643b3ce6cc861888c5156bd91","sitening",NA,NA,NA,NA
"8a0b747136011961f397256db16bcce2","sitestatr-com",NA,NA,NA,NA
"ee8616e63b4803249240a5ece36e268d","sitewit","seed",NA,"2007-03-01",825000
"ee8616e63b4803249240a5ece36e268d","sitewit","venture","1","2013-06-16",1500000
"b60f87d106c4efb604c64bc32f60dbc8","siteworx",NA,NA,NA,NA
"8f21a300a1c0632ca2ae114422bf4c08","sitweet",NA,NA,NA,NA
"1da3f4d6a32338dcfcee3b833446ea3e","siva-therapeutics","venture",NA,"2012-12-20",4e+05
"f634bb390d604303f75bd35c1c76c713","siwa-inc",NA,NA,NA,NA
"77dcbf53047d04912bdbf7f2cdaa3b33","six-degrees-of-data","undisclosed",NA,"2013-09-01",1e+05
"1877c9907badd67080991ae45491d71c","six-voice",NA,NA,NA,NA
"219ad133770a25a274f040bc3a6c6c67","sixfacecloud-com",NA,NA,NA,NA
"632920be99a3d59bf033ef7bd507620d","sixgill",NA,NA,NA,NA
"4e0a06eb62c5be3fee00a745ba4ab3cc","sizem",NA,NA,NA,NA
"7a0655eb888168568a3e23b7840cc5da","sizeup",NA,NA,NA,NA
"ffb571e6a0f0a1d825653ac07473265c","sizzlepig",NA,NA,NA,NA
"ed6fa12b3793acd1ce99c754939eca1c","sjb-research",NA,NA,NA,NA
"49edd279e40fef7815198596b11e1619","sk-biopharmaceuticals","undisclosed",NA,"2012-03-03",NA
"397f572dd6385bc1919e7abb64a6bf54","skcript",NA,NA,NA,NA
"f389839bfcd64bb29ad3e0ae413a835d","skedastic-systems",NA,NA,NA,NA
"bed76b0d64fd13210abae9d0a114c568","skeeled-s--r-l",NA,NA,NA,NA
"34ba978987b60fd2c66f8864ef1a9bdd","skein",NA,NA,NA,NA
"1cb85a54d082ea0f354c4be00514cda7","skillpixels","venture",NA,"2014-10-07",2100000
"d20f7bd80ca10ff63fcd3bd1ffb11103","skimbox",NA,NA,NA,NA
"8c8ccaf0aaa4657dc801e072e3de0647","skin-scan","seed",NA,"2010-10-01",68630
"f46e88fa96fede3a04479cf0cfb588bd","skinmedica","venture","E","2005-04-06",1.5e+07
"f46e88fa96fede3a04479cf0cfb588bd","skinmedica","venture",NA,"2009-06-11",9438712
"3886681ed7f911f2e81521a81c496817","skiplino","seed",NA,"2015-08-01",NA
"d625f5352e0080a8f25d7bda3b6ed59b","skipstone",NA,NA,NA,NA
"992fb9fdf3ae9dd28cf2d012196ae889","skive-it-inc",NA,NA,NA,NA
"748a1404adbd9c91f53284c6e4553b27","skorboard",NA,NA,NA,NA
"5950e34504fb424e0e9ad0089df2ddbb","skroot",NA,NA,NA,NA
"2723dbcb737b9ac8e24801f2df2b46ba","skuldtech","seed",NA,"2013-09-11",1286600
"f8f6729de840a92457d3e157f479c373","skupe-net",NA,NA,NA,NA
"c7dc0f8896b3a7e4f0e1b6a56617bd29","sky-analytics",NA,NA,NA,NA
"3491fb15e05c5546705f810e33f87250","skybeam",NA,NA,NA,NA
"ccf20abf894d8ff220f0da4988cb9c2f","skybiometry",NA,NA,NA,NA
"6892273b224f136e0f37cb68e35971dc","skybuffer",NA,NA,NA,NA
"274c4570c633c31f7dc3baa40746dcef","skycache","venture",NA,"2012-04-01",1e+06
"274c4570c633c31f7dc3baa40746dcef","skycache","private_equity",NA,"2013-04-01",11258800
"1b781a8a47f98f1bb001cca972743e4a","skychat",NA,NA,NA,NA
"9453d4bd9f8817a64c32e4c1511084ac","skycision",NA,NA,NA,NA
"832f9d0d0a8e0cf1b3143683443bc372","skydisc-inc","seed",NA,"2016-01-13",848543.2351
"d36c5d17e10b7eaa0aa6d913ba28a551","skyepharma",NA,NA,NA,NA
"18c677eee20716ae29663cc2497c13ee","skyfii-limited","post_ipo_equity",NA,"2015-11-03",4e+06
"34f5785cb4afaa7457fb5d86ffbe1265","skyline","seed",NA,"2015-11-01",36000
"7d28aff24dd9ef9a1fcb12066e2d5d9c","skyline-labs-inc",NA,NA,NA,NA
"a9007213c76ba83d11a26efad16a9637","skylinx-technologies",NA,NA,NA,NA
"10297137abdd3e656031f89499a94a30","skymind","seed",NA,"2015-04-04",NA
"87b82890d2f6ca21ad7b9b861722c2e1","skyphrase","grant",NA,"2013-03-01",NA
"87b82890d2f6ca21ad7b9b861722c2e1","skyphrase","seed",NA,"2012-01-01",250000
"c8cd020dbb3fc64fddb8c7470b2263d6","skyrove",NA,NA,NA,NA
"e4122d0b757f328c3748d1c4593d2b50","skystar-bio-pharm",NA,NA,NA,NA
"e9f0d654c2cff5d5db9df9dacda8b763","skytide","venture","a","2005-08-15",6e+06
"aede3100620c18a9b890c45371c67fe0","skytree","venture",NA,"2012-10-23",1e+06
"aede3100620c18a9b890c45371c67fe0","skytree","debt_financing",NA,"2012-10-24",1075000
"aede3100620c18a9b890c45371c67fe0","skytree","seed",NA,"2012-02-23",1500000
"aede3100620c18a9b890c45371c67fe0","skytree","venture","1","2013-04-30",1.8e+07
"b14866629ae2659d0a32fcac85aeb571","sl-pathology-leasing-of-texas","venture",NA,"2010-02-11",1800000
"ae6222665a4051bbdcef8af53351b856","slamdata","convertible_note",NA,"2014-09-11",250000
"ae6222665a4051bbdcef8af53351b856","slamdata","seed",NA,"2015-07-30",3633838
"989e73baa85d765c303d7ece9a8beac8","slate",NA,NA,NA,NA
"7aad75a8aefcff0b44f421b4b1dcea6f","slate-pharmaceuticals","venture","A","2008-07-25",5e+06
"7aad75a8aefcff0b44f421b4b1dcea6f","slate-pharmaceuticals","debt_financing",NA,"2010-09-24",1990000
"7aad75a8aefcff0b44f421b4b1dcea6f","slate-pharmaceuticals","venture",NA,"2010-01-29",2787000
"cde5e779c56cd372006b020c142ea60e","sleek-machine",NA,NA,NA,NA
"597afa812342cf5b49c802dca5c82e7a","sleep-asap",NA,NA,NA,NA
"f880937351cfb1f10e0e52d6388772fd","slideflickr",NA,NA,NA,NA
"f8a15c3b90c7d3ecb944eecc6e4189b0","slife-labs",NA,NA,NA,NA
"f5330af67c41716df947052174c19eee","slik-io",NA,NA,NA,NA
"266f91aec058d79dfb17dea9ef5e8937","slingkast",NA,NA,NA,NA
"460f7c9f9e35c8c8be89fa015577ce52","slipchip","venture","B","2015-03-06",26550002
"93578f7d90e0ba1e5756a37819ba896f","sloning-biotechnology","venture","e","2007-11-01",6778810
"93578f7d90e0ba1e5756a37819ba896f","sloning-biotechnology","venture","c","2005-05-18",3912510
"cdec523a7c8d8534b9bcbe16ee8df07c","sm-ventures-inc-",NA,NA,NA,NA
"e7ec1dbd1d945d1948a15bda697605dd","smaarts-inc",NA,NA,NA,NA
"a62192356503d40896ebf36bc1658215","smart-biotech",NA,NA,NA,NA
"c6a1c73d8fe20ccfa06defb775a40759","smart-cells",NA,NA,NA,NA
"f04739967a5c6f149f3a61c6ce12e037","smart-cube","venture","a","2011-09-28",6410909
"06b7548a5811aa2a81246e750dbf5071","smart-document-scanner",NA,NA,NA,NA
"be5fa13d89a33654a351f429f721f65b","smart-host","debt_financing",NA,"2015-03-19",277500
"e8067ee6eaa6695933f7657b4c9ddf2f","smart-mocha","seed",NA,"2013-10-11",18000
"e8067ee6eaa6695933f7657b4c9ddf2f","smart-mocha","seed",NA,"2013-03-21",NA
"e8067ee6eaa6695933f7657b4c9ddf2f","smart-mocha","seed",NA,"2014-01-15",NA
"248ad39271e6777ad3d5284ed525a0e6","smart-moderation",NA,NA,NA,NA
"f459c4c97949cc93ac714998dc75c3ef","smart-picture-technologies","seed",NA,"2013-06-05",175000
"44e2411052acb5eb5e60133711886949","smart-selling-tools",NA,NA,NA,NA
"34d56165b305ebc9c1d896445a02223b","smart-sparrow","venture","b","2014-03-01",1e+07
"34d56165b305ebc9c1d896445a02223b","smart-sparrow","venture","a","2011-01-01",2e+06
"a13aca82461072bb1e6c6b2979e66e30","smart-therapeutics",NA,NA,NA,NA
"d49e84df6d305a30dfb2ccd952266743","smart-fertilizer","private_equity",NA,"2014-09-17",750000
"fd8f6273150cdd79094fca9e6091c626","smart2on",NA,NA,NA,NA
"42c9fa0a2b4d289c017d839e6b8730f5","smartaction",NA,NA,NA,NA
"0b1063f8e96e9805bbe1b05a85bd38d8","smartassistant","private_equity",NA,"2013-12-01",7e+05
"0b1063f8e96e9805bbe1b05a85bd38d8","smartassistant","private_equity",NA,"2014-12-01",1e+06
"3b86d5e1ef87b3e4966a8268f4d84511","smartbeds",NA,NA,NA,NA
"288a93ae4f7044411504114b703f3370","smartbridge",NA,NA,NA,NA
"40ab3efdd1e8c5c3160ce8372ba48f10","smartcells","debt_financing",NA,"2009-07-29",1120000
"40ab3efdd1e8c5c3160ce8372ba48f10","smartcells","venture","1","2006-05-01",NA
"40ab3efdd1e8c5c3160ce8372ba48f10","smartcells","venture","1","2008-05-01",NA
"40ab3efdd1e8c5c3160ce8372ba48f10","smartcells","venture","1","2009-05-01",4100000
"37318b739d0fdc12a667f87057f4ddd1","smartcloud-3",NA,NA,NA,NA
"280554f850a24171573885453d70f8b6","smartcommunicator",NA,NA,NA,NA
"99b341b48a9ff175d747dd1d914d462e","smartdrive-systems","venture",NA,"2011-08-11",10149887
"99b341b48a9ff175d747dd1d914d462e","smartdrive-systems","venture",NA,"2012-06-18",4.7e+07
"99b341b48a9ff175d747dd1d914d462e","smartdrive-systems","venture","1","2009-12-16",2.5e+07
"99b341b48a9ff175d747dd1d914d462e","smartdrive-systems","venture","1","2007-11-14",4.6e+07
"99b341b48a9ff175d747dd1d914d462e","smartdrive-systems","venture","1","2007-01-23",NA
"99b341b48a9ff175d747dd1d914d462e","smartdrive-systems","venture",NA,"2015-03-30",5e+07
"89caa7811b100b39369ff3673a8f5a47","smarter-remarketer","venture",NA,"2012-11-13",3325496
"89caa7811b100b39369ff3673a8f5a47","smarter-remarketer","venture",NA,"2014-02-20",7e+06
"89caa7811b100b39369ff3673a8f5a47","smarter-remarketer","debt_financing",NA,"2014-08-26",7e+06
"89caa7811b100b39369ff3673a8f5a47","smarter-remarketer","venture","1","2015-07-15",8e+06
"0d00be797ae32d9646f64963f6baabd3","smartertools",NA,NA,NA,NA
"6ee7f812f6c6fe3ba0638a67621cf1d5","smartflow-technologies","seed",NA,"2011-08-11",8e+05
"6ee7f812f6c6fe3ba0638a67621cf1d5","smartflow-technologies","venture",NA,"2009-12-03",4373434
"6ee7f812f6c6fe3ba0638a67621cf1d5","smartflow-technologies","debt_financing",NA,"2009-11-25",2500000
"6643999beb56b97555b55e4250d83a5f","smartfocus-digital",NA,NA,NA,NA
"49150d9238329bc7b67fd3810f26886c","smartifik",NA,NA,NA,NA
"53bf62577150c45da472a5b76fe726dd","smart-insight-corporation","venture","C","2015-07-27",4099999
"e78d7e57cc12f48fe6e8254e838fa641","smartkarma","seed",NA,"2015-01-15",NA
"36ecaff1426bb79fe972c946653ee1ab","smartlet-co",NA,NA,NA,NA
"d577ca02f10ab76f5e5619e3551ccb86","smartly-io","venture","A","2015-04-30",2775372
"87b2976de0ad2d6cd8dc883b243cf745","smartprocure","venture","a","2013-06-01",1300000
"87b2976de0ad2d6cd8dc883b243cf745","smartprocure","seed",NA,"2012-05-01",5e+05
"87b2976de0ad2d6cd8dc883b243cf745","smartprocure","grant",NA,"2013-08-05",25000
"87b2976de0ad2d6cd8dc883b243cf745","smartprocure","venture","B","2014-12-06",NA
"dce0c34c0f842c702efbcd19df425d9d","cloudshopper",NA,NA,NA,NA
"f0c4d5065ea4c1c8811b6b5215db9d3c","transilio","venture","A","2013-08-01",3700000
"f0c4d5065ea4c1c8811b6b5215db9d3c","transilio","debt_financing",NA,"2015-07-21",2459222
"f0c4d5065ea4c1c8811b6b5215db9d3c","transilio","venture","A","2014-04-25",3300000
"301f520d29d22dbcb719f407a42af50e","smartuq","venture",NA,"2014-12-11",1789560
"3fa5658c78ec48d40f59ee7417c47456","smartvest",NA,NA,NA,NA
"3f8ed9f65be80b47ba98a70a9616b12d","smartvid-io","seed",NA,"2015-08-03",3400000
"9a28933a326a5e9fffb98075bb550272","smartzip","venture","a","2009-03-10",2050000
"9a28933a326a5e9fffb98075bb550272","smartzip","venture",NA,"2010-04-19",4500000
"9a28933a326a5e9fffb98075bb550272","smartzip","venture","B","2014-07-23",1.2e+07
"7f46d01ca26df2e1888ad3b5f3260511","smartzyme","venture",NA,"2015-10-27",4e+06
"01b7bf37026f8fe29e3d99142120d16f","smb-engine",NA,NA,NA,NA
"bd139f7fa77c96328a8b965cef473a01","smbscorecard",NA,NA,NA,NA
"6d2e71a546ed3c4cce74e74efb925213","smeebi",NA,NA,NA,NA
"d2d9397c1d839ccf047e078fbbfb464a","convonix",NA,NA,NA,NA
"ea5e5afa5255f2e8a0f43056031c3338","smileygo","angel",NA,"2015-05-01",5e+05
"ea5e5afa5255f2e8a0f43056031c3338","smileygo","seed",NA,"2015-04-06",NA
"9729218028460bef404e935799e01e61","smisson-cartledge-biomedical","venture",NA,"2011-11-17",316595
"9729218028460bef404e935799e01e61","smisson-cartledge-biomedical","debt_financing",NA,"2012-05-21",1e+06
"9729218028460bef404e935799e01e61","smisson-cartledge-biomedical","debt_financing",NA,"2012-07-27",2e+06
"9729218028460bef404e935799e01e61","smisson-cartledge-biomedical","venture",NA,"2010-12-16",116397
"8b7bed5395ffd0e4462ba70e487cddd6","ascentium","undisclosed",NA,"2009-08-05",NA
"f8488422e8e4e9fc651eb74d0f636ce8","smith-nephew",NA,NA,NA,NA
"8f20429c0ddfa9fc854c82a3fb21f528","smith-and-nephew-orthopedics",NA,NA,NA,NA
"243eeef813dceb635edfb4f78377f516","smithers-avanza","venture",NA,"2010-01-05",620000
"309c9dde00930702a2ec047ad37ac975","smithkline-french-laboratories",NA,NA,NA,NA
"1b38a542939aae9bb1d329314b9c9949","smithkline-and-french",NA,NA,NA,NA
"1e763b64df002ab7000a992b852c0cb6","smithkline-beecham-corporation",NA,NA,NA,NA
"fb3e2521c542898e17d1a8b57710a915","smoobility",NA,NA,NA,NA
"f65f9f9f7a96e919ac8d5c7f5f81a73b","smpl-bio",NA,NA,NA,NA
"2e4ff41c83cb76c97054df3a50db8424","smrt-mouth",NA,NA,NA,NA
"8d054d9fde2df922b3ab01853772afa7","smsa-crane-acquisition","venture",NA,"2014-02-27",3372371
"cf4d40904f99a9cd5bcdfae78c674b13","smsboy-com",NA,NA,NA,NA
"b31575ba60e3c14eaee69c66404272be","smsgroup",NA,NA,NA,NA
"07cee28f99cf9e7db0900f72917dd890","smync","seed",NA,"2015-10-23",NA
"d3bbe5c66cfe5e918942cfee9792632e","sna-consulting",NA,NA,NA,NA
"702ca40658324bdf266e21e51efa2004","snackablenews","seed",NA,"2015-01-10",50000
"56610d60266765162eba512964b7d33f","snap40",NA,NA,NA,NA
"ee536885ce7cafb94dd5f9a5c1594578","appedu","venture",NA,"2015-10-02",NA
"ee536885ce7cafb94dd5f9a5c1594578","appedu","seed",NA,"2015-08-19",1800000
"02488154d7481dca3631202927409b55","snapcart","seed",NA,"2016-01-05",1675000
"02488154d7481dca3631202927409b55","snapcart","seed",NA,"2015-03-01",NA
"dd86a04e2af86c8aa32ae60dcadd06a5","snap-engage",NA,NA,NA,NA
"53bc4874c8364b694107a099c2dc1b59","snapkinapp",NA,NA,NA,NA
"fd543124209f67405aa29fa8dea259be","snaplogic","venture","E","2015-12-10",37500000
"fd543124209f67405aa29fa8dea259be","snaplogic","venture","a","2007-05-22",2500000
"fd543124209f67405aa29fa8dea259be","snaplogic","venture",NA,"2014-04-02",1999999
"fd543124209f67405aa29fa8dea259be","snaplogic","venture","a","2009-10-29",2300000
"fd543124209f67405aa29fa8dea259be","snaplogic","venture","b","2010-10-29",1e+07
"fd543124209f67405aa29fa8dea259be","snaplogic","venture","c","2012-09-19",2e+07
"fd543124209f67405aa29fa8dea259be","snaplogic","venture",NA,"2014-07-22",1999999
"fd543124209f67405aa29fa8dea259be","snaplogic","venture","D","2014-10-21",2e+07
"55177b725eea36f0d4da5c051a87975f","snaplytics",NA,NA,NA,NA
"7b75be5a2867b3e9dcc08583d1cda992","snapretail","venture","a","2011-02-25",6e+06
"7b75be5a2867b3e9dcc08583d1cda992","snapretail","venture",NA,"2014-05-14",4800000
"7b75be5a2867b3e9dcc08583d1cda992","snapretail","venture",NA,"2015-01-02",1050000
"650986ac12bd8b4c9175f187a6e3fc2d","snapscore-me",NA,NA,NA,NA
"c82565ebd926ecb6c36ae261cf04960d","snapshot-gmbh","venture","B","2015-07-01",27838403.6346
"c82565ebd926ecb6c36ae261cf04960d","snapshot-gmbh","seed",NA,"2014-04-01",2203613
"594b1b955cdc7070f2efdb1f60ab889f","snaptivity","seed",NA,"2015-12-10",NA
"2c56b59af9b958f26dc8413b7c5719ca","snapwire","seed",NA,"2015-07-01",NA
"67e88d25a66dc1435ab60d03ce7bb040","snipd","seed",NA,"2008-06-01",15000
"809c88fd36d247644892e7495425e53b","snipp-interactive","venture",NA,"2015-07-01",6817616
"eea6988da421c067c82df8508b12142d","snowplow-analytics",NA,NA,NA,NA
"a7ff376571e37f08242508c685516385","sntmnt","seed",NA,"2012-03-23",50000
"519f4c6face3f857753c05efe8aaaa39","so1-gmbh","venture","a","2013-08-27",NA
"c7f008a2292245edf80d45e8c0c394e1","socal-patient-association","equity_crowdfunding",NA,"2014-11-28",5000
"6689ae0da2f7b980f9990fd62f8e3acb","socedo","venture",NA,"2016-01-12",1500000
"6689ae0da2f7b980f9990fd62f8e3acb","socedo","venture",NA,"2015-03-09",NA
"684383ba904596683c8d6a1203860072","sociable","venture","b","2011-10-26",7e+06
"684383ba904596683c8d6a1203860072","sociable","venture","a","2009-12-31",NA
"b55125808922bbd2ba1b410ed6cbd49d","sociack",NA,NA,NA,NA
"8ae05f157ddf00665a958dd859f340cb","social-alpha",NA,NA,NA,NA
"f18baa8b6438f73c159d5644097e9958","social-amp",NA,NA,NA,NA
"118f877c4bd58d790ba6c36565959ab5","social-arcade",NA,NA,NA,NA
"cf193e367b3d112e83be9da744baa1af","social-change-rewards","venture",NA,"2015-11-30",2e+06
"76487b890a40bb7123d36705ba4f25ea","social-elephants",NA,NA,NA,NA
"2b960f89dd08dd446a0868ec83a7975d","social-gaming-platform",NA,NA,NA,NA
"57d03f29581e146f5dc3a36aee50fb22","social-honey",NA,NA,NA,NA
"86258ef4c7ba2abd1f6d25d20f75edfe","social-insight-2",NA,NA,NA,NA
"4ee4f7a64abace7b5d6788a01828ed21","social-media-broadcasts-smb-limited","convertible_note",NA,"2013-09-01",850000
"4ee4f7a64abace7b5d6788a01828ed21","social-media-broadcasts-smb-limited","seed","1","2015-09-23",1e+06
"1eff1265f18a4ecf9e67356b4ec7327f","social-media-influence",NA,NA,NA,NA
"e1a5468b2cae82e261c1da0ef65dbd4b","social-status","seed",NA,"2015-10-21",412000
"e1a5468b2cae82e261c1da0ef65dbd4b","social-status","seed",NA,"2014-10-29",NA
"e55ad7656b59a1f4c6b325a19ccce4b2","social-strategi",NA,NA,NA,NA
"85001600de7a7c334539bc79755d5072","social-3",NA,NA,NA,NA
"7343b7d0ea1bb14534137cbd74930223","socialbakers","venture","b","2012-11-19",6e+06
"7343b7d0ea1bb14534137cbd74930223","socialbakers","venture","c","2014-02-18",2.6e+07
"7343b7d0ea1bb14534137cbd74930223","socialbakers","venture","a","2011-09-29",2e+06
"fed333e5275474131e3d5939d70541d2","socialbro","seed",NA,"2012-11-21",640250
"fed333e5275474131e3d5939d70541d2","socialbro","venture","1","2013-06-06",1800000
"fed333e5275474131e3d5939d70541d2","socialbro","angel",NA,"2012-10-24",829278
"fed333e5275474131e3d5939d70541d2","socialbro","seed",NA,"2011-11-16",NA
"5974b115ca8de10e6ee82c3b2a836d20","socialcode",NA,NA,NA,NA
"e440a781b1a12c2d0162b430f989f915","socialcompare","angel",NA,"2010-11-19",NA
"e4c7bb1d2666ccb3fe761e830d951b9d","socialdek",NA,NA,NA,NA
"4b55fcb8d0e6493a68706c8b5f091f41","socialexpress","seed",NA,"2012-04-04",19871
"4b55fcb8d0e6493a68706c8b5f091f41","socialexpress","seed",NA,"2013-03-27",319200
"48ce03c5cae137952ef7405cb48d9ef4","socialization-me",NA,NA,NA,NA
"e6d2dc1631d8b1524426b94b31f0a367","socialmart","grant",NA,"2011-06-24",50000
"e6d2dc1631d8b1524426b94b31f0a367","socialmart","seed",NA,"2013-04-18",150000
"31826c458838d10ea298591ebeb8bd1a","socialmatterz",NA,NA,NA,NA
"473f057a085027d657ead5b4c0e60032","socialmetrix",NA,NA,NA,NA
"f28d69fe5521ae52ec8b7b1f51fd7492","socialq",NA,NA,NA,NA
"eea1dee80d913ca81372d4d7c25ae6d1","socialrank","convertible_note",NA,"2015-12-01",925000
"eea1dee80d913ca81372d4d7c25ae6d1","socialrank","seed",NA,"2014-05-13",1150000
"8aec847858e33a3a32dba7d93956675b","socialrest",NA,NA,NA,NA
"0a92e75fc82664f85dc00de3afba8da3","socialscape",NA,NA,NA,NA
"fd4c27908cc0534d9d9435bec42fc361","socialsearch",NA,NA,NA,NA
"1242e96d820329c3525709797c061a82","socialtoo",NA,NA,NA,NA
"a7670ce066df729a3e935acc24db2805","socialtyze","venture","a","2010-01-01",1500000
"70a347c9b0f20c8ff763b549a43080b3","socialyzer",NA,NA,NA,NA
"0f2d4d7469fe11dc37bb27f14746275f","socilyzer",NA,NA,NA,NA
"cc69359b910773fd73e88f8574fd777f","sociolus",NA,NA,NA,NA
"9a13ba85ecd3b3861abab467d0b2c5f7","socital","seed",NA,"2014-09-10",235000
"cf9b7eed8b2d4a8457274286fee14a49","socrata","venture","b","2013-06-26",1.8e+07
"cf9b7eed8b2d4a8457274286fee14a49","socrata","venture","A","2008-01-31",6500000
"cf9b7eed8b2d4a8457274286fee14a49","socrata","venture","C","2014-11-25",3e+07
"5be0e276b539447a290a5983532ea058","socset","seed",NA,"2013-12-13",10000
"294b7d8ae8ecef88da4c9d8764415e46","socure","venture","A","2014-06-25",2200000
"294b7d8ae8ecef88da4c9d8764415e46","socure","venture","A","2014-10-28",2500000
"294b7d8ae8ecef88da4c9d8764415e46","socure","debt_financing",NA,"2015-08-04",2500000
"f96aada3a802a2902a283090bf709e3d","sofie-biosciences","venture","a","2013-10-15",5e+06
"f96aada3a802a2902a283090bf709e3d","sofie-biosciences","seed",NA,"2010-12-08",2e+06
"f96aada3a802a2902a283090bf709e3d","sofie-biosciences","grant",NA,"2014-10-17",1500000
"b643049161e56f4d3a6d47be86fda0a3","softbrands",NA,NA,NA,NA
"0e0e433b6f7d4fa92f8220e8f9d9d6da","softcrylic-llc",NA,NA,NA,NA
"a298980cd74ebf9ef570cad9b3ec6740","softek-storage-solutions",NA,NA,NA,NA
"e3dbb5441f25d75091ed1f0925ba25b2","softheon","venture",NA,"2009-03-14",2e+05
"aa6123595ca8ef68540067a4975659d5","softlanding-labs","debt_financing",NA,"2012-04-16",250000
"dddca1579d0a93c497c495a1ef2199a0","softvu",NA,NA,NA,NA
"28c5b9eb35c29eec970d7dc4a8e4c155","sogamo",NA,NA,NA,NA
"b9e2fd3fffb934f08de430ba51a60b02","sohalo","seed",NA,"2011-09-01",2600000
"b9e2fd3fffb934f08de430ba51a60b02","sohalo","venture","1","2013-06-01",3300000
"b9e2fd3fffb934f08de430ba51a60b02","sohalo","venture","1","2013-12-01",1e+07
"b000261e6493db57399b58602c1f318a","sohm","venture",NA,"2012-06-13",95000
"6065e043ac5b3b2094d3092a9a3fcb48","soilqualitylab",NA,NA,NA,NA
"c3890b6a89180b51147a2da1d1de9e23","soil-scout",NA,NA,NA,NA
"58827e06c456502c4a6c743cc2a33aff","soko-insight","seed",NA,"2015-11-13",12000
"0ea4d191145990dba885fbb00042a755","sokrati","venture","a","2011-03-09",1030000
"0ea4d191145990dba885fbb00042a755","sokrati","venture","B","2015-01-10",NA
"0ba649a7d72331e502818f3c0f825c5b","sol-elixirs","venture",NA,"2009-08-28",762500
"cc86152f62c96cf7df46757dc18979fa","solaeromed","seed",NA,"2015-11-03",NA
"cc86152f62c96cf7df46757dc18979fa","solaeromed","venture",NA,"2013-11-25",101035
"6f71dff8a669a18dc879c910826b8e8a","solana-surgical",NA,NA,NA,NA
"d82f236ed98cfe527921cdd7b9f086be","solavista","seed",NA,"2008-10-01",250000
"a7376074b358c4917daa894262432ac1","sold","seed",NA,"2012-06-01",NA
"e0b255f7756ad6a51ec851bfc9d815e1","soldthru",NA,NA,NA,NA
"7495c6ebb4f5a3b0c7e775c042c4ef15","solera-health-inc","venture","A","2015-11-03",3e+06
"8094135644102039b690448967bc1cb8","solera-networks","venture","b","2006-09-01",3900000
"8094135644102039b690448967bc1cb8","solera-networks","venture","b","2008-03-27",5e+06
"8094135644102039b690448967bc1cb8","solera-networks","venture","b","2009-04-15",7e+06
"8094135644102039b690448967bc1cb8","solera-networks","venture","d","2012-01-30",2e+07
"8094135644102039b690448967bc1cb8","solera-networks","venture","c","2010-07-26",1.5e+07
"8094135644102039b690448967bc1cb8","solera-networks","venture","a","2005-01-01",8e+05
"8094135644102039b690448967bc1cb8","solera-networks","venture","C","2008-12-18",7e+06
"a008bed72d0757857810b546dc168e88","solexa","private_equity",NA,"2006-09-20",7.5e+07
"a008bed72d0757857810b546dc168e88","solexa","private_equity",NA,"2005-11-21",6.5e+07
"a008bed72d0757857810b546dc168e88","solexa","private_equity",NA,"2005-04-22",32500000
"0adea056bd86327806234c275e489c34","solid-biosciences","venture","B","2015-11-03",42500000
"457e8a89a51d70d139e3b4120731715a","solidagex","debt_financing",NA,"2014-01-16",215000
"457e8a89a51d70d139e3b4120731715a","solidagex","seed",NA,"2012-01-06",1e+05
"e0976be1842c0081d46bf7e67d627703","soliday-telehealth",NA,NA,NA,NA
"ce33c06762ef1cab00ac4b932c68373d","solidi-storage",NA,NA,NA,NA
"7d35c2dfe27b708faad81b67c8671c40","solidq",NA,NA,NA,NA
"a6aaf54144f0f5225af4c3fca6eb5c70","solidware-2","seed",NA,"2014-10-01",NA
"99cdcfe0c6899f42c38a1eb03709810b","soligenix","undisclosed",NA,"2015-08-03",1e+07
"99cdcfe0c6899f42c38a1eb03709810b","soligenix","venture",NA,"2009-02-03",2384200
"99cdcfe0c6899f42c38a1eb03709810b","soligenix","grant",NA,"2014-02-16",3e+05
"99cdcfe0c6899f42c38a1eb03709810b","soligenix","seed",NA,"2013-05-03",1500000
"99cdcfe0c6899f42c38a1eb03709810b","soligenix","venture",NA,"2009-02-25",4500000
"99cdcfe0c6899f42c38a1eb03709810b","soligenix","post_ipo_equity",NA,"2013-06-26",7100000
"99cdcfe0c6899f42c38a1eb03709810b","soligenix","venture",NA,"2010-07-02",5904277
"a0bab98dbe30402a7f9e2928fde5e769","solink",NA,NA,NA,NA
"a1bd9b0132413755a269602bc243fcda","solivar-labs",NA,NA,NA,NA
"e3c3e76ca171d2232c0fb7c9e1ecffed","solomo-media",NA,NA,NA,NA
"2c36569f5bdab69db081849490169272","solomon-consulting",NA,NA,NA,NA
"8f697567ed525c6281f7ebf26df39135","solos-endoscopy","venture",NA,"2009-10-06",88000
"cbcc48576ff890fae3ee4faebbadaedc","solstas-lab-partners",NA,NA,NA,NA
"bcbe27a36dcced88ef9f1aa0a2a6e59d","solstice-biologics","venture","C","2015-12-30",4e+06
"bcbe27a36dcced88ef9f1aa0a2a6e59d","solstice-biologics","venture","a","2013-01-04",1.8e+07
"bcbe27a36dcced88ef9f1aa0a2a6e59d","solstice-biologics","private_equity",NA,"2012-12-28",7500000
"bcbe27a36dcced88ef9f1aa0a2a6e59d","solstice-biologics","private_equity",NA,"2012-12-12",3e+06
"bcbe27a36dcced88ef9f1aa0a2a6e59d","solstice-biologics","venture","B","2014-10-02",7500000
"cd5b9ad24d48d54a227530b68c964842","solstice-neurosciences","venture","b","2006-11-08",8.5e+07
"cd5b9ad24d48d54a227530b68c964842","solstice-neurosciences","venture",NA,"2005-07-01",8e+06
"65948eea405f4f47969b10485d77865b","solulink","venture",NA,"2010-12-01",NA
"65948eea405f4f47969b10485d77865b","solulink","debt_financing",NA,"2011-11-21",1e+06
"65948eea405f4f47969b10485d77865b","solulink","debt_financing",NA,"2013-12-02",430000
"65948eea405f4f47969b10485d77865b","solulink","debt_financing",NA,"2011-03-01",1460000
"0428e009d0daa4947825e24059b0a990","solus-biosystems","venture",NA,"2008-08-11",8e+05
"ddd2300f9e5c03f03216a51ab99e485b","solus-scientific-solutions","venture",NA,"2012-01-03",1090863
"fafc08ab1c673f966bf16aee05ccadf8","solution-dynamics-group","equity_crowdfunding",NA,"2014-03-05",NA
"58472aa4d7e477e82cc17ce0aea472be","solutionpath-limited",NA,NA,NA,NA
"ecab4f656a920c527bb55099470b06af","solvay-pharmaceuticals",NA,NA,NA,NA
"4b788db0b70c55b5e81c04a5bb85c6c5","solvebio","seed",NA,"2015-09-01",NA
"4b788db0b70c55b5e81c04a5bb85c6c5","solvebio","seed",NA,"2014-05-13",2e+06
"4a7b2643f60931e16e1ff03fb4c3e168","solvo-biotechnology",NA,NA,NA,NA
"9149e34c981b304f327a348381a19811","solynta",NA,NA,NA,NA
"82c5977fb192a7ddac69b638c80f9816","somae-health","venture",NA,"2010-03-17",82338
"82c5977fb192a7ddac69b638c80f9816","somae-health","venture",NA,"2009-10-15",45000
"828c030d0f0566626d63f3242b1645ec","somalogic","venture",NA,"2013-08-21",1e+07
"828c030d0f0566626d63f3242b1645ec","somalogic","venture","1","2010-11-17",14999998
"828c030d0f0566626d63f3242b1645ec","somalogic","venture","1","2010-08-20",4999995
"828c030d0f0566626d63f3242b1645ec","somalogic","grant",NA,"2014-06-04",1e+06
"828c030d0f0566626d63f3242b1645ec","somalogic","venture",NA,"2014-11-17",16500000
"d23eaf7c1c53037c1f84fa84a962379f","somanta-pharmaceuticals","venture",NA,"2005-08-22",1250000
"d23eaf7c1c53037c1f84fa84a962379f","somanta-pharmaceuticals","venture",NA,"2006-01-31",3670000
"37d1a6489915d264e85c914b4eb4d445","somark-innovations","undisclosed",NA,"2009-02-02",NA
"37d1a6489915d264e85c914b4eb4d445","somark-innovations","debt_financing",NA,"2012-02-01",3e+05
"e9d2b5df928ad2c5a3a36fed0561ad5f","somarus-inc",NA,NA,NA,NA
"2218cf5224139f48781dee94ecf6d04e","somatix","seed",NA,"2015-04-22",750000
"7ee8046cd17c872b1519f074330f7f89","somatix-therapy-corp",NA,NA,NA,NA
"f47598f957564aef5650867152597053","somatogen-inc",NA,NA,NA,NA
"c8b921ad0a5db1d15d04850cb284240e","somaxon-pharmaceuticals","venture","C","2005-06-06",6.5e+07
"c8b921ad0a5db1d15d04850cb284240e","somaxon-pharmaceuticals","venture",NA,"2009-07-08",5999990
"078ee3b0d7250b5b39cba825d11bf917","somerset-outpatient-surgery","venture",NA,"2009-06-08",580000
"078ee3b0d7250b5b39cba825d11bf917","somerset-outpatient-surgery","venture",NA,"2015-09-03",463770
"991c52e6716bdbdc817203668d351940","sometrics","venture","B","2009-10-16",4e+06
"991c52e6716bdbdc817203668d351940","sometrics","venture","a","2009-02-12",NA
"991c52e6716bdbdc817203668d351940","sometrics","venture","a","2008-05-14",1550000
"5231015f7ea4a682b84bdab31e9bcde9","somewrite","venture",NA,"2014-10-10",1100000
"af2265589d2bf32e92b9672f19077ce2","sommer-pharmaceuticals","venture",NA,"2010-10-14",750000
"7b4c4139af91b8026bff6c45300a6f1a","somnus-therapeutics","venture","a","2010-02-11",1.5e+07
"6808ace8bfe4f0daf0643ab973b1224a","sonamine",NA,NA,NA,NA
"1c2c77ce7202438831629bae3808ef52","sonarmed","venture","A","2010-09-16",1e+06
"1c2c77ce7202438831629bae3808ef52","sonarmed","debt_financing",NA,"2012-06-13",585000
"1c2c77ce7202438831629bae3808ef52","sonarmed","venture",NA,"2014-05-05",2622258
"1c2c77ce7202438831629bae3808ef52","sonarmed","venture",NA,"2015-01-07",1282534
"f2da8b732974547ad1c80ac6037ac1e7","sonata",NA,NA,NA,NA
"68c6f3d53e27fedcd4d0296212e7f88e","sonavex","venture",NA,"2015-10-19",320192
"68c6f3d53e27fedcd4d0296212e7f88e","sonavex","debt_financing",NA,"2015-06-29",315000
"68c6f3d53e27fedcd4d0296212e7f88e","sonavex","grant",NA,"2015-03-15",225000
"68c6f3d53e27fedcd4d0296212e7f88e","sonavex","grant",NA,"2015-06-30",150000
"68c6f3d53e27fedcd4d0296212e7f88e","sonavex","grant",NA,"2013-08-15",335000
"0d2cdec481d707b56a26b10897ea9d48","sonda41","seed",NA,"2012-06-01",NA
"61b0bab9d0460612bf05102469f936d1","sonendo","debt_financing",NA,"2009-06-11",718000
"61b0bab9d0460612bf05102469f936d1","sonendo","debt_financing",NA,"2014-03-24",1e+07
"61b0bab9d0460612bf05102469f936d1","sonendo","venture",NA,"2011-08-10",5931874
"61b0bab9d0460612bf05102469f936d1","sonendo","venture",NA,"2008-11-26",5e+05
"61b0bab9d0460612bf05102469f936d1","sonendo","venture","1","2012-06-28",9200000
"61b0bab9d0460612bf05102469f936d1","sonendo","venture","1","2013-06-04",1.8e+07
"61b0bab9d0460612bf05102469f936d1","sonendo","venture","1","2014-09-04",3.5e+07
"43a918e0170fe4dae0e8f22c4bf1ff91","sonexa-therapeutics","venture","a","2008-01-31",3e+07
"43a918e0170fe4dae0e8f22c4bf1ff91","sonexa-therapeutics","venture","a","2010-04-07",7e+06
"43a918e0170fe4dae0e8f22c4bf1ff91","sonexa-therapeutics","venture",NA,"2011-10-17",1e+06
"43a918e0170fe4dae0e8f22c4bf1ff91","sonexa-therapeutics","debt_financing",NA,"2012-08-02",1999995
"43a918e0170fe4dae0e8f22c4bf1ff91","sonexa-therapeutics","debt_financing",NA,"2012-04-03",1224992
"dcbeee5e773e2e1ab37ef1c52cb9e5a5","sonicanalytics",NA,NA,NA,NA
"850b845d88aab1efa04298418615fb84","sonivate-medical","venture",NA,"2011-02-07",130000
"850b845d88aab1efa04298418615fb84","sonivate-medical","venture",NA,"2013-06-12",760000
"850b845d88aab1efa04298418615fb84","sonivate-medical","debt_financing",NA,"2014-05-13",125000
"850b845d88aab1efa04298418615fb84","sonivate-medical","equity_crowdfunding",NA,"2012-02-29",NA
"38abe7e3014d2700a2f5e7a5a9d983e8","sonogenix","venture",NA,"2011-08-02",250000
"6a2c8df87f35b08c662fb2fbb4dc977b","sonoma-orthopedics","debt_financing",NA,"2010-11-03",1492968
"6a2c8df87f35b08c662fb2fbb4dc977b","sonoma-orthopedics","venture","1","2011-02-14",2.2e+07
"6a2c8df87f35b08c662fb2fbb4dc977b","sonoma-orthopedics","venture","1","2007-05-21",1e+07
"6a2c8df87f35b08c662fb2fbb4dc977b","sonoma-orthopedics","venture","1","2009-04-06",1.2e+07
"6a2c8df87f35b08c662fb2fbb4dc977b","sonoma-orthopedics","venture","1","2014-12-17",1.2e+07
"df072b1c725431778d288e5a3374cb47","sonosite",NA,NA,NA,NA
"7a46dc71990039cef41fff8a223551b9","rgenerator-sony-dadc",NA,NA,NA,NA
"c5e01de2a3d0de5e3da87fc41c3a4218","sooam-biotech",NA,NA,NA,NA
"318c5c51511a76e80a81e33cba011659","sookmook-future-informatics-foundation",NA,NA,NA,NA
"7aa18f71ba5e738abdb91e194a04fc9e","soothsayer-app",NA,NA,NA,NA
"172848e7bff165cec3f8b83bc28986cb","sopatec","venture","a","2013-02-04",NA
"0fae5baeb73ea635df456ec91c835f04","sophatar",NA,NA,NA,NA
"0138012c4472bfc56003934c6c1b13ed","sophia-genetics","venture","C","2015-12-16",1.5e+07
"0138012c4472bfc56003934c6c1b13ed","sophia-genetics","venture","B","2014-07-07",13750000
"34ac933c8da82b97cf256c332665a75c","sophion-bioscience",NA,NA,NA,NA
"7f2fc84056432c018c6ade7870ece8f0","sophiris-bio","venture",NA,"2010-04-15",226398
"7f2fc84056432c018c6ade7870ece8f0","sophiris-bio","venture",NA,"2010-09-29",3.5e+07
"7f2fc84056432c018c6ade7870ece8f0","sophiris-bio","venture",NA,"2014-05-17",2e+06
"e9433e91908891ba8b966d2b4e8d0978","sopreso","seed",NA,"2013-12-01",NA
"90d80a7ec7fc4d34358867bd75ece405","soprex",NA,NA,NA,NA
"342f01309647c777acbdc4940868dba6","sorbent-therapeutics","venture",NA,"2012-08-08",18056217
"342f01309647c777acbdc4940868dba6","sorbent-therapeutics","venture","1","2010-09-13",21800000
"342f01309647c777acbdc4940868dba6","sorbent-therapeutics","venture","1","2011-06-30",3.6e+07
"342f01309647c777acbdc4940868dba6","sorbent-therapeutics","venture",NA,"2013-04-01",2533000
"342f01309647c777acbdc4940868dba6","sorbent-therapeutics","debt_financing",NA,"2012-06-11",6e+06
"342f01309647c777acbdc4940868dba6","sorbent-therapeutics","venture","1","2014-05-15",6500000
"7279d8b6f5e324cdf4da6d0de89a9a9e","soreon-research",NA,NA,NA,NA
"361a4479eea505b29bcfde7ff8cc6c78","sorezki",NA,NA,NA,NA
"2d6904af7e645c74abcee8d8ddda9e5f","soricimed","seed",NA,"2011-10-18",109000
"d0213b1741ffa448231d803e472406fc","sorin-group",NA,NA,NA,NA
"fecb203832fb1f1f3e356b0d4091956d","sorrento-therapeutics","post_ipo_equity",NA,"2013-10-25",3e+07
"fecb203832fb1f1f3e356b0d4091956d","sorrento-therapeutics","venture",NA,"2012-01-11",2e+06
"fecb203832fb1f1f3e356b0d4091956d","sorrento-therapeutics","venture",NA,"2009-06-19",2300000
"fecb203832fb1f1f3e356b0d4091956d","sorrento-therapeutics","venture",NA,"2013-03-28",6418495
"fecb203832fb1f1f3e356b0d4091956d","sorrento-therapeutics","debt_financing",NA,"2013-10-22",1850000
"01aa229455ce4b6032ad6ef7fa21128a","sortex",NA,NA,NA,NA
"1255420cdfea2c6d9ec7847b34644183","sosei","undisclosed",NA,"2004-09-01",52065215
"47986c85a0de14541f079149ff3a387a","soshio",NA,NA,NA,NA
"67c04b98cfdecd2464b93a74e17d2029","sosho",NA,NA,NA,NA
"39041e626b24ae8d13474cea947e832c","sosventures",NA,NA,NA,NA
"754490bd4c3a749ea3e5f06adce43053","sota-solutions-gmbh-2","seed",NA,"2012-12-10",NA
"7210c5e5bbf8ae93dd94b26420de31db","sothic-bioscience-limited","seed",NA,"2015-04-30",50000
"2eef51324a2250cdd69011156829dad2","sotio",NA,NA,NA,NA
"adf46f63bbe1e31b86ed94fd2c58512f","sotrender","venture",NA,"2015-02-01",450000
"f73161ecbbd99b950278069d38f7206e","sound-pharmaceuticals","venture","c","2013-10-16",1.5e+07
"f73161ecbbd99b950278069d38f7206e","sound-pharmaceuticals","venture",NA,"2012-12-17",1515105
"f73161ecbbd99b950278069d38f7206e","sound-pharmaceuticals","debt_financing",NA,"2015-08-19",3e+05
"387b13fe5b2a6448d664076a3550b160","soundwave","venture",NA,"2013-07-01",9e+05
"387b13fe5b2a6448d664076a3550b160","soundwave","seed",NA,"2012-10-02",1e+06
"387b13fe5b2a6448d664076a3550b160","soundwave","seed",NA,"2012-02-01",NA
"387b13fe5b2a6448d664076a3550b160","soundwave","venture",NA,"2014-07-01",1e+06
"02eb98fdfce422ea3b922c0c728552c6","source-mdx","venture","b","2010-02-23",1509123
"02eb98fdfce422ea3b922c0c728552c6","source-mdx","debt_financing",NA,"2010-08-26",5e+05
"47bdc3c9623ff3a1717441acde49341c","sourcemedia",NA,NA,NA,NA
"57b94f5c0ed1e3f0cf4952a56882512c","southern-implants","venture",NA,"2009-06-09",3e+06
"57b94f5c0ed1e3f0cf4952a56882512c","southern-implants","venture",NA,"2010-06-18",2e+06
"0434a4961af7e1ae879f38893c4faad0","souzhou-ribo-life-science","venture","a","2014-01-07",7400000
"ddc376571cf4fb5561f07090fe9b9fd9","sov-therapeutics","venture",NA,"2010-02-18",2e+05
"ddc376571cf4fb5561f07090fe9b9fd9","sov-therapeutics","venture",NA,"2011-11-21",225000
"adc4de61e1ca8854df1c7ff52cbab286","sovereign-intelligence-llc-2","angel",NA,"2015-07-01",2100000
"bde2e4241a5b6f48864a9d447d79d1cd","sovi","seed",NA,"2014-03-01",20000
"5d2160a5cbe3d03afba1536533b81e1e","sovicell","undisclosed",NA,"2009-05-14",NA
"5d2160a5cbe3d03afba1536533b81e1e","sovicell","venture","1","2007-03-01",1190000
"6f7cc9e4910e100ac47f0e0717a3d0f6","sowingo",NA,NA,NA,NA
"b9912a0e37c47ea3bc708be1d7ec3cb4","sp-home-run-inc",NA,NA,NA,NA
"2d5a156b76bd07156aa36feafd674148","fulcrum-sp-materials","venture","a","2012-06-01",3300000
"2d5a156b76bd07156aa36feafd674148","fulcrum-sp-materials","venture","B","2014-06-20",2e+06
"2d5a156b76bd07156aa36feafd674148","fulcrum-sp-materials","convertible_note",NA,"2015-06-01",1200000
"10af5185364f4bed731cda9c9765acef","space-pencil","venture",NA,"2010-01-06",130185
"10af5185364f4bed731cda9c9765acef","space-pencil","venture","1","2009-07-27",2860000
"10af5185364f4bed731cda9c9765acef","space-pencil","seed",NA,"2008-06-01",1e+06
"10af5185364f4bed731cda9c9765acef","space-pencil","venture",NA,"2013-04-01",2e+05
"798681167805049f05d5bc0eaae3b714","spaceconnect","seed",NA,"2015-04-01",38126
"b0b149ce1f3c9e92a1b9a828d06671dc","spacecurve","venture","b","2014-03-05",5e+06
"b0b149ce1f3c9e92a1b9a828d06671dc","spacecurve","venture","a","2011-09-09",5243297
"b0b149ce1f3c9e92a1b9a828d06671dc","spacecurve","venture","b","2013-06-18",5e+06
"b0b149ce1f3c9e92a1b9a828d06671dc","spacecurve","seed",NA,"2010-08-26",1100000
"fc99b94fc9c5765460fc8c83ffecac36","spaceknow",NA,NA,NA,NA
"e8ea6b27d338b19c0ad3db9569116810","spaltudaq","venture","B","2007-03-19",2.9e+07
"6c26ec561a22bc92393aeba98807f3cd","spankwire",NA,NA,NA,NA
"4fa0b3fff60ae1b053bbedb744934332","spark-therapeutics","venture",NA,"2013-10-22",5e+07
"4fa0b3fff60ae1b053bbedb744934332","spark-therapeutics","venture","1","2014-05-27",72800000
"33428e4a54b319a570ee9e4d7663e5fd","spark59",NA,NA,NA,NA
"ff062a18ec1ee666087f9383dc1e4446","sparkbeyond",NA,NA,NA,NA
"1ae16103817d8c472b52ec73efc3643f","sparked",NA,NA,NA,NA
"7c0dd064f9407ceead1a81e184cf8692","refurit",NA,NA,NA,NA
"4ed0829cfa4c376823969a722bbceee3","sparkfund","venture","A","2014-12-04",2138980
"4ed0829cfa4c376823969a722bbceee3","sparkfund","seed",NA,"2014-01-01",7e+05
"03a007ffef61b47fdd2c44becc5df31d","sparkia",NA,NA,NA,NA
"ae2c5dfaf6d757ac90c79110c89d28a4","sparkling-logic",NA,NA,NA,NA
"1762da80f1cc00fca8d74a39e1f7a19e","sparkpage",NA,NA,NA,NA
"73791a622b90058bccfb8fb1f1acceee","sparkroom","venture","a","2008-03-18",4e+06
"72ad708d83b724abd37a8895adc92688","sparql-city","venture",NA,"2013-08-17",1e+07
"2d20f08b5fb9f077fd3bd8c617b14c0d","spartan-bioscience","venture",NA,"2009-04-15",150000
"2d20f08b5fb9f077fd3bd8c617b14c0d","spartan-bioscience","seed",NA,"2012-05-16",110000
"e6996ad0d622a649ce22de53695f4c91","sparteco",NA,NA,NA,NA
"c20e0a84c4b451aba84b20fd7ee0a114","spatialytics",NA,NA,NA,NA
"0f8f092fe577814c6462510c7f85d241","spawn-industries-inc-",NA,NA,NA,NA
"57568e8410e98133df208374fb6893ef","spaziodati","venture","a","2014-04-01",1800000
"57568e8410e98133df208374fb6893ef","spaziodati","seed",NA,"2012-11-09",NA
"5d5e290ec1b6d9cc6bffbd148106f8a4","speakworks","angel",NA,"2013-10-08",3e+05
"5d5e290ec1b6d9cc6bffbd148106f8a4","speakworks","angel",NA,"2012-07-16",375000
"81fb7c302ccf658cd4ee9aa82535dc68","spearfysh","venture",NA,"2011-10-27",250000
"81fb7c302ccf658cd4ee9aa82535dc68","spearfysh","angel",NA,"2013-09-10",3180000
"43c735ba4f39271288574955408471d1","specialized-pharmaceuticalss","venture",NA,"2009-03-26",623649
"0db8cabddc6cf6a939987d081a4e0d26","specialized-vascular-technologies","venture",NA,"2010-09-02",90249
"6975eff5f83c5aba96cc241a54050b51","specialty-surgery-of-secaucus","debt_financing",NA,"2010-07-09",2175000
"23542a4b03935366e0e06f207c61a2d8","specifiedby","seed",NA,"2014-04-02",189406
"b31a63d12ff9f54cc406c258bf87b0aa","specitrack",NA,NA,NA,NA
"e95628beafa0f218df32105d513736d6","spectaculr",NA,NA,NA,NA
"3418f9173df4281d614183fc6f6a672d","spectra-analysis-instruments","debt_financing",NA,"2012-05-25",675000
"3418f9173df4281d614183fc6f6a672d","spectra-analysis-instruments","venture","1","2006-02-02",1350000
"3418f9173df4281d614183fc6f6a672d","spectra-analysis-instruments","venture",NA,"2013-03-27",1352000
"3418f9173df4281d614183fc6f6a672d","spectra-analysis-instruments","venture","1","2008-10-16",2600000
"3418f9173df4281d614183fc6f6a672d","spectra-analysis-instruments","venture",NA,"2011-06-09",913927
"6b2c16cb282924cbe95c5442a181b8ba","spectral-diagnostics","post_ipo_equity",NA,"2016-01-29",1e+07
"6b2c16cb282924cbe95c5442a181b8ba","spectral-diagnostics","post_ipo_equity",NA,"2014-07-25",13200000
"17ad20fd816340d80099cf607f276c37","spectrascience","debt_financing",NA,"2012-09-06",260000
"17ad20fd816340d80099cf607f276c37","spectrascience","debt_financing",NA,"2012-01-27",3e+05
"17ad20fd816340d80099cf607f276c37","spectrascience","debt_financing",NA,"2014-01-09",1250000
"17ad20fd816340d80099cf607f276c37","spectrascience","venture",NA,"2010-08-03",3153231
"17ad20fd816340d80099cf607f276c37","spectrascience","venture",NA,"2009-05-19",930000
"6bcdb5dc89a99436b72d213ef5794276","spectropath","venture",NA,"2014-01-14",1927920
"0251fb8da2e14177fe7169fa3eb92712","spectrum-mobile","debt_financing",NA,"2010-09-24",650000
"d22fdb2a148de2acffa30d746f3b6a7c","spectrum-outsourcing",NA,NA,NA,NA
"9e054f0e64a7321ff6291865563d9f6b","spectrum-pharmaceuticals",NA,NA,NA,NA
"363d24ab6f33375a22379630853414fb","spectrum-dynamics",NA,NA,NA,NA
"ad70d55cdf931f0c3bccfd09b3700df2","spectrx-inc",NA,NA,NA,NA
"40e632db8a0bb12c8e5765caf798ae68","speechworks",NA,NA,NA,NA
"547809d6d5096f2a3c405739a35fc17c","speedsell",NA,NA,NA,NA
"f7bdff7c3519c1a0010b1d22a1628257","speid-associates-inc",NA,NA,NA,NA
"d9251bc261d47c72926eb0b610552530","spektrotech-america-inc-","seed",NA,"2014-12-14",350000
"3fd9ec03983da0da8a1539c82e7ecac3","spendedge",NA,NA,NA,NA
"3d2a909f60a4519061994acb3204725f","spendgo","venture","A","2013-01-01",2500000
"6af0003c33de964843793b23411a56d5","spendology-llc",NA,NA,NA,NA
"85f015266573bcc0e547ae65b55e89e2","spently",NA,NA,NA,NA
"e63d8d1bb92813b9a61f63682a9b5e38","spero-therapeutics","venture","a","2014-04-09",3e+06
"e63d8d1bb92813b9a61f63682a9b5e38","spero-therapeutics","seed",NA,"2010-01-01",NA
"e63d8d1bb92813b9a61f63682a9b5e38","spero-therapeutics","venture","A","2015-06-08",3e+07
"ce765293f57569fe22d7900275380e03","sphere-consulting",NA,NA,NA,NA
"6e84b6db2f7e92f81a634e3a2f6f6978","sphere-fluidics","undisclosed",NA,"2013-02-19",2476907
"6e84b6db2f7e92f81a634e3a2f6f6978","sphere-fluidics","venture","1","2014-06-24",2381613
"9d4780c48c7804ef19c2146bf325ca48","spherexx-com",NA,NA,NA,NA
"c029f089bf9bc00f41e0f3302919bb22","spherical-systems","equity_crowdfunding",NA,"2013-09-13",15826
"57ce2084b566b9dd4577dadba4d748ff","spherics-pharmaceuticals-inc","venture","C","2005-05-13",26400000
"f5179e85b868fafcaa7356bf23c788f2","spherium-biomed",NA,NA,NA,NA
"992238d2df441e14082c0274123072a0","spherotec",NA,NA,NA,NA
"06b1531805eb130cd24798ec96d6b888","sphynkx-therapeutics","venture",NA,"2012-01-18",50000
"f6b4527fea51d90b7efd3635a4bf8523","spi-bio",NA,NA,NA,NA
"12fce5462d15720f9897b9bbe8b0fb99","spichers-security",NA,NA,NA,NA
"55ad73c1205d28476ebdeb272a491866","spider-strategies",NA,NA,NA,NA
"d8bd3e79a07485b87e70e068d8a89681","spider-io",NA,NA,NA,NA
"daaffd91722b31752545869cdf4ae6eb","spider90-com",NA,NA,NA,NA
"22fde8577cde85dd60b0448e7d717a14","spiderbook","seed",NA,"2013-11-01",1700000
"591242badb0b4d2f2b2aa037a7a3a387","spikes-cavell-co","venture","a","2009-11-17",3350177.2802
"591242badb0b4d2f2b2aa037a7a3a387","spikes-cavell-co","venture",NA,"2007-07-06",1310000
"7ffafa495d7c928e743862d097471b7b","spin-media-marketing-inc",NA,NA,NA,NA
"c2cf9385a06da3970ff65881115b05fe","spin-darc",NA,NA,NA,NA
"ce797db2944188257352c3ce6df97389","spinal-concepts-inc",NA,NA,NA,NA
"34fc46a22fb109b1352741b23cdf1f22","spinal-integration","venture",NA,"2009-09-26",40000
"e6f87cf789fbc4ad704b9e2082d2ceca","spinal-kinetics","debt_financing",NA,"2009-09-21",5300000
"e6f87cf789fbc4ad704b9e2082d2ceca","spinal-kinetics","venture",NA,"2014-06-04",3.4e+07
"c004c34f161a9fcca72364728974483a","spinal-muscular-atrophy-foundation",NA,NA,NA,NA
"bf0b65444848947d144a758f7aa8e1a1","spinal-restoration","venture","B","2007-10-09",1.6e+07
"bf0b65444848947d144a758f7aa8e1a1","spinal-restoration","venture",NA,"2012-10-23",5e+06
"bf0b65444848947d144a758f7aa8e1a1","spinal-restoration","private_equity",NA,"2010-03-17",19999999
"bf0b65444848947d144a758f7aa8e1a1","spinal-restoration","seed",NA,"2013-01-02",2999999
"fb589a00c0e96a84d4a387b4833818c8","spine-pain-management","debt_financing",NA,"2010-10-15",1e+05
"70039fbefbe19bf5c7d2ae0b33203fb6","spinifex-pharmaceuticals","venture","b","2011-08-23",1.9e+07
"70039fbefbe19bf5c7d2ae0b33203fb6","spinifex-pharmaceuticals","venture","c","2014-04-10",4.5e+07
"27feded356bd13054a5d79d3b8b85045","spinnaker-biosciences","venture","a","2010-12-14",1e+06
"27feded356bd13054a5d79d3b8b85045","spinnaker-biosciences","venture",NA,"2015-05-29",9e+05
"eb72fba990bb0c8b2e5ca2a7bc5e2b3d","spinnakr","seed",NA,"2013-06-10",1e+06
"eb72fba990bb0c8b2e5ca2a7bc5e2b3d","spinnakr","seed",NA,"2011-10-26",2e+05
"59b3d06fdf803524bb8fffd08b2ba21c","spinomix","venture","a","2013-01-09",3e+06
"b56bc4a1723afdd19e9f56cf3ed69f1a","spinotech",NA,NA,NA,NA
"deb3f963f2a3c454b0304c4625e400f8","spinx-technologies","venture","b","2005-09-06",12483000
"0b9f8460be3402aae7f2c0106c410e66","spiral-genetics","convertible_note",NA,"2016-01-11",250000
"0b9f8460be3402aae7f2c0106c410e66","spiral-genetics","angel",NA,"2012-08-10",7e+05
"0b9f8460be3402aae7f2c0106c410e66","spiral-genetics","venture","1","2013-03-12",3215591
"42172b7d9d7a0a121bc1c10e6a9b31b0","spiralclick-web-technologies",NA,NA,NA,NA
"36c8f9e315f6eac50e960d103593e307","spire-technologies","venture","a","2013-12-11",8e+06
"f33cf6489253f2a78b4b383cf62b0f37","spirit-digital-media",NA,NA,NA,NA
"70bbc709bbf3eb8b4ad8d7e574522df2","spirogen",NA,NA,NA,NA
"f0f3057ad20b80587330be2bb3004f02","nasoform","venture",NA,"2013-04-26",4e+06
"f0f3057ad20b80587330be2bb3004f02","nasoform","venture","1","2015-04-20",18500000
"7a2ac538e7ff4c3e07a9b8b8a90d904d","splan","seed",NA,"2014-01-03",50000
"b5aa911168e766babbff350c59a74874","splash-online-presence-management","seed",NA,"2014-11-14",50000
"50f15ec8ad830ea5c38cf34aefbed433","splice-machine","venture","C","2016-01-20",9e+06
"50f15ec8ad830ea5c38cf34aefbed433","splice-machine","venture","a","2012-10-17",4e+06
"50f15ec8ad830ea5c38cf34aefbed433","splice-machine","venture","B","2014-02-10",1.5e+07
"50f15ec8ad830ea5c38cf34aefbed433","splice-machine","venture","B","2014-08-06",3e+06
"2764541497acb1b3d868c726025f4956","splitforce","venture",NA,"2014-02-13",150000
"2764541497acb1b3d868c726025f4956","splitforce","seed",NA,"2014-06-09",150000
"474de3a7309b2df3e87b665cc7c638b8","splitsage","venture",NA,"2015-06-24",110000
"c500d6d31adbff916ce39f5cc3c0fc4e","splory","angel",NA,"2014-02-02",NA
"8741e41256f9e2e8efeddda4e076bb94","splurgy","venture","a","2011-12-01",550000
"806a92c79857ddec346b787c7af8a1e6","splyce",NA,NA,NA,NA
"e8b093f19a611eca4213200bde50980d","splyt",NA,NA,NA,NA
"eb8c7bcdee388be75413868530fe1b24","spo-medical","venture",NA,"2010-08-02",438250
"eb8c7bcdee388be75413868530fe1b24","spo-medical","seed",NA,"2013-05-23",250000
"8ccddf69ef69bd65b342cf27c9cde36b","spoonity","seed",NA,"2014-02-14",204545
"3fbc59f907bcea328d203c297cfcf0ad","sportego","seed",NA,"2014-06-02",30000
"57ab13051df96b52d942f0c879b97057","sportingportal",NA,NA,NA,NA
"20ff3991dc082b86342f5d264f486b4b","sportolutions",NA,NA,NA,NA
"770061288876c7decc88c5f987eb4407","sportronix",NA,NA,NA,NA
"69652f43bd4fd07509f3cf5b30eea716","sports-aptitude",NA,NA,NA,NA
"4642c7d9c9c5ee14504aa08f5dfb50a7","sports-data-hub",NA,NA,NA,NA
"4f638473877c213aef6b6bc5b41caaa0","sports-podiatrists",NA,NA,NA,NA
"46877c3ae0416cf3a77e8c4b6c57ea4d","sports-reference",NA,NA,NA,NA
"83c1336511f4f2283dedfc62fb0ab1a1","sportsformulator",NA,NA,NA,NA
"cfb40a2b3408a77518168c84e498e3ac","sportsvolcano",NA,NA,NA,NA
"420563961162bd0fc9d5af2449cf2f23","sportybird","seed",NA,"2013-01-15",25000
"420563961162bd0fc9d5af2449cf2f23","sportybird","seed",NA,"2013-08-08",70000
"e2535021cf209a1ec196a3d21dabe445","spot-influence","seed",NA,"2010-08-01",18000
"e2535021cf209a1ec196a3d21dabe445","spot-influence","seed",NA,"2011-05-10",340969
"28b872e6627f78e8cd2e724991a945a2","spot-trender",NA,NA,NA,NA
"8c07f7fe23ee40906f01ae6c5c4ea14d","spot-on-marketing-solutions",NA,NA,NA,NA
"f087574cd0b00b002335049f24232665","spotfire",NA,NA,NA,NA
"211d3973c29ff9d668640c55037f33cc","spotlight-reporting",NA,NA,NA,NA
"fef33643b754bf3cab82f97f37435be0","spotpulse",NA,NA,NA,NA
"1a221da05e022eac2cca7c7ad79685b7","spotright","venture",NA,"2012-07-26",3e+06
"1a221da05e022eac2cca7c7ad79685b7","spotright","venture",NA,"2013-05-24",2870890
"1a221da05e022eac2cca7c7ad79685b7","spotright","venture","1","2015-04-02",6200000
"1a221da05e022eac2cca7c7ad79685b7","spotright","seed",NA,"2010-11-30",2200000
"6a1e83799547a2e157fc096516119648","spotter-group",NA,NA,NA,NA
"b243cc6f1ad937b8665b9021fbf09cb1","spotterrf","venture",NA,"2010-06-01",NA
"d29f29542dfa447498ebb33ac4383b34","spotwise","seed",NA,"2014-08-21",NA
"98387b9c5c9d64d5f016fb7a04a056b0","spreo",NA,NA,NA,NA
"9052c2e82f22ebc5c4092e907113ecc1","spring-bank-pharmaceuticals","grant",NA,"2011-05-05",3900000
"9052c2e82f22ebc5c4092e907113ecc1","spring-bank-pharmaceuticals","debt_financing",NA,"2014-02-03",6333250
"9052c2e82f22ebc5c4092e907113ecc1","spring-bank-pharmaceuticals","debt_financing",NA,"2013-01-25",4200000
"9052c2e82f22ebc5c4092e907113ecc1","spring-bank-pharmaceuticals","venture",NA,"2015-01-13",11562168
"e927e379dabfc587ab43c5cc34b97c41","spring-pharmaceuticals","venture",NA,"2010-01-22",3750000
"95446c5ce08d0805eb58f73ae9dd1462","springbot","venture","A","2013-07-24",4e+06
"95446c5ce08d0805eb58f73ae9dd1462","springbot","seed",NA,"2013-03-01",NA
"95446c5ce08d0805eb58f73ae9dd1462","springbot","venture","B","2015-06-05",6e+06
"b22c38c491c03e1c7fc025aedc435d84","enliven-marketing-technologies","venture",NA,"2015-12-09",1e+05
"b22c38c491c03e1c7fc025aedc435d84","enliven-marketing-technologies","venture",NA,"2007-10-18",10340000
"b22c38c491c03e1c7fc025aedc435d84","enliven-marketing-technologies","venture",NA,"2005-07-26",1970000
"0c8cc2fc1b241423ae1b74b717524e7e","springleaf-therapeutics","venture","a","2009-11-30",4230000
"0c8cc2fc1b241423ae1b74b717524e7e","springleaf-therapeutics","venture","b","2011-07-08",19047501
"2789ae19e269ede606e63e5958a0b128","springtab",NA,NA,NA,NA
"8dbbaa491528beec9550bbc5b35639dc","sprinklr","venture","b","2013-02-05",1.5e+07
"8dbbaa491528beec9550bbc5b35639dc","sprinklr","venture","a","2012-03-07",5e+06
"8dbbaa491528beec9550bbc5b35639dc","sprinklr","venture","C","2013-11-05",17500000
"8dbbaa491528beec9550bbc5b35639dc","sprinklr","venture","D","2014-04-29",4e+07
"8dbbaa491528beec9550bbc5b35639dc","sprinklr","venture","E","2015-03-31",4.6e+07
"1a5a673cc05b20ed1ac6b680be245e39","sprint-bioscience","undisclosed",NA,"2012-10-19",NA
"1a5a673cc05b20ed1ac6b680be245e39","sprint-bioscience","undisclosed",NA,"2010-11-25",NA
"114c9410bd2ee48c2d10ace57cbf8457","sprmarket",NA,NA,NA,NA
"854cab53955759307888a977dcb4fd2e","sprout-pharmaceuticals","venture",NA,"2012-07-13",2e+07
"854cab53955759307888a977dcb4fd2e","sprout-pharmaceuticals","venture",NA,"2013-06-26",4791913
"854cab53955759307888a977dcb4fd2e","sprout-pharmaceuticals","venture",NA,"2014-07-18",4303856
"854cab53955759307888a977dcb4fd2e","sprout-pharmaceuticals","venture",NA,"2015-06-08",50000008
"a2d7a6deb359e0845ca6a94f988d1249","sproutloud",NA,NA,NA,NA
"dfa3591f5158965eb48949fc3afd893e","sproutrobot",NA,NA,NA,NA
"d9216584ed1fbb0889a7d5db884545a0","spsmedical",NA,NA,NA,NA
"074856c23b444214cdd6d51674210248","spurry-io",NA,NA,NA,NA
"b846dd7c0b4ad96dccf305349f370261","spydermate",NA,NA,NA,NA
"efc185570a31cae310d5623572d5e01b","spyglass-technologies",NA,NA,NA,NA
"cfcaad3b06098664cc279c62fa3ffee4","sqba",NA,NA,NA,NA
"c51a6cd727aebdb9b631450303f7b930","sqi-diagnostics","post_ipo_equity",NA,"2014-04-10",4200000
"81990eeaed3473d8f35570c26738d49a","sqlstream","venture","A","2011-05-20",7500000
"81990eeaed3473d8f35570c26738d49a","sqlstream","venture",NA,"2011-04-06",270100
"cd70393a1c9561026afbe3cb59bcaeea","sqream-technologies","venture",NA,"2015-06-04",7400000
"3a558fc8d7e94d800b3dd7bd86c03da0","sqreen",NA,NA,NA,NA
"c44426afbd4940a4e210032178494850","sqrrl","seed",NA,"2012-08-20",2e+06
"c44426afbd4940a4e210032178494850","sqrrl","venture","1","2013-10-21",5200000
"c44426afbd4940a4e210032178494850","sqrrl","venture","1","2015-02-18",7e+06
"cc94c67ecd75e776763dc9c06d82571f","squadle","seed",NA,"2015-10-19",1e+06
"cc94c67ecd75e776763dc9c06d82571f","squadle","seed",NA,"2014-08-18",NA
"8b03cd97d8a022468d0d980f092d414e","square","venture","b","2011-01-10",27500000
"8b03cd97d8a022468d0d980f092d414e","square","venture","c","2011-12-09",3e+06
"8b03cd97d8a022468d0d980f092d414e","square","venture","d","2012-09-17",2e+08
"8b03cd97d8a022468d0d980f092d414e","square","debt_financing",NA,"2014-04-07",1e+08
"8b03cd97d8a022468d0d980f092d414e","square","venture","a","2009-11-01",1e+07
"8b03cd97d8a022468d0d980f092d414e","square","venture","C","2011-06-28",1e+08
"8b03cd97d8a022468d0d980f092d414e","square","venture","E","2014-10-05",1.5e+08
"8b03cd97d8a022468d0d980f092d414e","square","private_equity",NA,"2015-04-01",NA
"8b03cd97d8a022468d0d980f092d414e","square","private_equity",NA,"2015-03-02",NA
"677630913682ce60e1f2aaf76de90cfd","squareone-consulting",NA,NA,NA,NA
"bb3b8f055f3da33df6b9eefafb01df7e","squareporch-2",NA,NA,NA,NA
"814883f613a10547ca2f93cfc5d85353","squeakee","angel",NA,"2012-12-21",NA
"95592fef66a1d4784f5db809e0c090b4","squid-solutions",NA,NA,NA,NA
"3d9b3a2277fe5857ebd5d5d9ce5f9f7a","squirro","seed",NA,"2013-01-18",NA
"3d9b3a2277fe5857ebd5d5d9ce5f9f7a","squirro","angel",NA,"2012-02-01",1500000
"3d9b3a2277fe5857ebd5d5d9ce5f9f7a","squirro","venture","1","2013-05-07",NA
"badce9cc0987177b0b552b09b073fd93","squiz-uk",NA,NA,NA,NA
"a78e138af283eb1db69d81ea2c343595","sqz-biotech","grant",NA,"2013-10-29",1e+05
"a78e138af283eb1db69d81ea2c343595","sqz-biotech","venture",NA,"2014-04-07",15000
"a78e138af283eb1db69d81ea2c343595","sqz-biotech","venture","1","2015-06-24",5e+06
"055b1d394ef2448e09cf5df4a4a1c98e","sr-tech-group",NA,NA,NA,NA
"083a861694d8e3a7f41cd5923c5d34ec","srch2","seed",NA,"2013-08-30",770000
"083a861694d8e3a7f41cd5923c5d34ec","srch2","seed",NA,"2012-02-15",370000
"083a861694d8e3a7f41cd5923c5d34ec","srch2","undisclosed",NA,"2013-04-24",NA
"083a861694d8e3a7f41cd5923c5d34ec","srch2","seed",NA,"2013-02-15",370000
"7c0cb49203c5083438a7d433597a8aec","srs-holdings","venture",NA,"2011-12-08",1020000
"5c53adb6377232718af480cfe5a99f22","srs-medical-systems","venture",NA,"2010-07-01",3770000
"5c53adb6377232718af480cfe5a99f22","srs-medical-systems","debt_financing",NA,"2009-04-01",1339750
"bfc791ad627dffcfb47bde39abe7a65b","ssg-now",NA,NA,NA,NA
"adef12da172ca287777b781e1e77fa8b","shotspotter","venture",NA,"2012-10-02",1.2e+07
"adef12da172ca287777b781e1e77fa8b","shotspotter","venture",NA,"2006-04-11",9400000
"adef12da172ca287777b781e1e77fa8b","shotspotter","venture","1","2008-05-13",7500000
"adef12da172ca287777b781e1e77fa8b","shotspotter","venture","1","2015-09-08",9682006
"adef12da172ca287777b781e1e77fa8b","shotspotter","venture","1","2007-06-05",1.2e+07
"adef12da172ca287777b781e1e77fa8b","shotspotter","venture",NA,"2011-06-16",10500000
"adef12da172ca287777b781e1e77fa8b","shotspotter","venture",NA,"2012-07-01",6851000
"1fff204aa6a28f44eba820d09b3921af","st-francis-medical-technologies-inc",NA,NA,NA,NA
"bd1de73e85e7c410cb7a800288dc3765","st-francis-medical-technology",NA,NA,NA,NA
"9a2266da01df26358d5b39318b2972e2","st3","seed",NA,"2015-06-30",16674
"c89cf61321359ea5ef6f318a2a7724ec","stabilitech","venture","c","2011-08-06",3500000
"f6a827a0b12e94d282a1c52a28a6ad94","stackfolio",NA,NA,NA,NA
"ad97a5399c5bce740a14d629a3dffaaa","stacklead","seed",NA,"2014-01-01",NA
"0a30a775830c5548d214e4bd3642eae4","stackmeup",NA,NA,NA,NA
"72ae0c90533a8149927b8af57d456b8f","stackpath-research-services-private-limited",NA,NA,NA,NA
"d2893c83c0a7210f9626403c954d4e44","stadium-runner",NA,NA,NA,NA
"c89d1b64eaeaeff475f41c5d2fca63fe","staffinsight","seed",NA,"2013-09-26",NA
"a9b83761cda66b01b851d8a4a8518a7c","stage-cell-therapeutics",NA,NA,NA,NA
"d8622ae42a01857e47a9acefb0f2dbe1","stage-i-diagnostics","venture",NA,"2012-08-15",20000
"d8622ae42a01857e47a9acefb0f2dbe1","stage-i-diagnostics","venture",NA,"2009-06-12",1e+05
"d8622ae42a01857e47a9acefb0f2dbe1","stage-i-diagnostics","equity_crowdfunding",NA,"2010-04-21",NA
"d8622ae42a01857e47a9acefb0f2dbe1","stage-i-diagnostics","venture",NA,"2014-11-26",301250
"a4a7c82910a56d04c3f205bedab80da2","stagemark","venture","b","2007-04-23",1600000
"a4a7c82910a56d04c3f205bedab80da2","stagemark","venture",NA,"2006-03-21",210000
"a4a7c82910a56d04c3f205bedab80da2","stagemark","venture",NA,"2006-02-23",90000
"e7b2b46c525113d5aed0081a59cc0761","stakana-analytics",NA,NA,NA,NA
"ff4178d14462ee6b4eeb90af711c73cd","stance-io",NA,NA,NA,NA
"6db6a051b7cd9be33e746db610814e01","standard-and-poors",NA,NA,NA,NA
"821591967f33ba10e2f1ec376b1a0b24","stanford-linear-accelerator-center",NA,NA,NA,NA
"1a84b435faf02eb304b70b303b8f2e33","stanford-technology-group",NA,NA,NA,NA
"23ff4138a3b676d6ea02a6a47bfa1783","stanmore-implants","undisclosed",NA,"2011-07-20",6452960
"748466b5de995a5eef7f4054ea15ddf2","stansberry-associates-investment-research",NA,NA,NA,NA
"710fa91f4174493dc6082a15b10107bc","staphoff-biotech","venture",NA,"2012-10-11",25000
"ad4f00aebd435eb0ed2cbbffae24a4e7","starcom-ip",NA,NA,NA,NA
"81df5581c46a6279d33dc83dbf0415d4","starfish-etl",NA,NA,NA,NA
"d641fd0216aa0f0130ef2f1a9190145c","starfleet-media",NA,NA,NA,NA
"77da0e61ec08ed70455cc0ec55977220","starhome-mach",NA,NA,NA,NA
"4d8f3dcfe7cc8b2434c39939dd9bbdf4","starion-instruments",NA,NA,NA,NA
"b738c4f3b88c684f1d9d2a5cda4363c4","starmine",NA,NA,NA,NA
"acd2ff58e1759650493173be0d5c3718","starschema-ltd",NA,NA,NA,NA
"88a6b62301108de15cad82bfad679828","start-you-up-accelerator",NA,NA,NA,NA
"20310c80b074268a32876cd568ee2b82","startup-3",NA,NA,NA,NA
"677cc664381abf51f74441c5dc0657ff","startup-network-2","grant",NA,"2012-11-12",31777
"677cc664381abf51f74441c5dc0657ff","startup-network-2","undisclosed",NA,"2014-04-01",137725
"1ff08f8b7d7620833a762e96f2f7996f","startup-a-muckerlab-company",NA,NA,NA,NA
"544a5747fd512614db2f4a1c9a22d7ad","startup-ml",NA,NA,NA,NA
"c64feb10c572a618dbefed37e2fe08de","startupblink","seed",NA,"2013-09-15",28000
"1a14920ba463381e7fb04c0e9d73fb51","startupbootcamp-istanbul",NA,NA,NA,NA
"ae0b986c7b9cb49a036fb4abefa86dc2","startups-watch",NA,NA,NA,NA
"2960fce5d4afe7830ff811e0206d6f55","startupsocials",NA,NA,NA,NA
"701c8cb9b140f2c8e3fb92eb64d86f93","startx","grant",NA,"2013-09-04",3600000
"701c8cb9b140f2c8e3fb92eb64d86f93","startx","venture",NA,"2013-02-07",4e+05
"701c8cb9b140f2c8e3fb92eb64d86f93","startx","grant",NA,"2012-08-23",8e+05
"3d98898d54b2d9c8190535142c767c05","stashmetrics","seed",NA,"2014-01-01",107504
"3d98898d54b2d9c8190535142c767c05","stashmetrics","seed",NA,"2015-09-17",464144.8132
"4cfbd85549c864216f82e066ac7b420e","stason-animal-health","venture","a","2012-06-15",4200000
"09548c7bddfd6eb60dbac34213ae6b37","stat-diagnostica","venture","b","2013-05-06",28966470
"09548c7bddfd6eb60dbac34213ae6b37","stat-diagnostica","venture","a","2011-06-16",2817600
"41b251990abf4da9ec853265fb525656","stat-io","venture",NA,"2013-07-22",NA
"b2ff99e52b8f253701239dda0989f7b3","statace","seed",NA,"2013-09-01",39652
"b2ff99e52b8f253701239dda0989f7b3","statace","seed",NA,"2014-05-01",83097
"6f35d01bfe97069cceecc40011cbc34f","statdash",NA,NA,NA,NA
"828896362ac32a7e3f9d4e2654d77c76","statflo","seed",NA,"2015-09-11",NA
"2f72fc1f99fec5a5bfe02bdbf2ada882","statiq","angel",NA,"2013-12-01",750000
"fa1a83cd09ac8078b401aaf1aecc355a","statista",NA,NA,NA,NA
"24692f83a472ba2783a9891eca3ac147","statistical-consultants-ltd",NA,NA,NA,NA
"bdb73ac78fb2d05e3019e2ac5050c8ea","statisticstimes",NA,NA,NA,NA
"3f183b68fa26175ac1232e12557f9205","statmilk",NA,NA,NA,NA
"f72bbb0507a1cef249c384fde1973809","statricks",NA,NA,NA,NA
"b878aa041909980474c22ae710d604b7","statsheet","venture","a","2010-08-04",1300000
"b878aa041909980474c22ae710d604b7","statsheet","venture",NA,"2011-09-12",4e+06
"7bff9600ed6fe45dfd808a5a33be904e","statsims-com","seed",NA,"2013-06-01",663800
"7bff9600ed6fe45dfd808a5a33be904e","statsims-com","seed",NA,"2012-05-01",150000
"da8a54c780d70528a5e82004cf9b038b","statsmix","seed",NA,"2010-08-01",12000
"22272235ed06ce8bc34f6dc0d38150b7","peekanalytics","angel",NA,"2013-12-15",1100000
"22272235ed06ce8bc34f6dc0d38150b7","peekanalytics","seed",NA,"2015-02-03",1250000
"84c582040a9fdbeab9988caec46293ab","stattleship",NA,NA,NA,NA
"70aabe713ee5aa04c0643d6b93ecd678","statugle",NA,NA,NA,NA
"06255830b7c0acdd00ae47351ef08a73","status-labs",NA,NA,NA,NA
"86cd2f6c74f99e7fe0239f9795dc29e9","statvoo",NA,NA,NA,NA
"6ecb6a5795ea6d1c5bfd5a20887625c7","statwing","angel",NA,"2014-01-30",NA
"6ecb6a5795ea6d1c5bfd5a20887625c7","statwing","seed",NA,"2012-08-01",NA
"19f61ae24a2ffe84ad56d5de4a0d5747","statwolf",NA,NA,NA,NA
"63a967cad3f84febc3bca5b7c7a159cf","stayonsearch",NA,NA,NA,NA
"00001b2da4f755d5d69a17acbac9c17b","std-risk-calculator",NA,NA,NA,NA
"15b54c078452a6c7ee713d429649a04e","steadyserv","convertible_note",NA,"2015-01-28",5500000
"15b54c078452a6c7ee713d429649a04e","steadyserv","convertible_note",NA,"2013-03-25",1500000
"15b54c078452a6c7ee713d429649a04e","steadyserv","venture","1","2014-04-09",6e+06
"15b54c078452a6c7ee713d429649a04e","steadyserv","venture",NA,"2015-06-17",1e+06
"a947b941be1d3127e4b15cb7961a849b","stealth-therapeutics","venture",NA,"2014-08-26",451916
"ea884c792d72fdd7816565ae5c5453ae","steamsharp-technology","angel",NA,"2013-03-05",4e+05
"82c357f2ea7f3298463e7c2912860a93","steel-house-labs",NA,NA,NA,NA
"01767029386bfe594375d61e21d90fc3","steelhouse","venture",NA,"2015-12-10",4.9e+07
"01767029386bfe594375d61e21d90fc3","steelhouse","venture",NA,"2012-07-11",8250000
"01767029386bfe594375d61e21d90fc3","steelhouse","venture","1","2011-12-03",6300000
"01767029386bfe594375d61e21d90fc3","steelhouse","seed",NA,"2010-03-01",NA
"b087627346e8bf469535d2c71681e483","steelorbis",NA,NA,NA,NA
"b5f65fb980df5cc9abd1f4abf696766b","steep-hill-cannabis-analysis-laboratory","equity_crowdfunding",NA,"2015-03-12",2e+06
"b5f65fb980df5cc9abd1f4abf696766b","steep-hill-cannabis-analysis-laboratory","venture",NA,"2015-08-25",1000050
"86d4a39b45c7e6c5c41350e8f1f23c8e","stellar-biotechnologies","venture",NA,"2010-11-18",81396
"86d4a39b45c7e6c5c41350e8f1f23c8e","stellar-biotechnologies","venture","1","2012-10-31",1005800
"86d4a39b45c7e6c5c41350e8f1f23c8e","stellar-biotechnologies","seed",NA,"2013-04-11",1613700
"86d4a39b45c7e6c5c41350e8f1f23c8e","stellar-biotechnologies","private_equity",NA,"2013-09-23",1.2e+07
"86d4a39b45c7e6c5c41350e8f1f23c8e","stellar-biotechnologies","venture",NA,"2010-04-22",2784684
"86d4a39b45c7e6c5c41350e8f1f23c8e","stellar-biotechnologies","venture",NA,"2011-03-08",81396
"b60946afa88ea5f89e3529aa9181cbc8","stellate",NA,NA,NA,NA
"85088b2087f3ec6d00dee631c72a094f","stem-cell-regenerative-medicine-international-inc",NA,NA,NA,NA
"b73cd18d094ac34f9779555a88778428","stem-cell-center-of-thailand",NA,NA,NA,NA
"9ae14507c4ba4db7e3f98bfe0d820664","stem-cell-therapeutics","venture",NA,"2013-12-16",3.3e+07
"24b930706b9c0f3c8fda2196eb3943a1","stem-centrx","venture",NA,"2011-03-16",23526990
"24b930706b9c0f3c8fda2196eb3943a1","stem-centrx","venture","1","2015-09-09",2.5e+08
"24b930706b9c0f3c8fda2196eb3943a1","stem-centrx","venture","1","2014-05-30",2e+08
"61037e8e44196c7f4cca6a1da012a832","stembiosys","seed",NA,"2013-02-12",2e+06
"61037e8e44196c7f4cca6a1da012a832","stembiosys","venture","1","2015-04-14",8e+06
"c6dd9b927297c00b53981ea9358771c2","stemcells","post_ipo_equity",NA,"2014-07-21",2e+07
"9bd0d64d3e30077c696f60e1ef6f408f","stemedica-cell-technologies","venture","b","2009-12-31",2.2e+07
"fdc07b2c206e1e804a5406d02bc77a79","stemgenics","venture",NA,"2016-01-14",930000
"3437da5eb2ac251be4e44307a9d94792","stemgent","venture","b","2009-03-01",1.4e+07
"3437da5eb2ac251be4e44307a9d94792","stemgent","venture",NA,"2012-02-01",6300000
"3437da5eb2ac251be4e44307a9d94792","stemgent","debt_financing",NA,"2011-10-31",580000
"3437da5eb2ac251be4e44307a9d94792","stemgent","debt_financing",NA,"2011-04-13",750000
"3437da5eb2ac251be4e44307a9d94792","stemgent","venture",NA,"2012-08-13",11300000
"3437da5eb2ac251be4e44307a9d94792","stemgent","debt_financing",NA,"2009-11-25",2700000
"3437da5eb2ac251be4e44307a9d94792","stemgent","venture","b","2011-06-10",10627591
"3437da5eb2ac251be4e44307a9d94792","stemgent","venture",NA,"2010-05-13",5627599
"be7b0aa6e829ff9d249a44a9be1d9b37","stemina-biomarker-discovery","venture","a","2009-11-12",1100000
"be7b0aa6e829ff9d249a44a9be1d9b37","stemina-biomarker-discovery","venture",NA,"2007-12-19",1500000
"be7b0aa6e829ff9d249a44a9be1d9b37","stemina-biomarker-discovery","venture",NA,"2014-11-19",2300000
"be7b0aa6e829ff9d249a44a9be1d9b37","stemina-biomarker-discovery","venture",NA,"2015-01-13",2602187
"9c1366dcb73b866c96bc35aa7b0f7f74","stemline-therapeutics","debt_financing",NA,"2012-01-17",740000
"9c1366dcb73b866c96bc35aa7b0f7f74","stemline-therapeutics","venture","1","2008-04-09",12500000
"9c1366dcb73b866c96bc35aa7b0f7f74","stemline-therapeutics","venture",NA,"2010-04-27",6e+05
"9c1366dcb73b866c96bc35aa7b0f7f74","stemline-therapeutics","venture",NA,"2010-03-29",1250000
"849f2f69a87aa3386f4671a2e3ca8017","stemnion","venture",NA,"2016-01-13",1710796
"849f2f69a87aa3386f4671a2e3ca8017","stemnion","seed",NA,"2012-07-13",570746
"b3611c9d554e9a4a542fae62c643b798","stempar-sciences","undisclosed",NA,"2013-01-02",NA
"30c4ef895bc3d59f2dbb8e9fa6e2f62a","stempath","venture",NA,"2006-02-24",1e+06
"d684b4113d8d3455134a1fdcf42449de","stemtek-therapeutics",NA,NA,NA,NA
"8db1c6d06a4da2044bfe83b77c0e5f00","stemtronix",NA,NA,NA,NA
"a4468da04621fa78ed8d1e6937a41b75","stepmiles-marketing",NA,NA,NA,NA
"e154a89e03572e5db19e45d179d0c0dd","stereolabs",NA,NA,NA,NA
"7dd263c447b47acff45971ccc6d6e6a6","stereotaxis","venture","a","2012-05-29",1e+07
"86d4ca602c45aa6c8ef494171486c3f0","stericycle",NA,NA,NA,NA
"c64301084e0de78ed57a4d484fd2cc78","steris-corporation","debt_financing",NA,"2010-05-21",285000
"18689347573a584789cad499141b3ebf","sterling-analytics",NA,NA,NA,NA
"7a115e461aa0a6c92b3fc93f2ec4f7a0","sterling-commerce",NA,NA,NA,NA
"9db4821a940bf133f83d3c8c004e002f","stetic",NA,NA,NA,NA
"5b75ea65885b611e9068224872993bb2","stevia-first","venture",NA,"2014-10-02",1500000
"1409caa2942cb19756446e5bd90976c9","stheno-corporation","seed",NA,"2007-01-30",NA
"1409caa2942cb19756446e5bd90976c9","stheno-corporation","debt_financing",NA,"2007-04-20",2527430
"1409caa2942cb19756446e5bd90976c9","stheno-corporation","seed",NA,"2006-04-07",NA
"1409caa2942cb19756446e5bd90976c9","stheno-corporation","seed",NA,"2005-03-03",NA
"1409caa2942cb19756446e5bd90976c9","stheno-corporation","seed",NA,"2005-08-01",NA
"73fb9742a314d16fbc791790b32179a6","stickergiant",NA,NA,NA,NA
"d70f3f92b47548d111fabe29badf619c","stiefel",NA,NA,NA,NA
"86da5987690691d19d08f5555a42939d","stimulate-solutions",NA,NA,NA,NA
"6957a5c1de373453a7318e040871040b","stirplate-io","seed",NA,"2014-07-14",20000
"6957a5c1de373453a7318e040871040b","stirplate-io","seed",NA,"2014-12-14",575000
"2059e09206abfe7bdbdaafe3c46742cb","stock-market-secrets",NA,NA,NA,NA
"a0f42c7106f9f9ff038daec9806df9f3","stockal","angel",NA,"2015-10-20",NA
"500903ab6d04d799787e42aa8f6c3f19","stockamp-and-associates",NA,NA,NA,NA
"a2bec13eeeb980c117301f85b74410af","stockato-llc",NA,NA,NA,NA
"07fb7ddc2d0b5be520686001dd40c4d1","instense","equity_crowdfunding",NA,"2015-08-20",713020.3026
"07fb7ddc2d0b5be520686001dd40c4d1","instense","seed",NA,"2015-10-05",7e+05
"07fb7ddc2d0b5be520686001dd40c4d1","instense","seed",NA,"2015-08-04",709459.4595
"e552c88d92643564133612e2a4029cf3","stockpad",NA,NA,NA,NA
"3e534919731b012a2cb46ef035c1187d","stockton-group",NA,NA,NA,NA
"9ed50bba9fa10e111da72110af578ce5","stoehr-interactive",NA,NA,NA,NA
"b050779764e959651d3885b77818753a","storedot","venture","B","2014-10-01",4.2e+07
"b050779764e959651d3885b77818753a","storedot","venture","A","2013-06-26",6e+06
"b050779764e959651d3885b77818753a","storedot","venture","B","2014-06-12",1e+07
"b050779764e959651d3885b77818753a","storedot","venture","C","2015-08-19",1.8e+07
"58fe586f998b81eddbb842707e50bc92","storeflix","undisclosed",NA,"2012-04-07",NA
"58fe586f998b81eddbb842707e50bc92","storeflix","debt_financing",NA,"2012-03-28",5e+05
"58fe586f998b81eddbb842707e50bc92","storeflix","venture",NA,"2015-07-17",250000
"ac911b1a9ef051040cf5d8a8eaccb503","storeness","seed",NA,"2015-08-03",27433
"5706695a511a8e957be054092e84522d","analoc",NA,NA,NA,NA
"7f0424bf9e61b2149e69e67aca8b6f34","stormsplitter",NA,NA,NA,NA
"54ddf836fbe27b588107b90ca2b68d5c","storyshelter",NA,NA,NA,NA
"0ebc9d2d1c79a3c980540da5e707e542","stradvision-inc",NA,NA,NA,NA
"11a1fa548668cda014ebda4dd4747498","strain-merchant","seed",NA,"2015-06-01",NA
"da5b08c961fbfa129b100b70f1a83434","http-strandreports-com-",NA,NA,NA,NA
"7c70cf664aacda71e80e76d7331bf2ca","strand-diagnostics","venture","a","2012-03-28",3e+07
"d08683e37b9c49ae5b8ff9deb3fca555","strand-life-sciences",NA,NA,NA,NA
"1e9a9c32c8bce8fc2bac9e357579793d","strap","seed",NA,"2014-07-18",20000
"1e9a9c32c8bce8fc2bac9e357579793d","strap","seed",NA,"2014-12-02",1200000
"3f33eb2f1338bcc46251614e0e8521a1","stratagene",NA,NA,NA,NA
"06aaa1ca3d262a073c23631f173ddef8","stratagent-life-sciences","venture","b","2007-05-11",1.6e+07
"0f39e94a3b04a80bfdd80503797ab53e","stratasan","seed",NA,"2012-09-01",481756
"0f39e94a3b04a80bfdd80503797ab53e","stratasan","seed",NA,"2012-11-01",750000
"6aa6ed53f5407451bc5d136e00134b07","stratatech-corporation","debt_financing",NA,"2010-04-06",3e+06
"7568fa27e8026eb9fdc75e34bdf0b3af","stratebi",NA,NA,NA,NA
"94af738ac47445e34ea782c686844be4","strategic-blend",NA,NA,NA,NA
"50e1216332937b0d820ba8e6a10a4eea","strategic-decisions-group",NA,NA,NA,NA
"5959b71e613d08c9c5fb75429526fae6","strategic-science-technologies","venture",NA,"2014-01-06",5061900
"d57b600f880c9d72375db096716e73ff","strategis",NA,NA,NA,NA
"f6ae0c430c65119846768f3205fa00d8","strategy-analytics",NA,NA,NA,NA
"ace07cdad92c980fd72cea6d0d0ab786","strategy-global-business-development-",NA,NA,NA,NA
"f84064cec90a63f04b44d0b953c56942","taste-analytics","venture",NA,"2016-01-13",1700000
"f84064cec90a63f04b44d0b953c56942","taste-analytics","seed",NA,"2015-03-01",1150000
"7bbe001bc357a87f57e83053abecc386","strat-io","venture","A","2014-03-07",NA
"d8614d8345869146c4838ccc5ce76b90","stratos-genomics","grant",NA,"2011-08-25",829000
"d8614d8345869146c4838ccc5ce76b90","stratos-genomics","venture","1","2010-09-07",4e+06
"d8614d8345869146c4838ccc5ce76b90","stratos-genomics","venture","1","2011-06-08",2100000
"d8614d8345869146c4838ccc5ce76b90","stratos-genomics","venture",NA,"2012-10-10",2e+06
"d8614d8345869146c4838ccc5ce76b90","stratos-genomics","venture",NA,"2013-09-04",2e+06
"d8614d8345869146c4838ccc5ce76b90","stratos-genomics","venture","1","2014-05-13",1e+07
"d8614d8345869146c4838ccc5ce76b90","stratos-genomics","venture","1","2015-06-16",1.5e+07
"f206ee026a3916392831a7c7907854ab","streamdrill",NA,NA,NA,NA
"46f22156f58d742654cdbc169b14e3bd","streamhub-by-five-cool",NA,NA,NA,NA
"43fdff995b48416c0f44caf18d8c6f55","streamline-health-solutions","venture","a","2012-08-31",1.2e+07
"d694c96ff2359895b8dc65d3f0d45661","streamlyzer-inc","seed",NA,"2015-04-01",NA
"35643852973a3b145c0b8f40df686add","streamone",NA,NA,NA,NA
"57728856874942a23c0210ab0421b2f5","streamrail","venture","A","2015-04-04",NA
"c72bd59d8d64546d0134cc09e1d09632","streamscience",NA,NA,NA,NA
"fc24a35a73f58276d4ae9145907b6cd7","streethawk","seed",NA,"2011-05-01",1000
"fc24a35a73f58276d4ae9145907b6cd7","streethawk","seed",NA,"2014-07-01",755803
"29c033948e252520bfc43a223f16196e","strengthsfinder",NA,NA,NA,NA
"de1a0771d349467d760bd301f0e2eeb0","webaction","venture","B","2013-07-03",1.1e+07
"de1a0771d349467d760bd301f0e2eeb0","webaction","venture","A","2012-05-01",1e+06
"de1a0771d349467d760bd301f0e2eeb0","webaction","venture","B","2015-09-14",2e+07
"c31e26ea2e95f5c3d9eccd4db2ae54c2","strike-social",NA,NA,NA,NA
"8257e697aca8e4fcf02886ae856c52c7","strips",NA,NA,NA,NA
"626c045d38d3994e5db7cb92e0860ba3","stromedix","venture","b","2008-04-21",2.5e+07
"626c045d38d3994e5db7cb92e0860ba3","stromedix","venture","c","2011-01-26",2e+06
"626c045d38d3994e5db7cb92e0860ba3","stromedix","venture","a","2007-03-22",1e+06
"2a0e4384ecc4890a97e2cb4b4f43093f","cortendo","private_equity",NA,"2014-10-30",1.1e+07
"2a0e4384ecc4890a97e2cb4b4f43093f","cortendo","post_ipo_equity",NA,"2015-01-13",27500000
"2a0e4384ecc4890a97e2cb4b4f43093f","cortendo","post_ipo_equity",NA,"2015-07-17",33224981
"2e93e405383382054a548c9d3ea9fa4d","sprinkle","seed",NA,"2013-01-02",1e+05
"4168ae051743b7d703d9947d420f0cce","stryde",NA,NA,NA,NA
"0ddcc0a78f7469850638dacdbb5ef503","stryker",NA,NA,NA,NA
"e900235d39a0fbdd026062c74f1b41a8","studentlink",NA,NA,NA,NA
"10aa5cce4f97b6cd9aee4f0a88d09e1b","studio-malatesta",NA,NA,NA,NA
"de199e8cdd7f270c87e0a57baef0de38","stx-healthcare-management-services","venture",NA,"2009-12-23",29929682
"de199e8cdd7f270c87e0a57baef0de38","stx-healthcare-management-services","debt_financing",NA,"2010-05-20",5785555
"eb147ab39a3a810ae6455f5f4be755b4","stylesage","seed",NA,"2015-03-23",733000
"61cda19b08644867c3c116d8f8a15910","styliff","undisclosed",NA,"2014-08-08",NA
"30a2b9842b28a2fc4e6f8df141b4ceca","stylitics","venture",NA,"2014-08-01",NA
"30a2b9842b28a2fc4e6f8df141b4ceca","stylitics","angel",NA,"2012-09-01",1900000
"30a2b9842b28a2fc4e6f8df141b4ceca","stylitics","venture",NA,"2014-01-28",1700000
"30a2b9842b28a2fc4e6f8df141b4ceca","stylitics","angel",NA,"2011-08-30",810000
"30a2b9842b28a2fc4e6f8df141b4ceca","stylitics","venture",NA,"2015-04-29",1195944
"3b41cb43205e87ecb9e5eeca8bd1c161","suanfarma-biotech",NA,NA,NA,NA
"7b015c13ed1c13b29dab4eaa4f586615","subarctic-limited","seed",NA,"2013-01-01",15000
"ca1f64c8e96344db7d068e125e799c6b","subillion",NA,NA,NA,NA
"d2ade0183bd9ce3ce036a12d8789ad7a","subitec","venture","b","2012-07-16",5479650
"d2ade0183bd9ce3ce036a12d8789ad7a","subitec","venture","a","2007-06-14",811544
"96d093a2e3e3f560556b14e08357a38b","subtext3",NA,NA,NA,NA
"30bec4900197a021afc8ab065fc1502d","sucampo-pharmaceuticals",NA,NA,NA,NA
"49d36264618a1654bc876e44fd7cdf6b","success-software-solutions",NA,NA,NA,NA
"d5a224fcceb9e01f96bc89e5b0b1609a","suda","venture",NA,"2013-11-13",5600000
"45575ebe781774132cf412132284a40c","sugardrop",NA,NA,NA,NA
"b10cbda04c6f92bc3aca5213d13205b7","sumagreen",NA,NA,NA,NA
"46ed06b0ad6051e44b565075deb9cccb","sumall","debt_financing",NA,"2013-07-11",2e+06
"46ed06b0ad6051e44b565075deb9cccb","sumall","venture",NA,"2012-06-01",1500000
"46ed06b0ad6051e44b565075deb9cccb","sumall","venture","1","2012-11-21",6e+06
"46ed06b0ad6051e44b565075deb9cccb","sumall","venture","1","2013-12-03",4e+06
"46ed06b0ad6051e44b565075deb9cccb","sumall","venture",NA,"2015-04-01",NA
"99538c9736e78cc0f78fe75dfa9ddffb","sumamisg",NA,NA,NA,NA
"4aa974e3a79f2258a6d54aace4c837db","sumatosoft",NA,NA,NA,NA
"9d98cb4c0aba3118a9818cc3f9b1fe9d","summit-corporation","post_ipo_equity",NA,"2014-03-04",11644000
"f8e5a68400e8444c085bb9b6bf8ea183","summly","venture",NA,"2012-10-01",1230000
"f8e5a68400e8444c085bb9b6bf8ea183","summly","seed",NA,"2011-09-13",3e+05
"92080cc34e333fb89542d97ca5a15fe0","sumo-logic","venture","b","2012-01-31",1.5e+07
"92080cc34e333fb89542d97ca5a15fe0","sumo-logic","venture","c","2012-11-29",3e+07
"92080cc34e333fb89542d97ca5a15fe0","sumo-logic","venture","D","2014-05-20",3e+07
"92080cc34e333fb89542d97ca5a15fe0","sumo-logic","venture","E","2015-06-01",8e+07
"434f6e4d773d0510e9bfa82f97f80581","sumobrain",NA,NA,NA,NA
"0980f8c2b5e7219a7dfed8b3499a6d35","sun-biopharma","debt_financing",NA,"2014-02-04",3100000
"0980f8c2b5e7219a7dfed8b3499a6d35","sun-biopharma","debt_financing",NA,"2013-05-23",9e+05
"0980f8c2b5e7219a7dfed8b3499a6d35","sun-biopharma","venture",NA,"2012-02-25",548898
"ef4846d3c5d8f7d0bde3c87d8e173381","sun-diagnostics","venture",NA,"2014-01-28",50000
"b07d8339211bf45d3c6903a727586aef","sun-pharma",NA,NA,NA,NA
"d30bfdb16663ca6edb0a540972fcd721","sunbeam","venture",NA,"2013-12-11",9329636
"082f662e7b5cb5fc83828134b1812c50","sundance-diagnostics","seed",NA,"2013-03-04",1000
"082f662e7b5cb5fc83828134b1812c50","sundance-diagnostics","venture",NA,"2015-05-19",5513
"fe0428f60a79cc1b7680e3291b506a86","sunesis-pharmaceuticals","venture",NA,"2009-04-07",43500000
"4f43a64cc4124003f72cbe583d4e39d5","sunient",NA,NA,NA,NA
"dd1b6347525e70dfbf9e02b9e46e0884","sunny-side-up",NA,NA,NA,NA
"3ceb757664846dca41a072d0ceb2a38f","sunovion-pharmaceuticals",NA,NA,NA,NA
"51f092c7198349812eef4aeb1fdfe141","sunshine-biopharma","venture",NA,"2012-08-30",459313
"f6eb9cb9390cac75db7521f2bed193c6","sunshine-heart","venture",NA,"2010-11-30",3500000
"f6eb9cb9390cac75db7521f2bed193c6","sunshine-heart","venture",NA,"2011-08-10",4969631
"f6eb9cb9390cac75db7521f2bed193c6","sunshine-heart","venture",NA,"2013-05-20",1500000
"f6eb9cb9390cac75db7521f2bed193c6","sunshine-heart","venture",NA,"2012-09-19",7e+05
"f6eb9cb9390cac75db7521f2bed193c6","sunshine-heart","venture",NA,"2012-02-22",2112769
"f6eb9cb9390cac75db7521f2bed193c6","sunshine-heart","post_ipo_debt",NA,"2015-03-02",360000
"4dd782b75561203fc71e3c741ca83de7","suntec-web-services",NA,NA,NA,NA
"69b8250649e2e469994b0261976cc644","sunten-phytotech","venture","B","2006-12-21",1e+07
"a55d56cc423710ea341fa861fb4bf231","superbac","venture","a","2007-01-01",NA
"86f26e42087d948b8215b3e78f72bb39","superbrain-by-super-analytics",NA,NA,NA,NA
"a20fda04109516d298898e5482582c65","superderivatives","undisclosed",NA,"2008-01-01",NA
"a20fda04109516d298898e5482582c65","superderivatives","debt_financing",NA,"2008-01-01",2e+07
"bd01ffe97ec9f9944b627cfcfaccb9cf","superfly-3","undisclosed",NA,"2011-01-01",5e+05
"bd01ffe97ec9f9944b627cfcfaccb9cf","superfly-3","undisclosed",NA,"2015-01-01",1e+06
"a104190abfc188892645ace2a2d36dc7","supergen","venture",NA,"2009-10-22",3e+06
"2820e3e64e9d19da2d3aea7f45539a6c","supernus-pharmaceuticals","debt_financing",NA,"2011-01-26",3e+07
"2820e3e64e9d19da2d3aea7f45539a6c","supernus-pharmaceuticals","private_equity",NA,"2012-01-08",4.2e+07
"803125c5cb58f584ec68d15567d33094","supersonic-imagine","private_equity",NA,"2013-04-02",35952000
"803125c5cb58f584ec68d15567d33094","supersonic-imagine","venture","1","2010-11-29",45353700
"803125c5cb58f584ec68d15567d33094","supersonic-imagine","private_equity",NA,"2014-04-10",20767569
"803125c5cb58f584ec68d15567d33094","supersonic-imagine","venture","1","2006-03-01",11895509
"803125c5cb58f584ec68d15567d33094","supersonic-imagine","venture","1","2008-10-23",25878800
"8ee5e80b0431da5c077fb5c8e2530607","supersum-technology-group",NA,NA,NA,NA
"74559641da8107b52998fd8a53e6a457","supportland",NA,NA,NA,NA
"0059ddde8c8e2058f0e4cf9225ab8ae6","suppremol","venture","B","2008-07-15",24950205.5346
"0059ddde8c8e2058f0e4cf9225ab8ae6","suppremol","venture","a","2006-05-24",5150000
"0059ddde8c8e2058f0e4cf9225ab8ae6","suppremol","venture","c","2010-12-17",20553000
"0059ddde8c8e2058f0e4cf9225ab8ae6","suppremol","venture","d","2013-05-21",12222700
"442e6e83b8f2a1fbeb4b7736969ab19b","supra-nimbus-corporation",NA,NA,NA,NA
"8b9fad4d26a91715d9f06fffbe8c9364","surado-solutions",NA,NA,NA,NA
"d3f3ff79b8925ae4c728d8206374edb5","sureclinical",NA,NA,NA,NA
"5e5fe79185b2779b93dc73ba323c7aae","suregene","venture",NA,"2009-05-14",4e+05
"b823d3bb0d4c8a6a4093653090e4db50","surface-logix","venture","D","2007-03-24",19900000
"b823d3bb0d4c8a6a4093653090e4db50","surface-logix","venture",NA,"2010-07-16",3999974
"254eb99acc09a1a10ce482f30f50b481","surface-oncology","venture","A","2015-01-08",3.5e+07
"df756f67296f7a7bf3c087f046389d9b","surflabs",NA,NA,NA,NA
"3f10f367d1afc111915c1719eddf880a","hacksurfer","venture",NA,"2014-04-23",3500000
"3f10f367d1afc111915c1719eddf880a","hacksurfer","venture","1","2015-02-26",5200011
"64b3faec5ec1f44186bd68c7f5431d1a","surge-beacon",NA,NA,NA,NA
"c3872313772900d080e9846c494404d1","surgical-care-affiliates","seed",NA,"2011-10-05",745170
"c3872313772900d080e9846c494404d1","surgical-care-affiliates","venture",NA,"2007-07-10",2.5e+07
"f019a54d1ced7b46284435e4089c2f1e","surmodics-pharmaceuticals",NA,NA,NA,NA
"fe342759b037675ea31deddec2b1ff14","surroundsme","seed",NA,"2013-04-29",20000
"68b705817c8f5758a5985d2f7de5f630","survata","seed",NA,"2012-06-01",17000
"68b705817c8f5758a5985d2f7de5f630","survata","seed",NA,"2013-06-04",1700000
"68b705817c8f5758a5985d2f7de5f630","survata","venture","1","2015-07-21",6e+06
"f8a29a24c9ba109b2ab1e7911d0338fb","surveyshare",NA,NA,NA,NA
"4f7f3032d5d52ce84a681c30b0106651","survicate","seed",NA,"2015-03-09",135000
"84562cbd247138d565ac13bd36babc14","susurrus",NA,NA,NA,NA
"d54e9a8bc3445f82b2ae5c7605706f24","sutro-biopharma","venture","c","2012-05-08",16500000
"d54e9a8bc3445f82b2ae5c7605706f24","sutro-biopharma","venture","b","2007-12-10",2.1e+07
"d54e9a8bc3445f82b2ae5c7605706f24","sutro-biopharma","venture","b","2009-03-30",1.5e+07
"d54e9a8bc3445f82b2ae5c7605706f24","sutro-biopharma","venture",NA,"2007-10-16",305000
"d54e9a8bc3445f82b2ae5c7605706f24","sutro-biopharma","venture","a","2006-01-01",1e+06
"d54e9a8bc3445f82b2ae5c7605706f24","sutro-biopharma","venture","c","2010-11-17",36500000
"d54e9a8bc3445f82b2ae5c7605706f24","sutro-biopharma","venture","d","2013-12-11",2.6e+07
"4cf9023b3036f3cb9eca6061e888c1a9","suzerein-solutions","angel",NA,"2009-03-01",260000
"36657400436e4bd648ba23f052b6ba5e","svbio","venture",NA,"2011-08-01",NA
"36657400436e4bd648ba23f052b6ba5e","svbio","venture","1","2015-02-19",20500000
"97d03de962b292e75765d66b035ae0c1","svp-advisors",NA,NA,NA,NA
"b96721a70a424b96d68e226284fd5346","swag-r-inc-","seed",NA,"2014-03-31",325000
"b96721a70a424b96d68e226284fd5346","swag-r-inc-","convertible_note","1","2014-11-15",NA
"323ab75a0061661370520ce2b3af59b2","swallow-solutions","venture","A","2015-03-13",2060130
"97dcedd15ab1bfa837a21d859307da9c","swan-insights","seed",NA,"2014-09-12",1099517
"0b2570d271bf67e502cd7d78dbb4f235","swan-island-networks","venture",NA,"2012-04-16",603171
"fa4b39dd8c1e4617d3d73dbd6432aacb","swar-gusta-luggage-company","venture","A","2016-01-06",NA
"6a2cce1ccdf3d8eef223610f6b45affb","swarm-mobile","seed",NA,"2012-10-10",1e+06
"6a2cce1ccdf3d8eef223610f6b45affb","swarm-mobile","venture","1","2013-12-02",3500000
"9d010b653dc67b358c841ba135f1905d","swarmly",NA,NA,NA,NA
"451fb88224506adbf21bb85339b1dd16","capacity-sports",NA,NA,NA,NA
"be055906f6127dbe5aa037357b505785","sway-medical-technologies","venture","a","2013-06-21",750000
"5ad4052851b0bc799a79df33677c6e1d","swayable",NA,NA,NA,NA
"7f1a58a8d02dd2537bdd946c921ff8af","swedish-orphan-biovitrum",NA,NA,NA,NA
"e8a9dc3d0ae3c7384b02cb46bb0d2e6b","sweet-tooth","seed",NA,"2012-05-07",1003851
"86af1322e5725b14406a460e283a8720","swelen",NA,NA,NA,NA
"72b8a49410c97654acce993800b77cb3","chainperks",NA,NA,NA,NA
"6756f76bf0ec2b6efaaa9e1bbb2cfd21","swellpath",NA,NA,NA,NA
"d347fd518ef0d4d345bc01ae6fcd02de","swift-biosciences","venture",NA,"2012-02-13",5e+05
"d347fd518ef0d4d345bc01ae6fcd02de","swift-biosciences","venture","1","2010-08-19",3e+06
"d347fd518ef0d4d345bc01ae6fcd02de","swift-biosciences","venture","1","2013-10-17",7e+06
"d347fd518ef0d4d345bc01ae6fcd02de","swift-biosciences","venture",NA,"2015-09-10",1499999
"d31d571ee312fd45e0446ff59af2bb55","swift-rivers",NA,NA,NA,NA
"08c706c982988eed251eab372a2b4379","swiftbot",NA,NA,NA,NA
"86f157c1a153d118349fe5f1d3a40099","swiftceipt",NA,NA,NA,NA
"a352e1be177e7b434d7e9547cd7733bc","swiftiq",NA,NA,NA,NA
"a046fa616d874bacd5e74a3e1061bd7a","swiftknowledge",NA,NA,NA,NA
"edf26ed8a2878d7dc068ba0faf58543c","iconic-data","seed",NA,"2012-04-04",NA
"edf26ed8a2878d7dc068ba0faf58543c","iconic-data","seed",NA,"2012-01-01",NA
"6bfff87ab9cdda588573dda556b1dcae","swipp","debt_financing",NA,"2012-05-23",5e+05
"6bfff87ab9cdda588573dda556b1dcae","swipp","venture","1","2012-05-23",3001000
"6bfff87ab9cdda588573dda556b1dcae","swipp","venture","1","2013-04-22",2e+06
"6bfff87ab9cdda588573dda556b1dcae","swipp","venture","1","2012-06-21",3500000
"6f47f155922897b5d0d0f45f22de6d92","swipt",NA,NA,NA,NA
"95ad127c29181d323a9394ee71acefaa","swish-analytics","seed",NA,"2015-08-24",20000
"4aad851cec0eeefaf3e70ab0a49a2839","swiss-dna-bank",NA,NA,NA,NA
"881e234e8c1b9d446441cecab447d24e","swiss-medical-group",NA,NA,NA,NA
"4fa10eb3f20548359ac42c8986f8d368","switch-automation","seed",NA,"2015-11-01",36000
"4fa10eb3f20548359ac42c8986f8d368","switch-automation","seed",NA,"2015-02-10",972233.0248
"87f5fb02a58e7ff99bbd2dfd63308f8c","switch-concepts",NA,NA,NA,NA
"3820bf7e8222b3f5f34d4df31174f028","swmf-life-science-fund",NA,NA,NA,NA
"5e5f2db5376fc0c68da4bacc5275f41d","sword-diagnostics","venture",NA,"2005-04-01",5e+05
"5e5f2db5376fc0c68da4bacc5275f41d","sword-diagnostics","venture","1","2007-03-05",1490000
"5e5f2db5376fc0c68da4bacc5275f41d","sword-diagnostics","venture","1","2006-10-13",1600000
"5e5f2db5376fc0c68da4bacc5275f41d","sword-diagnostics","debt_financing",NA,"2009-10-14",435831
"5e5f2db5376fc0c68da4bacc5275f41d","sword-diagnostics","debt_financing",NA,"2012-12-28",1274971
"5e5f2db5376fc0c68da4bacc5275f41d","sword-diagnostics","debt_financing",NA,"2015-05-13",150000
"81bc36b0365d74f49fb2d37294e56e60","swrve-new-media","non_equity_assistance",NA,"2015-05-01",NA
"81bc36b0365d74f49fb2d37294e56e60","swrve-new-media","venture","1","2015-11-11",3e+07
"81bc36b0365d74f49fb2d37294e56e60","swrve-new-media","venture","1","2012-11-12",6250000
"81bc36b0365d74f49fb2d37294e56e60","swrve-new-media","seed",NA,"2011-09-08",2700000
"81bc36b0365d74f49fb2d37294e56e60","swrve-new-media","angel",NA,"2009-01-10",2189440
"81bc36b0365d74f49fb2d37294e56e60","swrve-new-media","venture","1","2014-09-18",1e+07
"c3541048b996cb0d700552942d4ecb7c","syandus","venture",NA,"2009-10-13",532500
"b5df3659f3b459260e864edf3bbbd385","sybaris-analytics",NA,NA,NA,NA
"38e2426f273edf289385eb87230d62d1","sybenetix",NA,NA,NA,NA
"facf896e457f2decbf4792b8f37121a2","sycamore-robotics",NA,NA,NA,NA
"057f70a151eb40b9dc6aecca0423e53b","sygnis-pharma",NA,NA,NA,NA
"feb71ac773e26536cd8f1247b822227d","symberix",NA,NA,NA,NA
"e38f27342d3c7fae41b5f1eca0285a4e","symbio-pharmaceuticals","venture","e","2011-02-25",2.4e+07
"e38f27342d3c7fae41b5f1eca0285a4e","symbio-pharmaceuticals","undisclosed",NA,"2012-12-27",17680390
"eeb6d2eb82ff8c4d87e787c0e7991508","symbiocelltech","venture",NA,"2014-03-21",2e+05
"0dce68cd0483401d2ee50402b7f7d0f0","symbiota","venture","A","2014-11-13",7500000
"f1e7bd55000dbd6e5c4bc0d4e28a4aeb","symbiotec-pharmalab","venture",NA,"2013-10-22",4.8e+07
"237568a24ff9f273a28add0fab72c4f6","symborg",NA,NA,NA,NA
"5999ab47b0f9ed2f5914f9347d6327df","symbyo-dental",NA,NA,NA,NA
"97b96b47cfefd04770da0a0fa9416ac3","symetis","venture","c","2010-10-08",25800000
"97b96b47cfefd04770da0a0fa9416ac3","symetis","venture","D","2012-05-03",NA
"a011083844570652d36d6a5aca3a437c","symic-biomedical","venture","A","2015-12-01",2.5e+07
"a011083844570652d36d6a5aca3a437c","symic-biomedical","venture",NA,"2013-11-08",1375687
"a011083844570652d36d6a5aca3a437c","symic-biomedical","venture","A","2015-01-05",1.5e+07
"a011083844570652d36d6a5aca3a437c","symic-biomedical","grant",NA,"2015-08-27",1500000
"f5a7c7e889b1c53f516d4b5156a47de7","symmetric-computing","seed",NA,"2010-10-21",50000
"f4046f104f50b1ce9c028ae0d1362220","symmetry-therapeutics-inc",NA,NA,NA,NA
"b59908925a1f0f582a81a1775cb10e4c","symphogen","venture",NA,"2007-02-01",6497866.5338
"b59908925a1f0f582a81a1775cb10e4c","symphogen","debt_financing",NA,"2015-10-22",76630962.3146
"b59908925a1f0f582a81a1775cb10e4c","symphogen","private_equity",NA,"2009-02-02",42108000
"b59908925a1f0f582a81a1775cb10e4c","symphogen","private_equity",NA,"2011-01-06",130910000
"b59908925a1f0f582a81a1775cb10e4c","symphogen","undisclosed",NA,"2008-06-10",NA
"b59908925a1f0f582a81a1775cb10e4c","symphogen","venture","1","2006-01-10",2.5e+07
"b59908925a1f0f582a81a1775cb10e4c","symphogen","venture","1","2011-02-14",135400000
"b59908925a1f0f582a81a1775cb10e4c","symphogen","private_equity",NA,"2013-05-03",53767400
"7727de51f56ab6c2691df910a901fc8f","symphony-allegro",NA,NA,NA,NA
"fe49e5ae1832d50d6dfe97697eccd10e","symphony-dynamo","venture",NA,"2006-04-19",2e+07
"4da87acffd83ccd4986a8110ab7e386e","symphony-vida",NA,NA,NA,NA
"71b34fd4e96f07af9a1a320fe559b02a","symrise",NA,NA,NA,NA
"aabe3b0393ba6c71716ca7109daf9988","symyx",NA,NA,NA,NA
"1a89d1b48ac207ad4ac0c6d154abe835","synaffix","venture","a","2014-02-18",NA
"76c1b61634dfbdbe4c210e652841217d","synageva","venture","f","2009-04-15",3e+07
"76c1b61634dfbdbe4c210e652841217d","synageva","venture","f","2009-10-22",1.2e+07
"76c1b61634dfbdbe4c210e652841217d","synageva","venture",NA,"2011-03-21",2.5e+07
"76c1b61634dfbdbe4c210e652841217d","synageva","venture","f","2010-08-02",3e+06
"2c0da24107aeeb24e181956da924e97e","synagile","venture",NA,"2011-05-04",898618
"68b709167771141b33af2cc839f772a5","synapbox","seed",NA,"2015-01-27",1e+05
"8359e8e7f440e9b894704f54ef69c98e","synapcell","venture","a","2009-03-06",4430000
"006008cdbfcc420e8579ebe08964b516","synapsify","seed",NA,"2013-02-26",6e+05
"006008cdbfcc420e8579ebe08964b516","synapsify","venture",NA,"2014-07-23",850000
"bafed7674dfae99d4bbdec8830bed9a4","synbio-consulting",NA,NA,NA,NA
"9b413d8838784e8da3a267e21b8912b1","synbiobeta",NA,NA,NA,NA
"6781ed0090cf2dbca295c6b855ddec7f","synbody-biotechnology","seed",NA,"2012-03-13",750000
"55a167d2ece153c23f668eb28e9116cc","synced",NA,NA,NA,NA
"2d0205844994e112042a6a2af1855732","synchroneuron","venture","a","2012-02-06",6e+06
"2d0205844994e112042a6a2af1855732","synchroneuron","venture","B","2014-07-02",2e+07
"37d2fb6c04e8d1afa6add3bd6e6dd43e","synchrony-innovations",NA,NA,NA,NA
"d5fab9fa07cc0285612ad398eca016ec","synchropet","debt_financing",NA,"2015-07-07",725000
"2789fccae0479caf82a433b5307e8405","syncsite-inc",NA,NA,NA,NA
"ad9ecd162c5e4eb2a2004ca11496c186","syncsort",NA,NA,NA,NA
"80df2107435a0435f0658cac8f7aa669","syndaver-labs",NA,NA,NA,NA
"1bef3ecc3256411024694a8dc5238fcd","sndax-pharmaceuticals","venture","A","2007-04-03",4e+07
"1bef3ecc3256411024694a8dc5238fcd","sndax-pharmaceuticals","venture",NA,"2014-02-13",1728471
"1bef3ecc3256411024694a8dc5238fcd","sndax-pharmaceuticals","venture","a","2010-03-16",9e+06
"1bef3ecc3256411024694a8dc5238fcd","sndax-pharmaceuticals","debt_financing",NA,"2010-04-05",6006000
"1bef3ecc3256411024694a8dc5238fcd","sndax-pharmaceuticals","venture","b","2013-08-27",26600000
"1bef3ecc3256411024694a8dc5238fcd","sndax-pharmaceuticals","debt_financing",NA,"2014-09-18",4947480
"1bef3ecc3256411024694a8dc5238fcd","sndax-pharmaceuticals","venture",NA,"2015-06-15",23961064
"1bef3ecc3256411024694a8dc5238fcd","sndax-pharmaceuticals","venture","C","2015-08-24",8e+07
"d5bdeff54dfaf677dd7a670d3b58362a","syndevrx","debt_financing",NA,"2013-05-31",1610000
"d5bdeff54dfaf677dd7a670d3b58362a","syndevrx","venture",NA,"2009-07-23",569659
"d5bdeff54dfaf677dd7a670d3b58362a","syndevrx","debt_financing",NA,"2010-05-10",225000
"29148de5328171643c77c053b0d51086","syndexa-pharmaceuticals","venture","b","2012-01-05",8500000
"29148de5328171643c77c053b0d51086","syndexa-pharmaceuticals","venture","b","2008-05-30",1.5e+07
"c98d7c8c576fbf7c570763a692b85807","syndicate-pro",NA,NA,NA,NA
"53cb19515d31462c91e491563e6c83a8","syndicated-loan-direct",NA,NA,NA,NA
"8360aa57d27b7db3f9f4f7f16bd5ccec","syndio",NA,NA,NA,NA
"f88c56ca91f5c90969d9041f5fed264b","synduit",NA,NA,NA,NA
"045535d0ebe0105eaa9f4c498b36654a","synedgen","venture",NA,"2013-04-29",3183437
"045535d0ebe0105eaa9f4c498b36654a","synedgen","venture",NA,"2014-08-14",607440
"045535d0ebe0105eaa9f4c498b36654a","synedgen","venture",NA,"2015-03-03",3500000
"9c56849964f8c8d6c7c9582bf96d513f","synereca-pharmaceuticals","venture",NA,"2011-02-08",340000
"9c56849964f8c8d6c7c9582bf96d513f","synereca-pharmaceuticals","debt_financing",NA,"2014-09-16",1400000
"9c56849964f8c8d6c7c9582bf96d513f","synereca-pharmaceuticals","venture",NA,"2015-08-04",6e+05
"c3d834384d606b9315a44d6f73b8bd82","synergene-therapeutics","venture",NA,"2014-04-02",2381000
"c3d834384d606b9315a44d6f73b8bd82","synergene-therapeutics","venture",NA,"2011-09-14",1570000
"c3d834384d606b9315a44d6f73b8bd82","synergene-therapeutics","venture",NA,"2014-12-16",6368989
"c1691c7bb9e2985072753120e1b88fb2","synergos-2","seed",NA,"2012-02-15",40000
"aabfb307e9e5df052d6e79901b4c9623","synergy-biomedical","venture",NA,"2014-03-05",611900
"aabfb307e9e5df052d6e79901b4c9623","synergy-biomedical","venture",NA,"2012-07-24",412212
"aabfb307e9e5df052d6e79901b4c9623","synergy-biomedical","venture",NA,"2011-09-30",2e+05
"952a58b6649f7a5fb4775d8a2127fccd","synergy-biotech",NA,NA,NA,NA
"5bcedf1930e33a0e63ef6e3e829862de","synergy-pharmaceuticals","venture",NA,"2009-02-12",15870000
"5bcedf1930e33a0e63ef6e3e829862de","synergy-pharmaceuticals","venture",NA,"2010-08-20",4e+05
"5bcedf1930e33a0e63ef6e3e829862de","synergy-pharmaceuticals","venture",NA,"2011-06-20",1161243
"3b8a342ac2a0ea30ffa5c231e4506f2a","synergy-sports-technologies",NA,NA,NA,NA
"1bb167ab0d680e102a389ea239ca7a7c","synergy-vision",NA,NA,NA,NA
"cbc9d580227100a7d7c4fd432448eb95","syneron-medical",NA,NA,NA,NA
"f69a0026564316d3ccdf4405f154a258","synerscope","angel",NA,"2011-03-01",1900000
"f69a0026564316d3ccdf4405f154a258","synerscope","venture","1","2015-07-01",NA
"9784784e2aa810a240c4a7c72eda2fbb","synerz-medical","venture",NA,"2013-12-27",1085000
"9784784e2aa810a240c4a7c72eda2fbb","synerz-medical","debt_financing",NA,"2015-03-03",650000
"c7e745484a77e47d0e136047855beea4","synesis","seed",NA,"2008-01-01",1e+06
"c7e745484a77e47d0e136047855beea4","synesis","grant",NA,"2012-05-30",406000
"be75b7a05d4512299e1699e60b7f301f","synetiq","seed",NA,"2014-11-01",351498
"be75b7a05d4512299e1699e60b7f301f","synetiq","seed",NA,"2013-11-01",54513
"5828b89ef942590c78314639ecdcdf25","synexus",NA,NA,NA,NA
"a21ef07b824b06f6c174901f82bbc71d","synference","seed",NA,"2013-01-01",70000
"5025080c7415f00d5791c00a6f7d8910","syngenta-biotechnology-inc",NA,NA,NA,NA
"9422cda1067a501da68df5acd4a7ff20","synlogic","venture","A","2014-07-22",29400000
"9422cda1067a501da68df5acd4a7ff20","synlogic","venture","A","2014-10-07",5e+06
"5ab3b89cc687545de2c4124af58e0471","synomia",NA,NA,NA,NA
"7ccb457bcdaf2fc60f45f35b3e6012cd","synosia-therapeutics","venture","c","2010-10-12",3e+07
"7ccb457bcdaf2fc60f45f35b3e6012cd","synosia-therapeutics","venture","b","2009-01-01",2.9e+07
"7ccb457bcdaf2fc60f45f35b3e6012cd","synosia-therapeutics","venture",NA,"2007-01-05",32500000
"df34341c502459291edf470bbbce1786","synoste-oy","venture",NA,"2016-01-21",NA
"df34341c502459291edf470bbbce1786","synoste-oy","venture",NA,"2013-11-14",3602480
"df34341c502459291edf470bbbce1786","synoste-oy","venture","1","2015-05-06",2200000
"739aa8bd1ee586064cd2f66aee4ea3b6","synovex","venture",NA,"2012-10-11",3500000
"7d69361168cdc07864b3bd8bda680ccc","synpromics-ltd","venture",NA,"2015-08-17",3285922
"3f2976291c1df385f8515ea1f04ab92c","synta-pharmaceuticals","venture",NA,"2006-10-22",4e+07
"3f2976291c1df385f8515ea1f04ab92c","synta-pharmaceuticals","venture",NA,"2010-01-08",23100000
"3f2976291c1df385f8515ea1f04ab92c","synta-pharmaceuticals","venture",NA,"2010-01-19",3750000
"3f2976291c1df385f8515ea1f04ab92c","synta-pharmaceuticals","post_ipo_equity",NA,"2015-04-01",38500000
"2a16dd2aa8b350657e28cc1a05d2eb52","syntarga","undisclosed",NA,"2010-11-28",NA
"4b48f5af1a89eceb5faf96b3b083ac00","syntasa",NA,NA,NA,NA
"edbc915add1d4f3ea88e1bd5d59c195b","syntaxin","venture","b","2007-10-31",3.2e+07
"edbc915add1d4f3ea88e1bd5d59c195b","syntaxin","venture","a","2005-11-14",10390000
"edbc915add1d4f3ea88e1bd5d59c195b","syntaxin","venture","c","2010-11-11",2.9e+07
"34825923170080c918ab51cd5803c128","syntegrate",NA,NA,NA,NA
"449bb07e1259844dc20e753f5b8f4284","syneract",NA,NA,NA,NA
"3fa188bd3337ddf58208367b6d773329","syntervention","venture",NA,"2012-05-15",39000
"46da22221a0d3313483a9f574d5abfe7","syntex-research",NA,NA,NA,NA
"aaf74740778a52756962bdaa22ca6bfb","synthace","venture",NA,"2014-12-05",NA
"aaf74740778a52756962bdaa22ca6bfb","synthace","seed",NA,"2013-09-24",1969826
"aaf74740778a52756962bdaa22ca6bfb","synthace","seed",NA,"2013-04-12",9e+05
"121961d6dc6ed08c966a51deacdc51ac","stealthy","venture","a","2013-07-05",8294226
"121961d6dc6ed08c966a51deacdc51ac","stealthy","debt_financing",NA,"2012-08-14",250000
"5b66664504c08bedfe7c22624c9edf83","synthelis","venture",NA,"2014-01-21",784826
"ceaadb167a41332339bc8a5da9716c6d","synthesio","seed",NA,"2006-06-18",60000
"ceaadb167a41332339bc8a5da9716c6d","synthesio","venture","1","2014-03-14",2e+07
"ceaadb167a41332339bc8a5da9716c6d","synthesio","seed",NA,"2008-12-30",120000
"ceaadb167a41332339bc8a5da9716c6d","synthesio","venture","1","2011-09-14",2e+06
"5e942553f997a38a371cafda8a0dfc76","synthesys-research","debt_financing",NA,"2009-12-17",10814567
"2ad9393cdddc0cfd85697641d8acadcc","synthetic-biologics","grant",NA,"2013-09-23",5303380
"2ad9393cdddc0cfd85697641d8acadcc","synthetic-biologics","private_equity",NA,"2012-11-06",10800000
"ae8e583020124d767c4349867574211a","synthetic-genomics","venture","B","2013-02-05",10000001
"ae8e583020124d767c4349867574211a","synthetic-genomics","venture","a","2005-12-23",3e+07
"ee815aeae3cb0ffc42852f3bc1625f5a","synthicity",NA,NA,NA,NA
"a9b6deddd269ca3e4a91425fd89cf326","synthorx","venture","A","2014-04-21",6e+06
"e5a5f1c3a44ff5bcd930e58841ec28d7","syntropharma","venture",NA,"2009-12-29",640000
"e5a5f1c3a44ff5bcd930e58841ec28d7","syntropharma","venture","1","2006-11-24",1932043
"86f83ef9d65d8cb10ac16b874ed42d5c","syros-pharmaceuticals","venture","C","2016-01-12",4e+07
"86f83ef9d65d8cb10ac16b874ed42d5c","syros-pharmaceuticals","venture","a","2013-04-11",3e+07
"86f83ef9d65d8cb10ac16b874ed42d5c","syros-pharmaceuticals","venture","B","2014-10-27",5.3e+07
"b3cdcd656920e7496c57caed2c973174","sysomos","seed",NA,"2008-12-18",250000
"9ea80e55ea3ad9006281a86c5ae85af6","systech-integrators",NA,NA,NA,NA
"072483442745d1a0d287d4ed5dea48c4","systech-international",NA,NA,NA,NA
"6e1ac9e602a10822292095801f09c730","systems-in-motion",NA,NA,NA,NA
"9622dcf5a0c60c489c775744fa63117b","systemsx-ch",NA,NA,NA,NA
"9bd64d148ead019b557488af5b06eef4","sytrue",NA,NA,NA,NA
"0ac66abf62e270a5696bf3b32c366d56","syva-diagnostics",NA,NA,NA,NA
"16186ae5e93c9cf2029729992891defe","syzen-analytics","venture",NA,"2014-03-03",1e+05
"2781358bf3fa9c2558dec79d87c9a581","szemio",NA,NA,NA,NA
"292c75e638d7e123c470f1145f58bc37","szl-it","seed",NA,"2013-08-26",50000
"292c75e638d7e123c470f1145f58bc37","szl-it","angel",NA,"2014-06-07",1500000
"07a4b1cd0d62c41b11531a4282264a3b","t-cell",NA,NA,NA,NA
"8f4b19e206e100004d0a71ca8e83ce06","t-pro-solutions","venture",NA,"2014-06-18",780000
"8f4b19e206e100004d0a71ca8e83ce06","t-pro-solutions","seed",NA,"2014-06-03",780000
"ac85af9c74af14f457781ac074f3012a","t1d-exchange",NA,NA,NA,NA
"919027b48048b03d52efe7162be66c14","t3d-therapeutics","venture",NA,"2014-03-17",660997
"919027b48048b03d52efe7162be66c14","t3d-therapeutics","seed",NA,"2013-08-08",437000
"919027b48048b03d52efe7162be66c14","t3d-therapeutics","venture",NA,"2015-03-13",115002
"919027b48048b03d52efe7162be66c14","t3d-therapeutics","grant",NA,"2015-03-24",2e+06
"f2777a867b5344740060c88851c9d842","tatelecom",NA,NA,NA,NA
"6f93eb0aac93ebf7aa581e8e9a3c3e73","tableau",NA,NA,NA,NA
"eaf7c7bb36e2e38b77ec94e7e06daea9","tableau-software","venture","a","2004-01-01",5e+06
"eaf7c7bb36e2e38b77ec94e7e06daea9","tableau-software","venture","b","2008-08-01",1e+07
"d490a38181fd729866ea6de8940d4e58","taboola","venture","b","2008-11-18",4500000
"d490a38181fd729866ea6de8940d4e58","taboola","venture","a","2007-11-01",1500000
"d490a38181fd729866ea6de8940d4e58","taboola","venture","d","2013-02-19",1.5e+07
"d490a38181fd729866ea6de8940d4e58","taboola","venture","b","2011-08-25",9e+06
"d490a38181fd729866ea6de8940d4e58","taboola","venture","c","2012-06-26",1e+07
"d490a38181fd729866ea6de8940d4e58","taboola","venture","E","2015-02-04",1.17e+08
"d490a38181fd729866ea6de8940d4e58","taboola","venture",NA,"2015-06-04",3e+06
"cb643b016f621c0c8735d3c6ff1b2444","tabsys","private_equity",NA,"2015-06-30",125675.5058
"cb643b016f621c0c8735d3c6ff1b2444","tabsys","seed",NA,"2013-04-01",121648
"cb643b016f621c0c8735d3c6ff1b2444","tabsys","seed",NA,"2013-11-01",142447.8625
"cd9c3b94083a155995b83f2298881335","tacere-therapeutics","seed",NA,"2006-10-12",NA
"3385c716ff10eaff4e6e86212f8c288d","tachyus","venture",NA,"2014-04-10",7200000
"3385c716ff10eaff4e6e86212f8c288d","tachyus","debt_financing",NA,"2013-05-01",528000
"3385c716ff10eaff4e6e86212f8c288d","tachyus","venture","1","2015-06-01",1.3e+07
"bf45d18c2ae127b62901fd31edd440c8","taconic-farms",NA,NA,NA,NA
"1c7189592be43dab446e7a01e7528318","tactx-medical",NA,NA,NA,NA
"ecfa5635cda7d7c9d6554865140c2c39","tagb-io",NA,NA,NA,NA
"1ffb07c1f0c3ee1e140e3fef07971e2c","tagetik",NA,NA,NA,NA
"aa4fa71ac0f857598a18d48790b744b3","tagg",NA,NA,NA,NA
"efafc4aa0aedbe24b1a981b9878711e6","tagga","angel",NA,"2009-06-22",4e+05
"efafc4aa0aedbe24b1a981b9878711e6","tagga","venture",NA,"2010-02-16",47560
"07afc9f7471e26281318c674f85fa2e9","taggpic",NA,NA,NA,NA
"bd4dff3792374da318f6cfd7ec8dc624","tagmmer",NA,NA,NA,NA
"36dc5a42e51cae9eac6f473423c6b0a4","tagstand-2",NA,NA,NA,NA
"212c928443bac88f1318e4f675818b1e","tagsumo",NA,NA,NA,NA
"3f892cf70c16acb79a376eebf2a045bb","tagsurf",NA,NA,NA,NA
"adbf3bc4b8262474cfe57cdc53502676","taia-global","angel",NA,"2014-09-02",NA
"96d85ff49429c95b125f1ae5421a20de","taiga-biotechnologies","debt_financing",NA,"2010-04-15",246000
"96d85ff49429c95b125f1ae5421a20de","taiga-biotechnologies","venture",NA,"2014-06-04",3199997
"96d85ff49429c95b125f1ae5421a20de","taiga-biotechnologies","venture",NA,"2015-06-02",11999968
"eb35736afd938eb789d377986ba390bc","taigen","venture","b","2004-03-16",3.8e+07
"eb35736afd938eb789d377986ba390bc","taigen","venture","c","2009-01-01",3.7e+07
"7f8f7b111d9af181904a33b0e760f4fb","tail","angel",NA,"2013-01-01",5e+05
"925dc665e6a9f732d8080297aee7e302","tailwind","seed",NA,"2013-11-06",1e+06
"37b45fabcf2b67c884de73f11faa6242","taimed-biologics","venture","b","2010-03-31",2.2e+07
"d575a0412a08b472e67238f07e5ee5bf","taiwan-biotech",NA,NA,NA,NA
"24f31f2ac4b72650bfb6c1adbfe35f12","taiyen-biotech",NA,NA,NA,NA
"566c6cdc38292c20fe965507cb0868ba","tajitsu","seed",NA,"2012-10-01",2e+05
"566c6cdc38292c20fe965507cb0868ba","tajitsu","angel",NA,"2013-10-01",5e+05
"566c6cdc38292c20fe965507cb0868ba","tajitsu","seed",NA,"2014-05-01",6e+05
"af297ab06baf8f21fe8c9fc5fce99264","tak-analytics",NA,NA,NA,NA
"9df7b725da31f30439b1bc461d85f3db","take-net",NA,NA,NA,NA
"7ce9015fbb02e300dfc0de8d085e204e","takeda-bio-development-center",NA,NA,NA,NA
"d5751380de16dcdd3e7d1fb835fb718d","takeda-cambridge","venture","d","2006-07-07",12960000
"d5751380de16dcdd3e7d1fb835fb718d","takeda-cambridge","venture",NA,"2005-01-07",9380000
"98b114581ab5d1879f079aecf9455aa8","takeda-pharmaceutical",NA,NA,NA,NA
"aff96d5a72b9eb9142f34df12d6e004a","takefivepr",NA,NA,NA,NA
"b8f28a903be4fed586c73eabeead032c","takipi","seed",NA,"2011-12-01",NA
"b8f28a903be4fed586c73eabeead032c","takipi","venture","1","2013-12-04",4500000
"9e1209c947d026de6493fc697b4f43db","talech","seed",NA,"2014-01-01",NA
"a98ce8218e92999228f0e4ecb560310d","talecris-biotherapeutics",NA,NA,NA,NA
"bca7151df3139126b61a2b7a7723bc4e","talend","venture","b","2007-07-16",3500000
"bca7151df3139126b61a2b7a7723bc4e","talend","venture","d","2010-04-19",8080000
"bca7151df3139126b61a2b7a7723bc4e","talend","venture","c","2009-01-26",1.2e+07
"bca7151df3139126b61a2b7a7723bc4e","talend","venture","a","2006-06-01",4e+06
"bca7151df3139126b61a2b7a7723bc4e","talend","private_equity",NA,"2010-11-10",3.4e+07
"bca7151df3139126b61a2b7a7723bc4e","talend","venture",NA,"2013-12-11",4e+07
"acf5865d18c93575919bd0d8f82aec2d","talentbase",NA,NA,NA,NA
"5da8d6c556f7ebc6d450f287b451107a","talentiq","seed",NA,"2015-11-30",3e+05
"5da8d6c556f7ebc6d450f287b451107a","talentiq","seed",NA,"2015-11-06",150000
"5da8d6c556f7ebc6d450f287b451107a","talentiq","seed",NA,"2015-06-12",50000
"5da8d6c556f7ebc6d450f287b451107a","talentiq","seed",NA,"2015-08-19",75000
"294406548363285e7d11c530a7ef94ba","talentoday","seed",NA,"2013-09-01",650000
"294406548363285e7d11c530a7ef94ba","talentoday","seed",NA,"2014-10-01",8e+05
"c607c6c912b9d2fb0973bb50248deb76","talentora",NA,NA,NA,NA
"cd6e687dc839b6b6392c27fc54499111","talentsity","seed",NA,"2015-09-01",65000
"f423166162a0671add7f03ed0df46e1b","taligen-therapeutics","venture","b","2010-08-23",1e+07
"f423166162a0671add7f03ed0df46e1b","taligen-therapeutics","venture","a","2005-08-01",3750000
"f423166162a0671add7f03ed0df46e1b","taligen-therapeutics","venture","b","2008-01-01",6.5e+07
"4b50aa2cd23e7ed34b74414812c2231f","talima-therapeutics","venture",NA,"2005-04-01",2e+06
"4b50aa2cd23e7ed34b74414812c2231f","talima-therapeutics","venture","1","2007-05-29",1.9e+07
"a51c96ab03439bf7a9aa8e2d0a596971","talix","venture",NA,"2016-01-11",1.4e+07
"123836e900dae323dacf6b0d54c2e3bc","talkable","venture",NA,"2012-01-27",1200000
"123836e900dae323dacf6b0d54c2e3bc","talkable","seed",NA,"2011-03-01",NA
"8f076a1adf821e0ba4263c047056da56","talking20",NA,NA,NA,NA
"798fa1c79f478e3e58e3908cfd54f576","talking-data","venture","a","2013-11-26",1e+07
"798fa1c79f478e3e58e3908cfd54f576","talking-data","venture","B","2014-09-26",NA
"798fa1c79f478e3e58e3908cfd54f576","talking-data","seed",NA,"2013-06-01",NA
"3481a983e50e1c660692a9ccd8954135","talkinggame",NA,NA,NA,NA
"36ae2daecc8e8a085d495416e2804e77","talkingpoint-inc",NA,NA,NA,NA
"caf0dab653f22c574c325286f46800c2","talkwalker","venture",NA,"2013-07-01",4e+06
"356d2f38a775e01ba537046823d309d3","talkwheel","seed",NA,"2011-10-11",8e+05
"356d2f38a775e01ba537046823d309d3","talkwheel","seed",NA,"2014-04-16",1200000
"edcf0d3b19bfa03aba3054cf1f25ddea","taller-innovacin-abierta",NA,NA,NA,NA
"ef6599e83f1811a9f2493d02a37164ec","talon-therapeutics","venture",NA,"2012-01-11",10315800
"dd483295316d0e4b81d0ae7fb78531bc","talygen",NA,NA,NA,NA
"39087e8cb29084ed832dd4357e3eaceb","tamecco","venture","A","2015-12-17",2700000
"39087e8cb29084ed832dd4357e3eaceb","tamecco","seed",NA,"2014-03-12",1300000
"39087e8cb29084ed832dd4357e3eaceb","tamecco","seed",NA,"2013-01-20",8e+05
"e3ef53dea5c1a7c5b30fad4fa1d5a099","tamir-biotechnology","venture",NA,"2009-11-02",3250000
"e3ef53dea5c1a7c5b30fad4fa1d5a099","tamir-biotechnology","venture",NA,"2013-07-01",1e+06
"e3ef53dea5c1a7c5b30fad4fa1d5a099","tamir-biotechnology","undisclosed",NA,"2014-05-07",750311
"e3ef53dea5c1a7c5b30fad4fa1d5a099","tamir-biotechnology","debt_financing",NA,"2015-09-10",8e+05
"716e78ab20bc9f3bdd6c1e8c3fdec460","tamoco","seed",NA,"2012-10-02",NA
"716e78ab20bc9f3bdd6c1e8c3fdec460","tamoco","venture",NA,"2014-08-21",5e+06
"38b64a43111c032d19087910633bf851","tamr","venture","A","2014-05-19",1.6e+07
"38b64a43111c032d19087910633bf851","tamr","venture","B","2015-06-19",25200000
"6102379f2f106cc368be02b608ec7c94","coefficient","angel",NA,"2013-04-30",150000
"6102379f2f106cc368be02b608ec7c94","coefficient","angel",NA,"2012-08-01",3e+05
"6102379f2f106cc368be02b608ec7c94","coefficient","venture",NA,"2014-01-10",125000
"6102379f2f106cc368be02b608ec7c94","coefficient","venture",NA,"2014-10-31",950000
"5bd42f756fc6f44ac09d7113b21b134f","tandem-labs","venture","A","2005-06-23",18800000
"ff4a5aa9b0602e704fd4c15d07055550","tandem-technologies","venture",NA,"2010-06-08",12500000
"45ac4a7272bae2a4d070cac6f6b249a0","tangent-data-services","venture",NA,"2014-08-25",458538
"e38a624206db354d257a60a8a2d920a1","tangosol",NA,NA,NA,NA
"e80dddeb272a46e44e4308bd43c04597","tangshan-huakai-biotechnology-united",NA,NA,NA,NA
"66967f7281d850539cb25ca35279004c","tank-top-tv","seed",NA,"2013-05-01",52792
"66967f7281d850539cb25ca35279004c","tank-top-tv","grant",NA,"2012-06-01",15442
"e0ea11ab1f255f84528dcf0599ae1fe3","tansna-therapeutics","seed",NA,"2013-02-19",NA
"e0ea11ab1f255f84528dcf0599ae1fe3","tansna-therapeutics","undisclosed",NA,"2013-09-20",NA
"8ee8e84470f614e1eb0321428add27dd","tao-sales","seed",NA,"2013-12-18",20000
"080d0c8eada9e285fa3ece8031694dd8","tapclicks","angel",NA,"2012-12-21",1500000
"080d0c8eada9e285fa3ece8031694dd8","tapclicks","seed",NA,"2014-06-30",2500000
"080d0c8eada9e285fa3ece8031694dd8","tapclicks","seed",NA,"2014-11-01",2e+06
"10d690f583b4d04129fac675d3881192","tapcliq",NA,NA,NA,NA
"434279f69c8bf5dd191e8e66115bfb77","tapheaven-inc",NA,NA,NA,NA
"9c990562a247f12f1d9c98829b28be90","tapimmune","debt_financing",NA,"2009-11-10",135000
"9c990562a247f12f1d9c98829b28be90","tapimmune","debt_financing",NA,"2009-11-10",350000
"9c990562a247f12f1d9c98829b28be90","tapimmune","venture",NA,"2009-11-10",7e+05
"9c990562a247f12f1d9c98829b28be90","tapimmune","venture",NA,"2010-06-20",1275000
"118b3bdf886746610ea5d1451c466be0","taplytics","seed",NA,"2014-01-01",NA
"118b3bdf886746610ea5d1451c466be0","taplytics","seed",NA,"2015-05-20",2400000
"71ec2629caad7b4c964e19bb8110bf36","tapmap",NA,NA,NA,NA
"046fbc94a74a28dc103173df9bc93be1","tapngo-us",NA,NA,NA,NA
"3ae443b44a8295ff68717ac400d388a0","taproot-ventures",NA,NA,NA,NA
"b37b15166f97129f98948c482a9dfcaf","taptape",NA,NA,NA,NA
"6179216ffb068c7e9079ce2874d1c190","taptica","angel",NA,"2012-01-01",6e+05
"6179216ffb068c7e9079ce2874d1c190","taptica","undisclosed",NA,"2013-08-01",NA
"c5d2be1900e82ba8f07df2b3f8211755","taptrax","seed",NA,"2015-02-15",NA
"48eeddea29df8bf8028f41647b21f9af","tapway","seed",NA,"2015-09-30",NA
"4da1dd5b234b1d716a9edf4bb4b7dfbe","tara-biosystems","seed",NA,"2016-01-08",2250000
"a23ec6ee639daaa76201273c05a9cde1","taranis-2","venture",NA,"2015-03-09",NA
"41fc614280e35e83d5065a2fc60d8e0c","tarefa-simple","seed",NA,"2015-02-03",11118.3037
"5c9e4e67f4485684d3bfa339b2ebcb07","targacept","venture","A","2000-08-01",31414483
"5c9e4e67f4485684d3bfa339b2ebcb07","targacept","venture","B","2002-12-05",4.6e+07
"7a2425beffed362bd3cbfed1078fa27f","targanox","venture","a","2009-03-14",5100000
"d9176a798ff333c7dfe74f1e9dd35ac2","american-stem-cell","venture",NA,"2009-07-15",2500000
"2a50e4a5712f65ce513be0a1f903a735","targegen","venture","D","2007-07-12",4e+07
"2a50e4a5712f65ce513be0a1f903a735","targegen","debt_financing",NA,"2009-09-21",3728379
"3e3cdb49f02444f4b7592d3ebc58f6cb","targesome",NA,NA,NA,NA
"0e77a6323973d53f0750bf85f88d2c0d","target-data-2","debt_financing",NA,"2012-08-15",1e+06
"0e77a6323973d53f0750bf85f88d2c0d","target-data-2","venture",NA,"2011-02-10",3350000
"0e77a6323973d53f0750bf85f88d2c0d","target-data-2","venture",NA,"2014-12-18",2e+06
"0e77a6323973d53f0750bf85f88d2c0d","target-data-2","debt_financing",NA,"2015-08-28",1475000
"1a2714a430874063459ca0201ae469e8","target-info-labs",NA,NA,NA,NA
"9c5b76e130907fdb099dd982b9fa02e4","targetbase-marketing",NA,NA,NA,NA
"2ec595daaaf30112951063d5bebdfa98","targeted-genetics",NA,NA,NA,NA
"889f9ee76112b70c2cfd0ef80fb5d460","targeted-growth","venture","D","2007-02-07",22300000
"889f9ee76112b70c2cfd0ef80fb5d460","targeted-growth","venture","d","2006-05-22",1e+07
"889f9ee76112b70c2cfd0ef80fb5d460","targeted-growth","venture",NA,"2012-07-02",5e+06
"a97e2bb33d16f422ec4f7649d10ee271","targeted-medical-pharma",NA,NA,NA,NA
"c8b83eba2fa677d0244436812f5bb132","targetings",NA,NA,NA,NA
"5859dd3cbba183ef88d05c0d8899e499","targetrx",NA,NA,NA,NA
"b2ca1cecf3208dce9393c515ef670c47","targetsmart-communications",NA,NA,NA,NA
"30af076d519f4606c75a0589d01a0bed","targetta",NA,NA,NA,NA
"4a52a406bbbebdbe6872384f39dfabef","targit",NA,NA,NA,NA
"b0b0c8dd04fb51e5b1571aa863c79cf5","targovax","venture","a","2013-06-06",3600000
"6d1a25475bb92e1d1562198fdce6bd0b","taris-biomedical","private_equity",NA,"2015-10-27",3.2e+07
"6d1a25475bb92e1d1562198fdce6bd0b","taris-biomedical","venture","1","2009-06-25",1.5e+07
"6d1a25475bb92e1d1562198fdce6bd0b","taris-biomedical","venture","1","2011-04-13",18300000
"6d1a25475bb92e1d1562198fdce6bd0b","taris-biomedical","private_equity",NA,"2013-03-18",13500000
"6d1a25475bb92e1d1562198fdce6bd0b","taris-biomedical","venture",NA,"2009-12-04",5000001
"e2846a17abf4c05eed96141dd4ea6096","tarpon-biosystems","debt_financing",NA,"2012-07-31",5e+05
"e2846a17abf4c05eed96141dd4ea6096","tarpon-biosystems","debt_financing",NA,"2011-04-08",786000
"e2846a17abf4c05eed96141dd4ea6096","tarpon-biosystems","venture",NA,"2010-05-14",855000
"e2846a17abf4c05eed96141dd4ea6096","tarpon-biosystems","venture",NA,"2010-07-20",1431281
"f78bdf3ac40c3e1e22c0159786cdb8cf","tarsa-therapeutics","venture",NA,"2011-07-12",24500000
"f78bdf3ac40c3e1e22c0159786cdb8cf","tarsa-therapeutics","venture",NA,"2009-10-23",12050000
"f78bdf3ac40c3e1e22c0159786cdb8cf","tarsa-therapeutics","debt_financing",NA,"2011-04-21",15500000
"f78bdf3ac40c3e1e22c0159786cdb8cf","tarsa-therapeutics","venture","1","2010-01-17",2.4e+07
"f78bdf3ac40c3e1e22c0159786cdb8cf","tarsa-therapeutics","venture","1","2012-03-16",2.8e+07
"f78bdf3ac40c3e1e22c0159786cdb8cf","tarsa-therapeutics","venture","1","2014-05-29",7e+06
"f78bdf3ac40c3e1e22c0159786cdb8cf","tarsa-therapeutics","debt_financing",NA,"2014-08-13",1e+07
"1706b0cd689eac6590ca17e3228c1cf4","tascenthttp-www-tascent-com","venture","A","2015-09-17",18500000
"cd452aeb52ee9f79ae90cd2f8a80c277","taskbucks","venture",NA,"2015-11-16",1.5e+07
"d19d572c0e9e99860f855ddb5e19bb2a","taskpipes","venture",NA,"2013-12-01",NA
"d19d572c0e9e99860f855ddb5e19bb2a","taskpipes","seed",NA,"2014-12-01",120000
"7f6c0187e78bdece1647a8bb898a91bd","tastemakerx","venture","a","2012-02-08",1800000
"7f6c0187e78bdece1647a8bb898a91bd","tastemakerx","venture","b","2013-03-07",1250000
"3499709d0d3fb36469245fd16c0643c6","tatakoto",NA,NA,NA,NA
"e398ff4799e8a9c277649adea8845550","tattify",NA,NA,NA,NA
"46013145b53682244b0261dc43f7ca58","tau-therapeutics","venture",NA,"2014-06-12",12837500
"264e3067c09146563bddd0111202b0ac","taueret-laboratories",NA,NA,NA,NA
"904a3caad1c6f19bb7a4d64a22ef7e2a","tauriga-sciences",NA,NA,NA,NA
"dcfebd6319244b8a86ebaa79e05b8c91","taurx-pharmaceuticals","private_equity",NA,"2015-10-08",1.35e+08
"dcfebd6319244b8a86ebaa79e05b8c91","taurx-pharmaceuticals","venture",NA,"2012-11-20",31500000
"dcfebd6319244b8a86ebaa79e05b8c91","taurx-pharmaceuticals","private_equity",NA,"2013-03-05",10500000
"62145f5cbf2df3da5d8ade77efb22dd8","taveo",NA,NA,NA,NA
"35826bf6af8c63721d6634d844da1c83","tavex",NA,NA,NA,NA
"66565a64a4512967a6a81fcaf6163659","tawesoft-ltd",NA,NA,NA,NA
"6dad6a1347d6983511d6e492809d1519","taxassist-accountants",NA,NA,NA,NA
"0dfddad051cf7ddd1fbca61aebbb7597","tazti",NA,NA,NA,NA
"d1ee49b6b91a46340b450901d2fe1e39","tb-biosciences","venture","a","2013-07-18",1500000
"70c5120589b658ca96b77699f1e87046","tbc-holdings",NA,NA,NA,NA
"b0f0a46f8c2dfd5049a6cb61acf8ecfb","tbg-london",NA,NA,NA,NA
"5021726fbbcf664b8be81449f5be59e2","tbit-sistemas","venture","A","2015-01-02",1503657
"2ca1e92cb318765856643c53a7b66569","tcd-pharma","venture","a","2010-03-17",8940000
"1428b0b62384d5e80ea2d0905585c13d","tdc-as",NA,NA,NA,NA
"ab6856e0639cf4053f2de983d6838819","tdx","undisclosed",NA,"2013-01-01",NA
"1c14dfab5c5a70ed41afdc4bdaf77f1a","teachly",NA,NA,NA,NA
"f478ad09062145ab358edd5d886a2f73","teak","seed",NA,"2013-10-11",20000
"f478ad09062145ab358edd5d886a2f73","teak","seed",NA,"2013-05-01",125000
"0ec22c4350d62a2a308775ac64a2eaa8","teamie","seed",NA,"2011-03-24",387000
"72ce69d99894394a4939d626e7dd9bc4","teamlinks","venture",NA,"2010-01-13",2238920
"72ce69d99894394a4939d626e7dd9bc4","teamlinks","equity_crowdfunding",NA,"2009-07-23",NA
"6f92f36159dd7ca44c5daf04432cfd2e","tecbridge",NA,NA,NA,NA
"1bd618f220f591e69de535163cfbb770","tech-facts",NA,NA,NA,NA
"3aa5e1703af500e86bade092cc5fce8b","tech-pinions",NA,NA,NA,NA
"783059381f4ab5957dd24266125ca0ba","tech2globe-software-development-data-management-services-company",NA,NA,NA,NA
"12c6b385b53f08239de43bbdb7378773","techaspect-solutions",NA,NA,NA,NA
"adfc2eea78c281e4178668113409e062","techbase",NA,NA,NA,NA
"7f06fccf65f4ca28757aa82bd87b90b0","techchart",NA,NA,NA,NA
"63bb0fbdaf04e5e5f2abd51bbfbf434f","techistweb",NA,NA,NA,NA
"de22453e4862f13c55e84d4e61ea348b","techleads-online",NA,NA,NA,NA
"c3e4e844c95ad01777aa830c50be4a9d","techlookup-com",NA,NA,NA,NA
"f113fe012c6b859457dc9575f85a5e83","techmarc-labs-inc-",NA,NA,NA,NA
"7043479dc1cc8eda8e1b508e98595e45","technest-report",NA,NA,NA,NA
"ef54627f0e39eb1436e0373457f8f5d9","technical-associates-of-charlotte-p-c",NA,NA,NA,NA
"2588a33698ec3f232e4f98145c1920de","technimotion","venture",NA,"2009-06-06",180000
"5a68e708e845c82d098c8ddbef0298f4","technipoint",NA,NA,NA,NA
"0faf41227ec3f8e4f6c2d82ee27511ff","techno-aide",NA,NA,NA,NA
"810fbc3f8a427f9e2e647a041110d375","technobotz",NA,NA,NA,NA
"eef459c1c8dd1a8324f79769477e61d6","technologie-biolactis","venture","a","2006-02-07",1e+07
"982fa8b01b1b710225373a0a0a1ec60f","technology-advisors-inc",NA,NA,NA,NA
"6795a66b0e3178462269b18f04426c49","technology-evaluation-centers",NA,NA,NA,NA
"c63db4e68b47c551845a2929eaab72b1","technology-laboratory",NA,NA,NA,NA
"6173a5c4b7a363060ea3ddf9ebc57223","techpool-bio-pharma","venture",NA,"2009-06-05",20480000
"667356061f897625a66a0524c6657497","techtrendsit",NA,NA,NA,NA
"09f7295c2e16b048663fa3a8af29c43d","techulon","venture",NA,"2011-04-13",8e+05
"09f7295c2e16b048663fa3a8af29c43d","techulon","venture",NA,"2009-07-01",265000
"5aaed3d23567a15643572fb36cd3f319","tecnofarma",NA,NA,NA,NA
"deeb90f5d06c1846b7819d09c5bf56bb","tecomet",NA,NA,NA,NA
"401560b8886e0c99841a2b25ce78000d","tecrea",NA,NA,NA,NA
"7724d9c672eb1ceec1af897ede32f111","tecsol-software-pvt-ltd",NA,NA,NA,NA
"94f6b2206af66807e29a5633979ba3ed","tecto-id",NA,NA,NA,NA
"d205329cfa0f48a44290cc79e09efbac","tedi",NA,NA,NA,NA
"63268566d4c322c7464cb14efc6c2f18","tekmira-pharmaceuticals",NA,NA,NA,NA
"b701adb356113d9879718c7e1cd87469","teknicks",NA,NA,NA,NA
"2d524a2158fed88d765ab827382f682b","teknobuilding",NA,NA,NA,NA
"7c92792ea8cb7d0c33eba34c7c9775ac","teknovisio",NA,NA,NA,NA
"4637a9390df343bb355ecc7f6ffc010d","tekstum",NA,NA,NA,NA
"1b3539f8f1020ffd665a7b1b3ad16c49","tela-bio","private_equity",NA,"2013-08-14",6e+06
"1b3539f8f1020ffd665a7b1b3ad16c49","tela-bio","venture",NA,"2014-10-08",45370140
"1b3539f8f1020ffd665a7b1b3ad16c49","tela-bio","venture",NA,"2014-11-24",5e+05
"4907af900461864866724ee889bded51","teleanalysis",NA,NA,NA,NA
"e12816b5c6eb2ac9b3176a0f8613fc14","telectic","seed",NA,"2015-10-22",2319019.8276
"e6741841baf53d363da2f05e89e2bcb2","telegraph-hill-program-initiatives",NA,NA,NA,NA
"6b6bfe84850f429b1d13ecd4a74a4a7d","telemo-health",NA,NA,NA,NA
"eb97e26694b3ce2dc8a39ccb2dcdc776","telentrada",NA,NA,NA,NA
"8e594217119d0bbec5dbb0bef0b78e5c","teleretail-corporation","grant",NA,"2015-12-18",0
"8e594217119d0bbec5dbb0bef0b78e5c","teleretail-corporation","seed",NA,"2014-04-02",3e+05
"8e594217119d0bbec5dbb0bef0b78e5c","teleretail-corporation","seed",NA,"2013-07-01",50000
"8e594217119d0bbec5dbb0bef0b78e5c","teleretail-corporation","angel",NA,"2014-01-01",5e+05
"8d8422655c9ff3c3335f33c63a40db17","telesciences",NA,NA,NA,NA
"f36c0dc180aec2320144b62952ba5096","telesign-corporation","venture","A","2012-05-11",2.9e+07
"f36c0dc180aec2320144b62952ba5096","telesign-corporation","venture","B","2014-04-29",4e+07
"f36c0dc180aec2320144b62952ba5096","telesign-corporation","venture","B","2014-07-03",9e+06
"3318b325ef801e8984da9f4eb2995c6d","teleskin","seed",NA,"2014-09-17",86758.5613
"5cc832eab81d43a6a2f394d8beeeafb2","telesofia-medical","seed",NA,"2013-04-24",1e+06
"5cc832eab81d43a6a2f394d8beeeafb2","telesofia-medical","venture",NA,"2014-07-22",NA
"8003991d1aa96191c0b5f796a40454eb","telesta-therapeutics","venture",NA,"2015-08-20",28600000
"8b236fab43b231c952254ebdfd7d2fe4","teletrac-inc",NA,NA,NA,NA
"0b1dae89bafc44e67ac974a55272dcbe","teletracking-technologies",NA,NA,NA,NA
"dbedc8d286722f036776cad9c29c3d16","telik","venture",NA,"2014-05-22",4581250
"267cebcff2c5b526c7363f465e707ca9","tellagence","undisclosed",NA,"2015-04-17",NA
"267cebcff2c5b526c7363f465e707ca9","tellagence","venture","1","2012-05-31",25000
"267cebcff2c5b526c7363f465e707ca9","tellagence","venture",NA,"2013-01-29",NA
"267cebcff2c5b526c7363f465e707ca9","tellagence","venture",NA,"2014-01-27",NA
"267cebcff2c5b526c7363f465e707ca9","tellagence","undisclosed",NA,"2014-12-08",NA
"fbabdd43d7a0caca2846977de6702ed1","tellapart","venture","a","2010-04-13",4750000
"fbabdd43d7a0caca2846977de6702ed1","tellapart","seed",NA,"2009-07-17",NA
"fbabdd43d7a0caca2846977de6702ed1","tellapart","venture","b","2011-06-13",1.3e+07
"f43f75b3e3cd7d1edbc20a7055386d85","tellient",NA,NA,NA,NA
"50c03dd1cce747e65a1659611bc49101","telligent-data",NA,NA,NA,NA
"a5c88d319825c56a32f659269842b70e","telller","seed",NA,"2013-12-01",250000
"b5aa4d46b577377618423f2efacd7392","tellmegen","undisclosed",NA,"2014-06-12",270862
"c58d1486bbdda87a4c90574c30661885","tellspec",NA,NA,NA,NA
"8b3805d272c9ede9153dd7290e54f497","tellystream-by-greenflow",NA,NA,NA,NA
"32732caf7758f4418eabdbf0783492a0","telormedix","venture","b","2012-02-28",8300000
"32732caf7758f4418eabdbf0783492a0","telormedix","venture","b","2013-12-02",7925456
"1830a91b1d79b31804542f90b6982ef4","telsar-pharma","venture","a","2012-04-24",1.4e+07
"73a4c766cbbf63b1da4592b04bfe69b7","telspan-data",NA,NA,NA,NA
"aa7347168556bcff8868488f989470a1","telus-2",NA,NA,NA,NA
"5d024d8a12e7e5b1f3c320d991a2c0f1","templeman-automation",NA,NA,NA,NA
"373d1317f2aa78b56dcc338c44dab59c","tempo-ai-sri-spin-off-m","venture","a","2013-06-20",1e+07
"373d1317f2aa78b56dcc338c44dab59c","tempo-ai-sri-spin-off-m","seed",NA,"2011-12-01",2500000
"2e31d4d0be79502ca4239d2eb9618247","tempo-for-jira",NA,NA,NA,NA
"1af3178ca9568ab4b6b8fc345f334abc","tempo","venture","a","2013-10-09",3200000
"1af3178ca9568ab4b6b8fc345f334abc","tempo","seed",NA,"2012-01-01",118000
"1af3178ca9568ab4b6b8fc345f334abc","tempo","seed",NA,"2012-05-01",750000
"2fb6cc697a584cc23938fbb70e672999","tenderfish",NA,NA,NA,NA
"bfe14a3adf327a1a7edb53b6d4e65903","tendyne-holdings","venture","a","2013-05-20",11476197
"bfe14a3adf327a1a7edb53b6d4e65903","tendyne-holdings","debt_financing",NA,"2014-03-07",1e+06
"bfe14a3adf327a1a7edb53b6d4e65903","tendyne-holdings","venture","c","2014-04-09",2.5e+07
"26076d53b40dcb83988707e5a91e1906","tenet-healthcare-corporation",NA,NA,NA,NA
"0d0581b5cc058e1a7b8b8ecb2a0826f6","tengion","venture","c","2007-10-15",3.3e+07
"0d0581b5cc058e1a7b8b8ecb2a0826f6","tengion","venture","b","2006-06-23",5e+07
"0d0581b5cc058e1a7b8b8ecb2a0826f6","tengion","venture","a","2005-08-03",3.9e+07
"0d0581b5cc058e1a7b8b8ecb2a0826f6","tengion","venture",NA,"2011-03-16",31354278
"0d0581b5cc058e1a7b8b8ecb2a0826f6","tengion","debt_financing",NA,"2012-10-10",15005251
"0d0581b5cc058e1a7b8b8ecb2a0826f6","tengion","debt_financing",NA,"2013-08-07",74304002
"0d0581b5cc058e1a7b8b8ecb2a0826f6","tengion","venture","d","2013-07-01",33600000
"0d0581b5cc058e1a7b8b8ecb2a0826f6","tengion","venture","C","2008-11-19",2.1e+07
"922e86e52d7042b70174bd61c119a143","tenkod","private_equity",NA,"2014-01-01",170000
"922e86e52d7042b70174bd61c119a143","tenkod","seed",NA,"2014-07-01",5e+05
"210803347feb562b839924aba402a4c4","tenon-medical","venture",NA,"2012-10-17",5e+05
"ebe2dafb621d06eebb943c89378a0398","tensegrity-technologies","debt_financing",NA,"2011-04-27",981990
"d9c5d93e4f4d7e71dad10e8b456c513a","tensei-data",NA,NA,NA,NA
"898616c982c73593f8c458e7fc6b763b","tensha-therapeutics","venture","a","2011-09-12",1.5e+07
"bf6d91421f3784c67509dc0a6ae2edcd","tensor-media",NA,NA,NA,NA
"f2073d88da79ca6f94bd798d24d759dc","terafold-biologics-inc","seed",NA,"2013-03-13",40000
"6e00f0f74fdd9815ac2aee7910624525","teramatrix-technologies",NA,NA,NA,NA
"c1a4afc09a58811cd1a14f82c47ad24c","terapeak","venture","a","2010-12-21",3923937
"c1a4afc09a58811cd1a14f82c47ad24c","terapeak","angel",NA,"2008-04-17",998490
"d8953a11876d41368a417077d9888129","terapio","venture","a","2009-11-30",5e+06
"d8953a11876d41368a417077d9888129","terapio","venture",NA,"2008-06-18",1700000
"0675393d28ed3ac0b1a16265213e19fc","tercica","private_equity",NA,"2007-07-06",8e+06
"0675393d28ed3ac0b1a16265213e19fc","tercica","private_equity",NA,"2005-10-14",7.5e+07
"33f75d8fa6ba7e2f16cc7f2ef489a9ec","tergum","seed",NA,"2013-02-22",117500
"ba6e5c508fd69f93e9e0fae8c83240c2","terminus",NA,NA,NA,NA
"9f2534b614659de121dfc7510f7eee72","terrasoft",NA,NA,NA,NA
"e49da2263f7ba0c8b4d390fbf9b76b12","terraverde-renewable-partners-llc",NA,NA,NA,NA
"24818224b9e512c3ab5dfef06e1a6d89","terrazoom",NA,NA,NA,NA
"157b71f7c3b6cd88dcf4aff720cd5b35","territorio-creativo",NA,NA,NA,NA
"f2757482c92cfecdc2c59a87bda82349","tervela","venture","d","2009-09-15",1.8e+07
"f2757482c92cfecdc2c59a87bda82349","tervela","venture","c","2008-01-14",2e+07
"7c139694110cbe398d4a5519c4211941","tesa",NA,NA,NA,NA
"1105e7980b12832def3b5cb6edc87e04","tesaro","venture","a","2010-05-28",6e+07
"1105e7980b12832def3b5cb6edc87e04","tesaro","post_ipo_equity",NA,"2013-03-06",9.1e+07
"1105e7980b12832def3b5cb6edc87e04","tesaro","venture","b","2011-06-21",1.01e+08
"2589058ea746fc9f88bace23ecdd3e3e","teselagen",NA,NA,NA,NA
"342c822611230e7f5859c8d3e05f46c7","tesorx-pharma","venture",NA,"2013-07-30",3922979
"342c822611230e7f5859c8d3e05f46c7","tesorx-pharma","venture",NA,"2012-07-16",5922610
"342c822611230e7f5859c8d3e05f46c7","tesorx-pharma","venture",NA,"2014-05-15",1985000
"342c822611230e7f5859c8d3e05f46c7","tesorx-pharma","venture","1","2014-08-05",1e+07
"28106c600a3a0327f3b6b77fbdcbb5d4","testcloud",NA,NA,NA,NA
"386e8450c76683db91fb8e0a96c3ed14","tetherex-pharmaceuticals","debt_financing",NA,"2015-06-17",6e+05
"672a888a1adda4aa93032ececd84c665","tethis-2","venture",NA,"2015-12-10",2101283
"672a888a1adda4aa93032ececd84c665","tethis-2","debt_financing",NA,"2014-03-05",430700
"672a888a1adda4aa93032ececd84c665","tethis-2","seed",NA,"2013-02-06",775000
"ad61f1512dc6b7190d3d5777ab78d09b","tethys-bioscience","venture","C","2008-01-10",NA
"ad61f1512dc6b7190d3d5777ab78d09b","tethys-bioscience","venture","d","2009-11-09",2.5e+07
"ad61f1512dc6b7190d3d5777ab78d09b","tethys-bioscience","venture","a","2005-10-31",5400000
"237f8a8c01086b01ac9ba0e3cdbfca70","tetra-discovery","debt_financing",NA,"2013-07-11",666000
"237f8a8c01086b01ac9ba0e3cdbfca70","tetra-discovery","seed",NA,"2013-09-30",1e+06
"237f8a8c01086b01ac9ba0e3cdbfca70","tetra-discovery","debt_financing",NA,"2014-08-14",279000
"237f8a8c01086b01ac9ba0e3cdbfca70","tetra-discovery","seed",NA,"2015-09-03",1e+06
"d46c188d82b3653b0a2db163b8061bf1","tetragenetics","grant",NA,"2016-01-14",1540000
"d46c188d82b3653b0a2db163b8061bf1","tetragenetics","venture",NA,"2012-08-28",2474231
"d46c188d82b3653b0a2db163b8061bf1","tetragenetics","venture",NA,"2009-11-24",490308
"d46c188d82b3653b0a2db163b8061bf1","tetragenetics","venture",NA,"2013-06-05",502000
"d46c188d82b3653b0a2db163b8061bf1","tetragenetics","venture",NA,"2015-03-09",338191
"e6d9112875f4d6ac618a4e2f240e7092","tetralogic-pharmaceuticals","venture","c","2010-08-10",3.2e+07
"e6d9112875f4d6ac618a4e2f240e7092","tetralogic-pharmaceuticals","venture","c","2011-01-04",2.3e+07
"e6d9112875f4d6ac618a4e2f240e7092","tetralogic-pharmaceuticals","debt_financing",NA,"2010-03-24",2e+06
"e6d9112875f4d6ac618a4e2f240e7092","tetralogic-pharmaceuticals","venture","c","2011-05-24",6e+06
"e6d9112875f4d6ac618a4e2f240e7092","tetralogic-pharmaceuticals","venture","c","2010-09-27",5e+06
"e6d9112875f4d6ac618a4e2f240e7092","tetralogic-pharmaceuticals","debt_financing",NA,"2012-12-13",5e+06
"ee6c6c6589070b963ba988b565891f52","tetraphase-pharmaceuticals","venture","A","2006-11-27",10040000
"ee6c6c6589070b963ba988b565891f52","tetraphase-pharmaceuticals","venture","c","2010-06-01",4.5e+07
"ee6c6c6589070b963ba988b565891f52","tetraphase-pharmaceuticals","venture",NA,"2009-09-22",1e+07
"ee6c6c6589070b963ba988b565891f52","tetraphase-pharmaceuticals","venture","a","2008-08-07",1.5e+07
"cc70b2f2cc18ae083848206599ad6797","teva-pharmaceutical-industries",NA,NA,NA,NA
"7d237dfb127996cabeae93f1c0cf5275","tevizz","seed",NA,"2013-04-01",8e+05
"7a52b77581a506e41dcf05a9598165a8","texas-biotechnology-corporation",NA,NA,NA,NA
"6f9189db1b23475233b487b4b730f7ab","the-texas-emerging-technology-fund",NA,NA,NA,NA
"f6dcf4f99a70cc2ada7cdc3387a258ab","texifter","seed",NA,"2011-01-15",180000
"72a2d4b26a857d8b1e5a3062cb4f325b","text-factory","seed",NA,"2015-10-22",176506.5816
"8da9c12af0b5bafb3c5f723b030b8ead","textimator",NA,NA,NA,NA
"8f8140de74769742459fd962b1cfe2d5","textminded",NA,NA,NA,NA
"bbb16a5df1b14773d025f710eff8af3b","textnomics",NA,NA,NA,NA
"399feda273a1fca82086d7233c1ad089","textocat",NA,NA,NA,NA
"c5e4eeaef3748b6f9e114527da14dd68","textractme",NA,NA,NA,NA
"cf3dd6370165adfa23224e8a53cfb14a","texts-from-last-night",NA,NA,NA,NA
"855750cb3bc9f037fcfa6217ff9c7bba","textual-analytics-solutions","venture",NA,"2008-06-18",250000
"d139cc70928eaf2054c3833a0d0a3b4e","tfunnel",NA,NA,NA,NA
"37efd8dc4a48d68e3f80a81b111715f6","tg-therapeutics","venture","a","2012-02-29",2.5e+07
"ecd282c9a4e0559fea8a2496ebfa451b","tgr-biosciences","venture",NA,"2005-07-26",2240000
"5f85452de8bd386cab9c4fbee4ce67c9","tgs-knee-innovations","venture",NA,"2010-02-18",6e+05
"5f85452de8bd386cab9c4fbee4ce67c9","tgs-knee-innovations","venture",NA,"2011-05-20",1532250
"22b54aa4a706b339b7f3f2f97048fa48","thallion-pharmaceuticals",NA,NA,NA,NA
"7a6e788c3aa5d5839031c89d95ffb127","thar-geothermal","seed",NA,"2011-06-30",NA
"d7d35e16d835361cb440ab139fa66113","thar-pharmaceuticals","venture","a","2011-01-05",4311656
"d7d35e16d835361cb440ab139fa66113","thar-pharmaceuticals","debt_financing",NA,"2013-11-20",3940000
"d7d35e16d835361cb440ab139fa66113","thar-pharmaceuticals","debt_financing",NA,"2009-12-21",1242000
"d7d35e16d835361cb440ab139fa66113","thar-pharmaceuticals","seed",NA,"2013-09-22",NA
"d7d35e16d835361cb440ab139fa66113","thar-pharmaceuticals","debt_financing",NA,"2014-09-02",115000
"f0687f41249f30fbca28cf8ec0d72fa1","thatneedle",NA,NA,NA,NA
"1f1d7ffe3fbdda3918a0751a7afac1ce","the-10-percent-agency","angel",NA,"2015-01-20",NA
"b9284e7e06e1f4b38d274afc2f148fc7","the-advisory-board-company","venture",NA,"2007-11-27",NA
"7a2ea4e393149df1528fb82402efae1b","the-alex-edwards-consulting-group",NA,NA,NA,NA
"cf58ee29192cb6d9edcdbfe8fa2d2e3e","the-ant-works","angel",NA,"2014-03-28",1e+05
"5f7682c9397ead072872b68de33532ca","the-appside",NA,NA,NA,NA
"b24553b870e9c69d5f0016dbe3612465","the-box-populi","undisclosed",NA,"2014-04-12",NA
"f024f5aef440d317f3822256b972f700","the-brian-madden-company",NA,NA,NA,NA
"22da3204a6153d4aa54d37bb0fbf8d84","the-buying-networks","equity_crowdfunding",NA,"2013-11-14",NA
"38a03b42ae7bbe9a15d4ba5e213c06ca","the-cambridge-group",NA,NA,NA,NA
"a8ab5624206a0f7c505eb802fa444bb3","techknit-it-enabled-services-pvt-ltd",NA,NA,NA,NA
"e82cd6d4b8067bd2026a3bdcf087d4fd","the-chocolate",NA,NA,NA,NA
"dc1f03939ccef5b6c5ea692c02194e98","the-cloudminer",NA,NA,NA,NA
"4ec3f360159e9bcaa5a0e7e768e5159e","the-comments-section",NA,NA,NA,NA
"b19a6f3e9b93d9bd32555d3b2250d0d5","the-conversion-republic",NA,NA,NA,NA
"b025f06c2f0a109678511955d495d476","the-createch-group",NA,NA,NA,NA
"f998b21c91061334fe4bb1b25825cd79","the-curious-al-company","seed",NA,"2015-10-01",894429.382
"24774ba19294076c526bb7cc574fa110","the-daily-smarter",NA,NA,NA,NA
"9726765c688f6ef7b29f02e6c29f0c74","the-design-boyz-ltd",NA,NA,NA,NA
"c9af28ccb2aa011cba6179cd66404cf4","the-digital-consultancy",NA,NA,NA,NA
"3422c7d19d42ae8f0fdb12c7b13d387e","the-east-campus-biotech-business-incubator",NA,NA,NA,NA
"cd96ab3976c9e7baa5f7d8aa4755dea1","the-economist-intelligence-unit---eiu",NA,NA,NA,NA
"88fe267c885a5a4daf5992534f0368a2","the-event-app",NA,NA,NA,NA
"24b13c6bb27b80595cdeafc612a15b6d","the-experience-project",NA,NA,NA,NA
"140f5ff0f6b89b0197a40aae163c01ab","the-falconry-group",NA,NA,NA,NA
"ebc4fa85b1304b84bc34352958e0539c","the-found-table",NA,NA,NA,NA
"5a1db5df391cdebfd327e8fc8b38352f","the-fuelist",NA,NA,NA,NA
"1884cfc748e816a93108223968b146aa","the-gomez-firm",NA,NA,NA,NA
"f1967a406cd9b35127e123129d5026df","the-gothard-group",NA,NA,NA,NA
"2493678d2621958ca5d6a5671c5d5835","the-hackerati",NA,NA,NA,NA
"a089a2caa2f35101a5b4551b992382a6","the-hitch","venture",NA,"2013-08-01",50000
"c51eabefe0b653a386e94e4d882bc204","the-hudson-institute",NA,NA,NA,NA
"d096b4c380108be9922e94ca2ef4bb21","the-immune-response-corporation",NA,NA,NA,NA
"c9094d4114b8b1ee86d43ffe8df5600f","the-independent-co-founder-of-webcontentspecialists",NA,NA,NA,NA
"8f9e361f8cbc27920add0d82e371b0e0","the-insight-effect-group",NA,NA,NA,NA
"37cc1d4abcd24ce826950a9313365768","the-internet-time-machine",NA,NA,NA,NA
"6693e5930129ea806b3a71f886afb7e4","the-jackson-laboratory","grant",NA,"2011-04-13",429933
"6693e5930129ea806b3a71f886afb7e4","the-jackson-laboratory","grant",NA,"2011-09-30",5.8e+07
"6693e5930129ea806b3a71f886afb7e4","the-jackson-laboratory","grant",NA,"2015-08-10",1500000
"e725e9737e05e3f97dec4f8d85aa8e36","the-jonah-group",NA,NA,NA,NA
"5cbe1d75a01a0a88913288e8ff4681df","the-kerekes-group",NA,NA,NA,NA
"3e806bd0f6f698b629fdeb49c5e6b01f","the-liposome-company",NA,NA,NA,NA
"2f6e4c9e0287930db6df80c7666a6f5a","the-loadstar",NA,NA,NA,NA
"93d04afbcfee70fd8d661aa20bda97b2","the-loncar-cancer-immunotherapy-index",NA,NA,NA,NA
"3460112ef4ea36ae29903d31833df448","the-longevity-fund",NA,NA,NA,NA
"514dd54bf4311438c1bd62edffeb6f3e","the-lost-agency",NA,NA,NA,NA
"d9f1113a64f34564cf23830dfb18271a","the-marine-biological-association-of-the-uk",NA,NA,NA,NA
"e6a9ba55205c0cee9e78e10824878058","the-marketing-science-department",NA,NA,NA,NA
"7d48c8bfd6d03da0c19f1868b349bde3","the-mcgraw-hill-companies",NA,NA,NA,NA
"1c5283a71324d029c046f1d7bb627f56","the-media-kitchen",NA,NA,NA,NA
"b04a5431e262ace4dd99c3b262854ba5","the-medicines-company",NA,NA,NA,NA
"3ba3cc8aae67c189ebf893d492b3f291","the-middleby-corp",NA,NA,NA,NA
"f08e1b65caff511aea29c2095b3883d1","the-on-demand-economy",NA,NA,NA,NA
"1aece70f597aee3f89d3df7f09dcb09e","the-peckham-society",NA,NA,NA,NA
"d7e765870202d1bd0b8004ee0bf8d2eb","the-pedowitz-group",NA,NA,NA,NA
"4d044100512bbeab7473d1dbb0d214e2","the-publisher-desk",NA,NA,NA,NA
"b1c4f150e9f3df17f4b9ebfc2977a3de","the-romero-agency",NA,NA,NA,NA
"6aa4f6314bfae578577c7b77c74a0753","seoeng",NA,NA,NA,NA
"3dc1e33be8f816792748064e1a1ed830","the-social-foundry",NA,NA,NA,NA
"26d9e16e869bae783b52a5b1ada273af","the-social-station",NA,NA,NA,NA
"550a7ad8825f1f2cd5d6b66833af1226","the-sports-quotient",NA,NA,NA,NA
"a7b69d1e20ef7396e14fee49182512a9","the-stakeholder-company","seed",NA,"2012-12-01",482786
"98f38245bcf60a4c097e40c0a28b16cc","the-sterling-group",NA,NA,NA,NA
"48c9a0201ef7e2c71708affc1b5a44c0","the-sumo-advantage",NA,NA,NA,NA
"0237347d8c2f89e5bb57e1331ecf54a9","the-super-h-index",NA,NA,NA,NA
"194e05d1975816d92b5ce492f6730668","the-surgical-center","venture",NA,"2009-10-14",134452
"31ae91229f188e0b92533cbdc20dacb3","safety-with-accountability-transparency-swat",NA,NA,NA,NA
"cb78568dc06a0426ba440f1697dce152","the-target-labs",NA,NA,NA,NA
"8ac32cbb48c4ef850c95390b49d4dcac","the-tech-stuff",NA,NA,NA,NA
"0e1d9da21fc6286f37b65e9d1dd4f282","the-ticket-fairy","seed",NA,"2015-05-20",485000
"0e1d9da21fc6286f37b65e9d1dd4f282","the-ticket-fairy","seed",NA,"2015-08-17",120000
"4d3f6782a4b2dc1d98aaa4100e2b82b8","the-timken-company",NA,NA,NA,NA
"a2cb7620468f70da59cb0701c7d3e632","the-toro-company",NA,NA,NA,NA
"f1a2e868fabf19effa66ca3301b75c52","the-voice-software",NA,NA,NA,NA
"93118072f701c7f86ee58073298790b2","the-web-index",NA,NA,NA,NA
"767131ceebc82a38b5a8b0517247ba34","the-wellcome-foundation",NA,NA,NA,NA
"c8ae1bd436a7cdb49457b8ddd641f093","the-world-of-pictures","angel",NA,"2012-06-01",80093
"12056794cdaacf4988d3567b232212ee","theboomtown",NA,NA,NA,NA
"e581211dc83cf21bf3ba7e091bbc6d44","thehomesites-com",NA,NA,NA,NA
"09f5769bfa6c54cb95e95d7644cf3cbd","theken-spine",NA,NA,NA,NA
"45fd3ef539304bb3722c0d29a0e083b2","thelial-technologies","angel",NA,"2009-07-01",84549
"45fd3ef539304bb3722c0d29a0e083b2","thelial-technologies","seed",NA,"2010-12-01",392584
"bec6b20a015cd7a291197e6ad78bc757","themis-bioscience","venture",NA,"2015-05-06",7800000
"ac4eaabadd193be13dcaa9233309c712","theocorp-holding-company","venture",NA,"2009-05-01",9e+05
"b8ed57809d3396ac64394fc10bb6b5d0","therabiol","venture",NA,"2012-10-15",150000
"04ac841f26fcdfe5e8ed2215f5e6799b","therabiologics-inc","equity_crowdfunding",NA,"2012-07-30",NA
"b4e4dabe696f62fb21134581205e5e33","therabron","venture","B","2015-11-09",6750000
"b4e4dabe696f62fb21134581205e5e33","therabron","venture","B","2014-12-17",11100000
"51e09a44a831d36d0a292ed694e015e9","therachon","venture","A","2015-09-30",3.5e+07
"48defeaec3459fa5c18ece953bd6d35b","theraclone-sciences","venture","b","2010-03-17",1500000
"48defeaec3459fa5c18ece953bd6d35b","theraclone-sciences","venture","b","2013-03-25",8e+06
"48defeaec3459fa5c18ece953bd6d35b","theraclone-sciences","debt_financing",NA,"2013-03-25",6e+06
"48defeaec3459fa5c18ece953bd6d35b","theraclone-sciences","venture","b","2011-11-08",11584603
"48defeaec3459fa5c18ece953bd6d35b","theraclone-sciences","venture",NA,"2015-05-07",3080000
"29d0fe79f5e7ead370dc8ca103fcc7ae","theracoat","venture","a","2013-05-21",7e+06
"98952a2998ba11c13096e09395b4dfd5","theracos","private_equity",NA,"2016-01-15",2.5e+07
"98952a2998ba11c13096e09395b4dfd5","theracos","private_equity",NA,"2013-09-23",93092700
"c70c3d66102938f9bb19f6e3dd35e367","theracrine",NA,NA,NA,NA
"caf4d8effa46230bfbc6bac7bfdc654e","theragene-pharmaceuticals","venture",NA,"2014-03-14",348000
"caf4d8effa46230bfbc6bac7bfdc654e","theragene-pharmaceuticals","venture",NA,"2015-08-11",2e+05
"4f6a78493a7db70d1362b5e1ba96db92","theragenic",NA,NA,NA,NA
"c590dc7c33a9597547b5407521941991","theramyt-novobiologics","venture","a","2013-10-11",4500000
"06fdc30c99cd05f3a098385c34b3e2f5","theranos","venture",NA,"2010-07-08",4.5e+07
"06fdc30c99cd05f3a098385c34b3e2f5","theranos","venture","1","2005-02-11",5800000
"06fdc30c99cd05f3a098385c34b3e2f5","theranos","venture","1","2006-02-21",9100000
"06fdc30c99cd05f3a098385c34b3e2f5","theranos","venture","1","2006-11-17",28500000
"06fdc30c99cd05f3a098385c34b3e2f5","theranos","private_equity",NA,"2014-06-12",NA
"6a0a953e22829b6073c9f7031275b443","theranostics-health","venture",NA,"2011-06-21",530000
"6a0a953e22829b6073c9f7031275b443","theranostics-health","venture",NA,"2012-12-28",1500000
"6a0a953e22829b6073c9f7031275b443","theranostics-health","venture",NA,"2011-05-22",1e+06
"6a0a953e22829b6073c9f7031275b443","theranostics-health","venture",NA,"2014-04-15",2e+05
"6a0a953e22829b6073c9f7031275b443","theranostics-health","debt_financing",NA,"2013-07-30",1095000
"6a0a953e22829b6073c9f7031275b443","theranostics-health","venture",NA,"2015-06-29",855000
"6a0a953e22829b6073c9f7031275b443","theranostics-health","debt_financing",NA,"2015-01-16",3e+05
"4f0bda713ca29363d770245362545144","theranova-llc",NA,NA,NA,NA
"a6423277610564d41bd3bf7b2eb26793","therapeutic-human-polyclonals",NA,NA,NA,NA
"b19b897bb71c5fbf4edbb35c6ac6a1b1","therapeutic-monitoring-services","venture",NA,"2009-10-08",1e+05
"0d3488466d0e96936a2304fe8a379e37","therapeutic-peptides",NA,NA,NA,NA
"4477b91c8b2dd0c81cb3817445ee103f","therapeutic-proteins","venture",NA,"2010-07-13",2500000
"e375ad10d7678b56c081c31334797ea1","therapeutic-solutions-international","venture",NA,"2015-05-07",1e+05
"da6c5b745b9519cb6faf9026a982d51d","therapeuticsmd","post_ipo_equity",NA,"2013-10-10",3.3e+07
"da6c5b745b9519cb6faf9026a982d51d","therapeuticsmd","post_ipo_equity",NA,"2012-10-11",8500001
"11a7af8184cc7e8b2ad1092a4683dee9","therapix-biosciences",NA,NA,NA,NA
"3944863cd011d862dd2dbfc71f953dfd","theraplay",NA,NA,NA,NA
"09fca6e1fadbd209e16ff643e9277ab7","therasim","venture","a","2010-01-07",1250000
"fa93e0e5fb7f52be20b85821d6c86b9c","therasis","venture","a","2009-12-08",1.2e+07
"3f872f45ee78ff14d9dfaa0082556cef","therasport-physical-therapy","seed",NA,"2012-10-09",50000
"64774f18569c87a535fa000683fd01eb","theratechnologies",NA,NA,NA,NA
"ddf4463cd740bf39bb4c25cbf3034c66","theratest-laboratories","venture",NA,"2015-02-10",490000
"be1eb28fd7d73404bc07755e4006a01d","theravance","private_equity",NA,"2010-11-29",129375000
"55e56cd382d2c7824609c1fcb2924e36","theravasc","venture",NA,"2014-03-18",350000
"55e56cd382d2c7824609c1fcb2924e36","theravasc","venture",NA,"2013-11-14",172501
"55e56cd382d2c7824609c1fcb2924e36","theravasc","venture",NA,"2010-01-06",5e+05
"55e56cd382d2c7824609c1fcb2924e36","theravasc","venture","1","2010-09-27",2350000
"89528634e78180889533b79d8ac6654f","theravectys","venture","d","2013-10-16",18913020
"89528634e78180889533b79d8ac6654f","theravectys","venture","c","2012-09-04",9409092
"89528634e78180889533b79d8ac6654f","theravectys","grant",NA,"2015-01-26",2127246
"a1530e48328174074627c0aee7057931","theravida","venture",NA,"2012-04-01",1e+06
"a1530e48328174074627c0aee7057931","theravida","debt_financing",NA,"2010-07-06",3600000
"a1530e48328174074627c0aee7057931","theravida","venture","1","2012-03-23",8904894
"0c0955a179b3b4a2c313bef5bbf926fa","therewolf",NA,NA,NA,NA
"6baed35de669ded47b3494359629de8d","thermalin-diabetes","seed",NA,"2010-03-29",250000
"6baed35de669ded47b3494359629de8d","thermalin-diabetes","venture","1","2013-07-10",3142094
"6baed35de669ded47b3494359629de8d","thermalin-diabetes","venture",NA,"2010-10-21",1903897
"6baed35de669ded47b3494359629de8d","thermalin-diabetes","debt_financing",NA,"2013-09-03",2525000
"6baed35de669ded47b3494359629de8d","thermalin-diabetes","venture","1","2011-03-28",2850000
"6baed35de669ded47b3494359629de8d","thermalin-diabetes","venture","1","2014-07-28",5900000
"4f1937820d5a8147cbe795a43b8367a7","thermedical","venture","a","2012-03-20",1500000
"4f1937820d5a8147cbe795a43b8367a7","thermedical","venture","a","2013-05-15",5500000
"301493726a2aebc780e329400005c228","thermo-electron",NA,NA,NA,NA
"b0422dd2b32aefc0a274c65351f5c8a9","thermo-fisher-scientific",NA,NA,NA,NA
"dcd4961513e7aa44cbe19159ae1ff6ca","thermoaura","grant",NA,"2013-11-01",750000
"cf78d8eca45058d072b70c890d539314","theron-pharmaceuticals","debt_financing",NA,"2009-05-05",180000
"cf78d8eca45058d072b70c890d539314","theron-pharmaceuticals","venture",NA,"2010-05-17",957670
"cf78d8eca45058d072b70c890d539314","theron-pharmaceuticals","venture",NA,"2011-05-19",662550
"cf78d8eca45058d072b70c890d539314","theron-pharmaceuticals","venture",NA,"2015-08-06",409099
"06c608cb360987830bfa9cd76816f497","therosteon","undisclosed",NA,"2008-04-01",NA
"f4e531258ffb58767e5456db42124145","thesan-pharmaceuticals","venture","a","2012-10-31",1.6e+07
"f4e531258ffb58767e5456db42124145","thesan-pharmaceuticals","venture","b","2014-02-24",4.9e+07
"2b3c96937b9a31dc00bbcf4b1f3fddc7","thescaffold",NA,NA,NA,NA
"a8387be12db9c894995e9ee11cd8082a","theshelf","seed",NA,"2013-05-01",NA
"eafbe18a0677bf5fe02fb3700c4dfb12","thesocialcv-com","venture","a","2008-01-01",950000
"0260f5eb509cc8ee369f33a7fc2b234c","thesuitest",NA,NA,NA,NA
"118d5eba4792ae3e286e13cdea44d077","thesys-group",NA,NA,NA,NA
"f21d78e1b4d1bf2043aae6f4d9597287","thetaray","venture","C","2015-12-01",1.5e+07
"f21d78e1b4d1bf2043aae6f4d9597287","thetaray","seed",NA,"2013-01-01",NA
"f21d78e1b4d1bf2043aae6f4d9597287","thetaray","undisclosed",NA,"2013-08-05",NA
"f21d78e1b4d1bf2043aae6f4d9597287","thetaray","venture",NA,"2014-07-01",NA
"f21d78e1b4d1bf2043aae6f4d9597287","thetaray","venture","B","2014-07-29",1e+07
"9df628ee71d049878a700ad8ee9f7571","thetus-corporation",NA,NA,NA,NA
"b6b126e83cc646f7768ea44913bfd3a9","thewebminer",NA,NA,NA,NA
"cdc6cadc778266e95f83538c25b78eff","thewhollysee",NA,NA,NA,NA
"6a5c7bf7b2a82dfc9e147067e8324f17","thewonk-eu",NA,NA,NA,NA
"e6edabb2e79b17bdf0abbd6687a0c186","theysay","undisclosed",NA,"2012-02-17",791661
"e6edabb2e79b17bdf0abbd6687a0c186","theysay","venture","1","2014-12-18",1566301
"4ee8546c97280a17d56e850d755891b9","things-for-work",NA,NA,NA,NA
"bc600351f1a1045dba434a21fa894503","think-analytics-india",NA,NA,NA,NA
"3c18f6bc70f36ddceb69962fc647478f","think-big-analytics","seed",NA,"2013-02-05",3e+06
"3c18f6bc70f36ddceb69962fc647478f","think-big-analytics","venture",NA,"2012-07-18",1200010
"553915cf974bc9205524ddf8f4b14998","think-mantra",NA,NA,NA,NA
"0d8aa530759b7e9d657adf02ae7a52d9","thinkfusion",NA,NA,NA,NA
"d8882866e44eec823360de681c237268","thinking-machines-corporation",NA,NA,NA,NA
"1f47bbb4ed3ac4d98f030e3f83c0d0b1","thinking-solutions",NA,NA,NA,NA
"89696d74d1ebb867ee81e403b9ef0613","thinkmarketgrow",NA,NA,NA,NA
"0ca15f5b1a6a51544c0f828638abd73d","thinknation","seed",NA,"2014-03-05",30000
"0ca15f5b1a6a51544c0f828638abd73d","thinknation","seed",NA,"2015-09-10",250000
"7b41e65984d9b8a8ffea7b2fce595646","thinknum","seed",NA,"2014-07-28",1e+06
"fcc0901d691407bea019a4ba6efce6cb","thinksmart","angel",NA,"2014-07-18",838540.3987
"fcc0901d691407bea019a4ba6efce6cb","thinksmart","angel",NA,"2008-12-28",2597645
"165430f4ccac64b9143ff8d3d51cfa22","thinkvine","venture","c","2012-01-10",8e+06
"165430f4ccac64b9143ff8d3d51cfa22","thinkvine","venture","C","2012-12-10",3e+06
"165430f4ccac64b9143ff8d3d51cfa22","thinkvine","venture","C","2014-05-25",1e+06
"f5bdfddd9e4034a816d4f3fec1fb026a","thinxnet",NA,NA,NA,NA
"b8faf080e8e6a0c64e51e5979ff64e8f","third-wave-technologies","venture",NA,"2007-12-10",2.5e+07
"7a3256c1de60ea99ad4653c00a639191","thirdshelf",NA,NA,NA,NA
"08dc62c16b2160d8322f87b957d402a8","thirdsight",NA,NA,NA,NA
"a3eca882c703d04d1ccd8d4297c8214a","thirstie","seed",NA,"2015-03-19",1100000
"6b5bf9c194c0f2835c54f90191e1c3c8","this-here",NA,NA,NA,NA
"1452a96f72dfefe0033f496a2baa9ca3","thomas-medical",NA,NA,NA,NA
"af1cb2342108fc02272a5ade65278655","thomson-reuters",NA,NA,NA,NA
"f3b7e83c25a8ecd2c04d77c7aa6fea9b","thoratec",NA,NA,NA,NA
"73b7dce43b44b6673fa1c7a7011b0e4e","thorne-holding","venture",NA,"2010-07-07",3.3e+07
"73b7dce43b44b6673fa1c7a7011b0e4e","thorne-holding","venture",NA,"2011-05-24",12700000
"2c571f22f7406efe52f79f2ec18d4952","thought-into-design",NA,NA,NA,NA
"41bf4218b98be00505ffc71867f54a89","thoughtleadr","angel",NA,"2011-05-16",4e+05
"7f7d0d151d29374bb790b13f18a98153","thoughtly","angel",NA,"2013-12-10",125000
"7f7d0d151d29374bb790b13f18a98153","thoughtly","seed",NA,"2015-02-26",NA
"3ac9c01e847f752a181b0f2828571088","thoughtspot","venture","a","2012-06-16",10700000
"3ac9c01e847f752a181b0f2828571088","thoughtspot","venture","B","2014-06-18",3e+07
"5bf250da79959a6baacb28d8c485ca74","thoughtstream-consulting",NA,NA,NA,NA
"f652167ba34d4e0804b9ebe8ad50e3b0","thrasos","venture","c","2012-10-25",3.5e+07
"f652167ba34d4e0804b9ebe8ad50e3b0","thrasos","venture","D","2015-03-31",2.1e+07
"193a903a798164e891790345b183c2eb","thrasys-inc",NA,NA,NA,NA
"587cd7368f6f70cc929f56b4862c64e0","thrdplace","seed",NA,"2012-03-21",NA
"d3777e709d0bb2ac9e8cf6486c305c99","thre3d",NA,NA,NA,NA
"51db5fc3b8cc6421e76e01f44671f874","thread-com","seed",NA,"2013-12-01",2500000
"51db5fc3b8cc6421e76e01f44671f874","thread-com","venture",NA,"2012-12-01",NA
"51db5fc3b8cc6421e76e01f44671f874","thread-com","venture","1","2015-08-23",8e+06
"c150be179fd2f1251e1e63a780f15271","threadweather",NA,NA,NA,NA
"6541f6deb3fcc516dfedc4807e58e15c","threatgrid","seed",NA,"2012-06-01",NA
"3eda22cb76f458bf266d162ff6dfb1ec","threatspike-labs","seed",NA,"2014-06-26",169986
"f8d4593ea41d8a22959a40b8292e7172","threattrack-security","seed",NA,"2013-08-29",NA
"6a5bd22249dd0ed4871fad45a8840379","three-rivers-pharmaceuticals","venture",NA,"2009-04-21",6555000
"14856d0dd792514d17d3ef7d822b8d59","three-ventures",NA,NA,NA,NA
"31923c2bc573712b82103b24959a2f90","threshold-pharmaceuticals","venture",NA,"2009-10-07",3.5e+07
"31923c2bc573712b82103b24959a2f90","threshold-pharmaceuticals","venture",NA,"2012-04-11",2e+07
"d879b3cd636eb66bfe4a5aa5efebafa5","thrive-solo","seed",NA,"2013-12-23",163391
"e0e9ddb8936aa34419801dd497462f64","thrive-bioscience","debt_financing",NA,"2015-12-11",2175000
"e0e9ddb8936aa34419801dd497462f64","thrive-bioscience","seed",NA,"2015-08-18",4e+06
"3d92133cf2c360a287f307f298aae1a3","thrive-digital",NA,NA,NA,NA
"efbba3bf7be33ecbcb6db0c6f520adba","thrivehive","seed",NA,"2013-07-09",1500000
"efbba3bf7be33ecbcb6db0c6f520adba","thrivehive","venture",NA,"2012-06-27",NA
"efbba3bf7be33ecbcb6db0c6f520adba","thrivehive","seed",NA,"2015-08-15",2500000
"f0cccd8cce32b18c99aa1572108878ca","thrombogenics","grant",NA,"2014-03-10",3859800
"af3e5cf4f1340e865b010258ead99771","thrombolytic-science-international","venture",NA,"2012-01-12",7500000
"7758702e6321ee5516d911a5dc9aaf34","thrombovision","venture","a","2007-09-13",4e+06
"f56c627ef6f902e63e15f28c4fe5f1bc","thumbtack-technology",NA,NA,NA,NA
"8038458f65d20dd1abc7af19716d349c","thunder-campaign-2",NA,NA,NA,NA
"8dc7d4f01fc51734fbd4984f603ba8e0","thunderbolt-labs",NA,NA,NA,NA
"6622e9afc65eebde04f9a38efd3865c9","tianjin-cansino-biotechnology-inc","venture","C","2015-11-03",3e+07
"b06f6044847568df2598dd0d058a6da2","tianjin-greenbio-materials","venture",NA,"2010-12-01",3450000
"b06f6044847568df2598dd0d058a6da2","tianjin-greenbio-materials","venture","1","2008-03-01",2e+07
"78c78b60b6eca476e400f026f4258af0","suzhou-tianma-medical-group","venture",NA,"2013-06-01",12533912
"78c78b60b6eca476e400f026f4258af0","suzhou-tianma-medical-group","venture","1","2007-10-01",NA
"78c78b60b6eca476e400f026f4258af0","suzhou-tianma-medical-group","venture","1","2007-01-01",5291933
"4c8a7a465b780f34cd1820d427e7ebe2","zhejiang-tianyuan-bio-pharmaceutical-company-limited","venture","a","2007-01-01",NA
"86a28443b7ce3ed834a6aaf1c01c050c","tibbr",NA,NA,NA,NA
"f4938b60deedf5908fd4d12512dd0576","tibco-software-inc","debt_financing",NA,"2009-11-27",2e+06
"ad3ff9265cd84a861e1c9c32360498d8","tiberend-strategic-advisors",NA,NA,NA,NA
"339604be72d995b25374d0e009e0c14b","tickerhound",NA,NA,NA,NA
"c82d070ebdb9e1e85cb101b3f76e9ad1","tickete-snapnwin",NA,NA,NA,NA
"5bd8ec6e67e03975c274b6c6d950f881","tickle-me",NA,NA,NA,NA
"f6116f342723b12e7f509486ade11518","ticklr",NA,NA,NA,NA
"3f933203456976c87a81f8425c9f4d35","tickto",NA,NA,NA,NA
"d42f44cfb57f8fc0df84c31cbae139ba","tickto-2",NA,NA,NA,NA
"94353741189d15777bffd8f3ed6f657f","tico",NA,NA,NA,NA
"ce7522215014f9c70dd1306f5009c344","tidalscale","seed",NA,"2013-02-07",NA
"ce7522215014f9c70dd1306f5009c344","tidalscale","seed",NA,"2013-09-16",3032066
"ce7522215014f9c70dd1306f5009c344","tidalscale","venture","1","2014-11-05",8759547
"e08e2261ff1a0608074ed550db7722df","tide-analytics",NA,NA,NA,NA
"bb241da51015e90d574350bbd0a161a7","tidemark","venture","b","2011-10-18",4e+06
"bb241da51015e90d574350bbd0a161a7","tidemark","venture","d","2013-08-01",1.3e+07
"bb241da51015e90d574350bbd0a161a7","tidemark","venture","c","2012-01-18",2.4e+07
"bb241da51015e90d574350bbd0a161a7","tidemark","venture","a","2010-10-07",6300000
"bb241da51015e90d574350bbd0a161a7","tidemark","venture",NA,"2013-12-27",1070901
"bb241da51015e90d574350bbd0a161a7","tidemark","venture","E","2014-04-28",3.2e+07
"bb241da51015e90d574350bbd0a161a7","tidemark","venture","F","2015-06-16",2.5e+07
"c56f2242bcbb5bf34e09e27388ecb952","tier5",NA,NA,NA,NA
"38f5d7baac877b8735d495059deeefc0","tigenix","private_equity",NA,"2015-11-25",9262906.8492
"38f5d7baac877b8735d495059deeefc0","tigenix","private_equity",NA,"2013-11-20",15439200
"38f5d7baac877b8735d495059deeefc0","tigenix","debt_financing",NA,"2013-12-25",13700000
"38f5d7baac877b8735d495059deeefc0","tigenix","private_equity",NA,"2013-07-18",8362900
"38f5d7baac877b8735d495059deeefc0","tigenix","undisclosed",NA,"2009-06-25",7500000
"197a14d677270fad0be9e08048f8827f","tiger-analytics",NA,NA,NA,NA
"53391a1fdcbea5b503b6c69b120f3709","tigerlily","venture",NA,"2011-05-03",1300000
"f9becb0b0097751f6b36f4a392118207","hangzhou-tigermed-technology-co-ltd","venture","A","2008-07-18",5e+06
"f9becb0b0097751f6b36f4a392118207","hangzhou-tigermed-technology-co-ltd","venture",NA,"2010-03-01",2e+06
"024a30504af0159bd389315886fca9fc","tigertext","venture","C","2015-11-12",5e+07
"024a30504af0159bd389315886fca9fc","tigertext","venture","a","2012-02-02",8200000
"024a30504af0159bd389315886fca9fc","tigertext","angel",NA,"2010-09-28",1900000
"024a30504af0159bd389315886fca9fc","tigertext","venture","b","2014-01-27",2.1e+07
"5a37a2cdb896598836e713381d2c394a","tigervine",NA,NA,NA,NA
"edb48931e156679a7902d1930a4d796c","tigris-pharmaceuticals","venture","B","2007-01-17",1.6e+07
"edb48931e156679a7902d1930a4d796c","tigris-pharmaceuticals","venture","c","2010-09-28",6500000
"c5927860354141e73fc1a1ace28d0081","tikcro",NA,NA,NA,NA
"731adc30bfcc9f8e2a928c44bd6b235d","tiksoo",NA,NA,NA,NA
"28866cdfe5cea5baf62bafcd057e2ff4","tileboard",NA,NA,NA,NA
"e7f4e93ad9947f55ab69bb4d333e4569","tilofy","convertible_note",NA,"2015-04-21",NA
"e7f4e93ad9947f55ab69bb4d333e4569","tilofy","seed",NA,"2014-10-07",1e+06
"e7f4e93ad9947f55ab69bb4d333e4569","tilofy","seed",NA,"2013-05-01",20000
"fde1e6f5a1a25874c041c1f1d84ac8af","tiltan-pharma","venture",NA,"2014-02-05",1500000
"807b64b86bf24eaa061f130d8a5f77fc","timberfish-technologies","equity_crowdfunding",NA,"2013-10-22",NA
"78c1c0538a7294228d44b049848819e4","timeful","venture","A","2014-05-16",7e+06
"a23ca48be5fcd35872be6b6a70d00171","timematics",NA,NA,NA,NA
"beddcea7cc4244ace7ef193b88eefea3","timeop",NA,NA,NA,NA
"3bd7bf04f90ddd0194fdbb4f04480d28","times-twenty-five-leanciti-ltd-",NA,NA,NA,NA
"7916560e6cd5079289cfa4bfa221b235","timetric","seed",NA,"2010-03-23",NA
"b89e6a204f86b55a07a2882672acff1f","timply",NA,NA,NA,NA
"16100e4d03d7bc774fd8c6c6f9487ee8","tinyclues","venture","A","2015-12-10",5466372.6973
"16100e4d03d7bc774fd8c6c6f9487ee8","tinyclues","seed",NA,"2013-11-12",1900000
"2038cb71cbb259b4f38dc19ebcbdd0ed","tioga-pharmaceuticals","venture","a","2010-02-17",1.8e+07
"2038cb71cbb259b4f38dc19ebcbdd0ed","tioga-pharmaceuticals","debt_financing",NA,"2009-10-23",3e+06
"2038cb71cbb259b4f38dc19ebcbdd0ed","tioga-pharmaceuticals","debt_financing",NA,"2009-05-26",2e+06
"2038cb71cbb259b4f38dc19ebcbdd0ed","tioga-pharmaceuticals","venture","a","2006-01-09",2.4e+07
"2038cb71cbb259b4f38dc19ebcbdd0ed","tioga-pharmaceuticals","venture","b","2012-04-12",1e+07
"96454bbdaf5063ecffacbbae6dfa0a80","tipflare",NA,NA,NA,NA
"5eeddfec9f6e1eb9f8e241076b350a4b","tiq-solutions-gmbh",NA,NA,NA,NA
"068a931a997c76ecb4d0715709a4f0c3","tiquetaque","angel",NA,"2015-11-01",258703.4301
"31cde2d606f5e494321aafada4681735","tissue-analytics","seed",NA,"2015-05-17",750000
"24a1294d44096887268a8efb3fd39b4e","tissue-genesis","venture",NA,"2011-01-05",4461600
"24a1294d44096887268a8efb3fd39b4e","tissue-genesis","venture",NA,"2012-01-04",7737709
"24a1294d44096887268a8efb3fd39b4e","tissue-genesis","venture",NA,"2010-04-22",1240000
"24a1294d44096887268a8efb3fd39b4e","tissue-genesis","venture",NA,"2014-09-03",5e+05
"66a611fc7bf34d2ca0546a3e0efe393b","tissue-regeneration-systems","venture","A","2008-05-01",2e+06
"66a611fc7bf34d2ca0546a3e0efe393b","tissue-regeneration-systems","private_equity",NA,"2012-09-07",4638821
"66a611fc7bf34d2ca0546a3e0efe393b","tissue-regeneration-systems","venture","b","2013-08-22",4600000
"66a611fc7bf34d2ca0546a3e0efe393b","tissue-regeneration-systems","venture",NA,"2015-05-19",4093181
"18e02e5f61dc6b1e316381df9fc98077","tissue-regeneration-technologies",NA,NA,NA,NA
"532a9fb621daafe7093076d3bd93ab4a","tissueinformatics","venture",NA,"2002-01-24",12500000
"945fd668bf4a83eafa6cbdb2aa032e32","tissuelab","venture",NA,"2005-12-06",2360000
"945fd668bf4a83eafa6cbdb2aa032e32","tissuelab","venture",NA,"2007-07-27",1640000
"cf029c5e76986576a0b7f107a3e1c24d","tissuetech","venture",NA,"2013-10-15",1417500
"cf029c5e76986576a0b7f107a3e1c24d","tissuetech","private_equity",NA,"2013-08-22",1e+07
"cf029c5e76986576a0b7f107a3e1c24d","tissuetech","venture",NA,"2012-10-15",1372500
"cf029c5e76986576a0b7f107a3e1c24d","tissuetech","venture","1","2013-08-22",1e+07
"cf029c5e76986576a0b7f107a3e1c24d","tissuetech","venture",NA,"2015-06-24",1.5e+07
"9d510ed2e39136cf33d98202b20b9985","titan-analytics",NA,NA,NA,NA
"317e44bd95b22cde22b668dfe1f784d1","titan-biotech",NA,NA,NA,NA
"45468f2d6269e4f41d56e349407b5a9b","titan-pharmaceuticals","post_ipo_equity",NA,"2013-11-13",5e+06
"ddd6a9742dab74f2549fc4bd019d061c","titanium-investments",NA,NA,NA,NA
"2eb832ad747fbf7b6a034583bff95df5","tivorsan-pharmaceuticals","venture",NA,"2012-01-05",1e+06
"b71c01c40504d9286b4be4bff9fa2d5e","tkt",NA,NA,NA,NA
"d45ed34945f1f42f59e46e3b4a9e8dad","tlc-global-impression",NA,NA,NA,NA
"0a0f5767d8544c885a7ed2e5e7d42a63","tm-bioscience","venture",NA,"2006-11-28",4e+06
"0a0f5767d8544c885a7ed2e5e7d42a63","tm-bioscience","venture",NA,"2005-11-23",9e+06
"137e67445a893e0a7c2b65ab372736d4","tmj-health","venture",NA,"2014-01-15",2e+06
"dd39d8568e282fd8c9f2852def7b0b62","tmj-implants",NA,NA,NA,NA
"67d2d1b53cf83eb1ed6bbb08bff071f1","tmm-data",NA,NA,NA,NA
"6ad0ca91b5af38567e0a804c73a7f11c","tmm-industries",NA,NA,NA,NA
"bc3c695fd1ffaa3605945b5cf34d0583","tms-neurohealth-centers-tysons-corner","seed",NA,"2011-08-23",750000
"fde4875e233ca55ffe52fbffbcaf2b3b","tmt-associates-inc",NA,NA,NA,NA
"a1911f8abda2f82540a93432ba25bcb7","tng-pharmaceuticals","venture","a","2014-02-06",4600000
"1c14d29715e52617408ad8a5d996b1ba","to-the-new-digital",NA,NA,NA,NA
"374393dcdfb638129cfbed272c4e6c35","to-bbb","venture","A","2007-07-06",5445090
"374393dcdfb638129cfbed272c4e6c35","to-bbb","venture","B","2011-02-03",5501029
"374393dcdfb638129cfbed272c4e6c35","to-bbb","debt_financing",NA,"2011-03-31",1695681
"374393dcdfb638129cfbed272c4e6c35","to-bbb","venture","C","2013-04-25",3252963
"374393dcdfb638129cfbed272c4e6c35","to-bbb","venture","C","2014-07-02",13686068
"4157109f9e72688ca124359da8c89ba9","toast","venture","B","2016-01-05",3e+07
"4157109f9e72688ca124359da8c89ba9","toast","debt_financing",NA,"2015-08-06",2950000
"b6f9b99f92505b5f0bc03898f804e6c6","tobira-therapeutics","venture","A","2007-08-02",3.1e+07
"b6f9b99f92505b5f0bc03898f804e6c6","tobira-therapeutics","venture",NA,"2010-07-13",4999999
"b6f9b99f92505b5f0bc03898f804e6c6","tobira-therapeutics","debt_financing",NA,"2010-03-11",4e+06
"b6f9b99f92505b5f0bc03898f804e6c6","tobira-therapeutics","venture","b","2010-09-29",3.1e+07
"b6f9b99f92505b5f0bc03898f804e6c6","tobira-therapeutics","debt_financing",NA,"2014-06-30",1.5e+07
"2442a6233f1a0999d6ed4635e516bb13","tocagen","venture",NA,"2011-11-08",15310930
"2442a6233f1a0999d6ed4635e516bb13","tocagen","venture","1","2010-03-09",7800000
"2442a6233f1a0999d6ed4635e516bb13","tocagen","venture",NA,"2010-10-05",5269000
"2442a6233f1a0999d6ed4635e516bb13","tocagen","venture","1","2009-11-23",9116162
"2442a6233f1a0999d6ed4635e516bb13","tocagen","venture","1","2010-02-26",3000001
"2442a6233f1a0999d6ed4635e516bb13","tocagen","venture","1","2009-06-02",10846000
"2442a6233f1a0999d6ed4635e516bb13","tocagen","venture",NA,"2015-08-10",28804537
"2442a6233f1a0999d6ed4635e516bb13","tocagen","venture",NA,"2012-12-05",9055340
"3555aa6daf93db42596e45cc7b925550","tofler",NA,NA,NA,NA
"07e8b8c0ce439bbcb7d772d323bde656","tokai-pharmaceuticals","venture",NA,"2013-05-15",19999993
"07e8b8c0ce439bbcb7d772d323bde656","tokai-pharmaceuticals","venture","1","2011-09-20",2.3e+07
"07e8b8c0ce439bbcb7d772d323bde656","tokai-pharmaceuticals","venture","1","2009-06-09",2.2e+07
"07e8b8c0ce439bbcb7d772d323bde656","tokai-pharmaceuticals","venture","1","2013-05-15",35500000
"820452c2057701eb136f94f982c8ed31","tokalas","venture",NA,"2014-03-05",3090000
"820452c2057701eb136f94f982c8ed31","tokalas","venture",NA,"2015-08-10",3149995
"acbb1efe1993f54069e9a29ba17dbfd0","tokamak-solutions","undisclosed",NA,"2011-03-20",274902
"25358dd5fb93b8a0480b3a89e22a8a62","tolab",NA,NA,NA,NA
"e2bfdff0c48ff322e00666b74649dd34","toledo-data-scraping",NA,NA,NA,NA
"2647bdc9bbbbb8663ecb4697805933ac","tolera-therapeutics","venture","b","2012-10-16",5500000
"2647bdc9bbbbb8663ecb4697805933ac","tolera-therapeutics","debt_financing",NA,"2013-10-08",1052710
"2647bdc9bbbbb8663ecb4697805933ac","tolera-therapeutics","debt_financing",NA,"2012-05-15",1465000
"2647bdc9bbbbb8663ecb4697805933ac","tolera-therapeutics","venture","a","2008-06-16",NA
"2647bdc9bbbbb8663ecb4697805933ac","tolera-therapeutics","venture",NA,"2010-06-03",4056000
"2647bdc9bbbbb8663ecb4697805933ac","tolera-therapeutics","debt_financing",NA,"2014-09-17",250000
"2c424d9d624932e5188a0f8aa8bfd9bf","tolero-pharmaceuticals","venture",NA,"2012-07-27",3334560
"2c424d9d624932e5188a0f8aa8bfd9bf","tolero-pharmaceuticals","venture","1","2014-11-05",22400000
"233adb6f1cd6422be0429e30f6a8c3ac","tolerx","venture","D","2006-10-21",6.1e+07
"233adb6f1cd6422be0429e30f6a8c3ac","tolerx","venture",NA,"2010-12-01",1500000
"500a6ec44570f02c5bdd854bec8026e8","tolmar",NA,NA,NA,NA
"9a7f6d5401c051f5af47434cb4b25a63","toltec-pharmaceuticals","venture",NA,"2016-01-19",4029537
"29ef71445b618937cba2a0d45e48490f","tolven-inc","venture","a","2010-11-22",3614333
"b2a7298e1fdb7b30bb122284e6a42b21","tom-sawyer-software",NA,NA,NA,NA
"7f40f34fcde7a4f9da65ad99471b53a3","toma-biosciences","venture","A","2014-01-22",3597498
"7f40f34fcde7a4f9da65ad99471b53a3","toma-biosciences","venture",NA,"2015-08-05",5088920
"42affad1af2a4b33b0facbdb834102bb","tomobox",NA,NA,NA,NA
"fb6b360bb15aac93c9adbb4d0a9ab1f6","tonix-pharmaceuticals-holding","debt_financing",NA,"2011-10-20",1625000
"fb6b360bb15aac93c9adbb4d0a9ab1f6","tonix-pharmaceuticals-holding","debt_financing",NA,"2012-11-21",710000
"11702b82455c3ec949c3c480b0e191a6","tooinvest",NA,NA,NA,NA
"2b0db583e39fe8ef2d7224938af8a2bc","tooth-bank","venture",NA,"2014-03-18",2e+05
"f3b52ff8b8645f6cc695ce21b9766ba5","top-agents",NA,NA,NA,NA
"b95c2680d442dd540b30202ee940db0c","top-data-science",NA,NA,NA,NA
"881f470beca2ee83992cb5de43a98e2e","top-scholar-co",NA,NA,NA,NA
"6f59f235d11cc67f2f64045b8ae2e504","top-secret-agency",NA,NA,NA,NA
"67bff0b1fef320fdd6e66d4f4b96a356","topbox","angel",NA,"2014-11-01",1500000
"9803722ad1c59726b27e2646b30eff0d","topcat-research","venture",NA,"2011-07-14",80606
"f9c19fe8773b1ab9197352da10b9d213","topcompetitors",NA,NA,NA,NA
"4b4d9f61a474ae0f2b4b2a50fc64b8e3","topic-technologies",NA,NA,NA,NA
"d759f2f5c452ff1296dba3e03c54181d","topica","venture","b","2011-10-18",2.7e+07
"d759f2f5c452ff1296dba3e03c54181d","topica","venture",NA,"2013-06-10",31519071
"31d7987dbf6688020a9bfdcbeb4d11dd","topicmarks","seed",NA,"2011-03-18",150000
"3cf3cd26ca13d4f7e1874dd2d3a0f1dd","topikality",NA,NA,NA,NA
"fe9ba43b1b99e1529ea6d40645b22bc6","topokine-therapeutics","undisclosed",NA,"2014-04-02",NA
"91c3695177d10b1154136ed747f752f5","topopps","seed",NA,"2014-03-17",7e+05
"91c3695177d10b1154136ed747f752f5","topopps","seed",NA,"2014-09-24",1250000
"91c3695177d10b1154136ed747f752f5","topopps","seed",NA,"2015-02-06",2e+06
"91c3695177d10b1154136ed747f752f5","topopps","seed",NA,"2015-09-08",1600000
"65f73425e6aff04206d29bf5530c1597","topotarget-a-s",NA,NA,NA,NA
"41e65d405fb2b97a2e8935b7a598bf01","toppharm-consulting",NA,NA,NA,NA
"adfa284f1787da13585604183570c15e","topple-track","seed",NA,"2013-01-01",250000
"e9a733f59f5b28bb707200664ca789be","topster",NA,NA,NA,NA
"f0692b5bdf161e1b91872c1626d87227","topsy-labs","venture","a","2008-01-01",9e+05
"f0692b5bdf161e1b91872c1626d87227","topsy-labs","venture","b","2008-12-01",1.1e+07
"f0692b5bdf161e1b91872c1626d87227","topsy-labs","debt_financing",NA,"2009-03-01",3e+06
"f0692b5bdf161e1b91872c1626d87227","topsy-labs","venture",NA,"2012-10-01",5300000
"f0692b5bdf161e1b91872c1626d87227","topsy-labs","undisclosed",NA,"2009-05-25",NA
"f0692b5bdf161e1b91872c1626d87227","topsy-labs","venture","c","2011-03-10",1.5e+07
"2b4b2a6c1b8697a3da7ac09c90fa3857","torch-group","private_equity",NA,"2011-09-16",5400000
"7ac913fa4eaac922224d615731b32cb4","tornado-medical-systems","venture",NA,"2010-11-09",4900364
"7ac913fa4eaac922224d615731b32cb4","tornado-medical-systems","venture",NA,"2011-05-12",6917343
"7ac913fa4eaac922224d615731b32cb4","tornado-medical-systems","venture",NA,"2013-03-13",2925746
"7ac913fa4eaac922224d615731b32cb4","tornado-medical-systems","venture",NA,"2014-09-10",NA
"25de93f04dca9244abf143e61e27f88d","torrent-pharmaceuticals",NA,NA,NA,NA
"e9421d3b471a9b115aa20e0bc97af6f1","torreya-insights",NA,NA,NA,NA
"7c2141a0e62984f279fdbbe9f9d0d964","tosk","venture",NA,"2014-07-31",5449274
"6fe28a85cb2ddaf4d513b114764d3083","total-nutraceutical-solutions","venture",NA,"2011-07-29",207500
"6fe28a85cb2ddaf4d513b114764d3083","total-nutraceutical-solutions","venture",NA,"2009-06-15",409500
"7a248390fbf62150b7423f80d144252b","total-telecom",NA,NA,NA,NA
"d97936aa6bbeab3f408752311ecbc608","totango","venture",NA,"2015-05-01",7e+06
"d97936aa6bbeab3f408752311ecbc608","totango","venture","1","2011-07-28",3800000
"d97936aa6bbeab3f408752311ecbc608","totango","venture","1","2014-02-05",15500000
"d97936aa6bbeab3f408752311ecbc608","totango","seed",NA,"2010-01-01",NA
"68665baadf2cfee4409fac5742f5e4a8","totems","seed",NA,"2011-09-08",70220
"68665baadf2cfee4409fac5742f5e4a8","totems","seed",NA,"2012-11-29",1e+06
"5b9d7b70bab3b8d5fd76936a6d96fdde","totombola",NA,NA,NA,NA
"1a54e817f72b7804798334007b18ac7f","touchxpay",NA,NA,NA,NA
"6d46070e0bba69c223e20a7fcc8ef86f","touch-bionics","debt_financing",NA,"2010-12-20",3885144.7605
"6d46070e0bba69c223e20a7fcc8ef86f","touch-bionics","grant",NA,"2010-01-30",1289342
"6d46070e0bba69c223e20a7fcc8ef86f","touch-bionics","undisclosed",NA,"2011-10-08",3883556
"b540a8d6a195cdda7246eb6820338fd3","toughsurgery","seed",NA,"2014-05-19",1e+06
"a44a2d6792acaaf076e12f00bb5c6623","touchcommerce","venture","C","2006-12-18",7750000
"a44a2d6792acaaf076e12f00bb5c6623","touchcommerce","venture","D","2007-08-28",5e+06
"3635faf20b87cc71cd47bdebac0b4740","touchdata",NA,NA,NA,NA
"ae598f57cb3ec7c65d40999f15508fc0","touchmobi","angel",NA,"2012-06-12",250000
"58cf20a8dbf7e6e7c3feae3999937f7b","touchstone-systems-ltd",NA,NA,NA,NA
"e9a1ef884102790dea1696aa7726284c","touchstone-ventures",NA,NA,NA,NA
"e3c1f76d41f39b4738ed4ba3fb4e718d","tower3",NA,NA,NA,NA
"497ab5402500304f498b2fefa8e758c0","tp-therapeutics","venture",NA,"2014-01-06",1429999
"7c442665e08abf84ef1676f88442b022","tpg-direct",NA,NA,NA,NA
"7976545fff18b3ddfddde4cb1ede315c","tpp-global-development","venture","a","2010-07-19",12200000
"e49323c19b43abf3f9e36d7c2c1d3bb7","tr-spencer-associates-p-c",NA,NA,NA,NA
"735cb14312a4b37d2326d67b1a0156ba","traak-systems","venture",NA,"2009-03-19",220000
"735cb14312a4b37d2326d67b1a0156ba","traak-systems","venture",NA,"2010-09-01",261837
"f63506baf3f1e3e9f85a87a51bcc4632","trac-emc-safety","grant",NA,"2010-01-12",225962
"10526c3b7d6c044344777c7ccbdf305b","track","venture","a","2009-06-17",NA
"4528f1d3db13832284377b6ae601e3ba","track-social",NA,NA,NA,NA
"0273c3aa0418e71cb4d61abf62cc1933","trackboost",NA,NA,NA,NA
"8597bedaf8ba84168d5e7728312cc174","trackerbird",NA,NA,NA,NA
"093270de79b667918a9d37118e34a5da","tracking-first",NA,NA,NA,NA
"5af65b94524d40eed66b038ce8995d8b","tracking-net",NA,NA,NA,NA
"b89e81af8ace913caff8b044fb3d97ce","trackingbird",NA,NA,NA,NA
"6628c26a7265b5d36b7ade672bf80878","trackingmind",NA,NA,NA,NA
"93c4ad0193a142e60e5eca472e0e2f16","trackmaven","seed",NA,"2013-05-29",1250000
"93c4ad0193a142e60e5eca472e0e2f16","trackmaven","venture","1","2014-02-04",6500000
"93c4ad0193a142e60e5eca472e0e2f16","trackmaven","venture","1","2014-10-21",8e+06
"93c4ad0193a142e60e5eca472e0e2f16","trackmaven","debt_financing",NA,"2014-12-09",6e+06
"fdea69580775da4469c7d917b59388be","tracknext-com",NA,NA,NA,NA
"4295c6eb9b4dbdc6b80fd01892b1cb83","trackometrix",NA,NA,NA,NA
"2622978fcb998841c7ba3034302bcdc9","trackpal",NA,NA,NA,NA
"23aab8c27f2f0eacd53ba0848f786633","tracksale",NA,NA,NA,NA
"51bb35010e490eb13f4b6a2ec5d897dc","trackset",NA,NA,NA,NA
"66df3bf5f277ebc41db87407fc8eafd9","tracksimple",NA,NA,NA,NA
"c3b32664718d5412478d6790d492d839","trackwave",NA,NA,NA,NA
"2a59bbd893cb5620df66391997c737de","tracon-pharmaceuticals","convertible_note",NA,"2007-04-27",9500000
"2a59bbd893cb5620df66391997c737de","tracon-pharmaceuticals","venture","1","2011-04-20",1.4e+07
"2a59bbd893cb5620df66391997c737de","tracon-pharmaceuticals","debt_financing",NA,"2010-10-25",1540000
"2a59bbd893cb5620df66391997c737de","tracon-pharmaceuticals","venture","1","2014-09-22",2.7e+07
"9cdb95a7c57d79e959c2d33833418b22","tracour","angel",NA,"2013-03-01",135000
"9cdb95a7c57d79e959c2d33833418b22","tracour","seed",NA,"2014-05-13",335000
"9798ae584ab2d41793c4e34cbb161a1d","tracx","venture","b","2012-02-16",4400000
"9798ae584ab2d41793c4e34cbb161a1d","tracx","venture","b","2013-03-08",3500000
"9798ae584ab2d41793c4e34cbb161a1d","tracx","venture","C","2015-02-02",1.8e+07
"6034d40c1d857bae7f200b9fa7c12adb","tracxn","venture",NA,"2016-01-06",NA
"6034d40c1d857bae7f200b9fa7c12adb","tracxn","venture","1","2015-04-28",3500000
"6034d40c1d857bae7f200b9fa7c12adb","tracxn","venture","1","2015-06-19",1e+07
"320b1b0f8744f693fc318a61ad228289","tradehelm",NA,NA,NA,NA
"6b80a8167f6010a909e0a80d9c205aeb","magick-nu","angel",NA,"2015-12-21",450000
"6b80a8167f6010a909e0a80d9c205aeb","magick-nu","seed",NA,"2013-08-15",250000
"6b80a8167f6010a909e0a80d9c205aeb","magick-nu","angel",NA,"2014-06-16",2e+05
"6b80a8167f6010a909e0a80d9c205aeb","magick-nu","angel",NA,"2015-03-26",340000
"0b0b41564c8dda20d968351f1d14b935","trafficcast","venture","a","2008-01-22",3500000
"0b0b41564c8dda20d968351f1d14b935","trafficcast","venture",NA,"2007-01-01",250000
"0fc7248749d50a9cada812810361c9fe","trafficestimate",NA,NA,NA,NA
"4bebe9cb0abd9593cc9cac8706f9b200","trafinity",NA,NA,NA,NA
"3ad118348cb6bdb2421fcef4442c54c7","tragara","venture","A","2007-03-15",4e+07
"3ad118348cb6bdb2421fcef4442c54c7","tragara","venture","b","2010-04-15",5e+06
"3ad118348cb6bdb2421fcef4442c54c7","tragara","debt_financing",NA,"2012-08-08",4e+06
"3ad118348cb6bdb2421fcef4442c54c7","tragara","debt_financing",NA,"2015-07-17",1201200
"3ad118348cb6bdb2421fcef4442c54c7","tragara","venture",NA,"2015-09-02",13058784
"9a6d326426d5855df144ec00650d1099","trailhead",NA,NA,NA,NA
"983baa778a5bcc89d415938bd051114d","trailhead-lodge","venture",NA,"2011-11-07",9690000
"4ae54e74004b719b316e47c8ffda1239","traily",NA,NA,NA,NA
"31bbf689a59c1405c9ab22e0dba11f46","traintracks",NA,NA,NA,NA
"fc23072c6e8da0adf2ac06e0792e0f2e","traitperception","seed",NA,"2012-07-31",NA
"fc23072c6e8da0adf2ac06e0792e0f2e","traitperception","venture","1","2014-07-03",4700000
"6d9760303b39aeb551d8e1e69093e6d3","trajectory-inc-2","seed",NA,"2013-11-20",1e+06
"40ea29462cab1e32665ee61115072d16","trak-io","angel",NA,"2014-04-07",150000
"5ff973d3ea361c8347703729179cb957","trakken-technologies",NA,NA,NA,NA
"0fe433f60da154f683a727f4f9101a7d","trakkies-research","seed",NA,"2015-04-04",16390
"5c2c2590b162331c3ea4d6f5d1e44837","trampoline-systems","venture",NA,"2009-08-11",544000
"5c2c2590b162331c3ea4d6f5d1e44837","trampoline-systems","seed",NA,"2003-10-01",4e+05
"5c2c2590b162331c3ea4d6f5d1e44837","trampoline-systems","angel",NA,"2006-04-15",4e+05
"5c2c2590b162331c3ea4d6f5d1e44837","trampoline-systems","venture",NA,"2007-03-15",5799118.534
"5c2c2590b162331c3ea4d6f5d1e44837","trampoline-systems","angel",NA,"2010-12-01",515661
"66b1be1beb51cb7e43abeccd7ffdd832","tranquilmed","grant",NA,"2010-04-05",27000
"60c98d70c1860763b9d26016ea2599d3","trans1",NA,NA,NA,NA
"0b26d548fb70b6164c95041027bc82d9","transalgae",NA,NA,NA,NA
"9aeee254182a50b03535450971cb6715","transave","debt_financing",NA,"2009-11-03",5542573
"9aeee254182a50b03535450971cb6715","transave","debt_financing",NA,"2010-06-25",5499999
"dad8c6cc516c8cbbbaa453f4513f9e8a","transbiodiesel","venture","a","2008-10-13",1500000
"5df1203b6fb78bb80ac01f3863b190af","transbiomed","venture",NA,"2011-02-19",1635240
"2e5fb680b673496f3dee33f0afa92846","transcardiac-therapeutics","venture",NA,"2009-07-30",2e+05
"a54db8953c348df1ca07c6d50a2e1d96","transcense",NA,NA,NA,NA
"776de6b1cae4648f148fb5cd5b0fc7a0","transcept-pharmaceuticals","venture","d","2007-03-08",4e+07
"00bb6d80f0750edcbe0a53159eb51721","transcorp","venture",NA,"2011-05-12",755958
"147a2cb4d8dd1c8f8609ca5be316ef82","transcriptic","seed",NA,"2014-02-14",2800000
"147a2cb4d8dd1c8f8609ca5be316ef82","transcriptic","seed",NA,"2012-11-28",1200000
"147a2cb4d8dd1c8f8609ca5be316ef82","transcriptic","venture","1","2014-07-01",1750000
"147a2cb4d8dd1c8f8609ca5be316ef82","transcriptic","venture","1","2015-02-19",8500000
"147a2cb4d8dd1c8f8609ca5be316ef82","transcriptic","seed",NA,"2014-12-01",120000
"a4d49e1cfc5d928bb7cc270332e4e62d","transdel-pharmaceuticals",NA,NA,NA,NA
"08043aa59bec7c3fca14e93ccfd51fac","transenda-international",NA,NA,NA,NA
"628fa95f25e6c228c24ee4ab1694ebc8","transera-communications","venture","d","2009-03-12",1.7e+07
"628fa95f25e6c228c24ee4ab1694ebc8","transera-communications","venture","c","2006-11-01",1e+07
"628fa95f25e6c228c24ee4ab1694ebc8","transera-communications","venture","b","2005-08-17",1e+07
"a865e0221dc76779205582a1db4633e9","transgene",NA,NA,NA,NA
"3aeb8fa63f6fff5569721f0982eb7a09","transgenomic","venture",NA,"2016-01-20",2199676
"3aeb8fa63f6fff5569721f0982eb7a09","transgenomic","grant",NA,"2015-12-23",1500000
"3aeb8fa63f6fff5569721f0982eb7a09","transgenomic","venture","1","2014-03-06",7e+06
"3aeb8fa63f6fff5569721f0982eb7a09","transgenomic","debt_financing",NA,"2012-01-13",3e+06
"3aeb8fa63f6fff5569721f0982eb7a09","transgenomic","post_ipo_debt",NA,"2015-01-16",750000
"3aeb8fa63f6fff5569721f0982eb7a09","transgenomic","post_ipo_equity",NA,"2015-07-17",3039760
"a1f4d69394a134abd1a1dcdda72d06f4","transgenrx","debt_financing",NA,"2010-08-04",420000
"a1f4d69394a134abd1a1dcdda72d06f4","transgenrx","venture",NA,"2010-10-14",6505600
"913f168969330837fad49ac0dd12d5bc","transhield",NA,NA,NA,NA
"ee58e451b854425f5f273cdbb3f0d61e","transition-therapeutics","post_ipo_equity",NA,"2013-08-16",1.1e+07
"ee58e451b854425f5f273cdbb3f0d61e","transition-therapeutics","post_ipo_equity",NA,"2014-06-06",30800000
"c9fa52561e0a6216990ec9efaee8ecaf","transkaryotic-therapies-inc",NA,NA,NA,NA
"07d33e9b39c7c6ce7def7edebf3ec11c","translated",NA,NA,NA,NA
"45a181b33898a9ea471932fb1efa5765","translational-genomics-research-institute-tgen",NA,NA,NA,NA
"55055f32e04e9a7520c6172a77114743","translational-software",NA,NA,NA,NA
"3e9c1b156f62938361f1ed449ca62d95","transluminal-technologies","venture",NA,"2015-05-21",1500004
"423a5c27f58e101297e82e6c4b8b0cb7","transmetric","non_equity_assistance",NA,"2013-12-20",NA
"190a2d24df2a2a2478da30d5fbbf5067","transmetrics","seed",NA,"2014-05-26",255000
"190a2d24df2a2a2478da30d5fbbf5067","transmetrics","angel",NA,"2014-05-26",415000
"026057b4e9c2a18f08e99adfe48ce172","transomic","venture",NA,"2012-03-08",20000
"b04be5595a6af75d5c815008b2f1396f","transorg-analytics",NA,NA,NA,NA
"871e9185ddd21454596d5d21db97dc5e","transpharma-medical","venture","c","2006-07-24",1.8e+07
"197744c0109db1af69940aaec94e2ed0","transplant-biomedicals","seed",NA,"2015-11-12",1607653.8614
"1cf49b0cff8263af8d03a2a706bf02d1","transplant-genomics-inc","debt_financing",NA,"2014-04-07",198000
"1cf49b0cff8263af8d03a2a706bf02d1","transplant-genomics-inc","debt_financing",NA,"2014-04-10",2815000
"433fac4104446e665ca24e5903f27f6d","transposagen-biopharmaceuticals","venture",NA,"2012-07-18",355000
"433fac4104446e665ca24e5903f27f6d","transposagen-biopharmaceuticals","grant",NA,"2013-06-21",4300000
"433fac4104446e665ca24e5903f27f6d","transposagen-biopharmaceuticals","venture",NA,"2011-12-20",725000
"c9af9133cc7ebfc4ea9c75d125f9fb24","transtech-pharma","venture",NA,"2010-06-08",5e+07
"2615ebc8809cbdf45520f0d5f8933600","transvoyant",NA,NA,NA,NA
"ceb7df4db2ad4226e81abe6983aa5c21","tranzlogic","venture",NA,"2013-05-14",799967
"ceb7df4db2ad4226e81abe6983aa5c21","tranzlogic","venture",NA,"2012-11-28",1e+06
"ceb7df4db2ad4226e81abe6983aa5c21","tranzlogic","venture",NA,"2012-12-22",7e+05
"eff7467de41b183956b18847e07ef4d0","tranzyme","venture",NA,"2007-11-01",2e+07
"eff7467de41b183956b18847e07ef4d0","tranzyme","venture","1","2005-05-13",NA
"f14e00c4ee2f334093aa17dbc1ffa52b","traphaco","venture",NA,"2007-12-11",10340000
"b80acd5c0c5af7a7d536f971db28b14e","trapit","venture","a","2012-01-08",6200000
"b80acd5c0c5af7a7d536f971db28b14e","trapit","venture",NA,"2010-10-13",1003800
"b80acd5c0c5af7a7d536f971db28b14e","trapit","debt_financing",NA,"2013-06-04",1037793
"b80acd5c0c5af7a7d536f971db28b14e","trapit","venture",NA,"2012-09-19",1874999
"b80acd5c0c5af7a7d536f971db28b14e","trapit","undisclosed",NA,"2014-12-09",1e+07
"92d0cc04bc70ef4d11761dc46814fee0","travanti-pharma","venture","b","2006-07-27",7500000
"d7738ffc60474efa5ec90a6e3c698f5a","travel-appeal","seed",NA,"2013-12-09",NA
"d7738ffc60474efa5ec90a6e3c698f5a","travel-appeal","seed",NA,"2015-04-02",107955
"ac9cd5c0357d5426f007bcfea4b8c676","travel-recon","seed",NA,"2015-09-29",680000
"ac9cd5c0357d5426f007bcfea4b8c676","travel-recon","seed",NA,"2015-02-01",25000
"a68dea84b6483e0ac935479598dde183","travelindex",NA,NA,NA,NA
"26aac41ed3e801b96f875b4373daad4a","traversa-therapeutics","venture","a","2008-02-04",2e+06
"26aac41ed3e801b96f875b4373daad4a","traversa-therapeutics","venture","b","2009-04-07",5e+06
"6862d514c8bdb62ebf374da804da7b1a","traverse-biosciences","debt_financing",NA,"2014-06-09",1e+05
"c68c422c7d33964478e0aab71da3ce2a","trax-technologies","venture","B","2013-02-14",1e+07
"c68c422c7d33964478e0aab71da3ce2a","trax-technologies","venture","A","2008-01-01",5e+06
"a3121e27d604ca2368d1e3634e0313c2","traxair","venture",NA,"2013-04-08",NA
"0520e735c7ba1fd13340302eef3cd079","traycer-diagnostic-systems","venture",NA,"2010-05-26",1502475
"0520e735c7ba1fd13340302eef3cd079","traycer-diagnostic-systems","venture",NA,"2013-09-06",5e+06
"0520e735c7ba1fd13340302eef3cd079","traycer-diagnostic-systems","venture",NA,"2012-10-04",505037
"0520e735c7ba1fd13340302eef3cd079","traycer-diagnostic-systems","venture","1","2008-01-23",2e+06
"7766a0d18bc65c1b8dcf1ac3910b6dca","trbo","venture","B","2014-07-31",NA
"e2fa2d3e1e20b27ca7fcfe249c1a3f18","treasure-data","seed",NA,"2012-11-01",1250000
"e2fa2d3e1e20b27ca7fcfe249c1a3f18","treasure-data","seed",NA,"2012-09-28",1500000
"e2fa2d3e1e20b27ca7fcfe249c1a3f18","treasure-data","venture","1","2013-07-22",5300000
"e2fa2d3e1e20b27ca7fcfe249c1a3f18","treasure-data","venture","1","2015-01-09",2.1e+07
"e2fa2d3e1e20b27ca7fcfe249c1a3f18","treasure-data","venture",NA,"2015-09-02",6e+06
"e757fafbccaa0f627cec47611021b731","treasure-valley-surgery-center","seed",NA,"2012-05-18",980000
"37e2c07e607daae6f8ced0c7c46dd3f7","treasure-valley-urology-services","seed",NA,"2014-07-18",45321
"37e2c07e607daae6f8ced0c7c46dd3f7","treasure-valley-urology-services","venture",NA,"2010-09-15",47965
"37e2c07e607daae6f8ced0c7c46dd3f7","treasure-valley-urology-services","venture",NA,"2014-05-05",47192
"37e2c07e607daae6f8ced0c7c46dd3f7","treasure-valley-urology-services","venture",NA,"2009-09-09",64552
"37e2c07e607daae6f8ced0c7c46dd3f7","treasure-valley-urology-services","venture",NA,"2010-01-14",127164
"37e2c07e607daae6f8ced0c7c46dd3f7","treasure-valley-urology-services","venture",NA,"2015-06-16",49820
"017330f0e9fbd23c10c661a18c5af918","treasury-intelligence-solutions","venture","B","2014-05-01",5539808
"7013f7a923268c17911c6a03cbf231a9","treat-u","seed",NA,"2013-07-25",1003918
"c86866c2efdd720888875d6291904030","treato","venture","b","2013-04-23",14500000
"ce967faa03718fd1edd5af81a5d83b22","treedom","angel",NA,"2012-11-01",65000
"ce967faa03718fd1edd5af81a5d83b22","treedom","grant",NA,"2013-01-15",5e+05
"e01e929e3a3bdbe6dd3cb24210d58a82","trefis","angel",NA,"2008-11-01",530000
"e01e929e3a3bdbe6dd3cb24210d58a82","trefis","venture","1","2010-06-02",1600000
"3dba9100369e9902c738781bb99ca538","trega-biosciences-inc",NA,NA,NA,NA
"193dfa206d6cdcc27db34b2693479343","trek-diagnostics-abmm-abmli-professional-recognition-award-selection-committee",NA,NA,NA,NA
"7a280d7e5f82256ef9ad647bc5e171a9","trellis-bioscience","debt_financing",NA,"2011-11-09",235000
"7a280d7e5f82256ef9ad647bc5e171a9","trellis-bioscience","venture","1","2007-02-14",1e+07
"7a280d7e5f82256ef9ad647bc5e171a9","trellis-bioscience","venture",NA,"2009-08-07",11715708
"82dd63bb1de3ee405b2d4060798243c5","trellis-earth-products","venture",NA,"2011-03-18",75000
"18baa7d87dc0c37f0895cd6a67064bb1","trelys","venture",NA,"2013-04-01",1250000
"18baa7d87dc0c37f0895cd6a67064bb1","trelys","seed",NA,"2013-06-13",2500000
"d78e40784b35da1bf6dab472feee5767","trend-hunter",NA,NA,NA,NA
"8a0461cdd25fb2abe40cc7af187de171","trend-cards",NA,NA,NA,NA
"44eeb13ef116c37c35623036df200469","trendably",NA,NA,NA,NA
"e101c7a62f2f57d4dd880a1f383ddcbb","trendalytics","seed",NA,"2013-01-24",40000
"e101c7a62f2f57d4dd880a1f383ddcbb","trendalytics","seed",NA,"2015-01-15",NA
"e101c7a62f2f57d4dd880a1f383ddcbb","trendalytics","undisclosed",NA,"2014-01-06",NA
"ca663112e02c372de06f7f037ade08c1","trendemon","seed",NA,"2015-08-28",8e+05
"ca663112e02c372de06f7f037ade08c1","trendemon","seed",NA,"2013-12-01",2e+05
"748613708872c40671ee1365e452579b","trendensity",NA,NA,NA,NA
"440726ffcc7d4a1071fe5d774a3a0a71","trending",NA,NA,NA,NA
"b4bc89c94735409314ee9011250d9f4c","trendlr","seed",NA,"2014-01-01",NA
"a0fe41a0c73f094631f425d16c652c5a","trendocean",NA,NA,NA,NA
"3511d320d6e5615b25ca744ed3c8eb2a","trendpo","seed",NA,"2013-06-17",2e+05
"4225a17fc02582d28e560d01038ef9a1","trendrr",NA,NA,NA,NA
"c6d24f4a5fc3af848e220a277319a354","trends-mobile-and-web-solutions",NA,NA,NA,NA
"dfa0d537285bb9e1e6b3fc8962406f35","trendslide","angel",NA,"2011-08-01",25000
"dfa0d537285bb9e1e6b3fc8962406f35","trendslide","seed",NA,"2012-03-01",1e+05
"3d7dd5ffdf3f160c7f0e2827b8063fd2","trendsmotion",NA,NA,NA,NA
"bdd0fee9c28d5a0fc1f3f74ed982ee8a","trendspottr",NA,NA,NA,NA
"a110175c616c5b51404c07cdd4dc013a","trendwise-analytics",NA,NA,NA,NA
"6a1453b8e6f0c9300a58be898b702864","trenndable",NA,NA,NA,NA
"c255a114cb4211e5282d95381f11ddd9","treparel-com","undisclosed",NA,"2009-04-14",NA
"553ecb8180a66f63a2e59170c690e859","trepscore-inc","seed",NA,"2014-10-27",NA
"3bfb716ce13bacf783416b4bf26467fd","tresata","venture",NA,"2011-05-31",5e+05
"3bfb716ce13bacf783416b4bf26467fd","tresata","seed",NA,"2012-12-04",750000
"c68cb3268735462623023972fcb4b873","tresensa","angel",NA,"2012-07-23",1500000
"c68cb3268735462623023972fcb4b873","tresensa","venture","1","2014-03-04",5e+06
"c68cb3268735462623023972fcb4b873","tresensa","angel",NA,"2013-04-01",5e+05
"c68cb3268735462623023972fcb4b873","tresensa","venture","1","2015-04-14",1999985
"eb402e17b1c919ce950bfbe471da15a9","trevena","grant",NA,"2011-08-19",1e+07
"eb402e17b1c919ce950bfbe471da15a9","trevena","venture","1","2008-03-01",2.4e+07
"eb402e17b1c919ce950bfbe471da15a9","trevena","venture","1","2010-07-14",3.5e+07
"eb402e17b1c919ce950bfbe471da15a9","trevena","venture","1","2013-05-09",6e+07
"eb402e17b1c919ce950bfbe471da15a9","trevena","post_ipo_equity",NA,"2014-11-05",4.5e+07
"200bdf417d83774f7ad1d532a8f84c7d","treventis","seed",NA,"2013-09-19",4400000
"8d55aa31b29856a3a487474605e22091","trevi-therapeutics","venture",NA,"2012-12-18",6564102
"8d55aa31b29856a3a487474605e22091","trevi-therapeutics","venture","1","2014-11-06",2.6e+07
"8d55aa31b29856a3a487474605e22091","trevi-therapeutics","debt_financing",NA,"2015-01-08",1.5e+07
"d21c77d33ccdf01f36b1c116d9a8b3b9","trgiman",NA,NA,NA,NA
"125cb1f713fc7d49551e9034d5b64a93","tri-d-systems","venture",NA,"2005-04-05",NA
"6bbbd7c02371a91e0adad11ee6d451e1","tri-medics","debt_financing",NA,"2012-07-27",160000
"8ff04b2db4cb3d59570f0eddf6759c2c","tri-script",NA,NA,NA,NA
"647e7621a9e86e0696c6a65ba790f869","triage-consulting-group",NA,NA,NA,NA
"b16352e37684a5a0c6c23dda303d15bf","trialfire",NA,NA,NA,NA
"bdabf450aa638377d9dcfcb1cb8b42c1","triangle-biosystems",NA,NA,NA,NA
"6c87d2a31da16e88c462a5f1ad7a5875","trianz","venture",NA,"2007-01-17",1.4e+07
"805c05a9552e7736580172bc8cf771d4","triax-pharmaceuticals",NA,NA,NA,NA
"01d858efcc7d20789fbdbe286bdebeab","tribe-wearables","seed",NA,"2013-11-25",135429.7864
"01d858efcc7d20789fbdbe286bdebeab","tribe-wearables","seed",NA,"2014-03-13",128660
"8c1248746c0693250921a19b0ef83f75","tribute-pharmaceuticals-canada","post_ipo_equity",NA,"2014-08-25",27900000
"8c1248746c0693250921a19b0ef83f75","tribute-pharmaceuticals-canada","venture",NA,"2015-06-05",4098025
"ee478f82c80e87a169939f61bb061226","tribzi","seed",NA,"2013-01-27",20203
"d86cadb3d13c2a9ea570df00a3af56e1","trice-orthopedics","debt_financing",NA,"2013-11-27",3e+06
"2540bab4e0b313d8c82cd3f8e93efbaa","tricida","venture",NA,"2014-01-30",4514244
"2540bab4e0b313d8c82cd3f8e93efbaa","tricida","venture","1","2014-09-04",1e+07
"2540bab4e0b313d8c82cd3f8e93efbaa","tricida","venture","1","2015-03-04",3e+07
"d6153b11dba213eba1436d61a6192e01","trident-clinical-research",NA,NA,NA,NA
"9154dfb09695493f262a5b3e58fec3d7","trigemina","venture",NA,"2009-12-23",304967
"9154dfb09695493f262a5b3e58fec3d7","trigemina","venture",NA,"2010-10-18",4e+05
"9154dfb09695493f262a5b3e58fec3d7","trigemina","venture","1","2013-06-17",4500000
"1773592340b20d794d756800733a5db7","trigenesis-therapeutics",NA,NA,NA,NA
"db41523250b9073d14de60d6d886782d","mobiusbobs-inc","seed",NA,"2014-01-01",1e+05
"db41523250b9073d14de60d6d886782d","mobiusbobs-inc","seed",NA,"2014-07-31",5e+05
"db41523250b9073d14de60d6d886782d","mobiusbobs-inc","seed",NA,"2015-06-16",5e+05
"2aff94a0cd17a40947f043072d5f6e8a","trillium-software",NA,NA,NA,NA
"21447a3429057ff69852b8ba5abb4ff7","trillium-therapeutics","venture",NA,"2011-05-12",1e+06
"8a9400df9ee4389a8c27337e03390233","trilogic-pharma","venture",NA,"2011-08-15",415000
"8a9400df9ee4389a8c27337e03390233","trilogic-pharma","venture",NA,"2007-09-06",1600000
"8a9400df9ee4389a8c27337e03390233","trilogic-pharma","venture",NA,"2012-08-01",222866
"8a9400df9ee4389a8c27337e03390233","trilogic-pharma","debt_financing",NA,"2010-04-02",735000
"dec573242ca95f4e14e62d1165287e04","trimel-pharmaceuticals","post_ipo_equity",NA,"2014-02-23",10500000
"dec573242ca95f4e14e62d1165287e04","trimel-pharmaceuticals","venture",NA,"2014-08-14",2131268
"2d4b475335fef3628e1129e1262cdbdf","trimeris",NA,NA,NA,NA
"7fab120dae9ccb705b580901f56747d8","trinity-biosystems","debt_financing",NA,"2009-11-13",7500000
"7fab120dae9ccb705b580901f56747d8","trinity-biosystems","venture","1","2006-07-18",2.1e+07
"5a1188024e332c53d47715b85b48cb69","trinity-biotech",NA,NA,NA,NA
"1141d6165392c644c2401f4cf907232e","trinity-insight",NA,NA,NA,NA
"89206a754701f94333100a9110d8f14c","trino-therapeutics","venture","a","2013-05-28",11579400
"bc38edb8f11db8c55e72b6c5a90ee708","triporg",NA,NA,NA,NA
"ea9bc488d074d55547b3f9711dc63db2","tripos-international",NA,NA,NA,NA
"3b3c6824b6df4f6a0450e49604269dd1","triptico",NA,NA,NA,NA
"7a291ad86ea6ecdf9ccae7a67f1341ea","trist","seed",NA,"2012-08-01",5e+05
"cfbcac2307be2336010e2a97f6cd46d9","tritel-computer-solutions",NA,NA,NA,NA
"7e4b9c38705de24cf9cde4aa3f3e3ab0","triton-algae-innovations","venture","a","2013-09-04",5e+06
"7e4b9c38705de24cf9cde4aa3f3e3ab0","triton-algae-innovations","venture",NA,"2015-06-15",5e+06
"df306fb61603c6f8e0ed96bf3177e6b4","triton-biosciences",NA,NA,NA,NA
"08770d4c03800f7faa937f636ab1ef1e","triton-research",NA,NA,NA,NA
"bb5dfa400233580464da45f493c01676","trius-therapeutics","venture",NA,"2006-02-01",NA
"bb5dfa400233580464da45f493c01676","trius-therapeutics","venture","1","2007-02-28",2e+07
"bb5dfa400233580464da45f493c01676","trius-therapeutics","debt_financing",NA,"2009-11-12",19163293
"bb5dfa400233580464da45f493c01676","trius-therapeutics","venture",NA,"2011-06-07",30162500
"3d82630591b68c328bfdd8dc2b444946","trivid",NA,NA,NA,NA
"d15e6162bac89e44ba75362025018844","trivitron-healthcare","venture",NA,"2007-11-02",1.1e+07
"d15e6162bac89e44ba75362025018844","trivitron-healthcare","venture",NA,"2013-12-10",24500000
"d15e6162bac89e44ba75362025018844","trivitron-healthcare","private_equity",NA,"2012-10-13",6e+07
"b6470e9f9a5deca27a4504eee3ed8996","triviumsoft",NA,NA,NA,NA
"0bfc74151db2dd3a2a628215a312fd90","trnk","seed",NA,"2013-07-22",25000
"0bfc74151db2dd3a2a628215a312fd90","trnk","angel",NA,"2015-02-05",165000
"1a33850032a2fa5001cbb16396c6067f","troglo",NA,NA,NA,NA
"38e96b01bef33e7060842a57d46748f0","trooval-com","venture",NA,"2010-06-04",1299980
"38e96b01bef33e7060842a57d46748f0","trooval-com","venture",NA,"2010-11-05",1600000
"69a057b71ec1d8eb06f6030e73066b92","trophos","venture","C","2007-09-05",11582485.4651
"c6552e700544fd2ace8791af00edbe2a","trout-group",NA,NA,NA,NA
"27793b4da39de4b266394ca0d46a3465","trovagene","venture","A","2012-12-19",3760000
"27793b4da39de4b266394ca0d46a3465","trovagene","private_equity",NA,"2012-03-27",6598200
"27793b4da39de4b266394ca0d46a3465","trovagene","debt_financing",NA,"2014-07-01",1.5e+07
"724700980ed822d9476e33a9358f8f17","trove","seed",NA,"2011-05-11",1200000
"724700980ed822d9476e33a9358f8f17","trove","seed",NA,"2013-08-26",1100000
"724700980ed822d9476e33a9358f8f17","trove","venture","1","2015-02-23",8400000
"1793fcbeacefe9dadf0b03d2d66190ae","tru-optik-data-corp","seed",NA,"2015-09-29",1700000
"e41f6609dfb6634919c79a136a61e2f9","trubion-pharmaceuticals","venture",NA,"2009-09-01",1e+07
"a7d7c772ae24e0f3102c35b68bd935bf","trudell-medical",NA,NA,NA,NA
"aae8df0820995687dca3c93307b43aa0","trudera",NA,NA,NA,NA
"ab9eaaebf8d06473db797dc6235f0342","true-dart-llc",NA,NA,NA,NA
"d6232c06710b0aa4350a1bda78026c7c","true-link-financial","seed",NA,"2013-03-01",NA
"d6232c06710b0aa4350a1bda78026c7c","true-link-financial","seed",NA,"2013-09-10",NA
"d6232c06710b0aa4350a1bda78026c7c","true-link-financial","seed",NA,"2015-01-21",3400000
"e688368d44abddace2dfa371292d4896","true-north-therapeutics","venture","C","2015-12-03",4e+07
"e688368d44abddace2dfa371292d4896","true-north-therapeutics","venture","A","2014-06-17",2.2e+07
"e688368d44abddace2dfa371292d4896","true-north-therapeutics","venture","B","2015-04-07",3.5e+07
"6ce4641340bf8dec7c7f7bda3b6a731a","true-office","venture","a","2013-01-24",3e+06
"133e774bdff4fe58c6af38ad7894c8b3","true-pivot","seed",NA,"2012-02-01",NA
"428c7fe2bb58232435a07a67122e0066","trueanalyst",NA,NA,NA,NA
"14c5b1f7b821b6ca0208ea4b3138bd37","trueanthem","seed",NA,"2013-08-29",2605104
"14c5b1f7b821b6ca0208ea4b3138bd37","trueanthem","venture",NA,"2015-09-03",1600000
"d821c5ecc89b10726265d6411072e5c3","truedash","seed",NA,"2016-01-04",NA
"d821c5ecc89b10726265d6411072e5c3","truedash","seed",NA,"2014-09-05",245548
"d821c5ecc89b10726265d6411072e5c3","truedash","seed",NA,"2015-01-20",385790
"12e6172cc8f99b375ad5c212f5c6579e","truelearn-inc",NA,NA,NA,NA
"e80b7e1599106a5574e27567c0db02ca","truelens","venture",NA,"2012-12-03",1200000
"21a9a3f81e3182548a9c1b3fb75eeab1","truevision","debt_financing",NA,"2010-02-12",3517228
"21a9a3f81e3182548a9c1b3fb75eeab1","truevision","debt_financing",NA,"2013-08-14",NA
"21a9a3f81e3182548a9c1b3fb75eeab1","truevision","debt_financing",NA,"2012-07-31",2326502
"21a9a3f81e3182548a9c1b3fb75eeab1","truevision","venture",NA,"2012-05-07",2500000
"21a9a3f81e3182548a9c1b3fb75eeab1","truevision","venture",NA,"2010-09-08",2215165
"21a9a3f81e3182548a9c1b3fb75eeab1","truevision","venture",NA,"2013-06-12",4020433
"84cf7d0d969dd42b054655431ccc2bcf","trufa","debt_financing",NA,"2015-12-04",1050000
"84cf7d0d969dd42b054655431ccc2bcf","trufa","venture","1","2013-12-04",4500000
"84cf7d0d969dd42b054655431ccc2bcf","trufa","venture","1","2014-09-30",6400000
"9f26a40b6125a17c8bfd8d9edec47fde","truinject","convertible_note",NA,"2013-05-13",2e+05
"9f26a40b6125a17c8bfd8d9edec47fde","truinject","convertible_note",NA,"2014-01-02",692500
"52926acd2f753751449d03c2a17ad4c6","trustev","seed",NA,"2013-12-16",5e+05
"52926acd2f753751449d03c2a17ad4c6","trustev","seed",NA,"2013-10-30",3e+06
"52926acd2f753751449d03c2a17ad4c6","trustev","angel",NA,"2013-02-14",3e+05
"52926acd2f753751449d03c2a17ad4c6","trustev","convertible_note",NA,"2014-11-01",4026121
"52926acd2f753751449d03c2a17ad4c6","trustev","seed",NA,"2015-07-01",NA
"a5b4d8052cf2208af77cce368ab27e96","trustfuel","venture",NA,"2015-08-14",4e+05
"647b6b1ca9a14c8285d2c4c2981c119f","trusting-social-co-","undisclosed",NA,"2015-03-30",NA
"bec02b05ed660ed99d56e6204f640a70","trustlayers",NA,NA,NA,NA
"68008f57f87b8f4f24da88b2b5f3282f","trustpharma",NA,NA,NA,NA
"3ca83495489503fda52092a19185f725","trustsphere",NA,NA,NA,NA
"3c9c1e4cc225515d156cc589faeaed09","truven-health-analytics","venture",NA,"2012-06-05",NA
"3c9c1e4cc225515d156cc589faeaed09","truven-health-analytics","grant",NA,"2015-03-16",1350000
"b2153a4f430d5b8125ee853c72122f65","truviso","venture",NA,"2009-07-20",3e+06
"cdb03923def77db7182560d5df53726a","trykaro",NA,NA,NA,NA
"5f7608f53870131976ffd6905d8c37d5","tryolabs","angel",NA,"2012-11-01",NA
"fb7361d0c605e573fdc3251cda07fd8d","tsepak-technologies","seed",NA,"2015-05-26",2e+05
"9b84b3cd62d87e38950500365c085bcd","tsu","venture",NA,"2014-10-21",7e+06
"9b84b3cd62d87e38950500365c085bcd","tsu","venture",NA,"2015-03-31",3599858
"3ea441b0d7280b806510f7dbad4deb5b","tti-turner-technology-instruments","debt_financing",NA,"2009-06-15",3069949
"8e53fc654fdcbf091dc33c0a2bf5852f","tts-pharma","venture",NA,"2012-12-01",880895
"f9cc5fd8edbd3ffcb2e6e7b248f2ab78","ttwick","angel",NA,"2013-05-03",455000
"f9cc5fd8edbd3ffcb2e6e7b248f2ab78","ttwick","venture",NA,"2014-01-01",2e+06
"e24d9888b1d7b59dfbaba02f85fc3b76","tubemogul","venture","a","2008-02-07",1500000
"e24d9888b1d7b59dfbaba02f85fc3b76","tubemogul","angel",NA,"2008-01-01",NA
"e24d9888b1d7b59dfbaba02f85fc3b76","tubemogul","venture","b","2009-03-31",3e+06
"e24d9888b1d7b59dfbaba02f85fc3b76","tubemogul","venture","b","2010-10-08",1e+07
"e24d9888b1d7b59dfbaba02f85fc3b76","tubemogul","seed",NA,"2007-10-15",NA
"e24d9888b1d7b59dfbaba02f85fc3b76","tubemogul","venture","c","2013-05-29",1e+07
"e24d9888b1d7b59dfbaba02f85fc3b76","tubemogul","venture","c","2012-12-20",28657047
"e24d9888b1d7b59dfbaba02f85fc3b76","tubemogul","secondary_market",NA,"2015-06-11",82900000
"4a9919a41ae423f15fa397755579194a","tubett","undisclosed",NA,"2014-02-01",NA
"8c0281628663d3cc516ee6cc7c268371","tubular-labs","debt_financing",NA,"2013-06-25",1e+06
"8c0281628663d3cc516ee6cc7c268371","tubular-labs","venture","1","2012-12-20",2500000
"8c0281628663d3cc516ee6cc7c268371","tubular-labs","seed",NA,"2012-10-03",650000
"8c0281628663d3cc516ee6cc7c268371","tubular-labs","venture","1","2014-04-22",1.1e+07
"8c0281628663d3cc516ee6cc7c268371","tubular-labs","venture","1","2015-04-27",6620374
"b11622a05c2b3e6ba5d1fa4d4b1236e1","tuebora","seed",NA,"2013-03-05",NA
"b11622a05c2b3e6ba5d1fa4d4b1236e1","tuebora","venture",NA,"2015-03-09",NA
"11232821b505e54a6b2aefd56f183c1a","tuee","seed",NA,"2013-03-11",50000
"11232821b505e54a6b2aefd56f183c1a","tuee","angel",NA,"2013-10-22",75000
"11232821b505e54a6b2aefd56f183c1a","tuee","angel",NA,"2014-12-01",1e+05
"11232821b505e54a6b2aefd56f183c1a","tuee","seed",NA,"2013-07-01",65000
"11232821b505e54a6b2aefd56f183c1a","tuee","debt_financing",NA,"2015-03-10",1e+05
"30eaa675ad03188315fbbf7cf92dbda4","tuitele",NA,NA,NA,NA
"d7763b605c69f20171b5f0620e67582c","tule",NA,NA,NA,NA
"5ed3d68c89b12ffd28894cb168a5a00b","tumbleweed-marketing-analytics",NA,NA,NA,NA
"6ac2032397187a003eb3bce8c9728e66","tune","venture","a","2013-05-21",9400000
"6ac2032397187a003eb3bce8c9728e66","tune","venture","B","2015-01-29",2.7e+07
"43a5f148815a73114bebb84ec990447b","tunedin",NA,NA,NA,NA
"3bfe92ce9b618b49f954f284fada558e","tunstall-healthcare-group",NA,NA,NA,NA
"7845697cc3a0135428c93cee63505530","tuplejump",NA,NA,NA,NA
"19a66799a2e4833632af7b0cb71cf518","tuq",NA,NA,NA,NA
"f7b3fba6b59649f9fc7a42be3f6e73bc","turbine-analytics-s-a","seed",NA,"2012-05-17",1e+06
"b8fa40fcbd49e32d4c0deaa08b7374e9","turing-data","private_equity",NA,"2011-12-27",1e+06
"4cc860365cd4c297ab9acd5eee9cb45f","turing-inc","seed",NA,"2014-09-01",1200000
"ae862bbaa1e15163459370759dda133d","turing-pharmaceuticals","venture","A","2015-08-10",9e+07
"fba346a20b60b9c5f1cf12abfd267151","turnoutnow",NA,NA,NA,NA
"76cc692c60766a2ef6ab9d04bc06ccc4","turnstone-biologics","venture","A","2015-10-27",11300000
"263f1bc875cd8140878d05ce30a79530","turnstyle-analytics","angel",NA,"2014-01-20",1e+06
"263f1bc875cd8140878d05ce30a79530","turnstyle-analytics","seed",NA,"2014-11-01",1780938.614
"f163c1afe79023f58cfa6f6083cb4b62","turnwasters",NA,NA,NA,NA
"97389c4e0cfc5ab2104028f1fe98a395","tutanota",NA,NA,NA,NA
"a9e7d80f0ddc556b36bc7d50cf102041","tute-genomics","seed",NA,"2014-01-01",1500000
"a9e7d80f0ddc556b36bc7d50cf102041","tute-genomics","venture","1","2014-12-04",2300000
"a9e7d80f0ddc556b36bc7d50cf102041","tute-genomics","venture","1","2015-06-16",3900000
"a1a25159f986c3dfe0550665d292c2f2","tv-map",NA,NA,NA,NA
"672763dbfce89c507948264855a6ce82","tv2-holding","debt_financing",NA,"2012-02-02",716101
"672763dbfce89c507948264855a6ce82","tv2-holding","venture",NA,"2010-07-15",4.5e+07
"672763dbfce89c507948264855a6ce82","tv2-holding","venture","1","2012-05-01",4000001
"672763dbfce89c507948264855a6ce82","tv2-holding","venture",NA,"2013-11-07",39643841
"672763dbfce89c507948264855a6ce82","tv2-holding","venture",NA,"2009-11-06",30505087
"d55f8f6658b05d82acc8fa9e71210de7","tvax-biomedical","debt_financing",NA,"2010-08-08",2000391
"d55f8f6658b05d82acc8fa9e71210de7","tvax-biomedical","venture",NA,"2013-01-07",2e+06
"d55f8f6658b05d82acc8fa9e71210de7","tvax-biomedical","venture",NA,"2014-12-02",1022737
"d55f8f6658b05d82acc8fa9e71210de7","tvax-biomedical","venture",NA,"2015-03-30",2e+06
"f47f0c2ace4cda48a13ba94e4c7764d5","tvbeat","seed",NA,"2013-07-02",120000
"f47f0c2ace4cda48a13ba94e4c7764d5","tvbeat","seed",NA,"2014-03-04",2250000
"21de489dfbc4f01efe5ea5e195b2a4e1","tvib",NA,NA,NA,NA
"e1ebb95f1701d5944f08f1549fd3498d","tvision-insights","venture","A","2015-12-16",2500000
"e1ebb95f1701d5944f08f1549fd3498d","tvision-insights","seed",NA,"2015-05-14",380000
"e1ebb95f1701d5944f08f1549fd3498d","tvision-insights","seed",NA,"2015-11-16",2800000
"e1ebb95f1701d5944f08f1549fd3498d","tvision-insights","grant",NA,"2015-11-16",50000
"e1ebb95f1701d5944f08f1549fd3498d","tvision-insights","seed",NA,"2015-04-01",4e+05
"5167279559ea00e1e0c98972f0570aeb","tvrunway",NA,NA,NA,NA
"d9bc620672da2b22e55ee0ebf21d908f","tweepsmap","grant",NA,"2015-07-20",NA
"d9bc620672da2b22e55ee0ebf21d908f","tweepsmap","seed",NA,"2015-03-03",NA
"d9bc620672da2b22e55ee0ebf21d908f","tweepsmap","grant",NA,"2013-05-01",NA
"d9bc620672da2b22e55ee0ebf21d908f","tweepsmap","grant",NA,"2014-04-01",NA
"2cf1a626f1138b2b87428bfdbf05695a","tweet-binder",NA,NA,NA,NA
"c216ea51348c18f061de562170bffc42","tweet-category","venture",NA,"2012-11-19",140382
"930beae885ac743cdfd7a056481edbf5","tweetfavy",NA,NA,NA,NA
"581e43ba2a586df85d095183b197d468","tweetiator",NA,NA,NA,NA
"f296be70da2794325039c316836b94e6","twenty20-2","seed",NA,"2012-06-29",1700000
"f296be70da2794325039c316836b94e6","twenty20-2","undisclosed",NA,"2011-12-31",NA
"f296be70da2794325039c316836b94e6","twenty20-2","venture","1","2015-02-26",8e+06
"f296be70da2794325039c316836b94e6","twenty20-2","seed",NA,"2014-04-01",NA
"9929a15e3aff47396be2566b91ce9076","twentyfeet","debt_financing",NA,"2013-07-12",2e+06
"cb883f8a8cacf3f86af513e0b1448d7d","twibitz",NA,NA,NA,NA
"a204b198fc55fb36f250fda384128e15","twiddly","seed",NA,"2014-10-28",30000
"bea2c8b9595f6aa76dad62f2e85ebd69","twin-disc",NA,NA,NA,NA
"803ed32985dac3029c6ee59ad6d5eb6b","twin-star-ecs","venture",NA,"2010-12-03",95000
"d12d8b0f4bd1173d565fdc748ce722be","twing-co",NA,NA,NA,NA
"b2b565cb3726adaed16d6cef11f71fb9","twinword",NA,NA,NA,NA
"8e6b9fd0b2d37b21f9fa8587c1180bff","twist-biosciences","venture","D","2016-01-19",6.1e+07
"8e6b9fd0b2d37b21f9fa8587c1180bff","twist-biosciences","venture","a","2014-02-10",9110714
"8e6b9fd0b2d37b21f9fa8587c1180bff","twist-biosciences","venture","B","2014-05-27",2.6e+07
"8e6b9fd0b2d37b21f9fa8587c1180bff","twist-biosciences","debt_financing",NA,"2014-09-30",1e+07
"8e6b9fd0b2d37b21f9fa8587c1180bff","twist-biosciences","venture","C","2015-06-09",3.7e+07
"7ef5955a1145a117f0528356a3bc6481","twist-of-lime",NA,NA,NA,NA
"3abe212b2012410e8022224ae1c0ad29","twist-systems",NA,NA,NA,NA
"143a4b5748c5c3ae9c37a2d491bbcb1d","twitrum",NA,NA,NA,NA
"79efacca496078725feedddbc6abb2e6","twitshoot",NA,NA,NA,NA
"5497cce6e99e403372a011391ee72031","twitsmash",NA,NA,NA,NA
"28a1da67dea979e9040eacef2de94563","twitsprout",NA,NA,NA,NA
"ec7ec6b10bb25ac8bb8863b716d6520f","twittercounter",NA,NA,NA,NA
"48f2c510798ac70a9e68046dd0837ea6","twitter-friends",NA,NA,NA,NA
"f13ff583b5ce983282a79599275521d9","twitturk",NA,NA,NA,NA
"d84b015718a3204d79e29a1746d69702","two-42-solutions","angel",NA,"2014-02-01",50000
"d84b015718a3204d79e29a1746d69702","two-42-solutions","angel",NA,"2014-05-01",50000
"d84b015718a3204d79e29a1746d69702","two-42-solutions","angel",NA,"2014-07-04",50000
"9ac135f256cd4c2efc0a365b6751a61a","twof","venture","A","2010-02-08",2148399
"3371bf5b47a5951035791664e4129ed4","twoxar-incorporated","seed",NA,"2015-11-19",3400000
"3371bf5b47a5951035791664e4129ed4","twoxar-incorporated","seed",NA,"2015-05-01",NA
"b810a3f7a7ce1591e0de4b9169ace1b8","txcell","venture","c","2012-11-26",16075360
"b810a3f7a7ce1591e0de4b9169ace1b8","txcell","venture",NA,"2014-04-14",21361708
"b810a3f7a7ce1591e0de4b9169ace1b8","txcell","venture","A","2004-10-01",13002827
"b810a3f7a7ce1591e0de4b9169ace1b8","txcell","venture","B","2008-02-01",19743385
"0283becadd5144cb4a637bd2ac9fb862","tyco-ventures",NA,NA,NA,NA
"9c65f3fae7382b0c94e9e569223ae339","tycoon",NA,NA,NA,NA
"fc403ed24f0bef6b81f3d3c9a4e4d69b","tydy","angel",NA,"2014-08-06",138000
"fc403ed24f0bef6b81f3d3c9a4e4d69b","tydy","debt_financing",NA,"2012-01-19",25000
"c14b764f385ff10361dd3bd36e641e45","tykli","angel",NA,"2012-01-03",65070
"c14b764f385ff10361dd3bd36e641e45","tykli","seed",NA,"2013-01-01",NA
"8e012a15106a00eb88e6b666ec977791","tyrogenex","debt_financing",NA,"2014-04-10",3294909
"8e012a15106a00eb88e6b666ec977791","tyrogenex","seed",NA,"2011-03-21",970000
"8e012a15106a00eb88e6b666ec977791","tyrogenex","venture","1","2014-06-19",1.5e+07
"b10b8b7bb3e3c3a313b61358fa386476","tyrx-pharma","venture",NA,"2010-12-08",2e+07
"38c628c10130f6c96348bae2735dc7e6","u-c-davis",NA,NA,NA,NA
"fee326fbeecb7b06f04173671f5612d7","u-s-healthworks","venture",NA,"2010-02-02",40500000
"4857b1ddaf99c13bd1ac80313b878b80","ub-downtown-biomedical-incubator",NA,NA,NA,NA
"0055df9af870032b27d5275881a12245","ubeeko","angel",NA,"2015-06-01",NA
"0055df9af870032b27d5275881a12245","ubeeko","seed",NA,"2015-09-10",NA
"59ec6d908bc2727838f3d4c683f2ff3d","uber-operations",NA,NA,NA,NA
"1d2700292521ad6f7f537497d7d2a1ac","uberflip",NA,NA,NA,NA
"a2de90fbc690c85cbe2cb26824152e85","ubertweek","seed",NA,"2011-12-05",NA
"9f69aae253725a8bd1077b679451df96","ubervu","seed",NA,"2008-09-01",73105
"9f69aae253725a8bd1077b679451df96","ubervu","venture",NA,"2009-01-30",512640
"ea7a4b36fec8e65c2f1e221c61872d0b","www-ubestbattery-com",NA,NA,NA,NA
"3b4bb23f41b7b8fc0f72aecdec5ae408","ubikod","seed",NA,"2009-05-01",265500
"3b4bb23f41b7b8fc0f72aecdec5ae408","ubikod","angel",NA,"2010-07-01",123280
"0be28bf932c295bfa608041ca7b985ec","ubinext",NA,NA,NA,NA
"bc19658edbc6a61e08ac60e559e8226e","ubiome","venture",NA,"2014-02-24",NA
"bc19658edbc6a61e08ac60e559e8226e","ubiome","product_crowdfunding",NA,"2012-11-16",351193
"bc19658edbc6a61e08ac60e559e8226e","ubiome","venture","1","2014-08-18",4500000
"bc19658edbc6a61e08ac60e559e8226e","ubiome","seed",NA,"2014-07-16",120000
"8c39d9d68db2ff20fb1b7375456a01b2","ubiq",NA,NA,NA,NA
"acaba64df5eadef7938921a9b32c039b","ubiquigent","seed",NA,"2013-09-18",757625
"9bc74b076eb9421bac22b35a12510017","ubix-labs","debt_financing",NA,"2015-01-14",2e+06
"9bc74b076eb9421bac22b35a12510017","ubix-labs","seed",NA,"2013-01-11",5e+05
"9bc74b076eb9421bac22b35a12510017","ubix-labs","seed",NA,"2013-07-26",5e+05
"9bc74b076eb9421bac22b35a12510017","ubix-labs","seed",NA,"2014-01-31",1050000
"ec8d887a19ecf47e72a4587b7f8be50e","ubm-tech",NA,NA,NA,NA
"2df6667dff5e9945cf4826f70af7f5ca","ubudu",NA,NA,NA,NA
"60f447e357427384a2b96e679deded6b","ucb-pharma","private_equity",NA,"2009-12-22",1e+08
"60f447e357427384a2b96e679deded6b","ucb-pharma","venture",NA,"2015-05-13",787628
"eb9b9977059f69dda618808ead5dcb37","uci-institute-for-innovation",NA,NA,NA,NA
"1c01fa18989c04340a9012e46a11380e","ufindads","seed",NA,"2013-11-01",2000
"1c01fa18989c04340a9012e46a11380e","ufindads","angel",NA,"2014-09-09",40000
"fd86472f1769f977d3e7c916ca1bc31a","ufo-delivery","seed",NA,"2015-08-01",1000
"0a47c775c5f4e3c3f051ce7296afc6d0","ufora","seed",NA,"2011-04-25",5e+06
"97cb40e2158c1bc772f40c132047b6ac","ugentec",NA,NA,NA,NA
"c6a5b5d29c73b676df093b37d58e666a","ugichem","private_equity",NA,"2013-05-28",2894850
"c6a5b5d29c73b676df093b37d58e666a","ugichem","venture","1","2007-05-17",1080000
"ce2b25259d6ce6567cff197532418c79","ugly-research",NA,NA,NA,NA
"c99d58c8cec3db2bfafdc64240029265","ukdk-limited",NA,NA,NA,NA
"751b9479482816e4f47e1e3bf9190237","uklipz-media","seed",NA,"2015-07-01",NA
"e3c0e6751206e1f9a7a7022cc501d59b","ukraine-venture-center",NA,NA,NA,NA
"2301173cd825b17e1d4ab90edb8a52f8","ullman-medical",NA,NA,NA,NA
"81a61d4e0b7a7a1e22e2ecf738b9ebbb","ulogica-llc",NA,NA,NA,NA
"55299c49568d5a6b1029fbb120404cc7","ultivue","venture","A","2015-10-13",5150000
"9506f7f4ed3b19032477623a386ed89b","ultra-knowledge",NA,NA,NA,NA
"78d378f437ec972b7e308b3986a1f415","ultradia",NA,NA,NA,NA
"9f1843c31a2f8583e837d0441b3deb23","ultragenyx-pharmaceutical","venture","a","2011-06-20",4.5e+07
"9f1843c31a2f8583e837d0441b3deb23","ultragenyx-pharmaceutical","venture","a","2012-07-30",15100000
"9f1843c31a2f8583e837d0441b3deb23","ultragenyx-pharmaceutical","private_equity",NA,"2012-12-31",75000005
"51933908d22211caefb71ee6015b09b4","ultralink",NA,NA,NA,NA
"c1bff278aa7ff39da4c8c2cb059eb8e3","ulula-4",NA,NA,NA,NA
"22f69acaed5ec501507009c114403ac1","uluru","venture",NA,"2014-03-17",42600
"22f69acaed5ec501507009c114403ac1","uluru","debt_financing",NA,"2012-07-10",2210000
"22f69acaed5ec501507009c114403ac1","uluru","venture",NA,"2013-01-11",4e+05
"22f69acaed5ec501507009c114403ac1","uluru","post_ipo_debt",NA,"2015-04-20",5e+05
"ac666e118f0e3caaaef3dd8f2baaa3ed","uman-pharma","venture",NA,"2011-11-11",26502948
"47ef5fc8bf8edabac9276a19c7c76aa6","umanick-technologies",NA,NA,NA,NA
"55a9d816335137339dc9f2a4bf25f60f","umanni",NA,NA,NA,NA
"d2ba4b7c05964c358f5698428fbf4768","umbel","venture","B","2015-11-18",2e+07
"d2ba4b7c05964c358f5698428fbf4768","umbel","venture",NA,"2012-04-02",3652364
"d2ba4b7c05964c358f5698428fbf4768","umbel","venture",NA,"2013-08-12",799579
"6423fdd71e3f62af67e7602f03ecbd5e","umeng","venture","a","2011-07-01",1e+07
"6423fdd71e3f62af67e7602f03ecbd5e","umeng","undisclosed",NA,"2010-11-01",NA
"2b35a3a24d1418afb2ce6f0bcd76014e","unata","seed",NA,"2013-01-01",1500000
"2b35a3a24d1418afb2ce6f0bcd76014e","unata","seed",NA,"2015-01-12",1200000
"b1cf7880bab1ee7626e6d04c8af0c974","unbabel","seed",NA,"2014-07-18",1500000
"b1cf7880bab1ee7626e6d04c8af0c974","unbabel","seed",NA,"2014-01-01",NA
"b1cf7880bab1ee7626e6d04c8af0c974","unbabel","venture",NA,"2015-07-14",NA
"a704fe54e888609d112a55102d25dfc7","unchained-labs","venture","A","2015-02-12",2.5e+07
"7e0267774af1370ba14d00e76bae3cd6","uncover-truth",NA,NA,NA,NA
"0d5a7163b1fdf197ef1c2a7ad14d9141","uncoverly",NA,NA,NA,NA
"9a48fde099ea6cf790563705461ac91a","understory","seed",NA,"2014-04-30",1900000
"9a48fde099ea6cf790563705461ac91a","understory","seed",NA,"2012-06-01",18000
"9a48fde099ea6cf790563705461ac91a","understory","seed",NA,"2013-07-01",50000
"bdd48f922b4e4633cd106349ce660976","unfold-2",NA,NA,NA,NA
"3f23b19f775186cdb7856a1741051ded","unfollowers",NA,NA,NA,NA
"4e6d18c8480e48cfec74a192e959f2ab","unfraud","grant",NA,"2014-09-01",32829
"4e6d18c8480e48cfec74a192e959f2ab","unfraud","seed",NA,"2015-05-26",1e+05
"5cd3652532e42c64d86130c0c0adc29b","uni-b-solutions-llc-",NA,NA,NA,NA
"a6b8ea654d358b59a2495a561d91adcb","unica","venture",NA,"1999-11-29",6750000
"a750b2922d347af3cd20fc40e0a6d9e8","unicorn",NA,NA,NA,NA
"6a379b9acb2fb3eb186dc1c519f4943e","unicorn-media",NA,NA,NA,NA
"8bdeaeb20543d213cb336302996b8a3c","unidesq-platform","seed",NA,"2015-02-01",NA
"d992d4f3a0a39c1b7e6cc7b5d895d4b3","unified","venture","A","2012-06-07",1.4e+07
"d992d4f3a0a39c1b7e6cc7b5d895d4b3","unified","venture","B","2015-09-10",3e+07
"d992d4f3a0a39c1b7e6cc7b5d895d4b3","unified","debt_financing",NA,"2015-09-10",1e+07
"ad1cfdce1744a95329e2897e157a6a23","the-ubi","angel",NA,"2014-03-02",990990
"ad1cfdce1744a95329e2897e157a6a23","the-ubi","product_crowdfunding",NA,"2012-08-13",229500
"ad1cfdce1744a95329e2897e157a6a23","the-ubi","convertible_note",NA,"2013-10-01",97087
"3840df6e078795bdd1d7177096be7933","unifood-us",NA,NA,NA,NA
"a72c0a731a773729659585cfa88498eb","unigene-laboratories","debt_financing",NA,"2013-04-22",750000
"a72c0a731a773729659585cfa88498eb","unigene-laboratories","debt_financing",NA,"2010-03-17",13600000
"a72c0a731a773729659585cfa88498eb","unigene-laboratories","debt_financing",NA,"2012-10-09",4e+06
"a72c0a731a773729659585cfa88498eb","unigene-laboratories","debt_financing",NA,"2010-03-29",19400000
"710212e366a1d594fb9df30543f74370","appozite",NA,NA,NA,NA
"eee21bc15bbddfda53f5be5329074066","union-spring-pharmaceuticals","venture","a","2009-10-01",5e+06
"b85e315ca61cadc16a785c57300a4361","uniqreate-limited",NA,NA,NA,NA
"1ad51a4e3416957005b79420e4e8d5fc","uniqure","private_equity",NA,"2013-07-09",5.8e+07
"1ad51a4e3416957005b79420e4e8d5fc","uniqure","debt_financing",NA,"2014-07-01",2e+07
"2996ece9da0524d6ae0c30ed29684e49","unisense-fertilitech","private_equity",NA,"2013-03-08",2e+07
"a3344a0399d74ab22533246873d42da4","united-biosource-corporation","venture",NA,"2010-08-13",37800
"f6d4eb3f76de3274af439b120075a952","united-communications-group",NA,NA,NA,NA
"47c2b37d4619e61910096456333cefa1","united-health-beijing-zhongliankang-biological-technology","venture","B","2014-07-11",6700000
"f9c35082335a635c23293c234b4e0e9d","united-orthopedic-group","venture",NA,"2013-05-30",2105265
"c2b3fc7df884a115abcc4a6b5b35511f","united-pharmacy-partners-uppi","venture",NA,"2011-04-05",105000
"06660f5a523846ca94aa6a38a0c8b67d","united-states-council-for-international-business-uscib",NA,NA,NA,NA
"4b46f7154c710167678b8b3e75fc505d","united-states-surgical-corporation",NA,NA,NA,NA
"ae16082db9f8b42c1eccc4b125321d1b","united-therapeutics-unither",NA,NA,NA,NA
"73ec90fe3d7bcbc9c308fedd433189e6","unither-pharmaceuticals",NA,NA,NA,NA
"9a9816b8cc6311392febd5a673de9c6e","unity-mobile","angel",NA,"2007-01-01",NA
"eb1e137842f12f713a51c0e129b39335","univercells","venture",NA,"2015-10-23",3377617.6537
"a614ea444dcbd3f0aeddb7ccce27f12c","universal-bio-mining",NA,NA,NA,NA
"830989b24c7b691d67d998b089f0a1ac","universal-biosensors","venture",NA,"2014-01-02",985095
"9d614b79fa1d2081eb06f5f8c7cedce2","universal-robotics","venture",NA,"2009-05-15",1302515
"7c929dd6a4f887142642fafe53e5f81c","unleash",NA,NA,NA,NA
"e535befec26d3f956e3bd312a0e24754","unlimcloud",NA,NA,NA,NA
"0c4b6e1fb7a8b14db09617c398fa2dd4","unlockd",NA,NA,NA,NA
"e2dba60e2c616ab39d8fe47e31a26978","unmetric","venture","b","2013-09-01",5500000
"e2dba60e2c616ab39d8fe47e31a26978","unmetric","venture","a","2012-04-13",3200000
"5db5c000093a35e751490e6e30430d80","unomedical-woundcare-and-ophthalmic-business",NA,NA,NA,NA
"3a8481a89184f1b4b6ecd013db6f3a5e","unomy","seed",NA,"2012-01-01",NA
"3a8481a89184f1b4b6ecd013db6f3a5e","unomy","angel",NA,"2013-12-31",NA
"3a8481a89184f1b4b6ecd013db6f3a5e","unomy","seed","1","2014-06-15",NA
"d57e45de47813e434fe435ac6983296d","unquote",NA,NA,NA,NA
"d41ce3d77899b7a68dce229996c77d76","unrival","seed",NA,"2014-01-20",164223
"8276e1bf7a0ea4eec7a2f0eb304e6dfa","unscrambl",NA,NA,NA,NA
"07c0a98f3d5eb18273537dfb296b1c85","unsilo","seed",NA,"2012-06-01",NA
"07c0a98f3d5eb18273537dfb296b1c85","unsilo","seed",NA,"2013-09-26",1e+06
"821a74f528fd91143c97a241561e0465","untangl",NA,NA,NA,NA
"d6d83b8ef03b038e828779564c510adc","unum-therapeutics","venture","A","2014-10-21",1.2e+07
"d6d83b8ef03b038e828779564c510adc","unum-therapeutics","venture","B","2015-06-11",6.5e+07
"9c60508b13ece967eded8faa8897c06e","uobis",NA,NA,NA,NA
"20ca5a0939d5f1d3f56f80594c99fe8d","up-my-game","seed",NA,"2013-09-13",242718
"8b58d35d36f513a80312de0eb113fa86","upbuild-llc",NA,NA,NA,NA
"29e4631116c719f23a4efc22b30bb93c","upc-solar",NA,NA,NA,NA
"2c9f0b3c0441b578fa47de6ff7582768","updatenode",NA,NA,NA,NA
"98615b970d9b4abb02317321a9f830da","updownleftright","angel",NA,"2015-04-30",675000
"45ef4f467c1f70a72a2fa1aac37285c7","upfront-chromatography","venture",NA,"2007-09-24",9200000
"e6602217e6851646692d26170a73ff39","upgrade-digital",NA,NA,NA,NA
"5f39bda5bf14b5515b65970443e2aea0","uplytic",NA,NA,NA,NA
"760b2b84eed50d3d8383f3398c658e2e","upper-quadrant",NA,NA,NA,NA
"eaf3a7e4f6cbd161056129aaf1e801a9","managize",NA,NA,NA,NA
"900ff950cc3932d11ed5456eb3024265","upsight","venture",NA,"2014-01-13",5543333
"900ff950cc3932d11ed5456eb3024265","upsight","venture","1","2010-06-29",4500000
"900ff950cc3932d11ed5456eb3024265","upsight","venture","1","2011-11-10",1.2e+07
"900ff950cc3932d11ed5456eb3024265","upsight","angel",NA,"2010-04-09",1e+06
"900ff950cc3932d11ed5456eb3024265","upsight","venture","1","2013-12-31",NA
"900ff950cc3932d11ed5456eb3024265","upsight","debt_financing",NA,"2015-04-17",7e+06
"3dce641350971d3f2f5bc6abc1cf8435","upsnap","venture","E","2009-11-20",NA
"3dce641350971d3f2f5bc6abc1cf8435","upsnap","venture","B","2006-11-29",NA
"f89a8b84e067612caac9ed83f1b69556","upstream-analytics",NA,NA,NA,NA
"3bd005f4b11b82943ac374dc333123a5","upstream-commerce","venture",NA,"2013-02-05",3e+06
"3bd005f4b11b82943ac374dc333123a5","upstream-commerce","undisclosed",NA,"2012-12-01",NA
"3bd005f4b11b82943ac374dc333123a5","upstream-commerce","undisclosed",NA,"2013-07-12",NA
"3bd005f4b11b82943ac374dc333123a5","upstream-commerce","venture","1","2011-03-28",1250000
"3bd005f4b11b82943ac374dc333123a5","upstream-commerce","debt_financing",NA,"2014-12-01",2e+06
"3b2155ada2b9242b7d8c9e0e57976e55","upswing",NA,NA,NA,NA
"e13f1a7d5ce7896ff23b3e828884f522","uptake-3","venture","A","2015-10-27",4.5e+07
"977d9134828c63e3732b3b79a003b11e","uptake-medical","debt_financing",NA,"2015-12-02",1928783
"977d9134828c63e3732b3b79a003b11e","uptake-medical","debt_financing",NA,"2011-07-13",4920616
"977d9134828c63e3732b3b79a003b11e","uptake-medical","debt_financing",NA,"2009-05-20",3136333
"977d9134828c63e3732b3b79a003b11e","uptake-medical","venture","1","2012-03-13",40259226
"977d9134828c63e3732b3b79a003b11e","uptake-medical","venture","1","2010-07-07",17500000
"977d9134828c63e3732b3b79a003b11e","uptake-medical","venture",NA,"2010-06-02",600600
"b3648086021d3f078c1da1c8c405060b","uptilab",NA,NA,NA,NA
"fbce84844ef820830a04ea8d0c923e3a","upwell-web-performance",NA,NA,NA,NA
"cfd466233ca0c151edd2f1f5ca92327f","urban-data-analytics",NA,NA,NA,NA
"ff40bfb133da8d8cc3ed1210da936f1a","urban-engines","undisclosed",NA,"2014-05-01",NA
"86badc3fdb745b82def1684050ca6691","urbanmapping","seed",NA,"2006-05-01",4e+05
"2f805f4db0852a761f2b3deaefddfcb3","urbanbaze",NA,NA,NA,NA
"e79a3c10539e90c4f1a714b9ebbb6a02","urgent-career","venture","a","2009-10-09",NA
"1d8f3d968765115ae1f913695ebfce95","urgentcare",NA,NA,NA,NA
"6bc246c327de80d8238327b8e979f5a5","urigen-pharmaceuticals","debt_financing",NA,"2013-07-19",750000
"6bc246c327de80d8238327b8e979f5a5","urigen-pharmaceuticals","venture",NA,"2015-07-14",3e+05
"958690bcc5d1f2d1a466bc0c2c511662","uromedica","debt_financing",NA,"2012-12-28",1250000
"9b08c6148c1794005406a1402353f7bc","urosens","seed",NA,"2013-06-19",1136438
"a05b0c8ecdb1b04a20040665dbfcd7cd","urotec","seed",NA,"2008-03-26",NA
"2db311b61c7c7cede5f5923e1f3cd6a3","us-biologic","seed",NA,"2014-05-06",625000
"2db311b61c7c7cede5f5923e1f3cd6a3","us-biologic","seed",NA,"2014-10-03",625000
"835caa26eeb6727729501e8c9518b7ad","us-chia",NA,NA,NA,NA
"fb1b9c12f6baf6f1aa1c3e60810ad9db","us-health-broker-com","venture",NA,"2010-07-13",1010004
"dfafb589a2ec946208acde4c9e822186","us-healthvest","venture","a","2013-03-04",3.6e+07
"77822ec38ceced66f8ec6f8364d8fdda","userate","angel",NA,"2011-06-22",1e+06
"d1b2b7cf9390e18f4cf804b44075910e","usalytics",NA,NA,NA,NA
"a1fe4b8d5a7c798347e06e91ecae43be","uscom",NA,NA,NA,NA
"5b36d4c82185cb8f6978cc95474233ad","usds","venture",NA,"2010-04-05",1530000
"5b36d4c82185cb8f6978cc95474233ad","usds","venture","1","2013-04-30",4578466
"88d71e31d08284dc1a2593521de25346","usedata",NA,NA,NA,NA
"0eb57734e78e06d7544c596b5f8f4511","use-it-better","seed",NA,"2012-07-01",40000
"f885680008092ade6881c73d1a005dc0","user-local","venture",NA,"2015-05-25",1728109
"536fea3f80d18b1491cc1a4da8d2c5b4","usercycle","seed",NA,"2014-12-21",120000
"cb0c120692237783b3a79e80c34790e0","userevents","undisclosed",NA,"2012-01-01",244778
"b6d43f03619b104a8117cb01ce526286","useriq","seed",NA,"2014-05-01",1200000
"107cc18d2a51a8fc33d5119b2e1cbb48","usermind-inc","venture","a","2013-09-24",7600000
"541f4008b09408b5bace4ca7e734e9ac","usermojo","seed",NA,"2010-03-01",18000
"c9997a84d4e10780d5851dddc15bd9f7","userreport",NA,NA,NA,NA
"96aa23ff0113469331b395f147534485","userthought",NA,NA,NA,NA
"f192b0dc19f3e4e97afa731e45d27c55","usinlife",NA,NA,NA,NA
"a24acc89f3ccd6c60942105636faa9f5","usis-holdings","venture",NA,"2009-04-02",550000
"ccbde7dea48542057b91121e6926a9e4","usmeu","seed",NA,"2015-03-01",NA
"73b8a15647a50971fd437cdf67e6ddaf","usretina","venture",NA,"2015-11-20",5018171
"73b8a15647a50971fd437cdf67e6ddaf","usretina","venture",NA,"2015-01-13",2663571
"ced19cd3577b02e0dd5b8f8989c0f16d","uteron-pharma",NA,NA,NA,NA
"0357cd1358d37fc1a13a82b092de59f0","uv-flu-technologies","venture",NA,"2010-01-20",254117
"88732e9d40d2af2c9bfdeb8b83408094","uvlrx-therapeutics","venture",NA,"2014-02-07",389000
"88732e9d40d2af2c9bfdeb8b83408094","uvlrx-therapeutics","venture",NA,"2013-09-23",144000
"88732e9d40d2af2c9bfdeb8b83408094","uvlrx-therapeutics","venture",NA,"2015-02-19",385000
"88732e9d40d2af2c9bfdeb8b83408094","uvlrx-therapeutics","venture",NA,"2015-07-21",25200
"f1994a378694dff9a1272112f2d18d65","uwi-technology","venture",NA,"2012-10-16",921614
"f1994a378694dff9a1272112f2d18d65","uwi-technology","angel",NA,"2014-10-27",1930921
"da6a2c9bcd0b6901117ca9da5cf82fa4","ux-passion",NA,NA,NA,NA
"c2fa917656fe82ffc3b7e6825ee6ad2b","uxcam","seed",NA,"2014-08-01",1e+05
"c2fa917656fe82ffc3b7e6825ee6ad2b","uxcam","venture",NA,"2014-02-03",NA
"82ec3e900d9d6311a3f237f030137f6b","uxplr",NA,NA,NA,NA
"222c85774e4caa7a1bcbd9d78ad5cff2","uxprobe","seed",NA,"2015-12-08",108596.892
"1058384a6ccfadbdc49f1c24cd2dcdf7","v-clip-pharmaceuticals",NA,NA,NA,NA
"b3919c854c25623d2e8c2a0aa6baa295","v-wave","venture","B","2016-01-11",2.8e+07
"b3919c854c25623d2e8c2a0aa6baa295","v-wave","venture",NA,"2013-07-03",2e+06
"757f6c4c87e9aafd013a86c64a7490e6","v12-group",NA,NA,NA,NA
"0fc46053a366837a6b736034f803ddcd","vab-media-digital-agency",NA,NA,NA,NA
"a62aed5e837a9a494efbd1b8511a148c","vhra-info-the-vacation-home-rentals-aid",NA,NA,NA,NA
"53c119402cb4a3653ddec5b4ca19133a","vacci-test",NA,NA,NA,NA
"3b31ab465857c49c6a3cf72a1a37279f","vaccibody","seed",NA,"2013-06-26",943077
"3b31ab465857c49c6a3cf72a1a37279f","vaccibody","grant",NA,"2012-11-12",2547000
"da2e40b32d757daa815ba0cae1b9f73b","vaccine-technologies-international","venture",NA,"2010-10-21",17750025
"b2a99c15e3c2a3a48a7f079d819419cb","vaccinogen","venture",NA,"2008-12-03",4008472
"b2a99c15e3c2a3a48a7f079d819419cb","vaccinogen","venture",NA,"2011-06-03",7600000
"b2a99c15e3c2a3a48a7f079d819419cb","vaccinogen","venture",NA,"2013-03-22",6642878
"b2a99c15e3c2a3a48a7f079d819419cb","vaccinogen","debt_financing",NA,"2014-01-29",8e+05
"b2a99c15e3c2a3a48a7f079d819419cb","vaccinogen","post_ipo_equity",NA,"2014-08-25",8e+07
"d8c690a4325077d0c21bc8f8090b3bdd","vaccsys","venture",NA,"2008-06-20",9e+06
"bb49cdfc3dca258b913476efa4bed790","vacunek","venture",NA,"2007-01-01",277000
"601eabeb381c485bcb3187d7104f50c5","valcu",NA,NA,NA,NA
"51f9040d7a6a80ad6a387b430a272518","valderm","venture","a","2007-08-17",3370000
"21d7270e3fb6323a4829b6c62d6d391a","valeant-pharmaceuticals-international",NA,NA,NA,NA
"be6d55a1d52245f69a8dcebc86ec1a8b","valen-technologies","undisclosed",NA,"2011-09-07",7500000
"be6d55a1d52245f69a8dcebc86ec1a8b","valen-technologies","venture","1","2007-11-13",6500000
"be6d55a1d52245f69a8dcebc86ec1a8b","valen-technologies","venture",NA,"2009-12-04",770000
"05c7f4d4d6f18b147cc59fd030f647d4","valence-health","venture",NA,"2012-06-19",3e+07
"05c7f4d4d6f18b147cc59fd030f647d4","valence-health","venture",NA,"2014-11-19",1.5e+07
"93235b380546705f93c4aa98c750af1b","valentia-biopharma","undisclosed",NA,"2008-06-26",NA
"106ea9659a31d3cd4cca7e5bf19eaacb","valeo-medical","venture","c","2013-05-09",1e+06
"fb64f2db1836b3e49b23232af569223d","valerion-therapeutics","grant",NA,"2013-05-30",1195762
"128a4ca9c731547a37e50ad43aac621a","valerion-therapeutics-llc","venture","a","2012-03-05",2e+07
"90a89171fe331755785e8a5a83048e7d","valeritas","debt_financing",NA,"2013-06-04",1e+08
"90a89171fe331755785e8a5a83048e7d","valeritas","venture","1","2011-09-12",1.5e+08
"90a89171fe331755785e8a5a83048e7d","valeritas","venture",NA,"2014-07-11",21951220
"e7b39967e66157c048cd5557c949c190","valiance-solutions",NA,NA,NA,NA
"0954a0605d08194d183a775f53ac54c3","validatio",NA,NA,NA,NA
"84c8e7b9c2022b1ebbb45cda5537a1fc","validity","venture","e","2012-10-19",2e+07
"84c8e7b9c2022b1ebbb45cda5537a1fc","validity","venture","d","2010-07-28",12600000
"84c8e7b9c2022b1ebbb45cda5537a1fc","validity","venture","a","2006-10-17",2e+07
"84c8e7b9c2022b1ebbb45cda5537a1fc","validity","venture","b","2007-12-01",2e+07
"84c8e7b9c2022b1ebbb45cda5537a1fc","validity","venture","c","2009-03-11",1e+07
"b2f8fe922171f3c078897d1d167625b6","validsoft",NA,NA,NA,NA
"2d42cfe730f8b621d572b46a671eb39f","validus-technologies-corporation","venture",NA,"2009-10-13",5795201
"c5f1415e33e656bd0420ecac6384db63","valipharma",NA,NA,NA,NA
"8fae64e218bcda92c52c00d44d8ede11","valirx","post_ipo_equity",NA,"2015-03-05",1224392
"44590451fb5aa74273761d8004d47ce0","vality-technology",NA,NA,NA,NA
"8c9905590daefa150c209ffb0ad7de34","valmont",NA,NA,NA,NA
"1ebbeb9acfd241650bdb6c103c051de5","valneva","venture",NA,"2013-06-14",51721320
"d7d98e425c7d1effb2478b024e0ed724","valocor-therapeutics","undisclosed",NA,"2010-05-25",NA
"0ea5d87eed331adde2902ef6faf5bf8e","valor-medical","venture",NA,"2009-08-05",4080255
"36e4264ba500941a369bf41379377191","valor-water-analytics","seed",NA,"2015-04-01",1e+06
"36e4264ba500941a369bf41379377191","valor-water-analytics","seed",NA,"2014-08-20",120000
"36e4264ba500941a369bf41379377191","valor-water-analytics","seed",NA,"2014-12-01",120000
"08ce1f8dd04c012898db82bd974783aa","valossa","seed",NA,"2015-12-21",650000
"9a8ec6cc1fd32dff815572a20743c406","valuable-keyword",NA,NA,NA,NA
"f3d879d7d11232c6dd62d54c52844fca","valuation-app","venture",NA,"2014-03-27",3.5e+07
"8aa05512be1eb8a411ecea250cfb97de","value-chain-solution-india-pvt-ltd",NA,NA,NA,NA
"81ea021770fd83270c6360db6f754b55","valuemedics-research",NA,NA,NA,NA
"ac140a437b62c326696c7231a715c020","valuescope","angel",NA,"2007-01-01",NA
"9bb7fe11ebdc420221586dbf5163caad","vanda-pharmaceuticals","post_ipo_equity",NA,"2014-10-29",5.4e+07
"bcd7de2266f597d351da4a10db685097","vandalia-research","angel",NA,"2005-09-09",925000
"bcd7de2266f597d351da4a10db685097","vandalia-research","venture","1","2008-05-01",750000
"bcd7de2266f597d351da4a10db685097","vandalia-research","private_equity",NA,"2010-05-12",749999
"27ad9cf0ef3f99412c6743bf7647b8b3","vanedge",NA,NA,NA,NA
"a526f54970bbfff78cfc65498d203222","vanquish-oncology","venture",NA,"2014-04-10",4386221
"d10e56cf3c4ff2e1c68c621b6eeda0f8","vanson-halosource","venture","B","2005-03-17",5e+06
"5b1de0534fc20ee506c61ba271a9592f","vantage-analytics","seed",NA,"2014-08-19",1100000
"cfd2fb05cc95b0ca7c664fa9385e6671","vantage-clinical-consulting",NA,NA,NA,NA
"133d199ce024915fc578038450ce3bb0","vantage-hospice","seed",NA,"2012-01-10",686000
"b502f06c0824a3bec8a6d34c84df9273","vantage-sports","seed",NA,"2015-08-01",2e+06
"b502f06c0824a3bec8a6d34c84df9273","vantage-sports","undisclosed",NA,"2014-09-01",7e+05
"b502f06c0824a3bec8a6d34c84df9273","vantage-sports","venture",NA,"2014-05-08",1600000
"850bc25bab1fef0fba2ddf61903da1cd","vantia-therapeutics","venture","b","2011-07-06",6500000
"9e1678aa05e6cfaad047d8b430fae794","vapi","angel",NA,"2014-05-01",77000
"cfd56202a7a5e98b7e3de8ea3ed2a8b0","vapotherm","venture",NA,"2015-12-01",1.5e+07
"cfd56202a7a5e98b7e3de8ea3ed2a8b0","vapotherm","venture","1","2007-11-01",11250000
"cfd56202a7a5e98b7e3de8ea3ed2a8b0","vapotherm","venture",NA,"2008-08-14",20500000
"cfd56202a7a5e98b7e3de8ea3ed2a8b0","vapotherm","venture","1","2014-04-03",2.4e+07
"cfd56202a7a5e98b7e3de8ea3ed2a8b0","vapotherm","venture","1","2013-04-25",2.9e+07
"cfd56202a7a5e98b7e3de8ea3ed2a8b0","vapotherm","venture","1","2015-07-13",2e+07
"96c4dfa13bbd49dfc2832aa02adac6d4","varada-innovations","seed",NA,"2013-01-01",15000
"7df448f101b7f69abea9716198715bda","variad-diagnostics","undisclosed",NA,"2014-05-28",1e+05
"5d3da2f40bac4ab170e7e34ab835510c","variation-biotechnologies","venture","A","2007-01-04",35700000
"6a550a95e2a9972c44c134fa35a6f9c6","varigence",NA,NA,NA,NA
"ebc13c1f95b91b08a28516c8e23c20c5","varinode-2","convertible_note",NA,"2014-08-19",NA
"deefe8fe15da5edce25a4e53eb625c77","varonis-systems","venture","b","2006-05-08",10140000
"deefe8fe15da5edce25a4e53eb625c77","varonis-systems","venture",NA,"2012-02-09",1e+06
"deefe8fe15da5edce25a4e53eb625c77","varonis-systems","venture",NA,"2009-01-22",1.5e+07
"deefe8fe15da5edce25a4e53eb625c77","varonis-systems","venture",NA,"2010-08-24",147682
"deefe8fe15da5edce25a4e53eb625c77","varonis-systems","venture",NA,"2011-03-07",2500003
"2abad5d1acbca7d5a508e946adfe6eaa","varsa-health","seed",NA,"2014-10-01",50000
"eeb9df4a82e3423553145992fe2921b6","vascular-biogenics-ltd","venture",NA,"2015-11-08",1.5e+07
"3c617d69b620a510168573535e465f33","vascular-designs","venture",NA,"2010-12-15",294481
"b76899b516b2aa028766827574c5ea0e","vascular-imaging","venture",NA,"2009-09-24",2386283
"1990151fb5d409631d26cdd20cd313a5","vascular-magnetics","venture","a","2012-02-22",7e+06
"db9a5efadbdb78053b37481452e96288","vascular-pathways","venture","b","2010-11-01",1.4e+07
"db9a5efadbdb78053b37481452e96288","vascular-pathways","debt_financing",NA,"2014-06-24",5e+06
"a89e7c8112d89417f0d87be19d759f66","vascular-pharmaceuticals","venture","B","2016-01-07",3e+06
"a89e7c8112d89417f0d87be19d759f66","vascular-pharmaceuticals","debt_financing",NA,"2013-04-23",1e+06
"a89e7c8112d89417f0d87be19d759f66","vascular-pharmaceuticals","venture","a","2012-09-12",1.6e+07
"a89e7c8112d89417f0d87be19d759f66","vascular-pharmaceuticals","venture","A","2015-03-03",9e+06
"f27bc18de7ee5af55379bb9b9ef06c01","vascular-therapies","debt_financing",NA,"2011-04-25",1375000
"f27bc18de7ee5af55379bb9b9ef06c01","vascular-therapies","debt_financing",NA,"2011-04-25",646340
"f27bc18de7ee5af55379bb9b9ef06c01","vascular-therapies","debt_financing",NA,"2011-04-25",348000
"f27bc18de7ee5af55379bb9b9ef06c01","vascular-therapies","venture",NA,"2011-06-14",3159325
"f27bc18de7ee5af55379bb9b9ef06c01","vascular-therapies","venture",NA,"2013-07-11",5195226
"f27bc18de7ee5af55379bb9b9ef06c01","vascular-therapies","venture",NA,"2015-02-19",16200000
"60758d063a3b00d68972bfd4b9f29477","vasculox","venture",NA,"2015-02-12",1269350
"60758d063a3b00d68972bfd4b9f29477","vasculox","venture",NA,"2015-08-10",8134451
"930e1d98db8772b9887bc9a6d08009b1","vasogen-inc",NA,NA,NA,NA
"e26da816082955126d44877bfbaf7a49","vasogenix","venture",NA,"2009-01-29",4e+05
"834fd8fbc055a4553ac73ebeac9b6e0e","vasolux-microsystems","seed",NA,"2009-07-28",380000
"d0cf6f2f892359b2e572b66e00ce39fa","vasopharm","venture",NA,"2016-01-21",21773684.3251
"d0cf6f2f892359b2e572b66e00ce39fa","vasopharm","grant",NA,"2004-02-11",NA
"d0cf6f2f892359b2e572b66e00ce39fa","vasopharm","venture","1","2006-01-30",11800000
"d0cf6f2f892359b2e572b66e00ce39fa","vasopharm","venture","1","2009-05-04",6e+06
"d0cf6f2f892359b2e572b66e00ce39fa","vasopharm","venture","1","2013-06-24",6500000
"349f16a49a7db366703b324c116c5753","vaxart","venture","a","2007-11-15",3300000
"349f16a49a7db366703b324c116c5753","vaxart","venture","b","2010-01-14",3500000
"349f16a49a7db366703b324c116c5753","vaxart","venture","b","2010-03-04",9e+06
"349f16a49a7db366703b324c116c5753","vaxart","venture","c","2013-08-06",2e+07
"349f16a49a7db366703b324c116c5753","vaxart","venture","b","2012-06-29",16868419
"778ed3cdc4c000060c6a777c7586f65b","vaxcare","debt_financing",NA,"2012-10-02",1500000
"fcb555107efe703b9554ecc4ea5322eb","vaxdesign",NA,NA,NA,NA
"c917a18af8524fe3972f0b4c235d0b16","vaxess-technologies","venture","a","2013-05-23",3750000
"c917a18af8524fe3972f0b4c235d0b16","vaxess-technologies","debt_financing",NA,"2013-12-01",1e+06
"c917a18af8524fe3972f0b4c235d0b16","vaxess-technologies","grant",NA,"2015-01-01",150000
"c917a18af8524fe3972f0b4c235d0b16","vaxess-technologies","non_equity_assistance",NA,"2015-02-03",1e+06
"c917a18af8524fe3972f0b4c235d0b16","vaxess-technologies","grant",NA,"2015-04-06",2e+05
"1ae4170f80912db40901ec5df0b85643","vaxgen",NA,NA,NA,NA
"235ca9e63393278e8a18cdbb40a7f885","vaxil-biotherapeutics",NA,NA,NA,NA
"44c216e56cba10c189652594aa2f12ce","vaximm","venture",NA,"2011-01-12",8e+06
"6eb57c6ab3fd6094f2dd8b51ed619058","vaxin-inc","venture",NA,"2015-02-17",1.6e+07
"7635f325b7c28d0db428df100ae21e8b","vaxinnate","venture",NA,"2015-09-28",3248047
"7635f325b7c28d0db428df100ae21e8b","vaxinnate","grant",NA,"2014-01-28",2100000
"7635f325b7c28d0db428df100ae21e8b","vaxinnate","venture","1","2006-10-25",4e+07
"7635f325b7c28d0db428df100ae21e8b","vaxinnate","venture","1","2009-06-14",3e+07
"7635f325b7c28d0db428df100ae21e8b","vaxinnate","debt_financing",NA,"2012-02-24",24810408
"7635f325b7c28d0db428df100ae21e8b","vaxinnate","venture","1","2014-10-02",6e+06
"b65acc7753684a2058740b30b2b701ca","vaxxas","venture","A","2011-08-02",1.5e+07
"b65acc7753684a2058740b30b2b701ca","vaxxas","venture","B","2015-02-10",2.5e+07
"33c2c18ce669ee83016c8baefd0e4284","vayar-vision",NA,NA,NA,NA
"1d03235076a79aae55395bb4d5bef1aa","vbact",NA,NA,NA,NA
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","post_ipo_equity",NA,"2014-08-14",1.1e+07
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","debt_financing",NA,"2012-07-02",1200000
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","debt_financing",NA,"2013-03-08",751061
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","debt_financing",NA,"2014-03-25",1500000
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","debt_financing",NA,"2013-12-24",1375000
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","debt_financing",NA,"2013-08-26",250000
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","debt_financing",NA,"2010-11-17",4331932
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","debt_financing",NA,"2011-07-15",3500000
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","debt_financing",NA,"2012-02-13",2200000
"404653417aa51f3cc920ebc566145b66","vbi-vaccines","post_ipo_equity",NA,"2015-08-26",6285700
"7e4b5a94ea46dc0b8fa6470798aa137c","vbl-therapeutics",NA,NA,NA,NA
"8f3343865acbd74f390c759f690d0977","vbout-com","seed",NA,"2016-02-02",NA
"c907aca387fac70d6235750dd6003f20","vbox","venture",NA,"2011-04-27",1543860
"c907aca387fac70d6235750dd6003f20","vbox","debt_financing",NA,"2014-08-14",5e+05
"597bbc0c9ac3904fdbccf482f2e63462","vbrand","seed",NA,"2014-09-01",8e+05
"ac3c357f37ed6d3b0aa84d0fff467e81","vc-experts",NA,NA,NA,NA
"2d0e93288b807e6e4c41cf1a8ff39e52","vcare-corporation",NA,NA,NA,NA
"0d94cb2d2c5fdab00c5b93df2dd15341","vcerto",NA,NA,NA,NA
"50a368bcf1319ed6c85e95b112cddc7a","vcognition",NA,NA,NA,NA
"8f0e8187ab9d6696018d4845ac97b660","ve-interactive",NA,NA,NA,NA
"5884867bc3eac79b5abf145f8f055db6","veact","venture","A","2015-10-26",3029946.8933
"6b1ceca43f7f91e26b5f677456b6a0ca","vecta-software",NA,NA,NA,NA
"bc359d7b21360eceed5066e5c5c1e2e6","vectoris-pharma",NA,NA,NA,NA
"57576b33880730e45c7e104ab6f1d554","veda-semantics",NA,NA,NA,NA
"36aae66cdf1a255bdf3400f0b48b08b7","vedantra-pharmaceuticals","venture",NA,"2012-08-03",3300000
"ddda41ee3074b0059d0cce2238d71be3","veebit",NA,NA,NA,NA
"d9e60e577bae1c286e8749e2ec3eddf2","veed",NA,NA,NA,NA
"255ef8794df1942ce01be636b4471bd4","veeda-oncology",NA,NA,NA,NA
"03991e9882534c4ec9072cacd3c5b060","veeip","seed",NA,"2013-06-01",NA
"f66a3b7f0ca40c18ed2045a78acecd04","veezio",NA,NA,NA,NA
"dadd83a37be9c4fb45aad746ea85ceab","vehcon","venture",NA,"2014-02-02",150000
"dadd83a37be9c4fb45aad746ea85ceab","vehcon","venture","1","2013-06-17",1200000
"dadd83a37be9c4fb45aad746ea85ceab","vehcon","venture",NA,"2014-08-25",192000
"dadd83a37be9c4fb45aad746ea85ceab","vehcon","venture",NA,"2015-07-13",571736
"06a73d114256356a2bbbab692fd8c599","vehicle-data-science",NA,NA,NA,NA
"3821c23a8d8e4f745b32a53725db66b1","vein-clinics-of-america",NA,NA,NA,NA
"1720287bf2c0eb87d86e43e5ecb7d7dc","velcera",NA,NA,NA,NA
"bccedefdf708d7e6cc3191c71e69d8e0","veleza","angel",NA,"2015-02-01",241086
"2c00c478dbef244a3691c13300b932e7","vellem",NA,NA,NA,NA
"4b18eb62d1a72c71b4db0ce3d416e18c","vello-systems","venture",NA,"2011-10-12",2.5e+07
"1a7a68485e04aa89849a634632dca2d4","velocidata","venture",NA,"2013-07-18",1e+07
"1a7a68485e04aa89849a634632dca2d4","velocidata","venture",NA,"2013-10-18",598145
"1a7a68485e04aa89849a634632dca2d4","velocidata","debt_financing",NA,"2015-01-13",1522269
"1a7a68485e04aa89849a634632dca2d4","velocidata","venture",NA,"2015-09-16",1500000
"ccc516437a70ea8b050d5bed94225e2b","velocity-digital",NA,NA,NA,NA
"3bac7822eb99d94540159b21aae52cfb","velomedix","venture","c","2012-02-08",10200000
"3bac7822eb99d94540159b21aae52cfb","velomedix","venture","b","2011-11-08",5300000
"3bac7822eb99d94540159b21aae52cfb","velomedix","venture","a","2009-11-11",3500000
"eca436fbfc1d907315f8c70a7da55702","velos-2","venture","b","2011-03-01",1750000
"eca436fbfc1d907315f8c70a7da55702","velos-2","venture",NA,"2011-12-01",1500000
"eca436fbfc1d907315f8c70a7da55702","velos-2","venture","a","2010-01-21",1625000
"eca436fbfc1d907315f8c70a7da55702","velos-2","venture",NA,"2013-02-19",1e+06
"0845bf47ae84b2ff6fda9aeabca78e7d","velos",NA,NA,NA,NA
"80f63f054c22993c62bc560bb8e45b54","vem-global",NA,NA,NA,NA
"a4c77eb5103ba6db8c1fefde4c66552e","vemt",NA,NA,NA,NA
"4b3dcce389efca990017cd85a799ed01","venalytica",NA,NA,NA,NA
"8a0e8fea30de929bd3563db8d2d37e2c","venatorx-pharmaceuticals","venture",NA,"2013-12-04",3419051
"e9860420af30fd9b7842c15bf2663a33","venga","venture","a","2014-01-15",1e+06
"e9860420af30fd9b7842c15bf2663a33","venga","seed",NA,"2012-03-01",NA
"e9860420af30fd9b7842c15bf2663a33","venga","undisclosed",NA,"2012-09-18",NA
"b0b2bf162f367879649eba21f224a20f","veniti","venture","a","2011-03-07",13500000
"b0b2bf162f367879649eba21f224a20f","veniti","venture",NA,"2013-06-04",9720856
"b0b2bf162f367879649eba21f224a20f","veniti","venture","C","2015-03-10",1.7e+07
"c31cd0c9b7ea14207306ed1cf2ab9f68","venn-life-sciences",NA,NA,NA,NA
"71a62f1fdfb369b575e63d5ccfbaf5a8","venneos","seed",NA,"2015-09-11",1127972
"b862ef17b76707ed30c014a8d5f54c8c","venngage",NA,NA,NA,NA
"8a364c93a5bec9b60c50cc049e9475a1","venomtech-limited","equity_crowdfunding",NA,"2015-02-21",539168.4553
"50625eb162cb601ffbf0ef3f83a08d64","vensun-pharmaceuticals","debt_financing",NA,"2015-10-08",4e+06
"50625eb162cb601ffbf0ef3f83a08d64","vensun-pharmaceuticals","venture","1","2013-12-19",15800000
"50625eb162cb601ffbf0ef3f83a08d64","vensun-pharmaceuticals","venture",NA,"2012-03-28",5708000
"6ca59e2f6e9e98893648e034985a1511","ventana-analytics",NA,NA,NA,NA
"b902d7e9a928fbe34430a6514d726077","ventario","seed",NA,"2013-12-01",24796
"b902d7e9a928fbe34430a6514d726077","ventario","seed",NA,"2013-10-02",50000
"f2b52839e457ef8e2f28dd0435eac086","ventirx-pharmaceuticals","venture","A","2010-01-13",2.5e+07
"f2b52839e457ef8e2f28dd0435eac086","ventirx-pharmaceuticals","venture","B","2014-09-23",50602514
"f2b52839e457ef8e2f28dd0435eac086","ventirx-pharmaceuticals","venture","A","2007-03-06",26600000
"f2b52839e457ef8e2f28dd0435eac086","ventirx-pharmaceuticals","seed",NA,"2006-01-01",2300000
"034b25a676c9d7298ad483d521518a16","ventria-bioscience",NA,NA,NA,NA
"4489f83b8cf283d48ef58d48a512bc5c","ventripoint-diagnostics","venture",NA,"2010-10-18",97714
"4489f83b8cf283d48ef58d48a512bc5c","ventripoint-diagnostics","venture",NA,"2011-01-04",1452748
"4489f83b8cf283d48ef58d48a512bc5c","ventripoint-diagnostics","venture",NA,"2010-04-01",138214
"4489f83b8cf283d48ef58d48a512bc5c","ventripoint-diagnostics","debt_financing",NA,"2013-05-24",748000
"4489f83b8cf283d48ef58d48a512bc5c","ventripoint-diagnostics","venture",NA,"2012-05-15",264605
"4489f83b8cf283d48ef58d48a512bc5c","ventripoint-diagnostics","venture",NA,"2011-06-17",1159798
"4489f83b8cf283d48ef58d48a512bc5c","ventripoint-diagnostics","post_ipo_debt",NA,"2015-03-26",199718
"4489f83b8cf283d48ef58d48a512bc5c","ventripoint-diagnostics","post_ipo_equity",NA,"2015-05-28",8e+05
"879dbdf5412adfaa94b13fe3f421dec6","ventrix","convertible_note",NA,"2012-05-31",5163118
"879dbdf5412adfaa94b13fe3f421dec6","ventrix","debt_financing",NA,"2010-07-16",147000
"abb98a6f7df6e15dbe479937225bd9c7","ventrix-2","venture","A","2015-02-10",1790166.2587
"e07d39de612c9103796c0b35cfbc5b75","ventrus-biosciences","debt_financing",NA,"2010-04-27",2725000
"76616c3709f79542a41511a85cebd360","venture-catalysts","seed",NA,"2011-06-13",40000
"cbae190e29ff4daba1da2c4d468963dc","venture-grove",NA,NA,NA,NA
"49c8ce68b0a49f965981db62126dbb16","venture-intelligence",NA,NA,NA,NA
"09b266125f4a08467cbc8e0766f787ae","venture-management-company",NA,NA,NA,NA
"256db0d840aebc6bce3d9d46ecbc1d10","venture-scanner",NA,NA,NA,NA
"78c771cd13cdd29ccab7961570d0dd5c","venus-concept","debt_financing",NA,"2015-11-03",2e+07
"78c771cd13cdd29ccab7961570d0dd5c","venus-concept","venture",NA,"2014-05-22",1e+07
"40ebebb1786d0e96d2cf8cdeefddc1a3","veracity-financial-group",NA,NA,NA,NA
"0c247e851cd294575974563d02e99bf9","veracyte","private_equity",NA,"2012-10-01",14950000
"0c247e851cd294575974563d02e99bf9","veracyte","venture","1","2010-06-11",2.8e+07
"0c247e851cd294575974563d02e99bf9","veracyte","venture","1","2013-06-28",2.8e+07
"8638bc784ba7984b7300b44398db929a","veralytics",NA,NA,NA,NA
"5d9d904354b54dcd583fdc223de72499","verascan-inc-",NA,NA,NA,NA
"ac5e90400e575774bbf4419d827bb3a5","verastem","venture","b","2011-07-14",3.2e+07
"ac5e90400e575774bbf4419d827bb3a5","verastem","venture","c","2011-11-11",2e+07
"ac5e90400e575774bbf4419d827bb3a5","verastem","private_equity",NA,"2012-07-19",2e+06
"ac5e90400e575774bbf4419d827bb3a5","verastem","venture","a","2010-11-16",1.6e+07
"6db0e588b9b0dd755f3c833395a4d920","verasun-energy",NA,NA,NA,NA
"4cc39428e7c0f226ca529a04e33edbe5","veratect","debt_financing",NA,"2009-10-06",4200000
"9bf969603804d87ade566ca341610e00","verathon",NA,NA,NA,NA
"ae6f9fd2eac3b4418b46934a356bfff9","verato","venture","A","2015-01-28",12500000
"96235bedcddb9ba281d939e5e1c2c914","verax-biomedical","debt_financing",NA,"2012-10-25",3298121
"96235bedcddb9ba281d939e5e1c2c914","verax-biomedical","venture",NA,"2007-06-21",3e+06
"96235bedcddb9ba281d939e5e1c2c914","verax-biomedical","venture","1","2007-12-17",2540000
"96235bedcddb9ba281d939e5e1c2c914","verax-biomedical","venture",NA,"2013-10-09",1.2e+07
"96235bedcddb9ba281d939e5e1c2c914","verax-biomedical","venture",NA,"2011-03-22",1300000
"96235bedcddb9ba281d939e5e1c2c914","verax-biomedical","venture",NA,"2009-04-17",2079142
"96235bedcddb9ba281d939e5e1c2c914","verax-biomedical","venture",NA,"2015-01-21",4e+06
"5fe918a3f58e1d3c3925976a98d572b2","verbatim",NA,NA,NA,NA
"eed76c9242c1d534e0d25a4f535410b5","verbble",NA,NA,NA,NA
"57be0621473647cc1239f7d22404dc7f","verbind",NA,NA,NA,NA
"7fe698f11a1de04267dfe0035a4ebc66","vercela",NA,NA,NA,NA
"a734c2592f347a06f93bc77eb722bdd8","verdafero",NA,NA,NA,NA
"6bbfc5b94e50d95258bd6f7cd7d13506","verdeeco","venture","a","2011-07-14",8e+05
"6bbfc5b94e50d95258bd6f7cd7d13506","verdeeco","venture","b","2012-11-28",714205
"0133e167b2b5b665c76ce2a65203263d","verdezyne","venture",NA,"2005-09-01",NA
"0133e167b2b5b665c76ce2a65203263d","verdezyne","venture","1","2007-07-12",7e+06
"0133e167b2b5b665c76ce2a65203263d","verdezyne","undisclosed",NA,"2011-05-10",NA
"0133e167b2b5b665c76ce2a65203263d","verdezyne","venture",NA,"2009-11-02",3e+06
"0133e167b2b5b665c76ce2a65203263d","verdezyne","venture",NA,"2010-02-11",9e+06
"0133e167b2b5b665c76ce2a65203263d","verdezyne","venture",NA,"2014-03-28",4.8e+07
"c7aa6e94f2dec4506c0ac27c3a69fda4","verenium","venture",NA,"2008-08-06",9e+07
"c7aa6e94f2dec4506c0ac27c3a69fda4","verenium","venture","1","2012-12-19",7309564
"ac1e0d763aa26ca6c87e4900116cbdc7","vergence-labs",NA,NA,NA,NA
"5f951406dc7734ef86770b115b5cdc04","veridiem-inc","venture","D","2004-04-05",5e+06
"744678b6efbd015dbf80b3266dac1a1c","verisk-health",NA,NA,NA,NA
"e3bb061737b7791830778a4322f78fb3","veritainer","debt_financing",NA,"2009-06-02",1140800
"e3bb061737b7791830778a4322f78fb3","veritainer","debt_financing",NA,"2010-08-04",6e+05
"e3bb061737b7791830778a4322f78fb3","veritainer","debt_financing",NA,"2013-02-22",3190000
"2793572d334fc609022d8c6d38953295","verity-consulting-limited",NA,NA,NA,NA
"fcb6917adc3c23fefe6bd47826f52813","verity-studios",NA,NA,NA,NA
"e37cd50a5edaa6a169af4c4713a823ad","verix","venture","b","2006-02-12",12700000
"de9b414baa8822ef8db455b466e0be7b","vermillion-inc","venture",NA,"2013-05-24",13242500
"de9b414baa8822ef8db455b466e0be7b","vermillion-inc","venture",NA,"2010-01-12",43049858
"de9b414baa8822ef8db455b466e0be7b","vermillion-inc","post_ipo_equity",NA,"2013-12-20",17600000
"de9b414baa8822ef8db455b466e0be7b","vermillion-inc","post_ipo_equity",NA,"2014-12-23",10500000
"3a1750592981d8bb070dadad85b9ce0e","vernax",NA,NA,NA,NA
"73fd979c1f31072c5ec1f658ca7693f2","vernox-labs",NA,NA,NA,NA
"2b94dc428e110aa952f86156cb42d96e","vero",NA,NA,NA,NA
"1aea32c760841b35bfdc2b0f9c310000","vero-analytics","seed",NA,"2014-11-13",550000
"fdb5821cae175c059a192390e8235bbe","verona-pharma","venture","a","2012-02-06",11500000
"416f1505af5bf42f3e7f5a59db054e02","verseon","post_ipo_equity","B","2015-05-14",5832264
"aae0c1c9e7468c33e06c3945529ce695","versium-analytics-inc","angel",NA,"2013-09-09",2500000
"aae0c1c9e7468c33e06c3945529ce695","versium-analytics-inc","debt_financing",NA,"2015-04-24",3e+05
"88bd7dfbb5cb592fc1a0da7d605137ab","vertascale","seed",NA,"2012-01-01",NA
"83736774ccac0c6042f4b77f409c2069","vertex-pharmaceuticals","post_ipo_equity",NA,"2009-09-30",3.5e+07
"83736774ccac0c6042f4b77f409c2069","vertex-pharmaceuticals","venture",NA,"2009-03-17",2397225
"83736774ccac0c6042f4b77f409c2069","vertex-pharmaceuticals","post_ipo_debt",NA,"2009-09-30",1.2e+08
"83736774ccac0c6042f4b77f409c2069","vertex-pharmaceuticals","post_ipo_equity",NA,"2009-12-03",4.43e+08
"c642589d675889521bde7613ec26ee77","vertica-systems","venture","b","2007-02-14",16500000
"c642589d675889521bde7613ec26ee77","vertica-systems","venture","a","2006-01-01",7e+06
"c642589d675889521bde7613ec26ee77","vertica-systems","venture",NA,"2005-04-01",7e+06
"943f88a076e317fad4e07904f7723533","vertical-acuity","venture","a","2008-09-01",NA
"943f88a076e317fad4e07904f7723533","vertical-acuity","debt_financing",NA,"2010-04-20",625000
"943f88a076e317fad4e07904f7723533","vertical-acuity","debt_financing",NA,"2009-06-30",150000
"943f88a076e317fad4e07904f7723533","vertical-acuity","venture",NA,"2011-10-05",4709609
"943f88a076e317fad4e07904f7723533","vertical-acuity","debt_financing",NA,"2012-03-30",750000
"654dde68611dca6b6b8a5b684581fea9","vertical-health-solutions","venture",NA,"2012-11-19",958800
"654dde68611dca6b6b8a5b684581fea9","vertical-health-solutions","venture",NA,"2010-12-08",750000
"10123a5dc86f3d517d1185b4aee3dbf3","vertical-knowledge","venture","A","2013-12-27",8875000
"2e18e95051de65f83859021198f3dd8f","vertice",NA,NA,NA,NA
"466c8d7b63c1b40febfaf711293f53c3","vertishear","venture",NA,"2010-09-16",3e+05
"466c8d7b63c1b40febfaf711293f53c3","vertishear","venture",NA,"2014-03-20",2e+05
"466c8d7b63c1b40febfaf711293f53c3","vertishear","venture",NA,"2012-08-21",1e+05
"fb9f182935d12bce2bfb838dd6bee3b0","verto-analytics","venture","A","2014-04-24",5400000
"fb9f182935d12bce2bfb838dd6bee3b0","verto-analytics","venture","B","2014-09-16",2400000
"88a6fa48837945a5694308644268ef7e","vertos-medical","debt_financing",NA,"2013-05-02",1800000
"88a6fa48837945a5694308644268ef7e","vertos-medical","venture",NA,"2013-06-19",2.3e+07
"88a6fa48837945a5694308644268ef7e","vertos-medical","venture","1","2010-01-17",15500000
"88a6fa48837945a5694308644268ef7e","vertos-medical","venture","1","2008-07-15",1.2e+07
"88a6fa48837945a5694308644268ef7e","vertos-medical","venture","1","2007-03-01",4192607
"88a6fa48837945a5694308644268ef7e","vertos-medical","venture","1","2006-04-25",725000
"88a6fa48837945a5694308644268ef7e","vertos-medical","convertible_note",NA,"2012-05-07",5e+06
"88a6fa48837945a5694308644268ef7e","vertos-medical","venture",NA,"2011-05-20",8e+06
"88a6fa48837945a5694308644268ef7e","vertos-medical","debt_financing",NA,"2012-12-27",2052644
"88a6fa48837945a5694308644268ef7e","vertos-medical","venture",NA,"2015-05-13",5971186
"c7d4690552ea98718482ba61506d69e9","sleep-nation","private_equity",NA,"2012-06-21",7150000
"f5f399821a02b33b7af537cfbb982730","verva-pharmaceuticals",NA,NA,NA,NA
"abd71f081dad81d393b2192bc1c3d9bf","verycloud",NA,NA,NA,NA
"7324c287458368c5b4ba8b772c487e6a","vesocclude-medical","venture",NA,"2011-10-25",1515615
"b43a03fe8c0f97de0009dcc7559f3e09","vessel","seed",NA,"2014-08-01",NA
"b43a03fe8c0f97de0009dcc7559f3e09","vessel","seed",NA,"2014-01-30",1e+05
"b43a03fe8c0f97de0009dcc7559f3e09","vessel","seed",NA,"2013-01-01",NA
"3349d005bde6ad2b9998a6e9a8f5f7d8","vessel-visualization",NA,NA,NA,NA
"eaf8d37f42378332b9b4e9eaf720f302","vestaron-corporation","venture","b","2012-05-08",10200000
"eaf8d37f42378332b9b4e9eaf720f302","vestaron-corporation","venture","C","2014-08-21",1e+07
"eaf8d37f42378332b9b4e9eaf720f302","vestaron-corporation","venture","C","2014-10-28",4e+06
"eaf8d37f42378332b9b4e9eaf720f302","vestaron-corporation","venture",NA,"2007-10-29",NA
"d9d8b3f7fa8fd7336f40045f8db2cf78","vestigen",NA,NA,NA,NA
"64425720912bb18c26bca875d853f69f","vet-therapeutics",NA,NA,NA,NA
"785d5084b672d5577ee1202bb2dbbac0","vetcentric","venture","b","2010-10-27",3e+06
"028935a9cba8914d1f16d3183cbed1e1","vextras",NA,NA,NA,NA
"f411df6ba5edd44d540c3e54f942c562","veylinx",NA,NA,NA,NA
"4591778ff3f0422870412d28ae00e434","vg-life-sciences","seed",NA,"2013-10-02",2235000
"4591778ff3f0422870412d28ae00e434","vg-life-sciences","seed",NA,"2013-03-01",550000
"1340a0e2d500ba5968d3e6c8d41b620d","vgti-florida","grant",NA,"2013-07-15",3600000
"f216365094feea4c33c7e2f7f981ae0f","vi-bryant",NA,NA,NA,NA
"423206f254f8a4dd2c141af901216e1c","viasense",NA,NA,NA,NA
"f003496dac3b58f35e73c602d0b7b76a","via-pharmaceuticals","debt_financing",NA,"2009-03-13",1e+07
"f003496dac3b58f35e73c602d0b7b76a","via-pharmaceuticals","debt_financing",NA,"2010-11-17",3201397
"71a76d8d4eb9557a26a5dab7ba167d0f","via-science",NA,NA,NA,NA
"bfd19ec4c79c8e58b6ffa857ecb5da76","viaccess",NA,NA,NA,NA
"0b364a20ee885b7873f512aa5e659b96","viacyte","venture","c","2013-07-10",10600000
"0b364a20ee885b7873f512aa5e659b96","viacyte","venture",NA,"2006-05-03",2e+07
"0b364a20ee885b7873f512aa5e659b96","viacyte","venture","c","2007-07-16",2.5e+07
"0b364a20ee885b7873f512aa5e659b96","viacyte","venture","C","2014-08-08",5400000
"0b364a20ee885b7873f512aa5e659b96","viacyte","venture","D","2014-08-25",2e+07
"0b364a20ee885b7873f512aa5e659b96","viacyte","grant",NA,"2014-09-11",16600000
"50adfab03313928841a5d162c5a1037f","viafoura",NA,NA,NA,NA
"46d44f3af767b71b3a5d9ddee702fdad","viagen",NA,NA,NA,NA
"9684e430a9ffb6e9dd50c617bef8b29a","viagene-inc",NA,NA,NA,NA
"e8e321c99f20bcbc5d91b39129e46ec2","viamet-pharmaceuticals","venture","A","2005-08-26",2e+05
"e8e321c99f20bcbc5d91b39129e46ec2","viamet-pharmaceuticals","venture","b","2009-07-07",24999997
"e8e321c99f20bcbc5d91b39129e46ec2","viamet-pharmaceuticals","venture","a","2007-06-07",4e+06
"e8e321c99f20bcbc5d91b39129e46ec2","viamet-pharmaceuticals","venture","D","2014-10-21",6e+07
"e8e321c99f20bcbc5d91b39129e46ec2","viamet-pharmaceuticals","grant",NA,"2015-06-04",1950000
"626629ba4269a6772fc3b580684f6af7","viavoo","venture","a","2011-12-05",2016300
"65a45024c1d94a3fae014500d261d39d","vibby","angel",NA,"2015-04-01",NA
"c39d17f168c6e4a81bd872592040c629","viberate",NA,NA,NA,NA
"25dbeae7dc498b38db862e2e657af750","vibosity",NA,NA,NA,NA
"e95801210c30e001a66458a82646a69c","vical",NA,NA,NA,NA
"4cc3935bd2db7be1474402c5d263f2ce","vicept-therapeutics","venture","a","2010-06-30",1.6e+07
"e725883a09741c85051b52c2ac33a241","vichara-technologies",NA,NA,NA,NA
"0def73481743bc5c838430f67d3d0382","vicksweb",NA,NA,NA,NA
"5ebca3f6bf766c416286e4f7bc0ae1db","victory-pharma","venture",NA,"2009-03-20",9999997
"ed361a61475947be245c7c2db8d342fc","victrio","venture","a","2010-12-14",5e+06
"757d5d7da4836c643d71225f57c177cf","vicuron-pharmaceuticals",NA,NA,NA,NA
"789fe7417c6842113e0fa1de5b367f35","vicus-therapeutics","venture",NA,"2012-12-01",14558000
"789fe7417c6842113e0fa1de5b367f35","vicus-therapeutics","angel",NA,"2009-06-24",686564
"789fe7417c6842113e0fa1de5b367f35","vicus-therapeutics","angel",NA,"2010-08-12",755000
"d33abdf9fad01a2c73a2926906be5a49","vidid",NA,NA,NA,NA
"047fce77d6a724e9dcdc018dd8afc9c2","vida-diagnostics","venture",NA,"2009-06-10",3e+05
"047fce77d6a724e9dcdc018dd8afc9c2","vida-diagnostics","venture",NA,"2014-10-23",2500000
"047fce77d6a724e9dcdc018dd8afc9c2","vida-diagnostics","debt_financing",NA,"2014-10-23",5e+05
"fe4f5993b7e5b8ac558f72e585544035","vida-therapeutics","private_equity",NA,"2013-07-10",1800000
"fe4f5993b7e5b8ac558f72e585544035","vida-therapeutics","venture",NA,"2013-04-25",750000
"303f35e08829fc73609ff1f2512886ab","vidara-therapeutics",NA,NA,NA,NA
"e50d6614415db23dcb2f29af810d1359","vidcaster","venture","A","2014-02-15",1300000
"e50d6614415db23dcb2f29af810d1359","vidcaster","seed",NA,"2013-01-15",1200000
"af403f722fb0dae623d8dbc47f5a7ceb","vidcruiter","undisclosed",NA,"2012-08-14",NA
"3a030c6ef5e00e25c8a0e0978b111211","videntifier-technologies",NA,NA,NA,NA
"bbc898e4d69b5862308ae41086b1806b","videobserver",NA,NA,NA,NA
"6f8039bf9dfb9d83b6f3ab53d3f37ec4","videoiq","debt_financing",NA,"2013-09-20",2521956
"6f8039bf9dfb9d83b6f3ab53d3f37ec4","videoiq","venture","1","2008-07-10",1e+07
"6f8039bf9dfb9d83b6f3ab53d3f37ec4","videoiq","venture","1","2007-04-26",8e+06
"6f8039bf9dfb9d83b6f3ab53d3f37ec4","videoiq","venture",NA,"2010-01-25",6013133
"6f8039bf9dfb9d83b6f3ab53d3f37ec4","videoiq","venture","1","2012-01-10",3500000
"6f8039bf9dfb9d83b6f3ab53d3f37ec4","videoiq","venture","1","2011-09-12",7500000
"1b756d11350d808c4c4910f1acd401e3","videojuicer",NA,NA,NA,NA
"fd9ac00c92a278700659e069829af195","videologygroup","venture","b","2010-02-16",1.6e+07
"fd9ac00c92a278700659e069829af195","videologygroup","private_equity",NA,"2012-08-20",13191580
"fd9ac00c92a278700659e069829af195","videologygroup","venture","d","2013-05-28",6e+07
"fd9ac00c92a278700659e069829af195","videologygroup","venture","a","2008-02-26",1.5e+07
"fd9ac00c92a278700659e069829af195","videologygroup","venture","c","2011-03-31",3e+07
"24863c8e8a13d486f63bfe6b4e0d79f7","videregen","venture",NA,"2014-10-24",4977547
"77fc87ac55303d8572b2b88265f2bd43","viderian",NA,NA,NA,NA
"4cfc5abda30764287a400dbf3890ddf9","vidient","venture","b","2005-10-18",1.2e+07
"32e4902042028ac48e453e864c175f02","vidimetrics",NA,NA,NA,NA
"53baed17d1ae3bce54ca4db92b796d47","vidiq","seed",NA,"2012-08-01",2e+06
"53baed17d1ae3bce54ca4db92b796d47","vidiq","seed",NA,"2013-02-26",2e+06
"53baed17d1ae3bce54ca4db92b796d47","vidiq","seed",NA,"2012-03-01",NA
"3434a5de542a4fe401f1ec3542e97607","vidiro",NA,NA,NA,NA
"6dc47ae1d7e83519f39090c769079f49","vidooly","seed",NA,"2015-06-03",1e+06
"272a73c2175007e38d45cd3324413792","vidooya",NA,NA,NA,NA
"1866936ee6b4d8dc3d3018aa58d89dd9","vidora","convertible_note",NA,"2015-08-17",NA
"4adff0d39a1a5c95a31be9c75b17dbc6","vidscale",NA,NA,NA,NA
"71322c7efca43d0c277f353c3d23a5ce","vidus-ocular",NA,NA,NA,NA
"078a7da5a4c61db93aef8c6125931bef","vidyard","venture","C","2016-01-26",3.5e+07
"078a7da5a4c61db93aef8c6125931bef","vidyard","venture","a","2013-03-21",6e+06
"078a7da5a4c61db93aef8c6125931bef","vidyard","venture",NA,"2011-11-17",1650000
"078a7da5a4c61db93aef8c6125931bef","vidyard","seed",NA,"2011-06-01",NA
"078a7da5a4c61db93aef8c6125931bef","vidyard","venture","B","2015-01-14",1.8e+07
"d2e05ec3b1c156c10ce4ce1b3b765f85","viewdle","undisclosed",NA,"2008-03-24",NA
"d2e05ec3b1c156c10ce4ce1b3b765f85","viewdle","venture","1","2009-01-01",2e+06
"d2e05ec3b1c156c10ce4ce1b3b765f85","viewdle","venture","1","2010-10-05",1e+07
"119914d43e6680bf4b71809c1f3df788","viewics-inc","venture","A","2014-10-15",8e+06
"119914d43e6680bf4b71809c1f3df788","viewics-inc","seed",NA,"2013-05-20",NA
"4c155c63deea502d2f00269d693a8111","viewray","venture","B","2008-01-23",2.5e+07
"4c155c63deea502d2f00269d693a8111","viewray","venture",NA,"2011-09-02",1e+07
"4c155c63deea502d2f00269d693a8111","viewray","venture","c","2012-03-13",4.5e+07
"4c155c63deea502d2f00269d693a8111","viewray","venture","c","2010-08-25",2e+07
"4c155c63deea502d2f00269d693a8111","viewray","venture",NA,"2013-12-17",3e+07
"4c155c63deea502d2f00269d693a8111","viewray","debt_financing",NA,"2011-06-23",1e+07
"4c155c63deea502d2f00269d693a8111","viewray","venture","d","2013-05-21",1.5e+07
"4c155c63deea502d2f00269d693a8111","viewray","venture","C","2015-01-09",16273385
"4c155c63deea502d2f00269d693a8111","viewray","venture",NA,"2015-03-04",1.5e+07
"4c155c63deea502d2f00269d693a8111","viewray","debt_financing",NA,"2015-06-30",5e+07
"e18f229fb8e98e7f4ca5d0badd6869ce","viewsy","seed",NA,"2012-04-04",19713
"e18f229fb8e98e7f4ca5d0badd6869ce","viewsy","seed",NA,"2014-01-31",678422
"be9e8c1832645febd9acb4ab010c460c","viewthrough-measurement-association",NA,NA,NA,NA
"d3ad0799b9791d008cccd62addbbb32c","vigeo-therapeutics",NA,NA,NA,NA
"688f602c3a499c28b8d9f35d6f6c932f","vigiglobe","seed",NA,"2014-07-09",NA
"688f602c3a499c28b8d9f35d6f6c932f","vigiglobe","venture","1","2014-09-05",2e+06
"0a77efa9d52ac5c2629d9d0cc7d5a752","vigilant-biosciences","venture","a","2014-03-25",2e+06
"0a77efa9d52ac5c2629d9d0cc7d5a752","vigilant-biosciences","debt_financing",NA,"2014-03-25",3e+05
"0a77efa9d52ac5c2629d9d0cc7d5a752","vigilant-biosciences","venture","B","2015-02-24",5500000
"4dd28a8632db8446a5540d2ccf149125","vigilant-medical",NA,NA,NA,NA
"0c4c85a9d45076740162cb7834974107","vigilent","venture",NA,"2012-01-12",3e+06
"0c4c85a9d45076740162cb7834974107","vigilent","venture",NA,"2012-03-27",6700000
"0c4c85a9d45076740162cb7834974107","vigilent","venture",NA,"2010-10-21",160000
"0c4c85a9d45076740162cb7834974107","vigilent","undisclosed",NA,"2013-06-07",NA
"0c4c85a9d45076740162cb7834974107","vigilent","debt_financing",NA,"2010-01-29",8e+05
"02eaac4a94865bf585624645ec4adae7","viisights","seed",NA,"2016-01-19",1200000
"8b959118854711081d3c772008e2b9bd","viiv-healthcare",NA,NA,NA,NA
"96f5e6dc16d5a89b5cd6dc4da94f5d30","viking-systems","venture",NA,"2011-05-31",3e+06
"7e8338a013241cff29899469e1f3e5a0","vilicus-ventures-llc",NA,NA,NA,NA
"70e4d04e886b70804d54874f4da8112b","vindicia","venture","d","2009-07-13",7500000
"70e4d04e886b70804d54874f4da8112b","vindicia","venture","a","2004-01-01",1e+06
"70e4d04e886b70804d54874f4da8112b","vindicia","venture","b","2005-01-01",3500000
"70e4d04e886b70804d54874f4da8112b","vindicia","venture","c","2008-03-31",5600000
"70e4d04e886b70804d54874f4da8112b","vindicia","venture","e","2010-11-01",2e+07
"0338a4a16e6d05d340b2f499ce0f1d6c","vinoetic-inc",NA,NA,NA,NA
"d08c55bb32af13949ff601e312c3085c","vinomis-laboratories","venture",NA,"2011-03-29",207250
"d08c55bb32af13949ff601e312c3085c","vinomis-laboratories","seed",NA,"2013-06-11",393363
"b1802540691c149a9d43e2978c395175","vioma",NA,NA,NA,NA
"77a2e4c5074c478640328d2d549d29e2","vioptix","convertible_note",NA,"2010-06-21",2826676
"77a2e4c5074c478640328d2d549d29e2","vioptix","venture","1","2010-01-25",3e+06
"77a2e4c5074c478640328d2d549d29e2","vioptix","venture","1","2008-01-10",12200000
"6ae37acc74da746663c5f6198034cd80","viporbit-software","angel",NA,"2013-03-01",2e+05
"6ae37acc74da746663c5f6198034cd80","viporbit-software","angel",NA,"2010-05-01",1e+06
"6ae37acc74da746663c5f6198034cd80","viporbit-software","angel",NA,"2012-10-01",1300000
"6ae37acc74da746663c5f6198034cd80","viporbit-software","angel",NA,"2013-09-23",1e+06
"6ae37acc74da746663c5f6198034cd80","viporbit-software","equity_crowdfunding",NA,"2014-08-27",NA
"6ae37acc74da746663c5f6198034cd80","viporbit-software","venture",NA,"2015-06-09",650000
"ab2da5bfe9c8c1d3c23e533ebb73a6de","viragen","venture",NA,"2007-04-16",3e+06
"ab2da5bfe9c8c1d3c23e533ebb73a6de","viragen","venture",NA,"2005-09-15",1230000
"ab2da5bfe9c8c1d3c23e533ebb73a6de","viragen","venture",NA,"2006-03-21",5200000
"89f8a05bdfd80da34478027320f42354","viral-management",NA,NA,NA,NA
"54474eb3bb21dede208218c26358a5c0","viralconnect",NA,NA,NA,NA
"89809a1f3b5e991f845969bf94335e19","viralsteroids",NA,NA,NA,NA
"a33e0a3d0120b3c311168c858dffb495","viraltracker",NA,NA,NA,NA
"95b586c3807f904ca4165b2c44cd101e","viralytics","post_ipo_equity",NA,"2014-03-13",2.7e+07
"f24ace80b115e076947292f51262c033","virax","post_ipo_equity",NA,"2014-03-24",3e+06
"6d55f24fed7d83b44d4fddc8d0a31c6c","virdante-pharmaceuticals","venture","a","2009-11-25",3e+07
"6d55f24fed7d83b44d4fddc8d0a31c6c","virdante-pharmaceuticals","venture",NA,"2011-10-14",30075000
"a508cff2db3a7450a62c66b75d061f1c","virexx-medical",NA,NA,NA,NA
"8d8966f91ca701d896f50511046cdec8","viridaxis","venture","b","2007-10-22",1410000
"09bed66b0c2a0555fbf28c93c26272eb","virobay","debt_financing",NA,"2010-01-14",3e+05
"09bed66b0c2a0555fbf28c93c26272eb","virobay","venture","1","2010-06-16",1e+07
"09bed66b0c2a0555fbf28c93c26272eb","virobay","venture","1","2014-07-16",8e+06
"c62738f0f13fd78b8debac4840473a41","viroblock","venture","c","2012-02-14",3600000
"dc68ef3e591c6c2ad0365d611374ee7c","viroclinics-biosciences","undisclosed",NA,"2014-01-09",NA
"defe07d844ee3b64d835898786a718e0","virocyt","venture","a","2013-04-11",4700000
"defe07d844ee3b64d835898786a718e0","virocyt","venture",NA,"2015-06-17",4e+06
"eca8b00b7b8412dabb04c54ff586c84f","virometix-ag","venture",NA,"2015-12-29",NA
"eca8b00b7b8412dabb04c54ff586c84f","virometix-ag","venture",NA,"2014-11-28",NA
"ce7608172ed7b9b35b81f6d5480f3dfc","viron-therapeutics","venture","a","2006-05-16",2e+07
"f369e2f8437cb73768f319f93eb09e8e","viropharma",NA,NA,NA,NA
"2352e701e22e129e57b7e2365030fe66","viroxis","private_equity",NA,"2013-04-22",7795000
"2352e701e22e129e57b7e2365030fe66","viroxis","debt_financing",NA,"2010-01-14",500700
"2352e701e22e129e57b7e2365030fe66","viroxis","venture","1","2010-10-15",2500000
"394577a2f10aae007942c0e06cd1f7ea","virtdb",NA,NA,NA,NA
"d4f3b071b20e0313ec0be2c40aab5b81","virtrue",NA,NA,NA,NA
"cce31ef1f11fcc7daa6bfb55288f76e7","virtualemployee-com",NA,NA,NA,NA
"f0ca939bf113580b2e5aaf8a11e77d02","virtual-logistics-inc",NA,NA,NA,NA
"8f75a1ba5263fb65ab938941941cdad8","virtual-media-international",NA,NA,NA,NA
"3d677476c110e0aeb4137d2381a80d6c","virtual-medical-centre",NA,NA,NA,NA
"4c784c61a02be3e3aba9863e0dd36f86","virtual-seo-man",NA,NA,NA,NA
"cd90775f33a0a0a9421e4ca09e1f802e","virtual-strategy-magazine",NA,NA,NA,NA
"d21f88cd5bd9f7a8bb3883450faf89b1","virtually-canadian",NA,NA,NA,NA
"835d0bb0b9caf379c91700bb0841b90f","virtualscopics","venture","c","2012-04-18",3e+06
"6ea3424d633a8d80b2806c83dd3dfe97","virtucon-ventures",NA,NA,NA,NA
"db163bdf61ae4f9db8ee5298e38d8699","virtuous","seed",NA,"2014-07-01",NA
"db163bdf61ae4f9db8ee5298e38d8699","virtuous","seed",NA,"2015-06-10",7e+05
"957b86c41110ea142ca326f95f088e88","virustotal",NA,NA,NA,NA
"c935120a23d42ca8ae3a66ce12d426c9","virxsys","venture",NA,"2006-12-13",2e+07
"c935120a23d42ca8ae3a66ce12d426c9","virxsys","venture",NA,"2011-04-07",33814349
"c935120a23d42ca8ae3a66ce12d426c9","virxsys","venture","1","2005-10-11",3e+07
"c935120a23d42ca8ae3a66ce12d426c9","virxsys","venture",NA,"2011-11-10",1e+06
"28706d069da2470ba24625cd073b19f2","vis","angel",NA,"2012-08-27",1500000
"03ed2e898d7b2a5fe19e41ced3f08060","visalyze",NA,NA,NA,NA
"91dd550da1104bd3b019c3e184b5f969","visbit-inc","seed",NA,"2015-04-10",NA
"b8e6e2486b7b6fd386800afab7892f5e","viscovery","venture","A","2015-03-24",5e+06
"1498e7a23888b07489d996b3535e6bc7","visen-medical","venture","B","2007-10-19",7500000
"1498e7a23888b07489d996b3535e6bc7","visen-medical","venture","B","2008-04-21",5e+06
"1498e7a23888b07489d996b3535e6bc7","visen-medical","venture",NA,"2009-10-08",885418
"4b960ebe9f390010b6037578a9f34a11","visenze","venture","a","2014-02-18",3500000
"8bced70bdc2f5826f52c972654d2b309","visgo-therapeutics","venture",NA,"2015-03-09",725349
"b2db7f0802b93481a0ae784d29417a91","visible-equity",NA,NA,NA,NA
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","debt_financing",NA,"2014-07-11",2802652
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","venture","1","2006-08-01",3500000
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","venture","1","2007-09-01",1.2e+07
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","venture",NA,"2009-10-01",2e+06
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","venture","1","2010-01-13",2.2e+07
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","venture",NA,"2012-06-04",2.4e+07
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","venture","1","2009-05-23",6e+06
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","debt_financing",NA,"2009-12-03",1e+06
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","venture",NA,"2011-09-22",4e+06
"c25bd4adca69a28ec71800aa668947d2","visibletechnologies","venture","1","2011-03-31",6e+06
"ff86a0a89dce451baa7c7a068cdd801b","visidom",NA,NA,NA,NA
"545c4c8179d2f8b7c93a07b8a9b4796c","visier","venture","a","2011-09-05",6e+06
"545c4c8179d2f8b7c93a07b8a9b4796c","visier","venture","b","2013-05-30",1.5e+07
"545c4c8179d2f8b7c93a07b8a9b4796c","visier","venture","C","2014-06-10",25500000
"d895f8f9fa854e37bff18ba04c925925","visify",NA,NA,NA,NA
"2b1e6f7035b9cab87813760b7f0fae75","visio-ingenii-ltd","seed",NA,"2012-12-31",161841
"f72ad4e0ff36e9b442328886ca2628a2","vision-chain-inc","debt_financing",NA,"2009-08-31",180000
"45df3e901e514e97dd5d10c366694b3e","vision-sciences","venture",NA,"2011-02-01",10500000
"ac990066988c4942db0297c127fdeb55","vision-ai",NA,NA,NA,NA
"c9901bc8a6aa69b1159fbbd1ce2a8f58","visionary-mobile","venture",NA,"2011-10-27",752500
"c9901bc8a6aa69b1159fbbd1ce2a8f58","visionary-mobile","venture",NA,"2011-09-20",602500
"c9901bc8a6aa69b1159fbbd1ce2a8f58","visionary-mobile","venture",NA,"2012-04-11",215000
"e66c88db0c8dc7769cf621a9192bc824","visionary-pharmaceuticals","seed",NA,"2011-07-27",NA
"3283dfdd7f1ae54e9aae498db4e6d9ac","visiongate","venture",NA,"2011-10-19",2e+06
"3283dfdd7f1ae54e9aae498db4e6d9ac","visiongate","venture",NA,"2009-09-01",1780000
"3283dfdd7f1ae54e9aae498db4e6d9ac","visiongate","debt_financing",NA,"2009-04-10",490000
"3283dfdd7f1ae54e9aae498db4e6d9ac","visiongate","venture",NA,"2015-05-26",6206206
"3283dfdd7f1ae54e9aae498db4e6d9ac","visiongate","debt_financing",NA,"2015-09-23",3753500
"6fcf84e03d2d249dc57bdab248fb2ba9","visionize",NA,NA,NA,NA
"34e48f09d3d0400d875b79a7fac837b4","visionwang",NA,NA,NA,NA
"1d666cb31ab390b2a6169b2b0648d186","visitrend","seed",NA,"2013-11-01",1250000
"a470539be986edf9bfc4b43a71e09759","visor-adl","seed",NA,"2015-11-17",5e+05
"817b1e866453b2856f2e4a1b2013adcf","vissee-ltd","seed",NA,"2012-02-21",1100000
"1558992c664fbbc84f567d73ddc1244a","vista-medical-technologies-inc",NA,NA,NA,NA
"11980a045b877c0c98f14a86f31880cb","vistagen-therapeutics","post_ipo_equity",NA,"2013-04-10",3.6e+07
"11980a045b877c0c98f14a86f31880cb","vistagen-therapeutics","venture",NA,"2007-08-10",3750000
"11980a045b877c0c98f14a86f31880cb","vistagen-therapeutics","venture",NA,"2008-12-22",1e+06
"11980a045b877c0c98f14a86f31880cb","vistagen-therapeutics","debt_financing",NA,"2012-03-07",5e+05
"11980a045b877c0c98f14a86f31880cb","vistagen-therapeutics","undisclosed",NA,"2014-07-02",1570000
"11980a045b877c0c98f14a86f31880cb","vistagen-therapeutics","venture",NA,"2015-08-06",1930281
"22db0d068c2fc3e1af14709c1c34f574","visterra","debt_financing",NA,"2010-08-10",6e+06
"22db0d068c2fc3e1af14709c1c34f574","visterra","venture","1","2012-11-09",26099699
"22db0d068c2fc3e1af14709c1c34f574","visterra","venture","1","2013-12-02",8100000
"22db0d068c2fc3e1af14709c1c34f574","visterra","venture",NA,"2009-12-07",3200000
"22db0d068c2fc3e1af14709c1c34f574","visterra","venture","1","2014-10-02",3e+07
"369f07a2669de09dfdcee9114f008c98","visual-insights",NA,NA,NA,NA
"cac083836b1f8bf6570c2d86b9e44059","visual-iq","venture","a","2010-08-20",3e+06
"cac083836b1f8bf6570c2d86b9e44059","visual-iq","venture","b","2012-06-25",1.2e+07
"cd1b7b6fc8cf791478719db92881c757","visual-mining","venture","a","1997-12-19",4e+06
"fa9507d56f9768e4172bed4f41e388a3","visual-revenue","seed",NA,"2011-07-28",512000
"fa9507d56f9768e4172bed4f41e388a3","visual-revenue","venture","1","2012-01-26",1700000
"6343e8b56f5022e806684ada59174ccd","visual-tagging-sevices",NA,NA,NA,NA
"4ba8a197f11f807baff725c76625c453","visualase-inc","venture","A","2010-02-01",3500000
"4ba8a197f11f807baff725c76625c453","visualase-inc","venture","B","2012-05-01",5200000
"119e7ad8cec6f69682bd42d17dc06b92","visualbee",NA,NA,NA,NA
"5285ce67c6754c5d828a75c6524f226a","visualcue",NA,NA,NA,NA
"9fd78f243605697f2bd1ac9332a31729","imagini","venture",NA,"2007-05-25",5e+06
"9fd78f243605697f2bd1ac9332a31729","imagini","venture","1","2012-01-01",1e+07
"9fd78f243605697f2bd1ac9332a31729","imagini","venture","1","2009-02-25",13550000
"7775d2fcaca4c302764f7d0b13109d47","visualgraph",NA,NA,NA,NA
"ce28f0e02de4d77b62dfd0b6f2f3c6a1","visualino",NA,NA,NA,NA
"379bb4d6c229dbe61c3bbd49b25acbec","visualinsights-co",NA,NA,NA,NA
"d33d4d522763ca78557761d1993fd31f","visualnest","seed",NA,"2012-06-01",235350
"b7caed6d621c98ec204f39983a18ada7","visualsonics",NA,NA,NA,NA
"6af721b6c5e32e78d226d30f0978340f","visus-technology","debt_financing",NA,"2013-03-29",150000
"6af721b6c5e32e78d226d30f0978340f","visus-technology","venture",NA,"2015-05-06",2569159
"6d111d516ae57cf4166adfc9d0c44088","vitadigest",NA,NA,NA,NA
"f7a9b5d4ac84330f14604b399bac3df9","vital-ai",NA,NA,NA,NA
"791ad0b58aefa29ddbe8a376aef1e2a7","vital-connect","private_equity",NA,"2011-11-15",10759116
"791ad0b58aefa29ddbe8a376aef1e2a7","vital-connect","venture","1","2013-04-23",3200000
"1c66d90534617610df2433f7a2db590f","vital-therapies","venture","C","2007-10-10",28100000
"1c66d90534617610df2433f7a2db590f","vital-therapies","private_equity",NA,"2012-11-07",86145589
"1c66d90534617610df2433f7a2db590f","vital-therapies","private_equity",NA,"2014-03-07",13928129
"1c66d90534617610df2433f7a2db590f","vital-therapies","convertible_note",NA,"2011-06-22",16251091
"1c66d90534617610df2433f7a2db590f","vital-therapies","venture","d","2011-06-23",22617179
"1c66d90534617610df2433f7a2db590f","vital-therapies","venture",NA,"2012-02-02",4347018
"1c66d90534617610df2433f7a2db590f","vital-therapies","debt_financing",NA,"2012-06-28",2500000
"1c66d90534617610df2433f7a2db590f","vital-therapies","private_equity",NA,"2014-01-31",31979470
"8a09a6c7e8619944f9eafdc8b358a3ed","vital-vio","venture",NA,"2014-03-11",NA
"8a09a6c7e8619944f9eafdc8b358a3ed","vital-vio","venture","1","2013-07-30",NA
"0e42bd92c18f74d82d22542d617b3b97","vitaldent","private_equity",NA,"2013-12-02",128660000
"85dab58de5811b531e80463d6f647a87","vitalea-science","venture",NA,"2009-08-03",260000
"f5063ad2d4177c17ce18469e788a6e24","vitalmedix","debt_financing",NA,"2009-06-18",1e+05
"94cc25a1a45405f6e723b048981cf39f","vitamedmd","venture",NA,"2010-04-12",3278000
"dbc80b619edabd7ae36237fc2d42db8d","vitamin-research-products","private_equity",NA,"2012-02-23",4500023
"7d3bb6de299dcef23f566793dbcf83b8","vitanlink",NA,NA,NA,NA
"4e6d4fcb3b9dfafd04cddb47c3b365a9","vitapath-genetics","venture","b","2011-08-12",4152504
"4e6d4fcb3b9dfafd04cddb47c3b365a9","vitapath-genetics","venture","C","2012-04-01",4710000
"4e6d4fcb3b9dfafd04cddb47c3b365a9","vitapath-genetics","venture","c","2012-08-06",5037974
"4e6d4fcb3b9dfafd04cddb47c3b365a9","vitapath-genetics","venture","a","2009-11-02",6e+06
"4e6d4fcb3b9dfafd04cddb47c3b365a9","vitapath-genetics","private_equity",NA,"2012-07-01",328000
"d5b27d91dde8792e24aa9b690faf18f5","vitargent","venture","A","2015-01-23",NA
"99356de7a99b7caa6e6b3baa8cbbe271","viteava-pharmaceuticals",NA,NA,NA,NA
"a518e58f27d6a3d1947fa0848483cb05","vititude",NA,NA,NA,NA
"b03866923a676e1ddfade37c64ec36e0","vitria",NA,NA,NA,NA
"2316544d78078d5f179f200f71ac18e1","vitria-technology-inc",NA,NA,NA,NA
"b2ce38aea9a29a7260347e527f65e2a7","vitrolife",NA,NA,NA,NA
"1901110429fc210e7a6f3c74c26311e6","vitruvias-therapeutics","venture",NA,"2013-11-19",750000
"1901110429fc210e7a6f3c74c26311e6","vitruvias-therapeutics","venture",NA,"2014-08-05",2e+05
"f360046f169a9c3c7285f9bb8c211ca6","viur",NA,NA,NA,NA
"648ab1fa9859ac2f7183820dfa005fa5","vivabi",NA,NA,NA,NA
"5104ac38f568ae0af414c928688057f5","vivabiocell","seed",NA,"2007-07-12",606672
"0b69cd922636718f92fd42bbf2e2a663","vivakor","venture",NA,"2014-02-12",2062875
"0b69cd922636718f92fd42bbf2e2a663","vivakor","debt_financing",NA,"2013-04-26",677000
"d29a6fc5a9cc06f1d5387f787ebd55ae","vivaldi-biosciences","venture",NA,"2010-07-08",1974546
"d29a6fc5a9cc06f1d5387f787ebd55ae","vivaldi-biosciences","venture","1","2007-05-18",2e+06
"9e65bc2331f458f6a4f0ad352e681d8d","vivametrica",NA,NA,NA,NA
"1c19ec76e8626571a713084ce6529292","vivaray","debt_financing",NA,"2010-08-16",6e+05
"dbb9efe52e9f03cfb40a4d2442c2caa4","vivebio","venture",NA,"2012-11-27",3673000
"16138ab39516cac3d59d0fc16f0152e4","vivendy-therapeutics","venture",NA,"2008-01-01",30530000
"7509c1923400ff9c867718a061cda4a9","vivex-biomedical","venture","A","2016-01-05",6600000
"7509c1923400ff9c867718a061cda4a9","vivex-biomedical","venture","A","2013-09-19",7600000
"6b89c0a5bd5e03e4ae26db53b705a20a","vivid-imaging",NA,NA,NA,NA
"6f3f91d999afb1452e6115d8eb38dc2b","vividcortex","undisclosed",NA,"2013-04-04",NA
"6f3f91d999afb1452e6115d8eb38dc2b","vividcortex","seed",NA,"2012-10-12",673000
"6f3f91d999afb1452e6115d8eb38dc2b","vividcortex","seed",NA,"2013-08-07",2e+06
"3b4a5bebf33da54b88f34adf88f7597d","vivoforce-com",NA,NA,NA,NA
"6650b9f024d9723906c8b2d13a6f8f74","vivolux","undisclosed",NA,"2011-11-07",NA
"306b69b41b8c2775f75c06d7202f9cd3","vivus",NA,NA,NA,NA
"627ae263a25dc4de1dd72761410b7e04","vize-software",NA,NA,NA,NA
"cab872256028111a91988af0b2d19815","vizzboard",NA,NA,NA,NA
"5e25796846f2d9b7f3066582fca614ee","vizzop",NA,NA,NA,NA
"e2b2b45cc80c36ad97f9ee63e67f8ddb","vlex","venture",NA,"2012-01-21",5160800
"c5e4090aac01a930b3d5a55c30d4412a","vlife-sciences-technologies-pvt-ltd",NA,NA,NA,NA
"b63a93bb27301a4df476869ca2b6fe25","vlst-corporation","venture","b","2006-06-16",5.5e+07
"a42173cd309436d2aea2ce69c93dce79","vm-discovery","venture","b","2006-01-03",970000
"a42173cd309436d2aea2ce69c93dce79","vm-discovery","venture","C","2014-07-23",12600000
"0ba562ede0568de86fd4d261ef89b7cf","vmray-gmbh","seed",NA,"2014-05-16",NA
"4d970bf5c93f8d2c86a0e276524d730a","vngrs",NA,NA,NA,NA
"36a1392a723658aff020cc0ca5c1a7dc","vocalis",NA,NA,NA,NA
"acc62dbc7a1da21d4eaeb469e24d71d6","vocaltap","seed",NA,"2013-05-17",NA
"d8111a6ebe81657e41a80ae16e6c466b","vocalzoom","venture",NA,"2015-01-07",NA
"d8111a6ebe81657e41a80ae16e6c466b","vocalzoom","venture","1","2010-07-26",7e+05
"d8111a6ebe81657e41a80ae16e6c466b","vocalzoom","venture","1","2014-08-01",9e+06
"d8111a6ebe81657e41a80ae16e6c466b","vocalzoom","venture","1","2012-11-19",3e+06
"779a48b11aabb98aab4228d0d9294b40","vocare","venture",NA,"2010-12-02",1625000
"a2adbb4197473713c98005cb7cec1a18","vocus",NA,NA,NA,NA
"fcb3af71c281a9e881a65bd6d67a7104","voicebase","venture",NA,"2015-08-01",1e+07
"fcb3af71c281a9e881a65bd6d67a7104","voicebase","venture",NA,"2016-01-14",1e+07
"fcb3af71c281a9e881a65bd6d67a7104","voicebase","venture","1","2010-09-15",7e+05
"fcb3af71c281a9e881a65bd6d67a7104","voicebase","venture","1","2013-07-30",5e+06
"35c3dbd42651d3081cf6ed12cbc68a17","voicebox-technologies","venture","c","2010-12-30",5268902
"35c3dbd42651d3081cf6ed12cbc68a17","voicebox-technologies","venture",NA,"2009-12-14",8267208
"8ffb63c05091ff69df251442b1749c77","voiceprism-innovations","venture",NA,"2009-11-03",1200000
"3449bf35a9080b17360147b1c0f1f27e","voicesphere",NA,NA,NA,NA
"70ea620deaa5927a1ac59cda0b7e3461","voicevault",NA,NA,NA,NA
"498e2599287dcfd5c7e8888edbbbdede","voiq","seed",NA,"2015-09-01",2e+06
"498e2599287dcfd5c7e8888edbbbdede","voiq","seed",NA,"2014-10-15",20000
"498e2599287dcfd5c7e8888edbbbdede","voiq","seed",NA,"2013-01-01",3e+05
"498e2599287dcfd5c7e8888edbbbdede","voiq","seed",NA,"2012-06-04",25000
"a22c41038e37e6c9d99127c21566fd30","volatix",NA,NA,NA,NA
"94f4b5c5777e0086097c26cee52e5836","volcano-corporation",NA,NA,NA,NA
"ba85bdfd8d83121b6f4327d30d185374","volitionrx","post_ipo_equity",NA,"2014-02-28",3e+06
"ba85bdfd8d83121b6f4327d30d185374","volitionrx","post_ipo_equity",NA,"2014-10-14",1e+06
"2855aebbe3b63bc8cc3999c152aa14e8","volometrix","venture","a","2012-04-20",1600000
"2855aebbe3b63bc8cc3999c152aa14e8","volometrix","venture","a","2013-04-24",3300000
"2855aebbe3b63bc8cc3999c152aa14e8","volometrix","venture","B","2014-10-13",1.2e+07
"44ae14174d6b92c624badd1ac9c3e749","voltaiq",NA,NA,NA,NA
"51ee0deff0acc663d359d94bf7c2b9bf","voltari","private_equity",NA,"2007-02-27",5e+07
"51ee0deff0acc663d359d94bf7c2b9bf","voltari","venture","1","2001-01-01",5362120
"51ee0deff0acc663d359d94bf7c2b9bf","voltari","venture","1","2002-01-01",11472000
"51ee0deff0acc663d359d94bf7c2b9bf","voltari","private_equity",NA,"2008-01-02",1.85e+08
"51ee0deff0acc663d359d94bf7c2b9bf","voltari","private_equity",NA,"2006-08-11",3.2e+07
"51ee0deff0acc663d359d94bf7c2b9bf","voltari","private_equity",NA,"2006-04-25",4e+07
"32aed29101604072802ef7aefe77b846","voltdb","venture","a","2012-04-11",590000
"32aed29101604072802ef7aefe77b846","voltdb","venture","b","2014-03-14",8e+06
"32aed29101604072802ef7aefe77b846","voltdb","venture","a","2010-09-07",5e+06
"32aed29101604072802ef7aefe77b846","voltdb","venture",NA,"2015-07-22",9820864
"f9ce2addf790699a64e146499b517d69","voolgo","seed",NA,"2011-01-01",NA
"6553a6aa1ab5c4bdab7d66295d5d3d8c","voorka","seed",NA,"2015-03-15",NA
"b6a18ae89cc4632c8e2217fe83d2edaa","vorketing","convertible_note",NA,"2014-05-01",23526
"b6a18ae89cc4632c8e2217fe83d2edaa","vorketing","seed",NA,"2015-05-01",11795
"b6a18ae89cc4632c8e2217fe83d2edaa","vorketing","convertible_note",NA,"2015-06-01",395765
"6629637d9768a93bc7708fbaa9a3458e","vorpala",NA,NA,NA,NA
"db428eea5e6dedc36dd31b44716a9b47","vortio",NA,NA,NA,NA
"942ebb0182d343beda3948ac5ccb0c0a","votertide","seed",NA,"2012-02-01",5e+05
"04513a453eb38f8dc90f4e2adf15b82f","votorantim-novos-negcios-ltda",NA,NA,NA,NA
"68d0ca53b7878702d20c9c7069acfa7f","vouch","seed",NA,"2011-08-04",NA
"92b6bcd8b204936c8d1b17a268d7aa50","voxapp","angel",NA,"2013-08-26",NA
"92b6bcd8b204936c8d1b17a268d7aa50","voxapp","seed",NA,"2013-08-14",NA
"2859b0de2dbdab5199b81229bc833f03","voxpopme","seed",NA,"2015-10-08",1500000
"2859b0de2dbdab5199b81229bc833f03","voxpopme","angel",NA,"2013-08-01",167176
"2859b0de2dbdab5199b81229bc833f03","voxpopme","seed",NA,"2013-01-04",32336
"2859b0de2dbdab5199b81229bc833f03","voxpopme","angel",NA,"2013-03-24",197996
"2859b0de2dbdab5199b81229bc833f03","voxpopme","angel",NA,"2014-02-18",334354
"2859b0de2dbdab5199b81229bc833f03","voxpopme","seed",NA,"2015-07-10",77102.1912
"2859b0de2dbdab5199b81229bc833f03","voxpopme","seed",NA,"2015-02-18",150000
"2859b0de2dbdab5199b81229bc833f03","voxpopme","seed",NA,"2014-12-15",235000
"2859b0de2dbdab5199b81229bc833f03","voxpopme","seed",NA,"2013-05-15",202450
"3465296086dc7f6435d81706d6f2521e","voxware-inc","venture",NA,"2010-09-17",2250000
"3465296086dc7f6435d81706d6f2521e","voxware-inc","venture","1","2014-04-24",NA
"eadfabff64efbc75aa14ebc6d06e9918","voyager-therapeutics","venture","a","2014-02-12",4.5e+07
"eadfabff64efbc75aa14ebc6d06e9918","voyager-therapeutics","venture","B","2015-04-13",6e+07
"1550a82a96f9bea74fc75b89ccdca9f7","voyanta",NA,NA,NA,NA
"641c85363c987c88a4297d611b847788","voziq-inc",NA,NA,NA,NA
"7eac4e3e8242b6514706a7dd6ef73395","vphrase",NA,NA,NA,NA
"402e204a785f9404a98589fc2ac94dfc","vr1","venture",NA,"2012-11-07",624000
"402e204a785f9404a98589fc2ac94dfc","vr1","debt_financing",NA,"2013-07-01",530000
"402e204a785f9404a98589fc2ac94dfc","vr1","debt_financing",NA,"2014-05-14",335000
"402e204a785f9404a98589fc2ac94dfc","vr1","venture",NA,"2014-09-16",900279
"6367c617b9a9560727d95763370e9b2b","vrai-mobile-limited-3","seed",NA,"2014-05-21",168501
"c5c01f7bb1db5625bf7f50469c66cd40","vrcommerce","seed",NA,"2015-12-01",15000
"916805b34d94f6dbaf14697d8f3284d2","vsh",NA,NA,NA,NA
"b01ae93a0699edabb7550e0064455f51","vsholding",NA,NA,NA,NA
"d9ea3d1c41c8c6df7c6048e9b2512d56","vtesse","venture","A","2014-01-07",2.5e+07
"39f918d84c024af22ae2103b1eee92d4","vtisystems",NA,NA,NA,NA
"da178206be63cc237ac0ab4c0ff2eed7","vtm","venture",NA,"2012-01-23",2015130
"ae3e179b86ef72eece0392b5360d3404","vtt",NA,NA,NA,NA
"8bc6c6fcc850e2e22afc5fdb52decaf5","vu-security","angel",NA,"2007-11-28",1e+06
"8bc6c6fcc850e2e22afc5fdb52decaf5","vu-security","seed",NA,"2013-03-01",25000
"8bc6c6fcc850e2e22afc5fdb52decaf5","vu-security","seed",NA,"2013-04-28",10000
"bf679221b42e4252a8eed97487f8dd91","vuact",NA,NA,NA,NA
"214e0bfaad5407aa94a3c2e94c6b292d","vue",NA,NA,NA,NA
"bd8ba5b2dc1871d847707bdd1c47b1c7","vue-2",NA,NA,NA,NA
"5acb9bafa9a310f983c5ce25b1d0384f","vue-analytics",NA,NA,NA,NA
"c7733be0860ddee76a4b5409f8cec497","vulcan-technologies",NA,NA,NA,NA
"0ceecb763d2ddfd5c54995eb8ebf57bc","vulcano-security-gmbh",NA,NA,NA,NA
"0cc0cfff91b469bdaf2fe0f201283d48","vuma-pacific",NA,NA,NA,NA
"b751044a74cccdc0394d8c2dc7eeff76","vuru","seed",NA,"2015-04-29",1e+06
"7109737b5512fd1d125f597d88733a45","vusay","angel",NA,"2014-01-01",NA
"832132f497c125ee873a3555195c75f6","vuurr",NA,NA,NA,NA
"a9c6a664a5cf2ac1a4f657ba6bdc82a4","vwr-international",NA,NA,NA,NA
"fd52993510d33171d73981006ca4c42e","vyking","seed",NA,"2016-01-12",1088688.167
"bc38b38d801181c91b734ac5a81f56a4","vymo",NA,NA,NA,NA
"14fb42d1007bb393a75e95ddb9188e0a","vyome-biosciences","venture","B","2014-08-12",8e+06
"14fb42d1007bb393a75e95ddb9188e0a","vyome-biosciences","seed",NA,"2010-11-01",1e+06
"14fb42d1007bb393a75e95ddb9188e0a","vyome-biosciences","venture","A","2012-09-12",3300000
"4b9b213f34f0c0e416b641053746c957","vysibility",NA,NA,NA,NA
"105113ab67edb5acc56aaae28727bd2f","vyta",NA,NA,NA,NA
"134879b0757ed8f8f009a9f5c9f6d437","vyu-inc","seed",NA,"2014-10-08",825000
"65fec39a92eece76ca2a8d4ea055e18a","w2o-group",NA,NA,NA,NA
"d563af56e095ec5af856e9a35d3df83b","w2s-solutions-2",NA,NA,NA,NA
"7ff1d98e64d90f68dfb34a711881836d","w3counter",NA,NA,NA,NA
"237a7f6c6c55a23bdf7113be2d7692af","w3m-labs",NA,NA,NA,NA
"9045f3972967feac2e9da6fb75aeca07","w3techs",NA,NA,NA,NA
"8d8940017b79b52a347793dd9f333af4","waag-society",NA,NA,NA,NA
"6bce0db854c55866e1c16548c3ef240b","waddapp-com","angel",NA,"2012-01-01",453176
"60d6c3c081ecb478c2aee2bda27b770d","wade-wendy","seed",NA,"2015-10-28",1500000
"9bb7f9a09dba74ad9a5e6bedbd5a1913","wafergen-biosystems","venture","A","2009-09-15",6261250
"9bb7f9a09dba74ad9a5e6bedbd5a1913","wafergen-biosystems","venture","B","2010-02-24",5085500
"9bb7f9a09dba74ad9a5e6bedbd5a1913","wafergen-biosystems","private_equity",NA,"2012-06-01",30550000
"9bb7f9a09dba74ad9a5e6bedbd5a1913","wafergen-biosystems","private_equity",NA,"2013-08-27",1.5e+07
"1e15213a3754ca5723e794bdc9d77431","wakati","seed",NA,"2015-09-15",4e+05
"21c19a1262a1cb37a43a06484b2cb2e6","wakatime",NA,NA,NA,NA
"2b2788262b0d16a0fc228e3df2ada289","waldo-networks","venture","a","2010-08-11",878990
"2b2788262b0d16a0fc228e3df2ada289","waldo-networks","venture","a","2011-01-18",499999
"2b2788262b0d16a0fc228e3df2ada289","waldo-networks","venture","b","2012-11-26",1608416
"6556af80e7ed21db38b0005a621e37a7","walk",NA,NA,NA,NA
"086900c2b4403e627099309143b299e1","walkbase","venture","a","2013-11-12",3859800
"086900c2b4403e627099309143b299e1","walkbase","seed",NA,"2013-04-17",3e+05
"dc156485a3af684cbf1ce576d4d5a951","walker-assoicates-dba-dlevy-com",NA,NA,NA,NA
"a9743c2994a35857e532a9f76d81003b","walking-the-talk",NA,NA,NA,NA
"06ab7ee597228a1e0f020f2ddd0878b5","walkmore","seed",NA,"2013-07-01",NA
"78e69c73b456298d8c37b48256a76f16","wallpaperpimper-com",NA,NA,NA,NA
"3ff5746cf7688ec2ec7b69e95d516352","wallpoper",NA,NA,NA,NA
"673b51098f2f1641a8c7a7802df4f1ee","wallsensor",NA,NA,NA,NA
"577beaae007b20736a19cdd9068ad8e1","walvax-biotechnology","post_ipo_equity",NA,"2014-08-08",72800000
"1172d531ed21211b9f175a5ac8a3d44d","wammi",NA,NA,NA,NA
"bddab089f0a5502a99f41be1cd65cc4f","wannado","seed",NA,"2011-05-01",15000
"bddab089f0a5502a99f41be1cd65cc4f","wannado","angel",NA,"2012-01-01",450000
"bddab089f0a5502a99f41be1cd65cc4f","wannado","venture",NA,"2015-07-10",346670
"49829f7b2fe7dcd89f858e2d2a85c945","wanted-technologies","venture","a","2000-06-10",2036189
"49829f7b2fe7dcd89f858e2d2a85c945","wanted-technologies","post_ipo_equity",NA,"2005-10-06",2250000
"49829f7b2fe7dcd89f858e2d2a85c945","wanted-technologies","post_ipo_equity",NA,"2007-07-11",1217747
"49829f7b2fe7dcd89f858e2d2a85c945","wanted-technologies","angel",NA,"1999-01-01",4e+05
"49829f7b2fe7dcd89f858e2d2a85c945","wanted-technologies","secondary_market",NA,"2013-12-11",7718867
"49829f7b2fe7dcd89f858e2d2a85c945","wanted-technologies","secondary_market",NA,"2014-03-28",NA
"877831a10cac55d698379ce6f3f18d8d","wappalyzer",NA,NA,NA,NA
"03074845906ed19b3a009a0164b074a9","wappier",NA,NA,NA,NA
"733b18f23fd9e6b3b54bc31d2949a6f5","warlock",NA,NA,NA,NA
"ddd434525923e1021bf0dbcec0e5fb22","warmpicture-royalty-free-images",NA,NA,NA,NA
"2cc3a9324ec5db9c7700b30fd9fb4f57","warner-chilcott",NA,NA,NA,NA
"0160735333089fa78ff6cc0691d65003","warwick-analytics","seed",NA,"2013-03-01",4e+05
"9eb43b5eb9c7e1271357fe82d010dd8a","wasatch-microfluidics","venture",NA,"2012-01-25",2e+05
"9eb43b5eb9c7e1271357fe82d010dd8a","wasatch-microfluidics","venture",NA,"2014-01-03",482631
"9eb43b5eb9c7e1271357fe82d010dd8a","wasatch-microfluidics","venture",NA,"2014-07-01",2e+06
"154eccb151a88fdf89b92eac5da15569","washington-biotechnology-biomedical-association",NA,NA,NA,NA
"127125c31c89949bbff4d50101d84b80","washington-data-scraping",NA,NA,NA,NA
"6681e589b120a4a336e8642b58c854a7","washington-post-digital",NA,NA,NA,NA
"c4a3be92e53981ccfd07c34bac01be94","washington-technology",NA,NA,NA,NA
"2f02dea182b59d7fe9852f877d47104e","watchfrog","venture","a","2008-04-14",NA
"6d5500d7ce50a307a6f1a6e8479ad957","watchtower",NA,NA,NA,NA
"a4112a863b249ce3bec2c2963162caae","waterstone-pharmaceuticals","venture",NA,"2012-08-21",3392121
"a4112a863b249ce3bec2c2963162caae","waterstone-pharmaceuticals","debt_financing",NA,"2012-09-26",1.9e+07
"a5109ebe5afe54c73adb7cf2b7b7a5e9","watrhub","venture",NA,"2015-10-05",487445
"a5109ebe5afe54c73adb7cf2b7b7a5e9","watrhub","seed",NA,"2013-02-21",NA
"238d519d306c08278e34f220d6f1fb62","watsin","venture","A","1996-01-01",NA
"6eb4acbe9cc1f0e2a9200079fd5fed72","watson-pharmaceuticals",NA,NA,NA,NA
"1136d53b9bcbac7866ad0b2fc630561a","wattminder",NA,NA,NA,NA
"0933b77fd84803cb4ce1f553066fb5bc","watty",NA,NA,NA,NA
"ad2b2b17f60557907e60336fba0b8082","wave-life-sciences","post_ipo_equity",NA,"2015-12-14",3e+07
"ad2b2b17f60557907e60336fba0b8082","wave-life-sciences","venture","1","2015-02-02",1.8e+07
"ad2b2b17f60557907e60336fba0b8082","wave-life-sciences","venture","1","2015-08-18",6.6e+07
"e5a5d532329bc8d8eb9ac7eeb691031f","wavecatch","seed",NA,"2011-08-01",220000
"e5a5d532329bc8d8eb9ac7eeb691031f","wavecatch","angel",NA,"2012-04-01",3e+05
"a3546d2c8e7817cbc53c3c2f0f5f1ba6","wavefront","venture","A","2014-08-25",NA
"e245bc6af9991c220a50fdd048703918","wavestore",NA,NA,NA,NA
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","venture","B","2007-05-31",1.3e+07
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","venture","c","2009-02-01",20100000
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","venture",NA,"2014-03-06",2893286
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","debt_financing",NA,"2011-01-11",3500000
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","venture","d","2013-06-24",1.1e+07
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","venture","d","2011-05-12",15900000
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","debt_financing",NA,"2014-02-14",750000
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","debt_financing",NA,"2010-07-15",6e+06
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","debt_financing",NA,"2012-02-01",1500000
"3b050703816acdf51cc100f03a27b3ae","wavetec-vision","venture",NA,"2012-04-09",16500000
"8425a22b5bdd8026bb893b502d5ed25f","waypoint-building-group",NA,NA,NA,NA
"d0d0d4f161a93a9103e7594e367adc36","wayve","seed",NA,"2015-09-29",455452.909964551
"d5e931849d5be29d4e6a5dc4d0e84f12","wayway",NA,NA,NA,NA
"df7bc2cd7f1e7f0cf5f3ab65b37d753b","datanext","seed",NA,"2015-06-01",3e+05
"9306eff49a75854b506e20f1f014bd51","wealthengine","venture","B","2014-05-20",5100000
"9306eff49a75854b506e20f1f014bd51","wealthengine","venture",NA,"2011-01-04",2500000
"9306eff49a75854b506e20f1f014bd51","wealthengine","venture","a","2010-03-01",5e+06
"9306eff49a75854b506e20f1f014bd51","wealthengine","debt_financing",NA,"2012-12-31",1200001
"9306eff49a75854b506e20f1f014bd51","wealthengine","undisclosed",NA,"2012-04-27",NA
"72c2fa35771a63c514ca3258681129fd","wealthport",NA,NA,NA,NA
"5ed2a42b7e1537432dd26eb54d528769","wearable-experiments",NA,NA,NA,NA
"a17ab2874455c36993d7c892707d0f52","weather-analytics","venture","A","2015-10-02",12950815
"a17ab2874455c36993d7c892707d0f52","weather-analytics","convertible_note",NA,"2013-08-05",1750000
"a17ab2874455c36993d7c892707d0f52","weather-analytics","venture",NA,"2014-06-23",795000
"e20933a6626af23298b4cf77fdba374b","weather-unlocked",NA,NA,NA,NA
"048d3d9df84918ad68c7a224a4d50f0a","weatheralpha",NA,NA,NA,NA
"6c46fb3b2834427e4fc68c07a4e7a77c","weaverlabs","seed",NA,"2014-12-01",NA
"6c46fb3b2834427e4fc68c07a4e7a77c","weaverlabs","debt_financing",NA,"2015-01-13",1e+05
"af86bc888f8ce503bc64e848015c83c8","web-and-virtual-entities-consulting",NA,NA,NA,NA
"c47015a425914c845b1e53ebb78feb3a","web-control-room",NA,NA,NA,NA
"4f4f044707bec2a617fdfb497249129e","web-robots","seed",NA,"2015-09-01",280908.3452
"f90457e736afe5f1e99f285f88b860bd","web-scraping-ukraine-2",NA,NA,NA,NA
"fc2f21bfba90575433bbac92b4a7196c","web-seo-analytics",NA,NA,NA,NA
"bff5e1dc65832d1b242fbd7e74914bc1","web2asia",NA,NA,NA,NA
"58fe4ef0db87413858ca1c61e0e6088b","webbula",NA,NA,NA,NA
"1360a884fefb4a3425064fd183d42709","webclicktracker",NA,NA,NA,NA
"7f521e2a209a58779d65efe625c034bb","webcollage","venture","F","2008-03-24",1e+07
"7f521e2a209a58779d65efe625c034bb","webcollage","venture","e","2007-05-10",3590000
"7f521e2a209a58779d65efe625c034bb","webcollage","venture","G","2010-11-14",1035415
"7f521e2a209a58779d65efe625c034bb","webcollage","venture","G","2009-03-10",2008940
"7f521e2a209a58779d65efe625c034bb","webcollage","venture","G","2010-02-04",4008940
"398046b59e727831db70702868e51371","webcrunch-technology",NA,NA,NA,NA
"16b63d61716a960ca077f75b4309c284","webdataguru",NA,NA,NA,NA
"9bef1a168b635f4de24eb71a258f3365","webgility","debt_financing",NA,"2015-03-12",2500000
"f88a6abf3d29a5557e81932c5c5033e1","webinfinity","seed",NA,"2013-06-17",1500000
"26fa1aae2e4a3bdc9e1aa2c32cc8162c","webjets","seed",NA,"2014-10-13",135000
"c4ce11a4abee13ad8bffc7f6e9e00d6c","weblineindia",NA,NA,NA,NA
"533fc9ac1afe3688023749fdd1052eaa","weblyzard-technology-gmbh-2",NA,NA,NA,NA
"1423edefcb3b83fb26b84c02ad300885","webmap",NA,NA,NA,NA
"04978f4738d1815c7b1ac2777305776a","webmedx","undisclosed",NA,"1996-10-01",NA
"df6199a5164ee34b98a27f360f3ffa5c","webmuch-software",NA,NA,NA,NA
"02067d0e4a2d763a21c84745116d5b61","webnetix",NA,NA,NA,NA
"29b44048d0473c75dfa4b2cdaf9829cb","webpageanalyse",NA,NA,NA,NA
"411f13c4c6a069be67defd968805cb9a","webpromo",NA,NA,NA,NA
"13d000fba348e0ade9a0c3c04e545e73","webproof",NA,NA,NA,NA
"698fc83589380a2f6ca7a2be0e82d48f","webranking",NA,NA,NA,NA
"e9f70b5ed49491206bad32537f956936","webreep",NA,NA,NA,NA
"a4ef0528d00591431e39ef013bdad18b","webropol",NA,NA,NA,NA
"c5082bbf5fecfff61c158492cfe4e1c2","websand","seed",NA,"2014-01-01",264626
"c5082bbf5fecfff61c158492cfe4e1c2","websand","undisclosed",NA,"2013-09-01",42634
"6a8149cb9da20d2c21985d16f26205dd","websidestory","undisclosed",NA,"1999-06-18",NA
"30e30ce68ef438f0e1a81733c87ce4a9","website-optimization-llc",NA,NA,NA,NA
"2043e3791e684016268deca24331a074","website-scraping-services",NA,NA,NA,NA
"045ba3cbcb70ea4f45658ea1e5b0e902","websitebox",NA,NA,NA,NA
"c2135d5840c3446f0b1eeee039e86384","webstatshq",NA,NA,NA,NA
"29a754f6cbf07fb7f9c51b7f153c6991","webstop",NA,NA,NA,NA
"e26a483f9b45e603792c3442eea42daa","wedding-com-my","seed",NA,"2014-12-01",3e+05
"175ee897ef90bc34b4855963f71011f1","weesteer","seed",NA,"2015-04-04",5e+06
"91b88d8c7ee837c6e0abc9b49c5b387f","weetab","venture",NA,"2015-09-04",NA
"21185727a1fd87a56e962784b99d53f9","weft","seed",NA,"2014-03-05",1e+06
"21185727a1fd87a56e962784b99d53f9","weft","convertible_note",NA,"2015-07-17",1995000
"944249756a011d2cc8234ee14df66ef0","wegora",NA,NA,NA,NA
"bd28c8b5c007a34c58cc8ffd8f934f8e","weissbeerger","seed",NA,"2013-01-01",1e+06
"bd28c8b5c007a34c58cc8ffd8f934f8e","weissbeerger","angel",NA,"2011-10-01",2500000
"bd28c8b5c007a34c58cc8ffd8f934f8e","weissbeerger","venture","1","2015-06-01",4e+06
"963d1683410766b26cc31714ee150e68","weld-2",NA,NA,NA,NA
"7582d70108863b4b195ec93099e32496","welichem-biotech",NA,NA,NA,NA
"932fc578002ce3debfad0358a258c022","well-being-digital",NA,NA,NA,NA
"268cd278aff79c2136ce30f2e45fcce4","wellaware-systems","venture","a","2011-10-27",1310000
"268cd278aff79c2136ce30f2e45fcce4","wellaware-systems","venture",NA,"2012-10-16",2e+06
"268cd278aff79c2136ce30f2e45fcce4","wellaware-systems","venture","a","2009-12-08",7500000
"f06100e10ba1a8e65b93a59e9f76e532","wellcome-trust-sanger-institute",NA,NA,NA,NA
"755ffe4765bc459a93b9750e417d15e3","wellfire-interactive",NA,NA,NA,NA
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","debt_financing",NA,"2014-02-25",1e+06
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","venture","1","2011-04-20",6e+06
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","debt_financing",NA,"2013-11-14",1e+06
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","debt_financing",NA,"2013-10-24",1505000
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","debt_financing",NA,"2010-06-23",550000
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","debt_financing",NA,"2012-06-05",2e+06
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","debt_financing",NA,"2011-06-24",1770000
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","venture",NA,"2014-03-26",1.5e+07
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","venture","1","2012-12-28",1700000
"4b365f53d87e16fecbc2472b59b2ec4a","wellfount","debt_financing",NA,"2015-02-27",1500000
"148c4f5ddfd8a770bba8d10f9b14e281","wellgen","venture","c","2007-10-29",9500000
"148c4f5ddfd8a770bba8d10f9b14e281","wellgen","venture",NA,"2004-03-25",3e+06
"64ad9ad00bbc3fcf8f5314080d42823f","wellmetris","equity_crowdfunding",NA,"2014-05-19",NA
"2d628ba24bfa20c704a4d85dac61b8b8","wellpartner","venture","C","2007-03-27",7500000
"2d628ba24bfa20c704a4d85dac61b8b8","wellpartner","venture","D","2008-08-05",16100000
"2d628ba24bfa20c704a4d85dac61b8b8","wellpartner","venture",NA,"2005-01-12",1.4e+07
"2d628ba24bfa20c704a4d85dac61b8b8","wellpartner","venture",NA,"2012-02-13",3e+06
"70ea9276446e755fa3f4ada7aa4558d4","wellpepper","debt_financing",NA,"2014-03-26",176097
"c6d611cc7255b6fd7cf9d9c32b437d8b","wellspring-pharmaceutical",NA,NA,NA,NA
"4ab46f22713b291391c695bdacb0439b","wemark-digital","angel",NA,"2015-04-01",2e+05
"5748ea30052cf2ff4be6fd428ff510a1","wenjuan-com","venture","A","2013-07-01",1624255
"5748ea30052cf2ff4be6fd428ff510a1","wenjuan-com","venture",NA,"2015-01-29",5500000
"92b1ff4deb5fc0034aa290351d9ddd44","weogeo","debt_financing",NA,"2009-07-08",80000
"7599737ae2f94985e783af9700a41f61","weotta","undisclosed",NA,"2013-05-30",NA
"b9c88fd1005e30485144b09cb7729cff","wesawit",NA,NA,NA,NA
"0ad9f6b3f3b7a9c36a7b3aa88618f592","wesee",NA,NA,NA,NA
"1f4b8cccb7013ecc5244128f70e5c1ea","west-fraser-timber",NA,NA,NA,NA
"b62592fbc6becb6fb8fc7fed58a61b8c","west-interactive",NA,NA,NA,NA
"33d95d83f1e0308c9b124758fed47390","western-pca-clinics","seed",NA,"2011-12-08",225000
"4c35ddbff7178bd6d5bca5cbcd7bee7c","wesync-app",NA,NA,NA,NA
"58bb95836d1ff390c4cbd09c0cfd937a","wetrip",NA,NA,NA,NA
"94addc70cc9e39b60866a0dad85d8bc5","whatagraph",NA,NA,NA,NA
"59c524303c5b4057f49950d17caa0ec7","whatcounts",NA,NA,NA,NA
"f8191e67e57a6b6dedb9c3c0bf1a8f7c","whatman-hemasure-inc",NA,NA,NA,NA
"98930ccafc2b4bbc90222cc5b0d97d0d","whatsbusy",NA,NA,NA,NA
"b273a812a81be12d3c72b4f942269418","whatsnexx","venture","b","2013-06-27",2330000
"b273a812a81be12d3c72b4f942269418","whatsnexx","venture",NA,"2010-11-01",NA
"665666a635ea1f0025834da93a3ea326","whereadbouts",NA,NA,NA,NA
"53011330312298cd89d481a9143e55f4","whereoware",NA,NA,NA,NA
"2271f49ab98e39426f2832ecf4de0220","wherescape",NA,NA,NA,NA
"c6cf77d32609df11de679e072b589c74","whetlab",NA,NA,NA,NA
"50968a549cfea3a7c2aced9411b96804","whistler-technologies","seed",NA,"2015-01-01",30000
"50968a549cfea3a7c2aced9411b96804","whistler-technologies","seed",NA,"2015-05-01",350000
"428c2684248aa018771abf07038b062d","whistlestop","seed",NA,"2011-07-01",4e+05
"ccea5b8a0592964d28015e070e988c82","whit-li",NA,NA,NA,NA
"213d3bae22197114fa34afd3b15ccf3a","whitehead-institute-for-biomedical-research",NA,NA,NA,NA
"cb941a4784d39cdea7bd8c82ac03c027","whitepages-com","venture","a","2005-08-01",4.5e+07
"ca9b7514d0c69404d37880cfd9189090","whiztec-net",NA,NA,NA,NA
"0e998c1fb0920cb3f9aadab92c6f164f","inlogy","seed",NA,"2011-05-06",2e+06
"0e998c1fb0920cb3f9aadab92c6f164f","inlogy","convertible_note",NA,"2012-01-01",1800000
"4268b9dfd01c922998c62ca35917b25e","whoknows","seed",NA,"2015-08-01",NA
"4268b9dfd01c922998c62ca35917b25e","whoknows","venture",NA,"2013-11-14",4500000
"4268b9dfd01c922998c62ca35917b25e","whoknows","seed",NA,"2013-10-08",250000
"4268b9dfd01c922998c62ca35917b25e","whoknows","venture",NA,"2014-06-04",NA
"4b672741a43e0e66bd6f8af8ffc15ad2","whole-biome",NA,NA,NA,NA
"a0739207ce73e53628fa839393e1f00e","wholebrain",NA,NA,NA,NA
"06a470ac1f6f3c12189966763d0510ec","wholemeaning","seed",NA,"2014-12-10",5e+05
"06a470ac1f6f3c12189966763d0510ec","wholemeaning","seed",NA,"2013-04-01",3e+05
"054ab6de50a2cc9cc63887410b1af2a0","whos-amung-us",NA,NA,NA,NA
"5648ff9f8a3b73b2030ea597f5f6d5e8","whose-your-landlord",NA,NA,NA,NA
"799ba41a2957e22b327915e60a7c4224","wia",NA,NA,NA,NA
"0f9ead79fb4b8e2e08c11b59be24f5b3","wibi-works",NA,NA,NA,NA
"9b2127c1ee200f2fa9aa8d7240d76f69","wide-eyes-technologies",NA,NA,NA,NA
"d8cbbf6d49747c815873322049938b05","wide-out-workforces-inc",NA,NA,NA,NA
"88ea8ae842934143f69f7da3a21646cf","wideangle-metrics","seed",NA,"2010-02-01",1e+05
"283b5e584259e0c0f37adf2041ffa5cb","wieden-kennedy",NA,NA,NA,NA
"445fa1323cd3d51855edfecfd6df5d3a","wifi-runners","angel",NA,"2015-07-01",NA
"6646b8d0512ae9510f8acd47a151859e","wifigen",NA,NA,NA,NA
"38603af9b1d03d9345792d6ce1bb83ae","wikiaboutme",NA,NA,NA,NA
"839ca4ada4436556fed9af668b1a90d2","wikidata","grant",NA,"2013-07-17",2e+05
"626d95be313007fc517a56a7ce0885ea","wikidi-cz",NA,NA,NA,NA
"98f5e41eed25cde769be532874101dd6","wikido",NA,NA,NA,NA
"31ae34b1ce26eb532d833e83bfd1e524","wilex","venture",NA,"2010-03-23",27070000
"31ae34b1ce26eb532d833e83bfd1e524","wilex","undisclosed",NA,"1999-03-01",NA
"681b24bacfc28c1a72153ef147a0d71e","wilmington-pharmaceuticals","venture","b","2006-10-26",1300000
"012cfb856daca5c8703b440678161b73","wilmington-pharmatech",NA,NA,NA,NA
"50cdddbac1d3fc942f7d1e34920a6215","wilson-therapeutics","venture","b","2014-04-16",4e+07
"db4afcc7321571a21b74851ed1d39ee2","wimetrics",NA,NA,NA,NA
"b64d761481e7b811bccd512626bfb123","windmill-cardiovascular-systems","venture",NA,"2012-09-11",420000
"b64d761481e7b811bccd512626bfb123","windmill-cardiovascular-systems","venture",NA,"2011-08-08",5e+05
"dbc341b5b77b5eff6e48e2045b141cb1","windpole-ventures","venture","a","2010-01-01",1025000
"06491a3e399ec6afc7a28f8b363cfbb2","windsor-circle","venture",NA,"2011-04-27",350000
"06491a3e399ec6afc7a28f8b363cfbb2","windsor-circle","venture",NA,"2012-09-04",1100000
"06491a3e399ec6afc7a28f8b363cfbb2","windsor-circle","venture","1","2013-08-26",645000
"06491a3e399ec6afc7a28f8b363cfbb2","windsor-circle","venture","1","2013-11-14",950000
"06491a3e399ec6afc7a28f8b363cfbb2","windsor-circle","venture","1","2014-08-12",5250000
"06491a3e399ec6afc7a28f8b363cfbb2","windsor-circle","venture","1","2014-09-16",1e+06
"99a85a492a23425bac3e1ed309cb5345","windward-naval","venture","A","2013-11-07",5e+06
"99a85a492a23425bac3e1ed309cb5345","windward-naval","venture","B","2015-04-27",10800000
"c9769c5a6b39c69b9526c0a8f26cad52","windward-studios",NA,NA,NA,NA
"0ea5545453d199764f714bd6c32c1555","wine-kloud",NA,NA,NA,NA
"b750104ec23ce7f2b27c0ca021a073b3","winefetch",NA,NA,NA,NA
"7079bc409a8b545caacdfe31d31f8eb6","winny",NA,NA,NA,NA
"aa0a5874ab469886c22d8633241e2c9d","winston-pharmaceuticals","grant",NA,"2012-04-09",375000
"0980c5b5506c0a66de1405878087d9e6","winterwell",NA,NA,NA,NA
"2028f1d1dcbec5ac7b8514fd7a162e9d","wir3s","seed",NA,"2013-07-29",230627
"74cb735b62c37f878521f2cfe97e6e04","wired-buzz-media",NA,NA,NA,NA
"66bb5d5aff5f270e55356e36b06bf0c8","wiredelta",NA,NA,NA,NA
"8bb1b86aaf111208b58eed53ce9ff937","wiredminds-ag",NA,NA,NA,NA
"69d42dc67c0583c4e1b54583bba1a87c","wiredset",NA,NA,NA,NA
"87f310004f2361c23b2f871aba135533","wireimage",NA,NA,NA,NA
"4d2b16efcf90ebe0dceee347cd1f906e","wisdomforce-technologies",NA,NA,NA,NA
"ae77481995266a9a9418c481e78b96eb","wise-io","venture","a","2014-03-17",2586554
"ae77481995266a9a9418c481e78b96eb","wise-io","seed",NA,"2013-04-26",NA
"ae77481995266a9a9418c481e78b96eb","wise-io","seed",NA,"2012-11-01",28000
"f71d47f3193afb7c1d32fe4052b5710e","wisemuv",NA,NA,NA,NA
"c509b3cf75173c7fc37cdfc5fce4eb1e","wisertogether","seed",NA,"2011-06-30",1703774
"c509b3cf75173c7fc37cdfc5fce4eb1e","wisertogether","venture","1","2011-10-17",3e+06
"c509b3cf75173c7fc37cdfc5fce4eb1e","wisertogether","venture",NA,"2013-05-04",5e+06
"c509b3cf75173c7fc37cdfc5fce4eb1e","wisertogether","venture",NA,"2013-08-01",750001
"c509b3cf75173c7fc37cdfc5fce4eb1e","wisertogether","undisclosed",NA,"2014-01-15",NA
"c509b3cf75173c7fc37cdfc5fce4eb1e","wisertogether","venture","1","2014-09-24",9e+06
"8bc3aa14cfbf67cdc0956b08d9b6b038","wise-window","venture",NA,"2008-12-01",NA
"a7cf93a377a8e1152568e70fb17643e3","wishery","seed",NA,"2011-10-19",NA
"1bb357f9f282b2861a6050c0ccd8c080","wishplz",NA,NA,NA,NA
"91796f47022bc3f19795eb05e9b459d9","wishpond",NA,NA,NA,NA
"70f3c06c87c9c1ad9879d682da29891d","wisp",NA,NA,NA,NA
"8e4c52d38962e48ab32adeba61fed8e0","wissome",NA,NA,NA,NA
"4d810b2b663e646ee07efef2e2f94eed","wistar-institute","grant",NA,"2015-03-13",1100000
"5911e8c3ec020605e099c0e2769dc8d3","witbe",NA,NA,NA,NA
"fbd147e5d4ed5c87e9f97c9f33ba6e3e","witget","angel",NA,"2013-07-15",1e+05
"d2a0da2896cd0571cc91dc0c2765d842","witvox",NA,NA,NA,NA
"cfa3df2244149a33513ab32d7ba93e9a","wivlabs","angel",NA,"2013-09-09",1e+06
"ef6063c3530c0e5c27aa1e8611fa554d","wizdee","seed",NA,"2014-05-12",1045607
"44ce707481e64966dadd0d964c39b9bb","wizeline","seed",NA,"2013-11-27",1700000
"44ce707481e64966dadd0d964c39b9bb","wizeline","venture","1","2014-06-01",6735583
"572ab647c5228f990172b2604d427fdd","wizhunt-locals-inc","venture","A","2015-10-24",0
"572ab647c5228f990172b2604d427fdd","wizhunt-locals-inc","seed",NA,"2013-02-01",60000
"db4fa486bba0c435bc82a352481b27b6","wmc-global",NA,NA,NA,NA
"cab67a8d0207357377f46851d5885810","wockhardt",NA,NA,NA,NA
"3663fd99690077fa04f3ff1e076b4d36","wogic",NA,NA,NA,NA
"c6ea108781774e32b29dd09584c2a383","wolters-kluwer-law-business",NA,NA,NA,NA
"d87b73948b18141334bd2c082ba58724","womply","venture",NA,"2014-01-01",NA
"d87b73948b18141334bd2c082ba58724","womply","venture",NA,"2014-08-01",NA
"d87b73948b18141334bd2c082ba58724","womply","seed",NA,"2011-05-01",NA
"effed3967d467bb213ce3378b1281abf","wonderflow","seed",NA,"2014-04-01",20658
"430c96460e1fa9b24e64bcd0953eae05","wondergraphs",NA,NA,NA,NA
"18fe8d5c719c26650ea2208ce7b6d811","wondernet",NA,NA,NA,NA
"7b06824a4e01966aa2248946e37649bd","wonka-lab",NA,NA,NA,NA
"3cb21460b0adbcea6344660dd8ce78a5","woodward-asset-capital",NA,NA,NA,NA
"b383fabdd7f2b34f7c19f8fb8564baf5","woopra","undisclosed",NA,"2012-01-01",NA
"ca44f4e0e5732d3e461486b896279dca","wooqer",NA,NA,NA,NA
"5c280151ac615f629e5d2a9785395d92","woorank",NA,NA,NA,NA
"825288b123c59e2c6d0e754e5e3526cd","wopsy",NA,NA,NA,NA
"4594d739d90f7538a8f58bbb33c1d21e","wordiz-it",NA,NA,NA,NA
"5d55ebc9fc79dbc4fcfbf609177a4473","workato",NA,NA,NA,NA
"47875dc4634688c9b3c472680090513a","workday-ventures",NA,NA,NA,NA
"ff010545255ac1282fcc2eda4909bb0a","workdigital",NA,NA,NA,NA
"15fa249c267fc4d1bf51db2c2af2fe92","workfuze",NA,NA,NA,NA
"ac10a7c33b58633500d4abcda3b88892","working-social",NA,NA,NA,NA
"d7fb2157ed45fc673491055aa558c780","worksure-medpharma-consultancy-india-pvt-ltd",NA,NA,NA,NA
"4ee7a8c591b2efc99856d07121c337f6","workup",NA,NA,NA,NA
"c0fe50b55f3524adfb8015a9c7686ca4","workzeit",NA,NA,NA,NA
"6702e55d1a171ebadeadd66942c20c13","world-biotechnology",NA,NA,NA,NA
"9bfada46cbfb4cfa4cae6da1754b2546","world-reviewer","seed",NA,"2007-01-01",NA
"8ab901c0c93de15c1caf2f5074b169b7","worldlogger",NA,NA,NA,NA
"7dd79f36349f966adf1e0e71925e5a1c","worldwide-biotech-pharmaceutical",NA,NA,NA,NA
"f2e2e7278dcdb9c73941d0d36f7e3873","worldwinger","seed",NA,"2014-08-31",25000
"f2e2e7278dcdb9c73941d0d36f7e3873","worldwinger","seed",NA,"2014-01-30",18000
"788d11f297c101895ebd614c144f9fea","wovenware",NA,NA,NA,NA
"e202b0a50c98c689984bd63e58a3ea72","wp-rocket-holdings","venture","a","2011-08-30",25480000
"5a15a6d7822c080b3239c8f7e6bdcff0","wp-stream",NA,NA,NA,NA
"4dfacace5e5a01aaba8cc276c9c834dc","wp-creo",NA,NA,NA,NA
"b0778dd6d722796229d17864adfa9639","wrangler",NA,NA,NA,NA
"3519bdb8e3a9ee37070e2949a8669dc7","write-or-read",NA,NA,NA,NA
"0d683b3421f12cd293e683a143d54a8f","writepath","seed",NA,"2014-06-03",525000
"1dcee8c31d1af2c8ddb737efabf28fd5","writers-per-hour",NA,NA,NA,NA
"4a08a38b8d9cdc1621061b0cca59eeda","wrnch","seed",NA,"2014-05-01",454545
"c7b5876282168a4f8abfcd3cd56aa791","wsi-connect",NA,NA,NA,NA
"2cf61fd7e51d755987c9f9d0ebef9916","wunderdata","angel",NA,"2014-01-07",NA
"e0473eba5d8ceb959d91289cf51b7bea","wututu","venture","b","2009-10-01",NA
"8eeb1b1bcc2c6e433a09e8cd1ddbaef8","wuxi-apptec","venture",NA,"2005-02-01",1.1e+07
"8eeb1b1bcc2c6e433a09e8cd1ddbaef8","wuxi-apptec","venture","1","2008-07-01",6.3e+07
"8eeb1b1bcc2c6e433a09e8cd1ddbaef8","wuxi-apptec","venture","1","2007-02-01",17270000
"8eeb1b1bcc2c6e433a09e8cd1ddbaef8","wuxi-apptec","venture","1","2006-10-01",NA
"8eeb1b1bcc2c6e433a09e8cd1ddbaef8","wuxi-apptec","venture","1","2005-07-01",2200000
"a94a211afed0a58924ab110e873180fd","wuxi-pharmatech-cayman",NA,NA,NA,NA
"0f5d02bc0f1ee4e080d33124953783ea","wyeth-pharmaceuticals",NA,NA,NA,NA
"40e919a0639171165387ce7945e1901b","wyeth-research",NA,NA,NA,NA
"a042701521f301c9484b97f174b8753f","wylio","seed",NA,"2011-01-01",1000
"b4a656ea710845bf2f292aa30662633d","wyndow-inc",NA,NA,NA,NA
"5bfef0b232871cfe1b982d94813a2650","wynyard-group","post_ipo_equity",NA,"2015-06-10",28440601
"5bfef0b232871cfe1b982d94813a2650","wynyard-group","post_ipo_equity",NA,"2014-03-31",30434782
"db77d13d255572c6f9c9f86cf7a5cb75","x-body","venture",NA,"2012-01-23",4140000
"db77d13d255572c6f9c9f86cf7a5cb75","x-body","venture",NA,"2015-04-08",2662465
"b64fef92d10d22fd9c0150843de446bb","x-chem",NA,NA,NA,NA
"e8140bed94cd104f334f8047ace2a466","x-nav-technologies","venture",NA,"2014-10-20",7e+05
"71089925eddffa4fcf3756a8704c927c","x-ray-analytics",NA,NA,NA,NA
"47761f22054a8d8f5493219f55d73480","x13",NA,NA,NA,NA
"6323f3371dbf5811fc03453a5e0aeb23","xaandia",NA,NA,NA,NA
"689e7a3a7f22a59e704dfe8da8c9e505","xactly-corp","venture","f","2010-08-03",1.2e+07
"689e7a3a7f22a59e704dfe8da8c9e505","xactly-corp","venture","c","2007-04-23",1.5e+07
"689e7a3a7f22a59e704dfe8da8c9e505","xactly-corp","venture","d","2008-04-30",3e+07
"689e7a3a7f22a59e704dfe8da8c9e505","xactly-corp","venture",NA,"2012-10-01",1370000
"689e7a3a7f22a59e704dfe8da8c9e505","xactly-corp","venture","b","2006-03-24",8e+06
"689e7a3a7f22a59e704dfe8da8c9e505","xactly-corp","venture","e","2010-07-07",7500000
"689e7a3a7f22a59e704dfe8da8c9e505","xactly-corp","venture","F","2014-12-01",1.2e+07
"173c541177e81dbd03f8f0212b89797d","xagenic","venture","a","2012-01-30",1e+07
"173c541177e81dbd03f8f0212b89797d","xagenic","undisclosed",NA,"2011-02-07",NA
"173c541177e81dbd03f8f0212b89797d","xagenic","venture","B","2014-07-14",25500000
"173c541177e81dbd03f8f0212b89797d","xagenic","venture","B","2015-07-09",11798141.6616
"9680912a286c2900964430d23d59f646","xanadu",NA,NA,NA,NA
"212aeae8df26b76833d1b18c45998f65","xanodyne","venture","A","2007-07-27",2.5e+07
"212aeae8df26b76833d1b18c45998f65","xanodyne","venture","d","2009-10-30",87783861
"e9d39ea73c04364d71a8a81cfaa189b7","xb-global-corp",NA,NA,NA,NA
"8351d331a1186e50dd85131c9289b641","xbiotech",NA,NA,NA,NA
"cc92efaccd04d12446c55d661e15c2fd","xbrane-bioscience",NA,NA,NA,NA
"9b41e2b97af4d462e73e2fed9ab8f205","xbt-social",NA,NA,NA,NA
"777edd843152444fc57d4ca2fbe5de80","xceleron","venture","B","2006-12-05",3951996.4169
"777edd843152444fc57d4ca2fbe5de80","xceleron","venture",NA,"2012-02-06",2400000
"777edd843152444fc57d4ca2fbe5de80","xceleron","undisclosed",NA,"2010-01-20",NA
"777edd843152444fc57d4ca2fbe5de80","xceleron","venture",NA,"2005-05-25",3653122
"e66356a4b7189a29f58d9717ad466ae1","xcell-biosciences","seed",NA,"2014-10-15",120000
"4acc32054162904252c43955879fc7e8","xcellerex","venture","C","2007-10-12",3.1e+07
"f5069a698b155534686476d3b5c235b3","xcilo-llc",NA,NA,NA,NA
"954fcc5cf200591a1ac9396b3eea4bc4","lifelong-wellness","angel",NA,"2013-07-26",2e+05
"17853eafb7094c66e7e0ec8c37a27322","xdayta",NA,NA,NA,NA
"57141a501107da86dc5c26873d751ed1","xdynia","venture",NA,"2012-02-21",50000
"57141a501107da86dc5c26873d751ed1","xdynia","venture","1","2013-03-29",212500
"7892d9ac177f1454fa6416828c1db259","xeddi-llc","seed",NA,"2015-01-01",1250000
"4b582854014f2d80c75050d0124a5925","xellia-pharmaceuticals",NA,NA,NA,NA
"2dacd915ee649c962ccba870bc37c50f","xen",NA,NA,NA,NA
"046a5024a8dd808a925f13e9053bf716","xencor","venture","E","2007-10-25",1.5e+07
"046a5024a8dd808a925f13e9053bf716","xencor","debt_financing",NA,"2009-04-10",6e+06
"046a5024a8dd808a925f13e9053bf716","xencor","debt_financing",NA,"2010-12-27",7500000
"046a5024a8dd808a925f13e9053bf716","xencor","venture",NA,"2013-07-01",7597653
"fbfe539a370b319bcd2407cfb8a09593","xeneta","seed",NA,"2013-04-11",1574280
"fbfe539a370b319bcd2407cfb8a09593","xeneta","seed",NA,"2014-03-02",1640000
"fbfe539a370b319bcd2407cfb8a09593","xeneta","venture","1","2015-02-05",5300000
"1768b54189dbe1b6049e1c1878f32b79","xenetic-biosciences","venture",NA,"2014-01-31",1e+07
"df3033cf5d6fa0ad3e3dd7d75c6af671","xenex-disinfection-services","venture",NA,"2013-11-21",11300000
"df3033cf5d6fa0ad3e3dd7d75c6af671","xenex-disinfection-services","venture",NA,"2015-01-27",2.5e+07
"880537a7c6ac6dd0bfe93f7ee8b3301e","xenogen-biosciences",NA,NA,NA,NA
"7f6685dddba1ef1c278ab66ad4c49a93","xenome","venture",NA,"2008-07-24",6e+06
"7f6685dddba1ef1c278ab66ad4c49a93","xenome","venture",NA,"2007-11-27",1e+07
"7f6685dddba1ef1c278ab66ad4c49a93","xenome","venture",NA,"2005-04-06",2500000
"7f6685dddba1ef1c278ab66ad4c49a93","xenome","venture",NA,"2010-04-22",1e+07
"60a1bc23c0bf8319450caf0c091a516f","xenoport","venture",NA,"2012-11-21",2e+07
"60a1bc23c0bf8319450caf0c091a516f","xenoport","venture","1","2004-01-14",3.7e+07
"60a1bc23c0bf8319450caf0c091a516f","xenoport","venture","1","2004-12-07",NA
"60a1bc23c0bf8319450caf0c091a516f","xenoport","venture",NA,"2002-06-01",43900000
"7e87fc4ed3de085246caccac952376ff","xention","venture","d","2010-11-24",12700000
"6e83525ce31317daca229d7e45a79423","xeris-pharmaceuticals","venture","C","2016-01-07",4.1e+07
"6e83525ce31317daca229d7e45a79423","xeris-pharmaceuticals","debt_financing",NA,"2013-07-11",2300000
"6e83525ce31317daca229d7e45a79423","xeris-pharmaceuticals","venture","a","2011-12-12",1500000
"6e83525ce31317daca229d7e45a79423","xeris-pharmaceuticals","venture","B","2015-01-07",1.3e+07
"6e83525ce31317daca229d7e45a79423","xeris-pharmaceuticals","non_equity_assistance",NA,"2010-12-20",NA
"6e83525ce31317daca229d7e45a79423","xeris-pharmaceuticals","debt_financing",NA,"2015-01-07",4900000
"8610b0946af90334cb29bdbf4155e6eb","xeround","venture","B","2007-04-23",7e+06
"8610b0946af90334cb29bdbf4155e6eb","xeround","venture","b","2008-07-09",1.6e+07
"8610b0946af90334cb29bdbf4155e6eb","xeround","venture","a","2005-03-17",6500000
"8610b0946af90334cb29bdbf4155e6eb","xeround","debt_financing",NA,"2011-03-31",4e+06
"8610b0946af90334cb29bdbf4155e6eb","xeround","venture","c","2011-12-14",9300000
"8610b0946af90334cb29bdbf4155e6eb","xeround","venture","d","2012-10-15",4e+06
"d9f8bc5f98ae400fa3af618b32855349","xgraph","venture","a","2010-07-07",3750000
"4dfd66cece699f15b8a24036d42fd20d","xhale","venture","c","2014-01-15",15985452
"4dfd66cece699f15b8a24036d42fd20d","xhale","grant",NA,"2014-04-18",622000
"4dfd66cece699f15b8a24036d42fd20d","xhale","venture",NA,"2014-07-22",4552730
"bc41ac366e6a289c26b510e707e82cea","xian-jiaoda-bao-sai-bio-technology",NA,NA,NA,NA
"e218c066cc4950547af7ab16710bf31a","xigen","venture","a","2005-09-06",2.1e+07
"e218c066cc4950547af7ab16710bf31a","xigen","venture","b","2009-11-20",2e+07
"0c7b11ffc2801f46e0a2b11cd0f53ca0","xigo-nanotools","seed",NA,"2008-11-01",NA
"0c7b11ffc2801f46e0a2b11cd0f53ca0","xigo-nanotools","seed",NA,"2009-12-01",NA
"0c7b11ffc2801f46e0a2b11cd0f53ca0","xigo-nanotools","seed",NA,"2010-11-01",NA
"0c7b11ffc2801f46e0a2b11cd0f53ca0","xigo-nanotools","seed",NA,"2012-02-01",NA
"0c7b11ffc2801f46e0a2b11cd0f53ca0","xigo-nanotools","seed",NA,"2014-05-01",NA
"24e589a2b092e867467129fa8dfb7029","xtra-iq-inc","seed",NA,"2014-11-18",725000
"61e3b65c8ddeb45d1bd4ab54f5a087b8","xo1","venture","a","2013-06-17",1.1e+07
"f5e7f64232ea7cdc0efe9a5c5f712709","xockets","seed",NA,"2012-07-01",28000
"f5e7f64232ea7cdc0efe9a5c5f712709","xockets","seed",NA,"2015-08-12",5335323
"4540d1deb481f18ab3389cbe469bcb8c","xoma",NA,NA,NA,NA
"6f8fd15267e2f5fe9957b83344561b91","zowi-inc",NA,NA,NA,NA
"c4e509f89ddb6f24a5e84dba5cfff160","xpandforce",NA,NA,NA,NA
"ff6970be385468ee07bb3440fe0204e3","xperio-labs",NA,NA,NA,NA
"9ec253828dec1e478c7a1d2d3c104f9b","xphase-pharmaceuticals",NA,NA,NA,NA
"c54d4881b4a70e4331b8b3ec8f222c78","xplain-io",NA,NA,NA,NA
"2fa7b3e0849403e59e2c67bd4a477e85","xplenty","seed",NA,"2012-06-15",NA
"2fa7b3e0849403e59e2c67bd4a477e85","xplenty","venture","1","2014-10-20",3e+06
"8121d15bb8af56761c567e0857b774dd","xplore-mobility","debt_financing",NA,"2011-09-20",25000
"a65d6082091f2a29c70851f647d56078","xplr","seed",NA,"2012-08-01",150000
"f096a3c53cfb939112741695509f0254","xpolog",NA,NA,NA,NA
"8269d832bc2ac5362fe5cb4dfdd9cebf","xradia","venture",NA,"2007-01-16",4e+06
"8269d832bc2ac5362fe5cb4dfdd9cebf","xradia","venture","1","2007-03-08",7e+06
"34943ca5eab02d7506a4e5a6adaa981c","xresults-inc",NA,NA,NA,NA
"3b3174d25a5ac9c81ffcc5b85feabaa4","xrispi-labs-ltd","angel",NA,"2014-03-20",3e+05
"68aa887c85a43e4118c8cc1321d55497","xrpro","venture",NA,"2015-01-16",8855000
"7d01f1aebbae7ac62141c64a95d50da9","xsigo","undisclosed",NA,"2009-05-15",NA
"7d01f1aebbae7ac62141c64a95d50da9","xsigo","undisclosed",NA,"2011-01-01",NA
"70e6c9043ab60664a8f10272a3640d3e","xtendsys",NA,NA,NA,NA
"a0bb82c3d6fdb1b7e17d4a60e0b4f003","xtime","venture","C","2014-03-04",NA
"a0bb82c3d6fdb1b7e17d4a60e0b4f003","xtime","venture",NA,"2012-11-13",2.3e+07
"a0bb82c3d6fdb1b7e17d4a60e0b4f003","xtime","venture",NA,"2000-01-01",5400000
"47c99e0c76ed99d03df571533fb5a2a9","xtl-biopharmaceuticals-ltd",NA,NA,NA,NA
"c2487907f0e71dc9020c883da44bd504","xtreme-ux",NA,NA,NA,NA
"ff6054118ede543bc8addf25e70d1bc5","xtremepush",NA,NA,NA,NA
"b2e60d683a7b7aafc9958a4f94d6a8ef","xtremesignpost",NA,NA,NA,NA
"eef3d14c7ec99c9106180015121c9254","xtuple","venture",NA,"2015-06-19",2e+05
"73774410ee312d6a53bc165fe9704bc5","xubex",NA,NA,NA,NA
"dfbab1c4e962123a492f8ea0f955cc0d","hubei-xunda-pharmaceutical-co-ltd","venture","B","2011-08-01",652511
"dfbab1c4e962123a492f8ea0f955cc0d","hubei-xunda-pharmaceutical-co-ltd","venture","A","2008-06-01",1729106
"fadeec5781896c0cc7fa9945afbb4587","xylogenics","venture",NA,"2010-05-13",225000
"fadeec5781896c0cc7fa9945afbb4587","xylogenics","venture",NA,"2010-12-20",3e+05
"f49c32847fb19a6eef843a64f79179ea","xylos-corporation","venture",NA,"2010-05-20",1500000
"97c71840e2bff61276d2dd77f2f4dcaa","xytis","venture","b","2006-01-09",24500000
"69097e985ce5b00f9a1f30adfd1e310b","yaantu-ltd-",NA,NA,NA,NA
"25b9fc48e84898928ebec48a31e974ef","yaap",NA,NA,NA,NA
"2c6328688b3d75206c097a84763040a0","yactraq-online","seed",NA,"2012-10-01",516000
"5fbd71d20e2c925def32ee357ce364fa","yadata","seed",NA,"2006-04-01",3e+05
"5fbd71d20e2c925def32ee357ce364fa","yadata","venture","1","2007-02-01",4e+06
"bc42d4cb5a7bba5d01a6e0c09ec1e9c2","yandex","venture","a","2000-04-01",5300000
"f7d5673af709b3d4831dc4290ef17f5d","yaoota-com","venture","A","2015-10-01",2700000
"f7d5673af709b3d4831dc4290ef17f5d","yaoota-com","seed",NA,"2013-01-01",NA
"45bf47241e76f2f80b9f36a397bbfc1d","yap","angel",NA,"2007-01-19",1500000
"45bf47241e76f2f80b9f36a397bbfc1d","yap","venture",NA,"2010-10-07",2e+06
"45bf47241e76f2f80b9f36a397bbfc1d","yap","venture","1","2008-06-18",6500000
"45bf47241e76f2f80b9f36a397bbfc1d","yap","debt_financing",NA,"2010-10-07",2e+06
"39976e9d8a517b6ca9edbc8b99d4ff4e","yapjoy-inc-",NA,NA,NA,NA
"e2cfe4a0ebced9fac033fff5ab30e1d0","yarcdata",NA,NA,NA,NA
"aed98c8f7eb5d561f2eb6b88c1d6328a","yaro",NA,NA,NA,NA
"497bbbaae058f7f9ae56bd76f2167c14","yaupon-therapeutics","venture","B","2006-11-13",4e+06
"497bbbaae058f7f9ae56bd76f2167c14","yaupon-therapeutics","venture","C","2007-11-26",14500000
"497bbbaae058f7f9ae56bd76f2167c14","yaupon-therapeutics","debt_financing",NA,"2010-11-23",2e+06
"497bbbaae058f7f9ae56bd76f2167c14","yaupon-therapeutics","venture","d","2011-08-11",14400000
"497bbbaae058f7f9ae56bd76f2167c14","yaupon-therapeutics","venture",NA,"2009-08-13",3140000
"d3352a4e4fbf5b25993cfd2d732e0561","yay-images",NA,NA,NA,NA
"4ed3caa08b983f81e1b250668747222e","ycharts","seed",NA,"2010-03-19",1500000
"4ed3caa08b983f81e1b250668747222e","ycharts","venture","1","2011-11-18",3250000
"4ed3caa08b983f81e1b250668747222e","ycharts","venture","1","2013-05-09",3900000
"4ed3caa08b983f81e1b250668747222e","ycharts","venture","1","2015-05-18",6e+06
"8d8b2a4fdcb133ab1be21a0fb44e5a2d","ydigital-asia","seed",NA,"2014-08-01",5e+05
"865d10b28b07a2f49c2d693647e5aadf","yecuris","venture",NA,"2009-07-17",1250000
"b015f58c5ede0f47dc912625d5a9c68b","yeonmi-park",NA,NA,NA,NA
"c1b24a434eb182898579d3579907d3f6","yesgraph","seed",NA,"2013-05-22",1300000
"c1b24a434eb182898579d3579907d3f6","yesgraph","seed",NA,"2015-02-27",1e+06
"0541a73a58844aba3c79a2068f44a7d2","yet-analytics-inc-","seed",NA,"2015-11-18",1300000
"1017f8cf62e3710c15e1ff24e3156af6","yeti-data","seed",NA,"2013-06-01",1e+06
"4265947ee1108d3cbe6899dd69450055","yhat","seed",NA,"2013-10-01",1e+06
"4265947ee1108d3cbe6899dd69450055","yhat","seed",NA,"2015-01-01",120000
"4265947ee1108d3cbe6899dd69450055","yhat","seed",NA,"2015-05-30",1500000
"a520aaaf22140cda2fe65f0d914ae4d7","yidio","seed",NA,"2009-11-12",350000
"27845fe0c19733f85f9b896848f6a07b","yieldbot","venture","a","2013-07-01",5e+06
"27845fe0c19733f85f9b896848f6a07b","yieldbot","venture","a","2012-02-22",4200000
"27845fe0c19733f85f9b896848f6a07b","yieldbot","seed",NA,"2010-12-01",1200000
"27845fe0c19733f85f9b896848f6a07b","yieldbot","venture","B","2014-06-05",1.8e+07
"4dd50720616ae4ac50a55aa61a471c91","yieldify","venture","A","2015-06-25",11500000
"4dd50720616ae4ac50a55aa61a471c91","yieldify","seed",NA,"2014-01-01",NA
"a7cfb23c259291ed33def13d1233a5c5","yipitdata",NA,NA,NA,NA
"0909de647f1ac2b430f6a2790e4effeb","ylopo","seed",NA,"2014-06-04",NA
"691a54f4047736c6dc2ca77cc5bddd9e","ym-biosciences",NA,NA,NA,NA
"cd1c7dfddaf0bf4c3b7ac9a47a8561df","ynsect","venture","A","2014-02-25",2473037.0269
"cd1c7dfddaf0bf4c3b7ac9a47a8561df","ynsect","venture","B","2014-12-17",6836034.6028
"6f27d0570c8e8c726fc5c00ed307de05","yocter",NA,NA,NA,NA
"2d4cf453e07787dc9692b5af97efce28","yodil","venture","b","2012-04-29",NA
"7d4ac671ef1e452691aa153b3e340dd9","yodle","venture","b","2007-11-01",1.2e+07
"7d4ac671ef1e452691aa153b3e340dd9","yodle","venture","a","2006-11-01",3e+06
"7d4ac671ef1e452691aa153b3e340dd9","yodle","venture","c","2009-01-12",1e+07
"7d4ac671ef1e452691aa153b3e340dd9","yodle","venture","d","2010-02-01",10000002
"7d4ac671ef1e452691aa153b3e340dd9","yodle","venture","e","2013-02-27",5e+06
"3328f22b2305618527a4a1529220ad9c","yoi","seed",NA,"2013-06-01",1500000
"118c4c850efed2db76e019bd7cb0f60c","yones","seed",NA,"2013-11-01",125000
"6f404243f270ed1499d0ffb5a5ae7b4b","york-pharma",NA,NA,NA,NA
"86c276828cf1c470857fb47e59d6712a","yorn","seed",NA,"2015-05-06",1e+05
"a5ae0a40556d1e8bf3186b6084098247","yossarianlives",NA,NA,NA,NA
"edfb03bffd4c369a71281c5506add08b","yotta-technologies",NA,NA,NA,NA
"5fd120fca401828dc1f6551757f7bdc8","yotta-inc",NA,NA,NA,NA
"aab445aa8aeebf23822184ac6f8aa1ff","yottaasys",NA,NA,NA,NA
"b47249bbdc3f4384d5ee9f8eaf88e3f0","you-are-my-guide",NA,NA,NA,NA
"23200a4c1638469be36af3bc80d2c2ba","you-know-watt","seed",NA,"2013-03-14",18600
"23200a4c1638469be36af3bc80d2c2ba","you-know-watt","seed",NA,"2014-07-14",1450000
"ac6ac5b8aca9ab2d3ff0aba86ab9896f","youappi","seed",NA,"2012-07-02",1e+06
"ac6ac5b8aca9ab2d3ff0aba86ab9896f","youappi","seed",NA,"2013-06-05",1e+06
"ac6ac5b8aca9ab2d3ff0aba86ab9896f","youappi","venture","1","2014-10-22",3e+06
"d8efbe9d5d146c8dccf55675706ac627","youbl",NA,NA,NA,NA
"746b24668b3ddd746dd5d9d505e0db21","youcalc","seed",NA,"2003-06-01",440000
"746b24668b3ddd746dd5d9d505e0db21","youcalc","seed",NA,"2007-02-01",1200000
"746b24668b3ddd746dd5d9d505e0db21","youcalc","venture","1","2008-01-01",2200000
"a43ff1dd4405f66b9b7f95266ef87732","youeye","venture",NA,"2014-02-04",950000
"a43ff1dd4405f66b9b7f95266ef87732","youeye","angel",NA,"2013-05-07",3e+06
"a43ff1dd4405f66b9b7f95266ef87732","youeye","undisclosed",NA,"2011-05-01",3e+05
"a43ff1dd4405f66b9b7f95266ef87732","youeye","debt_financing",NA,"2014-12-08",1214000
"a43ff1dd4405f66b9b7f95266ef87732","youeye","venture",NA,"2015-03-19",3300000
"fab40142d8f526c9e3f471499c53db68","youfood",NA,NA,NA,NA
"3deec0e2dd2c088fecb074ce8b9cf29e","youneeq","seed",NA,"2011-08-09",180000
"0a8f3586e40c184f2d15654867fa1187","young-dental-sf",NA,NA,NA,NA
"7e65d3bc6687d9c53c1c4937d4b0d732","young-in-frontier",NA,NA,NA,NA
"c5bb39085ca1f7ed1596baf2a9aff5e8","your-maths-tutor",NA,NA,NA,NA
"93e2efe89c607502eb37a3a98ea4b14a","youredi",NA,NA,NA,NA
"3dbe5fc429bdb4f7747fefcd6c2983c1","youscan","seed",NA,"2010-04-17",54107.1863
"40396f11ad653b2b23afb196a5a1c468","youtrendit",NA,NA,NA,NA
"e74dba5e801b189b9809d90e522f8346","yoyodyne-entertainment",NA,NA,NA,NA
"e374720aa6ade5c5cb98f080ce9a8900","yoyometrics",NA,NA,NA,NA
"6714cea65082472ae1f1937ced113711","yporia",NA,NA,NA,NA
"57962d8b9acc851dac9303a3f9c24137","ysura",NA,NA,NA,NA
"3ae9b0a1b37987f548044586d68fdfba","yttro","seed",NA,"2014-10-13",NA
"59bf06f70238695493d3afbce92d95be","yummly","seed",NA,"2010-11-16",1850000
"59bf06f70238695493d3afbce92d95be","yummly","debt_financing",NA,"2012-01-09",5e+05
"59bf06f70238695493d3afbce92d95be","yummly","venture","1","2012-03-21",6e+06
"59bf06f70238695493d3afbce92d95be","yummly","debt_financing",NA,"2010-08-30",808698
"59bf06f70238695493d3afbce92d95be","yummly","venture","1","2015-09-01",1.5e+07
"f7cecf2fc82a177ee83d3dc5bdd8dcb7","yummy-food","seed",NA,"2013-03-11",10000
"0d19413aea9429a3c5844eebb1f7f925","yuvue-llc",NA,NA,NA,NA
"65d649e144dcb6f594f2bcdcac99dca4","zabecor-pharmaceuticals","venture",NA,"2009-04-01",50000
"014689168c37134139537b58ee83c762","zacharon-pharmaceuticals","venture",NA,"2010-06-24",5e+05
"014689168c37134139537b58ee83c762","zacharon-pharmaceuticals","convertible_note",NA,"2012-04-04",33000
"26b3b05360706ae212851db9d6bed08a","zafgen","debt_financing",NA,"2012-08-28",3e+06
"26b3b05360706ae212851db9d6bed08a","zafgen","venture","1","2010-03-29",2.8e+07
"26b3b05360706ae212851db9d6bed08a","zafgen","venture","1","2013-12-04",4.5e+07
"26b3b05360706ae212851db9d6bed08a","zafgen","venture","1","2012-12-04",2.1e+07
"26b3b05360706ae212851db9d6bed08a","zafgen","venture","1","2006-09-11",5180000
"26b3b05360706ae212851db9d6bed08a","zafgen","venture","1","2011-07-07",3.3e+07
"26b3b05360706ae212851db9d6bed08a","zafgen","debt_financing",NA,"2014-04-17",2e+07
"5fdc520852f471765b43db35c639bbee","zafu-com","venture","b","2007-08-10",4100000
"68f449922cbed7e6e9a8f238dd32d170","zakipoint","venture",NA,"2015-02-02",370000
"e712e81117f3729d55746a69f4b7a79c","zalicus","venture",NA,"2011-06-29",8500000
"2a41d009fc4295ad6eaaa22dd922a202","zaloni",NA,NA,NA,NA
"b043fdaeecf053cf3e1c867b10c77d0c","zane-benefits-inc","seed",NA,"2015-06-09",1500000
"0e5f54b6cea5b5b7ff0f2bcbe70abe37","zanran",NA,NA,NA,NA
"f30b266064a26eb31de14c18abcf781f","zap-com","seed",NA,"2015-10-15",NA
"f30b266064a26eb31de14c18abcf781f","zap-com","seed",NA,"2012-10-01",NA
"f30b266064a26eb31de14c18abcf781f","zap-com","venture",NA,"2014-06-06",850000
"29a6a485cb959809ff7f7c91c27611c7","zapaday",NA,NA,NA,NA
"f35ab68bcb697432cf57cffe42ff7064","zapier","seed",NA,"2012-10-31",1200000
"109994807e6bf3752daf1855167a8350","zauber","venture",NA,"2012-04-24",1e+06
"30d817d74c4deb947e08c692040a886c","zdrowegeny-pl","venture",NA,"2015-08-17",NA
"9883a6ef087b831d652f6dfd9bf237e6","zeakal","venture","a","2013-03-26",3800000
"587f3d14d3f393b08dc4e53321f8c154","zealand-pharma",NA,NA,NA,NA
"268b593429279cf7bdeb5d07fa02d76a","zealr","seed",NA,"2015-08-18",7500
"8295919661faf3243f55e44c58f89b5d","zebi","seed",NA,"2016-01-27",1e+06
"d7aefa02053d5757d1cea1d6f78389f1","zebra-biologics","venture",NA,"2015-12-02",3000060
"d7aefa02053d5757d1cea1d6f78389f1","zebra-biologics","venture",NA,"2013-11-08",9000170
"416a98b5342a9abae58ce46babb0d858","zeclinics",NA,NA,NA,NA
"b2df39c9b2e9a4d2439cbc6b10487306","zelos-therapeutics","seed",NA,"2011-08-17",2793488
"b2df39c9b2e9a4d2439cbc6b10487306","zelos-therapeutics","debt_financing",NA,"2010-05-21",922243
"b2df39c9b2e9a4d2439cbc6b10487306","zelos-therapeutics","debt_financing",NA,"2009-03-03",1500000
"ee07b06580d0d3402cff2b031ca42d73","zeltiq-aesthetics","venture","d","2010-06-03",2.5e+07
"ee07b06580d0d3402cff2b031ca42d73","zeltiq-aesthetics","venture","c","2008-07-22",25124200
"ee07b06580d0d3402cff2b031ca42d73","zeltiq-aesthetics","venture","b","2007-10-29",20300000
"aaacf662ffa43de69ff3485a14d6c6ea","zembu-labs-inc",NA,NA,NA,NA
"0dc02b404e6d8a253865920c7daafe89","zementis",NA,NA,NA,NA
"1e145ee29ab9cfa87153fc5e2664fc3b","zencast",NA,NA,NA,NA
"9d943c90bff8c8fb6bfa1b47e87b55b2","zencx",NA,NA,NA,NA
"8f68b9532f392dadf1b99a40457d11fe","zenda-technologies","seed",NA,"2008-01-01",3e+06
"efc7f7c846c693afb9c7ee966432ba9a","zeneca-agrochemicals",NA,NA,NA,NA
"c257e2ad0fffe13d95593fcdd25d4913","zenergy-works",NA,NA,NA,NA
"b9e926ff73a89ffac75d5609d578456d","zenith-epigenetics","private_equity",NA,"2014-03-14",8e+06
"b9e926ff73a89ffac75d5609d578456d","zenith-epigenetics","private_equity",NA,"2014-07-23",4600000
"b9e926ff73a89ffac75d5609d578456d","zenith-epigenetics","private_equity",NA,"2015-05-19",4e+06
"d6a8b5accff68d9997f07ec93ac2c9bf","zenreach","venture",NA,"2015-03-01",NA
"cdd9f4a47689148358bd648cfcecbf61","zent","venture",NA,"2013-05-17",25000
"8dac92ca4540663f94aa900f1ed18948","zenti","seed",NA,"2014-09-09",1500000
"3010eb0f5eb87e75f019125887688d00","zentila","angel",NA,"2011-01-01",1500000
"3010eb0f5eb87e75f019125887688d00","zentila","venture","1","2013-05-22",2100000
"3010eb0f5eb87e75f019125887688d00","zentila","debt_financing",NA,"2015-12-03",1360000
"2e19b724c862dd27ad8a9d6631936a2b","zentrick","seed",NA,"2012-01-01",388436
"2e19b724c862dd27ad8a9d6631936a2b","zentrick","venture","1","2013-12-22",3e+06
"436a142e0dd12d61255c9caeb7c7e558","valu-valu",NA,NA,NA,NA
"291907b8940cc08fd7a47c95b84a39da","zeo","debt_financing",NA,"2011-11-08",1e+06
"291907b8940cc08fd7a47c95b84a39da","zeo","debt_financing",NA,"2012-05-03",2e+06
"291907b8940cc08fd7a47c95b84a39da","zeo","venture","1","2011-01-06",12338500
"291907b8940cc08fd7a47c95b84a39da","zeo","debt_financing",NA,"2010-08-06",1e+06
"291907b8940cc08fd7a47c95b84a39da","zeo","debt_financing",NA,"2009-12-15",2500000
"291907b8940cc08fd7a47c95b84a39da","zeo","venture","1","2009-12-15",8300000
"d3ffd7c3ed774d7f7accccb25e3ddc6e","zeolife","equity_crowdfunding",NA,"2013-06-25",NA
"6e9ee56092c7657a185faedae767c87e","zeomatrix","venture",NA,"2010-04-20",40000
"6f2731bf77292328c4dd2a4db0f1b607","zephyr-47",NA,NA,NA,NA
"1e5472947fbfefd3e314872777bb6673","zephyr-health","venture","b","2014-01-08",1.5e+07
"1e5472947fbfefd3e314872777bb6673","zephyr-health","venture","a","2013-01-01",1e+06
"1e5472947fbfefd3e314872777bb6673","zephyr-health","venture","C","2015-08-19",17477051
"dfb2107e2ae0f80a02e66645505cc818","zephyr-technology","venture","b","2009-07-07",2e+06
"dfb2107e2ae0f80a02e66645505cc818","zephyr-technology","venture",NA,"2013-05-08",2440000
"dfb2107e2ae0f80a02e66645505cc818","zephyr-technology","venture","c","2012-05-16",8864965
"e79ae288502901fa2e13273cf08ef4fb","zephyrus-biosciences","seed",NA,"2014-09-10",1500000
"e79ae288502901fa2e13273cf08ef4fb","zephyrus-biosciences","grant",NA,"2014-09-10",360000
"713580bda330035908d74a81cb9be1c5","zeppelin","seed",NA,"2012-08-01",118000
"6107b11167efb5ce8a72fe3672990219","zepteon","venture",NA,"2015-04-16",210000
"b5decbd328cb15ba49deef3e89f41bf5","zergnet","venture","A","2014-11-05",3200000
"b5decbd328cb15ba49deef3e89f41bf5","zergnet","seed",NA,"2012-10-13",1e+06
"acd32ca622624dcc1964e365ee1015b9","zero-gravity-solutions","post_ipo_equity",NA,"2015-11-20",3e+06
"acd32ca622624dcc1964e365ee1015b9","zero-gravity-solutions","venture",NA,"2014-07-18",1700000
"ced5146ae3efc07d0f9943dace07b1c3","zeroblock",NA,NA,NA,NA
"1ffda2625dc8302293713d0107a3c349","zerocrime",NA,NA,NA,NA
"8981241b2c6f7f7fb35b6ec853b534d7","zestfinance","venture","C","2013-07-31",2e+07
"8981241b2c6f7f7fb35b6ec853b534d7","zestfinance","debt_financing",NA,"2015-10-06",1.5e+08
"8981241b2c6f7f7fb35b6ec853b534d7","zestfinance","venture","a","2011-07-21",1.9e+07
"8981241b2c6f7f7fb35b6ec853b534d7","zestfinance","venture","B","2012-01-19",7.3e+07
"8981241b2c6f7f7fb35b6ec853b534d7","zestfinance","venture","c","2013-07-31",2e+07
"82b58f875d31677bc533145213125ad6","zet-universe","seed",NA,"2012-04-15",2000
"82b58f875d31677bc533145213125ad6","zet-universe","seed",NA,"2013-08-14",NA
"82b58f875d31677bc533145213125ad6","zet-universe","seed",NA,"2010-10-01",10000
"5a74be1a3cb6574972778f1e0561e4d4","zetarx-biosciences","venture",NA,"2012-12-12",2e+06
"5a74be1a3cb6574972778f1e0561e4d4","zetarx-biosciences","venture",NA,"2010-12-22",750000
"22542f95fc4a903ab37ccdb6e171d11a","zetdata",NA,NA,NA,NA
"001e12da151c1caed8984df437b5d99d","zetroz","grant",NA,"2015-09-25",4e+05
"001e12da151c1caed8984df437b5d99d","zetroz","debt_financing",NA,"2011-06-23",1e+05
"001e12da151c1caed8984df437b5d99d","zetroz","venture","1","2013-04-21",2600000
"001e12da151c1caed8984df437b5d99d","zetroz","debt_financing",NA,"2010-05-14",205000
"001e12da151c1caed8984df437b5d99d","zetroz","venture","1","2013-06-10",1900000
"001e12da151c1caed8984df437b5d99d","zetroz","venture",NA,"2014-06-25",2019998
"001e12da151c1caed8984df437b5d99d","zetroz","grant",NA,"2014-09-19",625000
"001e12da151c1caed8984df437b5d99d","zetroz","debt_financing",NA,"2014-10-17",5e+06
"290164cea1cf6689b2cea3809e621b7e","zettamonk",NA,NA,NA,NA
"fb18ef69a41bea7cca1a879f560fd81b","zeuss","seed",NA,"2012-10-15",NA
"fb18ef69a41bea7cca1a879f560fd81b","zeuss","convertible_note",NA,"2013-08-19",7e+05
"6c73e134ae6f216348ed47124625fc47","nanjing-zhima-information-technology-co-ltd","seed",NA,"2013-12-15",164473
"416372b5c79d54696c6aea020a1b5560","ziarco","venture","a","2012-10-30",7601832
"416372b5c79d54696c6aea020a1b5560","ziarco","venture","B","2014-11-10",3.3e+07
"9ca6a7e302a254ee8a3ed1bcd064c221","ziegler-cat",NA,NA,NA,NA
"b1ea7f926c16a5f497dea01aa7fbe46f","zignal-labs","venture","C","2015-10-20",1.5e+07
"b1ea7f926c16a5f497dea01aa7fbe46f","zignal-labs","venture","A","2013-01-31",4200000
"b1ea7f926c16a5f497dea01aa7fbe46f","zignal-labs","venture","B","2014-10-23",10700000
"b1ea7f926c16a5f497dea01aa7fbe46f","zignal-labs","undisclosed",NA,"2012-01-08",NA
"a555acf1529ebf125dc416dc3dcf101e","zilico","venture",NA,"2012-06-21",1546558
"2496bb57ee07c70816b00113f3748207","ziligence",NA,NA,NA,NA
"87468f54b953e4fa1e8d83edc0079ead","zillabyte","seed",NA,"2012-04-20",NA
"87468f54b953e4fa1e8d83edc0079ead","zillabyte","seed",NA,"2013-06-05",1500000
"0681041bc8f5e8e1b70257c76587325d","zilpy",NA,NA,NA,NA
"bd9aa1b4cfd87371a3dca49491d72043","zimmerman-advertising",NA,NA,NA,NA
"7a2ac2c8f1c46a9f1735bb431aa270ba","zimstocks",NA,NA,NA,NA
"03f9d3ebfc59d3b5358eeb8d460e8d5f","zinc-ahead","private_equity",NA,"2013-06-21",NA
"e810cf534494e64d59f7e34e77c939f6","zineone",NA,NA,NA,NA
"6872a0033d3818863d92f6be11d3e3c1","zing-2","undisclosed",NA,"2013-07-01",NA
"81bcf14dd14d1c7a7c3c967b830ea6a3","zingbox","venture","A","2015-11-24",NA
"81bcf14dd14d1c7a7c3c967b830ea6a3","zingbox","seed",NA,"2014-12-12",1500000
"7fd57170c1c629275390950a83b93dbb","zinier","seed",NA,"2015-02-10",NA
"873e10d221fb6c03bd4a0759d3dad3a5","zinmobi","seed",NA,"2014-03-04",720496
"02c8cdc57b70a535823e63038d35ad68","zinobe",NA,NA,NA,NA
"39870894bdf7331344e259303db50a28","ziopharm-oncology","venture",NA,"2009-09-28",5059527
"39870894bdf7331344e259303db50a28","ziopharm-oncology","post_ipo_equity",NA,"2015-01-28",57500000
"c7ad14ffb2f884f71c8f09343d1da04c","ziqitza-health-care","venture","B","2010-03-26",4250000
"c7ad14ffb2f884f71c8f09343d1da04c","ziqitza-health-care","venture","A","2007-03-07",1500000
"ea4e654de7ddf6b4ed335b3ba22b844d","zirmed","venture",NA,"2010-12-10",NA
"ab5bf1eed0b887c3e830623084944109","zivo",NA,NA,NA,NA
"6b15ce9d55f7b44d8ef133579129257f","ziza","angel",NA,"2015-11-30",100606.1077
"57d22ea28e7f0d0e248daafeb6e505b8","tyrosine-pharmaceuticals","venture",NA,"2013-09-25",1e+05
"19f75631f0d94b16552aa3e5d4ae557b","zocom",NA,NA,NA,NA
"a121d12b69cd71ac6f5d3cbbb18d12bf","zodius-capital",NA,NA,NA,NA
"7c62218c8f860a77f757f5bc9816f119","zoetis",NA,NA,NA,NA
"79d58badca08cf0d36fb918f677647e9","zogenix","venture","B","2008-01-09",1.8e+07
"79d58badca08cf0d36fb918f677647e9","zogenix","venture","b","2009-10-05",35957968
"79d58badca08cf0d36fb918f677647e9","zogenix","venture","a","2006-08-28",6e+07
"79d58badca08cf0d36fb918f677647e9","zogenix","debt_financing",NA,"2009-05-29",3100000
"79d58badca08cf0d36fb918f677647e9","zogenix","venture",NA,"2010-07-13",1.5e+07
"79d58badca08cf0d36fb918f677647e9","zogenix","venture","b","2009-12-15",35004188
"c3f7c0e5df6737c5dc7b0a28127ae9fd","zoined-inc-",NA,NA,NA,NA
"b71b4cc9b8dd0e817f87a10004b3682a","zokem","venture",NA,"2010-06-08",2388400
"b60bd0afc2b3eae18f3bf66616a95739","zolar-technology-mfg-co-inc",NA,NA,NA,NA
"535da597189c875561739eaf5216e0a3","zoliro","seed",NA,"2014-11-13",NA
"535da597189c875561739eaf5216e0a3","zoliro","venture",NA,"2015-02-08",NA
"1fabce4ebc079cac55bfd8fb5621fa96","zomato","venture","E","2014-11-18",6e+07
"1fabce4ebc079cac55bfd8fb5621fa96","zomato","venture",NA,"2010-08-01",1e+06
"1fabce4ebc079cac55bfd8fb5621fa96","zomato","venture","a","2011-09-01",3500000
"1fabce4ebc079cac55bfd8fb5621fa96","zomato","venture","d","2013-11-06",3.7e+07
"1fabce4ebc079cac55bfd8fb5621fa96","zomato","venture","b","2012-09-01",2300000
"1fabce4ebc079cac55bfd8fb5621fa96","zomato","venture","c","2013-02-21",1e+07
"1fabce4ebc079cac55bfd8fb5621fa96","zomato","venture","F","2015-04-10",5e+07
"1fabce4ebc079cac55bfd8fb5621fa96","zomato","venture","G","2015-09-07",6e+07
"368fb6a12c7cfca30d3371293d9da7bd","zomobo-co",NA,NA,NA,NA
"91888cb48e96bcb0d4eb86e7ff6141ae","zoner-ag",NA,NA,NA,NA
"7341179df1c6373d2ff7a85ff89a2c09","zoomcharts","seed",NA,"2013-04-12",261918
"7341179df1c6373d2ff7a85ff89a2c09","zoomcharts","seed",NA,"2014-10-15",636710
"ab1e90636a2c6735777599631aec760b","zoomdata","venture","a","2013-07-10",4100000
"ab1e90636a2c6735777599631aec760b","zoomdata","seed",NA,"2012-11-13",1100000
"ab1e90636a2c6735777599631aec760b","zoomdata","venture","B","2014-10-06",1.7e+07
"6861db1bf4984936701b9aa4bc65809e","zoominfo","venture","a","2004-07-01",7e+06
"d4f84e4d07f177bc90ee5e48e47d947d","zoomph","seed",NA,"2012-01-01",5e+05
"d88d4334eb547f2c30165e26695ed372","zoomspring-seo",NA,NA,NA,NA
"58c3f164bc7c79173afacad090041d8f","zootool",NA,NA,NA,NA
"a5dc68bc3b2f2c68d9c7243ff3398584","zopaf",NA,NA,NA,NA
"4b13852e7eb4b6c516764ddd8b2791a2","zorilla-research-llc","seed",NA,"2014-06-01",NA
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","venture","a","2007-11-15",9e+07
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","debt_financing",NA,"2014-03-05",2500000
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","venture","b","2009-08-06",3e+07
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","debt_financing",NA,"2013-09-19",3030000
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","debt_financing",NA,"2011-09-23",4705630
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","venture",NA,"2010-08-18",3111261
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","venture","b","2010-03-30",9009000
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","debt_financing",NA,"2014-12-04",1333000
"52c946f5d5200c1c3f7cae7edaf8a93c","zosano-pharma","post_ipo_equity",NA,"2015-02-03",14999996
"aea4f51d11a9c3c4fc91728f6659323a","zotec-partners",NA,NA,NA,NA
"fdcd015b75e84c0c1228f560e268fea0","zs-genetics","debt_financing",NA,"2012-01-06",620000
"fdcd015b75e84c0c1228f560e268fea0","zs-genetics","venture","1","2014-04-09",1724963
"fdcd015b75e84c0c1228f560e268fea0","zs-genetics","venture",NA,"2014-05-16",1e+05
"fdcd015b75e84c0c1228f560e268fea0","zs-genetics","venture",NA,"2015-05-06",170000
"ffd3e2ecf76461354b419a861965223d","zs-pharma","venture","c","2012-10-23",4.6e+07
"ffd3e2ecf76461354b419a861965223d","zs-pharma","venture","d","2014-03-05",5.5e+07
"ffd3e2ecf76461354b419a861965223d","zs-pharma","venture",NA,"2010-12-20",792000
"ffd3e2ecf76461354b419a861965223d","zs-pharma","venture",NA,"2010-12-14",1195972
"ffd3e2ecf76461354b419a861965223d","zs-pharma","post_ipo_debt",NA,"2014-07-18",2e+07
"891040a308d6c0d23ad14ff0a032304e","zuman","venture","A","2015-05-11",4e+06
"233082b9172fb5aa97c4012dd674f3d4","zumatek","debt_financing",NA,"2010-11-23",150000
"5455a61ee111f905f74160b73e0705d2","zumetrics",NA,NA,NA,NA
"c1fe5c78396e836421dda101b02c6077","zumi-networks","seed",NA,"2013-10-01",5e+05
"b972d63a982cf507f952987b5a4e8957","zursh","seed",NA,"2014-05-01",25000
"6c6742492e58ad112ef02a3f44135ec2","zuum",NA,NA,NA,NA
"bca711ea3b78330370b46a6ee4bcb3b0","zwilio",NA,NA,NA,NA
"d8186989e4050d7f1b7a96e1b280b696","zyboorg-tech",NA,NA,NA,NA
"9ff0aab5ccba6992590f3d82ea0d736a","zymenex",NA,NA,NA,NA
"9b3e50ab73ddff5befc1296b8cc58a44","zymequest-inc",NA,NA,NA,NA
"8a1ec47d7d6f122cee1488ed8cb33df5","zymergen","seed",NA,"2014-01-01",NA
"8a1ec47d7d6f122cee1488ed8cb33df5","zymergen","venture","1","2015-06-16",4.4e+07
"10a0292f2d60b278dcd7ee43d7c309f2","zymetis","grant",NA,"2010-01-31",1500000
"10a0292f2d60b278dcd7ee43d7c309f2","zymetis","venture",NA,"2010-01-11",757464
"10a0292f2d60b278dcd7ee43d7c309f2","zymetis","undisclosed",NA,"2007-01-01",NA
"429f28b81f22277db27c144f214b1513","zymetx",NA,NA,NA,NA
"64bab0f9ccadea90c99c05e6490d0e05","zymeworks","venture","A","2016-01-08",61500000
"64bab0f9ccadea90c99c05e6490d0e05","zymeworks","venture",NA,"2014-01-09",1.5e+07
"64bab0f9ccadea90c99c05e6490d0e05","zymeworks","venture","d","2011-09-22",8100000
"64bab0f9ccadea90c99c05e6490d0e05","zymeworks","venture",NA,"2012-09-06",1.1e+07
"64bab0f9ccadea90c99c05e6490d0e05","zymeworks","venture","c","2009-06-26",3500000
"64bab0f9ccadea90c99c05e6490d0e05","zymeworks","angel",NA,"2008-03-03",1300000
"64bab0f9ccadea90c99c05e6490d0e05","zymeworks","venture",NA,"2015-01-13",23988700
"64bab0f9ccadea90c99c05e6490d0e05","zymeworks","venture",NA,"2015-02-27",1785700
"654344cdadfc84c488fd1a4be70f1269","ymiausifotografai-lt",NA,NA,NA,NA
"7d27303e8a46c487099778379239734c","zyngenia","venture","a","2010-09-09",2.5e+07
"edebcc5b42ae8d4beab07b49c55f4d8f","zynk-software-limited",NA,NA,NA,NA
"2504a3b0cba8f85e1ea3706be6f012f1","zyomyx-inc","venture",NA,"2010-01-29",555016
"2504a3b0cba8f85e1ea3706be6f012f1","zyomyx-inc","venture",NA,"2013-07-11",14219999
"2504a3b0cba8f85e1ea3706be6f012f1","zyomyx-inc","grant",NA,"2014-03-26",7500000
"2504a3b0cba8f85e1ea3706be6f012f1","zyomyx-inc","venture","1","2013-06-30",1.2e+07
"8ea5c08afa90c5e0c57b799e4082faca","zyraz-technology","venture","a","2009-10-09",7991547
"8ea5c08afa90c5e0c57b799e4082faca","zyraz-technology","angel",NA,"2008-01-01",2007363
"8ea5c08afa90c5e0c57b799e4082faca","zyraz-technology","grant",NA,"2009-09-11",5400000
"8ea5c08afa90c5e0c57b799e4082faca","zyraz-technology","private_equity",NA,"2013-02-15",20967
"40df34c80322cb027f24d60226150984","zytoprotec","venture","a","2013-01-29",2686600
"a93a5aedb4567f557cbb0aa4b22720d1","zzalpha",NA,NA,NA,NA
"f5f515f50b73e17f18ba9bf1fb2bf4b9","zzish","seed",NA,"2014-03-24",320000
"f5f515f50b73e17f18ba9bf1fb2bf4b9","zzish","angel",NA,"2014-10-31",4e+05
"f5f515f50b73e17f18ba9bf1fb2bf4b9","zzish","grant",NA,"2015-02-25",4e+05
"e12bc5eefb358f539427040317d4e187","enso","seed",NA,"2015-07-01",27838.4036
